<SEC-DOCUMENT>0000310764-25-000023.txt : 20250212
<SEC-HEADER>0000310764-25-000023.hdr.sgml : 20250212
<ACCEPTANCE-DATETIME>20250212114717
ACCESSION NUMBER:		0000310764-25-000023
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		141
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250212
DATE AS OF CHANGE:		20250212

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STRYKER CORP
		CENTRAL INDEX KEY:			0000310764
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				381239739
		STATE OF INCORPORATION:			MI
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13149
		FILM NUMBER:		25613381

	BUSINESS ADDRESS:	
		STREET 1:		1941 STRYKER WAY
		CITY:			PORTAGE
		STATE:			MI
		ZIP:			49002
		BUSINESS PHONE:		2693852600

	MAIL ADDRESS:	
		STREET 1:		1941 STRYKER WAY
		CITY:			PORTAGE
		STATE:			MI
		ZIP:			49002
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>syk-20241231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:66138c84-a1f4-4bd1-9e3f-a7dda17467bc,g:664b5418-33ef-4591-a7dd-ebf51b747252,d:1442ddc197954361b38cabd10df2e256-->
<html xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2024" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:syk="http://www.stryker.com/20241231" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>syk-20241231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-54">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-55">2024</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-56">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-57">0000310764</ix:nonNumeric><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" id="f-131">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" id="f-132">&#8212;</ix:nonFraction><ix:nonNumeric contextRef="c-45" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="f-409">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-47" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="f-411">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-49" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="f-414">P4Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="c-52" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-425">33.33</ix:nonFraction><ix:nonNumeric contextRef="c-14" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-816">http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-15" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-817">http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-14" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-820">http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-15" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-821">http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-15" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-824">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-14" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-825">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-14" name="us-gaap:SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration" id="f-856">http://fasb.org/us-gaap/2024#AccountsPayableTradeCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-15" name="us-gaap:SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration" id="f-857">http://fasb.org/us-gaap/2024#AccountsPayableTradeCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-14" name="us-gaap:SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration" id="f-858">http://fasb.org/us-gaap/2024#AccountsPayableTradeCurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="syk-20241231.xsd"/></ix:references><ix:resources><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>syk:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes2.125Due2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes3375Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes2.625Due2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes3.375Due2032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes3.625Due2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialInterventionalSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialInterventionalSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialInterventionalSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopedicsEnablingTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopedicsEnablingTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopedicsEnablingTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:CerusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:CerusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-02</xbrli:startDate><xbrli:endDate>2023-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:CerusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:CerusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">syk:CustomerAndDistributorRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:CerusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">syk:CustomerAndDistributorRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:CerusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:CerusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:CerusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-02</xbrli:startDate><xbrli:endDate>2023-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">syk:RecallMattersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">syk:RecallMattersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">syk:SpineReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">syk:SpinalImplantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">syk:OrthopaedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375DueMay152024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-01</xbrli:startDate><xbrli:endDate>2024-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375DueMay152024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.250Due2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4625Due2046Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.625Due2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:FloatingRateSeniorNotesDueNovember162024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-01</xbrli:startDate><xbrli:endDate>2024-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.250Due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-01</xbrli:startDate><xbrli:endDate>2024-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.250Due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375DueMay152024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375DueMay152024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:VariousMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:VariousMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.250Due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.250Due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.150Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.150Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.500Due2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.500Due2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.125DueNovember2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.125DueNovember2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.650Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.650Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.850Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.850Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3375Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3375Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.250Due2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.950Due2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.950Due2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.625Due2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-364"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.625Due2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-365"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-367"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375Due2032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375Due2032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.625DueSeptember112034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-370"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.625DueSeptember112034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.625Due2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-372"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.100Due2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.100Due2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.375due2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-375"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.375due2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-376"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4625Due2046Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.900due2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-378"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.900due2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-384"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">syk:AccruedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">syk:AccruedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-387"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-390"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-411"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-431"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-432"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-433"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-434"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-435"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-436"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-437"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-438"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-439"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-440"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-441"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-442"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-443"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-444"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-445"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-446"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-447"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-448"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-449"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-450"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-451"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-452"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-453"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-454"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-455"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-456"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-457"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-458"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-459"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-460"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-461"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-462"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-463"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-464"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-465"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-466"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-467"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-468"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-469"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-470"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-471"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-472"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-473"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-474"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">syk:LongLivedAssetsAndIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-475"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">syk:LongLivedAssetsAndIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-476"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">syk:LongLivedAssetsAndIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-477"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">syk:SpinalImplantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-478"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">syk:SpinalImplantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-479"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:InariMedicalInc.MergerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-480"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:InariMedicalInc.MergerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-481"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.550DueFebruary102027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-482"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.700DueFebruary102028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-483"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.850DueFebruary102030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-484"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes5.200DueFebruary282035Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-485"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-486"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-487"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-488"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-489"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-490"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-491"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i1442ddc197954361b38cabd10df2e256_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:540.00pt"><tr><td style="width:1.0pt"/><td style="width:49.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:486.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">December 31</ix:nonNumeric>, 2024</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><br/>OR<br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:540.00pt"><tr><td style="width:1.0pt"/><td style="width:49.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:486.25pt"/><td style="width:1.0pt"/></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="f-5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commission file number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-13149</ix:nonNumeric> </span></div><div style="text-align:center"><img src="syk-20241231_g1.jpg" alt="strykerlogoa72.jpg" style="height:53px;margin-bottom:5pt;vertical-align:text-bottom;width:201px"/><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">STRYKER CORP</ix:nonNumeric>ORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.194%"><tr><td style="width:1.0%"/><td style="width:15.093%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.093%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.095%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.457%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Michigan</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">38-1239739</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(State of incorporation)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">1941 Stryker Way,</ix:nonNumeric></span></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">Portage,</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-12">Michigan</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">49002</ix:nonNumeric></span></td></tr><tr><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">(269)</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">385-2600</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(Registrant&#8217;s telephone number, including area code)</span></td></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.873%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:Security12bTitle" id="f-16">Common Stock, $.10 Par Value</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:TradingSymbol" id="f-17">SYK</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:Security12bTitle" id="f-19">2.125% Notes due 2027</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:TradingSymbol" id="f-20">SYK27</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-21">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-4" name="dei:Security12bTitle" id="f-22">3.375% Notes due 2028</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-4" name="dei:TradingSymbol" id="f-23">SYK28</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-4" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-24">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-5" name="dei:Security12bTitle" id="f-25">0.750% Notes due 2029</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-5" name="dei:TradingSymbol" id="f-26">SYK29</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-5" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-27">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-6" name="dei:Security12bTitle" id="f-28">2.625% Notes due 2030</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-6" name="dei:TradingSymbol" id="f-29">SYK30</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-6" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-30">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-7" name="dei:Security12bTitle" id="f-31">1.000% Notes due 2031</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-7" name="dei:TradingSymbol" id="f-32">SYK31</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-7" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-33">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-8" name="dei:Security12bTitle" id="f-34">3.375% Notes due 2032</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-8" name="dei:TradingSymbol" id="f-35">SYK32</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-8" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-36">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-9" name="dei:Security12bTitle" id="f-37">3.625% Notes due 2036</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-9" name="dei:TradingSymbol" id="f-38">SYK36</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-9" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-39">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Securities registered pursuant to Section&#160;12(g) of the Act: <ix:nonNumeric contextRef="c-1" name="dei:Security12gTitle" id="f-40">None</ix:nonNumeric> </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-41">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;       No</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#9744;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9744;              </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-42">No</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-43">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;      No</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#9744;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-44">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9746; &#160;&#160;&#160;&#160;      </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.228%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.997%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.435%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.092%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-45">Large accelerated filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-46">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Small reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="f-47">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="f-48">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.                                                                                                                                        </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-49">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).                                                                                                </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;&#160;&#160; Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-50">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">The aggregate market value of the voting stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="f-51">123,147,898,554</ix:nonFraction> at June&#160;30, 2024. There were <ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-52">381,579,123</ix:nonFraction> shares outstanding of the registrant&#8217;s common stock, $0.10 par value, on January&#160;31, 2025.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-53" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Portions of the proxy statement to be filed with the U.S. Securities and Exchange Commission relating to the 2025 Annual Meeting of Shareholders (the 2025 proxy statement) are incorporated by reference into Part III.</span></div></ix:nonNumeric><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i1442ddc197954361b38cabd10df2e256_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.929%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART I</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Business</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk Factors</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unresolved Staff Comments</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_19">12</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 1C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cybersecurity</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_22">12</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Properties</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_25">12</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Legal Proceedings</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_28">13</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mine Safety Disclosures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_31">13</a></span></div></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART II</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_37">13</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selected Financial Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_40">14</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_43">15</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quantitative and Qualitative Disclosures About Market Risk</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_76">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial Statements and Supplementary Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_79">25</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Report of Independent Registered Public Accounting Firm (PCAOB ID: <ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-58">42</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_79">25</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_82">26</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Comprehensive Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_88">26</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Balance Sheets</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_91">27</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Shareholders&#8217; Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_94">28</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Cash Flows</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_97">29</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes to Consolidated Financial Statements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_100">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_151">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item&#160;9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Controls and Procedures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_154">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item&#160;9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Information</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_157">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item&#160;9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Disclosure Regarding Foreign Jurisdictions That Prevent Inspections</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_160">45</a></span></div></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART III</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Directors, Executive Officers and Corporate Governance</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_166">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Compensation</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_169">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_172">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certain Relationships and Related Transactions, and Director Independence</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_175">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal Accountant Fees and Services</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_178">46</a></span></div></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART IV</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibits, Financial Statement Schedules</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_184">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form 10-K Summary</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_190">50</a></span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i1442ddc197954361b38cabd10df2e256_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div id="i1442ddc197954361b38cabd10df2e256_13"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:261.00pt"><tr><td style="width:1.0pt"/><td style="width:58.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:198.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 1.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BUSINESS.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker Corporation (Stryker or the Company) is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our core values guide our behaviors and actions and are fundamental to how we execute our mission.</span></div><div style="margin-bottom:6pt;text-align:center"><img src="syk-20241231_g2.jpg" alt="missionvaluesa10.jpg" style="height:186px;margin-bottom:5pt;vertical-align:text-bottom;width:348px"/></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker was incorporated in Michigan in 1946 as the successor company to a business founded in 1941 by Dr. Homer H. Stryker, a prominent orthopaedic surgeon and inventor of several medical products. Our products are sold in approximately 75 countries through company-owned subsidiaries and branches as well as third-party dealers and distributors, and include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and artificial intelligence-assisted virtual care platform technology; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties. Most of our products are marketed directly to doctors, hospitals and other healthcare facilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As used herein, and except where the context otherwise requires, "Stryker," "we," "us," and "our" refer to Stryker Corporation and its consolidated subsidiaries.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Business Segments and Geographic Information</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We segregate our operations into two reportable business segments: (i) MedSurg and Neurotechnology and (ii) Orthopaedics. Financial information regarding our reportable business segments and certain geographic information is included under "Consolidated Results of Operations" in Item 7 of this report and Note 14 to our Consolidated Financial Statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">In the fourth quarter 2024 we reorganized our Spine business to align with certain updates to our internal reporting structure. The spine enabling technologies portfolio (Enabling Technologies) was reclassified to Other Orthopaedics and Spine, the Interventional Spine (IVS) portfolio was reclassified to Neuro Cranial and the remaining Spine business was renamed to Spinal Implants. In addition, we changed the name of our &#8220;Orthopaedics and Spine&#8221; operating segment to &#8220;Orthopaedics.&#8221;   </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:30.312%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.804%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Quarterly Net Sales - Enabling Technologies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mar 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Jun 30</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sep 30</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dec 31</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">152</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">149</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">131</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:30.312%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.804%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Quarterly Net Sales - IVS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mar 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Jun 30</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sep 30</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dec 31</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">413</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">327</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">282</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:30.312%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.804%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Quarterly Net Sales - Spinal Implants</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mar 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Jun 30</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sep 30</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dec 31</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">707</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">713</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">733</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:30.312%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.415%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Net Sales by Reportable Segment</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,595</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,498</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">MedSurg and Neurotechnology</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Our neurotechnology offering includes products used for minimally invasive endovascular procedures; a comprehensive line of products for traditional brain and open skull based surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products (Neuro Cranial); and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke (Neurovascular). The craniomaxillofacial implant offering includes cranial, maxillofacial and chest wall devices as well as dural substitutes and sealants. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are one of five leading global competitors in Instruments; the other four being Zimmer Biomet Holdings, Inc. (Zimmer), Medtronic plc (Medtronic), Johnson &amp; Johnson MedTech (a subsidiary of Johnson &amp; Johnson) and ConMed Linvatec, Inc. (a subsidiary of CONMED Corporation). We are one of seven leading global competitors in Endoscopy; the other six being Karl Storz GmbH &amp; Co., Olympus Optical Co. Ltd., Smith &amp; Nephew plc (Smith &amp; Nephew), ConMed Linvatec, Arthrex, Inc. and STERIS plc. We are one of five leading global competitors in Medical; the other four being Baxter International Inc., Zoll Medical Corporation, Medline Industries and Ferno-Washington, Inc. We are one of five leading global competitors in Neurotechnology; the other four being Medtronic, Johnson &amp; Johnson Medtech, Terumo Corporation and Penumbra, Inc.    </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:30.312%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.415%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Composition of MedSurg and Neurotechnology Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,834&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,518</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,163</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,893</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2024 Instruments launched SurgiCount+ powered by Triton, which combines our existing sponge counting technology with artificial intelligence and quantifying blood loss software.  We also launched CoPilot, which combines with our Spine Q guidance system to help surgeons plan and perform certain spinal procedures, including supporting bone resection, pedicle preparation and screw delivery.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition we completed the acquisition of Vertos Medical, Inc., a leader in interventional pain management solutions for chronic lower back pain caused by lumbar spinal stenosis. The acquisition of Vertos is complementary to our Interventional Spine business as we continue to focus on advanced pain procedures.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Endoscopy continued to deliver its 4K 1788 Camera platform to the market. Our 1788 Camera platform features several enhancements for a broader range of clinical applications and specialties, including urology, neurology and ear, nose and throat and can be used to visualize indocyanine green and Cytalux.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Medical launched the LIFEPAK 35 monitor/defibrillator, our next generation platform designed to optimize care with new clinical features such as the new Glasgow 30.4 algorithm, cprINSIGHT, 15-lead monitoring capabilities, and STJ insight and mapping. LIFEPAK 35 combines a modern intuitive touch screen display and increased processing power with Bluetooth and WiFi data connectivity.  </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Medical also completed the acquisition of care.ai, a virtual care and ambient intelligence solutions platform. care.ai adds complementary technology that is expected to integrate seamlessly with the Vocera platform (Vocera) and Stryker&#8217;s devices, providing customers with an enterprise-wide ecosystem that is intended to deliver dynamic clinical workflows and further the development of smart care facilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Neurovascular initiated a targeted launch of the Surpass Elite Flow Diverting Stent (FDS) in the U.S. and South Korea. Surpass Elite FDS is designed to reduce thrombin generation when compared to unmodified stents. Additionally, Neurovascular launched Surpass Evolve FDS in Japan. The Stryker FDS platform is designed to effectively treat aneurysms by redirecting blood flow away from the aneurysm to promote healing. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Orthopaedics</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. We bring patients and physicians advanced implant designs and specialized instrumentation that make orthopaedic surgery and recovery simpler, faster and more effective. We support surgeons with the technologies, products and services they need to support each patient&#8217;s clinical challenge. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are one of four leading global competitors for joint replacement and trauma and extremities products and robotics; the other three being Zimmer, Johnson &amp; Johnson MedTech and Smith &amp; Nephew.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:30.312%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.415%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Composition of Orthopaedics Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,447&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spinal Implants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,077</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,335</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,556</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2024 we continued the full commercial launch of our Triathlon Hinge revision knee system. Triathlon Hinge received approval in August of 2023 and is now released in the U.S., Ca</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">nada and New Zealand. We also continued delivering growth in total hip arthroplasty, particularly in the primary segment where Direct Anterior Reconstructive Technology and Mako Total Hip can help to reduce, if not eliminate, a surgeon's use of intraoperative fluoroscopy during direct anterior hip procedures. With the acquisition of SERF SAS, we strengthened distribution in key European markets and continue to scale differentiated solutions such as the Novae monolithic dual mobility cup engineered to deliver greater hip stability and reduce dislocation risk.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continued to expand our global footprint of Mako SmartRobotics&#8482; in 2024 which is now sold in more than 45 countries. To date more than one million robotic Mako Total Knees and 1.5 million robotic procedures across Total Hips, Total Knees and Partial Knees have been performed globally. Stryker&#8217;s Joint Replacement division also launched the &#8220;Scan. Plan. Mako Can.&#8221; direct to patient campaign, accelerating awareness of Mako technology in the U.S.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our spine enabling technologies portfolio includes best in class imaging solutions, image-guided surgical technology, patient specific implants and digital health solutions supporting surgeons and their patients throughout the continuum of care. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In December 2024 we performed our first Mako Shoulder procedure using robotic-arm assistance to remove bone, prepare the glenoid surface and enable positioning and placement of the Perform Reversed Glenoid implant. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2024 Trauma launched Pangea, a comprehensive variable angle plating portfolio designed to optimize plate fit to bone utilizing simple, intuitive instrumentation that enhances ease of use and reproducibility.  These combined solutions empower Stryker to deliver a complete portfolio across all trauma segments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Raw Materials and Inventory</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Raw materials essential to our business are generally readily available from multiple sources; however, certain of our raw materials are currently sourced from single suppliers. Substantially all products we manufacture are stocked in inventory, while certain MedSurg products are assembled to order.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Patents and Trademarks</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Patents and trademarks are significant to our business to the extent that a product or an attribute of a product represents a unique design or process. Patent protection of such products restricts competitors from duplicating these unique designs and features. We seek to obtain patent protection on our products whenever appropriate for protecting our competitive advantage. On December&#160;31, 2024 we owned approximately 5,600 United States patents and approximately 8,600 patents in other countries.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our business is generally not seasonal in nature; however, the number of orthopaedic implant surgeries is typically lower in the </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">summer months, and sales of capital equipment are generally higher in the fourth quarter.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In each of our product lines we compete with local and global companies. The development of innovative products is important to our success in all areas of our business. Competition in research involving the development and improvement of new and existing products and processes is particularly significant. The competitive environment requires substantial investments in continuing research and maintaining sales forces.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe our commitment to innovation, quality and service and our reputation differentiates us in the highly competitive product categories in which we operate and enables us to compete effectively. We believe that our competitive position in the future will depend to a large degree on our ability to develop new products and make improvements to existing products. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Regulation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our businesses are subject to varying degrees of governmental regulation in the countries in which we operate, and the general trend is toward increasingly stringent regulation. We are required to comply with the unique regulatory requirements of each country in which we market and sell our products.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the United States the Medical Device Amendments of 1976 to the Federal Food, Drug and Cosmetic Act and its subsequent amendments and the regulations issued and proposed thereunder provide for federal regulation by the United States Food and Drug Administration (FDA) of the design, manufacture and marketing of medical devices, including most of our products. In addition, state licensing requirements often apply to certain of our business operations and products. On the federal level, many of our new products fall into FDA classifications that require notification submitted as a 510(k) and review by the FDA before we begin marketing them. Certain of our products require extensive clinical testing, consisting of safety and efficacy studies, followed by pre-market approval applications for specific surgical indications. Certain of our products also fall under other FDA classifications, such as drugs and Human Cells, Tissues, and Cellular and Tissue-Based Products.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The FDA's Quality System regulations set forth standards for our product design and manufacturing processes, require the maintenance of certain records and provide for inspections of our facilities by the FDA. There are also certain requirements of state, local and foreign governments that must be complied with in the manufacture and marketing of our products.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The European Union enacted the European Union Medical Device Regulation in May 2017 with an original effective date of May 2022, which imposes stricter requirements for the marketing and sale of medical devices, including in the areas of clinical evaluation requirements, quality systems, labeling and post-market surveillance. Extended transition timelines were published in 2023 which range from May 2026 through December 2028 depending on the type of device and our implementation is on track to meet these timelines.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Initiatives to limit the growth of general healthcare expenses and hospital costs are ongoing in the markets we do business. These initiatives are sponsored by government agencies, legislative bodies and the private sector and include price regulation and competitive pricing. It is not possible to predict at this time the long-term impact of such cost containment measures on our future business. In addition, business practices in the healthcare industry are scrutinized, particularly in the United States, by federal and state government agencies. Any resulting </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">investigations and prosecutions potentially carry the risk of significant civil and criminal penalties.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Environment</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are subject to various rules and regulation in the United States and internationally related to the protection of human health and the environment. Our operations involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. We believe our policies, practices and procedures are properly designed to comply, in all material respects, with applicable environmental laws and regulations. We do not expect compliance with these requirements to have a material effect on purchases of property, plant and equipment, cash flows, net earnings or competitive position. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Employees </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2024 we had approximately 53,000 employees globally, with approximately 27,000 employees in the United States. Our talented employees are an integral reason for our standing as a global leader in medical technologies where, together with our customers, we are driven to make healthcare better. Our company values of integrity, accountability, people and performance are a key component of that mission. Our people, as one of our core values, continue to be a key focus.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our success depends on our ability to attract the best talent. To do so, we continue to focus on creating and maintaining a great workplace. We believe in attracting the right people, maintaining and building employee engagement and developing our employees. We believe when people are able to do what they do best, they will look forward to coming to work and, in turn, will deliver great business results.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our leadership team and Board of Directors receive regular updates on our people and culture strategy and provide feedback on our strategy and goals, including alignment to our mission and values, peer benchmarking and stakeholder feedback.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Employee Development</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our employee development is extensive and exists at all levels of the organization, including company-wide training on our Code of Conduct, job-related technical training and management and leadership training. Our development programs include on-the-job learning, coaching and mentoring, management and leadership development courses, team building and collaboration training and immersive experiences with expert partners. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We encourage all employees to establish development objectives, in partnership with their manager, to help employees gain the needed development experience to grow their careers. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Employee Engagement</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">An engaged workplace culture that drives performance and business outcomes is central to our mission. Listening to and learning from our employees forms the foundation of an engaging culture. More than 90% of our employees participate in our annual engagement survey, which provides a valued platform for listening and allows us to take action based on the feedback collected. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We supplement our annual engagement survey with targeted pulse surveys to gather feedback on topics relevant to the current climate.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also provide tools and resources that enable managers and teams to act on the insights we gain from our surveys and to drive employee engagement and strong business outcomes.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Diversity, Equity and Inclusion (DE&amp;I)</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">An essential part of our culture is respecting each individual&#8217;s strengths and values. Building on this foundation, we are focused on maintaining an inclusive, engaging work environment in keeping with our values of integrity and people. Our DE&amp;I strategy is centered around these three commitments:</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Strengthen the diversity of our workforce</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Advance a culture of inclusion, engagement and belonging</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Maximize the power of inclusion to drive innovation and growth</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are advancing our commitments through the following actions, among others:</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Increasing access to talent through strategic partnerships and campaigns</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Growing and engaging talent with a range of opportunities to learn and develop</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Aligning our employee resource groups, which are open to all employees, to focus on creating community and belonging</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Attracting and Hiring</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We understand that every employee drives our success. We focus on attracting, identifying and selecting strong candidates who will be successful at Stryker and ensuring that each person we hire brings the talent, expertise and passion we need to continue to be successful.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Health and Safety</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ensuring our employees' safety is a top priority. It is a responsibility that we share throughout the company and one that has evolved to meet the needs of our workforce. Employees' safety risks vary depending on the roles they perform, so we tailor our safety efforts accordingly.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Competitive Pay and Benefits</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our compensation and benefits programs are designed to attract and retain top talent and to incentivize performance and alignment to our mission and values.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We offer market-competitive base pay and benefits to our employees in countries around the world. We regularly evaluate our compensation and benefit offerings and levels, using recognized outside consulting firms to ensure internal fairness and competitiveness in our offerings.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Most of our employees also have variable components to their compensation packages that reward employees based on individual, business unit and/or company-wide performance.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our proxy statement provides more detail on the competitive compensation programs we offer to our executive officers.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Information about our Executive Officers</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.099%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">As of January 31, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">First Became an Executive Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Kevin A. Lobo</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chair, Chief Executive Officer and President</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Yin C. Becker</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">61</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vice President, Chief Corporate Affairs Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">William E. Berry Jr.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vice President, Chief Accounting Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2014</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Glenn S. Boehnlein</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vice President, Chief Financial Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">M. Kathryn Fink</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vice President, Chief Human Resources Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Robert S. Fletcher</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vice President, Chief Legal Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Viju S. Menon</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Group President, Global Quality and Operations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">J. Andrew Pierce</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Group President, MedSurg and Neurotechnology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spencer S. Stiles</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Group President, Orthopaedics</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each of our executive officers was elected by our Board of Directors to serve in the office indicated until the first meeting of the Board of Directors following the annual meeting of shareholders in 2025 or until a successor is chosen and qualified or until his or her resignation or removal. Each of our executive officers held the position above or served Stryker in various executive or administrative capacities for at least five years.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Available Information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our main corporate website address is </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">www.stryker.com. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The information on our website is not incorporated by reference into this report. Copies of our filings with the United States Securities and Exchange Commission (SEC) are available free of charge on our website within the "Investors Relations" section as soon as reasonably practicable after having been electronically filed or furnished to the SEC. All SEC filings are also available at the SEC's website at </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">www.sec.gov</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div id="i1442ddc197954361b38cabd10df2e256_16"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;1A.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RISK FACTORS.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This report contains statements that are not historical facts and are considered &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current projections about operations, industry conditions, financial condition and liquidity. Words that identify forward-looking statements include, without limitation, words such as &#8220;may,&#8221; &#8220;could,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;possible,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;forecast,&#8221; &#8220;potential,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;may impact,&#8221; &#8220;on track,&#8221; &#8220;goal,&#8221; &#8220;strategy&#8221; and words and terms of similar substance used in connection with any discussion of future operating or financial performance, an acquisition or our businesses. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Those statements are not guarantees and are subject to risks, uncertainties and assumptions that are difficult to predict. Therefore, actual results could differ materially and adversely from these forward-looking statements, historical experience or our present expectations. Some important factors that could cause our actual results to differ from our expectations in any forward-looking statements include: </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">weakening of economic conditions, or the anticipation thereof, that could adversely affect the level of demand for our or Inari Medical, Inc.&#8217;s (&#8220;Inari&#8221;) products;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">geopolitical risks, including from international conflicts, which could, among other things, lead to increased market volatility;</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">pricing pressures generally, including cost-containment measures that have adversely affected and could in the future adversely affect the price of or demand for our or Inari&#8217;s products;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">changes in foreign currency exchange markets;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">legislative and regulatory actions; </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">unanticipated issues arising in connection with clinical studies and otherwise that affect approval of new products, including Inari products, by the FDA and foreign regulatory agencies;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">inflationary pressures;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">increased interest rates or interest rate volatility;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">supply chain disruptions;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">changes in labor markets; </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">changes in coverage and reimbursement levels from third-party payors;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">changes in the competitive environment;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">breaches, failures or other disruptions of our or our vendors&#8217; or customers&#8217; information technology systems or products, including by cyber-attack, data leakage, unauthorized access or theft;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">a significant increase in product liability claims;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">the ultimate total cost with respect to recall-related and other regulatory and quality matters;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">the impact of investigative and legal proceedings and compliance risks;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">resolution of tax audits;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">changes in tax laws and regulations;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">the impact of legislation to reform the healthcare system in the United States or other countries;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">costs to comply with medical device regulations;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">changes in financial markets;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">changes in our credit ratings;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">our ability to integrate and realize the anticipated benefits of acquisitions in full or at all or within the expected timeframes, including our acquisition of Inari;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">our ability to realize any anticipated cost savings;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">potential negative impacts resulting from climate change or other environmental, social and governance and sustainability related matters;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">the impact on our operations and financial results of any public health emergency and any related policies and actions by governments or other third parties; </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">uncertainties as to the timing of the tender offer for shares of Inari common stock and the subsequent merger with Inari; </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">uncertainties as to how many of Inari&#8217;s stockholders will tender their shares in the tender offer; </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">the failure to satisfy any of the closing conditions to the acquisition of Inari, including the expiration or termination of the Hart-Scott-Rodino Antitrust Improvements Act waiting period (and the risk that such governmental approval may result in the imposition of conditions that could adversely affect the expected benefits of the transaction);</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">delays in consummating the acquisition of Inari or the risk that the transaction may not close at all; </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">unexpected liabilities, costs, charges or expenses in connection with the acquisition of Inari;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">the effects of the proposed Inari transaction (or the announcement thereof) on the parties&#8217; relationships with employees, customers, other business partners or governmental entities; and</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">other risks detailed in our filings with the SEC. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">While we believe that the assumptions underlying such forward-looking statements are reasonable, there can be no assurance that future events or developments will not cause such statements to be inaccurate. All forward-looking statements </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">contained in this report are qualified in their entirety by this cautionary statement. We expressly disclaim any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that affect the likelihood that actual results will differ from those contained in the forward-looking statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our operations and financial results are subject to various risks and uncertainties discussed below that could materially and adversely affect our business, cash flows, financial condition and results of operations. Additional risks and uncertainties not currently known to us or that we currently deem not to be material or that could apply to any company may also materially and adversely affect our business, cash flows, financial condition or results of operations. If any of the risks discussed below or other risks actually occur or continue to occur, our business, financial condition, operating results or cash flows could be materially adversely affected. Accordingly, you should carefully consider the following risk factors, as well as other information contained in or incorporated by reference in this report.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BUSINESS AND OPERATIONAL RISKS</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We use a variety of raw materials, components, devices and third-party services in our global supply chains, production and distribution processes; significant shortages, price increases or unavailability of third-party services have in the past increased, and could in the future increase, our operating costs and could require significant capital expenditures or adversely impact the competitive position of our products:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Our reliance on certain suppliers to secure raw materials, components and finished devices, and on certain third-party service providers, such as sterilization service providers, exposes us to the risk of product shortages and unanticipated increases in prices, whether due to inflationary pressure, regulatory changes, litigation exposure, geopolitical tensions or otherwise. For example, in the past we experienced limited product availability due to an electronic components shortage in certain product lines. If a similar shortage occurs in the future with respect to any raw materials or components, we may not be able to obtain them from our suppliers on a timely basis, or at all, or identify alternative suppliers. In addition, several raw materials, components, finished devices and services are procured from a sole source due to, among other things, the quality considerations, unique intellectual property considerations or constraints associated with regulatory requirements. If sole-source suppliers or service providers are unable or unwilling to deliver these materials or services as a result of financial difficulties, business disruptions, acquisition by a third party, natural disasters or otherwise, we may not be able to manufacture or have available one or more products during such period of unavailability and our business could suffer, possibly materially. In certain cases, we may not be able to establish additional or replacement suppliers for such materials or service providers for such services in a timely or cost-effective manner, often as a result of FDA and other regulations that require, among other things, validation of materials, components and services prior to their use in or with our products. In certain instances we have been unable to meet demand due to supply chain challenges, which has led to loss of sales. Although the impacts have not been material to date, an inability to meet demand due to supply chain challenges in the future could materially adversely impact our reputation, the competitive position of our products and our business. Any of the foregoing risks could have a material adverse impact on our profitability and results of operations.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, in recent years, the market has experienced inflationary pressures in part due to global supply chain disruptions, labor shortages and other impacts following the COVID-19 pandemic. Inflation in the United States and in many of the countries where we conduct business has resulted in, and may in the future result in, high interest rates and increased capital, energy, shipping and labor costs, weakening or strengthening exchange rates against the United States Dollar and other similar effects. We have experienced, and may in the future experience, inflationary increases in manufacturing costs and operating expenses, as well as negative impacts from weakening or strengthening exchange rates against the United States Dollar. Although we have been able to pass certain cost increases on to our customers, we have not been able to pass along all cost increases and we cannot guarantee that we will be able to do so in the future. Inflation, high interest rates or interest rate volatility may also cause our customers to reduce or delay orders for our products and services. Any of the foregoing could have a material adverse impact on our sales, profitability and results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We are subject to pricing pressures as a result of cost containment measures in the United States and other countries and other factors, including changes in reimbursement practices and coverage policies and third-party payor cost containment measures:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Initiatives to limit the growth of general healthcare expenses and hospital costs are ongoing in the markets in which we do business. These initiatives are sponsored by government agencies, legislative bodies and the private sector and include price regulation and competitive pricing. For example, China has implemented a volume-based procurement process designed to decrease prices for medical devices and other products. Pricing pressure has also increased due to continued consolidation among healthcare providers, trends toward managed care, the shift toward governments becoming the primary payers of healthcare expenses, reduction in coverage or reimbursement levels and medical procedure volumes and government laws and regulations relating to sales and promotion, reimbursement and pricing generally. Coverage policies and reimbursement levels can vary across the payer community globally, regionally, and locally, and may affect which products customers purchase, the market acceptance rate for new technologies and the prices customers are willing to pay for those products in a particular jurisdiction. Furthermore, any changes to the coverage or reimbursement landscape, or adverse decisions relating to our products by administrators of these systems could significantly reduce reimbursement for procedures using our products or result in denial of reimbursement for those products, which could adversely affect customer demand, or the price customers are willing to pay for such products. Public and private payers have challenged, and are expected to continue to challenge, prices charged for medical products and services. Such downward pricing pressures from any or all of these payers may result in an adverse effect on our business, results of operations, financial condition and cash flows.  We have also reduced prices for certain products due to increased competition and if we further reduce prices, we could become less profitable. In addition, due to healthcare industry consolidation in recent years, competition to provide goods and services to industry participants has become, and may continue to become, more intense, and this consolidation has produced, and may continue to produce, larger enterprises with more bargaining power. Pricing pressures related to any of the foregoing or other factors have impacted and could in the future impact our results of operations and profitability.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We operate in a highly competitive industry in which competition and the regulatory burden in the development and improvement of new and existing products is significant: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The markets in which we compete are highly competitive, and a significant element of our strategy is to increase revenue growth by focusing on innovation, new product development and improvement of existing products. New business models, products and surgical procedures, as well as improvements to existing products, are introduced on an ongoing basis and our present or future products could be rendered obsolete or uneconomical by internal or external technological advances, including by our existing competitors and new market entrants, which could adversely impact demand for certain of our existing products. The success of our products and services depends on, among other things, our ability to properly identify customer needs and predict future needs; innovate and develop new technologies, services and applications at an accelerated pace; and appropriately allocate our research and development spending to products and services with higher growth. Our existing competitors and new market entrants may respond more quickly to or integrate new or emerging technologies such as robotics, artificial intelligence and machine learning in their product offerings, undertake more extensive marketing campaigns, have greater access to clinical information to support ongoing product position in the market, have greater financial, marketing and other resources or be more successful in attracting potential customers, employees and strategic partners. There can be no assurance that any products now in development, or that we may seek to develop in the future, will achieve technological feasibility, obtain regulatory approval or gain market acceptance. If we are unable to develop and launch new products, our ability to maintain or expand our market position in the markets in which we participate may be negatively impacted.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We may be unable to maintain adequate working relationships with healthcare professionals:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We work with healthcare professionals in a transparent and responsible manner and seek to maintain these relationships with respected physicians and medical personnel in healthcare organizations, such as hospitals and universities, who assist in product research and development. We rely on these professionals to assist us in the development and improvement of proprietary products. If we are unable to maintain these relationships due to regulatory restrictions, hospital access restrictions for non-patients or for other reasons, our ability to develop, market and sell new and improved products could be adversely affected. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We rely on indirect distribution channels and major distributors that are independent of Stryker: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In many markets we rely on indirect distribution channels to market, distribute and sell our products. These indirect channels often are the main point of contact for the healthcare professionals and healthcare organization customers who buy and use our products. Our ability to continue to market, distribute and sell our products may be at risk if the indirect channels become insolvent, choose to sell competitive products, choose to stop selling medical technology, fail to adhere to Stryker requirements or are subject to new or additional government regulation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We are subject to risks associated with our extensive global operations:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We develop, manufacture and distribute our products globally. Our global operations are subject to risks and costs related to, among other things, changes in coverage or reimbursement levels from third-party payors in the United States and other countries; changes in regulatory requirements (such as the staggered phase-in period for manufacturers to comply with </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the European Union Medical Device Regulation (MDR) through December 2028); differing local product preferences and product requirements; diminished protection of intellectual property in some countries; tariffs and other trade protection measures, as well as increasing localization and protectionism policies in certain jurisdictions; international trade disputes and import or export requirements; difficulty in staffing and managing foreign operations; introduction of new internal business structures and programs; political and economic instability and uncertainty; current or potential geopolitical conflicts, such as the tensions between China and Taiwan and the wars in Ukraine and the Middle East, and related sanctions and other developments; disruptions of transportation, including port closures, increased border controls or border closures or reduced transportation availability, due to military conflicts, a global pandemic of contagious diseases like COVID-19 or otherwise; increased energy or transportation costs; fluctuations in currency exchange rates and financial markets; and increased security threats to our supply chain. Many of these risks are rapidly evolving and subject to an accelerating pace of change. Our business could be adversely impacted if we are unable to successfully manage these and other risks of global operations in an increasingly volatile environment. In addition, in many countries, the laws and regulations applicable to us or our industry are evolving, and we have in certain cases become subject to divergent and conflicting laws and regulations across our operations, which has increased the risks we are subject to.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We may be unable to capitalize on previous or future acquisitions:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In addition to internally developed products, we invest in new products and technologies through acquisitions. Such investments are inherently risky, and we cannot guarantee that any acquisition will be successful or will not have a material unfavorable impact on us. The risks include the activities required and resources allocated to integrate new businesses, diversion of management time that could adversely affect management&#8217;s ability to focus on other projects, the inability to realize the expected benefits, savings or synergies from the acquisition, the loss of key personnel, litigation resulting from the acquisition and exposure to unexpected liabilities of acquired companies. Certain acquisitions are subject to antitrust and competition laws, and antitrust scrutiny by regulatory agencies and changes to the regulatory approval process in the United States and foreign jurisdictions may cause approvals to take longer than anticipated to obtain, not be obtained at all, or contain burdensome conditions, which may jeopardize, delay or reduce the anticipated benefits of acquisitions to us and could impede the execution of our business strategy. In addition, we cannot be certain that the businesses we acquire will become or remain profitable.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We, our business partners or our third-party vendors could experience a material failure or breach of a key information technology system, network, process or site: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We rely extensively on information technology (IT) systems to conduct business. In addition, we rely on networks and services, including internet sites, cloud and software-as-a-service solutions, data hosting and processing facilities and tools and other hardware, software (including open-source software) and technical applications and platforms, some of which are managed, hosted, provided and/or used by third parties or their vendors, to assist in conducting our business. Furthermore, numerous and evolving cybersecurity threats have posed, and will continue to pose, risks to the security of our IT systems, networks and product offerings, as well as the confidentiality, availability and integrity of our data. Emerging technologies such as generative artificial intelligence (AI) may be used by malicious actors to create more targeted </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">phishing narratives, spread disinformation about us or our products or otherwise strengthen social engineering capabilities. Some of our products, services, and information technology systems contain or use open-source software which poses particular risks, including potential security vulnerabilities, licensing compliance issues and quality issues. We, our customers and third-party hosting services have experienced, and expect to continue to experience, security breaches of, unauthorized access to, and disruptions of, products or systems. While such breaches, unauthorized access and disruptions have not had a material effect on us to date, we cannot guarantee that any future breach or unauthorized access will not be material and any breach or unauthorized access could impact the use of such products and systems and the security of information stored therein. Although we have made investments and expect to continue to make investments seeking to address these threats, including monitoring of networks and systems, use of artificial intelligence, hiring of experts, employee training and security policies for employees and third-party providers, the techniques used in these attacks change frequently and may be difficult to detect for periods of time and we may face difficulties in anticipating and implementing adequate preventative measures. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When cybersecurity or other technology related incidents occur, we follow our incident response protocols and address them in accordance with applicable governmental regulations and other legal requirements. Our response to these incidents and our investments to protect our product offerings and information technology infrastructure and data may not shield us from significant losses and potential liability or prevent any future interruption or breach of our systems. Moreover, given the increasing complexity and sophistication of the techniques used by threat actors to obtain unauthorized access or disable or degrade systems, a cyberattack could occur and persist for an extended period of time before being detected, and we may not anticipate these acts or mitigate them adequately or timely, which may compound damages before the incident is discovered or remediated. The extent of a particular cyber incident and the steps that we may need to take to investigate the incident may not be immediately clear, and it may take a significant amount of time before such investigation can be completed and full and reliable information about the incident is known. New regulations may require us to disclose information about a material cybersecurity incident before it has been resolved or fully investigated. Additionally, as threats continue to evolve and increase, and as the regulatory environment and customer requirements related to information security, data collection and use, and privacy become increasingly rigorous, we may be required to devote significant additional resources to modify and enhance our security controls and to identify and remediate any security vulnerabilities, which could adversely impact our net income. In addition, a significant number of our employees working remotely has exposed us, and may continue to expose us, to greater risks related to cybersecurity and cyber-liability. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Hardware and software failures or delays in our key information technology systems, networks, processes or sites could disrupt our operations, cause the loss of confidential information or otherwise adversely impact our business. Our systems, networks, processes and sites may be vulnerable to damage, disruptions and shutdown from a variety of sources, including malfunctions in maintenance updates or security patches, design defects, the age of the technology, network failures, modernization or other initiatives, human acts and natural disasters. For example, some of our information technology systems contain legacy third-party software components for which we depend on a layered security </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">approach to protect against exploitation, which may not be effective. Any such damage or disruptions could also compromise the security of our information systems and networks. These issues can also arise as a result of failures by, or in the software or hardware of, third parties, including networks or service providers, with whom we do business and over whom we have limited or no control. Any disruption or failure of our systems, networks, processes or sites could have a material impact on our business and operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If our IT systems, networks or processes are damaged or cease to function properly for any reason, the networks, service providers, hardware or software we rely upon fail to function properly, or we or one of our third-party providers suffer a loss or disclosure of our business or stakeholder information due to any number of causes ranging from catastrophic events or power outages to improper data handling or security breaches or unauthorized access and our business continuity plans do not effectively address these failures on a timely basis, we may be exposed to reputational, competitive and business harm as well as litigation and regulatory action and fines, penalties and expenses related thereto.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">An inability to successfully manage the implementation of our new commercial global enterprise resource planning (ERP) system could adversely affect our operations and operating results: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are in the process of implementing a new commercial ERP system. This system will replace many of our existing operating and financial systems. The implementation is a major undertaking, both financially and from a management and personnel perspective. Any material disruptions, delays or deficiencies in the design and implementation of our new ERP system could adversely affect our ability to process orders, ship products, provide services and customer support, send invoices and track payments, fulfill contractual obligations or otherwise operate our business.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We may be unable to attract, develop and retain executives and key employees:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Our sales, technical and other key personnel play an integral role in the development, marketing and selling of new and existing products. Our future performance also depends in large part on the continued services of our senior management. If we are unable to recruit, hire, develop and retain a talented, competitive workforce in our highly competitive industry, or if we are unable to plan effective succession for the future, we may not be able to meet our strategic business objectives. Inflationary pressures, labor demand and shortages and other macroeconomic factors have increased and could further increase the cost of labor and could harm our ability to recruit, hire and retain talented employees. In addition, increased unionization could negatively impact our labor costs and ability to create an engaging, connected culture, which could adversely affect our ability to recruit, hire, develop and retain a talented, competitive workforce. Further, if we are unable to maintain competitive and equitable compensation and benefit programs, including incentive programs which reward financial and operational performance, our ability to recruit, hire, engage, motivate and retain talent could be negatively affected. Additionally, if we are unable to maintain an inclusive culture that aligns our diverse workforce with our mission and values, it could adversely impact our ability to recruit, hire, develop and retain key talent. Further, our remote and hybrid work practices, ability to provide flexible and alternative work arrangements, and our practices relating to corporate responsibility may not meet the needs or expectations of our employees, including senior management or other key employees, which could negatively impact our ability to attract and retain highly skilled employees, or </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">may harm our culture and/or decrease employee engagement, which could adversely impact our ability to recruit, hire, develop and retain a talented, competitive workforce. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Effective succession planning is also important to our long-term success. Failure to ensure effective transfer of knowledge and smooth transitions involving executives and other key employees could hinder our strategic planning and execution. Changes in our management team may be disruptive to our business, and any failure to successfully integrate key new hires or promoted employees could adversely affect our business and results of operations. The loss of the services of any of our senior management or other key personnel, or our inability to attract highly qualified senior management and other key personnel, could harm our business. Our ability to execute our business strategy could be impaired if we are unable to replace such persons timely. In addition, recent legal and regulatory changes affect our ability to enforce post-termination obligations from certain employees with respect to non-competition, non-solicitation and protection of confidential information. This may negatively impact our ability to retain employees and protect our information and relationships with customers and other third parties. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Interruption of manufacturing operations could adversely affect our business:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We and our suppliers have manufacturing and supply sites all over the world. However, the manufacturing of certain of our product lines is concentrated in one or more plants or geographic regions. We have principal manufacturing and distribution facilities in the United States in Arizona, California, Florida, Illinois, Indiana, Michigan, Minnesota, New Jersey, Puerto Rico, Tennessee, Texas, Utah, Virginia and Washington, and outside the United States in China, France, Germany, Ireland, Mexico, the Netherlands, Poland, Switzerland and Turkey. Damage to our facilities, to our suppliers&#8217; or service providers&#8217; facilities, or to our central distribution centers as a result of natural disasters, fires, explosions or otherwise, as well as issues in our manufacturing arising from a failure to follow specific internal protocols and procedures, compliance concerns relating to the quality systems regulation, equipment breakdown or malfunction, IT system failures or cybersecurity incidents, environmental hazard incidents or changes to environmental regulations or other factors, could adversely affect the availability of our products. In the event of an interruption in manufacturing, we may be unable to move quickly to alternate means of producing and distributing affected products to meet customer demand. In the event of a significant interruption, we may experience lengthy delays in resuming production or distribution of affected products due to the need for regulatory approvals, and we may experience loss of market share, additional expense and harm to our reputation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Our insurance program may not be adequate to cover future losses: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We maintain third-party insurance to cover our exposure to certain property and casualty losses and are self-insured for claims and expenses related to other property and casualty losses, including product liability, intellectual property infringement and enforcement, environmental, and cybersecurity and data privacy losses. We manage a portion of our exposure to self-insured losses through a wholly-owned captive insurance company. Insurance coverage limits provided by third-party insurers and/or our captive insurance company may not be sufficient to fully cover certain losses we may experience.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We have experienced, and may continue to experience, a significant and unpredictable need to adjust our operations as market demand for certain of our products has shifted and continues to shift or as may be mandated by </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">governmental authorities:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Some of our products are particularly sensitive to reductions in elective medical procedures. It is not possible to predict whether elective medical procedures will be suspended or reduced in the future and, to the extent individuals and customers are required to delay or cancel elective procedures, our business, cash flows, financial condition and results of operations could be negatively affected. Further, our customers have experienced, and may continue to experience, staffing shortages that may result in decreased demand for our products, which could negatively affect our business and financial results. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unpredictable increases in demand for certain of our products have exceeded in the past, and could exceed in the future, our capacity to meet such demand timely, which could adversely affect our customer relationships and result in negative publicity. In this regard, the accelerated development and production of products and services to address medical and other requirements could increase the risk of regulatory enforcement actions, product defects or related claims or reputational harm, among other things.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Our use of AI and other emerging technologies could adversely impact our business and financial results: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have begun to deploy AI and other emerging technologies in various facets of our operations and we continue to explore further use cases. The rapid advancement of these technologies presents opportunities for us in research, manufacturing, commercialization, and other business endeavors, but also entails risks, including that AI-generated content, analyses, or recommendations we utilize could be deficient, that our competitors may more quickly or effectively adopt AI capabilities, or that our use of AI or other emerging technologies increases regulatory, cybersecurity and other significant risks. In addition, any disruption or failure in the AI functionality we incorporate into our business activities, products or services could adversely impact our business or result in delays or errors in our product offerings. The legal and regulatory landscape surrounding AI technologies is rapidly evolving and uncertain, including in the areas of intellectual property, cybersecurity and privacy and data protection. Compliance with new or changing laws, regulations or industry standards relating to AI may impose significant costs on us and limit our ability to effectively develop, deploy or use AI technologies. Furthermore, if we are unable to effectively manage the use of AI technologies by our employees and service providers, our confidential information, intellectual property and reputation could be put at risk.  Failure to appropriately respond to this evolving landscape may result in reputational, competitive and business harm as well as litigation and regulatory action and fines, penalties and expenses related thereto. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pandemics and public health emergencies, and the fear thereof, have in the past materially adversely affected and could in the future materially adversely affect, our operations, supply chain, manufacturing, product distribution, customers and other business activities: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In connection with prior pandemics, governmental authorities and private enterprises implemented, and may in the future implement in connection with another pandemic or public health emergency (or in response to the fear thereof), measures, such as travel bans and restrictions, quarantines, shelter-in-place orders and shutdowns. Our customers, global suppliers, distributors and manufacturing facilities have in the past been, and could in the future be, materially affected by restrictive measures implemented in response to a pandemic or public health emergency, which has in the past caused and could in the future cause them to be unable to hire and retain employees, </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">distribute or use our products or provide required services. We have as a result experienced, and could in the future experience, delays in, or the suspension of, our manufacturing operations, sales activities, research and product development activities, regulatory work streams, clinical development programs and other important commercial functions, which may result in our inability to satisfy consumer demand for our products in a timely manner or at all and which could harm our reputation, future sales and profitability. The extent of any future pandemic or public health emergency&#8217;s effect on our business and industry will depend on, among other things, the severity of the disease, the successful development, distribution and acceptance of vaccines for diseases, future resurgences and/or the spread of disease variants, all of which are uncertain and difficult to predict. The COVID-19 pandemic materially impacted us, and any future pandemic or public health emergency could materially impact us and would heighten many of the other risks described in this report.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LEGAL AND REGULATORY RISKS</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Current economic and political conditions make tax rules in jurisdictions subject to significant change</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">: Our future results of operations could be affected by changes in the effective tax rate as a result of changes in tax laws, regulations and judicial rulings. We are continuing to evaluate the impact of tax reform in the countries in which we operate as new guidance is published and new regulations are adopted. In addition, further changes in the tax laws could arise, including as a result of the base erosion and profit shifting project undertaken by the Organisation for Economic Cooperation and Development (OECD). The OECD, which represents a coalition of member countries, has put forth two proposed frameworks that revise the existing profit allocation and nexus rules (Pillar 1) and ensure a minimal level of taxation (Pillar 2), respectively. In 2022 the European Union member states agreed to implement the Inclusive Framework&#8217;s global corporate minimum tax rate of 15%, and various countries within and outside the European Union have either enacted or proposed new tax laws implementing Pillar Two in 2024. The OECD continues to release additional guidance and we anticipate more countries will enact similar tax laws.  Some of the new tax laws are effective in 2024 while others will be effective in future years. These tax law changes and any additional contemplated tax law changes, could increase tax expense in future periods.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We could be negatively impacted by future changes in the allocation of income to each of the income tax</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">jurisdictions in which we operate:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We operate in multiple income tax jurisdictions both in the United States and internationally. Accordingly, our management must determine the appropriate allocation of income to each jurisdiction based on current interpretations of complex income tax regulations. Income tax authorities regularly perform audits of our income tax filings. Income tax audits associated with the allocation of income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period to resolve and may result in significant income tax adjustments. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">The impact of healthcare reform legislation on our business remains uncertain: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Several markets where we sell our products are making efforts to expand access to healthcare or health insurance coverage while decreasing costs. These efforts may have a direct or unintended negative impact on access to medical technology and could have a significant effect on our business. Both in the U.S. and internationally, governmental authorities may make legislative or administrative reforms to existing reimbursement programs, make adverse decisions relating to our </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">products&#8217; coverage or reimbursement, or make changes to patient access to healthcare, all of which could adversely impact the demand for and usage of our products or the prices that our customers are willing to pay for them. We cannot predict what healthcare programs and regulations could ultimately be implemented at the federal or state level or the effect that any future legislation or regulation in the United States may have on our business. Similarly, we cannot predict the impact that healthcare reform legislation in other countries where we sell our products may have on our business.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We are subject to extensive governmental regulation relating to the classification, manufacturing, sterilization, licensing, labeling, marketing and sale of our products:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The classification, manufacturing, sterilization, licensing, labeling, marketing and sale of our products are subject to extensive and evolving regulations and rigorous regulatory enforcement by the FDA, state governments, European Union and other governmental authorities in the United States and internationally. These governmental authorities may impose additional requirements or limits on the methods, procedures or agents we use to manufacture and sterilize our products, which could have a negative impact on our business. For example, governmental authorities in the United States and internationally have or are considering adopting regulations on the use of per- and polyfluoroalkyl substances. In addition, the process of obtaining licenses, regulatory clearances and/or approvals to market and sell our products can be costly and time consuming and the clearances and/or approvals might not be granted timely. We have ongoing responsibilities under the laws and regulations applicable to the manufacturing of products within our facilities and those contracted by third parties that are subject to periodic inspections by the FDA, state Boards of Pharmacy and other governmental authorities to determine compliance with the quality system, medical device reporting regulations and other requirements. We may also be subject to legal obligations in some countries that require disclosure or sharing of proprietary information. We incur significant costs to comply with regulations, including the MDR. If we fail to comply with applicable regulatory requirements, we may be subject to a range of sanctions, including substantial fines, warning letters that require corrective action, product seizures, recalls, import restrictions, the suspension of product manufacturing or sales, revocation of approvals, exclusion from future participation in government healthcare programs, substantial fines and criminal prosecution. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We are subject to federal, state and foreign healthcare regulations, including anti-bribery, anti-corruption, anti-kickback and false claims laws, globally and could face substantial penalties if we fail to comply with such regulations and laws:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The relationships that we, and third parties that market and/or sell our products, have with healthcare professionals, such as physicians, hospitals, healthcare organizations and others, are subject to scrutiny under various state and federal laws often referred to collectively as healthcare fraud and abuse laws. In addition, the United States and foreign government regulators have increased the enforcement of the Foreign Corrupt Practices Act (FCPA) and other anti-bribery and anti-kickback laws. We also must comply with a variety of other laws that impose extensive tracking and reporting related to all transfers of value provided to certain healthcare professionals and others. These laws and regulations are broad in scope and are subject to evolving interpretation and we have in the past been, and in the future could be, required to incur substantial costs to investigate, audit and monitor compliance or to alter our practices. Violations or alleged violations of these laws have in </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the past resulted and could in the future result in investigations, litigation or government proceedings, and we have been and may in the future be subject to criminal or civil penalties and sanctions, including substantial fines, imprisonment of current or former employees and exclusion from participation in governmental healthcare programs. For example, in 2013 and 2018 we settled claims brought by the SEC related to the FCPA. Pursuant to these settlements, we paid fines and penalties and retained an independent compliance consultant. We continue to implement recommendations that resulted from the independent compliance consultant&#8217;s review of our commercial practices to enhance our commercial business practices. In addition, we are currently investigating whether certain business activities in certain foreign countries violated provisions of the FCPA and have been contacted by the SEC, United States Department of Justice and certain other regulatory authorities. Although we are currently unable to predict the outcome of the investigations or the potential impact, if any, on our financial statements, the impacts could potentially be significant.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We are subject to privacy, data protection and data security regulations and laws globally, and could face substantial penalties if we fail to comply with such regulations and laws: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are subject to a variety of laws and regulations globally regarding privacy, data protection, and data security, including those related to the collection, storage, handling, use, disclosure, transfer and security of personally identifiable healthcare information. For example, in the United States, privacy and security regulations under the Health Insurance Portability and Accountability Act of 1996, including the expanded requirements under the Health Information Technology for Economic and Clinical Health Act of 2009, establish comprehensive standards with respect to the use and disclosure of protected health information (PHI), by covered entities, in addition to setting standards to protect the confidentiality, integrity and security of PHI. Regulators are also imposing new data privacy and security requirements, including new and greater monetary fines for privacy violations. For example, the European Union&#8217;s General Data Protection Regulation (GDPR) established rules regarding the handling of personal data. Non-compliance with the GDPR may result in monetary penalties of up to 4% of total company revenue. Various U.S. states and other governmental authorities around the world have imposed or are considering similar types of laws and regulations, data breach reporting and penalties for non-compliance and increasing security requirements. These laws and regulations are broad in scope and are subject to evolving interpretation and enforcement and we have in the past been, and in the future could be, required to incur substantial costs to monitor compliance or to alter our practices. As new privacy-related laws and regulations are implemented, the time and resources needed for us to comply with such laws and regulations, as well as our potential liability for non-compliance and reporting obligations in the case of data breaches, have increased and may further increase.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We may be adversely affected by product liability claims, unfavorable court decisions or legal settlements:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We are exposed to potential product liability risks inherent in the design, manufacture and marketing of medical devices, many of which are implanted in the human body for long periods of time or indefinitely. We are currently defendants in a number of product liability matters, including those relating to our Rejuvenate and ABGII Modular-Neck hip stems, LFIT Anatomic CoCr V40 Femoral Heads and the product liability lawsuits and claims relating to Wright Medical Group N.V. (Wright) legacy hip products discussed in Note 7 to our Consolidated Financial </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Statements. These matters are subject to uncertainties and outcomes are not predictable. Further, the European Representative Actions Directive (the Collective Redress Directive) mandates a class action regime in each EU member state to facilitate domestic and cross-border class actions in a wide range of areas, including product liability claims with medical devices. The European Product Liability Directive was revised in 2024 and will become fully adopted into each member state&#8217;s national laws by 2026. The revised Product Liability Directive and Collective Redress Directive exposes us to additional litigation risks and could result in significant legal expenses. In addition, we may incur significant legal expenses or reputational damage for product liability claims regardless of whether we are found to be liable. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Intellectual property litigation and infringement claims could cause us to incur significant expenses or prevent us from selling certain of our products: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The medical device industry is characterized by extensive intellectual property litigation and, from time to time, we are the subject of claims of infringement or misappropriation. Regardless of the outcome, such claims are expensive to defend and divert management and operating personnel from other business issues. A successful claim or claims of patent or other intellectual property infringement against us could result in payment of significant monetary damages and/or royalty payments or negatively impact our ability to sell current or future products in the affected category.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Dependence on intellectual proprietary rights and failing to protect such rights or to be successful in litigation related to such rights may impact offerings in our product portfolios: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our long-term success largely depends on our ability to market technologically competitive products. If we fail to obtain or maintain adequate intellectual property protection, it could allow others to sell products that directly compete with proprietary features in our product portfolio. Also, our issued patents may be subject to claims challenging their validity and scope and raising other issues. In addition, currently pending or future patent applications may not result in issued patents and the expiration of patents may lead to a loss of exclusive rights and/or increased competition.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">MARKET RISKS</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We have exposure to exchange rate fluctuations on cross border transactions and translation of local currency results into United States Dollars:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We report our financial results in United States Dollars and approximately 25% of our net sales are denominated in foreign currencies, including the Australian Dollar, British Pound, Canadian Dollar, Euro and Japanese Yen. Cross border transactions with external parties, financing transactions in currencies other than the United States Dollar and intercompany relationships result in increased exposure to foreign currency exchange effects. While we use derivative instruments to manage the impact of currency exchange, our hedging strategies may not be successful, and our unhedged exposures continue to be subject to currency fluctuations. In addition, the weakening or strengthening of the United States Dollar results in favorable or unfavorable translation effects when the results of our foreign locations are translated into United States Dollars. In recent years, currency exchange rates have been especially volatile, and these currency fluctuations have affected, and may continue to affect, our results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Additional capital that we may require in the future may not be available to us or may only be available to us on unfavorable terms, which could negatively affect our liquidity: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">factors, including operating requirements, current and future acquisitions and the need to refinance existing debt. Our ability to issue additional debt or enter into other financing arrangements on acceptable terms could be adversely affected by our debt levels, unfavorable changes in economic conditions or uncertainties that affect the capital markets. Changes in credit ratings issued by nationally recognized credit rating agencies could also adversely affect our access to and cost of financing. Higher borrowing costs or the inability to access capital markets could adversely affect our ability to support future growth and operating requirements. In addition, we have experienced, and could in the future experience, loss of sales and profits due to delayed payments or insolvency of healthcare professionals, hospitals and other customers and suppliers facing liquidity issues due to the current macroeconomic environment, type and number of conditions being treated or for other reasons. As a result, we may be compelled to take additional measures to preserve our cash flow, including through the reduction of operating expenses or suspension of dividend payments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ENVIRONMENTAL, SOCIAL AND GOVERNANCE RISKS</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We could be negatively impacted by corporate responsibility and sustainability-related matters:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Governments, investors, customers, employees and other stakeholders have been focused on corporate responsibility practices and disclosures, and expectations in this area continue to rapidly evolve, including in diverging directions. On occasion, we announce new initiatives and make disclosures, including goals, under our corporate responsibility framework. This framework is aligned with our areas of interest and applicable regulatory requirements, which include environment and sustainability, workforce-related issues, diversity, equity and inclusion and supply chain management, among others. Implementation of these initiatives involves risks and uncertainties, requires investments and depends in part on third-party performance or data that is outside our control. We cannot guarantee that we will achieve our announced corporate responsibility initiatives. The criteria by which our corporate responsibility practices are assessed may change due to the quickly evolving landscape, which could result in greater regulatory requirements or expectations of us and cause us to undertake costly initiatives to satisfy such new criteria. Moreover, the increasing attention to corporate responsibility initiatives could also result in, among other things, reduced demand for our products, reduced profits, increased investigations and litigation and an increased risk of reputational damage. If we are unable to satisfy evolving criteria, certain investors and other stakeholders may conclude that our policies and/or actions with respect to corporate responsibility matters are inadequate or undesirable. If we fail or are perceived to have failed to achieve previously announced initiatives or goals, comply with corporate responsibility laws and regulations, meet evolving expectations or accurately disclose our progress, we could face legal and regulatory proceedings and our reputation, business, financial condition and results of operations could be adversely impacted.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Physical effects of climate change or legal, regulatory or market measures intended to address climate change could adversely affect our operations and operating results:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Risks associated with climate change are subject to increasing societal, regulatory and political focus in the United States and globally. Shifts in weather patterns caused by climate change have increased and are expected to further increase the frequency, severity or duration of certain adverse weather conditions and natural disasters, such as hurricanes, tornadoes, earthquakes, wildfires, droughts, extreme temperatures and flooding, which could cause more significant business and supply chain </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">interruptions, damage to our products and facilities as well as the infrastructure of hospitals, medical care facilities and other customers, reduced workforce availability, increased costs of raw materials and components, increased liabilities and decreased revenues than what we have experienced in the past from such events. In addition, increased public concern over climate change has resulted in certain, and could result in additional, new legal or regulatory requirements designed to mitigate the effects of climate change, which could include the adoption of more stringent environmental laws and regulations or stricter enforcement of existing laws and regulations. Such developments could result in increased compliance costs and adverse impacts on raw material availability and sourcing, manufacturing operations and the distribution of our products, which could adversely affect our operations and operating results.</span></div><div id="i1442ddc197954361b38cabd10df2e256_19"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;1B.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">UNRESOLVED STAFF COMMENTS.</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div id="i1442ddc197954361b38cabd10df2e256_22"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;1C.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CYBERSECURITY.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">RISK MANAGEMENT AND STRATEGY</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="f-59" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true" id="f-60">We review cybersecurity risk as part of our overall enterprise risk management program.</ix:nonNumeric> This ensures that cybersecurity risk management remains a top priority in our business strategy and operations.</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">MANAGEMENT'S ROLE IN MANAGING RISK</span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="f-61" continuedAt="f-61-1" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="f-63" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="f-62" escape="true">Primary management responsibility for assessing, monitoring and managing our cybersecurity risks rests with our <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true" id="f-64">chief information security officer ("CISO")</ix:nonNumeric></ix:nonNumeric>. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" id="f-65" escape="true">Our current CISO has over 30 years of experience in information technology including over 20 years in cybersecurity and oversees a team of cybersecurity professionals with over 140 security, risk, and compliance certifications. The CISO is regularly informed about recent developments in cybersecurity, including potential threats and innovative risk management techniques.</ix:nonNumeric></ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CISO implements and oversees processes for the regular monitoring of our information systems. We use various tools and methodologies to manage cybersecurity risk that are tested regularly. We also monitor and evaluate our cybersecurity posture and performance on an ongoing basis through regular vulnerability scans, penetration tests and threat intelligence feeds. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true" id="f-66" continuedAt="f-66-1">In addition, we engage third-party consultants to conduct annual cybersecurity assessments and to conduct audits for compliance with regulatory, Sarbanes-Oxley Act, Service Organization Control Type 2 and</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:continuation id="f-66-1" continuedAt="f-66-2"> </ix:continuation></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-66-2">International Organization for Standardization standards.</ix:continuation> We also engage third parties to assess our cybersecurity maturity and risk management programs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use a cross-departmental approach to addressing cybersecurity risk, with our cybersecurity, product security and legal teams presenting quarterly on key topics to a committee of leaders in finance, regulatory, and corporate affairs functions. This leadership committee meets quarterly to ensure that we have input and oversight from critical stakeholders into our cybersecurity program and evolving issues.</span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="f-67" continuedAt="f-67-1" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CISO oversees a training and awareness program for employees to take part in protecting the Company against cybersecurity risks. We have implemented annual mandatory security education to help employees understand cybersecurity risks and comply with our cybersecurity policies. Additionally, we provide frequent communications around pertinent cybersecurity topics and policies to all employees. We also provide additional </span></div></ix:nonNumeric></ix:nonNumeric></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="f-61-1"><ix:continuation id="f-67-1"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cybersecurity and data protection training to employees in certain roles. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true" id="f-68">As part of our cybersecurity risk management program, we also conduct cybersecurity and privacy assessments on all third parties who integrate with Stryker&#8217;s data, network, systems and products. We use a combination of internal and external tools to confirm that these third parties meet our security requirements. We leverage standard industry threat model and privacy impact assessment concepts to confirm that data minimization and adequate data protections are in place. We perform supplemental reviews as necessary, commensurate with the risk associated with each vendor.</ix:nonNumeric></span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the event of a cybersecurity incident, we have an incident response plan that includes immediate actions to mitigate the impact and long-term strategies for remediation and prevention of future incidents. The cybersecurity and product security teams routinely practice this plan with functions across the organization. We conduct tabletop exercises with senior management, during which we practice the procedures in place to ensure that potentially material cybersecurity risks and incidents are escalated to management and the Board of Directors where applicable.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">GOVERNANCE</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-70" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="f-69" escape="true">Cybersecurity risks are overseen by the full Board of Directors and the Audit Committee. The Audit Committee is central to the Board of Directors&#8217; oversight of cybersecurity risks and bears the primary responsibility for overseeing cybersecurity risk. The Audit Committee actively participates in strategic decisions related to cybersecurity, offering guidance and approval for major cybersecurity initiatives. This involvement ensures that cybersecurity considerations are integrated into our broader strategic objectives.</ix:nonNumeric></ix:nonNumeric> </span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-71" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true" id="f-72">CISO</ix:nonNumeric> provides comprehensive updates to the Audit Committee quarterly and the full Board of Directors periodically. These briefings include a range of topics, including:</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Current cybersecurity landscape and emerging threats&#894;</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Status of ongoing cybersecurity initiatives and strategies&#894;</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Incident reports and learnings from any cybersecurity events&#894; </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Metrics demonstrating company and industry-standard prevention of common threats; and</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Regulatory changes impacting cybersecurity requirements and strategy.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors is aware of the critical nature of managing risks associated with cybersecurity threats and is actively engaged in our cybersecurity risk management strategy.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">RISKS FROM CYBERSECURITY THREATS</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false" id="f-73">Although cybersecurity risks have not materially affected us, including our business strategy, results of operations or financial condition, to date, we face numerous and evolving cybersecurity threats in our business.</ix:nonNumeric> For more information about the cybersecurity risks we face, see the risk factor entitled "We, our business partners or our third-party vendors could experience a material failure or breach of a key information technology system, network, process or site" in Item 1A. Risk Factors.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i1442ddc197954361b38cabd10df2e256_25"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;2.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PROPERTIES.</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have approximately 27 company-owned and 297 leased locations worldwide including 45 manufacturing locations. We believe that our properties are in good operating condition and adequate for the manufacture and distribution of our products. </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We do not anticipate difficulty in renewing existing leases as they expire or in finding alternative facilities.</span></div><div id="i1442ddc197954361b38cabd10df2e256_28"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;3.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LEGAL PROCEEDINGS.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are involved in various ongoing proceedings, legal actions and claims arising in the normal course of our business, including proceedings related to product, labor, intellectual property and other matters. Refer to Note 7 to our Consolidated Financial Statements for further information.</span></div><div id="i1442ddc197954361b38cabd10df2e256_31"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;4.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MINE SAFETY DISCLOSURES.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i1442ddc197954361b38cabd10df2e256_34"></div><div style="text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART II</span></td></tr></table></div><div id="i1442ddc197954361b38cabd10df2e256_37"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;5.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MARKET FOR THE REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our common stock is traded on the New York Stock Exchange under the symbol SYK.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Board of Directors considers payment of cash dividends at its quarterly meetings. On January&#160;31, 2025 there were 2,510 shareholders of record of our common stock.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We did not repurchase any shares in the three months ended December&#160;31, 2024 and the total dollar value of shares that could be acquired under our authorized repurchase program at December&#160;31, 2024 was $1,033. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the fourth quarter 2024 we did not issue shares of our common stock as performance incentive awards to employees. When issued, these shares are not registered under the Securities Act of 1933 based on the conclusion that the awards are not events of sale within the meaning of Section 2(a)(3) of the Act.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following graph compares our total returns (including reinvestment of dividends) against the Standard&#160;&amp; Poor&#8217;s (S&amp;P) 500 Index and the S&amp;P 500 Health Care Index. The graph assumes $100 (not in millions) invested on December&#160;31, 2019 in our common stock and each of the indices.</span></div><div style="text-align:center"><img src="syk-20241231_g3.jpg" alt="982" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:348px"/></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Company / Index</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stryker Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">118.17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">130.25</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">120.59</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">149.29</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">181.15</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">S&amp;P 500 Index</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">152.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">157.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">197.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">S&amp;P 500 Health Care Index</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">113.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">143.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">140.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">143.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">146.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13</span></div></td></tr></table></div></div></div><div id="i1442ddc197954361b38cabd10df2e256_40"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.650%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;6.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SELECTED FINANCIAL DATA.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:53.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.244%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.244%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Statement of Earnings Data</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">22,595</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">20,498</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14,440</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13,058</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11,578</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,968</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,057</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research, development and engineering expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and other impairments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,751&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,737&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,384&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,834&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,689</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,888</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,841</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,584</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,492</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,673</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,683</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,281</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,954</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,993</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,165</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,358</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,994</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,599</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dividends declared per share of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.240</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.050</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.835</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.585</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.355</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Data</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and current marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">42,971</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">39,912</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">36,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">34,631</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">34,330</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">20,634</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18,593</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">16,616</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14,877</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13,084</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Data </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,242</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,711</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,624</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,263</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,277</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Data</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of shareholders of record</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Approximate number of employees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span></div></td></tr></table></div></div></div><div id="i1442ddc197954361b38cabd10df2e256_43"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.650%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;7.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</span></td></tr></table></div><div id="i1442ddc197954361b38cabd10df2e256_46"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">About Stryker</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology, and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. Our goal is to achieve sales growth at the high-end of the medical technology (MedTech) industry and maintain our long-term capital allocation strategy that prioritizes: (1) Acquisitions, (2) Dividends and (3) Share repurchases.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Overview of 2024</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2024 we achieved reported net sales growth of 10.2%. Excluding the impact of acquisitions and divestitures, sales grew 10.2% in constant currency. We reported net earnings of $2,993 and net earnings per diluted share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$7.76. Excluding the impact of certain items, we achieved adjusted net earnings</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of $4,700 and adjusted net earnings per diluted share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of $12.19 representing growth of 15.0%. </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continued our capital allocation strategy by investing $1,628 in acquisitions and paying $1,219 in dividends to our shareholders. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2024 we completed various acquisitions for total consideration of $1,628 in upfront payments, net of cash acquired, as well as $400 of contingent consideration if certain commercial or clinical milestones are achieved. Refer to Note 6 to our Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In May 2024 we repaid the outstanding $600 principal amount of the 3.375% senior unsecured notes due May 15, 2024. In September 2024 we issued $750 of 4.250% senior unsecured notes due September 11, 2029, &#8364;800 of 3.375% senior unsecured notes due September 11, 2032, $750 of 4.625% senior unsecured notes due September 11, 2034 and &#8364;600 of 3.625% senior unsecured notes due September 11, 2036. In November 2024 we repaid the outstanding  &#8364;500 of floating rate senior notes and in December 2024 we repaid &#8364;850 of 0.250% senior unsecured notes.</span></div><div id="i1442ddc197954361b38cabd10df2e256_49"></div></div></div><div style="margin-top:15pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Refer to "Non-GAAP Financial Measures" for a discussion of non-GAAP financial measures used in this report and a reconciliation to the most directly comparable GAAP financial measure.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED RESULTS OF OPERATIONS</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:34.235%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.419%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.428%"/><td style="width:0.1%"/></tr><tr style="height:9pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percentage Change</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024 vs. 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023 vs. 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,595</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,498</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research, development and engineering expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill and other impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">nm</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,993</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,165</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,358</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">34.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings per diluted share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.76</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8.25</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted net earnings per diluted share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.19</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10.60</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9.34</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">nm - not meaningful</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:36.469%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.419%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.419%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.419%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.419%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.419%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.419%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.425%"/><td style="width:0.1%"/></tr><tr style="height:9pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Geographic and Segment Net Sales</span></div></td><td colspan="15" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percentage Change</span></td></tr><tr style="height:9pt"><td colspan="15" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024 vs. 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023 vs. 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Constant<br/>Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Constant<br/>Currency</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Geographic:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,595</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,498</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,595</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,498</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:17.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.471%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.471%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.471%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.898%"/><td style="width:0.1%"/></tr><tr><td colspan="66" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Supplemental Net Sales Growth Information</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Percentage Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2024 vs. 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2023 vs. 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">International</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Constant Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Constant Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Constant Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Constant Currency</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,518</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,163</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,893</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spinal Implants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,077</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,335</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,556</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,595</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,498</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: In the fourth quarter 2024 we reorganized our Spine business to align with certain updates to our internal reporting structure. The  spine enabling technologies portfolio (Enabling Technologies) was reclassified to Other Orthopaedics, the interventional spine portfolio was reclassified to Neuro Cranial and the remaining Spine business was renamed to Spinal Implants. Neuro Cranial includes sales related to interventional spine of $413, $327 and $282 for 2024, 2023 and 2022. Other Orthopaedics includes sales related to Enabling Technologies of $152, $149 and $131 for 2024, 2023 and 2022. In the first quarter 2024 a product line previously included in Instruments has been reclassified to Endoscopy to align with a change in our internal reporting structure. We have reflected these changes in all historical periods presented.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div id="i1442ddc197954361b38cabd10df2e256_52"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Consolidated Net Sales</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consolidated net sales in 2024 increased 10.2% as reported and 10.7% in constant currency, as foreign currency exchange rates negatively impacted net sales by 0.5%. Excluding the 0.5% impact of acquisitions and divestitures, net sales in constant currency increased by 9.1% from increased unit volume and 1.1% due to higher prices. The unit volume increase was primarily due to higher shipments across all businesses.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consolidated net sales in 2023 increased 11.1% as reported and 11.6% in constant currency, as foreign currency exchange rates negatively impacted net sales by 0.5%. Excluding the 0.1% impact of acquisitions and divestitures, net sales in constant currency increased by 10.9% from increased unit volume and 0.6% due to higher prices. The unit volume increase was due to higher shipments across all MedSurg and Neurotechnology businesses and most Orthopaedics businesses.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">MedSurg and Neurotechnology Net Sales</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">MedSurg and Neurotechnology net sales in 2024 increased 11.1% as reported and 11.6% in constant currency, as foreign currency exchange rates negatively impacted net sales by 0.5%. Excluding the 0.4% impact of acquisitions and divestitures, net sales in constant currency increased by 9.5% from increased unit volume and 1.7% due to higher prices. The unit volume increase was due to higher shipments across all MedSurg and Neurotechnology businesses. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">MedSurg and Neurotechnology net sales in 2023 increased 11.7% as reported and 12.2% in constant currency, as foreign currency exchange rates negatively impacted net sales by 0.5%. Excluding the 0.3% impact of acquisitions and divestitures, net sales in constant currency increased by 10.2% from increased unit volume and 1.7% due to higher prices. The unit volume increase was due to higher shipments across all MedSurg and Neurotechnology businesses. </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Orthopaedics Net Sales</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Orthopaedics net sales in 2024 increased 8.9% as reported and 9.4% in constant currency, as foreign currency exchange rates negatively impacted net sales by 0.5%. Excluding the 0.7% impact of acquisitions and divestitures, net sales in constant currency increased by 8.7% from increased unit volume. The unit volume increase was due to higher shipments across all Orthopaedics businesses.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Orthopaedics net sales in&#160;2023&#160;increased 10.3% as reported and 10.9% in constant currency, as foreign currency exchange rates negatively impacted net sales by 0.6%. Excluding the 0.1% impact of acquisitions and divestitures, net sales in constant currency increased by 11.9% from increased unit volume partially offset by 1.1% due to lower prices. The unit volume increase was due to higher shipments across most Orthopaedics businesses. </span></div><div id="i1442ddc197954361b38cabd10df2e256_55"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Gross Profit</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross profit was $14,440, $13,058 and $11,578 in 2024, 2023, and 2022. The key components of the change were: </span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross Profit <br/>Percent Net Sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">62.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sales pricing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20 bps</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Volume and mix</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100 bps</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Manufacturing and supply chain costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(40) bps</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped up to fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10 bps</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">63.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sales pricing</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40 bps</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Volume and mix</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60 bps</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Manufacturing and supply chain costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(40) bps</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped up to fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(20) bps</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Structural optimization and other special charges</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(20) bps</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">63.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross profit as a percentage of net sales increased to 63.9% in 2024 from 63.7% in 2023 due to higher sales pricing and favorable volume partially offset by higher manufacturing and supply chain costs primarily due to inflationary pressures impacting fixed and variable manufacturing costs as well as higher amortization of inventory stepped up to fair value. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross profit as a percentage of net sales increased to 63.7% in 2023 from 62.8% in 2022 due to higher sales pricing and favorable volume offset by higher manufacturing and supply chain costs primarily due to higher raw material costs in the first six months of 2023 and supply chain inefficiencies.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">While segment mix was not a significant driver of the change in gross profit as a percent of net sales between 2024, 2023 and 2022, we generally expect segment mix to have an unfavorable impact for the foreseeable future as we anticipate more rapid sales growth in our lower gross margin MedSurg and Neurotechnology segment than our Orthopaedics segment.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Research, Development and Engineering Expenses</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research, development and engineering expenses as a percentage of net sales in 2024 decreased to 6.5% from 6.8% in 2023 primarily due to lower spend on medical device regulations in the European Union.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research, development and engineering expenses as a percentage of net sales in 2023 decreased to 6.8% from 7.9% in 2022 primarily due to increased spending for product launches, the write-off of certain intangible assets and higher spend related to the new medical device regulations in the European Union in 2022.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Selling, General and Administrative Expenses </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Selling, general and administrative expenses as a percentage of net sales in 2024 decreased to 34.0% from 34.7% in 2023 primarily due to continued spend discipline and lower charges for structural optimization and certain legal matters partially offset by higher acquisition-related costs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Selling, general and administrative expenses as a percentage of net sales in 2023 of 34.7% remained relatively flat with 34.6%  in 2022 as charges of $132 related to share-based awards for Vocera employees that vested upon our acquisition in 2022 were partially offset by disciplined increases in spend and investments in 2023 to support our growth, including sales growth incentives and increased spend on travel and meetings. In addition, in 2022 we determined that certain commercial and regulatory milestones related to technology acquired in the purchase of Mobius Imaging and Cardan Robotics were no longer probable of being achieved and recorded $110 to reduce the fair value of contingent consideration.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Amortization of Intangible Assets</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization of intangible assets was $623, $635 and $627 in 2024, 2023 and 2022. These amounts include amortization related to intangible assets acquired in 2024 from various acquisitions, 2023 from Cerus Endovascular Limited (Cerus) and  2022 from Vocera. Refer to Notes 6 and 8 to our Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Goodwill and Other Impairments</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2024 and 2022 we recorded goodwill impairment charges of  $456 and $216</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">related to our Spine business. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2024 we recognized an estimated loss of $362</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">as a result of classifying certain assets in our Spinal Implants business as held for sale. Refer to Notes 8, 16 and 17 to our Consolidated Financial Statements for further information.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2024, 2023 and 2022 we recorded other impairments of $159, $36 and $54. Refer to Notes 15 and 16 to our Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating Income</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating income was $3,689, $3,888 and $2,841 in 2024, 2023 and 2022. Operating income decreased as a percentage of sales to 16.3% in 2024 from 19.0% in 2023 and increased from 15.4% in 2022. Refer to the comments above for discussion of the primary drivers of the change.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">MedSurg and Neurotechnology operating income as a percentage of net sales increased to 29.6% in 2024 from 28.5% in 2023. MedSurg and Neurotechnology operating income as a percentage of net sales increased to 28.5% in 2023 from 26.0% in 2022. Orthopaedics operating income as a percentage of net sales increased to 28.5% in 2024 from 27.2% in 2023. Orthopaedics operating income as a percentage of net sales increased to 27.2% in 2023 from 29.1% in 2022. The key components of the change were:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Income<br/>Percent Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">26.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">29.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sales pricing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">70 bps </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(30) bps</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Volume</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100 bps </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80 bps</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Manufacturing and supply chain costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">90 bps </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(220) bps</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research, development and engineering expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50 bps </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20 bps</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(60) bps </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(40) bps</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">28.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">27.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sales pricing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">70 bps </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0 bps</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Volume</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40 bps </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">70 bps</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Manufacturing and supply chain costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(40) bps </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(20) bps</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research, development and engineering expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0 bps </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10 bps</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40 bps </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">70 bps</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">29.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">28.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The increase in MedSurg and Neurotechnology operating income as a percentage of net sales in 2024 from 2023 was primarily driven by higher unit volumes, higher prices and a decrease in selling, general and administrative expenses as a percentage of sales partially offset by higher manufacturing and supply chain costs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The increase in MedSurg and Neurotechnology operating income as a percentage of net sales in 2023 from 2022 was primarily driven by higher unit volumes, higher prices and lower manufacturing and supply chain costs due to supply chain challenges impacting capital products in our MedSurg businesses in 2022 which improved in 2023 partially offset by higher selling, general and administrative expenses as a percentage of sales due to continued investments including sales growth incentives and a more normalized cadence of travel and meetings.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The increase in Orthopaedics operating income as a percentage of net sales for 2024 from 2023 was primarily driven by higher sales volumes and a decrease in selling, general and administrative expenses as a percentage of sales partially offset by higher manufacturing and supply chain costs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The decrease in Orthopaedics operating income as a percentage of net sales for 2023 from 2022 was primarily driven by higher  higher manufacturing and supply chain costs primarily due to increased inventory reserves partially offset by higher unit volumes.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income (expense), net was ($197), ($215) and ($158) in 2024, 2023 and 2022. The decrease in net expense in 2024 from 2023 was primarily due to higher interest income partially offset by lower interest expense in 2024. The increase in net expense in 2023 from 2022 was primarily due to the release of accrued interest of $50 in 2022 related to the effective settlement of the United States federal income tax audit for years 2014 through 2018. Refer to Note 11 to our Consolidated Financial Statements for further information and higher interest income in 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Our effective tax rate was 14.3%, 13.8% and 12.1% for 2024, 2023 and 2022. The effective income tax rate for 2024 decreased from 2023 due to the 2024 deferred tax benefit on the outside basis difference related to the anticipated sale of the Spinal Implants business partially offset by the 2023 tax effect related to transfers of intellectual property between tax jurisdictions. The effective income tax rate for 2023 increased from 2022 due to the 2022 effective settlement of the United States federal income tax audit for years 2014 through 2018 and the 2022 reversal of deferred income tax on undistributed earnings of foreign subsidiaries partially offset by the 2023 tax effect related to transfers of intellectual property between tax jurisdictions. Additionally, the effective income tax rates for 2024, 2023 and 2022 reflect the continued lower effective income tax rates as a result of our European operations and certain discrete tax items.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Organisation for Economic Cooperation and Development (OECD), which represents a coalition of member countries, has put forth two proposed base erosion and profit shifting frameworks that revise the existing profit allocation and nexus rules (Pillar One) and ensure a minimal level of taxation (Pillar Two). On December 12, 2022 the European Union member states agreed to implement the Inclusive Framework&#8217;s global corporate minimum tax rate of 15%, and various countries within and outside the European Union have either enacted or proposed new tax laws implementing Pillar Two in 2024. The OECD continues to release additional guidance and we anticipate more countries will enact similar tax laws. Some of the new tax laws became effective in 2024 while others will be effective in future years. These tax law changes and any additional contemplated tax law changes could increase tax expense in future periods.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net Earnings</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net earnings for 2024 increased to $2,993 or $7.76 per diluted share from $3,165 or $8.25 per diluted share in 2023 and $2,358 or $6.17 per diluted share in 2022. Refer to the comments above for discussion of the primary drivers of the change.</span></div><div id="i1442ddc197954361b38cabd10df2e256_58"></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We supplement the reporting of our financial information determined under accounting principles generally accepted in the United States (GAAP) with certain non-GAAP financial measures, including percentage sales growth in constant currency; percentage organic sales growth; adjusted gross profit; adjusted selling, general and administrative expenses; adjusted research, development and engineering expenses; adjusted operating income; adjusted other income (expense), net; adjusted income taxes; adjusted effective income tax rate; adjusted net earnings; and adjusted net earnings per diluted share (Diluted EPS). We believe these non-GAAP financial measures provide meaningful information to assist investors and shareholders in understanding our financial results and assessing our prospects for future performance. Management believes percentage sales growth in constant currency and the other adjusted measures described above are important indicators of our operations because they </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">exclude items that may not be indicative of or are unrelated to our core operating results and provide a baseline for analyzing trends in our underlying businesses. Management uses these non-GAAP financial measures for reviewing the operating results of reportable business segments and analyzing potential future business trends in connection with our budget process and bases certain management incentive compensation on these non-GAAP financial measures. To measure percentage sales growth in constant currency, we remove the impact of changes in foreign currency exchange rates that affect the comparability and trend of sales. Percentage sales growth in constant currency is calculated by translating current and prior year results at the same foreign currency exchange rate. To measure percentage organic sales growth, we remove the impact of changes in foreign currency exchange rates, acquisitions and divestitures, which affect the comparability and trend of sales. Percentage organic sales growth is calculated by translating current year and prior year results at the same foreign currency exchange rates excluding the impact of acquisitions and divestitures. To measure earnings performance on a consistent and comparable basis, we exclude certain items that affect the comparability of operating results and the trend of earnings. The income tax effect of each adjustment was determined based on the tax effect of the jurisdiction in which the related pre-tax adjustment was recorded. These adjustments are irregular in timing and may not be indicative of our past and future performance. The following are examples of the types of adjustments that may be included in a period:</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Acquisition and integration-related costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Costs related to integrating recently acquired businesses (e.g., costs associated with the termination of sales relationships, employee retention and workforce reductions, manufacturing integration costs and other integration-related activities), changes in the fair value of contingent consideration, amortization of inventory stepped-up to fair value, specific costs (e.g., deal costs and costs associated with legal entity rationalization) related to the consummation of the acquisition process and legal entity rationalization and acquisition-related tax items.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Amortization of purchased intangible assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Periodic amortization expense related to purchased intangible assets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Structural optimization and other special charges.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Costs associated with employee retention and workforce reductions, the closure or transfer of manufacturing and other facilities (e.g., site closure costs, contract termination costs and redundant employee costs during the work transfers), product line exits (primarily inventory, long-lived asset and specifically-identified intangible asset write-offs), certain long-lived and intangible asset write-offs and impairments and other charges.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Medical device regulations.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Costs specific to updating our quality system, product labeling, asset write-offs and product remanufacturing to comply with the new medical device reporting regulations and other requirements of the European Union.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Recall-related matters</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Changes in our best estimate of the  probable loss, or the minimum of the range of probable losses when a best estimate within a range is not known, to resolve the Rejuvenate, LFIT V40, Wright legacy hip products and other product recalls.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Regulatory and legal matters</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Changes in our best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within a range is not known, to resolve certain regulatory or other legal matters </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and the amount of favorable awards from settlements.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Tax matters</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Impact of accounting for certain significant and discrete tax items.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures with other companies' non-GAAP financial measures having the same or similar names. These adjusted financial measures should not be considered in isolation or as a substitute for reported sales growth, gross profit, selling, general and administrative expenses, research, development and engineering expenses, operating income, other income (expense), net, income taxes, effective income tax rate, net earnings and net earnings per diluted share, the most directly comparable GAAP financial measures. These </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">non-GAAP financial measures are an additional way of viewing aspects of our operations when viewed with our GAAP results and the reconciliations to corresponding GAAP financial measures at the end of the discussion of Consolidated Results of Operations below. We strongly encourage investors and shareholders to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted-average diluted shares outstanding used in the calculation of adjusted net earnings per diluted share are the same as those used in the calculation of reported net earnings per diluted share for the respective period.</span></div><div id="i1442ddc197954361b38cabd10df2e256_61"></div></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reconciliation of the Most Directly Comparable GAAP Financial Measure to Non-GAAP Financial Measure</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:30.471%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.913%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.132%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.165%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross Profit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Selling, General &amp; Administrative Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Research, Development &amp; Engineering Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Income (Expense), Net</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income Taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective<br/>Tax Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,440</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,685</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,466</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,689</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(197)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">499</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,993</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.76</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped-up to fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other acquisition and integration-related (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of purchased intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Structural optimization and other special charges (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill and other impairments (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations (d)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters (e)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters (f)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax matters (g)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,565</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,436</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,414</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,715</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(196)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">819</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,700</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.19</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:30.471%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.913%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.132%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.165%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross Profit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Selling, General &amp; Administrative Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Research, Development &amp; Engineering Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Income (Expense), Net</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income Taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective<br/>Tax Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,058</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,111</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,388</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,888</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(215)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">508</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,165</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8.25</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped-up to fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other acquisition and integration-related (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of purchased intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Structural optimization and other special charges (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill and other impairments (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations (d)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters (e)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters (f)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax matters (g)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,099</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,851</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,293</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,955</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(223)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">666</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,066</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10.60</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross Profit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Selling, General &amp; Administrative Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Research, Development &amp; Engineering Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Income (Expense), Net</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income Taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective<br/>Tax Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,578</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,386</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,454</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,841</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(158)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">325</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,358</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped-up to fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other acquisition and integration-related (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of purchased intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Structural optimization and other special charges (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill and other impairments (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations (d)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters (e)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters (f)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax matters (g)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,649</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,035</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,230</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,384</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(233)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">580</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,571</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9.34</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:112%">(a) Charges represent certain acquisition and integration-related costs associated with acquisitions, including:</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.012%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Termination of sales relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee retention and workforce reductions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in the fair value of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Manufacturing integration costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock compensation payments upon a change in control</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other integration-related activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjustments to Operating Income </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">138</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Charges for acquisition-related tax provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income taxes related to acquisition and integration-related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjustments to Income Taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(25)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjustments to Net Earnings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">85</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">45</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">104</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:112%">(b) Structural optimization and other special charges represent the costs associated with: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.012%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee retention and workforce reductions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Closure/transfer of manufacturing and other facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Product line exits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Termination of sales relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjustments to Operating Income </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">138</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">170</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">295</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjustments to Other Income (Expense), Net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjustments to Income Taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">61</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjustments to Net Earnings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">110</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">132</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">234</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:112%">(c) Goodwill and other impairments represent the costs associated with: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.012%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Certain long-lived and intangible asset write-offs and impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Product line exits (e.g., long-lived asset and specifically-identified intangible asset write-offs)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjustments to Operating Income </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">977</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">270</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjustments to Income Taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">125</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjustments to Net Earnings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">852</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">265</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:142%">(d)  Charges represent the costs specific to updating our quality system, product labeling, asset write-offs and product remanufacturing to comply with the medical device reporting regulations and other requirements of the new medical device regulations in the European Union.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:142%">(e)  Charges represent changes in our best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within a range is not known, to resolve certain recall-related matters.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:142%">(f)  Charges represent changes in our best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within a range is not known, to resolve certain regulatory or other legal matters and the amount of favorable awards from settlements.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:142%">(g)   Benefits / (charges) represent the accounting impact of certain significant and discrete tax items, including:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.012%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Adjustments related to the transfer of certain intellectual properties between tax jurisdictions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Certain tax audit settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">162</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reversal of deferred income tax on undistributed earnings of foreign subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">71</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred tax benefit on outside basis related to the anticipated sale of the Spinal Implants business</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">170</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other significant and discrete tax items</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(60)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjustments to Income Taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(28)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(51)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits for certain tax audit settlements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other tax related adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(30)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjustments to Other Income (Expense), Net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(75)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjustments to Net Earnings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">28</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">43</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(66)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span><br/></span></div><div id="i1442ddc197954361b38cabd10df2e256_64"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL CONDITION AND LIQUIDITY</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.980%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.258%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,242&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,624&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(962)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,924)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,594)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(749)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">681</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,127</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,100)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe our financial condition continues to be of high quality, as evidenced by our ability to generate substantial cash from operations and to readily access capital markets at competitive rates despite the current macroeconomic environment. Operating cash flow provides the primary source of cash to fund operating needs and capital expenditures. Excess operating cash is used first to fund acquisitions to complement our portfolio of </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">businesses. Other discretionary uses include dividends and share repurchases. We supplement operating cash flow with debt to fund our activities as necessary. Our overall cash position reflects our business results and a global cash management strategy that takes into account liquidity management, economic factors and tax considerations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash provided by operating activities was $4,242, $3,711 and $2,624 in 2024, 2023 and 2022. The increase in 2024 was primarily due to higher cash earnings partially offset by changes in working capital. The increase in 2023 from 2022 was primarily due to higher net earnings and increased collections on accounts receivable.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash used in investing activities was $3,000, $962 and $2,924 in 2024, 2023 and 2022. Cash used in 2024 included cash paid for various acquisitions and purchases of short-term investments partially offset by proceeds from the settlement of certain foreign currency forward contracts designated as net investment hedges. The decrease in cash used in 2023 was primarily due to lower amounts paid for acquisitions. Our 2023 acquisitions included Cerus and in 2022 we acquired Vocera.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash used in financing activities was $525, $1,594 and $749 in 2024, 2023 and 2022. Cash used in 2024 was primarily driven by dividend payments of $1,219 and repayments of $2,039 to pay off maturing senior unsecured notes. These repayments were offset by net proceeds of $3,011 from the issuance of senior unsecured notes as described in Note 10 to our Consolidated Financial statements. In 2023 we received proceeds of 1,241 from issuance of long-term debt and made payments of $2,058 on long-term debt and dividend payments of $1,139. In 2022 we made payments of $653 on long-term debt and dividend payments of $1,051. There were no share repurchases in 2024, 2023 or 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We maintain debt levels that we consider appropriate after evaluating a number of factors including cash requirements for ongoing operations, investment and financing plans (including acquisitions and share repurchase activities) and overall cost of capital. Refer to Note 10 to our Consolidated Financial Statements for further information.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:63.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.715%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.715%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.717%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends paid per common share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.78&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total dividends paid to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents and marketable securities were $3,743 and $3,053, and our current assets exceeded current liabilities by $7,231 and $4,597 on December&#160;31, 2024 and 2023. In addition, we have $750 of short-term investments which mature in the first quarter of 2025. We anticipate being able to support our short-term liquidity and operating needs from a variety of sources including cash from operations, commercial paper and existing credit lines. We also have a revolving credit agreement maturing in October 2026 with an aggregate principal amount of $2,250.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We raised funds in the capital markets in the past and may continue to do so from time-to-time. We continue to have strong investment-grade short-term and long-term debt ratings that we believe should enable us to refinance our debt as needed.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our cash, cash equivalents and marketable securities held in locations outside the United States was approximately 20% and 25% on December&#160;31, 2024 and 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Guarantees and Other Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We do not have guarantees or other off-balance sheet financing arrangements, including variable interest entities, of a magnitude that we believe could have a material impact on our financial condition or liquidity.</span></div><div id="i1442ddc197954361b38cabd10df2e256_67"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONTRACTUAL OBLIGATIONS AND FORWARD-LOOKING CASH REQUIREMENTS</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2024 we recorded charges for various legal matters as further described in Note 7 to our Consolidated Financial Statements. Recorded reserves represent the best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known. The final outcome of these matters is dependent on many variables that are difficult to </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">predict. The ultimate cost to entirely resolve these matters may be materially different from the amount of the current estimates and could have a material adverse effect on our financial position, results of operations and cash flows. We are not able to reasonably estimate the future periods in which payments will be made.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As further described in Note 11 to our Consolidated Financial Statements, on December&#160;31, 2024 we had a reserve for uncertain income tax positions of $349. Due to uncertainties regarding the ultimate resolution of income tax audits, we are not able to reasonably estimate the future periods in which any income tax payments to settle these uncertain income tax positions will be made.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As further described in Note 12 to our Consolidated Financial Statements, on December&#160;31, 2024 our defined benefit pension plans were underfunded by $290, of which approximately $291 related to plans outside the United States. Due to the rules affecting tax-deductible contributions in the jurisdictions in which the plans are offered and the impact of future plan asset performance, changes in interest rates and potential changes in legislation in the United States and other foreign jurisdictions, we are not able to reasonably estimate the amounts that may be required to fund defined benefit pension plans. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.095%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.095%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Contractual Obligations</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026-2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028-2029</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">After 2029</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt repayments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest payments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unconditional purchase obligations</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States Tax Cuts and Jobs Act Transition Tax</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21,187</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,801</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,950</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,152</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,284</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div id="i1442ddc197954361b38cabd10df2e256_70"></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In preparing our financial statements in accordance with generally accepted accounting principles, there are certain accounting policies, which may require substantial judgment or estimation in their application. We believe these accounting policies and the others set forth in Note 1 to our Consolidated Financial Statements are critical to understanding our results of operations and financial condition.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Actual results could differ from our estimates and assumptions, and any such differences could be material to our results of operations and financial condition. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our annual tax rate is determined based on our income, statutory tax rates and the tax impacts of items treated differently for tax purposes than for financial reporting purposes. Tax law requires certain items be included in the tax return at different times than the items are reflected in the financial statements. Some of these differences are permanent, such as expenses that are not deductible in our tax return, and some differences are temporary and reverse over time, such as depreciation expense. These temporary differences create deferred tax assets and liabilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax assets generally represent the tax effect of items that can be used as a tax deduction or credit in future years for which we have already recorded the tax benefit in our income statement. Deferred tax liabilities generally represent tax expense recognized in our financial statements for which payment was deferred, the tax effect of expenditures for which a deduction was taken in our tax return but has not yet been recognized in our financial statements or assets recorded at fair value in business combinations for which there was no corresponding tax basis adjustment.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inherent in determining our annual tax rate are judgments regarding business plans, tax planning opportunities and expectations about future outcomes. Realization of certain deferred tax assets is dependent upon generating sufficient taxable income in the appropriate jurisdiction prior to the expiration of the carryforward periods. Although realization is not assured, management believes it is more likely than not that our deferred tax assets, net of valuation allowances, will be realized.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We operate in multiple jurisdictions with complex tax policy and regulatory environments. In certain of these jurisdictions, we may take tax positions that management believes are supportable but are potentially subject to successful challenge by the applicable taxing authority. These differences of interpretation with the respective governmental taxing authorities can be impacted by the local economic and fiscal environment. We evaluate our tax positions and establish liabilities in accordance with the applicable accounting guidance on uncertainty in income taxes. We review these tax uncertainties in light of changing facts and circumstances, such as the progress of tax audits, and adjust them accordingly. We have a number of audits in process in various jurisdictions. Although the resolution of these tax positions is uncertain, based on currently available information, we believe that it is more likely than not that the ultimate outcomes will not have a material adverse effect on our financial position, results of operations or cash flows.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the number of estimates and assumptions inherent in calculating the various components of our tax provision, certain changes or future events, such as changes in tax legislation, geographic mix of earnings, completion of tax audits or earnings repatriation plans, could have an impact on those estimates and our effective tax rate.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Acquisitions, Goodwill and Intangibles, and Long-Lived Assets</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our financial statements include the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded on the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Significant judgment is required in estimating the fair value of intangible assets and in assigning their respective useful lives. Accordingly, we typically obtain the assistance of third-party valuation specialists for significant items. The fair value estimates are based on available historical information and on future expectations and assumptions deemed reasonable by management but are inherently uncertain. We typically use an income method to estimate the fair value of intangible assets, which is based on forecasts of the expected future cash flows attributable to the respective assets. Significant estimates and assumptions inherent in the valuations reflect a consideration of other marketplace participants and include the amount and timing of future cash flows (including expected growth rates and profitability), the underlying product or technology life cycles, the economic barriers to entry and the discount rate applied to the cash flows. Unanticipated market or macroeconomic events and circumstances may occur that could affect the accuracy or validity of the estimates and assumptions. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Determining the useful life of an intangible asset also requires judgment. With the exception of certain trade names, the majority of our acquired intangible assets (e.g., certain trademarks or brands, customer and distributor relationships, patents and technologies) are expected to have determinable useful lives. Our assessment as to the useful lives of these intangible assets </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">is based on a number of factors including competitive environment, market share, trademark, brand history, underlying product life cycles, operating plans and the macroeconomic environment of the countries in which the trademarked or branded products are sold. Our estimates of the useful lives of determinable-lived intangibles are primarily based on these same factors. Determinable-lived intangible assets are amortized to expense over their estimated useful life. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations, IPRD is considered to be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions, IPRD is expensed immediately unless there is an alternative future use.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets and goodwill are not amortized but are tested annually for impairment or whenever events or circumstances indicate such assets may be impaired. Our annual impairment testing date is October 31. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When it is unlikely that an indefinite-lived intangible asset or goodwill of a reporting unit is impaired, we perform a qualitative assessment. For goodwill, that qualitative assessment may be periodically supplemented with a corroborative quantitative analysis. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When necessary, we perform a quantitative impairment test and determine the fair value of the indefinite-lived intangible asset or reporting unit using an income approach. For the quantitative impairment test of goodwill, we corroborate our concluded value under the income approach using a market approach that utilizes trading multiples derived from a peer set of similar companies. The income approach calculates the present value of estimated future cash flows and requires certain assumptions and estimates be made regarding market conditions and our future profitability. Considerable management judgment is necessary to evaluate the impact of operating and macroeconomic changes and to estimate future cash flows used to measure fair value. Assumptions used in our impairment evaluations, such as forecasted growth rates and cost of capital, are consistent with internal business plans. We believe such assumptions and estimates are also comparable to those that would be used by other marketplace participants. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review our other long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows, which is at the individual asset level or the asset group level. The undiscounted cash flows expected to be generated by the related assets are estimated over their useful life based on updated projections. If the evaluation indicates that the carrying amount of the assets may not be recoverable, any potential impairment is measured based upon the fair value of the related assets or asset group as determined by an appropriate market appraisal or other valuation technique. Assets classified as held for sale, if any, are recorded at the lower of carrying amount or fair value less costs to sell. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2022 we recognized a goodwill impairment charge of $216 for the Spine reporting unit. Due to the impairment charge in 2022, we performed a quantitative impairment test for our Spine reporting unit at October 31, 2023 and determined that its fair value exceeded its carrying amount and no additional impairment charges were recorded. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Spine business&#8217;s operating results continue to be affected by inflationary pressures and the competitive environment. These </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">inputs were included in the updated projections used in our annual long-range financial plan, which was approved during the third quarter 2024. Additionally, it was considered likely that we would reorganize our Spine reporting unit during the fourth quarter 2024 to separate the spine enabling technologies portfolio (Enabling Technologies) from the spinal implant portfolio (Spinal Implants). While changes in reporting units are accounted for on a prospective basis, they may be an indicator that goodwill of a reporting unit is potentially impaired. As a result of these factors, we performed a quantitative impairment test of the Spine reporting unit at September 30, 2024. The outcome of the impairment test was that the fair value of the Spine reporting unit exceeded its carrying amount by 9% and we did not record any impairment charges in the third quarter 2024.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the minimal passing margin of the quantitative impairment test performed at September 30, 2024 and an increase in the discount rate impacting the Spine reporting unit&#8217;s weighted average cost of capital used to discount the estimated future cash flows, we performed a quantitative impairment test for our Spine reporting unit at October 31, 2024.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As the impairment test indicated that goodwill was impaired, we evaluated the recoverability of the underlying asset groups prior to performing a quantitative goodwill impairment test for our Spine reporting unit at October 31, 2024. There were no indicators of impairment of the long-lived assets of the Enabling Technologies asset group; however, we determined that further evaluation of the Spinal Implants asset group was necessary. A recoverability test was performed by comparing the undiscounted cash flows of the Spinal Implants asset group to its carrying amount. Significant inputs to the analysis included assumptions for future revenue growth, operating margin, remaining useful life of the primary asset and the salvage value of the net assets. As a result, we determined that the undiscounted cash flows of the Spinal Implants asset group exceeded its net carrying amount by over 80% and further testing of long-lived assets was not necessary. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As we determined that there was no impairment of long-lived assets in the Spine reporting unit, we completed the quantitative goodwill impairment test and concluded that our Spine reporting unit's carrying amount was in excess of its estimated fair value and recognized a goodwill impairment charge of $273. The impairment charge for the Spine reporting unit was driven by a decrease in future product demand due to the competitive environment and an increase in the Spine reporting unit&#8217;s weighted average cost of capital.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In our quantitative goodwill impairment tests performed at September 30 and October 31, the fair value of our Spine reporting unit was determined using a discounted cash flow analysis, which is a form of the income approach. Significant inputs to the analysis included assumptions for future revenue growth, operating margin and the rate used to discount the estimated future cash flows to their present value based on the reporting unit&#8217;s estimated weighted average cost of capital. Our assumptions for revenue growth and operating margin considered several operating factors, including surgery volumes, increased costs and our competitive environment. We believe our estimates are appropriate based upon current and future market conditions and the best information available at the impairment assessment date. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Historical goodwill impairment assessments for our other reporting units have indicated that their implied fair values exceed their respective carrying amounts by at least 100%. We did not identify any factors in 2024 or 2023 that would lead us to believe </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">that those reporting units are at risk of a goodwill impairment. Accordingly, we performed qualitative assessments and concluded it was more likely than not that the fair values of those reporting units exceeded their respective carrying amounts. Future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill and indefinite-lived intangible assets, including discount rates and cash flow projections, could result in significantly different estimates of fair value. A significant reduction in estimated fair values could result in impairment charges that could materially affect our results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the fourth quarter 2024 management committed to a plan to sell certain assets associated with the Spinal Implants business (disposal group) and such assets were classified as held for sale beginning November 2024. We tested the net carrying amounts of other assets, such as working capital accounts, and determined that there was no impairment as the fair values of these assets approximated their carrying values.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill was allocated to the disposal group and the retained portion of the Spine reporting unit based on the relative fair values. Goodwill allocated to the disposal group was tested for impairment which resulted in an impairment charge of $183. The fair value of the disposal group was measured based upon unobservable amounts, such as the estimated selling price derived from Company-specific information and market conditions. We believe our estimates are appropriate based upon current and future market conditions and the best information available at the impairment assessment date. As of December 31, 2024, there is no goodwill remaining attributable to the Spinal Implants disposal group.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Finally we compared the carrying amount of the disposal group to the fair value less cost to sell. As a result, we recognized an estimated loss of $362 to record the disposal group at its fair value less cost to sell within goodwill and other impairments in our Consolidated Statements of Earnings. The fair value of the disposal group was measured using a discounted cash flow analysis based upon unobservable inputs, such as estimated selling price derived from Company-specific information, market conditions and the rate used to discount the estimated future cash flows to their present value based on factors including the disposal group&#8217;s cost of equity and market yield rates, which are Level 3 inputs. Future changes in the judgments, assumptions and estimates that are used in our fair value estimate, including discount rates and cash flow projections, could result in a significantly different estimate of fair value. In January 2025 we entered into a definitive agreement to sell the Spinal Implants disposal group as further discussed in Note 17. The terms of the definitive agreement were materially the same as those considered as inputs to the valuation of the disposal group at December 31, 2024. A change in the amount or timing of consideration received could increase the fair value by up to $84 or decrease the fair value by up to $218. Refer to Notes 16 and 17 to the Consolidated Financial Statements for additional information on the assets classified as held for sale and the definitive agreement announced to sell certain assets within our Spinal Implants business.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the fourth quarter 2024 subsequent to the October 31 impairment test, we combined the remainder of the Spine reporting unit representing the Enabling Technologies portfolio into our Joint Replacement reporting unit to align to certain updates to our internal reporting structure. As a result, the goodwill of approximately $580 remaining after allocation to the disposal group was reassigned to the Joint Replacement reporting unit.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">23</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Legal and Other Contingencies</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are involved in various ongoing proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor, intellectual property and other matters that are more fully described in Note 7 to our Consolidated Financial Statements. The outcomes of these matters will generally not be known for prolonged periods of time. In certain of the legal proceedings, the claimants seek damages, as well as other compensatory and equitable relief, that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief. For legal matters for which management had sufficient information to reasonably estimate our future obligations, a liability representing management's best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, for the resolution of these legal matters is recorded. The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those projected by management, additional expense may be incurred, which could unfavorably affect future operating results. We are currently self-insured for certain claims and expenses. The ultimate cost to us with respect to product liability claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.</span></div><div id="i1442ddc197954361b38cabd10df2e256_73"></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NEW ACCOUNTING PRONOUNCEMENTS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to Note 1 to our Consolidated Financial Statements for further information.</span></div><div id="i1442ddc197954361b38cabd10df2e256_76"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.471%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:72.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;7A.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We sell our products globally and, as a result, our operations and financial results could be significantly affected by market risk exposure from exchange rate risk. Our operating results are primarily exposed to changes in exchange rates among the United States Dollar, Australian Dollar, British Pound, Canadian Dollar, Euro and Japanese Yen. We develop and manufacture products in the United States, Canada, China, Costa Rica, France, Germany, India, Ireland, Israel, Mexico, Poland, Switzerland, Turkey and the United Kingdom and incur costs in the applicable local currencies. This global deployment of facilities serves to partially mitigate the impact of currency exchange rate changes on our cost of sales. Refer to Notes 1, 4 and 5 to our Consolidated Financial Statements for information regarding our use of derivative instruments to mitigate these risks. A hypothetical 10% change in foreign currencies relative to the United States Dollar would change the December&#160;31, 2024 fair value of these instruments by approximately $489. </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24</span></div></td></tr></table></div></div></div><div id="i1442ddc197954361b38cabd10df2e256_79"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.984%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;8.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of Stryker Corporation</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Stryker Corporation and subsidiaries (the Company) as of December 31, 2024 and 2023, the related consolidated statements of earnings, comprehensive income, shareholders&#8217; equity and cash flows for each of the three years in the period ended December 31, 2024, and the related notes and financial statement schedule listed in the Index at Item 15(a) (collectively referred to as the &#8220;consolidated financial statements&#8220;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024, in conformity with U.S. generally accepted accounting principles. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February 12, 2025 expressed an unqualified opinion thereon.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Critical Audit Matter</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the account or disclosure to which it relates.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.484%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Uncertain Tax Positions</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As described in Note 11 to the consolidated financial statements, the Company operates in multiple jurisdictions with complex tax policy and regulatory environments and establishes reserves for uncertain tax positions in accordance with the accounting guidance governing uncertainty in income taxes. Assessing tax positions involves judgment including interpreting tax laws of multiple jurisdictions and assumptions relevant to the measurement of an unrecognized tax benefit, including the estimated amount of tax liability that may be incurred should the tax position not be sustained upon inspection by a tax authority. These judgments and assumptions can significantly affect the reserve for uncertain tax positions. At December 31, 2024, the Company had accrued liabilities of $349 million relating to uncertain tax positions.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s accounting process for uncertain tax positions. For example, we tested controls over management&#8217;s identification of uncertain tax positions and its application of the recognition and measurement principles, including management&#8217;s review of the inputs and calculations of unrecognized income tax benefits when recorded.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our audit procedures to test the Company&#8217;s uncertain tax positions included, among others, involvement of our tax professionals, including transfer pricing professionals. This included evaluating third-party transfer pricing studies obtained by the Company and assessing the Company&#8217;s correspondence with the relevant tax authorities. We analyzed the Company&#8217;s assumptions and data used to determine the amount of tax benefit to recognize and tested the accuracy of the calculations. Our testing also included the evaluation of the ongoing positions and consideration of changes, the recording of penalties and interest and the ultimate settlement and payment of certain tax matters. We also evaluated the adequacy of the Company&#8217;s disclosures included in Note 11 related to these tax matters.</span></div><div style="text-align:justify"><span><br/></span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">/s/&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-74">Ernst&#160;&amp; Young LLP</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 1974.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-75">Grand Rapids, Michigan</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;12, 2025 </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25</span></div></td></tr></table></div></div></div><div id="i1442ddc197954361b38cabd10df2e256_82"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stryker Corporation and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EARNINGS</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:60.320%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.298%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-76">22,595</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-77">20,498</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-78">18,449</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-79">8,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-80">7,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-81">6,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-82">14,440</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-83">13,058</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-84">11,578</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research, development and engineering expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-85">1,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-86">1,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-87">1,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-88">7,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-89">7,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-90">6,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-91">623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-92">635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-93">627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and other impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-94">977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-95">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-96">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="f-97">10,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="f-98">9,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="f-99">8,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-100">3,689</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-101">3,888</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-102">2,841</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-103">197</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-104">215</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-105">158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-106">3,492</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-107">3,673</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-108">2,683</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-109">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-110">508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-111">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-112">2,993</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-113">3,165</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-114">2,358</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-115">7.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-116">8.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-117">6.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-118">7.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-119">8.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-120">6.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-average shares outstanding (in millions):</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-121">381.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-122">379.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-123">378.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive employee stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="f-124">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="f-125">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="f-126">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-127">385.6</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-128">383.7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-129">382.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Anti-dilutive shares excluded from the calculation of dilutive employee stock options were <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-130">4.3</ix:nonFraction> in 2022 and de minimis in all other periods.</span></div><div><span><br/></span></div><div id="i1442ddc197954361b38cabd10df2e256_88"></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:60.320%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.298%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-133">2,993</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-134">3,165</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-135">2,358</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="f-136">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-137">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-138">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pension plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-139">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-140">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-141">186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses) on designated hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-142">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-143">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-144">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial statement translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-145">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-146">124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-147">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total other comprehensive income (loss), net of tax</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-148">123</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-149">195</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-150">310</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-151">3,116</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-152">2,970</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-153">2,668</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to Consolidated Financial Statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">26</span></div></td></tr></table></div></div></div><div id="i1442ddc197954361b38cabd10df2e256_91"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stryker Corporation and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.012%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-154">3,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-155">2,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:OtherShortTermInvestments" scale="6" id="f-156">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:OtherShortTermInvestments" format="ixt:fixed-zero" scale="6" id="f-157">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="f-158">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="f-159">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, less allowance of $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="f-160">213</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="f-161">182</ix:nonFraction> in 2023)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="f-162">3,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="f-163">3,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Inventories:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Materials and supplies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="f-164">1,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="f-165">1,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-166">336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-167">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="f-168">3,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="f-169">3,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total inventories</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="f-170">4,774</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="f-171">4,843</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="6" id="f-172">1,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="f-173">857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-174">14,847</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-175">12,518</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Property, plant and equipment:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land, buildings and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="syk:LandBuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="f-176">1,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="syk:LandBuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="f-177">1,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-178">5,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-179">4,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-180">6,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-181">6,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less allowance for depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-182">3,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-183">3,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-184">3,448</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-185">3,215</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-186">15,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-187">15,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangibles, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-188">4,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-189">4,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncurrent deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-190">1,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-191">1,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-192">2,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-193">2,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-194">42,971</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-195">39,912</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities and shareholders' equity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="f-196">1,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="f-197">1,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-198">1,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-199">1,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-200">539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-201">391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DividendsPayableCurrent" scale="6" id="f-202">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DividendsPayableCurrent" scale="6" id="f-203">304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-204">2,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-205">2,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current maturities of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="f-206">1,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="f-207">2,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-208">7,616</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-209">7,921</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, excluding current maturities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-210">12,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-211">10,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="f-212">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="f-213">567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-214">2,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-215">1,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-216">22,337</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-217">21,319</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shareholders' equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-15" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-218"><ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-219">0.10</ix:nonFraction></ix:nonFraction> par value</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:CommonStockValueOutstanding" scale="6" id="f-220">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:CommonStockValueOutstanding" scale="6" id="f-221">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-222">2,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-223">2,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-224">18,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-225">16,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-226">293</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-227">416</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total shareholders' equity</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-228">20,634</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-229">18,593</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities &amp; shareholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-230">42,971</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-231">39,912</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to Consolidated Financial Statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">27</span></div></td></tr></table></div></div></div><div id="i1442ddc197954361b38cabd10df2e256_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stryker Corporation and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.727%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.689%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-232">380.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-233">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-234">378.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-235">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-236">377.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-237">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under stock compensation and benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-238">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="f-239">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-240">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="f-241">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-242">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="f-243">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-244">381.4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-245">38</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-246">380.1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-247">38</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-248">378.7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-249">38</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-250">2,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-251">2,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-252">1,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under stock compensation and benefit plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-253">68</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-254">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-255">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-256">229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-257">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-258">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-259">2,361</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-260">2,200</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-261">2,034</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-262">16,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-263">14,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-264">13,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-265">2,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-266">3,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-267">2,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends declared</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="6" id="f-268">1,236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-6" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="6" id="f-269">1,159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-6" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="6" id="f-270">1,073</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-271">18,528</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-272">16,771</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-273">14,765</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-274">416</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-275">221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-276">531</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-277">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-278">195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-279">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-280">293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-281">416</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-282">221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total shareholders' equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-283">20,634</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-284">18,593</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-285">16,616</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to Consolidated Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">28</span></div></td></tr></table></div></div></div><div id="i1442ddc197954361b38cabd10df2e256_97"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stryker Corporation and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:64.129%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.029%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-286">2,993</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-287">3,165</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-288">2,358</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:Depreciation" scale="6" id="f-289">427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:Depreciation" scale="6" id="f-290">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:Depreciation" scale="6" id="f-291">371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="f-292">623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="f-293">635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="f-294">627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and other impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-295">977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-296">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-297">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="f-298">229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="f-299">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="f-300">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sale of inventory stepped up to fair value at acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="syk:InventorySteppedUpToFairValueAtAcquisition" scale="6" id="f-301">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="syk:InventorySteppedUpToFairValueAtAcquisition" format="ixt:fixed-zero" scale="6" id="f-302">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="syk:InventorySteppedUpToFairValueAtAcquisition" scale="6" id="f-303">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income tax (benefit) expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-304">370</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-305">206</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-306">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-307">321</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-308">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-309">579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-310">206</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-311">797</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-312">762</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="6" id="f-313">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="6" id="f-314">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="6" id="f-315">290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="f-316">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="f-317">516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="f-318">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="f-319">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="f-320">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="f-321">238</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="f-322">306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="f-323">134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="f-324">107</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-325">4,242</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-326">3,711</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-327">2,624</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="f-328">1,628</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="f-329">390</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="f-330">2,563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="6" id="f-331">750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:fixed-zero" scale="6" id="f-332">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:fixed-zero" scale="6" id="f-333">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="f-334">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="f-335">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="f-336">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="f-337">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="f-338">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="f-339">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-340">755</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-341">575</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-342">588</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from settlement of net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromHedgeInvestingActivities" scale="6" id="f-343">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:ProceedsFromHedgeInvestingActivities" format="ixt:fixed-zero" scale="6" id="f-344">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:ProceedsFromHedgeInvestingActivities" scale="6" id="f-345">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other investing, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-346">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-347">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-348">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-349">3,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-350">962</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-351">2,924</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds (payments) on short-term borrowings, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="f-352">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="f-353">540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="f-354">375</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-355">3,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-356">1,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-357">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-358">2,039</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-359">2,058</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="f-360">653</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of dividends </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="f-361">1,219</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="f-362">1,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="f-363">1,051</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for taxes from withheld shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-364">195</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-365">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-366">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-367">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-368">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-369">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by (used in) financing activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-370">525</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-371">1,594</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-372">749</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-373">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-374">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-375">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-376">681</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="f-377">1,127</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="f-378">1,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-379">2,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-380">1,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-381">2,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-382">3,652</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-383">2,971</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-384">1,844</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental cash flow disclosure:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes, net of refunds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="f-385">989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="f-386">693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="f-387">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest on debt</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="f-388">396</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="f-389">356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="f-390">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to Consolidated Financial Statements.</span></div><div style="text-align:right"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">29</span></div></td></tr></table></div></div></div><div id="i1442ddc197954361b38cabd10df2e256_100"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div id="i1442ddc197954361b38cabd10df2e256_103"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 1 - <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-391" continuedAt="f-391-1" escape="true">SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="f-391-1" continuedAt="f-391-2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Nature of Operations: </span><ix:nonNumeric contextRef="c-1" name="us-gaap:NatureOfOperations" id="f-392" continuedAt="f-392-1" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker (the "Company," "we," "us," or "our") is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Our products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and artificial intelligence-assisted virtual care platform technology; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties.</span></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-392-1">During the fourth quarter 2024 we changed the name of our &#8220;Orthopaedics and Spine&#8221; operating segment to &#8220;Orthopaedics.&#8221;</ix:continuation> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis of Presentation and Consolidation: </span><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-393" continuedAt="f-393-1" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Consolidated Financial Statements include the Company and its subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. We have no material interests in variable interest entities. Certain prior year amounts have been reclassified to conform with current year presentation in our Consolidated Financial Statements.</span></ix:nonNumeric></div><ix:continuation id="f-393-1"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our reportable segments and related disclosures reflect certain reclassifications of prior year amounts from our Orthopaedics segment to our MedSurg and Neurotechnology segment due to changes in our internal reporting structure.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates: </span><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-394" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of net sales and expenses in the reporting period. Actual results could differ from those estimates.</span></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Revenue Recognition: </span><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="f-395" continuedAt="f-395-1" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales are recognized as the performance obligations to deliver products or services (including services under extended warranty service contracts) are satisfied and are recorded based on the amount of consideration we expect to receive in exchange for satisfying the performance obligations. Our sales are recognized primarily when we transfer control to the customer, which can be on the date of shipment, the date of receipt by the customer or, for most Orthopaedics products, when we have received a purchase order and appropriate notification the product has been used or implanted. Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time.</span></ix:nonNumeric></div><ix:continuation id="f-395-1" continuedAt="f-395-2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales represent the amount of consideration we expect to receive from customers in exchange for transferring products and services. Net sales exclude sales, value added and other taxes we collect from customers. Other costs to obtain and fulfill contracts are generally expensed as incurred due to the short-term nature of most of our sales. We extend terms of payment to our customers based on commercially reasonable terms for the markets of our customers, while also considering their credit quality.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A provision for estimated sales returns, discounts and rebates is recognized as a reduction of sales in the same period that the sales are recognized. Our estimate of the provision for sales </span></div></ix:continuation></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><ix:continuation id="f-391-2" continuedAt="f-391-3"><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="f-395-2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">returns has been established based on contract terms with our customers and historical business practices and current trends. Shipping and handling costs charged to customers are included in net sales.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cost of Sales: </span><ix:nonNumeric contextRef="c-1" name="us-gaap:CostOfSalesPolicyTextBlock" id="f-396" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of sales include direct materials and supplies consumed in the manufacture of product, as well as manufacturing labor, depreciation expense and direct overhead expense necessary to acquire and convert the purchased materials and supplies into finished product. Cost of sales also includes the cost to distribute products to customers, inbound freight costs, warehousing costs and other shipping and handling activity.</span></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Research, Development and Engineering Expenses: </span><ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="f-397" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research, development and engineering costs are charged to expense as incurred and include research, development and engineering activities relating to the development of new products, improvement of existing products, technical support of products and compliance with governmental regulations for the protection of customers and patients. Costs primarily include salaries, wages, consulting and depreciation and maintenance of research facilities and equipment.</span></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Selling, General and Administrative Expenses: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Costs <ix:nonNumeric contextRef="c-1" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" id="f-398" escape="true">include selling expenses, marketing expenses, administrative and other indirect overhead costs, amortization of loaner instrumentation, depreciation and amortization expense of non-manufacturing assets and other miscellaneous operating items.</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Currency Translation: </span><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-399" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial statements of subsidiaries outside the United States generally are measured using the local currency as the functional currency. Adjustments to translate those statements into United States Dollars are recorded in other comprehensive income (OCI). Transactional exchange gains and losses are included in other income (expense), net.</span></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash Equivalents: </span><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-400" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Highly liquid investments with remaining stated maturities of three months or less when purchased or other money market instruments that are redeemable upon demand are considered cash equivalents and recorded at cost.</span></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Short-term Investments: </span><ix:nonNumeric contextRef="c-1" name="syk:ShortTermInvestmentsPolicyPolicyTextBlock" id="f-401" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Short-term investments that have a maturity greater than three months and less than a year from the date of purchase primarily include time deposits, certificates of deposit, commercial paper, bonds and notes, substantially all of which are denominated in United States Dollars and are stated at cost plus accrued interest, which approximates fair value. We expect to hold all of our short-term investments to maturity.</span></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Marketable Securities: </span><ix:nonNumeric contextRef="c-1" name="us-gaap:MarketableSecuritiesPolicy" id="f-402" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities include marketable debt securities and mutual funds. Mutual funds are acquired to offset changes in certain liabilities related to deferred compensation arrangements and are expected to be used to settle these liabilities and are recognized in other noncurrent assets. Pursuant to our investment policy, all individual marketable security investments must have a minimum credit quality of single A (Standard&#160;&amp; Poor&#8217;s and Fitch) and A2 (Moody&#8217;s Corporation) at the time of acquisition, while the overall portfolio of marketable securities must maintain a minimum average credit quality of double A (Standard&#160;&amp; Poor&#8217;s and Fitch) or Aa (Moody&#8217;s Corporation). In the event of a rating downgrade below the minimum credit quality subsequent to purchase, the marketable security investment is evaluated to determine the appropriate action to take to minimize the overall risk to our marketable security investment portfolio. Our marketable securities are classified as available-for-sale and trading securities. Investments in trading securities represent participant-directed investments of deferred employee compensation.</span></ix:nonNumeric></div></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><ix:continuation id="f-391-3" continuedAt="f-391-4"><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounts Receivable: </span><ix:nonNumeric contextRef="c-1" name="us-gaap:ReceivablesPolicyTextBlock" id="f-403" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable include trade and other miscellaneous receivables. An allowance is maintained for doubtful accounts for estimated losses in the collection of accounts receivable. Estimates are made regarding the ability of customers to make required payments based on historical credit experience, current market conditions and expected credit losses. Accounts receivable are written off when all reasonable collection efforts are exhausted.</span></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Inventories: </span><ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryPolicyTextBlock" id="f-404" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value, with cost generally determined using the first-in, first-out (FIFO) cost method. For excess and obsolete inventory resulting from the potential inability to sell specific products at prices in excess of current carrying costs, reserves are maintained to reduce current carrying cost to net realizable value.</span></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Financial Instruments:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueOptionTextBlock" id="f-405" continuedAt="f-405-1" escape="true">Our financial instruments include cash, cash equivalents, marketable securities, accounts receivable, other investments, accounts payable, debt and foreign currency exchange contracts. The carrying value of our financial instruments, with the exception of our senior unsecured notes, approximates fair value on December&#160;31, 2024 and 2023. Refer to Notes 3 and 10 for further details. </ix:nonNumeric></span></div><ix:continuation id="f-405-1"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All marketable securities are recognized at fair value. Adjustments to the fair value of marketable securities that are classified as available-for-sale are recognized as increases or decreases, net of income taxes, within accumulated other comprehensive income (AOCI) in shareholders&#8217; equity and adjustments to the fair value of marketable securities that are classified as trading are recognized in earnings. The amortized cost of marketable debt securities is adjusted for amortization of premiums and discounts to maturity computed under the effective interest method. Such amortization and interest and realized gains and losses are included in other income (expense), net. The cost of securities sold is determined by the specific identification method.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review declines in the fair value of our investments classified as available-for-sale to determine whether the decline in fair value is a result of credit loss or other factors. Impairments of available-for-sale marketable debt securities related to credit loss are included in earnings and impairments related to other factors are recognized within AOCI.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivatives:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativesPolicyTextBlock" id="f-406" continuedAt="f-406-1" escape="true">All derivatives are recognized at fair value and reported on a gross basis. We enter into forward currency exchange contracts to mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, thereby limiting our risk that would otherwise result from changes in exchange rates. The periods of the forward currency exchange contracts correspond to the periods of the exposed transactions, with realized gains and losses included in the measurement and recording of transactions denominated in the nonfunctional currencies. All forward currency exchange contracts are recorded at their fair value each period.</ix:nonNumeric></span></div><ix:continuation id="f-406-1" continuedAt="f-406-2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. These nonfunctional currency exposures principally relate to forecasted intercompany sales and purchases of manufactured products and generally have maturities up to <ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativeTermOfContract" format="ixt-sec:durwordsen" id="f-407">eighteen months</ix:nonNumeric>. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="f-406-2" continuedAt="f-406-3"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">earnings and is included in cost of goods sold. Cash flows associated with these hedges are included in cash provided by operating activities in the same category as the cash flows from the items being hedged.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts are used to offset our exposure to the change in value of specific foreign currency denominated assets and liabilities, primarily intercompany payables and receivables. These derivatives are not designated as hedges and, therefore, changes in the value of these forward contracts are recognized in earnings, thereby offsetting the current earnings effect of the related changes in value of foreign currency denominated assets and liabilities. The estimated fair value of our forward currency exchange contracts represents the measurement of the contracts at month-end spot rates as adjusted by current forward points. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate derivative and non-derivative financial instruments as net investment hedges of our investments in certain international subsidiaries. For derivative instruments that are designated and qualify as a net investment hedge, the effective portion of the derivative's gain or loss is recognized in OCI and reported as a component of AOCI. We have elected to use the spot method to assess effectiveness for our derivatives designated as net investment hedges. Accordingly, the change in fair value attributable to changes in the spot rate is recorded in AOCI. We exclude the spot-forward difference from the assessment of hedge effectiveness and amortize this amount separately on a straight-line basis over the term of the forward contracts. This amortization is recognized in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate forward starting interest rate derivative instruments as cash flow hedges to manage the exposure to interest rate volatility with regard to future issuance and refinancing of debt. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into earnings and is included in interest expense within other income (expense), net. </span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-406-3">Interest rate derivative instruments designated as fair value hedges have been used in the past to manage the exposure to interest rate movements and to reduce borrowing costs by converting fixed-rate debt into floating-rate debt. Under these agreements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount.</ix:continuation> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Property, Plant and Equipment:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-408" escape="true">Property, plant and equipment is stated at cost. Depreciation is generally computed by the straight-line method over the estimated useful lives of <span style="-sec-ix-hidden:f-409">three</span> to <ix:nonNumeric contextRef="c-46" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-410">30</ix:nonNumeric> years for buildings and improvements and <span style="-sec-ix-hidden:f-411">three</span> to <ix:nonNumeric contextRef="c-48" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-412">15</ix:nonNumeric> years for machinery and equipment.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="f-413" continuedAt="f-413-1" escape="true">Goodwill represents the excess of purchase price over fair value of tangible net assets of acquired businesses at the acquisition date, after amounts allocated to other identifiable intangible assets. Factors that contribute to the recognition of goodwill include synergies that are specific to our business and not available to other market participants and are expected to increase net sales and profits; acquisition of a talented workforce; cost savings opportunities; the strategic benefit of expanding our presence in core and adjacent markets; and diversifying our product portfolio.</ix:nonNumeric></span></div><ix:continuation id="f-413-1" continuedAt="f-413-2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of other identifiable intangible assets acquired in a business combination are primarily determined using the income </span></div></ix:continuation></div></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><ix:continuation id="f-391-4" continuedAt="f-391-5"><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="f-413-2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">approach. Other intangible assets include, but are not limited to, developed technology, customer and distributor relationships (which reflect expected continued customer or distributor patronage) and trademarks and patents. Intangible assets with determinable useful lives are amortized on a straight-line basis over their estimated useful lives of <span style="-sec-ix-hidden:f-414">four</span> to <ix:nonNumeric contextRef="c-50" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-415">40</ix:nonNumeric> years. Certain acquired trade names are considered to have indefinite lives and are not amortized, but are assessed annually for potential impairment as described below.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations IPRD is considered to be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions IPRD is expensed immediately unless there is an alternative future use.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Goodwill, Intangibles and Long-Lived Asset Impairment Tests:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="syk:GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" id="f-416" continuedAt="f-416-1" escape="true">We perform our annual impairment test for goodwill as of October 31 each year. We consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill and periodically corroborate that assessment with quantitative information. In certain circumstances, we may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. Indefinite-lived intangible assets are also tested at least annually for impairment by comparing the individual carrying values to the fair value.</ix:nonNumeric></span></div><ix:continuation id="f-416-1"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows. Undiscounted cash flows expected to be generated by the related assets are estimated over the asset's useful life based on updated projections. If the evaluation indicates that the carrying amount of the asset may not be recoverable, any potential impairment is measured based upon the fair value of the related asset or asset group as determined by an appropriate market appraisal or other valuation technique.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Assets and Liabilities Held for Sale: </span><ix:nonNumeric contextRef="c-1" name="syk:AssetsAndLiabilitiesHeldForSalePolicyTextBlock" id="f-417" continuedAt="f-417-1" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">classify assets and liabilities or disposal groups to be sold as held for sale in the period in which all of the following criteria are met: management, having the authority to approve the action, commits to a plan to sell the disposal group; the disposal group is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such disposal groups; an active program to locate a buyer and other actions required to complete the plan to sell the disposal group have been initiated; the sale of the disposal group is probable, and transfer of the disposal group is expected to qualify for recognition as a completed sale within one year, except if events or circumstances beyond our control extend the period of time required to sell the disposal group beyond one year; the disposal group is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.</span></ix:nonNumeric></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="f-417-1"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We initially measure a disposal group that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held for sale criteria are met. Conversely, gains are not recognized on the sale of a disposal group until the sale is completed. We assess the fair value of a disposal group, less any costs to sell, each reporting period it remains classified as held for sale and report any subsequent changes as an adjustment to the carrying value of the disposal group, as long as the new carrying value does not exceed the carrying value of the disposal group at the time it was initially classified as held for sale.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Upon determining that a disposal group meets the criteria to be classified as held for sale, we cease depreciation and amortization of the assets and disclose the major classes of assets and liabilities of the disposal group in the Notes to the Consolidated Financial Statements. Refer to Note 16 for further information.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Share-Based Compensation:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> S<ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-418" continuedAt="f-418-1" escape="true">hare-based compensation is in the form of stock options, restricted stock units (RSUs) and performance stock units (PSUs). Stock options are granted under long-term incentive plans to certain key employees and non-employee directors at an exercise price not less than the fair market value of the underlying common stock, which is the quoted closing price of our common stock on the day prior to the date of grant. The options are granted for periods of up to <ix:nonNumeric contextRef="c-51" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="f-419">10</ix:nonNumeric> years and become exercisable in varying installments.</ix:nonNumeric></span></div><ix:continuation id="f-418-1"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We grant RSUs to key employees and non-employee directors and PSUs to certain key employees under our long-term incentive plans. The fair value of RSUs is determined based on the number of shares granted and the quoted closing price of our common stock on the date of grant, adjusted for the fact that RSUs do not include anticipated dividends. RSUs generally vest in one-third increments over a <ix:nonNumeric contextRef="c-52" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-420">three-year</ix:nonNumeric> period and are settled in stock. PSUs are earned over a <ix:nonNumeric contextRef="c-53" name="syk:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" format="ixt-sec:durwordsen" id="f-421">three-year</ix:nonNumeric> performance cycle and vest in March of the year following the end of that performance cycle. The number of PSUs that will ultimately be earned is based on our performance relative to pre-established goals in that <ix:nonNumeric contextRef="c-53" name="syk:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" format="ixt-sec:durwordsen" id="f-422">three-year</ix:nonNumeric> performance cycle. The fair value of PSUs is determined based on the quoted closing price of our common stock on the day of grant.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Compensation expense is recognized in the Consolidated Statements of Earnings based on the estimated fair value of the awards on the grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized associated with such grants will be reversed.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-423" continuedAt="f-423-1" escape="true">Deferred income tax assets and liabilities are determined based on differences between financial reporting and income tax bases of assets and liabilities and are measured using the enacted income tax rates in effect for the years in which the differences are expected to reverse. Deferred income tax benefits generally represent the change in net deferred income tax assets and liabilities in the year. Other amounts result from </ix:nonNumeric></span></div></div></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">32</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="f-391-5" continuedAt="f-391-6"><ix:continuation id="f-423-1"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">adjustments related to acquisitions and foreign currency as appropriate.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We operate in multiple income tax jurisdictions both within the United States and internationally. Accordingly, management must determine the appropriate allocation of income to each of these jurisdictions based on current interpretations of complex income tax regulations. Income tax authorities in these jurisdictions regularly perform audits of our income tax filings. Income tax audits associated with the allocation of this income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period of time to resolve and may result in significant income tax adjustments if changes to the income allocation are required between jurisdictions with different income tax rates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Tax Cuts and Jobs Act (the Act) was enacted in 2017 in the United States. The Act also subjects a United States shareholder to tax on Global Intangible Low-Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to account for GILTI tax in the year the tax is incurred.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-424" continuedAt="f-424-1" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2024 the Financial Accounting Standards Board (FASB) issued ASU 2024-03 (Subtopic 220-40): </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which requires disaggregation of certain expense captions into specified categories in disclosures within the Notes to the Consolidated Financial Statements. The new disclosure requirements are effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. We are currently evaluating these new expanded disclosure requirements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In December 2023 the FASB issued ASU 2023-09 (Topic 740): </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes: Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which expands the existing rules on income tax disclosures. This update requires entities to disclose specific categories in the tax rate reconciliation, provide additional information for reconciling items that meet a quantitative threshold and disclose additional information about income taxes paid on an annual basis. The new disclosure requirements are effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating these new expanded disclosure requirements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 1, 2024 we adopted ASU 2023-07, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Refer to Note 14 for further information.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><ix:continuation id="f-424-1" continuedAt="f-424-2"><ix:continuation id="f-391-6" continuedAt="f-391-7"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 1, 2023 we adopted ASU 2022-04, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Liabilities - Supplier Finance Programs: Disclosure of Supplier Finance Program Obligations</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-424-2"><ix:continuation id="f-391-7">. Refer to Note 7 for required disclosures.</ix:continuation></ix:continuation>  </span></div><div id="i1442ddc197954361b38cabd10df2e256_109"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 2 - <ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-426" continuedAt="f-426-1" escape="true">REVENUE RECOGNITION</ix:nonNumeric></span></div><ix:continuation id="f-426-1" continuedAt="f-426-2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We disaggregate our net sales by business and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time. In 2024 less than <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="syk:PercentageofServiceRevenueRecognizeoverTime" scale="-2" id="f-427">10</ix:nonFraction>% of our sales were recognized as services transferred over time. Refer to Note 1 for further discussion on our revenue recognition policies. </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><ix:continuation id="f-426-2" continuedAt="f-426-3"><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the fourth quarter 2024 we reorganized our Spine business to align with certain updates to our internal reporting structure. The spine enabling technologies portfolio (Enabling Technologies) was reclassified to Other Orthopaedics and Spine, the interventional spine portfolio was reclassified to Neuro Cranial and the remaining Spine business was renamed to Spinal Implants. In addition, we changed the name of our &#8220;Orthopaedics and Spine&#8221; operating segment to &#8220;Orthopaedics.&#8221; Neuro Cranial includes sales related to interventional spine of $<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-428">413</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-429">327</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-430">282</ix:nonFraction> for 2024, 2023 and 2022. Other Orthopaedics includes sales related to Enabling Technologies of $<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-431">152</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-432">149</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-433">131</ix:nonFraction> for 2024, 2023 and 2022. In the first quarter of 2024 a product line previously included in Instruments has been reclassified to Endoscopy to align with a change in our internal reporting structure. We have reflected these changes in all historical periods presented. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-434" escape="true"><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-435">2,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-436">2,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-437">2,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-438">3,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-439">3,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-440">2,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-441">3,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-442">3,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-443">3,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-444">1,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-445">1,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-446">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-447">2,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-448">1,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-449">1,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-450">13,518</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-451">12,163</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-452">10,893</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-453">2,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-454">2,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-455">1,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-456">1,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-457">1,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-458">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-459">3,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-460">3,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-461">2,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spinal Implants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-462">707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-463">713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-464">733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-465">712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-466">658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-467">606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-468">9,077</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-469">8,335</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-470">7,556</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-471">22,595</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-472">20,498</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-473">18,449</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">United States Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-474">2,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-475">2,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-476">1,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-477">2,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-478">2,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-479">2,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-480">3,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-481">2,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-482">2,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-483">506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-484">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-485">446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-486">1,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-487">1,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-488">1,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-489">10,517</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-490">9,328</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-491">8,248</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-492">1,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-493">1,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-494">1,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-495">1,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-496">988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-497">896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-498">2,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-499">2,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-500">2,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spinal Implants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-501">489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-502">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-503">511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-504">504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-505">468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-506">455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-507">6,426</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-508">5,929</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-509">5,390</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-510">16,943</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-511">15,257</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-512">13,638</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">International Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-513">567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-514">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-515">469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-516">597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-517">555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-518">514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-519">661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-520">674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-521">609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-522">801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-523">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-524">754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-525">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-526">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-527">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-528">3,001</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-529">2,835</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-530">2,645</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-531">659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-532">597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-533">504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-534">645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-535">556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-536">517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-537">921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-538">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-539">772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spinal Implants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-540">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-541">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-542">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-543">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-544">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-545">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-546">2,651</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-547">2,406</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-548">2,166</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-549">5,652</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-550">5,241</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-551">4,811</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="f-426-3" continuedAt="f-426-4"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">MedSurg and Neurotechnology</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">MedSurg and Neurotechnology products include surgical equipment, patient and caregiver safety technologies (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical), minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke (Neurovascular), cranial, maxillofacial and chest wall devices as well as dural substitutes and sealants; a comprehensive line of products for traditional brain and open skull based surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products (Neuro Cranial). Substantially all MedSurg and Neurotechnology sales are recognized when a purchase order has been received and control has transferred. For certain Endoscopy, Instruments and Medical services, we may recognize sales over time as we satisfy performance obligations that may include an obligation to complete installation, provide training and perform ongoing services, generally performed within one year.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Orthopaedics</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries, and cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. Substantially all Orthopaedics sales are recognized when we have received a purchase order and appropriate notification the product has been used or implanted. Substantially all Spinal Implants sales are recognized when a purchase order has been received and control has transferred. For certain Orthopaedic products in the "other" category, we recognize sales at a point in time, as well as over time for performance obligations that may include an obligation to complete installation and provide training and ongoing services. Performance obligations are generally satisfied within one year.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Costs to Obtain or Fulfill a Contract</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We typically do not incur costs to fulfill a contract before a product or service is provided to a customer due to the nature of our products and services. Our costs to obtain contracts are typically in the form of sales commissions paid to employees or third-party agents. Certain sales commissions paid to employees prior to recognition of sales are recorded as deferred contract costs. We expense sales commissions associated with obtaining a contract at the time of the sale or as incurred as the amortization period is generally less than one year. These costs have been presented within selling, general and administrative expenses. On December&#160;31, 2024 and 2023 deferred contracts costs recorded in our Consolidated Balance Sheets were not significant. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets and Liabilities </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our contract assets primarily relate to conditional rights to consideration for work completed but not billed at the reporting date. On December&#160;31, 2024 and 2023 contract assets recorded in our Consolidated Balance Sheets were not significant.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our contract liabilities arise as a result of consideration received from customers at inception of contracts for certain businesses or where the timing of billing for services precedes satisfaction of our performance obligations. This occurs primarily when payment is received upfront for certain multi-period extended warranty service contracts. Our contract liabilities of $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-552">978</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-553">860</ix:nonFraction> on </span></div></div></ix:continuation><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="f-426-4"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2024 and 2023 are classified within accrued expenses and other liabilities and other noncurrent liabilities within our Consolidated Balance Sheets based on the timing of when we expect to complete our performance obligations. <ix:nonNumeric contextRef="c-1" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="f-554" continuedAt="f-554-1" escape="true">Changes in contract liabilities during the year were as follows:</ix:nonNumeric></span></div><ix:continuation id="f-554-1"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.658%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning contract liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-555">860</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Revenue recognized from beginning of year contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-556">553</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net advance consideration received during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="syk:ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" scale="6" id="f-557">671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending contract liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-558">978</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Transfers and Servicing of Financial Assets </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We sell certain customer lease agreements and the related leased assets to third-party financial institutions to accelerate our cash collection cycle. The lease receivables are sold without recourse and are derecognized from our Consolidated Balance Sheets at the time of sale. Under the terms of our arrangements, we collect lease payments on behalf of the financial institutions but maintain no other form of continuing involvement. Sales of these lease agreements are classified as operating activities in our Consolidated Statements of Cash Flows. Fees earned for our servicing activities are immaterial. Revenue related to customer lease agreements sold under these arrangements represented less than 3% of our total revenue for 2024, 2023 and 2022.</span></div><div id="i1442ddc197954361b38cabd10df2e256_112"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 3 - <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-559" continuedAt="f-559-1" escape="true">FAIR VALUE MEASUREMENTS </ix:nonNumeric></span></div><ix:continuation id="f-559-1" continuedAt="f-559-2"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets and liabilities carried at fair value are classified in their entirety based on the lowest level of input and disclosed in one of the following three categories:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.107%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted market prices in active markets for identical assets or liabilities.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unobservable inputs reflecting our assumptions or external inputs from active markets.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Use of observable market data, when available, is required in making fair value measurements. When inputs used fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement. We determine fair value for Level 1 instruments using exchange-traded prices for identical instruments. We determine fair value of Level 2 instruments using exchange-traded prices of similar instruments, where available, or utilizing other observable inputs that take into account our credit risk and that of our counterparties. Foreign currency exchange contracts and interest rate hedges, when outstanding, are included in Level 2 and are primarily valued using standard calculations and models that use readily observable market data as their basis. Our Level 3 liabilities are comprised of contingent consideration arising from recently completed acquisitions. We determine fair value of these Level 3 liabilities using a discounted cash flow technique. Significant unobservable inputs were used in our assessment of fair value, including assumptions regarding future business results, discount rates, discount periods and probability assessments based on the likelihood of reaching various targets. We remeasure the fair value of our assets and liabilities each reporting period. We record the changes in fair value within selling, general and administrative expense.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2024 we recorded $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="f-560">208</ix:nonFraction> of contingent consideration related to various acquisitions described in Note 6.</span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">34</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="f-559-2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2023 we recorded $<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-561">192</ix:nonFraction> of contingent consideration related to the acquisition of Cerus described in Note 6.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were no significant transfers into or out of any level of the fair value hierarchy in 2024.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-562" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"/><td style="width:64.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.179%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.253%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.180%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Assets Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-563">3,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-564">2,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="f-565">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="6" id="f-566">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trading marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-6" name="us-gaap:TradingSecuritiesDebt" scale="6" id="f-567">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:TradingSecuritiesDebt" scale="6" id="f-568">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-569">4,661</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-570">3,180</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Available-for-sale marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and asset-backed debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="f-571">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="f-572">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States agency debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="f-573">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="f-574">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States treasury debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="f-575">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="f-576">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="f-577">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="f-578">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total available-for-sale marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="f-579">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="f-580">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="f-581">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="f-582">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-583">316</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-584">198</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-585">4,977</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-586">3,378</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"/><td style="width:64.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.179%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.253%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.180%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Liabilities Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred compensation arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-6" name="syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" scale="6" id="f-587">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" scale="6" id="f-588">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-589">259</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-590">209</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="f-591">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="f-592">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-593">77</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-594">97</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contingent consideration:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-595">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-596">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" scale="6" id="f-597">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" scale="6" id="f-598">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in estimate and foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" scale="6" id="f-599">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" scale="6" id="f-600">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="f-601">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="f-602">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ending</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-603">452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-604">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3 - Liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-605">452</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-606">289</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-607">788</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-608">595</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="f-609" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"/><td style="width:64.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.179%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.253%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.180%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Fair Value of Available for Sale Securities by Maturity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="f-610">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="f-611">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due after one year through three years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" scale="6" id="f-612">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" scale="6" id="f-613">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2024 the aggregate difference between the cost and fair value of available-for-sale marketable securities was nominal. Interest income on cash and cash equivalents, short-term investments and marketable securities income was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InterestIncomeInterestEarningAsset" scale="6" id="f-614">139</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:InterestIncomeInterestEarningAsset" scale="6" id="f-615">75</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:InterestIncomeInterestEarningAsset" scale="6" id="f-616">25</ix:nonFraction> in 2024, 2023 and 2022, which was recorded in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our investments in available-for-sale marketable securities had a minimum credit quality rating of A2 (Moody's), A (Standard &amp; Poor's) and A (Fitch). We do not plan to sell the investments, and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost basis, which may be maturity.</span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div id="i1442ddc197954361b38cabd10df2e256_115"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 4 - <ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="f-617" continuedAt="f-617-1" escape="true">DERIVATIVE INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="f-617-1" continuedAt="f-617-2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use operational and economic hedges, foreign currency exchange forward contracts, net investment hedges (both derivative and non-derivative financial instruments) and interest rate derivative instruments to manage the impact of currency exchange and interest rate fluctuations on earnings, cash flow and equity. We do not enter into derivative instruments for speculative purposes. We are exposed to potential credit loss in the event of nonperformance by counterparties on our outstanding derivative instruments but do not anticipate nonperformance by any of our counterparties. Should a counterparty default, our maximum loss exposure is the asset balance of the instrument. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign Currency Hedges</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="f-618" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.661%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash Flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Investment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Designated</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-619">1,588</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-620">2,338</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-621">5,164</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-622">9,090</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-198" name="us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1" format="ixt-sec:duryear" id="f-623">9.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-624">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-625">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-626">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-627">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-628">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-629">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="f-630">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-631">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-632">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-633">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-634">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-635">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-636">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-637">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-638">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-639">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="f-640">15</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="f-641">55</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="f-642">78</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="f-643">148</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash Flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Investment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Designated</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-644">1,650</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-645">1,662</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-646">4,315</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-647">7,627</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-219" name="us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1" format="ixt-sec:duryear" id="f-648">2.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-649">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-650">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-651">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-652">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-653">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="f-654">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="f-655">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-656">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-657">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-658">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-659">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-660">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-661">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-662">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-663">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-664">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="f-665">8</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="f-666">31</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-6" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="f-667">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="f-668">19</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We had &#8364;<ix:nonFraction unitRef="eur" contextRef="c-195" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="f-669">2.3</ix:nonFraction>&#160;billion and &#8364;<ix:nonFraction unitRef="eur" contextRef="c-216" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="f-670">1.5</ix:nonFraction>&#160;billion at December 31, 2024 and 2023 in certain forward currency contracts designated as net investment hedges, for which the maximum term is <ix:nonNumeric contextRef="c-198" name="us-gaap:DerivativeTermOfContract" format="ixt-sec:duryear" id="f-671">9.7</ix:nonNumeric> years, to hedge a portion of our investments in certain of our entities with functional currencies denominated in Euros. In addition to these derivative financial instruments designated as net investment hedges, we had &#8364;<ix:nonFraction unitRef="eur" contextRef="c-236" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="f-672">5.0</ix:nonFraction>&#160;billion and &#8364;<ix:nonFraction unitRef="eur" contextRef="c-237" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="f-673">4.9</ix:nonFraction>&#160;billion at December 31, 2024 and 2023 of senior unsecured notes designated as net investment hedges to selectively hedge portions of our investment in certain international subsidiaries. The currency effects of our Euro-denominated senior unsecured notes are reflected in AOCI within shareholders' equity where they offset gains and losses recorded on our net investment in international subsidiaries.</span></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2024 we settled certain foreign currency forward contracts designated as net investment hedges resulting in cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromHedgeInvestingActivities" scale="6" id="f-674">99</ix:nonFraction>. The amounts in AOCI related to settled net investment hedges will remain in AOCI until the hedged investment is either sold or substantially liquidated.</span></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The total after-tax gain (loss) recognized in OCI related to designated net investment hedges was $<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="f-675">325</ix:nonFraction> in 2024.</span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">35</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="f-617-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="f-676" escape="true"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:28.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.440%"/><td style="width:0.1%"/></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Currency Exchange Rate Gains (Losses) Recognized in Net Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recognized in:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-677">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-678">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-679">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net Investment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-680">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-681">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-682">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-Designated</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-683">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-684">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-685">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-686">106</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-687">98</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-688">92</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pretax gains (losses) on derivatives designated as cash flow hedges of $<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="f-689">14</ix:nonFraction> and net investment hedges of $<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-6" name="us-gaap:DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" scale="6" id="f-690">43</ix:nonFraction> recorded in AOCI are expected to be reclassified to cost of sales and other income (expense), net in earnings within 12 months of December&#160;31, 2024. This cash flow hedge reclassification is primarily due to the sale of inventory that includes previously hedged purchases. A component of the AOCI amounts related to net investment hedges is reclassified over the life of the hedge instruments as we elected to exclude the initial value of the component related to the spot-forward difference from the effectiveness assessment. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Interest Rate Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pretax gains of $<ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="f-691">4</ix:nonFraction> recorded in AOCI related to interest rate hedges closed in conjunction with debt issuances are expected to be reclassified to other income (expense), net in earnings within 12 months of December&#160;31, 2024. The cash flow effect of interest rate hedges is recorded in cash flow from operations.</span></div></ix:continuation><div id="i1442ddc197954361b38cabd10df2e256_118"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 5 - <ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="f-692" continuedAt="f-692-1" escape="true">ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME (AOCI)</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-693" escape="true"><ix:continuation id="f-692-1"><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:26.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.868%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.868%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.902%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Marketable Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedges</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial Statement Translation</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-694">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-695">31</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-696">52</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-697">303</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-698">221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="f-699">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="f-700">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="f-701">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="f-702">157</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="f-703">196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="6" id="f-704">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="f-705">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="f-706">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="f-707">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="f-708">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="f-709">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="f-710">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-6" sign="-" name="us-gaap:CostOfRevenue" scale="6" id="f-711">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="f-712">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-6" sign="-" name="us-gaap:CostOfRevenue" scale="6" id="f-713">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="f-714">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-715">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-716">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-717">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-718">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-719">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-720">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-721">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-722">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-723">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-724">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-725">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-726">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-727">124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-728">195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="f-729">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-730">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-731">39</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-732">427</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-733">416</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="f-734">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="f-735">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="f-736">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="f-737">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="f-738">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="6" id="f-739">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="f-740">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="f-741">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="f-742">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="f-743">128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="f-744">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="f-745">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-6" sign="-" name="us-gaap:CostOfRevenue" scale="6" id="f-746">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="f-747">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-6" sign="-" name="us-gaap:CostOfRevenue" scale="6" id="f-748">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="f-749">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="f-750">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-751">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-752">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-753">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-754">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-755">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-756">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-757">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-758">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="f-759">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-760">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-761">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-762">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-763">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="f-764">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-765">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-766">31</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-767">328</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-768">293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i1442ddc197954361b38cabd10df2e256_121"></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 6 - <ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="f-769" continuedAt="f-769-1" escape="true">ACQUISITIONS</ix:nonNumeric></span></div><ix:continuation id="f-769-1" continuedAt="f-769-2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We acquire stock in companies and various assets that continue to support our capital deployment and product development strategies. Cash paid for acquisitions, net of cash acquired was $<ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="f-770">1,628</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="f-771">390</ix:nonFraction>  in 2024 and 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2024 we completed various acquisitions for total consideration that includes $<ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="f-772">1,628</ix:nonFraction> in upfront payments, net of cash acquired, and $<ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" scale="6" id="f-773">400</ix:nonFraction> contingent upon the achievement of certain commercial or clinical milestones. The combined acquisition-date fair values of the contingent milestone payments totaled $<ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-774">208</ix:nonFraction>. The acquired companies expand the product portfolios of our Instruments, Endoscopy, Medical and Neuro Cranial businesses within MedSurg and Neurotechnology and our Trauma and Extremities and Joint Replacement businesses within Orthopaedics. The purchase price allocation for our acquisitions are based on preliminary valuations, primarily related to developed technology </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="f-769-2" continuedAt="f-769-3"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and customer relationships. Goodwill attributable to the acquisitions reflects the strategic benefits of expanding our market presence, diversifying our product portfolio and advancing innovations. This goodwill is not deductible for tax purposes. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 2, 2023 we acquired Cerus for net cash consideration of $<ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="f-775">289</ix:nonFraction> and up to $<ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="f-776">225</ix:nonFraction> in future milestone payments that had a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-777">192</ix:nonFraction> at the acquisition date. Cerus designs, develops and manufactures neurovascular products used for the treatment of hemorrhagic stroke. Cerus is part of our Neurovascular business within MedSurg and Neurotechnology. Goodwill attributable to the acquisition is not deductible for tax purposes.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="f-778" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The purchase price allocations for the acquisitions completed in 2024 and Cerus are:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.956%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.463%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.465%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Purchase Price Allocation of Acquired Net Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cerus</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tangible assets acquired:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="f-779">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="f-780">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="f-781">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="f-782">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="6" id="f-783">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="6" id="f-784">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="f-785">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="f-786">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-6" name="syk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" scale="6" id="f-787">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-6" name="syk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" format="ixt:fixed-zero" scale="6" id="f-788">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="f-789">205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="f-790">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="f-791">102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="f-792">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="f-793">596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="f-794">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="f-795">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:fixed-zero" scale="6" id="f-796">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="f-797">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:fixed-zero" scale="6" id="f-798">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="f-799">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:fixed-zero" scale="6" id="f-800">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-801">1,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-6" name="us-gaap:Goodwill" scale="6" id="f-802">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price, net of cash acquired of $<ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="f-803">57</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="f-804">7</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="f-805">1,836</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="f-806">481</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average amortization period at acquisition (years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-292" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-807">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-293" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-808">13</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-294" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-809">14</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-295" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-810">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-296" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-811">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-769-3">The purchase price allocation for Cerus was finalized in the second quarter 2024 with no material adjustments.</ix:continuation> </span></div><div id="i1442ddc197954361b38cabd10df2e256_124"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 7 - <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-812" continuedAt="f-812-1" escape="true">CONTINGENCIES AND COMMITMENTS</ix:nonNumeric></span></div><ix:continuation id="f-812-1" continuedAt="f-812-2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are involved in various ongoing proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor, intellectual property and other matters, the most significant of which are more fully described below. The outcomes of these matters will generally not be known for prolonged periods of time. In certain of the legal proceedings the claimants seek damages as well as other compensatory and equitable relief that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief. For legal matters for which management had sufficient information to reasonably estimate our future obligations, a liability representing management's best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, is recorded. The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those estimated by management, additional expense may be incurred, which could unfavorably affect future operating results. We are self-insured for certain claims and expenses. The ultimate cost to us with respect to product liability claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.</span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">36</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="f-812-2" continuedAt="f-812-3"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are currently investigating whether certain business activities in certain foreign countries violated provisions of the FCPA and have engaged outside counsel to conduct these investigations. We have been contacted by the United States Securities and Exchange Commission, United States Department of Justice and certain other regulatory authorities and are cooperating with these agencies. At this time we are unable to predict the outcome of the investigations or the potential impact, if any, on our financial statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have conducted voluntary recalls of certain products, including our Rejuvenate and ABG II Modular-Neck hip stems and certain lot-specific sizes and offsets of LFIT Anatomic CoCr V40 Femoral Heads. Additionally, we are responsible for certain product liability claims, primarily related to certain hip products sold by Wright prior to its 2014 divestiture of the OrthoRecon business.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have incurred, and expect to incur in the future, costs associated with the defense and settlement of claims and lawsuits. Based on the information that has been received related to the matters discussed above, we recorded charges of $<ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-6" name="us-gaap:LossContingencyLossInPeriod" scale="6" id="f-813">17</ix:nonFraction> in 2024 and our accrual for these matters was $<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="f-814">202</ix:nonFraction> at December&#160;31, 2024, representing our best estimate of probable loss. The final outcomes of these matters are dependent on many factors that are difficult to predict. Accordingly the ultimate cost related to these matters may be materially different than the amount of our current estimate and accruals and could have a material adverse effect on our results of operations and cash flows.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Leases</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment under operating leases. We evaluate our contracts to identify leases, which is generally if there is an identified asset and we have the right to direct the use of and obtain substantially all of the economic benefit from the use of the identified asset. Certain of our lease agreements contain rent escalation clauses (including index-based escalations), rent holidays, capital improvement funding or other lease incentives. We recognize our minimum rental expense on a straight-line basis over the term of the lease beginning with the date of initial control of the asset. Right-of-use assets are recorded in Other noncurrent assets on our Consolidated Balance Sheets. Current and noncurrent lease liabilities are recorded in Accrued expenses and other liabilities and Other noncurrent liabilities, respectively.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have made certain significant assumptions and judgments when recording leases. For all asset classes, we do not recognize a right-of-use asset and lease liability for short-term leases. We also do not separate non-lease components from lease components to which they relate and account for the combined lease and non-lease components as a single lease component. The determination of the discount rate used in a lease is our incremental borrowing rate which is based on what we would normally pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-815" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"/><td style="width:58.493%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.376%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.253%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.378%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-816"><span style="-sec-ix-hidden:f-817">Right-of-use assets</span></span> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-818">516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-819">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-820"><span style="-sec-ix-hidden:f-821">Lease liabilities, current</span></span> </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-822">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-823">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-824"><span style="-sec-ix-hidden:f-825">Lease liabilities, noncurrent</span></span> </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-826">379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-827">356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-14" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-828">5.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;text-indent:-0.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-15" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-829">5.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-14" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-830">3.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-15" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-831">3.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease expense totaled $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-832">190</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-833">172</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-834">149</ix:nonFraction> in 2024, 2023 and 2022.</span></div></div></ix:continuation><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="f-812-3"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Future Obligations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have purchase commitments for materials, supplies, services and property, plant and equipment as part of the normal course of business. In addition, we lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment under operating leases. Refer to Note 10 for more information on the debt obligations.</span></div><ix:nonNumeric contextRef="c-1" name="srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock" id="f-835" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2029</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt repayments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="f-836">1,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="f-837">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="f-838">779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="6" id="f-839">1,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="6" id="f-840">1,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="f-841">7,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear" format="ixt:num-dot-decimal" scale="6" id="f-842">2,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueInSecondYear" scale="6" id="f-843">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueInThirdYear" scale="6" id="f-844">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueInFourthYear" scale="6" id="f-845">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueInFifthYear" scale="6" id="f-846">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueAfterFifthYear" scale="6" id="f-847">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Minimum lease payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="f-848">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="f-849">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="f-850">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="f-851">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="f-852">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="f-853">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Other Contractual Obligations and Commitments</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We participate in a supplier financing program that enables our suppliers, at their sole discretion, to sell their Stryker receivables to a financial institution on a non-recourse basis in order to be paid earlier than our payment terms provide. Under this program, we agree to pay participating banks the stated amount of confirmed invoices from its designated suppliers on the original maturity dates of the invoices, generally within 90 days of the invoice date. We or the banks may agree to terminate the agreements with advance notice. Separately, the banks may have arrangements with the suppliers that provide them the option to request early payment from the bank for invoices confirmed by us. Our outstanding balances of confirmed invoices in the programs were $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:SupplierFinanceProgramObligationCurrent" scale="6" id="f-854">71</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:SupplierFinanceProgramObligationCurrent" scale="6" id="f-855">51</ix:nonFraction> in 2024 and 2023 and are included within <span style="-sec-ix-hidden:f-856"><span style="-sec-ix-hidden:f-857"><span style="-sec-ix-hidden:f-858">Accounts payable</span></span></span> of the consolidated balance sheets. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SupplierFinanceProgramTableTextBlock" id="f-859" escape="true"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning confirmed obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:SupplierFinanceProgramObligation" scale="6" id="f-860">51</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:SupplierFinanceProgramObligationIncrease" scale="6" id="f-861">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:SupplierFinanceProgramObligationDecreaseSettlement" scale="6" id="f-862">372</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending confirmed obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:SupplierFinanceProgramObligation" scale="6" id="f-863">71</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i1442ddc197954361b38cabd10df2e256_127"></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 8 - <ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="f-864" continuedAt="f-864-1" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="f-864-1" continuedAt="f-864-2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In our annual impairment tests of goodwill as of October 31, 2024 and 2023 we performed a quantitative assessment of the Spine reporting unit using a discounted cash flow analysis to estimate the fair value. Significant inputs to the analysis included assumptions for future revenue growth and operating margin. The analysis also included a rate to discount the estimated future cash flow projections to their present value based on the reporting unit&#8217;s estimated weighted average cost of capital. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2024 the carrying value of the Spine reporting unit exceeded its fair value and a charge of $<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="f-865">273</ix:nonFraction> was recognized in goodwill and other impairments in the Consolidated Statements of Earnings. The impairment charge for the Spine reporting unit was driven by a decrease in future product demand due to the competitive environment and an increase in the Spine reporting unit&#8217;s weighted average cost of capital. Subsequent to the annual goodwill impairment test management committed to a plan to sell certain assets associated with&#8239;the Spinal Implants business (disposal group).&#8239;Goodwill was allocated to the disposal group based on the relative fair values of the disposal group and the portion of the Spine reporting unit that will be retained. Goodwill allocated to the disposal group was tested for impairment which resulted in an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="f-866">183</ix:nonFraction> recognized in goodwill and other impairments. Refer to Note 16 for additional information on the assets classified as held for sale. For our annual impairment test in 2023 we also elected to perform a quantitative assessment. As a result of that assessment we concluded that the goodwill of the Spine reporting unit was not impaired in 2023.</span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="f-864-2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For our other reporting units, we considered qualitative indicators of impairment as it was considered more likely than not that the fair values of those reporting units exceeded their respective carrying values. No impairment was identified for those reporting units in 2024 or 2023. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill, including discount and tax rates and future cash flow projections, could result in significantly different estimates of the fair values. A significant reduction in the estimated fair values could result in impairment charges that could materially affect our results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill of $<ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-6" name="us-gaap:GoodwillTransfers" scale="6" id="f-867"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-6" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="f-868">117</ix:nonFraction></ix:nonFraction> previously reported within Orthopaedics was reclassified to MedSurg and Neurotechnology to reflect the reclassification of the interventional spine reporting unit from Orthopaedics to MedSurg and Neurotechnology to align with certain updates in our internal reporting structure. Goodwill recorded in the first three quarters of 2024 related to interventional spine is presented in the additions and adjustments line within MedSurg and Neurotechnology. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfGoodwillTextBlock" id="f-869" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.037%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.037%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.132%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Changes in the Net Carrying Value of Goodwill by Segment</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-870">7,935</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-871">6,945</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-872">14,880</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="f-873">301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="f-874">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="f-875">301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="f-876">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="f-877">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="f-878">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-879">8,270</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-880">6,973</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-881">15,243</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-882">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="f-883">456</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="f-884">456</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="f-885">852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="f-886">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="f-887">1,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="f-888">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="f-889">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="f-890">84</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-891">9,208</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-892">6,647</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-893">15,855</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-894" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.394%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:23.037%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.037%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.132%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Other Intangible Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less<br/>Accumulated<br/>Amortization</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Developed technologies</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-895">5,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-896">2,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-897">2,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-898">5,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-899">2,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-900">2,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Customer relationships</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-901">3,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-902">1,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-903">1,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-904">2,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-905">1,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-906">1,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Patents</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-907">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-908">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-909">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-910">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-911">302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-912">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Trademarks</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-913">413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-914">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-915">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-916">427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-917">246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-918">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">In-process research and development</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-919">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="f-920">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-921">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-922">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="f-923">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-924">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-925">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-926">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-927">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-928">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-929">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-930">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-931">9,416</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-932">5,021</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-933">4,395</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-934">9,549</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-935">4,956</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-936">4,593</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="f-937" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:19.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.787%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Amortization Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2029</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="f-938">605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="f-939">550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="f-940">528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="f-941">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="f-942">465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i1442ddc197954361b38cabd10df2e256_130"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 9 - <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-943" continuedAt="f-943-1" escape="true">CAPITAL STOCK</ix:nonNumeric></span></div><ix:continuation id="f-943-1" continuedAt="f-943-2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate number of shares of all classes of stock which we are authorized to issue is up to <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="syk:CommonAndPreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-944">1,000,500,000</ix:nonFraction>, divided into two classes consisting of <ix:nonFraction unitRef="shares" contextRef="c-14" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-945">500,000</ix:nonFraction> shares of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-946">1</ix:nonFraction> par value preferred stock and <ix:nonFraction unitRef="shares" contextRef="c-14" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-947">1,000,000,000</ix:nonFraction> shares of common stock with a par </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><ix:continuation id="f-943-2" continuedAt="f-943-3"><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-948">0.10</ix:nonFraction>. <ix:nonFraction unitRef="shares" contextRef="c-14" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-949">No</ix:nonFraction> shares of preferred stock were outstanding on December&#160;31, 2024.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We made no repurchases of shares in 2024. The manner, timing and amount of repurchases are determined by management based on an evaluation of market conditions, stock price and other factors and are subject to regulatory considerations. Purchases are made from time-to-time in the open market, in privately negotiated transactions or otherwise. On December&#160;31, 2024 the total dollar value of shares that could be purchased under our authorized repurchase program was $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="f-950">1,033</ix:nonFraction>.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares reserved for future compensation grants of our common stock were <ix:nonFraction unitRef="shares" contextRef="c-14" decimals="-6" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="6" id="f-951">18</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="c-15" decimals="-6" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="6" id="f-952">20</ix:nonFraction>&#160;million&#160;on December&#160;31, 2024 and 2023. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We measure the cost of employee stock options based on the grant-date fair value and recognize that cost using the straight-line method over the period in which a recipient is required to provide services in exchange for the options, typically the vesting period. The weighted-average fair value per share of options is estimated on the date of grant using the Black-Scholes option pricing model. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-953" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.558%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Option Value and Assumptions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average fair value per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-954">118.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-955">83.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-956">68.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-957">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-958">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-959">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-960">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-961">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-962">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-963">29.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-964">29.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-965">27.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected option life (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-966">6.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-12" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-967">6.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-13" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-968">5.9</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The risk-free interest rate for periods within the expected life of options granted is based on the United States Treasury yield curve in effect at the time of grant. Expected stock price volatility is based on the historical volatility of our stock. The expected option life, representing the period of time that options granted are expected to be outstanding, is based on historical option exercise and employee termination data. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-969" escape="true"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:22.819%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.479%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.513%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.196%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">2024 Stock Option Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares <br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Term (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding January&#160;1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="f-970">11.5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-15" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-971">189.70</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="f-972">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-973">339.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="f-974">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-975">134.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="6" id="f-976">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-977">274.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding December&#160;31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="f-978">10.8</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-979">214.87</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-980">5.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-981">1,572.6</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercisable December&#160;31</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="f-982">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-983">175.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-984">3.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="6" id="f-985">1,223.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options expected to vest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="6" id="f-986">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="f-987">275.67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-988">7.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="f-989">331.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options, which represents the cumulative difference between the fair market value of the underlying common stock and the option exercise prices, exercised was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="f-990">362</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="f-991">318</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="f-992">218</ix:nonFraction> in 2024, 2023 and 2022. Exercise prices for options outstanding ranged from $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-993">92.24</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-994">339.77</ix:nonFraction> on December&#160;31, 2024. On December&#160;31, 2024 there was $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="f-995">159</ix:nonFraction> of unrecognized compensation cost related to nonvested stock options granted under the long-term incentive plans. That cost is expected to be recognized as expense over the weighted-average period of approximately <ix:nonNumeric contextRef="c-1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-996">1.5</ix:nonNumeric> years.</span></div></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">38</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="f-943-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="f-997" escape="true"><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.118%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.405%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.405%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.129%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.135%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares<br/>(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant&#160;Date Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-321" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="f-998">0.7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-322" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="f-999">0.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-321" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1000">246.98</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-322" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1001">250.17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-52" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="f-1002">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-53" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="f-1003">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-52" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1004">332.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-53" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1005">305.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-52" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="f-1006">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-53" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="f-1007">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-52" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1008">244.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-53" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1009">233.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-52" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="6" id="f-1010">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-53" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="6" id="f-1011">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-52" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1012">276.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-53" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1013">233.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on December 31</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-323" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="f-1014">0.7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-324" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="f-1015">0.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-323" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1016">290.58</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-324" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1017">287.51</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2024 there was $<ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="f-1018">90</ix:nonFraction> of unrecognized compensation cost related to nonvested RSUs. That cost is expected to be recognized as expense over the weighted-average period of approximately <ix:nonNumeric contextRef="c-52" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="f-1019">one year</ix:nonNumeric>. The weighted-average grant date fair value per share of RSUs granted was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-52" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1020">332.64</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-325" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1021">257.09</ix:nonFraction> in 2024 and 2023. The fair value of RSUs and PSUs vested in 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-6" name="syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" scale="6" id="f-1022">81</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-6" name="syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" scale="6" id="f-1023">23</ix:nonFraction>. On December&#160;31, 2024 there was $<ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="f-1024">23</ix:nonFraction> of unrecognized compensation cost related to nonvested PSUs. That cost is expected to be recognized as expense over the weighted-average period of approximately <ix:nonNumeric contextRef="c-53" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="f-1025">one year</ix:nonNumeric>. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Employee Stock Purchase Plans (ESPP)</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Employees may participate in our ESPP provided they meet certain eligibility requirements. The purchase price for our common stock under the terms of the ESPP is defined as <ix:nonFraction unitRef="number" contextRef="c-326" decimals="INF" name="syk:PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" scale="-2" id="f-1026">95</ix:nonFraction>% of the closing stock price on the last trading day of a purchase period. We issued <ix:nonFraction unitRef="shares" contextRef="c-326" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1027">173,708</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-327" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1028">190,524</ix:nonFraction> shares under the ESPP in 2024 and 2023.</span></div></ix:continuation><div id="i1442ddc197954361b38cabd10df2e256_133"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 10 - <ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-1029" continuedAt="f-1029-1" escape="true">DEBT AND CREDIT FACILITIES</ix:nonNumeric></span></div><ix:continuation id="f-1029-1" continuedAt="f-1029-2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have lines of credit issued by various financial institutions that are available to fund our day-to-day operating needs. Certain of our credit facilities require us to comply with financial and other covenants. We were in compliance with all covenants on December&#160;31, 2024. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2024 there were <ix:nonFraction unitRef="usd" contextRef="c-14" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="f-1030"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="INF" name="us-gaap:CommercialPaper" format="ixt:fixed-zero" scale="0" id="f-1031">no</ix:nonFraction></ix:nonFraction> borrowings outstanding under our revolving credit facility or our commercial paper program which allows for maturities up to <ix:nonNumeric contextRef="c-328" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="f-1032">397</ix:nonNumeric> days from the date of issuance. The maximum amount of our commercial paper that can be outstanding at any time is $<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1033">2,250</ix:nonFraction>. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In May 2024 we repaid the outstanding $<ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="f-1034">600</ix:nonFraction> principal amount of the <ix:nonFraction unitRef="number" contextRef="c-331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1035">3.375</ix:nonFraction>% senior unsecured notes due May 15, 2024. In September 2024 we issued $<ix:nonFraction unitRef="usd" contextRef="c-332" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-1036">750</ix:nonFraction> of <ix:nonFraction unitRef="number" contextRef="c-332" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1037">4.250</ix:nonFraction>% senior unsecured notes due September 11, 2029, &#8364;<ix:nonFraction unitRef="eur" contextRef="c-333" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-1038">800</ix:nonFraction> of <ix:nonFraction unitRef="number" contextRef="c-333" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1039">3.375</ix:nonFraction>% senior unsecured notes due September 11, 2032, $<ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-1040">750</ix:nonFraction> of <ix:nonFraction unitRef="number" contextRef="c-334" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1041">4.625</ix:nonFraction>% senior unsecured notes due September 11, 2034 and &#8364;<ix:nonFraction unitRef="eur" contextRef="c-335" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-1042">600</ix:nonFraction> of <ix:nonFraction unitRef="number" contextRef="c-335" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1043">3.625</ix:nonFraction>% senior unsecured notes due September 11, 2036. In November 2024 we repaid the outstanding &#8364;<ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="f-1044">500</ix:nonFraction> of floating rate senior notes and in December 2024 we repaid &#8364;<ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="f-1045">850</ix:nonFraction> of <ix:nonFraction unitRef="number" contextRef="c-338" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1046">0.250</ix:nonFraction>% senior unsecured notes. The following table summarizes our total debt at December 31:</span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="f-1029-2" continuedAt="f-1029-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="f-1047" escape="true"><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:0.1%"/><td style="width:2.401%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:57.570%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.463%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Total Debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Due</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Senior unsecured notes:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-339" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1048">3.375</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-6" name="us-gaap:UnsecuredDebt" format="ixt:fixed-zero" scale="6" id="f-1049">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-340" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1050">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 16, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-341" decimals="-6" name="us-gaap:UnsecuredDebt" format="ixt:fixed-zero" scale="6" id="f-1051">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-342" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1052">554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-343" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1053">0.250</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-344" decimals="-6" name="us-gaap:UnsecuredDebt" format="ixt:fixed-zero" scale="6" id="f-1054">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1055">940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-345" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1056">1.150</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-345" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1057">649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-346" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1058">648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-333" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1059">3.375</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 1, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1060">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-347" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1061">749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-348" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1062">3.500</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1063">998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1064">997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-350" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1065">2.125</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1066">777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1067">828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-352" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1068">3.650</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 7, 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1069">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1070">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-354" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1071">4.850</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 8, 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1072">596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1073">596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-356" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1074">3.375</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 11, 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-356" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1075">621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-357" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1076">661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-358" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1077">0.750</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 1, 2029</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-358" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1078">828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-359" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1079">883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-332" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1080">4.250</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 11, 2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-332" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1081">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-360" decimals="-6" name="us-gaap:UnsecuredDebt" format="ixt:fixed-zero" scale="6" id="f-1082">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-361" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1083">1.950</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2030</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-361" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1084">993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-362" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1085">991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-363" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1086">2.625</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-363" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1087">669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1088">713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-365" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1089">1.000</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2031</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1090">772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1091">823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-367" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1092">3.375</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 11, 2032</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1093">824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-6" name="us-gaap:UnsecuredDebt" format="ixt:fixed-zero" scale="6" id="f-1094">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-369" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1095">4.625</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 11, 2034</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1096">740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-370" decimals="-6" name="us-gaap:UnsecuredDebt" format="ixt:fixed-zero" scale="6" id="f-1097">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-335" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1098">3.625</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 11, 2036</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1099">613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-371" decimals="-6" name="us-gaap:UnsecuredDebt" format="ixt:fixed-zero" scale="6" id="f-1100">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-372" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1101">4.100</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 1, 2043</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-372" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1102">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-373" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1103">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-374" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1104">4.375</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2044</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-374" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1105">396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-375" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1106">396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-334" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1107">4.625</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2046</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1108">984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-376" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1109">983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-377" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1110">2.900</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2050</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-377" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1111">643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-378" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="f-1112">642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:OtherLongTermDebt" scale="6" id="f-1113">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:OtherLongTermDebt" format="ixt:fixed-zero" scale="6" id="f-1114">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="f-1115">13,597</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="f-1116">12,995</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less current maturities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1117">1,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1118">2,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-1119">12,188</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-1120">10,901</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="12" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="f-1121">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="f-1122">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Borrowing capacity on existing facilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1123">2,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1124">2,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of senior unsecured notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1125">12,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1126">12,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of the senior unsecured notes was estimated using quoted interest rates, maturities and amounts of borrowings based on quoted active market prices and yields that took into account the underlying terms of the debt instruments. Substantially all of our debt is classified within Level 2 of the fair value hierarchy.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-1029-3">Interest expense on outstanding debt and credit facilities, including required fees incurred, that were included in other income (expense), net, totaled $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InterestExpenseDebt" scale="6" id="f-1127">396</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:InterestExpenseDebt" scale="6" id="f-1128">356</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:InterestExpenseDebt" scale="6" id="f-1129">337</ix:nonFraction> in 2024, 2023 and 2022.</ix:continuation> </span></div><div id="i1442ddc197954361b38cabd10df2e256_136"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 11 - <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-1130" continuedAt="f-1130-1" escape="true">INCOME TAXES</ix:nonNumeric></span><ix:continuation id="f-1130-1" continuedAt="f-1130-2"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></ix:continuation></div><ix:continuation id="f-1130-2" continuedAt="f-1130-3"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our effective tax rate was <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1131">14.3</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1132">13.8</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1133">12.1</ix:nonFraction>% for 2024, 2023 and 2022. The effective income tax rate for 2024 increased from 2023 due to the 2024 deferred tax benefit on the outside basis difference related to the anticipated sale of the Spinal Implants business partially offset by the 2023 tax effect related to transfers of intellectual property between tax jurisdictions. The effective income tax rate for 2023 increased from 2022 due to the 2022 effective settlement of the United States federal income tax audit for years 2014 through 2018 and the 2022 reversal of deferred income tax on undistributed earnings of foreign subsidiaries partially offset by the 2023 tax effect related to transfers of intellectual property between tax jurisdictions. Additionally, the effective income tax rates for 2024, 2023 and 2022 reflect the continued lower effective income tax rates as a result of our European operations and certain discrete tax items.  </span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">39</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><ix:continuation id="f-1130-3" continuedAt="f-1130-4"><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-1134" escape="true"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Effective Income Tax Rate Reconciliation</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1135">21.0</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1136">21.0</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1137">21.0</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local income taxes, less federal deduction</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-1138">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-1139">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-1140">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign income tax at rates other than 21%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-1141">4.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-1142">6.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-1143">4.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax related to repatriation of foreign earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" scale="-2" id="f-1144">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" scale="-2" id="f-1145">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" sign="-" name="syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" scale="-2" id="f-1146">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="f-1147">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="f-1148">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="f-1149">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intellectual property transfers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" format="ixt:fixed-zero" scale="-2" id="f-1150">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" sign="-" name="syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" scale="-2" id="f-1151">3.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" scale="-2" id="f-1152">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal audit settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" format="ixt:fixed-zero" scale="-2" id="f-1153">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" format="ixt:fixed-zero" scale="-2" id="f-1154">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" scale="-2" id="f-1155">6.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="f-1156">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" format="ixt:fixed-zero" scale="-2" id="f-1157">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="f-1158">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Outside basis difference related to the anticipated sale of the Spinal Implants business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="syk:EffectiveIncomeTaxRateReconciliationOutsideBasisDifference" scale="-2" id="f-1159">4.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="syk:EffectiveIncomeTaxRateReconciliationOutsideBasisDifference" format="ixt:fixed-zero" scale="-2" id="f-1160">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="syk:EffectiveIncomeTaxRateReconciliationOutsideBasisDifference" format="ixt:fixed-zero" scale="-2" id="f-1161">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-1162">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-1163">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-1164">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1165">14.3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1166">13.8</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1167">12.1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-1168" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Earnings Before Income Taxes&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="f-1169">523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="f-1170">701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="f-1171">407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="f-1172">2,969</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="f-1173">2,972</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="f-1174">2,276</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-1175">3,492</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-1176">3,673</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-1177">2,683</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Income Tax Expense (Benefit)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current income tax expense (benefit):</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-1178">490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-1179">236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-1180">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="f-1181">90</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="f-1182">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="f-1183">64</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-1184">289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-1185">430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-1186">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total current income tax expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-1187">869</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-1188">714</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-1189">267</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax expense (benefit):</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-1190">462</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-1191">212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-1192">179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-1193">76</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-1194">20</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-1195">30</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-1196">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-1197">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-1198">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax expense (benefit)</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-1199">370</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-1200">206</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-1201">58</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1202">499</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1203">508</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1204">325</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest included in other income (expense), net was expense of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="f-1205">13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="f-1206">1</ix:nonFraction> in 2024 and 2023 and income of $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="f-1207">71</ix:nonFraction> in 2022. The United States federal deferred income tax expense (benefit) includes the utilization of net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" scale="6" id="f-1208">9</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" scale="6" id="f-1209">189</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" scale="6" id="f-1210">56</ix:nonFraction> in 2024, 2023 and 2022.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-1211" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Deferred Income Tax Assets and Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="f-1212">551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="f-1213">521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" scale="6" id="f-1214">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" scale="6" id="f-1215">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="syk:DeferredTaxAssetsDepreciationAndAmortization" scale="6" id="f-1216">715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="syk:DeferredTaxAssetsDepreciationAndAmortization" scale="6" id="f-1217">918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DeferredTaxAssetsStateTaxes" scale="6" id="f-1218">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DeferredTaxAssetsStateTaxes" scale="6" id="f-1219">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="f-1220">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="f-1221">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development capitalization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="syk:DeferredTaxAssetsResearchAndDevelopmentCapitalization" scale="6" id="f-1222">408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="syk:DeferredTaxAssetsResearchAndDevelopmentCapitalization" scale="6" id="f-1223">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International interest expense carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DeferredTaxAssetInterestCarryforward" scale="6" id="f-1224">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DeferredTaxAssetInterestCarryforward" scale="6" id="f-1225">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="f-1226">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="f-1227">385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Outside basis difference related to the anticipated sale of the Spinal Implants business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="syk:DeferredTaxAssetsOutsideBasisDifference" scale="6" id="f-1228">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="syk:DeferredTaxAssetsOutsideBasisDifference" format="ixt:fixed-zero" scale="6" id="f-1229">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="f-1230">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="f-1231">235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-1232">3,090</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-1233">2,889</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less valuation allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-1234">228</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-1235">223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-1236">2,862</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-1237">2,666</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="syk:DeferredTaxLiabilitiesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1238">1,141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="syk:DeferredTaxLiabilitiesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1239">1,012</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Undistributed earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="f-1240">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="f-1241">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1242">1,202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1243">1,059</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="f-1244">1,660</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="f-1245">1,607</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent deferred income tax assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-1246">1,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-1247">1,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-1248">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-1249">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="f-1250">1,660</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="f-1251">1,607</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued interest was $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" scale="6" id="f-1252">71</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" scale="6" id="f-1253">67</ix:nonFraction> on December&#160;31, 2024 and 2023 which was reported in accrued expenses and other liabilities and other noncurrent liabilities.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">United States federal loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-379" decimals="-6" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-1254">335</ix:nonFraction>, with $<ix:nonFraction unitRef="usd" contextRef="c-379" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="6" id="f-1255">70</ix:nonFraction> of associated deferred tax asset and with $<ix:nonFraction unitRef="usd" contextRef="c-379" decimals="-6" name="syk:OperatingLossCarryforwardsSubjectToValuationAllowance" scale="6" id="f-1256">2</ix:nonFraction> being subject to a valuation allowance, begin to expire in 2025. United States state loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-380" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1257">3,480</ix:nonFraction>, with $<ix:nonFraction unitRef="usd" contextRef="c-380" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="6" id="f-1258">85</ix:nonFraction> associated deferred tax asset and with $<ix:nonFraction unitRef="usd" contextRef="c-380" decimals="-6" name="syk:OperatingLossCarryforwardsSubjectToValuationAllowance" scale="6" id="f-1259">49</ix:nonFraction> being subject to a valuation allowance, begin to expire in 2025. International loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-6" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-1260">269</ix:nonFraction>, with $<ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="6" id="f-1261">69</ix:nonFraction> of associated deferred tax asset and with $<ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-6" name="syk:OperatingLossCarryforwardsSubjectToValuationAllowance" scale="6" id="f-1262">63</ix:nonFraction> being subject to a valuation allowance, begin to expire in 2026; however, some have no expiration. We also have tax credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="f-1263">204</ix:nonFraction> with $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:TaxCreditCarryforwardValuationAllowance" scale="6" id="f-1264">83</ix:nonFraction> being subject to a full valuation allowance. The credits with a full valuation allowance begin to expire in 2025. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We recorded deferred income tax on undistributed earnings of foreign subsidiaries not determined to be indefinitely reinvested. In 2022 it was determined that, based on our revised capital plan, certain cash outside the United States would no longer need to be repatriated during the period previously contemplated. As a result deferred taxes of $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings" scale="6" id="f-1265">71</ix:nonFraction> that were recorded on the associated earnings were reversed. The amount of undistributed earnings of foreign subsidiaries determined to be indefinitely reinvested at December 31, 2024 was approximately $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-8" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="f-1266">10</ix:nonFraction>&#160;billion. Determination of the total amount of unrecognized deferred income tax on undistributed earnings of foreign subsidiaries is not practicable.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="f-1267" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.258%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Uncertain Income Tax Positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning uncertain tax positions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1268">371</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1269">286</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to current year income tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="f-1270">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="f-1271">102</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to prior year income tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="6" id="f-1272">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-1273">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Decreases related to prior year income tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-1274">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-1275">33</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements of income tax audits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="f-1276">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="f-1277">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Statute of limitations expirations and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="f-1278">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:fixed-zero" scale="6" id="f-1279">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" scale="6" id="f-1280">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation" scale="6" id="f-1281">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending uncertain tax positions</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1282">349</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1283">371</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1284">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1285">371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our income tax expense would have been reduced by $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" scale="6" id="f-1286">224</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" scale="6" id="f-1287">248</ix:nonFraction> in 2024 and 2023 had these uncertain income tax positions been favorably resolved. It is reasonably possible that the amount of unrecognized tax benefits will significantly change due to one or more of the following events in the next 12 months: expiring statutes, audit activity, tax payments, competent authority proceedings related to transfer pricing or final decisions in matters that are the subject of controversy in various taxing jurisdictions in which we operate, including inventory transfer pricing, cost sharing, product royalty and foreign branch arrangements. We are not able to reasonably estimate the amount or the future periods in which changes in unrecognized tax benefits may be resolved. Interest incurred associated with uncertain tax positions is included in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the normal course of business, income tax authorities in various income tax jurisdictions both within the United States and internationally conduct routine audits of our income tax returns filed in prior years. These audits are generally designed to determine if individual income tax authorities are in agreement with our interpretations of complex income tax regulations regarding the allocation of income to the various income tax jurisdictions. Any income tax audit assessment or draft income tax audit assessment received at the conclusion of an audit is reviewed and evaluated for proper financial statement treatment. We have not received any audit assessments or draft assessments that have not been reviewed and evaluated.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income tax expense in 2022 decreased $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxSettlements" scale="6" id="f-1288">162</ix:nonFraction> due to the effective settlement of the United States federal income tax audit for years 2014 through 2018. In addition 2022 other income (expense), net includes a benefit of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="syk:IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" scale="6" id="f-1289">50</ix:nonFraction> related to the release of accrued interest </span></div></div></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">40</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-1130-4">associated with this settlement. Income tax years are open from 2019 through the current year for the United States federal jurisdiction. Income tax years open for our other major jurisdictions range from 2010 through the current year.</ix:continuation> </span></div><div id="i1442ddc197954361b38cabd10df2e256_139"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 12 - <ix:nonNumeric contextRef="c-1" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="f-1290" continuedAt="f-1290-1" escape="true">RETIREMENT PLANS</ix:nonNumeric></span></div><ix:continuation id="f-1290-1" continuedAt="f-1290-2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide certain employees with defined contribution plans and other types of retirement plans. A portion of our retirement plan expense under the defined contribution plans is funded with Stryker common stock. The use of Stryker common stock represents a non-cash operating activity that is not reflected in our Consolidated Statements of Cash Flows.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DefinedContributionPlanDisclosuresTableTextBlock" id="f-1291" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:61.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.430%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="f-1292">376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="f-1293">327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="f-1294">305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expense funded with Stryker common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="f-1295">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="f-1296">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="f-1297">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stryker common stock held by plan:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dollar amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany" scale="6" id="f-1298">781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany" scale="6" id="f-1299">649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany" scale="6" id="f-1300">522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares (in millions)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="syk:DefinedContributionRetirementPlansCommonStockHeldByCompany" scale="6" id="f-1301">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-5" name="syk:DefinedContributionRetirementPlansCommonStockHeldByCompany" scale="6" id="f-1302">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-5" name="syk:DefinedContributionRetirementPlansCommonStockHeldByCompany" scale="6" id="f-1303">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Value as a percentage of total plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" scale="-2" id="f-1304">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="2" name="syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" scale="-2" id="f-1305">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="2" name="syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" scale="-2" id="f-1306">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain of our subsidiaries have both funded and unfunded defined benefit pension plans covering some or all of their employees. The majority of our defined benefit pension plans have projected benefit obligations in excess of plan assets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Discount Rate</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The discount rates were selected using a hypothetical portfolio of high quality bonds on December 31 that would provide the necessary cash flows to match our projected benefit payments. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Expected Return on Plan Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected return on plan assets is determined by applying the target allocation in each asset category of plan investments to the anticipated return for each asset category based on historical and projected returns. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock" id="f-1307" escape="true"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:61.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.430%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Net Periodic Pension Cost</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1308">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1309">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1310">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-12" name="syk:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="f-1311"><ix:nonNumeric contextRef="c-1" name="syk:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="f-1312"><ix:nonNumeric contextRef="c-13" name="syk:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="f-1313">Interest cost</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1314">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1315">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1316">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="f-1317">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="f-1318">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="f-1319">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="f-1320">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="f-1321">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="f-1322">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="f-1323">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="f-1324">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="f-1325">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1326">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1327">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1328">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Changes in assets and benefit obligations recognized in OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net actuarial gain (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="f-1329">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="f-1330">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="f-1331">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized net actuarial (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="f-1332">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="f-1333">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="f-1334">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prior service credit and transition amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="f-1335">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="f-1336">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="f-1337">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in other comprehensive income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-1338">43</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-1339">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-1340">252</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in net periodic benefit cost and OCI</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="f-1341">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="f-1342">104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="f-1343">193</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-average rates used to determine net periodic benefit cost:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="f-1344">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="f-1345">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="f-1346">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-1347">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-1348">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-1349">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="f-1350">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="f-1351">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="f-1352">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate used to determine projected benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" scale="-2" id="f-1353">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" scale="-2" id="f-1354">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" scale="-2" id="f-1355">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The actuarial gain (loss) for all pension plans was primarily related to a change in the discount rate used to measure the benefit obligations of those plans.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Investment Strategy</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The investment strategy for our defined benefit pension plans is to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><ix:continuation id="f-1290-2"><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">tolerances.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" id="f-1356" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1357">492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1358">485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-1359">782</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-1360">826</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="f-1361">290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="f-1362">341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent assets&#8212;other assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-382" decimals="-6" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="f-1363">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-383" decimals="-6" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="f-1364">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current liabilities&#8212;accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="f-1365">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-385" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="f-1366">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-386" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="f-1367">335</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-387" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="f-1368">359</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pre-tax amounts recognized in AOCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized net actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-388" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="f-1369">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="f-1370">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-388" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="f-1371">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="f-1372">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="f-1373">14</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="f-1374">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" id="f-1375" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Benefit Obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning projected benefit obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-1376">826</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-1377">673</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1378">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1379">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1380">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1381">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="f-1382">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="f-1383">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="f-1384">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="f-1385">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial (gains) losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="f-1386">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="f-1387">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="f-1388">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="f-1389">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending projected benefit obligations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-1390">782</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-1391">826</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending accumulated benefit obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="f-1392">748</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="f-1393">790</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" id="f-1394" continuedAt="f-1394-1" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="f-1395">485</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="f-1396">420</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actual return</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="f-1397">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="f-1398">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="f-1399">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="f-1400">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="f-1401">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="f-1402">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="f-1403">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="f-1404">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="f-1405">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="f-1406">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending fair value of plan assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="f-1407">492</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="f-1408">485</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="f-1409" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:33.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.652%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Allocation of Plan Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025 Target</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024 Actual</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023 Actual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-390" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="f-1410">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-390" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1411">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-391" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1412">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-392" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="f-1413">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-392" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1414">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-393" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1415">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-394" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="f-1416">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-394" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1417">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-395" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1418">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-14" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="f-1419">100</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-14" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1420">100</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-15" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1421">100</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><ix:continuation id="f-1394-1"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.511%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Valuation of Plan Assets </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1422">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1423">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-398" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1424">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1425">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-400" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1426">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-401" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1427">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1428">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-390" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1429">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1430">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1431">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1432">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1433">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1434">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1435">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1436">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-410" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1437">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1438">31</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1439">404</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1440">57</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1441">492</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-411" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1442">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-412" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1443">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-413" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1444">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-414" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1445">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-415" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1446">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-416" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1447">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-417" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1448">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1449">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-418" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1450">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-419" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1451">185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-420" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1452">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-421" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1453">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-422" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1454">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1455">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1456">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-425" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1457">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1458">42</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1459">378</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1460">65</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1461">485</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Level 3 pension plan assets primarily include guaranteed investment contracts with insurance companies. The insurance contracts guarantee us principal repayment and a fixed rate of return. The $<ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="f-1462">8</ix:nonFraction> decrease in Level 3 pension plan assets is primarily driven by the change in the corresponding pension liability. We expect to contribute $<ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" scale="6" id="f-1463">21</ix:nonFraction> to our defined benefit pension plans in 2025.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="f-1464" escape="true"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.535%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Future Benefit Payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2029</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2030-2034</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="f-1465">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="f-1466">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="f-1467">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="f-1468">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="f-1469">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="f-1470">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">41</span></div></td></tr></table></div></div></div><div id="i1442ddc197954361b38cabd10df2e256_142"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 13 - <ix:nonNumeric contextRef="c-1" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="f-1471" continuedAt="f-1471-1" escape="true">SUMMARY OF QUARTERLY DATA (UNAUDITED)</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" id="f-1472" escape="true"><ix:continuation id="f-1471-1"><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.031%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024 Quarters</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-426" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1473">5,243</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1474">5,422</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1475">5,494</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1476">6,436</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-426" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-1477">3,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-1478">3,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-1479">3,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-1480">4,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-426" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1481">923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1482">998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-1483">1,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1484">528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-426" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-1485">788</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-1486">825</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-1487">834</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-1488">546</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-426" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1489">2.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-427" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1490">2.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-428" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1491">2.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-429" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1492">1.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-426" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1493">2.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-427" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1494">2.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-428" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1495">2.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-429" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1496">1.41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-426" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-1497">0.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-427" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-1498">0.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-428" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-1499">0.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-429" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-1500">0.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023 Quarters</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-430" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1501">4,778</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-431" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1502">4,996</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-432" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1503">4,909</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-433" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1504">5,815</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-430" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-1505">3,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-431" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-1506">3,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-432" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-1507">3,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-433" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-1508">3,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-430" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1509">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-431" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1510">899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-432" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1511">869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-433" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-1512">1,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-430" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-1513">592</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-431" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-1514">738</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-432" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-1515">692</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-433" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1516">1,143</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-430" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1517">1.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-431" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1518">1.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-432" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1519">1.82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-433" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1520">3.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-430" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1521">1.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-431" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1522">1.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-432" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1523">1.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-433" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1524">2.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-430" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-1525">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-431" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-1526">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-432" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-1527">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-433" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-1528">0.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i1442ddc197954361b38cabd10df2e256_145"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 14 - <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-1529" continuedAt="f-1529-1" escape="true">SEGMENT AND GEOGRAPHIC DATA</ix:nonNumeric></span></div><ix:continuation id="f-1529-1" continuedAt="f-1529-2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 1, 2024 we adopted ASU 2023-07, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which expands disclosure requirements to require entities to disclose significant segment expenses that are regularly provided to or easily computed from information regularly provided to the chief operating decision maker. We have updated our disclosures to include our significant segment expenses that are regularly provided to our chief operating decision maker (CODM).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We segregate our operations into <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-1530">two</ix:nonFraction> reportable business segments: (i) MedSurg and Neurotechnology and (ii) Orthopaedics which aligns to our internal reporting structure and how our CODM assesses the performance of and allocates resources. The CODM is the Chief Executive Officer. The CODM makes decisions on resource allocation, assesses performance of the business, and monitors budget versus actual results using segment operating income. Our reportable segments and related disclosures reflect certain reclassifications of prior year amounts from our Orthopaedics segment to our MedSurg and Neurotechnology segment due to changes in our internal reporting structure.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Corporate and Other category shown in the table below includes corporate and administration, corporate initiatives and share-based compensation, which includes compensation related to employee stock options, restricted stock units and performance stock unit grants and director stock options and restricted stock unit grants.</span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><ix:continuation id="f-1529-2" continuedAt="f-1529-3"><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:nonNumeric contextRef="c-1" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="f-1531" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.383%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.383%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.385%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Results</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-434" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1532">13,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-435" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1533">12,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-436" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1534">10,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-437" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1535">9,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-438" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1536">8,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-439" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1537">7,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-440" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1538">22,595</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-441" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1539">20,498</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-442" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1540">18,449</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-434" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-1541">5,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-435" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-1542">4,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-436" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-1543">4,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-437" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-1544">2,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-438" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-1545">2,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-439" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-1546">1,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cost of sales </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-440" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-1547">7,720</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-441" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-1548">7,130</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-442" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-1549">6,557</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-434" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-1550">784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-435" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-1551">702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-436" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-1552">682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-437" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-1553">540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-438" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-1554">508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-439" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-1555">477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment research, development and engineering expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-440" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1556">1,324</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-441" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1557">1,210</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-442" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1558">1,159</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-434" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-1559">3,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-435" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-1560">2,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-436" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-1561">2,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-437" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-1562">3,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-438" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-1563">2,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-439" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-1564">2,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment selling, general and administrative expenses </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-440" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-1565">6,314</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-441" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-1566">5,856</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-442" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-1567">5,172</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-434" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1568">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-435" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1569">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-436" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1570">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-437" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1571">433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-438" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1572">386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-439" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1573">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-440" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1574">641</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-441" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1575">567</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-442" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1576">528</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-443" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1577">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-444" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1578">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-445" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1579">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-440" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-1580">623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-441" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-1581">635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-442" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-1582">627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1583">1,426</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1584">1,341</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1585">1,278</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-434" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1586">4,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-435" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1587">3,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-436" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1588">2,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-437" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1589">2,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-438" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1590">2,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-439" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1591">2,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-440" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1592">6,595</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-441" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1593">5,735</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-442" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1594">5,033</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Items not allocated to segments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-443" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="f-1595">880</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-444" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="f-1596">780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-445" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="f-1597">649</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped up to fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-6" name="syk:InventorySteppedUpToFairValueAtAcquisition" scale="6" id="f-1598">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-6" name="syk:InventorySteppedUpToFairValueAtAcquisition" format="ixt:fixed-zero" scale="6" id="f-1599">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-6" name="syk:InventorySteppedUpToFairValueAtAcquisition" format="ixt:fixed-zero" scale="6" id="f-1600">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="f-1601">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="f-1602">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="f-1603">138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-1604">623</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-1605">635</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-1606">627</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Structural optimization and other special charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="f-1607">138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="f-1608">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="f-1609">295</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill and other impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-1610">977</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-1611">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-1612">270</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-6" name="syk:MedicalDeviceRegulationsExpense" scale="6" id="f-1613">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-6" name="syk:MedicalDeviceRegulationsExpense" scale="6" id="f-1614">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-6" name="syk:MedicalDeviceRegulationsExpense" scale="6" id="f-1615">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-6" name="syk:RejuvenateABGIIHipRecallCharges" scale="6" id="f-1616">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-6" name="syk:RejuvenateABGIIHipRecallCharges" scale="6" id="f-1617">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-6" sign="-" name="syk:RejuvenateABGIIHipRecallCharges" scale="6" id="f-1618">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-6" name="us-gaap:LegalFees" scale="6" id="f-1619">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-6" name="us-gaap:LegalFees" scale="6" id="f-1620">92</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-6" name="us-gaap:LegalFees" scale="6" id="f-1621">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1622">3,689</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1623">3,888</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1624">2,841</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-1625" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.949%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.949%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.695%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Assets and Capital Spending</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-449" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1626">23,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-450" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1627">20,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-451" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1628">18,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1629">18,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1630">41,622</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-454" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1631">38,827</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1632">1,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-456" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1633">1,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1634">42,971</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1635">39,912</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchases of property, plant and equipment:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-437" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="f-1636">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-438" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="f-1637">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-439" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="f-1638">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-434" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="f-1639">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-435" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="f-1640">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-436" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="f-1641">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-440" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="f-1642">506</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-441" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="f-1643">362</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-442" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="f-1644">348</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-443" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="f-1645">249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-444" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="f-1646">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-445" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="f-1647">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="f-1648">755</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="f-1649">575</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="f-1650">588</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We measure the financial results of our reportable segments using an internal performance measure that excludes acquisition and integration-related charges, structural optimization and other special charges, goodwill and other impairments, reserves for certain product recall matters and reserves for certain legal and regulatory matters. Identifiable assets are those assets used exclusively in the operations of each business segment or allocated when used jointly. Corporate assets are principally property, plant and equipment and noncurrent assets. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The countries in which we have local revenue generating operations have been combined into the following geographic areas: the United States; Europe, Middle East, Africa; Asia Pacific; and other foreign countries, which include Canada and countries in the Latin American region. Net sales are reported based on the geographic area of the Stryker location where the sales to the customer originated. </span></div></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" id="f-1651" escape="true"><ix:continuation id="f-1529-3"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.762%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.949%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.949%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.696%"/><td style="width:0.1%"/></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Geographic Information</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Property, Plant and Equipment</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1652">16,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1653">15,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1654">13,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-1655">1,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-1656">1,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1657">2,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1658">2,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1659">2,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-462" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-1660">1,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-1661">1,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-464" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1662">2,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1663">1,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1664">1,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-467" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-1665">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-468" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-1666">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-469" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-1667">735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-470" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-1668">677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-6" name="us-gaap:Revenues" scale="6" id="f-1669">578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-1670">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-1671">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1672">22,595</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1673">20,498</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-1674">18,449</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-1675">3,448</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-1676">3,215</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i1442ddc197954361b38cabd10df2e256_148"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 15 - <ix:nonNumeric contextRef="c-1" name="us-gaap:AssetImpairmentChargesTextBlock" id="f-1677" continuedAt="f-1677-1" escape="true">ASSET IMPAIRMENTS</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-1677-1">During 2024, 2023 and 2022 we recorded impairment charges of $<ix:nonFraction unitRef="usd" contextRef="c-474" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-1678">159</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-475" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-1679">36</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-476" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-1680">54</ix:nonFraction> to write off long-lived and intangible assets excluding long-lived assets held for sale which included charges related to certain product line exits</ix:continuation>.</span></div><div id="i1442ddc197954361b38cabd10df2e256_1790"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 16 - <ix:nonNumeric contextRef="c-1" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="f-1681" continuedAt="f-1681-1" escape="true">ASSETS HELD FOR SALE</ix:nonNumeric></span></div><ix:continuation id="f-1681-1"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the fourth quarter 2024 management committed to a plan to sell certain assets associated with the Spinal Implants business and such assets were classified as held for sale beginning November 2024. As a result we recognized an estimated loss of $<ix:nonFraction unitRef="usd" contextRef="c-477" decimals="-6" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" scale="6" id="f-1682">362</ix:nonFraction> to record the disposal group at its fair value less cost to sell within goodwill and other impairments in our Consolidated Statements of Earnings. The fair value of the disposal group was measured using a discounted cash flow analysis based upon unobservable inputs, such as estimated selling price derived from Company-specific information, market conditions and the rate used to discount the estimated future cash flows to their present value based on factors including the disposal group&#8217;s cost of equity and market yield rates, which are Level 3 inputs. Future changes in the judgments, assumptions and estimates that are used in our fair value estimate, including discount rates and cash flow projections, could result in a significantly different estimate of fair value. In January 2025 we entered into a definitive agreement to sell the Spinal Implants disposal group as further discussed in Note 17. The terms of the definitive agreement were materially the same as those considered as inputs to the valuation of the disposal group at December 31, 2024. A change in the amount or timing of consideration received could increase the fair value by up to $<ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-6" name="syk:DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue" scale="6" id="f-1683">84</ix:nonFraction> or decrease the fair value by up to $<ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-6" sign="-" name="syk:DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue" scale="6" id="f-1684">218</ix:nonFraction>.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A valuation allowance was recorded to reflect the estimated loss on the disposal group. The assets associated with the Spinal Implants disposal group are reported in our Orthopaedics segment. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="f-1685" continuedAt="f-1685-1" escape="true">The assets and liabilities held for sale are classified within prepaid expenses and other current assets and accrued expenses and other liabilities in our Consolidated Balance Sheets and included the following as of December 31, 2024:</ix:nonNumeric></span></div><ix:continuation id="f-1685-1"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="f-1686">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total inventories </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="f-1687">183</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="6" id="f-1688">10</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Property, plant and equipment, net </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" scale="6" id="f-1689">51</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangibles, net </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" scale="6" id="f-1690">326</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent deferred income tax assets </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" scale="6" id="f-1691">9</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" scale="6" id="f-1692">171</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Valuation allowance </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-6" name="syk:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" scale="6" id="f-1693">362</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets held for sale </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="f-1694">450</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts payable </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" scale="6" id="f-1695">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued compensation </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-6" name="syk:DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent" scale="6" id="f-1696">26</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-6" name="syk:DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent" scale="6" id="f-1697">29</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" scale="6" id="f-1698">21</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="f-1699">104</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div id="i1442ddc197954361b38cabd10df2e256_1800"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 17 - <ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-1700" continuedAt="f-1700-1" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><ix:continuation id="f-1700-1"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In January 2025 we announced a definitive merger agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. (Inari). Pursuant to the agreement we commenced a tender offer to purchase all of the outstanding shares of common stock of Inari for $<ix:nonFraction unitRef="usdPerShare" contextRef="c-479" decimals="0" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="f-1701">80</ix:nonFraction> per share in cash, or an aggregate purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="c-480" decimals="-8" name="us-gaap:BusinessCombinationPriceOfAcquisitionExpected" format="ixt:num-dot-decimal" scale="9" id="f-1702">4.9</ix:nonFraction>&#160;billion. The boards of directors of both Stryker and Inari have unanimously approved the transaction. We expect the acquisition to close in the first quarter of 2025, subject to completion of the tender offer and other customary closing conditions. Inari&#8217;s product portfolio includes mechanical thrombectomy solutions for peripheral vascular diseases such as deep vein thrombosis and pulmonary embolism. Following closing, we plan to integrate Inari into our MedSurg and Neurotechnology segment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In January 2025 we announced a definitive agreement to sell our United States Spinal Implants business to Viscogliosi Brothers, LLC. The definitive agreement includes a binding offer to sell our Spinal Implants business in France, subject to required consultations with employees and employee representatives. We expect the sale of the United States business to close in the first half of 2025, subject to customary closing conditions. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In February 2025 we issued $<ix:nonFraction unitRef="usd" contextRef="c-481" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-1703">500</ix:nonFraction> of <ix:nonFraction unitRef="number" contextRef="c-481" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1704">4.550</ix:nonFraction>% senior unsecured notes due February 10, 2027, $<ix:nonFraction unitRef="usd" contextRef="c-482" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-1705">700</ix:nonFraction> of <ix:nonFraction unitRef="number" contextRef="c-482" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1706">4.700</ix:nonFraction>% senior unsecured notes due February 10, 2028, $<ix:nonFraction unitRef="usd" contextRef="c-483" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-1707">800</ix:nonFraction> of <ix:nonFraction unitRef="number" contextRef="c-483" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1708">4.850</ix:nonFraction>% senior unsecured notes due February 10, 2030 and $<ix:nonFraction unitRef="usd" contextRef="c-484" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1709">1,000</ix:nonFraction> of <ix:nonFraction unitRef="number" contextRef="c-484" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1710">5.200</ix:nonFraction>% senior unsecured notes due February 10, 2035. We intend to use the net proceeds from the notes due in 2030 and 2035, together with cash on hand or other immediately available funds, to consummate the Inari Tender Offer and to pay related fees and expenses. We intend to use the net proceeds from the notes due in 2027 and 2028 for general corporate purposes, which may include working capital, other acquisitions  and repayment of indebtedness.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">43</span></div></td></tr></table></div></div></div><div id="i1442ddc197954361b38cabd10df2e256_151"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;9.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.</span></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.&#160;</span></div><div id="i1442ddc197954361b38cabd10df2e256_154"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;9A.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CONTROLS AND PROCEDURES.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's management, with the participation of the Chief Executive Officer and Chief Financial Officer (the Certifying Officers), evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended) (Exchange Act) as of December&#160;31, 2024. Based on that evaluation, the Certifying Officers concluded that the Company&#8217;s disclosure controls and procedures were effective as of December&#160;31, 2024.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There was no change to our internal control over financial reporting during the fourth quarter of 2024 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management's Report on Internal Control Over Financial Reporting</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). The Company's internal control over financial reporting was designed to provide reasonable assurance to the Company's management and Board of Directors regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that: (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company's assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's management assessed the effectiveness of our internal control over financial reporting on December&#160;31, 2024. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Internal Control&#8212;Integrated Framework (2013)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Based on its assessment, management concluded that our internal control over financial reporting was effective as of December&#160;31, 2024.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker&#8217;s independent registered public accounting firm has issued an audit report on their assessment of the effectiveness of the Company&#8217;s internal control over financial reporting.</span></div><div style="margin-bottom:3pt"><span><br/></span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of Stryker Corporation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Opinion on Internal Control Over Financial Reporting </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have audited Stryker Corporation and subsidiaries&#8217; internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Stryker Corporation and subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on the COSO criteria. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the 2024 consolidated financial statements of the Company and our report dated February 12, 2025 expressed an unqualified opinion thereon.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis for Opinion </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.  </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">44</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">assets that could have a material effect on the financial statements. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">/s/&#160;&#160;&#160;&#160;Ernst&#160;&amp; Young LLP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Grand Rapids, Michigan</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;12, 2025 </span></div><div id="i1442ddc197954361b38cabd10df2e256_157"></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;9B.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OTHER INFORMATION.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-429" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1711"><ix:nonNumeric contextRef="c-429" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1712"><ix:nonNumeric contextRef="c-429" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1713"><ix:nonNumeric contextRef="c-429" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1714">Trading Plan Arrangements</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain of our officers or directors have made elections to participate in and are participating in, our employee stock purchase plan and 401(k) plan and have made and may from time to time make elections to have shares withheld to cover withholding taxes due or pay the exercise price of stock options, restricted stock units and performance stock units which may constitute non-Rule 10b5&#8211;1 trading arrangements (as defined in Item 408(c) of Regulation S-K).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Disclosure Pursuant to Section 13(r) of the Exchange Act</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Section 13(r) of the Exchange Act requires an issuer to disclose in its annual or quarterly reports whether it or any of its affiliates knowingly engaged in certain activities, transactions or dealings relating to parties subject to sanctions administered by the Office of Foreign Assets Control (OFAC) within the United States Department of the Treasury, whether or not such activities are prohibited or sanctionable under United States law. On March 2, 2021 the United States government designated the Russian Federal Security Service (FSB) under additional sanctions authorities. On the same day, OFAC issued General License No. 1B (OFAC General License) which generally authorizes certain licensing, permitting, certification, notification and related transactions with the FSB as may be required pursuant to Russian encryption product import controls for the importation, distribution or use of certain information technology products and radio frequency technology products in the Russian Federation. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As required under Russian law and as permitted under the OFAC General License one of our subsidiaries in Russia periodically files notifications with or applies for import licenses and permits from the FSB on our behalf in connection with the importation of our products into Russia. These notification and licensing activities are free of charge and none of our gross revenue or net profits are attributable to such activities. We expect to continue to file notifications with and apply for import licenses and permits from the FSB to qualify our products for importation and distribution in the Russian Federation to the extent required under Russian law but only so long as such notification and licensing activities are authorized by the OFAC General License, any successor general license or other authorization issued by OFAC.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the fourth quarter of 2024 we filed two notifications with the FSB as described above.</span></div><div id="i1442ddc197954361b38cabd10df2e256_160"></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;9C.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div id="i1442ddc197954361b38cabd10df2e256_163"></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART III</span></td></tr></table></div><div id="i1442ddc197954361b38cabd10df2e256_166"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;10.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information regarding our executive officers appears under the caption "Information about our Executive Officers" in Part I, Item 1 of this report.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information regarding our directors and certain corporate governance and other matters appearing under the captions "Proposal 1&#8212;Election of Directors," "Corporate Governance," and "Additional Information&#8212;Delinquent Section 16(a) Reports" in the 2025 proxy statement is incorporated herein by reference.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have adopted Corporate Policy 6 (Trading in Securities by Company Personnel) and Insider Trading Guidelines (collectively, Insider Trading Policies)  which govern the purchase, sale and/or other disposition of our securities by our directors, officers and employees, as well as by the Company itself, that we believe are reasonably designed to promote compliance with insider trading laws, rules and regulations and New York Stock Exchange listing standards. Copies of the Insider Trading Policies are filed as Exhibits 19(i) and 19(ii) to this report.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Corporate Governance Guidelines adopted by our Board of Directors, as well as the charters of each of the Audit Committee, the Governance and Nominating Committee and the Compensation Committee and the Code of Conduct applicable to the principal executive officer, president, principal financial officer and principal accounting officer or controller or persons performing similar functions are posted on the "Corporate Governance" section of our website at </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">www.stryker.com</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. </span></div><div id="i1442ddc197954361b38cabd10df2e256_169"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;11.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EXECUTIVE COMPENSATION.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information regarding the compensation of our management appearing under the captions "Compensation Discussion and Analysis," "Compensation and Human Capital Committee Report," "Executive Compensation" and "Compensation of Directors" in the 2025 proxy statement is incorporated herein by reference.</span></div><div id="i1442ddc197954361b38cabd10df2e256_172"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;12.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The information under the caption "Stock Ownership" in the 2025 proxy statement is incorporated herein by reference. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2024 we had an equity compensation plan under which options were granted at a price not less than fair market value at the date of grant and under which awards of restricted stock units (RSUs) and performance stock units (PSUs) were made. Options and RSUs were also awarded under a previous plan. Additional information regarding our equity compensation plans appears in Note 1 and Note 9 to our Consolidated Financial Statements. On December&#160;31, 2024 we also had a stock performance incentive award program pursuant to which shares of our common stock were and may be issued to certain employees with respect to performance. The status of these plans, each of which were previously submitted to and approved by our shareholders, on December&#160;31, 2024 is as follows:</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">45</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2024 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:23.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Plan</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of&#160;<br/>securities to be issued upon exercise&#160;of&#160;<br/>outstanding&#160;<br/>options, warrants and rights</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-average exercise price of outstanding&#160;<br/>options, warrants and rights</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of&#160;securities remaining available for future issuance under equity compensation&#160;<br/>plans (excluding shares&#160;reflected&#160;in&#160;<br/>the&#160;first&#160;column)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2008 Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">N/A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,603,619</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2011 Long-Term Incentive Plan</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,683,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">214.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,075,592</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2011 Performance Incentive Award Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">247,764</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21,926,975</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2011 Long-Term Incentive Plan securities to be issued upon exercise include 671,627 RSUs and 179,868 PSUs. The weighted-average exercise prices does not take these awards into account. </span></div><div id="i1442ddc197954361b38cabd10df2e256_175"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;13.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The information under the caption "Corporate Governance" and "Corporate Governance&#8212;Certain Relationships and Related Party Transactions" in the 2025 proxy statement is incorporated herein by reference.</span></div><div id="i1442ddc197954361b38cabd10df2e256_178"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;14.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PRINCIPAL ACCOUNTANT FEES AND SERVICES.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The information under the caption "Proposal 2&#8212;Ratification of Appointment of our Independent Registered Public Accounting Firm" in the 2025 proxy statement is incorporated herein by reference.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">46</span></div></td></tr></table></div></div></div><div id="i1442ddc197954361b38cabd10df2e256_181"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART IV</span></td></tr></table></div><div id="i1442ddc197954361b38cabd10df2e256_184"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.650%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;15.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EXHIBITS, FINANCIAL STATEMENT SCHEDULES.</span></td></tr></table></div><ix:nonNumeric contextRef="c-1" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="f-1715" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:4.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.254%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.754%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial Statements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The following Consolidated Financial Statements are set forth in Part II, Item 8 of this report.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Report of Independent Registered Public Accounting Firm</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_79">25</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Earnings for 2024, 2023 and 2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_82">26</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Comprehensive Income for 2024, 2023 and 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_88">26</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Balance Sheets on 2024 and 2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_91">27</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Shareholders&#8217; Equity for 2024, 2023 and 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_94">28</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Cash Flows for 2024, 2023 and 2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_97">29</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes to Consolidated Financial Statements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1442ddc197954361b38cabd10df2e256_100">30</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) 2.</span></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial Statement Schedules</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Consolidated Financial Statement schedule of Stryker Corporation and its subsidiaries is:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Costs &amp;<br/>Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Uncollectible Amounts Written Off, Net of Recoveries</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Changes in Foreign Currency Exchange Rates</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance<br/>at End<br/>of Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DEDUCTED FROM ASSET ACCOUNTS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for Doubtful Accounts:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-485" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1716">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-486" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1717">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-486" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="f-1718">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-486" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="6" id="f-1719">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-487" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1720">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-488" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1721">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-489" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1722">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-489" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="f-1723">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-489" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="6" id="f-1724">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-485" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1725">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-490" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1726">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-491" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1727">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-491" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="f-1728">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-491" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="6" id="f-1729">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-488" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1730">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other schedules for which provision is made in the applicable accounting regulation of the United States Securities and Exchange Commission are not required under the related instructions or are inapplicable and, therefore, have been omitted.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div></ix:nonNumeric><div id="i1442ddc197954361b38cabd10df2e256_187"></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FORM 10-K&#8212;ITEM 15(a) 3. AND ITEM&#160;15(c)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">STRYKER CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.973%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:66.834%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 2&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Plan of Acquisition, Reorganization, Arrangement, Liquidation or Succession</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312519285387/d818709dex21.htm">Purchase Agreement, dated as of November 4, 2019, among Stryker Corporation, Stryker B.V. and Wright Medical Group N.V. &#8212; Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Form 8-K dated November 6, 2019 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#169;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312522006816/d105293dex21.htm">Agreement and Plan of Merger, dated as of January 6, 2022, by and among Stryker Corporation, Voice Merger Sub Corp., and Vocera Communications, Inc. &#8212; Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Form 8-K dated January 11, 2022 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312525002537/d899660dex21.htm">Agreement and Plan of Merger, dated January 6, 2025, by and between Stryker Corporation and Inari Medical, Inc. &#8212; Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Form 8-K dated January 7, 2025 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 3&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Articles of Incorporation and By-Laws</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076418000205/ex3i10qq32018.htm">Restated Articles of Incorporation &#8212; Incorporated by reference to Exhibit 3(i) to the Company's Form 10-Q for the quarterly period ended September 30, 2018 (Commission File No. 00-09165).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076423000017/ex3iiamendedbylaws-nov2022.htm">Amended and Restated Bylaws - Incorporated by reference to Exhibit 3(ii) to the Company's Form 10-K for the year ended December 31, 2022 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 4&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Instruments defining the rights of security holders, including indentures&#8212;We agree to furnish to the Commission upon request a copy of each instrument pursuant to which long-term debt of Stryker Corporation and its subsidiaries not exceeding 10% of the total assets of Stryker Corporation and its consolidated subsidiaries is authorized.</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312510007135/dex41.htm">Indenture, dated January 15, 2010, between Stryker Corporation and U.S. Bank National Association.&#8212; Incorporated by reference to Exhibit 4.1 to the Company's Form 8-K dated January 15, 2010 (Commission File No. 000-09165).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">47</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.973%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:66.834%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312513123574/d508904dex43.htm">Fifth Supplemental Indenture (including the form of 2043 note) dated March 25, 2013, between Stryker Corporation and U.S. Bank National Association.&#8212; Incorporated by reference to Exhibit 4.3 to the Company's Form 8-K dated March 25, 2013 (Commission File No. 000-09165).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312514175095/d720177dex43.htm">Seventh Supplemental Indenture (including the form of 2044 note), dated May 1, 2014, between Stryker Corporation and U.S. Bank National Association.&#8212; Incorporated by reference to Exhibit 4.3 to the Company's Form 8-K dated May 1, 2014 (Commission File No. 000-09165).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iv)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312515358209/d46878dex42.htm">Eighth Supplemental Indenture (including the form of 2025 note), dated October 29, 2015, between Stryker Corporation and U.S. Bank National association.&#8212; Incorporated by reference to Exhibit 4.2 to the Company's Form 8-K dated October 29, 2015 (Commission File No. 000-09165).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(v)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312516499457/d159431dex44.htm">Eleventh Supplemental Indenture (including the form of the 2026 note), dated March 10, 2016, between Stryker Corporation and U.S. Bank National Association.&#8212; Incorporated by reference to Exhibit 4.4 to the Company's Form 8-K dated March 10, 2016 (Commission File No. 000-09615).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(vi)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312516499457/d159431dex45.htm">Twelfth Supplemental Indenture (including the form of the 2046 note), dated March 10, 2016, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.5 to the Company's Form 8-K dated March 10, 2016 (Commission File No. 000-09615).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(vii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312518073610/d518544dex42.htm">Fourteenth Supplemental Indenture (including the form of the 2028 note), dated March 7, 2018, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.2 to the Company's Form 8-K dated March 7, 2018 (Commission File No. 000-09615).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(viii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312518339720/d661644dex43.htm">Sixteenth Supplemental Indenture (including the form of the 2027 note), dated November 30, 2018, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.3 to the Company's Form 8-K dated November 30, 2018 (Commission File No. 000-09615).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ix)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312518339720/d661644dex44.htm">Seventeenth Supplemental Indenture (including the form of the 2030 note), dated November 30, 2018, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.4 to the Company's Form 8-K dated November 30, 2018 (Commission File No. 000-09615).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(x)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312519305266/d103227dex43.htm">Twentieth Supplemental Indenture (including the form of the 2029 note), dated December 3, 2019, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.3 to the Company's Form 8-K dated December 3, 2019 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xi)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312519305266/d103227dex44.htm">Twenty-First Supplemental Indenture (including the form of the 2031 note), dated December 3, 2019, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.4 to the Company's Form 8-K dated December 3, 2019 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312520160734/d927297dex42.htm">Twenty-Second Supplemental Indenture (including the form of the 2025 note), dated June 4, 2020, between Stryker Corporation and U.S. Bank National Association, as trustee - Incorporated by reference to Exhibit 4.2 to the Company&#8217;s Form 8-K dated June 4, 2020 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xiii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312520160734/d927297dex43.htm">Twenty-Third Supplemental Indenture (including the form of the 2030 note), dated June 4, 2020, between Stryker Corporation and U.S. Bank National Association &#8212; Incorporated by reference to Exhibit 4.3 to the Company&#8217;s Form 8-K dated June 4, 2020 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xiv)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312520160734/d927297dex44.htm">Twenty-Fourth Supplemental Indenture (including the form of the 2050 note), dated June 4, 2020, between Stryker Corporation and U.S. Bank National Association &#8212; Incorporated by reference to Exhibit 4.4 to the Company&#8217;s Form 8-K dated June 4, 2020 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xv)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312523291773/d54031dex42.htm">Twenty-Sixth Supplemental Indenture (including the form of the 2028 note), dated December 8, 2023, between Stryker Corporation and U.S. Bank Trust Company, National Association, as trustee &#8212; Incorporated by reference to Exhibit 4.2 to the Company&#8217;s Form 8-K dated December 8, 2023 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xvi)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312523292590/d18061dex42.htm">Twenty-Seventh Supplemental Indenture (including the form of the 2028 note), dated December 11, 2023, between Stryker Corporation and U.S. Bank Trust Company, National Association, as trustee &#8212; Incorporated by reference to Exhibit 4.2 to the Company&#8217;s Form 8-K dated December 11, 2023 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xvii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312524217275/d894557dex42.htm">Twenty-Eighth Supplemental Indenture (including the form of 2032 note), dated September 11, 2024, between Stryker Corporation and U.S. Bank Trust Company, National Association, as trustee &#8212; Incorporated by reference to Exhibit 4.2 to the Company&#8217;s Form 8-K dated September 11, 2024 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xviii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312524217275/d894557dex43.htm">Twenty-Ninth Supplemental Indenture (including the form of 2036 note), dated September 11, 2024, between Stryker Corporation and U.S. Bank Trust Company, National Association, as trustee &#8212; Incorporated by reference to Exhibit 4.3 to the Company&#8217;s Form 8-K dated September 11, 2024 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xix)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312524217275/d894557dex44.htm">Thirtieth Supplemental Indenture (including the form of 2029 note), dated September 11, 2024, between Stryker Corporation and U.S. Bank Trust Company, National Association, as trustee &#8212; Incorporated by reference to Exhibit 4.4 to the Company&#8217;s Form 8-K dated September 11, 2024 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xx)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312524217275/d894557dex45.htm">Thirty-First Supplemental Indenture (including the form of 2034 note), dated September 11, 2024, between Stryker Corporation and U.S. Bank Trust Company, National Association, as trustee &#8212; Incorporated by reference to Exhibit 4.5 to the Company&#8217;s Form 8-K dated September 11, 2024 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxi)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312525023587/d907608dex42.htm">Thirty-Second Supplemental Indenture (including the form of 2027 note), dated February 10, 2025, between Stryker Corporation and U.S. Bank Trust Company, National Association, as trustee &#8212; Incorporated by reference to Exhibit 4.2 to the Company&#8217;s Form 8-K dated February 10, 2025 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312525023587/d907608dex43.htm">Thirty-Third Supplemental Indenture (including the form of 2028 note), dated February 10, 2025, between Stryker Corporation and U.S. Bank Trust Company, National Association, as trustee &#8212; Incorporated by reference to Exhibit 4.3 to the Company&#8217;s Form 8-K dated February 10, 2025 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxiii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312525023587/d907608dex44.htm">Thirty-Fourth Supplemental Indenture (including the form of 2030 note), dated February 10, 2025, between Stryker Corporation and U.S. Bank Trust Company, National Association, as trustee &#8212; Incorporated by reference to Exhibit 4.4 to the Company&#8217;s Form 8-K dated February 10, 2025 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxiv)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312525023587/d907608dex45.htm">Thirty-Fifth Supplemental Indenture (including the form of 2035 note), dated February 10, 2025, between Stryker Corporation and U.S. Bank Trust Company, National Association, as trustee &#8212; Incorporated by reference to Exhibit 4.5 to the Company&#8217;s Form 8-K dated February 10, 2025 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxv)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex4xxv1231202410k.htm">Description of Securities</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit&#160;10&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Material contracts</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)*</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex10i2025stockoptionawardl.htm">Form of grant notice and terms and conditions for stock options granted in 2025 under the 2011 Long-Term Incentive Plan.</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">48</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.973%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:66.834%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex10ii2025rsuawardletteran.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2025 under the 2011 Long-Term Incentive Plan.</a></span></div><div><span><br/></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex10iii2025psuawardlettera.htm">Form of grant notice and terms and conditions for performance stock units granted in 2025 under the 2011 Long-Term Incentive Plan.</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iv)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex10iv2025norersuawardlett.htm">Form of grant notice and terms and conditions for restricted stock units with no retirement provisions granted in 2025 under the 2011 Long-Term Incentive Plan.</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(v)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076424000098/ex10i2024non-employeedirec.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2024 under the 2011 Long-Term Incentive Plan to non-employee directors &#8212; Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Form 10-Q for the quarterly period ended June 30, 2024 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(vi)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076424000024/ex10i2024nqstockoptionawar.htm">Form of grant notice and terms and conditions for stock options granted in 2024 under the 2011 Long-Term Incentive Plan  &#8212; Incorporated by reference to Exhibit 10(i) to the Company&#8217;s Form 10-K for the year ended December 31, 2023 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(vii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076424000024/ex10ii2024rsuawardletteran.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2024 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(ii) to the Company&#8217;s Form 10-K for the year ended December 31, 2023 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(viii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076424000024/ex10iii2024psuawardlettera.htm">Form of grant notice and terms and conditions for performance stock units granted in 2024 under the 2011 Long-Term Incentive Plan  &#8212; Incorporated by reference to Exhibit 10(iii) to the Company&#8217;s Form 10-K for the year ended December 31, 2023 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ix)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076423000106/ex10i630202310q.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2023 under the 2011 Long-Term Incentive Plan to non-employee directors  &#8212; Incorporated by reference to Exhibit 10(i) to the Company&#8217;s Form 10-Q for the quarterly period ended June 30, 2023 (Commission File No. 000-09165).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(x)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076423000017/ex10i2023nqstockoptionawar.htm">Form of grant notice and terms and conditions for stock options granted in 2023 under the 2011 Long-Term Incentive Plan - Incorporated by reference to Exhibit 10(i) to the Company's Form 10-K for the year ended December 31, 2022 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xi)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076423000017/ex10ii2023rsuawardletteran.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2023 under the 2011 Long-Term Incentive Plan - Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-K for the year ended December 31, 2022 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076423000017/ex10iii2023psuawardlettera.htm">Form of grant notice and terms and conditions for performance stock units granted in 2023 under the 2011 Long-Term Incentive Plan - Incorporated by reference to Exhibit 10(iii) to the Company's Form 10-K for the year ended December 31, 2022 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xiii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076422000092/ex10i630202210q.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2022 under the 2011 Long-Term Incentive Plan to non-employee directors &#8212; Incorporated by reference to Exhibit 10(i) to the Company's Form 10-Q for the quarterly period ended June 30, 2022 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xiv)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076422000028/ex10i2022nqstockoptionawar.htm">Form of grant notice and terms and conditions for stock options granted in 2022 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(i) to the Company's Form 10-K for the year ended December 31, 2021 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xv)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076422000028/ex10ii2022rsustockoptionaw.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2022 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-K for the year ended December 31, 2021 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xvi)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076422000028/ex10iii2022psustockoptiona.htm">Form of grant notice and terms and conditions for performance stock units granted in 2022 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(iii) to the Company's Form 10-K for the year ended December 31, 2021 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xvii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10i2021nqstockoptionawar.htm">Form of grant notice and terms and conditions for stock options granted in 2021 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(i) to the Company's Form 10-K for the year ended December 31, 2020 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xviii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10i1231201910k.htm">2011 Long-Term Incentive Plan (as amended effective February 4, 2020) &#8212; Incorporated by reference to Exhibit 10(i) to the Company's Form 10-K for the year ended December 31, 2019 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xix)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10ii1231201910k.htm">Form of grant notice and terms and conditions for stock options granted in 2020 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-K for the year ended December 31, 2019 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xx)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10vi1231201910k.htm">Supplemental Savings and Retirement Plan (as amended effective January 1, 2008 and January 1, 2019) &#8212; Incorporated by reference to Exhibit 10(vi) to the Company's Form 10-K for the year ended December 31, 2019 (Commission File No. 001-13149)</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">.</span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxi)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076419000014/ex10ii12311810k.htm">Form of grant notice and terms and conditions for stock options granted in 2019 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-K for the year ended December 31, 2018 (Commission File No. 001-13149).&#160;</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076418000031/ex10ii12311710k.htm">Form of grant notice and terms and conditions for stock options granted in 2018 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-K for the year ended December 31, 2017 (Commission File No. 000-09165).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxiii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076407000052/sykex101.htm">Stryker Corporation Executive Bonus Plan &#8212; Incorporated by reference to Exhibit 10.1 to the Company's Form 8-K dated February 21, 2007 (Commission File No. 000-09165).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxiv)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076416000206/syk8kex10212616.htm">Letter Agreement between Stryker Corporation and Glenn Boehnlein &#8212; Incorporated by reference to Exhibit 10.2 to the Company's Form 8-K dated January 26, 2016 (Commission File No. 000-09165)</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">.</span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxv)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076409000035/sykex10xiv.htm">Form of Indemnification Agreement for Directors &#8212; Incorporated by reference to Exhibit 10 (xiv) to the Company's Form 10-K for the year ended December 31, 2008 (Commission File No. 000-09165).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxvi)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076409000035/sykex10xv.htm">Form of Indemnification Agreement for Certain Officers&#8212;Incorporated by reference to Exhibit 10 (xv) to the Company's Form 10-K for the year ended December 31, 2008 (Commission File No. 000-09165).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">49</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.973%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:66.834%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxvii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076415000022/ex10xxiii10k2014.htm">Settlement Agreement between Howmedica Osteonics Corp. and the counsel listed on the signature pages thereto, dated as of November 3, 2014 (Rejuvenate and ABF II Hip Implant Products Liability Litigation) &#8212; Incorporated by reference to Exhibit 10xxiii to the Company's Form 10-K for the year ended December 31, 2014 (Commission File No. 000-09165).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxviii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076421000146/ex10i2021creditagreement.htm">Credit Agreement, dated as of October 26, 2021, among Stryker Corporation as borrower; the lenders party thereto; and Wells Fargo Bank, N.A., as administrative agent &#8212; Incorporated by reference to Exhibit 10(i) to the Company's Form 10-Q for the quarterly period ended September 30, 2021 (Commission File No. 001-13149).</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxix)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312523169034/d483687dex101.htm">Amendment No. 1, dated June 15, 2023, to Credit Agreement, dated as of October 26, 2021, by and among Stryker Corporation, the other borrowers party thereto, the lenders from time to time party thereto and Wells Fargo Bank, National Association, as administrative agent &#8212; Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Form 8-K dated June 16, 2023 (Commission File No. 000-09165).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxx)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076424000098/ex10iiamendment2tocreditag.htm">Amendment No. 2, dated June 4, 2024, to Credit Agreement, dated as of October 26, 2021, by and among Stryker Corporation, the other borrowers party thereto, the lenders from time to time party thereto and Wells Fargo Bank, National Association, as administrative agent &#8212; Incorporated by reference to Exhibit 10.2 to the Company's Form 10-Q for the quarterly period ended June 30, 2024 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxxi)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex10xxxitransitionagreemen.htm">Transition Agreement, dated January 24, 2025, between Stryker Corporation and Glenn S. Boehnlein</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">.</span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxxii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000119312525014415/d919971dex102.htm">Letter Agreement, dated January 27, 2025, between Stryker Corporation and Preston Wells &#8212; Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Form 8-K dated January 28, 2025 (Commission File No. 001-13149).</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 19&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-1731">Insider Trading Policy</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex19icorporatepolicy6_as.htm">Corporate Policy No. 6</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex19iiinsidertradingguid.htm">Insider Trading Guidelines</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 21&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Subsidiaries of the registrant</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex21i1231202410k.htm">List of Subsidiaries.</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 23&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consent of experts and counsel</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex23i1231202410k.htm">Consent of Independent Registered Public Accounting Firm.</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.973%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:66.834%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 31&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rule 13a-14(a) Certifications</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex31i1231202410k.htm">Certification by Principal Executive Officer of Stryker Corporation.</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex31ii1231202410k.htm">Certification by Principal Financial Officer of Stryker Corporation.</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 32&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18 U.S.C. Section 1350 Certifications</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;&#8224;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex32i1231202410k.htm">Certification by Principal Executive Officer of Stryker Corporation.</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;&#8224;</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex32ii1231202410k.htm">Certification by Principal Financial Officer of Stryker Corporation.</a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 97&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Policy Relating to Recovery of Erroneously Awarded Compensation</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/310764/000031076424000024/ex97istrykercorporationman.htm">Stryker Corporation Mandatory Clawback Policy  &#8212; Incorporated by reference to Exhibit 97(i) to the Company's Form 10-K for the year ended December 31, 2023 (Commission File No. 001-13149). </a></span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit&#160;101&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL (Inline Extensible Business Reporting Language) Documents</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Instance Document</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Schema Document</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Calculation Linkbase Document</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Definition Linkbase Document</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Label Linkbase Document</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Presentation Linkbase Document</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Compensation arrangement</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Filed with this Form 10-K</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8224;&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Furnished with this Form 10-K</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#169;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. Stryker hereby agrees to furnish supplementally a copy of any omitted schedule upon request by the U.S. Securities and Exchange Commission.</span></td></tr></table></div><div id="i1442ddc197954361b38cabd10df2e256_190"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.650%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;16.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FORM 10-K SUMMARY.</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">50</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STRYKER CORPORATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 FORM 10-K</span></div></td></tr></table></div></div><div style="text-align:justify"><span><br/></span></div><div id="i1442ddc197954361b38cabd10df2e256_193"></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.929%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">STRYKER CORPORATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 12, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ GLENN S. BOEHNLEIN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Glenn S. Boehnlein</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vice President, Chief Financial Officer</span></td></tr></table></div><div style="margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on the date indicated above on behalf of the registrant and in the capacities indicated.&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:47.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.997%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ KEVIN A. LOBO</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ GLENN S. BOEHNLEIN</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kevin A. Lobo</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Glenn S. Boehnlein</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chair, Chief Executive Officer and President</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vice President, Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ WILLIAM E. BERRY JR.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">William E. Berry, Jr.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vice President, Chief Accounting Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ SHERILYN S. MCCOY</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ ANDREW K. SILVERNAIL</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sherilyn S. McCoy</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Andrew K. Silvernail</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lead Independent Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ MARY K. BRAINERD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ LISA M. SKEETE TATUM</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mary K. Brainerd</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lisa M. Skeete Tatum</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ GIOVANNI CAFORIO</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ RONDA E. STRYKER</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Giovanni Caforio, M.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ronda E. Stryker</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ RACHEL M. RUGGERI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ RAJEEV SURI</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rachel M. Ruggeri</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rajeev Suri</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ ALLAN C. GOLSTON</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allan C. Golston</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">51</span></div></td></tr></table></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.25
<SEQUENCE>2
<FILENAME>ex4xxv1231202410k.htm
<DESCRIPTION>EX-4.25
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i5ca9f47978cb4d62bb0203d7000c0cd0_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxv)</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Description of Capital Stock</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following description is a summary of certain terms of the capital stock of Stryker Corporation (&#8220;Stryker&#8221; or the &#8220;Company&#8221;). It does not purport to be complete and is subject in all respects to the applicable provisions of the Michigan Business Corporation Act, as amended, or the MBCA, our Restated Articles of Incorporation, as amended, or our articles, and our Bylaws, as amended, or our bylaws. As used in this exhibit, and except where the context otherwise requires, &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Stryker Corporation.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Capital Stock</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our authorized capital stock consists of (1) 1,000,000,000 shares of common stock, $0.10 par value per share and (2) 500,000 shares of preferred stock, $1.00 par value per share. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each share of common stock entitles the holder thereof to one vote for each share held by it of record on each matter submitted to a vote. Other than the election of directors, if an action is to be taken by vote of the shareholders, it will be authorized by a majority of the votes cast by the holders of shares entitled to vote on the action, unless a greater vote is required in our articles or bylaws. Directors are elected by a majority of the votes cast by the holders of shares entitled to vote (and for such purpose, a majority of the votes cast means that the number of shares voted &#8220;for&#8221; a nominee must exceed the number of votes cast &#8220;against&#8221; that nominee)&#894; provided, however, that if as of the record date for a meeting at which directors will be elected, there are more nominees than positions on the board of directors to be filled by election at such meeting, each director shall be elected by a plurality of the votes cast at the election.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Subject to the prior payment or provision therefor of dividends on the preferred stock, if any, holders of the common stock are entitled to receive ratably such dividends, if any, as may be declared from time to time by our Board of Directors out of funds legally available therefor. Holders of our common stock have no conversion, preemptive or other rights to subscribe for any securities of ours, and there are no redemption or sinking fund provisions with respect to such shares. In the event of any liquidation, dissolution or distribution of our assets and after satisfaction of the preferential requirements of the preferred stock, if any, holders of common stock will be entitled to share ratably in the distribution of the remaining assets of the Company available for distribution. The rights, preferences and privileges of holders of common stock are subject to applicable law and the rights of the holders of any shares of preferred stock and any additional classes of stock that we may issue in the future.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our articles authorize our Board of Directors to issue up to 500,000 shares of preferred stock in one or more series, with such distinctive designation or title and in such number of shares as may be authorized by our Board of Directors. Our Board of Directors is authorized to prescribe the relative rights and preferences of each series, and the limitations applicable thereto, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">including but not limited to the following&#58; (1) the voting powers, full, special, or limited, or no voting powers of each such series&#894; (2) the rate, terms and conditions on which dividends will be paid, whether such dividends will be cumulative, and what preference such dividends shall have in relation to the dividends on other series or classes of stock&#894; (3) the rights, terms and conditions, if any, for conversion of such series of preferred stock into shares of other series or classes of stock&#894; (4) any right of the Company to redeem the shares of such series of preferred stock, and the price, time and conditions of such redemption, including the provisions for any sinking fund&#894; and (5) the rights of holders of such series of preferred stock in relation to the rights of other series and classes of stock upon the liquidation, dissolution or distribution of our assets. Unless otherwise provided by our Board of Directors, upon repurchase by the Company, redemption or conversion, shares of preferred stock will revert to authorized but unissued shares and may be reissued as shares of any series of preferred stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Limitation of Liability</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our articles provide that, to the full extent authorized or permitted by the MBCA, directors of Stryker will not be personally liable to Stryker or its shareholders for any acts or omissions in such person&#8217;s capacity as a director. Such limitation of liability does not affect the availability of equitable remedies such as injunctive relief or rescission. These provisions will not limit the liability of directors under federal securities laws.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Certain Statutory, Articles and Bylaw Provisions Affecting Shareholders</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Certain provisions in our articles and bylaws and the MBCA may have the effect of delaying, deferring or preventing a change of control of the Company or may operate only with respect to extraordinary corporate transactions involving the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Business Combination Act</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We are subject to the provisions of Chapter 7A of the MBCA, which provides that business combinations between a Michigan corporation and a beneficial owner of shares entitled to 10% or more of the voting power of such corporation generally require the affirmative vote of 90% of the votes of each class of stock entitled to vote and not less than two-thirds of each class of stock entitled to vote (excluding voting shares owned by such 10% owner). Chapter 7A defines a &#8220;business combination&#8221; to encompass any merger, conversion, consolidation, share exchange, sale, lease, transfer or other disposition of assets, stock issue, liquidation, dissolution or reclassification of securities involving an interested shareholder or certain affiliates. An &#8220;interested shareholder&#8221; is generally any person who owns 10% or more of the voting shares of the corporation. An &#8220;affiliate&#8221; is a person who directly or indirectly controls, is controlled by, or is under common control with, a specified person. Such requirements do not apply if the transaction satisfies fairness standards, other specified conditions are met and the interested shareholder has been such for at least five years.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Article and Bylaw Provisions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our articles and bylaws include a number of provisions that may have the effect of encouraging persons considering unsolicited tender offers or other unilateral takeover proposals to negotiate with our Board of Directors rather than pursue non-negotiated takeover attempts. These provisions include an advance notice requirement for director nominations and actions to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">be taken at annual meetings of shareholders and the availability of authorized but unissued blank check preferred stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Advance Notice Requirement</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our bylaws set forth advance notice procedures with regard to shareholder proposals relating to the nomination of candidates for election as directors or new business to be presented at meetings of shareholders. These procedures provide that notice of such shareholder proposals must be timely given in writing to the secretary of Stryker prior to the meeting at which the action is to be taken. Generally, to be timely, notice must be received at the principal executive offices of Stryker not less than 90 days nor more than 120 days prior to the meeting. The advance notice requirement does not give the Board of Directors any power to approve or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">disapprove shareholder director nominations or proposals but may have the effect of precluding the consideration of certain business at a meeting if the proper notice procedures are not followed.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Special Meetings of Shareholders</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Under our bylaws, special meetings of shareholders may be called by the chair of our Board of Directors, our chief executive officer, our president or by order of our Board of Directors. Our bylaws provide that a special meeting of the shareholders shall be called by the chief executive officer upon written request of one or more record holders of shares of our common stock representing not less than 25% of our issued and outstanding shares of common stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Blank Check Preferred Stock</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our preferred stock could be deemed to have an anti-takeover effect in that, if a hostile takeover situation should arise, shares of preferred stock could be issued to purchasers sympathetic with our management or others in such a way as to render more difficult or to discourage a merger, tender offer, proxy contest, the assumption of control by a holder of a large block of our securities or the removal of incumbent management.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The effects of the issuance of one or more series of the preferred stock on the holders of our common stock could include&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">reduction of the amount otherwise available for payments of dividends on common stock if dividends are payable on the series of preferred stock&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">restrictions on dividends on our common stock if dividends on the series of preferred stock are in arrears&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">dilution of the voting power of our common stock if the series of preferred stock has voting rights, including a possible &#8220;veto&#8221; power if the series of preferred stock has class voting rights&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">dilution of the equity interest of holders of our common stock if the series of preferred stock is convertible, and is converted, into our common stock&#894; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">restrictions on the rights of holders of our common stock to share in our assets upon liquidation until satisfaction of any liquidation preference granted to the holders of the series of preferred stock.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Transfer Agent and Registrar</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The transfer agent and registrar for our common stock is Equiniti Trust Company, LLC.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Listing</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our common stock is listed on the New York Stock Exchange under the symbol &#8220;SYK.&#8221;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Description of Debt Securities&#58;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.125% Notes due 2027</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.625% Notes due 2030</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company&#8217;s 2.125% Notes due 2027 (the &#8220;2027 notes&#8221;) and the Company&#8217;s 2.625% Notes due 2030 (the &#8220;2030 notes&#8221; and, together with the 2027 notes, the &#8220;notes&#8221;) were issued under a base indenture, dated as of January 15, 2010, between the Company and U.S. Bank Trust Company, National Association, as trustee, as supplemented by the applicable supplemental indenture governing a particular series of notes (as so supplemented, the &#8220;Indenture&#8221;). This summary is subject to and qualified in its entirety by reference to all of the provisions of the Indenture and the notes, including definitions of certain terms used in the Indenture and the notes.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The 2027 notes and the 2030 notes were issued as separate series of debt securities under the Indenture. The notes are senior unsecured obligations of ours and rank equally in right of payment with our other existing and future senior unsecured indebtedness. The notes are not secured by any of our assets. Any future claims of our secured lenders with respect to assets securing their loans will be prior to any claim of the holders of the notes with respect to those assets. Holders of secured debt that we have now or may issue in the future may foreclose on the assets securing such debt, reducing the cash flow from the foreclosed property available for payment of unsecured debt, including the notes. Holders of our secured debt also would have priority over unsecured creditors in the event of our bankruptcy, liquidation or similar proceeding to the extent of the value of the collateral securing such debt. The notes are structurally subordinated to all liabilities of our subsidiaries, including trade payables. Because we conduct many of our operations through our subsidiaries, our right to participate in any distribution of the assets of a subsidiary when it winds up its business is subject to the prior claims of the creditors of that subsidiary. This means that your right to payment as a holder of our notes is also subject to the prior claims of these creditors if a subsidiary liquidates or reorganizes or otherwise winds up its business. If we are a creditor of any of our subsidiaries, our right as a creditor would be subordinated to any security interest in the assets of those subsidiaries and any indebtedness of our subsidiaries senior in right of payment to that held by us. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture does not limit the amount of notes, unsecured debentures or other evidences of indebtedness that we may issue under the Indenture and provides that notes, unsecured debentures or other evidences of indebtedness may be issued from time to time in one or more series. We may from time to time, without notice to or the consent of the holders of the notes, create and issue additional notes of any series having the same ranking and terms and conditions as the notes of the same series, except for the issue date, the public offering price and, in some cases, the first interest payment date. Any additional notes having such similar terms, together with the notes offered of the same series, will constitute a single series of securities under the Indenture. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We issued the notes in fully registered book-entry form without coupons and in denominations of &#8364;100,000 and integral multiples of &#8364;1,000 thereafter.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Principal of and interest on the notes are payable, and the notes are transferable or exchangeable, at the office or offices or agency maintained by us for these purposes. Payment of interest on the notes may be made at our option by check mailed to the registered holders thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The 2027 notes and the 2030 notes are listed on the New York Stock Exchange under the symbols &#8220;SYK27,&#8221; and &#8220;SYK30,&#8221; respectively. We have no obligation to maintain such listings, and we may delist any series of the notes at any time. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">U.S. Bank Trust Company, National Association is registrar and transfer agent for the notes. Upon notice to the trustee, we may change the registrar or transfer agent.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Interest</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The 2027 notes and the 2030 notes bear interest from the date of issuance, payable annually on November 30 of each year, beginning November 30, 2019, to the persons in whose names such notes are registered at the close of business on the business day (for this purpose, a day on which Clearstream and Euroclear are open for business) immediately preceding the relevant interest payment. Interest on the notes is computed on the basis of the actual number of days in the period for which interest is being calculated and the actual number of days from and including the last date on which interest was paid on the notes, to, but excluding, the next scheduled interest payment date. This payment convention is referred to as Actual&#47;Actual (ICMA) as defined in the rulebook of the International Capital Market Association.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If any interest payment date would otherwise be a day that is not a business day, such interest payment date will be postponed to the next date that is a business day and no interest will accrue on the amounts payable from and after such interest payment date to the next business day. If the maturity date of any series of the notes falls on a day that is not a business day, the related payment of principal, premium, if any, and interest will be made on the next business day as if it were made on the date such payment was due, and no interest will accrue on the amounts so payable for the period from and after such date to the next business day.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Business Day</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of the notes, a &#8220;business day&#8221; is any day that is not a Saturday, Sunday or other day on which banking institutions in New York City, London or another place of payment on the notes are authorized or required by law to close and on which the Trans-European Automated Real-Time Gross Settlement Express Transfer system (the TARGET2 system), or any successor thereto, is open.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Issuance in euro</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All payments of interest, premium, if any, and principal, including payments made upon any redemption or repurchase of the notes, will be made in euro&#894; provided that if the euro is unavailable to us due to the imposition of exchange controls or other circumstances beyond our </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">control or if the euro is no longer being used by the then member states of the European Monetary Union that have adopted the euro as their currency or for the settlement of</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">transactions by public institutions of or within the international banking community, then all payments in respect of the notes will be made in U.S. dollars until the euro is again available to us or so used. In such circumstances, the amount payable on any date in euro will be converted into U.S. dollars at the rate mandated by the Board of Governors of the Federal Reserve System as of the close of business on the second business day prior to the relevant payment date or, if the Board of Governors of the Federal Reserve System has not announced a rate of conversion, on the basis of the most recent U.S. dollar&#47;euro exchange rate published in The Wall Street Journal on or prior to the second business day prior to the relevant payment date or, in the event The Wall Street Journal has not published such exchange rate, the rate is determined in our sole discretion on the basis of the most recently available market exchange rate for the euro. Any payment in respect of the notes so made in U.S. dollars do not constitute an Event of Default (as defined in the Indenture). Neither the trustee nor the paying agent shall have any responsibility for any calculation or conversion in connection with the foregoing. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Optional Redemption</font></div><div style="text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We may redeem the notes prior to August 31, 2027 in the case of the 2027 notes and August 31, 2030 in the case of the 2030 notes, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to the greater of&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1)   100% of the principal amount of the applicable series of the notes to be redeemed&#894; or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2)   an amount determined by the Quotation Agent (as defined below) equal to the sum of the present values of the remaining scheduled payments of principal, premium, if any, and interest thereon (not including any portion of such payments of interest accrued to the date of redemption) to August 31, 2027 with respect to the 2027 notes and August 31, 2030 with respect to the 2030 notes, discounted to the date of redemption on an annual basis (Actual&#47;Actual (ICMA) at the Comparable Government Bond Rate (as defined below), plus 30 basis points with respect to the 2027 notes and 35 basis points with respect to the 2030 notes, plus accrued and unpaid interest thereon to, but not including, the date of redemption.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On or after August 31, 2027, in the case of the 2027 notes and August 31, 2030, in the case of the 2030 notes, we may redeem the applicable series of the notes, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to 100% of the principal amount of such series of the notes, plus accrued and unpaid interest to, but not including, the redemption date.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The principal amount of any note remaining outstanding after a redemption in part shall be &#8364;100,000 or a higher integral multiple of &#8364;1,000. Notwithstanding the foregoing, installments of interest on any series of the notes that are due and payable on interest payment dates falling on or prior to a redemption date will be payable on the interest payment date to the registered holders as of the close of business on the relevant record date.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Comparable Government Bond&#8221; means, in relation to any Comparable Government Bond Rate calculation, at the discretion of an independent investment bank selected by us (the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Quotation Agent&#8221;), a German government bund whose maturity is closest to the par call date, or if such Quotation Agent in its discretion determines that such similar bond is not in issue, such other German government bund as such Quotation Agent may, with the advice of three brokers of, and&#47;or market makers in, German government bunds selected by us, determine to be appropriate for determining the Comparable Government Bond Rate.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Comparable Government Bond Rate&#8221; means the price, expressed as a percentage (rounded to three decimal places, with 0.0005 being rounded upwards), at which the gross redemption yield on the notes to be redeemed, if they were to be purchased at such price on the third business day prior to the date fixed for redemption, would be equal to the gross redemption yield on such business day of the Comparable Government Bond on the basis of the middle market price of the Comparable Government Bond prevailing at 11&#58;00 a.m. (London time) on such business day as determined by the Quotation Agent selected by us.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notice of any redemption will be mailed (or, in the case of notes held in book-entry form, be transmitted electronically) at least 10 days but not more than 60 days before the redemption date to each registered holder of the applicable series of the notes to be redeemed. Unless we default in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the applicable series of the notes or portions thereof called for redemption. If less than all of the applicable series of the notes are to be redeemed, the notes to be redeemed will be selected by the trustee in accordance with the standard procedures of the depositary. If the notes to be redeemed are not global notes then held by Euroclear or Clearstream, the trustee will select the notes to be redeemed on a pro rata basis. If the notes are listed on the NYSE or any other national securities exchange, the trustee will select notes in compliance with the requirements of the NYSE or other principal national securities exchange on which the notes are listed. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if less than all of a series of notes are to be redeemed, no notes of such series of a principal amount of &#8364;100,000 or less shall be redeemed in part. If money sufficient to pay the redemption price on the series of notes (or portions thereof) to be redeemed on the redemption date is deposited with the paying agent on or before the redemption date and certain other conditions are satisfied, then on and after such redemption date, interest will cease to accrue on such series of the notes (or such portion thereof) called for redemption.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Optional Redemption for Tax Reasons</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes of any series may be redeemed at our option in whole, but not in part, on not less than 10 nor more than 60 days&#8217; prior notice, at 100% of the principal amount of such series, together with accrued and unpaid interest, if any, to, but excluding, the redemption date if, as a result of any change in, or amendment to, the laws, regulations or rulings of the United States (or any political subdivision or taxing authority thereof or therein having power to tax), or any change in official position regarding application or interpretation of those laws, regulations or rulings (including a holding by a court of competent jurisdiction), which change, amendment, application or interpretation is announced or becomes effective on or after the original issue date with respect to the notes, we become or, based upon a written opinion of independent counsel selected by us, will become obligated to pay additional amounts as described below in &#8220;&#8212;Payment of Additional Amounts.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Payment of Additional Amounts</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All payments of principal, interest, and premium, if any, in respect of the notes will be made free and clear of, and without withholding or deduction for, any present or future taxes, assessments, duties or governmental charges of whatever nature imposed, levied or collected by the United States (or any political subdivision or taxing authority thereof or therein having power to tax), unless such withholding or deduction is required by law or the official interpretation or administration thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will, subject to the exceptions and limitations set forth below, pay as additional interest in respect of the notes such additional amounts as are necessary in order that the net payment by us of the principal of, premium, if any, and interest in respect of the notes to a holder who is not a United States person (as defined below), after withholding or deduction for any present or future tax, assessment, duties or other governmental charge imposed by the United States (or any political subdivision or taxing authority thereof or therein having power to tax), will not be less than the amount provided in the notes to be then due and payable&#894; provided, however, that the foregoing obligation to pay additional amounts shall not apply&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1)   to the extent any tax, assessment or other governmental charge would not have been imposed but for the holder (or the beneficial owner for whose benefit such holder holds such note), or a fiduciary, settlor, beneficiary, member or shareholder of the holder if the holder is an estate, trust, partnership or corporation, or a person holding a power over an estate or trust administered by a fiduciary holder, being considered as&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a)   being or having been engaged in a trade or business in the United States or having or having had a permanent establishment in the United States&#894;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b)   having a current or former connection with the United States (other than a connection arising solely as a result of the ownership of the notes, the receipt of any payment in respect of the notes or the enforcement of any rights hereunder), including being or having been a citizen or resident of the United States&#894;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c)   being or having been a personal holding company, a passive foreign investment company or a controlled foreign corporation for U.S. federal income tax purposes, a foreign tax-exempt organization, or a corporation that has accumulated earnings to avoid U.S. federal income tax&#894;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d)   being or having been a &#8220;10-percent shareholder&#8221; of the Company as defined in section 871(h)(3) of the United States Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) or any successor provision&#894; or</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e)   being a bank receiving payments on an extension of credit made pursuant to a loan agreement entered into in the ordinary course of its trade or business, as described in section 881(c)(3)(A) of the Code or any successor provision&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2)   to any holder that is not the sole beneficial owner of the notes, or a portion of the notes, or that is a fiduciary, partnership, limited liability company or other fiscally transparent entity, but only to the extent that a beneficial owner with respect to the holder, a beneficiary or settlor with respect to the fiduciary, or a beneficial owner or member of the partnership, limited liability company or other fiscally transparent entity would not have been entitled to the payment of an additional amount had the beneficiary, settlor, beneficial owner or member received directly its beneficial or distributive share of the payment&#894;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3)   to the extent any tax, assessment or other governmental charge that would not have been imposed but for the failure of the holder or any other person to comply with certification, identification or information reporting requirements concerning the nationality, residence, identity or connection with the United States of the holder or beneficial owner of the notes, if compliance is required by statute, by regulation of the United States or any taxing authority therein or by an applicable income tax treaty to which the United States is a party as a precondition to exemption from such tax, assessment or other governmental charge&#894;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4)   to any tax, assessment or other governmental charge that is imposed otherwise than by withholding by us or a paying agent from the payment&#894;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5)   to any tax, assessment or other governmental charge required to be withheld by any paying agent from any payment of principal of or interest on any notes, if such payment can be made without such withholding by any other paying agent&#894;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6)   to any estate, inheritance, gift, sales, transfer, wealth, capital gains or personal property tax or similar tax, assessment or other governmental charge, or excise tax imposed on the transfer of notes&#894;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7)   to the extent any tax, assessment or other governmental charge would not have been imposed but for the presentation by the holder of any note, where presentation is required, for payment on a date more than 30 days after the date on which payment became due and payable or the date on which payment thereof is duly provided for, whichever occurs later except to the extent that the beneficiary or holder thereof would have been entitled to the payment of additional amounts had such note been presented for payment on any day during such 30-day period&#894;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8)   to any tax, assessment or other governmental charge imposed under sections 1471 through 1474 of the Code (or any amended or successor provisions), any current or future regulations or official interpretations thereof, any agreement entered into pursuant to section 1471(b) of the Code or any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement entered into in connection with the implementation of such sections of the Code, whether currently in effect or as published and amended from time to time&#894;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9)   to any tax, assessment or other governmental charge that is imposed or withheld solely by reason of a change in law, regulation, or administrative or judicial interpretation that becomes effective more than 15 days after the payment becomes due or is duly provided for, whichever occurs later&#894; or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10) in the case of any combination of the above numbered items. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes are subject in all cases to any tax, fiscal or other law or regulation or administrative or judicial interpretation applicable to the notes. Except as specifically provided under this heading &#8220;&#8212;Payment of Additional Amounts,&#8221; we are not required to make any payment for any tax, assessment or other governmental charge imposed by any government or a political subdivision or taxing authority of or in any government or political subdivision. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As used under this heading &#8220;&#8212;Payment of Additional Amounts&#8221; and under the heading &#8220;&#8212;Optional Redemption for Tax Reasons,&#8221; the term &#8220;United States&#8221; means the United States of America, its territories and possessions, the states of the United States and the District of Columbia, and the term &#8220;United States person&#8221; means (i) any individual who is a citizen or resident of the United States for U.S. federal income tax purposes, (ii) a corporation, partnership or other entity created or organized in or under the laws of the United States, any state of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">United States or the District of Columbia (other than a partnership that is not treated as a United States person for United States federal income tax purposes), (iii) any estate the income of which is subject to U.S. federal income taxation regardless of its source, or (iv) any trust if a United</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">States court can exercise primary supervision over the administration of the trust and one or more United States persons can control all substantial trust decisions, or if a valid election is in place to treat the trust as a United States person.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Repurchase at the Option of Holders Upon Change of Control Repurchase Event</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If a Change of Control Repurchase Event (as defined below) occurs in respect of a series of notes, unless we have exercised our right to redeem the notes of such series as described above under &#8220;&#8212;Optional Redemption,&#8221; we will be required to make an offer (a &#8220;Change of Control Offer&#8221;) to each holder of notes of such series to repurchase all or any part (in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount) of that holder&#8217;s notes at a repurchase price in cash equal to 101% of the aggregate principal amount of notes repurchased plus any accrued and unpaid interest on the notes repurchased to, but not including, the date of such repurchase. Within 30 days following any Change of Control Repurchase Event or, at our option, prior to any Change of Control (as defined below), but after the public announcement of an impending Change of Control, we will mail a notice to each holder, with a copy to the trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Repurchase Event and offering to repurchase notes on the payment date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed. The notice shall, if mailed prior to the date of consummation of the Change of Control, state that the offer to purchase is conditioned on the Change of Control Repurchase Event occurring on or prior to the payment date specified in the notice.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will comply with the requirements of Rule 14e-1 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, and any other securities laws and regulations thereunder, to the extent those laws and regulations are applicable in connection with the repurchase of the notes as a result of a Change of Control Repurchase Event. To the extent that the provisions of any securities laws or regulations conflict with the Change of Control Repurchase Event provisions of the notes, we will comply with the applicable securities laws and regulations and will not be deemed to have breached our obligations under the Change of Control Repurchase Event provisions of the notes by virtue of such conflict.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On the Change of Control Repurchase Event payment date, we will, to the extent lawful&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">accept for payment all notes or portions of notes (in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount) properly tendered pursuant to our offer&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">deposit with the paying agent an amount equal to the aggregate purchase price in respect of all notes or portions of notes properly tendered&#894; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">deliver or cause to be delivered to the trustee for cancellation the notes properly accepted, together with an officers&#8217; certificate stating the aggregate principal amount of notes being repurchased by us.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The paying agent will promptly mail to each holder of notes properly tendered the purchase price for the notes, and the trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each holder a new note equal in principal amount to any unpurchased portion of any notes surrendered&#894; provided, that each new note will be in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will not be required to make a Change of Control Offer upon a Change of Control Repurchase Event if (i) a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for a Change of Control Offer made by us and such third party purchases all notes properly tendered and not withdrawn under its offer or (ii) we have previously or concurrently mailed a redemption notice with respect to all of the outstanding notes as described under &#8220;Optional Redemption&#8221; above.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If holders of not less than 90% in aggregate principal amount of the outstanding notes of any series validly tender and do not withdraw such notes in a Change of Control Offer and we, or any third party making such an offer in lieu of us as described above, purchases all of the notes of such series validly tendered and not withdrawn by such holders, we or such third party will have the right, upon not less than 10 days nor more than 60 days&#8217; prior notice, provided that such notice is given not more than 30 days following such repurchase pursuant to the Change of Control Offer described above, to redeem all notes of such series that remain outstanding following such purchase on a date specified in such notice (the &#8220;Second Change of Control Payment Date&#8221;) and at a price in cash equal to 101% of the aggregate principal amount of notes of such series repurchased plus any accrued and unpaid interest on the notes repurchased to, but not including, the Second Change of Control Payment Date.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We have no present intention to engage in a transaction involving a Change of Control, although it is possible that we would decide to do so in the future. We could, in the future, enter into certain transactions, including acquisitions, refinancings or other recapitalizations, that would not constitute a Change of Control but that could increase the amount of debt outstanding at such time or otherwise affect our capital structure or credit ratings.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Definitions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Below Investment Grade Rating Event&#8221; means the notes of such series are rated below Investment Grade by each of the Rating Agencies on any date during the period commencing upon the first public notice of the occurrence of a Change of Control or our intention to effect a Change of Control and ending 60 days following public notice of the occurrence of the related Change of Control (which period shall be extended so long as the rating of the notes of such series is under publicly announced consideration for possible downgrade by any of the Rating Agencies, provided that no such extension shall occur if on such 60th day the notes of such series are rated Investment Grade by at least one of such Rating Agency and are not subject to review for possible downgrade by such Rating Agency)&#894; provided further that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating shall not be deemed to have occurred in respect of a particular Change of Control (and thus shall not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Control Repurchase Event hereunder) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or inform the trustee in writing at its request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control shall have occurred at the time of the Below Investment Grade Rating Event).</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Change of Control&#8221; means the occurrence of any of the following&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1)   the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of our assets and those of our subsidiaries taken as a whole to any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than us or one of our subsidiaries&#894;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2)   the adoption of a plan relating to our liquidation or dissolution&#894;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3)   the first day on which a majority of the members of our Board of Directors are not Continuing Directors&#894; or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4)   the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than us or one or more of our subsidiaries, becomes the beneficial owner (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of more than 50% of the then outstanding number of shares of our Voting Stock.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, a transaction will not be considered to be a Change of Control if (a) we become a direct or indirect wholly-owned subsidiary of a holding company and (b)(i) immediately following that transaction, the direct or indirect holders of the Voting Stock of the holding company are substantially the same as the holders of our Voting Stock immediately prior to that transaction or (ii) immediately following that transaction, no person is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of such holding company.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Change of Control Repurchase Event&#8221; means the occurrence of both a Change of Control and a Below Investment Grade Rating Event.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Continuing Directors&#8221; means, as of any date of determination, any member of our Board of Directors who (1) was a member of such Board of Directors on the date of the issuance of the notes&#894; or (2) was nominated for election, elected or appointed to such Board of Directors with the approval of a majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination, election or appointment (either by a specific vote or by approval of our proxy statement in which such member was named as a nominee for election as a director). &#8220;Investment Grade&#8221; means a rating of Baa3 or better by Moody&#8217;s (or its equivalent under any successor rating categories of Moody&#8217;s) and a rating of BBB- or better by S&#38;P (or its equivalent under any successor rating categories of S&#38;P) or the equivalent investment grade credit rating from any additional Rating Agency or Rating Agencies selected by us.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Moody&#8217;s&#8221; means Moody&#8217;s Investors Service Inc., a subsidiary of Moody&#8217;s Corporation, and its successors.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Rating Agency&#8221; means (1) each of Moody&#8217;s and S&#38;P&#894; and (2) if any of Moody&#8217;s or S&#38;P ceases to rate the notes or fails to make a rating of the notes publicly available for reasons outside of our control, a &#8220;nationally recognized statistical rating organization&#8221; within the meaning of Section 3(a)(62) under the Exchange Act, selected by us as a replacement agency for Moody&#8217;s or S&#38;P, or both of them, as the case may be.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;S&#38;P&#8221; means S&#38;P Global Ratings Inc., a division of S&#38;P Global Inc. and its successors.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Voting Stock&#8221; of any specified person as of any date means the capital stock of such person that is at the time entitled to vote generally in the election of the board of directors of such person. The definition of &#8220;Change of Control&#8221; includes a phrase relating to the direct or indirect sale, transfer, conveyance or other disposition of &#8220;all or substantially all&#8221; of our assets and those of our subsidiaries, taken as a whole. Although there is a limited body of case law interpreting the phrase &#8220;substantially all,&#8221; there is no precise established definition of the phrase under applicable law. Accordingly, the ability of a holder of notes to require us to repurchase the notes as a result of a sale, transfer, conveyance or other disposition of less than all of our assets and the assets of our subsidiaries, taken as a whole, to another person or group may be uncertain.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Certain Covenants</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Limitation on Liens</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture contains a covenant that we will not, and we will not permit any of our Restricted Subsidiaries to, issue, assume or guarantee any Indebtedness secured by any Mortgage upon any of our Principal Properties or those of any of our Restricted Subsidiaries without equally and ratably securing the notes (and, if we so determine, any other Indebtedness ranking equally with the notes) with such Indebtedness.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This covenant will not prevent us or any of our Restricted Subsidiaries from issuing, assuming or guaranteeing&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">any purchase money mortgage on such Principal Property prior to, simultaneously with or within 180 days after the later of (1) the acquisition or completion of construction or completion of substantial reconstruction, renovation, remodeling, expansion or improvement (each, a substantial improvement&#8221;) of such Principal Property or (2) the placing in operation of such property after the acquisition or completion of any such construction or substantial improvement&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Mortgages on a Principal Property existing at the time of acquisition, including acquisition through merger or consolidation&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">Mortgages existing on the date of the initial issuance of the notes, Mortgages on assets of a corporation or other business entity existing on the date it becomes a Restricted Subsidiary or is merged or consolidated with us or a Restricted Subsidiary or at the time the corporation or the business entity sells, leases or otherwise disposes of its property as an entirety or substantially as an entirety to us or a Restricted Subsidiary or Mortgages on the assets of a Subsidiary that is newly designated as a Restricted Subsidiary if the Mortgage would have been permitted under the provisions of this paragraph if such Mortgage was created while the Subsidiary was a Restricted Subsidiary&#894;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Mortgages in favor of us or a Restricted Subsidiary&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">Mortgages for taxes, assessments or governmental charges or levies that are not delinquent or that are being contested in good faith&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.01pt">Carriers&#8217;, warehousemen&#8217;s, materialmen&#8217;s, repairmen&#8217;s, mechanic&#8217;s, landlords&#8217; and other similar Mortgages arising in ordinary course of business that are not delinquent or remain payable without penalty or that are being contested in good faith&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Mortgages (other than any Mortgage imposed by the Employee Retirement Income Security Act of 1974) consisting of pledges or deposits required in the ordinary course of business in connection with workers&#8217; compensation, unemployment insurance and other social security legislation&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Easements, rights-of-way, restrictions, encroachments, imperfections and other similar encumbrances affecting real property that, in the aggregate, are not substantial in amount and do not in any case materially detract from the value of the Principal Property subject thereto or materially interfere with the ordinary conduct of our and our Subsidiaries&#8217; business, taken as a whole&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.67pt">Mortgages arising by reason of deposits with, or the giving of any form of security to, any governmental agency or anybody created or approved by law or governmental regulation, including any zoning or similar law or right reserved to or vested in any governmental office or agency to control or regulate the use of any real property&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.67pt">Mortgages arising from filing Uniform Commercial Code financing statements relating solely to leases&#894; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Mortgages to secure Indebtedness incurred to extend, renew, refinance or replace Indebtedness secured by any Mortgages referred to above, provided that the principal amount of the extended, renewed, refinanced or replaced Indebtedness does not exceed the principal amount of Indebtedness so extended, renewed, refinanced or replaced, plus transaction costs and fees, and that any such Mortgage applies only to the same property or assets subject to the prior permitted Mortgage (and, in the case of real property, improvements).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Limitations on Sale and Leaseback Transactions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture contains a covenant that we will not, and will not permit our Restricted Subsidiaries to, enter into any arrangement with any person providing for the leasing by us or any Restricted Subsidiary of any Principal Property owned or acquired thereafter that has been or is to be sold or transferred by us or such Restricted Subsidiary to such person with the intention of taking back a lease of such Principal Property, a &#8220;sale and leaseback transaction,&#8221; without equally and ratably securing the notes (and, if we shall so determine, any other Indebtedness ranking equally with the notes), unless&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">within 180 days after the receipt of the proceeds of the sale or transfer, we or any Restricted Subsidiary apply an amount equal to the greater of the net proceeds of the sale or transfer or the fair value of such Principal Property at the time of such sale or transfer to any (or a combination) of (1) the prepayment or retirement (other than any mandatory prepayment or retirement) of our Senior Funded Debt or (2) the purchase, construction, development, expansion or improvement of other comparable property, subject in each case to credits for voluntary retirements of Senior Funded Debt&#894; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">we or such Restricted Subsidiary would be entitled, at the effective date of the sale or transfer, to incur Indebtedness secured by a Mortgage on such Principal Property, in an amount at least equal to the Attributable Debt in respect of the sale and leaseback transaction, without equally and ratably securing the notes pursuant to &#8220;&#8212;Limitation on Liens&#8221; described above.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The foregoing restriction will not apply to&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">any sale and leaseback transaction for a term of not more than three years including renewals&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">any sale and leaseback transaction with respect to a Principal Property if a binding commitment with respect thereto is entered into within three years after the later of (1) the date of the issuance of the notes under the Supplemental Indenture, or (2) the date such Principal Property was acquired&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">any sale and leaseback transaction with respect to a Principal Property if a binding commitment with respect thereto is entered into within 180 days after the later of the date such property was acquired and, if applicable, the date such property was first placed in operation&#894; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">any sale and leaseback transaction between us and a Restricted Subsidiary or between Restricted Subsidiaries.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Exception to Limitations for Exempted Debt</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the limitations in the Indenture on liens and sale and leaseback transactions, we or our Restricted Subsidiaries may, in addition to amounts permitted under such restrictions and without equally and ratably securing the notes, create or assume and renew, extend or replace Mortgages, or enter into sale and leaseback transactions without any obligation to retire any Senior Funded Debt of us or any Restricted Subsidiary, provided that at the time of such creation, assumption, renewal, extension or replacement of a Mortgage or at the time of entering into such sale and leaseback transactions, and after giving effect thereto, Exempted Debt does not exceed 15% of our Consolidated Net Tangible Assets.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Definitions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of the Indenture&#58;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Attributable Debt&#8221; in respect of a sale and leaseback transaction means, at the time of determination, the present value (discounted at the imputed rate of interest of such transaction as determined in good faith by us) of the obligation of the lessee for net rental payments during the remaining term of the lease included in such sale and leaseback transaction (including any period for which such lease has been extended or may, at the option of the lessor, be extended). The term &#8220;net rental payments&#8221; under any lease for any period means the sum of the rental and other payments required to be paid in such period by the lessee thereunder, not including any amounts required to be paid by such lessee (whether or not designated as rental or additional rent) on account of maintenance and repairs, insurance, taxes, assessments, water rates or similar charges required to be paid by such lessee thereunder or any amount required to be paid by lessee thereunder contingent upon the amount of maintenance and repairs, insurance, taxes, assessments, water rates or similar charges. In the case of any lease that is terminable by the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">lessee upon the payment of a penalty, such net amount shall be the lesser of (x) the net amount determined assuming termination upon the first date such lease may be terminated (in which case the net amount shall also include the amount of the penalty, but shall not include any rent that would be required to be paid under such lease subsequent to the first date upon which it may be so terminated) or (y) the net amount determined assuming no such termination.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Consolidated Net Tangible Assets&#8221; means the total amounts of assets (less depreciation and valuation reserves and other reserves and items deductible from gross book value of specific asset accounts under generally accepted accounting principles) that under generally accepted accounting principles would be included on a consolidated balance sheet of us and our consolidated Restricted Subsidiaries after deducting (1) all current liabilities, excluding current liabilities that could be classified as long-term debt under generally accepted accounting principles and current liabilities that are by their terms extendable or renewable at the obligor&#8217;s option to a time more than 12 months after the time as of which the amount of current liabilities is being computed&#894; (2) investments in Unrestricted Subsidiaries&#894; and (3) all trade names, trademarks, licenses, patents, copyrights and goodwill, organizational and development costs, deferred charges, other than prepaid items such as insurance, taxes, interest, commissions, rents and similar items and tangible assets being amortized, and amortized debt discount and expense, less unamortized premium.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Exempted Debt&#8221; means the sum of the following items outstanding as of the date Exempted Debt is being determined (1) Indebtedness of us and our Restricted Subsidiaries secured by a Mortgage and not permitted to exist under the Indenture and (2) Attributable Debt of us and our Restricted Subsidiaries in respect of all sale and leaseback transactions not permitted under the Indenture.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Funded Debt&#8221; means Indebtedness that matures more than one year from the date of creation, or that is extendable or renewable at the sole option of the obligor so that it may become payable more than one year from such date. Funded Debt does not include (1) obligations created pursuant to leases, (2) any Indebtedness or portion thereof maturing by its terms within one year from the time of any computation of the amount of outstanding</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Funded Debt unless such Indebtedness shall be extendable or renewable at the sole option of the obligor in such manner that it may become payable more than one year from such time, or (3) any Indebtedness for the payment or redemption of which money in the necessary amount shall have been deposited in trust either at or before the maturity date thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Indebtedness&#8221; means any and all of the obligations of a person for money borrowed that in accordance with generally accepted accounting principles would be reflected on the balance sheet of such person as a liability as of the date of which the Indebtedness is to be determined. For the avoidance of doubt, a change in generally accepted accounting principles subsequent to the issue date of the notes shall not be deemed an incurrence of Indebtedness.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Investment&#8221; means any investment in stock, evidences of Indebtedness, loans or advances, however made or acquired, but does not include our account receivable or the accounts receivable of any Restricted Subsidiary arising from transactions in the ordinary course of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">business, or any evidences of Indebtedness, loans or advance made in connection with the sale to any Subsidiary of our accounts receivable or the accounts receivable of any Restricted Subsidiary arising from transactions in the ordinary course of business.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Mortgage&#8221; means any mortgage, security interest, pledge, lien or other encumbrance.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Principal Property&#8221; means all real property and improvements thereon owned by us or a Restricted Subsidiary, including, without limitation, any manufacturing, warehouse, distribution or research facility, and improvements therein, having a net book value in excess of 2% of Consolidated Net Tangible Assets that is located within the United States, excluding its territories and possessions and Puerto Rico. This term does not include any real</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">property and improvements thereon that our Board of Directors declares by resolution not to be of material importance to the total business conducted by us and our Restricted Subsidiaries taken as a whole.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Restricted Subsidiary&#8221; means a Subsidiary that owns a Principal Property.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Senior Funded Debt&#8221; means all Funded Debt (except Funded Debt, the payment of which is subordinated to the payment of the notes).</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Subsidiary&#8221; means a corporation, partnership or other legal entity of which, in the case of a corporation, more than 50% of the outstanding voting stock is owned, directly or indirectly, by us or by one or more other Subsidiaries, or by us and one or more other Subsidiaries or, in the case of any partnership or other legal entity, more than 50% of the ordinary capital interests is, at the time, directly or indirectly owned or controlled by us or by one or more other Subsidiaries. For the purposes of this definition, &#8220;voting stock&#8221; means the equity interest that ordinarily has voting power for the election of directors, managers or trustees of an entity, or persons performing similar functions, whether at all times or only so long as no senior class of equity</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">interest has such voting power by reason of any contingency.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Unrestricted Subsidiary&#8221; means any Subsidiary other than a Restricted Subsidiary.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Consolidation, Merger and Sale of Assets</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We may consolidate or merge with or into any other corporation, and we may sell or transfer all or substantially all of our assets to another corporation, provided, among other things, that (a) we are the surviving corporation or the corporation formed by or resulting from any such</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">consolidation or merger or the transferee of such assets shall be a corporation organized and existing under the laws of the United States, any state thereof or the District of Columbia and shall expressly assume by supplemental indenture payment of the principal of, and premium, if any, and interest, if any, on the notes issued under the Indenture and the performance and observance of the Indenture and (b) we or such successor corporation shall not immediately thereafter be in default under the Indenture.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Events of Default</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following events are defined in the Indenture as &#8220;Events of Default&#8221;&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">default in the payment of any installment of interest on any series of notes for 30 days after becoming due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">default in the payment of principal or premium, if any, of any series of notes when due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">default in the deposit of any sinking fund payment, when due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">default in the performance of any other covenant for 90 days after notice, which must be sent by either the trustee or holders of 25% of the principal amount of the notes of the affected series&#894; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">certain events of bankruptcy, insolvency or reorganization.</font></div><div><font><br></font></div><div style="text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an Event of Default occurs and continues with respect to a series of notes, either the trustee or the holders of at least 25% in principal amount of the outstanding notes of such series may declare the entire principal amount of all of such series to be due and payable&#894; provided that, in the case of an Event of Default involving certain events of bankruptcy, insolvency or reorganization, such acceleration is automatic&#894; and, provided further, that after such acceleration, but before a judgment or decree based on acceleration, the holders of a majority in aggregate principal amount of the outstanding notes of that series may, subject to certain conditions, rescind and annul such acceleration if all Events of Default, other than the nonpayment of accelerated principal, have been cured or waived. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Description of Debt Securities&#58;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">0.750% Notes due 2029</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.000 % Notes due 2031</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company&#8217;s 0.750% Notes due 2029 (the &#8220;2029 notes&#8221;) and 1.000% Notes due 2031 (the &#8220;2031 notes&#8221; and, together with the 2029 notes, the &#8220;notes&#8221;) were issued under a base indenture, dated as of January 15, 2010, between the Company and U.S. Bank Trust Company, National Association, as trustee, as supplemented by the applicable supplemental indenture governing a particular series of notes (as so supplemented, the &#8220;Indenture&#8221;). This summary is subject to and qualified in its entirety by reference to all of the provisions of the Indenture and the notes, including definitions of certain terms used in the Indenture and the notes. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes were issued as separate series of debt securities under the Indenture. The notes are senior unsecured obligations of ours and rank equally in right of payment with our other existing and future senior unsecured indebtedness. The notes are not secured by any of our assets. Any future claims of our secured lenders with respect to assets securing their loans will be prior to any claim of the holders of the notes with respect to those assets. Holders of secured debt that we have now or may issue in the future may foreclose on the assets securing such debt, reducing the cash flow from the foreclosed property available for payment of unsecured debt, including the notes. Holders of our secured debt also would have priority over unsecured creditors in the event of our bankruptcy, liquidation or similar proceeding to the extent of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">value of the collateral securing such debt. The notes are structurally subordinated to all liabilities of our subsidiaries, including trade payables. Because we conduct many of our operations through our subsidiaries, our right to participate in any distribution of the assets of a subsidiary when it winds up its business is subject to the prior claims of the creditors of that subsidiary. This means that your right to payment as a holder of our notes is also subject to the prior claims of these creditors if a subsidiary liquidates or reorganizes or otherwise winds up its business. If we are a creditor of any of our subsidiaries, our right as a creditor would be subordinated to any security interest in the assets of those subsidiaries and any indebtedness of our subsidiaries senior in right of payment to that held by us. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture does not limit the amount of notes, unsecured debentures or other evidences of indebtedness that we may issue under the Indenture and provides that notes, unsecured debentures or other evidences of indebtedness may be issued from time to time in one or more series. We may from time to time, without notice to or the consent of the holders of the notes, create and issue additional notes of any series having the same ranking and terms and conditions as the notes of the same series, except for the issue date, the public offering price and, in some cases, the first interest payment date. Any additional notes having such similar terms, together with the notes offered of the same series, will constitute a single series of securities under the Indenture. If the additional notes of a series, if any, are not fungible with the notes of that series offered for U.S. federal income tax purposes, the additional notes will have a separate CUSIP number.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We issued the notes in fully registered book-entry form without coupons and in denominations of &#8364;100,000 and integral multiples of &#8364;1,000 thereafter.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Principal of and interest on the notes are payable, and the notes are transferable or exchangeable, at the office or offices or agency maintained by us for these purposes. Payment of interest on the notes may be made at our option by check mailed to the registered holders thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The the 2029 notes and the 2031 notes are listed on the New York Stock Exchange under the symbols &#8220;SYK24A,&#8221; &#8220;SYK29&#8221; and &#8220;SYK31,&#8221; respectively. We have no obligation to maintain such listings, and we may delist any series of the notes at any time.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Elavon Financial Services DAC, U.K. Branch is paying agent for the notes. U.S. Bank Trust Company, National Association is registrar and transfer agent for the notes. Upon notice to the trustee, we may change the paying agent, registrar or transfer agent.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Interest</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The 2031 notes bear interest from the date of issuance, payable annually on December 3 of each year, beginning December 3, 2020, and the 2029 notes bear interest from the date of issuance, payable annually on March 1 of each year, beginning March 1, 2021, to the persons in whose names such notes are registered at the close of business on the business day (for this purpose, a day on which Clearstream and Euroclear are open for business) immediately preceding the relevant interest payment. Interest on the notes is computed on the basis of the actual number of days in the period for which interest is being calculated and the actual number </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of days from and including the last date on which interest was paid on the notes (or December 3, 2019, if no interest has been paid on the applicable series of notes), to, but excluding, the next scheduled interest payment date. This payment convention is referred to as Actual&#47;Actual (ICMA) as defined in the rulebook of the International Capital Market Association.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If any interest payment date would otherwise be a day that is not a business day, such interest payment date will be postponed to the next date that is a business day and no interest will accrue on the amounts payable from and after such interest payment date to the next business day. If the maturity date of any series of notes falls on a day that is not a business day, the related payment of principal, premium, if any, and interest will be made on the next business day as if it were made on the date such payment was due, and no interest will accrue on the amounts so payable for the period from and after such date to the next business day.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Business Day</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of the notes, a &#8220;business day&#8221; is any day that is not a Saturday, Sunday or other day on which banking institutions in New York City, London or another place of payment on the notes are authorized or required by law to close and on which the Trans-European Automated Real-Time Gross Settlement Express Transfer system (the TARGET2 system), or any successor thereto, is open.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Issuance in euro</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All payments of interest, premium, if any, and principal, including payments made upon any redemption or repurchase of the notes, will be made in euro&#894; provided that if the euro is unavailable to us due to the imposition of exchange controls or other circumstances beyond our control or if the euro is no longer being used by the then member states of the European Monetary Union that have adopted the euro as their currency or for the settlement of transactions by public institutions of or within the international banking community, then all payments in respect of the notes will be made in U.S. dollars until the euro is again available to us or so used. In such circumstances, the amount payable on any date in euro will be converted into U.S. dollars at the rate mandated by the Board of Governors of the Federal Reserve System as of the close of business on the second business day prior to the relevant payment date or, if the Board of Governors of the Federal Reserve System has not announced a rate of conversion, on the basis of the most recent U.S. dollar&#47;euro exchange rate published in The Wall Street Journal on or prior to the second business day prior to the relevant payment date or, in the event The Wall Street Journal has not published such exchange rate, the rate will be determined in our sole discretion on the basis of the most recently available market exchange rate for the euro. Any payment in respect of the notes so made in U.S. dollars will not constitute an Event of Default (as defined in the Indenture). Neither the trustee nor the paying agent shall have any responsibility for any calculation or conversion in connection with the foregoing.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Investors are subject to foreign exchange risks as to payments of principal, premium, if any, and interest that may have important economic and tax consequences to them. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Optional Redemption</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We may redeem the notes prior to December 1, 2028 in the case of the 2029 notes and September 3, 2031 in the case of the 2031 notes, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to the greater of&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1)   100% of the principal amount of the applicable series of notes to be redeemed&#894; or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2)   an amount determined by the Quotation Agent (as defined below) equal to the sum of the present values of the remaining scheduled payments of principal, premium, if any, and interest thereon (not including any portion of such payments of interest accrued to the date of redemption) to December 1, 2028 with respect to the 2029 notes and September 3, 2031 with respect to the 2031 notes, discounted to the date of redemption on an annual basis (Actual&#47;Actual (ICMA) at the Comparable Government Bond Rate (as defined below)), plus 20 basis points with respect to the 2029 notes and 25 basis points with respect to the 2031 notes,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">plus accrued and unpaid interest thereon to, but not including, the date of redemption.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On or after December 1, 2028 in the case of the 2029 notes and September 3, 2031 in the case of the 2031 notes, we may redeem the applicable series of notes, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to 100% of the principal amount of such series of notes, plus accrued and unpaid interest to, but not including, the redemption date.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The principal amount of any note remaining outstanding after a redemption in part shall be &#8364;100,000 or a higher integral multiple of &#8364;1,000. Notwithstanding the foregoing, installments of interest on any series of notes that are due and payable on interest payment dates falling on or prior to a redemption date will be payable on the interest payment date to the registered holders as of the close of business on the relevant record date.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Comparable Government Bond&#8221; means, in relation to any Comparable Government Bond Rate calculation, at the discretion of an independent investment bank selected by us (the &#8220;Quotation Agent&#8221;), a German government bund whose maturity is closest to the par call date, or if such Quotation Agent in its discretion determines that such similar bond is not in issue, such other German government bund as such Quotation Agent may, with the advice of three brokers of, and&#47;or market makers in, German government bunds selected by us, determine to be appropriate for determining the Comparable Government Bond Rate.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Comparable Government Bond Rate&#8221; means the price, expressed as a percentage (rounded to three decimal places, with 0.0005 being rounded upwards), at which the gross redemption yield on the notes to be redeemed, if they were to be purchased at such price on the third business day prior to the date fixed for redemption, would be equal to the gross redemption yield on such business day of the Comparable Government Bond on the basis of the middle market price of the Comparable Government Bond prevailing at 11&#58;00 A.M. (London time) on such business day as determined by the Quotation Agent selected by us.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notice of any redemption will be sent (or, in the case of notes held in book-entry form, be transmitted electronically) at least 10 days but not more than 60 days before the redemption date </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">to each registered holder of the applicable series of notes to be redeemed. Unless we default in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the applicable series of notes or portions thereof called for redemption. If less than all of the applicable series of notes are to be redeemed, the notes to be redeemed will be selected by the trustee in accordance with the standard procedures of the depositary. If the notes to be redeemed are not global notes then held by Euroclear or Clearstream, the trustee will select the notes to be redeemed on a pro rata basis. If the notes are listed on the NYSE or any other national securities exchange, the trustee will select notes in compliance with the requirements of the NYSE or other principal national securities exchange on which the notes are listed. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if less than all of a series of notes is to be redeemed, no notes of such series of a principal amount of &#8364;100,000 or less shall be redeemed in part. If money sufficient to pay the redemption price on the series of notes (or portions thereof) to be redeemed on the redemption date is deposited with the paying agent on or before the redemption date and certain other conditions are satisfied, then on and after such redemption date, interest will cease to accrue on such series of notes (or such portion thereof) called for redemption.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Special Mandatory Redemption</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If we do not satisfy the minimum tender and other conditions in the Purchase Agreement and consummate the Wright Tender Offer on or prior to February 4, 2021, or if, prior to such date, we notify the trustee in writing that the Purchase Agreement has been terminated (each, a &#8220;Special Mandatory Redemption Event&#8221;), the provisions set forth below will be applicable (other than with respect to the 2029 notes). The 2029 notes will not be subject to the special mandatory redemption and will remain outstanding (unless otherwise redeemed) even if the Wright Tender Offer is not consummated on or prior to February 4, 2021. If a Special Mandatory Redemption Event occurs, we will be required to redeem each series of notes (other than the 2029 notes) in the manner set forth below in whole and not in part at a special mandatory redemption price (the &#8220;Special Mandatory Redemption Price&#8221;) equal to 101% of the aggregate principal amount of such series, plus accrued and unpaid interest, if any, to, but excluding, the Special Mandatory Redemption Date (as defined below) (subject to the right of holders of record on the relevant record date to receive interest due on any interest payment date that is on or prior to the Special Mandatory Redemption Date).</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Upon the occurrence of a Special Mandatory Redemption Event, we will promptly (but in no event later than ten business days following such Special Mandatory Redemption Event) notify the trustee in writing of such event (such notice to include the officers&#8217; certificate required by the Indenture), and the trustee shall, no later than five business days following receipt of such notice from us, notify the holders of each series of notes (such date of notification to such holders, the &#8220;Redemption Notice Date&#8221;) that all of the outstanding notes will be redeemed at the Special Mandatory Redemption Price on the third business day following the Redemption Notice Date (such date, the &#8220;Special Mandatory Redemption Date&#8221;) automatically and without any further action by the holders of the notes, in each case in accordance with the applicable provisions of the Indenture. At or prior to 12&#58;00 p.m. (New York City time) on the business day immediately preceding the Special Mandatory Redemption Date, we will deposit with the trustee funds sufficient to pay the Special Mandatory Redemption Price for the notes. If such deposit is </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">made as provided above, the notes will cease to bear interest on and after the Special Mandatory Redemption Date.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If we fail to pay the Special Mandatory Redemption Price, it will be an event of default with respect to each series of notes (other than the 2029 notes) under the Indenture.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Optional Redemption for Tax Reasons</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes of any series may be redeemed at our option in whole, but not in part, on not less than 10 nor more than 60 days&#8217; prior notice, at 100% of the principal amount of such series together with accrued and unpaid interest, if any, to, but excluding, the redemption date if, as a result of any change in, or amendment to, the laws, regulations or rulings of the United States (or any political subdivision or taxing authority thereof or therein having power to tax), or any change in official position regarding application or interpretation of those laws, regulations or rulings (including a holding by a court of competent jurisdiction), which change, amendment, application or interpretation is announced or becomes effective on or after the original issue date with respect to the notes, we become or, based upon a written opinion of independent counsel selected by us, will become obligated to pay additional amounts as described below in &#8220;&#8212; Payment of Additional Amounts.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Payment of Additional Amounts</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All payments of principal, interest, and premium, if any, in respect of the notes will be made free and clear of, and without withholding or deduction for, any present or future taxes, assessments, duties or governmental charges of whatever nature imposed, levied or collected by the United States (or any political subdivision or taxing authority thereof or therein having power to tax), unless such withholding or deduction is required by law or the official interpretation or administration thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will, subject to the exceptions and limitations set forth below, pay as additional interest in respect of the notes such additional amounts as are necessary in order that the net payment by us of the principal of, premium, if any, and interest in respect of the notes to a holder who is not a United States person (as defined below), after withholding or deduction for any present or future tax, assessment, duties or other governmental charge imposed by the United States (or any political subdivision or taxing authority thereof or therein having power to tax), will not be less than the amount provided in the notes to be then due and payable&#59; provided, however, that the foregoing obligation to pay additional amounts shall not apply&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1)   to the extent any tax, assessment or other governmental charge would not have been imposed but for the holder (or the beneficial owner for whose benefit such holder holds such note), or a fiduciary, settlor, beneficiary, member or shareholder of the holder if the holder is an estate, trust, partnership or corporation, or a person holding a power over an estate or trust administered by a fiduciary holder, being considered as&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a)   being or having been engaged in a trade or business in the United States or having or having had a permanent establishment in the United States&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b)   having a current or former connection with the United States (other than a connection arising solely as a result of the ownership of the notes, the receipt of any payment in respect of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the notes or the enforcement of any rights hereunder), including being or having been a citizen or resident of the United States&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c)   being or having been a personal holding company, a passive foreign investment company or a controlled foreign corporation for U.S. federal income tax purposes, a foreign tax-exempt organization, or a corporation that has accumulated earnings to avoid U.S. federal income tax&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d)   being or having been a &#8220;10-percent shareholder&#8221; of the Company as defined in section 871(h)(3) of the United States Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) or any successor provision&#59; or</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e)   being a bank receiving payments on an extension of credit made pursuant to a loan agreement entered into in the ordinary course of its trade or business, as described in section 881(c)(3)(A) of the Code or any successor provision&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2)   to any holder that is not the sole beneficial owner of the notes, or a portion of the notes, or that is a fiduciary, partnership, limited liability company or other fiscally transparent entity, but only to the extent that a beneficial owner with respect to the holder, a beneficiary or settlor with respect to the fiduciary, or a beneficial owner or member of the partnership, limited liability company or other fiscally transparent entity would not have been entitled to the payment of an additional amount had the beneficiary, settlor, beneficial owner or member received directly its beneficial or distributive share of the payment&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3)   to the extent any tax, assessment or other governmental charge that would not have been imposed but for the failure of the holder or any other person to comply with certification, identification or information reporting requirements concerning the nationality, residence, identity or connection with the United States of the holder or beneficial owner of the notes, if compliance is required by statute, by regulation of the United States or any taxing authority therein or by an applicable income tax treaty to which the United States is a party as a precondition to exemption from such tax, assessment or other governmental charge&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4)   to any tax, assessment or other governmental charge that is imposed otherwise than by withholding by us or a paying agent from the payment&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5)   to any tax, assessment or other governmental charge required to be withheld by any paying agent from any payment of principal of or interest on any notes, if such payment can be made without such withholding by any other paying agent&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6)   to any estate, inheritance, gift, sales, transfer, wealth, capital gains or personal property tax or similar tax, assessment or other governmental charge, or excise tax imposed on the transfer of notes&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7)   to the extent any tax, assessment or other governmental charge would not have been imposed but for the presentation by the holder of any note, where presentation is required, for payment on a date more than 30 days after the date on which payment became due and payable or the date on which payment thereof is duly provided for, whichever occurs later except to the extent that the beneficiary or holder thereof would have been entitled to the payment of additional amounts had such note been presented for payment on any day during such 30-day period&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8)   to any tax, assessment or other governmental charge imposed under sections 1471 through 1474 of the Code (or any amended or successor provisions), any current or future regulations or official interpretations thereof, any agreement entered into pursuant to section 1471(b) of the Code or any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement entered into in connection with the implementation of such sections of the Code, whether currently in effect or as published and amended from time to time&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9)   to any tax, assessment or other governmental charge that is imposed or withheld solely by reason of a change in law, regulation, or administrative or judicial interpretation that becomes effective more than 15 days after the payment becomes due or is duly provided for, whichever occurs later&#59; or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10) in the case of any combination of the above numbered items. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes are subject in all cases to any tax, fiscal or other law or regulation or administrative or judicial interpretation applicable to the notes. Except as specifically provided under this heading &#8220;&#8212;Payment of Additional Amounts,&#8221; we are not required to make any payment for any tax, assessment or other governmental charge imposed by any government or a political subdivision or taxing authority of or in any government or political subdivision.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As used under this heading &#8220;&#8212;Payment of Additional Amounts&#8221; and under the heading &#8220;&#8212;Optional Redemption for Tax Reasons,&#8221; the term &#8220;United States&#8221; means the United States of America, its territories and possessions, the states of the United States and the District of Columbia, and the term &#8220;United States person&#8221; means (i) any individual who is a citizen or resident of the United States for U.S. federal income tax purposes, (ii) a corporation, partnership or other entity created or organized in or under the laws of the United States, any state of the United States or the District of Columbia (other than a partnership that is not treated as a United States person for United States federal income tax purposes), (iii) any estate the income of which is subject to U.S. federal income taxation regardless of its source, or (iv) any trust if a United States court can exercise primary supervision over the administration of the trust and one or more United States persons can control all substantial trust decisions, or if a valid election is in place to treat the trust as a United States person.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Repurchase at the Option of Holders Upon Change of Control Repurchase Event</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If a Change of Control Repurchase Event (as defined below) occurs in respect of a series of notes, unless we have exercised our right to redeem the notes of such series as described above under &#8220;&#8212;Optional Redemption or &#8220;Optional Redemption for Tax Reasons&#8221; or have been required to redeem the notes as described under &#8220;&#8212;Special Mandatory Redemption&#8221; we will be required to make an offer (a &#8220;Change of Control Offer&#8221;) to each holder of such series of notes to repurchase all or any part (in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount) of that holder&#8217;s notes at a repurchase price in cash equal to 101% of the aggregate principal amount of notes repurchased plus any accrued and unpaid interest on the notes repurchased to, but not including, the date of such repurchase. Within 30 days following any Change of Control Repurchase Event or, at our option, prior to any Change of Control (as defined below), but after the public announcement of an impending Change of Control, we will mail a notice to each holder, with a copy to the trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Repurchase Event and offering to repurchase notes on the payment date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed. The notice will, if mailed prior to the date of consummation of the Change of Control, state that the offer to purchase is conditioned on the Change of Control Repurchase Event occurring on or prior to the payment date specified in the notice.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will comply with the requirements of Rule 14e-1 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, and any other securities laws and regulations thereunder, to the extent those laws and regulations are applicable in connection with the repurchase of the notes as a result of a Change of Control Repurchase Event. To the extent that the provisions of any securities laws or regulations conflict with the Change of Control Repurchase Event provisions of the notes, we will comply with the applicable securities laws and regulations and will not be deemed to have breached our obligations under the Change of Control Repurchase Event provisions of the notes by virtue of such conflict.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On the Change of Control Repurchase Event payment date, we will, to the extent lawful&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.67pt">accept for payment all notes or portions of notes (in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount) properly tendered pursuant to our offer&#59;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:8.34pt">deposit with the paying agent an amount equal to the aggregate purchase price in respect of all notes or portions of notes properly tendered&#59; and</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:5.01pt">deliver or cause to be delivered to the trustee for cancellation the notes properly accepted, together with an officers&#8217; certificate stating the aggregate principal amount of notes being repurchased by us.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The paying agent will promptly mail to each holder of notes properly tendered the purchase price for the notes, and the trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each holder a new note equal in principal amount to any unpurchased portion of any notes surrendered&#59; provided, that each new note will be in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will not be required to make a Change of Control Offer upon a Change of Control Repurchase Event if (i) a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for a Change of Control Offer made by us and such third party purchases all notes properly tendered and not withdrawn under its offer or (ii) we have previously or concurrently mailed a redemption notice with respect to all of the outstanding notes as described under &#8220;Optional Redemption&#8221; above.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If holders of not less than 90% in aggregate principal amount of the outstanding notes of any series validly tender and do not withdraw such notes in a Change of Control Offer and we, or any third party making such an offer in lieu of us as described above, purchases all of the notes of such series validly tendered and not withdrawn by such holders, we or such third party will have the right, upon not less than 10 days nor more than 60 days&#8217; prior notice, provided that such notice is given not more than 30 days following such repurchase pursuant to the Change of Control Offer described above, to redeem all notes of such series that remain outstanding following such purchase on a date specified in such notice (the &#8220;Second Change of Control Payment Date&#8221;) and at a price in cash equal to 101% of the aggregate principal amount of notes of such series repurchased plus any accrued and unpaid interest on the notes repurchased to, but not including, the Second Change of Control Payment Date.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We have no present intention to engage in a transaction involving a Change of Control, although it is possible that we would decide to do so in the future. We could, in the future, enter into certain transactions, including acquisitions, refinancings or other recapitalizations, that would not constitute a Change of Control but that could increase the amount of debt outstanding at such time or otherwise affect our capital structure or credit ratings.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Definitions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Below Investment Grade Rating Event&#8221; means the notes of such series are rated below Investment Grade by each of the Rating Agencies on any date during the period commencing upon the first public notice of the occurrence of a Change of Control or our intention to effect a Change of Control and ending 60 days following public notice of the occurrence of the related Change of Control (which period shall be extended so long as the rating of the notes of such series is under publicly announced consideration for possible downgrade by any of the Rating Agencies, provided that no such extension shall occur if on such 60th day the notes of such series are rated Investment Grade by at least one of such Rating Agency and are not subject to review for possible downgrade by such Rating Agency)&#59; provided further that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating shall not be deemed to have occurred in respect of a particular Change of Control (and thus shall not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Repurchase Event hereunder) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or inform the trustee in writing at its request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control shall have occurred at the time of the Below Investment Grade Rating Event).</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Change of Control&#8221; means the occurrence of any of the following&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1)   the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of our assets and those of our subsidiaries taken as a whole to any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than us or one of our subsidiaries&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2)   the adoption of a plan relating to our liquidation or dissolution&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3)   the first day on which a majority of the members of our Board of Directors are not Continuing Directors&#59; or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4)   the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than us or one or more of our subsidiaries, becomes the beneficial owner (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of more than 50% of the then outstanding number of shares of our Voting Stock.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, a transaction will not be considered to be a Change of Control if (a) we become a direct or indirect wholly-owned subsidiary of a holding company and (b)(i) immediately following that transaction, the direct or indirect holders of the Voting Stock of the holding company are substantially the same as the holders of our Voting Stock immediately </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">prior to that transaction or (ii) immediately following that transaction, no person is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of such holding company.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Change of Control Repurchase Event&#8221; means the occurrence of both a Change of Control and a Below Investment Grade Rating Event.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Continuing Directors&#8221; means, as of any date of determination, any member of our Board of Directors who (1) was a member of such Board of Directors on the date of the issuance of the notes&#59; or (2) was nominated for election, elected or appointed to such Board of Directors with the approval of a majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination, election or appointment (either by a specific vote or by approval of our proxy statement in which such member was named as a nominee for election as a director).</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Investment Grade&#8221; means a rating of Baa3 or better by Moody&#8217;s (or its equivalent under any successor rating categories of Moody&#8217;s) and a rating of BBB- or better by S&#38;P (or its equivalent under any successor rating categories of S&#38;P) or the equivalent investment grade credit rating from any additional Rating Agency or Rating Agencies selected by us.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Moody&#8217;s&#8221; means Moody&#8217;s Investors Service Inc., a subsidiary of Moody&#8217;s Corporation, and its successors.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Rating Agency&#8221; means (1) each of Moody&#8217;s and S&#38;P&#59; and (2) if any of Moody&#8217;s or S&#38;P ceases to rate the notes or fails to make a rating of the notes publicly available for reasons outside of our control, a &#8220;nationally recognized statistical rating organization&#8221; within the meaning of Section 3(a)(62) under the Exchange Act, selected by us as a replacement agency for Moody&#8217;s or S&#38;P, or both of them, as the case may be.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;S&#38;P&#8221; means S&#38;P Global Ratings Inc., a division of S&#38;P Global Inc. and its successors.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Voting Stock&#8221; of any specified person as of any date means the capital stock of such person that is at the time entitled to vote generally in the election of the board of directors of such person.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The definition of &#8220;Change of Control&#8221; includes a phrase relating to the direct or indirect sale, transfer, conveyance or other disposition of &#8220;all or substantially all&#8221; of our assets and those of our subsidiaries, taken as a whole. Although there is a limited body of case law interpreting the phrase &#8220;substantially all,&#8221; there is no precise established definition of the phrase under applicable law. Accordingly, the ability of a holder of notes to require us to repurchase the notes as a result of a sale, transfer, conveyance or other disposition of less than all of our assets and the assets of our subsidiaries, taken as a whole, to another person or group may be uncertain.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Certain Covenants</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Limitation on Liens</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture contains a covenant that we will not, and we will not permit any of our Restricted Subsidiaries to, issue, assume or guarantee any Indebtedness secured by any Mortgage upon any of our Principal Properties or those of any of our Restricted Subsidiaries without equally and ratably securing the notes (and, if we so determine, any other Indebtedness ranking equally with the notes) with such Indebtedness.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This covenant will not prevent us or any of our Restricted Subsidiaries from issuing, assuming or guaranteeing&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">any purchase money mortgage on such Principal Property prior to, simultaneously with or within 180 days after the later of (1) the acquisition or completion of construction or completion of substantial reconstruction, renovation, remodeling, expansion or improvement (each, a &#8220;substantial improvement&#8221;) of such Principal Property or (2) the placing in operation of such property after the acquisition or completion of any such construction or substantial improvement&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Mortgages on a Principal Property existing at the time of acquisition, including acquisition through merger or consolidation&#59; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">Mortgages existing on the date of the initial issuance of the notes, Mortgages on assets of a corporation or other business entity existing on the date it becomes a Restricted Subsidiary or is merged or consolidated with us or a Restricted Subsidiary or at the time the corporation or other business entity sells, leases or otherwise disposes of its property as an entirety or substantially as an entirety to us or a Restricted Subsidiary or Mortgages on the assets of a Subsidiary that is newly designated as a Restricted Subsidiary if the Mortgage would have been permitted under the provisions of this paragraph if such Mortgage was created while the Subsidiary was a Restricted Subsidiary&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Mortgages in favor of us or a Restricted Subsidiary&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">Mortgages for taxes, assessments or governmental charges or levies that are not delinquent or that are being contested in good faith&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.01pt">Carriers&#8217;, warehousemen&#8217;s, materialmen&#8217;s, repairmen&#8217;s, mechanic&#8217;s, landlords&#8217; and other similar Mortgages arising in ordinary course of business that are not delinquent or remain payable without penalty or that are being contested in good faith&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Mortgages (other than any Mortgage imposed by the Employee Retirement Income Security Act of 1974) consisting of pledges or deposits required in the ordinary course of business in connection with workers&#8217; compensation, unemployment insurance and other social security legislation&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Easements, rights-of-way, restrictions, encroachments, imperfections and other similar encumbrances affecting real property that, in the aggregate, are not substantial in amount and do not in any case materially detract from the value of the Principal Property subject thereto or materially interfere with the ordinary conduct of our and our Subsidiaries&#8217; business, taken as a whole&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.67pt">Mortgages arising by reason of deposits with, or the giving of any form of security to, any governmental agency or anybody created or approved by law or governmental regulation, including any zoning or similar law or right reserved to or vested in any governmental office or agency to control or regulate the use of any real property&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.67pt">Mortgages arising from filing Uniform Commercial Code financing statements relating solely to leases&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Mortgages to secure Indebtedness incurred to extend, renew, refinance or replace Indebtedness secured by any Mortgages referred to above, provided that the principal amount of the extended, renewed, refinanced or replaced Indebtedness does not exceed the principal amount of Indebtedness so extended, renewed, refinanced or replaced, plus transaction costs and fees, and that any such Mortgage applies only to the same property or assets subject to the prior permitted Mortgage (and, in the case of real property, improvements).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Limitations on Sale and Leaseback Transactions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture contains a covenant that we will not, and will not permit our Restricted Subsidiaries to, enter into any arrangement with any person providing for the leasing by us or any Restricted Subsidiary of any Principal Property owned or acquired thereafter that has been or is to be sold or transferred by us or such Restricted Subsidiary to such person with the intention of taking back a lease of such Principal Property, a &#8220;sale and leaseback transaction,&#8221; without equally and ratably securing the notes (and, if we shall so determine, any other Indebtedness ranking equally with the notes), unless&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">within 180 days after the receipt of the proceeds of the sale or transfer, we or any Restricted Subsidiary apply an amount equal to the greater of the net proceeds of the sale or transfer or the fair value of such Principal Property at the time of such sale or transfer to any (or a combination) of (1) the prepayment or retirement (other than any mandatory prepayment or retirement) of our Senior Funded Debt or (2) the purchase, construction, development, expansion or improvement of other comparable property, subject in each case to credits for voluntary retirements of Senior Funded Debt&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">we or such Restricted Subsidiary would be entitled, at the effective date of the sale or transfer, to incur Indebtedness secured by a Mortgage on such Principal Property, in an amount at least equal to the Attributable Debt in respect of the sale and leaseback transaction, without equally and ratably securing the notes pursuant to &#8220;&#8212;Limitation on Liens&#8221; described above.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The foregoing restriction will not apply to&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">any sale and leaseback transaction for a term of not more than three years including renewals&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">any sale and leaseback transaction with respect to a Principal Property if a binding commitment with respect thereto is entered into within three years after the later of (1) the date of the issuance of the notes under the Supplemental Indenture, or (2) the date such Principal Property was acquired&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">any sale and leaseback transaction with respect to a Principal Property if a binding commitment with respect thereto is entered into within 180 days after the later of the date such property was acquired and, if applicable, the date such property was first placed in operation&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">any sale and leaseback transaction between us and a Restricted Subsidiary or between Restricted Subsidiaries.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Exception to Limitations for Exempted Debt</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the limitations in the Indenture on liens and sale and leaseback transactions, we or our Restricted Subsidiaries may, in addition to amounts permitted under such restrictions and without equally and ratably securing the notes, create or assume and renew, extend or replace Mortgages, or enter into sale and leaseback transactions without any obligation to retire any Senior Funded Debt of us or any Restricted Subsidiary, provided that at the time of such creation, assumption, renewal, extension or replacement of a Mortgage or at the time of entering into such sale and leaseback transactions, and after giving effect thereto, Exempted Debt does not exceed 15% of our Consolidated Net Tangible Assets.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Definitions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of the Indenture&#58;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Attributable Debt&#8221; in respect of a sale and leaseback transaction means, at the time of determination, the present value (discounted at the imputed rate of interest of such transaction as determined in good faith by us) of the obligation of the lessee for net rental payments during the remaining term of the lease included in such sale and leaseback transaction (including any period for which such lease has been extended or may, at the option of the lessor, be extended). The term &#8220;net rental payments&#8221; under any lease for any period means the sum of the rental and other payments required to be paid in such period by the lessee thereunder, not including any amounts required to be paid by such lessee (whether or not designated as rental or additional rent) on account of maintenance and repairs, insurance, taxes, assessments, water rates or similar charges required to be paid by such lessee thereunder or any amount required to be paid by lessee thereunder contingent upon the amount of maintenance and repairs, insurance, taxes, assessments, water rates or similar charges. In the case of any lease that is terminable by the lessee upon the payment of a penalty, such net amount shall be the lesser of (x) the net amount determined assuming termination upon the first date such lease may be terminated (in which case the net amount shall also include the amount of the penalty, but shall not include any rent that would be required to be paid under such lease subsequent to the first date upon which it may be so terminated) or (y) the net amount determined assuming no such termination.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Consolidated Net Tangible Assets&#8221; means the total amounts of assets (less depreciation and valuation reserves and other reserves and items deductible from gross book value of specific asset accounts under generally accepted accounting principles) that under generally accepted accounting principles would be included on a consolidated balance sheet of us and our consolidated Restricted Subsidiaries after deducting (1) all current liabilities, excluding current liabilities that could be classified as long-term debt under generally accepted accounting principles and current liabilities that are by their terms extendable or renewable at the obligor&#8217;s option to a time more than 12 months after the time as of which the amount of current liabilities is being computed&#59; (2) investments in Unrestricted Subsidiaries&#59; and (3) all trade names, trademarks, licenses, patents, copyrights and goodwill, organizational and development costs, deferred charges, other than prepaid items such as insurance, taxes, interest, commissions, rents and similar items and tangible assets being amortized, and amortized debt discount and expense, less unamortized premium.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Exempted Debt&#8221; means the sum of the following items outstanding as of the date Exempted Debt is being determined (1) Indebtedness of us and our Restricted Subsidiaries secured by a Mortgage and not permitted to exist under the Indenture and (2) Attributable Debt of us and our Restricted Subsidiaries in respect of all sale and leaseback transactions not permitted under the Indenture.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Funded Debt&#8221; means Indebtedness that matures more than one year from the date of creation, or that is extendable or renewable at the sole option of the obligor so that it may become payable more than one year from such date. Funded Debt does not include (1) obligations created pursuant to leases, (2) any Indebtedness or portion thereof maturing by its terms within one year from the time of any computation of the amount of outstanding Funded Debt unless such Indebtedness shall be extendable or renewable at the sole option of the obligor in such manner that it may become payable more than one year from such time, or (3) any Indebtedness for the payment or redemption of which money in the necessary amount shall have been deposited in trust either at or before the maturity date thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Indebtedness&#8221; means any and all of the obligations of a person for money borrowed that in accordance with generally accepted accounting principles would be reflected on the balance sheet of such person as a liability as of the date of which the Indebtedness is to be determined. Notwithstanding the foregoing, a change in generally accepted accounting principles subsequent to November 30, 2018 shall not be deemed an incurrence of Indebtedness.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Investment&#8221; means any investment in stock, evidences of Indebtedness, loans or advances, however made or acquired, but does not include our account receivable or the accounts receivable of any Restricted Subsidiary arising from transactions in the ordinary course of business, or any evidences of Indebtedness, loans or advance made in connection with the sale to any Subsidiary of our accounts receivable or the accounts receivable of any Restricted Subsidiary arising from transactions in the ordinary course of business.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Mortgage&#8221; means any mortgage, security interest, pledge, lien or other encumbrance.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Principal Property&#8221; means all real property and improvements thereon owned by us or a Restricted Subsidiary, including, without limitation, any manufacturing, warehouse, distribution or research facility, and improvements therein, having a net book value in excess of 2% of Consolidated Net Tangible Assets that is located within the United States, excluding its territories and possessions and Puerto Rico. This term does not include any real property and improvements thereon that our Board of Directors declares by resolution not to be of material importance to the total business conducted by us and our Restricted Subsidiaries taken as a whole.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Restricted Subsidiary&#8221; means a Subsidiary that owns a Principal Property.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Senior Funded Debt&#8221; means all Funded Debt (except Funded Debt, the payment of which is subordinated to the payment of the notes).</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Subsidiary&#8221; means a corporation, partnership or other legal entity of which, in the case of a corporation, more than 50% of the outstanding voting stock is owned, directly or indirectly, by us or by one or more other Subsidiaries, or by us and one or more other Subsidiaries or, in the case of any partnership or other legal entity, more than 50% of the ordinary capital interests is, at the time, directly or indirectly owned or controlled by us or by one or more other Subsidiaries. For the purposes of this definition, &#8220;voting stock&#8221; means the equity interest that ordinarily has voting power for the election of directors, managers or trustees of an entity, or persons performing similar functions, whether at all times or only so long as no senior class of equity interest has such voting power by reason of any contingency.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Unrestricted Subsidiary&#8221; means any Subsidiary other than a Restricted Subsidiary.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Consolidation, Merger and Sale of Assets</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We may consolidate or merge with or into any other corporation, and we may sell or transfer all or substantially all of our assets to another corporation, provided, among other things, that (a) we are the surviving corporation or the corporation formed by or resulting from any such</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">consolidation or merger or the transferee of such assets shall be a corporation organized and existing under the laws of the United States, any state thereof or the District of Columbia and shall expressly assume by supplemental indenture payment of the principal of, and premium, if any, and interest, if any, on the notes issued under the Indenture and the performance and observance of the Indenture and (b) we or such successor corporation shall not immediately thereafter be in default under the Indenture.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Events of Default</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following events are defined in the Indenture as &#8220;Events of Default&#8221;&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">default in the payment of any installment of interest on any series of notes for 30 days after becoming due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">default in the payment of principal or premium, if any, of any series of notes when due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">default in the deposit of any sinking fund payment, when due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">default in the performance of any other covenant for 90 days after notice, which must be sent by either the trustee or holders of 25% of the principal amount of the notes of the affected series&#894; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">certain events of bankruptcy, insolvency or reorganization.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an Event of Default occurs and continues with respect to a series of notes, either the trustee or the holders of at least 25% in principal amount of the outstanding notes of such series may declare the entire principal amount of all the notes of such series to be due and payable&#894; provided that, in the case of an Event of Default involving certain events of bankruptcy, insolvency or reorganization, such acceleration is automatic&#894; and, provided further, that after such acceleration, but before a judgment or decree based on acceleration, the holders of a majority in aggregate principal amount of the outstanding notes of that series may, subject to certain conditions, rescind and annul such acceleration if all Events of Default, other than the nonpayment of accelerated principal, have been cured or waived. </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Description of Debt Securities&#58;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.375% Notes due 2028</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company&#8217;s 3.375% Notes due 2028 (the &#8220;notes&#8221;) were issued under a base indenture, dated as of January 15, 2010, between the Company and U.S. Bank Trust Company, National Association, as trustee, as supplemented by the applicable supplemental indenture governing the notes (as so supplemented, the &#8220;Indenture&#8221;). This summary is subject to and qualified in its entirety by reference to all of the provisions of the Indenture and the notes, including definitions of certain terms used in the Indenture and the notes. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes were issued as a separate series of debt securities under the Indenture. The notes are senior unsecured obligations of ours and rank equally in right of payment with our other existing and future senior unsecured indebtedness. The notes are not secured by any of our assets. Any future claims of our secured lenders with respect to assets securing their loans will be prior to any claim of the holders of the notes with respect to those assets. Holders of secured debt that we have now or may issue in the future may foreclose on the assets securing such debt, reducing the cash flow from the foreclosed property available for payment of unsecured debt, including the notes. Holders of our secured debt also would have priority over unsecured creditors in the event of our bankruptcy, liquidation or similar proceeding to the extent of the value of the collateral securing such debt. The notes are structurally subordinated to all liabilities of our subsidiaries, including trade payables. Because we conduct many of our operations through our subsidiaries, our right to participate in any distribution of the assets of a subsidiary when it winds up its business is subject to the prior claims of the creditors of that subsidiary. This means that your right to payment as a holder of our notes is also subject to the prior claims of these creditors if a subsidiary liquidates or reorganizes or otherwise winds up its business. If we are a creditor of any of our subsidiaries, our right as a creditor would be subordinated to any security interest in the assets of those subsidiaries and any indebtedness of our subsidiaries senior in right of payment to that held by us. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture does not limit the amount of notes, unsecured debentures or other evidences of indebtedness that we may issue under the Indenture and provides that notes, unsecured debentures or other evidences of indebtedness may be issued from time to time in one or more series. We may from time to time, without notice to or the consent of the holders of the notes, create and issue additional notes having the same ranking and terms and conditions as the notes, except for the issue date, the public offering price and, in some cases, the first interest payment date. Any additional notes having such similar terms, together with the notes, will constitute a single series of securities under the Indenture. If the additional notes, if any, are not fungible with the notes offered for U.S. federal income tax purposes, the additional notes will have a separate CUSIP number.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes were issued in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 in excess thereof and represented by one or more global notes deposited with, or on behalf of, a common depositary and registered in the name of the nominee of the common </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">depositary for the accounts of Clearstream Banking, S.A. and Euroclear Bank SA&#47;NV, as operator of the Euroclear System. Book-entry interests in the notes and all transfers relating to the notes will be reflected in the book-entry records of Clearstream and Euroclear.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Principal of and interest on the notes are payable, and the notes are transferable or exchangeable, at the office or offices or agency maintained by us for these purposes. Payment of interest on the notes may be made at our option by check mailed to the registered holders thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes are listed on the New York Stock Exchange under the symbol &#8220;SYK28.&#8221; We have no obligation to maintain such listing, and we may delist the notes at any time.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Elavon Financial Services DAC, U.K. Branch is paying agent for the notes. U.S. Bank Trust Company, National Association is registrar and transfer agent for the notes. Upon notice to the trustee, we may change the paying agent, registrar or transfer agent.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Interest</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes bear interest at the rate of 3.375% per annum from the date of original issuance or from the most recent interest payment date to which interest has been paid or provided for. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We make interest payments on the notes annually in arrears on December 11 of each year (each, an &#8220;interest payment date&#8221;), commencing on December 11, 2024, to the holders of record at the close of business on the day immediately preceding the relevant interest payment date (regardless of whether such day is a business day). Interest on the notes is computed on the basis of the actual number of days in the period for which interest is being calculated and the actual number of days from and including the last date on which interest was paid on the notes (or December 11, 2023, if no interest has been paid on the notes), to, but excluding, the next scheduled interest payment date. This payment convention is referred to as Actual&#47;Actual (ICMA) as defined in the rulebook of the International Capital Market Association. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an interest payment date or the maturity date with respect to the notes falls on a day that is not a business day, the payment will be made on the next business day as if it were made on the date the payment was due, and no interest will accrue on the amount so payable for the period from and after that interest payment date or the maturity date, as the case may be, to the date the payment is made. Interest payments will include accrued interest from and including the date of issue or from and including the last date in respect of which interest has been paid, as the case may be, to, but excluding, the interest payment date or the maturity date, as the case may be.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A &#8220;business day&#8221; is any day that is not a Saturday, Sunday or other day on which banking institutions in New York City, London or another place of payment on the notes are authorized or required by law to close and on which the Trans-European Automated Real-Time Gross Settlement Express Transfer system (the TARGET2 system), or any successor thereto, is open.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Issuance in euro</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All payments of interest, premium, if any, and principal, including payments made upon any redemption or repurchase of the notes, will be made in euro&#894; provided that if the euro is </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">unavailable to us due to the imposition of exchange controls or other circumstances beyond our control or if the euro is no longer being used by the then member states of the European Monetary Union that have adopted the euro as their currency or for the settlement of transactions by public institutions of or within the international banking community, then all payments in respect of the notes will be made in U.S. dollars until the euro is again available to us or so used. In such circumstances, the amount payable on any date in euro will be converted into U.S. dollars at the rate mandated by the Board of Governors of the Federal Reserve System as of the close of business on the second business day prior to the relevant payment date or, if the Board of Governors of the Federal Reserve System has not announced a rate of conversion, on the basis of the most recent U.S. dollar&#47;euro exchange rate published in The Wall Street Journal on or prior to the second business day prior to the relevant payment date or, in the event The Wall Street Journal has not published such exchange rate, the rate will be determined in our sole discretion on the basis of the most recently available market exchange rate for the euro. Any payment in respect of the notes so made in U.S. dollars will not constitute an Event of Default (as defined in the Indenture). Neither the trustee nor the paying agent shall have any responsibility for any calculation or conversion in connection with the foregoing.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Investors are subject to foreign exchange risks as to payments of principal, premium, if any, and interest that may have important economic and tax consequences to them. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Optional Redemption</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We may redeem the notes prior to September 11, 2028 (the &#8220;Par Call Date&#8221;), in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to the greater of&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1)   100% of the principal amount of the notes to be redeemed&#894; or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2)   an amount determined by the Quotation Agent (as defined below) equal to the sum of the present values of the remaining scheduled payments of principal, premium, if any, and interest thereon (not including any portion of such payments of interest accrued to the date of redemption) to the Par Call Date, discounted to the date of redemption on an annual basis (Actual&#47;Actual (ICMA) at the Comparable Government Bond Rate (as defined below)), plus 20 basis points,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">plus accrued and unpaid interest thereon to, but not including, the date of redemption.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On or after the Par Call Date, we may redeem the notes, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to 100% of the principal amount of the notes, plus accrued and unpaid interest to, but not including, the redemption date.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The principal amount of any note remaining outstanding after a redemption in part shall be &#8364;100,000 or a higher integral multiple of &#8364;1,000. Notwithstanding the foregoing, installments of interest on the notes that are due and payable on interest payment dates falling on or prior to a redemption date will be payable on the interest payment date to the registered holders as of the close of business on the relevant record date.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Comparable Government Bond&#8221; means, in relation to any Comparable Government Bond Rate calculation, at the discretion of an independent investment bank selected by us (the &#8220;Quotation Agent&#8221;), a German government bund whose maturity is closest to the Par Call Date, or if such Quotation Agent in its discretion determines that such similar bond is not in issue, such other German government bund as such Quotation Agent may, with the advice of three brokers of, and&#47;or market makers in, German government bunds selected by us, determine to be appropriate for determining the Comparable Government Bond Rate.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Comparable Government Bond Rate&#8221; means the price, expressed as a percentage (rounded to three decimal places, with 0.0005 being rounded upwards), at which the gross redemption yield on the notes to be redeemed, if they were to be purchased at such price on the third business day prior to the date fixed for redemption, would be equal to the gross redemption yield on such business day of the Comparable Government Bond on the basis of the middle market price of the Comparable Government Bond prevailing at 11&#58;00 A.M. (London time) on such business day as determined by the Quotation Agent selected by us.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notice of any redemption will be sent (or, in the case of notes held in book-entry form, be transmitted electronically) at least 10 days but not more than 60 days before the redemption date to each registered holder of the notes to be redeemed. Unless we default in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the notes or portions thereof called for redemption. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If less than all of the notes are to be redeemed, the notes to be redeemed will be selected by the trustee in accordance with the standard procedures of the depositary. If the notes to be redeemed are not global notes then held by Euroclear or Clearstream, the trustee will select the notes to be redeemed on a pro rata basis. If the notes are listed on the NYSE or any other national securities exchange, the trustee will select notes in compliance with the requirements of the NYSE or other principal national securities exchange on which the notes are listed. Notwithstanding the foregoing, if less than all of the notes are to be redeemed, no notes of a principal amount of &#8364;100,000 or less shall be redeemed in part. If money sufficient to pay the redemption price on the notes (or portions thereof) to be redeemed on the redemption date is deposited with the paying agent on or before the redemption date and certain other conditions are satisfied, then on and after such redemption date, interest will cease to accrue on the notes (or such portion thereof) called for redemption.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notice of any redemption may, at our discretion, be subject to one or more conditions precedent, including, but not limited to, completion of an equity offering, a financing, or other corporate transaction. In addition, if such redemption or notice is subject to satisfaction of one or more conditions precedent, such notice shall state that, in our discretion, such notice may be rescinded in the event that any or all such conditions shall not have been satisfied by the redemption date.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Optional Redemption for Tax Reasons</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes may be redeemed at our option at any time in whole, but not in part, on not less than 10 nor more than 60 days&#8217; prior notice, at 100% of the principal amount of the notes </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">together with accrued and unpaid interest, if any, to, but excluding, the redemption date if, as a result of any change in, or amendment to, the laws, regulations or rulings of the United States (or any political subdivision or taxing authority thereof or therein having power to tax), or any change in official position regarding application or interpretation of those laws, regulations or rulings (including a holding by a court of competent jurisdiction), which change, amendment, application or interpretation is announced or becomes effective on or after the original issue date with respect to the notes, we become or, based upon a written opinion of independent counsel selected by us, will become obligated to pay additional amounts as described below in &#8220;&#8212; Payment of Additional Amounts.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Payment of Additional Amounts</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All payments of principal, interest, and premium, if any, in respect of the notes will be made free and clear of, and without withholding or deduction for, any present or future taxes, assessments, duties or governmental charges of whatever nature imposed, levied or collected by the United States (or any political subdivision or taxing authority thereof or therein having power to tax), unless such withholding or deduction is required by law or the official interpretation or administration thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will, subject to the exceptions and limitations set forth below, pay as additional interest in respect of the notes such additional amounts as are necessary in order that the net payment by us of the principal of, premium, if any, and interest in respect of the notes to a holder who is not a United States person (as defined below), after withholding or deduction for any present or future tax, assessment, duties or other governmental charge imposed by the United States (or any political subdivision or taxing authority thereof or therein having power to tax), will not be less than the amount provided in the notes to be then due and payable&#59; provided, however, that the foregoing obligation to pay additional amounts shall not apply&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1)   to the extent any tax, assessment or other governmental charge would not have been imposed but for the holder (or the beneficial owner for whose benefit such holder holds such note), or a fiduciary, settlor, beneficiary, member or shareholder of the holder if the holder is an estate, trust, partnership or corporation, or a person holding a power over an estate or trust administered by a fiduciary holder, being considered as&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a)   being or having been engaged in a trade or business in the United States or having or having had a permanent establishment in the United States&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b)   having a current or former connection with the United States (other than a connection arising solely as a result of the ownership of the notes, the receipt of any payment in respect of the notes or the enforcement of any rights hereunder), including being or having been a citizen or resident of the United States&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c)   being or having been a personal holding company, a passive foreign investment company or a controlled foreign corporation for U.S. federal income tax purposes, a foreign tax-exempt organization, or a corporation that has accumulated earnings to avoid U.S. federal income tax&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d)   being or having been a &#8220;10-percent shareholder&#8221; of the Company as defined in section 871(h)(3) of the United States Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) or any successor provision&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e)   being a bank receiving payments on an extension of credit made pursuant to a loan agreement entered into in the ordinary course of its trade or business, as described in section 881(c)(3)(A) of the Code or any successor provision&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2)   to any holder that is not the sole beneficial owner of the notes, or a portion of the notes, or that is a fiduciary, partnership, limited liability company or other fiscally transparent entity, but only to the extent that a beneficial owner with respect to the holder, a beneficiary or settlor with respect to the fiduciary, or a beneficial owner or member of the partnership, limited liability company or other fiscally transparent entity would not have been entitled to the payment of an additional amount had the beneficiary, settlor, beneficial owner or member received directly its beneficial or distributive share of the payment&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3)   to the extent any tax, assessment or other governmental charge that would not have been imposed but for the failure of the holder or any other person to comply with certification, identification or information reporting requirements concerning the nationality, residence, identity or connection with the United States of the holder or beneficial owner of the notes, if compliance is required by statute, by regulation of the United States or any taxing authority therein or by an applicable income tax treaty to which the United States is a party as a precondition to exemption from such tax, assessment or other governmental charge&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4)   to any tax, assessment or other governmental charge that is imposed otherwise than by withholding by us or any paying agent from the payment&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5)   to any tax, assessment or other governmental charge required to be withheld by any paying agent from any payment of principal of or interest on any notes, if such payment can be made without such withholding by any other paying agent&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6)   to any estate, inheritance, gift, sales, transfer, wealth, capital gains or personal property tax or similar tax, assessment or other governmental charge, or excise tax imposed on the transfer of notes&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7)   to the extent any tax, assessment or other governmental charge would not have been imposed but for the presentation by the holder of any note, where presentation is required, for payment on a date more than 30 days after the date on which payment became due and payable or the date on which payment thereof is duly provided for, whichever occurs later except to the extent that the beneficiary or holder thereof would have been entitled to the payment of additional amounts had such note been presented for payment on any day during such 30-day period&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8)   to any tax, assessment or other governmental charge imposed under sections 1471 through 1474 of the Code (or any amended or successor provisions), any current or future regulations or official interpretations thereof, any agreement entered into pursuant to section 1471(b) of the Code or any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement entered into in connection with the implementation of such sections of the Code, whether currently in effect or as published and amended from time to time&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9)   to any tax, assessment or other governmental charge that is imposed or withheld solely by reason of a change in law, regulation, or administrative or judicial interpretation that becomes effective more than 15 days after the payment becomes due or is duly provided for, whichever occurs later&#59; or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10) in the case of any combination of the above numbered items. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes are subject in all cases to any tax, fiscal or other law or regulation or administrative or judicial interpretation applicable to the notes. Except as specifically provided </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">under this heading &#8220;&#8212;Payment of Additional Amounts,&#8221; we are not required to make any payment for any tax, assessment or other governmental charge imposed by any government or a political subdivision or taxing authority of or in any government or political subdivision.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As used under this heading &#8220;&#8212;Payment of Additional Amounts&#8221; and under the heading &#8220;&#8212;Optional Redemption for Tax Reasons,&#8221; the term &#8220;United States&#8221; means the United States of America, its territories and possessions, the states of the United States and the District of Columbia, and the term &#8220;United States person&#8221; means (i) any individual who is a citizen or resident of the United States for U.S. federal income tax purposes, (ii) a corporation, partnership or other entity created or organized in or under the laws of the United States, any state of the United States or the District of Columbia (other than a partnership that is not treated as a United States person for United States federal income tax purposes), (iii) any estate the income of which is subject to U.S. federal income taxation regardless of its source, or (iv) any trust if a United States court can exercise primary supervision over the administration of the trust and one or more United States persons can control all substantial trust decisions, or if a valid election is in place to treat the trust as a United States person.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Repurchase at the Option of Holders Upon Change of Control Repurchase Event</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If a Change of Control Repurchase Event (as defined below) occurs, unless we have exercised our right to redeem the notes as described above under &#8220;&#8212;Optional Redemption or &#8220;Optional Redemption for Tax Reasons,&#8221; we will be required to make an offer (a &#8220;Change of Control Offer&#8221;) to each holder of notes to repurchase all or any part (in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 in excess thereof) of that holder&#8217;s notes at a repurchase price in cash equal to 101% of the aggregate principal amount of notes repurchased plus any accrued and unpaid interest on the notes repurchased to, but not including, the date of such repurchase. Within 30 days following any Change of Control Repurchase Event or, at our option, prior to any Change of Control (as defined below), but after the public announcement of an impending Change of Control, we will mail a notice to each holder, with a copy to the trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Repurchase Event and offering to repurchase notes on the payment date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed. The notice will, if mailed prior to the date of consummation of the Change of Control, state that the offer to purchase is conditioned on a Change of Control Repurchase Event occurring on or prior to the payment date specified in the notice.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will comply with the requirements of Rule 14e-1 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, and any other securities laws and regulations thereunder, to the extent those laws and regulations are applicable in connection with the repurchase of the notes as a result of a Change of Control Repurchase Event. To the extent that the provisions of any securities laws or regulations conflict with the Change of Control Repurchase Event provisions of the notes, we will comply with the applicable securities laws and regulations and will not be deemed to have breached our obligations under the Change of Control Repurchase Event provisions of the notes by virtue of such conflict.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On the Change of Control Repurchase Event payment date, we will, to the extent lawful&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.67pt">accept for payment all notes or portions of notes (in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 in excess thereof) properly tendered pursuant to our offer&#59;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:8.34pt">deposit with the paying agent an amount equal to the aggregate purchase price in respect of all notes or portions of notes properly tendered&#59; and</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:5.01pt">deliver or cause to be delivered to the trustee for cancellation the notes properly accepted, together with an officers&#8217; certificate stating the aggregate principal amount of notes being repurchased by us.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The paying agent will promptly mail to each holder of notes properly tendered the purchase price for the notes, and the trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each holder a new note equal in principal amount to any unpurchased portion of any notes surrendered&#59; provided, that each new note will be in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 in excess thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will not be required to make a Change of Control Offer upon a Change of Control Repurchase Event if (i) a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for a Change of Control Offer made by us and such third party purchases all notes properly tendered and not withdrawn under its offer or (ii) we have previously or concurrently mailed a redemption notice with respect to all of the outstanding notes as described under &#8220;Optional Redemption&#8221; above.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If holders of not less than 90% in aggregate principal amount of the outstanding notes validly tender and do not withdraw such notes in a Change of Control Offer and we, or any third party making such an offer in lieu of us as described above, purchases all of the notes validly tendered and not withdrawn by such holders, we or such third party will have the right, upon not less than 10 days nor more than 60 days&#8217; prior notice, provided that such notice is given not more than 30 days following such repurchase pursuant to the Change of Control Offer described above, to redeem all notes that remain outstanding following such purchase on a date specified in such notice (the &#8220;Second Change of Control Payment Date&#8221;) and at a price in cash equal to 101% of the aggregate principal amount of notes repurchased plus any accrued and unpaid interest on the notes repurchased to, but not including, the Second Change of Control Payment Date.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We have no present intention to engage in a transaction involving a Change of Control, although it is possible that we would decide to do so in the future. We could, in the future, enter into certain transactions, including acquisitions, refinancings or other recapitalizations, that would not constitute a Change of Control but that could increase the amount of debt outstanding at such time or otherwise affect our capital structure or credit ratings.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Definitions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Below Investment Grade Rating Event&#8221; means the notes are rated below Investment Grade by each of the Rating Agencies on any date during the period commencing upon the first public notice of the occurrence of a Change of Control or our intention to effect a Change of Control and ending 60 days following public notice of the occurrence of the related Change of Control (which period shall be extended so long as the rating of the notes is under publicly </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">announced consideration for possible downgrade by any of the Rating Agencies, provided that no such extension shall occur if on such 60th day the notes are rated Investment Grade by at least one of such Rating Agency and are not subject to review for possible downgrade by such Rating Agency)&#59; provided further that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating shall not be deemed to have occurred in respect of a particular Change of Control (and thus shall not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Repurchase Event hereunder) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or inform the trustee in writing at its request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control shall have occurred at the time of the Below Investment Grade Rating Event).</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Change of Control&#8221; means the occurrence of any of the following&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1)   the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of our assets and those of our subsidiaries taken as a whole to any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than us or one of our subsidiaries&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2)   the adoption of a plan relating to our liquidation or dissolution&#59; or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3)   the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than us or one or more of our subsidiaries, becomes the beneficial owner (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of more than 50% of the then outstanding number of shares of our Voting Stock.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, a transaction will not be considered to be a Change of Control if (a) we become a direct or indirect wholly-owned subsidiary of a holding company and (b)(i) immediately following that transaction, the direct or indirect holders of the Voting Stock of the holding company are substantially the same as the holders of our Voting Stock immediately prior to that transaction or (ii) immediately following that transaction, no person is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of such holding company.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Change of Control Repurchase Event&#8221; means the occurrence of both a Change of Control and a Below Investment Grade Rating Event.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Investment Grade&#8221; means a rating of Baa3 or better by Moody&#8217;s (or its equivalent under any successor rating categories of Moody&#8217;s) and a rating of BBB- or better by S&#38;P (or its equivalent under any successor rating categories of S&#38;P) or the equivalent investment grade credit rating from any additional Rating Agency or Rating Agencies selected by us.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Moody&#8217;s&#8221; means Moody&#8217;s Investors Service Inc., a subsidiary of Moody&#8217;s Corporation, and its successors.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Rating Agency&#8221; means (1) each of Moody&#8217;s and S&#38;P&#59; and (2) if any of Moody&#8217;s or S&#38;P ceases to rate the notes or fails to make a rating of the notes publicly available for reasons </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">outside of our control, a &#8220;nationally recognized statistical rating organization&#8221; within the meaning of Section 3(a)(62) under the Exchange Act, selected by us as a replacement agency for Moody&#8217;s or S&#38;P, or both of them, as the case may be.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;S&#38;P&#8221; means S&#38;P Global Ratings Inc., a division of S&#38;P Global Inc. and its successors.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Voting Stock&#8221; of any specified person as of any date means the capital stock of such person that is at the time entitled to vote generally in the election of the board of directors of such person.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The definition of &#8220;Change of Control&#8221; includes a phrase relating to the direct or indirect sale, transfer, conveyance or other disposition of &#8220;all or substantially all&#8221; of our assets and those of our subsidiaries, taken as a whole. Although there is a limited body of case law interpreting the phrase &#8220;substantially all,&#8221; there is no precise established definition of the phrase under applicable law. Accordingly, the ability of a holder of notes to require us to repurchase the notes as a result of a sale, transfer, conveyance or other disposition of less than all of our assets and the assets of our subsidiaries, taken as a whole, to another person or group may be uncertain.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Certain Covenants</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Limitation on Liens</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture contains a covenant that we will not, and we will not permit any of our Restricted Subsidiaries to, issue, assume or guarantee any Indebtedness secured by any Mortgage upon any of our Principal Properties or those of any of our Restricted Subsidiaries without equally and ratably securing the notes (and, if we so determine, any other Indebtedness ranking equally with the notes) with such Indebtedness.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This covenant will not prevent us or any Restricted Subsidiary from issuing, assuming or guaranteeing&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">any purchase money mortgage on such Principal Property prior to, simultaneously with or within 180 days after the later of (1) the acquisition or completion of construction or completion of substantial reconstruction, renovation, remodeling, expansion or improvement (each, a &#8220;substantial improvement&#8221;) of such Principal Property or (2) the placing in operation of such property after the acquisition or completion of any such construction or substantial improvement&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Mortgages on a Principal Property existing at the time of acquisition, including acquisition through merger or consolidation&#59; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">Mortgages existing on the date of the initial issuance of the notes, Mortgages on assets of a corporation or other business entity existing on the date it becomes a Restricted Subsidiary or is merged or consolidated with us or a Restricted Subsidiary or at the time the corporation or other business entity sells, leases or otherwise disposes of its property as an entirety or substantially as an entirety to us or a Restricted Subsidiary or Mortgages on the assets of a Subsidiary that is newly designated as a Restricted Subsidiary if the Mortgage would have been permitted under the provisions of this paragraph if such Mortgage was created while the Subsidiary was a Restricted Subsidiary&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Mortgages in favor of us or a Restricted Subsidiary&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">Mortgages for taxes, assessments or governmental charges or levies that are not delinquent or that are being contested in good faith&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.01pt">Carriers&#8217;, warehousemen&#8217;s, materialmen&#8217;s, repairmen&#8217;s, mechanic&#8217;s, landlords&#8217; and other similar Mortgages arising in ordinary course of business that are not delinquent or remain payable without penalty or that are being contested in good faith&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Mortgages (other than any Mortgage imposed by the Employee Retirement Income Security Act of 1974) consisting of pledges or deposits required in the ordinary course of business in connection with workers&#8217; compensation, unemployment insurance and other social security legislation&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Easements, rights-of-way, restrictions, encroachments, imperfections and other similar encumbrances affecting real property that, in the aggregate, are not substantial in amount and do not in any case materially detract from the value of the Principal Property subject thereto or materially interfere with the ordinary conduct of our and our Subsidiaries&#8217; business, taken as a whole&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.67pt">Mortgages arising by reason of deposits with, or the giving of any form of security to, any governmental agency or anybody created or approved by law or governmental regulation, including any zoning or similar law or right reserved to or vested in any governmental office or agency to control or regulate the use of any real property&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.67pt">Mortgages arising from filing Uniform Commercial Code financing statements relating solely to leases&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Mortgages to secure Indebtedness incurred to extend, renew, refinance or replace Indebtedness secured by any Mortgages referred to above, provided that the principal amount of the extended, renewed, refinanced or replaced Indebtedness does not exceed the principal amount of Indebtedness so extended, renewed, refinanced or replaced, plus transaction costs and fees, and that any such Mortgage applies only to the same property or assets subject to the prior permitted Mortgage (and, in the case of real property, improvements).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Limitations on Sale and Leaseback Transactions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture contains a covenant that we will not, and will not permit any Restricted Subsidiary to, enter into any arrangement with any person providing for the leasing by us or any Restricted Subsidiary of any Principal Property owned or acquired thereafter that has been or is to be sold or transferred by us or such Restricted Subsidiary to such person with the intention of taking back a lease of such Principal Property, a &#8220;sale and leaseback transaction,&#8221; without equally and ratably securing the notes (and, if we so determine, any other Indebtedness ranking equally with the notes), unless&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">within 180 days after the receipt of the proceeds of the sale or transfer, we or any Restricted Subsidiary apply an amount equal to the greater of the net proceeds of the sale or transfer or the fair value of such Principal Property at the time of the sale or transfer to any (or a combination) of (1) the prepayment or retirement (other than any mandatory prepayment or retirement) of our Senior Funded Debt or (2) the purchase, construction, development, expansion or improvement of other comparable property, subject in each case to credits for voluntary retirements of our Senior Funded Debt&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">we or such Restricted Subsidiary would be entitled, at the effective date of the sale or transfer, to incur Indebtedness secured by a Mortgage on such Principal Property, in an amount at least equal to the Attributable Debt in respect of the sale and leaseback transaction, without equally and ratably securing the notes pursuant to &#8220;&#8212;Limitation on Liens&#8221; described above.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The foregoing restriction will not apply to&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">any sale and leaseback transaction for a term of not more than three years including renewals&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:8pt">any sale and leaseback transaction with respect to a Principal Property if a binding commitment with respect thereto is entered into within three years after the later of (1) the date of the issuance of the notes under the Supplemental Indenture, or (2) the date such Principal Property was acquired&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:8.67pt">any sale and leaseback transaction with respect to a Principal Property if a binding commitment with respect thereto is entered into within 180 days after the later of the date such property was acquired and, if applicable, the date such property was first placed in operation&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:8pt">any sale and leaseback transaction between us and a Restricted Subsidiary or between Restricted Subsidiaries.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Exception to Limitations for Exempted Debt</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the limitations in the Indenture on liens and sale and leaseback transactions, we or any Restricted Subsidiary may, in addition to sale and leaseback transactions permitted under such restrictions and without equally and ratably securing the notes, create or assume and renew, extend or replace Mortgages, or enter into any sale and leaseback transaction without any obligation to retire any of our or any Restricted Subsidiary&#8217;s Senior Funded Debt, provided that, at the time of such creation, assumption, renewal, extension or replacement of a Mortgage or at the time of entering into such sale and leaseback transactions, and after giving effect thereto, our Exempted Debt does not exceed 15% of our Consolidated Net Tangible Assets.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Definitions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of the Indenture&#58;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Attributable Debt&#8221; in respect of a sale and leaseback transaction means, at the time of determination, the present value (discounted at the imputed rate of interest of such transaction as determined in good faith by us) of the obligation of the lessee for net rental payments during the remaining term of the lease included in such sale and leaseback transaction (including any period for which such lease has been extended or may, at the option of the lessor, be extended). The term &#8220;net rental payments&#8221; under any lease for any period means the sum of the rental and other payments required to be paid in such period by the lessee thereunder, not including any amounts required to be paid by such lessee (whether or not designated as rental or additional rent) on account of maintenance and repairs, insurance, taxes, assessments, water rates or similar charges required to be paid by such lessee thereunder or any amount required to be paid by lessee thereunder contingent upon the amount of maintenance and repairs, insurance, taxes, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">assessments, water rates or similar charges. In the case of any lease that is terminable by the lessee upon the payment of a penalty, such net amount shall be the lesser of (x) the net amount determined assuming termination upon the first date such lease may be terminated (in which case the net amount shall also include the amount of the penalty, but shall not include any rent that would be required to be paid under such lease subsequent to the first date upon which it may be so terminated) or (y) the net amount determined assuming no such termination.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Consolidated Net Tangible Assets&#8221; means the total amounts of assets (less depreciation and valuation reserves and other reserves and items deductible from gross book value of specific asset accounts under generally accepted accounting principles) that under generally accepted accounting principles would be included on a consolidated balance sheet of us and our consolidated Restricted Subsidiaries after deducting (1) all current liabilities, excluding current liabilities that could be classified as long-term debt under generally accepted accounting principles and current liabilities that are by their terms extendable or renewable at the obligor&#8217;s option to a time more than 12 months after the time as of which the amount of current liabilities is being computed&#59; (2) Investments in Unrestricted Subsidiaries&#59; and (3) all trade names, trademarks, licenses, patents, copyrights and goodwill, organizational and development costs, deferred charges, other than prepaid items such as insurance, taxes, interest, commissions, rents and similar items and tangible assets being amortized, and amortized debt discount and expense, less unamortized premium.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Exempted Debt&#8221; means the sum of the following items outstanding as of the date Exempted Debt is being determined (1) Indebtedness of us and our Restricted Subsidiaries secured by a Mortgage and not permitted to exist under the Indenture and (2) Attributable Debt of us and our Restricted Subsidiaries in respect of all sale and leaseback transactions not permitted under the Indenture.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Funded Debt&#8221; means Indebtedness that matures more than one year from the date of creation, or that is extendable or renewable at the sole option of the obligor so that it may become payable more than one year from such date. Funded Debt does not include (1) obligations created pursuant to leases, (2) any Indebtedness or portion thereof maturing by its terms within one year from the time of any computation of the amount of outstanding Funded Debt unless such Indebtedness shall be extendable or renewable at the sole option of the obligor in such manner that it may become payable more than one year from such time, or (3) any Indebtedness for the payment or redemption of which money in the necessary amount shall have been deposited in trust either at or before the maturity date thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Indebtedness&#8221; means any and all of the obligations of a person for money borrowed that in accordance with generally accepted accounting principles would be reflected on the balance sheet of such person as a liability as of the date of which the Indebtedness is to be determined. Notwithstanding the foregoing, a change in generally accepted accounting principles subsequent to November 30, 2018 shall not be deemed an incurrence of Indebtedness.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Investment&#8221; means any investment in stock, evidences of Indebtedness, loans or advances, however made or acquired, but does not include our account receivable or the accounts </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">receivable of any Restricted Subsidiary arising from transactions in the ordinary course of business, or any evidences of Indebtedness, loans or advance made in connection with the sale to any Subsidiary of our accounts receivable or the accounts receivable of any Restricted Subsidiary arising from transactions in the ordinary course of business.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Mortgage&#8221; means any mortgage, security interest, pledge, lien or other encumbrance.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Principal Property&#8221; means all real property and improvements thereon owned by us or a Restricted Subsidiary, including, without limitation, any manufacturing, warehouse, distribution or research facility, and improvements therein, having a net book value in excess of 2% of Consolidated Net Tangible Assets that is located within the United States, excluding its territories and possessions and Puerto Rico. This term does not include any real property and improvements thereon that our Board of Directors declares by resolution not to be of material importance to the total business conducted by us and our Restricted Subsidiaries taken as a whole.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Restricted Subsidiary&#8221; means a Subsidiary that owns a Principal Property.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Senior Funded Debt&#8221; means all Funded Debt (except Funded Debt, the payment of which is subordinated to the payment of the notes).</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Subsidiary&#8221; means a corporation, partnership or other legal entity of which, in the case of a corporation, more than 50% of the outstanding voting stock is owned, directly or indirectly, by us or by one or more other Subsidiaries, or by us and one or more other Subsidiaries or, in the case of any partnership or other legal entity, more than 50% of the ordinary capital interests is, at the time, directly or indirectly owned or controlled by us or by one or more other Subsidiaries. For the purposes of this definition, &#8220;voting stock&#8221; means the equity interest that ordinarily has voting power for the election of directors, managers or trustees of an entity, or persons performing similar functions, whether at all times or only so long as no senior class of equity interest has such voting power by reason of any contingency.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Unrestricted Subsidiary&#8221; means any Subsidiary other than a Restricted Subsidiary.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Consolidation, Merger and Sale of Assets</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We may consolidate or merge with or into any other corporation, and we may sell or transfer all or substantially all of our assets to another corporation, provided, among other things, that (a) we are the surviving corporation or the corporation formed by or resulting from any such</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">consolidation or merger or the transferee of such assets shall be a corporation organized and existing under the laws of the United States, any state thereof or the District of Columbia and shall expressly assume by supplemental indenture payment of the principal of, and premium, if any, and interest, if any, on the notes issued under the Indenture and the performance and observance of the Indenture and (b) we or such successor corporation shall not immediately thereafter be in default under the Indenture.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Events of Default</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following events are defined in the Indenture as &#8220;Events of Default&#8221;&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">default in the payment of any installment of interest on any series of notes for 30 days after becoming due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">default in the payment of principal or premium, if any, of any series of notes when due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">default in the deposit of any sinking fund payment, when due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">default in the performance of any other covenant for 90 days after notice, which must be sent by either the trustee or holders of 25% of the principal amount of the notes of the affected series&#894; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">certain events of bankruptcy, insolvency or reorganization.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an Event of Default occurs and continues with respect to a series of notes, either the trustee or the holders of at least 25% in principal amount of the outstanding notes of such series may declare the entire principal amount of all the notes of such series to be due and payable&#894; provided that, in the case of an Event of Default involving certain events of bankruptcy, insolvency or reorganization, such acceleration is automatic&#894; and, provided further, that after such acceleration, but before a judgment or decree based on acceleration, the holders of a majority in aggregate principal amount of the outstanding notes of that series may, subject to certain conditions, rescind and annul such acceleration if all Events of Default, other than the nonpayment of accelerated principal, have been cured or waived.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Description of Debt Securities&#58;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.375% Notes due 2032</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.625% Notes due 2036</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company&#8217;s 3.375% Notes due 2032 (the &#8220;2032 notes&#8221;) and 3.625% Notes due 2036 (the &#8220;2036 notes&#8221; and, together with the 2032 notes, the &#8220;notes&#8221;) were issued under a base indenture, dated as of January 15, 2010, between the Company and U.S. Bank Trust Company, National Association, as trustee, as supplemented by the applicable supplemental indenture governing a particular series of notes (as so supplemented, the &#8220;Indenture&#8221;). This summary is subject to and qualified in its entirety by reference to all of the provisions of the Indenture and the notes, including definitions of certain terms used in the Indenture and the notes. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The 2032 and the 2036 notes were issued as separate series of debt securities under the Indenture. The notes are senior unsecured obligations of ours and rank equally in right of payment with our other existing and future senior unsecured indebtedness. The notes are not secured by any of our assets. Any future claims of our secured lenders with respect to assets securing their loans will be prior to any claim of the holders of the notes with respect to those assets. Holders of secured debt that we have now or may issue in the future may foreclose on the assets securing such debt, reducing the cash flow from the foreclosed property available for payment of unsecured debt, including the notes. Holders of our secured debt also would have priority over unsecured creditors in the event of our bankruptcy, liquidation or similar proceeding to the extent of the value of the collateral securing such debt. The notes are structurally subordinated to all liabilities of our subsidiaries, including trade payables. Because </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">we conduct many of our operations through our subsidiaries, our right to participate in any distribution of the assets of a subsidiary when it winds up its business is subject to the prior claims of the creditors of that subsidiary. This means that your right to payment as a holder of our notes is also subject to the prior claims of these creditors if a subsidiary liquidates or reorganizes or otherwise winds up its business. If we are a creditor of any of our subsidiaries, our right as a creditor would be subordinated to any security interest in the assets of those subsidiaries and any indebtedness of our subsidiaries senior in right of payment to that held by us. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture does not limit the amount of notes, unsecured debentures or other evidences of indebtedness that we may issue under the Indenture and provides that notes, unsecured debentures or other evidences of indebtedness may be issued from time to time in one or more series. We may from time to time, without notice to, or the consent of, the holders of the applicable series of the notes, create and issue additional notes of that series having the same ranking and terms and conditions as the notes of that series, except for the issue date, the public offering price and, in some cases, the first interest payment date. Any additional notes of either series having such similar terms, together with the notes of that series offered, will constitute a single series of securities under the Indenture. If the additional notes of a series, if any, are not fungible with the notes of that series offered for U.S. federal income tax purposes, the additional notes will have a separate CUSIP number.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes were issued in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 in excess thereof and represented by one or more global notes deposited with, or on behalf of, a common depositary and registered in the name of the nominee of the common depositary for the accounts of Clearstream Banking, S.A. (&#8220;Clearstream&#8221;) and Euroclear Bank SA&#47;NV (&#8220;Euroclear&#8221;), as operator of the Euroclear System. Book-entry interests in the notes and all transfers relating to the notes will be reflected in the book-entry records of Clearstream and Euroclear.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Principal of and interest on the notes are payable, and the notes are transferable or exchangeable, at the office or offices or agency maintained by us for these purposes. Payment of interest on the notes may be made at our option by check mailed to the registered holders thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The 2032 notes and the 2036 notes are listed on the New York Stock Exchange under the symbols &#8220;SYK32&#8221; and &#8220;SYK36,&#8221; respectively. We have no obligation to maintain such listings, and we may delist any series of the notes at any time.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Elavon Financial Services DAC is paying agent for the notes. U.S. Bank Trust Company, National Association is registrar and transfer agent for the notes. Upon notice to the trustee, we may change the paying agent, registrar or transfer agent.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Principal Amount, Maturity and Interest</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The 2032 notes are limited to &#8364;800,000,000 in aggregate principal amount and will mature on September 11, 2032 (the &#8220;2032 maturity date&#8221;), and the 2036 notes are limited to &#8364;600,000,000 in aggregate principal amount and will mature on September 11, 2036 (the &#8220;2036 </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">maturity date&#8221; and, together with the 2032 maturity date, each, a &#8220;maturity date&#8221;). The 2032 notes bear interest at the rate of 3.375% per annum from the date of original issuance or from the most recent interest payment date to which interest has been paid or provided for. The 2036 notes bear interest at the rate of 3.625% per annum from the date of original issuance or from the most interest payment date to which interest has been paid or provided for. We make interest payments on the notes annually in arrears on September 11 of each year (each, an &#8220;interest payment date&#8221;), commencing on September 11, 2025, to the holders of record at the close of business on the day immediately preceding the relevant interest payment date (regardless of whether such day is a business day). Interest on the notes is computed on the basis of the actual number of days in the period for which interest is being calculated divided by the actual number of days from and including the last date on which interest was paid on the notes (or September 11, 2024, if no interest has been paid on the applicable series of the notes), to, but excluding, the next scheduled interest payment date. This payment convention is referred to as &#8220;Actual&#47;Actual (ICMA)&#8221; or &#8220;ICMA Actual&#47;Actual&#8221;, as described in the handbook of the International Capital Market Association.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an interest payment date or the maturity date with respect to either series of the notes falls on a day that is not a business day, the payment will be made on the next business day as if it were made on the date the payment was due, and no interest will accrue on the amount so payable for the period from and after that interest payment date or the maturity date, as the case may be, to the date the payment is made. Interest payments include accrued interest from and including the date of issue or from and including the last date in respect of which interest has been paid, as the case may be, to, but excluding, the interest payment date or the maturity date, as the case may be.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A &#8220;business day&#8221; is any day that is not a Saturday, Sunday or other day on which banking institutions in New York City, London or another place of payment on the notes are authorized or required by law to close and on which the Trans-European Automated Real-Time Gross Settlement Express Transfer system (known as the T2 system), or any successor or replacement system, is open.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Issuance in Euro</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All payments of interest, premium, if any, and principal, including payments made upon any redemption or repurchase of the notes, will be made in euro&#894; provided that if the euro is unavailable to us due to the imposition of exchange controls or other circumstances beyond our control or if the euro is no longer being used by the then member states of the European Monetary Union that have adopted the euro as their currency or for the settlement of transactions by public institutions of or within the international banking community, then all payments in respect of the notes will be made in U.S. dollars until the euro is again available to us or so used. In such circumstances, the amount payable on any date in euro will be converted into U.S. dollars at the rate mandated by the Board of Governors of the Federal Reserve System as of the close of business on the second business day prior to the relevant payment date or, if the Board of Governors of the Federal Reserve System has not announced a rate of conversion, on the basis of the most recent U.S. dollar&#47;euro exchange rate published in The Wall Street Journal on or prior to the second business day prior to the relevant payment date or, in the event The Wall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Street Journal has not published such exchange rate, the rate will be determined in our sole discretion on the basis of the most recently available market exchange rate for the euro. Any payment in respect of the notes so made in U.S. dollars will not constitute an Event of Default (as defined in the Indenture). Neither the trustee nor the paying agent shall have any responsibility for any calculation or conversion in connection with the foregoing.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Investors are subject to foreign exchange risks as to payments of principal, premium, if any, and interest that may have important economic and tax consequences to them. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Optional Redemption</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We may redeem the 2032 notes prior to June 11, 2032 (the &#8220;2032 Par Call Date&#8221;) and the 2036 notes prior to June 11, 2036 (the &#8220;2036 Par Call Date&#8221; and, together with the 2032 Par Call Date, each, a &#8220;Par Call Date&#8221;) in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to the greater of&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1)   100% of the principal amount of the notes of the applicable series to be redeemed&#59; or </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2)   an amount determined by the Quotation Agent (as defined below) equal to the sum of the present values of the remaining scheduled payments of principal, premium, if any, and interest thereon (not including any portion of such payments of interest accrued to the date of redemption) to the applicable Par Call Date, discounted to the date of redemption on an annual basis (Actual&#47;Actual (ICMA) at the Comparable Government Bond Rate (as defined below)), plus 20 basis points, in the case of the 2032 notes, and 25 basis points, in the case of the 2036 notes, </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">plus accrued and unpaid interest thereon to, but not including, the date of redemption.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On or after the applicable Par Call Date, we may redeem the applicable series of the notes, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to 100% of the principal amount of such series of the notes, plus accrued and unpaid interest to, but not including, the redemption date.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The principal amount of any note remaining outstanding after a redemption in part shall be &#8364;100,000 or a higher integral multiple of &#8364;1,000. Notwithstanding the foregoing, installments of interest on either series of the notes that are due and payable on interest payment dates falling on or prior to a redemption date will be payable on the interest payment date to the registered holders as of the close of business on the relevant record date.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Comparable Government Bond&#8221; means, in relation to any Comparable Government Bond Rate calculation, at the discretion of an independent investment bank selected by us (the &#8220;Quotation Agent&#8221;), a Federal Government Bond of the Bundesrepublik Deutschland (a &#8220;German government bond&#8221;) whose maturity is closest to the Par Call Date, or if such Quotation Agent in its discretion determines that such similar bond is not in issue, such other German government bond as such Quotation Agent may, with the advice of three brokers of, and&#47;or market makers in, German government bonds selected by us, determine to be appropriate for determining the Comparable Government Bond Rate.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Comparable Government Bond Rate&#8221; means the price, expressed as a percentage (rounded to three decimal places, with 0.0005 being rounded upwards), at which the gross redemption yield on the notes to be redeemed, if they were to be purchased at such price on the third business day prior to the date fixed for redemption, would be equal to the gross redemption yield on such business day of the Comparable Government Bond on the basis of the middle market price of the Comparable Government Bond prevailing at 11&#58;00 A.M. (London time) on such business day as determined by the Quotation Agent selected by us.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notice of any redemption will be sent (or, in the case of notes held in book-entry form, be transmitted electronically) at least 10 days but not more than 60 days before the redemption date to each registered holder of the notes to be redeemed. Unless we default in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the notes or portions thereof called for redemption. If less than all of the notes of a series are to be redeemed, the notes of such series to be redeemed will be selected by the trustee in accordance with the standard procedures of the depositary. If the notes of a series to be redeemed are not global notes then held by Euroclear or Clearstream, the trustee will select the notes of that series to be redeemed on a pro rata basis. If the notes are listed on the NYSE or any other national securities exchange, the trustee will select notes in compliance with the requirements of the NYSE or other principal national securities exchange on which the notes are listed. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if less than all of the notes of a series is to be redeemed, no notes of that series of a principal amount of &#8364;100,000 or less shall be redeemed in part. If money sufficient to pay the redemption price on the notes (or portions thereof) of a series to be redeemed on the redemption date is deposited with the paying agent on or before the redemption date and certain other conditions are satisfied, then on and after such redemption date, interest will cease to accrue on the notes (or such portion thereof) of such series called for redemption.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notice of any redemption may, at our discretion, be subject to one or more conditions precedent, including, but not limited to, completion of an equity offering, a financing, or other corporate transaction. In addition, if such redemption or notice is subject to satisfaction of one or more conditions precedent, such notice shall state that, in our discretion, such notice may be rescinded in the event that any or all such conditions shall not have been satisfied by the redemption date. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Optional Redemption for Tax Reasons</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes of either series may be redeemed at our option at any time in whole, but not in part, on not less than 10 nor more than 60 days&#8217; prior notice, at 100% of the principal amount of the notes of such series together with accrued and unpaid interest, if any, to, but excluding, the redemption date if, as a result of any change in, or amendment to, the laws, regulations or rulings of the United States (or any political subdivision or taxing authority thereof or therein having power to tax), or any change in official position regarding application or interpretation of those laws, regulations or rulings (including a holding by a court of competent jurisdiction), which change, amendment, application or interpretation is announced or becomes effective on or after the original issue date with respect to the notes, we become or, based upon a written opinion of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">independent counsel selected by us, will become obligated to pay additional amounts as described below in &#8220;&#8212; Payment of Additional Amounts.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Payment of Additional Amounts</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All payments of principal, interest, and premium, if any, in respect of the notes will be made free and clear of, and without withholding or deduction for, any present or future taxes, assessments, duties or governmental charges of whatever nature imposed, levied or collected by the United States (or any political subdivision or taxing authority thereof or therein having power to tax), unless such withholding or deduction is required by law or the official interpretation or administration thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will, subject to the exceptions and limitations set forth below, pay as additional interest in respect of the notes such additional amounts as are necessary in order that the net payment by us of the principal of, premium, if any, and interest in respect of the notes to a holder who is not a United States person (as defined below), after withholding or deduction for any present or future tax, assessment, duties or other governmental charge imposed by the United States (or any political subdivision or taxing authority thereof or therein having power to tax), will not be less than the amount provided in the notes to be then due and payable&#59; provided, however, that the foregoing obligation to pay additional amounts shall not apply&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1)   to the extent any tax, assessment or other governmental charge would not have been imposed but for the holder (or the beneficial owner for whose benefit such holder holds such note), or a fiduciary, settlor, beneficiary, member or shareholder of the holder if the holder is an estate, trust, partnership or corporation, or a person holding a power over an estate or trust administered by a fiduciary holder, being considered as&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a)   being or having been engaged in a trade or business in the United States or having or having had a permanent establishment in the United States&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b)   having a current or former connection with the United States (other than a connection arising solely as a result of the ownership of the notes, the receipt of any payment in respect of the notes or the enforcement of any rights hereunder), including being or having been a citizen or resident of the United States&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c)   being or having been a personal holding company, a passive foreign investment company or a controlled foreign corporation for U.S. federal income tax purposes, a foreign tax-exempt organization, or a corporation that has accumulated earnings to avoid U.S. federal income tax&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d)   being or having been a &#8220;10-percent shareholder&#8221; of the Company as defined in section 871(h)(3) of the United States Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) or any successor provision&#59; or</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e)   being a bank receiving payments on an extension of credit made pursuant to a loan agreement entered into in the ordinary course of its trade or business, as described in section 881(c)(3)(A) of the Code or any successor provision&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2)   to any holder that is not the sole beneficial owner of the notes, or a portion of the notes, or that is a fiduciary, partnership, limited liability company or other fiscally transparent entity, but only to the extent that a beneficial owner with respect to the holder, a beneficiary or settlor with respect to the fiduciary, or a beneficial owner or member of the partnership, limited liability company or other fiscally transparent entity would not have been entitled to the payment of an </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">additional amount had the beneficiary, settlor, beneficial owner or member received directly its beneficial or distributive share of the payment&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3)   to the extent any tax, assessment or other governmental charge that would not have been imposed but for the failure of the holder or any other person to comply with certification, identification or information reporting requirements concerning the nationality, residence, identity or connection with the United States of the holder or beneficial owner of the notes, if compliance is required by statute, by regulation of the United States or any taxing authority therein or by an applicable income tax treaty to which the United States is a party as a precondition to exemption from such tax, assessment or other governmental charge&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4)   to any tax, assessment or other governmental charge that is imposed otherwise than by withholding by us or a paying agent from the payment&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5)   to any tax, assessment or other governmental charge required to be withheld by any paying agent from any payment of principal of or interest on any notes, if such payment can be made without such withholding by any other paying agent&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6)   to any estate, inheritance, gift, sales, transfer, wealth, capital gains or personal property tax or similar tax, assessment or other governmental charge, or excise tax imposed on the transfer of notes&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7)   to the extent any tax, assessment or other governmental charge would not have been imposed but for the presentation by the holder of any note, where presentation is required, for payment on a date more than 30 days after the date on which payment became due and payable or the date on which payment thereof is duly provided for, whichever occurs later except to the extent that the beneficiary or holder thereof would have been entitled to the payment of additional amounts had such note been presented for payment on any day during such 30-day period&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8)   to any tax, assessment or other governmental charge imposed under sections 1471 through 1474 of the Code (or any amended or successor provisions), any current or future regulations or official interpretations thereof, any agreement entered into pursuant to section 1471(b) of the Code or any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement entered into in connection with the implementation of such sections of the Code, whether currently in effect or as published and amended from time to time&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9)   to any tax, assessment or other governmental charge that is imposed or withheld solely by reason of a change in law, regulation, or administrative or judicial interpretation that becomes effective more than 15 days after the payment becomes due or is duly provided for, whichever occurs later&#59; or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10) in the case of any combination of the above numbered items. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes are subject in all cases to any tax, fiscal or other law or regulation or administrative or judicial interpretation applicable to the notes. Except as specifically provided under this heading &#8220;&#8212;Payment of Additional Amounts,&#8221; we are not required to make any payment for any tax, assessment or other governmental charge imposed by any government or a political subdivision or taxing authority of or in any government or political subdivision.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As used under this heading &#8220;&#8212;Payment of Additional Amounts&#8221; and under the heading &#8220;&#8212;Optional Redemption for Tax Reasons,&#8221; the term &#8220;United States&#8221; means the United States of America, its territories and possessions, the states of the United States and the District of Columbia, and the term &#8220;United States person&#8221; means (i) any individual who is a citizen or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">resident of the United States for U.S. federal income tax purposes, (ii) a corporation, partnership or other entity created or organized in or under the laws of the United States, any state of the United States or the District of Columbia (other than a partnership that is not treated as a United States person for United States federal income tax purposes), (iii) any estate the income of which is subject to U.S. federal income taxation regardless of its source, or (iv) any trust if a United States court can exercise primary supervision over the administration of the trust and one or more United States persons can control all substantial trust decisions, or if a valid election is in place to treat the trust as a United States person.</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sinking Fund</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes will not be entitled to any sinking fund.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Repurchase at the Option of Holders Upon Change of Control Repurchase Event</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If a Change of Control Repurchase Event (as defined below) occurs in respect of a series of the notes, unless we have exercised our right to redeem the notes of such series as described above under &#8220;&#8212;Optional Redemption or &#8220;&#8212;Optional Redemption for Tax Reasons,&#8221; we will be required to make an offer (a &#8220;Change of Control Offer&#8221;) to each holder of such series of notes to repurchase all or any part (in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 in excess thereof) of that holder&#8217;s notes at a repurchase price in cash equal to 101% of the aggregate principal amount of notes repurchased plus any accrued and unpaid interest on the notes repurchased to, but not including, the date of such repurchase. Within 30 days following any Change of Control Repurchase Event or, at our option, prior to any Change of Control (as defined below), but after the public announcement of an impending Change of Control, we will mail a notice to each holder, with a copy to the trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Repurchase Event and offering to repurchase notes on the payment date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed. The notice will, if mailed prior to the date of consummation of the Change of Control, state that the offer to purchase is conditioned on a Change of Control Repurchase Event occurring on or prior to the payment date specified in the notice.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will comply with the requirements of Rule 14e-1 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, and any other securities laws and regulations thereunder, to the extent those laws and regulations are applicable in connection with the repurchase of the notes as a result of a Change of Control Repurchase Event. To the extent that the provisions of any securities laws or regulations conflict with the Change of Control Repurchase Event provisions of the notes, we will comply with the applicable securities laws and regulations and will not be deemed to have breached our obligations under the Change of Control Repurchase Event provisions of the notes by virtue of such conflict.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On the Change of Control Repurchase Event payment date, we will, to the extent lawful&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.67pt">accept for payment all notes or portions of notes (in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 in excess thereof) properly tendered pursuant to our offer&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:8.34pt">deposit with the paying agent an amount equal to the aggregate purchase price in respect of all notes or portions of notes properly tendered&#59; and</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:5.01pt">deliver or cause to be delivered to the trustee for cancellation the notes properly accepted, together with an officers&#8217; certificate stating the aggregate principal amount of notes being repurchased by us.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The paying agent will promptly mail to each holder of notes properly tendered the purchase price for the notes, and the trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each holder a new note equal in principal amount to any unpurchased portion of any notes surrendered&#59; provided, that each new note will be in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 in excess thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will not be required to make a Change of Control Offer upon a Change of Control Repurchase Event if (i) a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for a Change of Control Offer made by us and such third party purchases all notes properly tendered and not withdrawn under its offer or (ii) we have previously or concurrently mailed a redemption notice with respect to all of the outstanding notes as described under &#8220;Optional Redemption&#8221; above.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If holders of not less than 90% in aggregate principal amount of the outstanding notes of either series validly tender and do not withdraw such notes in a Change of Control Offer and we, or any third party making such an offer in lieu of us as described above, purchases all of the notes of such series validly tendered and not withdrawn by such holders, we or such third party will have the right, upon not less than 10 days nor more than 60 days&#8217; prior notice, provided that such notice is given not more than 30 days following such repurchase pursuant to the Change of Control Offer described above, to redeem all notes of such series that remain outstanding following such purchase on a date specified in such notice (the &#8220;Second Change of Control Payment Date&#8221;) and at a price in cash equal to 101% of the aggregate principal amount of notes of such series repurchased plus any accrued and unpaid interest on the notes of such series repurchased to, but not including, the Second Change of Control Payment Date.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We have no present intention to engage in a transaction involving a Change of Control, although it is possible that we would decide to do so in the future. We could, in the future, enter into certain transactions, including acquisitions, refinancings or other recapitalizations, that would not constitute a Change of Control but that could increase the amount of debt outstanding at such time or otherwise affect our capital structure or credit ratings.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Definitions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Below Investment Grade Rating Event&#8221; means the notes of such series are rated below Investment Grade by each of the Rating Agencies on any date during the period commencing upon the first public notice of the occurrence of a Change of Control or our intention to effect a Change of Control and ending 60 days following public notice of the occurrence of the related Change of Control (which period shall be extended so long as the rating of the notes of such series is under publicly announced consideration for possible downgrade by any of the Rating Agencies, provided that no such extension shall occur if on such 60th day the notes of such series </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">are rated Investment Grade by at least one of such Rating Agency and are not subject to review for possible downgrade by such Rating Agency)&#59; provided further that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating shall not be deemed to have occurred in respect of a particular Change of Control (and thus shall not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Repurchase Event hereunder) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or inform the trustee in writing at its request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control shall have occurred at the time of the Below Investment Grade Rating Event).</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Change of Control&#8221; means the occurrence of any of the following&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1)   the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of our assets and those of our subsidiaries taken as a whole to any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than us or one of our subsidiaries&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2)   the adoption of a plan relating to our liquidation or dissolution&#59; or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4)   the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than us or one or more of our subsidiaries, becomes the beneficial owner (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of more than 50% of the then outstanding number of shares of our Voting Stock.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, a transaction will not be considered to be a Change of Control if (a) we become a direct or indirect wholly-owned subsidiary of a holding company and (b)(i) immediately following that transaction, the direct or indirect holders of the Voting Stock of the holding company are substantially the same as the holders of our Voting Stock immediately prior to that transaction or (ii) immediately following that transaction, no person is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of such holding company.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Change of Control Repurchase Event&#8221; means the occurrence of both a Change of Control and a Below Investment Grade Rating Event.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Investment Grade&#8221; means a rating of Baa3 or better by Moody&#8217;s (or its equivalent under any successor rating categories of Moody&#8217;s) and a rating of BBB- or better by S&#38;P (or its equivalent under any successor rating categories of S&#38;P) or the equivalent investment grade credit rating from any additional Rating Agency or Rating Agencies selected by us.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Moody&#8217;s&#8221; means Moody&#8217;s Investors Service Inc., a subsidiary of Moody&#8217;s Corporation, and its successors.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Rating Agency&#8221; means (1) each of Moody&#8217;s and S&#38;P&#59; and (2) if any of Moody&#8217;s or S&#38;P ceases to rate the notes or fails to make a rating of the notes publicly available for reasons </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">outside of our control, a &#8220;nationally recognized statistical rating organization&#8221; within the meaning of Section 3(a)(62) under the Exchange Act, selected by us as a replacement agency for Moody&#8217;s or S&#38;P, or both of them, as the case may be.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;S&#38;P&#8221; means S&#38;P Global Ratings Inc., a division of S&#38;P Global Inc. and its successors.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Voting Stock&#8221; of any specified person as of any date means the capital stock of such person that is at the time entitled to vote generally in the election of the board of directors of such person.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The definition of &#8220;Change of Control&#8221; includes a phrase relating to the direct or indirect sale, transfer, conveyance or other disposition of &#8220;all or substantially all&#8221; of our assets and those of our subsidiaries, taken as a whole. Although there is a limited body of case law interpreting the phrase &#8220;substantially all,&#8221; there is no precise established definition of the phrase under applicable law. Accordingly, the ability of a holder of notes to require us to repurchase the notes as a result of a sale, transfer, conveyance or other disposition of less than all of our assets and the assets of our subsidiaries, taken as a whole, to another person or group may be uncertain.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Certain Covenants</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Limitation on Liens</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture contains a covenant that we will not, and we will not permit any of our Restricted Subsidiaries (as defined below) to, issue, assume or guarantee any Indebtedness (as defined below) secured by any Mortgage (as defined below) upon any of our Principal Properties (as defined below) or those of any of our Restricted Subsidiaries without equally and ratably securing the notes (and, if we so determine, any other Indebtedness ranking equally with the notes) with such Indebtedness.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This covenant will not prevent us or any Restricted Subsidiary from issuing, assuming or guaranteeing&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">any purchase money mortgage on such Principal Property prior to, simultaneously with or within 180 days after the later of (1) the acquisition or completion of construction or completion of substantial reconstruction, renovation, remodeling, expansion or improvement (each, a &#8220;substantial improvement&#8221;) of such Principal Property or (2) the placing in operation of such property after the acquisition or completion of any such construction or substantial improvement&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Mortgages on a Principal Property existing at the time of acquisition, including acquisition through merger or consolidation&#59; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">Mortgages existing on the date of the initial issuance of the notes, Mortgages on assets of a corporation or other business entity existing on the date it becomes a Restricted Subsidiary or is merged or consolidated with us or a Restricted Subsidiary or at the time the corporation or other business entity sells, leases or otherwise disposes of its property as an entirety or substantially as an entirety to us or a Restricted Subsidiary or Mortgages on the assets of a Subsidiary (as defined below) that is newly designated as a Restricted Subsidiary if the Mortgage would have been permitted under the provisions of this </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">paragraph if such Mortgage was created while the Subsidiary was a Restricted Subsidiary&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Mortgages in favor of us or a Restricted Subsidiary&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">Mortgages for taxes, assessments or governmental charges or levies that are not delinquent or that are being contested in good faith&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.01pt">Carriers&#8217;, warehousemen&#8217;s, materialmen&#8217;s, repairmen&#8217;s, mechanic&#8217;s, landlords&#8217; and other similar Mortgages arising in ordinary course of business that are not delinquent or remain payable without penalty or that are being contested in good faith&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Mortgages (other than any Mortgage imposed by the Employee Retirement Income Security Act of 1974) consisting of pledges or deposits required in the ordinary course of business in connection with workers&#8217; compensation, unemployment insurance and other social security legislation&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Easements, rights-of-way, restrictions, encroachments, imperfections and other similar encumbrances affecting real property that, in the aggregate, are not substantial in amount and do not in any case materially detract from the value of the Principal Property subject thereto or materially interfere with the ordinary conduct of our and our Subsidiaries&#8217; business, taken as a whole&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.67pt">Mortgages arising by reason of deposits with, or the giving of any form of security to, any governmental agency or any body created or approved by law or governmental regulation, including any zoning or similar law or right reserved to or vested in any governmental office or agency to control or regulate the use of any real property&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.67pt">Mortgages arising from filing Uniform Commercial Code financing statements relating solely to leases&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Mortgages to secure Indebtedness incurred to extend, renew, refinance or replace Indebtedness secured by any Mortgages referred to above, provided that the principal amount of the extended, renewed, refinanced or replaced Indebtedness does not exceed the principal amount of Indebtedness so extended, renewed, refinanced or replaced, plus transaction costs and fees, and that any such Mortgage applies only to the same property or assets subject to the prior permitted Mortgage (and, in the case of real property, improvements).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Limitations on Sale and Leaseback Transactions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture contains a covenant that we will not, and will not permit any Restricted Subsidiary to, enter into any arrangement with any person providing for the leasing by us or any Restricted Subsidiary of any Principal Property owned or acquired thereafter that has been or is to be sold or transferred by us or such Restricted Subsidiary to such person with the intention of taking back a lease of such Principal Property, a &#8220;sale and leaseback transaction,&#8221; without equally and ratably securing the notes (and, if we so determine, any other Indebtedness ranking equally with the notes), unless&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">within 180 days after the receipt of the proceeds of the sale or transfer, we or any Restricted Subsidiary apply an amount equal to the greater of the net proceeds of the sale or transfer or the fair value of such Principal Property at the time of the sale or transfer to any (or a combination) of (1) the prepayment or retirement (other than any mandatory prepayment or retirement) of our Senior Funded Debt or (2) the purchase, construction, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">development, expansion or improvement of other comparable property, subject in each case to credits for voluntary retirements of our Senior Funded Debt&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">we or such Restricted Subsidiary would be entitled, at the effective date of the sale or transfer, to incur Indebtedness secured by a Mortgage on such Principal Property, in an amount at least equal to the Attributable Debt (as defined below) in respect of the sale and leaseback transaction, without equally and ratably securing the notes pursuant to &#8220;&#8212;Limitation on Liens&#8221; described above.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The foregoing restriction will not apply to&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">any sale and leaseback transaction for a term of not more than three years including renewals&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">any sale and leaseback transaction with respect to a Principal Property if a binding commitment with respect thereto is entered into within three years after the later of (1) the date of the issuance of the notes under the Supplemental Indenture, or (2) the date such Principal Property was acquired&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">any sale and leaseback transaction with respect to a Principal Property if a binding commitment with respect thereto is entered into within 180 days after the later of the date such property was acquired and, if applicable, the date such property was first placed in operation&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">any sale and leaseback transaction between us and a Restricted Subsidiary or between Restricted Subsidiaries.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Exception to Limitations for Exempted Debt</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the limitations in the Indenture on liens and sale and leaseback transactions, we or any Restricted Subsidiary may, in addition to sale and leaseback transactions permitted under such restrictions and without equally and ratably securing the notes, create or assume and renew, extend or replace Mortgages, or enter into any sale and leaseback transaction without any obligation to retire any of our or any Restricted Subsidiary&#8217;s Senior Funded Debt (as defined below), provided that, at the time of such creation, assumption, renewal, extension or replacement of a Mortgage or at the time of entering into such sale and leaseback transactions, and after giving effect thereto, our Exempted Debt (as defined below) does not exceed 15% of our Consolidated Net Tangible Assets (as defined below).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Definitions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of the Indenture&#58;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Attributable Debt&#8221; in respect of a sale and leaseback transaction means, at the time of determination, the present value (discounted at the imputed rate of interest of such transaction as determined in good faith by us) of the obligation of the lessee for net rental payments during the remaining term of the lease included in such sale and leaseback transaction (including any period for which such lease has been extended or may, at the option of the lessor, be extended). The term &#8220;net rental payments&#8221; under any lease for any period means the sum of the rental and other payments required to be paid in such period by the lessee thereunder, not including any amounts required to be paid by such lessee (whether or not designated as rental or additional rent) on account of maintenance and repairs, insurance, taxes, assessments, water rates or similar charges </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">required to be paid by such lessee thereunder or any amount required to be paid by lessee thereunder contingent upon the amount of maintenance and repairs, insurance, taxes, assessments, water rates or similar charges. In the case of any lease that is terminable by the lessee upon the payment of a penalty, such net amount shall be the lesser of (x) the net amount determined assuming termination upon the first date such lease may be terminated (in which case the net amount shall also include the amount of the penalty, but shall not include any rent that would be required to be paid under such lease subsequent to the first date upon which it may be so terminated) or (y) the net amount determined assuming no such termination.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Consolidated Net Tangible Assets&#8221; means the total amounts of assets (less depreciation and valuation reserves and other reserves and items deductible from gross book value of specific asset accounts under generally accepted accounting principles) that under generally accepted accounting principles would be included on a consolidated balance sheet of us and our consolidated Restricted Subsidiaries after deducting (1) all current liabilities, excluding current liabilities that could be classified as long-term debt under generally accepted accounting principles and current liabilities that are by their terms extendable or renewable at the obligor&#8217;s option to a time more than 12 months after the time as of which the amount of current liabilities is being computed&#59; (2) Investments in Unrestricted Subsidiaries&#59; and (3) all trade names, trademarks, licenses, patents, copyrights and goodwill, organizational and development costs, deferred charges, other than prepaid items such as insurance, taxes, interest, commissions, rents and similar items and tangible assets being amortized, and amortized debt discount and expense, less unamortized premium.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Exempted Debt&#8221; means the sum of the following items outstanding as of the date Exempted Debt is being determined (1) Indebtedness of us and our Restricted Subsidiaries secured by a Mortgage and not permitted to exist under the Indenture and (2) Attributable Debt of us and our Restricted Subsidiaries in respect of all sale and leaseback transactions not permitted under the Indenture.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Funded Debt&#8221; means Indebtedness that matures more than one year from the date of creation, or that is extendable or renewable at the sole option of the obligor so that it may become payable more than one year from such date. Funded Debt does not include (1) obligations created pursuant to leases, (2) any Indebtedness or portion thereof maturing by its terms within one year from the time of any computation of the amount of outstanding Funded Debt unless such Indebtedness shall be extendable or renewable at the sole option of the obligor in such manner that it may become payable more than one year from such time, or (3) any Indebtedness for the payment or redemption of which money in the necessary amount shall have been deposited in trust either at or before the maturity date thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Indebtedness&#8221; means any and all of the obligations of a person for money borrowed that in accordance with generally accepted accounting principles would be reflected on the balance sheet of such person as a liability as of the date of which the Indebtedness is to be determined. Notwithstanding the foregoing, a change in generally accepted accounting principles subsequent to November 30, 2018 shall not be deemed an incurrence of Indebtedness.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Investment&#8221; means any investment in stock, evidences of Indebtedness, loans or advances, however made or acquired, but does not include our account receivable or the accounts receivable of any Restricted Subsidiary arising from transactions in the ordinary course of business, or any evidences of Indebtedness, loans or advance made in connection with the sale to any Subsidiary of our accounts receivable or the accounts receivable of any Restricted Subsidiary arising from transactions in the ordinary course of business.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Mortgage&#8221; means any mortgage, security interest, pledge, lien or other encumbrance.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Principal Property&#8221; means all real property and improvements thereon owned by us or a Restricted Subsidiary, including, without limitation, any manufacturing, warehouse, distribution or research facility, and improvements therein, having a net book value in excess of 2% of Consolidated Net Tangible Assets that is located within the United States, excluding its territories and possessions and Puerto Rico. This term does not include any real property and improvements thereon that our Board of Directors declares by resolution not to be of material importance to the total business conducted by us and our Restricted Subsidiaries taken as a whole.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Restricted Subsidiary&#8221; means a Subsidiary that owns a Principal Property.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Senior Funded Debt&#8221; means all Funded Debt (except Funded Debt, the payment of which is subordinated to the payment of the notes).</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Subsidiary&#8221; means a corporation, partnership or other legal entity of which, in the case of a corporation, more than 50% of the outstanding voting stock is owned, directly or indirectly, by us or by one or more other Subsidiaries, or by us and one or more other Subsidiaries or, in the case of any partnership or other legal entity, more than 50% of the ordinary capital interests is, at the time, directly or indirectly owned or controlled by us or by one or more other Subsidiaries. For the purposes of this definition, &#8220;voting stock&#8221; means the equity interest that ordinarily has voting power for the election of directors, managers or trustees of an entity, or persons performing similar functions, whether at all times or only so long as no senior class of equity interest has such voting power by reason of any contingency.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Unrestricted Subsidiary&#8221; means any Subsidiary other than a Restricted Subsidiary.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Consolidation, Merger and Sale of Assets</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We may consolidate or merge with or into any other corporation, and we may sell or transfer all or substantially all of our assets to another corporation, provided, among other things, that (a) we are the surviving corporation or the corporation formed by or resulting from any such</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">consolidation or merger or the transferee of such assets shall be a corporation organized and existing under the laws of the United States, any state thereof or the District of Columbia and shall expressly assume by supplemental indenture payment of the principal of, and premium, if any, and interest, if any, on the notes issued under the Indenture and the performance and observance of the Indenture and (b) we or such successor corporation shall not immediately thereafter be in default under the Indenture.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Exhibit 4(xxi)</font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Events of Default</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following events are defined in the Indenture as &#8220;Events of Default&#8221;&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">default in the payment of any installment of interest on any series of notes for 30 days after becoming due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">default in the payment of principal or premium, if any, of any series of notes when due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">default in the deposit of any sinking fund payment, when due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">default in the performance of any other covenant for 90 days after notice, which must be sent by either the trustee or holders of 25% of the principal amount of the debt securities of the affected series&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">certain events of bankruptcy, insolvency or reorganization&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.01pt">any other Event of Default that may be set forth in the supplemental indenture or board resolution with respect to a particular series of debt securities. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an Event of Default occurs and continues with respect to a series of notes, either the trustee or the holders of at least 25% in principal amount of the outstanding debt securities of such series (or such lesser amount as may be provided for in the debt securities of such series) may declare the entire principal amount of all the debt securities of such series to be due and payable&#894; provided that, in the case of an Event of Default involving certain events of bankruptcy, insolvency or reorganization, such acceleration is automatic&#894; and, provided further, that after such acceleration, but before a judgment or decree based on acceleration, the holders of a majority in aggregate principal amount of the outstanding debt securities of that series may, subject to certain conditions, rescind and annul such acceleration if all Events of Default, other than the nonpayment of accelerated principal, have been cured or waived. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ex10i2025stockoptionawardl.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i31b2f1941d224240a3606878c70b1714_1"></div><div style="min-height:56.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div><font><br></font></div><div style="margin-top:11.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;Kevin A. Lobo</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;Chair and CEO</font></div></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="strykerlogoa72b.jpg" src="strykerlogoa72b.jpg" style="height:54px;margin-bottom:5pt;vertical-align:text-bottom;width:202px"></div></td></tr></table></div><div style="padding-left:5.25pt;padding-right:427.9pt"><font><br></font></div><div style="margin-top:4.3pt"><font><br></font></div><div style="padding-left:5.25pt;padding-right:346.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:219%">Personal and Confidential February 5, 2025</font></div><div><font><br></font></div><div style="margin-top:3.1pt"><font><br></font></div><div style="padding-left:5.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">First Name Last Name</font></div><div style="margin-top:5.95pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear First Name,</font></div><div style="margin-top:7.45pt"><font><br></font></div><div style="padding-left:6.75pt;padding-right:6.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I am pleased to inform you that you are one of a select group of individuals receiving a stock option and restricted stock units (RSUs) award in 2025. We use these awards to reward performers who we believe will be key contributors to our growth well into the future. The total Award Date Value (ADV) of your awards is approximately USD $xx,xxx.</font></div><div style="margin-top:11.4pt;padding-left:6.75pt;padding-right:6.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are awarding you a nonstatutory stock option for xxx shares of Stryker Corporation Common Stock at a price of USD $xxx.xx per share. Except as otherwise provided in the Terms and Conditions, you may exercise this option at 20% per year beginning on February 5, 2026, and it will expire on February 4, 2035.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:6.8pt;padding-right:6.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">You must &#8220;Accept&#8221; the award online via the UBS One Source web site located at </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">www.ubs.com&#47;onesource&#47;SYK</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">between March 4 and March 31, 2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The detailed terms of the option are in the Terms and Conditions, any applicable country addendum and the provisions of the Company's 2011 Long- Term Incentive Plan, as Amended and Restated. Those documents, together with the related Prospectus, are available on the UBS One Source web site, and you should read them before accepting the awards. In addition, you may be asked to sign the most recent version of Stryker&#8217;s Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement (&#8220;Non-Compete Agreement&#8221;) in connection with the award. If you are asked to sign the Non-Compete Agreement, it will be emailed to you and you will be asked to sign the document electronically via Adobe Sign by March 31, 2025. The exercisability of the options is conditioned on you having signed the Non-Compete Agreement by March 31, 2025, where permitted by applicable law.</font></div><div style="margin-top:0.7pt"><font><br></font></div><div style="padding-left:6.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You can find additional educational materials on the UBS One Source web site in the Resources section, including Stock Option brochure and Stock Option Tax Questions &#38; Answers.</font></div><div style="padding-left:6.8pt"><font><br></font></div><div style="padding-left:6.8pt"><font><br></font></div><div style="padding-left:5.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sincerely,</font></div><div style="margin-top:3.9pt"><font><br></font></div><div style="padding-left:5.3pt"><img alt="image_1b.jpg" src="image_1b.jpg" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:61px"></div><div style="padding-left:5.3pt"><font><br></font></div><div style="padding-left:5.3pt"><font><br></font></div><div style="margin-top:4.4pt;padding-left:5.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kevin A. Lobo</font></div><div style="margin-top:0.05pt;padding-left:5.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chair and Chief Executive Officer</font></div><div><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="margin-top:3.65pt;padding-left:3.5pt;padding-right:3.5pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="margin-top:11.65pt;padding-left:3.47pt;padding-right:3.47pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TERMS AND CONDITIONS</font></div><div style="margin-top:0.35pt;padding-left:3.5pt;padding-right:3.5pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RELATING TO NONSTATUTORY STOCK OPTIONS GRANTED</font></div><div style="margin-top:0.35pt;padding-left:3.52pt;padding-right:3.52pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PURSUANT TO THE 2011 LONG-TERM INCENTIVE PLAN, AS AMENDED AND RESTATED</font></div><div style="margin-top:11.6pt;padding-left:5pt;padding-right:10.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt">The Options to purchase Shares of Stryker Corporation (the &#34;Company&#34;) granted to you during 2025 are subject to these Terms and Conditions Relating to Nonstatutory Stock Options Granted Pursuant to the 2011 Long-Term Incentive Plan, as Amended and Restated (the &#34;Terms and Conditions&#34;) and all of the terms and conditions of the Stryker Corporation 2011 Long-Term Incentive Plan, as Amended and Restated (the &#34;2011 Plan&#34;), which is incorporated herein by reference. In the case of a conflict between these Terms and Conditions and the terms of the 2011 Plan, the provisions of the 2011 Plan will govern. Capitalized terms used but not defined herein have the meaning provided therefor in the 2011 Plan. For purposes of these Terms and Conditions, &#34;Employer&#34; means the Company or any Subsidiary that employs you on the applicable date, and &#34;Stock Plan Administrator&#34; means UBS Financial Services Inc. (or any other independent service provider engaged by the Company to assist with the implementation, operation and administration of the 2011 Plan).</font></div><div style="margin-top:11pt;padding-left:5pt;padding-right:11.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt">Upon the termination of your employment with your Employer, your right to exercise the Options shall be only as follows&#58;</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.7pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(1)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.96pt">If your employment is terminated by reason of Disability (as such term is defined in the 2011 Plan) or death, you, your legal representative or your estate shall have the right, for a period of one (1) year following such termination, to exercise the Options with respect to all or any part of the Shares subject thereto, regardless of whether the right to purchase such Shares had vested on or before the date of your termination by Disability or death.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:11.65pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(2)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.96pt">If your employment is terminated by reason of Retirement (as such term is defined in the 2011 Plan) prior to the date that your Options become fully vested, you will continue to vest in your Options in accordance with the vesting schedule as set forth in the award letter as if you had continued your employment with your Employer. You (or your estate in the event of your death after your termination by Retirement) shall have the right, at any time on or prior to the 10th anniversary of the grant date, to exercise the vested portion of the Options.</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:11.7pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(3)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.96pt">If you cease to be an Employee for any reason other than those provided in (a) or (b) above, you or your estate (in the event of your death after such termination) may, within the 30-day period following such termination, exercise the Options with respect to only such number of Shares as to which the right of exercise had vested on or before the Termination Date. If you are resident or employed outside of the United States, &#34;Termination Date&#34; shall mean the last day on which you are an Employee of your Employer, provided that (1) your notice period is 12 months or less, or (2) your employment ends less than 12 months after the date on which you signed your termination agreement. Other than Section 16 officers (as defined below), if your notice period exceeds 12 months, then &#34;Termination Date&#34; will be 12 months after the date on which notice was given, whether it be by you or your Employer. If your employment ends more than 12 months after you signed your termination agreement, then &#8220;Termination Date&#8221; will be 12 months after the date on which you signed your termination agreement. </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">If you are an officer of the Company and in such capacity are subject to reporting under Section 16 of the U.S. Securities Exchange Act of 1934 (a &#8220;Section 16 officer&#8221;) on the date on which notice was given, &#34;Termination Date&#34; shall mean the last day on which you are an Employee of your Employer.</font></div><div style="margin-top:10.95pt;padding-left:4.5pt;text-align:justify;text-indent:71.05pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.96pt">Notwithstanding the foregoing, the Options shall not be exercisable in whole or in part (i) after the 10th anniversary of the grant date or (ii) except as provided in Section 3(c) hereof or in the event of termination of employment because of Disability, Retirement or death, unless you shall have continued in the employ of the Company or one of its Subsidiaries for one (1) year following the date of grant of the Options.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.7pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(5)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.96pt">Notwithstanding the foregoing, if you are eligible for Retirement but cease to be an Employee for any other reason before you retire, the right to exercise the Options shall be determined as if your employment ceased by reason of Retirement.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:11.8pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(6)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.96pt">If you are both an Employee and a Director, the provisions of this Section 2 shall not apply until such time as you are neither an Employee nor a Director.</font></div><div style="margin-top:11.25pt;padding-left:4.5pt;text-align:justify;text-indent:35.8pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.36pt">The number of Shares subject to the Options and the price to be paid therefor shall be subject to adjustment and the term and exercise dates hereof may be accelerated as follows&#58;</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:10.55pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(1)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.96pt">In the event that the Shares, as presently constituted, shall be changed into or exchanged for a different number or kind of shares of stock or other securities of the Company or of another corporation (whether by reason of merger, consolidation, recapitalization, reclassification, split-up, combination of shares, or otherwise) or if the number of such Shares shall be increased through the payment of a stock dividend or a dividend on the Shares of rights or warrants to purchase securities of the Company shall be made, then there shall be substituted for or added to each Share theretofore subject to the Options the number and kind of shares of stock or other securities into which each outstanding Share shall be so changed, or for which each such Share shall be exchanged, or to which each such Share shall be entitled. The Options shall also be appropriately amended as to price and other terms as may be necessary to reflect the foregoing events. In the event there shall be any other change in the number or kind of the outstanding Shares, or of any stock or other securities into which such Common Stock shall have been exchanged, then if the Committee shall, in its sole discretion, determine that such change equitably requires an adjustment in the Options, such adjustment shall be made in accordance with such determination.</font></div><div style="margin-top:10.85pt;padding-left:5pt;padding-right:11.6pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(2)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.96pt">Fractional Shares resulting from any adjustment in the Options may be settled in cash or otherwise as the Committee shall determine, in its sole discretion. Notice of any adjustment will be given to you and such adjustment (whether or not such notice is given) shall be effective and binding for all purposes hereof.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.55pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(3)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.96pt">The Committee shall have the power to amend the Options to permit the exercise of the Options (and to terminate any unexercised Options) prior to the effectiveness of (i) any disposition of substantially all of the assets of the Company or your Employer, (ii) the shutdown, discontinuance of operations or dissolution of the Company or your Employer, or (iii) the merger or consolidation of the Company or your Employer with or into any other unrelated corporation.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:10.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt">To exercise the Options, you must complete the on-line exercise procedures as established through the Stock Plan Administrator at www.ubs.com&#47;onesource&#47;SYK or by telephone at +1 860 727 1515 (or such other direct dial-in number that may be established from time to time). As part of such procedures, you shall be required to specify the number of Shares that you elect to purchase and the date on which such purchase is to be made, and you shall be required to make full payment of the Exercise Price. An Option shall not be deemed to have been exercised (i.e., the exercise date shall not be deemed to have occurred) until the notice of such exercise and payment in full of the Exercise Price are provided. The exercise date will be defined by the New York Stock Exchange (&#34;NYSE&#34;) trading hours. If an exercise is completed after the market close or on a weekend, the exercise will be dated the next following trading day.</font></div><div style="margin-top:11pt;padding-left:5pt;padding-right:10.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">The Exercise Price may be paid in such manner as the Committee may specify from time to time in its sole discretion and as established through Stock Plan Administrator, including (but not limited to) the following methods&#58; (i) by a net exercise arrangement pursuant to which the Company will reduce the number of Shares issued upon exercise by the largest whole number of Shares with an aggregate Fair Market Value on the date of purchase sufficient to cover the aggregate Exercise Price&#59; (ii) by a broker- assisted cashless exercise transaction pursuant to which the Stock Plan Administrator loans funds to you to enable you to pay the aggregate Exercise Price and purchase Shares, and then sells a sufficient &#91;whole&#93; number of the purchased Shares on your behalf to enable you to repay the aggregate Exercise Price (with the remaining Shares and&#47;or cash then delivered by Stock Plan Administrator to you) or (iii) cash payment. In cases where you utilize the net exercise arrangement and the Fair Market Value of the number of whole Shares withheld or sold, as applicable, is greater than the aggregate Exercise Price, the Company shall make a cash payment to you equal to the difference as soon as administratively practicable.</font></div><div style="margin-top:3.65pt;padding-left:5pt;padding-right:11.55pt;text-align:justify;text-indent:35.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">5.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.16pt">If you are resident and&#47;or employed outside of the United States, you agree, as a condition of the grant of the Options, to repatriate all payments attributable to the Shares and&#47;or </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="margin-top:3.65pt;padding-left:5pt;padding-right:11.55pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">cash acquired under the 2011 Plan (including, but not limited to, dividends and any proceeds derived from the sale of the Shares acquired pursuant to the Options) if required by and in accordance with local foreign exchange rules and regulations in your country of residence (and country of employment, if different). In addition, you also agree to take any and all actions, and consent to any and all actions taken by the Company and its Subsidiaries, as may be required to allow the Company and its Subsidiaries to comply with local laws, rules and regulations in your country of residence (and country of employment, if different). Finally, you agree to take any and all actions as may be required to comply with your personal legal and tax obligations under local laws, rules and regulations in your country of residence (and country of employment, if different).</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:11.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">6.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt">If you are resident or employed in a country that is a member of the European Union, the grant of the Options and these Terms and Conditions are intended to comply with the age discrimination provisions of the EU Equal Treatment Framework Directive, as implemented into local law (the &#34;Age Discrimination Rules&#34;). To the extent that a court or tribunal of competent jurisdiction determines that any provision of these Terms and Conditions is invalid or unenforceable, in whole or in part, under the Age Discrimination Rules, the Company, in its sole discretion, shall have the power and authority to revise or strike such provision to the minimum extent necessary to make it valid and enforceable to the full extent permitted under local law.</font></div><div style="margin-top:11.05pt;padding-left:5pt;padding-right:11.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">7.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt">Regardless of any action the Company and&#47;or your Employer take with respect to any or all income tax (including U.S. federal, state and local taxes and&#47;or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related withholding (&#34;Tax-Related Items&#34;), you acknowledge that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that the Company and your Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Options, including the grant of the Options, the vesting of the Options, the exercise of the Options, the subsequent sale of any Shares acquired pursuant to the Options and the receipt of any dividends and (ii) do not commit to structure the terms of the grant or any aspect of the Options to reduce or eliminate your liability for Tax-Related Items. Further, if you become subject to taxation in more than one country between the grant date and the date of any relevant taxable or tax withholding event, as applicable, you acknowledge that the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one country.</font></div><div style="margin-top:10.95pt;padding-left:5pt;padding-right:11.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Prior to the delivery of Shares upon exercise of your Options, if your country of residence (and&#47;or your country of employment, if different) requires withholding of Tax-Related Items, the Company may withhold a number of whole Shares otherwise issuable upon exercise of the Options that have an aggregate Fair Market Value that the Company, taking into account local requirements and administrative issues, determines in its sole discretion is appropriate to cover withholding for Tax-Related Items with respect to the Shares. The cash equivalent of the Shares withheld will be used to settle the obligation to withhold the Tax-Related Items. In cases where the Fair Market Value of the number of whole Shares withheld at the time of exercise is greater than the amount required to be paid to the relevant government authorities with respect to withholding for Tax-Related Items, the Company shall make a cash payment to you equal to the difference as soon as administratively practicable. In the event that withholding in Shares is prohibited or problematic under applicable law or causes adverse consequences to the Company or your Employer, your Employer may withhold the Tax-Related Items required to be withheld with respect to the Shares (i) from the proceeds of the sale of Shares acquired upon exercise of the Options either through a voluntary sale or through a mandatory sale arranged by the Company (on your behalf pursuant to this authorization without further consent), or (ii) in cash from your regular salary and&#47;or wages or other amounts payable to you. In the event the withholding requirements are not satisfied through the withholding of Shares or through your regular salary and&#47;or wages or any other amounts payable to you by your Employer, no Shares will be issued to you (or your estate) upon exercise of the Options unless and until satisfactory arrangements (as determined by the Board of Directors) have been made by you with respect to the payment of any Tax-Related Items that the Company or your Employer determines, in its sole discretion, should be withheld or collected with respect to such Options. By accepting these Options, you expressly consent to the withholding of Shares and&#47;or withholding from your regular salary and&#47;or wages or other amounts payable to you as provided for hereunder. All other Tax-Related Items related to the Options and any Shares delivered in payment thereof are your sole responsibility.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="margin-top:10.6pt;padding-left:5pt;padding-right:11.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">8.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt">The Options are intended to be exempt from the requirements of Code Section 409A. The 2011 Plan and these Terms and Conditions shall be administered and interpreted in a manner consistent with this intent. If the Company determines that these Terms and Conditions are subject to Code Section 409A and that it has failed to comply with the requirements of that Section, the Company may, at the Company's sole discretion and without your consent, amend these Terms and Conditions to cause them to comply with Code Section 409A or be exempt from Code Section 409A.</font></div><div style="margin-top:3.65pt;padding-left:5pt;padding-right:11.4pt;text-align:justify;text-indent:35.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">9.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.16pt">If you were required to sign the &#34;Stryker Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement&#34; or a similar agreement in order to receive the Options or have previously signed such an agreement and you breach any non-competition, non-solicitation or non-disclosure provision or provision as to ownership of inventions contained therein at any time while employed by the Company or a Subsidiary or during the one-year period following termination of employment, any unexercised portion of the Options shall be rescinded and you shall return to the Company all Shares that were acquired upon exercise of the Options that you have not disposed of and the Company shall repay you an amount for each such Share equal to the lesser of the Exercise Price or the Fair Market Value of a Share at such time. Further, you shall pay to the Company an amount equal to the profit realized by you (if any) on all Shares that were acquired upon exercise of the Options that you have disposed of. For purposes of the preceding sentence, the profit shall be the positive difference between the Fair Market Value of the Shares at the time of disposition and the Exercise Price.</font></div><div style="margin-top:11.05pt;padding-left:5pt;padding-right:11.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">10.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The Options shall be transferable only by will or the laws of descent and distribution and shall be exercisable during your lifetime only by you. If you purport to make any transfer of the Options, except as aforesaid, the Options and all rights thereunder shall terminate immediately.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:10.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">11.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The Options shall not be exercisable in whole or in part, and the Company shall not be obligated to issue any Shares subject to the Options, if such exercise and sale would, in the opinion of counsel for the Company, violate the Securities Act of 1933 or any other U.S. federal, state or non-U.S. statute having similar requirements as it may be in effect at the time. The Options are subject to the further requirement that, if at any time the Board of Directors shall determine in its discretion that the listing or qualification of the Shares subject to the Options under any securities exchange requirements or under any applicable law, or the consent or approval of any governmental regulatory body, is necessary or desirable as a condition of or in connection with the issuance of Shares pursuant to the Options, the Options may not be exercised in whole or in part unless such listing, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Board of Directors.</font></div><div style="margin-top:10.95pt;padding-left:5pt;padding-right:11.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">12.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The grant of the Options shall not confer upon you any right to continue in the employ of your Employer nor limit in any way the right of your Employer to terminate your employment at any time. You shall have no rights as a shareholder of the Company with respect to any Shares issuable upon the exercise of the Options until the date of issuance of such Shares.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">13.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">You acknowledge and agree that the 2011 Plan is discretionary in nature and may be amended, cancelled, or terminated by the Company, in its sole discretion, at any time. The grant of the Options under the 2011 Plan is a one-time benefit and does not create any contractual or other right to receive a grant of Options or any other award under the 2011 Plan or other benefits in lieu thereof in the future. Future grants, if any, will be at the sole discretion of the Company, including, but not limited to, the form and timing of any grant, the number of Shares subject to the grant, the vesting provisions and the exercise price. Any amendment, modification or termination of the 2011 Plan shall not constitute a change or impairment of the terms and conditions of your employment with your Employer.</font></div><div style="margin-top:11.05pt;padding-left:5pt;padding-right:10.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">14.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">Your participation in the 2011 Plan is voluntary. The value of the Options and any other awards granted under the 2011 Plan is an extraordinary item of compensation outside the scope of your employment (and your employment contract, if any). Any grant under the 2011 Plan, including the grant of the Options, is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, holiday pay, long-service awards, pension, or retirement benefits or similar payments.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="margin-top:11.05pt;padding-left:5pt;padding-right:10.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">15.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The Options are granted solely by the Company.&#160; Your Employer and any other Subsidiary are not a party to these Terms and Conditions, and any rights you may have under these Terms and Conditions may be raised only against the Company (and may not be raised against your Employer or any other Subsidiary).</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:11.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">16.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">These Terms and Conditions shall bind and inure to the benefit of the Company, its successors and assigns and you and your estate in the event of your death.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.4pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">17.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The Options are Nonstatutory Stock Options and shall not be treated as Incentive Stock Options.</font></div><div style="margin-top:11.25pt;padding-left:5pt;padding-right:11.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">18.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The Company is located at 1941 Stryker Way, Portage, Michigan 49002, U.S.A. and grants Options under the 2011 Plan to employees of the Company and Subsidiaries in its sole discretion. In conjunction with the Company's grant of the Options under the 2011 Plan and its ongoing administration of such awards, the Company is providing the following information about its data collection, processing and transfer practices (&#34;Personal Data Activities&#34;). In accepting the grant of the Options, you expressly and explicitly consent to the Personal Data Activities as described herein.</font></div><div style="margin-top:11.25pt;padding-left:5pt;padding-right:11.55pt;text-align:justify;text-indent:71.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(1)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.01pt">The Company collects, processes and uses your personal data, including your name, home address, email address, and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all Options or any other equity compensation awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the Options under the 2011 Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan. The Company's legal basis for the collection, processing and usage of your personal data is your consent.</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:10.55pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(2)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.96pt">The Company transfers your personal data to the Stock Plan Administrator. In the future, the Company may select a different Stock Plan Administrator and share your personal data with another company that serves in a similar manner, </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">including, but not limited to, the Company's outside legal counsel as well as the Company&#8217;s auditor</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan. You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:11.75pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(3)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.96pt">The Company and the Stock Plan Administrator are based in the United States. You should note that your country of residence may have enacted data privacy laws that are different from the United States. The Company's legal basis for the transfer of your personal data to the United States is your consent.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:10.45pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(4)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.96pt">Your participation in the 2011 Plan and your grant of consent is purely voluntary. You may deny or withdraw your consent at any time. If you do not consent, or if you withdraw your consent, you may be unable to participate in the 2011 Plan. This would not affect your existing employment or salary&#59; instead, you merely may forfeit the opportunities associated with the 2011 Plan.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:10.45pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(5)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.96pt">You may have a number of rights under the data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country or residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of your personal data. To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company's Human Resources Department.</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:10.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">19.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The grant of the Options is not intended to be a public offering of securities in your country of residence (and country of employment, if different). The Company has not submitted any </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:10.55pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">registration statement, prospectus or other filing(s) with the local securities authorities (unless otherwise required under local law). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">No employee of the Company is permitted to advise you on whether you should purchase Shares under the 2011 Plan or provide you with any legal, tax or financial advice with respect to the grant or exercise of your Options. Investment in Shares involves a degree of risk. Before deciding to purchase Shares pursuant to the Options, you should carefully consider all risk factors and tax considerations relevant to the acquisition of Shares under the 2011 Plan or the disposition of them. Further, you should carefully review all of the materials related to the Options and the 2011 Plan, and you should consult with your personal legal, tax and financial advisors for professional advice in relation to your personal circumstances.</font></div><div style="margin-top:10.95pt;padding-left:5pt;padding-right:11.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">20.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">All questions concerning the construction, validity and interpretation of the Options and the 2011 Plan shall be governed and construed according to the laws of the state of Michigan, without regard to the application of the conflicts of laws provisions thereof. Any disputes regarding the Options or the 2011 Plan shall be brought only in the state or federal courts of the state of Michigan.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">21.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The Company may, in its sole discretion, decide to deliver any documents related to the Options or other awards granted to you under the 2011 Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the 2011 Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div style="margin-top:3.65pt;padding-left:5pt;padding-right:11.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">22.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The invalidity or unenforceability of any provision of the 2011 Plan or these Terms and Conditions shall not affect the validity or enforceability of any other provision of the 2011 Plan or these Terms and Conditions. </font></div><div style="margin-top:3.65pt;padding-left:5pt;padding-right:11.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">23.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">If you are resident outside of the United States, you acknowledge and agree that it is your express intent that these Terms and Conditions, the 2011 Plan and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the Options be drawn up in English. If you have received these Terms and Conditions, the 2011 Plan or any other documents related to the Options translated into a language other than English and the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:11.4pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">24.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">You acknowledge that, depending on your or your broker's country of residence or where the Shares are listed, you may be subject to insider trading restrictions and&#47;or market abuse laws which may affect your ability to accept, acquire, sell or otherwise dispose of Shares, rights to Shares (e.g., Options) or rights linked to the value of Shares during such times you are considered to have &#34;inside information&#34; regarding the Company as defined in the laws or regulations in your country of employment (and country of residence, if different). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before you possessed inside information. Furthermore, you could be prohibited from (i) disclosing the inside information to any third party (other than on a &#34;need to know&#34; basis) and (ii) &#34;tipping&#34; third parties or causing them otherwise to buy or sell securities. Third parties include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. You acknowledge that it is your responsibility to comply with any restrictions and are advised to speak to your personal advisor on this matter.</font></div><div style="margin-top:10.9pt;padding-left:5pt;padding-right:10.3pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">25.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">Notwithstanding any provisions of these Terms and Conditions to the contrary, the Options shall be subject to any special terms and conditions for your country of residence (and country of employment, if different) set forth in an addendum to these Terms and Conditions (an &#34;Addendum&#34;). Further, if you transfer your residence and&#47;or employment to another country reflected in an Addendum to these Terms and Conditions at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such special terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer). In all circumstances, any applicable Addendum shall constitute part of these Terms and Conditions.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="margin-top:10.95pt;padding-left:5pt;padding-right:11.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">26.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The Company reserves the right to impose other requirements on the Options, any Shares acquired pursuant to the Options and your participation in the 2011 Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan. Such requirements may include (but are not limited to) requiring you to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-top:3.65pt;padding-left:5pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">27.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;padding-left:17.27pt">This Section 27 applies only to those persons whom the Company's Recoupment Policy applies (the corporate officers elected by the Company's Board of Directors other than Assistant Controllers, Assistant Secretaries and Assistant Treasurers). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Notwithstanding any other provision of these Terms and Conditions to the contrary, you acknowledge and agree that your Options, any Shares acquired pursuant thereto and&#47;or any amount received with respect to any sale of such Shares are subject to potential cancellation, recoupment, rescission, payback or other action in accordance with the terms of the Company's Recoupment Policy as in effect on the date of grant (a copy of which has been furnished to you) and as the Recoupment Policy may be amended from time to time in order to comply with changes in laws, rules or regulations that are applicable to such Options and Shares. You agree and consent to the Company's application, implementation and enforcement of (a) the Recoupment Policy and (b) any provision of applicable law relating to cancellation, recoupment, rescission or payback of compensation and expressly agree that the Company may take such actions as are necessary to effectuate the Recoupment Policy (as applicable to you) or applicable law without further consent or action being required by you. For purposes of the foregoing, you expressly and explicitly authorize the Company to issue instructions, on your behalf, to </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">the Stock Plan Administrator and any other</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> brokerage firm and&#47;or third party administrator engaged by the Company to hold your Shares and other amounts acquired under the 2011 Plan to re-convey, transfer or otherwise return such Shares and&#47;or other amounts to the Company. In the case of a conflict between these Terms and Conditions and the Recoupment Policy, the terms of the Recoupment Policy shall prevail. </font></div><div style="margin-top:3.65pt;padding-left:5pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">28.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;padding-left:17.27pt">This Section 28 applies only to those persons whom the Company's clawback policy applies. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Notwithstanding anything in these Terms and Conditions to the contrary, the Options evidenced by these Terms and Conditions may be subject to (i) recoupment in accordance with or in order to comply with the terms and provisions of the Company's clawback policy, as may be in effect from time to time (including, but not limited to, the Mandatory Clawback Policy), to the extent such policies are applicable to you and (ii) any other compensation recovery policy adopted after the Options are granted to facilitate compliance with applicable law, including in response to the requirements of Section 10D of the Exchange Act, the U.S. Securities and Exchange Commission&#8217;s final rules thereunder, and any applicable listing rules or other rules and regulations implementing the foregoing. For purposes of the foregoing, you expressly and explicitly authorize the Company to issue instructions, on your behalf, to the Stock Plan Administrator and any other brokerage firm and&#47;or third party administrator engaged by the Company to hold your Shares and other amounts acquired under the 2011 Plan to re-convey, transfer or otherwise return such Shares and&#47;or other amounts to the Company.</font></div><div style="margin-top:11.05pt;padding-left:5pt;padding-right:11.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">29.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;padding-left:17.27pt">By accepting the grant of Options, you acknowledge that you have read these Terms and Conditions, the Addendum to these Terms and Conditions (as applicable) and the 2011 Plan and specifically accept and agree to the provisions therein.</font></div><div style="margin-top:11.2pt;padding-left:3.52pt;padding-right:3.52pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">***********************</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i31b2f1941d224240a3606878c70b1714_4"></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:3.65pt;padding-left:3.5pt;padding-right:3.5pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="margin-top:11.15pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ADDENDUM TO<br>TERMS AND CONDITIONS<br>RELATING TO RESTRICTED STOCK UNITS GRANTED<br>PURSUANT TO THE 2011 PLAN, AS AMENDED AND RESTATED</font></div><div style="margin-top:3.65pt;padding-left:3.5pt;padding-right:3.5pt;text-align:center"><font><br></font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:11.5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">In addition to the terms of the 2011 Plan and the Terms and Conditions, the Options are subject to the following additional terms and conditions (the &#34;Addendum&#34;). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">The information reflected in this Addendum is based on the securities, exchange control and other laws in effect in the respective countries as of November 2024. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">All capitalized terms as contained in this Addendum shall have the same meaning as set forth in the 2011 Plan and the Terms and Conditions. Pursuant to Section 25 of the Terms and Conditions, if you transfer your residence and&#47;or employment to another country reflected in an Addendum at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).</font></div><div style="margin-top:10.95pt;padding-left:5pt;padding-right:11.8pt;text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">Data Privacy Information&#58; European Union (&#34;EU&#34;) &#47; European Economic Area (&#34;EEA&#34;) &#47; Switzerland and the United Kingdom*</font></div><div style="margin-top:11.25pt;padding-left:5pt;padding-right:11.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:119%">*The below information is for data privacy purposes only and you should determine whether any other special terms and conditions apply to your awards in these jurisdictions.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. If you reside and&#47;or you are employed in the EU &#47; EEA, Switzerland or the United Kingdom the following provision replaces Section 18 of the Terms and Conditions&#58;</font></div><div style="margin-top:11.25pt;padding-left:5pt;padding-right:11.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">The Company is located at 1941 Stryker Way, Portage, Michigan 49002, U.S.A. and grants Options under the 2011 Plan to employees of the Company and its Subsidiaries in its sole discretion. You should review the following information about the Company's data processing practices.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:10.35pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(1)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.96pt;text-decoration:underline">Data Collection, Processing and Usage</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Pursuant to applicable data protection laws, you are hereby notified that the Company collects, processes and uses certain personally identifiable information about you for the legitimate interest of implementing, administering and managing the 2011 Plan and generally administering equity awards&#59; specifically, including your name, home address, email address and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all options or any other awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the Options under the 2011 Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan. The Company's collection, processing, use and transfer of your personal data is necessary for the performance of the Company's contractual obligations under </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:10.35pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">the 2011 Plan and pursuant to the Company's legitimate interest of managing and generally administering employee equity awards. Your refusal to provide personal data would make it impossible for the Company to perform its contractual obligations and may affect your ability to participate in the 2011 Plan. As such, by participating in the 2011 Plan, you voluntarily acknowledge the collection, processing and use of your personal data as described herein.</font></div><div style="margin-top:10.8pt;padding-left:5pt;padding-right:11.7pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(2)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.96pt;text-decoration:underline">Stock Plan Administration Service Provider</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The Company transfers participant data to the Stock Plan Administrator. In the future, the Company may select a different Stock Plan Administrator and share your data with another company that serves in a similar manner,</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> including, but not limited to, the Company's outside legal counsel as well as the Company&#8217;s auditor</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan. You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div style="margin-top:10.8pt;padding-left:5pt;padding-right:11.7pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(3)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.96pt;text-decoration:underline">International Data Transfers</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The Company and the Stock Plan Administrator are based in the United States. The Company can only meet its contractual obligations to you if your personal data is transferred to the United States. The Company's legal basis for the transfer of your personal data to the United States is to satisfy its contractual obligations to you and&#47;or its use of the standard data protection clauses adopted by the EU Commission.</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:11.45pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(4)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.96pt;text-decoration:underline">Data Retention</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The Company will use your personal data only as long as is necessary to implement, administer and manage your participation in the 2011 Plan or as required to comply with legal or regulatory obligations, including under tax and security laws. When the Company no longer needs your personal data, the Company will remove it from its systems. If the Company keeps your data longer, it would be to satisfy legal or regulatory obligations and the Company's legal basis would be for compliance with relevant laws or regulations.</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:11.55pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(5)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.96pt;text-decoration:underline">Data Subject Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You may have a number of rights under data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country of residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of your personal data. To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company's Human Resources Department.</font></div><div style="margin-top:11.1pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARGENTINA</font></div><div style="margin-top:11.6pt;padding-left:5pt;padding-right:11.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Neither the grant of the Options, nor the issuance of Shares subject to the exercise of the Options, constitutes a public offering in Argentina. The grant of Options pursuant to the 2011 Plan is a private placement and is not subject to any filing or disclosure requirements in Argentina.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. By accepting the Options, you acknowledge that you are proficient in reading and understanding English and fully understands the terms of the </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:11.5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">documents related to the Options (the Terms and Conditions, this Addendum and the 2011 Plan), which were provided in the English language. You accept the terms of these documents accordingly.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.3pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%;text-decoration:underline">Consentimiento ling&#252;&#237;stico.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%"> Al aceptar las Opciones, usted reconoce que domina la lectura y la comprensi&#243;n del ingl&#233;s y comprende plenamente los t&#233;rminos de los documentos relacionados con las Opciones (los T&#233;rminos y condiciones, este Anexo y el Plan 2011), que se proporcionaron en ingl&#233;s. Usted acepta los t&#233;rminos de estos documentos en consecuencia.</font></div><div style="margin-top:11.15pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AUSTRALIA</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:11.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Options Conditioned on Satisfaction of Regulatory Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. If you are (a) a director of a Subsidiary incorporated in Australia, or (b) a person who is a management-level executive of a Subsidiary incorporated in Australia and who also is a director of a Subsidiary incorporated outside of Australia, the grant of the Options is conditioned upon satisfaction of the shareholder approval provisions of section 200B of the Corporations Act 2001 (Cth) in Australia.</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:11.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The grant of Options is being made under Division 1A, Part 7.12 of the Corporations Act 2001 (Cth). Additional details and terms of the grant are set forth in the ESS Offer Document to Australian Resident Employees, which in included as Exhibit A to this Addendum. By accepting the Options, you acknowledge and confirm that you have reviewed the Australian ESS Offer Document. In the event of any inconsistency between the Terms and Conditions and the terms set forth in the ESS Offer Document, the terms in the ESS Offer Document will prevail.</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:11.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Tax Notification.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">The 2011 Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) applies (subject to conditions in the Act).</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:11.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Exchange control reporting is required for cash transactions exceeding AUD 10,000 and international fund transfers. The Australian bank assisting with the transaction will file the report. If there is no Australian bank involved in the transfer, you personally will be required to file the report. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.15pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AUSTRIA</font></div><div style="margin-top:11.8pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you hold Shares obtained under the 2011 Plan or cash (including proceeds from the sale of Shares) outside Austria, you may be required to submit quarterly reports to the Austrian National Bank. An exemption applies if the value of the Shares held outside Austria of any quarter does not exceed a certain threshold (currently &#8364;5,000,000). The deadline for filing the quarterly report is the 15th of the month following the end of the respective quarter.  When the Shares are sold, you may be required to comply with certain exchange control obligations if the cash proceeds from the sale is held outside Austria, as a separate reporting requirement applies to any non-Austrian cash accounts. If the transaction volume of all of your cash accounts abroad exceeds a certain threshold (currently &#8364;10,000,000), the movements and the balance of all accounts must be reported monthly, as of the last day of the </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:11.8pt;padding-left:6pt;padding-right:6.65pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">month, on or before the 15th day of the following month, on the prescribed forms.  The thresholds described above may be subject to change. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div><font><br></font></div><div style="margin-top:10.9pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BELGIUM</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.312%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.743%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:109%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:109%">Number of Shares&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:109%">Date of Grant&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:109%">Exercise Price&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:1.2pt"><font><br></font></div><div style="margin-top:1.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:11.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Acceptance of Options</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. For the Options to be subject to taxation at the time of grant, you must affirmatively accept the Options in writing within 60 days of the date of grant specified above by signing below and returning this original executed Addendum to&#58;</font></div><div style="margin-top:11.2pt;padding-left:166.8pt;padding-right:166.8pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Stock Plan Administration 1941 Stryker Way</font></div><div style="margin-top:2.2pt;padding-left:3.52pt;padding-right:3.52pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Portage, Michigan 49002 (U.S.A)</font></div><div style="margin-top:2.65pt;padding-left:5pt;padding-right:11.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">I hereby accept the &#91;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;text-decoration:underline"> ____ </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">&#93; (number) Options granted to me by the Company on the date of grant. I also acknowledge that I have been encouraged to discuss the acceptance of the Options and the applicable tax treatment with a financial and&#47;or tax advisor, and that my decision to accept the Options is made with full knowledge of the applicable consequences.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:11.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">If you are accepting the Options in writing within 60 days of the date of grant, you must select one of the alternatives below&#58;</font></div><div style="margin-top:10.5pt;padding-left:76.3pt;padding-right:5.25pt;text-indent:-18pt"><font style="font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%"></font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">I AGREE AND UNDERTAKE </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">that (1) I will not exercise the Options before the end of the third calendar year following the calendar year in which the date of grant falls, and (2) I will not transfer the Options under any circumstances during my lifetime so the Options are subject to a lower valuation for Belgium tax purposes pursuant to the article 43, &#167;6 of the Belgian law of 26 March 1999.</font></div><div style="margin-top:10.25pt;padding-left:76.3pt;padding-right:5.25pt;text-indent:-18pt"><font style="font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%"></font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;text-decoration:underline">I DO NO</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">T AGREE AND UNDERTAKE </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">that (1) I will not exercise the Options before the end of the third calendar year following the calendar year in which the date of grant falls, and (2) I will not transfer the Options under any circumstances during my lifetime so the Options are subject to a lower valuation for Belgium tax purposes pursuant to the article 43, &#167;6 of the Belgian law of 26 March 1999.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.506%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"><div style="padding-left:7.77pt;padding-right:2.77pt;text-align:justify;text-indent:35.3pt"><font><br></font></div></td></tr><tr style="height:19pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"><div style="padding-left:7.77pt;padding-right:2.77pt;text-align:justify;text-indent:35.3pt"><font><br></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="padding-left:7.77pt;padding-right:2.77pt;text-align:justify;text-indent:35.3pt"><font><br></font></div></td></tr></table></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Employee Signature&#58;</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:9.8pt;padding-left:5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Employee Printed Name&#58;</font></div><div style="margin-top:9.75pt;padding-left:5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date of Acceptance&#58;</font></div><div><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If you fail to affirmatively accept the Options in writing within 60 days of the date of grant, the Options will not be subject to taxation at the time of grant but instead will be subject to taxation on the date you exercise the Options (or such other treatment as may apply under Belgian tax law at the time of exercise).</font></div><div style="margin-top:11.45pt;padding-left:5pt;padding-right:11.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Belgian residents are required to report any security (e.g, Shares acquired under the 2011 Plan) or bank account established outside of Belgium on their personal annual tax return. In a separate report, Belgian residents also are required to provide a central contact point of the National Bank of Belgium with the account number of those foreign bank accounts, the name of the bank with which the accounts were opened and the country in which they were opened in a separate report. This report, as well as additional information on how to complete it, can be found on the website of the National Bank of Belgium, </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.nbb.be</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, under the </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Kredietcentrales &#47; Centrales des credits </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">caption. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:11.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.36pt;text-decoration:underline">Stock Exchange Tax Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. A stock exchange tax applies to transactions executed by Belgian residents through a non-Belgian financial intermediary, such as a U.S. broker. The stock exchange tax will apply when Shares acquired pursuant to the Options are sold. You should consult with a personal tax or financial advisor for additional details on your obligations with respect to the stock exchange tax.</font></div><div style="margin-top:11.5pt;padding-left:5pt;padding-right:10.25pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.36pt;text-decoration:underline">Annual Securities Account Tax</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. An annual securities accounts tax may be payable if the total value of securities held in a Belgian or foreign securities account (e.g., Shares acquired under the 2011 Plan) exceeds a certain threshold on four reference dates within the relevant reporting period (i.e., December 31, March 31, June 30 and September 30). In such case, the tax will be due on the value of the qualifying securities held in such account. You should consult with a personal tax or financial advisor for additional details on your obligations with respect to the annual securities account tax.</font></div><div><font><br></font></div><div style="margin-top:11.35pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BRAZIL</font></div><div style="margin-top:11.6pt;padding-left:5pt;padding-right:11.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Labor Law Acknowledgment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. By accepting the Options, you acknowledge and agree, for all legal purposes, that (a) the benefits provided under the Terms and Conditions and the 2011 Plan are the result of commercial transactions unrelated to your employment&#59; (b) the Terms and Conditions and the 2011 Plan are not a part of the terms and conditions of your employment&#59; and (c) the income from the Options, if any, is not part of your remuneration from employment.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:11.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. By accepting the Options, you acknowledge and agree to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:11.55pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">the exercise of the Options, the issuance and&#47;or sale of Shares acquired under the 2011 Plan and the receipt of any dividends.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:10.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. If you are resident or domiciled in Brazil, you will be required to submit an annual declaration of assets and rights held outside of Brazil to the Central Bank of Brazil if the aggregate value of such assets and rights is greater than USD1 million as of December 31 of each year. If the aggregate value exceeds USD100 million as of the end of each quarter, a declaration must be submitted quarterly. Assets and rights that must be reported include Shares acquired under the 2011 Plan. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.05pt;padding-left:5pt;padding-right:11.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Tax on Financial Transaction (IOF)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Repatriation of funds (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">e.g.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, the proceeds from the sale of Shares) into Brazil and the conversion of USD into BRL associated with such fund transfers may be subject to the Tax on Financial Transactions. It is your responsibility to comply with any applicable Tax on Financial Transactions arising from your participation in the 2011 Plan. You should consult with your personal tax advisor for additional details.</font></div><div style="margin-top:11.15pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">COLOMBIA</font></div><div style="margin-top:3.65pt;padding-left:5pt;padding-right:10.35pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. In addition to the provisions of Section 14 of the Terms and Conditions you acknowledge that, pursuant to Article 128 of the Colombian Labor Code, the 2011 Plan and related benefits do not constitute a component of your &#34;salary&#34; for any legal purpose. Therefore, they will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as legal&#47;fringe benefits, vacations, indemnities, payroll taxes, social insurance contributions and&#47;or any other labor-related amount which may be payable.  </font></div><div style="margin-top:3.65pt;padding-left:5pt;padding-right:10.35pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The Shares subject to the Options are not and will not be registered in the Colombian registry of publicly traded securities (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">Registro Nacional de Valores y Emisores</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">) and therefore the Shares may not be offered to the public in Colombia. Nothing in this document should be construed as the making of a public offer of securities in Colombia.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Investments in assets located outside Colombia (including Shares) are subject to registration with the Central Bank (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">Banco de la Rep&#250;blica</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">), as foreign investments held abroad, regardless of value. In addition, all payments related to the liquidation of such investments must be transferred through the Colombian foreign exchange market (e.g. local banks), which includes the obligation of correctly completing and filing the appropriate foreign exchange form (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">declaraci&#243;n de cambio</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">). You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.05pt;padding-left:5pt;padding-right:11.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. An annual informative return must be filed with the Colombian Tax Office detailing any assets held abroad (including the Shares acquired under the 2011 Plan). If the individual value of any of these assets exceeds a certain threshold, each asset must be described (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">e.g., </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">its nature and its value) and the jurisdiction in which it is located must be disclosed. You acknowledge that you personally are responsible for complying with this tax reporting requirement. You should consult with your </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:11.05pt;padding-left:5pt;padding-right:11.55pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.1pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">COSTA RICA</font></div><div style="margin-top:11.6pt;padding-left:5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No country specific provisions.</font></div><div style="margin-top:11.65pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">DENMARK</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:11.55pt;text-align:justify;text-indent:35.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.16pt;text-decoration:underline">Treatment of Options upon Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Notwithstanding any provision in the Terms and Conditions or the 2011 Plan to the contrary, unless you are a member of registered management who is not considered a salaried employee, the treatment of the Options upon a termination of employment which is not a result of death shall be governed by Sections 4 and 5 of the Danish Act on Stock Option in Employment Relations </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(the &#34;Act&#34;). You acknowledge any grant of Options under the 2011 Plan is subject to the rules of such amended Act. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">However, if the provisions in the Terms and Conditions or the 2011 Plan governing the treatment of the Options upon a termination of employment are more favorable, then the provisions of the Terms and Conditions or the 2011 Plan will govern, as set forth in the Employer Statement, included as Exhibit B to this Addendum, and which is being provided to comply with the Act.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:11.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Danish residents who establish an account holding Shares or an account holding cash outside Denmark must report the account to the Danish Tax Administration as part of their annual tax return under the section related to foreign affairs and income. The form which should be used in this respect can be obtained from a local bank. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.1pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FINLAND</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Withholding of Tax-Related Items</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Notwithstanding anything in Section 5 of the Terms and Conditions to the contrary, if you are a local national of Finland, any Tax-Related Items shall be withheld only in cash from your regular salary&#47;wages or other amounts payable to you in cash or such other withholding methods as may be permitted under the 2011 Plan and allowed under local law.</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Finland has not adopted any specific reporting requirements with respect to foreign assets&#47;accounts. However, you should check your pre-completed tax return to confirm that the ownership of Shares and other securities (foreign or domestic) are correctly reported. If you find any errors or omissions, you must make the necessary corrections electronically or by sending specific paper forms to the local tax authorities. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div><font><br></font></div><div style="margin-top:11.65pt;padding-left:5pt"><font><br></font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:11.15pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FRANCE</font></div><div style="margin-top:11.6pt;padding-left:5pt;padding-right:11.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Non-Qualified Nature of Options</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The Award granted pursuant to the Terms and Conditions is not intended to be &#8220;French-qualified&#8221; and is ineligible for specific tax and&#47;or social security treatment in France under Sections L. 225-197-1 to L. 225-197-5 and Sections L. 22-10-59 to L. 22-10-60 of the French Commercial Code, as amended.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The value of any cash or securities imported to or exported from France without the use of a financial institution must be reported to the customs and excise authorities when the value of such cash or securities is equal to or greater than a certain amount (currently &#8364;10,000). You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:10.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. French residents must report annually any shares and bank accounts held outside France, including the accounts that were opened, used and&#47;or closed during the tax year, to the French tax authorities, on an annual basis on a special Form N&#176; 3916, together with your personal income tax return. Failure to report triggers a significant penalty. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:10.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Use of English Language</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. By accepting the Options, you acknowledge and agree that it is your express wish that the Terms and Conditions, this Addendum, as well as all other documents, notices and legal proceedings entered into, given or instituted pursuant to your Options, either directly or indirectly, be drawn up in English.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;text-decoration:underline">Langue anglaise</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">. En acceptant l'allocation de votre Option, vous reconnaissez et acceptez avoir souhait&#233; que le Termes et Conditions, le pr&#233;sent avenant, ainsi que tous autres documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaires intent&#233;es, relatifs, directement ou indirectement, &#224; l'allocation de votre Option, soient r&#233;dig&#233;s en anglais.</font></div><div style="margin-top:11.15pt;padding-left:5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:11.25pt;padding-left:5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2025 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.428%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Signature</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Name (Printed)</font></div></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Date</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr></table></div><div><font><br></font></div><div style="margin-top:2.15pt"><font><br></font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:11.05pt;padding-left:5pt;text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GERMANY</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Exchange Control Information.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> Cross-border payments in excess of &#8364;12,500 in connection with</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> 2011 Plan (e.g., proceeds from the </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">sale of Shares acquired under the 2011 Plan)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> and&#47;or if the Company withholds or sells Shares with a value in excess of EUR 12,500 for any Tax-Related Items, </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> must be reported to the German Federal Bank (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">Bundesbank</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">) by the fifth day of the month following the month in which the payment is received or made. If you acquire Shares with a value in excess of &#8364;12,500, the Employer will report the acquisition of such Shares to the German Federal Bank. If you otherwise make or receive a payment in excess of &#8364;12,500, you personally must report the payment to Bundesbank electronically using the &#8220;General Statistics Reporting Portal&#8221; (&#8220;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">Allgemeines Meldeportal Statistik</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">&#8221;) available via Bundesbank&#8217;s website (</font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;text-decoration:underline">www.bundesbank.de</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">). You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the</font></div><div style="margin-top:3.65pt;padding-left:5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Plan.</font></div><div style="margin-top:11.65pt;padding-left:74.7pt;text-align:justify;text-indent:-34.4pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.06pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. German residents must notify their </font></div><div style="margin-top:0.35pt;padding-left:5pt;padding-right:11.7pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">local tax office of the acquisition of Shares when they file their personal income tax returns for the relevant year if the value of the Shares acquired exceeds &#8364;150,000 or in the unlikely event that the resident holds Shares exceeding 10% of the Company&#8217;s total Shares outstanding. However, if the Shares are listed on a recognized U.S. stock exchange and you own less than 1% of the total Shares, this requirement will not apply even if Shares with a value exceeding &#8364;150,000 are acquired. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.05pt;padding-left:5pt;text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">HONG KONG</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:11.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Important Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Warning&#58; The contents of the Terms and Conditions, this Addendum, the 2011 Plan, and all other materials pertaining to the Options and&#47;or the 2011 Plan have not been reviewed by any regulatory authority in Hong Kong. You are hereby advised to exercise caution in relation to the offer thereunder. If you have any doubts about any of the contents of the aforesaid materials, you should obtain independent professional advice.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:11.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. If, for any reason, Shares are issued to you within six (6) months of the grant date, you agree that you will not sell or otherwise dispose of any such Shares prior to the six-month anniversary of the grant date.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:11.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Notwithstanding anything to the contrary in this Addendum, the Terms and Conditions or the 2011 Plan, the Options shall be settled only in Shares (and may not be settled in cash).</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Nature of the Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The Company specifically intends that the 2011 Plan will not be treated as an occupational retirement scheme for purposes of the Occupational Retirement Schemes Ordinance (&#34;ORSO&#34;). To the extent any court, tribunal or legal&#47;regulatory body in Hong Kong determines that the 2011 Plan constitutes an occupational retirement scheme for the purposes of ORSO, the grant of the Options shall be null and void.</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:11.15pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">INDIA</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Tax Collection at Source</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. If you remit funds from India to pay the exercise price, you may be subject to Tax Collection at Source (&#8220;TCS&#8221;) if your annual remittances out of India exceed a certain amount (currently INR 700,000). You may be required to provide a declaration to the bank remitting the funds to determine if the TCS limit has been reached. If deemed necessary to comply with applicable laws, the Company may require you to pay for the Shares purchased on exercise, and any Tax-Related Items through a cashless exercise or net exercise method. The Company reserves the right to prescribe alternative methods of payment depending on the development of local laws.</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Any funds realized in connection with the 2011 Plan (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">e.g.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, proceeds from the sale of Shares and cash dividends paid on the Shares) must be repatriated to India within a specified period of time after receipt as prescribed under Indian exchange control laws.  You are personally responsible for obtaining a foreign inward remittance certificate (&#8220;FIRC&#8221;) from the bank where you deposit the foreign currency and holding the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India or your Employer requests proof of repatriation.  You are personally responsible for complying with exchange control laws in India, and neither the Company nor your Employer will be liable for any fines or penalties resulting from your failure to comply with applicable laws.  You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You are required to declare your foreign bank accounts and any foreign financial assets (including Shares acquired under the 2011 Plan held outside India) in your annual tax return. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.1pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">IRELAND</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:10.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Director Notification Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. If you are a director, shadow director or secretary of an Irish subsidiary whose interest in the Company represents more than 1% of the Company&#8217;s voting share capital, you are required to notify such Irish subsidiary in writing within a certain time period. upon the acquisition of the Options or any Shares issued pursuant to the Options. This notification requirement also applies with</font></div><div style="margin-top:3.65pt;padding-left:5pt;padding-right:5.25pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">respect to the interests in the Company of your spouse or children under the age of 18 (whose interests will be attributed to you in your capacity as a director, shadow director or secretary of the Irish subsidiary).</font></div><div style="margin-top:11.25pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ITALY</font></div><div style="margin-top:11.8pt;padding-left:5pt;padding-right:11.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Italian residents who, at any time during the fiscal year, hold foreign financial assets (including cash and Shares) which may generate income taxable in Italy are required to report these assets on their annual tax returns (UNICO Form, RW Schedule) for the year during which the assets are held, or on a special form if no tax return is due. These reporting obligations will also apply to Italian residents who are the beneficial owners of foreign financial assets under Italian money laundering provisions. You </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:11.8pt;padding-left:5pt;padding-right:11.55pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:11.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.36pt;text-decoration:underline">Foreign Asset Tax</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The value of any Shares (and other financial assets) held outside Italy by individuals resident of Italy may be subject to a foreign asset tax. The taxable amount will be the fair market value of the financial assets (e.g., Shares) assessed at the end of the calendar year. The value of financial assets held abroad must be reported in Form RM of the annual return. You should consult your personal tax advisor for additional information on the foreign asset tax.</font></div><div style="margin-top:11.3pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">JAPAN</font></div><div style="margin-top:11.85pt;padding-left:5pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you acquire Shares valued at more than &#165;100,000,000 in a single transaction, you must file a Securities Acquisition Report with the Ministry of Finance through the Bank of Japan within 20 days of the purchase of the Shares. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.5pt;padding-left:5pt;padding-right:11.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You will be required to report details of any assets held outside Japan as of December 31st to the extent such assets have a total net fair market value exceeding &#165;50,000,000. This report is due by March 15 each year. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div><font><br></font></div><div style="margin-top:11.3pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MEXICO</font></div><div style="margin-top:11.6pt;padding-left:5pt;padding-right:11.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Commercial Relationship</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You expressly recognize that your participation in the 2011 Plan and the Company's grant of the Options does not constitute an employment relationship between you and the Company. You have been granted the Options as a consequence of the commercial relationship between the Company and the Subsidiary in Mexico that employs you, and the Company's Subsidiary in Mexico is your sole employer. Based on the foregoing, (a) you expressly recognize the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan do not establish any rights between you and the Company's Subsidiary in Mexico that employs you, (b) the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan are not part of the employment conditions and&#47;or benefits provided by the Company's Subsidiary in Mexico that employs you, and (c) any modification or amendment of the 2011 Plan by the Company, or a termination of the 2011 Plan by the Company, shall not constitute a change or impairment of the terms and conditions of your employment with the Company's Subsidiary in Mexico that employs you.</font></div><div style="margin-top:10.95pt;padding-left:5pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You expressly recognize and acknowledge that the Company's grant of the Options and the underlying Shares under the 2011 Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico. In addition, the 2011 Plan, the Terms and Conditions and any other document relating to the Options may not be publicly distributed in Mexico. These materials are addressed to you only because of your existing relationship with the Company and these materials should not be reproduced or copied </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:10.95pt;padding-left:5pt;padding-right:11.5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">in any form. The offer contained in these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of the Employer in Mexico made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.</font></div><div style="margin-top:3.65pt;padding-left:5pt;padding-right:11.35pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Extraordinary Item of Compensation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You expressly recognize and acknowledge that your participation in the 2011 Plan is a result of the discretionary and unilateral decision of the Company, as well as your free and voluntary decision to participate in the 2011 Plan in accord with the terms and conditions of the 2011 Plan, the Terms and Conditions, and this Addendum. As such, you acknowledge and agree that the Company may, in its sole discretion, amend and&#47;or discontinue your participation in the 2011 Plan at any time and without any liability. The value of the Options is an extraordinary item of compensation outside the scope of your employment contract, if any. The Options are not part of your regular or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits, or any similar payments, which are the exclusive obligations of the Company's Subsidiary in Mexico that employs you.</font></div><div style="margin-top:11pt;padding-left:5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:11.25pt;padding-left:5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2025 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">.</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.428%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Signature</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Name (Printed)</font></div></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Date</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="margin-top:2.2pt"><font><br></font></div><div><font><br></font></div><div style="padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NETHERLANDS</font></div><div style="margin-top:11.6pt;padding-left:5pt;padding-right:11.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Waiver of Termination Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. As a condition to the grant of the Options, you hereby waive any and all rights to compensation or damages as a result of the termination of your employment with the Company and your Employer for any reason whatsoever, insofar as those rights result or may result from</font></div><div style="padding-left:5pt;padding-right:11.45pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(a) the loss or diminution in value of such rights or entitlements under the 2011 Plan, or (b) you ceasing to have rights under or ceasing to be entitled to any awards under the 2011 Plan as a result of such termination.</font></div><div style="margin-top:11.15pt;padding-left:5.05pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NEW ZEALAND</font></div><div style="margin-top:11.6pt;padding-left:5.05pt;padding-right:10.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.31pt;text-decoration:underline">WARNING</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You are being offered Options in Stryker Corporation. If the Company runs into financial difficulties and is wound up, you may lose some or all your investment. New Zealand law normally requires people who offer financial products to give information to </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:11.6pt;padding-left:5.05pt;padding-right:10.6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">investors before they invest. This requires those offering financial products to have disclosed information that is important for investors to make an informed decision. The usual rules do not apply to this offer because it is an offer made under the Employee Share Scheme exemption. As a result, you may not be given all the information usually required. You will also have fewer other legal protections for this investment. You should ask questions, read all documents carefully, and seek independent financial advice before accepting the offer. The Company's Shares are currently traded on the New York Stock Exchange under the ticker symbol &#34;SYK&#34; and Shares acquired under the 2011 Plan may be sold through this exchange. You may end up selling the Shares at a price that is lower than the value of the Shares when you acquired them. The price will depend on the demand for the Company's Shares. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">The Company's most recent annual report (which includes the Company's financial statements) is available at </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%;text-decoration:underline">https&#58;&#47;&#47;investors.stryker.com&#47;financial-information&#47;annual-reports&#47;default.aspx</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">You are entitled to receive a copy of this report, free of charge, upon written request to the Company at </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">.</font></div><div style="margin-top:10.85pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">POLAND</font></div><div style="margin-top:11.85pt;padding-left:5pt;padding-right:11.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you maintain bank or brokerage accounts holding cash and foreign securities (including Shares) outside of Poland, you will be required to report information to the National Bank of Poland on transactions and balances in such accounts if the value of such cash and securities exceeds PLN 7 million. If required, such reports must be filed on special forms available on the website of the National Bank of Poland. Further, any transfer of funds in excess of a certain threshold (generally, EUR 15,000) into or out of Poland must be effected through a bank account in Poland. Finally, you are required to store all documents connected with any foreign exchange transactions that you engage in for a period of five years, as measured from the end of the year in which such transaction occurred. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.55pt;padding-left:5pt;padding-right:11.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Polish residents holding foreign securities (e.g., Shares) and&#47;or maintaining accounts abroad are obligated to file quarterly reports with the National Bank of Poland incorporating information on transactions and balances of the securities and cash deposited in such accounts if the value of such securities and cash (when combined with all other assets held abroad) exceeds PLN 7,000,000. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.4pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PORTUGAL</font></div><div style="margin-top:11.65pt;padding-left:5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No country specific provisions.</font></div><div style="margin-top:11.6pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PUERTO RICO</font></div><div style="margin-top:11.65pt;padding-left:5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No country specific provisions.</font></div><div style="margin-top:11.6pt;padding-left:5pt"><font><br></font></div><div style="margin-top:11.15pt;padding-left:5pt"><font><br></font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:11.15pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ROMANIA</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:11.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You are not required to seek special authorization from the National Bank of Romania in order to open or maintain a foreign bank account. However, if you remit foreign currency into Romania (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">e.g.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, proceeds from the sale of Shares), you may be required to provide the Romanian bank through which the foreign currency is transferred with appropriate documentation. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.1pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SINGAPORE</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:11.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Qualifying Person Exemption</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The following provision shall replace Section 18 of the Terms and Conditions&#58;</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:10.45pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">The grant of the Options under the 2011 Plan is being made pursuant to the &#34;Qualifying Person&#34; exemption&#34; under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (&#34;SFA&#34;). The 2011 Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore. You should note that, as a result, the Options are subject to section 257 of the SFA and you will not be able to make (a) any subsequent sale of the Shares in Singapore or (ii) any offer of such subsequent sale of the Shares subject to the Options in Singapore, unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA (Chapter 289, 2006 Ed.).</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Director Reporting Notification</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. If you are a director, associate director or shadow director of a Singapore company, you are subject to certain notification requirements under the Singapore Companies Act. Among these requirements is an obligation to notify the Singapore company in writing when you receive an interest (e.g., Options or Shares) in the Company or any related company. In addition, you must notify the Singapore company when you sell Shares (including when you sell Shares acquired upon exercise of the Options). These notifications must be made within two business days of acquiring or disposing of any interest in the Company or any related company. In addition, a notification must be made of your interests in the Company or any related company within two business days of becoming a director.</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Insider Trading Notice</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You acknowledge that you should be aware of the Singapore insider-trading rules, which may impact your ability to acquire or dispose of Shares.  Under the Singapore insider-trading rules, you are prohibited from selling Shares when you are in possession of information concerning the Company which is not generally available and which you know or should know will have a material effect on the price of such Shares once such information is generally available.</font></div><div style="margin-top:11.05pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SOUTH AFRICA</font></div><div style="margin-top:11.6pt;padding-left:5pt;padding-right:10.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. In addition to the provisions of Section 7 of the Terms and Conditions, you agree to notify your Employer in South Africa of the amount of any gain realized upon exercise of the Options. If you fail to advise your Employer of the gain realized upon exercise, you may be liable for a fine. You will be responsible for paying any difference between the actual tax liability and the amount withheld.</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:3.65pt;padding-left:5pt;padding-right:11.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Exchange Control Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You are solely responsible for complying with applicable exchange control regulations and rulings (the &#34;Exchange Control Regulations&#34;) in South Africa. As the Exchange Control Regulations change frequently and without notice, you should consult your legal advisor prior to the acquisition or sale of Shares under the 2011 Plan to ensure compliance with current Exchange Control Regulations. Neither the Company nor any of its Subsidiaries will be liable for any fines or penalties resulting from your failure to comply with applicable laws. </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:11.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Securities Law Information and Deemed Acceptance of Options</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Neither the Options nor the underlying Shares shall be publicly offered or listed on any stock exchange in South Africa. The offer is intended to be private pursuant to Section 96 of the Companies Act and is not subject to the supervision of any South African governmental authority. Pursuant to Section 96 of the Companies Act, the Options offer must be finalized on or before the 60th day following the grant date. If you do not want to accept the Options, you are required to decline the Options no later than the 60th day following the grant date. If you do not reject the Options on or before the 60th day following the grant date, you will be deemed to accept the Options.</font></div><div style="margin-top:11pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SOUTH KOREA</font></div><div style="margin-top:10.95pt;padding-left:5pt;padding-right:10.55pt;text-align:justify;text-indent:35.29pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.37pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Korean residents who sell Shares acquired under the 2011 Plan and&#47;or receive cash dividends on the Shares may have to file a report with a Korean foreign exchange bank, provided the proceeds are in excess of USD5,000 (per transaction) and deposited into a non-Korean bank account. A report may not be required if proceeds are deposited into a non-Korean brokerage account. It is your responsibility to ensure compliance with any applicable exchange control reporting obligations.  You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:11.6pt;text-align:justify;text-indent:35.29pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.37pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Korean residents must declare all foreign financial accounts (e.g., non-Korean bank accounts, brokerage accounts) to the Korean tax authority and file a report with respect to such accounts in June of the following year if the monthly balance of such accounts exceeds KRW 500 million (or an equivalent amount in foreign currency) on any month-end date during a calendar year. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div><font><br></font></div><div style="margin-top:11.15pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SPAIN</font></div><div style="margin-top:3.65pt;padding-left:5pt;padding-right:11.65pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.66pt;text-decoration:underline">Acknowledgement of Discretionary Nature of the 2011 Plan&#59; No Vested Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. In accepting the Options, you acknowledge that you consent to participation in the 2011 Plan and have received a copy of the 2011 Plan. You understand that the Company has unilaterally, gratuitously and in its sole discretion granted Options under the 2011 Plan to individuals who may be employees of the Company or its Subsidiaries throughout the world. The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Company or any of its Subsidiaries on an ongoing basis. Consequently, you understand that the Options are granted on the assumption and condition that the Options and the Shares acquired upon exercise of the Options shall not become a part of any employment contract (either with the Company or any of its Subsidiaries) </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:3.65pt;padding-left:5pt;padding-right:11.65pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever. In addition, you understand that this grant would not be made to you but for the assumptions and conditions referenced above. Thus, you acknowledge and freely accept that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, the Options shall be null and void.  You understand and agree that, as a condition of the grant of the Options, any unvested Options as of the date you cease active employment and any vested portion of the Options not exercised within the post- termination exercise period set out in the Terms and Conditions will be forfeited without entitlement to the underlying Shares or to any amount of indemnification in the event of the termination of employment by reason of, but not limited to, (i) material modification of the terms of employment under Article 41 of the Workers' Statute or (ii) relocation under Article 40 of the Workers' Statute. You acknowledge that you have read and specifically accept the conditions referred to in the Terms and Conditions regarding the impact of a termination of employment on your Options.</font></div><div style="margin-top:11.05pt;padding-left:5pt;padding-right:10.35pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. If you hold 10% or more of the Share capital of the Company or such other amount that would entitle you to join the Company's board of directors, the acquisition, ownership and disposition of such Shares must be declared for statistical purposes to the </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">Spanish Direcci&#243;n General de Comercio e Inversiones </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(the Bureau for Commerce and Investments), which is a department of the Ministry of Economy and Competitiveness. The declaration (via Form 6) must be made in January for Shares acquired or disposed of during the prior calendar year and&#47;or for Shares owned as of December 31 of the prior calendar year&#59; provided, if the value of the Shares acquired or sold exceeds &#8364;1,502,530, the declaration must be filed within one month of the acquisition or disposition of the Shares, as applicable. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11pt;padding-left:5pt;padding-right:10.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. To the extent you hold rights or assets (e.g., cash or the Shares held in a bank or brokerage account) outside of Spain with a value in excess of &#8364;50,000 per type of right or asset as of December 31 each year (or at any time during the year in which you sell or dispose of such right or asset), you are required to report information on such rights and assets on your tax return for such year. After such rights or assets are initially reported, the reporting obligation will only apply for subsequent years if the value of any previously-reported rights or assets increases by more than &#8364;20,000 per type of right or asset as of each subsequent December 31, or if you sell Shares or cancel bank accounts that were previously reported. Failure to comply with this reporting requirement may result in penalties to the Spanish residents. In addition, you may be required to electronically declare to the Bank of Spain any foreign accounts (including brokerage accounts held abroad), any foreign instruments (including Shares acquired under the 2011 Plan), and any transactions with non-Spanish residents (including any payments of Shares made pursuant to the 2011 Plan), depending on the balances in such accounts together with the value of such instruments as of December 31 of the relevant year, or the volume of transactions with non-Spanish residents during the relevant year. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:10.85pt;padding-left:5pt;padding-right:11.85pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.65pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2025 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.65pt;text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.428%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Signature</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Name (Printed)</font></div></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Date</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="margin-top:10.6pt"><font><br></font></div><div><font><br></font></div><div style="padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SWEDEN</font></div><div style="margin-top:12pt;padding-left:5.05pt;padding-right:11.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.31pt;text-decoration:underline">Exercise by Cash Payment Only</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything in Section 4 of the Terms and Conditions to the contrary, if you are a local national of Sweden, you may exercise the Options only by means of a cash payment or such other methods as may be permitted under the 2011 Plan and allowed under local law.</font></div><div style="margin-top:12pt;padding-left:5.05pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.31pt;text-decoration:underline">Withholding of Tax-Related Items</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything in the Terms and Conditions to the contrary, if you are a local national of Sweden, any Tax-Related Items shall be withheld only in cash from your regular salary&#47;wages or other amounts payable to you in cash, or such other withholding methods as may be permitted under the 2011 Plan and allowed under local law. Additionally, the Company and&#47;or the Employer may withhold Tax-Related Items from salary in an amount up to the statutory maximum withholding limitations, however, the Company and&#47;or your Employer will not withhold amounts in excess of your statutory maximum withholding limitations.</font></div><div style="margin-top:11.1pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SWITZERLAND</font></div><div style="margin-top:11.6pt;padding-left:5pt;padding-right:10.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Neither this document nor any other materials relating to the Options (a) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (&#34;FinSA&#34;) (b) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an employee of the Company or (c) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority (&#34;FINMA&#34;).</font></div><div style="margin-top:11.15pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TAIWAN</font></div><div style="margin-top:11.6pt;padding-left:5pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Securities Law Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The offer of participation in the 2011 Plan is available only for employees of the Company and its Subsidiaries. The offer of participation in the 2011 Plan is not a public offer of securities by a Taiwanese company.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.4pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You may acquire and remit foreign currency (including proceeds from the sale of Shares acquired under the 2011 Plan) into Taiwan up to USD5,000,000 per year without justification. If the transaction amount is TWD$500,000 or more in a single transaction, you must submit a Foreign Exchange Transaction Form and also provide </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.4pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">supporting documentation to the satisfaction of the remitting bank. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.1pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">T&#220;RKIYE</font></div><div style="margin-top:11.6pt;padding-left:5pt;padding-right:11.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Under Turkish law, you are not permitted to sell any Shares acquired under the 2011 Plan within Turkey. The Shares are currently traded on the New York Stock Exchange, which is located outside of Turkey, under the ticker symbol &#34;SYK&#34; and the Shares may be sold through this exchange.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:11.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Financial Intermediary Obligation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You acknowledge that any activity related to investments in foreign securities (e.g., the sale of Shares) should be conducted through a bank or financial intermediary institution licensed by the Turkey Capital Markets Board and should be reported to the Turkish Capital Markets Board. You solely are responsible for complying with this requirement and should consult with a personal legal advisor for further information regarding any obligations in this respect.</font></div><div style="margin-top:11.15pt;padding-left:5.05pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED ARAB EMIRATES</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:10.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The offer of the Options is available only for select Employees of the Company and its Subsidiaries and is in the nature of providing incentives in the United Arab Emirates. The 2011 Plan and the Terms and Conditions are intended for distribution only to such individuals and must not be delivered to, or relied on by any other person. Prospective purchasers of securities should conduct their own due diligence.</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:11.6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with this statement, including the 2011 Plan and the Terms and Conditions, or any other incidental communication materials distributed in connection with the Options. Further, neither the Ministry of Economy nor the Dubai Department of Economic Development has approved this statement nor taken steps to verify the information set out in it, and has no responsibility for it. Residents of the United Arab Emirates who have any questions regarding the contents of the 2011 Plan and the Terms and Conditions should obtain independent advice.</font></div><div style="margin-top:12pt;padding-left:5.05pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED KINGDOM</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:11.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">No Exercise by Using Existing Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Notwithstanding anything in Section 4 of the Terms and Conditions to the contrary, if you are resident in the United Kingdom, you shall not be permitted to use existing Shares for exercising the Options and paying the Exercise Price.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Income Tax and Social Insurance Contribution Withholding</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The following provision shall supplement Section 7 of the Terms and Conditions&#58;</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Without limitation to Section 7 of the Terms and Conditions, you agree that you are liable for all Tax- Related Items and hereby covenant to pay all such Tax-Related Items, as and when requested by the Company, your Employer or by HM Revenue and Customs (&#34;HMRC&#34;) (or any other tax authority or any other relevant authority). You also agree to indemnify and keep indemnified the Company and your Employer against any Tax-Related Items that they are </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:11.5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">required to pay or withhold or have paid or will pay to HMRC on your behalf (or any other tax authority or any other relevant authority).</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:10.35pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Exclusion of Claim</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You acknowledge and agree that you will have no entitlement to compensation or damages in consequence of the termination of your employment with the Company and the Subsidiary that employs you for any reason whatsoever and whether or not in breach of contract, insofar as any purported claim to such entitlement arises or may arise from your ceasing to have rights under or to be entitled to exercise the Options as a result of such termination of employment (whether the termination is in breach of contract or otherwise), or from the loss or diminution in value of the Options. Upon the grant of the Options, you shall be deemed irrevocably to have waived any such entitlement.</font></div><div style="margin-top:11.1pt;padding-left:3.52pt;padding-right:3.52pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">****************************</font></div><div><font><br></font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.52pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:11.05pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT A</font></div><div style="padding-right:48pt"><font><br></font></div><div style="padding-right:48pt"><font><br></font></div><div style="padding-right:48pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:14pt;font-weight:700;line-height:120%">ESS OFFER DOCUMENT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STRYKER CORPORATION </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2011 LONG-TERM INCENTIVE PLAN, AS AMENDED</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OFFER OF NONSTATUORY STOCK OPTIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TO AUSTRALIAN RESIDENTS </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DATED&#58;   February 5, 2025</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">INVESTMENT IN SHARES INVOLVES A DEGREE OF RISK.  EMPLOYEES WHO PARTICIPATE IN THE PLAN SHOULD MONITOR THEIR PARTICIPATION AND CONSIDER ALL RISK FACTORS RELEVANT TO THE ACQUISITION OF COMMON STOCK UNDER THE PLAN AS SET OUT IN THIS ESS OFFER DOCUMENT AND THE ADDITIONAL DOCUMENTS.  THE INFORMATION CONTAINED IN THIS ESS OFFER DOCUMENT AND THE ADDITIONAL DOCUMENTS IS GENERAL ADVICE ONLY. EMPLOYEES SHOULD CONSIDER SEEKING ADVICE FROM AN INDEPENDENT PERSON LICENSED BY THE AUSTRALIAN SECURITIES AND INVESTMENTS COMMISSION TO GIVE ADVICE REGARDING PARTICIPATION IN THE PLAN.</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i31b2f1941d224240a3606878c70b1714_7"></div><hr style="page-break-after:always"><div style="min-height:46.8pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OFFER TO AUSTRALIAN RESIDENT EMPLOYEES</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2011 LONG-TERM INCENTIVE PLAN, AS AMENDED</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To Eligible Participants&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This ESS Offer Document sets out information regarding the grant of Nonstatutory Stock Options (&#34;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Options</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#34;) by Stryker Corporation (the &#34;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#34;) under the Stryker Corporation 2011 Long-Term Incentive Plan, as amended (the &#34;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#34;) to</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Australian resident employees of the Company and its subsidiaries and affiliates (&#34;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Eligible Participants</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#34;).</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has adopted the Plan to advance the interests of the Company and its subsidiaries and affiliates (the &#34;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Group</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#34;) by providing certain Eligible Participants a larger personal and financial interest in the success of the Company and to enable the Company to compete effectively with others for the services of new employees and directors as may be needed for the continued improvement of the enterprise. This ESS Offer Document specifically addresses the grant of Options.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Terms defined in the Plan have the same meaning in this ESS Offer Document.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;OFFER OF OPTIONS</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This is an offer made by the Company under the Plan to Eligible Participants of Options to acquire shares in the Company&#8217;s common stock (&#34;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#34;) under the Plan.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Options are granted with an exercise price equal to the fair market value of the underlying Shares on the date of grant and represent a right to purchase Shares in the future, subject to satisfaction of vesting requirements and the payment of the exercise price.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;TERMS OF GRANT</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The terms of the grant of Options incorporate the Plan, the CEO Award Letter and the Terms and Conditions Relating to Nonstatutory Stock Options Granted Pursuant to the 2011 Long-Term Incentive Plan&#8221; (together the &#34;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Terms and Conditions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#34;).  The rules of the Plan are incorporated into the Terms and Conditions and this ESS Offer Document by reference.  By accepting the grant of Options, you agree to be bound by the rules of this ESS Offer Document, the Plan and the Terms and Conditions. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This offer is being made under Division 1A of Part 7.12 of the Corporations Act 2001 (Cth) (the &#8220;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Act</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  For purposes of that Division, the Terms and Conditions are to be regarded as a part of this ESS Offer Document.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;ADDITIONAL DOCUMENTS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In addition to the information set out in this ESS Offer Document, attached are copies of the following documents (as are appropriate with respect to your Option(s)) (collectively, the &#34;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Additional Documents</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#34;)&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.99pt">the Plan&#59;</font></div><div style="height:48.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.8pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.28pt">the U.S. Plan Prospectus, dated 7 February 2018</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.55pt">the Terms and Conditions Relating to Nonstatutory Stock Options Granted Pursuant to the Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.19pt">the Australian tax supplement to the U.S. Plan prospectus entitled &#8220;Stryker Corporation Nonstatutory Stock Options Summary of Employee Tax Obligations&#8221;&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.99pt">CEO Award Letter&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:23.21pt">the Stryker Corporation &#34;Your Stock Option Program&#34; brochure.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Please note that the U.S. Plan prospectus is not a prospectus for the purposes of the Corporations Act 2001 and has not been modified for Australia.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Additional Documents provide further information necessary to make an informed investment decision in relation to your participation in the Plan.  </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;RELIANCE ON STATEMENTS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You should not rely upon any oral statements made to you in relation to this offer.  You should only rely upon the statements contained in this ESS Offer Document and the Additional Documents when considering your participation in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;WHO IS ELIGIBLE TO PARTICIPATE&#63;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You are eligible to participate under the Plan if, at the time of the offer, you are an Australian resident employee or director of the Company or an Australian subsidiary and meet the eligibility requirements established under the Plan.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36.7pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Committee is authorized to determine the eligible employees to whom, and the time or times at which, Options will be granted, the number of Shares subject to an Option, the exercise price of the Options, the time or times within which Options will be subject to forfeiture, the time or times at which the restrictions will terminate and all other terms and conditions of the grants. You will be required to pay an exercise price to acquire Shares pursuant to an Option (as described below).</font></div><div style="padding-left:36.7pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Stock Options</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;WHAT IS A NON-QUALIFIED STOCK OPTION&#63;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">An Option granted pursuant to the Plan gives the Eligible Participant the right, but not the obligation, to purchase a specified number of Shares at an exercise price fixed at the date of the grant.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:37.05pt;text-align:justify;text-indent:-37.05pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;WHEN CAN I EXERCISE MY OPTIONS&#63;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Subject to the limitations specified in the Plan, the CEO Award Letter will set out when the Options become vested and may be exercised and when they will lapse.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:37.05pt;text-align:justify;text-indent:-37.05pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;WHAT IS THE EXERCISE PRICE OF THE OPTIONS&#63;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The exercise price (i.e., the price you must pay to acquire Shares on the exercise of an Option) (&#34;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exercise Price</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#34;) is determined by the Committee, as set out in the Plan. The Exercise Price will be no less than 100% of the Fair Market Value of a Share on the grant date of the Option.</font></div><div style="height:48.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.8pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GENERAL INFORMATION</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;WHAT IS A SHARE OF THE COMPANY&#63;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Shares of common stock in a U.S. corporation are analogous to ordinary shares of an Australian corporation.  Each holder of Shares is entitled to one vote for every Share held in the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dividends may be paid on the Shares out of any funds of the Company legally available for dividends at the discretion of the Board of Directors of the Company. </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The issued capital of the Company is currently comprised only of shares of common stock.  The Company's Shares are listed and may be traded on the New York Stock Exchange.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Shares are not liable to any further calls for payment of capital or for other assessment by the Company and have no sinking fund provisions, pre-emptive rights, conversion rights or redemption provisions.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;HOW CAN I OBTAIN THE CURRENT SHARE PRICE IN AUSTRALIAN DOLLARS&#63;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You may ascertain the current market price of the Shares as traded on the NYSE at </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;www.nyse.com&#47;index</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> under the ticker symbol &#8220;SYK.&#8221;  The Australian dollar equivalent of that price can be obtained at&#58; </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;www.rba.gov.au&#47;statistics&#47;frequency&#47;exchange-rates.html</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;WHAT ADDITIONAL RISK FACTORS APPLY TO AUSTRALIAN RESIDENTS&#8217; PARTICIPATION IN THE PLAN&#63;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Participants should consider the risk factors relevant to investment in securities generally and, in particular, to the acquisition and holding of Shares.  You should be aware that in addition to fluctuations in value caused by the fortunes of the Company, the Australian dollar value of your Shares will be affected by the U.S.$&#47;A$ exchange rate.  Participation in the Plan involves certain risks related to fluctuations in this rate of exchange.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There is no guarantee that the price of the Shares will increase.  Factors which may affect the price of the Shares include fluctuations in the domestic and international market for listed stocks, general economic conditions, including interest rates, inflation rates, legislation or regulation, the nature of the markets in which the Company operates and general operational and business risks.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;PLAN MODIFICATION, TERMINATION, ETC.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to Article 3 of the Plan, the Plan will be administered by the Compensation Committee.  The Compensation Committee, from time to time, may alter, amend, modify or suspend the Plan at any time and from time to time.</font></div><div style="height:48.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.8pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;WHAT ARE THE AUSTRALIAN TAXATION CONSEQUENCES OF PARTICIPATION IN THE PLAN&#63;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Please see the Additional Document entitled &#8220;Stryker Corporation Nonstatutory Stock Option Summary of Employee Tax Obligations&#8221; for information regarding the Australian tax treatment of your award.  </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">STATUTORY TERMS AND CONDITIONS</font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As noted above, this offer is being made under Division 1A of Part 7.12 of the Act.  To comply with that Division, the following terms are included&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:50.48pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.388%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#a6a6a6;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;Application Period</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This offer remains open until the date specified in your Terms and Conditions Relating to Nonstatutory Stock Options Granted Pursuant to the Plan (the &#8220;Application Period&#8221;).  You may accept this offer at any time up until then.</font></div></td></tr><tr><td colspan="3" style="background-color:#a6a6a6;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.&#160;&#160;&#160;&#160;Acquisition of Options</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You cannot acquire any Options until at least 14 days after receiving this ESS Offer Document.</font></div></td></tr><tr><td colspan="3" style="background-color:#a6a6a6;border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C&#160;&#160;&#160;&#160;Terms Relating to Disclosure</font></div></td></tr></table></div><div style="height:48.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.8pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="padding-left:50.48pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.388%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.97pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This offer is also subject to the following terms relating to disclosure&#58;<br>this ESS Offer Document and the terms of the offer&#58;<br>must not include a misleading or deceptive statement&#59; and<br>must not omit any information that would result in this document or terms of the offer being misleading or deceptive&#59;<br>the Company must provide you with an updated ESS Offer Document as soon as practicable after becoming aware that the document that was provided has become out of date, or is otherwise not correct, in a material respect&#59;<br>each person mentioned in items 2, 3 and 4 of the table below must notify, in writing, the Company as soon as practicable if, during the Application Period, the person becomes aware that&#58;<br>a material statement in the documents mentioned in paragraph (a) is misleading or deceptive&#59; or<br>information was omitted from any of those documents that has resulted in one or more of those documents being misleading or deceptive&#59; or<br>a new circumstance has arisen during the Application Period which means the ESS Offer Document is out of date, or otherwise not correct, in a material respect&#59; and<br>if you suffer loss or damage because of a contravention of a term of the offer covered by paragraph (a), (b) or (c) above, you can recover the amount of loss or damage in accordance with the table below.<br>For the purposes of paragraph (d) above, an ESS participant must be able to recover loss or damage in accordance with the following table&#58;<br>Item<br>You may recover loss or damage suffered as a result of a contravention of<br>from these people...<br></font><font style="font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1<br>a term of the offer covered by any of the following paragraphs&#58;<br>paragraph (a) (misleading or deceptive statements and omissions)&#59;<br>paragraph (b) (out of date ESS Offer Document)<br>the Company<br></font><font style="font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2<br>a term of the offer covered by any of the following paragraphs&#58;<br>paragraph (a) (misleading or deceptive statements and omissions)&#59;<br>paragraph (b) (outdated ESS Offer Document)<br>each director of the Company<br></font><font style="font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3<br>a term of the offer covered by any of the following paragraphs&#58;<br>paragraph (a) (misleading or deceptive statements and omissions)&#59;<br>paragraph (b) (out of date ESS Offer Document)<br>a person named, with their consent, in an ESS Offer Document or the terms of the offer as a proposed director of the Company<br></font><font style="font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4<br>a term of the offer covered by paragraph (a) (misleading or deceptive statements and omissions)<br>a person named, with their consent, in the ESS Offer Document or the terms of the offer as having made&#58;<br>the misleading or deceptive statement&#59; or<br>a statement on which the misleading or deceptive statement is based<br></font><font style="font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5<br>a term of the offer covered by paragraph (c) (failure to notify the Company of misleading or deceptive statement and omissions or new circumstances)<br>the person mentioned in item 2, 3 or 4 of this table who failed to notify the Company in accordance with the term covered by paragraph (c)<br></font><font style="font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br></font></td></tr></table></div><div style="height:48.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.8pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="padding-left:50.48pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.388%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#a6a6a6;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:5.67pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D&#160;&#160;&#160;&#160;Exclusions from Liability</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.97pt;padding-right:5.32pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A person mentioned in the table in section C above is not liable for any loss or damage suffered by you because of a contravention of a term of the offer covered by paragraph (a) or (b) of section C above if&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:32.72pt;padding-right:12.82pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.26pt">the person&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:38.77pt;padding-right:12.82pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.07pt">made all inquiries (if any) that were reasonable in the circumstances&#59; and</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:38.77pt;padding-right:12.82pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:10.3pt">after doing so, believed on reasonable grounds that the statement was not misleading or deceptive&#59; or</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:32.72pt;padding-right:12.82pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.69pt">the person did not know that the statement was misleading or deceptive&#59; or</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:32.72pt;padding-right:12.82pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.26pt">the person placed reasonable reliance on information given to the person by&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:38.77pt;padding-right:12.82pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.07pt">if the person is a body corporate or a responsible entity of a registered scheme - someone other than a director, employee or agent of the body corporate or responsible entity&#59; or</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:38.77pt;padding-right:12.82pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:10.3pt">if the person is an individual&#8212;someone other than an employee or agent of the individual&#59; or</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:25.27pt;padding-right:12.82pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:10.84pt">for a person mentioned in column 2 of item 3 or 4 of the table in section C above - the person proves that they publicly withdrew their consent to being named in the document in that way&#59; or</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:25.27pt;padding-right:12.82pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.41pt">the contravention arose because of a new circumstance that has arisen since the ESS Offer Document was prepared and the person proves that they were not aware of the matter.</font></div></td></tr></table></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;WHAT ARE THE U.S. TAXATION CONSEQUENCES OF PARTICIPATION IN THE PLAN&#63;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Participants will not be subject to U.S. tax consequences by reason only of the acquisition of Shares and&#47;or the sale of Shares.  However, liability to U.S. taxes may accrue if the Eligible Participants are otherwise subject to U.S. taxes.<br><br>Again, the above is an indication only of the likely U.S. tax consequences for Eligible Participants who accept Options granted under the Plan.  Employees should seek advice as to the U.S. taxation consequences of participation from their personal tax advisers.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">*          *          *          *          *</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We urge you to carefully review the information contained in this ESS Offer Document and the Additional Documents.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div><font><br></font></div><div style="height:48.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.8pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:11.05pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT B</font></div><div style="margin-top:11.05pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2011 LONG-TERM INCENTIVE PLAN, AS AMENDED AND RESTATED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br>EMPLOYER INFORMATION STATEMENT &#8211; DENMARK<br>STOCK OPTION GRANT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to section 3(1) of the Danish Act on the Use of Rights to Purchase or Subscribe for Shares etc. in Employment Relationships (the &#34;Stock Option Act&#34;), Stryker Corporation (the &#8220;Company&#8221;) is providing you with the following information regarding the Company&#8217;s stock option (&#8220;Option&#8221;) grant in a separate written statement. This statement contains only the information mentioned in the Stock Option Act&#59; the other terms and conditions of your Option grant are described in detail in the Stryker Corporation 2011 Long-Term Incentive Plan, as Amended and Restated  (the &#34;2011 Plan&#34;), the Terms and Conditions Related to Nonstatutory Stock Options Granted Pursuant to the 2011 Long-Term Incentive Plan (the &#8220;Option Agreement&#8221;) and the CEO Award Letter for the Option grant, all of which have been provided to you.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IMPORTANT NOTE&#58; The Stock Option Act only applies to Options granted under the 2011 Plan to employees of the Company and its Subsidiaries, and does not apply to individuals, including managers, who are not regarded as &#34;employees&#34; as defined under the Stock Option Act. If you are not an employee of the Company or one of its Subsidiaries within the meaning of the Stock Option Act, this Employer Information Statement shall not apply to you, you may not rely upon any of the information contained herein and the provisions described herein shall be void and ineffective.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Date of Grant</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Grant Date of the Option is the date that the Compensation and Human Capital Committee of the Board of Directors (the &#8220;Committee&#8221;) approved a grant for you and determined it would be effective.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Terms and Conditions of the Grant</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The grant of the Option is made at the sole discretion of the Committee.  In its assessment, the Committee has considered a number of factors in granting the Options to you, including (but not limited to) the Company&#8217;s latest annual results, your personal performance and your value for the future growth, development and operation of the Company.  Notwithstanding your personal performance and the development of the Company, the Company may decide, in its sole discretion, not to grant an Option to you in the future.  Under the terms of the Plan and the Agreement, you have no entitlement or claim to receive future Option grants.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Vesting Dates and Exercise Period</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Your Option shall vest over a period of time (&#8220;vesting period&#8221;), provided you remain employed by or in the service of the Company or a Subsidiary and any performance or other vesting conditions set forth in the Plan and the Agreements are satisfied, unless the Option is vested or terminated earlier for the reasons set forth in the Plan and the Agreements and subject to Section 5 of this statement.</font></div><div style="padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Exercise Price</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-28.35pt"><font><br></font></div><div style="height:48.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.8pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the Option exercise period, your Option can be exercised to purchase shares of the Company&#8217;s common stock at a price corresponding to the fair market value of the stock at the time of grant, as determined by the Company. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;Your Rights upon Termination</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The treatment of your Option awards upon termination of your employment will be determined in accordance with the following unless the terms contained in the Agreement and in the 2011 Plan are more favorable to you.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Your Option will survive and will not be forfeited if your employment is terminated by your employer for any reason other than your breach of contract (as determined under Danish law) or summary dismissal. This means that you may be entitled to continue to vest in the Option award as if you were still an employee in accordance with your Agreement and the 2011 Plan. Also, you may be entitled to receive an additional Option grant, proportionate to the length of your employment in the accounting year in which your employment is terminated, to which you would have been entitled according to agreement or custom had you still been employed at the end of the accounting year. This provision will not apply if the termination is due to your breach of your employment contract or in case of your justified summary dismissal, in which case the Option will lapse to the extent the Option has not vested on the effective date of termination of your employment. Such lapse will take place automatically without notice on the effective date of termination of your employment.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you terminate your employment due to your employer's material breach (as determined under Danish law), or if your employment terminates because you reach the age of retirement for employees of your employer or because you are entitled to receive old-age pension from the Danish state or your employer, the Option award shall continue on unchanged terms as if you had still been employed. Also, you may be entitled to receive an additional Option grant, proportionate to the length of your employment in the accounting year in which your employment is terminated, to which you would have been entitled according to agreement or custom had you still been employed at the end of the accounting year or at the date of grant.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you terminate your employment for other reasons,  your Option award will be forfeited as per the effective date of termination of your employment unless otherwise set out in the terms of the Agreement. In addition, you will be ineligible to receive any additional Option grants after your resignation.</font></div><div style="padding-left:28.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;Financial Aspects of Participating in the 2011 Plan</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Option grant has no immediate financial consequences for you. The value of the Option award will not be taken into account when calculating holiday allowances, pension contributions or other statutory consideration calculated on the basis of salary. The tax treatment of the Option award depends on a number of aspects and thus, you are encouraged to seek particular advice regarding your tax position. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Shares of stock are financial instruments and investing in stock will always have financial risk. The possibility of profit at the time of vesting will not only be dependent on the Company&#8217;s financial development, but inter alia also on the general development of the stock market. In addition, before or after you vest in your Option award, the shares of Company stock could decrease in value even below the price of such stock on the Date of Grant.</font></div><div style="padding-left:28.35pt;text-align:justify"><font><br></font></div><div style="height:48.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.8pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;Other Issues</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Apart from Clause 5 in this Statement (regarding your rights upon termination of employment), this Statement does not intend to alter any provisions of the 2011 Plan or the Agreement (or any related document), and the 2011 Plan and the Agreement (and any related document) shall prevail in case of any ambiguities. However, your mandatory rights under the Stock Option Act shall prevail in case of any ambiguities.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Plan Administrator </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Stryker Corporation</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Portage, Michigan USA</font></div><div style="padding-left:5pt;text-align:justify;text-indent:35.3pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:48.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.8pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2011 LONG-TERM INCENTIVE PLAN, SOM REVIDERET OG GENFREMSAT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br>ARBEJDSGIVERERKL&#198;RING &#8211; DANMARK<br>TILDELING AF AKTIEOPTIONER</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I henhold til &#167; 3, stk. 1, i lov om brug af k&#248;beret eller tegningsret til aktier m.v. i ans&#230;ttelsesforhold (&#34;Aktieoptionsloven&#34;) giver Stryker Corporation (&#34;Selskabet&#34;) dig hermed i en s&#230;rskilt skriftlig erkl&#230;ring f&#248;lgende oplysninger om Selskabets tildeling af aktieoptioner (&#34;Optioner&#34;). Denne erkl&#230;ring indeholder kun de oplysninger, der er n&#230;vnt i Aktieoptionsloven. De &#248;vrige vilk&#229;r og betingelser for din Optionstildeling er n&#230;rmere beskrevet i Selskabets </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">2011 Long-Term Incentive Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, som revideret og genfremsat  (&#34;2011-Planen&#34;), </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Terms and Conditions Related to Nonstatutory Stock Options Granted Pursuant to the 2011 Long-Term Incentive Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (&#34;Optionsaftalen&#34;), og CEO-tildelingsbrevene vedr&#248;rende henholdsvis Optionstildelingen, hvilke dokumenter alle er blevet udleveret til dig.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">VIGTIGT&#58; Aktieoptionsloven g&#230;lder kun for Optioner, der i henhold til 2011-Planen er tildelt til l&#248;nmodtagere i Selskabet og dets Datterselskaber, og g&#230;lder ikke for personer, herunder ledere, der ikke anses for at v&#230;re &#34;l&#248;nmodtagere&#34; som defineret i Aktieoptionsloven. Hvis du ikke er l&#248;nmodtager i Selskabet eller i et af dets Datterselskaber i Aktieoptionslovens forstand, g&#230;lder denne Arbejdsgivererkl&#230;ring ikke for dig, hvorfor du ikke vil kunne henholde dig til nogen af oplysningerne heri, og de heri anf&#248;rte bestemmelser vil ikke have virkning.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Tidspunkt for tildeling</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Tidspunktet for Optionstildelingen er den dato, hvor det af Bestyrelsen nedsatte Udvalg for Vederlag og Menneskelig Kapital (&#34;Udvalget&#34;) godkendte tildelingen til dig og besluttede, at den skulle tr&#230;de i kraft.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Kriterier og betingelser for tildeling</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Optionstildelingen sker alene efter Udvalgets eget sk&#248;n.  Udvalget har i sin vurdering inddraget en r&#230;kke faktorer i forbindelse med Optionstildelingen til dig, herunder (men ikke begr&#230;nset til) Selskabets seneste &#229;rsresultat, din personlige performance og din betydning for Selskabets fremtidige v&#230;kst, udvikling og drift.  Uanset din personlige performance og Selskabets udvikling kan Selskabet frit v&#230;lge ikke at tildele dig Optioner fremover.  I henhold til bestemmelserne i Planen og Aftalen har du ikke nogen ret til eller noget krav p&#229; fremover at modtage Options tildelinger.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Modningstidspunkter og udnyttelsesperiode</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Din Option modnes over en periode (&#34;modningsperioden&#34;), forudsat at du fortsat er ansat i eller arbejder for Selskabet eller et Datterselskab, og forudsat at alle de i Planen og Aftalerne beskrevne performance- og modningsbetingelser er opfyldt, medmindre Optionen modnes eller bortfalder p&#229; et tidligere tidspunkt som f&#248;lge af de i Planen og Aftalerne anf&#248;rte &#229;rsager og med forbehold for pkt. 5 i denne erkl&#230;ring.</font></div><div style="padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Udnyttelseskurs</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-28.35pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I udnyttelsesperioden for Optioner kan din Option udnyttes til k&#248;b af ordin&#230;re aktier i Selskabet til en kurs svarende til aktiernes markedsv&#230;rdi p&#229; tildelingstidspunktet som fastsat af Selskabet. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:48.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.8pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;Din retsstilling i forbindelse med fratr&#230;den</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I forbindelse med din fratr&#230;den vil dine Optionstildelinger blive behandlet som f&#248;lger, medmindre vilk&#229;rene i Aftalen og i 2011-Planen er mere fordelagtige for dig.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Din Option bortfalder ikke, hvis din fratr&#230;den skyldes opsigelse fra din arbejdsgivers side, medmindre der er tale om misligholdelse fra din side (som defineret i dansk ret) eller bortvisning. Dette betyder, at du m&#229;ske vil v&#230;re berettiget til, at din Option fortsat modnes i overensstemmelse med din Aftale og 2011-Planen, som om du stadig var ansat. Endvidere vil du m&#229;ske v&#230;re berettiget til at modtage en yderligere Optionstildeling, som beregnes forholdsm&#230;ssigt i forhold til, hvor l&#230;nge du er ansat i det regnskabs&#229;r, hvori du fratr&#230;der, og som du ville have v&#230;ret berettiget til i henhold til aftale eller s&#230;dvane, s&#229;fremt du stadig havde v&#230;ret ansat ved udgangen af regnskabs&#229;ret. Denne bestemmelse g&#230;lder ikke, s&#229;fremt din fratr&#230;den skyldes opsigelse p&#229; grund af din misligholdelse af ans&#230;ttelseskontrakten eller berettiget bortvisning, i hvilket tilf&#230;lde Optionen bortfalder, i det omfang de ikke er modnet ved ans&#230;ttelsesforholdets oph&#248;r. Bortfaldet sker automatisk uden varsel ved ans&#230;ttelsesforholdets oph&#248;r.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hvis du fratr&#230;der din stilling som f&#248;lge af v&#230;sentlig misligholdelse fra din arbejdsgivers side (som defineret i dansk ret), eller hvis du fratr&#230;der, fordi du n&#229;r pensionsalderen for l&#248;nmodtagere hos din arbejdsgiver, eller fordi du har ret til at modtage alderspension fra den danske stat eller din arbejdsgiver, vil din Optionstildeling forts&#230;tte p&#229; u&#230;ndrede vilk&#229;r, som om du stadig var ansat.   Endvidere vil du m&#229;ske v&#230;re berettiget til at modtage en yderligere Optionstildeling, som beregnes forholdsm&#230;ssigt i forhold til, hvor l&#230;nge du er ansat i det regnskabs&#229;r, hvori du fratr&#230;der, og som du ville have v&#230;ret berettiget til i henhold til aftale eller s&#230;dvane, s&#229;fremt du stadig havde v&#230;ret ansat ved udgangen af regnskabs&#229;ret eller p&#229; tildelingstidspunktet.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hvis du fratr&#230;der din stilling af andre &#229;rsager, vil din Optionstildeling bortfalde ved ans&#230;ttelsesforholdets oph&#248;r, medmindre andet fremg&#229;r af Aftalen. Endvidere vil du ikke v&#230;re berettiget til at f&#229; tildelt yderligere Optioner efter din fratr&#230;den.</font></div><div style="padding-left:28.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;&#216;konomiske aspekter ved at deltage i 2011-Planen</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Optionstildelingen har ingen umiddelbare &#248;konomiske konsekvenser for dig. V&#230;rdien af Optionstildelingen indg&#229;r ikke i beregningen af feriepenge, pensionsbidrag eller andre lovpligtige, vederlagsafh&#230;ngige ydelser. Den skattem&#230;ssige behandling af Optionstildelingen afh&#230;nger af flere forhold, og du opfordres derfor til at s&#248;ge s&#230;rskilt r&#229;dgivning vedr&#248;rende din skattem&#230;ssige situation. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Aktier er finansielle instrumenter, og investering i aktier vil altid v&#230;re forbundet med en &#248;konomisk risiko. Muligheden for en gevinst p&#229; modningstidspunktet afh&#230;nger ikke alene af Selskabets &#248;konomiske udvikling, men ogs&#229; af bl.a. den generelle udvikling p&#229; aktiemarkedet. Derudover kan v&#230;rdien af Selskabets aktier b&#229;de f&#248;r og efter modningen af din Optionstildeling falde til en v&#230;rdi, der m&#229;ske endda ligger under kursen p&#229; tildelingstidspunktet.</font></div><div style="padding-left:28.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;&#216;vrige oplysninger</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Med undtagelse af pkt. 5 i denne erkl&#230;ring (vedr&#248;rende din retsstilling i forbindelse med fratr&#230;den) har denne erkl&#230;ring ikke til form&#229;l at &#230;ndre nogen af bestemmelserne i 2011-Planen eller Aftalen (eller i tilh&#248;rende dokumenter), og 2011-Planen og Aftalen (og eventuelle tilh&#248;rende dokumenter) har forrang i tilf&#230;lde af uoverensstemmelser. Dine ufravigelige rettigheder i henhold til Aktieoptionsloven har dog forrang i tilf&#230;lde af uklarhed.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:48.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.8pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Planadministrator </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Stryker Corporation</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Portage, Michigan USA</font></div><div style="margin-top:11.1pt;padding-left:3.52pt;padding-right:3.52pt;text-align:center"><font><br></font></div><div style="margin-top:11.1pt;padding-left:3.52pt;padding-right:3.52pt;text-align:center"><font><br></font></div><div style="height:48.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>ex10ii2025rsuawardletteran.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ia853adc2842843c292ab002ee46eb823_1"></div><div style="min-height:56.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.15pt;padding-left:6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">                                                                                                                           </font></div><div style="margin-top:1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;Kevin A. Lobo</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;Chair and CEO</font></div></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="strykerlogoa72.jpg" src="strykerlogoa72.jpg" style="height:54px;margin-bottom:5pt;vertical-align:text-bottom;width:202px"></div></td></tr></table></div><div style="margin-top:11.15pt;padding-right:347.6pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Personal and Confidential</font></div><div style="margin-top:11.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  February 5, 2025</font></div><div style="margin-top:11.15pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  First Name Last Name</font></div><div style="margin-top:3.75pt;padding-left:6pt;text-align:justify;text-indent:35.3pt"><font><br></font></div><div style="margin-top:0.05pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Dear First Name,</font></div><div style="margin-top:7.45pt;padding-left:6pt;text-align:justify;text-indent:35.3pt"><font><br></font></div><div style="padding-left:6.75pt;padding-right:2.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I am pleased to inform you that you are one of a select group of individuals receiving a restricted stock units (RSUs) award in 2025. We use these awards to reward performers who we believe will be key contributors to our growth well into the future. The total Award Date Value (ADV) of your award is approximately USD $xx,xxx.</font></div><div style="margin-top:11.35pt;padding-left:6.75pt;padding-right:2.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You are receiving xxx RSUs with respect to Common Stock of Stryker Corporation. Except as otherwise provided in the Terms and Conditions, one-third of these RSUs will vest on March 21 of each of the three years beginning March 21, 2026.</font></div><div style="margin-top:0.1pt;padding-left:6pt;text-align:justify;text-indent:35.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6.75pt;padding-right:6.2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:117%">You must &#8220;Accept&#8221; the award online via the UBS One Source web site located at </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:117%;text-decoration:underline">www.ubs.com&#47;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:117%"> </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:117%;text-decoration:underline">onesource&#47;SYK</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:117%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:117%">between March 4 and March 31, 2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:117%">. The detailed terms of the RSUs are in the Terms and Conditions, any applicable country addendum and the provisions of the Company's 2011 Long-Term Incentive Plan, as Amended and Restated. Those documents, together with the related Prospectus, are available on the UBS One Source web site, and you should read them before accepting the awards. In addition, you may be asked to sign the most recent version of Stryker&#8217;s Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement (&#8220;Non-Compete Agreement&#8221;) in connection with these awards. If you are asked to sign the Non-Compete Agreement, it will be emailed to you and you will be asked to sign the document electronically via Adobe Sign by March 31, 2025. The vesting of the RSUs is conditioned on you having signed the Non-Compete Agreement by March 31, 2025, where permitted by applicable law.</font></div><div style="margin-top:10.95pt;padding-left:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You can find additional educational materials on the UBS One Source web site in the Resources section, including RSU brochure and RSU Tax Questions &#38; Answers.</font></div><div style="margin-bottom:3pt;padding-left:6pt;text-align:justify;text-indent:35.3pt"><font><br></font></div><div style="margin-top:3.9pt"><font><br></font></div><div style="margin-top:4.4pt;padding-left:5.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sincerely,</font></div><div style="padding-left:5.3pt"><img alt="image_1.jpg" src="image_1.jpg" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:61px"></div><div style="margin-top:4.4pt;padding-left:5.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kevin A. Lobo</font></div><div style="margin-top:0.05pt;padding-left:5.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chair and Chief Executive Office</font></div><div style="margin-top:11.15pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;padding-left:6pt;text-indent:35.3pt"><font><br></font></div><div style="margin-top:0.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </font></div><div style="margin-top:11.15pt;padding-left:6pt;text-indent:35.3pt"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.15pt;padding-left:6pt;text-indent:35.3pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="margin-top:2pt"><font><br></font></div><div style="padding-left:0.47pt;padding-right:0.47pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TERMS AND CONDITIONS</font></div><div style="margin-top:0.35pt;padding-left:0.5pt;padding-right:0.5pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RELATING TO RESTRICTED STOCK UNITS GRANTED</font></div><div style="margin-top:0.35pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PURSUANT TO THE 2011 LONG-TERM INCENTIVE PLAN, AS AMENDED AND RESTATED</font></div><div style="margin-top:11.6pt;padding-left:5.95pt;padding-right:5.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.41pt">The Restricted Stock Units (&#34;RSUs&#34;) with respect to Common Stock of Stryker Corporation (the &#34;Company&#34;) granted to you during 2025 are subject to these Terms and Conditions Relating to Restricted Stock Units Granted Pursuant to the 2011 Long-Term Incentive Plan, as Amended and Restated (the &#34;Terms and Conditions&#34;) and all of the terms and conditions of the Stryker Corporation 2011 Long-Term Incentive Plan, as Amended and Restated (the &#34;2011 Plan&#34;), which is incorporated herein by reference. In the case of a conflict between these Terms and Conditions and the terms of the 2011 Plan, the provisions of the 2011 Plan will govern. Capitalized terms used but not defined herein have the meaning provided therefor in the 2011 Plan. For purposes of these Terms and Conditions, &#34;Employer&#34; means the Company or any Subsidiary that employs you on the applicable date, and &#34;Stock Plan Administrator&#34; means UBS Financial Services Inc. (or any other independent service provider engaged by the Company to assist with the implementation, operation and administration of the 2011 Plan).</font></div><div style="margin-top:11pt;padding-left:73.2pt;text-align:justify;text-indent:-31.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.61pt">Your right to receive the Shares issuable pursuant to the RSUs shall be only as follows&#58;</font></div><div style="margin-top:11.6pt;padding-left:5.95pt;padding-right:6.75pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.73pt">If you continue to be an Employee, you will receive the Shares underlying the RSUs that have become vested as soon as administratively possible following the vesting date as set forth in the award letter.</font></div><div style="margin-top:11.2pt;padding-left:5.95pt;padding-right:5.5pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.08pt">If you cease to be an Employee by reason of Disability (as such term is defined in the 2011 Plan or determined under local law) or death prior to the date that your RSUs become fully vested, you or your estate will become fully vested in your RSUs, and you, your legal representative or your estate will receive all of the underlying Shares as soon as administratively practicable following your termination by Disability or death.</font></div><div style="margin-top:11.15pt;padding-left:5.95pt;padding-right:6.7pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:18.25pt">If you cease to be an Employee by reason of Retirement (as such term is defined in the 2011 Plan or determined under local law) prior to the date that your RSUs become fully vested, you (or your estate in the event of your death after your termination by Retirement) will continue to vest in your RSUs in accordance with the vesting schedule as set forth in the award letter as if you had continued your employment with your Employer.</font></div><div style="margin-top:11.15pt;padding-left:5.95pt;padding-right:6.35pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17pt">If you cease to be an Employee prior to the date that your RSUs become fully vested for any reason other than those provided in (b) or (c) above, you shall cease vesting in your RSUs effective as of your Termination Date. If you are resident or employed outside of the United States, &#34;Termination Date&#34; shall mean the last day on which you are an Employee of your Employer, provided that (1) your notice period is 12 months or less, or (2) your employment ends less than 12 months after the date on which you signed your termination agreement. Other than Section 16 officers (as defined below), if your notice period exceeds 12 months, then &#34;Termination Date&#34; will be 12 months after the date on which notice was given, whether it be by you or your Employer. If your employment ends more than 12 months after you signed your termination agreement, then &#8220;Termination Date&#8221; will be 12 months after the date on which you signed your termination agreement. If you are an officer of the Company and in such capacity are subject to reporting under Section 16 of the U.S. Securities Exchange Act of 1934 (a &#8220;Section 16 officer&#8221;) on the date on which notice was given, &#34;Termination Date&#34; shall mean the last day on which you are an Employee of your Employer.</font></div><div style="margin-top:11pt;padding-left:5.95pt;padding-right:5.6pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(e)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.74pt">Notwithstanding the foregoing, the Company may, in its sole discretion, settle your RSUs in the form of&#58; (i) a cash payment to the extent settlement in Shares (1) is prohibited under local law,</font></div><div style="padding-left:5.95pt;padding-right:5.6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(2) would require you, the Company and&#47;or your Employer to obtain the approval of any governmental and&#47;or regulatory body in your country of residence (and country of employment, if different), or (3) is administratively burdensome&#59; or (ii) Shares, but require you to immediately sell </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="padding-left:5.95pt;padding-right:5.6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">such Shares (in which case, the Company shall have the authority to issue sales instructions in relation to such Shares on your behalf).</font></div><div style="margin-top:11.1pt;padding-left:5.95pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.41pt">The number of Shares subject to the RSUs shall be subject to adjustment and the vesting dates hereof may be accelerated as follows&#58;</font></div><div style="margin-top:11.25pt;padding-left:5.95pt;padding-right:5.5pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.73pt">In the event that the Shares, as presently constituted, shall be changed into or exchanged for a different number or kind of shares of stock or other securities of the Company or of another corporation (whether by reason of merger, consolidation, recapitalization, reclassification, split-up, combination of shares, or otherwise) or if the number of such Shares shall be increased through the</font></div><div style="margin-top:3.65pt;padding-left:6pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">payment of a stock dividend or a dividend on the Shares of rights or warrants to purchase securities of the Company shall be made, then there shall be substituted for or added to each Share theretofore subject to the RSUs the number and kind of shares of stock or other securities into which each outstanding Share shall be so changed, or for which each such Share shall be exchanged, or to which each such Share shall be entitled. The other terms of the RSUs shall also be appropriately amended as may be necessary to reflect the foregoing events. In the event there shall be any other change in the number or kind of the outstanding Shares, or of any stock or other securities into which such Shares shall have been exchanged, then if the Committee shall, in its sole discretion, determine that such change equitably requires an adjustment in the RSUs, such adjustment shall be made in accordance with such determination.</font></div><div style="margin-top:11.05pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.03pt">&#91;Fractional Shares resulting from any adjustment in the RSUs may be settled in cash or otherwise as the Committee shall determine, in its sole discretion. Notice of any adjustment will be given to you and such adjustment (whether or not such notice is given) shall be effective and binding for all purposes hereof.&#93;</font></div><div style="margin-top:11.15pt;padding-left:6pt;padding-right:5.55pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:18.2pt">The Committee shall have the power to amend the RSUs to permit the immediate vesting of the RSUs (and to terminate any unvested RSUs) and the distribution of the underlying Shares prior to the effectiveness of (i) any disposition of substantially all of the assets of the Company or your Employer, (ii) the shutdown, discontinuance of operations or dissolution of the Company or your Employer, or (iii) the merger or consolidation of the Company or your Employer with or into any other unrelated corporation.</font></div><div style="margin-top:11.1pt;padding-left:6pt;padding-right:5.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt">If you are resident and&#47;or employed outside of the United States, you agree, as a condition of the grant of the RSUs, to repatriate all payments attributable to the Shares and&#47;or cash acquired under the 2011 Plan (including, but not limited to, dividends, dividend equivalents and any proceeds derived from the sale of the Shares acquired pursuant to the RSUs) if required by and in accordance with local foreign exchange rules and regulations in your country of residence (and country of employment, if different). In addition, you also agree to take any and all actions, and consent to any and all actions taken by the Company and its Subsidiaries, as may be required to allow the Company and its Subsidiaries to comply with local laws, rules and regulations in your country of residence (and country of employment, if different). Finally, you agree to take any and all actions as may be required to comply with your personal legal and tax obligations under local laws, rules and regulations in your country of residence (and country of employment, if different).</font></div><div style="margin-top:11pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">5.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt">If you are resident and&#47;or employed in a country that is a member of the European Union, the grant of the RSUs and these Terms and Conditions are intended to comply with the age discrimination provisions of the EU Equal Treatment Framework Directive, as implemented into local law (the &#34;Age Discrimination Rules&#34;). To the extent that a court or tribunal of competent jurisdiction determines that any provision of these Terms and Conditions is invalid or unenforceable, in whole or in part, under the Age Discrimination Rules, the Company, in its sole discretion, shall have the power and authority to revise or strike such provision to the minimum extent necessary to make it valid and enforceable to the full extent permitted under local law.</font></div><div style="margin-top:11pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">6.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt">Regardless of any action the Company and&#47;or your Employer take with respect to any or all income tax (including U.S. federal, state and local taxes and&#47;or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related withholding (&#34;Tax-Related Items&#34;), you acknowledge that the ultimate liability for all Tax-Related Items legally due by you is and remains </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11pt;padding-left:6pt;padding-right:6.6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">your responsibility and that the Company and your Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including the grant of the RSUs, the vesting of the RSUs, the subsequent sale of any Shares acquired pursuant to the RSUs and the receipt of any dividends or dividend equivalents and (ii) do not commit to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate your liability for Tax-Related Items. Further, if you become subject to taxation in more than one country between the grant date and the date of any relevant taxable or tax withholding event, as applicable, you acknowledge that your Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one country.</font></div><div style="margin-top:10.95pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Prior to any taxable event, if your country of residence (and&#47;or your country of employment, if different) requires withholding of Tax-Related Items, the Company shall withhold a number of whole Shares that have an aggregate Fair Market Value that the Company, taking into account local requirements and administrative issues, determines in its sole discretion is appropriate to cover withholding for Tax-Related Items with respect to the Shares. The cash equivalent of the Shares withheld will be used to settle the obligation to withhold the Tax-Related Items. In cases where the Fair Market Value of the number of whole Shares withheld is greater than the amount required to be paid to the relevant government authorities with respect to withholding for Tax-Related Items, the Company shall make a cash payment to you equal to the difference as soon as administratively practicable. In the event that withholding in Shares is prohibited or problematic under applicable law or otherwise may trigger adverse consequences to the Company or your Employer, your Employer shall withhold the Tax-Related Items required to be withheld with respect to the Shares in cash from your regular salary and&#47;or wages or other amounts payable to you. In the event the withholding requirements are not satisfied through the withholding of Shares or through your regular salary and&#47;or wages or any other amounts payable to you by your Employer, no Shares will be issued to you (or your estate) unless and until satisfactory arrangements (as determined by the Board of Directors) have been made by you with respect to the payment of any Tax-Related Items that the Company or your Employer determines, in its sole discretion, should be withheld or collected with respect to such RSUs. By accepting these RSUs, you expressly consent to the withholding of Shares and&#47;or withholding from your regular salary and&#47;or wages or other amounts payable to you as provided for hereunder. All other Tax- Related Items related to the RSUs and any Shares delivered in payment thereof are your sole responsibility.</font></div><div style="margin-top:10.8pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">7.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt">The RSUs are intended to be exempt from the requirements of Code Section 409A. The 2011 Plan and these Terms and Conditions shall be administered and interpreted in a manner consistent with this intent. If the Company determines that these Terms and Conditions are subject to Code Section 409A and that it has failed to comply with the requirements of that Section, the Company may, at the Company's sole discretion and without your consent, amend these Terms and Conditions to cause them to comply with Code Section 409A or be exempt from Code Section 409A.</font></div><div style="margin-top:11.1pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">8.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt">If you were required to sign the &#34;Stryker Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement&#34; or a similar agreement in order to receive the RSUs or have previously signed such an agreement and you breach any non-competition, non-solicitation or nondisclosure provision or provision as to ownership of inventions contained therein at any time while employed by the Company or a Subsidiary, or during the one-year period following termination of employment, any unvested RSUs shall be rescinded and you shall return to the Company all Shares that were acquired upon vesting of the RSUs that you have not disposed of. Further, you shall pay to the Company an amount equal to the profit realized by you (if any) on all Shares that were acquired upon vesting of the RSUs that you have disposed of. For purposes of the preceding sentence, the profit shall be the Fair Market Value of the Shares at the time of disposition.</font></div><div style="margin-top:11pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">9.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt">The RSUs shall be transferable only by will or the laws of descent and distribution. If you purport to make any transfer of the RSUs, except as aforesaid, the RSUs and all rights thereunder shall terminate immediately.</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:5.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">10.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.27pt">The RSUs shall not be vested in whole or in part, and the Company shall not be obligated to issue any Shares subject to the RSUs, if such issuance would, in the opinion of counsel for the Company, violate the Securities Act of 1933 or any other U.S. federal, state or non-U.S. statute having similar requirements as it may be in effect at the time. The RSUs are subject to the further </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">requirement that, if at any time the Board of Directors shall determine in its discretion that the listing or qualification of the Shares subject to the RSUs under any securities exchange requirements or under any applicable law, or the consent or approval of any governmental regulatory body, is necessary or desirable as a condition of or in connection with the issuance of Shares pursuant to the RSUs, the RSUs may not be vested in whole or in part unless such listing, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Board of Directors.</font></div><div style="margin-top:11pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">11.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.27pt">The grant of the RSUs shall not confer upon you any right to continue in the employ of your Employer nor limit in any way the right of your Employer to terminate your employment at any time. You shall have no rights as a shareholder of the Company with respect to any Shares issuable upon the vesting of the RSUs until the date of issuance of such Shares.</font></div><div style="margin-top:11pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">12.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.27pt">You acknowledge and agree that the 2011 Plan is discretionary in nature and may be amended, cancelled, or terminated by the Company, in its sole discretion, at any time. The grant of the RSUs under the 2011 Plan is a one-time benefit and does not create any contractual or other right to receive a grant of RSUs or any other award under the 2011 Plan or other benefits in lieu thereof in the future. Future grants, if any, will be at the sole discretion of the Company, including, but not limited to, the form and timing of any grant, the number of Shares subject to the grant, and the vesting provisions. Any amendment, modification or termination of the 2011 Plan shall not constitute a change or impairment of the terms and conditions of your employment with your Employer.</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:5.35pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">13.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.27pt">Your participation in the 2011 Plan is voluntary. The value of the RSUs and any other awards granted under the 2011 Plan is an extraordinary item of compensation outside the scope of your employment (and your employment contract, if any). Any grant under the 2011 Plan, including the grant of the RSUs, is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, holiday pay, bonuses, long-service awards, pension, or retirement benefits or similar payments.</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:5.35pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">14.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.27pt">The RSUs are granted solely by the Company.&#160; Your Employer and any other Subsidiary are not a party to these Terms and Conditions, and any rights you may have under these Terms and Conditions may be raised only against the Company (and may not be raised against your Employer or any other Subsidiary).</font></div><div style="margin-top:11.1pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">15.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.27pt">These Terms and Conditions shall bind and inure to the benefit of the Company, its successors and assigns and you and your estate in the event of your death.</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">16.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.27pt">The Company is located at 1941 Stryker Way, Portage, Michigan 49002, U.S.A. and grants RSUs under the 2011 Plan to employees of the Company and Subsidiaries in its sole discretion. In conjunction with the Company's grant of the RSUs under the 2011 Plan and its ongoing administration of such awards, the Company is providing the following information about its data collection, processing and transfer practices (&#34;Personal Data Activities&#34;). In accepting the grant of the RSUs, you expressly and explicitly consent to the Personal Data Activities as described herein.</font></div><div style="margin-top:11.1pt;padding-left:6pt;padding-right:5.45pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.68pt">The Company collects, processes and uses your personal data, including your name, home address, email address, and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all RSUs or any other equity compensation awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the RSUs under the 2011 Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan. The Company's legal basis for the collection, processing and usage of your personal data is your consent.</font></div><div style="margin-top:11.05pt;padding-left:6pt;padding-right:5.55pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.03pt">The Company transfers your personal data to the Stock Plan Administrator. In the future, the Company may select a different Stock Plan Administrator and share your personal data with another company that serves in a similar manner,</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:119%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">including, but not limited to, the Company's outside legal counsel as well as the Company&#8217;s auditor. The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.05pt;padding-left:6pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">under the 2011 Plan You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div style="margin-top:11.1pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:18.2pt">The Company and the Stock Plan Administrator are based in the United States. You should note that your country of residence may have enacted data privacy laws that are different from the United States. The Company's legal basis for the transfer of your personal data to the United States is your consent.</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:5.45pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.95pt">Your participation in the 2011 Plan and your grant of consent is purely voluntary. You may deny or withdraw your consent at any time. If you do not consent, or if you withdraw your consent, you may be unable to participate in the 2011 Plan. This would not affect your existing employment or salary&#59; instead, you merely may forfeit the opportunities associated with the 2011 Plan.</font></div><div style="margin-top:11.15pt;padding-left:6pt;padding-right:5.45pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(e)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.69pt">You may have a number of rights under the data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country or residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of your personal data. To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company's Human Resources Department.</font></div><div style="margin-top:11.05pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">17.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.27pt">The grant of the RSUs is not intended to be a public offering of securities in your country of residence (and country of employment, if different). The Company has not submitted any registration statement, prospectus or other filing(s) with the local securities authorities (unless otherwise required under local law). No employee of the Company is permitted to advise you on whether you should acquire</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Shares under the 2011 Plan or provide you with any legal, tax or financial advice with respect to the grant of the RSUs. The acquisition of Shares involves certain risks, and you should carefully consider all risk factors and tax considerations relevant to the acquisition of Shares under the 2011 Plan or the disposition of them. Further, you should carefully review all of the materials related to the RSUs and the 2011 Plan, and you should consult with your personal legal, tax and financial advisors for professional advice in relation to your personal circumstances.</font></div><div style="margin-top:11.15pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">18.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.27pt">All questions concerning the construction, validity and interpretation of the RSUs and the 2011 Plan shall be governed and construed according to the laws of the state of Michigan, without regard to the application of the conflicts of laws provisions thereof. Any disputes regarding the RSUs or the 2011 Plan shall be brought only in the state or federal courts of the state of Michigan.</font></div><div style="margin-top:11.15pt;padding-left:6pt;padding-right:6.4pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">19.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.27pt">The Company may, in its sole discretion, decide to deliver any documents related to the RSUs or other awards granted to you under the 2011 Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the 2011 Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div style="margin-top:11.1pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">20.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.27pt">The invalidity or unenforceability of any provision of the 2011 Plan or these Terms and Conditions shall not affect the validity or enforceability of any other provision of the 2011 Plan or these Terms and Conditions.</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">21.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.27pt">If you are resident outside of the United States, you acknowledge and agree that it is your express intent that these Terms and Conditions, the 2011 Plan and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the RSUs be drawn up in English. If you have received these Terms and Conditions, the 2011 Plan or any other documents related to the RSUs translated into a language other than English and the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-top:11.1pt;padding-left:6pt;padding-right:6.4pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">22.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.27pt">You acknowledge that, depending on your or your broker's country of residence or where the Shares are listed, you may be subject to insider trading restrictions and&#47;or market abuse laws which may affect your ability to accept, acquire, sell or otherwise dispose of Shares, rights to </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.1pt;padding-left:6pt;padding-right:6.4pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Shares (e.g., RSUs) or rights linked to the value of Shares during such times you are considered to have &#34;inside information&#34; regarding the Company as defined in the laws or regulations in your country of employment (and country of residence, if different). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before you possessed inside information. Furthermore, you could be prohibited from (i) disclosing the inside information to any third party (other than on a &#34;need to know&#34; basis) and (ii) &#34;tipping&#34; third parties or causing them otherwise to buy or sell securities. Third parties include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. You acknowledge that it is your responsibility to comply with any restrictions and are advised to speak to your personal advisor on this matter.</font></div><div style="margin-top:10.95pt;padding-left:6pt;padding-right:5.3pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">23.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.27pt">Notwithstanding any provisions of these Terms and Conditions to the contrary, the RSUs shall be subject to any special terms and conditions for your country of residence (and country of employment, if different) set forth in an addendum to these Terms and Conditions (an &#34;Addendum&#34;). Further, if you transfer your residence and&#47;or employment to another country reflected in an Addendum to these Terms and Conditions at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such special terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer). In all circumstances, any applicable Addendum shall constitute part of these Terms and Conditions.</font></div><div style="margin-top:10.95pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">24.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.27pt">The Company reserves the right to impose other requirements on the RSUs, any Shares acquired pursuant to the RSUs and your participation in the 2011 Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan. Such requirements may include (but are not limited to) requiring you to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-top:11.65pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">25.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;padding-left:16.27pt">This Section 25 applies only to those persons whom the Company's Recoupment Policy applies (the corporate officers elected by the Company's Board of Directors other than Assistant Controllers, Assistant Secretaries and Assistant Treasurers). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Notwithstanding any other provision of these Terms and Conditions to the contrary, you acknowledge and agree that your RSUs, any Shares acquired pursuant thereto and&#47;or any amount received with respect to any sale of such Shares are subject to potential cancellation, recoupment, rescission, payback or other action in accordance with the terms of the Company's Recoupment Policy as in effect on the date of grant (a copy of which has been furnished to you) and as the Recoupment Policy may be amended from time to time in order to comply with changes in laws, rules or regulations that are applicable to such RSUs and Shares. You agree and consent to the Company's application, implementation and enforcement of (a) the Recoupment Policy and (b) any provision of applicable law relating to cancellation, recoupment, rescission or payback of compensation and expressly agree that the Company may take such actions as are necessary to effectuate the Recoupment Policy (as applicable to you) or applicable law without further consent or action being required by you. For purposes of the foregoing, you expressly and explicitly authorize the Company to issue instructions, on your behalf, to the Stock Plan Administrator and any other brokerage firm and&#47;or third party administrator engaged by the Company to hold your Shares and other amounts acquired under the 2011 Plan to re-convey, transfer or otherwise return such Shares and&#47;or other amounts to the Company. In the case of a conflict between these Terms and Conditions and the Recoupment Policy, the terms of the Recoupment Policy shall prevail.</font></div><div style="margin-top:11.65pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">26.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;padding-left:16.27pt">This Section 26 applies only to those persons whom the Company's clawback policy applies. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Notwithstanding anything in these Terms and Conditions to the contrary, the RSUs evidenced by these Terms and Conditions may be subject to (i) recoupment in accordance with or in order to comply with the terms and provisions of the Company's clawback policy, as may be in effect from time to time (including, but not limited to, the Mandatory Clawback Policy), to the extent such policies are applicable to you and (ii) any other compensation recovery policy adopted after the RSUs are granted to facilitate compliance with applicable law, including in response to the </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.65pt;padding-left:6pt;padding-right:6.45pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">requirements of Section 10D of the Exchange Act, the U.S. Securities and Exchange Commission&#8217;s final rules thereunder, and any applicable listing rules or other rules and regulations implementing the foregoing.  For purposes of the foregoing, you expressly and explicitly authorize the Company to issue instructions, on your behalf, to the Stock Plan Administrator and any other brokerage firm and&#47;or third party administrator engaged by the Company to hold your Shares and other amounts acquired under the 2011 Plan to re-convey, transfer or otherwise return such Shares and&#47;or other amounts to the Company.</font></div><div style="margin-top:11.05pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">27.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;padding-left:16.27pt">By accepting the grant of the RSUs, you acknowledge that you have read these Terms and Conditions, the Addendum to these Terms and Conditions (as applicable) and the 2011 Plan and specifically accept and agree to the provisions therein.</font></div><div style="margin-top:11.2pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">***********************</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ia853adc2842843c292ab002ee46eb823_4"></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:3.65pt;padding-left:0.5pt;padding-right:0.5pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="margin-top:11.65pt;padding-left:198.75pt;padding-right:189.75pt;text-indent:27.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">ADDENDUM TO TERMS AND CONDITIONS</font></div><div style="padding-left:100.35pt;padding-right:66.9pt;text-indent:25.65pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">RELATING TO RESTRICTED STOCK UNITS GRANTED PURSUANT TO THE 2011 PLAN, AS AMENDED AND RESTATED</font></div><div style="margin-top:11.15pt;padding-left:6pt;padding-right:6.5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">In addition to the terms of the 2011 Plan and the Terms and Conditions, the RSUs are subject to the following additional terms and conditions (the &#34;Addendum&#34;). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">The information reflected in this Addendum is based on the securities, exchange control and other laws in effect in the respective countries as of November 2024. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">All capitalized terms as contained in this Addendum shall have the same meaning as set forth in the 2011 Plan and the Terms and Conditions. Pursuant to Section 23 of the Terms and Conditions, if you transfer your residence and&#47;or employment to another country reflected in an Addendum at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).</font></div><div style="margin-top:10.95pt;padding-left:6pt;padding-right:6.8pt;text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">Data Privacy Information&#58; European Union (&#34;EU&#34;) &#47; European Economic Area (&#34;EEA&#34;) &#47; Switzerland and the United Kingdom*</font></div><div style="margin-top:11.25pt;padding-left:6pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:119%">*The below information is for data privacy purposes only and you should determine whether any other special terms and conditions apply to your awards in these jurisdictions.</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. If you reside and&#47;or you are employed in the EU &#47; EEA, Switzerland or the United Kingdom the following provision replaces Section 16 of the Terms and Conditions&#58;</font></div><div style="margin-top:11.25pt;padding-left:6pt;padding-right:6.7pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">The Company is located at 1941 Stryker Way, Portage, Michigan 49002, U.S.A. and grants RSUs under the 2011 Plan to employees of the Company and its Subsidiaries in its sole discretion. You should review the following information about the Company's data processing practices.</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:5.35pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.68pt;text-decoration:underline">Data Collection, Processing and Usage</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Pursuant to applicable data protection laws, you are hereby notified that the Company collects, processes and uses certain personally identifiable information about you for the legitimate interest of implementing, administering and managing the 2011 Plan and generally administering equity awards&#59; specifically, including your name, home address, email address and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all options or any other awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the RSUs under the 2011 Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan. The Company's collection, processing, use and transfer of your personal data is necessary for the performance of the Company's contractual obligations under the 2011 Plan and pursuant to the Company's legitimate interest of managing and generally administering employee equity awards. Your refusal to provide personal data would make it impossible for the Company to perform its contractual obligations and may affect your ability to participate in the 2011 Plan. As such, by participating in the 2011 Plan, you voluntarily acknowledge the collection, processing and use of your personal data as described herein.</font></div><div style="margin-top:10.8pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.03pt;text-decoration:underline">Stock Plan Administration Service Provider</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The Company transfers participant data to the Stock Plan Administrator. In the future, the Company may select a different Stock Plan Administrator and share your data with another company that serves in a similar manner, including, but not limited to, the Company's outside legal counsel as well as the Company&#8217;s auditor. The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan. You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div style="margin-top:10.8pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:18.2pt;text-decoration:underline">International Data Transfers</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The Company and the Stock Plan Administrator are based in the United States. The Company can only meet its contractual obligations to you if your personal data is transferred to the United States. The Company's legal basis for the transfer of your personal data to the United States is to satisfy its contractual obligations to you and&#47;or its use of the standard data protection clauses adopted by the EU Commission.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.65pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.95pt;text-decoration:underline">Data Retention</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The Company will use your personal data only as long as is necessary to implement, administer and manage your participation in the 2011 Plan or as required to comply with legal or regulatory obligations, including under tax and security laws. When the Company no longer needs your personal data, the Company will remove it from its systems. If the Company keeps your data longer, it would be to satisfy legal or regulatory obligations and the Company's legal basis would be for compliance with relevant laws or regulations.</font></div><div style="margin-top:11.1pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(e)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.69pt;text-decoration:underline">Data Subject Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You may have a number of rights under data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country of residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of your personal data. To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company's Human Resources Department.</font></div><div style="margin-top:11.1pt;padding-left:6pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARGENTINA</font></div><div style="margin-top:11.6pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Neither the grant of the RSUs, nor the issuance of Shares subject to the RSUs, constitutes a public offering in Argentina. The grant of RSUs pursuant to the 2011 Plan is a private placement and is not subject to any filing or disclosure requirements in Argentina.</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. By accepting the RSUs, you acknowledge that you are proficient in reading and understanding English and fully understands the terms of the documents related to the RSUs (the Terms and Conditions, this Addendum and the 2011 Plan), which were provided in the English language. You accept the terms of these documents accordingly.</font></div><div style="margin-top:11.6pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Consentimiento ling&#252;&#237;stico.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> Al aceptar las RSU, usted reconoce que domina la lectura y la comprensi&#243;n del ingl&#233;s y comprende plenamente los t&#233;rminos de los documentos relacionados con las RSU (los T&#233;rminos y condiciones, este Anexo y el Plan 2011), que se proporcionaron en ingl&#233;s. Usted acepta los t&#233;rminos de estos documentos en consecuencia.</font></div><div><font><br></font></div><div style="padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AUSTRALIA</font></div><div style="margin-top:11.65pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">RSUs Conditioned on Satisfaction of Regulatory Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. If you are (a) a director of a Subsidiary incorporated in Australia, or (b) a person who is a management-level executive of a Subsidiary incorporated in Australia and who also is a director of a Subsidiary incorporated outside of Australia, the grant of the RSUs is conditioned upon satisfaction of the shareholder approval provisions of section 200B of the Corporations Act 2001 (Cth) in Australia.</font></div><div style="margin-top:11.15pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. This grant of RSUs is being made under Division 1A Part 7.12 of the Australian Corporations Act 2001 (Cth). If Shares acquired under the 2011 Plan are offered for sale to a person or entity resident in Australia, your offer may be subject to disclosure requirements under Australian law. You should obtain legal advice on any disclosure obligations prior to making any such offer.</font></div><div style="margin-top:11.15pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Tax Notification</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">  </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">The 2011 Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) applies (subject to conditions in the Act).</font></div><div style="margin-top:11.15pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Exchange control reporting is required for cash transactions exceeding AUD 10,000 and international fund transfers. The Australian bank assisting with the transaction will file the report. If there is no Australian bank involved in the transfer, you personally will be required to file the report. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.15pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AUSTRIA</font></div><div style="margin-top:11.8pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you hold Shares obtained under the 2011 Plan or cash (including proceeds from the sale of Shares) outside Austria, you may be required to submit quarterly reports to the Austrian National Bank. An exemption applies if the value of the Shares held outside Austria of any quarter does not exceed a certain threshold (currently &#8364;5,000,000). The deadline for filing the quarterly report is the 15th of the month following the end of the respective quarter.  When the Shares are sold, you may be required to comply with certain exchange control obligations if the cash proceeds from the sale is held outside </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.8pt;padding-left:6pt;padding-right:6.65pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Austria, as a separate reporting requirement applies to any non-Austrian cash accounts. If the transaction volume of all of your cash accounts abroad exceeds a certain threshold (currently &#8364;10,000,000), the movements and the balance of all accounts must be reported monthly, as of the last day of the month, on or before the 15th day of the following month, on the prescribed forms.  The thresholds described above may be subject to change. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:5.75pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BELGIUM</font></div><div style="margin-top:11.85pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Belgian residents are required to report any security (e.g, Shares acquired under the 2011 Plan) or bank account established outside of Belgium on their personal annual tax return. In a separate report, Belgian residents also are required to provide a central contact point of the National Bank of Belgium with the account number of those foreign bank accounts, the name of the bank with which the accounts were opened and the country in which they were opened in a separate report. This report, as well as additional information on how to complete it, can be found on the website of the National Bank of Belgium, </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.nbb.be</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, under the </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Kredietcentrales &#47; Centrales des credits </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">caption. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.7pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Stock Exchange Tax Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. A stock exchange tax applies to transactions executed by Belgian residents through a non-Belgian financial intermediary, such as a U.S. broker. The stock exchange tax will apply when Shares acquired pursuant to the RSUs are sold. You should consult with a personal tax or financial advisor for additional details on your obligations with respect to the stock exchange tax.</font></div><div style="margin-top:11.45pt;padding-left:6pt;padding-right:5.25pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Annual Securities Account Tax</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. An annual securities accounts tax may be payable if the total value of securities held in a Belgian or foreign securities account (e.g., Shares acquired under the 2011 Plan) exceeds a certain threshold on four reference dates within the relevant reporting period (i.e., December 31, March 31, June 30 and September 30). In such case, the tax will be due on the value of the qualifying securities held in such account. You should consult with a personal tax or financial advisor for additional details on your obligations with respect to the annual securities account tax.</font></div><div style="margin-top:11.35pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BRAZIL</font></div><div style="margin-top:11.6pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Labor Law Acknowledgment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. By accepting the RSUs, you acknowledge and agree, for all legal purposes, that (a) the benefits provided under the Terms and Conditions and the 2011 Plan are the result of commercial transactions unrelated to your employment&#59; (b) the Terms and Conditions and the 2011 Plan are not a part of the terms and conditions of your employment&#59; and (c) the income from the RSUs, if any, is not part of your remuneration from employment.</font></div><div style="margin-top:11.15pt;padding-left:6pt;padding-right:5.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. By accepting the RSUs, you acknowledge and agree to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with the vesting of the RSUs, the issuance and&#47;or sale of Shares acquired under the 2011 Plan and the receipt of any dividends.</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:5.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. If you are resident or domiciled in Brazil, you will be required to submit an annual declaration of assets and rights held outside of Brazil to the Central Bank of Brazil if the aggregate value of such assets and rights is greater than USD1 million as of December 31 of each year. If the aggregate value exceeds USD100 million as of the end of each quarter, a declaration must be submitted quarterly. Assets and rights that must be reported include Shares acquired under the 2011 Plan. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.1pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Tax on Financial Transaction (IOF)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Repatriation of funds (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">e.g.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, the proceeds from the sale of Shares) into Brazil and the conversion of USD into BRL associated with such fund transfers may be subject to the Tax on Financial Transactions. It is your responsibility to comply with any applicable Tax on Financial Transactions arising from your participation in the 2011 Plan. You should consult with your personal tax advisor for additional details.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.25pt;padding-left:5.75pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CANADA&#160;&#160;&#160;&#160;</font></div><div style="margin-top:11.6pt;padding-left:5.75pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.61pt;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Notwithstanding anything to the contrary in the Terms and Conditions or the 2011 Plan, the RSUs shall be settled only in Shares (and may not be settled in cash).</font></div><div style="margin-top:11.25pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The following supplements Section 2(b) of the Terms and Conditions as well as any other section required to give effect to the same&#58;</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:6.35pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">In the event of your termination of employment for any reason (other than by reason of death, Disability or Retirement), either by you or by the Employer, with or without cause, your rights to vest or to continue to vest in the RSUs and receive Shares under the 2011 Plan, if any, will terminate as of the actual Termination Date. For this purpose, the &#34;Termination Date&#34; shall mean the last day on which you are actively employed by the Employer, and shall not include or be extended by any period following such day during which you are in receipt of or eligible to receive any notice of termination, pay in lieu of notice of termination, severance pay or any other payments or damages, whether arising under statute, contract or at common law.</font></div><div style="margin-top:11.05pt;padding-left:6pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued entitlement to vesting during a statutory notice period, your right to vest in the RSUs under the 2011 Plan, if any, will terminate effective as of the last day of your minimum statutory notice period, but you will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of your statutory notice period, nor will you be entitled to any compensation for lost vesting.</font></div><div style="margin-top:11.15pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:21.66pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Specified foreign property, including the RSUs, Shares acquired under the 2011 Plan, and other rights to receive shares of a non-Canadian company held by a Canadian resident generally must be reported annually on a Form T1135 (Foreign Income Verification Statement) if the total cost of the specified foreign property exceeds C$100,000 at any time during the year. Thus, the unvested portion of the RSUs must be reported &#8211; generally at a nil cost &#8211; if the C$100,000 cost threshold is exceeded because you holds other specified foreign property. When Shares are acquired, their cost generally is the adjusted cost base (&#8220;ACB&#8221;) of the Shares. The ACB ordinarily will equal the fair market value of the Shares at the time of acquisition, but if you owns other Shares, the ACB may need to be averaged with the ACB of the other Shares. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:10.95pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:11.25pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2025 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.086%"><tr><td style="width:1.0%"></td><td style="width:45.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.115%"></td><td style="width:0.1%"></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Signature</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Name (Printed)</font></div></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Date</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="margin-top:11.25pt;padding-left:6pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CHILE</font></div><div style="margin-top:11.65pt;padding-left:82.2pt;text-align:justify;text-indent:-40.9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:32.56pt;text-decoration:underline">Private Placement</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The following provision shall replace Section 17 of the Terms</font></div><div style="margin-top:0.35pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and Conditions&#58;</font></div><div style="margin-top:11.65pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">The grant of the RSUs hereunder is not intended to be a public offering of securities in Chile but instead is intended to be a private placement.</font></div><div style="margin-top:3.65pt;padding-left:9pt;text-indent:67.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.73pt">The starting date of the offer will be the grant date, and this offer conforms to General Ruling no. 336 of the Chilean Commission for the Financial Markets (&#34;CMF&#34;)&#59;</font></div><div style="margin-top:11.65pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.03pt">The offer deals with securities not registered in the registry of securities or in the registry of foreign securities of the CMF, and therefore such securities are not subject to its oversight&#59;</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:18.2pt">The Company, as the issuer, is not obligated to provide public information in Chile regarding the foreign securities, as such securities are not registered with the CMF&#59; and</font></div><div style="margin-top:11.25pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.95pt">The Shares, as foreign securities, shall not be subject to public offering as long as they are not registered with the corresponding registry of securities in Chile.</font></div><div style="margin-top:12pt;padding-left:5.75pt;padding-right:6.5pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%;padding-left:17.76pt">La fecha de inicio de la oferta ser&#225; el de la fecha de otorgamiento y esta oferta se acoge a la norma de Car&#225;cter General n&#176; 336 de la Comisi&#243;n para el Mercado Financiero Chilena (&#34;CMF&#34;)&#59;</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%;padding-left:17.56pt">La oferta versa sobre valores no inscritos en el registro de valores o en el registro de valores extranjeros que lleva la CMF, por lo que tales valores no est&#225;n sujetos a la fiscalizaci&#243;n de &#233;sta&#59;</font></div><div style="margin-top:11.25pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%;padding-left:18.53pt">Por tratar de valores no inscritos no existe la obligaci&#243;n por parte del emisor de entregar en chile informaci&#243;n p&#250;blica respecto de esos valores&#59; y</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%;padding-left:16.95pt">Esos valores no podr&#225;n ser objeto de oferta p&#250;blica mientras no sean inscritos en el registro de valores correspondiente.</font></div><div style="margin-top:11.45pt;padding-left:6pt;padding-right:5.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If your aggregate investments held outside of Chile (including the value of Shares acquired under the 2011 Plan) are equal to or greater than USD5,000,000, you must provide the Central Bank with updated information accumulated for a three-month period within 45 calendar days of March 31, June 30 and September 30 and within 60 calendar days of December 31. Annex 3.1 of Chapter XII of the Foreign Exchange Regulations Manual must be used to file this report. You are not required to repatriate funds obtained from the sale of Shares or the receipt of any dividends to Chile. However, if you decide to repatriate such funds, you must do so through the Formal Exchange Market if the funds exceed USD10,000. In such case, you must report the payment to a commercial bank or the registered foreign exchange office receiving the funds. If you do not repatriate the funds and instead use such funds for the payment of other obligations contemplated under a different Chapter of the Foreign Exchange Regulations, you must sign Annex 1 of the Manual of Chapter XII of the Foreign Exchange Regulations and file it directly with the Central Bank within the first 10 days of the month immediately following the transaction. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.95pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Chilean Internal Revenue Service (&#8220;CIRS&#8221;) requires all taxpayers to provide information annually regarding&#58; (a) any taxes paid abroad which they will use as a credit against Chilean income taxes, and (b) the results of foreign investments. These annual reporting obligations must be complied with by submitting a sworn statement setting forth this information before July 1 of each year. The sworn statement disclosing this information (or </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Formularios</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) must be submitted electronically through the CIRS website, </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.sii.cl</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, using Form 1929. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.45pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CHINA</font></div><div style="margin-top:11.6pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">RSUs Conditioned on Satisfaction of Regulatory Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. If you are a People's Republic of China (&#34;PRC&#34;) national, the grant of the RSUs is conditioned upon the Company securing all necessary approvals from the PRC State Administration of Foreign Exchange to permit the operation of the 2011 Plan and the participation of PRC nationals employed by your Employer, as determined by the Company in its sole discretion.</font></div><div style="margin-top:3.65pt;padding-left:5.75pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.61pt;text-decoration:underline">Sale of Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Notwithstanding anything to the contrary in the 2011 Plan, upon any termination of employment with your Employer, you shall be required to sell all Shares acquired under the 2011 Plan within such time period as may be established by the PRC State Administration of Foreign Exchange.</font></div><div style="margin-top:11.25pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Exchange Control Restrictions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You acknowledge and agree that you will be required immediately to repatriate to the PRC the proceeds from the sale of any Shares acquired under the 2011 Plan, as well as any other cash amounts attributable to the Shares acquired under the 2011 Plan (collectively, &#34;Cash Proceeds&#34;). Further, you acknowledge and agree that the repatriation of the Cash Proceeds must be effected through a special bank account established by your Employer, the Company or one of its Subsidiaries, and you hereby consent and agree that the Cash Proceeds may be transferred to such account by the Company on your behalf prior to being delivered to you. The Cash Proceeds may be paid to you in U.S. dollars or local currency at the </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.25pt;padding-left:6pt;padding-right:6.45pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Company's discretion. If the Cash Proceeds are paid to you in U.S. dollars, you understand that a U.S. dollar bank account must be established and maintained in China so that the proceeds may be deposited into such account. Additionally, if the Company changes its Stock Plan Administrator, you acknowledge and agree that the Company may transfer any Shares issued under the 2011 Plan to the new designated Stock Plan Administrator if necessary for legal or administrative reasons. You agree to sign any documentation necessary to facilitate the transfer. If the Cash Proceeds are paid to you in local currency, you acknowledge and agree that the Company is under no obligation to secure any particular exchange conversion rate and that the Company may face delays in converting the Cash Proceeds to local currency due to exchange control restrictions. You agree to bear any currency fluctuation risk between the time the Shares are sold and the Cash Proceeds are converted into local currency and distributed to you. You further agree to comply with any other requirements that may be imposed by your Employer, the Company and its Subsidiaries in the future in order to facilitate compliance with exchange control requirements in the PRC.</font></div><div style="margin-top:10.7pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">COLOMBIA</font></div><div style="margin-top:11.6pt;padding-left:6pt;padding-right:5.35pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. In addition to the provisions of Section 13 of the Terms and Conditions you acknowledge that, pursuant to Article 128 of the Colombian Labor Code, the 2011 Plan and related benefits do not constitute a component of your &#34;salary&#34; for any legal purpose. Therefore, they will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as legal&#47;fringe benefits, vacations, indemnities, payroll taxes, social insurance contributions and&#47;or any other labor-related amount which may be payable.</font></div><div style="margin-top:11.15pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The Shares subject to the RSUs are not and will not be registered in the Colombian registry of publicly traded securities (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">Registro Nacional de Valores y Emisores</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">) and therefore the Shares may not be offered to the public in Colombia. Nothing in this document should be construed as the making of a public offer of securities in Colombia.</font></div><div style="margin-top:11.15pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Investments in assets located outside Colombia (including Shares) are subject to registration with the Central Bank (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">Banco de la Rep&#250;blica</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">), as foreign investments held abroad, regardless of value. In addition, all payments related to the liquidation of such investments must be transferred through the Colombian foreign exchange market (e.g. local banks), which includes the obligation of correctly completing and filing the appropriate foreign exchange form (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">declaraci&#243;n de cambio</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">). You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.05pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. An annual informative return must be filed with the Colombian Tax Office detailing any assets held abroad (including the Shares acquired under the 2011 Plan). If the individual value of any of these assets exceeds a certain threshold, each asset must be described (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">e.g., </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">its nature and its value) and the jurisdiction in which it is located must be disclosed. You acknowledge that you personally are responsible for complying with this tax reporting requirement. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.1pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">COSTA RICA</font></div><div style="margin-top:11.65pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No country specific provisions.</font></div><div style="margin-top:11.6pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">DENMARK</font></div><div style="margin-top:12pt;padding-left:5.75pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.61pt;text-decoration:underline">Treatment of RSUs upon Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Notwithstanding any provision in the Terms and Conditions or the 2011 Plan to the contrary, unless you are a member of registered management who is not considered a salaried employee, the treatment of the RSUs upon a termination of employment which is not a result of death shall be governed by Sections 4 and 5 of the Danish Act on Stock Option in Employment Relations (the &#34;Act&#34;). You acknowledge any grant of RSUs under the 2011 Plan is subject to the rules of such amended Act. However, if the provisions in the Terms and Conditions or the 2011 Plan governing the treatment of the RSUs upon a termination of employment are more favorable, then the provisions of the Terms and Conditions or the 2011 Plan will govern, as set forth in the Employer Statement, included as Exhibit A to this Addendum, and which is being provided to comply with the Act.</font></div><div style="margin-top:12pt;padding-left:5.75pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.61pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Danish residents who establish an account holding Shares or an account holding cash outside Denmark must report the account to the Danish Tax </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:12pt;padding-left:5.75pt;padding-right:6.5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Administration as part of their annual tax return under the section related to foreign affairs and income. The form which should be used in this respect can be obtained from a local bank. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.1pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FINLAND</font></div><div style="margin-top:11.6pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Withholding of Tax-Related Items</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Notwithstanding anything in Section 6 of the Terms and Conditions to the contrary, if you are a local national of Finland, any Tax-Related Items shall be withheld only in cash from your regular salary&#47;wages or other amounts payable to you in cash or such other withholding methods as may be permitted under the 2011 Plan and allowed under local law.</font></div><div style="margin-top:11.15pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Finland has not adopted any specific reporting requirements with respect to foreign assets&#47;accounts. However, you should check your pre-completed tax return to confirm that the ownership of Shares and other securities (foreign or domestic) are correctly reported. If you find any errors or omissions, you must make the necessary corrections electronically or by sending specific paper forms to the local tax authorities. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.1pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FRANCE</font></div><div style="margin-top:11.65pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Non-Qualified Nature of RSUs</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The Award granted pursuant to the Terms and Conditions is not intended to be &#8220;French-qualified&#8221; and is ineligible for specific tax and&#47;or social security treatment in France under Sections L. 225-197-1 to L. 225-197-5 and Sections L. 22-10-59 to L. 22-10-60 of the French Commercial Code, as amended.</font></div><div style="margin-top:11.15pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The value of any cash or securities imported to or exported from France without the use of a financial institution must be reported to the customs and excise authorities when the value of such cash or securities is equal to or greater than a certain amount (currently &#8364;10,000). You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.15pt;padding-left:6pt;padding-right:5.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. French residents must report annually any shares and bank accounts held outside France, including the accounts that were opened, used and&#47;or closed during the tax year, to the French tax authorities, on an annual basis on a special Form N&#176; 3916, together with your personal income tax return. Failure to report triggers a significant penalty. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.1pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Use of English Language</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. By accepting your RSUs, you acknowledge and agree that it is your wish that the Terms and Conditions, this Addendum, as well as all other documents, notices and legal proceedings entered into, given or instituted pursuant to your RSUs, either directly or indirectly, be drawn up in English.</font></div><div style="margin-top:11.15pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Langue anglaise</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. En acceptant l'allocation de vos RSUs, vous reconnaissez et acceptez avoir</font></div><div style="margin-top:3.65pt;padding-left:6pt;padding-right:6.5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">souhait&#233; que le Termes et Conditions, le pr&#233;sent avenant, ainsi que tous autres documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaires intent&#233;es, relatifs, directement ou indirectement, &#224; l'allocation de vos RSUs, soient r&#233;dig&#233;s en anglais.</font></div><div style="margin-top:11.2pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:11.25pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2025 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:11.15pt;padding-left:6pt;text-indent:35.3pt"><font><br></font></div><div style="margin-top:11.15pt;padding-left:6pt;text-indent:35.3pt"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.086%"><tr><td style="width:1.0%"></td><td style="width:45.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.115%"></td><td style="width:0.1%"></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Signature</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Name (Printed)</font></div></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Date</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="margin-top:11.05pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GERMANY</font></div><div style="margin-top:11.65pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> Cross-border payments in excess of &#8364;12,500 in connection with the 2011 Plan (</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">e.g.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, proceeds from the sale of Shares acquired under the 2011 Plan) and&#47;or if the Company withholds or sells Shares with a value in excess of EUR 12,500 for any Tax-Related Items, </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">must be reported to the German Federal Bank (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">Bundesbank</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">) by the fifth day of the month following the month in which the payment is received or made. If you acquire Shares with a value in excess of &#8364;12,500, the Employer will report the acquisition of such Shares to the German Federal Bank. If you otherwise make or receive a payment in excess of &#8364;12,500, you personally must report the payment to Bundesbank electronically using the &#8220;General Statistics Reporting Portal&#8221; (&#8220;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">Allgemeines Meldeportal Statistik</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">&#8221;) available via Bundesbank&#8217;s website (</font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;text-decoration:underline">www.bundesbank.de</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">). You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. German residents must notify their local tax office of the acquisition of Shares when they file their personal income tax returns for the relevant year if the value of the Shares acquired exceeds &#8364;150,000 or in the unlikely event that the resident holds Shares exceeding 10% of the Company&#8217;s total Shares outstanding. However, if the Shares are listed on a recognized U.S. stock exchange and you own less than 1% of the total Shares, this requirement will not apply even if Shares with a value exceeding &#8364;150,000 are acquired. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.05pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">HONG KONG</font></div><div style="margin-top:11.6pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Important Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Warning&#58; The contents of the Terms and Conditions, this Addendum, the 2011 Plan, and all other materials pertaining to the RSUs and&#47;or the 2011 Plan have not been reviewed by any regulatory authority in Hong Kong. You are hereby advised to exercise caution in relation to the offer thereunder. If you have any doubts about any of the contents of the aforesaid materials, you should obtain independent professional advice.</font></div><div style="margin-top:11.15pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. If, for any reason, Shares are issued to you within six (6) months of the grant date, you agree that you will not sell or otherwise dispose of any such Shares prior to the six-month anniversary of the grant date.</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Notwithstanding anything to the contrary in this Addendum, the Terms and Conditions or the 2011 Plan, the RSUs shall be settled only in Shares (and may not be settled in cash).</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Nature of the 2011 Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The Company specifically intends that the 2011 Plan will not be treated as an occupational retirement scheme for purposes of the Occupational Retirement Schemes Ordinance (&#34;ORSO&#34;). To the extent any court, tribunal or legal&#47;regulatory body in Hong Kong determines that the 2011 Plan constitutes an occupational retirement scheme for the purposes of ORSO, the grant of the RSUs shall be null and void.</font></div><div style="margin-top:11.25pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">INDIA</font></div><div style="margin-top:11.6pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Any funds realized in connection with the 2011 Plan (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">e.g.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, proceeds from the sale of Shares and cash dividends paid on the Shares) must be repatriated to India within a specified period of time after receipt as prescribed under Indian exchange control laws.  You are personally responsible for obtaining a foreign inward remittance certificate (&#8220;FIRC&#8221;) from the bank where you deposit the foreign currency and holding the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India or your Employer requests proof of repatriation.  You are personally responsible for complying with </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.6pt;padding-left:6pt;padding-right:6.7pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">exchange control laws in India, and neither the Company nor your Employer will be liable for any fines or penalties resulting from your failure to comply with applicable laws.  You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You are required to declare your foreign bank accounts and any foreign financial assets (including Shares acquired under the 2011 Plan held outside India) in your annual tax return. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.1pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">IRELAND</font></div><div style="margin-top:11.85pt;padding-left:6pt;padding-right:5.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Director Notification Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you are a director, shadow director or secretary of an Irish subsidiary whose interest in the Company represents more than 1% of the Company&#8217;s voting share capital, you are required to notify such Irish subsidiary in writing within a certain time period. upon the acquisition of RSUs or any Shares issued pursuant to RSUs. This notification requirement also applies with respect to the interests in the Company of your spouse or children under the age of 18 (whose interests will be attributed to you in your capacity as a director, shadow director or secretary of the Irish subsidiary).</font></div><div style="margin-top:11.35pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ISRAEL</font></div><div style="margin-top:12.1pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Tax Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company obtained a tax ruling from the Israeli Tax Authority (&#8220;ITA&#8221;) on 30 April 2024 which determined that the taxable event for the RSUs granted to employees in Israel will be upon the vesting of the RSUs and the issuance of the Shares (the &#8220;Tax Ruling&#8221;). You may review a copy of the Tax Ruling by contacting stockplanadministration&#64;stryker.com. By accepting the RSUs, you acknowledge and declare that you are aware of the Tax Ruling specifying that the RSUs will be subject to income tax and social insurance contributions at vesting&#47;settlement of the RSUs and at which time tax withholding will be required. The payment of any tax due upon sale of any Shares is your personal liability. Furthermore, the Tax Ruling determined that if you choose not to sell the Shares acquired upon vesting&#47;settlement of the RSUs immediately following issuance of such Shares, you will have to transfer your Shares, within 10 calendar days of the date such Shares are deposited into your brokerage account with the Stock Plan Administrator, to a personal brokerage account in Israel. Pursuant to the Tax Ruling, you are not permitted to hold the Shares in your brokerage account with the Stock Plan Administrator t. Notwithstanding the aforesaid, you acknowledge and declare that you are aware, accept and will have no claims or arguments towards the Company if it applies for and&#47;or will apply for any other or additional tax rulings with the ITA with respect to the Israeli tax treatment of the RSUs, including the RSUs that were granted and&#47;or the RSUs that may be granted in the future, or if it decides not to do so.</font></div><div style="margin-top:12.1pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The grant of the RSUs pursuant to the 2011 Plan does not constitute a public offering under the Securities Law, 1968.</font></div><div style="margin-top:11.25pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ITALY</font></div><div style="margin-top:11.85pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Italian residents who, at any time during the fiscal year, hold foreign financial assets (including cash and Shares) which may generate income taxable in Italy are required to report these assets on their annual tax returns (UNICO Form, RW Schedule) for the year during which the assets are held, or on a special form if no tax return is due. These reporting obligations will also apply to Italian residents who are the beneficial owners of foreign financial assets under Italian money laundering provisions. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:3.85pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:39pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.66pt;text-decoration:underline">Foreign Asset Tax</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The value of any Shares (and other financial assets) held outside Italy by individuals resident of Italy may be subject to a foreign asset tax. The taxable amount will be the fair market value of the financial assets (e.g., Shares) assessed at the end of the calendar year. The value of financial assets held abroad must be reported in Form RM of the annual return. You should consult your personal tax advisor for additional information on the foreign asset tax.</font></div><div style="margin-top:11.25pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">JAPAN</font></div><div style="margin-top:11.8pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you acquire Shares valued at more than &#165;100,000,000 in a single transaction, you must file a Securities Acquisition Report with the Ministry of Finance through the Bank </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.8pt;padding-left:6pt;padding-right:6.5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of Japan within 20 days of the purchase of the Shares. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.5pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You will be required to report details of any assets held outside Japan as of December 31st to the extent such assets have a total net fair market value exceeding &#165;50,000,000. This report is due by March 15 each year. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.3pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MEXICO</font></div><div style="margin-top:11.65pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Commercial Relationship</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You expressly recognize that your participation in the 2011 Plan and the Company's grant of the RSUs does not constitute an employment relationship between you and the Company. You have been granted the RSUs as a consequence of the commercial relationship between the Company and the Subsidiary in Mexico that employs you, and the Company's Subsidiary in Mexico is your sole employer. Based on the foregoing, (a) you expressly recognize the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan do not establish any rights between you and the Company's Subsidiary in Mexico that employs you, (b) the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan are not part of the employment conditions and&#47;or benefits provided by the Company's Subsidiary in Mexico that employs you, and (c) any modification or amendment of the 2011 Plan by the Company, or a termination of the 2011 Plan by the Company, shall not constitute a change or impairment of the terms and conditions of your employment with the Company's Subsidiary in Mexico that employs you.</font></div><div style="margin-top:10.95pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You expressly recognize and acknowledge that the Company's grant of RSUs and the underlying Shares under the 2011 Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico. In addition, the 2011 Plan, the Terms and Conditions and any other document relating to the RSUs may not be publicly distributed in Mexico. These materials are addressed to you only because of your existing relationship with the Company and these materials should not be reproduced or copied in any form. The offer contained in these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of the Employer in Mexico made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.</font></div><div style="margin-top:10.95pt;padding-left:6pt;padding-right:6.35pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Extraordinary Item of Compensation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You expressly recognize and acknowledge that your participation in the 2011 Plan is a result of the discretionary and unilateral decision of the Company, as well as your free and voluntary decision to participate in the 2011 Plan in accord with the terms and conditions of the 2011 Plan, the Terms and Conditions, and this Addendum. As such, you acknowledge and agree that the Company may, in its sole discretion, amend and&#47;or discontinue your participation in the 2011 Plan at any time and without any liability. The value of the RSUs is an extraordinary item of compensation outside the scope of your employment contract, if any. The RSUs are not part of your regular or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits, or any similar payments, which are the exclusive obligations of the Company's Subsidiary in Mexico that employs you.</font></div><div style="margin-top:11pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:11.2pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2025 TO</font></div><div style="margin-top:3.65pt;padding-left:6pt"><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.</font></div><div style="margin-top:3.65pt;padding-left:6pt"><font><br></font></div><div style="margin-top:3.65pt;padding-left:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.086%"><tr><td style="width:1.0%"></td><td style="width:45.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.115%"></td><td style="width:0.1%"></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Signature</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Name (Printed)</font></div></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Date</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:0.05pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NETHERLANDS</font></div><div style="margin-top:11.6pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Waiver of Termination Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. As a condition to the grant of the RSUs, you hereby waive any and all rights to compensation or damages as a result of the termination of your employment with the Company and your Employer for any reason whatsoever, insofar as those rights result or may result from (a) the loss or diminution in value of such rights or entitlements under the 2011 Plan, or (b) you ceasing to have rights under or ceasing to be entitled to any awards under the 2011 Plan as a result of such termination.</font></div><div style="margin-top:11.1pt;padding-left:5.75pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.61pt;text-decoration:underline">Tax Deferral Upon Retirement</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Unless you otherwise elect by contacting Stryker no later than April 28, 2025, you hereby agree that upon Retirement eligibility, the RSUs shall not become taxable until the date of settlement when Shares are actually delivered or otherwise made available.</font></div><div style="margin-top:11.2pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NEW ZEALAND</font></div><div style="margin-top:11.05pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">WARNING</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You are being offered RSUs to be settled in the form of shares of Stryker Corporation common stock. If the Company runs into financial difficulties and is wound up, you may lose some or all your investment. New Zealand law normally requires people who offer financial products to give information to investors before they invest. This requires those offering financial products to have disclosed information that is important for investors to make an informed decision. The usual rules do not apply to this offer because it is an offer made under the Employee Share Scheme exemption. As a result, you may not be given all the information usually required.  You will also have fewer other legal protections for this investment. You should ask questions, read all documents carefully, and seek independent financial advice before accepting the offer. The Company's Shares are currently traded on the New York Stock Exchange under the ticker symbol &#34;SYK&#34; and Shares acquired under the 2011 Plan may be sold through this exchange. You may end up selling the Shares at a price that is lower than the value of the Shares when you acquired them. The price will depend on the demand for the Company's Shares. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">The Company's most recent annual report (which includes the Company's financial statements) is available at </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%;text-decoration:underline">https&#58;&#47;&#47;investors.stryker.com&#47;financial-information&#47;annual-reports&#47;default.aspx</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">. You are entitled to receive a copy of this report, free of charge, upon written request to the Company at </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">.</font></div><div style="margin-top:11.05pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">POLAND</font></div><div style="margin-top:11.8pt;padding-left:6.5pt;padding-right:5.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:121%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:121%;padding-left:21.86pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:121%">. If you maintain bank or brokerage accounts holding cash and foreign securities (including Shares) outside of Poland, you will be required to report information to the National Bank of Poland on transactions and balances in such accounts if the value of such cash and securities exceeds PLN 7 million. If required, such reports must be filed on special forms available on the website of the National Bank of Poland. Further, any transfer of funds in excess of a certain threshold (generally, EUR 15,000) into or out of Poland must be effected through a bank account in Poland. Finally, you are required to store all documents connected with any foreign exchange transactions that you engage in for a period of five years, as measured from the end of the year in which such transaction occurred. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.8pt;padding-left:6.5pt;padding-right:5.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:121%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:121%;padding-left:21.86pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:121%">.  Polish residents holding foreign securities(e.g., Shares) and&#47;or maintaining accounts abroad are obligated to file quarterly reports with the National Bank of Poland incorporating information on transactions and balances of the securities and cash deposited in such accounts if the value of such securities and cash (when combined with all other assets held abroad) exceeds PLN 7,000,000. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.85pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PORTUGAL</font></div><div style="margin-top:12.05pt;padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No country specific provisions.</font></div><div style="margin-top:11.65pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PUERTO RICO</font></div><div style="margin-top:11.6pt;padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No country specific provisions.</font></div><div style="margin-top:11.65pt;padding-left:6pt"><font><br></font></div><div style="margin-top:11.05pt;padding-left:6pt"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.05pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ROMANIA</font></div><div style="margin-top:11.8pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You are not required to seek special authorization from the National Bank of Romania in order to open or maintain a foreign bank account. However, if you remit foreign currency into Romania (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, proceeds from the sale of Shares), you may be required to provide the Romanian bank through which the foreign currency is transferred with appropriate documentation. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.35pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RUSSIA</font></div><div style="margin-top:11.65pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">IMPORTANT EMPLOYEE NOTIFICATION.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> You may be required to repatriate certain cash amounts received with respect to the RSUs to Russia as soon as you intend to use those cash amounts for any purpose, including reinvestment. If the repatriation requirement applies, such funds must initially be credited to you through a foreign currency account at an authorized bank in Russia. After the funds are initially received in Russia, they may be further remitted to foreign banks in accordance with Russian exchange control laws. Under the Directive N 5371-U of the Russian Central Bank (the &#34;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">CBR</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">&#34;), the repatriation requirement may not apply in certain cases with respect to cash amounts received in an account that is considered by the CBR to be a foreign brokerage account. Statutory exceptions to the repatriation requirement also may apply. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">You should contact your personal advisor to ensure compliance with the applicable exchange control requirements prior to vesting in the RSUs and&#47;or selling the Shares acquired pursuant to the RSUs.</font></div><div style="margin-top:10.95pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">SECURITIES LAW NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The grant of RSUs and the issuance of Shares upon vesting are not intended to be an offering of securities with the Russian Federation, and the Terms and Conditions, the 2011 Plan, this Addendum and all other materials that you receive in connection with the grant of RSUs and your participation in the 2011 Plan (collectively, &#34;Grant Materials&#34;) do not constitute advertising or a solicitation within the Russian Federation. In connection with your grant of RSUs, the Company has not submitted any registration statement, prospectus or other filing with the Russian Federal Bank or any other governmental or regulatory body within the Russian Federation, and the Grant Materials expressly may not be used, directly or indirectly, for the purpose of making a securities offering or public circulation of Shares within the Russian Federation. Any Shares acquired under the 2011 Plan will be maintained on your behalf outside of Russia. Moreover, you will not be permitted to sell or otherwise alienate any Shares directly to other Russian legal entities or individuals.</font></div><div style="margin-top:10.95pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">EXCHANGE CONTROL NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You are solely responsible for complying with applicable Russian exchange control regulations. Since the exchange control regulations change frequently and without notice, you should consult your legal advisor prior to the acquisition or sale of Shares under the 2011 Plan to ensure compliance with current regulations. As noted, it is your personal responsibility to comply with Russian exchange control laws, and neither the Company nor any Subsidiary will be liable for any fines or penalties resulting from failure to comply with applicable laws.</font></div><div style="margin-top:10.95pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">ANTI-CORRUPTION NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Anti-corruption laws prohibit certain public servants, their spouses and their dependent children from owning any foreign source financial instruments (e.g., shares of foreign companies such as the Company). Accordingly, you should inform the Company if you are covered by these laws as this relates to your acquisition of Shares under the 2011 Plan.</font></div><div style="margin-top:11.65pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SINGAPORE</font></div><div style="margin-top:11.6pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Qualifying Person Exemption</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The following provision shall replace Section 16 of the Terms and Conditions&#58;</font></div><div style="margin-top:11.25pt;padding-left:6pt;padding-right:6.65pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">The grant of the RSUs under the 2011 Plan is being made pursuant to the &#34;Qualifying Person&#34; exemption&#34; under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (&#34;SFA&#34;). The 2011 Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore. You should note that, as a result, the RSUs are subject to section 257 of the SFA and you will not be able to make (a) any subsequent sale of the Shares in Singapore or (ii) any offer of such subsequent sale of the Shares subject to the RSUs in Singapore, unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA (Chapter 289, 2006 Ed.).</font></div><div style="margin-top:11.05pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Director Reporting Notification</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. If you are a director, associate director or shadow director of a Singapore company, you are subject to certain notification requirements under the Singapore Companies Act. </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.05pt;padding-left:6pt;padding-right:6.55pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Among these requirements is an obligation to notify the Singapore company in writing when you receive an interest (e.g., RSUs or Shares) in the Company or any related company. In addition, you must notify the Singapore company when you sell Shares (including when you sell Shares acquired at vesting of the RSUs). These notifications must be made within two business days of acquiring or disposing of any interest in the Company or any related company. In addition, a notification must be made of your interests in the Company or any related company within two business days of becoming a director.</font></div><div style="margin-top:11.05pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Insider Trading Notice.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">You acknowledge that you should be aware of the Singapore insider-trading rules, which may impact your ability to acquire or dispose of Shares. Under the Singapore insider-trading rules, you are prohibited from selling Shares when you are in possession of information concerning the Company which is not generally available and which you know or should know will have a material effect on the price of such Shares once such information is generally available.</font></div><div style="margin-top:11.05pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SOUTH AFRICA</font></div><div style="margin-top:11.65pt;padding-left:6pt;padding-right:5.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. In addition to the provisions of Section 6 of the Terms and Conditions, you agree to notify your Employer in South Africa of the amount of any gain realized upon vesting of the RSUs. If you fail to advise your Employer of the gain realized upon vesting of the RSUs, you may be liable for a fine. You will be responsible for paying any difference between the actual tax liability and the amount withheld.</font></div><div style="margin-top:11.8pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You are solely responsible for complying with applicable exchange control regulations and rulings (the &#34;Exchange Control Regulations&#34;) in South Africa. As the Exchange Control Regulations change frequently and without notice, you should consult your legal advisor prior to the acquisition or sale of Shares under the 2011 Plan to ensure compliance with current Exchange Control Regulations. Neither the Company nor any of its Subsidiaries will be liable for any fines or penalties resulting from your failure to comply with applicable laws. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.8pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information and Deemed Acceptance of RSUs</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Neither the RSUs nor the underlying Shares shall be publicly offered or listed on any stock exchange in South Africa. The offer is intended to be private pursuant to Section 96 of the Companies Act and is not subject to the supervision of any South African governmental authority. Pursuant to Section 96 of the Companies Act, the RSU offer must be finalized on or before the 60th day following the grant date. If you do not want to accept the RSUs, you are required to decline the RSUs no later than the 60th day following the grant date. If you do not reject the RSUs on or before the 60th day following the grant date, you will be deemed to accept the RSUs.</font></div><div style="margin-top:11.05pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SOUTH KOREA</font></div><div style="margin-top:11.8pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:39pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.66pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Korean residents who sell Shares acquired under the 2011 Plan and&#47;or receive cash dividends on the Shares may have to file a report with a Korean foreign exchange bank, provided the proceeds are in excess of USD5,000 (per transaction) and deposited into a non-Korean bank account. A report may not be required if proceeds are deposited into a non-Korean brokerage account. It is your responsibility to ensure compliance with any applicable exchange control reporting obligations.  You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.8pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:39pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.66pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Korean residents must declare all foreign financial accounts (e.g., non-Korean bank accounts, brokerage accounts) to the Korean tax authority and file a report with respect to such accounts in June of the following year if the monthly balance of such accounts exceeds KRW 500 million (or an equivalent amount in foreign currency) on any month-end date during a calendar year. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.35pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SPAIN</font></div><div style="margin-top:10.85pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:39pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:18.66pt;text-decoration:underline">Acknowledgement of Discretionary Nature of the 2011 Plan&#59; No Vested Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. In accepting the RSUs, you acknowledge that you consent to participation in the 2011 Plan and have received a copy of the 2011 Plan. You understand that the Company has unilaterally, gratuitously and in its sole discretion granted RSUs under the 2011 Plan to individuals who may be employees of the Company or its Subsidiaries throughout the </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:10.85pt;padding-left:6pt;padding-right:6.55pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">world. The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Company or any of its Subsidiaries on an ongoing basis. Consequently, you understand that the RSUs are granted on the assumption and condition that the RSUs and the Shares acquired upon vesting of the RSUs shall not become a part of any employment contract (either with the Company or any of its Subsidiaries) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever. In addition, you understand that this grant would not be made to you but for the assumptions and conditions referenced above. Thus, you acknowledge and freely accept that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, the RSUs shall be null and void.  You understand and agree that, as a condition of the grant of the RSUs, any unvested RSUs as of the date you cease active employment will be forfeited without entitlement to the underlying Shares or to any amount of indemnification in the event of the termination of employment by reason of, but not limited to, (i) material modification of the terms of employment under Article 41 of the Workers' Statute or (ii) relocation under Article 40 of the Workers' Statute. You acknowledge that you have read and specifically accept the conditions referred to in the Terms and Conditions regarding the impact of a termination of employment on your RSUs.</font></div><div style="margin-top:10.85pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:39pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:18.66pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. If you hold 10% or more of the Share capital of the Company or such other amount that would entitle you to join the Company's board of directors, the acquisition, ownership and disposition of such Shares must be declared for statistical purposes to the </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:119%">Spanish Direcci&#243;n General de Comercio e Inversiones </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(the Bureau for Commerce and Investments), which is a department of the Ministry of Economy and Competitiveness. The declaration (via Form 6) must be made in January for Shares acquired or disposed of during the prior calendar year and&#47;or for Shares owned as of December 31 of the prior calendar year&#59; provided, if the value of the Shares acquired or sold exceeds &#8364;1,502,530, the declaration must be filed within one month of the acquisition or disposition of the Shares, as applicable. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:10.85pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:39pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:18.66pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. To the extent you hold rights or assets (e.g., cash or the Shares held in a bank or brokerage account) outside of Spain with a value in excess of &#8364;50,000 per type of right or asset as of December 31 each year (or at any time during the year in which you sell or dispose of such right or asset), you are required to report information on such rights and assets on your tax return for such year. After such rights or assets are initially reported, the reporting obligation will only apply for subsequent years if the value of any previously-reported rights or assets increases by more than &#8364;20,000 per type of right or asset as of each subsequent December 31, or if you sell Shares or cancel bank accounts that were previously reported. Failure to comply with this reporting requirement may result in penalties to the Spanish residents. In addition, you may be required to electronically declare to the Bank of Spain any foreign accounts (including brokerage accounts held abroad), any foreign instruments (including Shares acquired under the 2011 Plan), and any transactions with non-Spanish residents (including any payments of Shares made pursuant to the 2011 Plan), depending on the balances in such accounts together with the value of such instruments as of December 31 of the relevant year, or the volume of transactions with non-Spanish residents during the relevant year. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.05pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:11.25pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2025 TO </font><font style="color:#002755;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">STOCKPLANADMINISTRATION&#64;STRYKER.COM.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.086%"><tr><td style="width:1.0%"></td><td style="width:45.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.115%"></td><td style="width:0.1%"></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Signature</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Name (Printed)</font></div></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Date</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr></table></div><div><font><br></font></div><div style="margin-top:11.1pt;padding-left:6pt"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.05pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SWITZERLAND</font></div><div style="margin-top:11.6pt;padding-left:6pt;padding-right:5.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Neither this document nor any other materials relating to the RSUs (a) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (&#34;FinSA&#34;) (b) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an employee of the Company or (c) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority (&#34;FINMA&#34;).</font></div><div style="margin-top:11.1pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TAIWAN</font></div><div style="margin-top:11.65pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Securities Law Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The offer of participation in the 2011 Plan is available only for employees of the Company and its Subsidiaries. The offer of participation in the 2011 Plan is not a public offer of securities by a Taiwanese company.</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:6.4pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You may acquire and remit foreign currency (including proceeds from the sale of Shares acquired under the 2011 Plan) into Taiwan up to USD5,000,000 per year without justification. If the transaction amount is TWD$500,000 or more in a single transaction, you must submit a Foreign Exchange Transaction Form and also provide supporting documentation to the satisfaction of the remitting bank. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.05pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THAILAND</font></div><div style="margin-top:3.85pt;padding-left:6pt;padding-right:6.35pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.66pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you receive proceeds from the sale of Shares or cash dividends in relation to the Shares in excess of USD1,000,000 in a single transaction, you must immediately repatriate the funds to Thailand (or utilize such funds offshore for permissible purposes) and convert the funds to Thai Baht within 360 days of repatriation or deposit the funds in an authorized foreign exchange account in Thailand. You are also required to provide details of the transaction (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">i.e.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, identification information and purpose of the transaction) to the receiving bank. If you do not repatriate such funds and utilizes them offshore for permissible purposes (i.e., purposes not listed in the negative list prescribed by the Bank of Thailand), you must obtain a waiver of the repatriation requirement from a commercial bank in Thailand by submitting an application and supporting documents evidencing that such funds will be utilized offshore for permissible purposes. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:11.65pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">T&#220;RKIYE</font></div><div style="margin-top:11.6pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Under Turkish law, you are not permitted to sell any Shares acquired under the 2011 Plan within Turkey. The Shares are currently traded on the New York Stock Exchange, which is located outside of Turkey, under the ticker symbol &#34;SYK&#34; and the Shares may be sold through this exchange.</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Financial Intermediary Obligation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You acknowledge that any activity related to investments in foreign securities (e.g., the sale of Shares) should be conducted through a bank or financial intermediary institution licensed by the Turkey Capital Markets Board and should be reported to the Turkish Capital Markets Board. You solely are responsible for complying with this requirement and should consult with a personal legal advisor for further information regarding any obligations in this respect.</font></div><div style="margin-top:11.1pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED ARAB EMIRATES</font></div><div style="margin-top:11.65pt;padding-left:6pt;padding-right:5.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The offer of the RSUs is available only for select Employees of the Company and its Subsidiaries and is in the nature of providing incentives in the United Arab Emirates. The 2011 Plan and the Terms and Conditions are intended for distribution only to such individuals and must not be delivered to, or relied on by any other person.</font></div><div style="margin-top:11.15pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Prospective purchasers of securities should conduct their own due diligence.</font></div><div style="margin-top:11.65pt;padding-left:6pt;padding-right:6.6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with this statement, including the 2011 Plan and the Terms and Conditions, or any other incidental communication materials distributed in connection with the RSUs. Further, neither the Ministry of Economy nor the Dubai Department of Economic Development has approved this statement nor taken steps to verify the information set out in it, and has no responsibility for it. Residents of the United Arab </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.65pt;padding-left:6pt;padding-right:6.6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Emirates who have any questions regarding the contents of the 2011 Plan and the Terms and Conditions should obtain independent advice.</font></div><div style="margin-top:11.05pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED KINGDOM</font></div><div style="margin-top:11.65pt;padding-left:5.75pt;padding-right:6.5pt;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.61pt">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;text-decoration:underline">Income Tax and Social Insurance Contribution Withholding</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The following provision shall supplement Section 6 of the Terms and Conditions&#58;</font></div><div style="margin-top:11.2pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Without limitation to Section 6 of the Terms and Conditions, you agree that you are liable for all Tax- Related Items and hereby covenant to pay all such Tax-Related Items, as and when requested by the Company, your Employer or by HM Revenue and Customs (&#34;HMRC&#34;) (or any other tax authority or any other relevant authority). You also agree to indemnify and keep indemnified the Company and your Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC on your behalf (or any other tax authority or any other relevant authority).</font></div><div style="margin-top:11.15pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:22.36pt;text-decoration:underline">Exclusion of Claim</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. You acknowledge and agree that you will have no entitlement to compensation or damages in consequence of the termination of your employment with the Company and your Employer for any reason whatsoever and whether or not in breach of contract, insofar as any purported claim to such entitlement arises or may arise from your ceasing to have rights under or to be entitled to vest in the RSUs as a result of such termination of employment (whether the termination is in breach of contract or otherwise), or from the loss or diminution in value of the RSUs. Upon the grant of the RSUs, you shall be deemed irrevocably to have waived any such entitlement.</font></div><div style="margin-top:11.05pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">****************************</font></div><div><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:11.05pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT A</font></div><div style="margin-top:11.05pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2011 LONG-TERM INCENTIVE PLAN, AS AMENDED AND RESTATED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br>EMPLOYER INFORMATION STATEMENT &#8211; DENMARK<br>RESTRICTED STOCK UNIT GRANT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to section 3(1) of the Danish Act on the Use of Rights to Purchase or Subscribe for Shares etc. in Employment Relationships (the &#34;Stock Option Act&#34;), Stryker Corporation (the &#8220;Company&#8221;) is providing you with the following information regarding the Company&#8217;s restricted stock unit (&#34;RSU&#34;) grant in a separate written statement. This statement contains only the information mentioned in the Stock Option Act&#59; the other terms and conditions of your RSU grant are described in detail in the Stryker Corporation 2011 Long-Term Incentive Plan, as Amended and Restated  (the &#34;2011 Plan&#34;), the Terms and Conditions Related to Restricted Stock Units Granted Pursuant to the 2011 Long-Term Incentive Plan (the &#8220;RSU Agreement&#8221;) and the CEO Award Letter for the RSU grant, all of which have been provided to you.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IMPORTANT NOTE&#58; The Stock Option Act only applies to RSUs granted under the 2011 Plan to employees of the Company and its Subsidiaries, and does not apply to individuals, including managers, who are not regarded as &#34;employees&#34; as defined under the Stock Option Act. If you are not an employee of the Company or one of its Subsidiaries within the meaning of the Stock Option Act, this Employer Information Statement shall not apply to you, you may not rely upon any of the information contained herein and the provisions described herein shall be void and ineffective.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Date of Grant</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Grant Date of the RSU is the date that the Compensation and Human Capital Committee of the Board of Directors (the &#8220;Committee&#8221;) approved a grant for you and determined it would be effective.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Terms and Conditions of the Grant</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The grant of RSU is made at the sole discretion of the Committee.  In its assessment, the Committee has considered a number of factors in granting the RSUs to you, including (but not limited to) the Company&#8217;s latest annual results, your personal performance and your value for the future growth, development and operation of the Company.  Notwithstanding your personal performance and the development of the Company, the Company may decide, in its sole discretion, not to grant an RSU to you in the future.  Under the terms of the Plan and the Agreement, you have no entitlement or claim to receive future RSU grants.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Vesting Dates and Exercise Period</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Your RSU shall vest over a period of time (&#8220;vesting period&#8221;), provided you remain employed by or in the service of the Company or a Subsidiary and any performance or other vesting conditions set forth in the Plan and the Agreements are satisfied, unless the RSU are vested or terminated earlier for the reasons set forth in the Plan and the Agreements and subject to Section 5 of this statement.</font></div><div style="padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Exercise Price</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For RSUs, you pay no monetary consideration to receive the RSU nor do you pay any price to receive the shares of the Company&#8217;s common stock issued upon vesting.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;Your Rights upon Termination</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The treatment of your RSU awards upon termination of your employment will be determined in accordance with the following unless the terms contained in the Agreement and in the 2011 Plan are more favorable to you.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Your RSU will survive and will not be forfeited if your employment is terminated by your employer for any reason other than your breach of contract (as determined under Danish law) or summary dismissal. This means that you may be entitled to continue to vest in the award as if you were still an employee in accordance with your Agreement and the 2011 Plan. Also, you may be entitled to receive an additional RSU grant, proportionate to the length of your employment in the accounting year in which your employment is terminated, to which you would have been entitled according to agreement or custom had you still been employed at the end of the accounting year. This provision will not apply if the termination is due to your breach of your employment contract or in case of your justified summary dismissal, in which case the RSU will lapse to the extent the RSU has not vested on the effective date of termination of your employment. Such lapse will take place automatically without notice on the effective date of termination of your employment.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you terminate your employment due to your employer's material breach (as determined under Danish law), or if your employment terminates because you reach the age of retirement for employees of your employer or because you are entitled to receive old-age pension from the Danish state or your employer, the RSU award shall continue on unchanged terms as if you had still been employed. Also, you may be entitled to receive an additional RSU grant, proportionate to the length of your employment in the accounting year in which your employment is terminated, to which you would have been entitled according to agreement or custom had you still been employed at the end of the accounting year or at the date of grant.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you terminate your employment for other reasons,  your RSU award will be forfeited as per the effective date of termination of your employment unless otherwise set out in the terms of the Agreement. In addition, you will be ineligible to receive any additional RSU grants after your resignation.</font></div><div style="padding-left:28.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;Financial Aspects of Participating in the 2011 Plan</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The RSU grant has no immediate financial consequences for you. The value of the RSU award will not be taken into account when calculating holiday allowances, pension contributions or other statutory consideration calculated on the basis of salary. The tax treatment of the RSU award depends on a number of aspects and thus, you are encouraged to seek particular advice regarding your tax position. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Shares of stock are financial instruments and investing in stock will always have financial risk. The possibility of profit at the time of vesting will not only be dependent on the Company&#8217;s financial development, but inter alia also on the general development of the stock market. In addition, before or after you vest in your RSU award, the shares of Company stock could decrease in value even below the price of such stock on the Date of Grant.</font></div><div style="padding-left:28.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;Other Issues</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Apart from Clause 5 in this Statement (regarding your rights upon termination of employment), this Statement does not intend to alter any provisions of the 2011 Plan or the Agreement (or any related document), and the 2011 Plan and the Agreement (and any related document) shall prevail in case of any ambiguities. However, your mandatory rights under the Stock Option Act shall prevail in case of any ambiguities.  </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Plan Administrator </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Stryker Corporation</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Portage, Michigan USA</font></div><div style="margin-top:11.15pt;padding-left:6pt;text-align:justify;text-indent:35.3pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2011 LONG-TERM INCENTIVE PLAN, SOM REVIDERET OG GENFREMSAT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br>ARBEJDSGIVERERKL&#198;RING &#8211; DANMARK<br>TILDELING OG RSU'ER</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I henhold til &#167; 3, stk. 1, i lov om brug af k&#248;beret eller tegningsret til aktier m.v. i ans&#230;ttelsesforhold (&#34;Aktieoptionsloven&#34;) giver Stryker Corporation (&#34;Selskabet&#34;) dig hermed i en s&#230;rskilt skriftlig erkl&#230;ring f&#248;lgende oplysninger om Selskabets tildeling af RSU'er (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) . Denne erkl&#230;ring indeholder kun de oplysninger, der er n&#230;vnt i Aktieoptionsloven. De &#248;vrige vilk&#229;r og betingelser for din RSU-tildeling er n&#230;rmere beskrevet i Selskabets </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">2011 Long-Term Incentive Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, som revideret og genfremsat  (&#34;2011-Planen&#34;), </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Terms and Conditions Related to Restricted Stock Units Granted Pursuant to the 2011 Long-Term Incentive Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (&#34;RSU-Aftalen) og CEO-tildelingsbrevene vedr&#248;rende henholdsvis RSU-tildelingen, hvilke dokumenter alle er blevet udleveret til dig.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">VIGTIGT&#58; Aktieoptionsloven g&#230;lder kun for RSU'er, der i henhold til 2011-Planen er tildelt til l&#248;nmodtagere i Selskabet og dets Datterselskaber, og g&#230;lder ikke for personer, herunder ledere, der ikke anses for at v&#230;re &#34;l&#248;nmodtagere&#34; som defineret i Aktieoptionsloven. Hvis du ikke er l&#248;nmodtager i Selskabet eller i et af dets Datterselskaber i Aktieoptionslovens forstand, g&#230;lder denne Arbejdsgivererkl&#230;ring ikke for dig, hvorfor du ikke vil kunne henholde dig til nogen af oplysningerne heri, og de heri anf&#248;rte bestemmelser vil ikke have virkning.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Tidspunkt for tildeling</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Tidspunktet for RSU-tildelingen er den dato, hvor det af Bestyrelsen nedsatte Udvalg for Vederlag og Menneskelig Kapital (&#34;Udvalget&#34;) godkendte tildelingen til dig og besluttede, at den skulle tr&#230;de i kraft.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Kriterier og betingelser for tildeling</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">RSU-tildelingen sker alene efter Udvalgets eget sk&#248;n.  Udvalget har i sin vurdering inddraget en r&#230;kke faktorer i forbindelse med RSU-tildelingen til dig, herunder (men ikke begr&#230;nset til) Selskabets seneste &#229;rsresultat, din personlige performance og din betydning for Selskabets fremtidige v&#230;kst, udvikling og drift.  Uanset din personlige performance og Selskabets udvikling kan Selskabet frit v&#230;lge ikke at tildele dig RSU'er fremover.  I henhold til bestemmelserne i Planen og Aftalen har du ikke nogen ret til eller noget krav p&#229; fremover at modtage RSU-tildelinger.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Modningstidspunkter og udnyttelsesperiode</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Din RSU modnes over en periode (&#34;modningsperioden&#34;), forudsat at du fortsat er ansat i eller arbejder for Selskabet eller et Datterselskab, og forudsat at alle de i Planen og Aftalerne beskrevne performance- og modningsbetingelser er opfyldt, medmindre RSU'en modnes eller bortfalder p&#229; et tidligere tidspunkt som f&#248;lge af de i Planen og Aftalerne anf&#248;rte &#229;rsager og med forbehold for pkt. 5 i denne erkl&#230;ring.</font></div><div style="padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Udnyttelseskurs</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hvad ang&#229;r RSU'er, skal du ikke betale noget vederlag for at modtage RSU'en, ligesom du ikke skal betale noget for at modtage de ordin&#230;re aktier i Selskabet, der udstedes ved modning.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;Din retsstilling i forbindelse med fratr&#230;den</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I forbindelse med din fratr&#230;den vil dine RSU-tildelinger blive behandlet som f&#248;lger, medmindre vilk&#229;rene i Aftalen og i 2011-Planen er mere fordelagtige for dig.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Din RSU bortfalder ikke, hvis din fratr&#230;den skyldes opsigelse fra din arbejdsgivers side, medmindre der er tale om misligholdelse fra din side (som defineret i dansk ret) eller bortvisning. Dette betyder, at du m&#229;ske vil v&#230;re berettiget til, at din RSU fortsat modnes i overensstemmelse med din Aftale og 2011-Planen, som om du stadig var ansat. Endvidere vil du m&#229;ske v&#230;re berettiget til at modtage en yderligere RSU-tildeling, som beregnes forholdsm&#230;ssigt i forhold til, hvor l&#230;nge du er ansat i det regnskabs&#229;r, hvori du fratr&#230;der, og som du ville have v&#230;ret berettiget til i henhold til aftale eller s&#230;dvane, s&#229;fremt du stadig havde v&#230;ret ansat ved udgangen af regnskabs&#229;ret. Denne bestemmelse g&#230;lder ikke, s&#229;fremt din fratr&#230;den skyldes opsigelse p&#229; grund af din misligholdelse af ans&#230;ttelseskontrakten eller berettiget bortvisning, i hvilket tilf&#230;lde RSU'en bortfalder, i det omfang de ikke er modnet ved ans&#230;ttelsesforholdets oph&#248;r. Bortfaldet sker automatisk uden varsel ved ans&#230;ttelsesforholdets oph&#248;r.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hvis du fratr&#230;der din stilling som f&#248;lge af v&#230;sentlig misligholdelse fra din arbejdsgivers side (som defineret i dansk ret), eller hvis du fratr&#230;der, fordi du n&#229;r pensionsalderen for l&#248;nmodtagere hos din arbejdsgiver, eller fordi du har ret til at modtage alderspension fra den danske stat eller din arbejdsgiver, vil din RSU-tildeling forts&#230;tte p&#229; u&#230;ndrede vilk&#229;r, som om du stadig var ansat.   Endvidere vil du m&#229;ske v&#230;re berettiget til at modtage en yderligere RSU-tildeling, som beregnes forholdsm&#230;ssigt i forhold til, hvor l&#230;nge du er ansat i det regnskabs&#229;r, hvori du fratr&#230;der, og som du ville have v&#230;ret berettiget til i henhold til aftale eller s&#230;dvane, s&#229;fremt du stadig havde v&#230;ret ansat ved udgangen af regnskabs&#229;ret eller p&#229; tildelingstidspunktet.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hvis du fratr&#230;der din stilling af andre &#229;rsager, vil din RSU-tildeling bortfalde ved ans&#230;ttelsesforholdets oph&#248;r, medmindre andet fremg&#229;r af Aftalen. Endvidere vil du ikke v&#230;re berettiget til at f&#229; tildelt yderligere RSU'er efter din fratr&#230;den.</font></div><div style="padding-left:28.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;&#216;konomiske aspekter ved at deltage i 2011-Planen</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">RSU-tildelingen har ingen umiddelbare &#248;konomiske konsekvenser for dig. V&#230;rdien af RSU-tildelingen indg&#229;r ikke i beregningen af feriepenge, pensionsbidrag eller andre lovpligtige, vederlagsafh&#230;ngige ydelser. Den skattem&#230;ssige behandling af RSU-tildelingen afh&#230;nger af flere forhold, og du opfordres derfor til at s&#248;ge s&#230;rskilt r&#229;dgivning vedr&#248;rende din skattem&#230;ssige situation. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Aktier er finansielle instrumenter, og investering i aktier vil altid v&#230;re forbundet med en &#248;konomisk risiko. Muligheden for en gevinst p&#229; modningstidspunktet afh&#230;nger ikke alene af Selskabets &#248;konomiske udvikling, men ogs&#229; af bl.a. den generelle udvikling p&#229; aktiemarkedet. Derudover kan v&#230;rdien af Selskabets aktier b&#229;de f&#248;r og efter modningen af din RSU-tildeling falde til en v&#230;rdi, der m&#229;ske endda ligger under kursen p&#229; tildelingstidspunktet.</font></div><div style="padding-left:28.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;&#216;vrige oplysninger</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Med undtagelse af pkt. 5 i denne erkl&#230;ring (vedr&#248;rende din retsstilling i forbindelse med fratr&#230;den) har denne erkl&#230;ring ikke til form&#229;l at &#230;ndre nogen af bestemmelserne i 2011-Planen eller Aftalen (eller i tilh&#248;rende dokumenter), og 2011-Planen og Aftalen (og eventuelle tilh&#248;rende dokumenter) har forrang i tilf&#230;lde af uoverensstemmelser. Dine ufravigelige rettigheder i henhold til Aktieoptionsloven har dog forrang i tilf&#230;lde af uklarhed.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Planadministrator </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Stryker Corporation</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Portage, Michigan USA</font></div><div style="margin-top:11.05pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>5
<FILENAME>ex10iii2025psuawardlettera.htm
<DESCRIPTION>EX-10.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i84cbe642ee644a23844848140a39381a_1"></div><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.226%"><tr><td style="width:1.0%"></td><td style="width:67.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;Kevin A. Lobo</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;Chair and CEO</font></div></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="strykerlogoa72c.jpg" src="strykerlogoa72c.jpg" style="height:54px;margin-bottom:5pt;vertical-align:text-bottom;width:202px"></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personal and Confidential </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 5, 2025</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">First Name Last Name</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear First Name,</font></div><div style="margin-top:11.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I am pleased to inform you that as an SLT member, you are receiving a performance stock units (PSUs) award in 2025. We use these awards to reward performers who we believe will be key contributors to our growth well into the future. The total Award Date Value (ADV) of your award is approximately USD $xx,xxx.</font></div><div style="margin-top:11.4pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are awarding you xxx PSUs. The number of PSUs actually earned will be dependent upon Stryker&#8217;s financial performance during the three-year period ending December 31, 2027. Refer to the Terms and Conditions accompanying the 2025 PSUs award for specific criteria associated with vesting in such award. In order to earn any of the PSUs, you must be continuously employed with Stryker through the vesting date of March 21, 2028 except as otherwise provided in the Terms and Conditions.</font></div><div style="margin-top:0.3pt;text-align:justify;text-indent:35.3pt"><font><br></font></div><div style="margin-top:0.05pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">You must &#8220;Accept&#8221; the award online via the UBS One Source web site located at </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">www.ubs.com&#47;onesource&#47;SYK</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">between March 4 and March 31, 2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The detailed terms of the PSUs are in the Terms and Conditions, any applicable country addendum and the provisions of the Company's 2011 Long- Term Incentive Plan, as Amended and Restated. Those documents, together with the related Prospectus, are available on the UBS One Source web site, and you should read them before accepting the award. In addition, you may be asked to sign the most recent version of Stryker&#8217;s Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement (&#8220;Non-Compete Agreement&#8221;) in connection with the award. If you are asked to sign the Non-Compete Agreement, it will be emailed to you and you will be asked to sign the document electronically via Adobe Sign by March 31, 2025. The vesting of the PSUs is conditioned on you having signed the Non-Compete Agreement by March 31, 2025, where permitted by applicable law.</font></div><div style="margin-top:0.65pt;text-align:justify;text-indent:35.3pt"><font><br></font></div><div style="margin-top:0.05pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You can find additional educational materials on the UBS One Source web site in the Resources section.</font></div><div style="padding-left:6.75pt;padding-right:5.9pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sincerely,</font></div><div style="margin-top:11.15pt;padding-left:7pt;text-indent:35.3pt"><font><br></font></div><div><img alt="image_1c.jpg" src="image_1c.jpg" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:62px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kevin A. Lobo</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chair and Chief Executive Officer</font></div><div><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:3.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="margin-top:11.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TERMS AND CONDITIONS</font></div><div style="margin-top:0.35pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RELATING TO PERFORMANCE STOCK UNITS GRANTED</font></div><div style="margin-top:0.35pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PURSUANT TO THE 2011 LONG-TERM INCENTIVE PLAN, AS AMENDED AND RESTATED</font></div><div style="margin-top:11.6pt;padding-left:7pt;padding-right:5.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:21.36pt">The Performance Stock Units with respect to Common Stock of Stryker Corporation (the &#34;Company&#34;) granted to you during 2025 (the &#34;PSUs&#34;) are subject to these Terms and Conditions Relating to Performance Stock Units Granted Pursuant to the 2011 Long-Term Incentive Plan, as Amended and Restated (the &#34;Terms and Conditions&#34;) and all of the terms and conditions of the Stryker Corporation 2011 Long-Term Incentive Plan, as Amended and Restated (the &#34;2011 Plan&#34;), which is incorporated herein by reference. In the case of a conflict between these Terms and Conditions and the terms of the 2011 Plan, the provisions of the 2011 Plan will govern. Capitalized terms used but not defined herein have the meaning provided therefor in the 2011 Plan. For purposes of these Terms and Conditions, &#34;Employer&#34; means the Company or any Subsidiary that employs you on the applicable date, and &#34;Stock Plan Administrator&#34; means UBS Financial Services Inc. (or any other independent service provider engaged by the Company to assist with the implementation, operation and administration of the 2011 Plan).</font></div><div style="margin-top:11pt;padding-left:7pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:21.36pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Except as provided in Section 8(a) and 8(b), the vesting of your PSUs is dependent upon your remaining continuously employed with your Employer through March 21, 2028 (the &#34;Vesting Date&#34;) as well as upon the Company's financial performance during the three-year period ending December 31, 2027 (the &#34;Performance Period&#34;). Specifically, the vesting of any of the PSUs is dependent upon attainment of the Threshold Performance Target as set forth in Section 3. If the Threshold Performance Target is attained, then the vesting of 50% of the PSUs (the &#34;EPS PSUs&#34;) is dependent on Adjusted EPS Growth as set forth in Section 4, and vesting of the remaining 50% of the PSUs (the &#34;Sales Growth PSUs&#34;) is dependent on the Sales Growth Percentile Ranking as set forth in Section 5. The actual number of your PSUs that become vested, if any, shall be determined based on exercise of negative discretion by the Committee in accordance with Sections 4, 5 and 6 below.</font></div><div style="margin-top:11pt;padding-left:7pt;padding-right:5.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:21.36pt;text-decoration:underline">Threshold Performance Target</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. If the Company's Adjusted EPS Growth as of the last day of the Performance Period is less than 2.0%, none of your PSUs shall become vested and all of your PSUs shall be forfeited as of the last day of the Performance Period. If the Company's Adjusted EPS Growth as of the last day of the Performance Period is 2.0% or greater (the &#34;Threshold Performance Target&#34;) and, except as provided in Section 8(a) and 8(b), you remain in the continuous employment of Stryker through the Vesting Date, you shall become eligible to vest in up to 200% of your PSUs, although the actual number of your PSUs that become vested shall be determined based on exercise of negative discretion by the Committee in accordance with Sections 4, 5 and 6 below.</font></div><div style="margin-top:11.05pt;padding-left:74.2pt;text-align:justify;text-indent:-31.9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.56pt;text-decoration:underline">Adjusted EPS Growth</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:11.6pt;padding-left:7pt;padding-right:6.35pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.68pt">If the Threshold Performance Target is attained and, except as provided in Section 8(a) and 8(b), you have remained in the continuous employment of Stryker through the Vesting Date, then subject to Section 6 you shall become vested in the percentage of the EPS PSUs determined based on the Company's Adjusted EPS Growth using the table below, applying straight line interpolation rounded down to the nearest whole number of EPS PSUs for Adjusted EPS Growth resulting in vested EPS PSUs between 50% and 100% or between 100% and 200%.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.046%"><tr><td style="width:1.0%"></td><td style="width:19.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.874%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:700;line-height:10.50pt">&#60; Minimum</font></div></td><td colspan="3" style="border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:700;line-height:10.50pt">Minimum</font></div></td><td colspan="3" style="border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:700;line-height:10.50pt">Target</font></div></td><td colspan="3" style="border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:700;line-height:10.50pt">Maximum</font></div></td></tr><tr><td colspan="3" style="border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:9.8pt;font-weight:700;line-height:9.80pt">Adjusted EPS</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:12.30pt">Growth</font></div></td><td colspan="3" style="border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:9.85pt;font-weight:400;line-height:9.85pt">Less than 7%</font></div></td><td colspan="3" style="border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:9.85pt;font-weight:400;line-height:9.85pt">7%</font></div></td><td colspan="3" style="border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:9.85pt;font-weight:400;line-height:9.85pt">9% - 10%</font></div></td><td colspan="3" style="border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:9.85pt;font-weight:400;line-height:9.85pt">12% or more</font></div></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:9.8pt;font-weight:700;line-height:9.80pt">Vested Percent of</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:12.30pt">EPS PSUs</font></div></td><td colspan="3" style="border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:9.85pt;font-weight:400;line-height:9.85pt">0%</font></div></td><td colspan="3" style="border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:9.85pt;font-weight:400;line-height:9.85pt">50%</font></div></td><td colspan="3" style="border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:9.85pt;font-weight:400;line-height:9.85pt">100%</font></div></td><td colspan="3" style="border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:9.85pt;font-weight:400;line-height:9.85pt">200%</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-top:0.65pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:7pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any EPS PSUs that do not become vested in accordance with the foregoing shall be forfeited.</font></div><div style="margin-top:11.6pt;padding-left:7pt;padding-right:6.7pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.03pt">As soon as administratively practicable following the Vesting Date (but in no event later than December 31, 2028), the Company shall issue you the Shares underlying the vested EPS PSUs.</font></div><div style="margin-top:11.2pt;padding-left:111.35pt;text-align:justify;text-indent:-33.8pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.55pt">For purposes of these Terms and Conditions&#58;</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:3.65pt;padding-left:77.55pt;padding-right:6.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(i)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:19pt">&#34;Adjusted EPS&#34; for a calendar year shall mean the Company's net earnings per diluted share for such year as determined under U.S. generally accepted accounting principles (&#34;GAAP&#34;) but subject to such adjustments, if any, for non-GAAP financial measures that are reflected in a reconciliation to the GAAP financial statements included in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission.</font></div><div style="margin-top:11.15pt;padding-left:77.55pt;padding-right:6.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(ii)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.95pt">&#34;Adjusted EPS Growth&#34; shall mean the sum of the Annual Percentage Change in Adjusted EPS for the three (3) calendar years in the Performance Period divided by three (3).</font></div><div style="margin-top:11.15pt;padding-left:77.55pt;padding-right:6.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(iii)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:12.9pt">&#34;Annual Percentage Change in Adjusted EPS&#34; for a calendar year shall mean the amount by which the Adjusted EPS for such calendar year has increased or decreased relative to the immediately preceding calendar year, expressed as a positive or negative percentage (depending on whether Adjusted EPS increased or decreased) of the Adjusted EPS for such preceding calendar year.</font></div><div style="margin-top:11.15pt;padding-left:7pt;padding-right:5.55pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.95pt">Notwithstanding anything to the contrary herein, the Committee shall have discretion to make such adjustments to the foregoing metrics as it deems appropriate to reflect the impact of corporate transactions, accounting or tax law changes or extraordinary, unusual, nonrecurring or infrequent items&#59; provided, however, that for purposes of calculating the Threshold Performance Target in Section 3, in no case shall such adjustments have the net aggregate effect of increasing Adjusted EPS Growth.</font></div><div style="margin-top:11.15pt;padding-left:74.2pt;text-align:justify;text-indent:-31.9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.56pt;text-decoration:underline">Sales Growth Percentile Ranking</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:11.6pt;padding-left:7pt;padding-right:5.25pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.68pt">If the Threshold Performance Target is attained and, except as provided in Section 8(a) and 8(b), you have remained in the continuous employment of Stryker through the Vesting Date, then subject to Section 6 you shall become vested in the percentage of the Sales Growth PSUs based upon the Company's Sales Growth Percentile Ranking, as determined using the table below, applying straight line interpolation rounded down to the nearest whole number of Sales Growth PSUs for Sales Growth Percentile Ranking resulting in vested Sales Growth PSUs between 50% and 100% or between 100% and 200%.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.046%"><tr><td style="width:1.0%"></td><td style="width:19.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.874%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"><div style="padding-right:-2.63pt"><font><br></font></div></td><td colspan="3" style="border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:700;line-height:10.50pt">&#60; Minimum</font></div></td><td colspan="3" style="border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:700;line-height:10.50pt">Minimum</font></div></td><td colspan="3" style="border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:700;line-height:10.50pt">Target</font></div></td><td colspan="3" style="border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:700;line-height:10.50pt">Maximum</font></div></td></tr><tr><td colspan="3" style="border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.15pt;font-weight:700;line-height:10.15pt">Sales Growth</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:12.30pt">Percentile Ranking</font></div></td><td colspan="3" style="border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:10.50pt">Below 33rd</font></div></td><td colspan="3" style="border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:10.50pt">33rd</font></div></td><td colspan="3" style="border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:10.50pt">50th</font></div></td><td colspan="3" style="border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:10.50pt">75th and Above</font></div></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:9.75pt;font-weight:700;line-height:9.75pt">Vested Percent of</font></div><div style="margin-top:0.2pt;padding-right:26.57pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:110%">Sales Growth PSUs</font></div></td><td colspan="3" style="border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:9.85pt;font-weight:400;line-height:9.85pt">0%</font></div></td><td colspan="3" style="border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:9.85pt;font-weight:400;line-height:9.85pt">50%</font></div></td><td colspan="3" style="border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:9.85pt;font-weight:400;line-height:9.85pt">100%</font></div></td><td colspan="3" style="border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:9.85pt;font-weight:400;line-height:9.85pt">200%</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-top:0.7pt"><font><br></font></div><div style="padding-left:7pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Any Sales Growth PSUs that do not become vested in accordance with the foregoing shall be forfeited, and if the Company's Average Sales Growth in the Performance Period is equal to or less than zero, all of the Sales Growth PSUs shall be forfeited (irrespective of the Sales Growth Percentile Ranking).</font></div><div style="margin-top:11.2pt;padding-left:7pt;padding-right:6.6pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.03pt">As soon as administratively practicable following the Vesting Date (but in no event later than December 31, 2028), the Company shall issue you the Shares underlying the vested Sales Growth PSUs.</font></div><div style="margin-top:11.2pt;padding-left:111.35pt;text-align:justify;text-indent:-33.8pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.55pt">For purposes of these Terms and Conditions and subject to Section 5(d) below&#58;</font></div><div style="margin-top:11.6pt;padding-left:77.55pt;padding-right:6.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(i)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:19pt">&#34;Average Sales Growth&#34; shall mean, for the Company and each company in the Comparison Group, the sum of the Sales Growth for each Reporting Period ending within the Performance Period divided by three&#59;</font></div><div style="margin-top:11.2pt;padding-left:146.75pt;text-align:justify;text-indent:-33.2pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.7pt">&#34;Comparison Group&#34; shall mean&#58;</font></div><div style="margin-top:10.8pt;padding-left:180.15pt;text-indent:-31.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.45pt">Abbott Laboratories</font></div><div style="margin-top:10.8pt;padding-left:180.15pt;text-indent:-31.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.45pt">Baxter International Inc.</font></div><div style="margin-top:10.8pt;padding-left:180.15pt;text-indent:-31.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.45pt">Becton, Dickinson and Company</font></div><div style="margin-top:10.75pt;padding-left:180.15pt;text-indent:-31.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.45pt">Boston Scientific Corporation</font></div><div style="margin-top:10.85pt;padding-left:180.15pt;text-indent:-31.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.45pt">Danaher Corporation</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:10.8pt;padding-left:180.15pt;text-indent:-31.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.45pt">Fresenius Medical Care AG</font></div><div style="margin-top:10.8pt;padding-left:180.15pt;text-indent:-31.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.45pt">GE Healthcare Technologies</font></div><div style="margin-top:10.8pt;padding-left:180.15pt;text-indent:-31.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.45pt">Johnson &#38; Johnson (MedTech)</font></div><div style="margin-top:10.8pt;padding-left:180.15pt;text-indent:-31.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.45pt">Laboratory Corporation of America Holdings</font></div><div style="margin-top:10.8pt;padding-left:180.15pt;text-indent:-31.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.45pt">Medtronic plc</font></div><div style="margin-top:10.8pt;padding-left:180.15pt;text-indent:-31.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.45pt">Quest Diagnostics Incorporated</font></div><div style="margin-top:10.8pt;padding-left:183.4pt;padding-right:6.8pt;text-indent:-34.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:30.7pt">Royal Philips (combined segments of Diagnosis Treatment and Connected Care)</font></div><div style="margin-top:10.6pt;padding-left:180.15pt;text-indent:-31.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.45pt">Siemens Healthineers AG</font></div><div style="margin-top:10.8pt;padding-left:180.15pt;text-indent:-31.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.45pt">Smith &#38; Nephew plc</font></div><div style="margin-top:10.8pt;padding-left:180.15pt;text-indent:-31.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.45pt">Thermo Fisher Scientific Inc.</font></div><div style="margin-top:10.8pt;padding-left:180.15pt;text-indent:-31.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.45pt">Solventum Corporation</font></div><div style="margin-top:10.8pt;padding-left:180.15pt;text-indent:-31.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.45pt">Zimmer Biomet Holdings, Inc.</font></div><div style="margin-top:11.55pt;padding-left:77.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">For purposes of the foregoing, any company for which Sales Growth cannot be calculated for three full annual Reporting Periods ending within the Performance Period shall be excluded.</font></div><div style="margin-top:11.25pt;padding-left:77.55pt;padding-right:6.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(iii)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:12.9pt">&#34;Net Sales&#34; shall mean, for the Company and each company in the Comparison Group, net sales as publicly reported for the applicable Reporting Period.</font></div><div style="margin-top:11.2pt;padding-left:77.55pt;padding-right:6.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(iv)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:13.46pt">&#34;Reporting Period&#34; shall mean a calendar year in the case of the Company and each company in the Comparison Group that reports on a calendar year basis, and in the case of any other company in the Comparison Group, the four fiscal quarters that include the last fiscal quarter ending prior to December 31 for which such company has publicly reported prior to the following February 28.</font></div><div style="margin-top:11.15pt;padding-left:77.55pt;padding-right:5.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(v)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.51pt">&#34;Sales Growth&#34; for a Reporting Period shall mean the amount by which Net Sales has increased or decreased relative to the immediately preceding Reporting Period, expressed as a positive or negative percentage (depending on whether Net Sales increased or decreased) of the Net Sales for such preceding Reporting Period.</font></div><div style="margin-top:11.15pt;padding-left:77.55pt;padding-right:6.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(vi)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:13.46pt">&#34;Sales Growth Percentile Ranking&#34; shall mean the percentile ranking of the Company's Average Sales Growth relative to the Average Sales Growth for each company in the Comparison Group, rounded to the whole nearest percentile. For this purpose, the percentile ranking shall be calculated as 1 &#8211; (Rank-1)&#47;(Total of the Comparison Group plus the Company-1). For example, if the Company ranked 5th out of 18 companies including itself, the percentile rank would be calculated as 1 &#8211; (5-1)&#47;(18-1) or 1 &#8211; (4&#47;17) or 1-0.24 or the 76th percentile.</font></div><div style="margin-top:11.1pt;padding-left:7pt;padding-right:6.75pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.95pt">The Committee may make such revisions and adjustments to each of the items set forth in Sections 5(c)(i)-(vi) as it may determine necessary and appropriate in its discretion.</font></div><div style="margin-top:12pt;padding-left:9pt;padding-right:6.5pt;text-align:justify;text-indent:67.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">6.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt;text-decoration:underline">Discretion of the Committee</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. Notwithstanding anything in these Terms or Conditions or the 2011 Plan to the contrary, provided that the Threshold Performance Target has been attained, the Committee shall have the power and authority, in its sole and absolute exercise of negative discretion, to reduce or increase the vested PSUs such that the actual earned PSUs will be greater than or less than the vested PSUs, which increase or reduction may be made by taking into account any criteria the Committee deems appropriate&#59; provided further that notwithstanding anything in these Terms or Conditions to the contrary you shall not become vested in more than 200% of your PSUs.</font></div><div style="margin-top:11.15pt;padding-left:7pt;padding-right:5.4pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">7.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:21.36pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. In connection with your PSUs, you shall be entitled to receive all of the cash dividends for which the record date occurs during the period between the commencement of the Performance </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:11.15pt;padding-left:7pt;padding-right:5.4pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Period and the Vesting Date with respect to each Share underlying your vested PSUs (&#34;Dividend Equivalents&#34;). Dividend Equivalents shall be converted into their equivalent number of additional PSUs rounded down to the nearest whole number of PSUs based on the Fair Market Value of a Share on the Vesting Date, provided, that the maximum number of additional PSUs you may receive upon such conversion shall be equal to 200% of your originally granted PSUs. Such additional PSUs shall be subject to the terms and conditions applicable to the PSUs to which the Dividend Equivalents relate, including, without limitation, the vesting, forfeiture, and payment form and timing provisions contained herein.</font></div><div style="margin-top:11pt;padding-left:7pt;padding-right:5.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">8.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:21.36pt">In the event you cease to remain in the continuous employment of the Company or a Subsidiary for the entire period commencing on the grant date and ending on the applicable Vesting Date, your right to receive the Shares issuable pursuant to the PSUs shall be only as follows&#58;</font></div><div style="margin-top:11.2pt;padding-left:7pt;padding-right:6.65pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.68pt">Subject to Section 6, if you cease to be an Employee prior to the Vesting Date by reason of Disability (as such term is defined in the 2011 Plan) or death, you or your estate will become vested in full on the Vesting Date in your PSUs based upon the Company's Adjusted EPS Growth and Sales Growth Percentile Ranking for the Performance Period as determined pursuant to Sections 3, 4, 5 and 6 of these Terms and Conditions. You, your legal representative or your estate will receive all of the underlying Shares attributable to the vested PSUs as soon as administratively practicable following (and in no event more than ninety (90) days after) the Vesting Date.</font></div><div style="margin-top:11.05pt;padding-left:7pt;padding-right:6.85pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.03pt">If you cease to be an Employee prior to the Vesting Date by reason of Retirement (as such term is defined in the 2011 Plan), you will become vested in your PSUs as follows&#58;</font></div><div style="margin-top:11.25pt;padding-left:77.55pt;padding-right:6.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(i)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:19pt">If you meet both the terms of Retirement (as such term is defined in the 2011 Plan) and you have been an Employee for at least 12 months following the grant date of your PSUs, then you will become vested in full on the Vesting Date in your PSUs based upon the Company's Adjusted EPS Growth and Sales Growth Percentile Ranking for the Performance Period as determined pursuant to Sections 3, 4, 5 and 6 of these Terms and Conditions.</font></div><div style="margin-top:11.1pt;padding-left:77.55pt;padding-right:5.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(ii)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.95pt">If you meet the terms of Retirement (as such term is defined in the 2011 Plan) but you are not an Employee for at least 12 months following the grant date of your PSUs, then you will become vested on the Vesting Date in a pro-rata portion (determined by dividing (a) the number of days during the Performance Period in which you were an Employee by (b) the total number of days during the Performance Period) of your PSUs based upon the Company&#8217;s Adjusted EPS Growth and Sales Growth Percentile Ranking for the Performance Period as determined pursuant to Sections 3, 4, 5 and 6 of these Terms and Conditions. Such pro-rata portion for both the EPS PSUs and Sales Growth PSUs shall be rounded down to the nearest whole number to determine the final total number of PSUs that you will become vested in under this Section.</font></div><div style="margin-top:11.05pt;padding-left:113.1pt;text-align:justify;text-indent:-35.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.3pt">If you cease to be an Employee for any reason other than those provided in (a) and</font></div><div style="margin-top:0.35pt;padding-left:7pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(b) above and your Termination Date is prior to the Vesting Date, you shall immediately forfeit all PSUs granted hereunder effective as of your Termination Date. If you are resident or employed outside of the United States, &#34;Termination Date&#34; shall mean the last day on which you are an Employee of your Employer, provided that (1) your notice period is 12 months or less, or (2) your employment ends less than 12 months after the date on which you signed your termination agreement. </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Other than Section 16 officers (as defined below), if</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> your notice period exceeds 12 months, then &#34;Termination Date&#34; will be 12 months after the date on which notice was given, whether it be by you or your Employer. If your employment ends more than 12 months after you signed your termination agreement, then &#8220;Termination Date&#8221; will be 12 months after the date on which you signed your termination agreement. </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">If you are an officer of the Company and in such capacity are subject to reporting under Section 16 of the U.S. Securities Exchange Act of 1934 (a &#8220;Section 16 officer&#8221;) on the date on which notice was given, &#34;Termination Date&#34; shall mean the last day on which you are an Employee of your Employer.</font></div><div style="margin-top:12pt;padding-left:9.35pt;padding-right:6.5pt;text-align:justify;text-indent:66.25pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">9.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:24.06pt">Notwithstanding the foregoing, the Company may, in its sole discretion, settle the PSUs (and any Dividend Equivalents) in the form of&#58; (i) a cash payment to the extent settlement in Shares (1) is prohibited under local law, (2) would require you, the Company and&#47;or your Employer to obtain the approval of any governmental and&#47;or regulatory body in your country of residence (and country of employment, if different), or (3) is administratively burdensome&#59; or (ii) Shares, but require you to immediately sell such Shares (in which case, the Company shall have the authority to issue sales instructions in relation to such Shares on your behalf).</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:11.15pt;padding-left:7pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">10.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">The number of Shares subject to the PSUs shall be subject to adjustment and the vesting dates hereof may be accelerated as follows&#58;</font></div><div style="margin-top:11.2pt;padding-left:7pt;padding-right:5.55pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.68pt">In the event that the Shares, as presently constituted, shall be changed into or exchanged for a different number or kind of shares of stock or other securities of the Company or of another corporation (whether by reason of merger, consolidation, recapitalization, reclassification, split-up, combination of shares, or otherwise) or if the number of such Shares shall be increased through the payment of a stock dividend or a dividend on the Shares of rights or warrants to purchase securities of the Company shall be made, then there shall be substituted for or added to each Share theretofore subject to the PSUs the number and kind of shares of stock or other securities into which each outstanding Share shall be so changed, or for which each such Share shall be exchanged, or to which each such Share shall be entitled. The other terms of the PSUs shall also be appropriately amended as may be necessary to reflect the foregoing events. In the event there shall be any other change in the number or kind of the outstanding Shares, or of any stock or other securities into which such Shares shall have been exchanged, then if the Committee shall, in its sole discretion, determine that such change equitably requires an adjustment in the PSUs, such adjustment shall be made in accordance with such determination.</font></div><div style="margin-top:10.9pt;padding-left:7pt;padding-right:6.6pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.03pt">Fractional Shares resulting from any adjustment in the PSUs may be settled in cash or otherwise as the Committee shall determine, in its sole discretion. Notice of any adjustment will be given to you and such adjustment (whether or not such notice is given) shall be effective and binding for all purposes hereof.</font></div><div style="margin-top:11.15pt;padding-left:7pt;padding-right:5.55pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.2pt">The Committee shall have the power to amend the PSUs to permit the immediate vesting of the PSUs (and to terminate any unvested PSUs) and the distribution of the underlying Shares prior to the effectiveness of (i) any disposition of substantially all of the assets of the Company or your Employer, (ii) the shutdown, discontinuance of operations or dissolution of the Company or your Employer, or (iii) the merger or consolidation of the Company or your Employer with or into any other unrelated corporation.</font></div><div style="margin-top:11.1pt;padding-left:7pt;padding-right:5.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">11.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">If you are resident or employed outside of the United States, you agree, as a condition of the grant of the PSUs, to repatriate all payments attributable to the Shares and&#47;or cash acquired under the 2011 Plan (including, but not limited to, dividends, dividend equivalents and any proceeds derived from the sale of the Shares acquired pursuant to the PSUs) if required by and in accordance with local foreign exchange rules and regulations in your country of residence (and country of employment, if different). In addition, you also agree to take any and all actions, and consent to any and all actions taken by the Company and its Subsidiaries, as may be required to allow the Company and its Subsidiaries to comply with local laws, rules and regulations in your country of residence (and country of employment, if different). Finally, you agree to take any and all actions as may be required to comply with your personal legal and tax obligations under local laws, rules and regulations in your country of residence (and country of employment, if different).</font></div><div style="margin-top:11pt;padding-left:7pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">12.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">If you are resident and&#47;or employed in a country that is a member of the European Union, the grant of the PSUs and these Terms and Conditions are intended to comply with the age discrimination provisions of the EU Equal Treatment Framework Directive, as implemented into local law (the &#34;Age Discrimination Rules&#34;). To the extent that a court or tribunal of competent jurisdiction determines that any provision of these Terms and Conditions are invalid or unenforceable, in whole or in part, under the Age Discrimination Rules, the Company, in its sole discretion, shall have the power and authority to revise or strike such provision to the minimum extent necessary to make it valid and enforceable to the full extent permitted under local law.</font></div><div style="margin-top:11pt;padding-left:7pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">13.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">Regardless of any action the Company and&#47;or your Employer take with respect to any or all income tax (including U.S. federal, state and local taxes or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related withholding (&#34;Tax-Related Items&#34;), you acknowledge that the ultimate liability for all Tax-Related Items legally due by you are and remains your responsibility and that the Company and your Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the PSUs, including the grant of the PSUs, the vesting of the PSUs, the subsequent sale of any Shares acquired pursuant to the PSUs and the receipt of any dividends or dividend equivalents and (ii) do not commit to structure the terms of the grant or any aspect of the PSUs to reduce or eliminate your liability for Tax-Related Items. Further, if you become subject to taxation in more than one country between the grant date and the date of any relevant taxable or tax withholding event, as applicable, you acknowledge that your Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one country.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:11.05pt;padding-left:7pt;padding-right:6.25pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Prior to any taxable event, if your country of residence (and&#47;or your country of employment, if different) requires withholding of Tax-Related Items, the Company shall withhold a number of whole Shares that have an aggregate Fair Market Value that the Company, taking into account local requirements and administrative issues, determines in its sole discretion is appropriate to cover withholding for Tax-Related Items with respect to the Shares. The cash equivalent of the Shares withheld will be used to settle the obligation to withhold the Tax-Related Items. In cases where the Fair Market Value of the number of whole Shares withheld is greater than the amount required to be paid to the relevant government authorities with respect to withholding for Tax-Related Items, the Company shall make a cash payment to you equal to the difference as soon as administratively practicable. In the event that withholding in Shares is prohibited or problematic under applicable law or otherwise may trigger adverse consequences to the Company or your Employer, your Employer shall withhold the Tax-Related Items required to be withheld with respect to the Shares in cash from your regular salary and&#47;or wages or other amounts payable to you. In the event the withholding requirements are not satisfied through the withholding of Shares or through your regular salary and&#47;or wages or any other amounts payable to you by your Employer, no Shares will be issued to you (or your estate) unless and until satisfactory arrangements (as determined by the Board of Directors) have been made by you with respect to the payment of any Tax-Related Items that the Company or your Employer determines, in its sole discretion, should be withheld or collected with respect to such PSUs. By accepting these PSUs, you expressly consent to the withholding of Shares and&#47;or withholding from your regular salary and&#47;or wages or other amounts payable to you as provided for hereunder. All other Tax- Related Items related to the PSUs and any Shares delivered in payment thereof are your sole responsibility.</font></div><div style="margin-top:10.65pt;padding-left:7pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">14.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">The PSUs are intended to be exempt from the requirements of Code Section 409A. The 2011 Plan and these Terms and Conditions shall be administered and interpreted in a manner consistent with this intent. If the Company determines that these Terms and Conditions are subject to Code Section 409A and that it has failed to comply with the requirements of that Section, the Company may, at the Company's sole discretion and without your consent, amend these Terms and Conditions to cause them to comply with Code Section 409A or be exempt from Code Section 409A.</font></div><div style="margin-top:11.1pt;padding-left:7pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">15.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">If you were required to sign the &#34;Stryker Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement&#34; or a similar agreement in order to receive the PSUs or have previously signed such an agreement and you breach any non-competition, non-solicitation or non-disclosure provision or provision as to ownership of inventions contained therein at any time while employed by the Company or a Subsidiary, or during the one-year period following termination of employment, any unvested PSUs shall be rescinded and you shall return to the Company all Shares that were acquired upon vesting of the PSUs that you have not disposed of. Further, you shall pay to the Company an amount equal to the profit realized by you (if any) on all Shares that were acquired upon vesting of the PSUs that you have disposed of. For purposes of the preceding sentence, the profit shall be the Fair Market Value of the Shares at the time of disposition.</font></div><div style="margin-top:11pt;padding-left:7pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">16.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">The PSUs shall be transferable only by will or the laws of descent and distribution. If you shall purport to make any transfer of the PSUs, except as aforesaid, the PSUs and all rights thereunder shall terminate immediately.</font></div><div style="margin-top:11pt;padding-left:7pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">17.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">The PSUs shall not be vested in whole or in part, and the Company shall not be obligated to issue any Shares subject to the PSUs, if such issuance would, in the opinion of counsel for the Company, violate the Securities Act of 1933 or any other U.S. federal, state or non-U.S. statute having similar requirements as it may be in effect at the time. The PSUs are subject to the further requirement that, if at any time the Board of Directors shall determine in its discretion that the listing or qualification of the Shares subject to the PSUs under any securities exchange requirements or under any applicable law, or the consent or approval of any governmental regulatory body, is necessary or desirable as a condition of or in connection with the issuance of Shares pursuant to the PSUs, the PSUs may not be vested in whole or in part unless such listing, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Board of Directors.</font></div><div style="margin-top:11.15pt;padding-left:7pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">18.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">The grant of the PSUs shall not confer upon you any right to continue in the employ of your Employer nor limit in any way the right of your Employer to terminate your employment at any time. You shall have no rights as a shareholder of the Company with respect to any Shares issuable upon the vesting of the PSUs until the date of issuance of such Shares.</font></div><div style="margin-top:11.15pt;padding-left:7pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">19.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">You acknowledge and agree that the 2011 Plan is discretionary in nature and may be amended, cancelled, or terminated by the Company, in its sole discretion, at any time. The grant of the PSUs under the 2011 Plan is a one-time benefit and does not create any contractual or other right to receive a grant of PSUs or </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:11.15pt;padding-left:7pt;padding-right:6.5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">any other award under the 2011 Plan or other benefits in lieu thereof in the future. Future grants, if any, will be at the sole discretion of the Company, including, but not limited to, the form and timing of any grant, the number of Shares subject to the grant, and the vesting provisions. Any amendment, modification or termination of the 2011 Plan shall not constitute a change or impairment of the terms and conditions of your employment with your Employer.</font></div><div style="margin-top:11.05pt;padding-left:7pt;padding-right:5.35pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">20.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">Your participation in the 2011 Plan is voluntary. The value of the PSUs and any other awards granted under the 2011 Plan is an extraordinary item of compensation outside the scope of your employment (and your employment contract, if any). Any grant under the 2011 Plan, including the grant of the PSUs, is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, holiday pay, bonuses, long-service awards, pension, or retirement benefits or similar payments.</font></div><div style="margin-top:11.05pt;padding-left:7pt;padding-right:5.35pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">21.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">The PSUs are granted solely by the Company.&#160; Your Employer and any other Subsidiary are not a party to these Terms and Conditions, and any rights you may have under these Terms and Conditions may be raised only against the Company (and may not be raised against your Employer or any other Subsidiary).</font></div><div style="margin-top:11.1pt;padding-left:7pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">22.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">These Terms and Conditions shall bind and inure to the benefit of the Company, its successors and assigns and you and your estate in the event of your death.</font></div><div style="margin-top:11.25pt;padding-left:7pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">23.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">The Company is located at 1941 Stryker Way, Portage, Michigan 49002, U.S.A. and grants PSUs under the 2011 Plan to employees of the Company and Subsidiaries in its sole discretion. In conjunction with the Company's grant of the PSUs under the 2011 Plan and its ongoing administration of such awards, the Company is providing the following information about its data collection, processing and transfer practices (&#34;Personal Data Activities&#34;). In accepting the grant of the PSUs, you expressly and explicitly consent to the Personal Data Activities as described herein.</font></div><div style="margin-top:11.1pt;padding-left:7pt;padding-right:5.45pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.68pt">The Company collects, processes and uses your personal data, including your name, home address, email address, and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all PSUs or any other equity compensation awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the PSUs under the 2011 Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan. The Company's legal basis for the collection, processing and usage of your personal data is your consent.</font></div><div style="margin-top:11.05pt;padding-left:7pt;padding-right:5.55pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.03pt">The Company transfers your personal data to the Stock Plan Administrator. In the future, the Company may select a different Stock Plan Administrator and share your personal data with another company that serves in a similar manner</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">,</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:119%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">including, but not limited to, the Company's outside legal counsel as well as the Company&#8217;s auditor</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan. You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div style="margin-top:11.1pt;padding-left:7pt;padding-right:6.75pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.2pt">The Company and the Stock Plan Administrator are based in the United States. You should note that your country of residence may have enacted data privacy laws that are different from the United States. The Company's legal basis for the transfer of your personal data to the United States is your consent.</font></div><div style="margin-top:11.15pt;padding-left:7pt;padding-right:6.8pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.95pt">Your participation in the 2011 Plan and your grant of consent is purely voluntary. You may deny or withdraw your consent at any time. If you do not consent, or if you withdraw your consent, you may be unable to participate in the 2011 Plan. This would not affect your existing employment or salary&#59; instead, you merely may forfeit the opportunities associated with the 2011 Plan.</font></div><div style="margin-top:11.15pt;padding-left:7pt;padding-right:6.8pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(e)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:16.69pt">You may have a number of rights under the data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country or residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of your personal data. To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company's Human Resources Department.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:11.15pt;padding-left:7pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">24.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">The grant of the PSUs is not intended to be a public offering of securities in your country of residence (and country of employment, if different). The Company has not submitted any registration statement, prospectus or other filing(s) with the local securities authorities (unless otherwise required under local law). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">No employee of the Company is permitted to advise you on whether you should acquire Shares under the 2011 Plan or provide you with any legal, tax or financial advice with respect to the grant of the PSUs. The acquisition of Shares involves certain risks, and you should carefully consider all risk factors and tax considerations relevant to the acquisition of Shares under the 2011 Plan or the disposition of them. Further, you should carefully review all of the materials related to the PSUs and the 2011 Plan, and you should consult with your personal legal, tax and financial advisors for professional advice in relation to your personal circumstances.</font></div><div style="margin-top:11pt;padding-left:7pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">25.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">All questions concerning the construction, validity and interpretation of the PSUs and the 2011 Plan shall be governed and construed according to the laws of the state of Michigan, without regard to the application of the conflicts of laws provisions thereof. Any disputes regarding the PSUs or the 2011 Plan shall be brought only in the state or federal courts of the state of Michigan.</font></div><div style="margin-top:11.15pt;padding-left:7pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">26.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">The Company may, in its sole discretion, decide to deliver any documents related to the PSUs or other awards granted to you under the 2011 Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the 2011 Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div style="margin-top:11.15pt;padding-left:7pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">27.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">The invalidity or unenforceability of any provision of the 2011 Plan or these Terms and Conditions shall not affect the validity or enforceability of any other provision of the 2011 Plan or these Terms and Conditions.</font></div><div style="margin-top:11.2pt;padding-left:7pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">28.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">If you are resident outside of the United States, you acknowledge and agree that it is your express intent that these Terms and Conditions, the 2011 Plan and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the PSUs be drawn up in English. If you have received these Terms and Conditions, the 2011 Plan or any other documents related to the PSUs translated into a language other than English and the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-top:11.1pt;padding-left:7pt;padding-right:6.4pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">29.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">You acknowledge that, depending on your or your broker's country of residence or where the Shares are listed, you may be subject to insider trading restrictions and&#47;or market abuse laws which may affect your ability to accept, acquire, sell or otherwise dispose of Shares, rights to Shares (e.g., PSUs) or rights linked to the value of Shares during such times you are considered to have &#34;inside information&#34; regarding the Company as defined in the laws or regulations in your country of employment (and country of residence, if different). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before you possessed inside information. Furthermore, you could be prohibited from (i) disclosing the inside information to any third party (other than on a &#34;need to know&#34; basis) and (ii) &#34;tipping&#34; third parties or causing them otherwise to buy or sell securities. Third parties include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. You acknowledge that it is your responsibility to comply with any restrictions and are advised to speak to your personal advisor on this matter.</font></div><div style="margin-top:10.9pt;padding-left:7pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">30.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">Notwithstanding any provisions of these Terms and Conditions to the contrary, the PSUs shall be subject to any special terms and conditions for your country of residence (and country of employment, if different) set forth in an addendum to these Terms and Conditions (an &#34;Addendum&#34;). Further, if you transfer your residence and&#47;or employment to another country reflected in an Addendum to these Terms and Conditions at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such special terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer). In all circumstances, any applicable Addendum shall constitute part of these Terms and Conditions.</font></div><div style="margin-top:11.05pt;padding-left:7pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">31.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:15.27pt">The Company reserves the right to impose other requirements on the PSUs, any Shares acquired pursuant to the PSUs and your participation in the 2011 Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan. Such </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:11.05pt;padding-left:7pt;padding-right:6.45pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">requirements may include (but are not limited to) requiring you to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-top:11.1pt;padding-left:7pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">32.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;padding-left:15.27pt">This Section 32 applies only to those persons whom the Company's Recoupment Policy applies (the corporate officers elected by the Company's Board of Directors other than Assistant Controllers, Assistant Secretaries and Assistant Treasurers). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Notwithstanding any other provision of these Terms and Conditions to the contrary, you acknowledge and agree that your PSUs, any Shares acquired pursuant thereto and&#47;or any amount received with respect to any sale of such Shares are subject to potential cancellation, recoupment, rescission, payback or other action in accordance with the terms of the Company's Recoupment Policy as in effect on the date of grant (a copy of which has been furnished to you) and as the Recoupment Policy may be amended from time to time in order to comply with changes in laws, rules or regulations that are applicable to such PSUs and Shares. You agree and consent to the Company's application, implementation and enforcement of (a) the Recoupment Policy and (b) any provision of applicable law relating to cancellation, recoupment, rescission or payback of compensation and expressly agree that the Company may take such actions as are necessary to effectuate the Recoupment Policy (as applicable to you) or applicable law without further consent or action being required by you. For purposes of the foregoing, you expressly and explicitly authorize the Company to issue instructions, on your behalf, to any brokerage firm and&#47;or third party administrator engaged by the Company to hold your Shares and other amounts acquired under the 2011 Plan to re-convey, transfer or otherwise return such Shares and&#47;or other amounts to the Company. In the case of a conflict between these Terms and Conditions and the Recoupment Policy, the terms of the Recoupment Policy shall prevail.</font></div><div style="margin-top:10.75pt;padding-left:7pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">33.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;padding-left:15.27pt">This Section 33 applies only to those persons whom the Company's clawback policy applies. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Notwithstanding anything in these Terms and Conditions to the contrary, the PSUs evidenced by these Terms and Conditions may be subject to (i) recoupment in accordance with or in order to comply with the terms and provisions of the Company's clawback policy, as may be in effect from time to time (including, but not limited to, the Mandatory Clawback Policy), to the extent such policies are applicable to you and (ii) any other compensation recovery policy adopted after the PSUs are granted to facilitate compliance with applicable law, including in response to the requirements of Section 10D of the Exchange Act, the U.S. Securities and Exchange Commission&#8217;s final rules thereunder, and any applicable listing rules or other rules and regulations implementing the foregoing. </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">For purposes of the foregoing, you expressly and explicitly authorize the Company to issue instructions, on</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">your behalf, to the Stock Plan Administrator and any other brokerage firm and&#47;or third party administrator engaged by the Company to hold your Shares and other amounts acquired under the 2011 Plan to re-convey, transfer or otherwise return such Shares and&#47;or other amounts to the Company.</font></div><div style="margin-top:11.05pt;padding-left:7pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">34.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;padding-left:15.27pt">By accepting the grant of the PSUs, you acknowledge that you have read these Terms and Conditions, the Addendum to these Terms and Conditions (as applicable) and the 2011 Plan and specifically accept and agree to the provisions therein.</font></div><div style="margin-top:11.15pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">***********************</font></div><div style="text-align:center"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-top:3.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="margin-top:11.65pt;padding-left:199.75pt;padding-right:189.75pt;text-indent:27.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:119%">ADDENDUM TO TERMS AND CONDITIONS</font></div><div style="padding-left:101.35pt;padding-right:59pt;text-indent:17.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:119%">RELATING TO PERFORMANCE STOCK UNITS GRANTED PURSUANT TO THE 2011 PLAN, AS AMENDED AND RESTATED</font></div><div style="margin-top:11.15pt;padding-left:7pt;padding-right:6.5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">In addition to the terms of the 2011 Plan and the Terms and Conditions, the PSUs are subject to the following additional terms and conditions (the &#34;Addendum&#34;). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">The information reflected in this Addendum is based on the securities, exchange control and other laws in effect in the respective countries as of November 2024. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">All capitalized terms as contained in this Addendum shall have the same meaning as set forth in the 2011 Plan and the Terms and Conditions. Pursuant to Section 30 of the Terms and Conditions, if you transfer your residence and&#47;or employment to another country reflected in an Addendum at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).</font></div><div style="margin-top:12pt;padding-left:9pt;padding-right:6.8pt;text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Data Privacy Information&#58; European Union (&#34;EU&#34;) &#47; European Economic Area (&#34;EEA&#34;) &#47; Switzerland and the United Kingdom*</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">*The below information is for data privacy purposes only and you should determine whether any other special terms and conditions apply to your awards in these jurisdictions.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.54pt;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you reside and&#47;or you are employed in the EU &#47; EEA, Switzerland or the United Kingdom the following provision replaces Section 23 of the Terms and Conditions&#58;</font></div><div style="margin-top:12pt;padding-left:7pt;padding-right:6.7pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company is located at 1941 Stryker Way, Portage, Michigan 49002, U.S.A. and grants PSUs under the 2011 Plan to employees of the Company and its Subsidiaries in its sole discretion. You should review the following information about the Company's data processing practices.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.35pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.68pt;text-decoration:underline">Data Collection, Processing and Usage</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Pursuant to applicable data protection laws, you are hereby notified that the Company collects, processes and uses certain personally identifiable information about you for the legitimate interest of implementing, administering and managing the 2011 Plan and generally administering equity awards&#59; specifically, including your name, home address, email address and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all options or any other awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the PSUs under the 2011 Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan. The Company's collection, processing, use and transfer of your personal data is necessary for the performance of the Company's contractual obligations under the 2011 Plan and pursuant to the Company's legitimate interest of managing and generally administering employee equity awards. Your refusal to provide personal data would make it impossible for the Company to perform its contractual obligations and may affect your ability to participate in the 2011 Plan. As such, by participating in the 2011 Plan, you voluntarily acknowledge the collection, processing and use of your personal data as described herein.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.03pt;text-decoration:underline">Stock Plan Administration Service Provider</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company transfers participant data to the Stock Plan Administrator. In the future, the Company may select a different Stock Plan Administrator and share your data with another company that serves in a similar manner, including, but not limited to, the Company's outside legal counsel as well as the Company&#8217;s auditor. The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan. You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.2pt;text-decoration:underline">International Data Transfers</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company and the Stock Plan Administrator are based in the United States. The Company can only meet its contractual obligations to you if your personal data is transferred to the United States. The Company's legal basis for the transfer of your personal data to the United </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">States is to satisfy its contractual obligations to you and&#47;or its use of the standard data protection clauses adopted by the EU Commission.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.95pt;text-decoration:underline">Data Retention</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company will use your personal data only as long as is necessary to implement, administer and manage your participation in the 2011 Plan or as required to comply with legal or regulatory obligations, including under tax and security laws. When the Company no longer needs your personal data, the Company will remove it from its systems. If the Company keeps your data longer, it would be to satisfy legal or regulatory obligations and the Company's legal basis would be for compliance with relevant laws or regulations.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.69pt;text-decoration:underline">Data Subject Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You may have a number of rights under data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country of residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of your personal data. To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company's Human Resources Department.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARGENTINA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Neither the grant of the PSUs, nor the issuance of Shares subject to the PSUs, constitutes a public offering in Argentina. The grant of PSUs pursuant to the 2011 Plan is a private placement and is not subject to any filing or disclosure requirements in Argentina.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. By accepting the PSUs, you acknowledge that you are proficient in reading and understanding English and fully understands the terms of the documents related to the PSUs (the Terms and Conditions, this Addendum and the 2011 Plan), which were provided in the English language. You accept the terms of these documents accordingly.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Consentimiento ling&#252;&#237;stico.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> Al aceptar las PSU, usted reconoce que domina la lectura y la comprensi&#243;n del ingl&#233;s y comprende plenamente los t&#233;rminos de los documentos relacionados con las PSU (los T&#233;rminos y condiciones, este Anexo y el Plan 2011), que se proporcionaron en ingl&#233;s. Usted acepta los t&#233;rminos de estos documentos en consecuencia.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AUSTRALIA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">PSUs Conditioned on Satisfaction of Regulatory Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you are (a) a director of a Subsidiary incorporated in Australia, or (b) a person who is a management-level executive of a Subsidiary incorporated in Australia and who also is a director of a Subsidiary incorporated outside of Australia, the grant of the PSUs is conditioned upon satisfaction of the shareholder approval provisions of section 200B of the Corporations Act 2001 (Cth) in Australia.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This grant of PSUs is being made under Division 1A Part 7.12 of the Australian Corporations Act 2001 (Cth). If Shares acquired under the 2011 Plan are offered for sale to a person or entity resident in Australia, your offer may be subject to disclosure requirements under Australian law. You should obtain legal advice on any disclosure obligations prior to making any such offer.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Tax Notification</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 2011 Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) applies (subject to conditions in the Act).</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Exchange control reporting is required for cash transactions exceeding AUD 10,000 and international fund transfers. The Australian bank assisting with the transaction will file the report. If there is no Australian bank involved in the transfer, you personally will be required to file the report. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AUSTRIA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you hold Shares obtained under the 2011 Plan or cash (including proceeds from the sale of Shares) outside Austria, you may be required to submit quarterly reports to the Austrian National Bank. An exemption applies if the value of the Shares held outside Austria of any </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">quarter does not exceed a certain threshold (currently &#8364;5,000,000). The deadline for filing the quarterly report is the 15th of the month following the end of the respective quarter.  When the Shares are sold, you may be required to comply with certain exchange control obligations if the cash proceeds from the sale is held outside Austria, as a separate reporting requirement applies to any non-Austrian cash accounts. If the transaction volume of all of your cash accounts abroad exceeds a certain threshold (currently &#8364;10,000,000), the movements and the balance of all accounts must be reported monthly, as of the last day of the month, on or before the 15th day of the following month, on the prescribed forms.  The thresholds described above may be subject to change. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BELGIUM</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Belgian residents are required to report any security (e.g, Shares acquired under the 2011 Plan) or bank account established outside of Belgium on their personal annual tax return. In a separate report, Belgian residents also are required to provide a central contact point of the National Bank of Belgium with the account number of those foreign bank accounts, the name of the bank with which the accounts were opened and the country in which they were opened in a separate report. This report, as well as additional information on how to complete it, can be found on the website of the National Bank of Belgium, </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.nbb.be</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, under the </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Kredietcentrales &#47; Centrales des credits </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">caption. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Stock Exchange Tax Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. A stock exchange tax applies to transactions executed by Belgian residents through a non-Belgian financial intermediary, such as a U.S. broker. The stock exchange tax will apply when Shares acquired pursuant to the PSUs are sold. You should consult with a personal tax or financial advisor for additional details on your obligations with respect to the stock exchange tax.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.25pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Annual Securities Account Tax</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. An annual securities accounts tax may be payable if the total value of securities held in a Belgian or foreign securities account (e.g., Shares acquired under the 2011 Plan) exceeds a certain threshold on four reference dates within the relevant reporting period (i.e., December 31, March 31, June 30 and September 30). In such case, the tax will be due on the value of the qualifying securities held in such account. You should consult with a personal tax or financial advisor for additional details on your obligations with respect to the annual securities account tax.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BRAZIL</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Labor Law Acknowledgment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. By accepting the PSUs, you acknowledge and agree, for all legal purposes, that (a) the benefits provided under the Terms and Conditions and the 2011 Plan are the result of commercial transactions unrelated to your employment&#59; (b) the Terms and Conditions and the 2011 Plan are not a part of the terms and conditions of your employment&#59; and (c) the income from the PSUs, if any, is not part of your remuneration from employment.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. By accepting the PSUs, you acknowledge and agree to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with the vesting of the PSUs, the issuance and&#47;or sale of Shares acquired under the 2011 Plan and the receipt of any dividends.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you are resident or domiciled in Brazil, you will be required to submit an annual declaration of assets and rights held outside of Brazil to the Central Bank of Brazil if the aggregate value of such assets and rights is greater than USD1 million as of December 31 of each year. If the aggregate value exceeds USD100 million as of the end of each quarter, a declaration must be submitted quarterly. Assets and rights that must be reported include Shares acquired under the 2011 Plan. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Tax on Financial Transaction (IOF)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Repatriation of funds (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the proceeds from the sale of Shares) into Brazil and the conversion of USD into BRL associated with such fund transfers may be subject to the Tax on Financial Transactions. It is your responsibility to comply with any applicable Tax on Financial Transactions arising from your participation in the 2011 Plan. You should consult with your personal tax advisor for additional details.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CANADA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything to the contrary in the Terms and Conditions or the 2011 Plan, the PSUs shall be settled only in Shares (and may not be settled in cash).</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The following supplements Section 8(c) of the Terms and Conditions as well as any other section required to give effect to the same&#58;</font></div><div style="margin-top:12pt;padding-left:7pt;padding-right:6.35pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event of your termination of employment for any reason (other than by reason of death, Disability or Retirement), either by you or by the Employer, with or without cause, your rights to vest or to continue to vest in the PSUs and receive Shares under the 2011 Plan, if any, will terminate as of the actual Termination Date. For this purpose, the &#34;Termination Date&#34; shall mean the last day on which you are actively employed by the Employer, and shall not include or be extended by any period following such day during which you are in receipt of or eligible to receive any notice of termination, pay in lieu of notice of termination, severance pay or any other payments or damages, whether arising under statute, contract or at common law.</font></div><div style="margin-top:12pt;padding-left:7pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued entitlement to vesting during a statutory notice period, your right to vest in the PSUs under the 2011 Plan, if any, will terminate effective as of the last day of your minimum statutory notice period, but you will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of your statutory notice period, nor will you be entitled to any compensation for lost vesting.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.66pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Specified foreign property, including the PSUs, Shares acquired under the 2011 Plan, and other rights to receive shares of a non-Canadian company held by a Canadian resident generally must be reported annually on a Form T1135 (Foreign Income Verification Statement) if the total cost of the specified foreign property exceeds C$100,000 at any time during the year. Thus, the unvested portion of the PSUs must be reported &#8211; generally at a nil cost &#8211; if the C$100,000 cost threshold is exceeded because you holds other specified foreign property. When Shares are acquired, their cost generally is the adjusted cost base (&#8220;ACB&#8221;) of the Shares. The ACB ordinarily will equal the fair market value of the Shares at the time of acquisition, but if you owns other Shares, the ACB may need to be averaged with the ACB of the other Shares. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:12pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2025 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:6pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.086%"><tr><td style="width:1.0%"></td><td style="width:45.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.115%"></td><td style="width:0.1%"></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Signature</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Name (Printed)</font></div></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Date</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="margin-top:12pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CHILE</font></div><div style="margin-top:12pt;padding-left:82.2pt;text-align:justify;text-indent:-40.9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:32.56pt;text-decoration:underline">Private Placement</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The following provision shall replace Section 24 of the Terms</font></div><div style="margin-top:12pt;padding-left:7pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and Conditions&#58;</font></div><div style="margin-top:12pt;padding-left:7pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The grant of the PSUs hereunder is not intended to be a public offering of securities in Chile but instead is intended to be a private placement.</font></div><div style="margin-top:12pt;padding-left:9pt;text-indent:67.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.73pt">The starting date of the offer will be the grant date, and this offer conforms to General Ruling no. 336 of the Chilean Commission for the Financial Markets (&#34;CMF&#34;)&#59;</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.03pt">The offer deals with securities not registered in the registry of securities or in the registry of foreign securities of the CMF, and therefore such securities are not subject to its oversight&#59;</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.2pt">The Company, as the issuer, is not obligated to provide public information in Chile regarding the foreign securities, as such securities are not registered with the CMF&#59; and</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.95pt">The Shares, as foreign securities, shall not be subject to public offering as long as they are not registered with the corresponding registry of securities in Chile.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:17.51pt">La fecha de inicio de la oferta ser&#225; el de la fecha de otorgamiento y esta oferta se acoge a la norma de Car&#225;cter General n&#176; 336 de la Comisi&#243;n para el Mercado Financiero Chilena (&#34;CMF&#34;)&#59;</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:17.56pt">La oferta versa sobre valores no inscritos en el registro de valores o en el registro de valores extranjeros que lleva la CMF, por lo que tales valores no est&#225;n sujetos a la fiscalizaci&#243;n de &#233;sta&#59;</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.53pt">Por tratar de valores no inscritos no existe la obligaci&#243;n por parte del emisor de entregar en chile informaci&#243;n p&#250;blica respecto de esos valores&#59; y</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:16.95pt">Esos valores no podr&#225;n ser objeto de oferta p&#250;blica mientras no sean inscritos en el registro de valores correspondiente.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If your aggregate investments held outside of Chile (including the value of Shares acquired under the 2011 Plan) are equal to or greater than USD5,000,000, you must provide the Central Bank with updated information accumulated for a three-month period within 45 calendar days of March 31, June 30 and September 30 and within 60 calendar days of December 31. Annex 3.1 of Chapter XII of the Foreign Exchange Regulations Manual must be used to file this report. You are not required to repatriate funds obtained from the sale of Shares or the receipt of any dividends to Chile. However, if you decide to repatriate such funds, you must do so through the Formal Exchange Market if the funds exceed USD10,000. In such case, you must report the payment to a commercial bank or the registered foreign exchange office receiving the funds. If you do not repatriate the funds and instead use such funds for the payment of other obligations contemplated under a different Chapter of the Foreign Exchange Regulations, you must sign Annex 1 of the Manual of Chapter XII of the Foreign Exchange Regulations and file it directly with the Central Bank within the first 10 days of the month immediately following the transaction. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Chilean Internal Revenue Service (&#8220;CIRS&#8221;) requires all taxpayers to provide information annually regarding&#58; (a) any taxes paid abroad which they will use as a credit against Chilean income taxes, and (b) the results of foreign investments. These annual reporting obligations must be complied with by submitting a sworn statement setting forth this information before July 1 of each year. The sworn statement disclosing this information (or </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Formularios</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) must be submitted electronically through the CIRS website, </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.sii.cl</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, using Form 1929. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CHINA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">PSUs Conditioned on Satisfaction of Regulatory Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you are a People's Republic of China (&#34;PRC&#34;) national, the grant of the PSUs is conditioned upon the Company securing all necessary approvals from the PRC State Administration of Foreign Exchange to permit the operation of the 2011 Plan and the participation of PRC nationals employed by your Employer, as determined by the Company in its sole discretion.</font></div><div style="margin-top:12pt;padding-left:5.75pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.61pt;text-decoration:underline">Sale of Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything to the contrary in the 2011 Plan, upon any termination of employment with your Employer, you shall be required to sell all Shares acquired under the 2011 Plan within such time period as may be established by the PRC State Administration of Foreign Exchange.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Restrictions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You acknowledge and agree that you will be required immediately to repatriate to the PRC the proceeds from the sale of any Shares acquired under the 2011 Plan, as well as any other cash amounts attributable to the Shares acquired under the 2011 Plan (collectively, &#34;Cash Proceeds&#34;). Further, you acknowledge and agree that the repatriation of the Cash Proceeds must be effected through a </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.45pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">special bank account established by your Employer, the Company or one of its Subsidiaries, and you hereby consent and agree that the Cash Proceeds may be transferred to such account by the Company on your behalf prior to being delivered to you. The Cash Proceeds may be paid to you in U.S. dollars or local currency at the Company's discretion. If the Cash Proceeds are paid to you in U.S. dollars, you understand that a U.S. dollar bank account must be established and maintained in China so that the proceeds may be deposited into such account. Additionally, if the Company changes its Stock Plan Administrator, you acknowledge and agree that the Company may transfer any Shares issued under the 2011 Plan to the new designated Stock Plan Administrator if necessary for legal or administrative reasons. You agree to sign any documentation necessary to facilitate the transfer. If the Cash Proceeds are paid to you in local currency, you acknowledge and agree that the Company is under no obligation to secure any particular exchange conversion rate and that the Company may face delays in converting the Cash Proceeds to local currency due to exchange control restrictions. You agree to bear any currency fluctuation risk between the time the Shares are sold and the Cash Proceeds are converted into local currency and distributed to you. You further agree to comply with any other requirements that may be imposed by your Employer, the Company and its Subsidiaries in the future in order to facilitate compliance with exchange control requirements in the PRC.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">COLOMBIA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.35pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In addition to the provisions of Section 20 of the Terms and Conditions you acknowledge that, pursuant to Article 128 of the Colombian Labor Code, the 2011 Plan and related benefits do not constitute a component of your &#34;salary&#34; for any legal purpose. Therefore, they will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as legal&#47;fringe benefits, vacations, indemnities, payroll taxes, social insurance contributions and&#47;or any other labor-related amount which may be payable.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Shares subject to the PSUs are not and will not be registered in the Colombian registry of publicly traded securities (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Registro Nacional de Valores y Emisores</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) and therefore the Shares may not be offered to the public in Colombia. Nothing in this document should be construed as the making of a public offer of securities in Colombia.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Investments in assets located outside Colombia (including Shares) are subject to registration with the Central Bank (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Banco de la Rep&#250;blica</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), as foreign investments held abroad, regardless of value. In addition, all payments related to the liquidation of such investments must be transferred through the Colombian foreign exchange market (e.g. local banks), which includes the obligation of correctly completing and filing the appropriate foreign exchange form (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">declaraci&#243;n de cambio</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. An annual informative return must be filed with the Colombian Tax Office detailing any assets held abroad (including the Shares acquired under the 2011 Plan). If the individual value of any of these assets exceeds a certain threshold, each asset must be described (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">e.g., </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">its nature and its value) and the jurisdiction in which it is located must be disclosed. You acknowledge that you personally are responsible for complying with this tax reporting requirement. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">COSTA RICA</font></div><div style="margin-top:12pt;padding-left:7pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No country specific provisions.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">DENMARK</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.35pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Treatment of PSUs upon Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding any provision in the Terms and Conditions or the 2011 Plan to the contrary, unless you are a member of registered management who is not considered a salaried employee, the treatment of the PSUs upon a termination of employment which is not a result of death shall be governed by Sections 4 and 5 of the Danish Act on Stock Option in Employment Relations (the &#34;Act&#34;). You acknowledge any grant of PSUs under the 2011 Plan is subject to the rules of such Act. However, if the provisions in the Terms and Conditions or the 2011 Plan governing the treatment of the PSUs upon a termination of employment are more favorable, then the provisions of the Terms and Conditions or the 2011 Plan will govern, as set forth in the Employer Statement, included as Exhibit A to this Addendum, and which is being provided to comply with the Act.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Danish residents who establish an account holding Shares or an account holding cash outside Denmark must report the account to the Danish Tax Administration as part of their annual tax return under the section related to foreign affairs and income. The form which should be used in this respect can be obtained from a local bank. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FINLAND</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Withholding of Tax-Related Items</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything in Section 13 of the Terms and Conditions to the contrary, if you are a local national of Finland, any Tax-Related Items shall be withheld only in cash from your regular salary&#47;wages or other amounts payable to you in cash or such other withholding methods as may be permitted under the 2011 Plan and allowed under local law.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Finland has not adopted any specific reporting requirements with respect to foreign assets&#47;accounts. However, you should check your pre-completed tax return to confirm that the ownership of Shares and other securities (foreign or domestic) are correctly reported. If you find any errors or omissions, you must make the necessary corrections electronically or by sending specific paper forms to the local tax authorities. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FRANCE</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Non-Qualified Nature of PSUs</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Award granted pursuant to the Terms and Conditions is not intended to be &#8220;French-qualified&#8221; and is ineligible for specific tax and&#47;or social security treatment in France under Sections L. 225-197-1 to L. 225-197-5 and Sections L. 22-10-59 to L. 22-10-60 of the French Commercial Code, as amended.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The value of any cash or securities imported to or exported from France without the use of a financial institution must be reported to the customs and excise authorities when the value of such cash or securities is equal to or greater than a certain amount (currently &#8364;10,000). You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. French residents must report annually any shares and bank accounts held outside France, including the accounts that were opened, used and&#47;or closed during the tax year, to the French tax authorities, on an annual basis on a special Form N&#176; 3916, together with your personal income tax return. Failure to report triggers a significant penalty. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Use of English Language</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. By accepting your PSUs, you acknowledge and agree that it is your wish that the Terms and Conditions, this Addendum, as well as all other documents, notices and legal proceedings entered into, given or instituted pursuant to your PSUs, either directly or indirectly, be drawn up in English.</font></div><div style="margin-top:12pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Langue anglaise</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. En acceptant l'allocation de vos PSUs, vous reconnaissez et acceptez avoir</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">souhait&#233; que le Termes et Conditions, le pr&#233;sent avenant, ainsi que tous autres documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaires intent&#233;es, relatifs, directement ou indirectement, &#224; l'allocation de vos PSUs, soient r&#233;dig&#233;s en anglais.</font></div><div style="margin-top:12pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:12pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2025 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:6pt"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.086%"><tr><td style="width:1.0%"></td><td style="width:45.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.115%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Signature</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Name (Printed)</font></div></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Date</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GERMANY</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Cross-border payments in excess of &#8364;12,500 in connection with the 2011 Plan (</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, proceeds from the sale of Shares acquired under the 2011 Plan) and&#47;or if the Company withholds or sells Shares with a value in excess of EUR 12,500 for any Tax-Related Items, </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">must be reported to the German Federal Bank (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Bundesbank</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) by the fifth day of the month following the month in which the payment is received or made. If you acquire Shares with a value in excess of &#8364;12,500, the Employer will report the acquisition of such Shares to the German Federal Bank. If you otherwise make or receive a payment in excess of &#8364;12,500, you personally must report the payment to Bundesbank electronically using the &#8220;General Statistics Reporting Portal&#8221; (&#8220;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Allgemeines Meldeportal Statistik</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) available via Bundesbank&#8217;s website (</font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.bundesbank.de</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. German residents must notify their local tax office of the acquisition of Shares when they file their personal income tax returns for the relevant year if the value of the Shares acquired exceeds &#8364;150,000 or in the unlikely event that the resident holds Shares exceeding 10% of the Company&#8217;s total Shares outstanding. However, if the Shares are listed on a recognized U.S. stock exchange and you own less than 1% of the total Shares, this requirement will not apply even if Shares with a value exceeding &#8364;150,000 are acquired. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">HONG KONG</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Important Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Warning&#58; The contents of the Terms and Conditions, this Addendum, the 2011 Plan, and all other materials pertaining to the PSUs and&#47;or the 2011 Plan have not been reviewed by any regulatory authority in Hong Kong. You are hereby advised to exercise caution in relation to the offer thereunder. If you have any doubts about any of the contents of the aforesaid materials, you should obtain independent professional advice.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If, for any reason, Shares are issued to you within six (6) months of the grant date, you agree that you will not sell or otherwise dispose of any such Shares prior to the six-month anniversary of the grant date.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything to the contrary in this Addendum, the Terms and Conditions or the 2011 Plan, the PSUs shall be settled only in Shares (and may not be settled in cash).</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Nature of the 2011 Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company specifically intends that the 2011 Plan will not be treated as an occupational retirement scheme for purposes of the Occupational Retirement Schemes Ordinance (&#34;ORSO&#34;). To the extent any court, tribunal or legal&#47;regulatory body in Hong Kong determines that the 2011 Plan constitutes an occupational retirement scheme for the purposes of ORSO, the grant of the PSUs shall be null and void.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">INDIA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any funds realized in connection with the 2011 Plan (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, proceeds from the sale of Shares and cash dividends paid on the Shares) must be repatriated to India within a specified period of time after receipt as prescribed under Indian exchange control laws.  You are personally responsible for obtaining a foreign inward remittance certificate (&#8220;FIRC&#8221;) from the bank where you deposit the foreign currency and holding the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India or your Employer requests proof of repatriation.  You are personally responsible for complying with exchange control laws in India, and neither the Company nor your Employer will be liable for any fines or penalties resulting from your failure to comply with applicable laws.  You should consult with your personal </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You are required to declare your foreign bank accounts and any foreign financial assets (including Shares acquired under the 2011 Plan held outside India) in your annual tax return. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">IRELAND</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Director Notification Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you are a director, shadow director or secretary of an Irish subsidiary whose interest in the Company represents more than 1% of the Company&#8217;s voting share capital, you are required to notify such Irish subsidiary in writing within a certain time period. upon the acquisition of PSUs or any Shares issued pursuant to PSUs. This notification requirement also applies with respect to the interests in the Company of your spouse or children under the age of 18 (whose interests will be attributed to you in your capacity as a director, shadow director or secretary of the Irish subsidiary).</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ITALY</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Italian residents who, at any time during the fiscal year, hold foreign financial assets (including cash and Shares) which may generate income taxable in Italy are required to report these assets on their annual tax returns (UNICO Form, RW Schedule) for the year during which the assets are held, or on a special form if no tax return is due. These reporting obligations will also apply to Italian residents who are the beneficial owners of foreign financial assets under Italian money laundering provisions. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:34.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.16pt;text-decoration:underline">Foreign Asset Tax</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The value of any Shares (and other financial assets) held outside Italy by individuals resident of Italy may be subject to a foreign asset tax. The taxable amount will be the fair market value of the financial assets (e.g., Shares) assessed at the end of the calendar year. The value of financial assets held abroad must be reported in Form RM of the annual return. You should consult your personal tax advisor for additional information on the foreign asset tax.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">JAPAN</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you acquire Shares valued at more than &#165;100,000,000 in a single transaction, you must file a Securities Acquisition Report with the Ministry of Finance through the Bank of Japan within 20 days of the purchase of the Shares. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You will be required to report details of any assets held outside Japan as of December 31st to the extent such assets have a total net fair market value exceeding &#165;50,000,000. This report is due by March 15 each year. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MEXICO</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Commercial Relationship</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You expressly recognize that your participation in the 2011 Plan and the Company's grant of the PSUs does not constitute an employment relationship between you and the Company. You have been granted the PSUs as a consequence of the commercial relationship between the Company and the Subsidiary in Mexico that employs you, and the Company's Subsidiary in Mexico is your sole employer. Based on the foregoing, (a) you expressly recognize the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan do not establish any rights between you and the Company's Subsidiary in Mexico that employs you, (b) the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan are not part of the employment conditions and&#47;or benefits provided by the Company's Subsidiary in Mexico that employs you, and (c) any modification or amendment of the 2011 Plan by the Company, or a termination of the 2011 Plan by the Company, shall not constitute a change or impairment of the terms and conditions of your employment with the Company's Subsidiary in Mexico that employs you.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You expressly recognize and acknowledge that the Company's grant of PSUs and the underlying Shares under the 2011 Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico. In addition, the 2011 Plan, the Terms and Conditions and any other document relating to the PSUs may not be publicly distributed in Mexico. These materials are addressed to you only because of your existing relationship with the Company and these materials should not be reproduced or copied in any form. The offer contained in these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of the Employer in Mexico made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.35pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Extraordinary Item of Compensation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You expressly recognize and acknowledge that your participation in the 2011 Plan is a result of the discretionary and unilateral decision of the Company, as well as your free and voluntary decision to participate in the 2011 Plan in accord with the terms and conditions of the 2011 Plan, the Terms and Conditions, and this Addendum. As such, you acknowledge and agree that the Company may, in its sole discretion, amend and&#47;or discontinue your participation in the 2011 Plan at any time and without any liability. The value of the PSUs is an extraordinary item of compensation outside the scope of your employment contract, if any. The PSUs are not part of your regular or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits, or any similar payments, which are the exclusive obligations of the Company's Subsidiary in Mexico that employs you.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:13pt;font-weight:400;line-height:120%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:12pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2025 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:6pt"><font><br></font></div><div style="margin-top:12pt;padding-left:6pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.086%"><tr><td style="width:1.0%"></td><td style="width:45.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.115%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Signature</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Name (Printed)</font></div></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Date</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NETHERLANDS</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Waiver of Termination Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. As a condition to the grant of the PSUs, you hereby waive any and all rights to compensation or damages as a result of the termination of your employment with the Company and your Employer for any reason whatsoever, insofar as those rights result or may result from (a) the loss or diminution in value of such rights or entitlements under the 2011 Plan, or (b) you ceasing to have rights under or ceasing to be entitled to any awards under the 2011 Plan as a result of such termination.</font></div><div style="margin-top:12pt;padding-left:5.75pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.61pt;text-decoration:underline">Tax Deferral Upon Retirement</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Unless you otherwise elect by contacting Stryker no later than April 28, 2025, you hereby agree that upon Retirement eligibility, the PSUs shall not become taxable until the date of settlement when Shares are actually delivered or otherwise made available.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NEW ZEALAND</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">WARNING</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You are being offered PSUs to be settled in the form of shares of Stryker Corporation common stock. If the Company runs into financial difficulties and is wound up, you may lose some or all your investment. New Zealand law normally requires people who offer financial products to give information to investors before they invest. This requires those offering financial products to have disclosed information that is important for investors to make an informed decision. The usual rules do not apply to this offer because it is an offer made under the Employee Share Scheme exemption. As a result, you may not be given all the information usually required.  You will also have fewer other legal protections for this investment. You should ask questions, read all documents carefully, and seek independent financial advice before accepting the offer. The Company's Shares are currently traded on the New York Stock Exchange under the ticker symbol &#34;SYK&#34; </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.45pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and Shares acquired under the 2011 Plan may be sold through this exchange. You may end up selling the Shares at a price that is lower than the value of the Shares when you acquired them. The price will depend on the demand for the Company's Shares. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">The Company's most recent annual report (which includes the Company's financial statements) is available at &#91;</font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;investors.stryker.com&#47;financial-information&#47;sec-filings&#47;default.aspx</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#93;. You are entitled to receive a copy of this report, free of charge, upon written request to the Company at </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">POLAND</font></div><div style="margin-top:12pt;padding-left:6.5pt;padding-right:5.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.86pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you maintain bank or brokerage accounts holding cash and foreign securities (including Shares) outside of Poland, you will be required to report information to the National Bank of Poland on transactions and balances in such accounts if the value of such cash and securities exceeds PLN 7 million. If required, such reports must be filed on special forms available on the website of the National Bank of Poland. Further, any transfer of funds in excess of a certain threshold (generally, EUR 15,000) into or out of Poland must be effected through a bank account in Poland. Finally, you are required to store all documents connected with any foreign exchange transactions that you engage in for a period of five years, as measured from the end of the year in which such transaction occurred. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6.5pt;padding-right:5.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.86pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Polish residents holding foreign securities(e.g., Shares) and&#47;or maintaining accounts abroad are obligated to file quarterly reports with the National Bank of Poland incorporating information on transactions and balances of the securities and cash deposited in such accounts if the value of such securities and cash (when combined with all other assets held abroad) exceeds PLN 7,000,000. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PORTUGAL</font></div><div style="margin-top:12pt;padding-left:7pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No country specific provisions.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PUERTO RICO</font></div><div style="margin-top:12pt;padding-left:7pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No country specific provisions.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ROMANIA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You are not required to seek special authorization from the National Bank of Romania in order to open or maintain a foreign bank account. However, if you remit foreign currency into Romania (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, proceeds from the sale of Shares), you may be required to provide the Romanian bank through which the foreign currency is transferred with appropriate documentation. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RUSSIA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">IMPORTANT EMPLOYEE NOTIFICATION.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> You may be required to repatriate certain cash amounts received with respect to the PSUs to Russia as soon as you intend to use those cash amounts for any purpose, including reinvestment. If the repatriation requirement applies, such funds must initially be credited to you through a foreign currency account at an authorized bank in Russia. After the funds are initially received in Russia, they may be further remitted to foreign banks in accordance with Russian exchange control laws. Under the Directive N 5371-U of the Russian Central Bank (the &#34;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CBR</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;), the repatriation requirement may not apply in certain cases with respect to cash amounts received in an account that is considered by the CBR to be a foreign brokerage account. Statutory exceptions to the repatriation requirement also may apply. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">You should contact your personal advisor to ensure compliance with the applicable exchange control requirements prior to vesting in the PSUs and&#47;or selling the Shares acquired pursuant to the PSUs.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">SECURITIES LAW NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The grant of PSUs and the issuance of Shares upon vesting are not intended to be an offering of securities with the Russian Federation, and the Terms and Conditions, the 2011 Plan, this Addendum and all other materials that you receive in connection with the grant of PSUs and your participation in the 2011 Plan (collectively, &#34;Grant Materials&#34;) do not constitute advertising or a </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">solicitation within the Russian Federation. In connection with your grant of PSUs, the Company has not submitted any registration statement, prospectus or other filing with the Russian Federal Bank or any other governmental or regulatory body within the Russian Federation, and the Grant Materials expressly may not be used, directly or indirectly, for the purpose of making a securities offering or public circulation of Shares within the Russian Federation. Any Shares acquired under the 2011 Plan will be maintained on your behalf outside of Russia. Moreover, you will not be permitted to sell or otherwise alienate any Shares directly to other Russian legal entities or individuals.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">EXCHANGE CONTROL NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You are solely responsible for complying with applicable Russian exchange control regulations. Since the exchange control regulations change frequently and without notice, you should consult your legal advisor prior to the acquisition or sale of Shares under the 2011 Plan to ensure compliance with current regulations. As noted, it is your personal responsibility to comply with Russian exchange control laws, and neither the Company nor any Subsidiary will be liable for any fines or penalties resulting from failure to comply with applicable laws.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">ANTI-CORRUPTION NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Anti-corruption laws prohibit certain public servants, their spouses and their dependent children from owning any foreign source financial instruments (e.g., shares of foreign companies such as the Company). Accordingly, you should inform the Company if you are covered by these laws as this relates to your acquisition of Shares under the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SINGAPORE</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Qualifying Person Exemption</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The following provision shall replace Section 24 of the Terms and Conditions&#58;</font></div><div style="margin-top:12pt;padding-left:7pt;padding-right:6.65pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The grant of the PSUs under the 2011 Plan is being made pursuant to the &#34;Qualifying Person&#34; exemption&#34; under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (&#34;SFA&#34;). The 2011 Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore. You should note that, as a result, the PSUs are subject to section 257 of the SFA and you will not be able to make (a) any subsequent sale of the Shares in Singapore or (ii) any offer of such subsequent sale of the Shares subject to the PSUs in Singapore, unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA (Chapter 289, 2006 Ed.).</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Director Reporting Notification</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you are a director, associate director or shadow director of a Singapore company, you are subject to certain notification requirements under the Singapore Companies Act. Among these requirements is an obligation to notify the Singapore company in writing when you receive an interest (e.g., PSUs or Shares) in the Company or any related company. In addition, you must notify the Singapore company when you sell Shares (including when you sell Shares acquired at vesting of the PSUs). These notifications must be made within two business days of acquiring or disposing of any interest in the Company or any related company. In addition, a notification must be made of your interests in the Company or any related company within two business days of becoming a director.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Insider Trading Notice.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You acknowledge that you should be aware of the Singapore insider-trading rules, which may impact your ability to acquire or dispose of Shares.  Under the Singapore insider-trading rules, you are prohibited from selling Shares when you are in possession of information concerning the Company which is not generally available and which you know or should know will have a material effect on the price of such Shares once such information is generally available.</font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SOUTH AFRICA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In addition to the provisions of Section 13 of the Terms and Conditions, you agree to notify your Employer in South Africa of the amount of any gain realized upon vesting of the PSUs. If you fail to advise your Employer of the gain realized upon vesting of the PSUs, you may be liable for a fine. You will be responsible for paying any difference between the actual tax liability and the amount withheld.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You are solely responsible for complying with applicable exchange control regulations and rulings (the &#34;Exchange Control Regulations&#34;) in South Africa. As the Exchange Control Regulations change frequently and without notice, you should consult your legal advisor prior to the acquisition or sale of Shares under the 2011 Plan to ensure compliance with current Exchange Control Regulations. Neither the Company nor any of its Subsidiaries will be liable for any fines or penalties resulting from your failure to comply with applicable laws. You should consult with your personal advisor(s) regarding </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information and Deemed Acceptance of PSUs</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Neither the PSUs nor the underlying Shares shall be publicly offered or listed on any stock exchange in South Africa. The offer is intended to be private pursuant to Section 96 of the Companies Act and is not subject to the supervision of any South African governmental authority. pursuant to Section 96 of the Companies Act, the PSU offer must be finalized on or before the 60th day following the grant date. If you do not want to accept the PSUs, you are required to decline the PSUs no later than the 60th day following the grant date. If you do not reject the PSUs on or before the 60th day following the grant date, you will be deemed to accept the PSUs.</font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SOUTH KOREA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:39pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.66pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Korean residents who sell Shares acquired under the 2011 Plan and&#47;or receive cash dividends on the Shares may have to file a report with a Korean foreign exchange bank, provided the proceeds are in excess of USD5,000 (per transaction) and deposited into a non-Korean bank account. A report may not be required if proceeds are deposited into a non-Korean brokerage account. It is your responsibility to ensure compliance with any applicable exchange control reporting obligations.  You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:39pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.66pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Korean residents must declare all foreign financial accounts (e.g., non-Korean bank accounts, brokerage accounts) to the Korean tax authority and file a report with respect to such accounts in June of the following year if the monthly balance of such accounts exceeds KRW 500 million (or an equivalent amount in foreign currency) on any month-end date during a calendar year. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SPAIN</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:34.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.16pt;text-decoration:underline">Acknowledgement of Discretionary Nature of the 2011 Plan&#59; No Vested Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In accepting the PSUs, you acknowledge that you consent to participation in the 2011 Plan and have received a copy of the 2011 Plan. You understand that the Company has unilaterally, gratuitously and in its sole discretion granted PSUs under the 2011 Plan to individuals who may be employees of the Company or its Subsidiaries throughout the world. The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Company or any of its Subsidiaries on an ongoing basis. Consequently, you understand that the PSUs are granted on the assumption and condition that the PSUs and the Shares acquired upon vesting of the PSUs shall not become a part of any employment contract (either with the Company or any of its Subsidiaries) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever. In addition, you understand that this grant would not be made to you but for the assumptions and conditions referenced above. Thus, you acknowledge and freely accept that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, the PSUs shall be null and void.  You understand and agree that, as a condition of the grant of the PSUs, any unvested PSUs as of the date you cease active employment will be forfeited without entitlement to the underlying Shares or to any amount of indemnification in the event of the termination of employment by reason of, but not limited to, (i) material modification of the terms of employment under Article 41 of the Workers' Statute or (ii) relocation under Article 40 of the Workers' Statute. You acknowledge that you have read and specifically accept the conditions referred to in the Terms and Conditions regarding the impact of a termination of employment on your PSUs.</font></div><div style="margin-top:12pt;padding-left:5.75pt;padding-right:5.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.61pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you hold 10% or more of the Share capital of the Company or such other amount that would entitle you to join the Company's board of directors, the acquisition, ownership and disposition of such Shares must be declared for statistical purposes to the </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Spanish Direcci&#243;n General de Comercio e Inversiones </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(the Bureau for Commerce and Investments), which is a department of the Ministry of Economy and Competitiveness. The declaration (via Form 6) must be made in January for Shares acquired or disposed of during the prior calendar year and&#47;or for Shares owned as of December 31 of the prior calendar year&#59; provided, if the value of the Shares acquired or sold exceeds &#8364;1,502,530, the declaration must be filed within one month of the acquisition or disposition of the Shares, as applicable. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:12pt;padding-left:5.75pt;padding-right:5.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.61pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. To the extent you hold rights or assets (e.g., cash or the Shares held in a bank or brokerage account) outside of Spain with a value in excess of &#8364;50,000 per type of right or asset as of December 31 each year (or at any time during the year in which you sell or dispose of such right or asset), you are required to report information on such rights and assets on your tax return for such year. After such rights or assets are initially reported, the reporting obligation will only apply for subsequent years if the value of any previously-reported rights or assets increases by more than &#8364;20,000 per type of right or asset as of each subsequent December 31, or if you sell Shares or cancel bank accounts that were previously reported. Failure to comply with this reporting requirement may result in penalties to the Spanish residents. In addition, you may be required to electronically declare to the Bank of Spain any foreign accounts (including brokerage accounts held abroad), any foreign instruments (including Shares acquired under the 2011 Plan), and any transactions with non-Spanish residents (including any payments of Shares made pursuant to the 2011 Plan), depending on the balances in such accounts together with the value of such instruments as of December 31 of the relevant year, or the volume of transactions with non-Spanish residents during the relevant year. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:12pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2025 TO </font><font style="color:#002755;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">STOCKPLANADMINISTRATION&#64;STRYKER.COM.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="margin-top:12pt;padding-left:6pt"><font><br></font></div><div style="margin-top:12pt;padding-left:6pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.086%"><tr><td style="width:1.0%"></td><td style="width:45.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.115%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Signature</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Name (Printed)</font></div></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Date</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="margin-top:12pt;padding-left:6pt"><font><br></font></div><div style="margin-top:12pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SWITZERLAND</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Neither this document nor any other materials relating to the PSUs (a) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (&#34;FinSA&#34;) (b) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an employee of the Company or (c) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority (&#34;FINMA&#34;).</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TAIWAN</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The offer of participation in the 2011 Plan is available only for employees of the Company and its Subsidiaries. The offer of participation in the 2011 Plan is not a public offer of securities by a Taiwanese company.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.4pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You may acquire and remit foreign currency (including proceeds from the sale of Shares acquired under the 2011 Plan) into Taiwan up to USD5,000,000 per year without justification. If the transaction amount is TWD$500,000 or more in a single transaction, you must submit a Foreign Exchange Transaction Form and also provide supporting documentation to the satisfaction of the remitting bank. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THAILAND</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.35pt;text-align:justify;text-indent:39pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.66pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you receive proceeds from the sale of Shares or cash dividends in relation to the Shares in excess of USD1,000,000 in a single transaction, you must immediately repatriate the funds to Thailand (or utilize such funds offshore for permissible purposes) and convert the funds to Thai Baht </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.35pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">within 360 days of repatriation or deposit the funds in an authorized foreign exchange account in Thailand. You are also required to provide details of the transaction (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">i.e.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, identification information and purpose of the transaction) to the receiving bank. If you do not repatriate such funds and utilizes them offshore for permissible purposes (i.e., purposes not listed in the negative list prescribed by the Bank of Thailand), you must obtain a waiver of the repatriation requirement from a commercial bank in Thailand by submitting an application and supporting documents evidencing that such funds will be utilized offshore for permissible purposes. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">T&#220;RKIYE</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Under Turkish law, you are not permitted to sell any Shares acquired under the 2011 Plan within Turkey. The Shares are currently traded on the New York Stock Exchange, which is located outside of Turkey, under the ticker symbol &#34;SYK&#34; and the Shares may be sold through this exchange.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Financial Intermediary Obligation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You acknowledge that any activity related to investments in foreign securities (e.g., the sale of Shares) should be conducted through a bank or financial intermediary institution licensed by the Turkey Capital Markets Board and should be reported to the Turkish Capital Markets Board. You solely are responsible for complying with this requirement and should consult with a personal legal advisor for further information regarding any obligations in this respect.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED ARAB EMIRATES</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The offer of the PSUs is available only for select Employees of the Company and its Subsidiaries and is in the nature of providing incentives in the United Arab Emirates. The 2011 Plan and the Terms and Conditions are intended for distribution only to such individuals and must not be delivered to, or relied on by any other person.</font></div><div style="margin-top:12pt;padding-left:7pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Prospective purchasers of securities should conduct their own due diligence.</font></div><div style="margin-top:12pt;padding-left:7pt;padding-right:6.6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with this statement, including the 2011 Plan and the Terms and Conditions, or any other incidental communication materials distributed in connection with the PSUs. Further, neither the Ministry of Economy nor the Dubai Department of Economic Development has approved this statement nor taken steps to verify the information set out in it, and has no responsibility for it. Residents of the United Arab Emirates who have any questions regarding the contents of the 2011 Plan and the Terms and Conditions should obtain independent advice.</font></div><div style="margin-top:12pt;padding-left:9pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED KINGDOM</font></div><div style="margin-top:12pt;padding-left:5.75pt;padding-right:6.5pt;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.61pt">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Income Tax and Social Insurance Contribution Withholding</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The following provision shall supplement Section 13 of the Terms and Conditions&#58;</font></div><div style="margin-top:12pt;padding-left:7pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limitation to Section 13 of the Terms and Conditions, you agree that you are liable for all Tax- Related Items and hereby covenant to pay all such Tax-Related Items, as and when requested by the Company, your Employer or by HM Revenue and Customs (&#34;HMRC&#34;) (or any other tax authority or any other relevant authority). You also agree to indemnify and keep indemnified the Company and your Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC on your behalf (or any other tax authority or any other relevant authority).</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exclusion of Claim</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You acknowledge and agree that you will have no entitlement to compensation or damages in consequence of the termination of your employment with the Company and your Employer for any reason whatsoever and whether or not in breach of contract, insofar as any purported claim to such entitlement arises or may arise from your ceasing to have rights under or to be entitled to vest in the PSUs as a result of such termination of employment (whether the termination is in breach of contract or otherwise), or from the loss or diminution in value of the PSUs. Upon the grant of the PSUs, you shall be deemed irrevocably to have waived any such entitlement.</font></div><div style="margin-top:12pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">****************************</font></div><div><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:11.05pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT A</font></div><div style="margin-top:11.05pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2011 LONG-TERM INCENTIVE PLAN, AS AMENDED AND RESTATED</font></div><div style="margin-top:11.05pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br></font></div><div style="margin-top:11.05pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT A</font></div><div style="margin-top:11.05pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2011 LONG-TERM INCENTIVE PLAN, AS AMENDED AND RESTATED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br>EMPLOYER INFORMATION STATEMENT &#8211; DENMARK<br>PERFORMANCE STOCK UNIT GRANT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to section 3(1) of the Danish Act on the Use of Rights to Purchase or Subscribe for Shares etc. in Employment Relationships (the &#34;Stock Option Act&#34;), Stryker Corporation (the &#8220;Company&#8221;) is providing you with the following information regarding the Company&#8217;s performance stock unit (&#34;PSU&#34;) grant in a separate written statement. This statement contains only the information mentioned in the Stock Option Act&#59; the other terms and conditions of your PSU grant are described in detail in the Stryker Corporation 2011 Long-Term Incentive Plan, as Amended and Restated  (the &#34;2011 Plan&#34;), the Terms and Conditions Related to Performance Stock Units Granted Pursuant to the 2011 Long-Term Incentive Plan (the &#8220;PSU Agreement&#8221;) and the CEO Award Letter for the PSU grant, all of which have been provided to you.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IMPORTANT NOTE&#58; The Stock Option Act only applies to PSUs granted under the 2011 Plan to employees of the Company and its Subsidiaries, and does not apply to individuals, including managers, who are not regarded as &#34;employees&#34; as defined under the Stock Option Act. If you are not an employee of the Company or one of its Subsidiaries within the meaning of the Stock Option Act, this Employer Information Statement shall not apply to you, you may not rely upon any of the information contained herein and the provisions described herein shall be void and ineffective.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Date of Grant</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Grant Date of the PSU is the date that the Compensation and Human Capital Committee of the Board of Directors (the &#8220;Committee&#8221;) approved a grant for you and determined it would be effective.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Terms and Conditions of the Grant</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The grant of PSU is made at the sole discretion of the Committee.  In its assessment, the Committee has considered a number of factors in granting the PSUs to you, including (but not limited to) the Company&#8217;s latest annual results, your personal performance and your value for the future growth, development and operation of the Company.  Notwithstanding your personal performance and the development of the Company, the Company may decide, in its sole discretion, not to grant an PSU to you in the future.  Under the terms of the Plan and the Agreement, you have no entitlement or claim to receive future PSU grants.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Vesting Dates and Exercise Period</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Your PSU shall vest over a period of time (&#8220;vesting period&#8221;), provided you remain employed by or in the service of the Company or a Subsidiary and any performance or other vesting conditions set forth in the Plan and the Agreements are satisfied, unless the PSU are vested or terminated </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">earlier for the reasons set forth in the Plan and the Agreements and subject to Section 5 of this statement.</font></div><div style="padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Exercise Price</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-28.35pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For PSUs, you pay no monetary consideration to receive the PSU nor do you pay any price to receive the shares of the Company&#8217;s common stock issued upon vesting.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;Your Rights upon Termination</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The treatment of your PSU awards upon termination of your employment will be determined in accordance with the following unless the terms contained in the Agreement and in the 2011 Plan are more favorable to you.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Your PSU will survive and will not be forfeited if your employment is terminated by your employer for any reason other than your breach of contract (as determined under Danish law) or summary dismissal. This means that you may be entitled to continue to vest in the award as if you were still an employee in accordance with your Agreement and the 2011 Plan. Also, you may be entitled to receive an additional PSU grant, proportionate to the length of your employment in the accounting year in which your employment is terminated, to which you would have been entitled according to agreement or custom had you still been employed at the end of the accounting year. This provision will not apply if the termination is due to your breach of your employment contract or in case of your justified summary dismissal, in which case the PSU will lapse to the extent the PSU has not vested on the effective date of termination of your employment. Such lapse will take place automatically without notice on the effective date of termination of your employment.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you terminate your employment due to your employer's material breach (as determined under Danish law), or if your employment terminates because you reach the age of retirement for employees of your employer or because you are entitled to receive old-age pension from the Danish state or your employer, the PSU award shall continue on unchanged terms as if you had still been employed. Also, you may be entitled to receive an additional PSU grant, proportionate to the length of your employment in the accounting year in which your employment is terminated, to which you would have been entitled according to agreement or custom had you still been employed at the end of the accounting year or at the date of grant.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you terminate your employment for other reasons,  your PSU award will be forfeited as per the effective date of termination of your employment unless otherwise set out in the terms of the Agreement. In addition, you will be ineligible to receive any additional PSU grants after your resignation.</font></div><div style="padding-left:28.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;Financial Aspects of Participating in the 2011 Plan</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The PSU grant has no immediate financial consequences for you. The value of the PSU award will not be taken into account when calculating holiday allowances, pension contributions or other statutory consideration calculated on the basis of salary. The tax treatment of the PSU award depends on a number of aspects and thus, you are encouraged to seek particular advice regarding your tax position. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Shares of stock are financial instruments and investing in stock will always have financial risk. The possibility of profit at the time of vesting will not only be dependent on the Company&#8217;s financial development, but inter alia also on the general development of the stock market. In addition, before or after you vest in your PSU award, the shares of Company stock could decrease in value even below the price of such stock on the Date of Grant.</font></div><div style="padding-left:28.35pt;text-align:justify"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;Other Issues</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Apart from Clause 5 in this Statement (regarding your rights upon termination of employment), this Statement does not intend to alter any provisions of the 2011 Plan or the Agreement (or any related document), and the 2011 Plan and the Agreement (and any related document) shall prevail in case of any ambiguities. However, your mandatory rights under the Stock Option Act shall prevail in case of any ambiguities.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Plan Administrator </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Stryker Corporation</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Portage, Michigan USA</font></div><div style="margin-top:11.15pt;padding-left:7pt;text-align:justify;text-indent:35.3pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2011 LONG-TERM INCENTIVE PLAN, SOM REVIDERET OG GENFREMSAT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br>ARBEJDSGIVERERKL&#198;RING &#8211; DANMARK<br>TILDELING AF </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PR&#198;STATIONSBEGR&#198;NSEDE AKTIEENHEDER</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I henhold til &#167; 3, stk. 1, i lov om brug af k&#248;beret eller tegningsret til aktier m.v. i ans&#230;ttelsesforhold (&#34;Aktieoptionsloven&#34;) giver Stryker Corporation (&#34;Selskabet&#34;) dig hermed i en s&#230;rskilt skriftlig erkl&#230;ring f&#248;lgende oplysninger om Selskabets tildeling af PSU'er (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Performance Stock Units</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) . Denne erkl&#230;ring indeholder kun de oplysninger, der er n&#230;vnt i Aktieoptionsloven. De &#248;vrige vilk&#229;r og betingelser for din PSU-tildeling er n&#230;rmere beskrevet i Selskabets </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">2011 Long-Term Incentive Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, som revideret og genfremsat  (&#34;2011-Planen&#34;), </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Terms and Conditions Related to Performance Stock Units Granted Pursuant to the 2011 Long-Term Incentive Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (&#34;PSU-Aftalen) og CEO-tildelingsbrevene vedr&#248;rende henholdsvis PSU-tildelingen, hvilke dokumenter alle er blevet udleveret til dig.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">VIGTIGT&#58; Aktieoptionsloven g&#230;lder kun for PSU'er, der i henhold til 2011-Planen er tildelt til l&#248;nmodtagere i Selskabet og dets Datterselskaber, og g&#230;lder ikke for personer, herunder ledere, der ikke anses for at v&#230;re &#34;l&#248;nmodtagere&#34; som defineret i Aktieoptionsloven. Hvis du ikke er l&#248;nmodtager i Selskabet eller i et af dets Datterselskaber i Aktieoptionslovens forstand, g&#230;lder denne Arbejdsgivererkl&#230;ring ikke for dig, hvorfor du ikke vil kunne henholde dig til nogen af oplysningerne heri, og de heri anf&#248;rte bestemmelser vil ikke have virkning.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Tidspunkt for tildeling</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Tidspunktet for PSU-tildelingen er den dato, hvor det af Bestyrelsen nedsatte Udvalg for Vederlag og Menneskelig Kapital (&#34;Udvalget&#34;) godkendte tildelingen til dig og besluttede, at den skulle tr&#230;de i kraft.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Kriterier og betingelser for tildeling</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">PSU-tildelingen sker alene efter Udvalgets eget sk&#248;n.  Udvalget har i sin vurdering inddraget en r&#230;kke faktorer i forbindelse med PSU-tildelingen til dig, herunder (men ikke begr&#230;nset til) Selskabets seneste &#229;rsresultat, din personlige performance og din betydning for Selskabets fremtidige v&#230;kst, udvikling og drift.  Uanset din personlige performance og Selskabets udvikling kan Selskabet frit v&#230;lge ikke at tildele dig PSU'er fremover.  I henhold til bestemmelserne i Planen og Aftalen har du ikke nogen ret til eller noget krav p&#229; fremover at modtage PSU-tildelinger.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Modningstidspunkter og udnyttelsesperiode</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Din PSU modnes over en periode (&#34;modningsperioden&#34;), forudsat at du fortsat er ansat i eller arbejder for Selskabet eller et Datterselskab, og forudsat at alle de i Planen og Aftalerne beskrevne performance- og modningsbetingelser er opfyldt, medmindre PSU'en modnes eller bortfalder p&#229; et tidligere tidspunkt som f&#248;lge af de i Planen og Aftalerne anf&#248;rte &#229;rsager og med forbehold for pkt. 5 i denne erkl&#230;ring.</font></div><div style="padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Udnyttelseskurs</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hvad ang&#229;r PSU'er, skal du ikke betale noget vederlag for at modtage PSU'en, ligesom du ikke skal betale noget for at modtage de ordin&#230;re aktier i Selskabet, der udstedes ved modning.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;Din retsstilling i forbindelse med fratr&#230;den</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I forbindelse med din fratr&#230;den vil dine PSU-tildelinger blive behandlet som f&#248;lger, medmindre vilk&#229;rene i Aftalen og i 2011-Planen er mere fordelagtige for dig.  </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Din PSU bortfalder ikke, hvis din fratr&#230;den skyldes opsigelse fra din arbejdsgivers side, medmindre der er tale om misligholdelse fra din side (som defineret i dansk ret) eller bortvisning. Dette betyder, at du m&#229;ske vil v&#230;re berettiget til, at din PSU fortsat modnes i overensstemmelse med din Aftale og 2011-Planen, som om du stadig var ansat. Endvidere vil du m&#229;ske v&#230;re berettiget til at modtage en yderligere PSU-tildeling, som beregnes forholdsm&#230;ssigt i forhold til, hvor l&#230;nge du er ansat i det regnskabs&#229;r, hvori du fratr&#230;der, og som du ville have v&#230;ret berettiget til i henhold til aftale eller s&#230;dvane, s&#229;fremt du stadig havde v&#230;ret ansat ved udgangen af regnskabs&#229;ret. Denne bestemmelse g&#230;lder ikke, s&#229;fremt din fratr&#230;den skyldes opsigelse p&#229; grund af din misligholdelse af ans&#230;ttelseskontrakten eller berettiget bortvisning, i hvilket tilf&#230;lde PSU'en bortfalder, i det omfang de ikke er modnet ved ans&#230;ttelsesforholdets oph&#248;r. Bortfaldet sker automatisk uden varsel ved ans&#230;ttelsesforholdets oph&#248;r.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hvis du fratr&#230;der din stilling som f&#248;lge af v&#230;sentlig misligholdelse fra din arbejdsgivers side (som defineret i dansk ret), eller hvis du fratr&#230;der, fordi du n&#229;r pensionsalderen for l&#248;nmodtagere hos din arbejdsgiver, eller fordi du har ret til at modtage alderspension fra den danske stat eller din arbejdsgiver, vil din PSU-tildeling forts&#230;tte p&#229; u&#230;ndrede vilk&#229;r, som om du stadig var ansat.   Endvidere vil du m&#229;ske v&#230;re berettiget til at modtage en yderligere PSU-tildeling, som beregnes forholdsm&#230;ssigt i forhold til, hvor l&#230;nge du er ansat i det regnskabs&#229;r, hvori du fratr&#230;der, og som du ville have v&#230;ret berettiget til i henhold til aftale eller s&#230;dvane, s&#229;fremt du stadig havde v&#230;ret ansat ved udgangen af regnskabs&#229;ret eller p&#229; tildelingstidspunktet.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hvis du fratr&#230;der din stilling af andre &#229;rsager, vil din PSU-tildeling bortfalde ved ans&#230;ttelsesforholdets oph&#248;r, medmindre andet fremg&#229;r af Aftalen. Endvidere vil du ikke v&#230;re berettiget til at f&#229; tildelt yderligere PSU'er efter din fratr&#230;den.</font></div><div style="padding-left:28.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;&#216;konomiske aspekter ved at deltage i 2011-Planen</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">PSU-tildelingen har ingen umiddelbare &#248;konomiske konsekvenser for dig. V&#230;rdien af PSU-tildelingen indg&#229;r ikke i beregningen af feriepenge, pensionsbidrag eller andre lovpligtige, vederlagsafh&#230;ngige ydelser. Den skattem&#230;ssige behandling af PSU-tildelingen afh&#230;nger af flere forhold, og du opfordres derfor til at s&#248;ge s&#230;rskilt r&#229;dgivning vedr&#248;rende din skattem&#230;ssige situation. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Aktier er finansielle instrumenter, og investering i aktier vil altid v&#230;re forbundet med en &#248;konomisk risiko. Muligheden for en gevinst p&#229; modningstidspunktet afh&#230;nger ikke alene af Selskabets &#248;konomiske udvikling, men ogs&#229; af bl.a. den generelle udvikling p&#229; aktiemarkedet. Derudover kan v&#230;rdien af Selskabets aktier b&#229;de f&#248;r og efter modningen af din PSU-tildeling falde til en v&#230;rdi, der m&#229;ske endda ligger under kursen p&#229; tildelingstidspunktet.</font></div><div style="padding-left:28.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;&#216;vrige oplysninger</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Med undtagelse af pkt. 5 i denne erkl&#230;ring (vedr&#248;rende din retsstilling i forbindelse med fratr&#230;den) har denne erkl&#230;ring ikke til form&#229;l at &#230;ndre nogen af bestemmelserne i 2011-Planen eller Aftalen (eller i tilh&#248;rende dokumenter), og 2011-Planen og Aftalen (og eventuelle tilh&#248;rende dokumenter) har forrang i tilf&#230;lde af uoverensstemmelser. Dine ufravigelige rettigheder i henhold til Aktieoptionsloven har dog forrang i tilf&#230;lde af uklarhed.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:35.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Planadministrator </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Stryker Corporation</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Portage, Michigan USA</font></div><div style="margin-top:11.15pt;padding-left:7pt;padding-right:6.5pt;text-align:justify"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>6
<FILENAME>ex10iv2025norersuawardlett.htm
<DESCRIPTION>EX-10.4
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ie331d75eae0f4a2b85e870e51f6c1ac2_1"></div><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:11.6pt;padding-left:5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">                                                                                                                           </font><img alt="image_0a.jpg" src="image_0a.jpg" style="height:36px;margin-bottom:5pt;vertical-align:text-bottom;width:139px"></div><div style="margin-top:1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  Kevin A. Lobo</font></div><div style="margin-top:1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  Chair and CEO</font></div><div style="margin-top:11.6pt;padding-right:347.6pt;text-align:justify"><font><br></font></div><div style="margin-top:11.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Personal and Confidential</font></div><div style="margin-top:11.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  February 5, 2025</font></div><div style="margin-top:11.6pt;text-align:justify"><font><br></font></div><div style="margin-top:11.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  First Name Last Name</font></div><div style="margin-top:3.75pt;padding-left:5pt;text-align:justify;text-indent:35.3pt"><font><br></font></div><div style="margin-top:0.05pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Dear First Name,</font></div><div style="margin-top:7.45pt;padding-left:5pt;text-align:justify;text-indent:35.3pt"><font><br></font></div><div style="padding-left:6.75pt;padding-right:2.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I am pleased to inform you that you are one of a select group of individuals receiving a restricted stock units (RSUs) award in 2025. We use these awards to reward performers who we believe will be key contributors to our growth well into the future. The total Award Date Value (ADV) of your award is approximately USD $xx,xxx.</font></div><div style="margin-top:11.35pt;padding-left:6.75pt;padding-right:2.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You are receiving xxx RSUs with respect to Common Stock of Stryker Corporation. Except as otherwise provided in the Terms and Conditions, one-third of these RSUs will vest on March 21 of each of the three years beginning March 21, 2026.</font></div><div style="margin-top:0.1pt;padding-left:5pt;text-align:justify;text-indent:35.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6.75pt;padding-right:6.2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:117%">You must &#8220;Accept&#8221; the award online via the UBS One Source web site located at </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:117%;text-decoration:underline">www.ubs.com&#47;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:117%"> </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:117%;text-decoration:underline">onesource&#47;SYK</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:117%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:117%">between March 4 and March 31, 2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:117%">. The detailed terms of the RSUs are in the Terms and Conditions, any applicable country addendum and the provisions of the Company's 2011 Long-Term Incentive Plan, as Amended and Restated. Those documents, together with the related Prospectus, are available on the UBS One Source web site, and you should read them before accepting the awards. In addition, you may be asked to sign the most recent version of Stryker&#8217;s Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement (&#8220;Non-Compete Agreement&#8221;) in connection with these awards. If you are asked to sign the Non-Compete Agreement, it will be emailed to you and you will be asked to sign the document electronically via Adobe Sign by March 31, 2025. The vesting of the RSUs is conditioned on you having signed the Non-Compete Agreement by March 31, 2025, where permitted by applicable law.</font></div><div style="margin-top:10.95pt;padding-left:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You can find additional educational materials on the UBS One Source web site in the Resources section, including RSU brochure and RSU Tax Questions &#38; Answers.</font></div><div style="margin-top:10.95pt;padding-left:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sincerely,</font></div><div style="margin-top:11.6pt;text-align:justify"><img alt="image_1a.jpg" src="image_1a.jpg" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:61px"></div><div style="margin-top:11.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Kevin A. Lobo</font></div><div style="margin-top:0.05pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Chair and Chief Executive Officer</font></div><div><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:3.65pt;padding-left:1pt;padding-right:1pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="margin-top:2pt"><font><br></font></div><div style="padding-left:0.97pt;padding-right:0.97pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TERMS AND CONDITIONS</font></div><div style="margin-top:0.35pt;padding-left:1pt;padding-right:1pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RELATING TO RESTRICTED STOCK UNITS GRANTED</font></div><div style="margin-top:0.35pt;padding-left:1.02pt;padding-right:1.02pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PURSUANT TO THE 2011 LONG-TERM INCENTIVE PLAN, AS AMENDED AND RESTATED</font></div><div style="margin-top:11.6pt;padding-left:5pt;padding-right:5.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt">The Restricted Stock Units (&#34;RSUs&#34;) with respect to Common Stock of Stryker Corporation (the &#34;Company&#34;) granted to you during 2025 are subject to these Terms and Conditions Relating to Restricted Stock Units Granted Pursuant to the 2011 Long-Term Incentive Plan, as Amended and Restated (the &#34;Terms and Conditions&#34;) and all of the terms and conditions of the Stryker Corporation 2011 Long- Term Incentive Plan, as Amended and Restated (the &#34;2011 Plan&#34;), which is incorporated herein by reference. In the case of a conflict between these Terms and Conditions and the terms of the 2011 Plan, the provisions of the 2011 Plan will govern. Capitalized terms used but not defined herein have the meaning provided therefor in the 2011 Plan. For purposes of these Terms and Conditions, &#34;Employer&#34; means the Company or any Subsidiary that employs you on the applicable date, and &#34;Stock Plan Administrator&#34; means UBS Financial Services Inc. (or any other independent service provider engaged by the Company to assist with the implementation, operation and administration of the 2011 Plan).</font></div><div style="margin-top:11pt;padding-left:72.2pt;text-indent:-31.9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.56pt">Your right to receive the Shares issuable pursuant to the RSUs shall be only as follows&#58;</font></div><div style="margin-top:11.6pt;padding-left:5pt;padding-right:6.75pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:18.68pt">If you continue to be an Employee, you will receive the Shares underlying the RSUs that have become vested as soon as administratively possible following the vesting date as set forth in the award letter.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:5.5pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:18.03pt">If you cease to be an Employee by reason of Disability (as such term is defined in the 2011 Plan or determined under local law) or death prior to the date that your RSUs become fully vested, you or your estate will become fully vested in your RSUs, and you, your legal representative or your estate will receive all of the underlying Shares as soon as administratively practicable following your termination by Disability or death.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.45pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:19.2pt">If you cease to be an Employee prior to the date that your RSUs become fully vested for any reason other than those provided in (b), you shall cease vesting in your RSUs effective as of your Termination Date. If you are resident or employed outside of the United States, &#34;Termination Date&#34; shall mean the last day on which you are an Employee of your Employer, provided that (1) your notice period is 12 months or less, or (2) your employment ends less than 12 months after the date on which you signed your termination agreement. </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Other than Section 16 officers (as defined below), if</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> your notice period exceeds 12 months, then &#34;Termination Date&#34; will be 12 months after the date on which notice was given, whether it be by you or your Employer. If your employment ends more than 12 months after you signed your termination agreement, then &#8220;Termination Date&#8221; will be 12 months after the date on which you signed your termination agreement. </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">If you are an officer of the Company and in such capacity are subject to reporting under Section 16 of the U.S. Securities Exchange Act of 1934 (a &#8220;Section 16 officer&#8221;) on the date on which notice was given, &#34;Termination Date&#34; shall mean the last day on which you are an Employee of your Employer.</font></div><div style="margin-top:11pt;padding-left:5pt;padding-right:5.6pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.95pt">Notwithstanding the foregoing, the Company may, in its sole discretion, settle your RSUs in the form of&#58; (i) a cash payment to the extent settlement in Shares (1) is prohibited under local law,</font></div><div style="padding-left:5pt;padding-right:5.6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(2) would require you, the Company and&#47;or your Employer to obtain the approval of any governmental and&#47;or regulatory body in your country of residence (and country of employment, if different), or (3) is administratively burdensome&#59; or (ii) Shares, but require you to immediately sell such Shares (in which case, the Company shall have the authority to issue sales instructions in relation to such Shares on your behalf).</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.7pt;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt">The number of Shares subject to the RSUs shall be subject to adjustment and the vesting dates hereof may be accelerated as follows&#58;</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:5.55pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:18.68pt">In the event that the Shares, as presently constituted, shall be changed into or exchanged for a different number or kind of shares of stock or other securities of the Company or of another corporation (whether by reason of merger, consolidation, recapitalization, reclassification, split-up, combination of shares, or otherwise) or if the number of such Shares shall be increased through the payment of a stock dividend or a dividend on the Shares of rights or warrants to purchase securities of the Company shall be made, then there shall be substituted for or added to each Share theretofore subject to the RSUs the number and kind of shares of stock or other securities into which each outstanding Share shall be so changed, or for which each such Share shall be exchanged, or to which each such Share shall be entitled. The other terms of the RSUs shall also be </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">appropriately amended as may be necessary to reflect the foregoing events. In the event there shall be any other change in the number or kind of the outstanding Shares, or of any stock or other securities into which such Shares shall have been exchanged, then if the Committee shall, in its sole discretion, determine that such change equitably requires an adjustment in the RSUs, such adjustment shall be made in accordance with such determination.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:6.6pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:18.03pt">Fractional Shares resulting from any adjustment in the RSUs may be settled in cash or otherwise as the Committee shall determine, in its sole discretion. Notice of any adjustment will be given to you and such adjustment (whether or not such notice is given) shall be effective and binding for all purposes hereof.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:5.55pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:19.2pt">The Committee shall have the power to amend the RSUs to permit the immediate vesting of the RSUs (and to terminate any unvested RSUs) and the distribution of the underlying Shares prior to the effectiveness of (i) any disposition of substantially all of the assets of the Company or your Employer, (ii) the shutdown, discontinuance of operations or dissolution of the Company or your Employer, or (iii) the merger or consolidation of the Company or your Employer with or into any other unrelated corporation.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:5.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt">If you are resident and&#47;or employed outside of the United States, you agree, as a condition of the grant of the RSUs, to repatriate all payments attributable to the Shares and&#47;or cash acquired under the 2011 Plan (including, but not limited to, dividends, dividend equivalents and any proceeds derived from the sale of the Shares acquired pursuant to the RSUs) if required by and in accordance with local foreign exchange rules and regulations in your country of residence (and country of employment, if different). In addition, you also agree to take any and all actions, and consent to any and all actions taken by the Company and its Subsidiaries, as may be required to allow the Company and its Subsidiaries to comply with local laws, rules and regulations in your country of residence (and country of employment, if different). Finally, you agree to take any and all actions as may be required to comply with your personal legal and tax obligations under local laws, rules and regulations in your country of residence (and country of employment, if different).</font></div><div style="margin-top:10.95pt;padding-left:5pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">5.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt">If you are resident and&#47;or employed in a country that is a member of the European Union, the grant of the RSUs and these Terms and Conditions are intended to comply with the age discrimination provisions of the EU Equal Treatment Framework Directive, as implemented into local law (the &#34;Age Discrimination Rules&#34;). To the extent that a court or tribunal of competent jurisdiction determines that any provision of these Terms and Conditions is invalid or unenforceable, in whole or in part, under the Age Discrimination Rules, the Company, in its sole discretion, shall have the power and authority to revise or strike such provision to the minimum extent necessary to make it valid and enforceable to the full extent permitted under local law.</font></div><div style="margin-top:11.05pt;padding-left:5pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">6.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt">Regardless of any action the Company and&#47;or your Employer take with respect to any or all income tax (including U.S. federal, state and local taxes and&#47;or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related withholding (&#34;Tax-Related Items&#34;), you acknowledge that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that the Company and your Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including the grant of the RSUs, the vesting of the RSUs, the subsequent sale of any Shares acquired pursuant to the RSUs and the receipt of any dividends or dividend equivalents and (ii) do not commit to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate your liability for Tax-Related Items. Further, if you become subject to taxation in more than one country between the grant date and the date of any relevant taxable or tax withholding event, as applicable, you acknowledge that your Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one country.</font></div><div style="margin-top:10.95pt;padding-left:5pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Prior to any taxable event, if your country of residence (and&#47;or your country of employment, if different) requires withholding of Tax-Related Items, the Company shall withhold a number of whole Shares that have an aggregate Fair Market Value that the Company, taking into account local requirements and administrative issues, determines in its sole discretion is appropriate to cover withholding for Tax-Related Items with respect to the Shares. The cash equivalent of the Shares withheld will be used to settle the obligation to withhold the Tax-Related Items. In cases where the Fair Market Value of the number of whole Shares withheld is greater than the amount required to be paid to the relevant government authorities with respect to withholding for Tax-Related Items, the Company shall make a cash payment to you equal to the difference as soon as administratively practicable. In the event that withholding in Shares is prohibited or problematic under applicable law or otherwise may trigger adverse consequences to the Company or your Employer, your Employer shall withhold the Tax-Related Items required to be withheld with respect to the Shares in cash from </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:10.95pt;padding-left:5pt;padding-right:6.6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">your regular salary and&#47;or wages or other amounts payable to you. In the event the withholding requirements are not satisfied through the withholding of Shares or through your regular salary and&#47;or wages or any other amounts payable to you by your Employer, no Shares will be issued to you (or your estate) unless and until satisfactory arrangements (as determined by the Board of Directors) have been made by you with respect to the payment of any Tax-Related Items that the Company or your Employer determines, in its sole discretion, should be withheld or collected with respect to such RSUs. By accepting these RSUs, you expressly consent to the withholding of Shares and&#47;or withholding from your regular salary and&#47;or wages or other amounts payable to you as provided for hereunder. All other Tax- Related Items related to the RSUs and any Shares delivered in payment thereof are your sole responsibility.</font></div><div style="margin-top:11pt;padding-left:5pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">7.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt">The RSUs are intended to be exempt from the requirements of Code Section 409A. The 2011 Plan and these Terms and Conditions shall be administered and interpreted in a manner consistent with this intent. If the Company determines that these Terms and Conditions are subject to Code Section 409A and that it has failed to comply with the requirements of that Section, the Company may, at the Company's sole discretion and without your consent, amend these Terms and Conditions to cause them to comply with Code Section 409A or be exempt from Code Section 409A.</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">8.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt">If you were required to sign the &#34;Stryker Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement&#34; or a similar agreement in order to receive the RSUs or have previously signed such an agreement and you breach any non-competition, non-solicitation or nondisclosure provision or provision as to ownership of inventions contained therein at any time while employed by the Company or a Subsidiary, or during the one-year period following termination of employment, any unvested RSUs shall be rescinded and you shall return to the Company all Shares that were acquired upon vesting of the RSUs that you have not disposed of. Further, you shall pay to the Company an amount equal to the profit realized by you (if any) on all Shares that were acquired upon vesting of the RSUs that you have disposed of. For purposes of the preceding sentence, the profit shall be the Fair Market Value of the Shares at the time of disposition.</font></div><div style="margin-top:11pt;padding-left:5pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">9.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:23.36pt">The RSUs shall be transferable only by will or the laws of descent and distribution. If you purport to make any transfer of the RSUs, except as aforesaid, the RSUs and all rights thereunder shall terminate immediately.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:5.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">10.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The RSUs shall not be vested in whole or in part, and the Company shall not be obligated to issue any Shares subject to the RSUs, if such issuance would, in the opinion of counsel for the Company, violate the Securities Act of 1933 or any other U.S. federal, state or non-U.S. statute having similar requirements as it may be in effect at the time. The RSUs are subject to the further requirement that, if at any time the Board of Directors shall determine in its discretion that the listing or qualification of the Shares subject to the RSUs under any securities exchange requirements or under any applicable law, or the consent or approval of any governmental regulatory body, is necessary or desirable as a condition of or in connection with the issuance of Shares pursuant to the RSUs, the RSUs may not be vested in whole or in part unless such listing, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Board of Directors.</font></div><div style="margin-top:10.95pt;padding-left:5pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">11.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The grant of the RSUs shall not confer upon you any right to continue in the employ of your Employer nor limit in any way the right of your Employer to terminate your employment at any time. You shall have no rights as a shareholder of the Company with respect to any Shares issuable upon the vesting of the RSUs until the date of issuance of such Shares.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">12.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">You acknowledge and agree that the 2011 Plan is discretionary in nature and may be amended, cancelled, or terminated by the Company, in its sole discretion, at any time. The grant of the RSUs under the 2011 Plan is a one-time benefit and does not create any contractual or other right to receive a grant of RSUs or any other award under the 2011 Plan or other benefits in lieu thereof in the future. Future grants, if any, will be at the sole discretion of the Company, including, but not limited to, the form and timing of any grant, the number of Shares subject to the grant, and the vesting provisions. Any amendment, modification or termination of the 2011 Plan shall not constitute a change or impairment of the terms and conditions of your employment with your Employer.</font></div><div style="margin-top:11.05pt;padding-left:73.3pt;text-indent:-33pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.57pt">Your participation in the 2011 Plan is voluntary. The value of the RSUs and any other awards</font></div><div><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div><font><br></font></div><div style="margin-top:3.65pt;padding-left:5pt;padding-right:5.35pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">granted under the 2011 Plan is an extraordinary item of compensation outside the scope of your employment (and your employment contract, if any). Any grant under the 2011 Plan, including the grant of the RSUs, is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, holiday pay, bonuses, long-service awards, pension, or retirement benefits or similar payments.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">14.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The RSUs are granted solely by the Company.&#160; Your Employer and any other Subsidiary are not a party to these Terms and Conditions, and any rights you may have under these Terms and Conditions may be raised only against the Company (and may not be raised against your Employer or any other Subsidiary).</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">15.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">These Terms and Conditions shall bind and inure to the benefit of the Company, its successors and assigns and you and your estate in the event of your death.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">16.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The Company is located at 1941 Stryker Way, Portage, Michigan 49002, U.S.A. and grants RSUs under the 2011 Plan to employees of the Company and Subsidiaries in its sole discretion. In conjunction with the Company's grant of the RSUs under the 2011 Plan and its ongoing administration of such awards, the Company is providing the following information about its data collection, processing and transfer practices (&#34;Personal Data Activities&#34;). In accepting the grant of the RSUs, you expressly and explicitly consent to the Personal Data Activities as described herein.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:5.45pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:18.68pt">The Company collects, processes and uses your personal data, including your name, home address, email address, and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all RSUs or any other equity compensation awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the RSUs under the 2011 Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan. The Company's legal basis for the collection, processing and usage of your personal data is your consent.</font></div><div style="margin-top:11.05pt;padding-left:5pt;padding-right:5.55pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:18.03pt">The Company transfers your personal data to the Stock Plan Administrator. In the future, the Company may select a different Stock Plan Administrator and share your personal data with another company that serves in a similar manner,</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:119%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">including, but not limited to, the Company's outside legal counsel as well as the Company&#8217;s auditor. The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:6.75pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:19.2pt">The Company and the Stock Plan Administrator are based in the United States. You should note that your country of residence may have enacted data privacy laws that are different from the United States. The Company's legal basis for the transfer of your personal data to the United States is your consent.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:5.45pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.95pt">Your participation in the 2011 Plan and your grant of consent is purely voluntary. You may deny or withdraw your consent at any time. If you do not consent, or if you withdraw your consent, you may be unable to participate in the 2011 Plan. This would not affect your existing employment or salary&#59; instead, you merely may forfeit the opportunities associated with the 2011 Plan.</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:5.45pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(e)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:18.69pt">You may have a number of rights under the data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country or residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of your personal data. To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company's Human Resources Department.</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">17.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The grant of the RSUs is not intended to be a public offering of securities in your country of residence (and country of employment, if different). The Company has not submitted any registration statement, prospectus or other filing(s) with the local securities authorities (unless otherwise required under local law). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">No employee of the Company is permitted to advise you on whether you should acquire </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:6.6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">Shares under the 2011 Plan or provide you with any legal, tax or financial advice with respect to the grant of the RSUs. The acquisition of Shares involves certain risks, and you should carefully consider all risk factors and tax considerations relevant to the acquisition of Shares under the 2011 Plan or the disposition of them. Further, you should carefully review all of the materials related to the RSUs and the 2011 Plan, and you should consult with your personal legal, tax and financial advisors for professional advice in relation to your personal circumstances.</font></div><div style="margin-top:3.65pt;padding-left:5pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">18.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">All questions concerning the construction, validity and interpretation of the RSUs and the 2011 Plan shall be governed and construed according to the laws of the state of Michigan, without regard to the application of the conflicts of laws provisions thereof. Any disputes regarding the RSUs or the 2011 Plan shall be brought only in the state or federal courts of the state of Michigan.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:6.4pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">19.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The Company may, in its sole discretion, decide to deliver any documents related to the RSUs or other awards granted to you under the 2011 Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the 2011 Plan through an online or electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">20.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The invalidity or unenforceability of any provision of the 2011 Plan or these Terms and Conditions shall not affect the validity or enforceability of any other provision of the 2011 Plan or these Terms and Conditions.</font></div><div style="margin-top:11.2pt;padding-left:5pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">21.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">If you are resident outside of the United States, you acknowledge and agree that it is your express intent that these Terms and Conditions, the 2011 Plan and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the RSUs be drawn up in English. If you have received these Terms and Conditions, the 2011 Plan or any other documents related to the RSUs translated into a language other than English and the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:6.4pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">22.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">You acknowledge that, depending on your or your broker's country of residence or where the Shares are listed, you may be subject to insider trading restrictions and&#47;or market abuse laws which may affect your ability to accept, acquire, sell or otherwise dispose of Shares, rights to Shares (e.g., RSUs) or rights linked to the value of Shares during such times you are considered to have &#34;inside information&#34; regarding the Company as defined in the laws or regulations in your country of employment (and country of residence, if different). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before you possessed inside information. Furthermore, you could be prohibited from (i) disclosing the inside information to any third party (other than on a &#34;need to know&#34; basis) and (ii) &#34;tipping&#34; third parties or causing them otherwise to buy or sell securities. Third parties include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. You acknowledge that it is your responsibility to comply with any restrictions and are advised to speak to your personal advisor on this matter.</font></div><div style="margin-top:10.9pt;padding-left:5pt;padding-right:5.3pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">23.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">Notwithstanding any provisions of these Terms and Conditions to the contrary, the RSUs shall be subject to any special terms and conditions for your country of residence (and country of employment, if different) set forth in an addendum to these Terms and Conditions (an &#34;Addendum&#34;). Further, if you transfer your residence and&#47;or employment to another country reflected in an Addendum to these Terms and Conditions at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such special terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer). In all circumstances, any applicable Addendum shall constitute part of these Terms and Conditions.</font></div><div style="margin-top:11pt;padding-left:5pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">24.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%;padding-left:17.27pt">The Company reserves the right to impose other requirements on the RSUs, any Shares acquired pursuant to the RSUs and your participation in the 2011 Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan. Such requirements may include (but are not limited to) requiring you to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">25.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;padding-left:17.27pt">This Section 25 applies only to those persons whom the Company's Recoupment Policy applies (the corporate officers elected by the Company's Board of Directors other than Assistant </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:11.1pt;padding-left:5pt;padding-right:6.6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">Controllers, Assistant Secretaries and Assistant Treasurers). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Notwithstanding any other provision of these Terms and Conditions to the contrary, you acknowledge and agree that your RSUs, any Shares acquired pursuant thereto and&#47;or any amount received with respect to any sale of such Shares are subject to potential cancellation, recoupment, rescission, payback or other action in accordance with the terms of the Company's Recoupment Policy as in effect on the date of grant (a copy of which has been furnished to you) and as the Recoupment Policy may be amended from time to time in order to comply with changes in laws, rules or regulations that are applicable to such RSUs and Shares. You agree and consent to the Company's application, implementation and enforcement of (a) the Recoupment Policy and (b) any provision of applicable law relating to cancellation, recoupment, rescission or payback of compensation and expressly agree that the Company may take such actions as are necessary to effectuate the Recoupment Policy (as applicable to you) or applicable law without further consent or action being required by you. For purposes of the foregoing, you expressly and explicitly authorize the Company to issue instructions, on your behalf, to the Stock Plan Administrator and any other third party administrator engaged by the Company to hold your Shares and other amounts acquired under the 2011 Plan to re-convey, transfer or otherwise return such Shares and&#47;or other amounts to the Company. In the case of a conflict between these Terms and Conditions and the Recoupment Policy, the terms of the Recoupment Policy shall prevail.</font></div><div style="margin-top:10.95pt;padding-left:5pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">26.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;padding-left:17.27pt">This Section 26 applies only to those persons whom the Company's clawback policy applies. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Notwithstanding anything in these Terms and Conditions to the contrary, the RSUs evidenced by these Terms and Conditions may be subject to (i) recoupment in accordance with or in order to comply with the terms and provisions of the Company's clawback policy, as may be in effect from time to time (including, but not limited to, the Mandatory Clawback Policy), to the extent such policies are applicable to you and (ii) any other compensation recovery policy adopted after the RSUs are granted to facilitate compliance with applicable law, including in response to the requirements of Section 10D of the Exchange Act, the U.S. Securities and Exchange Commission&#8217;s final rules thereunder, and any applicable listing rules or other rules and regulations implementing the foregoing.</font></div><div style="margin-top:11pt;padding-left:5pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">27.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%;padding-left:17.27pt">By accepting the grant of the RSUs, you acknowledge that you have read these Terms and Conditions, the Addendum to these Terms and Conditions (as applicable) and the 2011 Plan and specifically accept and agree to the provisions therein.</font></div><div style="margin-top:11.2pt;padding-left:1.02pt;padding-right:1.02pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">***********************</font></div><div style="text-align:center"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-top:3.65pt;padding-left:1pt;padding-right:1pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="margin-top:11.65pt;padding-left:197.75pt;padding-right:189.75pt;text-indent:27.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:119%">ADDENDUM TO TERMS AND CONDITIONS</font></div><div style="padding-left:99.35pt;padding-right:66.9pt;text-indent:25.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:119%">RELATING TO RESTRICTED STOCK UNITS GRANTED PURSUANT TO THE 2011 PLAN, AS AMENDED AND RESTATED</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">In addition to the terms of the 2011 Plan and the Terms and Conditions, the RSUs are subject to the following additional terms and conditions (the &#34;Addendum&#34;). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:119%">The information reflected in this Addendum is based on the securities, exchange control and other laws in effect in the respective countries as of November 2024. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:119%">All capitalized terms as contained in this Addendum shall have the same meaning as set forth in the 2011 Plan and the Terms and Conditions. Pursuant to Section 23 of the Terms and Conditions, if you transfer your residence and&#47;or employment to another country reflected in an Addendum at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:6.8pt;text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Data Privacy Information&#58; European Union (&#34;EU&#34;) &#47; European Economic Area (&#34;EEA&#34;) &#47; Switzerland and the United Kingdom*</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">*The below information is for data privacy purposes only and you should determine whether any other special terms and conditions apply to your awards in these jurisdictions.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you reside and&#47;or you are employed in the EU &#47; EEA, Switzerland or the United Kingdom the following provision replaces Section 16 of the Terms and Conditions&#58;</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:6.7pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company is located at 1941 Stryker Way, Portage, Michigan 49002, U.S.A. and grants RSUs under the 2011 Plan to employees of the Company and its Subsidiaries in its sole discretion. You should review the following information about the Company's data processing practices.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.35pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.68pt;text-decoration:underline">Data Collection, Processing and Usage</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Pursuant to applicable data protection laws, you are hereby notified that the Company collects, processes and uses certain personally identifiable information about you for the legitimate interest of implementing, administering and managing the 2011 Plan and generally administering equity awards&#59; specifically, including your name, home address, email address and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all options or any other awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the RSUs under the 2011 Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan. The Company's collection, processing, use and transfer of your personal data is necessary for the performance of the Company's contractual obligations under the 2011 Plan and pursuant to the Company's legitimate interest of managing and generally administering employee equity awards. Your refusal to provide personal data would make it impossible for the Company to perform its contractual obligations and may affect your ability to participate in the 2011 Plan. As such, by participating in the 2011 Plan, you voluntarily acknowledge the collection, processing and use of your personal data as described herein.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.03pt;text-decoration:underline">Stock Plan Administration Service Provider</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company transfers participant data to the Stock Plan Administrator. In the future, the Company may select a different Stock Plan Administrator and share your data with another company that serves in a similar manner, including, but not limited to, the Company's outside legal counsel as well as the Company&#8217;s auditor. The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan. You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.2pt;text-decoration:underline">International Data Transfers</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company and the Stock Plan Administrator are based in the United States. The Company can only meet its contractual obligations to you if your personal data is transferred to the United States. The Company's legal basis for the transfer of your personal data to the United </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">States is to satisfy its contractual obligations to you and&#47;or its use of the standard data protection clauses adopted by the EU Commission.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.95pt;text-decoration:underline">Data Retention</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company will use your personal data only as long as is necessary to implement, administer and manage your participation in the 2011 Plan or as required to comply with legal or regulatory obligations, including under tax and security laws. When the Company no longer needs your personal data, the Company will remove it from its systems. If the Company keeps your data longer, it would be to satisfy legal or regulatory obligations and the Company's legal basis would be for compliance with relevant laws or regulations.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.69pt;text-decoration:underline">Data Subject Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You may have a number of rights under data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country of residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of your personal data. To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company's Human Resources Department.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARGENTINA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Neither the grant of the RSUs, nor the issuance of Shares subject to the RSUs, constitutes a public offering in Argentina. The grant of RSUs pursuant to the 2011 Plan is a private placement and is not subject to any filing or disclosure requirements in Argentina.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. By accepting the RSUs, you acknowledge that you are proficient in reading and understanding English and fully understands the terms of the documents related to the RSUs (the Terms and Conditions, this Addendum and the 2011 Plan), which were provided in the English language. You accept the terms of these documents accordingly.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Consentimiento ling&#252;&#237;stico.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> Al aceptar las RSU, usted reconoce que domina la lectura y la comprensi&#243;n del ingl&#233;s y comprende plenamente los t&#233;rminos de los documentos relacionados con las RSU (los T&#233;rminos y condiciones, este Anexo y el Plan 2011), que se proporcionaron en ingl&#233;s. Usted acepta los t&#233;rminos de estos documentos en consecuencia.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AUSTRALIA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">RSUs Conditioned on Satisfaction of Regulatory Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you are (a) a director of a Subsidiary incorporated in Australia, or (b) a person who is a management-level executive of a Subsidiary incorporated in Australia and who also is a director of a Subsidiary incorporated outside of Australia, the grant of the RSUs is conditioned upon satisfaction of the shareholder approval provisions of section 200B of the Corporations Act 2001 (Cth) in Australia.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This grant of RSUs is being made under Division 1A Part 7.12 of the Australian Corporations Act 2001 (Cth). If Shares acquired under the 2011 Plan are offered for sale to a person or entity resident in Australia, your offer may be subject to disclosure requirements under Australian law. You should obtain legal advice on any disclosure obligations prior to making any such offer.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Tax Notification</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 2011 Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) applies (subject to conditions in the Act).</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Exchange control reporting is required for cash transactions exceeding AUD 10,000 and international fund transfers. The Australian bank assisting with the transaction will file the report. If there is no Australian bank involved in the transfer, you personally will be required to file the report. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AUSTRIA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you hold Shares obtained under the 2011 Plan or cash (including proceeds from the sale of Shares) outside Austria, you may be required to submit quarterly reports </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to the Austrian National Bank. An exemption applies if the value of the Shares held outside Austria of any quarter does not exceed a certain threshold (currently &#8364;5,000,000). The deadline for filing the quarterly report is the 15th of the month following the end of the respective quarter.  When the Shares are sold, you may be required to comply with certain exchange control obligations if the cash proceeds from the sale is held outside Austria, as a separate reporting requirement applies to any non-Austrian cash accounts. If the transaction volume of all of your cash accounts abroad exceeds a certain threshold (currently &#8364;10,000,000), the movements and the balance of all accounts must be reported monthly, as of the last day of the month, on or before the 15th day of the following month, on the prescribed forms.  The thresholds described above may be subject to change. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:5.75pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BELGIUM</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Belgian residents are required to report any security (e.g, Shares acquired under the 2011 Plan) or bank account established outside of Belgium on their personal annual tax return. In a separate report, Belgian residents also are required to provide a central contact point of the National Bank of Belgium with the account number of those foreign bank accounts, the name of the bank with which the accounts were opened and the country in which they were opened in a separate report. This report, as well as additional information on how to complete it, can be found on the website of the National Bank of Belgium, </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.nbb.be</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, under the </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Kredietcentrales &#47; Centrales des credits </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">caption. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Stock Exchange Tax Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. A stock exchange tax applies to transactions executed by Belgian residents through a non-Belgian financial intermediary, such as a U.S. broker. The stock exchange tax will apply when Shares acquired pursuant to the RSUs are sold. You should consult with a personal tax or financial advisor for additional details on your obligations with respect to the stock exchange tax.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.25pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Annual Securities Account Tax</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. An annual securities accounts tax may be payable if the total value of securities held in a Belgian or foreign securities account (e.g., Shares acquired under the 2011 Plan) exceeds a certain threshold on four reference dates within the relevant reporting period (i.e., December 31, March 31, June 30 and September 30). In such case, the tax will be due on the value of the qualifying securities held in such account. You should consult with a personal tax or financial advisor for additional details on your obligations with respect to the annual securities account tax.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BRAZIL</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Labor Law Acknowledgment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. By accepting the RSUs, you acknowledge and agree, for all legal purposes, that (a) the benefits provided under the Terms and Conditions and the 2011 Plan are the result of commercial transactions unrelated to your employment&#59; (b) the Terms and Conditions and the 2011 Plan are not a part of the terms and conditions of your employment&#59; and (c) the income from the RSUs, if any, is not part of your remuneration from employment.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. By accepting the RSUs, you acknowledge and agree to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with the vesting of the RSUs, the issuance and&#47;or sale of Shares acquired under the 2011 Plan and the receipt of any dividends.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you are resident or domiciled in Brazil, you will be required to submit an annual declaration of assets and rights held outside of Brazil to the Central Bank of Brazil if the aggregate value of such assets and rights is greater than USD1 million as of December 31 of each year. If the aggregate value exceeds USD100 million as of the end of each quarter, a declaration must be submitted quarterly. Assets and rights that must be reported include Shares acquired under the 2011 Plan. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Tax on Financial Transaction (IOF)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Repatriation of funds (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the proceeds from the sale of Shares) into Brazil and the conversion of USD into BRL associated with such fund transfers may be subject to the Tax on Financial Transactions. It is your responsibility to comply with any applicable Tax on Financial Transactions arising from your participation in the 2011 Plan. You should consult with your personal tax advisor for additional details.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CANADA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything to the contrary in the Terms and Conditions or the 2011 Plan, the RSUs shall be settled only in Shares (and may not be settled in cash).</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The following supplements Section 2(b) of the Terms and Conditions as well as any other section required to give effect to the same&#58;</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:6.35pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event of your termination of employment for any reason (other than by reason of death or Disability), either by you or by the Employer, with or without cause, your rights to vest or to continue to vest in the RSUs and receive Shares under the 2011 Plan, if any, will terminate as of the actual Termination Date. For this purpose, the &#34;Termination Date&#34; shall mean the last day on which you are actively employed by the Employer, and shall not include or be extended by any period following such day during which you are in receipt of or eligible to receive any notice of termination, pay in lieu of notice of termination, severance pay or any other payments or damages, whether arising under statute, contract or at common law.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued entitlement to vesting during a statutory notice period, your right to vest in the RSUs under the 2011 Plan, if any, will terminate effective as of the last day of your minimum statutory notice period, but you will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of your statutory notice period, nor will you be entitled to any compensation for lost vesting.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.66pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Specified foreign property, including the RSUs, Shares acquired under the 2011 Plan, and other rights to receive shares of a non-Canadian company held by a Canadian resident generally must be reported annually on a Form T1135 (Foreign Income Verification Statement) if the total cost of the specified foreign property exceeds C$100,000 at any time during the year. Thus, the unvested portion of the RSUs must be reported &#8211; generally at a nil cost &#8211; if the C$100,000 cost threshold is exceeded because you holds other specified foreign property. When Shares are acquired, their cost generally is the adjusted cost base (&#8220;ACB&#8221;) of the Shares. The ACB ordinarily will equal the fair market value of the Shares at the time of acquisition, but if you owns other Shares, the ACB may need to be averaged with the ACB of the other Shares. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:12pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2025 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.212%"><tr><td style="width:1.0%"></td><td style="width:45.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.115%"></td><td style="width:0.1%"></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Signature</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Name (Printed)</font></div></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Date</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="margin-top:12pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CHILE</font></div><div style="margin-top:12pt;padding-left:82.2pt;text-align:justify;text-indent:-40.9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:32.56pt;text-decoration:underline">Private Placement</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The following provision shall replace Section 17 of the Terms</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and Conditions&#58;</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The grant of the RSUs hereunder is not intended to be a public offering of securities in Chile but instead is intended to be a private placement.</font></div><div style="margin-top:12pt;padding-left:9pt;text-indent:67.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.73pt">The starting date of the offer will be the grant date, and this offer conforms to General Ruling no. 336 of the Chilean Commission for the Financial Markets (&#34;CMF&#34;)&#59;</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.03pt">The offer deals with securities not registered in the registry of securities or in the registry of foreign securities of the CMF, and therefore such securities are not subject to its oversight&#59;</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.2pt">The Company, as the issuer, is not obligated to provide public information in Chile regarding the foreign securities, as such securities are not registered with the CMF&#59; and</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.95pt">The Shares, as foreign securities, shall not be subject to public offering as long as they are not registered with the corresponding registry of securities in Chile.</font></div><div style="margin-top:12pt;padding-left:5.75pt;padding-right:6.5pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:17.76pt">La fecha de inicio de la oferta ser&#225; el de la fecha de otorgamiento y esta oferta se acoge a la norma de Car&#225;cter General n&#176; 336 de la Comisi&#243;n para el Mercado Financiero Chilena (&#34;CMF&#34;)&#59;</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:17.56pt">La oferta versa sobre valores no inscritos en el registro de valores o en el registro de valores extranjeros que lleva la CMF, por lo que tales valores no est&#225;n sujetos a la fiscalizaci&#243;n de &#233;sta&#59;</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.53pt">Por tratar de valores no inscritos no existe la obligaci&#243;n por parte del emisor de entregar en chile informaci&#243;n p&#250;blica respecto de esos valores&#59; y</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:16.95pt">Esos valores no podr&#225;n ser objeto de oferta p&#250;blica mientras no sean inscritos en el registro de valores correspondiente.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If your aggregate investments held outside of Chile (including the value of Shares acquired under the 2011 Plan) are equal to or greater than USD5,000,000, you must provide the Central Bank with updated information accumulated for a three-month period within 45 calendar days of March 31, June 30 and September 30 and within 60 calendar days of December 31. Annex 3.1 of Chapter XII of the Foreign Exchange Regulations Manual must be used to file this report. You are not required to repatriate funds obtained from the sale of Shares or the receipt of any dividends to Chile. However, if you decide to repatriate such funds, you must do so through the Formal Exchange Market if the funds exceed USD10,000. In such case, you must report the payment to a commercial bank or the registered foreign exchange office receiving the funds. If you do not repatriate the funds and instead use such funds for the payment of other obligations contemplated under a different Chapter of the Foreign Exchange Regulations, you must sign Annex 1 of the Manual of Chapter XII of the Foreign Exchange Regulations and file it directly with the Central Bank within the first 10 days of the month immediately following the transaction. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Chilean Internal Revenue Service (&#8220;CIRS&#8221;) requires all taxpayers to provide information annually regarding&#58; (a) any taxes paid abroad which they will use as a credit against Chilean income taxes, and (b) the results of foreign investments. These annual reporting obligations must be complied with by submitting a sworn statement setting forth this information before July 1 of each year. The sworn statement disclosing this information (or </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Formularios</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) must be submitted electronically through the CIRS website, </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.sii.cl</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, using Form 1929. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CHINA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">RSUs Conditioned on Satisfaction of Regulatory Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you are a People's Republic of China (&#34;PRC&#34;) national, the grant of the RSUs is conditioned upon the Company securing all necessary approvals from the PRC State Administration of Foreign Exchange to permit the operation of the 2011 Plan and the participation of PRC nationals employed by your Employer, as determined by the Company in its sole discretion.</font></div><div style="margin-top:12pt;padding-left:5.75pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.61pt;text-decoration:underline">Sale of Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything to the contrary in the 2011 Plan, upon any termination of employment with your Employer, you shall be required to sell all Shares acquired under the 2011 Plan within such time period as may be established by the PRC State Administration of Foreign Exchange.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Restrictions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You acknowledge and agree that you will be required immediately to repatriate to the PRC the proceeds from the sale of any Shares acquired under the 2011 Plan, as well as any other cash amounts attributable to the Shares acquired under the 2011 Plan (collectively, &#34;Cash Proceeds&#34;). Further, you acknowledge and agree that the repatriation of the Cash Proceeds must be effected through a special bank account established by your Employer, the Company or one of its Subsidiaries, and you hereby consent and agree that the Cash Proceeds may be transferred to such account by the Company on your behalf </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.45pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">prior to being delivered to you. The Cash Proceeds may be paid to you in U.S. dollars or local currency at the Company's discretion. If the Cash Proceeds are paid to you in U.S. dollars, you understand that a U.S. dollar bank account must be established and maintained in China so that the proceeds may be deposited into such account. Additionally, if the Company changes its Stock Plan Administrator, you acknowledge and agree that the Company may transfer any Shares issued under the 2011 Plan to the new designated Stock Plan Administrator if necessary for legal or administrative reasons. You agree to sign any documentation necessary to facilitate the transfer. If the Cash Proceeds are paid to you in local currency, you acknowledge and agree that the Company is under no obligation to secure any particular exchange conversion rate and that the Company may face delays in converting the Cash Proceeds to local currency due to exchange control restrictions. You agree to bear any currency fluctuation risk between the time the Shares are sold and the Cash Proceeds are converted into local currency and distributed to you. You further agree to comply with any other requirements that may be imposed by your Employer, the Company and its Subsidiaries in the future in order to facilitate compliance with exchange control requirements in the PRC.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">COLOMBIA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.35pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In addition to the provisions of Section 13 of the Terms and Conditions you acknowledge that, pursuant to Article 128 of the Colombian Labor Code, the 2011 Plan and related benefits do not constitute a component of your &#34;salary&#34; for any legal purpose. Therefore, they will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as legal&#47;fringe benefits, vacations, indemnities, payroll taxes, social insurance contributions and&#47;or any other labor-related amount which may be payable.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Shares subject to the RSUs are not and will not be registered in the Colombian registry of publicly traded securities (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Registro Nacional de Valores y Emisores</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) and therefore the Shares may not be offered to the public in Colombia. Nothing in this document should be construed as the making of a public offer of securities in Colombia.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Investments in assets located outside Colombia (including Shares) are subject to registration with the Central Bank (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Banco de la Rep&#250;blica</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), as foreign investments held abroad, regardless of value. In addition, all payments related to the liquidation of such investments must be transferred through the Colombian foreign exchange market (e.g. local banks), which includes the obligation of correctly completing and filing the appropriate foreign exchange form (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">declaraci&#243;n de cambio</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. An annual informative return must be filed with the Colombian Tax Office detailing any assets held abroad (including the Shares acquired under the 2011 Plan). If the individual value of any of these assets exceeds a certain threshold, each asset must be described (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">e.g., </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">its nature and its value) and the jurisdiction in which it is located must be disclosed. You acknowledge that you personally are responsible for complying with this tax reporting requirement. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">COSTA RICA</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No country specific provisions.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">DENMARK</font></div><div style="margin-top:12pt;padding-left:5.75pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.61pt;text-decoration:underline">Treatment of RSUs upon Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding any provision in the Terms and Conditions or the 2011 Plan to the contrary, unless you are a member of registered management who is not considered a salaried employee, the treatment of the RSUs upon a termination of employment which is not a result of death shall be governed by Sections 4 and 5 of the Danish Act on Stock Option in Employment Relations (the &#34;Act&#34;). You acknowledge any grant of RSUs under the 2011 Plan is subject to the rules of such amended Act. However, if the provisions in the Terms and Conditions or the 2011 Plan governing the treatment of the RSUs upon a termination of employment are more favorable, then the provisions of the Terms and Conditions or the 2011 Plan will govern, as set forth in the Employer Statement, included as Exhibit A to this Addendum, and which is being provided to comply with the Act.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:12pt;padding-left:5.75pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.61pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Danish residents who establish an account holding Shares or an account holding cash outside Denmark must report the account to the Danish Tax Administration as part of their annual tax return under the section related to foreign affairs and income. The form which should be used in this respect can be obtained from a local bank. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FINLAND</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Withholding of Tax-Related Items</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything in Section 6 of the Terms and Conditions to the contrary, if you are a local national of Finland, any Tax-Related Items shall be withheld only in cash from your regular salary&#47;wages or other amounts payable to you in cash or such other withholding methods as may be permitted under the 2011 Plan and allowed under local law.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Finland has not adopted any specific reporting requirements with respect to foreign assets&#47;accounts. However, you should check your pre-completed tax return to confirm that the ownership of Shares and other securities (foreign or domestic) are correctly reported. If you find any errors or omissions, you must make the necessary corrections electronically or by sending specific paper forms to the local tax authorities. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FRANCE</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Non-Qualified Nature of RSUs</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Award granted pursuant to the Terms and Conditions is not intended to be &#8220;French-qualified&#8221; and is ineligible for specific tax and&#47;or social security treatment in France under Sections L. 225-197-1 to L. 225-197-5 and Sections L. 22-10-59 to L. 22-10-60 of the French Commercial Code, as amended.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The value of any cash or securities imported to or exported from France without the use of a financial institution must be reported to the customs and excise authorities when the value of such cash or securities is equal to or greater than a certain amount (currently &#8364;10,000). You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. French residents must report annually any shares and bank accounts held outside France, including the accounts that were opened, used and&#47;or closed during the tax year, to the French tax authorities, on an annual basis on a special Form N&#176; 3916, together with your personal income tax return. Failure to report triggers a significant penalty. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Use of English Language</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. By accepting your RSUs, you acknowledge and agree that it is your wish that the Terms and Conditions, this Addendum, as well as all other documents, notices and legal proceedings entered into, given or instituted pursuant to your RSUs, either directly or indirectly, be drawn up in English.</font></div><div style="margin-top:12pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Langue anglaise</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. En acceptant l'allocation de vos RSUs, vous reconnaissez et acceptez avoir</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">souhait&#233; que le Termes et Conditions, le pr&#233;sent avenant, ainsi que tous autres documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaires intent&#233;es, relatifs, directement ou indirectement, &#224; l'allocation de vos RSUs, soient r&#233;dig&#233;s en anglais.</font></div><div style="margin-top:12pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:12pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2025 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:6pt"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.212%"><tr><td style="width:1.0%"></td><td style="width:45.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.115%"></td><td style="width:0.1%"></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Signature</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Name (Printed)</font></div></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Date</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="margin-top:12pt;padding-left:6pt"><font><br></font></div><div style="margin-top:12pt;padding-left:5.75pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GERMANY</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Cross-border payments in excess of &#8364;12,500 in connection with the 2011 Plan (</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, proceeds from the sale of Shares acquired under the 2011 Plan) and&#47;or if the Company withholds or sells Shares with a value in excess of EUR 12,500 for any Tax-Related Items, </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">must be reported to the German Federal Bank (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Bundesbank</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) by the fifth day of the month following the month in which the payment is received or made. If you acquire Shares with a value in excess of &#8364;12,500, the Employer will report the acquisition of such Shares to the German Federal Bank. If you otherwise make or receive a payment in excess of &#8364;12,500, you personally must report the payment to Bundesbank electronically using the &#8220;General Statistics Reporting Portal&#8221; (&#8220;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Allgemeines Meldeportal Statistik</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) available via Bundesbank&#8217;s website (</font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.bundesbank.de</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. German residents must notify their local tax office of the acquisition of Shares when they file their personal income tax returns for the relevant year if the value of the Shares acquired exceeds &#8364;150,000 or in the unlikely event that the resident holds Shares exceeding 10% of the Company&#8217;s total Shares outstanding. However, if the Shares are listed on a recognized U.S. stock exchange and you own less than 1% of the total Shares, this requirement will not apply even if Shares with a value exceeding &#8364;150,000 are acquired. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">HONG KONG</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Important Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Warning&#58; The contents of the Terms and Conditions, this Addendum, the 2011 Plan, and all other materials pertaining to the RSUs and&#47;or the 2011 Plan have not been reviewed by any regulatory authority in Hong Kong. You are hereby advised to exercise caution in relation to the offer thereunder. If you have any doubts about any of the contents of the aforesaid materials, you should obtain independent professional advice.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If, for any reason, Shares are issued to you within six (6) months of the grant date, you agree that you will not sell or otherwise dispose of any such Shares prior to the six-month anniversary of the grant date.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.8pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything to the contrary in this Addendum, the Terms and Conditions or the 2011 Plan, the RSUs shall be settled only in Shares (and may not be settled in cash).</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Nature of the 2011 Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company specifically intends that the 2011 Plan will not be treated as an occupational retirement scheme for purposes of the Occupational Retirement Schemes Ordinance (&#34;ORSO&#34;). To the extent any court, tribunal or legal&#47;regulatory body in Hong Kong determines that the 2011 Plan constitutes an occupational retirement scheme for the purposes of ORSO, the grant of the RSUs shall be null and void.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">INDIA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any funds realized in connection with the 2011 Plan (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, proceeds from the sale of Shares and cash dividends paid on the Shares) must be repatriated to India within a specified period of time after receipt as prescribed under Indian exchange control laws.  You are personally responsible for obtaining a foreign inward remittance certificate (&#8220;FIRC&#8221;) from the bank where you deposit the </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">foreign currency and holding the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India or your Employer requests proof of repatriation.  You are personally responsible for complying with exchange control laws in India, and neither the Company nor your Employer will be liable for any fines or penalties resulting from your failure to comply with applicable laws.  You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.65pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You are required to declare your foreign bank accounts and any foreign financial assets (including Shares acquired under the 2011 Plan held outside India) in your annual tax return. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">IRELAND</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Director Notification Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you are a director, shadow director or secretary of an Irish subsidiary whose interest in the Company represents more than 1% of the Company&#8217;s voting share capital, you are required to notify such Irish subsidiary in writing within a certain time period. upon the acquisition of RSUs or any Shares issued pursuant to RSUs. This notification requirement also applies with respect to the interests in the Company of your spouse or children under the age of 18 (whose interests will be attributed to you in your capacity as a director, shadow director or secretary of the Irish subsidiary).</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ISRAEL</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Tax Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company obtained a tax ruling from the Israeli Tax Authority (&#8220;ITA&#8221;) on 30 April 2024 which determined that the taxable event for the RSUs granted to employees in Israel will be upon the vesting of the RSUs and the issuance of the Shares (the &#8220;Tax Ruling&#8221;). You may review a copy of the Tax Ruling by contacting stockplanadministration&#64;stryker.com. By accepting the RSUs, you acknowledge and declare that you are aware of the Tax Ruling specifying that the RSUs will be subject to income tax and social insurance contributions at vesting&#47;settlement of the RSUs and at which time tax withholding will be required. The payment of any tax due upon sale of any Shares is your personal liability. Furthermore, the Tax Ruling determined that if you choose not to sell the Shares acquired upon vesting&#47;settlement of the RSUs immediately following issuance of such Shares, you will have to transfer your Shares, within 10 calendar days of the date such Shares are deposited into your brokerage account with the Stock Plan Administrator, to a personal brokerage account in Israel. Pursuant to the Tax Ruling, you are not permitted to hold the Shares in your brokerage account with the Stock Plan Administrator t. Notwithstanding the aforesaid, you acknowledge and declare that you are aware, accept and will have no claims or arguments towards the Company if it applies for and&#47;or will apply for any other or additional tax rulings with the ITA with respect to the Israeli tax treatment of the RSUs, including the RSUs that were granted and&#47;or the RSUs that may be granted in the future, or if it decides not to do so.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The grant of the RSUs pursuant to the 2011 Plan does not constitute a public offering under the Securities Law, 1968.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ITALY</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Italian residents who, at any time during the fiscal year, hold foreign financial assets (including cash and Shares) which may generate income taxable in Italy are required to report these assets on their annual tax returns (UNICO Form, RW Schedule) for the year during which the assets are held, or on a special form if no tax return is due. These reporting obligations will also apply to Italian residents who are the beneficial owners of foreign financial assets under Italian money laundering provisions. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:39pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.66pt;text-decoration:underline">Foreign Asset Tax</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The value of any Shares (and other financial assets) held outside Italy by individuals resident of Italy may be subject to a foreign asset tax. The taxable amount will be the fair market value of the financial assets (e.g., Shares) assessed at the end of the calendar year. The value of financial assets held abroad must be reported in Form RM of the annual return. You should consult your personal tax advisor for additional information on the foreign asset tax.</font></div><div style="margin-top:12pt;padding-left:5pt"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">JAPAN</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you acquire Shares valued at more than &#165;100,000,000 in a single transaction, you must file a Securities Acquisition Report with the Ministry of Finance through the Bank of Japan within 20 days of the purchase of the Shares. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You will be required to report details of any assets held outside Japan as of December 31st to the extent such assets have a total net fair market value exceeding &#165;50,000,000. This report is due by March 15 each year. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MEXICO</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Commercial Relationship</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You expressly recognize that your participation in the 2011 Plan and the Company's grant of the RSUs does not constitute an employment relationship between you and the Company. You have been granted the RSUs as a consequence of the commercial relationship between the Company and the Subsidiary in Mexico that employs you, and the Company's Subsidiary in Mexico is your sole employer. Based on the foregoing, (a) you expressly recognize the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan do not establish any rights between you and the Company's Subsidiary in Mexico that employs you, (b) the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan are not part of the employment conditions and&#47;or benefits provided by the Company's Subsidiary in Mexico that employs you, and (c) any modification or amendment of the 2011 Plan by the Company, or a termination of the 2011 Plan by the Company, shall not constitute a change or impairment of the terms and conditions of your employment with the Company's Subsidiary in Mexico that employs you.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You expressly recognize and acknowledge that the Company's grant of RSUs and the underlying Shares under the 2011 Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico. In addition, the 2011 Plan, the Terms and Conditions and any other document relating to the RSUs may not be publicly distributed in Mexico. These materials are addressed to you only because of your existing relationship with the Company and these materials should not be reproduced or copied in any form. The offer contained in these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of the Employer in Mexico made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.35pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Extraordinary Item of Compensation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You expressly recognize and acknowledge that your participation in the 2011 Plan is a result of the discretionary and unilateral decision of the Company, as well as your free and voluntary decision to participate in the 2011 Plan in accord with the terms and conditions of the 2011 Plan, the Terms and Conditions, and this Addendum. As such, you acknowledge and agree that the Company may, in its sole discretion, amend and&#47;or discontinue your participation in the 2011 Plan at any time and without any liability. The value of the RSUs is an extraordinary item of compensation outside the scope of your employment contract, if any. The RSUs are not part of your regular or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits, or any similar payments, which are the exclusive obligations of the Company's Subsidiary in Mexico that employs you.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:12pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2025 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:6pt"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.212%"><tr><td style="width:1.0%"></td><td style="width:45.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.115%"></td><td style="width:0.1%"></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Signature</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Name (Printed)</font></div></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Date</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="margin-top:12pt;padding-left:6pt"><font><br></font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NETHERLANDS</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Waiver of Termination Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. As a condition to the grant of the RSUs, you hereby waive any and all rights to compensation or damages as a result of the termination of your employment with the Company and your Employer for any reason whatsoever, insofar as those rights result or may result from (a) the loss or diminution in value of such rights or entitlements under the 2011 Plan, or (b) you ceasing to have rights under or ceasing to be entitled to any awards under the 2011 Plan as a result of such termination.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NEW ZEALAND</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">WARNING</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You are being offered RSUs to be settled in the form of shares of Stryker Corporation common stock. If the Company runs into financial difficulties and is wound up, you may lose some or all your investment. New Zealand law normally requires people who offer financial products to give information to investors before they invest. This requires those offering financial products to have disclosed information that is important for investors to make an informed decision. The usual rules do not apply to this offer because it is an offer made under the Employee Share Scheme exemption. As a result, you may not be given all the information usually required.  You will also have fewer other legal protections for this investment. You should ask questions, read all documents carefully, and seek independent financial advice before accepting the offer. The Company's Shares are currently traded on the New York Stock Exchange under the ticker symbol &#34;SYK&#34; and Shares acquired under the 2011 Plan may be sold through this exchange. You may end up selling the Shares at a price that is lower than the value of the Shares when you acquired them. The price will depend on the demand for the Company's Shares. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">The Company's most recent annual report (which includes the Company's financial statements) is available at &#91;</font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;investors.stryker.com&#47;financial-information&#47;sec-</font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">filings&#47;default.aspx</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#93;. You are entitled to receive a copy of this report, free of charge, upon written request to the Company at </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">POLAND</font></div><div style="margin-top:12pt;padding-left:6.5pt;padding-right:5.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.86pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you maintain bank or brokerage accounts holding cash and foreign securities (including Shares) outside of Poland, you will be required to report information to the National Bank of Poland on transactions and balances in such accounts if the value of such cash and securities exceeds PLN 7 million. If required, such reports must be filed on special forms available on the website of the National Bank of Poland. Further, any transfer of funds in excess of a certain threshold (generally, EUR 15,000) into or out of Poland must be effected through a bank account in Poland. Finally, you are required to store all documents connected with any foreign exchange transactions that you engage in for a period of five years, as measured from the end of the year in which such transaction occurred. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6.5pt;padding-right:5.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.86pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Polish residents holding foreign securities(e.g., Shares) and&#47;or maintaining accounts abroad are obligated to file quarterly reports with the National Bank of Poland incorporating information on transactions and balances of the securities and cash deposited in such accounts if the value of such securities and cash (when combined with all other assets held abroad) exceeds PLN 7,000,000. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PORTUGAL</font></div><div style="margin-top:12pt;padding-left:5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No country specific provisions.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PUERTO RICO</font></div><div style="margin-top:12pt;padding-left:5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No country specific provisions.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ROMANIA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You are not required to seek special authorization from the National Bank of Romania in order to open or maintain a foreign bank account. However, if you remit foreign currency into Romania (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, proceeds from the sale of Shares), you may be required to provide the Romanian bank through which the foreign currency is transferred with appropriate documentation. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RUSSIA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">IMPORTANT EMPLOYEE NOTIFICATION.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> You may be required to repatriate certain cash amounts received with respect to the RSUs to Russia as soon as you intend to use those cash amounts for any purpose, including reinvestment. If the repatriation requirement applies, such funds must initially be credited to you through a foreign currency account at an authorized bank in Russia. After the funds are initially received in Russia, they may be further remitted to foreign banks in accordance with Russian exchange control laws. Under the Directive N 5371-U of the Russian Central Bank (the &#34;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CBR</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;), the repatriation requirement may not apply in certain cases with respect to cash amounts received in an account that is considered by the CBR to be a foreign brokerage account. Statutory exceptions to the repatriation requirement also may apply. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">You should contact your personal advisor to ensure compliance with the applicable exchange control requirements prior to vesting in the RSUs and&#47;or selling the Shares acquired pursuant to the RSUs.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">SECURITIES LAW NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The grant of RSUs and the issuance of Shares upon vesting are not intended to be an offering of securities with the Russian Federation, and the Terms and Conditions, the 2011 Plan, this Addendum and all other materials that you receive in connection with the grant of RSUs and your participation in the 2011 Plan (collectively, &#34;Grant Materials&#34;) do not constitute advertising or a solicitation within the Russian Federation. In connection with your grant of RSUs, the Company has not submitted any registration statement, prospectus or other filing with the Russian Federal Bank or any other governmental or regulatory body within the Russian Federation, and the Grant Materials expressly may not be used, directly or indirectly, for the purpose of making a securities offering or public circulation of Shares within the Russian Federation. Any Shares acquired under the 2011 Plan will be maintained on your behalf outside of Russia. Moreover, you will not be permitted to sell or otherwise alienate any Shares directly to other Russian legal entities or individuals.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">EXCHANGE CONTROL NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You are solely responsible for complying with applicable Russian exchange control regulations. Since the exchange control regulations change frequently and without notice, you should consult your legal advisor prior to the acquisition or sale of Shares under the 2011 Plan to ensure compliance with current regulations. As noted, it is your personal responsibility to comply with Russian exchange control laws, and neither the Company nor any Subsidiary will be liable for any fines or penalties resulting from failure to comply with applicable laws.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">ANTI-CORRUPTION NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Anti-corruption laws prohibit certain public servants, their spouses and their dependent children from owning any foreign source financial instruments (e.g., shares of foreign companies such as the Company). Accordingly, you should inform the Company if you are covered by these laws as this relates to your acquisition of Shares under the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SINGAPORE</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.75pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Qualifying Person Exemption</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The following provision shall replace Section 17 of the Terms and Conditions&#58;</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:6.65pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The grant of the RSUs under the 2011 Plan is being made pursuant to the &#34;Qualifying Person&#34; exemption&#34; under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (&#34;SFA&#34;). The 2011 Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore. You should note that, as a result, the RSUs are subject to section 257 of the SFA and you will not be able to make (a) any subsequent sale of the Shares in Singapore or (ii) any offer of such subsequent sale of the Shares subject to the RSUs in </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:12pt;padding-left:5pt;padding-right:6.65pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Singapore, unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA (Chapter 289, 2006 Ed.).</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Director Reporting Notification</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you are a director, associate director or shadow director of a Singapore company, you are subject to certain notification requirements under the Singapore Companies Act. Among these requirements is an obligation to notify the Singapore company in writing when you receive an interest (e.g., RSUs or Shares) in the Company or any related company. In addition, you must notify the Singapore company when you sell Shares (including when you sell Shares acquired at vesting of the RSUs). These notifications must be made within two business days of acquiring or disposing of any interest in the Company or any related company. In addition, a notification must be made of your interests in the Company or any related company within two business days of becoming a director.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Insider Trading Notice.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You acknowledge that you should be aware of the Singapore insider-trading rules, which may impact your ability to acquire or dispose of Shares.  Under the Singapore insider-trading rules, you are prohibited from selling Shares when you are in possession of information concerning the Company which is not generally available and which you know or should know will have a material effect on the price of such Shares once such information is generally available.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SOUTH AFRICA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In addition to the provisions of Section 6 of the Terms and Conditions, you agree to notify your Employer in South Africa of the amount of any gain realized upon vesting of the RSUs. If you fail to advise your Employer of the gain realized upon vesting of the RSUs, you may be liable for a fine. You will be responsible for paying any difference between the actual tax liability and the amount withheld.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You are solely responsible for complying with applicable exchange control regulations and rulings (the &#34;Exchange Control Regulations&#34;) in South Africa. As the Exchange Control Regulations change frequently and without notice, you should consult your legal advisor prior to the acquisition or sale of Shares under the 2011 Plan to ensure compliance with current Exchange Control Regulations. Neither the Company nor any of its Subsidiaries will be liable for any fines or penalties resulting from your failure to comply with applicable laws. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information and Deemed Acceptance of RSUs</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Neither the RSUs nor the underlying Shares shall be publicly offered or listed on any stock exchange in South Africa. The offer is intended to be private pursuant to Section 96 of the Companies Act and is not subject to the supervision of any South African governmental authority. Pursuant to Section 96 of the Companies Act, the RSU offer must be finalized on or before the 60th day following the grant date. If you do not want to accept the RSUs, you are required to decline the RSUs no later than the 60th day following the grant date. If you do not reject the RSUs on or before the 60th day following the grant date, you will be deemed to accept the RSUs.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SOUTH KOREA</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:39pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.66pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Korean residents who sell Shares acquired under the 2011 Plan and&#47;or receive cash dividends on the Shares may have to file a report with a Korean foreign exchange bank, provided the proceeds are in excess of USD5,000 (per transaction) and deposited into a non-Korean bank account. A report may not be required if proceeds are deposited into a non-Korean brokerage account. It is your responsibility to ensure compliance with any applicable exchange control reporting obligations.  You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:39pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.66pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Korean residents must declare all foreign financial accounts (e.g., non-Korean bank accounts, brokerage accounts) to the Korean tax authority and file a report with respect to such accounts in June of the following year if the monthly balance of such accounts exceeds KRW 500 million (or an equivalent amount in foreign currency) on any month-end date during a calendar year. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SPAIN</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:39pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.66pt;text-decoration:underline">Acknowledgement of Discretionary Nature of the 2011 Plan&#59; No Vested Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In accepting the RSUs, you acknowledge that you consent to participation in the 2011 Plan and have received a copy of the 2011 Plan. You understand that the Company has unilaterally, gratuitously and in its sole discretion granted RSUs under the 2011 Plan to individuals who may be employees of the Company or its Subsidiaries throughout the world. The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Company or any of its Subsidiaries on an ongoing basis. Consequently, you understand that the RSUs are granted on the assumption and condition that the RSUs and the Shares acquired upon vesting of the RSUs shall not become a part of any employment contract (either with the Company or any of its Subsidiaries) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever. In addition, you understand that this grant would not be made to you but for the assumptions and conditions referenced above. Thus, you acknowledge and freely accept that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, the RSUs shall be null and void.  You understand and agree that, as a condition of the grant of the RSUs, any unvested RSUs as of the date you cease active employment will be forfeited without entitlement to the underlying Shares or to any amount of indemnification in the event of the termination of employment by reason of, but not limited to, (i) material modification of the terms of employment under Article 41 of the Workers' Statute or (ii) relocation under Article 40 of the Workers' Statute. You acknowledge that you have read and specifically accept the conditions referred to in the Terms and Conditions regarding the impact of a termination of employment on your RSUs.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:39pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.66pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you hold 10% or more of the Share capital of the Company or such other amount that would entitle you to join the Company's board of directors, the acquisition, ownership and disposition of such Shares must be declared for statistical purposes to the </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Spanish Direcci&#243;n General de Comercio e Inversiones </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(the Bureau for Commerce and Investments), which is a department of the Ministry of Economy and Competitiveness. The declaration (via Form 6) must be made in January for Shares acquired or disposed of during the prior calendar year and&#47;or for Shares owned as of December 31 of the prior calendar year&#59; provided, if the value of the Shares acquired or sold exceeds &#8364;1,502,530, the declaration must be filed within one month of the acquisition or disposition of the Shares, as applicable. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.55pt;text-align:justify;text-indent:39pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.66pt;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. To the extent you hold rights or assets (e.g., cash or the Shares held in a bank or brokerage account) outside of Spain with a value in excess of &#8364;50,000 per type of right or asset as of December 31 each year (or at any time during the year in which you sell or dispose of such right or asset), you are required to report information on such rights and assets on your tax return for such year. After such rights or assets are initially reported, the reporting obligation will only apply for subsequent years if the value of any previously-reported rights or assets increases by more than &#8364;20,000 per type of right or asset as of each subsequent December 31, or if you sell Shares or cancel bank accounts that were previously reported. Failure to comply with this reporting requirement may result in penalties to the Spanish residents. In addition, you may be required to electronically declare to the Bank of Spain any foreign accounts (including brokerage accounts held abroad), any foreign instruments (including Shares acquired under the 2011 Plan), and any transactions with non-Spanish residents (including any payments of Shares made pursuant to the 2011 Plan), depending on the balances in such accounts together with the value of such instruments as of December 31 of the relevant year, or the volume of transactions with non-Spanish residents during the relevant year. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:12pt;padding-left:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2025 TO </font><font style="color:#002755;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">STOCKPLANADMINISTRATION&#64;STRYKER.COM.</font></div><div style="margin-top:12pt;padding-left:6pt"><font><br></font></div><div style="margin-top:12pt;padding-left:6pt"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.212%"><tr><td style="width:1.0%"></td><td style="width:45.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.115%"></td><td style="width:0.1%"></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Signature</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Employee Name (Printed)</font></div></td></tr><tr style="height:22pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:137%">Date</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-2.63pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="margin-top:12pt;padding-left:6pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SWITZERLAND</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Neither this document nor any other materials relating to the RSUs (a) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (&#34;FinSA&#34;) (b) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an employee of the Company or (c) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority (&#34;FINMA&#34;).</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TAIWAN</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The offer of participation in the 2011 Plan is available only for employees of the Company and its Subsidiaries. The offer of participation in the 2011 Plan is not a public offer of securities by a Taiwanese company.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.4pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You may acquire and remit foreign currency (including proceeds from the sale of Shares acquired under the 2011 Plan) into Taiwan up to USD5,000,000 per year without justification. If the transaction amount is TWD$500,000 or more in a single transaction, you must submit a Foreign Exchange Transaction Form and also provide supporting documentation to the satisfaction of the remitting bank. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THAILAND</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.35pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.66pt;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If you receive proceeds from the sale of Shares or cash dividends in relation to the Shares in excess of USD1,000,000 in a single transaction, you must immediately repatriate the funds to Thailand (or utilize such funds offshore for permissible purposes) and convert the funds to Thai Baht within 360 days of repatriation or deposit the funds in an authorized foreign exchange account in Thailand. You are also required to provide details of the transaction (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">i.e.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, identification information and purpose of the transaction) to the receiving bank. If you do not repatriate such funds and utilizes them offshore for permissible purposes (i.e., purposes not listed in the negative list prescribed by the Bank of Thailand), you must obtain a waiver of the repatriation requirement from a commercial bank in Thailand by submitting an application and supporting documents evidencing that such funds will be utilized offshore for permissible purposes. You should consult with your personal advisor(s) regarding any personal legal, regulatory or foreign exchange obligations you may have in connection with your participation in the 2011 Plan.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">T&#220;RKIYE</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Under Turkish law, you are not permitted to sell any Shares acquired under the 2011 Plan within Turkey. The Shares are currently traded on the New York Stock Exchange, which is located outside of Turkey, under the ticker symbol &#34;SYK&#34; and the Shares may be sold through this exchange.</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Financial Intermediary Obligation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You acknowledge that any activity related to investments in foreign securities (e.g., the sale of Shares) should be conducted through a bank or financial intermediary institution licensed by the Turkey Capital Markets Board and should be reported to the Turkish Capital Markets Board. You solely are responsible for complying with this requirement and should consult with a personal legal advisor for further information regarding any obligations in this respect.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED ARAB EMIRATES</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The offer of the RSUs is available only for select Employees of the Company and its Subsidiaries and is in the nature of providing incentives in the United Arab Emirates. The </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:12pt;padding-left:6pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2011 Plan and the Terms and Conditions are intended for distribution only to such individuals and must not be delivered to, or relied on by any other person.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Prospective purchasers of securities should conduct their own due diligence.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:6.6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with this statement, including the 2011 Plan and the Terms and Conditions, or any other incidental communication materials distributed in connection with the RSUs. Further, neither the Ministry of Economy nor the Dubai Department of Economic Development has approved this statement nor taken steps to verify the information set out in it, and has no responsibility for it. Residents of the United Arab Emirates who have any questions regarding the contents of the 2011 Plan and the Terms and Conditions should obtain independent advice.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="background-color:#bfbfbf;color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED KINGDOM</font></div><div style="margin-top:12pt;padding-left:5.75pt;padding-right:6.5pt;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.61pt">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Income Tax and Social Insurance Contribution Withholding</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The following provision shall supplement Section 6 of the Terms and Conditions&#58;</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:6.5pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limitation to Section 6 of the Terms and Conditions, you agree that you are liable for all Tax- Related Items and hereby covenant to pay all such Tax-Related Items, as and when requested by the Company, your Employer or by HM Revenue and Customs (&#34;HMRC&#34;) (or any other tax authority or any other relevant authority). You also agree to indemnify and keep indemnified the Company and your Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC on your behalf (or any other tax authority or any other relevant authority).</font></div><div style="margin-top:12pt;padding-left:6pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.36pt;text-decoration:underline">Exclusion of Claim</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. You acknowledge and agree that you will have no entitlement to compensation or damages in consequence of the termination of your employment with the Company and your Employer for any reason whatsoever and whether or not in breach of contract, insofar as any purported claim to such entitlement arises or may arise from your ceasing to have rights under or to be entitled to vest in the RSUs as a result of such termination of employment (whether the termination is in breach of contract or otherwise), or from the loss or diminution in value of the RSUs. Upon the grant of the RSUs, you shall be deemed irrevocably to have waived any such entitlement.</font></div><div style="margin-top:12pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">****************************</font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.5pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.5pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.5pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.5pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.5pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.5pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.5pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.5pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.5pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.5pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.5pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.5pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.5pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;padding-left:5pt;padding-right:6.5pt;text-align:justify"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="margin-top:11.05pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT A</font></div><div style="margin-top:11.05pt;padding-left:0.52pt;padding-right:0.52pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2011 LONG-TERM INCENTIVE PLAN, AS AMENDED AND RESTATED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br>EMPLOYER INFORMATION STATEMENT &#8211; DENMARK<br>RESTRICTED STOCK UNIT GRANT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to section 3(1) of the Danish Act on the Use of Rights to Purchase or Subscribe for Shares etc. in Employment Relationships (the &#34;Stock Option Act&#34;), Stryker Corporation (the &#8220;Company&#8221;) is providing you with the following information regarding the Company&#8217;s restricted stock unit (&#34;RSU&#34;) grant in a separate written statement. This statement contains only the information mentioned in the Stock Option Act&#59; the other terms and conditions of your RSU grant are described in detail in the Stryker Corporation 2011 Long-Term Incentive Plan, as Amended and Restated  (the &#34;2011 Plan&#34;), the Terms and Conditions Related to Restricted Stock Units Granted Pursuant to the 2011 Long-Term Incentive Plan (the &#8220;RSU Agreement&#8221;) and the CEO Award Letter for the RSU grant, all of which have been provided to you.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IMPORTANT NOTE&#58; The Stock Option Act only applies to RSUs granted under the 2011 Plan to employees of the Company and its Subsidiaries, and does not apply to individuals, including managers, who are not regarded as &#34;employees&#34; as defined under the Stock Option Act. If you are not an employee of the Company or one of its Subsidiaries within the meaning of the Stock Option Act, this Employer Information Statement shall not apply to you, you may not rely upon any of the information contained herein and the provisions described herein shall be void and ineffective.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Date of Grant</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Grant Date of the RSU is the date that the Compensation and Human Capital Committee of the Board of Directors (the &#8220;Committee&#8221;) approved a grant for you and determined it would be effective.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Terms and Conditions of the Grant</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The grant of RSU is made at the sole discretion of the Committee.  In its assessment, the Committee has considered a number of factors in granting the RSUs to you, including (but not limited to) the Company&#8217;s latest annual results, your personal performance and your value for the future growth, development and operation of the Company.  Notwithstanding your personal performance and the development of the Company, the Company may decide, in its sole discretion, not to grant an RSU to you in the future.  Under the terms of the Plan and the Agreement, you have no entitlement or claim to receive future RSU grants.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Vesting Dates and Exercise Period</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Your RSU shall vest over a period of time (&#8220;vesting period&#8221;), provided you remain employed by or in the service of the Company or a Subsidiary and any performance or other vesting conditions set forth in the Plan and the Agreements are satisfied, unless the RSU are vested or terminated earlier for the reasons set forth in the Plan and the Agreements and subject to Section 5 of this statement.</font></div><div style="padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Exercise Price</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For RSUs, you pay no monetary consideration to receive the RSU nor do you pay any price to receive the shares of the Company&#8217;s common stock issued upon vesting.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;Your Rights upon Termination</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The treatment of your RSU awards upon termination of your employment will be determined in accordance with the following unless the terms contained in the Agreement and in the 2011 Plan are more favorable to you.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Your RSU will survive and will not be forfeited if your employment is terminated by your employer for any reason other than your breach of contract (as determined under Danish law) or summary dismissal. This means that you may be entitled to continue to vest in the award as if you were still an employee in accordance with your Agreement and the 2011 Plan. Also, you may be entitled to receive an additional RSU grant, proportionate to the length of your employment in the accounting year in which your employment is terminated, to which you would have been entitled according to agreement or custom had you still been employed at the end of the accounting year. This provision will not apply if the termination is due to your breach of your employment contract or in case of your justified summary dismissal, in which case the RSU will lapse to the extent the RSU has not vested on the effective date of termination of your employment. Such lapse will take place automatically without notice on the effective date of termination of your employment.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you terminate your employment due to your employer's material breach (as determined under Danish law), or if your employment terminates because you reach the age of retirement for employees of your employer or because you are entitled to receive old-age pension from the Danish state or your employer, the RSU award shall continue on unchanged terms as if you had still been employed. Also, you may be entitled to receive an additional RSU grant, proportionate to the length of your employment in the accounting year in which your employment is terminated, to which you would have been entitled according to agreement or custom had you still been employed at the end of the accounting year or at the date of grant.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you terminate your employment for other reasons,  your RSU award will be forfeited as per the effective date of termination of your employment unless otherwise set out in the terms of the Agreement. In addition, you will be ineligible to receive any additional RSU grants after your resignation.</font></div><div style="padding-left:28.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;Financial Aspects of Participating in the 2011 Plan</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The RSU grant has no immediate financial consequences for you. The value of the RSU award will not be taken into account when calculating holiday allowances, pension contributions or other statutory consideration calculated on the basis of salary. The tax treatment of the RSU award depends on a number of aspects and thus, you are encouraged to seek particular advice regarding your tax position. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Shares of stock are financial instruments and investing in stock will always have financial risk. The possibility of profit at the time of vesting will not only be dependent on the Company&#8217;s financial development, but inter alia also on the general development of the stock market. In addition, before or after you vest in your RSU award, the shares of Company stock could decrease in value even below the price of such stock on the Date of Grant.</font></div><div style="padding-left:28.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;Other Issues</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Apart from Clause 5 in this Statement (regarding your rights upon termination of employment), this Statement does not intend to alter any provisions of the 2011 Plan or the Agreement (or any related document), and the 2011 Plan and the Agreement (and any related document) shall prevail in case of any ambiguities. However, your mandatory rights under the Stock Option Act shall prevail in case of any ambiguities.  </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Plan Administrator </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Stryker Corporation</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Portage, Michigan USA</font></div><div style="margin-top:11.6pt;padding-left:5pt;text-align:justify;text-indent:35.3pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STRYKER CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2011 LONG-TERM INCENTIVE PLAN, SOM REVIDERET OG GENFREMSAT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br>ARBEJDSGIVERERKL&#198;RING &#8211; DANMARK<br>TILDELING OG RSU'ER</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I henhold til &#167; 3, stk. 1, i lov om brug af k&#248;beret eller tegningsret til aktier m.v. i ans&#230;ttelsesforhold (&#34;Aktieoptionsloven&#34;) giver Stryker Corporation (&#34;Selskabet&#34;) dig hermed i en s&#230;rskilt skriftlig erkl&#230;ring f&#248;lgende oplysninger om Selskabets tildeling af RSU'er (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) . Denne erkl&#230;ring indeholder kun de oplysninger, der er n&#230;vnt i Aktieoptionsloven. De &#248;vrige vilk&#229;r og betingelser for din RSU-tildeling er n&#230;rmere beskrevet i Selskabets </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">2011 Long-Term Incentive Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, som revideret og genfremsat  (&#34;2011-Planen&#34;), </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Terms and Conditions Related to Restricted Stock Units Granted Pursuant to the 2011 Long-Term Incentive Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (&#34;RSU-Aftalen) og CEO-tildelingsbrevene vedr&#248;rende henholdsvis RSU-tildelingen, hvilke dokumenter alle er blevet udleveret til dig.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">VIGTIGT&#58; Aktieoptionsloven g&#230;lder kun for RSU'er, der i henhold til 2011-Planen er tildelt til l&#248;nmodtagere i Selskabet og dets Datterselskaber, og g&#230;lder ikke for personer, herunder ledere, der ikke anses for at v&#230;re &#34;l&#248;nmodtagere&#34; som defineret i Aktieoptionsloven. Hvis du ikke er l&#248;nmodtager i Selskabet eller i et af dets Datterselskaber i Aktieoptionslovens forstand, g&#230;lder denne Arbejdsgivererkl&#230;ring ikke for dig, hvorfor du ikke vil kunne henholde dig til nogen af oplysningerne heri, og de heri anf&#248;rte bestemmelser vil ikke have virkning.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Tidspunkt for tildeling</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Tidspunktet for RSU-tildelingen er den dato, hvor det af Bestyrelsen nedsatte Udvalg for Vederlag og Menneskelig Kapital (&#34;Udvalget&#34;) godkendte tildelingen til dig og besluttede, at den skulle tr&#230;de i kraft.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Kriterier og betingelser for tildeling</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">RSU-tildelingen sker alene efter Udvalgets eget sk&#248;n.  Udvalget har i sin vurdering inddraget en r&#230;kke faktorer i forbindelse med RSU-tildelingen til dig, herunder (men ikke begr&#230;nset til) Selskabets seneste &#229;rsresultat, din personlige performance og din betydning for Selskabets fremtidige v&#230;kst, udvikling og drift.  Uanset din personlige performance og Selskabets udvikling kan Selskabet frit v&#230;lge ikke at tildele dig RSU'er fremover.  I henhold til bestemmelserne i Planen og Aftalen har du ikke nogen ret til eller noget krav p&#229; fremover at modtage RSU-tildelinger.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Modningstidspunkter og udnyttelsesperiode</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Din RSU modnes over en periode (&#34;modningsperioden&#34;), forudsat at du fortsat er ansat i eller arbejder for Selskabet eller et Datterselskab, og forudsat at alle de i Planen og Aftalerne beskrevne performance- og modningsbetingelser er opfyldt, medmindre RSU'en modnes eller bortfalder p&#229; et tidligere tidspunkt som f&#248;lge af de i Planen og Aftalerne anf&#248;rte &#229;rsager og med forbehold for pkt. 5 i denne erkl&#230;ring.</font></div><div style="padding-left:28.35pt;text-align:justify;text-indent:-28.35pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Udnyttelseskurs</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hvad ang&#229;r RSU'er, skal du ikke betale noget vederlag for at modtage RSU'en, ligesom du ikke skal betale noget for at modtage de ordin&#230;re aktier i Selskabet, der udstedes ved modning.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;Din retsstilling i forbindelse med fratr&#230;den</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I forbindelse med din fratr&#230;den vil dine RSU-tildelinger blive behandlet som f&#248;lger, medmindre vilk&#229;rene i Aftalen og i 2011-Planen er mere fordelagtige for dig.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Din RSU bortfalder ikke, hvis din fratr&#230;den skyldes opsigelse fra din arbejdsgivers side, medmindre der er tale om misligholdelse fra din side (som defineret i dansk ret) eller bortvisning. Dette betyder, at du m&#229;ske vil v&#230;re berettiget til, at din RSU fortsat modnes i overensstemmelse med din Aftale og 2011-Planen, som om du stadig var ansat. Endvidere vil du m&#229;ske v&#230;re berettiget til at modtage en yderligere RSU-tildeling, som beregnes forholdsm&#230;ssigt i forhold til, hvor l&#230;nge du er ansat i det regnskabs&#229;r, hvori du fratr&#230;der, og som du ville have v&#230;ret berettiget til i henhold til aftale eller s&#230;dvane, s&#229;fremt du stadig havde v&#230;ret ansat ved udgangen af regnskabs&#229;ret. Denne bestemmelse g&#230;lder ikke, s&#229;fremt din fratr&#230;den skyldes opsigelse p&#229; grund af din misligholdelse af ans&#230;ttelseskontrakten eller berettiget bortvisning, i hvilket tilf&#230;lde RSU'en bortfalder, i det omfang de ikke er modnet ved ans&#230;ttelsesforholdets oph&#248;r. Bortfaldet sker automatisk uden varsel ved ans&#230;ttelsesforholdets oph&#248;r.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hvis du fratr&#230;der din stilling som f&#248;lge af v&#230;sentlig misligholdelse fra din arbejdsgivers side (som defineret i dansk ret), eller hvis du fratr&#230;der, fordi du n&#229;r pensionsalderen for l&#248;nmodtagere hos din arbejdsgiver, eller fordi du har ret til at modtage alderspension fra den danske stat eller din arbejdsgiver, vil din RSU-tildeling forts&#230;tte p&#229; u&#230;ndrede vilk&#229;r, som om du stadig var ansat.   Endvidere vil du m&#229;ske v&#230;re berettiget til at modtage en yderligere RSU-tildeling, som beregnes forholdsm&#230;ssigt i forhold til, hvor l&#230;nge du er ansat i det regnskabs&#229;r, hvori du fratr&#230;der, og som du ville have v&#230;ret berettiget til i henhold til aftale eller s&#230;dvane, s&#229;fremt du stadig havde v&#230;ret ansat ved udgangen af regnskabs&#229;ret eller p&#229; tildelingstidspunktet.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hvis du fratr&#230;der din stilling af andre &#229;rsager, vil din RSU-tildeling bortfalde ved ans&#230;ttelsesforholdets oph&#248;r, medmindre andet fremg&#229;r af Aftalen. Endvidere vil du ikke v&#230;re berettiget til at f&#229; tildelt yderligere RSU'er efter din fratr&#230;den.</font></div><div style="padding-left:28.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;&#216;konomiske aspekter ved at deltage i 2011-Planen</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">RSU-tildelingen har ingen umiddelbare &#248;konomiske konsekvenser for dig. V&#230;rdien af RSU-tildelingen indg&#229;r ikke i beregningen af feriepenge, pensionsbidrag eller andre lovpligtige, vederlagsafh&#230;ngige ydelser. Den skattem&#230;ssige behandling af RSU-tildelingen afh&#230;nger af flere forhold, og du opfordres derfor til at s&#248;ge s&#230;rskilt r&#229;dgivning vedr&#248;rende din skattem&#230;ssige situation. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Aktier er finansielle instrumenter, og investering i aktier vil altid v&#230;re forbundet med en &#248;konomisk risiko. Muligheden for en gevinst p&#229; modningstidspunktet afh&#230;nger ikke alene af Selskabets &#248;konomiske udvikling, men ogs&#229; af bl.a. den generelle udvikling p&#229; aktiemarkedet. Derudover kan v&#230;rdien af Selskabets aktier b&#229;de f&#248;r og efter modningen af din RSU-tildeling falde til en v&#230;rdi, der m&#229;ske endda ligger under kursen p&#229; tildelingstidspunktet.</font></div><div style="padding-left:28.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;&#216;vrige oplysninger</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Med undtagelse af pkt. 5 i denne erkl&#230;ring (vedr&#248;rende din retsstilling i forbindelse med fratr&#230;den) har denne erkl&#230;ring ikke til form&#229;l at &#230;ndre nogen af bestemmelserne i 2011-Planen eller Aftalen (eller i tilh&#248;rende dokumenter), og 2011-Planen og Aftalen (og eventuelle tilh&#248;rende dokumenter) har forrang i tilf&#230;lde af uoverensstemmelser. Dine ufravigelige rettigheder i henhold til Aktieoptionsloven har dog forrang i tilf&#230;lde af uklarhed.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10(iv)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Planadministrator </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Stryker Corporation</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Portage, Michigan USA</font></div><div style="margin-top:11.15pt;padding-right:6.5pt;text-align:justify"><font><br></font></div><div style="margin-top:11.15pt;padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.31
<SEQUENCE>7
<FILENAME>ex10xxxitransitionagreemen.htm
<DESCRIPTION>EX-10.31
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ib428a80724794793a53985d60fb946a5_1"></div><div style="min-height:4.32pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9.2pt;text-align:right"><font><br></font></div><div style="margin-top:9.2pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10(xxxi)</font></div><div><img alt="image_0.jpg" src="image_0.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:135px"></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:9.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.75pt;padding-right:432.85pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:232%">January 24, 2025 Dear Glenn&#58;</font></div><div style="padding-left:5.75pt;padding-right:4.9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with your decision to retire from Stryker and to develop a plan for transitioning your roles and responsibilities, it is with pleasure that I hereby confirm our offer for you to serve as Advisor to the CEO, reporting to Kevin Lobo, beginning on April 1, 2025 until March 31, 2026 (&#8220;Advisory Period&#8221;).</font></div><div style="margin-top:12.85pt;padding-left:5.75pt;padding-right:4.9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If you choose to accept this offer, as an Advisor to the CEO your responsibilities during the Advisory Period would include the following&#58; transitioning your responsibilities as the Vice President, Chief Financial Officer to the new leaders responsible for the areas of responsibility you currently lead, providing advice and information related to the CFO transition process, including, but not limited to finalizing quarter-end and year-end financials, serving as a key advisor to the CFO of Stryker with regard to various financial matters and relationships with investors, providing requested advice on potential mergers and acquisitions, executing materials required to remove yourself as an officer or signer on behalf of Stryker, and providing other leadership and support as requested by Stryker for other matters. At the end of the Advisory Period, your employment with Stryker will end. The terms of your compensation and benefits will remain the same as is currently in effect through the end of the Advisory Period, which for the avoidance of doubt will include the following&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:41.75pt;padding-right:13.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Your salary will remain at the annualized amount of $800,000. You will not be eligible for salary increases during Stryker&#8217;s regular compensation review process in 2025 or at any time during the term of your Advisory Period.</font></div><div style="margin-top:12.85pt;padding-left:41.75pt;padding-right:5.1pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">You will continue to be eligible for a 2025 incentive bonus with a target bonus percentage of 100% ($800,000) of your annual salary. Terms of the bonus and your objectives will remain consistent with the applicable Bonus Plan for 2025. Payout of the bonus will be made at the time bonuses are paid out to other Stryker employees.</font></div><div><font><br></font></div><div style="padding-left:41.75pt;padding-right:7.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">In exchange for your assistance in the transition of your roles and responsibility and agreeing to serve as Advisor to CEO through the Advisory Period, Stryker will pay you an incentive bonus in the amount of</font></div><div style="margin-top:0.05pt;padding-left:41.75pt;padding-right:4.9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$215,000. To receive the bonus, you must remain employed by Stryker, in good standing, through the Advisory Period and continue to support the transition as outlined above. Stryker will pay the incentive bonus within thirty (30) calendar days after the end of the Advisory Period.</font></div><div><font><br></font></div><div style="padding-left:41.8pt;padding-right:9pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Your participation in Stryker&#8217;s 401(k) plan, Supplemental Savings and Retirement Plan, executive health examination program, and stock awards including stock options, RSUs and PSUs will continue to be governed by the terms of those plans. Included in these terms is the ongoing vesting of granted stock awards through the end of the Advisory Period. You will not be eligible to receive any new stock awards during the term of your Advisory Period.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib428a80724794793a53985d60fb946a5_4"></div><hr style="page-break-after:always"><div style="min-height:85.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:41.75pt;padding-right:16.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Assuming the Board of Directors approves, we expect to provide you with a transition services benefit that is intended to assist you with the successful transfer of your current responsibilities to the leaders that will be assuming those responsibilities, and to support you in your move to retirement.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5.75pt;padding-right:4.9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Other provisions of your employment relationship with Stryker will continue in effect, meaning that you agree to abide by the requirements and guidelines set forth in Stryker&#8217;s Code of Conduct and other policies (including but not limited to guidelines concerning Conflicts of Interest), Stryker&#8217;s Employee Handbook and the terms of Stryker&#8217;s Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement that you signed. You also acknowledge that you are aware of Stryker&#8217;s at-will employment relationship with you.</font></div><div style="margin-top:12.85pt;padding-left:5.75pt;padding-right:4.9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To accept this offer, please sign this letter on the space provided below and return it to me. If you have any questions, please feel free to contact me.</font></div><div><font><br></font></div><div style="padding-left:5.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Sincerely,</font></div><div style="padding-left:5.75pt"><font><br></font></div><div style="padding-left:5.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Katy Fink</font></div><div style="padding-left:5.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Katy Fink</font></div><div style="padding-left:5.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Vice President, Chief Human Resources Officer</font></div><div><font><br></font></div><div style="padding-left:5.75pt;padding-right:4.9pt;text-indent:-0.05pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I accept this offer of employment during the Advisory Period with Stryker and agree to the terms and conditions outlined in this letter&#58;</font></div><div><font><br></font></div><div style="padding-left:5.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Glenn Boehnlein&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1&#47;24&#47;2025&#160;&#160;&#160;&#160;</font></div><div style="padding-left:5.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Glenn Boehnlein&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Date</font></div><div><font><br></font></div><div style="padding-left:5.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c&#58; Employee file, Kevin Lobo</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>8
<FILENAME>ex19icorporatepolicy6_as.htm
<DESCRIPTION>EX-19.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ex19icorporatepolicy6_as</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ex19icorporatepolicy6_as001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex19icorporatepolicy6_as001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    Corporate Policy 6  Trading in Securities by Company Personnel  Purpose  To outline the company&#8217;s policy concerning trading in securities by company personnel.  Scope  This Policy applies to all employees and directors of Stryker.  Basic policies  1. Confidential and proprietary information: Stryker&#8217;s employees and directors have access to corporate information, some  of which is highly confidential and of considerable value to Stryker and those with whom we do business. Employees and  directors who possess confidential information hold a special position of trust and confidence with regard to it and have an  important responsibility to keep such information within the company until it is made public. We also have a legal obligation  in this regard. It is both illegal and against Stryker policy for any individual to profit from undisclosed information relating  to the company.  2. No trading on material, nonpublic information  2.1. If an employee or director has material, non-public information relating to Stryker, it is the company&#8217;s policy that  neither that person, nor any person with whom he or she may have a business or family relationship, may buy or sell  shares of Stryker common stock or engage in any other action to take advantage of that information or pass it on to  others. This Policy applies as well to information obtained in the course of employment relating to Stryker&#8217;s customers,  suppliers, and other companies with which we do business and the purchase or sale of securities of those companies.  2.2. Information is material if a reasonable investor would consider it important in making a decision to buy or sell  securities. Both positive and negative information can be material. Examples of information generally regarded as  material are significant new contracts or the termination of existing contracts, potential acquisitions, mergers, changes  in estimates of earnings, increases or decreases in dividend payments, the introduction of important new product lines,  significant technological breakthroughs, commencement or settlement of major litigation, and changes in key  management personnel. You may not trade in securities while in possession of non-public information, or communicate  such information to others who might trade.  2.3. Information remains non-public until it has been effectively disclosed in a manner sufficient to insure its general  availability to the investing public. In order to afford Stryker&#8217;s stockholders and the investing public time to receive and  act upon information, you should not engage in transactions until the second business day after a public announcement  of the information has been made (the day of the announcement is not counted).  2.4. As a simple rule-of-thumb, you should treat all corporate information with discretion, discuss confidential information  only with those who have a right and need to know, and refrain from trading in securities until any inside information  you possess is made public.  2.5. The restrictions on trading set forth in this Policy do not apply to sales of Stryker common stock pursuant to a written  plan meeting the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934. Further information about  10b5-1 trading plans may be obtained from your broker and the corporate secretary.  3. Compliance: Stryker expects nothing short of full compliance with the letter and spirit of this statement of policy. The  consequences of illegal insider trading and tipping of others can be severe and include civil penalties and liability for both the  individuals involved and the company, criminal prosecution, with exposure to prison terms and additional fines if convicted,  and company-imposed sanctions, including dismissal. If you have questions about specific transactions or doubts as to your  responsibilities under this statement of policy, please contact Stryker&#8217;s chief legal officer or corporate secretary. The  ultimate responsibility for compliance, however, is yours.      www.stryker.com CP-006 Rev 8.0 Trading in Securities by Company Personnel | 1  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.2
<SEQUENCE>9
<FILENAME>ex19iiinsidertradingguid.htm
<DESCRIPTION>EX-19.2
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ex19iiinsidertradingguid</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ex19iiinsidertradingguid001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex19iiinsidertradingguid001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">1   Effective Date: August 1, 20231  Insider Trading Guidelines  In the course of performing their duties, employees and directors of Stryker Corporation  and its subsidiaries (collectively, &#8220;Stryker&#8221; or the &#8220;Company&#8221;) may learn material, non-public  information about Stryker or another company. This information may be valuable to those who  trade in Stryker&#8217;s securities, including common stock or public debt securities (collectively,  &#8220;Stryker Securities&#8221;), or the securities of other companies. It is the law, as well as the policy of  the Company, that this information may not be disclosed to anyone outside Stryker and that no  one may trade while in possession of material information not available to the general public.  Stryker is committed to protecting its confidential information. The Company&#8217;s policy in this  regard, which is applicable to all employees and directors, is set forth in Corporate Policy  Number Six, &#8220;Trading in Securities by Company Personnel&#8221; (the &#8220;Policy&#8221;). The Policy serves  the mutual interest of the Company and its employees and directors in limiting the potential for  an insider trading investigation or even the appearance that Stryker, its employees or its  directors may have violated the law. The Policy is available from the Human Resources  Department, or at http://www.stryker.com/corporatepolicies.    Insider trading is a serious legal matter. The law provides for significant civil and  criminal penalties for insider trading violations. Those penalties may be imposed upon  individuals who purchase or sell securities while in possession of material, non-public  information about the issuer or the securities. Civil and criminal liability could also extend to an  employee or director who &#8220;tips&#8221; another person about material, non-public information where  that person, in turn, buys or sells securities.     The Policy is simple. No trading is permitted while you have material, non-public  information. The Company is also prohibited from trading at any time in Stryker Securities on  the basis of material non-public information, consistent with applicable law. In all cases,  information should be considered &#8220;material&#8221; if it would be considered important by investors in  making decisions whether to purchase, sell or hold securities. Materiality will be construed  broadly and with the benefit of hindsight, and it is possible that a group of facts that are  immaterial on a stand-alone basis would be deemed material when pieced together. The  materiality of earnings information cannot be disputed. Other examples of types of information  that could be deemed material include a significant new contract or the termination of an  existing contract; mergers, acquisitions, joint ventures or dispositions or terminations thereof;  internal financial projections or changes in estimates of earnings; increases or decreases in  dividend payments; a change in control of the Company; new product developments; significant  technological breakthroughs; the status of regulatory approvals, cybersecurity incidents; ratings  changes; changes in senior management; and initiation or resolution of significant litigation or  government investigations or proceedings. This list is provided only for illustrative purposes and    1 These Insider Trading Guidelines supersede any previous Insider Trading Guidelines of the Company. In the event  of any conflict or inconsistency between these Guidelines and any other materials previously distributed by the  Company, these Guidelines shall govern.    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex19iiinsidertradingguid002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex19iiinsidertradingguid002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">2   is not exhaustive; other types of information may be material at any particular time depending  upon the circumstances. Our Corporate Secretary and Chief Legal Officer may always be  contacted for advice as to whether a particular fact pattern constitutes material non-public  information.    Non-public information, whether or not material, is information that has not been made  available to the general public. Information should also be treated as being non-public unless a  reasonable period of time has passed since it has been distributed by Stryker by means likely to  result in a general public awareness, for example, by publication of the information in a press  release or filing with the U.S. Securities and Exchange Commission. Information does not cease  to be &#8220;non-public&#8221; as a result of being the subject of rumors or other unofficial statements in the  marketplace and can be &#8220;non-public&#8221; even if the information was obtained by a Company  employee from a source outside of the Company.    In addition to the Policy, the Board of Directors has adopted the following guidelines  (these &#8220;Guidelines&#8221;) applicable to transactions in Stryker Securities by directors and certain  employees (&#8220;Covered Persons&#8221; as defined in Attachment A hereto). These Guidelines restrict  trading in Stryker Securities by any Covered Person to a limited &#8220;trading window&#8221; following the  release of annual or quarterly earnings provided he or she does not actually possess material  non-public information at that time. If you are a Covered Person, then this policy also applies  to your spouse and minor children, other family members who reside with you, anyone else who  lives with you and any other person or entity whose transactions in Stryker Securities are  directed by you or are subject to your influence or control (collectively, &#8220;Family Members&#8221;) and,  as a general matter, references in these Guidelines to Covered Persons also includes Family  Members. You are responsible for making sure that Family Members comply with these  Guidelines.    Set forth below is a discussion of the trading window and blackout periods and their  application to various stock-related events:    Trading Window Periods    Subject to the important qualifications set forth below, a Covered Person may engage in  purchases or sales of Stryker Securities only during the period beginning at 12:01 a.m., Eastern  time, on the second (2nd) trading day after the public release of the Company&#8217;s annual or  quarterly earnings (the day of the release is not counted) and ending at 11:59 p.m., Eastern time,  on the fifth (5th) business day of the third month of each reporting period (i.e., March, June,  September and December). A &#8220;trading day&#8221; is a day when the New York Stock Exchange is  open for transactions.    It is imperative that Covered Persons not trade in Stryker Securities even during a  trading window if they are in possession of material non-public information.    Blackout Periods    Conversely, a Covered Person may not engage in transactions in Stryker Securities during  the period beginning at 12:01 a.m., Eastern time, on the sixth (6th) business day of the last month  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex19iiinsidertradingguid003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex19iiinsidertradingguid003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">3   of each quarter (March, June, September, and December) and ending at 11:59 p.m., Eastern time,  on the first (1st) trading day after Stryker issues a press release disclosing its most recent  quarterly earnings (again, the day of the release is not counted).    Additional Blackout Periods; Early Closing of Trading Windows    There may be times during what would otherwise be a trading window when the  Company will advise certain persons, including certain Covered Persons, that trading must be  suspended or that a blackout period must be extended. It is important to note in that regard that  the facts giving rise to such a suspension or extension of a blackout period could be either  positive or negative. In addition, the fact of a suspension of trading privileges or that a blackout  is being extended is itself information that could be misinterpreted by the trading market and,  therefore, should not be disclosed to anyone, including other Stryker employees. At those times,  if you are affected, you will receive a separate communication from the Corporate Secretary or  Legal team advising of this situation.    Gifts    Gifts and donations of Stryker Securities by a Covered Person during a blackout period  require prior approval by the Corporate Secretary. Gifts and donations may not be made if a  Stryker employee or director is aware of material non-public information about Stryker or  Stryker Securities and has reason to believe, or is reckless in not knowing, that the recipient is  likely to sell the shares prior to the disclosure of the information.     Prohibition of Short Sales and Standardized Options Trading    Selling Stryker Securities short creates the appearance of an inherent conflict of interest  for Stryker employees and directors. A short sale is a bet that a security will decline in value.  Writing (selling) or buying standardized exchange-traded put and call options on Stryker  Securities may create a similar appearance or an appearance that a Covered Person has non-  public information suggesting a significant upcoming price movement. Accordingly, Covered  Persons are prohibited from short sales of and option trading on Stryker Securities at all times.    Prohibition of Pledging and Hedging    Margin Accounts and Pledges. Because a margin sale or foreclosure sale may occur at a  time when the pledgor is aware of material non-public information or otherwise is not permitted  to trade in Stryker Securities, Covered Persons may not hold Stryker Securities in a margin  account or otherwise pledge Stryker Securities as collateral for a loan, except for Stryker  Securities that had been pledged as of the effective date of these Guidelines or that already have  been pledged at the time an individual becomes a Covered Person.    Hedging Transactions. Covered Persons may not engage in hedging transactions such as  (but not limited to) zero-cost collars, equity swaps and forward sale contracts. Hedging  transactions may allow a director, officer or other employee to continue to own Stryker  Securities, but without the full risks and rewards of ownership. This may lead to the director,  officer or other employee no longer having the same objectives as the Company&#8217;s other  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex19iiinsidertradingguid004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex19iiinsidertradingguid004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">4   shareholders.    Pre-Clearance of Trades by Directors and Section 16 Officers    All trades in Stryker Securities by directors and officers subject to reporting under  Section 16 of the Securities Exchange Act of 1934 (&#8220;Section 16 officers&#8221;) and their Family  Members must be pre-cleared in advance by any two of the Corporate Secretary, Assistant  Secretary, Chief Legal Officer, Chief Financial Officer, Chief Accounting Officer or Corporate  Controller. One of the approvers must be the Corporate Secretary, Assistant Secretary or Chief  Legal Officer. The Company&#8217;s pre-clearance procedures are set forth in the memorandum entitled  &#8220;Section 16 Reporting and Other Responsibilities Related to Stryker Stock&#8221; provided to directors  and Section 16 officers during their onboarding process.    Exceptions to the Prohibitions on Trading    Exercise of Stock Options    Stock options may be exercised at any time without regard to possession of  material non-public information or a blackout period, provided the shares received upon  exercise are held, not traded. This includes a related election to withhold a portion of the  Stryker stock that would otherwise be issued upon exercise to pay the exercise price or  satisfy withholding tax obligations or to use already owned shares for those purposes.  The rationale is that the transaction is with the Company rather than the general public  and, accordingly, that concerns about the use of non-public inside information are not  present. It is important to note, however, that the public sale of shares of Stryker  Securities to finance the exercise of an option or the public sale of shares acquired upon  exercise of an option may only be made if the seller is not in possession of material non-  public information, and, with respect to Covered Persons, only during a trading window.    Employee Stock Purchase Plan    A participant in the Employee Stock Purchase Plan may only change the dollar  amount that is deducted from his or her paycheck, including starting or discontinuing  such deductions, if such participant is not in possession of material non-public  information at that time, and with respect to participants that are Covered Persons, only  during a trading window. Based on the current ESPP open enrollment periods and  trading windows, changes may only be made by a Covered Person during the first fifteen  (15) days of February, May, August and November of each year, and the first five (5)  business days of March, June, September and December of each year. In addition, note  that Stryker stock acquired for the account of a Covered Person pursuant to the Plan may  only be sold during a trading window and, again, only if the Covered Person is not in  possession of material non-public information at that time.    401(k) Plan    The trading restrictions in these Guidelines do not apply to purchases of Stryker  stock in the 401(k) Plan resulting from periodic contributions of money to the Plan  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex19iiinsidertradingguid005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex19iiinsidertradingguid005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">5   pursuant to payroll deduction elections. The trading restrictions do apply, however, to  elections made under the 401(k) Plan to: (a) increase or decrease the percentage of  periodic contributions that will be allocated to the Stryker stock fund, (b) transfer  amounts into or out of the Stryker stock fund, (c) borrow money against a 401(k) Plan  account if the loan will result in a liquidation of some or all of a Stryker stock fund  balance and (d) pre-pay a Plan loan if the pre-payment will result in allocation of loan  proceeds to the Stryker stock fund. It is important to note that the foregoing may only be  done by employees or directors who are not in possession of material non-public  information, and, with respect to Covered Persons, only during a trading window.    10b5-1 Trading Plans&#8212;An Exception to the Restrictions on Trading    The restrictions on trading set forth in these Guidelines do not apply to sales of  Stryker Securities that are made pursuant to a written plan meeting the requirements of  Rule 10b5-1 under the Securities Exchange Act of 1934 that has been approved by our  Corporate Secretary. Directors and Section 16 officers are also required to preclear any  other written trading arrangements (such as arrangements that are not intended to qualify  for the affirmative defense under Rule 10b5-1) with the Corporate Secretary. Any  amendment to, or termination of, a trading plan or arrangement must also be pre-cleared  with the Corporate Secretary. Any person with a 10b5-1 plan must be in compliance with  any stock ownership guidelines (if applicable to that person) after full implementation of  the 10b5-1 plan.     Questions    Any questions regarding these matters should be directed to our Corporate Secretary or  Chief Legal Officer.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex19iiinsidertradingguid006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex19iiinsidertradingguid006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">6   Guidelines for Trading in Stryker Securities  Attachment A      &#8220;Covered Person&#8221; is defined as:    Members of the Board of Directors   Corporate Officers (including Section 16 officers) and their administrative assistants  Anyone involved in the preparation of or who receives or has regular access to  consolidated financial information, including consolidated financial statements or  summaries of consolidated financial statements, and their administrative assistants  Anyone involved in the preparation of or who receives or has regular access to  consolidated daily sales information  and their administrative assistants  Members of the Legal function and other persons, in each case as deemed appropriate by  the Chief Legal Officer and Corporate Secretary  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>10
<FILENAME>ex21i1231202410k.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="id7f23fca2f71434ba94bc661c83b4254_1"></div><div style="min-height:60.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 21(i)</font></div><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">STRYKER CORPORATION LIST OF SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2024</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.410%"><tr><td style="width:1.0%"></td><td style="width:71.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.645%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">State or Country of Incorporation</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2Hip Holdings SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A&#239;mago SA</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Alcott Indemnity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Vermont</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Arrinex, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Artelon, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Berchtold + Fritz GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Berchtold Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Berchtold GmbH  &#38; Co. KG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BioMimetic Therapeutics USA, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BioMimetic Therapeutics, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cerus Endovascular, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cerus Endovascular Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changzhou Orthmed Medical Instrument Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EnMovi Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Entellus Medical, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gauss Surgical, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gongping (Shanghai) Medical Devices Trading Co. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HeartSine Technologies Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Howmedica International S. de R.L.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Panama</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Howmedica Osteonics Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - New Jersey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HyperBranch Medical Technology, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Imascap SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Imorphics Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Infinity MSD Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Infinity MSF Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">InstruMedics, L.L.C.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International Life Sciences, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Invuity, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jolife AB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">K2M, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MAKO Surgical Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">mfPHD, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Texas</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mobius Imaging, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MOLLI Surgical (US) Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MOLLI Surgical Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MOLLI Surgical Pte. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Muka Metal Ticaret ve Sanayi Anonim Sirketi</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nettrick Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NICO Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Indiana</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">North Georgia Industrial Supply, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Novadaq Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Novadaq Technologies ULC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N.V. Stryker S.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OOO Stryker (Stryker Ltd.)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orneo &#214;zel Sa&#287;l&#305;k Hizmetleri Medikal Ticaret Anonim &#350;irketi</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OrthoHelix Surgical Designs, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orthmed (Hong Kong) Medical Instrument Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orthosensor, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ortho-Space Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control (Shanghai) Sales Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control Lebanon Sales Offshore s.a.l.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lebanon</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control Manufacturing, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Washington</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control Operations Netherlands B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Washington</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">POMedical L.L.C.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Protheos SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr></table></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 21(i)</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.410%"><tr><td style="width:1.0%"></td><td style="width:71.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.645%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">State or Country of Incorporation</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sage Products Holdings II, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sage Products Holdings III, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sage Products, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SCI Calyx</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Serf S.r.l.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SERF Technologies SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Soci&#233;t&#233; d'Etudes de Recherches et de Fabrication</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spirox, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SSI Divestiture, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Massachusetts</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker (Barbados) Foreign Sales Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Barbados</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker (Beijing) Healthcare Products Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker (Shanghai) Healthcare Products Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker (Suzhou) Medical Technology Co Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker (Thailand) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thailand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker AB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Acquisitions B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Australia LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Australia Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Austria GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Austria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Berchtold B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Berlin GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Beteiligungs GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Canada ULC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Canadian Technologies ULC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Capital B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker China Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Colombia SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Colombia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Communications, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Corporation (Chile) y Compania Limitada</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chile</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Corporation (Malaysia) Sdn. Bhd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Malaysia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Customs Brokers, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Deutschland Services GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker do Brasil Ltda.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker EMEA Supply Chain Services B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Employment Company, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations Holdings I B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations Holdings II B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations Holdings III B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations Holdings LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Far East, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Foreign Acquisitions, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker France SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Funding B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Global Technology Center Private Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker GmbH &#38; Co. KG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Grundst&#252;cks GmbH &#38; Co KG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Grundst&#252;cks Verwaltungs GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Iberia, S.L. </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker IFSC Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker India Private Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker International Acquisitions B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker International Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Ireland Global Unlimited Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Ireland Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr></table></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 21(i)</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.410%"><tr><td style="width:1.0%"></td><td style="width:71.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.645%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">State or Country of Incorporation</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Ireland Technology Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Irish Holdings Unlimited Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Italia S.r.l.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Japan K.K.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Korea Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">South Korea</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Lebanon (Offshore) S.A.L.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lebanon</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Leibinger GmbH &#38; Co. KG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Luxembourg S.&#224;.r.l.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Malta Holdings Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Malta</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Malta International Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Malta</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Manufacturing Holding Company B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Manufacturing S. de R.L. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Mauritius Holding Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mauritius</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Mexico Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Mexico, S.A. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Nederland B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker New Zealand Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Zealand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker NV Operations Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker-Osteonics AG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Pacific Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Performance Solutions, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - New Jersey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Poland Manufacturing sp. z. o. o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Poland Services sp. z o.o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Polska sp.z.o.o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Portugal - Produtos Medicos, Unipessoal, Lda.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Professional Latin America S. de R.L. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Puerto Rico Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Puerto Rico Sales, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Puerto Rico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Puerto Rico, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Puerto Rico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Renovation Services, LLC </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Romania SRL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Romania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Sales, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Saudi Healthcare Services</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Saudi Arabia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Singapore Private Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker South Africa (Proprietary) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">South Africa</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Spain Medtech Holdings, S.L. </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Spine, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Spine S&#225;rl</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Spine SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Sustainability Solutions, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker T&#305;bbi Cihazlar&#305; Sanayi ve Ticaret Limited &#350;irketi</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Tijuana Operations, S. de R.L. de C.V. </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Trauma GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Turkish Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker UK Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker UK Technologies Holdings Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker U.S. Investments, Inc. </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Verwaltungs GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SYK Costa Rica Services Sociedad De Responsabilidad Limitada</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costa Rica</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thermedx, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Ohio</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TMG France SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TMJ Solutions, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Florida </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tornier Orthopedics Ireland Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tornier SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tornier, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trauson (China) Medical Instrument Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trauson (Hong Kong) Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trauson Holdings (BVI) Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">British Virgin Islands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trauson Holdings (Hong Kong) Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr></table></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 21(i)</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.410%"><tr><td style="width:1.0%"></td><td style="width:71.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.645%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">State or Country of Incorporation</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trauson Holdings Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cayman Islands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vertos Medical, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vocera Communications Australia Pty Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vocera Communications India Private Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vocera Communications, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vuaant, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical Costa Rica, S.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costa Rica</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical Group, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical Technology, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ZipLine Medical Hong Kong Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ZipLine Medical, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker Corporation directly or indirectly owns 100% of the outstanding voting securities of each of the above-named subsidiaries, with the exception of any designated by an asterisk (*), which Stryker Corporation directly or indirectly owns a majority of the outstanding voting securities.</font></div><div style="text-align:center"><font><br></font></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>11
<FILENAME>ex23i1231202410k.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="iffa4176793cc4c19a4fd6ddbd1027aff_1"></div><div style="min-height:72pt;width:100%"><div style="padding-left:72pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:116%">Exhibit 23(i)</font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">Consent of Independent Registered Public Accounting Firm</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%;padding-left:10.5pt">Registration Statement (Form S-3 No. 333-275853) of Stryker Corporation, and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%;padding-left:10.5pt">Registration Statement (Form S-8 No. 333-140961) pertaining to the 2006 Long-Term Incentive Plan of Stryker Corporation, and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%;padding-left:10.5pt">Registration Statements (Form S-8 No. 333-150396 and Form S-8 333-221959) pertaining to the 2008 Employee Stock Purchase Plan of Stryker Corporation, and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%;padding-left:10.5pt">Registration Statements (Form S-8 No. 333-179142 and Form S-8 333-221958) pertaining to the 2011 Long-Term Incentive Plan of Stryker Corporation&#59;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">of our reports dated February 12, 2025, with respect to the consolidated financial statements and schedule of Stryker Corporation and subsidiaries and the effectiveness of internal control over financial reporting of Stryker Corporation and subsidiaries included in this Annual Report (Form 10-K) for the year ended December 31, 2024.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:116%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:140%">Grand Rapids, Michigan</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:140%">February 12, 2025</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>12
<FILENAME>ex31i1231202410k.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i7662b11458b54597afeba2e2b0ddd19b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 31(i)</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Kevin A. Lobo, certify that&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  I have reviewed this Annual Report on Form 10-K for the year ended December&#160;31, 2024 of Stryker Corporation&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.  The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)  Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)  Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.  The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.209%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 12, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; KEVIN A. LOBO</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin A. Lobo</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair, Chief Executive Officer and President</font></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>13
<FILENAME>ex31ii1231202410k.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i5128a0c3a97e43b6aca433f1e5e4f97e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 31(ii)</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Glenn S. Boehnlein, certify that&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  I have reviewed this Annual Report on Form 10-K for the year ended December&#160;31, 2024 of Stryker Corporation&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.  The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)  Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)  Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.  The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.209%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 12, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; GLENN S. BOEHNLEIN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenn S. Boehnlein</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>14
<FILENAME>ex32i1231202410k.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i8e020a7e44474686a41fcdbd69591292_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 32(i) </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of Stryker Corporation (the &#34;Company&#34;) for the year ended December&#160;31, 2024 (the &#34;Report&#34;), I, Kevin A. Lobo, Chair, Chief Executive Officer and President of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58; </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.342%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 12, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; KEVIN A. LOBO</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin A. Lobo</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair, Chief Executive Officer and President</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>15
<FILENAME>ex32ii1231202410k.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i063b891da4e34ba190db272b7e5c9289_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 32(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of Stryker Corporation (the &#34;Company&#34;) for the year ended December&#160;31, 2024 (the &#34;Report&#34;), I, Glenn S. Boehnlein, Vice President, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58; </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.342%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 12, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; GLENN S. BOEHNLEIN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenn S. Boehnlein</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Chief Financial Officer</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>16
<FILENAME>syk-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:66138c84-a1f4-4bd1-9e3f-a7dda17467bc,g:664b5418-33ef-4591-a7dd-ebf51b747252-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:syk="http://www.stryker.com/20241231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.stryker.com/20241231">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="syk-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="syk-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="syk-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="syk-20241231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="COVERPAGE" roleURI="http://www.stryker.com/role/COVERPAGE">
        <link:definition>0000001 - Document - COVER PAGE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.stryker.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfEarnings" roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfEarnings">
        <link:definition>9952151 - Statement - Consolidated Statements Of Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfEarningsParenthetical" roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfEarningsParenthetical">
        <link:definition>9952152 - Statement - Consolidated Statements Of Earnings (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>9952153 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.stryker.com/role/ConsolidatedBalanceSheets">
        <link:definition>9952154 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParentheticals" roleURI="http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals">
        <link:definition>9952155 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfShareholdersEquity" roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity">
        <link:definition>9952156 - Statement - Consolidated Statements Of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfCashFlows" roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows">
        <link:definition>9952157 - Statement - Consolidated Statements Of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.stryker.com/role/SignificantAccountingPolicies">
        <link:definition>9952158 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.stryker.com/role/RevenueRecognition">
        <link:definition>9952159 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.stryker.com/role/FairValueMeasurements">
        <link:definition>9952160 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstruments" roleURI="http://www.stryker.com/role/DerivativeInstruments">
        <link:definition>9952161 - Disclosure - Derivative Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossIncomeAOCI" roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI">
        <link:definition>9952162 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://www.stryker.com/role/Acquisitions">
        <link:definition>9952163 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesandCommitments" roleURI="http://www.stryker.com/role/ContingenciesandCommitments">
        <link:definition>9952164 - Disclosure - Contingencies and Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>9952165 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStock" roleURI="http://www.stryker.com/role/CapitalStock">
        <link:definition>9952166 - Disclosure - Capital Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilities" roleURI="http://www.stryker.com/role/DebtandCreditFacilities">
        <link:definition>9952167 - Disclosure - Debt and Credit Facilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.stryker.com/role/IncomeTaxes">
        <link:definition>9952168 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlans" roleURI="http://www.stryker.com/role/RetirementPlans">
        <link:definition>9952169 - Disclosure - Retirement Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofQuarterlyDataUnaudited" roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited">
        <link:definition>9952170 - Disclosure - Summary of Quarterly Data (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicData" roleURI="http://www.stryker.com/role/SegmentandGeographicData">
        <link:definition>9952171 - Disclosure - Segment and Geographic Data</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetImpairments" roleURI="http://www.stryker.com/role/AssetImpairments">
        <link:definition>9952172 - Disclosure - Asset Impairments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsHeldforSale" roleURI="http://www.stryker.com/role/AssetsHeldforSale">
        <link:definition>9952173 - Disclosure - Assets Held for Sale</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.stryker.com/role/SubsequentEvents">
        <link:definition>9952174 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccountsNotes" roleURI="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsNotes">
        <link:definition>9952175 - Disclosure - Schedule II Valuation and Qualifying Accounts (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.stryker.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://www.stryker.com/role/RevenueRecognitionTables">
        <link:definition>9955512 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.stryker.com/role/FairValueMeasurementsTables">
        <link:definition>9955513 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsTables" roleURI="http://www.stryker.com/role/DerivativeInstrumentsTables">
        <link:definition>9955514 - Disclosure - Derivative Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossIncomeAOCITables" roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables">
        <link:definition>9955515 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTables" roleURI="http://www.stryker.com/role/AcquisitionsTables">
        <link:definition>9955516 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesandCommitmentsTables" roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsTables">
        <link:definition>9955517 - Disclosure - Contingencies and Commitments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsTables" roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables">
        <link:definition>9955518 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockTables" roleURI="http://www.stryker.com/role/CapitalStockTables">
        <link:definition>9955519 - Disclosure - Capital Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilitiesTables" roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesTables">
        <link:definition>9955520 - Disclosure - Debt and Credit Facilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.stryker.com/role/IncomeTaxesTables">
        <link:definition>9955521 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansTables" roleURI="http://www.stryker.com/role/RetirementPlansTables">
        <link:definition>9955522 - Disclosure - Retirement Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofQuarterlyDataUnauditedTables" roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables">
        <link:definition>9955523 - Disclosure - Summary of Quarterly Data (Unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicDataTables" roleURI="http://www.stryker.com/role/SegmentandGeographicDataTables">
        <link:definition>9955524 - Disclosure - Segment and Geographic Data (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsHeldforSaleTables" roleURI="http://www.stryker.com/role/AssetsHeldforSaleTables">
        <link:definition>9955525 - Disclosure - Assets Held for Sale (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDetails" roleURI="http://www.stryker.com/role/SignificantAccountingPoliciesDetails">
        <link:definition>9955526 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionNarrativeDetails" roleURI="http://www.stryker.com/role/RevenueRecognitionNarrativeDetails">
        <link:definition>9955527 - Disclosure - Revenue Recognition - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDisaggregatedSalesAnalysisDetails" roleURI="http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails">
        <link:definition>9955528 - Disclosure - Revenue Recognition - Disaggregated Sales Analysis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionChangesinContractLiabilitiesDetails" roleURI="http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails">
        <link:definition>9955529 - Disclosure - Revenue Recognition - Changes in Contract Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" roleURI="http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails">
        <link:definition>9955530 - Disclosure - Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAvailableForSaleSecuritiesDetails" roleURI="http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails">
        <link:definition>9955531 - Disclosure - Fair Value Measurements (Available-For-Sale Securities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>9955532 - Disclosure - Fair Value Measurements (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" roleURI="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails">
        <link:definition>9955533 - Disclosure - Derivative Instruments (Forward Currency Exchange Contracts) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsNarrativeDetails" roleURI="http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails">
        <link:definition>9955534 - Disclosure - Derivative Instruments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsMovementsoutofOCIDetails" roleURI="http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails">
        <link:definition>9955535 - Disclosure - Derivative Instruments (Movements out of OCI) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails">
        <link:definition>9955536 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNarrativeDetails" roleURI="http://www.stryker.com/role/AcquisitionsNarrativeDetails">
        <link:definition>9955537 - Disclosure - Acquisitions (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" roleURI="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails">
        <link:definition>9955538 - Disclosure - Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesandCommitmentsNarrativeDetails" roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails">
        <link:definition>9955539 - Disclosure - Contingencies and Commitments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesLeaseCostDetails" roleURI="http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails">
        <link:definition>9955540 - Disclosure - Commitments and Contingencies (Lease Cost) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails" roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails">
        <link:definition>9955541 - Disclosure - Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesandCommitmentsSupplierFinanceProgramDetails" roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsSupplierFinanceProgramDetails">
        <link:definition>9955542 - Disclosure - Contingencies and Commitments (Supplier Finance Program) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsGoodwillDetails" roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails">
        <link:definition>9955543 - Disclosure - Goodwill and Other Intangible Assets (Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails">
        <link:definition>9955544 - Disclosure - Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails" roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails">
        <link:definition>9955545 - Disclosure - Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockNarrativeDetails" roleURI="http://www.stryker.com/role/CapitalStockNarrativeDetails">
        <link:definition>9955546 - Disclosure - Capital Stock (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockOptionGrantAssumptionsDetails" roleURI="http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails">
        <link:definition>9955547 - Disclosure - Capital Stock (Option Grant Assumptions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockSummaryofStockOptionActivityDetails" roleURI="http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails">
        <link:definition>9955548 - Disclosure - Capital Stock (Summary of Stock Option Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockSummaryofRSUandPSUActivityDetails" roleURI="http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails">
        <link:definition>9955549 - Disclosure - Capital Stock (Summary of RSU and PSU Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilitiesNarrativeDetails" roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails">
        <link:definition>9955550 - Disclosure - Debt and Credit Facilities (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails">
        <link:definition>9955551 - Disclosure - Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1" roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1">
        <link:definition>9955551 - Disclosure - Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.stryker.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>9955552 - Disclosure - Income Taxes (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails">
        <link:definition>9955553 - Disclosure - Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails">
        <link:definition>9955554 - Disclosure - Income Taxes (Schedule of Earnings before Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails">
        <link:definition>9955555 - Disclosure - Income Taxes (Schedule of Provision for Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails">
        <link:definition>9955556 - Disclosure - Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1">
        <link:definition>9955556 - Disclosure - Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails">
        <link:definition>9955557 - Disclosure - Income Taxes (Schedule of Unresolved Income Tax Positions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails" roleURI="http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails">
        <link:definition>9955558 - Disclosure - Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" roleURI="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails">
        <link:definition>9955559 - Disclosure - Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansScheduleofChangeinBenefitObligationsDetails" roleURI="http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails">
        <link:definition>9955560 - Disclosure - Retirement Plans (Schedule of Change in Benefit Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansChangeinPlanAssetsDetails" roleURI="http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails">
        <link:definition>9955561 - Disclosure - Retirement Plans (Change in Plan Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails" roleURI="http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails">
        <link:definition>9955562 - Disclosure - Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails" roleURI="http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails">
        <link:definition>9955563 - Disclosure - Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansNarrativeDetails" roleURI="http://www.stryker.com/role/RetirementPlansNarrativeDetails">
        <link:definition>9955564 - Disclosure - Retirement Plans (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansExpectedBenefitPaymentsDetails" roleURI="http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails">
        <link:definition>9955565 - Disclosure - Retirement Plans (Expected Benefit Payments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofQuarterlyDataUnauditedDetails" roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails">
        <link:definition>9955566 - Disclosure - Summary of Quarterly Data (Unaudited) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails" roleURI="http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails">
        <link:definition>9955567 - Disclosure - Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicDataSegmentInformationDetails" roleURI="http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails">
        <link:definition>9955568 - Disclosure - Segment and Geographic Data (Segment Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails" roleURI="http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails">
        <link:definition>9955569 - Disclosure - Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetImpairmentsDetails" roleURI="http://www.stryker.com/role/AssetImpairmentsDetails">
        <link:definition>9955570 - Disclosure - Asset Impairments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsHeldforSaleDetails" roleURI="http://www.stryker.com/role/AssetsHeldforSaleDetails">
        <link:definition>9955571 - Disclosure - Assets Held for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.stryker.com/role/SubsequentEventsDetails">
        <link:definition>9955572 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccountsDetails" roleURI="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails">
        <link:definition>9955573 - Disclosure - Schedule II Valuation and Qualifying Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="syk_SeniorUnsecuredNotes2.125Due2027Member" abstract="true" name="SeniorUnsecuredNotes2.125Due2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes3375Due2028Member" abstract="true" name="SeniorUnsecuredNotes3375Due2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes0.750due2029Member" abstract="true" name="SeniorUnsecuredNotes0.750due2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes2.625Due2030Member" abstract="true" name="SeniorUnsecuredNotes2.625Due2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes1.000due2031Member" abstract="true" name="SeniorUnsecuredNotes1.000due2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes3.375Due2032Member" abstract="true" name="SeniorUnsecuredNotes3.375Due2032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes3.625Due2036Member" abstract="true" name="SeniorUnsecuredNotes3.625Due2036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="syk_LandBuildingsAndImprovementsGross" abstract="false" name="LandBuildingsAndImprovementsGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_InventorySteppedUpToFairValueAtAcquisition" abstract="false" name="InventorySteppedUpToFairValueAtAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" abstract="true" name="ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="syk_CapitalStockAbstract" abstract="true" name="CapitalStockAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="syk_ShortTermInvestmentsPolicyPolicyTextBlock" abstract="false" name="ShortTermInvestmentsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" abstract="false" name="GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock" abstract="false" name="AssetsAndLiabilitiesHeldForSalePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="syk_PerformanceStockUnitPsusMember" abstract="true" name="PerformanceStockUnitPsusMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="syk_NeuroCranialInterventionalSpineMember" abstract="true" name="NeuroCranialInterventionalSpineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_OtherOrthopedicsEnablingTechnologiesMember" abstract="true" name="OtherOrthopedicsEnablingTechnologiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_PercentageofServiceRevenueRecognizeoverTime" abstract="false" name="PercentageofServiceRevenueRecognizeoverTime" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="syk_MedSurgAndNeurotechnologyMember" abstract="true" name="MedSurgAndNeurotechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_OrthopaedicsAndSpineMember" abstract="true" name="OrthopaedicsAndSpineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_InstrumentsMember" abstract="true" name="InstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_EndoscopyMember" abstract="true" name="EndoscopyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_MedicalMember" abstract="true" name="MedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_NeurovascularMember" abstract="true" name="NeurovascularMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_NeuroCranialMember" abstract="true" name="NeuroCranialMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_OtherOrthopaedicsMember" abstract="true" name="OtherOrthopaedicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_KneesMember" abstract="true" name="KneesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_HipsMember" abstract="true" name="HipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_TraumaandExtremitiesMember" abstract="true" name="TraumaandExtremitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SpineMember" abstract="true" name="SpineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_MovementInContractLiabilitiesRollForward" abstract="true" name="MovementInContractLiabilitiesRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" abstract="false" name="ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" abstract="false" name="FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" abstract="false" name="AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_CerusMember" abstract="true" name="CerusMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_OtherIncomeexpenseMember" abstract="true" name="OtherIncomeexpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_VariousMember" abstract="true" name="VariousMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_CustomerAndDistributorRelationshipsMember" abstract="true" name="CustomerAndDistributorRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_RecallMattersMember" abstract="true" name="RecallMattersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SpineReportingUnitMember" abstract="true" name="SpineReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_OrthopaedicsMember" abstract="true" name="OrthopaedicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SpinalImplantsMember" abstract="true" name="SpinalImplantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_CommonAndPreferredStockSharesAuthorized" abstract="false" name="CommonAndPreferredStockSharesAuthorized" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" abstract="false" name="PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="syk_FloatingRateSeniorNotesDueNovember162024Member" abstract="true" name="FloatingRateSeniorNotesDueNovember162024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes4.850Due2028Member" abstract="true" name="SeniorUnsecuredNotes4.850Due2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes4.250Due2029Member" abstract="true" name="SeniorUnsecuredNotes4.250Due2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes0.250Due2024Member" abstract="true" name="SeniorUnsecuredNotes0.250Due2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes3.375DueMay152024Member" abstract="true" name="SeniorUnsecuredNotes3.375DueMay152024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes3.375Due2025Member" abstract="true" name="SeniorUnsecuredNotes3.375Due2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes4625Due2046Member" abstract="true" name="SeniorUnsecuredNotes4625Due2046Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes1.150Due2025Member" abstract="true" name="SeniorUnsecuredNotes1.150Due2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes3.500Due2026Member" abstract="true" name="SeniorUnsecuredNotes3.500Due2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes2.125DueNovember2027Member" abstract="true" name="SeniorUnsecuredNotes2.125DueNovember2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes3.650Due2028Member" abstract="true" name="SeniorUnsecuredNotes3.650Due2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes1.950Due2030Member" abstract="true" name="SeniorUnsecuredNotes1.950Due2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes4.625DueSeptember112034Member" abstract="true" name="SeniorUnsecuredNotes4.625DueSeptember112034Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes4.100Due2043Member" abstract="true" name="SeniorUnsecuredNotes4.100Due2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes4.375due2044Member" abstract="true" name="SeniorUnsecuredNotes4.375due2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes2.900due2050Member" abstract="true" name="SeniorUnsecuredNotes2.900due2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" abstract="false" name="IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_OperatingLossCarryforwardsSubjectToValuationAllowance" abstract="false" name="OperatingLossCarryforwardsSubjectToValuationAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" abstract="false" name="IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference" abstract="false" name="EffectiveIncomeTaxRateReconciliationOutsideBasisDifference" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="syk_DeferredTaxAssetsDepreciationAndAmortization" abstract="false" name="DeferredTaxAssetsDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization" abstract="false" name="DeferredTaxAssetsResearchAndDevelopmentCapitalization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_DeferredTaxAssetsOutsideBasisDifference" abstract="false" name="DeferredTaxAssetsOutsideBasisDifference" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_DeferredTaxLiabilitiesDepreciationAndAmortization" abstract="false" name="DeferredTaxLiabilitiesDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" abstract="false" name="DefinedContributionRetirementPlansCommonStockValueHeldByCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" abstract="false" name="DefinedContributionRetirementPlansCommonStockHeldByCompany" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" abstract="false" name="TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" abstract="false" name="DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" abstract="false" name="WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="syk_AccruedCompensationMember" abstract="true" name="AccruedCompensationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_MedicalDeviceRegulationsExpense" abstract="false" name="MedicalDeviceRegulationsExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_RejuvenateABGIIHipRecallCharges" abstract="false" name="RejuvenateABGIIHipRecallCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_CapitalExpendituresDuringPeriod" abstract="false" name="CapitalExpendituresDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_OtherForeignCountriesMember" abstract="true" name="OtherForeignCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_LongLivedAssetsAndIntangibleAssetsMember" abstract="true" name="LongLivedAssetsAndIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_InariMedicalInc.MergerMember" abstract="true" name="InariMedicalInc.MergerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes4.550DueFebruary102027Member" abstract="true" name="SeniorUnsecuredNotes4.550DueFebruary102027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes4.700DueFebruary102028Member" abstract="true" name="SeniorUnsecuredNotes4.700DueFebruary102028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes4.850DueFebruary102030Member" abstract="true" name="SeniorUnsecuredNotes4.850DueFebruary102030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes5.200DueFebruary282035Member" abstract="true" name="SeniorUnsecuredNotes5.200DueFebruary282035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>17
<FILENAME>syk-20241231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:66138c84-a1f4-4bd1-9e3f-a7dda17467bc,g:664b5418-33ef-4591-a7dd-ebf51b747252-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfEarnings" xlink:type="simple" xlink:href="syk-20241231.xsd#ConsolidatedStatementsOfEarnings"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b289d130-d201-4485-a1e4-a1e98f3a25ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_763d2f25-49a1-48f2-bc52-faabea2e55bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b289d130-d201-4485-a1e4-a1e98f3a25ff" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_763d2f25-49a1-48f2-bc52-faabea2e55bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dc114382-9a20-4150-a126-a30ddedd6e78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b289d130-d201-4485-a1e4-a1e98f3a25ff" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dc114382-9a20-4150-a126-a30ddedd6e78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_38adf84a-6822-4d93-9150-95fb8784bb92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ef674ac8-8969-41ad-861a-c58ff294e394" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_38adf84a-6822-4d93-9150-95fb8784bb92" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ef674ac8-8969-41ad-861a-c58ff294e394" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_498034aa-95b6-4a5e-83d4-9e0b62fc3ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_38adf84a-6822-4d93-9150-95fb8784bb92" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_498034aa-95b6-4a5e-83d4-9e0b62fc3ca3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_9b36878c-abf3-4d9f-9ded-5c93ea9b1500" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_38adf84a-6822-4d93-9150-95fb8784bb92" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_9b36878c-abf3-4d9f-9ded-5c93ea9b1500" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_4a6b1372-9419-479f-bc76-21a458f205dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_38adf84a-6822-4d93-9150-95fb8784bb92" xlink:to="loc_us-gaap_AssetImpairmentCharges_4a6b1372-9419-479f-bc76-21a458f205dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_21b7b4fd-ec5b-4b6f-af18-634aa9e88f30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3db74008-f46b-405b-ab54-7ac1d649e0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_21b7b4fd-ec5b-4b6f-af18-634aa9e88f30" xlink:to="loc_us-gaap_Revenues_3db74008-f46b-405b-ab54-7ac1d649e0b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_0b0211ce-f7b6-499e-873c-da78f64ab593" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_21b7b4fd-ec5b-4b6f-af18-634aa9e88f30" xlink:to="loc_us-gaap_CostOfRevenue_0b0211ce-f7b6-499e-873c-da78f64ab593" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a7a64dec-295b-4231-814f-15336823ba22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_46409d3b-ee98-46c2-8719-ee84064e6df5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a7a64dec-295b-4231-814f-15336823ba22" xlink:to="loc_us-gaap_GrossProfit_46409d3b-ee98-46c2-8719-ee84064e6df5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_3bc66dd8-ebc2-4e1e-b514-1b413512e3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a7a64dec-295b-4231-814f-15336823ba22" xlink:to="loc_us-gaap_OperatingExpenses_3bc66dd8-ebc2-4e1e-b514-1b413512e3c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_49bcdfb1-acb8-48cd-b15e-57ccfdb28604" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_be51e11d-4650-4bb6-b7f5-616a73a70ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_49bcdfb1-acb8-48cd-b15e-57ccfdb28604" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_be51e11d-4650-4bb6-b7f5-616a73a70ec3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_125cba60-c109-4183-aa9e-738bc43d0824" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_49bcdfb1-acb8-48cd-b15e-57ccfdb28604" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_125cba60-c109-4183-aa9e-738bc43d0824" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f6282225-bab3-4810-a4e2-1af806a9e0cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_90659053-0249-4502-a410-eaf754f77ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f6282225-bab3-4810-a4e2-1af806a9e0cd" xlink:to="loc_us-gaap_OperatingIncomeLoss_90659053-0249-4502-a410-eaf754f77ff3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_68bb00f9-0a7f-4755-81ab-0281801ce7db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f6282225-bab3-4810-a4e2-1af806a9e0cd" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_68bb00f9-0a7f-4755-81ab-0281801ce7db" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="syk-20241231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e8ae33ec-dc05-40c3-95aa-a4151394a368" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f51c4e7f-1e61-40fb-a8f4-0f21bbc87cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e8ae33ec-dc05-40c3-95aa-a4151394a368" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f51c4e7f-1e61-40fb-a8f4-0f21bbc87cc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_fe4c6e08-cb64-4cf9-80bc-16792d4fad40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e8ae33ec-dc05-40c3-95aa-a4151394a368" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_fe4c6e08-cb64-4cf9-80bc-16792d4fad40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_fc8377c1-458f-4cbc-9f95-09e3410190be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e8ae33ec-dc05-40c3-95aa-a4151394a368" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_fc8377c1-458f-4cbc-9f95-09e3410190be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c6f31447-b1e3-4216-9ab2-40163a344649" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e8ae33ec-dc05-40c3-95aa-a4151394a368" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c6f31447-b1e3-4216-9ab2-40163a344649" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5be3ad54-310c-4437-83b8-57e0054c9a65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_42eaa918-51d3-4225-b3b4-5f5b3424c3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5be3ad54-310c-4437-83b8-57e0054c9a65" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_42eaa918-51d3-4225-b3b4-5f5b3424c3b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9ce93aba-701f-4e40-a853-41975ecdee25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5be3ad54-310c-4437-83b8-57e0054c9a65" xlink:to="loc_us-gaap_NetIncomeLoss_9ce93aba-701f-4e40-a853-41975ecdee25" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="syk-20241231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0424d1f9-2885-4adc-b3b0-47e578542319" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_04b86d3d-8694-48ec-8963-15ee1ccddb61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0424d1f9-2885-4adc-b3b0-47e578542319" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_04b86d3d-8694-48ec-8963-15ee1ccddb61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_d2de04db-eb6b-4e8f-83de-f1128881c18c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0424d1f9-2885-4adc-b3b0-47e578542319" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_d2de04db-eb6b-4e8f-83de-f1128881c18c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_f21c884d-fbe6-4c14-b1d6-0e17b6cf77c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0424d1f9-2885-4adc-b3b0-47e578542319" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_f21c884d-fbe6-4c14-b1d6-0e17b6cf77c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9c45d4a4-7eeb-4429-9cc3-352630b7e442" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_e125a7c5-93f3-4eff-8efa-3e4a8505e587" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_9c45d4a4-7eeb-4429-9cc3-352630b7e442" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_e125a7c5-93f3-4eff-8efa-3e4a8505e587" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LandBuildingsAndImprovementsGross_699853e8-7bb9-4a8e-8180-69bebc593e80" xlink:href="syk-20241231.xsd#syk_LandBuildingsAndImprovementsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_9c45d4a4-7eeb-4429-9cc3-352630b7e442" xlink:to="loc_syk_LandBuildingsAndImprovementsGross_699853e8-7bb9-4a8e-8180-69bebc593e80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c5ba551a-383a-41b2-87e0-c6741ef24511" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0c78fa60-3660-4ba3-bb9f-5ec21f40d146" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_c5ba551a-383a-41b2-87e0-c6741ef24511" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_0c78fa60-3660-4ba3-bb9f-5ec21f40d146" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3f36a887-b5ee-4b24-b0aa-d8f222c09ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_c5ba551a-383a-41b2-87e0-c6741ef24511" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3f36a887-b5ee-4b24-b0aa-d8f222c09ea3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b61f14be-27d9-4ca5-a0ad-2a0886c266bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_204cf1b6-8eaa-4cb4-adb0-4d08c937e1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b61f14be-27d9-4ca5-a0ad-2a0886c266bf" xlink:to="loc_us-gaap_DebtCurrent_204cf1b6-8eaa-4cb4-adb0-4d08c937e1c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_39825d8d-30ff-41c6-883c-b5691ebf2023" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b61f14be-27d9-4ca5-a0ad-2a0886c266bf" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_39825d8d-30ff-41c6-883c-b5691ebf2023" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_bff12bbb-7f58-4edf-a987-0e0e96dd4aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b61f14be-27d9-4ca5-a0ad-2a0886c266bf" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_bff12bbb-7f58-4edf-a987-0e0e96dd4aa4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_e4a281f4-047c-435b-995f-2ae1ed90d838" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b61f14be-27d9-4ca5-a0ad-2a0886c266bf" xlink:to="loc_us-gaap_DividendsPayableCurrent_e4a281f4-047c-435b-995f-2ae1ed90d838" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_44322fc0-dbf7-4457-90ab-312191da7528" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b61f14be-27d9-4ca5-a0ad-2a0886c266bf" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_44322fc0-dbf7-4457-90ab-312191da7528" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_02d20067-5d90-4922-987a-49474cb96134" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b61f14be-27d9-4ca5-a0ad-2a0886c266bf" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_02d20067-5d90-4922-987a-49474cb96134" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6c0f6185-f7b0-484b-82e7-7ace3ea8539f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_188f0550-fea4-4504-a230-170d7fdfc55d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c0f6185-f7b0-484b-82e7-7ace3ea8539f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_188f0550-fea4-4504-a230-170d7fdfc55d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b341ad8f-96c4-45be-8512-87b3e1991468" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c0f6185-f7b0-484b-82e7-7ace3ea8539f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b341ad8f-96c4-45be-8512-87b3e1991468" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8335082c-ca02-4168-88e0-c07460324df9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c0f6185-f7b0-484b-82e7-7ace3ea8539f" xlink:to="loc_us-gaap_InventoryNet_8335082c-ca02-4168-88e0-c07460324df9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_26fbc6e6-4282-48c0-a688-69b37082399e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c0f6185-f7b0-484b-82e7-7ace3ea8539f" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_26fbc6e6-4282-48c0-a688-69b37082399e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e96607f2-f680-4fbd-8cb6-eb152b01aa3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c0f6185-f7b0-484b-82e7-7ace3ea8539f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e96607f2-f680-4fbd-8cb6-eb152b01aa3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermInvestments_21988d6b-abfb-46f8-9be9-87dc989a0862" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherShortTermInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c0f6185-f7b0-484b-82e7-7ace3ea8539f" xlink:to="loc_us-gaap_OtherShortTermInvestments_21988d6b-abfb-46f8-9be9-87dc989a0862" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_87523e48-f3c3-4c27-80a9-1ee4447b331d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_81e281e7-0f0b-4e13-9494-6d2a4df5d735" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_87523e48-f3c3-4c27-80a9-1ee4447b331d" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_81e281e7-0f0b-4e13-9494-6d2a4df5d735" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cedeb3d2-f6db-446a-8e6f-112d06909573" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_87523e48-f3c3-4c27-80a9-1ee4447b331d" xlink:to="loc_us-gaap_AssetsCurrent_cedeb3d2-f6db-446a-8e6f-112d06909573" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_221186bd-6320-410c-8745-0d9c649cd61f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_87523e48-f3c3-4c27-80a9-1ee4447b331d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_221186bd-6320-410c-8745-0d9c649cd61f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_967f8423-0009-413f-aa4c-72cbfb3325ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_87523e48-f3c3-4c27-80a9-1ee4447b331d" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_967f8423-0009-413f-aa4c-72cbfb3325ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1cbed659-a569-4297-881b-e65774ad8a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_87523e48-f3c3-4c27-80a9-1ee4447b331d" xlink:to="loc_us-gaap_Goodwill_1cbed659-a569-4297-881b-e65774ad8a0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_099980d5-43ff-413a-a4a0-153f00cb0920" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_87523e48-f3c3-4c27-80a9-1ee4447b331d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_099980d5-43ff-413a-a4a0-153f00cb0920" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_287b51dd-3198-408f-acd5-2b4146056a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_65aa3fa5-3793-4f22-98d8-965ea2933cab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_287b51dd-3198-408f-acd5-2b4146056a1c" xlink:to="loc_us-gaap_LiabilitiesCurrent_65aa3fa5-3793-4f22-98d8-965ea2933cab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_153f3a65-a037-4e5e-8f7b-7aebf3399755" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_287b51dd-3198-408f-acd5-2b4146056a1c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_153f3a65-a037-4e5e-8f7b-7aebf3399755" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_243d9810-8b75-495c-b2ea-74f8215865ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_287b51dd-3198-408f-acd5-2b4146056a1c" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_243d9810-8b75-495c-b2ea-74f8215865ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e73bc139-3696-468d-a77f-ffebfd2a9b03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_287b51dd-3198-408f-acd5-2b4146056a1c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e73bc139-3696-468d-a77f-ffebfd2a9b03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a16447ea-4baa-4b37-8ab6-c1b02d2ddd78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_fa136bbe-dada-403d-a05a-28a68b331d14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a16447ea-4baa-4b37-8ab6-c1b02d2ddd78" xlink:to="loc_us-gaap_Liabilities_fa136bbe-dada-403d-a05a-28a68b331d14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f9e45f8f-8e70-4b8f-8809-c9aadcf6d7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a16447ea-4baa-4b37-8ab6-c1b02d2ddd78" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f9e45f8f-8e70-4b8f-8809-c9aadcf6d7f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_27945688-24f3-412b-b25b-a040215485b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_e3f5835e-e304-4a57-8027-64eca0f25c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_27945688-24f3-412b-b25b-a040215485b9" xlink:to="loc_us-gaap_CommonStockValueOutstanding_e3f5835e-e304-4a57-8027-64eca0f25c8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_07028dce-3951-41da-964f-b75aa396677b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_27945688-24f3-412b-b25b-a040215485b9" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_07028dce-3951-41da-964f-b75aa396677b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f9a7e0e4-87a3-4746-bc06-a1d57921ba1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_27945688-24f3-412b-b25b-a040215485b9" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f9a7e0e4-87a3-4746-bc06-a1d57921ba1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f3792c7c-1cd6-4f74-a86d-0118a9cb4a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_27945688-24f3-412b-b25b-a040215485b9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f3792c7c-1cd6-4f74-a86d-0118a9cb4a7f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="syk-20241231.xsd#ConsolidatedStatementsOfCashFlows"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3acf38f1-e23c-4893-91ae-031f939898fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5bf32b2b-5c42-427c-9ae4-82c34105da8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3acf38f1-e23c-4893-91ae-031f939898fb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5bf32b2b-5c42-427c-9ae4-82c34105da8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_4669e614-a716-4f57-84b4-0dc26f802ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3acf38f1-e23c-4893-91ae-031f939898fb" xlink:to="loc_us-gaap_AdjustmentForAmortization_4669e614-a716-4f57-84b4-0dc26f802ab6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_0936e15a-2f64-4a8c-831c-66c9080e3f01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3acf38f1-e23c-4893-91ae-031f939898fb" xlink:to="loc_us-gaap_ShareBasedCompensation_0936e15a-2f64-4a8c-831c-66c9080e3f01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c3977746-c2b3-41cb-8150-391ae5fe07ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3acf38f1-e23c-4893-91ae-031f939898fb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c3977746-c2b3-41cb-8150-391ae5fe07ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_81deb2f8-71da-4f43-8e4c-1b4b5db5b400" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3acf38f1-e23c-4893-91ae-031f939898fb" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_81deb2f8-71da-4f43-8e4c-1b4b5db5b400" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_b6440aa3-f488-482b-92ca-3f5ba02cfe15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3acf38f1-e23c-4893-91ae-031f939898fb" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_b6440aa3-f488-482b-92ca-3f5ba02cfe15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1fb1dbd8-780b-4833-95fd-0efef9ebeb04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3acf38f1-e23c-4893-91ae-031f939898fb" xlink:to="loc_us-gaap_Depreciation_1fb1dbd8-780b-4833-95fd-0efef9ebeb04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_e34819f3-b6da-4b52-bb7e-c0753b6a122a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3acf38f1-e23c-4893-91ae-031f939898fb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_e34819f3-b6da-4b52-bb7e-c0753b6a122a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_afd8a909-3edc-41e0-9d64-9c2624a4c52a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3acf38f1-e23c-4893-91ae-031f939898fb" xlink:to="loc_us-gaap_NetIncomeLoss_afd8a909-3edc-41e0-9d64-9c2624a4c52a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_83202624-ef8f-404d-a5bc-d3fdc79d2d37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3acf38f1-e23c-4893-91ae-031f939898fb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_83202624-ef8f-404d-a5bc-d3fdc79d2d37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_eb240cff-dbd1-4808-a7aa-f5640c552d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3acf38f1-e23c-4893-91ae-031f939898fb" xlink:to="loc_us-gaap_AssetImpairmentCharges_eb240cff-dbd1-4808-a7aa-f5640c552d7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e4d81734-28f5-4a8b-8d6b-86af56544794" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3acf38f1-e23c-4893-91ae-031f939898fb" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e4d81734-28f5-4a8b-8d6b-86af56544794" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InventorySteppedUpToFairValueAtAcquisition_85317ad0-2944-4f8d-ad24-3fbed20bd0ee" xlink:href="syk-20241231.xsd#syk_InventorySteppedUpToFairValueAtAcquisition"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3acf38f1-e23c-4893-91ae-031f939898fb" xlink:to="loc_syk_InventorySteppedUpToFairValueAtAcquisition_85317ad0-2944-4f8d-ad24-3fbed20bd0ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72a5b4bf-4903-4986-8971-98bd629b3cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_11f92d0d-87f6-476e-a0cc-f06ce9f9af5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72a5b4bf-4903-4986-8971-98bd629b3cfa" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_11f92d0d-87f6-476e-a0cc-f06ce9f9af5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_1534c214-cd5a-4d27-9e13-94e769e2e666" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72a5b4bf-4903-4986-8971-98bd629b3cfa" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_1534c214-cd5a-4d27-9e13-94e769e2e666" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_38958dbb-9015-4a8f-9124-f4ff1f15c364" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72a5b4bf-4903-4986-8971-98bd629b3cfa" xlink:to="loc_us-gaap_PaymentsOfDividends_38958dbb-9015-4a8f-9124-f4ff1f15c364" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ca530744-858d-4446-b60d-b31f6fa1b729" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72a5b4bf-4903-4986-8971-98bd629b3cfa" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ca530744-858d-4446-b60d-b31f6fa1b729" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_4ea30a86-6498-48ca-96dc-69111d0e0829" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72a5b4bf-4903-4986-8971-98bd629b3cfa" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_4ea30a86-6498-48ca-96dc-69111d0e0829" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_86a6962f-01c7-4b40-9e5c-fa5872c9a55e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72a5b4bf-4903-4986-8971-98bd629b3cfa" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_86a6962f-01c7-4b40-9e5c-fa5872c9a55e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5c593638-9204-40e8-a45d-3f2e23e9afbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d469847f-53d1-4c8f-9c75-defbba700b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5c593638-9204-40e8-a45d-3f2e23e9afbf" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d469847f-53d1-4c8f-9c75-defbba700b8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_2ba9c4cc-7aed-44ea-b955-253667215df0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5c593638-9204-40e8-a45d-3f2e23e9afbf" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_2ba9c4cc-7aed-44ea-b955-253667215df0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_233671d3-52a9-4826-bfa1-18c924a6151f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5c593638-9204-40e8-a45d-3f2e23e9afbf" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_233671d3-52a9-4826-bfa1-18c924a6151f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0315e618-f827-4742-a694-d0b8868cd77a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5c593638-9204-40e8-a45d-3f2e23e9afbf" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0315e618-f827-4742-a694-d0b8868cd77a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3dc5c0cb-8fc8-4213-bbd2-1958adcbd30e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5c593638-9204-40e8-a45d-3f2e23e9afbf" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3dc5c0cb-8fc8-4213-bbd2-1958adcbd30e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_319feadb-873a-4dfc-9592-2c569db7bfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5c593638-9204-40e8-a45d-3f2e23e9afbf" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_319feadb-873a-4dfc-9592-2c569db7bfb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_458835d3-ba26-4fe6-bd7c-16cf669a61bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5c593638-9204-40e8-a45d-3f2e23e9afbf" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_458835d3-ba26-4fe6-bd7c-16cf669a61bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_89557c41-9fcf-4009-b975-c9ec5c44ae5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_de642f7c-64a9-4878-a109-aef4e5b02bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_89557c41-9fcf-4009-b975-c9ec5c44ae5c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_de642f7c-64a9-4878-a109-aef4e5b02bb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f82dc47d-ea5f-4f23-938b-48f9b46a1e41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_89557c41-9fcf-4009-b975-c9ec5c44ae5c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f82dc47d-ea5f-4f23-938b-48f9b46a1e41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c1957d32-46b7-4797-abe7-b511f5de2c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_89557c41-9fcf-4009-b975-c9ec5c44ae5c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c1957d32-46b7-4797-abe7-b511f5de2c6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_76edb1b3-7270-4f57-b811-d85293be252b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_89557c41-9fcf-4009-b975-c9ec5c44ae5c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_76edb1b3-7270-4f57-b811-d85293be252b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_66c04726-623c-4d04-8ce2-34e35dd9ed97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ed86d703-666b-46dd-b51b-ac87ac9a1532" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet_66c04726-623c-4d04-8ce2-34e35dd9ed97" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ed86d703-666b-46dd-b51b-ac87ac9a1532" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e170636e-efaa-43d4-b1b3-e7ebf70d4dab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet_66c04726-623c-4d04-8ce2-34e35dd9ed97" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e170636e-efaa-43d4-b1b3-e7ebf70d4dab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f33f36f1-b104-4202-ab56-02fd72bcd46f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_60de5eed-fe4e-4ce4-b33b-f62508464c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f33f36f1-b104-4202-ab56-02fd72bcd46f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_60de5eed-fe4e-4ce4-b33b-f62508464c5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_98623fdf-f238-46c2-b4ee-c5efde7cdac6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f33f36f1-b104-4202-ab56-02fd72bcd46f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_98623fdf-f238-46c2-b4ee-c5efde7cdac6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_720a4ea1-1624-4b82-bf5d-41fd8e1472d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f33f36f1-b104-4202-ab56-02fd72bcd46f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_720a4ea1-1624-4b82-bf5d-41fd8e1472d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_012ff1c4-5d95-453b-a618-45bbe732603f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f33f36f1-b104-4202-ab56-02fd72bcd46f" xlink:to="loc_us-gaap_Goodwill_012ff1c4-5d95-453b-a618-45bbe732603f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_31b0ea2a-0fbe-498c-87ff-2ca994a37db6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f33f36f1-b104-4202-ab56-02fd72bcd46f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_31b0ea2a-0fbe-498c-87ff-2ca994a37db6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_0a86f95f-3f4d-48c7-afb0-2a9cf9c1071b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f33f36f1-b104-4202-ab56-02fd72bcd46f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_0a86f95f-3f4d-48c7-afb0-2a9cf9c1071b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_a3e5e50e-cbb6-4eb3-bb12-0703e00f839a" xlink:href="syk-20241231.xsd#syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f33f36f1-b104-4202-ab56-02fd72bcd46f" xlink:to="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_a3e5e50e-cbb6-4eb3-bb12-0703e00f839a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_41e0a599-6ab4-4aa9-89a1-11517849f804" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f33f36f1-b104-4202-ab56-02fd72bcd46f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_41e0a599-6ab4-4aa9-89a1-11517849f804" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_465e166c-6dad-4f3b-81e5-aa11471cb691" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f33f36f1-b104-4202-ab56-02fd72bcd46f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_465e166c-6dad-4f3b-81e5-aa11471cb691" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b19ca55f-d383-4fdd-8730-e4e6b0812f67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7bfb6491-23ef-4e02-82d6-3ba2f5901a45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b19ca55f-d383-4fdd-8730-e4e6b0812f67" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7bfb6491-23ef-4e02-82d6-3ba2f5901a45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0729f13e-1169-4c6d-9d5b-851a1bd3c9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b19ca55f-d383-4fdd-8730-e4e6b0812f67" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0729f13e-1169-4c6d-9d5b-851a1bd3c9aa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_23163eeb-ff81-400f-a757-8deaeb8e731b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_9588820d-517d-4610-97f2-8c9f74d7f4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_23163eeb-ff81-400f-a757-8deaeb8e731b" xlink:to="loc_us-gaap_UnsecuredDebt_9588820d-517d-4610-97f2-8c9f74d7f4f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_172dc0a9-da7d-4ebe-8d75-995508b3d4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_23163eeb-ff81-400f-a757-8deaeb8e731b" xlink:to="loc_us-gaap_OtherLongTermDebt_172dc0a9-da7d-4ebe-8d75-995508b3d4fb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1" xlink:type="simple" xlink:href="syk-20241231.xsd#DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_49a60417-3121-4df8-b695-ab5c27403cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_045ec086-e65f-4fde-bcbf-b44f8b385e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_49a60417-3121-4df8-b695-ab5c27403cfe" xlink:to="loc_us-gaap_DebtCurrent_045ec086-e65f-4fde-bcbf-b44f8b385e0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e514ebd2-c968-490c-8f9f-50204f1327b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_49a60417-3121-4df8-b695-ab5c27403cfe" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e514ebd2-c968-490c-8f9f-50204f1327b0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e79ebcfb-687d-43d4-a471-9922a9aba42a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_39b15902-d0ff-4b52-bc32-04ce32f3fe25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e79ebcfb-687d-43d4-a471-9922a9aba42a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_39b15902-d0ff-4b52-bc32-04ce32f3fe25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_38a07b2b-399b-468a-9aeb-51c9ca82c2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e79ebcfb-687d-43d4-a471-9922a9aba42a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_38a07b2b-399b-468a-9aeb-51c9ca82c2b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_ed1795c2-786f-4396-b06d-bed1f1d37ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e79ebcfb-687d-43d4-a471-9922a9aba42a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_ed1795c2-786f-4396-b06d-bed1f1d37ea4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_14af964b-63e9-4268-a140-84e373657c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e79ebcfb-687d-43d4-a471-9922a9aba42a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_14af964b-63e9-4268-a140-84e373657c5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_6a6e695e-58b1-4100-8187-8aaa5a25ce9b" xlink:href="syk-20241231.xsd#syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e79ebcfb-687d-43d4-a471-9922a9aba42a" xlink:to="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_6a6e695e-58b1-4100-8187-8aaa5a25ce9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_436a8128-05fc-4ce1-a053-525ceb304d7a" xlink:href="syk-20241231.xsd#syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e79ebcfb-687d-43d4-a471-9922a9aba42a" xlink:to="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_436a8128-05fc-4ce1-a053-525ceb304d7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0cf6018c-616c-4dda-ad3a-a79751f2171e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e79ebcfb-687d-43d4-a471-9922a9aba42a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0cf6018c-616c-4dda-ad3a-a79751f2171e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference_8bc7433d-1697-4ea6-9e35-bae9c14874ce" xlink:href="syk-20241231.xsd#syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e79ebcfb-687d-43d4-a471-9922a9aba42a" xlink:to="loc_syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference_8bc7433d-1697-4ea6-9e35-bae9c14874ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_03944447-8aa8-422d-b2b8-5ab8030b2c81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e79ebcfb-687d-43d4-a471-9922a9aba42a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_03944447-8aa8-422d-b2b8-5ab8030b2c81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1aeda9a3-3dd5-45e0-8c4a-db5a7876d8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e79ebcfb-687d-43d4-a471-9922a9aba42a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1aeda9a3-3dd5-45e0-8c4a-db5a7876d8a4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af9fe5c2-9edc-4218-8258-632f3441bfd3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_f86fe875-4bc1-485d-b6d9-c09b979033b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af9fe5c2-9edc-4218-8258-632f3441bfd3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_f86fe875-4bc1-485d-b6d9-c09b979033b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_59d3fe83-ae28-44ff-9c71-eaa26a0f9a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af9fe5c2-9edc-4218-8258-632f3441bfd3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_59d3fe83-ae28-44ff-9c71-eaa26a0f9a9d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c578967a-b809-4f14-8185-566d4b00b5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_e5a906a7-fa1c-4c1f-bd53-b23dfcea592e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c578967a-b809-4f14-8185-566d4b00b5f7" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_e5a906a7-fa1c-4c1f-bd53-b23dfcea592e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_06cb0bf6-9a0f-4691-a887-28477af3396b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c578967a-b809-4f14-8185-566d4b00b5f7" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_06cb0bf6-9a0f-4691-a887-28477af3396b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_8a532949-7d03-4e0d-856f-3fa0e4cf308f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c578967a-b809-4f14-8185-566d4b00b5f7" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_8a532949-7d03-4e0d-856f-3fa0e4cf308f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c578b357-7d28-4b81-b3df-f98c219bd586" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_01826501-90d0-46bf-857e-9bc259c9a41a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c578b357-7d28-4b81-b3df-f98c219bd586" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_01826501-90d0-46bf-857e-9bc259c9a41a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_5c083196-2dbe-48f2-8940-7edddf9eac7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c578b357-7d28-4b81-b3df-f98c219bd586" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_5c083196-2dbe-48f2-8940-7edddf9eac7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_18a520ee-c121-4ce8-9f9c-2a0fb0b238b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c578b357-7d28-4b81-b3df-f98c219bd586" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_18a520ee-c121-4ce8-9f9c-2a0fb0b238b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2808715f-2d07-4569-842c-7b3ceab33435" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e72e3931-9500-4218-96ce-935eb576c16e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_2808715f-2d07-4569-842c-7b3ceab33435" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e72e3931-9500-4218-96ce-935eb576c16e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d3797d7a-f5ee-4674-9c56-f8c7eda450ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_2808715f-2d07-4569-842c-7b3ceab33435" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d3797d7a-f5ee-4674-9c56-f8c7eda450ed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_be848531-a6fc-4a7c-b97a-83e616f25da7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_0e0ee717-93e2-49fc-ae3b-3044e8eaf38c" xlink:href="syk-20241231.xsd#syk_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_be848531-a6fc-4a7c-b97a-83e616f25da7" xlink:to="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_0e0ee717-93e2-49fc-ae3b-3044e8eaf38c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_71e1f864-97c7-4208-abc0-e6ef1162f1ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_be848531-a6fc-4a7c-b97a-83e616f25da7" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_71e1f864-97c7-4208-abc0-e6ef1162f1ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_3edcfe92-a91c-483a-a9d3-e3de9e6c8ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_cd5a59c9-f406-4c3e-af99-3e7ef91a6dad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_3edcfe92-a91c-483a-a9d3-e3de9e6c8ca9" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_cd5a59c9-f406-4c3e-af99-3e7ef91a6dad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_0d39a645-d1fa-4dea-967a-c5589abcf240" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_3edcfe92-a91c-483a-a9d3-e3de9e6c8ca9" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_0d39a645-d1fa-4dea-967a-c5589abcf240" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_712e785b-86e8-4abd-8afa-80b297e64025" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_5aa8e5ff-34c2-4047-84ab-43c485803f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_712e785b-86e8-4abd-8afa-80b297e64025" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_5aa8e5ff-34c2-4047-84ab-43c485803f4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_428c9d0c-e353-45ff-bede-f8cf563fa864" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_712e785b-86e8-4abd-8afa-80b297e64025" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_428c9d0c-e353-45ff-bede-f8cf563fa864" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes_eec6ab17-4601-4fd5-b521-740896ed87e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_712e785b-86e8-4abd-8afa-80b297e64025" xlink:to="loc_us-gaap_DeferredTaxAssetsStateTaxes_eec6ab17-4601-4fd5-b521-740896ed87e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_86df168a-a5fd-4619-9042-3555ef11bd00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_712e785b-86e8-4abd-8afa-80b297e64025" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_86df168a-a5fd-4619-9042-3555ef11bd00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_88b1dac2-0892-429f-9bd2-b32f387dc190" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_712e785b-86e8-4abd-8afa-80b297e64025" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_88b1dac2-0892-429f-9bd2-b32f387dc190" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_33b16c68-40b0-4e1e-91ab-7c1a735663f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_712e785b-86e8-4abd-8afa-80b297e64025" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_33b16c68-40b0-4e1e-91ab-7c1a735663f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsDepreciationAndAmortization_ab269a95-8c7e-4fe2-b250-9d5c7019799d" xlink:href="syk-20241231.xsd#syk_DeferredTaxAssetsDepreciationAndAmortization"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_712e785b-86e8-4abd-8afa-80b297e64025" xlink:to="loc_syk_DeferredTaxAssetsDepreciationAndAmortization_ab269a95-8c7e-4fe2-b250-9d5c7019799d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization_f34f74fc-92ed-4147-85dd-34df286286ae" xlink:href="syk-20241231.xsd#syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_712e785b-86e8-4abd-8afa-80b297e64025" xlink:to="loc_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization_f34f74fc-92ed-4147-85dd-34df286286ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward_27cc3a2d-cfd2-4c79-a7fd-415e7f42ba89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_712e785b-86e8-4abd-8afa-80b297e64025" xlink:to="loc_us-gaap_DeferredTaxAssetInterestCarryforward_27cc3a2d-cfd2-4c79-a7fd-415e7f42ba89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsOutsideBasisDifference_7b2820b8-5d21-4d34-bf0c-e5f3089d75ff" xlink:href="syk-20241231.xsd#syk_DeferredTaxAssetsOutsideBasisDifference"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_712e785b-86e8-4abd-8afa-80b297e64025" xlink:to="loc_syk_DeferredTaxAssetsOutsideBasisDifference_7b2820b8-5d21-4d34-bf0c-e5f3089d75ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_fc52eaae-1f2c-4148-a843-ff5daf364087" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_96c8e787-e92b-4a16-b321-48f38e3fedbd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_fc52eaae-1f2c-4148-a843-ff5daf364087" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_96c8e787-e92b-4a16-b321-48f38e3fedbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9713170e-cb5e-4a6a-a671-dc34ba23dc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_fc52eaae-1f2c-4148-a843-ff5daf364087" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9713170e-cb5e-4a6a-a671-dc34ba23dc7a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1" xlink:type="simple" xlink:href="syk-20241231.xsd#IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c5520bfc-81b2-4e23-854f-b0a8e0862f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_7f173c7e-9697-44ef-b1db-3f4a21262b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c5520bfc-81b2-4e23-854f-b0a8e0862f5b" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_7f173c7e-9697-44ef-b1db-3f4a21262b3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_88d92f6f-5651-4b3c-b111-54327a55b354" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c5520bfc-81b2-4e23-854f-b0a8e0862f5b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_88d92f6f-5651-4b3c-b111-54327a55b354" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_c72166bd-f2a6-456c-a17b-da075124b27a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_552258c2-b157-47ef-b857-af0183751c61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_c72166bd-f2a6-456c-a17b-da075124b27a" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_552258c2-b157-47ef-b857-af0183751c61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_c16b2b2f-e256-46f7-9cee-935c4fc132f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_c72166bd-f2a6-456c-a17b-da075124b27a" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_c16b2b2f-e256-46f7-9cee-935c4fc132f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_05a247eb-2692-498d-9199-795612d742d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_b72d0ebd-e7a7-461a-a2b3-f5cf791a2e75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_05a247eb-2692-498d-9199-795612d742d5" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_b72d0ebd-e7a7-461a-a2b3-f5cf791a2e75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_53ed7b7a-c0f8-41f3-af08-6df545d71535" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_05a247eb-2692-498d-9199-795612d742d5" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_53ed7b7a-c0f8-41f3-af08-6df545d71535" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_2a61d068-e758-447a-823a-dd931ac286ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_05a247eb-2692-498d-9199-795612d742d5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_2a61d068-e758-447a-823a-dd931ac286ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_dd2ed8cd-0602-44e0-8bc4-c2d57f66834f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_05a247eb-2692-498d-9199-795612d742d5" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_dd2ed8cd-0602-44e0-8bc4-c2d57f66834f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_d5b43162-fb6a-4aed-8897-c0820939eb99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_05a247eb-2692-498d-9199-795612d742d5" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_d5b43162-fb6a-4aed-8897-c0820939eb99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_84fa87f8-19f0-4110-be92-0a19051643e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_b612c66a-d636-49e8-a303-44de37ac072b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_84fa87f8-19f0-4110-be92-0a19051643e3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_b612c66a-d636-49e8-a303-44de37ac072b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_9e9ebb5e-dd02-44b2-8b2e-8fc5fdb9b7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_84fa87f8-19f0-4110-be92-0a19051643e3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_9e9ebb5e-dd02-44b2-8b2e-8fc5fdb9b7bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_ec1fd4c1-e7a6-4f4f-be98-f7f185cd538e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_84fa87f8-19f0-4110-be92-0a19051643e3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_ec1fd4c1-e7a6-4f4f-be98-f7f185cd538e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_bc832b88-da69-4194-bb6a-62a2beb4f950" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_6ec9a242-d64c-4157-bff0-1d7e81effa41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_bc832b88-da69-4194-bb6a-62a2beb4f950" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_6ec9a242-d64c-4157-bff0-1d7e81effa41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e3f8aa60-a7f3-4684-b4fb-f07ea92fce04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_bc832b88-da69-4194-bb6a-62a2beb4f950" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e3f8aa60-a7f3-4684-b4fb-f07ea92fce04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_60d50171-6478-4687-8d5f-4ebdca515194" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_2379f0b7-d301-4886-bc33-57b6a0ff6622" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_60d50171-6478-4687-8d5f-4ebdca515194" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_2379f0b7-d301-4886-bc33-57b6a0ff6622" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_bf3f6b28-50bf-4f86-94d0-7dd84906139e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_60d50171-6478-4687-8d5f-4ebdca515194" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_bf3f6b28-50bf-4f86-94d0-7dd84906139e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AssetsHeldforSaleDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#AssetsHeldforSaleDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/AssetsHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_47ce16d5-abd0-4239-a437-f250ba0e0e38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_28f04422-89b1-4951-a21d-47cf3a533906" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_47ce16d5-abd0-4239-a437-f250ba0e0e38" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_28f04422-89b1-4951-a21d-47cf3a533906" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_de5fa774-6455-46be-9225-5f97680094ee" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_47ce16d5-abd0-4239-a437-f250ba0e0e38" xlink:to="loc_syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_de5fa774-6455-46be-9225-5f97680094ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_7b6bb042-a3fc-49ab-8ce0-91a71ed9a1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_47ce16d5-abd0-4239-a437-f250ba0e0e38" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_7b6bb042-a3fc-49ab-8ce0-91a71ed9a1e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_2607e52e-e508-4f74-b965-edb1d999e2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_47ce16d5-abd0-4239-a437-f250ba0e0e38" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_2607e52e-e508-4f74-b965-edb1d999e2f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_0fe54d70-43e7-4c34-ac7c-24f680d1b105" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_47ce16d5-abd0-4239-a437-f250ba0e0e38" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_0fe54d70-43e7-4c34-ac7c-24f680d1b105" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_70c4d5ec-ada5-4bec-ba9d-0e1f07ded52e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_47ce16d5-abd0-4239-a437-f250ba0e0e38" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_70c4d5ec-ada5-4bec-ba9d-0e1f07ded52e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_7ade06e7-1b02-4ea4-a3c9-a55329c3ed46" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_47ce16d5-abd0-4239-a437-f250ba0e0e38" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_7ade06e7-1b02-4ea4-a3c9-a55329c3ed46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_24717ab3-e678-4661-8b3e-f1ff27f6949d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_47ce16d5-abd0-4239-a437-f250ba0e0e38" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_24717ab3-e678-4661-8b3e-f1ff27f6949d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6fcdee65-b1d0-4c9c-9f22-fc7acb5ee9b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent_8df4d9a7-d6fe-4a94-843f-00021cac6800" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6fcdee65-b1d0-4c9c-9f22-fc7acb5ee9b1" xlink:to="loc_syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent_8df4d9a7-d6fe-4a94-843f-00021cac6800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent_6101828c-fa75-43d4-9c72-59132657c8cc" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6fcdee65-b1d0-4c9c-9f22-fc7acb5ee9b1" xlink:to="loc_syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent_6101828c-fa75-43d4-9c72-59132657c8cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_2043505d-d576-47fd-9ef7-e20d465bda5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6fcdee65-b1d0-4c9c-9f22-fc7acb5ee9b1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_2043505d-d576-47fd-9ef7-e20d465bda5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_c0d5d0df-66a0-4ee6-9c72-2b5f923c0c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6fcdee65-b1d0-4c9c-9f22-fc7acb5ee9b1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_c0d5d0df-66a0-4ee6-9c72-2b5f923c0c1d" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>18
<FILENAME>syk-20241231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:66138c84-a1f4-4bd1-9e3f-a7dda17467bc,g:664b5418-33ef-4591-a7dd-ebf51b747252-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.stryker.com/role/COVERPAGE" xlink:type="simple" xlink:href="syk-20241231.xsd#COVERPAGE"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/COVERPAGE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_667ff751-0521-4b9e-904a-db5b499cc366" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntitiesTable_667ff751-0521-4b9e-904a-db5b499cc366" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_84a74645-7e64-4dd8-a20d-80dff99945cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_667ff751-0521-4b9e-904a-db5b499cc366" xlink:to="loc_us-gaap_StatementClassOfStockAxis_84a74645-7e64-4dd8-a20d-80dff99945cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_84a74645-7e64-4dd8-a20d-80dff99945cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_84a74645-7e64-4dd8-a20d-80dff99945cc" xlink:to="loc_us-gaap_ClassOfStockDomain_84a74645-7e64-4dd8-a20d-80dff99945cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_84a74645-7e64-4dd8-a20d-80dff99945cc" xlink:to="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_549f7d37-7618-4f1a-bf03-8b714d64bcb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:to="loc_us-gaap_CommonStockMember_549f7d37-7618-4f1a-bf03-8b714d64bcb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.125Due2027Member_b6efb38d-8018-4fc7-9297-1a5314ed2878" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes2.125Due2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:to="loc_syk_SeniorUnsecuredNotes2.125Due2027Member_b6efb38d-8018-4fc7-9297-1a5314ed2878" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3375Due2028Member_4fe5bfdc-1db4-4b3f-af6e-6d9fccba74b0" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3375Due2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:to="loc_syk_SeniorUnsecuredNotes3375Due2028Member_4fe5bfdc-1db4-4b3f-af6e-6d9fccba74b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.750due2029Member_047e2c92-defd-458b-9cdf-8d7ea525b936" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes0.750due2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:to="loc_syk_SeniorUnsecuredNotes0.750due2029Member_047e2c92-defd-458b-9cdf-8d7ea525b936" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.625Due2030Member_78cea75f-7cf8-4b48-a917-88dbc85b4f50" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes2.625Due2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:to="loc_syk_SeniorUnsecuredNotes2.625Due2030Member_78cea75f-7cf8-4b48-a917-88dbc85b4f50" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.000due2031Member_565759f3-ace9-4547-ba8c-db7771e20f57" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes1.000due2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:to="loc_syk_SeniorUnsecuredNotes1.000due2031Member_565759f3-ace9-4547-ba8c-db7771e20f57" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375Due2032Member_57f37077-21af-4818-b30b-34a2bbac52cd" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.375Due2032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:to="loc_syk_SeniorUnsecuredNotes3.375Due2032Member_57f37077-21af-4818-b30b-34a2bbac52cd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.625Due2036Member_a66a4047-826b-4998-8a4c-e048d18ca433" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.625Due2036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:to="loc_syk_SeniorUnsecuredNotes3.625Due2036Member_a66a4047-826b-4998-8a4c-e048d18ca433" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_5cca9174-913f-4393-8383-a73a8c5d4817" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_DocumentType_5cca9174-913f-4393-8383-a73a8c5d4817" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_af909778-8f1e-4462-8508-de5a6e8ddf08" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_DocumentAnnualReport_af909778-8f1e-4462-8508-de5a6e8ddf08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_1841f264-6411-4ce6-b4d7-2f766cc54093" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_DocumentPeriodEndDate_1841f264-6411-4ce6-b4d7-2f766cc54093" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_921b1532-0a29-47e1-9ce8-d15274b7af04" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_CurrentFiscalYearEndDate_921b1532-0a29-47e1-9ce8-d15274b7af04" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_86b20622-1863-4fc1-9572-405c6f22a3bf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_DocumentTransitionReport_86b20622-1863-4fc1-9572-405c6f22a3bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_08679748-2475-4d21-9569-2da7ad373d64" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityFileNumber_08679748-2475-4d21-9569-2da7ad373d64" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c58d8289-bc24-4729-8113-90ad150ea584" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityRegistrantName_c58d8289-bc24-4729-8113-90ad150ea584" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1d6b23b6-b56f-4591-ad21-01c5b159274b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1d6b23b6-b56f-4591-ad21-01c5b159274b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4adbe232-2382-4e4c-b8de-f19d94f1c6a7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityTaxIdentificationNumber_4adbe232-2382-4e4c-b8de-f19d94f1c6a7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7ddc87c6-ce4c-4939-9893-0a00838dfd7b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityAddressAddressLine1_7ddc87c6-ce4c-4939-9893-0a00838dfd7b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_969b53a6-a60e-48bc-94cb-41e9328c1467" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityAddressCityOrTown_969b53a6-a60e-48bc-94cb-41e9328c1467" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_533544e4-efe8-4e31-9c92-be840a752fd3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityAddressStateOrProvince_533544e4-efe8-4e31-9c92-be840a752fd3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_dcde48e8-772a-4dce-9cc5-0c86ff5a99db" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityAddressPostalZipCode_dcde48e8-772a-4dce-9cc5-0c86ff5a99db" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_9fc312f1-b5d5-4fcf-b1af-d85b70bf9ab2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_CityAreaCode_9fc312f1-b5d5-4fcf-b1af-d85b70bf9ab2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b1fe90da-6af0-43d2-9e46-d4f683acba50" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_LocalPhoneNumber_b1fe90da-6af0-43d2-9e46-d4f683acba50" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4058775f-beab-4f45-8e95-2c8b8c1c9cb7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_Security12bTitle_4058775f-beab-4f45-8e95-2c8b8c1c9cb7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_068bc70d-9877-4b0e-ae1b-a14a25f1294a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_TradingSymbol_068bc70d-9877-4b0e-ae1b-a14a25f1294a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_43033a52-6297-4cd4-8949-fba80aaf8642" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_SecurityExchangeName_43033a52-6297-4cd4-8949-fba80aaf8642" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12gTitle_9ae50063-433d-449b-9334-3d73a636fd88" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_Security12gTitle_9ae50063-433d-449b-9334-3d73a636fd88" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_8c52fe34-621c-4674-9a77-7265b463088f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_8c52fe34-621c-4674-9a77-7265b463088f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_e5119625-528b-4cc6-b11a-61eec0742f64" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityVoluntaryFilers_e5119625-528b-4cc6-b11a-61eec0742f64" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_967d11ee-469e-4e70-928a-bb57b9e0f37d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityCurrentReportingStatus_967d11ee-469e-4e70-928a-bb57b9e0f37d" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_d1d42b4b-f68a-4763-aa76-e0a54f890815" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityInteractiveDataCurrent_d1d42b4b-f68a-4763-aa76-e0a54f890815" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_9313ad85-ab10-4685-a8a3-97f014b13f6d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityFilerCategory_9313ad85-ab10-4685-a8a3-97f014b13f6d" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_dc5d5c45-5568-4c7c-84d7-4ea67657e031" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityEmergingGrowthCompany_dc5d5c45-5568-4c7c-84d7-4ea67657e031" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_83f52156-a82e-4063-a556-8846ff8abb6b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntitySmallBusiness_83f52156-a82e-4063-a556-8846ff8abb6b" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_d1a04456-9553-4c6d-87cd-5e3420316471" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_IcfrAuditorAttestationFlag_d1a04456-9553-4c6d-87cd-5e3420316471" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_d090f724-2064-430a-ac4c-67e05d5c9bf0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_d090f724-2064-430a-ac4c-67e05d5c9bf0" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_9dc033a4-c70c-4300-9542-85258c3150d7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityShellCompany_9dc033a4-c70c-4300-9542-85258c3150d7" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_025c209a-e01b-4981-b01f-94375f8b7206" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityPublicFloat_025c209a-e01b-4981-b01f-94375f8b7206" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_cd258874-599b-4c25-bcb6-de679ed88fa7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_cd258874-599b-4c25-bcb6-de679ed88fa7" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_dfe3ab9c-87b4-45fb-9b11-f33e3f065645" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_dfe3ab9c-87b4-45fb-9b11-f33e3f065645" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b1dec1f0-ee0d-451d-941c-a264960b4149" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_AmendmentFlag_b1dec1f0-ee0d-451d-941c-a264960b4149" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_80816bb7-b0ba-436e-99b5-1a3647b6f375" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_DocumentFiscalYearFocus_80816bb7-b0ba-436e-99b5-1a3647b6f375" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_087ac581-d37b-4bac-ac7b-c1c3c16c355c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_087ac581-d37b-4bac-ac7b-c1c3c16c355c" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_d235a12a-89b5-48af-a05b-0b57b9168f37" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityCentralIndexKey_d235a12a-89b5-48af-a05b-0b57b9168f37" xlink:type="arc" order="35"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:type="simple" xlink:href="syk-20241231.xsd#ConsolidatedStatementsOfShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_55077951-e88d-49e5-a516-7e6cb6b09044" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6abb7195-06e5-4f78-a73d-7d71da8b05f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_55077951-e88d-49e5-a516-7e6cb6b09044" xlink:to="loc_us-gaap_StatementTable_6abb7195-06e5-4f78-a73d-7d71da8b05f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2bb3c894-dbb5-4660-a96a-90c366d183e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6abb7195-06e5-4f78-a73d-7d71da8b05f7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2bb3c894-dbb5-4660-a96a-90c366d183e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2bb3c894-dbb5-4660-a96a-90c366d183e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2bb3c894-dbb5-4660-a96a-90c366d183e9" xlink:to="loc_us-gaap_EquityComponentDomain_2bb3c894-dbb5-4660-a96a-90c366d183e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_299e3c40-00f4-42f9-bd47-e4054a82892e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2bb3c894-dbb5-4660-a96a-90c366d183e9" xlink:to="loc_us-gaap_EquityComponentDomain_299e3c40-00f4-42f9-bd47-e4054a82892e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bfce9d55-6ee2-431a-8e2e-5a27aa2d9737" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_299e3c40-00f4-42f9-bd47-e4054a82892e" xlink:to="loc_us-gaap_CommonStockMember_bfce9d55-6ee2-431a-8e2e-5a27aa2d9737" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_3f0a0c29-6e8b-4aea-b496-c970a4014046" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_299e3c40-00f4-42f9-bd47-e4054a82892e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_3f0a0c29-6e8b-4aea-b496-c970a4014046" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_17152498-de17-4a3a-9a2d-c2c37dd596c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_299e3c40-00f4-42f9-bd47-e4054a82892e" xlink:to="loc_us-gaap_RetainedEarningsMember_17152498-de17-4a3a-9a2d-c2c37dd596c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef6f37e0-d0e8-4587-ab1a-9b5be7705853" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_299e3c40-00f4-42f9-bd47-e4054a82892e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef6f37e0-d0e8-4587-ab1a-9b5be7705853" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55077951-e88d-49e5-a516-7e6cb6b09044" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f1999a4c-a0e1-4023-95fc-4142890bc4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f1999a4c-a0e1-4023-95fc-4142890bc4cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ca758e87-9d76-40d1-bee0-5c55b6e18de7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ca758e87-9d76-40d1-bee0-5c55b6e18de7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_bcfaae49-9050-4121-b905-401d17b6b9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_bcfaae49-9050-4121-b905-401d17b6b9d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_68a03a1e-cb58-461a-ba56-0f55519634b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_68a03a1e-cb58-461a-ba56-0f55519634b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_216b0aa0-2a8e-4acd-be82-a4fdc22e4089" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_216b0aa0-2a8e-4acd-be82-a4fdc22e4089" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0ada7af8-0c06-4618-8bf3-2c3046f7c600" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_NetIncomeLoss_0ada7af8-0c06-4618-8bf3-2c3046f7c600" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_4efd0ce1-39f0-4e11-9770-750e51da52e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_DividendsCash_4efd0ce1-39f0-4e11-9770-750e51da52e3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_83e8f3eb-5544-4041-9d4e-a7b8b34529f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_83e8f3eb-5544-4041-9d4e-a7b8b34529f1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1db110f6-5d04-4fd6-949c-74d9bb4813b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d73b1a71-1d7d-4863-b461-b26c8e87b67f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#SignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4a8c1842-5a5a-496d-aaec-cf6f0ecf74aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:to="loc_us-gaap_StatementTable_4a8c1842-5a5a-496d-aaec-cf6f0ecf74aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dfe65178-1a99-4f9c-9cad-528b75b0540a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4a8c1842-5a5a-496d-aaec-cf6f0ecf74aa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dfe65178-1a99-4f9c-9cad-528b75b0540a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dfe65178-1a99-4f9c-9cad-528b75b0540a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dfe65178-1a99-4f9c-9cad-528b75b0540a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dfe65178-1a99-4f9c-9cad-528b75b0540a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_863a0bdc-75e7-4e34-b382-555a460b9a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dfe65178-1a99-4f9c-9cad-528b75b0540a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_863a0bdc-75e7-4e34-b382-555a460b9a9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_0a7a8182-8847-4e92-b1d2-0c206da89807" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_863a0bdc-75e7-4e34-b382-555a460b9a9d" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_0a7a8182-8847-4e92-b1d2-0c206da89807" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_0af6f9ca-7a94-4799-9184-4e7008ee1e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_863a0bdc-75e7-4e34-b382-555a460b9a9d" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_0af6f9ca-7a94-4799-9184-4e7008ee1e4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d2c77a04-fd39-45b5-a5ce-88bae5f5ef18" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4a8c1842-5a5a-496d-aaec-cf6f0ecf74aa" xlink:to="loc_srt_RangeAxis_d2c77a04-fd39-45b5-a5ce-88bae5f5ef18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d2c77a04-fd39-45b5-a5ce-88bae5f5ef18_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d2c77a04-fd39-45b5-a5ce-88bae5f5ef18" xlink:to="loc_srt_RangeMember_d2c77a04-fd39-45b5-a5ce-88bae5f5ef18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b78e25c3-6110-4f0c-b0e3-5226f541c1e9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d2c77a04-fd39-45b5-a5ce-88bae5f5ef18" xlink:to="loc_srt_RangeMember_b78e25c3-6110-4f0c-b0e3-5226f541c1e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0fef606c-35e3-4f03-b494-ebf1f779e65e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b78e25c3-6110-4f0c-b0e3-5226f541c1e9" xlink:to="loc_srt_MinimumMember_0fef606c-35e3-4f03-b494-ebf1f779e65e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_adf9f59a-57f2-4218-8d4b-bea90f345040" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b78e25c3-6110-4f0c-b0e3-5226f541c1e9" xlink:to="loc_srt_MaximumMember_adf9f59a-57f2-4218-8d4b-bea90f345040" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d82539d7-a499-4801-ae4b-55be1e1b9115" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4a8c1842-5a5a-496d-aaec-cf6f0ecf74aa" xlink:to="loc_us-gaap_AwardTypeAxis_d82539d7-a499-4801-ae4b-55be1e1b9115" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d82539d7-a499-4801-ae4b-55be1e1b9115_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d82539d7-a499-4801-ae4b-55be1e1b9115" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d82539d7-a499-4801-ae4b-55be1e1b9115_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03df3f95-ef9d-438c-871a-e0ff0a0be2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d82539d7-a499-4801-ae4b-55be1e1b9115" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03df3f95-ef9d-438c-871a-e0ff0a0be2b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0d1fcfe6-e63e-4725-9998-292e49d0b3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03df3f95-ef9d-438c-871a-e0ff0a0be2b4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0d1fcfe6-e63e-4725-9998-292e49d0b3ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_bab0658f-265d-44c6-8c1c-b7f97c9763a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03df3f95-ef9d-438c-871a-e0ff0a0be2b4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_bab0658f-265d-44c6-8c1c-b7f97c9763a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_66dbf80a-8d5f-40b4-820e-870a537d53c3" xlink:href="syk-20241231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03df3f95-ef9d-438c-871a-e0ff0a0be2b4" xlink:to="loc_syk_PerformanceStockUnitPsusMember_66dbf80a-8d5f-40b4-820e-870a537d53c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_42cb6785-7128-4a56-8557-f3c9f4fe60cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:to="loc_us-gaap_DerivativeTermOfContract_42cb6785-7128-4a56-8557-f3c9f4fe60cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_4e3b7cf1-efc8-41ff-841e-9d905944c0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_4e3b7cf1-efc8-41ff-841e-9d905944c0ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d1e3cf29-430e-4dde-a010-97825f7dfc01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d1e3cf29-430e-4dde-a010-97825f7dfc01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_aed48c7d-da76-4c0c-a3f8-aef51e8776e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_aed48c7d-da76-4c0c-a3f8-aef51e8776e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4f942616-e91f-49ee-8609-2762cbc42092" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4f942616-e91f-49ee-8609-2762cbc42092" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_f65d3eed-c442-48cf-830f-b500fdd4a084" xlink:href="syk-20241231.xsd#syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:to="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_f65d3eed-c442-48cf-830f-b500fdd4a084" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_6cfd8340-77ec-4047-a5a8-13bf66e25403" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_6cfd8340-77ec-4047-a5a8-13bf66e25403" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognitionNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RevenueRecognitionNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_fb81d231-e7fd-4d75-8310-d435eb2062f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1a49ec32-4c64-4265-93be-7df4b4cbdb49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_fb81d231-e7fd-4d75-8310-d435eb2062f5" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1a49ec32-4c64-4265-93be-7df4b4cbdb49" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_53d0116c-0b3a-4674-a8fc-866e761c6c27" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1a49ec32-4c64-4265-93be-7df4b4cbdb49" xlink:to="loc_srt_ProductOrServiceAxis_53d0116c-0b3a-4674-a8fc-866e761c6c27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_53d0116c-0b3a-4674-a8fc-866e761c6c27_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_53d0116c-0b3a-4674-a8fc-866e761c6c27" xlink:to="loc_srt_ProductsAndServicesDomain_53d0116c-0b3a-4674-a8fc-866e761c6c27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d72712dc-6496-4bd2-991c-e6de5d19d0b1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_53d0116c-0b3a-4674-a8fc-866e761c6c27" xlink:to="loc_srt_ProductsAndServicesDomain_d72712dc-6496-4bd2-991c-e6de5d19d0b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeuroCranialInterventionalSpineMember_ac3b57ec-c907-46e0-8882-08968f0f6f7f" xlink:href="syk-20241231.xsd#syk_NeuroCranialInterventionalSpineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d72712dc-6496-4bd2-991c-e6de5d19d0b1" xlink:to="loc_syk_NeuroCranialInterventionalSpineMember_ac3b57ec-c907-46e0-8882-08968f0f6f7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherOrthopedicsEnablingTechnologiesMember_b52077f7-0965-42c8-b526-a34bbce9c92c" xlink:href="syk-20241231.xsd#syk_OtherOrthopedicsEnablingTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d72712dc-6496-4bd2-991c-e6de5d19d0b1" xlink:to="loc_syk_OtherOrthopedicsEnablingTechnologiesMember_b52077f7-0965-42c8-b526-a34bbce9c92c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PercentageofServiceRevenueRecognizeoverTime_fd5bcdd1-ad62-4455-9099-501add2e961b" xlink:href="syk-20241231.xsd#syk_PercentageofServiceRevenueRecognizeoverTime"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_fb81d231-e7fd-4d75-8310-d435eb2062f5" xlink:to="loc_syk_PercentageofServiceRevenueRecognizeoverTime_fd5bcdd1-ad62-4455-9099-501add2e961b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_04a52c96-5114-4ef1-8074-de3a0bc7b018" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_fb81d231-e7fd-4d75-8310-d435eb2062f5" xlink:to="loc_us-gaap_Revenues_04a52c96-5114-4ef1-8074-de3a0bc7b018" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_47e4ec9f-6aae-4363-8f7e-cd6d5053afc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_fb81d231-e7fd-4d75-8310-d435eb2062f5" xlink:to="loc_us-gaap_ContractWithCustomerLiability_47e4ec9f-6aae-4363-8f7e-cd6d5053afc8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RevenueRecognitionDisaggregatedSalesAnalysisDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_218e426a-55e9-4d7a-86f0-4c5d503568e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a2d30cff-17b0-440d-bf36-b2502ebe3d16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_218e426a-55e9-4d7a-86f0-4c5d503568e1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a2d30cff-17b0-440d-bf36-b2502ebe3d16" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f430ee38-b4b5-42bc-bb6f-987eba6be9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a2d30cff-17b0-440d-bf36-b2502ebe3d16" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f430ee38-b4b5-42bc-bb6f-987eba6be9f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f430ee38-b4b5-42bc-bb6f-987eba6be9f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f430ee38-b4b5-42bc-bb6f-987eba6be9f1" xlink:to="loc_us-gaap_SegmentDomain_f430ee38-b4b5-42bc-bb6f-987eba6be9f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9e3f354b-e6d7-42b2-81f2-5c98fdabcf0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f430ee38-b4b5-42bc-bb6f-987eba6be9f1" xlink:to="loc_us-gaap_SegmentDomain_9e3f354b-e6d7-42b2-81f2-5c98fdabcf0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_543d4187-f028-4017-971e-394587fee2dd" xlink:href="syk-20241231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9e3f354b-e6d7-42b2-81f2-5c98fdabcf0f" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_543d4187-f028-4017-971e-394587fee2dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_03290f5d-3c59-47fc-af02-378fa9beafff" xlink:href="syk-20241231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9e3f354b-e6d7-42b2-81f2-5c98fdabcf0f" xlink:to="loc_syk_OrthopaedicsAndSpineMember_03290f5d-3c59-47fc-af02-378fa9beafff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2939a106-19a6-44a7-9936-76bb16934ec9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a2d30cff-17b0-440d-bf36-b2502ebe3d16" xlink:to="loc_srt_ProductOrServiceAxis_2939a106-19a6-44a7-9936-76bb16934ec9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2939a106-19a6-44a7-9936-76bb16934ec9_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_2939a106-19a6-44a7-9936-76bb16934ec9" xlink:to="loc_srt_ProductsAndServicesDomain_2939a106-19a6-44a7-9936-76bb16934ec9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_2939a106-19a6-44a7-9936-76bb16934ec9" xlink:to="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InstrumentsMember_701df64e-8516-453a-b7d4-8185e6c46d35" xlink:href="syk-20241231.xsd#syk_InstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_InstrumentsMember_701df64e-8516-453a-b7d4-8185e6c46d35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EndoscopyMember_3adbd311-e8d3-408e-97ad-0c390ded18ab" xlink:href="syk-20241231.xsd#syk_EndoscopyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_EndoscopyMember_3adbd311-e8d3-408e-97ad-0c390ded18ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalMember_8dca1936-631c-4362-968a-b994908a4eb3" xlink:href="syk-20241231.xsd#syk_MedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_MedicalMember_8dca1936-631c-4362-968a-b994908a4eb3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeurovascularMember_bc5e5f0c-e406-4a15-ae21-52bf5c420796" xlink:href="syk-20241231.xsd#syk_NeurovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_NeurovascularMember_bc5e5f0c-e406-4a15-ae21-52bf5c420796" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeuroCranialMember_045fc08e-10cd-4d98-8bf2-0ffaae39bb23" xlink:href="syk-20241231.xsd#syk_NeuroCranialMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_NeuroCranialMember_045fc08e-10cd-4d98-8bf2-0ffaae39bb23" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherOrthopaedicsMember_66dbdbb0-fd50-4071-a4e7-c253db261ff8" xlink:href="syk-20241231.xsd#syk_OtherOrthopaedicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_OtherOrthopaedicsMember_66dbdbb0-fd50-4071-a4e7-c253db261ff8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_KneesMember_aa4edf4f-58d6-4a87-bc24-ec8501e42f3e" xlink:href="syk-20241231.xsd#syk_KneesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_KneesMember_aa4edf4f-58d6-4a87-bc24-ec8501e42f3e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_HipsMember_e2813fc6-3486-4a21-ae0a-0e148bedf39b" xlink:href="syk-20241231.xsd#syk_HipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_HipsMember_e2813fc6-3486-4a21-ae0a-0e148bedf39b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TraumaandExtremitiesMember_b5b6ae5f-0721-44f4-b1aa-71f414de0c10" xlink:href="syk-20241231.xsd#syk_TraumaandExtremitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_TraumaandExtremitiesMember_b5b6ae5f-0721-44f4-b1aa-71f414de0c10" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpineMember_7b7130d4-6840-4f1d-a294-a76d3fb0e6ee" xlink:href="syk-20241231.xsd#syk_SpineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_SpineMember_7b7130d4-6840-4f1d-a294-a76d3fb0e6ee" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_64cc9542-c8c8-4c46-b087-ff699ca40dee" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a2d30cff-17b0-440d-bf36-b2502ebe3d16" xlink:to="loc_srt_StatementGeographicalAxis_64cc9542-c8c8-4c46-b087-ff699ca40dee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_64cc9542-c8c8-4c46-b087-ff699ca40dee_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_64cc9542-c8c8-4c46-b087-ff699ca40dee" xlink:to="loc_srt_SegmentGeographicalDomain_64cc9542-c8c8-4c46-b087-ff699ca40dee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_52c869ee-a4c2-48f4-936d-001ad7777040" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_64cc9542-c8c8-4c46-b087-ff699ca40dee" xlink:to="loc_srt_SegmentGeographicalDomain_52c869ee-a4c2-48f4-936d-001ad7777040" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_21b13814-a033-40c6-82d1-3d750e1c3cf6" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_52c869ee-a4c2-48f4-936d-001ad7777040" xlink:to="loc_country_US_21b13814-a033-40c6-82d1-3d750e1c3cf6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_692f9982-9224-4e29-9019-b6cf8fb826fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_52c869ee-a4c2-48f4-936d-001ad7777040" xlink:to="loc_us-gaap_NonUsMember_692f9982-9224-4e29-9019-b6cf8fb826fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fec97489-5e07-4250-ab3c-94c498b4434c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_218e426a-55e9-4d7a-86f0-4c5d503568e1" xlink:to="loc_us-gaap_Revenues_fec97489-5e07-4250-ab3c-94c498b4434c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_340f2564-41a1-4536-81bb-ef72b1d00dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b5974d0e-547e-4915-b3f5-567687e160da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_340f2564-41a1-4536-81bb-ef72b1d00dd6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b5974d0e-547e-4915-b3f5-567687e160da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4c048e61-e62e-4abc-a918-3167bae318ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b5974d0e-547e-4915-b3f5-567687e160da" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4c048e61-e62e-4abc-a918-3167bae318ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4c048e61-e62e-4abc-a918-3167bae318ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4c048e61-e62e-4abc-a918-3167bae318ca" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4c048e61-e62e-4abc-a918-3167bae318ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_06f93b7e-3ac2-4eb4-9166-4b134e052f72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4c048e61-e62e-4abc-a918-3167bae318ca" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_06f93b7e-3ac2-4eb4-9166-4b134e052f72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d7a6d02c-fd86-4b01-bf85-32e0d08ce422" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_06f93b7e-3ac2-4eb4-9166-4b134e052f72" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d7a6d02c-fd86-4b01-bf85-32e0d08ce422" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ea733d33-d7c2-444e-93cf-06588b7bfe8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_06f93b7e-3ac2-4eb4-9166-4b134e052f72" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ea733d33-d7c2-444e-93cf-06588b7bfe8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ee2dde33-0e56-4157-aae8-18c357794469" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_06f93b7e-3ac2-4eb4-9166-4b134e052f72" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ee2dde33-0e56-4157-aae8-18c357794469" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_76fdcb97-3e6c-4203-9db7-a49873d16c94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b5974d0e-547e-4915-b3f5-567687e160da" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_76fdcb97-3e6c-4203-9db7-a49873d16c94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_76fdcb97-3e6c-4203-9db7-a49873d16c94_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_76fdcb97-3e6c-4203-9db7-a49873d16c94" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_76fdcb97-3e6c-4203-9db7-a49873d16c94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c903efa2-e939-4d65-9fa6-93cae7d2097c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_76fdcb97-3e6c-4203-9db7-a49873d16c94" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c903efa2-e939-4d65-9fa6-93cae7d2097c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_5a765a95-28bb-48c8-acfc-176bed34e431" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c903efa2-e939-4d65-9fa6-93cae7d2097c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_5a765a95-28bb-48c8-acfc-176bed34e431" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_73e56938-9300-4d9b-bf88-f106eff87fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b5974d0e-547e-4915-b3f5-567687e160da" xlink:to="loc_us-gaap_FinancialInstrumentAxis_73e56938-9300-4d9b-bf88-f106eff87fe4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_73e56938-9300-4d9b-bf88-f106eff87fe4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_73e56938-9300-4d9b-bf88-f106eff87fe4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_73e56938-9300-4d9b-bf88-f106eff87fe4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23373417-a5c3-4c77-9abb-37473584b7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_73e56938-9300-4d9b-bf88-f106eff87fe4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23373417-a5c3-4c77-9abb-37473584b7dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_912ace3c-2c15-4810-b04b-db8b0dfcb9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23373417-a5c3-4c77-9abb-37473584b7dd" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_912ace3c-2c15-4810-b04b-db8b0dfcb9f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_fbf567c0-1e57-4054-9ab9-c3fdb17afd77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23373417-a5c3-4c77-9abb-37473584b7dd" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_fbf567c0-1e57-4054-9ab9-c3fdb17afd77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_517ccf29-a049-4b49-a48d-6e6ddf9603c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23373417-a5c3-4c77-9abb-37473584b7dd" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_517ccf29-a049-4b49-a48d-6e6ddf9603c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_6dcd895d-e75e-45f6-b51f-28eb18efbc52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23373417-a5c3-4c77-9abb-37473584b7dd" xlink:to="loc_us-gaap_CertificatesOfDepositMember_6dcd895d-e75e-45f6-b51f-28eb18efbc52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_cc79a5b4-7cc7-4ddf-b2e3-06ec3e67b3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_340f2564-41a1-4536-81bb-ef72b1d00dd6" xlink:to="loc_us-gaap_AssetsAbstract_cc79a5b4-7cc7-4ddf-b2e3-06ec3e67b3eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6cabd616-d2c5-43a1-8a76-b496770ce2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_cc79a5b4-7cc7-4ddf-b2e3-06ec3e67b3eb" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6cabd616-d2c5-43a1-8a76-b496770ce2c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_4574c22e-5761-40f7-990d-de1e760b7440" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_cc79a5b4-7cc7-4ddf-b2e3-06ec3e67b3eb" xlink:to="loc_us-gaap_ShortTermInvestments_4574c22e-5761-40f7-990d-de1e760b7440" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebt_8601b5f2-9710-45de-9cd4-adda5b37da27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradingSecuritiesDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_cc79a5b4-7cc7-4ddf-b2e3-06ec3e67b3eb" xlink:to="loc_us-gaap_TradingSecuritiesDebt_8601b5f2-9710-45de-9cd4-adda5b37da27" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_643a8973-65ec-4acb-bec3-6354ee51968c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_cc79a5b4-7cc7-4ddf-b2e3-06ec3e67b3eb" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_643a8973-65ec-4acb-bec3-6354ee51968c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_d5d01bf1-c538-482a-ac30-8490d67a7022" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_cc79a5b4-7cc7-4ddf-b2e3-06ec3e67b3eb" xlink:to="loc_us-gaap_DerivativeAssets_d5d01bf1-c538-482a-ac30-8490d67a7022" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_b902137c-9633-4283-a974-a576c1f45b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_8c1c0b94-482c-461a-a484-59a579164672" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_cc79a5b4-7cc7-4ddf-b2e3-06ec3e67b3eb" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_8c1c0b94-482c-461a-a484-59a579164672" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_180b0708-05b3-4887-97af-ffa87e1cdee7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_340f2564-41a1-4536-81bb-ef72b1d00dd6" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_180b0708-05b3-4887-97af-ffa87e1cdee7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_3a3dab68-d87c-4135-ac5d-886c88a009d3" xlink:href="syk-20241231.xsd#syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_180b0708-05b3-4887-97af-ffa87e1cdee7" xlink:to="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_3a3dab68-d87c-4135-ac5d-886c88a009d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_46414d27-6972-483b-ad06-f31f7db39c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_180b0708-05b3-4887-97af-ffa87e1cdee7" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_46414d27-6972-483b-ad06-f31f7db39c2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_5512d22b-7095-49a3-98d2-a1f1febdd7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_180b0708-05b3-4887-97af-ffa87e1cdee7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_5512d22b-7095-49a3-98d2-a1f1febdd7dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_20396f2e-109b-42eb-84e1-e812e57c2805" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_5512d22b-7095-49a3-98d2-a1f1febdd7dc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_20396f2e-109b-42eb-84e1-e812e57c2805" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_81b2d6e4-7f37-464c-b835-e62486245d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_5512d22b-7095-49a3-98d2-a1f1febdd7dc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_81b2d6e4-7f37-464c-b835-e62486245d8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_5d9b4252-275f-440a-90f6-2dc417079a11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_5512d22b-7095-49a3-98d2-a1f1febdd7dc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_5d9b4252-275f-440a-90f6-2dc417079a11" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_430ce507-4331-4d15-9043-7f400f2e9a10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_5512d22b-7095-49a3-98d2-a1f1febdd7dc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_430ce507-4331-4d15-9043-7f400f2e9a10" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ae4ed353-0984-4b51-ab97-c8b5ab35e494" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_a5ce70be-3a6e-4d2a-83d3-8e3c7d40b8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_180b0708-05b3-4887-97af-ffa87e1cdee7" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_a5ce70be-3a6e-4d2a-83d3-8e3c7d40b8b7" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_733fd1f1-94a8-4ac8-9134-0601d03e9490" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c6d10db6-b314-4fad-bfb5-8bca4571ab8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_733fd1f1-94a8-4ac8-9134-0601d03e9490" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c6d10db6-b314-4fad-bfb5-8bca4571ab8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cd6d76f5-82c4-4710-9bd6-92ac9993c230" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c6d10db6-b314-4fad-bfb5-8bca4571ab8e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cd6d76f5-82c4-4710-9bd6-92ac9993c230" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cd6d76f5-82c4-4710-9bd6-92ac9993c230_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cd6d76f5-82c4-4710-9bd6-92ac9993c230" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cd6d76f5-82c4-4710-9bd6-92ac9993c230_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_57df5ae7-bfdb-42ca-ae71-df052ccd440b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cd6d76f5-82c4-4710-9bd6-92ac9993c230" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_57df5ae7-bfdb-42ca-ae71-df052ccd440b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CerusMember_22f74b73-bafb-4a60-9f11-60a11774b428" xlink:href="syk-20241231.xsd#syk_CerusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_57df5ae7-bfdb-42ca-ae71-df052ccd440b" xlink:to="loc_syk_CerusMember_22f74b73-bafb-4a60-9f11-60a11774b428" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_52dc4bf5-6000-43b8-98f9-744ea52c17fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_733fd1f1-94a8-4ac8-9134-0601d03e9490" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_52dc4bf5-6000-43b8-98f9-744ea52c17fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_09be0f7e-1e86-409a-bdb6-9949bc18d4de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_733fd1f1-94a8-4ac8-9134-0601d03e9490" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_09be0f7e-1e86-409a-bdb6-9949bc18d4de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeInterestEarningAsset_aa28bd07-7f51-445d-8361-8183fd10a0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeInterestEarningAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_733fd1f1-94a8-4ac8-9134-0601d03e9490" xlink:to="loc_us-gaap_InterestIncomeInterestEarningAsset_aa28bd07-7f51-445d-8361-8183fd10a0d5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_343140ee-0a39-40ab-9f32-4e6ab6b93673" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_b410da04-d1b4-4cc9-bb91-08d216345cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_343140ee-0a39-40ab-9f32-4e6ab6b93673" xlink:to="loc_us-gaap_DerivativeTable_b410da04-d1b4-4cc9-bb91-08d216345cbb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3478222f-c007-48ea-9c5e-04dd38140fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b410da04-d1b4-4cc9-bb91-08d216345cbb" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3478222f-c007-48ea-9c5e-04dd38140fe0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3478222f-c007-48ea-9c5e-04dd38140fe0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3478222f-c007-48ea-9c5e-04dd38140fe0" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3478222f-c007-48ea-9c5e-04dd38140fe0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_45641076-0140-4387-8c3d-e397d00f8f38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3478222f-c007-48ea-9c5e-04dd38140fe0" xlink:to="loc_us-gaap_HedgingRelationshipDomain_45641076-0140-4387-8c3d-e397d00f8f38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_55d6e4be-39ec-4c1e-9ecc-c1c76dfbd411" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_45641076-0140-4387-8c3d-e397d00f8f38" xlink:to="loc_us-gaap_CashFlowHedgingMember_55d6e4be-39ec-4c1e-9ecc-c1c76dfbd411" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_3fb7e9cd-f248-4d5e-ab11-85440d50284f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_45641076-0140-4387-8c3d-e397d00f8f38" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_3fb7e9cd-f248-4d5e-ab11-85440d50284f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c1f8f041-31a0-4b6f-9f41-58569f95ec57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b410da04-d1b4-4cc9-bb91-08d216345cbb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c1f8f041-31a0-4b6f-9f41-58569f95ec57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c1f8f041-31a0-4b6f-9f41-58569f95ec57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c1f8f041-31a0-4b6f-9f41-58569f95ec57" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c1f8f041-31a0-4b6f-9f41-58569f95ec57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d2473141-e05b-43d9-a968-f71c39da5dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c1f8f041-31a0-4b6f-9f41-58569f95ec57" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d2473141-e05b-43d9-a968-f71c39da5dc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_430d7fc9-f7c3-416e-82b6-25b1063a2114" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d2473141-e05b-43d9-a968-f71c39da5dc5" xlink:to="loc_us-gaap_ForeignExchangeContractMember_430d7fc9-f7c3-416e-82b6-25b1063a2114" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_3d06094b-f08d-46c3-a8c6-cca05a819ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b410da04-d1b4-4cc9-bb91-08d216345cbb" xlink:to="loc_us-gaap_HedgingDesignationAxis_3d06094b-f08d-46c3-a8c6-cca05a819ffd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3d06094b-f08d-46c3-a8c6-cca05a819ffd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_3d06094b-f08d-46c3-a8c6-cca05a819ffd" xlink:to="loc_us-gaap_HedgingDesignationDomain_3d06094b-f08d-46c3-a8c6-cca05a819ffd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_86e9ae30-5cc0-4a64-ba51-47e350d82a25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_3d06094b-f08d-46c3-a8c6-cca05a819ffd" xlink:to="loc_us-gaap_HedgingDesignationDomain_86e9ae30-5cc0-4a64-ba51-47e350d82a25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e29d179e-490c-4005-8785-34f8c4ae2bec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_86e9ae30-5cc0-4a64-ba51-47e350d82a25" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e29d179e-490c-4005-8785-34f8c4ae2bec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_b3ec6855-bb83-4d8a-adb2-6e8ec64e4b95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_86e9ae30-5cc0-4a64-ba51-47e350d82a25" xlink:to="loc_us-gaap_NondesignatedMember_b3ec6855-bb83-4d8a-adb2-6e8ec64e4b95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f90d0821-d8a2-41b2-89be-e1dabb9f1e48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b410da04-d1b4-4cc9-bb91-08d216345cbb" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f90d0821-d8a2-41b2-89be-e1dabb9f1e48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f90d0821-d8a2-41b2-89be-e1dabb9f1e48_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f90d0821-d8a2-41b2-89be-e1dabb9f1e48" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f90d0821-d8a2-41b2-89be-e1dabb9f1e48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b8d8b437-71a5-4ded-98bf-4477be876962" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f90d0821-d8a2-41b2-89be-e1dabb9f1e48" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b8d8b437-71a5-4ded-98bf-4477be876962" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_641365dc-4174-4ee7-96d0-9cb741ff168b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b8d8b437-71a5-4ded-98bf-4477be876962" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_641365dc-4174-4ee7-96d0-9cb741ff168b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_40ee74c2-04fb-4ce9-b9ba-bea35bc2d062" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b8d8b437-71a5-4ded-98bf-4477be876962" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_40ee74c2-04fb-4ce9-b9ba-bea35bc2d062" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b44b4f48-c95a-4b61-b450-a9a7d9cf6b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b8d8b437-71a5-4ded-98bf-4477be876962" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b44b4f48-c95a-4b61-b450-a9a7d9cf6b3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_14a50e29-2bce-4743-b622-12e282bc0227" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b8d8b437-71a5-4ded-98bf-4477be876962" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_14a50e29-2bce-4743-b622-12e282bc0227" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_5929ce78-a2b1-4348-ad17-cc7c3c77568e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_343140ee-0a39-40ab-9f32-4e6ab6b93673" xlink:to="loc_us-gaap_DerivativeNotionalAmount_5929ce78-a2b1-4348-ad17-cc7c3c77568e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_1d4304aa-12b3-42cb-a250-72ac6fce6e53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_343140ee-0a39-40ab-9f32-4e6ab6b93673" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_1d4304aa-12b3-42cb-a250-72ac6fce6e53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_70ccb687-f5c4-4095-afb8-2d0f0be9bcc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_343140ee-0a39-40ab-9f32-4e6ab6b93673" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_70ccb687-f5c4-4095-afb8-2d0f0be9bcc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_afbca11b-f9e0-4444-be12-5e63267fa0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_343140ee-0a39-40ab-9f32-4e6ab6b93673" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_afbca11b-f9e0-4444-be12-5e63267fa0a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_77cb1642-1a9d-47ed-b42c-c587c896808a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_343140ee-0a39-40ab-9f32-4e6ab6b93673" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_77cb1642-1a9d-47ed-b42c-c587c896808a" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#DerivativeInstrumentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e90b55da-bb33-4a1e-8e37-bcd20badbded" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_431bcaf1-9af6-4668-91c9-1f60550ea766" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e90b55da-bb33-4a1e-8e37-bcd20badbded" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_431bcaf1-9af6-4668-91c9-1f60550ea766" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_8cbb7a30-c916-47ab-ae84-945e857c47ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_431bcaf1-9af6-4668-91c9-1f60550ea766" xlink:to="loc_us-gaap_HedgingDesignationAxis_8cbb7a30-c916-47ab-ae84-945e857c47ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8cbb7a30-c916-47ab-ae84-945e857c47ea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_8cbb7a30-c916-47ab-ae84-945e857c47ea" xlink:to="loc_us-gaap_HedgingDesignationDomain_8cbb7a30-c916-47ab-ae84-945e857c47ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c9eb5d6a-21a6-4a7d-b32e-f8df59c4187a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_8cbb7a30-c916-47ab-ae84-945e857c47ea" xlink:to="loc_us-gaap_HedgingDesignationDomain_c9eb5d6a-21a6-4a7d-b32e-f8df59c4187a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_05a0eb85-a739-469b-9f4f-61e4d2b22bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_c9eb5d6a-21a6-4a7d-b32e-f8df59c4187a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_05a0eb85-a739-469b-9f4f-61e4d2b22bc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e1e39c73-c228-4de9-9b97-9af50f8e4070" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_431bcaf1-9af6-4668-91c9-1f60550ea766" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e1e39c73-c228-4de9-9b97-9af50f8e4070" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e1e39c73-c228-4de9-9b97-9af50f8e4070_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e1e39c73-c228-4de9-9b97-9af50f8e4070" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e1e39c73-c228-4de9-9b97-9af50f8e4070_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e4d09c9b-884c-4360-bde8-c76486569bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e1e39c73-c228-4de9-9b97-9af50f8e4070" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e4d09c9b-884c-4360-bde8-c76486569bcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a59085c8-02c7-4b1c-afaf-43802a02b8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e4d09c9b-884c-4360-bde8-c76486569bcd" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a59085c8-02c7-4b1c-afaf-43802a02b8a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_cd6265a4-a334-4f64-80e0-fb92f51b1e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e4d09c9b-884c-4360-bde8-c76486569bcd" xlink:to="loc_us-gaap_InterestRateSwapMember_cd6265a4-a334-4f64-80e0-fb92f51b1e5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_f2211354-fdec-4ea4-8d63-3242b757fcb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e4d09c9b-884c-4360-bde8-c76486569bcd" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_f2211354-fdec-4ea4-8d63-3242b757fcb6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_756d4ccd-b948-4e20-b5f5-1d14bc1d4aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_431bcaf1-9af6-4668-91c9-1f60550ea766" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_756d4ccd-b948-4e20-b5f5-1d14bc1d4aa5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_756d4ccd-b948-4e20-b5f5-1d14bc1d4aa5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_756d4ccd-b948-4e20-b5f5-1d14bc1d4aa5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_756d4ccd-b948-4e20-b5f5-1d14bc1d4aa5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_08838301-9e5d-434c-b814-159400cf2705" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_756d4ccd-b948-4e20-b5f5-1d14bc1d4aa5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_08838301-9e5d-434c-b814-159400cf2705" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_7d1858ef-5b4e-4054-bd3b-1c2393d5d3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_08838301-9e5d-434c-b814-159400cf2705" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_7d1858ef-5b4e-4054-bd3b-1c2393d5d3a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e0fd0e20-dfcc-4609-aa6b-6b7ac78f2711" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e90b55da-bb33-4a1e-8e37-bcd20badbded" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e0fd0e20-dfcc-4609-aa6b-6b7ac78f2711" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_2b337797-c220-4d99-8f82-db1c7caffbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e90b55da-bb33-4a1e-8e37-bcd20badbded" xlink:to="loc_us-gaap_DerivativeTermOfContract_2b337797-c220-4d99-8f82-db1c7caffbdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_27217e60-2fde-4da6-8742-c804b7f87469" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e90b55da-bb33-4a1e-8e37-bcd20badbded" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_27217e60-2fde-4da6-8742-c804b7f87469" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_fe77c023-493f-41f4-891f-999486a9de6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e90b55da-bb33-4a1e-8e37-bcd20badbded" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_fe77c023-493f-41f4-891f-999486a9de6e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b1193b73-0d75-4f33-960c-a641324843dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e90b55da-bb33-4a1e-8e37-bcd20badbded" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b1193b73-0d75-4f33-960c-a641324843dd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_e45afa04-108f-488c-b622-810b77484461" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e90b55da-bb33-4a1e-8e37-bcd20badbded" xlink:to="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_e45afa04-108f-488c-b622-810b77484461" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#DerivativeInstrumentsMovementsoutofOCIDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_1bed0401-c301-493f-a082-5f0a9143fbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c178efa7-a23e-4738-b01d-ba20aff0efdc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_1bed0401-c301-493f-a082-5f0a9143fbdd" xlink:to="loc_us-gaap_DerivativeTable_c178efa7-a23e-4738-b01d-ba20aff0efdc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_8939722f-a6a4-45bd-9c47-e3e293336687" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c178efa7-a23e-4738-b01d-ba20aff0efdc" xlink:to="loc_us-gaap_HedgingDesignationAxis_8939722f-a6a4-45bd-9c47-e3e293336687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8939722f-a6a4-45bd-9c47-e3e293336687_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_8939722f-a6a4-45bd-9c47-e3e293336687" xlink:to="loc_us-gaap_HedgingDesignationDomain_8939722f-a6a4-45bd-9c47-e3e293336687_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_01413e24-8909-43e1-9245-6697219827ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_8939722f-a6a4-45bd-9c47-e3e293336687" xlink:to="loc_us-gaap_HedgingDesignationDomain_01413e24-8909-43e1-9245-6697219827ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_da7c8f24-0613-4634-9666-5a00c24e37dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_01413e24-8909-43e1-9245-6697219827ee" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_da7c8f24-0613-4634-9666-5a00c24e37dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_550659af-12ba-4f3c-a6e1-c99f091f4ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_01413e24-8909-43e1-9245-6697219827ee" xlink:to="loc_us-gaap_NondesignatedMember_550659af-12ba-4f3c-a6e1-c99f091f4ef0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_982ab895-0973-4cc9-92e4-5e4f8f155919" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c178efa7-a23e-4738-b01d-ba20aff0efdc" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_982ab895-0973-4cc9-92e4-5e4f8f155919" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_982ab895-0973-4cc9-92e4-5e4f8f155919_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_982ab895-0973-4cc9-92e4-5e4f8f155919" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_982ab895-0973-4cc9-92e4-5e4f8f155919_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_efc6fe27-1751-410e-8ede-7d53c7ce4f97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_982ab895-0973-4cc9-92e4-5e4f8f155919" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_efc6fe27-1751-410e-8ede-7d53c7ce4f97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e26f6db8-d8f5-4ec8-b9ca-fdd96103ccab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_efc6fe27-1751-410e-8ede-7d53c7ce4f97" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e26f6db8-d8f5-4ec8-b9ca-fdd96103ccab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_176f05e2-1dcd-44c5-b83a-86bad6630482" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c178efa7-a23e-4738-b01d-ba20aff0efdc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_176f05e2-1dcd-44c5-b83a-86bad6630482" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_176f05e2-1dcd-44c5-b83a-86bad6630482_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_176f05e2-1dcd-44c5-b83a-86bad6630482" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_176f05e2-1dcd-44c5-b83a-86bad6630482_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9013e47c-c02b-434e-905a-37b96cd03dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_176f05e2-1dcd-44c5-b83a-86bad6630482" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9013e47c-c02b-434e-905a-37b96cd03dfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d96bafcd-0cb2-48e5-bc30-582081806fae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9013e47c-c02b-434e-905a-37b96cd03dfe" xlink:to="loc_us-gaap_CostOfSalesMember_d96bafcd-0cb2-48e5-bc30-582081806fae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherIncomeexpenseMember_f046b409-4662-42fa-90bb-708b03f29bfb" xlink:href="syk-20241231.xsd#syk_OtherIncomeexpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9013e47c-c02b-434e-905a-37b96cd03dfe" xlink:to="loc_syk_OtherIncomeexpenseMember_f046b409-4662-42fa-90bb-708b03f29bfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_0287c24f-87c9-42a2-93f0-7085379e9985" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1bed0401-c301-493f-a082-5f0a9143fbdd" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_0287c24f-87c9-42a2-93f0-7085379e9985" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_d631ceee-622a-4d70-9a62-fb917416f03c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1bed0401-c301-493f-a082-5f0a9143fbdd" xlink:to="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_d631ceee-622a-4d70-9a62-fb917416f03c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7712bb9c-478a-4e12-b170-27979d210803" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_3bc98e0c-e669-404d-be74-f817a50a7d05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7712bb9c-478a-4e12-b170-27979d210803" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_3bc98e0c-e669-404d-be74-f817a50a7d05" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1cb1ed3c-f30f-42c5-aaa3-d198bb258063" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_3bc98e0c-e669-404d-be74-f817a50a7d05" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1cb1ed3c-f30f-42c5-aaa3-d198bb258063" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1cb1ed3c-f30f-42c5-aaa3-d198bb258063_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1cb1ed3c-f30f-42c5-aaa3-d198bb258063" xlink:to="loc_us-gaap_EquityComponentDomain_1cb1ed3c-f30f-42c5-aaa3-d198bb258063_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e154da4c-0c92-480a-88e8-085b2c5cf097" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1cb1ed3c-f30f-42c5-aaa3-d198bb258063" xlink:to="loc_us-gaap_EquityComponentDomain_e154da4c-0c92-480a-88e8-085b2c5cf097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_08403766-ea40-490b-8c05-9166e35b8f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e154da4c-0c92-480a-88e8-085b2c5cf097" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_08403766-ea40-490b-8c05-9166e35b8f7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d5630b4b-036f-463c-8ccf-cc8e1781c79e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e154da4c-0c92-480a-88e8-085b2c5cf097" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d5630b4b-036f-463c-8ccf-cc8e1781c79e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_b3e32f4f-917b-4344-9452-4543f541402a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e154da4c-0c92-480a-88e8-085b2c5cf097" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_b3e32f4f-917b-4344-9452-4543f541402a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d169a709-45b2-4be8-acf6-ecefba86b1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e154da4c-0c92-480a-88e8-085b2c5cf097" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d169a709-45b2-4be8-acf6-ecefba86b1e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_34bf3749-ad80-4950-9d39-672d1f724b59" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_3bc98e0c-e669-404d-be74-f817a50a7d05" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_34bf3749-ad80-4950-9d39-672d1f724b59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_34bf3749-ad80-4950-9d39-672d1f724b59_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_34bf3749-ad80-4950-9d39-672d1f724b59" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_34bf3749-ad80-4950-9d39-672d1f724b59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_c0dd19b9-b621-4f23-abdb-8706de107b64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_34bf3749-ad80-4950-9d39-672d1f724b59" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_c0dd19b9-b621-4f23-abdb-8706de107b64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_5ac16570-2691-4013-b47b-7e5c50ef41f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_c0dd19b9-b621-4f23-abdb-8706de107b64" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_5ac16570-2691-4013-b47b-7e5c50ef41f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7712bb9c-478a-4e12-b170-27979d210803" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1533b411-e2b8-4f72-bdb1-27f239ba09ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1533b411-e2b8-4f72-bdb1-27f239ba09ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_6387048a-960b-4766-be75-2a1d465a1efb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_6387048a-960b-4766-be75-2a1d465a1efb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_b562a152-8f01-4b95-b0b4-5bab29835b79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_b562a152-8f01-4b95-b0b4-5bab29835b79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_1b81970c-7593-4ea6-9361-031a9f6998e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:to="loc_us-gaap_CostOfRevenue_1b81970c-7593-4ea6-9361-031a9f6998e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f4c84a8a-7da8-4e10-9833-5540513b20f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_f4c84a8a-7da8-4e10-9833-5540513b20f5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f6b32df6-d321-4033-b5bc-dd5691abd35c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f6b32df6-d321-4033-b5bc-dd5691abd35c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c56116ee-8638-4cce-beb5-4c555250a2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c56116ee-8638-4cce-beb5-4c555250a2fd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c5bf6438-32ac-4caf-8a82-6503847e843f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#AcquisitionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5f620c31-9261-4174-9f1d-69527491e571" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_541c91bd-8ff6-49e6-a1bd-91652271af18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5f620c31-9261-4174-9f1d-69527491e571" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_541c91bd-8ff6-49e6-a1bd-91652271af18" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8bada6c6-d2ba-486f-8a6b-e9e1abfff1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_541c91bd-8ff6-49e6-a1bd-91652271af18" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8bada6c6-d2ba-486f-8a6b-e9e1abfff1c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8bada6c6-d2ba-486f-8a6b-e9e1abfff1c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8bada6c6-d2ba-486f-8a6b-e9e1abfff1c3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8bada6c6-d2ba-486f-8a6b-e9e1abfff1c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34edde6d-472d-4ae2-b48e-c073e3b9d584" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8bada6c6-d2ba-486f-8a6b-e9e1abfff1c3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34edde6d-472d-4ae2-b48e-c073e3b9d584" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_VariousMember_004281ba-9bf9-4768-803f-b84d2ecda601" xlink:href="syk-20241231.xsd#syk_VariousMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34edde6d-472d-4ae2-b48e-c073e3b9d584" xlink:to="loc_syk_VariousMember_004281ba-9bf9-4768-803f-b84d2ecda601" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CerusMember_4c03ba41-4f30-4841-b4cd-dee56ebb1284" xlink:href="syk-20241231.xsd#syk_CerusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34edde6d-472d-4ae2-b48e-c073e3b9d584" xlink:to="loc_syk_CerusMember_4c03ba41-4f30-4841-b4cd-dee56ebb1284" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b03c4f18-5919-4b2c-b244-a5c2daf493df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5f620c31-9261-4174-9f1d-69527491e571" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b03c4f18-5919-4b2c-b244-a5c2daf493df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_8bdc4957-42f7-48f2-bd12-36d27af571e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5f620c31-9261-4174-9f1d-69527491e571" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_8bdc4957-42f7-48f2-bd12-36d27af571e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b92eddfb-6b7b-43b7-ba8f-2cb81d9c7377" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5f620c31-9261-4174-9f1d-69527491e571" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b92eddfb-6b7b-43b7-ba8f-2cb81d9c7377" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5be98638-2ffa-4d2b-8ae9-8cb08f98c82d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5f620c31-9261-4174-9f1d-69527491e571" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5be98638-2ffa-4d2b-8ae9-8cb08f98c82d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_d763cdcb-791a-47ab-9acd-03d8b14b9e12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5f620c31-9261-4174-9f1d-69527491e571" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_d763cdcb-791a-47ab-9acd-03d8b14b9e12" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6f323eb-a596-4c50-8279-e362fde7e7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6f323eb-a596-4c50-8279-e362fde7e7e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c6621a7d-186f-4be8-baa3-0f59be4a8368" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6f323eb-a596-4c50-8279-e362fde7e7e5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c6621a7d-186f-4be8-baa3-0f59be4a8368" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6621a7d-186f-4be8-baa3-0f59be4a8368_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c6621a7d-186f-4be8-baa3-0f59be4a8368" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6621a7d-186f-4be8-baa3-0f59be4a8368_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4dc776c9-c1bc-48bc-8bbe-bbef5e560be2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c6621a7d-186f-4be8-baa3-0f59be4a8368" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4dc776c9-c1bc-48bc-8bbe-bbef5e560be2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_VariousMember_82ea2bba-9e39-49ad-81e1-ffa04ad02265" xlink:href="syk-20241231.xsd#syk_VariousMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4dc776c9-c1bc-48bc-8bbe-bbef5e560be2" xlink:to="loc_syk_VariousMember_82ea2bba-9e39-49ad-81e1-ffa04ad02265" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CerusMember_0275306c-d4d6-4b6b-9566-68fa036ef91d" xlink:href="syk-20241231.xsd#syk_CerusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4dc776c9-c1bc-48bc-8bbe-bbef5e560be2" xlink:to="loc_syk_CerusMember_0275306c-d4d6-4b6b-9566-68fa036ef91d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_778f68a1-cbd8-4480-b188-d62c32c28f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6f323eb-a596-4c50-8279-e362fde7e7e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_778f68a1-cbd8-4480-b188-d62c32c28f1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_778f68a1-cbd8-4480-b188-d62c32c28f1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_778f68a1-cbd8-4480-b188-d62c32c28f1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_778f68a1-cbd8-4480-b188-d62c32c28f1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_778f68a1-cbd8-4480-b188-d62c32c28f1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CustomerAndDistributorRelationshipsMember_7a8b9211-c427-4eca-9e25-52932a96f8f6" xlink:href="syk-20241231.xsd#syk_CustomerAndDistributorRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:to="loc_syk_CustomerAndDistributorRelationshipsMember_7a8b9211-c427-4eca-9e25-52932a96f8f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_a58a4c4c-af72-4631-b009-7d621f4bb1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_a58a4c4c-af72-4631-b009-7d621f4bb1c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_9a037099-56cb-449d-a9d0-3cdb3d4f6925" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:to="loc_us-gaap_TradeNamesMember_9a037099-56cb-449d-a9d0-3cdb3d4f6925" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_23f34f2d-fc47-4533-ad74-f0fe7c00a952" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:to="loc_us-gaap_CustomerRelationshipsMember_23f34f2d-fc47-4533-ad74-f0fe7c00a952" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_2a6a86d9-7cf0-42ab-b755-76a72b12dd51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:to="loc_us-gaap_TrademarksMember_2a6a86d9-7cf0-42ab-b755-76a72b12dd51" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_53ac51e2-c482-44c0-8021-f982af820855" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:to="loc_us-gaap_PatentsMember_53ac51e2-c482-44c0-8021-f982af820855" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_f45ef898-1099-4820-a730-6ef5d0458a09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_f45ef898-1099-4820-a730-6ef5d0458a09" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a5aec1d4-01ef-4cdc-bab8-5e23ac2c2c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a5aec1d4-01ef-4cdc-bab8-5e23ac2c2c2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_7a029da2-93d2-4346-8a9e-980ed00b42b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_7a029da2-93d2-4346-8a9e-980ed00b42b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_177e7d8d-b5b5-4644-87d9-d9783463a6da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_177e7d8d-b5b5-4644-87d9-d9783463a6da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_12bb35e5-f89f-499a-9ea6-3bf95d0a7c87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_12bb35e5-f89f-499a-9ea6-3bf95d0a7c87" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_6191251e-413b-4830-8245-8f4e94608b72" xlink:href="syk-20241231.xsd#syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_6191251e-413b-4830-8245-8f4e94608b72" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f336e235-57c9-4972-8245-6f4fc28adcde" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f336e235-57c9-4972-8245-6f4fc28adcde" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_e4e86d7c-6045-40e1-9c06-21613ba98726" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_e4e86d7c-6045-40e1-9c06-21613ba98726" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_8ed368a5-7158-42cb-b5d3-068fb413afdf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_8ed368a5-7158-42cb-b5d3-068fb413afdf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0be612d5-e273-4dcb-a1c1-53275a83e4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_Goodwill_0be612d5-e273-4dcb-a1c1-53275a83e4e9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_21ed114e-ce16-482f-8629-b7652b30cb80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_21ed114e-ce16-482f-8629-b7652b30cb80" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_8c1fed0e-0025-4797-a68c-1ebe0d186bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_8c1fed0e-0025-4797-a68c-1ebe0d186bb4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_f10a0202-b1cf-4ee0-9797-ef175486cdab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_f10a0202-b1cf-4ee0-9797-ef175486cdab" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#ContingenciesandCommitmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_617b2286-b797-4563-93d0-6a8ee9ff93ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_2357e6ab-6839-46a0-9715-ace0622131b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_617b2286-b797-4563-93d0-6a8ee9ff93ef" xlink:to="loc_us-gaap_LossContingenciesTable_2357e6ab-6839-46a0-9715-ace0622131b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_41938610-ff1a-4f9d-8d65-318dcd311532" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2357e6ab-6839-46a0-9715-ace0622131b2" xlink:to="loc_srt_LitigationCaseAxis_41938610-ff1a-4f9d-8d65-318dcd311532" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_41938610-ff1a-4f9d-8d65-318dcd311532_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_41938610-ff1a-4f9d-8d65-318dcd311532" xlink:to="loc_srt_LitigationCaseTypeDomain_41938610-ff1a-4f9d-8d65-318dcd311532_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2f9529bd-4a86-4af3-bcbb-f88c9cbef172" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_41938610-ff1a-4f9d-8d65-318dcd311532" xlink:to="loc_srt_LitigationCaseTypeDomain_2f9529bd-4a86-4af3-bcbb-f88c9cbef172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_RecallMattersMember_15b665ca-55e4-4a67-8443-62cb4adb4ec6" xlink:href="syk-20241231.xsd#syk_RecallMattersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_2f9529bd-4a86-4af3-bcbb-f88c9cbef172" xlink:to="loc_syk_RecallMattersMember_15b665ca-55e4-4a67-8443-62cb4adb4ec6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_24c1aa55-b7ae-400f-b63b-2afb849fe05d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_617b2286-b797-4563-93d0-6a8ee9ff93ef" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_24c1aa55-b7ae-400f-b63b-2afb849fe05d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_c714edc5-bd5b-496b-a643-f0f68ba0c7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_617b2286-b797-4563-93d0-6a8ee9ff93ef" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_c714edc5-bd5b-496b-a643-f0f68ba0c7d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_2e60277d-f514-4831-88f0-a485a0401dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_617b2286-b797-4563-93d0-6a8ee9ff93ef" xlink:to="loc_us-gaap_OperatingLeaseExpense_2e60277d-f514-4831-88f0-a485a0401dc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationCurrent_524cab76-e38d-40d7-bd2e-45e2b59fc7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_617b2286-b797-4563-93d0-6a8ee9ff93ef" xlink:to="loc_us-gaap_SupplierFinanceProgramObligationCurrent_524cab76-e38d-40d7-bd2e-45e2b59fc7d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration_8ba992d8-1f70-485f-aee4-2329e164736c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_617b2286-b797-4563-93d0-6a8ee9ff93ef" xlink:to="loc_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration_8ba992d8-1f70-485f-aee4-2329e164736c" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#GoodwillandOtherIntangibleAssetsGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_1d8a5e47-d1ed-4097-bcec-6c4d384e8ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_33b40116-46b0-4635-9441-8b4f7bff585d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_1d8a5e47-d1ed-4097-bcec-6c4d384e8ab8" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_33b40116-46b0-4635-9441-8b4f7bff585d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_57219b17-53c8-4e55-857f-6738d147b5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_33b40116-46b0-4635-9441-8b4f7bff585d" xlink:to="loc_us-gaap_ReportingUnitAxis_57219b17-53c8-4e55-857f-6738d147b5bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_57219b17-53c8-4e55-857f-6738d147b5bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_57219b17-53c8-4e55-857f-6738d147b5bd" xlink:to="loc_us-gaap_ReportingUnitDomain_57219b17-53c8-4e55-857f-6738d147b5bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_6f1ff2cf-5726-4c30-9145-6581478ccdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_57219b17-53c8-4e55-857f-6738d147b5bd" xlink:to="loc_us-gaap_ReportingUnitDomain_6f1ff2cf-5726-4c30-9145-6581478ccdf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpineReportingUnitMember_e8b7b880-55d7-4506-aec5-2cbeb7d8f862" xlink:href="syk-20241231.xsd#syk_SpineReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_6f1ff2cf-5726-4c30-9145-6581478ccdf0" xlink:to="loc_syk_SpineReportingUnitMember_e8b7b880-55d7-4506-aec5-2cbeb7d8f862" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_1d306e1f-ded3-4f3b-8f73-58e244c2a17e" xlink:href="syk-20241231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_6f1ff2cf-5726-4c30-9145-6581478ccdf0" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_1d306e1f-ded3-4f3b-8f73-58e244c2a17e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsMember_eeb0b493-38cd-45be-ab74-0f673ffb3fdb" xlink:href="syk-20241231.xsd#syk_OrthopaedicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_6f1ff2cf-5726-4c30-9145-6581478ccdf0" xlink:to="loc_syk_OrthopaedicsMember_eeb0b493-38cd-45be-ab74-0f673ffb3fdb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1d52c770-7f3f-44ee-bb37-cf9bbf09c380" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_33b40116-46b0-4635-9441-8b4f7bff585d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1d52c770-7f3f-44ee-bb37-cf9bbf09c380" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1d52c770-7f3f-44ee-bb37-cf9bbf09c380_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1d52c770-7f3f-44ee-bb37-cf9bbf09c380" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1d52c770-7f3f-44ee-bb37-cf9bbf09c380_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_692475a5-c3b0-43af-bf35-24d4a6de1b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1d52c770-7f3f-44ee-bb37-cf9bbf09c380" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_692475a5-c3b0-43af-bf35-24d4a6de1b3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpinalImplantsMember_d387c26c-4ec8-489b-88aa-921f53ae25bb" xlink:href="syk-20241231.xsd#syk_SpinalImplantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_692475a5-c3b0-43af-bf35-24d4a6de1b3c" xlink:to="loc_syk_SpinalImplantsMember_d387c26c-4ec8-489b-88aa-921f53ae25bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4d613e06-b423-4174-945d-3887cf5b4213" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_33b40116-46b0-4635-9441-8b4f7bff585d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4d613e06-b423-4174-945d-3887cf5b4213" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4d613e06-b423-4174-945d-3887cf5b4213_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4d613e06-b423-4174-945d-3887cf5b4213" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4d613e06-b423-4174-945d-3887cf5b4213_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e541b5d9-f94b-4e27-9be6-1c8159696e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4d613e06-b423-4174-945d-3887cf5b4213" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e541b5d9-f94b-4e27-9be6-1c8159696e2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2d0bf4f7-f567-46aa-89f7-3c4de33b0c39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e541b5d9-f94b-4e27-9be6-1c8159696e2b" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2d0bf4f7-f567-46aa-89f7-3c4de33b0c39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_56006251-36e1-4a99-b3e1-3ac09879b919" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_33b40116-46b0-4635-9441-8b4f7bff585d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_56006251-36e1-4a99-b3e1-3ac09879b919" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_56006251-36e1-4a99-b3e1-3ac09879b919_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_56006251-36e1-4a99-b3e1-3ac09879b919" xlink:to="loc_us-gaap_SegmentDomain_56006251-36e1-4a99-b3e1-3ac09879b919_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_99166100-30ee-4605-ad67-620450475501" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_56006251-36e1-4a99-b3e1-3ac09879b919" xlink:to="loc_us-gaap_SegmentDomain_99166100-30ee-4605-ad67-620450475501" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_9afacfeb-5ee4-4e20-9e82-be77dc5490ef" xlink:href="syk-20241231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_99166100-30ee-4605-ad67-620450475501" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_9afacfeb-5ee4-4e20-9e82-be77dc5490ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_1754fe02-b201-47fd-9693-7f3e2f4c29aa" xlink:href="syk-20241231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_99166100-30ee-4605-ad67-620450475501" xlink:to="loc_syk_OrthopaedicsAndSpineMember_1754fe02-b201-47fd-9693-7f3e2f4c29aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2cbf4af9-6ffd-4dea-a33c-c461ef7a02ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1d8a5e47-d1ed-4097-bcec-6c4d384e8ab8" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2cbf4af9-6ffd-4dea-a33c-c461ef7a02ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_42c927ad-0183-4f02-a793-5c37a231e9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1d8a5e47-d1ed-4097-bcec-6c4d384e8ab8" xlink:to="loc_us-gaap_GoodwillTransfers_42c927ad-0183-4f02-a793-5c37a231e9ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_8be7aa99-0715-4fe0-bcbd-db3c631f52f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1d8a5e47-d1ed-4097-bcec-6c4d384e8ab8" xlink:to="loc_us-gaap_GoodwillRollForward_8be7aa99-0715-4fe0-bcbd-db3c631f52f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c08dc27b-2c50-4e76-ad4b-86d0e2e4d3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_8be7aa99-0715-4fe0-bcbd-db3c631f52f7" xlink:to="loc_us-gaap_Goodwill_c08dc27b-2c50-4e76-ad4b-86d0e2e4d3ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_9db06b6c-6c2a-45a0-a0f7-9f8850826a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_8be7aa99-0715-4fe0-bcbd-db3c631f52f7" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_9db06b6c-6c2a-45a0-a0f7-9f8850826a8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_f86b5c79-e698-4037-9914-7cd77a96c68d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_8be7aa99-0715-4fe0-bcbd-db3c631f52f7" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_f86b5c79-e698-4037-9914-7cd77a96c68d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_0583d4c5-aa5f-4b06-8b88-3a253c7c7d90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_40b57520-c89c-4201-a468-bef2db4f0a99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fe03aefb-058a-41c5-b55e-2e41b16d8c34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_92a420b9-cb66-41a1-ae44-d45dacd4f79f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fe03aefb-058a-41c5-b55e-2e41b16d8c34" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_92a420b9-cb66-41a1-ae44-d45dacd4f79f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7ca911df-e8d0-44d0-854a-83df556b619f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_92a420b9-cb66-41a1-ae44-d45dacd4f79f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7ca911df-e8d0-44d0-854a-83df556b619f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7ca911df-e8d0-44d0-854a-83df556b619f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7ca911df-e8d0-44d0-854a-83df556b619f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7ca911df-e8d0-44d0-854a-83df556b619f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4047882b-6a9a-4326-b3be-4bb75fcdbf25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7ca911df-e8d0-44d0-854a-83df556b619f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4047882b-6a9a-4326-b3be-4bb75fcdbf25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_746254ee-619a-400e-adab-cd864776be4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4047882b-6a9a-4326-b3be-4bb75fcdbf25" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_746254ee-619a-400e-adab-cd864776be4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_bd9d2a55-5e42-4f4c-bd0f-11bb4087e128" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4047882b-6a9a-4326-b3be-4bb75fcdbf25" xlink:to="loc_us-gaap_CustomerRelationshipsMember_bd9d2a55-5e42-4f4c-bd0f-11bb4087e128" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_f6ebdaa3-56b5-4c04-bb53-feb317a30d58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4047882b-6a9a-4326-b3be-4bb75fcdbf25" xlink:to="loc_us-gaap_PatentsMember_f6ebdaa3-56b5-4c04-bb53-feb317a30d58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_7b5d9755-cc92-4fe2-8c98-dcb2704d8365" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4047882b-6a9a-4326-b3be-4bb75fcdbf25" xlink:to="loc_us-gaap_TrademarksMember_7b5d9755-cc92-4fe2-8c98-dcb2704d8365" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_c069221f-555b-4323-9567-934249f188bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4047882b-6a9a-4326-b3be-4bb75fcdbf25" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_c069221f-555b-4323-9567-934249f188bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_b94c5e77-a776-49b8-a825-bd41743a291e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4047882b-6a9a-4326-b3be-4bb75fcdbf25" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_b94c5e77-a776-49b8-a825-bd41743a291e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3d77323e-5a4f-47da-9f50-22cf4c280dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fe03aefb-058a-41c5-b55e-2e41b16d8c34" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3d77323e-5a4f-47da-9f50-22cf4c280dc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ea26e071-0ce6-491a-b144-ab225affe529" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fe03aefb-058a-41c5-b55e-2e41b16d8c34" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ea26e071-0ce6-491a-b144-ab225affe529" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c2b67de9-e91d-4efe-a2d4-8be3541c2e04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fe03aefb-058a-41c5-b55e-2e41b16d8c34" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c2b67de9-e91d-4efe-a2d4-8be3541c2e04" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#CapitalStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/CapitalStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_34e51eed-b865-44e6-84b0-9d42b5ec6e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_34e51eed-b865-44e6-84b0-9d42b5ec6e9a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d6bbce6a-981b-4cca-ab59-c89246805d97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_34e51eed-b865-44e6-84b0-9d42b5ec6e9a" xlink:to="loc_us-gaap_AwardTypeAxis_d6bbce6a-981b-4cca-ab59-c89246805d97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d6bbce6a-981b-4cca-ab59-c89246805d97_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d6bbce6a-981b-4cca-ab59-c89246805d97" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d6bbce6a-981b-4cca-ab59-c89246805d97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8065569-d571-44e3-92b8-bf215e6559c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d6bbce6a-981b-4cca-ab59-c89246805d97" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8065569-d571-44e3-92b8-bf215e6559c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2677a993-c81b-4145-b9ab-3043c17a0c77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8065569-d571-44e3-92b8-bf215e6559c8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2677a993-c81b-4145-b9ab-3043c17a0c77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_ab347379-a878-4e70-855a-c838a4eb3346" xlink:href="syk-20241231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8065569-d571-44e3-92b8-bf215e6559c8" xlink:to="loc_syk_PerformanceStockUnitPsusMember_ab347379-a878-4e70-855a-c838a4eb3346" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_3e1d2ae4-94a8-4825-bdd4-f15ae696e45a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8065569-d571-44e3-92b8-bf215e6559c8" xlink:to="loc_us-gaap_EmployeeStockMember_3e1d2ae4-94a8-4825-bdd4-f15ae696e45a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CommonAndPreferredStockSharesAuthorized_a6be202d-eaf0-4024-8f11-25ba64190c41" xlink:href="syk-20241231.xsd#syk_CommonAndPreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_syk_CommonAndPreferredStockSharesAuthorized_a6be202d-eaf0-4024-8f11-25ba64190c41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_64c74ee7-1f22-48ec-bf21-f8d66def70b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_64c74ee7-1f22-48ec-bf21-f8d66def70b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9c949877-f8e9-40b2-9631-667c198b00d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9c949877-f8e9-40b2-9631-667c198b00d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_19b22191-04a0-42cb-a345-619e4b77004c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_19b22191-04a0-42cb-a345-619e4b77004c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8d1dfa3d-d6e0-46cb-9269-5716e404ad37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8d1dfa3d-d6e0-46cb-9269-5716e404ad37" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_ee3ff28e-7bb0-4b34-bac0-2e0142e2dac7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_ee3ff28e-7bb0-4b34-bac0-2e0142e2dac7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_4cc4cc9c-245b-44a0-9573-891e648e7a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_4cc4cc9c-245b-44a0-9573-891e648e7a2f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_abc9e33e-1962-4e75-bc93-25f4b978efc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_abc9e33e-1962-4e75-bc93-25f4b978efc4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0a3dc5da-d08c-4fe5-a8fc-cbbb410ffc70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0a3dc5da-d08c-4fe5-a8fc-cbbb410ffc70" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_f8529ed6-9025-426e-8a12-2410ca08970a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_f8529ed6-9025-426e-8a12-2410ca08970a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_25450403-05a9-49c6-97a7-93c4ab829f86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_25450403-05a9-49c6-97a7-93c4ab829f86" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_40ce7b5f-9759-4dd6-8939-a350b9d7810f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_40ce7b5f-9759-4dd6-8939-a350b9d7810f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f6f4285e-cd9c-42ab-9d6f-102b1e68c310" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f6f4285e-cd9c-42ab-9d6f-102b1e68c310" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_404c87b5-fc53-4f14-8392-4a4e6cc51de0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_404c87b5-fc53-4f14-8392-4a4e6cc51de0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_5f829154-4caa-476e-8af6-2f313c18bb3e" xlink:href="syk-20241231.xsd#syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_5f829154-4caa-476e-8af6-2f313c18bb3e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_0811a6aa-cf4f-499b-bf42-db4626ff83dd" xlink:href="syk-20241231.xsd#syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_0811a6aa-cf4f-499b-bf42-db4626ff83dd" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1ab9397d-302f-4b33-a764-af79f4e1eed6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1ab9397d-302f-4b33-a764-af79f4e1eed6" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#CapitalStockSummaryofRSUandPSUActivityDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_afc42930-055b-413b-a6e3-e531e2c26ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_a8fd5c21-989b-4ac2-a256-e3fa0f1d5c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_afc42930-055b-413b-a6e3-e531e2c26ad8" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_a8fd5c21-989b-4ac2-a256-e3fa0f1d5c2d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_67b5bc21-2658-4855-acdd-2223ce52dc12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a8fd5c21-989b-4ac2-a256-e3fa0f1d5c2d" xlink:to="loc_us-gaap_AwardTypeAxis_67b5bc21-2658-4855-acdd-2223ce52dc12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67b5bc21-2658-4855-acdd-2223ce52dc12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_67b5bc21-2658-4855-acdd-2223ce52dc12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67b5bc21-2658-4855-acdd-2223ce52dc12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_97fffc06-ed71-408b-9a65-a7dbb1057fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_67b5bc21-2658-4855-acdd-2223ce52dc12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_97fffc06-ed71-408b-9a65-a7dbb1057fbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e4bd45e5-3f85-4f30-a73b-d7304118a336" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_97fffc06-ed71-408b-9a65-a7dbb1057fbb" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e4bd45e5-3f85-4f30-a73b-d7304118a336" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_a59e0926-4885-43c4-97ba-b9f66ab9cb70" xlink:href="syk-20241231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_97fffc06-ed71-408b-9a65-a7dbb1057fbb" xlink:to="loc_syk_PerformanceStockUnitPsusMember_a59e0926-4885-43c4-97ba-b9f66ab9cb70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51c9cfd-708f-42b3-abcc-25c8ee784a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_afc42930-055b-413b-a6e3-e531e2c26ad8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51c9cfd-708f-42b3-abcc-25c8ee784a6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_42cdeac1-91c0-4080-b1b1-95ccf83b178c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51c9cfd-708f-42b3-abcc-25c8ee784a6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_42cdeac1-91c0-4080-b1b1-95ccf83b178c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1155ac2f-2596-4a3c-93aa-0b55f11a37a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51c9cfd-708f-42b3-abcc-25c8ee784a6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1155ac2f-2596-4a3c-93aa-0b55f11a37a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ffd67d0d-8e21-4843-8542-6039496c6526" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51c9cfd-708f-42b3-abcc-25c8ee784a6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ffd67d0d-8e21-4843-8542-6039496c6526" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b8cba498-b4b0-4da0-b37b-36e6ff38ff07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51c9cfd-708f-42b3-abcc-25c8ee784a6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b8cba498-b4b0-4da0-b37b-36e6ff38ff07" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_165df5ad-d83a-4418-ab3e-13d47818083c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12f9acbf-6805-485b-aa5c-eaaa140e2391" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_afc42930-055b-413b-a6e3-e531e2c26ad8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12f9acbf-6805-485b-aa5c-eaaa140e2391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_fc56468c-323b-4541-9044-5b2998508152" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12f9acbf-6805-485b-aa5c-eaaa140e2391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_fc56468c-323b-4541-9044-5b2998508152" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b2b5f638-85e4-4c19-96c3-1bdb5bf3064f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12f9acbf-6805-485b-aa5c-eaaa140e2391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b2b5f638-85e4-4c19-96c3-1bdb5bf3064f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1d7dc7e4-9030-42bb-bdb1-9904e7b7a339" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12f9acbf-6805-485b-aa5c-eaaa140e2391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1d7dc7e4-9030-42bb-bdb1-9904e7b7a339" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5cc261eb-224f-4fb0-9a02-d75d72fa9026" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12f9acbf-6805-485b-aa5c-eaaa140e2391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5cc261eb-224f-4fb0-9a02-d75d72fa9026" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0286404f-c6db-460a-8b91-907eec146697" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#DebtandCreditFacilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_7acd197e-c4c6-4961-861a-a82bbee58af2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_7acd197e-c4c6-4961-861a-a82bbee58af2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_a2103eb3-c818-473d-8e43-779ccfe46272" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7acd197e-c4c6-4961-861a-a82bbee58af2" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_a2103eb3-c818-473d-8e43-779ccfe46272" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_a2103eb3-c818-473d-8e43-779ccfe46272_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_a2103eb3-c818-473d-8e43-779ccfe46272" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_a2103eb3-c818-473d-8e43-779ccfe46272_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_268c6e4b-0f41-45fc-b727-c6568b748deb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_a2103eb3-c818-473d-8e43-779ccfe46272" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_268c6e4b-0f41-45fc-b727-c6568b748deb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_8de45ba3-0bbc-4856-a536-6483c595fc65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_268c6e4b-0f41-45fc-b727-c6568b748deb" xlink:to="loc_us-gaap_CommercialPaperMember_8de45ba3-0bbc-4856-a536-6483c595fc65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1c2c6de8-dc56-400e-990d-6f340ffeafc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7acd197e-c4c6-4961-861a-a82bbee58af2" xlink:to="loc_us-gaap_DebtInstrumentAxis_1c2c6de8-dc56-400e-990d-6f340ffeafc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1c2c6de8-dc56-400e-990d-6f340ffeafc5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1c2c6de8-dc56-400e-990d-6f340ffeafc5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1c2c6de8-dc56-400e-990d-6f340ffeafc5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1c2c6de8-dc56-400e-990d-6f340ffeafc5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_FloatingRateSeniorNotesDueNovember162024Member_eda7bfd3-f27d-42c6-99cb-e6e61a847ee0" xlink:href="syk-20241231.xsd#syk_FloatingRateSeniorNotesDueNovember162024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_FloatingRateSeniorNotesDueNovember162024Member_eda7bfd3-f27d-42c6-99cb-e6e61a847ee0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.850Due2028Member_c5334f58-7dba-4ef8-8990-30f948d532cd" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.850Due2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_SeniorUnsecuredNotes4.850Due2028Member_c5334f58-7dba-4ef8-8990-30f948d532cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3375Due2028Member_fd4c1d6f-3630-4dbc-b364-b3cae6632be4" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3375Due2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_SeniorUnsecuredNotes3375Due2028Member_fd4c1d6f-3630-4dbc-b364-b3cae6632be4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.250Due2029Member_9282e95e-e0a6-450f-8b9a-1d965171c5b4" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.250Due2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_SeniorUnsecuredNotes4.250Due2029Member_9282e95e-e0a6-450f-8b9a-1d965171c5b4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.250Due2024Member_1812b921-f78b-457b-9ac8-3ae7268f7ede" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes0.250Due2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_SeniorUnsecuredNotes0.250Due2024Member_1812b921-f78b-457b-9ac8-3ae7268f7ede" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375DueMay152024Member_cb184f89-e67b-47a2-bc80-d541b6affc5e" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.375DueMay152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_SeniorUnsecuredNotes3.375DueMay152024Member_cb184f89-e67b-47a2-bc80-d541b6affc5e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375Due2025Member_724d5870-6ef4-493c-9c55-23f23b5d7169" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.375Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_SeniorUnsecuredNotes3.375Due2025Member_724d5870-6ef4-493c-9c55-23f23b5d7169" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4625Due2046Member_c990a7ef-846c-4194-b8f2-9ad03c115d58" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4625Due2046Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_SeniorUnsecuredNotes4625Due2046Member_c990a7ef-846c-4194-b8f2-9ad03c115d58" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.625Due2036Member_a7cffcfa-cb61-46da-a662-ebd753b6db4f" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.625Due2036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_SeniorUnsecuredNotes3.625Due2036Member_a7cffcfa-cb61-46da-a662-ebd753b6db4f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_20566385-1043-485e-bd63-9455e68bc229" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:to="loc_us-gaap_CommercialPaper_20566385-1043-485e-bd63-9455e68bc229" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_aab5b4f2-265a-45e6-bb7b-68c0f62d10a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:to="loc_us-gaap_LineOfCredit_aab5b4f2-265a-45e6-bb7b-68c0f62d10a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_3b8aa3da-0e4c-4db7-aaef-4c35373df509" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:to="loc_us-gaap_DebtInstrumentTerm_3b8aa3da-0e4c-4db7-aaef-4c35373df509" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_55e7daca-a2a6-4e16-8622-32e07bca0d67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:to="loc_us-gaap_RepaymentsOfDebt_55e7daca-a2a6-4e16-8622-32e07bca0d67" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_adee6fd1-408b-4130-87a9-b156b835ad37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_adee6fd1-408b-4130-87a9-b156b835ad37" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_30d4e5fb-825f-480d-9584-ff75372518c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_30d4e5fb-825f-480d-9584-ff75372518c2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_f071c63f-f387-46ca-8a1d-02840b0cff67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:to="loc_us-gaap_InterestExpenseDebt_f071c63f-f387-46ca-8a1d-02840b0cff67" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_9683bf09-c526-4936-8307-80831596cf37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_9683bf09-c526-4936-8307-80831596cf37" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6fbd9056-a6bd-4e06-8f29-64baf6f572f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_9683bf09-c526-4936-8307-80831596cf37" xlink:to="loc_us-gaap_DebtInstrumentAxis_6fbd9056-a6bd-4e06-8f29-64baf6f572f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6fbd9056-a6bd-4e06-8f29-64baf6f572f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6fbd9056-a6bd-4e06-8f29-64baf6f572f8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6fbd9056-a6bd-4e06-8f29-64baf6f572f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6fbd9056-a6bd-4e06-8f29-64baf6f572f8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375DueMay152024Member_22b2d083-c314-4db2-b988-b7727652212d" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.375DueMay152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes3.375DueMay152024Member_22b2d083-c314-4db2-b988-b7727652212d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_VariousMember_09098de6-0436-41df-80fc-ffa460067150" xlink:href="syk-20241231.xsd#syk_VariousMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_VariousMember_09098de6-0436-41df-80fc-ffa460067150" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.250Due2024Member_ec9d2560-106a-4bdb-842e-897a39458d56" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes0.250Due2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes0.250Due2024Member_ec9d2560-106a-4bdb-842e-897a39458d56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.150Due2025Member_99fe7680-d818-4f91-ab9a-6f800cb423ed" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes1.150Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes1.150Due2025Member_99fe7680-d818-4f91-ab9a-6f800cb423ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375Due2025Member_3d393fa0-c803-4f2b-80dc-22d84b644445" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.375Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes3.375Due2025Member_3d393fa0-c803-4f2b-80dc-22d84b644445" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.500Due2026Member_ccace28c-6d80-4332-92c5-8cbf665833a2" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.500Due2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes3.500Due2026Member_ccace28c-6d80-4332-92c5-8cbf665833a2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.125DueNovember2027Member_5b04ddc5-d9df-4fa9-ba77-b336cb7e9dee" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes2.125DueNovember2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes2.125DueNovember2027Member_5b04ddc5-d9df-4fa9-ba77-b336cb7e9dee" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.650Due2028Member_bf8cbc5a-ffce-4192-9c54-5507fc6ba141" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.650Due2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes3.650Due2028Member_bf8cbc5a-ffce-4192-9c54-5507fc6ba141" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.850Due2028Member_f2057d67-b878-4e45-a893-6b456a013330" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.850Due2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes4.850Due2028Member_f2057d67-b878-4e45-a893-6b456a013330" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3375Due2028Member_a20496ab-f758-4ab2-961a-46ba4bc4bf7b" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3375Due2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes3375Due2028Member_a20496ab-f758-4ab2-961a-46ba4bc4bf7b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.750due2029Member_d5d910c7-28b0-439e-a03d-9d0d50a1731d" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes0.750due2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes0.750due2029Member_d5d910c7-28b0-439e-a03d-9d0d50a1731d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.250Due2029Member_f758d256-87e2-4609-b3b3-d5f30fe460a3" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.250Due2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes4.250Due2029Member_f758d256-87e2-4609-b3b3-d5f30fe460a3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.950Due2030Member_519c6c20-684e-411c-9cc4-62f4f26f68b4" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes1.950Due2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes1.950Due2030Member_519c6c20-684e-411c-9cc4-62f4f26f68b4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.625Due2030Member_23b615fa-30e1-4fac-82b8-d79a8549f398" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes2.625Due2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes2.625Due2030Member_23b615fa-30e1-4fac-82b8-d79a8549f398" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.000due2031Member_b23bbb62-14cc-4a03-8d16-797406ce7821" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes1.000due2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes1.000due2031Member_b23bbb62-14cc-4a03-8d16-797406ce7821" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375Due2032Member_fe2057da-d908-4dd8-aa18-f2a8589a248c" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.375Due2032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes3.375Due2032Member_fe2057da-d908-4dd8-aa18-f2a8589a248c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.625DueSeptember112034Member_f67fda6a-5a5a-4b6e-81b2-6a40ce41ec3f" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.625DueSeptember112034Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes4.625DueSeptember112034Member_f67fda6a-5a5a-4b6e-81b2-6a40ce41ec3f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.625Due2036Member_327d58fa-3a14-408a-b08a-0a82c7c9d35a" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.625Due2036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes3.625Due2036Member_327d58fa-3a14-408a-b08a-0a82c7c9d35a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.100Due2043Member_9df9d1c4-9611-4a9c-a3e1-2cd48bec0e91" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.100Due2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes4.100Due2043Member_9df9d1c4-9611-4a9c-a3e1-2cd48bec0e91" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.375due2044Member_47442691-2096-4dd9-9000-953666f00916" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.375due2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes4.375due2044Member_47442691-2096-4dd9-9000-953666f00916" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4625Due2046Member_6d3c338f-17e6-4e71-91e7-14efebbb773c" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4625Due2046Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes4625Due2046Member_6d3c338f-17e6-4e71-91e7-14efebbb773c" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.900due2050Member_f329ee26-4678-4c41-a6c3-f24b9fec1d60" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes2.900due2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes2.900due2050Member_f329ee26-4678-4c41-a6c3-f24b9fec1d60" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_20a60a93-8433-4e0a-9713-f51f3e641f08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_20a60a93-8433-4e0a-9713-f51f3e641f08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_f9f53617-f7d7-4c3c-893c-25ce422c6716" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_UnsecuredDebt_f9f53617-f7d7-4c3c-893c-25ce422c6716" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_5e21ecd2-a5a1-40cd-a449-ef9acd1599bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_OtherLongTermDebt_5e21ecd2-a5a1-40cd-a449-ef9acd1599bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_df6b8dbd-74f9-488a-b58b-7460da5f42cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_df6b8dbd-74f9-488a-b58b-7460da5f42cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_1d7d4fda-2ead-494a-8247-5b9d41cb51bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_DebtCurrent_1d7d4fda-2ead-494a-8247-5b9d41cb51bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_eb2f07ff-0a63-40b9-b7e0-dc6141185e60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_eb2f07ff-0a63-40b9-b7e0-dc6141185e60" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_67c2a95a-99f7-40be-b605-d1ed3f6d1684" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_67c2a95a-99f7-40be-b605-d1ed3f6d1684" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_8cd0135a-9d05-4bf0-b8f2-cade91f6d98d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_8cd0135a-9d05-4bf0-b8f2-cade91f6d98d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_eb5ec9d9-6cb5-43f0-96fe-3d5de11b0785" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_DebtInstrumentFairValue_eb5ec9d9-6cb5-43f0-96fe-3d5de11b0785" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_80c54c40-a9bf-4e22-852d-396b6c50e874" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_80c54c40-a9bf-4e22-852d-396b6c50e874" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_0c230b83-0a7b-452a-bc40-b77e44db8b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_80c54c40-a9bf-4e22-852d-396b6c50e874" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_0c230b83-0a7b-452a-bc40-b77e44db8b9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_0c230b83-0a7b-452a-bc40-b77e44db8b9e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_0c230b83-0a7b-452a-bc40-b77e44db8b9e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_0c230b83-0a7b-452a-bc40-b77e44db8b9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_3ab24095-adb1-4d8f-9965-3feb8b974e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_0c230b83-0a7b-452a-bc40-b77e44db8b9e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_3ab24095-adb1-4d8f-9965-3feb8b974e1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_5d98aa80-6d6f-4cc8-9a50-f7b127b7dd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_3ab24095-adb1-4d8f-9965-3feb8b974e1c" xlink:to="loc_us-gaap_DomesticCountryMember_5d98aa80-6d6f-4cc8-9a50-f7b127b7dd2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_0c1f5b0d-14a7-412c-9cf2-ecf6247a1e40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_3ab24095-adb1-4d8f-9965-3feb8b974e1c" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_0c1f5b0d-14a7-412c-9cf2-ecf6247a1e40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_19ead102-ec1c-4b4c-b7cb-0cb57b8411ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_3ab24095-adb1-4d8f-9965-3feb8b974e1c" xlink:to="loc_us-gaap_ForeignCountryMember_19ead102-ec1c-4b4c-b7cb-0cb57b8411ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8a1acc73-9d1d-4235-bffc-8f290659e9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8a1acc73-9d1d-4235-bffc-8f290659e9ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_04ce496f-70f7-4523-92d0-cb7418fcccf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_04ce496f-70f7-4523-92d0-cb7418fcccf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_a69504dd-abcf-4741-854a-ee77ac5a4085" xlink:href="syk-20241231.xsd#syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_a69504dd-abcf-4741-854a-ee77ac5a4085" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_00c31669-a209-420d-8915-37c03cc9223d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_00c31669-a209-420d-8915-37c03cc9223d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_e6ccbadc-c718-4e96-bc10-495cb0fc13e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_OperatingLossCarryforwards_e6ccbadc-c718-4e96-bc10-495cb0fc13e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_81ed6f20-4442-45b9-9cfb-bcd2925d1d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_81ed6f20-4442-45b9-9cfb-bcd2925d1d6b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_d7ca5d42-4bce-4396-a5ba-3df05a64c73a" xlink:href="syk-20241231.xsd#syk_OperatingLossCarryforwardsSubjectToValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_d7ca5d42-4bce-4396-a5ba-3df05a64c73a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_5a72032b-a26c-44c6-b162-53a3cf8bef49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_5a72032b-a26c-44c6-b162-53a3cf8bef49" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_c96544c5-9c02-49d9-b9ee-58963ce8356e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_c96544c5-9c02-49d9-b9ee-58963ce8356e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_8a1ca1d4-9b63-4165-ab5c-6286e7b0d3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_8a1ca1d4-9b63-4165-ab5c-6286e7b0d3f2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_842ebfab-e095-40d1-ab05-191d7771ad52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_842ebfab-e095-40d1-ab05-191d7771ad52" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_bc961102-506e-490c-ac19-b94228a06dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_bc961102-506e-490c-ac19-b94228a06dcc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_973db278-8d11-4c82-8df0-cfb1b7410d57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_973db278-8d11-4c82-8df0-cfb1b7410d57" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest_b8a2d372-c6ed-4b63-be8e-42aaba42b230" xlink:href="syk-20241231.xsd#syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest_b8a2d372-c6ed-4b63-be8e-42aaba42b230" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f2a0f270-306f-41ab-81ed-232e6ab04e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5f6ff722-fad9-4e19-baee-25fbb7491c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f2a0f270-306f-41ab-81ed-232e6ab04e8c" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5f6ff722-fad9-4e19-baee-25fbb7491c3b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4782f63d-2595-4234-90a7-f7d8f6067937" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5f6ff722-fad9-4e19-baee-25fbb7491c3b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4782f63d-2595-4234-90a7-f7d8f6067937" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4782f63d-2595-4234-90a7-f7d8f6067937_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4782f63d-2595-4234-90a7-f7d8f6067937" xlink:to="loc_us-gaap_EquityComponentDomain_4782f63d-2595-4234-90a7-f7d8f6067937_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e1eb0268-6dea-424f-82fd-94b8f94bb4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4782f63d-2595-4234-90a7-f7d8f6067937" xlink:to="loc_us-gaap_EquityComponentDomain_e1eb0268-6dea-424f-82fd-94b8f94bb4d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_ee69da25-6ea3-4ca7-81e5-bbb72256b1ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e1eb0268-6dea-424f-82fd-94b8f94bb4d2" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_ee69da25-6ea3-4ca7-81e5-bbb72256b1ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3e425ad0-10d8-43bc-811f-50bba00480de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5f6ff722-fad9-4e19-baee-25fbb7491c3b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3e425ad0-10d8-43bc-811f-50bba00480de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3e425ad0-10d8-43bc-811f-50bba00480de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3e425ad0-10d8-43bc-811f-50bba00480de" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3e425ad0-10d8-43bc-811f-50bba00480de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2cc41458-d456-44d4-b0c3-38ecf4912828" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3e425ad0-10d8-43bc-811f-50bba00480de" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2cc41458-d456-44d4-b0c3-38ecf4912828" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AccruedCompensationMember_7523e927-5170-43d4-8894-85c7a9c42041" xlink:href="syk-20241231.xsd#syk_AccruedCompensationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2cc41458-d456-44d4-b0c3-38ecf4912828" xlink:to="loc_syk_AccruedCompensationMember_7523e927-5170-43d4-8894-85c7a9c42041" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_86e09d24-acc8-45bf-accb-2b63032713d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2cc41458-d456-44d4-b0c3-38ecf4912828" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_86e09d24-acc8-45bf-accb-2b63032713d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_1b7589dc-63a8-44e7-b409-fed53c989d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2cc41458-d456-44d4-b0c3-38ecf4912828" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_1b7589dc-63a8-44e7-b409-fed53c989d4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_38ca1bc4-e4c8-483c-8ced-1ae6a5b10958" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f2a0f270-306f-41ab-81ed-232e6ab04e8c" xlink:to="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_38ca1bc4-e4c8-483c-8ced-1ae6a5b10958" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0edc222e-8751-487b-b90f-fdbcb6087307" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_38ca1bc4-e4c8-483c-8ced-1ae6a5b10958" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0edc222e-8751-487b-b90f-fdbcb6087307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7f079f2e-0c14-4717-a3b9-d6bdcd65d4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_38ca1bc4-e4c8-483c-8ced-1ae6a5b10958" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7f079f2e-0c14-4717-a3b9-d6bdcd65d4c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_32015bc0-27ee-4564-9f03-e337fb4e9400" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_38ca1bc4-e4c8-483c-8ced-1ae6a5b10958" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_32015bc0-27ee-4564-9f03-e337fb4e9400" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_13edd5c4-d980-42e7-8ff4-8b3ccfa3bf9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_38ca1bc4-e4c8-483c-8ced-1ae6a5b10958" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_13edd5c4-d980-42e7-8ff4-8b3ccfa3bf9d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_d63ecec1-7b99-424f-9dcc-d014f80ccd2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_38ca1bc4-e4c8-483c-8ced-1ae6a5b10958" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_d63ecec1-7b99-424f-9dcc-d014f80ccd2b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_f9456991-fa77-441c-a6b3-3c5930522652" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_38ca1bc4-e4c8-483c-8ced-1ae6a5b10958" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_f9456991-fa77-441c-a6b3-3c5930522652" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b475a5-3b6a-4794-bc92-e12165f74c87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2048ba05-5a40-4c0c-a3e3-32cd2e00e0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b475a5-3b6a-4794-bc92-e12165f74c87" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2048ba05-5a40-4c0c-a3e3-32cd2e00e0b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c67a85d0-d95c-49fd-947e-fbba9246bc31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2048ba05-5a40-4c0c-a3e3-32cd2e00e0b8" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c67a85d0-d95c-49fd-947e-fbba9246bc31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_c67a85d0-d95c-49fd-947e-fbba9246bc31_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c67a85d0-d95c-49fd-947e-fbba9246bc31" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_c67a85d0-d95c-49fd-947e-fbba9246bc31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_1d70604b-aa1e-4224-9d6a-732cf260b340" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c67a85d0-d95c-49fd-947e-fbba9246bc31" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_1d70604b-aa1e-4224-9d6a-732cf260b340" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_837e2833-1873-4174-9ff5-9fac078c2a30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1d70604b-aa1e-4224-9d6a-732cf260b340" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_837e2833-1873-4174-9ff5-9fac078c2a30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_ef4a18ca-fb9b-481e-9142-ae31eeaae0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDebtSecurityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1d70604b-aa1e-4224-9d6a-732cf260b340" xlink:to="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_ef4a18ca-fb9b-481e-9142-ae31eeaae0e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_08de8023-a603-4e52-a524-895ae9193c38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1d70604b-aa1e-4224-9d6a-732cf260b340" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_08de8023-a603-4e52-a524-895ae9193c38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_57ebf49b-3b92-4288-b410-b31d052ec627" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b475a5-3b6a-4794-bc92-e12165f74c87" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_57ebf49b-3b92-4288-b410-b31d052ec627" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_00eceb66-1ea5-4927-b40c-02b5dc9f1983" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b475a5-3b6a-4794-bc92-e12165f74c87" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_00eceb66-1ea5-4927-b40c-02b5dc9f1983" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_94df0f98-b9b0-4912-852d-7031555ab274" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b082d5c6-d97b-4c5a-9d79-c31fe1ba364d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_94df0f98-b9b0-4912-852d-7031555ab274" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b082d5c6-d97b-4c5a-9d79-c31fe1ba364d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_98e2a133-1df1-438f-a1c6-acc5f2aa57d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b082d5c6-d97b-4c5a-9d79-c31fe1ba364d" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_98e2a133-1df1-438f-a1c6-acc5f2aa57d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_98e2a133-1df1-438f-a1c6-acc5f2aa57d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_98e2a133-1df1-438f-a1c6-acc5f2aa57d8" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_98e2a133-1df1-438f-a1c6-acc5f2aa57d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_7008bbf1-ae39-4545-ad9b-ee0ea9c93f68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_98e2a133-1df1-438f-a1c6-acc5f2aa57d8" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_7008bbf1-ae39-4545-ad9b-ee0ea9c93f68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_8292b333-761e-49f3-bea9-82d7074f4ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_7008bbf1-ae39-4545-ad9b-ee0ea9c93f68" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_8292b333-761e-49f3-bea9-82d7074f4ff6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_bac7f16f-67a2-4f02-b795-9b11a4236aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_7008bbf1-ae39-4545-ad9b-ee0ea9c93f68" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_bac7f16f-67a2-4f02-b795-9b11a4236aa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_459489a4-f922-46b6-9591-734034081c16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_7008bbf1-ae39-4545-ad9b-ee0ea9c93f68" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_459489a4-f922-46b6-9591-734034081c16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_4abd179a-4902-4ae0-abc7-e092e092f6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_7008bbf1-ae39-4545-ad9b-ee0ea9c93f68" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_4abd179a-4902-4ae0-abc7-e092e092f6bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7d4803c-96f4-4476-8d4d-a8473706413d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b082d5c6-d97b-4c5a-9d79-c31fe1ba364d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7d4803c-96f4-4476-8d4d-a8473706413d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7d4803c-96f4-4476-8d4d-a8473706413d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7d4803c-96f4-4476-8d4d-a8473706413d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7d4803c-96f4-4476-8d4d-a8473706413d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2548b-861b-417c-8924-820d38d151d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7d4803c-96f4-4476-8d4d-a8473706413d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2548b-861b-417c-8924-820d38d151d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c73f2fc9-4952-4f6e-9a77-6c342681b140" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2548b-861b-417c-8924-820d38d151d7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c73f2fc9-4952-4f6e-9a77-6c342681b140" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b0934d3b-8456-4bb8-9273-fe3e5dc2c6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2548b-861b-417c-8924-820d38d151d7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b0934d3b-8456-4bb8-9273-fe3e5dc2c6d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ad4e7400-001b-4f4c-8de7-22326e23c4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2548b-861b-417c-8924-820d38d151d7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ad4e7400-001b-4f4c-8de7-22326e23c4d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9e81ed97-48df-49a5-ba0b-2d5a1579ccef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_94df0f98-b9b0-4912-852d-7031555ab274" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9e81ed97-48df-49a5-ba0b-2d5a1579ccef" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RetirementPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/RetirementPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_742c6276-7753-4fe4-b266-700537a6a6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5c587658-cc54-4294-b3a4-4e3057c6e848" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_742c6276-7753-4fe4-b266-700537a6a6cb" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5c587658-cc54-4294-b3a4-4e3057c6e848" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_783d177e-140f-4a4f-ad26-eb76f503bef4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5c587658-cc54-4294-b3a4-4e3057c6e848" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_783d177e-140f-4a4f-ad26-eb76f503bef4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_783d177e-140f-4a4f-ad26-eb76f503bef4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_783d177e-140f-4a4f-ad26-eb76f503bef4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_783d177e-140f-4a4f-ad26-eb76f503bef4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2ec80dd-1746-497a-9f7d-a6b68ebe2db5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_783d177e-140f-4a4f-ad26-eb76f503bef4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2ec80dd-1746-497a-9f7d-a6b68ebe2db5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_da88a6af-4a49-4cbf-8cbc-b0f5b30cbead" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2ec80dd-1746-497a-9f7d-a6b68ebe2db5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_da88a6af-4a49-4cbf-8cbc-b0f5b30cbead" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_067d8a43-44fc-450b-84dc-48038ea5aa7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_742c6276-7753-4fe4-b266-700537a6a6cb" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_067d8a43-44fc-450b-84dc-48038ea5aa7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_c307b72c-8665-42c8-a213-82558c95b348" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_742c6276-7753-4fe4-b266-700537a6a6cb" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_c307b72c-8665-42c8-a213-82558c95b348" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5a94bf71-b8c8-4cca-ab3b-0807ef48b4a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5a94bf71-b8c8-4cca-ab3b-0807ef48b4a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_fa59ed6d-4a5e-429f-9564-4bd77a35bd6a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5a94bf71-b8c8-4cca-ab3b-0807ef48b4a2" xlink:to="loc_srt_ConsolidationItemsAxis_fa59ed6d-4a5e-429f-9564-4bd77a35bd6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_fa59ed6d-4a5e-429f-9564-4bd77a35bd6a_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_fa59ed6d-4a5e-429f-9564-4bd77a35bd6a" xlink:to="loc_srt_ConsolidationItemsDomain_fa59ed6d-4a5e-429f-9564-4bd77a35bd6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6338a198-4d7c-48bd-8ac9-c238dfcb08b4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_fa59ed6d-4a5e-429f-9564-4bd77a35bd6a" xlink:to="loc_srt_ConsolidationItemsDomain_6338a198-4d7c-48bd-8ac9-c238dfcb08b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9c5f4329-2306-4174-9761-01960a6d36a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_6338a198-4d7c-48bd-8ac9-c238dfcb08b4" xlink:to="loc_us-gaap_OperatingSegmentsMember_9c5f4329-2306-4174-9761-01960a6d36a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_fc9770ef-e08a-4541-a234-6e2fd94e7114" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_6338a198-4d7c-48bd-8ac9-c238dfcb08b4" xlink:to="loc_us-gaap_CorporateNonSegmentMember_fc9770ef-e08a-4541-a234-6e2fd94e7114" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_48e3e5d3-a47b-460b-83c0-05583c0531b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_6338a198-4d7c-48bd-8ac9-c238dfcb08b4" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_48e3e5d3-a47b-460b-83c0-05583c0531b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3fbcafa5-8118-4663-b3d5-7cc8a745f081" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5a94bf71-b8c8-4cca-ab3b-0807ef48b4a2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3fbcafa5-8118-4663-b3d5-7cc8a745f081" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3fbcafa5-8118-4663-b3d5-7cc8a745f081_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3fbcafa5-8118-4663-b3d5-7cc8a745f081" xlink:to="loc_us-gaap_SegmentDomain_3fbcafa5-8118-4663-b3d5-7cc8a745f081_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_388d8ee5-355c-47b9-923a-ca9e76a89a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3fbcafa5-8118-4663-b3d5-7cc8a745f081" xlink:to="loc_us-gaap_SegmentDomain_388d8ee5-355c-47b9-923a-ca9e76a89a3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_d3b49a34-d82c-4a2e-a87a-5f71bb941427" xlink:href="syk-20241231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_388d8ee5-355c-47b9-923a-ca9e76a89a3a" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_d3b49a34-d82c-4a2e-a87a-5f71bb941427" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsMember_f8b8a430-38e3-47b5-bd7b-daf23e43d87d" xlink:href="syk-20241231.xsd#syk_OrthopaedicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_388d8ee5-355c-47b9-923a-ca9e76a89a3a" xlink:to="loc_syk_OrthopaedicsMember_f8b8a430-38e3-47b5-bd7b-daf23e43d87d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_3b2b29fa-f493-4e1e-b38d-fc2234d894c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_NumberOfReportableSegments_3b2b29fa-f493-4e1e-b38d-fc2234d894c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_cf10fc1a-75d4-4134-b0c6-a49cf8eb5bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_Revenues_cf10fc1a-75d4-4134-b0c6-a49cf8eb5bb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_f2b57212-338c-4a3c-93d4-10eb7eb73734" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_CostOfRevenue_f2b57212-338c-4a3c-93d4-10eb7eb73734" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_541c8ee4-dbec-4b4b-9768-5688a8930462" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_541c8ee4-dbec-4b4b-9768-5688a8930462" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_48b58a36-52d3-496f-8c1c-fe290828a733" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_48b58a36-52d3-496f-8c1c-fe290828a733" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d9cfffb8-33db-44eb-8e83-e6f19ba5202a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d9cfffb8-33db-44eb-8e83-e6f19ba5202a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_883e784c-673d-46a2-b3e5-8f207f2a6e26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_883e784c-673d-46a2-b3e5-8f207f2a6e26" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6e13cd2b-888d-4b7c-b7a8-21c8851e5cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_OperatingIncomeLoss_6e13cd2b-888d-4b7c-b7a8-21c8851e5cf1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_229009ba-e9cf-441c-b652-73886209aa58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_229009ba-e9cf-441c-b652-73886209aa58" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InventorySteppedUpToFairValueAtAcquisition_74c6d638-93be-481d-b4b8-7bf0d54cedd6" xlink:href="syk-20241231.xsd#syk_InventorySteppedUpToFairValueAtAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_syk_InventorySteppedUpToFairValueAtAcquisition_74c6d638-93be-481d-b4b8-7bf0d54cedd6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_3bbcc407-466a-410d-875d-d1fe9502d6db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_3bbcc407-466a-410d-875d-d1fe9502d6db" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_e5f8ea48-024d-4349-b3c4-e68c0a1c8727" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_RestructuringCosts_e5f8ea48-024d-4349-b3c4-e68c0a1c8727" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_539a2c86-168a-4738-9845-2201eb11e777" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_AssetImpairmentCharges_539a2c86-168a-4738-9845-2201eb11e777" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalDeviceRegulationsExpense_1955e7e3-57f7-4059-b6cc-fa7e63a94b7d" xlink:href="syk-20241231.xsd#syk_MedicalDeviceRegulationsExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_syk_MedicalDeviceRegulationsExpense_1955e7e3-57f7-4059-b6cc-fa7e63a94b7d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_RejuvenateABGIIHipRecallCharges_5720dd38-6a9a-4f38-8607-b0ee10172860" xlink:href="syk-20241231.xsd#syk_RejuvenateABGIIHipRecallCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_syk_RejuvenateABGIIHipRecallCharges_5720dd38-6a9a-4f38-8607-b0ee10172860" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_3cb801c3-50c5-4a80-a297-b3c19294be3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_LegalFees_3cb801c3-50c5-4a80-a297-b3c19294be3b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dd7b8751-1c4f-48c1-a772-150ab6b0730f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_NetIncomeLoss_dd7b8751-1c4f-48c1-a772-150ab6b0730f" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#SegmentandGeographicDataSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_771e32d4-25cf-4e96-aa95-a1cc69b9e506" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c2f188e8-ac04-4997-b322-c60e4ee5173c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_771e32d4-25cf-4e96-aa95-a1cc69b9e506" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c2f188e8-ac04-4997-b322-c60e4ee5173c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b1c256f7-a1c2-44f0-b2aa-814da980140f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c2f188e8-ac04-4997-b322-c60e4ee5173c" xlink:to="loc_srt_ConsolidationItemsAxis_b1c256f7-a1c2-44f0-b2aa-814da980140f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b1c256f7-a1c2-44f0-b2aa-814da980140f_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_b1c256f7-a1c2-44f0-b2aa-814da980140f" xlink:to="loc_srt_ConsolidationItemsDomain_b1c256f7-a1c2-44f0-b2aa-814da980140f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e197f2f3-07f3-4d17-a21c-5dbfd2cb34c1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_b1c256f7-a1c2-44f0-b2aa-814da980140f" xlink:to="loc_srt_ConsolidationItemsDomain_e197f2f3-07f3-4d17-a21c-5dbfd2cb34c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_273accef-e808-4919-b6e4-0c12187c90f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_e197f2f3-07f3-4d17-a21c-5dbfd2cb34c1" xlink:to="loc_us-gaap_OperatingSegmentsMember_273accef-e808-4919-b6e4-0c12187c90f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_4c42e973-bb44-4590-b963-30d2d1405aef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_e197f2f3-07f3-4d17-a21c-5dbfd2cb34c1" xlink:to="loc_us-gaap_CorporateNonSegmentMember_4c42e973-bb44-4590-b963-30d2d1405aef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3440e691-3480-4c03-8b7f-abea3291ae86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c2f188e8-ac04-4997-b322-c60e4ee5173c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3440e691-3480-4c03-8b7f-abea3291ae86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3440e691-3480-4c03-8b7f-abea3291ae86_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3440e691-3480-4c03-8b7f-abea3291ae86" xlink:to="loc_us-gaap_SegmentDomain_3440e691-3480-4c03-8b7f-abea3291ae86_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_abbb9aa6-c1b1-45fa-aa42-a0077723876b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3440e691-3480-4c03-8b7f-abea3291ae86" xlink:to="loc_us-gaap_SegmentDomain_abbb9aa6-c1b1-45fa-aa42-a0077723876b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_3190bcca-3080-4346-9407-7b89527d96d1" xlink:href="syk-20241231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_abbb9aa6-c1b1-45fa-aa42-a0077723876b" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_3190bcca-3080-4346-9407-7b89527d96d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsMember_b434693c-a3f3-405e-ae0e-ad6c9b1eb3d6" xlink:href="syk-20241231.xsd#syk_OrthopaedicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_abbb9aa6-c1b1-45fa-aa42-a0077723876b" xlink:to="loc_syk_OrthopaedicsMember_b434693c-a3f3-405e-ae0e-ad6c9b1eb3d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_849c95a6-0e75-431e-b153-086415e6dece" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_771e32d4-25cf-4e96-aa95-a1cc69b9e506" xlink:to="loc_us-gaap_Assets_849c95a6-0e75-431e-b153-086415e6dece" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalExpendituresDuringPeriod_a451d9bb-42f5-4a5d-a6c3-6300c48ec821" xlink:href="syk-20241231.xsd#syk_CapitalExpendituresDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_771e32d4-25cf-4e96-aa95-a1cc69b9e506" xlink:to="loc_syk_CapitalExpendituresDuringPeriod_a451d9bb-42f5-4a5d-a6c3-6300c48ec821" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0f72132e-acdf-4f36-aa26-79924d2f238b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_18876f2d-a8a8-4400-8cb6-01538f9a94bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0f72132e-acdf-4f36-aa26-79924d2f238b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_18876f2d-a8a8-4400-8cb6-01538f9a94bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_5d7fb061-440d-46f2-b02a-17d3c7042dc2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_18876f2d-a8a8-4400-8cb6-01538f9a94bf" xlink:to="loc_srt_StatementGeographicalAxis_5d7fb061-440d-46f2-b02a-17d3c7042dc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5d7fb061-440d-46f2-b02a-17d3c7042dc2_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_5d7fb061-440d-46f2-b02a-17d3c7042dc2" xlink:to="loc_srt_SegmentGeographicalDomain_5d7fb061-440d-46f2-b02a-17d3c7042dc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d2b85de9-ac16-420d-8635-2cce0fc9b5c4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_5d7fb061-440d-46f2-b02a-17d3c7042dc2" xlink:to="loc_srt_SegmentGeographicalDomain_d2b85de9-ac16-420d-8635-2cce0fc9b5c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d9cac9cc-096b-44b2-8530-741049676fe4" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d2b85de9-ac16-420d-8635-2cce0fc9b5c4" xlink:to="loc_country_US_d9cac9cc-096b-44b2-8530-741049676fe4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_44a68391-7517-40c3-99f5-fddd4fe161cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d2b85de9-ac16-420d-8635-2cce0fc9b5c4" xlink:to="loc_us-gaap_EMEAMember_44a68391-7517-40c3-99f5-fddd4fe161cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_bb9d459c-1bd9-4c45-bf5b-8bb4833c86e3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d2b85de9-ac16-420d-8635-2cce0fc9b5c4" xlink:to="loc_srt_AsiaPacificMember_bb9d459c-1bd9-4c45-bf5b-8bb4833c86e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherForeignCountriesMember_ad881456-3e2b-4806-83d1-72266acd2d49" xlink:href="syk-20241231.xsd#syk_OtherForeignCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d2b85de9-ac16-420d-8635-2cce0fc9b5c4" xlink:to="loc_syk_OtherForeignCountriesMember_ad881456-3e2b-4806-83d1-72266acd2d49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_acbb563c-0ae6-4f4d-94d1-1830320145a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0f72132e-acdf-4f36-aa26-79924d2f238b" xlink:to="loc_us-gaap_Revenues_acbb563c-0ae6-4f4d-94d1-1830320145a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_393bfd6a-8edc-47b1-a840-9effbe2f969e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0f72132e-acdf-4f36-aa26-79924d2f238b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_393bfd6a-8edc-47b1-a840-9effbe2f969e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AssetImpairmentsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#AssetImpairmentsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/AssetImpairmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_009676b5-5b9b-4b9d-9751-198e68957749" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_234860f3-6d89-4a87-8f6b-3aac6dd71d86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_009676b5-5b9b-4b9d-9751-198e68957749" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_234860f3-6d89-4a87-8f6b-3aac6dd71d86" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_88986512-5c65-4ee3-8cff-24e2c55a378b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_234860f3-6d89-4a87-8f6b-3aac6dd71d86" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_88986512-5c65-4ee3-8cff-24e2c55a378b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_88986512-5c65-4ee3-8cff-24e2c55a378b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_88986512-5c65-4ee3-8cff-24e2c55a378b" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_88986512-5c65-4ee3-8cff-24e2c55a378b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_ed0399e3-c0ba-45ac-89d8-a566ef2e6394" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_88986512-5c65-4ee3-8cff-24e2c55a378b" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_ed0399e3-c0ba-45ac-89d8-a566ef2e6394" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LongLivedAssetsAndIntangibleAssetsMember_29d851b3-4930-472a-9125-a9f60157eec2" xlink:href="syk-20241231.xsd#syk_LongLivedAssetsAndIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_ed0399e3-c0ba-45ac-89d8-a566ef2e6394" xlink:to="loc_syk_LongLivedAssetsAndIntangibleAssetsMember_29d851b3-4930-472a-9125-a9f60157eec2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_470205b4-208e-4c47-80f5-04a238692099" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_009676b5-5b9b-4b9d-9751-198e68957749" xlink:to="loc_us-gaap_AssetImpairmentCharges_470205b4-208e-4c47-80f5-04a238692099" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AssetsHeldforSaleDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#AssetsHeldforSaleDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/AssetsHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_49a75b6b-8051-4c69-9c3b-523a9799461d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a93ffe6d-e0e4-4c65-a493-70caaf989df7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_49a75b6b-8051-4c69-9c3b-523a9799461d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a93ffe6d-e0e4-4c65-a493-70caaf989df7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b91466aa-82e6-4a20-b5de-7b5a5dbc4afe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a93ffe6d-e0e4-4c65-a493-70caaf989df7" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b91466aa-82e6-4a20-b5de-7b5a5dbc4afe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b91466aa-82e6-4a20-b5de-7b5a5dbc4afe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b91466aa-82e6-4a20-b5de-7b5a5dbc4afe" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b91466aa-82e6-4a20-b5de-7b5a5dbc4afe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9c744ede-cdc2-4fb8-9ee8-763f4174f590" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b91466aa-82e6-4a20-b5de-7b5a5dbc4afe" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9c744ede-cdc2-4fb8-9ee8-763f4174f590" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e6014033-0345-45e4-a771-4b90ddb96333" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9c744ede-cdc2-4fb8-9ee8-763f4174f590" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e6014033-0345-45e4-a771-4b90ddb96333" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fabdac5f-feec-4e64-a047-e462efbcd146" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a93ffe6d-e0e4-4c65-a493-70caaf989df7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fabdac5f-feec-4e64-a047-e462efbcd146" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fabdac5f-feec-4e64-a047-e462efbcd146_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fabdac5f-feec-4e64-a047-e462efbcd146" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fabdac5f-feec-4e64-a047-e462efbcd146_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b2c5d0be-767e-4c19-aca1-5d3d5d1ba0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fabdac5f-feec-4e64-a047-e462efbcd146" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b2c5d0be-767e-4c19-aca1-5d3d5d1ba0b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpinalImplantsMember_1e3ff412-c8c4-455d-82b7-544e9e6fd207" xlink:href="syk-20241231.xsd#syk_SpinalImplantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b2c5d0be-767e-4c19-aca1-5d3d5d1ba0b2" xlink:to="loc_syk_SpinalImplantsMember_1e3ff412-c8c4-455d-82b7-544e9e6fd207" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_396e5781-dcd5-4968-9496-cbd552282c09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_49a75b6b-8051-4c69-9c3b-523a9799461d" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_396e5781-dcd5-4968-9496-cbd552282c09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue_2d94c84d-9513-4f2f-b417-c6368763ff0a" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_49a75b6b-8051-4c69-9c3b-523a9799461d" xlink:to="loc_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue_2d94c84d-9513-4f2f-b417-c6368763ff0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue_45e0d0c6-f2db-4e91-9c3f-edf131dd4d46" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_49a75b6b-8051-4c69-9c3b-523a9799461d" xlink:to="loc_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue_45e0d0c6-f2db-4e91-9c3f-edf131dd4d46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_49a75b6b-8051-4c69-9c3b-523a9799461d" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_0bbcc035-63fb-4aa8-862d-1be5494e2c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_0bbcc035-63fb-4aa8-862d-1be5494e2c4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_0008907d-981a-49a1-8110-42fc40652e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_0008907d-981a-49a1-8110-42fc40652e0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_dbbda89a-7420-433e-bbfa-c0965bc960f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_dbbda89a-7420-433e-bbfa-c0965bc960f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_f75f0778-4a7c-4c14-af42-0e8340cf7c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_f75f0778-4a7c-4c14-af42-0e8340cf7c9f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_3d80c562-1aef-4a01-aa03-e9f3ec57d7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_3d80c562-1aef-4a01-aa03-e9f3ec57d7ad" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_bc00bcb3-72b3-4d60-a5a5-85ae117a8c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_bc00bcb3-72b3-4d60-a5a5-85ae117a8c7e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_5a947b6a-2267-48d6-94f9-2560e8c4b50d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_5a947b6a-2267-48d6-94f9-2560e8c4b50d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_982e2126-efcc-4979-8e80-8d2fed2fa8eb" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_982e2126-efcc-4979-8e80-8d2fed2fa8eb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_c4085b0f-f2d3-4f26-918a-4a3b14a0216c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_c4085b0f-f2d3-4f26-918a-4a3b14a0216c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_bd7afd5f-e988-4cdf-82f1-60158febbb81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_49a75b6b-8051-4c69-9c3b-523a9799461d" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_bd7afd5f-e988-4cdf-82f1-60158febbb81" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_796306b2-fa2a-4f22-8c67-00d8bfb35534" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_bd7afd5f-e988-4cdf-82f1-60158febbb81" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_796306b2-fa2a-4f22-8c67-00d8bfb35534" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent_f8edaea5-32b3-4542-8a4e-7c55f76b0e8b" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_bd7afd5f-e988-4cdf-82f1-60158febbb81" xlink:to="loc_syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent_f8edaea5-32b3-4542-8a4e-7c55f76b0e8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent_d539f95d-cc7d-4685-a99f-4e9b7185b289" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_bd7afd5f-e988-4cdf-82f1-60158febbb81" xlink:to="loc_syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent_d539f95d-cc7d-4685-a99f-4e9b7185b289" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_44220358-95b0-4bfb-b180-35dcd463c62b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_bd7afd5f-e988-4cdf-82f1-60158febbb81" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_44220358-95b0-4bfb-b180-35dcd463c62b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_176e06dd-15f4-47a7-8fcd-1d3a64b28fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_bd7afd5f-e988-4cdf-82f1-60158febbb81" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_176e06dd-15f4-47a7-8fcd-1d3a64b28fc4" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_27730b12-36c2-4648-b7eb-c187a9c61841" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_ec02878f-e9df-4db6-992f-797618bfc9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_27730b12-36c2-4648-b7eb-c187a9c61841" xlink:to="loc_us-gaap_SubsequentEventTable_ec02878f-e9df-4db6-992f-797618bfc9fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5ba0d24a-93df-4be9-a578-8de9592fa751" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_ec02878f-e9df-4db6-992f-797618bfc9fd" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5ba0d24a-93df-4be9-a578-8de9592fa751" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5ba0d24a-93df-4be9-a578-8de9592fa751_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5ba0d24a-93df-4be9-a578-8de9592fa751" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5ba0d24a-93df-4be9-a578-8de9592fa751_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_46841459-6485-4a8e-b003-c3039fff836d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5ba0d24a-93df-4be9-a578-8de9592fa751" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_46841459-6485-4a8e-b003-c3039fff836d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c9734c23-2699-46ad-be50-965c5e99cdfb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_46841459-6485-4a8e-b003-c3039fff836d" xlink:to="loc_us-gaap_SubsequentEventMember_c9734c23-2699-46ad-be50-965c5e99cdfb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_50da3f07-6e12-451b-a343-39342ec2e35f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_ec02878f-e9df-4db6-992f-797618bfc9fd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_50da3f07-6e12-451b-a343-39342ec2e35f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_50da3f07-6e12-451b-a343-39342ec2e35f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_50da3f07-6e12-451b-a343-39342ec2e35f" xlink:to="loc_us-gaap_EquityComponentDomain_50da3f07-6e12-451b-a343-39342ec2e35f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bd409da6-a433-429a-8d0c-169363f3ae95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_50da3f07-6e12-451b-a343-39342ec2e35f" xlink:to="loc_us-gaap_EquityComponentDomain_bd409da6-a433-429a-8d0c-169363f3ae95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_87f0c239-7707-4dfd-bf01-f9b54a2d231b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bd409da6-a433-429a-8d0c-169363f3ae95" xlink:to="loc_us-gaap_CommonStockMember_87f0c239-7707-4dfd-bf01-f9b54a2d231b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0a2d7b8e-d5e2-4d01-a3d1-5080fec63206" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_ec02878f-e9df-4db6-992f-797618bfc9fd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0a2d7b8e-d5e2-4d01-a3d1-5080fec63206" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0a2d7b8e-d5e2-4d01-a3d1-5080fec63206_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0a2d7b8e-d5e2-4d01-a3d1-5080fec63206" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0a2d7b8e-d5e2-4d01-a3d1-5080fec63206_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea360b52-6737-4e60-851e-d3501333e15d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0a2d7b8e-d5e2-4d01-a3d1-5080fec63206" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea360b52-6737-4e60-851e-d3501333e15d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InariMedicalInc.MergerMember_f5752750-f5f4-4a85-a3f9-db95e94e9b3a" xlink:href="syk-20241231.xsd#syk_InariMedicalInc.MergerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea360b52-6737-4e60-851e-d3501333e15d" xlink:to="loc_syk_InariMedicalInc.MergerMember_f5752750-f5f4-4a85-a3f9-db95e94e9b3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cf1563ed-3f30-4e1e-b2d4-c2bee64a03a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_ec02878f-e9df-4db6-992f-797618bfc9fd" xlink:to="loc_us-gaap_DebtInstrumentAxis_cf1563ed-3f30-4e1e-b2d4-c2bee64a03a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cf1563ed-3f30-4e1e-b2d4-c2bee64a03a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cf1563ed-3f30-4e1e-b2d4-c2bee64a03a0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cf1563ed-3f30-4e1e-b2d4-c2bee64a03a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5a890692-e17e-489e-bfba-13abb47f09b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cf1563ed-3f30-4e1e-b2d4-c2bee64a03a0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5a890692-e17e-489e-bfba-13abb47f09b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.550DueFebruary102027Member_6c0524bf-08b2-42ec-9dd1-c25c69a360b7" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.550DueFebruary102027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5a890692-e17e-489e-bfba-13abb47f09b9" xlink:to="loc_syk_SeniorUnsecuredNotes4.550DueFebruary102027Member_6c0524bf-08b2-42ec-9dd1-c25c69a360b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.700DueFebruary102028Member_d7437674-8e85-45e2-bca4-7c7294bf10f2" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.700DueFebruary102028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5a890692-e17e-489e-bfba-13abb47f09b9" xlink:to="loc_syk_SeniorUnsecuredNotes4.700DueFebruary102028Member_d7437674-8e85-45e2-bca4-7c7294bf10f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.850DueFebruary102030Member_7bc9a3f6-bf86-4cb8-b7ce-63f48f3f8ad8" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.850DueFebruary102030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5a890692-e17e-489e-bfba-13abb47f09b9" xlink:to="loc_syk_SeniorUnsecuredNotes4.850DueFebruary102030Member_7bc9a3f6-bf86-4cb8-b7ce-63f48f3f8ad8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes5.200DueFebruary282035Member_bf46fb8b-7b05-4d06-8e22-2d5a9b91fe4f" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes5.200DueFebruary282035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5a890692-e17e-489e-bfba-13abb47f09b9" xlink:to="loc_syk_SeniorUnsecuredNotes5.200DueFebruary282035Member_bf46fb8b-7b05-4d06-8e22-2d5a9b91fe4f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5ed9aa1c-7b81-4f3c-970d-33bf600b625e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_ec02878f-e9df-4db6-992f-797618bfc9fd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5ed9aa1c-7b81-4f3c-970d-33bf600b625e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5ed9aa1c-7b81-4f3c-970d-33bf600b625e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5ed9aa1c-7b81-4f3c-970d-33bf600b625e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5ed9aa1c-7b81-4f3c-970d-33bf600b625e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_89d5892c-3759-42ae-b959-e4d90ad97c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5ed9aa1c-7b81-4f3c-970d-33bf600b625e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_89d5892c-3759-42ae-b959-e4d90ad97c9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c32916bd-dfd4-4814-ad93-0c39abb6e217" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_89d5892c-3759-42ae-b959-e4d90ad97c9a" xlink:to="loc_us-gaap_SeniorNotesMember_c32916bd-dfd4-4814-ad93-0c39abb6e217" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_78c31291-3f0e-4d78-b155-479cd22c4b58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_27730b12-36c2-4648-b7eb-c187a9c61841" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_78c31291-3f0e-4d78-b155-479cd22c4b58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationPriceOfAcquisitionExpected_2169f69c-90dc-454c-8bf2-566fa194c648" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationPriceOfAcquisitionExpected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_27730b12-36c2-4648-b7eb-c187a9c61841" xlink:to="loc_us-gaap_BusinessCombinationPriceOfAcquisitionExpected_2169f69c-90dc-454c-8bf2-566fa194c648" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2734d83f-abdb-4a66-b0c6-edf8c4aadf61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_27730b12-36c2-4648-b7eb-c187a9c61841" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2734d83f-abdb-4a66-b0c6-edf8c4aadf61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_59a24d20-6fec-449f-9a38-d3f999da7f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_27730b12-36c2-4648-b7eb-c187a9c61841" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_59a24d20-6fec-449f-9a38-d3f999da7f5d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#ScheduleIIValuationandQualifyingAccountsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c1c783a0-7ccf-46c7-8685-acce0e156a90" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_2f0d8dea-ba20-41a3-a532-f4cd76a0217f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c1c783a0-7ccf-46c7-8685-acce0e156a90" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_2f0d8dea-ba20-41a3-a532-f4cd76a0217f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_35e6903a-f732-4de7-8dda-20e941e96ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_2f0d8dea-ba20-41a3-a532-f4cd76a0217f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_35e6903a-f732-4de7-8dda-20e941e96ee5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_35e6903a-f732-4de7-8dda-20e941e96ee5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_35e6903a-f732-4de7-8dda-20e941e96ee5" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_35e6903a-f732-4de7-8dda-20e941e96ee5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_069663f1-a4f8-4784-baf7-0c2d84649f14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_35e6903a-f732-4de7-8dda-20e941e96ee5" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_069663f1-a4f8-4784-baf7-0c2d84649f14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForNotesReceivableMember_8dde1499-c52d-444f-bd57-970607465778" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForNotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_069663f1-a4f8-4784-baf7-0c2d84649f14" xlink:to="loc_us-gaap_AllowanceForNotesReceivableMember_8dde1499-c52d-444f-bd57-970607465778" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_0f45643e-b813-44c1-a70e-e821e3210394" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c1c783a0-7ccf-46c7-8685-acce0e156a90" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_0f45643e-b813-44c1-a70e-e821e3210394" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_c1229862-2893-4565-9c2a-707e3088003b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c1c783a0-7ccf-46c7-8685-acce0e156a90" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_c1229862-2893-4565-9c2a-707e3088003b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_fa2db0c7-e5e6-4cc0-9476-e3d475bc1160" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c1c783a0-7ccf-46c7-8685-acce0e156a90" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_fa2db0c7-e5e6-4cc0-9476-e3d475bc1160" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_8444c129-a9f9-4087-9ce5-0f6001201fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c1c783a0-7ccf-46c7-8685-acce0e156a90" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_8444c129-a9f9-4087-9ce5-0f6001201fc1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_1880d517-cdd1-4706-bbfe-1af464451267" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="101"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="31"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>19
<FILENAME>syk-20241231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:66138c84-a1f4-4bd1-9e3f-a7dda17467bc,g:664b5418-33ef-4591-a7dd-ebf51b747252-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_3c37fa31-3973-4e5b-a93f-d12c82003688_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_b3234b5e-e0b4-4a11-ac30-c3a6d1eed920_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining contractual term, Options expected to vest (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80df93d5-2b48-413c-bfd1-60d91daf0ab5_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net earnings to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetInterestCarryforward_939cb7b9-ee82-4390-8804-834df87ed7c7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International interest expense carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetInterestCarryforward_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset, Interest Carryforward</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:to="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_12810fb9-298c-4cac-ba0b-fb2fb98dfc3d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_59a6315a-a6f2-4290-a23d-d9875899db0c_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining shares authorized to be repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Remaining Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligationCurrent_0595373f-509c-4575-824c-ee92449b0d99_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplier finance obligation</link:label>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligationCurrent_label_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplier Finance Program, Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierFinanceProgramObligationCurrent" xlink:to="lab_us-gaap_SupplierFinanceProgramObligationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_e525db99-5441-489f-9745-05af8d5ecb0a_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_22c49c70-b503-47ce-ae35-3e1d6dd6dd5d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ee47866c-c728-49c8-aeff-1d09aa871243_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_f8da0bb6-4050-455a-bbfc-b394a95b0723_verboseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_fdc39352-98f0-4b2b-99cd-7c3ddb5c0edb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_d2642867-1359-4e67-834e-9bfae0e0d175_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_86b5139e-cd94-4ff3-80a3-bc236ff2bb64_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_bb68a8a0-2d26-4b39-b401-f22cbcd0e8a6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock_7f645f2c-51ea-48c7-8481-619137336173_terseLabel_en-US" xlink:label="lab_syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets And Liabilities Held For Sale</link:label>
    <link:label id="lab_syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock_label_en-US" xlink:label="lab_syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets And Liabilities Held For Sale [Policy Text Block]</link:label>
    <link:label id="lab_syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock_documentation_en-US" xlink:label="lab_syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets And Liabilities Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock" xlink:href="syk-20241231.xsd#syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock" xlink:to="lab_syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_4ca8637a-6d1f-445c-9a7b-e56180d616f0_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Dividends declared per share of common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_10bade74-5543-4467-87e3-d1985606017c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCash_8798aca2-899b-489e-86a3-72176520a900_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCash_label_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCash" xlink:to="lab_us-gaap_DividendsCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2d8cfaf9-fa53-4ddf-866f-103a14c13535_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, allowance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0cd7cac5-e424-4e16-bfd9-c261611e01e4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_965de48d-0d5e-4146-a4a6-75387d24f41b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_aaf4b25a-9d16-44b7-9ba8-87a2d610d5c4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_06d9e76a-8c74-4086-ae98-3146c48d0840_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_e2df647e-ce23-40ad-b739-5a27df89e174_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_336bb913-2f86-4a4a-997e-9ecd00342ea0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_5430028b-fe4b-4824-9a39-f3e513ee1dfb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_8fbe12a6-0746-4d7f-9957-0da5833ae4f6_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_2f3b9732-7782-4988-8fb0-176ff9b1e4ef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_0330b049-522a-45cd-ac8b-cd34ae88c5dc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gains (losses) on designated hedges</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_f0c6b39f-b058-42dd-93a7-e36cef37f0d4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_2e482cab-4405-4998-b055-10b8f646f79c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sales of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_4e6d4368-a667-401b-b364-e2e565a33e7a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_b80b7abd-47a9-494f-8fc1-6aa12dfffff3_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_d9b7a410-638b-403f-9f07-e1b08dd7aacf_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_0f7e4005-9bac-4090-8516-1f006aedec36_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories:</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3a8ef44b-ca36-4a5e-b90c-df7c1bde9a46_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of dilutive employee stock compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_7f360331-14ed-44e1-9874-df1a349a91ad_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other noncurrent assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_35d13b97-5141-40c7-ad9f-d74ab6a7930f_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_ee538bc1-ce7c-42ff-a35a-b19d648a8e6c_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_51ffa5de-e55b-412f-b009-a5b74b28266c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_9bf8412a-d32c-429a-8370-2b700b7b60d8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_684f38dd-885c-40a0-8ff7-8734486890a4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_1cd36f75-5099-4586-9038-69d6135c75fc_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncurrent deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0af45860-dd3a-48c2-a303-7fdaa8231ad5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_2746e4d1-cd81-4f9d-8705-a350d4e26245_terseLabel_en-US" xlink:label="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Future Purchase Obligations and Minimum Lease Payments</link:label>
    <link:label id="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_label_en-US" xlink:label="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:to="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_76d24394-0a13-4dac-9374-c4013bd9cef7_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_0a9a31be-9d85-475c-81dd-aaba04ca2f23_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reduction of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1f9ebedc-49ff-4af1-8f71-d3c9cc39e32b_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f8c9122c-9c49-435b-9601-38cc1bcbee10_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_955bfc99-9dc3-4f9c-86aa-15e418cd07bc_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue_42cdd3c2-2265-4e1c-b5c1-d88a90c8d451_negatedTerseLabel_en-US" xlink:label="lab_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decrease to fair value</link:label>
    <link:label id="lab_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue_label_en-US" xlink:label="lab_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Timing of Disposal, Potential Decrease In Fair Value</link:label>
    <link:label id="lab_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue_documentation_en-US" xlink:label="lab_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Timing of Disposal, Potential Decrease In Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue" xlink:to="lab_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_ba849eb2-b28b-4732-a37e-811e0b665bdb_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_74377c72-994c-4628-891c-33f8c80fdfbc_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_3a50bc09-225a-4245-b1aa-d2c1f0903209_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_9309186b-d1b1-4e9b-a4d3-450be331fd4e_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_eee5a5aa-4957-43bb-9e88-ca82efe6a74f_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">(Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_15f46c07-62b9-444a-90e3-990dc65d0280_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Uncollectible Amounts Written Off, Net of Recoveries</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_7c396c72-7b27-4630-9648-e01d94740d37_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_201eda3e-c1f3-4d9a-924c-5d50547fc9a5_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Anti-dilutive shares excluded from calculation of dilutive employee stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_9e08b89b-fc96-48e8-a148-4e71be7fa7d7_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_5a4061c1-1498-4030-87ab-a4d4a5c7b24c_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Goodwill, Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_b9dae95c-8e94-434b-b317-390454b43a1d_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Goodwill, Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_2635365f-4ead-42cc-b474-e644a37df87c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prior service cost and transition amount</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6853731d-4ebd-46ea-b051-dce01ef43919_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for taxes from withheld shares</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8d55f87f-1670-44d1-b8e4-664770e76c9b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_3ecf146c-6dc0-4d78-a7fa-f9ad15f38723_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_f738de9b-16ad-4b32-906b-b19cd341d30c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_6c01837d-8282-496c-a9f8-d8a603ed1c17_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_d36ff375-74f0-4070-9a96-c43e68ec4e48_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Derivative, fair value, net</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a40f63d9-f548-478b-b48b-ae11e1e04ae9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5684db56-6346-4dae-9914-c612087c1ddf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financing, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f0ebfc1f-8888-4239-937c-5612b4f95824_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeInterestEarningAsset_b1dd7351-91dd-4616-937e-ab5f5a6de1d9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeInterestEarningAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeInterestEarningAsset_label_en-US" xlink:label="lab_us-gaap_InterestIncomeInterestEarningAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income, Interest-Earning Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeInterestEarningAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeInterestEarningAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeInterestEarningAsset" xlink:to="lab_us-gaap_InterestIncomeInterestEarningAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_122f88fc-e5c6-4b4b-8f09-a858f88a7ffc_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_a30df3be-63af-4f05-9b20-2be125efb889_terseLabel_en-US" xlink:label="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating loss carryforwards, subject to full valuation allowance</link:label>
    <link:label id="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_label_en-US" xlink:label="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards, Subject to Valuation Allowance</link:label>
    <link:label id="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_documentation_en-US" xlink:label="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards, Subject to Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:href="syk-20241231.xsd#syk_OperatingLossCarryforwardsSubjectToValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:to="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_fc153126-6b4e-4855-8eed-8f3dce5288a3_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_3a17d51b-ca60-4dc9-aa2a-ae4e0af8990e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_1e041a05-cc2b-4746-98d3-ede2d69878f2_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_5e0e47d8-092e-47ef-8f6c-e6ea86cea9e5_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_71a2455c-b062-4ea9-8bb4-150ddf226d88_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_31985938-426f-46e1-aecd-a56e5e516324_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_733c72be-b1a9-40f7-8cca-499889d1295c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Property, Plant &amp; Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_1423bf8d-f26f-4d8e-948e-3961b8b43b0e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_87869299-657c-4485-8161-991ee5effade_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_VariousMember_39527c29-905f-4db6-a6ed-c3bd5479370a_terseLabel_en-US" xlink:label="lab_syk_VariousMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Various</link:label>
    <link:label id="lab_syk_VariousMember_label_en-US" xlink:label="lab_syk_VariousMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Various [Member]</link:label>
    <link:label id="lab_syk_VariousMember_documentation_en-US" xlink:label="lab_syk_VariousMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Various</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_VariousMember" xlink:href="syk-20241231.xsd#syk_VariousMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_VariousMember" xlink:to="lab_syk_VariousMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_e5d4b8ea-2882-4f37-bc37-35fdf5be9a51_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_c1aae116-a51d-4dd0-a09d-4986e107e2ea_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_42e358b4-1dc4-4d1d-9e9d-c661c47c0952_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, Exercisable at December 31 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_52c9f72a-d64c-4ea7-b1ea-b974952ddd64_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d06644da-f4d1-4d48-8d18-1f0f003fa13e_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average amortization period at acquisition (years):</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_567379ec-fedc-4f01-9cbb-0694ad32b1da_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_78de4fc5-548d-4d52-8807-59b3e9100f3e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_2d2a6d9a-5070-40cf-be52-34c52ff08363_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherShortTermInvestments_73a77fd8-5d6e-4c35-84d9-bd86a59b6c1b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_OtherShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_OtherShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherShortTermInvestments" xlink:to="lab_us-gaap_OtherShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_5a8bceb5-a108-4e20-b60e-d1e05b05b27f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss and credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_da621ba4-ff16-4d65-9ef4-4c6c3d3348e1_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_4618f6de-9518-4adf-a562-50d1f7d0aa8a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_a4c24ce3-2a4e-4791-9d34-631a22ad430d_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_20b9a4f2-3f33-49cd-bea4-3123de65bb63_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares, Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_f4ba0510-e9aa-4963-8c8c-216643570f3d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_68fd395b-5838-449c-a068-ff1a169d9594_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Exercise&#160;Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_e58f2a40-9d91-448d-b0ff-dce95d878a70_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_fedfab7a-beab-4642-bd4e-a2739db580c7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Statute of limitations expirations and other</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cd89eac8-bb60-464f-a3da-83cf6d8a9fdc_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_CerusMember_d73b3d17-0898-4925-b1f8-255a8b3f7d7b_terseLabel_en-US" xlink:label="lab_syk_CerusMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cerus</link:label>
    <link:label id="lab_syk_CerusMember_label_en-US" xlink:label="lab_syk_CerusMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cerus [Member]</link:label>
    <link:label id="lab_syk_CerusMember_documentation_en-US" xlink:label="lab_syk_CerusMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cerus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CerusMember" xlink:href="syk-20241231.xsd#syk_CerusMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_CerusMember" xlink:to="lab_syk_CerusMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_46a2e903-b586-476a-a7d0-2de0c48583c8_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_NeuroCranialMember_d5e68cee-676c-464e-a0d2-fe72e4952851_terseLabel_en-US" xlink:label="lab_syk_NeuroCranialMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Neuro Cranial</link:label>
    <link:label id="lab_syk_NeuroCranialMember_label_en-US" xlink:label="lab_syk_NeuroCranialMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Neuro Cranial [Member]</link:label>
    <link:label id="lab_syk_NeuroCranialMember_documentation_en-US" xlink:label="lab_syk_NeuroCranialMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Neuro Cranial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeuroCranialMember" xlink:href="syk-20241231.xsd#syk_NeuroCranialMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_NeuroCranialMember" xlink:to="lab_syk_NeuroCranialMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_44aaa0c5-dd63-4051-8644-671ef921a6cd_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_cac6a90a-2958-4ee7-bfb3-91ee70699933_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_317cd9d0-1fbf-42bc-bdef-5a8dc2f90f53_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_5bc9630a-18c2-4ef9-8a7a-f09001937dcf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_OtherIncomeexpenseMember_95b4ba76-488c-4f14-a6e0-bce4500025fd_terseLabel_en-US" xlink:label="lab_syk_OtherIncomeexpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_syk_OtherIncomeexpenseMember_label_en-US" xlink:label="lab_syk_OtherIncomeexpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income (expense) [Member]</link:label>
    <link:label id="lab_syk_OtherIncomeexpenseMember_documentation_en-US" xlink:label="lab_syk_OtherIncomeexpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Income (expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherIncomeexpenseMember" xlink:href="syk-20241231.xsd#syk_OtherIncomeexpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_OtherIncomeexpenseMember" xlink:to="lab_syk_OtherIncomeexpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_06d38cf2-132c-44ea-b8c8-e16d52713766_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in the Net Carrying Amount of Goodwill by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_97f3110e-1f0e-49b0-a441-3a988126fb93_terseLabel_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax related to repatriation of foreign earnings</link:label>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_label_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Earnings Repatriation, Percent</link:label>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_documentation_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Earnings Repatriation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:href="syk-20241231.xsd#syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:to="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_deaab3e4-008c-4347-9837-df4edb299999_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_16edffc9-4b95-451c-a99a-9b5a77ce337c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan expense</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_763a7ec1-c77b-4e62-b4e0-44ac2bcf2657_terseLabel_en-US" xlink:label="lab_syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement Of Income Or Comprehensive Income, Extensible List, Not Disclosed Flag</link:label>
    <link:label id="lab_syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_label_en-US" xlink:label="lab_syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement Of Income Or Comprehensive Income, Extensible List, Not Disclosed Flag</link:label>
    <link:label id="lab_syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_documentation_en-US" xlink:label="lab_syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement Of Income Or Comprehensive Income, Extensible List, Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:href="syk-20241231.xsd#syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:to="lab_syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_9f8d48f0-8339-42c8-b445-ffe20f6b90b2_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_fc3b3f03-672e-48b0-ae54-b39b6afd9507_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_495a2ed0-c17b-40c7-be3c-1ae8a47df26c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligationIncrease_e175432a-75df-4b1e-ae61-a61821b7f1ef_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligationIncrease_label_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplier Finance Program, Obligation, Addition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierFinanceProgramObligationIncrease" xlink:to="lab_us-gaap_SupplierFinanceProgramObligationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a02bad33-2d79-4226-aeae-828024d227af_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_f3f1ba7e-bc19-4fd6-82d5-56bcc720d195_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Balance [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_922f042e-dd80-4c0f-b008-bb7505b5d21d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business acquisition, share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_d20eb1b8-ea3f-44ed-b89a-0bae13aab3ac_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_70ca548b-e1f0-41e8-91a3-389d5c912f9b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_12137820-2eb5-44f4-8ff8-1764556cc831_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining contractual term, Options outstanding (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_584b144b-5896-42fb-8672-dc816e0c5b47_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_71c8ab50-3916-4523-a390-8666ebf4d5b1_negatedTerseLabel_en-US" xlink:label="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_label_en-US" xlink:label="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities Depreciation And Amortization</link:label>
    <link:label id="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_documentation_en-US" xlink:label="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities Depreciation And Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:href="syk-20241231.xsd#syk_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:to="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_eab9cf2a-47cf-44f5-b91c-aa2e7a361d4c_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cf7e3c2e-61de-4647-9ee0-cc24a9fad953_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_eb8b2d1e-ff10-45fb-aa61-5a9bba3e5af6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_5c0c1144-70cb-43c8-add7-257280f1c8ca_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_f78da001-7133-4ae6-850e-d33f3033d1ec_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_94e3c3fe-adcc-4a0b-b8d9-547f64a24074_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Actuarial (gains) losses</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_aa64d020-1561-44c3-99cb-22a5969e051d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales and Other Financial Information by Business Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_2c44b93d-f993-4626-84b7-e2d84e09dd2f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_e5cadc1b-eaf5-4ba7-8130-e68af7c5dee1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining contractual term, Exercisable (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a4e6465-0c01-4424-b008-d536fc7e0910_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_4683f1ff-740b-4628-b48b-629b5057030c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in Contract Liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_0bfe6847-8fef-4aaf-bdea-d243758244ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_85b0bc8e-7088-49a8-919d-a6e074d43210_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_9f9ea4c1-bea6-428a-8808-66213f4acf6e_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_0d4a0084-a0dd-4ce6-863f-d2e84cb101fb_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_d9c71ee8-5405-4e42-8bd9-ec32a6e303c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_4a145161-32b9-4c4a-9efb-6356151ad329_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligation_6b432960-d289-491f-a5ee-75245ea5fa16_periodStartLabel_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning confirmed obligations</link:label>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligation_9ebf0968-d2df-41a5-a060-4fca64b2c843_periodEndLabel_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending confirmed obligations</link:label>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligation_label_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplier Finance Program, Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierFinanceProgramObligation" xlink:to="lab_us-gaap_SupplierFinanceProgramObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_89c2adfd-a62d-445c-a4a9-8616517e6f7d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b9b00871-a74d-4ee0-b9a1-07aa61b6c06e_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_69498ae2-1975-47a9-af9a-2948d9aa0be9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_063c5f53-e7ad-49a4-85ee-19d090d799b7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_f685fb39-74fe-406d-9146-60ea4b13fe5f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_f4a0f0c0-e2ca-4a33-85a9-68a3931e13e0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_682db39e-d238-4f44-afa0-7e609b0b22b7_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net investment hedges expected to be reclassified to cost of sales and other income (expense)</link:label>
    <link:label id="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_3dd1fe9a-9709-428e-b58c-a25cc6116541_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax</link:label>
    <link:label id="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_label_en-US" xlink:label="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:to="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a147142a-0789-41ed-9bd6-5b2aaaf10733_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Purchase price, net of cash acquired of $57 and $7</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_1b0d69ff-330a-4953-b1d5-fe7170f9a13a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.625DueSeptember112034Member_a3cb7944-62a0-44b7-bd85-12ae637a9193_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.625DueSeptember112034Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.625% due September 11, 2034</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.625DueSeptember112034Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.625DueSeptember112034Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.625% due September 11, 2034 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.625DueSeptember112034Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.625DueSeptember112034Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.625% due September 11, 2034</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.625DueSeptember112034Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.625DueSeptember112034Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes4.625DueSeptember112034Member" xlink:to="lab_syk_SeniorUnsecuredNotes4.625DueSeptember112034Member" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_OrthopaedicsMember_cbc0afe7-e54a-4199-b58f-41294af7a3c1_terseLabel_en-US" xlink:label="lab_syk_OrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Orthopaedics</link:label>
    <link:label id="lab_syk_OrthopaedicsMember_label_en-US" xlink:label="lab_syk_OrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Orthopaedics [Member]</link:label>
    <link:label id="lab_syk_OrthopaedicsMember_documentation_en-US" xlink:label="lab_syk_OrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Orthopaedics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsMember" xlink:href="syk-20241231.xsd#syk_OrthopaedicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_OrthopaedicsMember" xlink:to="lab_syk_OrthopaedicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_18e8696f-bdf2-4351-82a0-088e51248ed8_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_abe01631-8958-440b-ad6a-c85aff4cf676_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_72323e28-3f80-47f5-b181-33b017212747_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amortization of prior service cost and transition amount</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_1bdb02be-8025-4f3c-8779-00c365820b3c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted net earnings per share of common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany_14953a6c-e50b-4720-927d-d25dbec71a7a_terseLabel_en-US" xlink:label="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stryker common stock held by plan, value as a percentage of total plan assets</link:label>
    <link:label id="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany_label_en-US" xlink:label="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Percentage of Defined Contribution Retirement Plan Assets Value Held by Company</link:label>
    <link:label id="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany_documentation_en-US" xlink:label="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Percentage of Defined Contribution Retirement Plan Assets Value Held by Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:href="syk-20241231.xsd#syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:to="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_InariMedicalInc.MergerMember_ff0ed118-01d4-4ff9-8465-f05ebf8fcb52_terseLabel_en-US" xlink:label="lab_syk_InariMedicalInc.MergerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inari</link:label>
    <link:label id="lab_syk_InariMedicalInc.MergerMember_label_en-US" xlink:label="lab_syk_InariMedicalInc.MergerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inari Medical, Inc. Merger [Member]</link:label>
    <link:label id="lab_syk_InariMedicalInc.MergerMember_documentation_en-US" xlink:label="lab_syk_InariMedicalInc.MergerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Inari Medical, Inc. Merger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InariMedicalInc.MergerMember" xlink:href="syk-20241231.xsd#syk_InariMedicalInc.MergerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_InariMedicalInc.MergerMember" xlink:to="lab_syk_InariMedicalInc.MergerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_ed418fb6-c571-4d60-9b61-348c2facf386_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_216af094-5b89-48ea-a723-1638b24a1b2a_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_PercentageofServiceRevenueRecognizeoverTime_40c74722-5f5a-4a0e-b9ab-3cdde2909e85_terseLabel_en-US" xlink:label="lab_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of sales recognized as services over time (less than)</link:label>
    <link:label id="lab_syk_PercentageofServiceRevenueRecognizeoverTime_label_en-US" xlink:label="lab_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of Service Revenue Recognize over Time</link:label>
    <link:label id="lab_syk_PercentageofServiceRevenueRecognizeoverTime_documentation_en-US" xlink:label="lab_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of Service Revenue Recognize over Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:href="syk-20241231.xsd#syk_PercentageofServiceRevenueRecognizeoverTime"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:to="lab_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_ebbb186f-2ab6-4c5c-b495-d4990f898f11_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current income tax expense</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_425d6c83-9c92-453a-9ab6-f7b025464e17_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_4aba49c7-b44f-439c-a704-c52eb9ba0676_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_cac0e264-9ca3-438b-9981-f20b86b646de_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency transaction gains (losses)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization_eefac180-04f3-458a-a0a9-2681daec31e1_terseLabel_en-US" xlink:label="lab_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development capitalization</link:label>
    <link:label id="lab_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization_label_en-US" xlink:label="lab_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Research And Development Capitalization</link:label>
    <link:label id="lab_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization_documentation_en-US" xlink:label="lab_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Research And Development Capitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization" xlink:href="syk-20241231.xsd#syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization" xlink:to="lab_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_6a57d72b-1b47-4647-978e-f9e146c5fd7b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_b42c2fa0-b715-4127-b973-c2873c596ea0_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Corporate and asset-backed debt securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_ef0e3d0f-056e-4466-a826-7e5cfac90d81_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_bfc6708c-5415-40c5-9a34-576e54f2d3a7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_7f71fad5-8e0c-41c1-abbd-94dc301194f9_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_3228cbbd-3753-4a53-af7d-29ce62c077eb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_05d8700a-c4f0-43c4-b61b-fe1d9d78f7f8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_1ff8f987-8b64-4067-a359-e66ea46b7e23_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_8bca4bfe-14ed-41f3-b1b6-5dc02cbe7e13_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_6105853c-66d5-4378-abc4-0cc2cc4fa566_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_e0280a33-14fc-447f-afdb-2be7383efa56_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Available-for-sale marketable securities:</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7448d69d-4201-4009-bd48-9dd4319a98a9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of Net Periodic Pension Cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_b65a5595-3fa9-4bea-9f8b-dc14d2406e3b_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency exchange forward contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_491e0789-f94b-41f2-ae38-e03d63d78aa0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate swap asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c263e306-4606-4287-a598-1ca72965ab4d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation cost not yet recognized, period for recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_07b5a0f1-6613-4ff8-bec6-3e118aae27be_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_c5fbb854-ebdb-4d4d-be37-427a590b8257_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.100Due2043Member_a64446d3-897d-48fc-a6f0-454a6966a628_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.100Due2043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.100% due 2043</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.100Due2043Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.100Due2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.100% due 2043 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.100Due2043Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.100Due2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.100% due 2043</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.100Due2043Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.100Due2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes4.100Due2043Member" xlink:to="lab_syk_SeniorUnsecuredNotes4.100Due2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_1855d5b5-14d8-426f-aed8-23b492b92919_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_7b20f499-984b-454e-9a89-f40c24590c19_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_c0b16396-e2a2-4a0c-ac9a-ccc9526d0f6f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_7cda2a99-f6ba-4e3e-b1d2-e3b5a3aeb5ba_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_63010691-0dd0-41a8-bca8-b8f33b8c7895_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_55b1641b-7a0b-4d1c-96d7-0e1d212d5bf2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9a5fbbb9-6607-413b-a96e-fb801c26b51f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.250Due2024Member_56735725-2d84-45e4-bf5a-575fe2211c2e_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.250Due2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 0.250% due 2024</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.250Due2024Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.250Due2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 0.250% Due 2024 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.250Due2024Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.250Due2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 0.250% due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.250Due2024Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes0.250Due2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes0.250Due2024Member" xlink:to="lab_syk_SeniorUnsecuredNotes0.250Due2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.625Due2036Member_cfb45c3a-35db-403f-a64b-1e76811e3027_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.625Due2036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.625% Notes due 2036</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.625Due2036Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.625Due2036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 3.625% due 2036 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.625Due2036Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.625Due2036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 3.625% due 2036</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.625Due2036Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.625Due2036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes3.625Due2036Member" xlink:to="lab_syk_SeniorUnsecuredNotes3.625Due2036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_edf73232-a0d1-4c88-b2dc-7598641c7d16_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from settlement of net investment hedges</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Hedge, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_e8b50bdb-801d-4386-b995-ce39e45ac40b_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.10 par value</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValueOutstanding" xlink:to="lab_us-gaap_CommonStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_LongLivedAssetsAndIntangibleAssetsMember_130f8c87-7e50-46e2-87f1-1069854e8d39_terseLabel_en-US" xlink:label="lab_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Assets and Intangible Assets</link:label>
    <link:label id="lab_syk_LongLivedAssetsAndIntangibleAssetsMember_label_en-US" xlink:label="lab_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Assets and Intangible Assets [Member]</link:label>
    <link:label id="lab_syk_LongLivedAssetsAndIntangibleAssetsMember_documentation_en-US" xlink:label="lab_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Long-Lived Assets and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:href="syk-20241231.xsd#syk_LongLivedAssetsAndIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:to="lab_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.850Due2028Member_7016c605-a430-4d9a-843b-e9e741c8f97c_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.850Due2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.850% Due 2028</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.850Due2028Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.850Due2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.850% Due 2028 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.850Due2028Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.850Due2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.850% Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.850Due2028Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.850Due2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes4.850Due2028Member" xlink:to="lab_syk_SeniorUnsecuredNotes4.850Due2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_a34fc94b-3843-430c-9fe6-124a7adc6a9d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_886b5b77-a30d-40cf-8f14-8e399c4630d2_verboseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">United States agency debt securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_cf6b1f4b-14c8-4291-865e-881390b0d89b_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_485b101e-1234-4506-9287-c46885c575ee_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_036c5d5c-f3a4-47e8-8a7f-fd3e416774de_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_f179fcf1-275d-4b20-80f3-445bed053fa1_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_e495f704-9454-4fcb-b57a-2f45e6954e62_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_177c563b-37a6-4b5d-b8d8-4a0c27546d7e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7364435f-61ae-4f66-94d9-f76eedae6e92_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_0b9fd017-05f8-4319-84b4-3c2fba774d4b_terseLabel_en-US" xlink:label="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforward recognized</link:label>
    <link:label id="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_label_en-US" xlink:label="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income tax expense (benefit), Portion of Net Operating Loss Carryforward Recognized</link:label>
    <link:label id="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_documentation_en-US" xlink:label="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income tax expense (benefit), Portion of Net Operating Loss Carryforward Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:href="syk-20241231.xsd#syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:to="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f3c6483a-9186-4afa-8a03-4bb22fa4c9dd_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value, Outstanding at January 1 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_120742ba-2c7d-4f66-b7c6-b56a39e2dfd9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value, Outstanding at December 31 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1d4af4a0-8fa8-4746-90bb-0fd981e32b43_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_d96a9163-7a27-45f4-82a7-d8b2efea6a57_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares, Options expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_c4796c90-fc18-42c6-b538-c01fac743e4d_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Charged&#160;to Costs &amp; Expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DeferredTaxAssetsDepreciationAndAmortization_f6a01520-d8c6-4444-bcb8-4f6bb6689e85_terseLabel_en-US" xlink:label="lab_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_syk_DeferredTaxAssetsDepreciationAndAmortization_label_en-US" xlink:label="lab_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Depreciation And Amortization</link:label>
    <link:label id="lab_syk_DeferredTaxAssetsDepreciationAndAmortization_documentation_en-US" xlink:label="lab_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Depreciation And Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:href="syk-20241231.xsd#syk_DeferredTaxAssetsDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:to="lab_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_fdc20f6a-f0c0-4ce6-8504-64599364e5ff_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued interest and penalties</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e9d1c0f0-8ed7-474a-9068-c951bafafa1f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_44cac0b2-2bf9-4aab-9c54-6b5531f00ed9_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, Options outstanding at January 1 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b6efc519-dced-45f4-8b56-9c676a21f069_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, Options outstanding at December 31 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_OtherOrthopaedicsMember_f8118e05-60d7-41c7-826c-6321dfb503c7_terseLabel_en-US" xlink:label="lab_syk_OtherOrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_syk_OtherOrthopaedicsMember_label_en-US" xlink:label="lab_syk_OtherOrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Orthopaedics [Member]</link:label>
    <link:label id="lab_syk_OtherOrthopaedicsMember_documentation_en-US" xlink:label="lab_syk_OtherOrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Orthopaedics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherOrthopaedicsMember" xlink:href="syk-20241231.xsd#syk_OtherOrthopaedicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_OtherOrthopaedicsMember" xlink:to="lab_syk_OtherOrthopaedicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_01cd8e76-d9c0-4514-a5e3-2f7082bf9115_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_ec1e49fd-30ce-4bd0-8e75-52ffcca09d16_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b685ffa6-0956-4cc6-93d9-1cd65b3ff9f7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Shares, Options outstanding at January 1 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9baa345f-f51f-4c98-970a-8916b7fc43fc_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Shares, Options outstanding at December 31 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_41c2929f-21c1-4aae-a3d0-bbfbc4dece9e_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_0147051c-9bdd-4dbb-918c-4dff6c8ecc8e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_979ad6fc-9018-47e5-b2eb-a05fc05c3880_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment:</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_23a78a69-a493-4740-b1d9-51d064ca9991_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_KneesMember_f0db0e3e-eb5d-4ae8-8345-329973a3d63c_terseLabel_en-US" xlink:label="lab_syk_KneesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Knees</link:label>
    <link:label id="lab_syk_KneesMember_label_en-US" xlink:label="lab_syk_KneesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Knees [Member]</link:label>
    <link:label id="lab_syk_KneesMember_documentation_en-US" xlink:label="lab_syk_KneesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Knees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_KneesMember" xlink:href="syk-20241231.xsd#syk_KneesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_KneesMember" xlink:to="lab_syk_KneesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_ca3792c6-134d-4746-a5f2-4c4c0fa66439_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_f7445359-d169-4bb8-8c18-b5130627350f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_cc0d6734-2593-4acd-98e5-949095e8a955_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">United States research and development credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c944acd8-1b30-4247-98bd-3e73e2f8f48a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value, Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_d018e7f7-cb5a-49d2-b76b-cbd3062ddc3b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_010d9c7f-82ca-4f73-afda-3e43e589fd84_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_43bada78-427c-4ae2-86e6-70ea89d7aef8_verboseLabel_en-US" xlink:label="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Due after one year through three years</link:label>
    <link:label id="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_label_en-US" xlink:label="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available for sale Securities, Debt Maturities, After One Through Three Years, Fair Value</link:label>
    <link:label id="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_documentation_en-US" xlink:label="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">This item represents the fair value of debt securities which are expected to mature after one through three years of the balance sheet date and which are categorized neither as held-to-maturity nor trading securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:href="syk-20241231.xsd#syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:to="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_144880b5-2969-4f28-9226-8d203a5c4191_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_15397bbc-b301-436a-88cf-bebf3fd7cc80_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_d60b5629-42a9-498d-9ac1-4399b1ad01f5_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_NeuroCranialInterventionalSpineMember_653ff43f-ae46-4e75-8119-dfc638a7b89b_terseLabel_en-US" xlink:label="lab_syk_NeuroCranialInterventionalSpineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Neuro Cranial - Interventional Spine</link:label>
    <link:label id="lab_syk_NeuroCranialInterventionalSpineMember_label_en-US" xlink:label="lab_syk_NeuroCranialInterventionalSpineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Neuro Cranial - Interventional Spine [Member]</link:label>
    <link:label id="lab_syk_NeuroCranialInterventionalSpineMember_documentation_en-US" xlink:label="lab_syk_NeuroCranialInterventionalSpineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Neuro Cranial - Interventional Spine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeuroCranialInterventionalSpineMember" xlink:href="syk-20241231.xsd#syk_NeuroCranialInterventionalSpineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_NeuroCranialInterventionalSpineMember" xlink:to="lab_syk_NeuroCranialInterventionalSpineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_RejuvenateABGIIHipRecallCharges_076de6e1-5f81-4530-97c2-78594f9a15a3_negatedLabel_en-US" xlink:label="lab_syk_RejuvenateABGIIHipRecallCharges" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Recall-related matters</link:label>
    <link:label id="lab_syk_RejuvenateABGIIHipRecallCharges_label_en-US" xlink:label="lab_syk_RejuvenateABGIIHipRecallCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rejuvenate / ABG II Hip Recall Charges</link:label>
    <link:label id="lab_syk_RejuvenateABGIIHipRecallCharges_documentation_en-US" xlink:label="lab_syk_RejuvenateABGIIHipRecallCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Rejuvenate / ABG II Hip Recall Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_RejuvenateABGIIHipRecallCharges" xlink:href="syk-20241231.xsd#syk_RejuvenateABGIIHipRecallCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_RejuvenateABGIIHipRecallCharges" xlink:to="lab_syk_RejuvenateABGIIHipRecallCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligationDecreaseSettlement_2d48162f-516b-41b2-bf40-91c7a4d4e71f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligationDecreaseSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligationDecreaseSettlement_label_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligationDecreaseSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplier Finance Program, Obligation, Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationDecreaseSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationDecreaseSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierFinanceProgramObligationDecreaseSettlement" xlink:to="lab_us-gaap_SupplierFinanceProgramObligationDecreaseSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_b3fd7029-c7e6-4ed4-802e-b2dca092f15f_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Funded status</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_LandBuildingsAndImprovementsGross_5b61e90f-717d-4713-b1d6-07324dfd38cd_terseLabel_en-US" xlink:label="lab_syk_LandBuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Land, buildings and improvements</link:label>
    <link:label id="lab_syk_LandBuildingsAndImprovementsGross_label_en-US" xlink:label="lab_syk_LandBuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Land, Buildings and Improvements, Gross</link:label>
    <link:label id="lab_syk_LandBuildingsAndImprovementsGross_documentation_en-US" xlink:label="lab_syk_LandBuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Land, Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LandBuildingsAndImprovementsGross" xlink:href="syk-20241231.xsd#syk_LandBuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_LandBuildingsAndImprovementsGross" xlink:to="lab_syk_LandBuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b63173d1-bb03-4d29-b32b-60c4199f2922_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_9a0df1b4-a2cf-448b-8f8b-ebdad8149a28_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_803d5976-9652-43fc-8fbd-b5b64aea6223_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7107b64e-8ef3-460b-9b12-e8d9fdddfdc0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_CapitalExpendituresDuringPeriod_88ca70cf-3fea-4fce-8511-e8f5e23f2f0b_terseLabel_en-US" xlink:label="lab_syk_CapitalExpendituresDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital Expenditures During Period</link:label>
    <link:label id="lab_syk_CapitalExpendituresDuringPeriod_label_en-US" xlink:label="lab_syk_CapitalExpendituresDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures During Period</link:label>
    <link:label id="lab_syk_CapitalExpendituresDuringPeriod_documentation_en-US" xlink:label="lab_syk_CapitalExpendituresDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capital Expenditures During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalExpendituresDuringPeriod" xlink:href="syk-20241231.xsd#syk_CapitalExpendituresDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_CapitalExpendituresDuringPeriod" xlink:to="lab_syk_CapitalExpendituresDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_333206e8-eef6-4174-8e9c-a5f19015ba67_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_e2ebd648-af93-4c5e-9b6e-831613554587_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning projected benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_658146fc-b178-4bc2-aad6-2af12e67ee04_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending projected benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_fe2ea30b-334c-49ea-8282-78df70c372a7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital shares reserved for future issuance</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_4385bb9e-8cde-4c8e-8f55-e4372fba11ab_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.125Due2027Member_fa7436b3-67d7-4796-8323-543c193ac95f_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2.125% Notes due 2027</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.125Due2027Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 2.125% Due 2027 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.125Due2027Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 2.125% Due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes2.125Due2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:to="lab_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1af334f8-d1b0-4bc4-8050-21b13fb70952_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Available-for-sale marketable securities</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_4c758e26-1878-4348-8f82-06595f06f49f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_219e4065-1cfb-41cd-808d-99dc2ff7b982_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less valuation allowances</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_0cf636fc-b15e-45ed-a410-438dcf3bde1a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Future milestone payout</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_75b9d55b-3592-4548-800c-4f63bcb41efb_totalLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt, Long-Term and Short-Term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_HipsMember_c13fcc48-7423-4879-9281-b80a684aa829_terseLabel_en-US" xlink:label="lab_syk_HipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hips</link:label>
    <link:label id="lab_syk_HipsMember_label_en-US" xlink:label="lab_syk_HipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hips [Member]</link:label>
    <link:label id="lab_syk_HipsMember_documentation_en-US" xlink:label="lab_syk_HipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Hips [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_HipsMember" xlink:href="syk-20241231.xsd#syk_HipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_HipsMember" xlink:to="lab_syk_HipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.700DueFebruary102028Member_50a47678-7e6e-4d56-965d-1491d5269a0e_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.700DueFebruary102028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.700% Due February 10, 2028</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.700DueFebruary102028Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.700DueFebruary102028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.700% Due February 10, 2028 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.700DueFebruary102028Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.700DueFebruary102028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.700% Due February 10, 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.700DueFebruary102028Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.700DueFebruary102028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes4.700DueFebruary102028Member" xlink:to="lab_syk_SeniorUnsecuredNotes4.700DueFebruary102028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_818a3133-5b18-4079-bca2-845f5d065bfa_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_9ded7973-026e-450a-95d5-cb470a7d405b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_939d5c17-1e82-4437-8196-dda055a433b6_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum term</link:label>
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_label_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Remaining Maturity of Foreign Currency Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:to="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a7797ff4-4376-4b67-aa15-d2ca0559e459_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTransfers_334909b7-bd81-40f3-ba8b-aa4fb1060a2a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill transfer</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers" xlink:to="lab_us-gaap_GoodwillTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_bdfd412d-9aae-41bb-82be-676920bb77f9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Derivative liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_AccruedCompensationMember_afb3cb1e-f7ab-4d21-98ed-c53081c66257_terseLabel_en-US" xlink:label="lab_syk_AccruedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Compensation</link:label>
    <link:label id="lab_syk_AccruedCompensationMember_label_en-US" xlink:label="lab_syk_AccruedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Compensation [Member]</link:label>
    <link:label id="lab_syk_AccruedCompensationMember_documentation_en-US" xlink:label="lab_syk_AccruedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AccruedCompensationMember" xlink:href="syk-20241231.xsd#syk_AccruedCompensationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_AccruedCompensationMember" xlink:to="lab_syk_AccruedCompensationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.650Due2028Member_49416df5-5498-4605-adc4-84282ca6b38c_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.650Due2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 3.650% due 2028</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.650Due2028Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.650Due2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 3.650% Due 2028 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.650Due2028Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.650Due2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 3.650% due 2028 [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.650Due2028Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.650Due2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes3.650Due2028Member" xlink:to="lab_syk_SeniorUnsecuredNotes3.650Due2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes3375Due2028Member_c4f77219-0736-4a59-a4ca-85e62a262397_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3375Due2028Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">3.375% Notes due 2028</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3375Due2028Member_e4ad4846-e3b1-41c3-89ab-7632eb9218c0_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3375Due2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 3.375% Due 2028</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3375Due2028Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3375Due2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 3.375% Due 2028 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3375Due2028Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3375Due2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 3.375% Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3375Due2028Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3375Due2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes3375Due2028Member" xlink:to="lab_syk_SeniorUnsecuredNotes3375Due2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_2642756d-12c3-4efd-92f6-9a048045f1bf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_RecallMattersMember_81dcdfd8-7fd5-44fe-957d-66dc0be4da22_terseLabel_en-US" xlink:label="lab_syk_RecallMattersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recall Matters</link:label>
    <link:label id="lab_syk_RecallMattersMember_label_en-US" xlink:label="lab_syk_RecallMattersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recall Matters [Member]</link:label>
    <link:label id="lab_syk_RecallMattersMember_documentation_en-US" xlink:label="lab_syk_RecallMattersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Recall Matters</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_RecallMattersMember" xlink:href="syk-20241231.xsd#syk_RecallMattersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_RecallMattersMember" xlink:to="lab_syk_RecallMattersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_928164e7-4741-4a5f-b6ee-1c38a4035a45_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c08bc11d-30fb-42bc-95b0-69ffb7ef3c20_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, Options expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_1ac4b7ae-1cc1-4f39-8596-f4e3f1c1b5c8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_d454c89f-6d40-4ac5-bf1e-0d7e5781c87a_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common Stock, $.10 Par Value</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_260ce232-3d10-43e3-9bf7-6f773ada69c6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SpinalImplantsMember_47b7b02e-ccdc-48ee-b7d7-4ab0b458f260_terseLabel_en-US" xlink:label="lab_syk_SpinalImplantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Spinal Implants</link:label>
    <link:label id="lab_syk_SpinalImplantsMember_label_en-US" xlink:label="lab_syk_SpinalImplantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Spinal Implants [Member]</link:label>
    <link:label id="lab_syk_SpinalImplantsMember_documentation_en-US" xlink:label="lab_syk_SpinalImplantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Spinal Implants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpinalImplantsMember" xlink:href="syk-20241231.xsd#syk_SpinalImplantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SpinalImplantsMember" xlink:to="lab_syk_SpinalImplantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0e5a07d6-bdd8-4952-80f5-58fd45d6e68c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_eddfebb3-a50c-4990-8c1f-a9e79e608d72_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_5178cb12-e33e-4fd8-a1e1-b743006ee865_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_a690943a-54fd-4fad-938f-d65105853e26_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Statement Translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b94d2fdc-9715-4d62-a230-d4f9dfabd2bc_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_388f7cf8-1c0e-42e4-8668-c9954c6f7007_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_e238220e-161c-48d8-9151-9698a786edb9_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment and Geographic Data</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_63eec12d-03b7-46de-a6ea-2718b6f5061b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b7687800-f69d-405f-90d0-f31b34c018dc_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_d2ea93b1-fc45-4eae-9626-4832e14031a1_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Charges during period</link:label>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_label_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Loss in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyLossInPeriod" xlink:to="lab_us-gaap_LossContingencyLossInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_4a877b83-e287-41b3-a172-a6619c9ffb1f_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total recognized in net periodic benefit cost and OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_e8403597-a15a-4c1a-a8e5-d214388f87b6_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_400d85cc-91ae-49c3-993e-f25aa6a95efd_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_916a0294-0b53-4640-bd1e-e4975b939a48_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_879d67d5-80cd-4f3b-a5ab-d1ef5eca15d7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_55612e4d-69e7-45cc-944f-3f5b5c6dc5c6_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.900due2050Member_b3c5d70d-e3a8-49f7-9ba1-93db280124f7_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 2.900% due 2050</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.900due2050Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 2.900% due 2050 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.900due2050Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 2.900% due 2050 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes2.900due2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:to="lab_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_55293710-abc7-451b-8f0e-c4da814a91b4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_8d23c77a-8040-444a-8785-5da3e776efc7_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_8df84e3d-14a4-486e-b0a2-965330965ffc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_384ff030-99d3-48af-ab2c-efb0517660a1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of short-term investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_22bfdc74-634e-4602-b217-7dea1d651f19_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Borrowing capacity on existing facilities</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForNotesReceivableMember_5240b0f5-2490-485e-94db-bd4cafe33ef6_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Notes Receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForNotesReceivableMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Notes Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForNotesReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForNotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForNotesReceivableMember" xlink:to="lab_us-gaap_AllowanceForNotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_9ffc933f-47e0-4d62-9326-e791a71330a8_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Undistributed earnings</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SpineMember_1332709a-dc00-4479-ab34-5c10eb8076ef_terseLabel_en-US" xlink:label="lab_syk_SpineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Spine</link:label>
    <link:label id="lab_syk_SpineMember_label_en-US" xlink:label="lab_syk_SpineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Spine [Member]</link:label>
    <link:label id="lab_syk_SpineMember_documentation_en-US" xlink:label="lab_syk_SpineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Spine [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpineMember" xlink:href="syk-20241231.xsd#syk_SpineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SpineMember" xlink:to="lab_syk_SpineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_aaab9090-b806-432f-8d43-2599cd423646_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, excluding current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_e9824477-5e89-4945-a8cb-8f23eb3bea62_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_72ef4241-fd2b-47fd-92f6-0f61352f6916_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_90527040-cea9-4dbd-80b4-8141226b079a_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd1656fa-6d60-4fab-a446-54148951097d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4d83e7cb-2e91-46e4-b690-5236de98b33c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_OtherForeignCountriesMember_cb8032d9-5ccd-4976-afad-9bef11347921_terseLabel_en-US" xlink:label="lab_syk_OtherForeignCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other foreign countries</link:label>
    <link:label id="lab_syk_OtherForeignCountriesMember_label_en-US" xlink:label="lab_syk_OtherForeignCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:label id="lab_syk_OtherForeignCountriesMember_documentation_en-US" xlink:label="lab_syk_OtherForeignCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherForeignCountriesMember" xlink:href="syk-20241231.xsd#syk_OtherForeignCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_OtherForeignCountriesMember" xlink:to="lab_syk_OtherForeignCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_c41ad227-11db-4d0c-8f42-80418ab748c0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_75e54ece-eb49-4868-8b21-c37b10fb0d88_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net earnings per share of common stock:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_d12d27e7-a5f8-4d10-b671-90640e009ee0_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_1bb3edbf-844f-4728-8701-606f369a38ac_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange and other</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Translation and Measurement Period Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375Due2032Member_baa654a6-ee96-4fa2-a6a1-eee5d1a5b523_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375Due2032Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.375% Notes due 2032</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375Due2032Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375Due2032Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 3.375% Due 2032 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375Due2032Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375Due2032Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 3.375% Due 2032</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375Due2032Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.375Due2032Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes3.375Due2032Member" xlink:to="lab_syk_SeniorUnsecuredNotes3.375Due2032Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_d8f53e60-1a24-45ed-8128-09596ab34d48_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_31b953e3-38ea-4cfc-9afb-2e4373211269_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flow hedge gain (loss) to be reclassified within twelve months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_4634a0c3-9974-4979-a9aa-fa4c5dc5f960_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_InventorySteppedUpToFairValueAtAcquisition_0f030c98-e3fe-4781-969f-e1f4df983d0f_terseLabel_en-US" xlink:label="lab_syk_InventorySteppedUpToFairValueAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of inventory stepped up to fair value at acquisition</link:label>
    <link:label id="lab_syk_InventorySteppedUpToFairValueAtAcquisition_0836066d-f102-422e-b186-fdc02fce26c2_negatedTerseLabel_en-US" xlink:label="lab_syk_InventorySteppedUpToFairValueAtAcquisition" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Sale of inventory stepped up to fair value at acquisition</link:label>
    <link:label id="lab_syk_InventorySteppedUpToFairValueAtAcquisition_label_en-US" xlink:label="lab_syk_InventorySteppedUpToFairValueAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Stepped-Up to Fair Value at Acquisition</link:label>
    <link:label id="lab_syk_InventorySteppedUpToFairValueAtAcquisition_documentation_en-US" xlink:label="lab_syk_InventorySteppedUpToFairValueAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Inventory, Stepped-Up to Fair Value at Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InventorySteppedUpToFairValueAtAcquisition" xlink:href="syk-20241231.xsd#syk_InventorySteppedUpToFairValueAtAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_InventorySteppedUpToFairValueAtAcquisition" xlink:to="lab_syk_InventorySteppedUpToFairValueAtAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_56f70149-3d12-4792-b27a-4accced460a9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_effba3be-a64e-4f80-bd88-46fc5520046e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_CapitalStockAbstract_f03c9678-1def-48de-9b57-648a4858f41b_terseLabel_en-US" xlink:label="lab_syk_CapitalStockAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital Stock [Abstract]</link:label>
    <link:label id="lab_syk_CapitalStockAbstract_label_en-US" xlink:label="lab_syk_CapitalStockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Stock [Abstract]</link:label>
    <link:label id="lab_syk_CapitalStockAbstract_documentation_en-US" xlink:label="lab_syk_CapitalStockAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capital Stock [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract" xlink:href="syk-20241231.xsd#syk_CapitalStockAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_CapitalStockAbstract" xlink:to="lab_syk_CapitalStockAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalFees_c371e628-5309-4eb9-a15f-ba48a87c4433_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Regulatory and legal matters</link:label>
    <link:label id="lab_us-gaap_LegalFees_label_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalFees" xlink:to="lab_us-gaap_LegalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_627c63f8-3f65-41f4-8c43-bf01e284f64a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaper_7ae2c563-137e-48dd-b28b-653150384e65_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaper_label_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaper" xlink:to="lab_us-gaap_CommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_1c820b8d-b3de-4621-a08d-a801e6d47b27_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan Disclosures</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:to="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_922fb5d9-d423-4679-8eae-976e22276337_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a280d976-d034-4417-9719-136aa4e45384_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent_94f6a8fd-0eda-417d-9c77-4a10d4703136_terseLabel_en-US" xlink:label="lab_syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent_label_en-US" xlink:label="lab_syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Compensation, Current</link:label>
    <link:label id="lab_syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent_documentation_en-US" xlink:label="lab_syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Compensation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent" xlink:to="lab_syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_8235fe73-0eed-4bdb-b975-081c06fa1584_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Machinery and Equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember_94408d9b-9999-44f0-b1e7-839a87b7a840_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Debt Security [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDebtSecurityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:to="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_6935744f-5d59-4120-b134-691b5addc7f0_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expenses, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_419fda3b-aad3-4725-8321-0a2e3213b0da_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Actual return</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_bc5036d8-b88f-4490-b732-a33065d3218d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_ae01faab-3071-4795-86b3-967525c9ad82_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Debt And Credit Facilities</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ffb17823-cce8-4ff9-9ede-2be1f789aa9d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_5cd97263-6e2c-4f0d-afdc-d3b099f90d97_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_d3dedb9c-4937-4e51-9a33-0fa1425c2ffc_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_20033586-04a5-407d-9f63-b576d5cdafed_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_6e6da38b-a288-41cd-b7a4-af72657a0304_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_fa084a1b-a783-43a7-8e96-43216702c898_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquisition and integration-related charges</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_9a1680b3-69bd-4371-a8b5-0ef621d4bfde_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e8df87c1-50de-4178-81e7-bd8ddcc26872_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other investing, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_3f872382-6e0a-4d8b-8307-c481d731ee15_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other noncurrent assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_774b4e1d-9468-4b98-a0fd-2a27350b3bf1_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_27cfca24-f078-4eac-b33a-dd10b16b6b03_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Quarterly Data</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_23742cae-12be-4c0b-9cb2-e145269683f6_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_7723f81f-530c-4420-843e-a531ad76cbc5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value, Cancelled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_e55baf65-f899-47a6-a54b-958fdfd305f8_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current income tax expense (benefit):</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_06ff5a04-f8be-451a-bd5f-2cc3018a5c8a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest_31f78b6d-4f45-43fb-a7ce-8b1bcbfcdf98_negatedTerseLabel_en-US" xlink:label="lab_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Tax settlement, release of accrued interest</link:label>
    <link:label id="lab_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest_label_en-US" xlink:label="lab_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit), Tax Settlement, Release Of Accrued Interest</link:label>
    <link:label id="lab_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest_documentation_en-US" xlink:label="lab_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit), Tax Settlement, Release Of Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" xlink:href="syk-20241231.xsd#syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" xlink:to="lab_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_161ed9b3-eca5-4890-90b9-dd55be0276bd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6db849e5-49f3-41e7-8f9e-9822104de7aa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_80dd161e-c424-4610-9c0a-8a6cc6e639ce_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plans</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_92063d26-7999-4cfe-8ac9-0077cbc56b4a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_32e39f08-547b-4d4b-8122-6a30d1a63e25_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_dc4d5dbb-352c-4da2-b668-049d85409c49_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_535b4f4b-37ac-41ce-a459-32902dd8ccd7_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_244b5fcc-b723-4ebc-a182-ba183e7622f2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange impact</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_4f61167a-babf-47ad-ba2b-d3206c8a3a90_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_a1b2df62-a950-419e-b295-b4cfe7021b4c_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8432f7d2-8c22-4cf4-b1d9-b3812144bc2e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares outstanding (in millions):</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_b1e91499-101c-4ca1-92bc-851c666d3d0e_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_c21248e5-7b14-459f-a0de-3a92e3f77ab1_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_3e449663-172b-4988-91c6-7c1176d655f9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6c6038ce-12a6-41b0-a2ab-fee28e445111_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_1f10fac1-41bc-4855-a323-edce64e18871_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_349dd9d7-5d35-4884-9266-7800625c4547_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_3ff94ebf-980d-4e88-a892-f5d964afd6bf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12gTitle_5383d1bb-b5ab-4159-b5bd-2a67505ef984_terseLabel_en-US" xlink:label="lab_dei_Security12gTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(g) Security</link:label>
    <link:label id="lab_dei_Security12gTitle_label_en-US" xlink:label="lab_dei_Security12gTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(g) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12gTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12gTitle" xlink:to="lab_dei_Security12gTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_e53f7748-ae8d-485b-9422-8d184c60f4ca_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nature of Operations</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3653190e-74b7-45ac-bcc5-b70206b3d272_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8f4ca9c4-3cae-49bd-b3b6-496350d8370c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations_64e95df5-a574-4295-abc6-0365069745c8_terseLabel_en-US" xlink:label="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average discount rate used to determine projected benefit obligations</link:label>
    <link:label id="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations_label_en-US" xlink:label="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Used in the Determination of the Projected Benefit Obligations</link:label>
    <link:label id="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations_documentation_en-US" xlink:label="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted Average Used in the Determination of the Projected Benefit Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:href="syk-20241231.xsd#syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:to="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_b4f4ff9f-fb84-42ae-8f1c-8397f2f1a5bc_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_2bfa6e92-dcbf-4881-ab37-323369712307_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_f76859d5-dbf4-4181-b182-6fed36260b3d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionAbstract_3274f888-4d5f-4fdf-860c-36612dcf497c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Recognition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionAbstract" xlink:to="lab_us-gaap_RevenueRecognitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_cd988958-6a22-44ee-8869-0befd2e47bae_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b7ad0b0c-3958-4535-8aec-0693d03c6a29_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_4b943c85-66dc-4de7-ab7c-56f5d0f58b30_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_bee380dd-5700-4fe6-824c-08a3cea27709_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2030-2034</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_e180b710-5029-4768-92e3-cfccc7a1ea60_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Allocation of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a724e597-82fa-428e-9144-761a15f680b0_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_CommonAndPreferredStockSharesAuthorized_6ab2eccc-07a7-4129-96e4-4501610d82fe_terseLabel_en-US" xlink:label="lab_syk_CommonAndPreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common and Preferred Stock, shares authorized (in shares)</link:label>
    <link:label id="lab_syk_CommonAndPreferredStockSharesAuthorized_label_en-US" xlink:label="lab_syk_CommonAndPreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common And Preferred Stock, Shares Authorized</link:label>
    <link:label id="lab_syk_CommonAndPreferredStockSharesAuthorized_documentation_en-US" xlink:label="lab_syk_CommonAndPreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common And Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CommonAndPreferredStockSharesAuthorized" xlink:href="syk-20241231.xsd#syk_CommonAndPreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_CommonAndPreferredStockSharesAuthorized" xlink:to="lab_syk_CommonAndPreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_InstrumentsMember_000929e6-012b-45a7-890c-6ab527f6a544_terseLabel_en-US" xlink:label="lab_syk_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Instruments</link:label>
    <link:label id="lab_syk_InstrumentsMember_label_en-US" xlink:label="lab_syk_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Instruments [Member]</link:label>
    <link:label id="lab_syk_InstrumentsMember_documentation_en-US" xlink:label="lab_syk_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InstrumentsMember" xlink:href="syk-20241231.xsd#syk_InstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_InstrumentsMember" xlink:to="lab_syk_InstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_87d2a163-8014-4cac-a85c-fecf7522f985_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_701613ef-e9f6-4572-bca6-3ae25005944a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_136e58af-b4d1-4fc3-9d9a-0e1b0236d26f_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2886ef8f-6adc-4e54-adce-bd5313458866_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9091baf3-6835-4ebd-b722-598774ef3b6a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value, Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_78d14d9e-6ba5-434c-8945-f6cd701858d8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining lease term (years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_22d3b82d-4131-4bd2-83bf-44325d129dc7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Costs of Retirement Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Costs of Retirement Plans [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_2bd52008-a182-4770-b5a6-a3cda158d06e_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of Changes in Foreign Currency Exchange Rates</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_af57b210-5e62-40ea-9ca6-1c2cd4686bc5_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax liabilities:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_d4271557-f31b-4dd9-8c5f-0b2dce7ccdc3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Expected Benefit Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_43f918ca-3f0f-4a36-b413-33f66fcb175c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_4fabc77b-abd5-4cf5-ab78-97f74f4e80fa_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_51c8cac2-cbaa-4111-96b4-b312a76f23cd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decreases related to prior year income tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c34f88cc-9566-4a71-8b0d-ed058852652b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_49560f24-5f86-4015-a848-d25be953c5a2_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_EndoscopyMember_ea222843-8ec0-4795-a13d-9134cd6b685d_terseLabel_en-US" xlink:label="lab_syk_EndoscopyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Endoscopy</link:label>
    <link:label id="lab_syk_EndoscopyMember_label_en-US" xlink:label="lab_syk_EndoscopyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Endoscopy [Member]</link:label>
    <link:label id="lab_syk_EndoscopyMember_documentation_en-US" xlink:label="lab_syk_EndoscopyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Endoscopy [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EndoscopyMember" xlink:href="syk-20241231.xsd#syk_EndoscopyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_EndoscopyMember" xlink:to="lab_syk_EndoscopyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.125DueNovember2027Member_fdf9b89b-f68c-4f7a-8667-0a84c313a939_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.125DueNovember2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, Due November 2027</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.125DueNovember2027Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.125DueNovember2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 2.125% Due November 2027 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.125DueNovember2027Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.125DueNovember2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 2.125% Due November 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.125DueNovember2027Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes2.125DueNovember2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes2.125DueNovember2027Member" xlink:to="lab_syk_SeniorUnsecuredNotes2.125DueNovember2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_NeurovascularMember_11a2afe5-9c07-4ecd-83e2-bffa2fb57846_terseLabel_en-US" xlink:label="lab_syk_NeurovascularMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Neurovascular</link:label>
    <link:label id="lab_syk_NeurovascularMember_label_en-US" xlink:label="lab_syk_NeurovascularMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Neurovascular [Member]</link:label>
    <link:label id="lab_syk_NeurovascularMember_documentation_en-US" xlink:label="lab_syk_NeurovascularMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Neurovascular</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeurovascularMember" xlink:href="syk-20241231.xsd#syk_NeurovascularMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_NeurovascularMember" xlink:to="lab_syk_NeurovascularMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_3b270071-e05c-40b3-babd-22a6e7173a7b_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total recognized in OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_455a64d5-eb21-4a9d-9924-9d619ba7c930_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_19f46ce4-a50f-4647-bcc0-d956a00923ab_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b30b6fd2-5e78-4686-9e2f-889f8687eebd_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Beginning of Period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6b82f126-9e28-4a2c-956d-4e101236274d_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), End of Period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c31693bc-6696-418d-aeb4-a2badb81e18d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_2b4bb25c-9f27-4206-8b1d-1fdfabffd8b0_terseLabel_en-US" xlink:label="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance period</link:label>
    <link:label id="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_label_en-US" xlink:label="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Performance Period</link:label>
    <link:label id="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_documentation_en-US" xlink:label="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:href="syk-20241231.xsd#syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:to="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d79c005c-7a61-4023-aafc-920f3cb47ecd_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_11a6a95b-097a-438d-a51e-6dc9e78bf389_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_860cdad0-7802-4b90-a6a0-4bfe197ae3a6_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_8a32ed3d-f1e5-4540-b69b-cec7bda9e510_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Target plan asset allocations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_e598bb12-2607-4c50-bc9b-ac0efc70aac5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares, Cancelled or forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_781c39c4-4406-4ec3-bae7-c8cac38d070d_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_e0f57bcb-b4c2-4285-ab77-5f34a070a320_terseLabel_en-US" xlink:label="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of closing stock price under ESPP</link:label>
    <link:label id="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_label_en-US" xlink:label="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of Closing Stock Price Represents Purchase Price Under ESPP</link:label>
    <link:label id="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_documentation_en-US" xlink:label="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of Closing Stock Price Represents Purchase Price Under ESPP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:href="syk-20241231.xsd#syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:to="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_0ccb94c8-eba6-48af-b7a3-2bedd3620986_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_fb77c617-e597-49f2-b627-cc68a80b7716_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions and adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_17682289-3069-4f6f-8d64-a2565de9c62d_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_d621f437-d137-478a-8849-305c202eb63b_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_MedicalMember_b07e8d33-29d0-4d7c-842c-1fc1b59dea9d_terseLabel_en-US" xlink:label="lab_syk_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical</link:label>
    <link:label id="lab_syk_MedicalMember_label_en-US" xlink:label="lab_syk_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical [Member]</link:label>
    <link:label id="lab_syk_MedicalMember_documentation_en-US" xlink:label="lab_syk_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalMember" xlink:href="syk-20241231.xsd#syk_MedicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_MedicalMember" xlink:to="lab_syk_MedicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_907a802b-1d25-42f1-ba4f-1ca9b43ff39f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_8d78cd69-8cff-4133-954d-10b39f4bd48a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ec06682f-8b2a-4b3d-9fd2-55655275dc89_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_0c2eca02-7bed-472b-82a5-3b50ea84553e_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credit carryforward, amount</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_3a35b33c-8724-422b-9698-e14880b999e0_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets [Abstract]</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_8c6827bc-4662-4f38-be79-441fa871d9cb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_8209241f-acf7-4c11-9414-6aeebde4663a_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_5357f6fa-c202-4491-9d93-025b1347a65d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SpineReportingUnitMember_023589b4-c132-48d4-a15e-17b5e0b31d4e_terseLabel_en-US" xlink:label="lab_syk_SpineReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Spine Reporting Unit</link:label>
    <link:label id="lab_syk_SpineReportingUnitMember_label_en-US" xlink:label="lab_syk_SpineReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Spine Reporting Unit [Member]</link:label>
    <link:label id="lab_syk_SpineReportingUnitMember_documentation_en-US" xlink:label="lab_syk_SpineReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Spine Reporting Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpineReportingUnitMember" xlink:href="syk-20241231.xsd#syk_SpineReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SpineReportingUnitMember" xlink:to="lab_syk_SpineReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_cd4dfe2f-1d08-4feb-8f51-427b51e4d3fa_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_f8d66595-8827-45b0-b129-11bf83e54d16_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAbstract_f95b9613-89ce-471a-b841-389eb065aa7e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Unclassified [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Unclassified [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAbstract" xlink:to="lab_us-gaap_LongTermDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bf28b35a-08c9-40c3-80d1-79c4a9cf3635_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax expense (benefit):</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_a6d9a1e5-4734-4ccc-969e-9e4ec058af54_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_cc8aa9c9-c659-49fa-8cb5-aa7a7a487bec_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_85b67e13-6593-4169-8291-81891eed41ea_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3bd88014-61b6-4a88-bcc9-6fe4145cf89c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_dc4979a8-56fa-46c4-b028-6cc44a417561_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ef48061a-1bc9-4510-bec2-44fa0cff7e4c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_682986d3-7aaf-4b5e-8c11-0f7e90cbc907_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_bd9473dd-2518-488a-9456-8cebe51e20f8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_0af54673-5bbf-46af-a758-781ff16f603b_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxSettlements_561ea127-94f0-4935-85ff-81645fa927f8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax settlement amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxSettlements_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Settlement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_85687bcc-0255-4735-913f-73f7c58c7d32_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities, noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_e9623f93-3b4c-4b18-a677-6f8b185f806d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_c2b42ac9-c681-462a-b132-7040a6390604_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_0688a812-93a7-4982-8ca5-d324b967b4a1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_778846d5-5661-4117-a99d-485fdd5447e3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_56faf39a-5102-4a39-8b9b-d44ea5ae37c9_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_6ac557a4-464c-4551-bc49-cfcaaa5d8a71_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_5ebbbba4-e277-460f-8792-3aec202d3682_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Maturities Of Long-Term Debt Disclosures</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_57b3bea1-fbd0-4dd7-af40-965cd637b80e_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increases related to prior year income tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1ddf6b8f-8cb8-4104-ba5f-e7a07a6b2431_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.250Due2029Member_a5346066-bb34-4f6e-9dcf-eca3deea9fd0_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.250Due2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 4.250% Due 2029</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.250Due2029Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.250Due2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 4.250% Due 2029 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.250Due2029Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.250Due2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 4.250% Due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.250Due2029Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.250Due2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes4.250Due2029Member" xlink:to="lab_syk_SeniorUnsecuredNotes4.250Due2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_8eb5a519-1d17-4816-8a20-2f4fcf8d62a8_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Patents</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_bb6096fe-a88d-432b-a320-5ca60e4da2db_verboseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">United States treasury debt securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_e2d0f9de-05ca-406d-a2d3-801052cae93f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other noncurrent assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_1b49e239-3214-476c-bad9-e11a74ff14b0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_b034d43e-b404-4005-9903-c92f5fe9e8b5_terseLabel_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intellectual property transfers</link:label>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_label_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Transfer Of Intellectual Property, Percent</link:label>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_documentation_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Transfer Of Intellectual Property, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:href="syk-20241231.xsd#syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:to="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_908f19a7-a503-486f-aaae-42d3049fcffe_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research, Development and Engineering Expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_6006bfe2-e2e0-4c03-8bdd-95e9b9479335_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes4625Due2046Member_3db28aaa-9709-4582-88b3-64ed6bed500d_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.625% due 2046</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4625Due2046Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.625% due 2046 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4625Due2046Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.625% due 2046</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4625Due2046Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:to="lab_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.625Due2030Member_a548353c-e717-473e-8e43-17f431973148_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2.625% Notes due 2030</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.625Due2030Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 2.625% Due 2030 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.625Due2030Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 2.625% Due 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes2.625Due2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:to="lab_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_90d62f84-6313-4964-a611-e0b7007f6f7c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized net actuarial gain (loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_80be9e38-354e-4f08-a0a5-3f441ae24e0f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_f8cdfc6a-4e62-4f85-aad3-123ef73d7b41_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Assets Held and Used by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Assets Held and Used by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:to="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration_577553e7-2cf3-4656-b606-9b1312080b0f_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsStateTaxes_7bff1fbb-ec6e-4ed9-97ed-59096b42c931_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsStateTaxes_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, State Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsStateTaxes" xlink:to="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5819bf52-4886-4ba5-aeae-c6f45dbd6777_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value, Options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_bbe38aaa-bc76-4f0b-b10c-6f4948821cea_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repatriation of foreign earnings reversed</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:to="lab_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_879e7b6d-2882-4a0d-a103-8da62eaebe23_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Developed technologies</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_a12de388-d23b-4a48-bb56-626d129592ff_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Developed technologies</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_1c92ed2f-3480-498a-8be9-0ad5273d3196_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOptionTextBlock_29390f68-1789-4594-924c-bea6268efd37_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOptionTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueOptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Option [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionTextBlock" xlink:to="lab_us-gaap_FairValueOptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_26952139-0fd2-4f18-8ca6-62236d56f825_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1df6dba6-b710-43b9-abb7-572a8e8ad4c2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_4adccbeb-a70f-4e75-b22c-042dfb19ce42_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Europe, Middle East, Africa</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration_f37adced-580d-4515-a61e-5728c16ebb78_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_3e732e9e-c3b8-4b32-b706-931bc59c5fb9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_8d0876ce-21d4-4a13-ae94-f2ba74290a50_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_b5df5764-ac91-4e82-b418-de17a46bcadf_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_fa27b666-7fb6-4ca7-b6a9-aefafc9f20f4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_e9f1ad5a-693c-4eb5-bb01-e9e19d78be3a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized prior service credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_f59e01de-d36c-4713-8b21-244883bd2e8a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States federal audit settlement</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Settlement, Domestic, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_PerformanceStockUnitPsusMember_9a9f2343-f28f-4fe8-9117-64a390c6c1cb_verboseLabel_en-US" xlink:label="lab_syk_PerformanceStockUnitPsusMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Performance Stock Units (PSUs)</link:label>
    <link:label id="lab_syk_PerformanceStockUnitPsusMember_3911b946-3828-4e4f-aeb0-e75bfb418acb_terseLabel_en-US" xlink:label="lab_syk_PerformanceStockUnitPsusMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Stock Units (PSUs)</link:label>
    <link:label id="lab_syk_PerformanceStockUnitPsusMember_label_en-US" xlink:label="lab_syk_PerformanceStockUnitPsusMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Stock Unit (PSUs) [Member]</link:label>
    <link:label id="lab_syk_PerformanceStockUnitPsusMember_documentation_en-US" xlink:label="lab_syk_PerformanceStockUnitPsusMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Performance Stock Unit (PSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember" xlink:href="syk-20241231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_PerformanceStockUnitPsusMember" xlink:to="lab_syk_PerformanceStockUnitPsusMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_2d4eb2cd-93a0-4846-9da9-b8328b64af21_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1799b4b7-f2aa-469b-9cec-ee89b3cb5074_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_45e4d3e9-d1e9-4050-a962-41568cf76d86_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_fe1b6850-1557-49e5-95ac-f22ff322d03f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Recognized net actuarial loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a8c51921-5908-4d3e-a2eb-e05e8d9be4fe_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation cost not yet recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_4b0cd9eb-d5df-4f35-bce7-0555f27ea1e1_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_FloatingRateSeniorNotesDueNovember162024Member_a9ac71f6-8a4f-41bf-b71c-0322e3eea69d_terseLabel_en-US" xlink:label="lab_syk_FloatingRateSeniorNotesDueNovember162024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Floating Rate Senior Notes Due November 16, 2024</link:label>
    <link:label id="lab_syk_FloatingRateSeniorNotesDueNovember162024Member_label_en-US" xlink:label="lab_syk_FloatingRateSeniorNotesDueNovember162024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Floating Rate Senior Notes Due November 16, 2024 [Member]</link:label>
    <link:label id="lab_syk_FloatingRateSeniorNotesDueNovember162024Member_documentation_en-US" xlink:label="lab_syk_FloatingRateSeniorNotesDueNovember162024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Floating Rate Senior Notes Due November 16, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_FloatingRateSeniorNotesDueNovember162024Member" xlink:href="syk-20241231.xsd#syk_FloatingRateSeniorNotesDueNovember162024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_FloatingRateSeniorNotesDueNovember162024Member" xlink:to="lab_syk_FloatingRateSeniorNotesDueNovember162024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_246f1465-9f3d-4f6c-bfbe-a8f3a0abffb5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_da26a4cf-dbfd-4101-aee0-0e572a85b59c_terseLabel_en-US" xlink:label="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</link:label>
    <link:label id="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_label_en-US" xlink:label="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</link:label>
    <link:label id="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_documentation_en-US" xlink:label="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:href="syk-20241231.xsd#syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:to="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_c0c0ac06-7add-4b32-9e05-fba68899138c_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_766d4e66-3a50-45e8-8ff8-199f564698bc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment operating income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_300e4ad2-b888-49dd-8d74-ac0d47701197_terseLabel_en-US" xlink:label="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares vested during the period</link:label>
    <link:label id="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_label_en-US" xlink:label="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value</link:label>
    <link:label id="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_documentation_en-US" xlink:label="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:href="syk-20241231.xsd#syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:to="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_b193f3fa-f586-4e7c-9cc4-26cb12fb56b9_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_aa418818-f7f3-4a56-847b-a9024569843a_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a068cdd0-0585-4b1d-9769-5a00b3027921_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value, Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_5c4a9c8a-07df-4c2b-9ef5-e0be92ac7d19_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_f6226533-d873-4c9f-950b-644f8fb839b7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_7bcee724-c747-4d30-8892-9904008acf8c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_9b420ffe-78fb-499d-9531-4db8a19b13e2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Materials and supplies</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_8810a6ed-9c3d-4bb3-a648-92aa41c29287_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_843bc9a8-a2ad-4b85-b1ab-9ff5b48b1380_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Change in estimate and foreign exchange</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_9f99d043-97b4-4ee4-83f9-ce13b927fb1b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographic Information on Net Sales and Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_c3fb1c19-51de-4b1f-87fe-39dfe58504dc_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c55c7ff2-b936-4ea8-8664-64952ad08ec6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4d850582-3c16-4f98-8271-f878b72fb797_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentChargesTextBlock_a2399077-f3a6-4b43-9396-06e9e0d66e98_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentChargesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Impairments</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentChargesTextBlock_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentChargesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Impairment Charges [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentChargesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentChargesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentChargesTextBlock" xlink:to="lab_us-gaap_AssetImpairmentChargesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_aba00aec-a32e-42a8-a417-b248e6e973be_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States state and local</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_2ac4cae4-8b86-4b1c-bf37-516852cb96f9_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency exchange forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference_fbc856de-3c1a-42a0-bdad-8927133ba5b6_terseLabel_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outside basis difference related to the anticipated sale of the Spinal Implants business</link:label>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference_label_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Outside Basis Difference</link:label>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference_documentation_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Outside Basis Difference</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference" xlink:href="syk-20241231.xsd#syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference" xlink:to="lab_syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_12ae6d02-0371-4c9d-a296-dc6813e2b855_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research, development and engineering expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_345d062a-23e1-4356-8200-5dad03a8d05e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock_bebdef41-09b8-46c2-bd1b-0c5fda7ff4c0_terseLabel_en-US" xlink:label="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, Intangibles and Long-Lived Asset Impairment Tests</link:label>
    <link:label id="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Long-Lived Assets Impairment Tests Policy [Policy Text Block]</link:label>
    <link:label id="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Goodwill and Long-Lived Assets Impairment Tests Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:href="syk-20241231.xsd#syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:to="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_a2e8d8d3-810f-4bb3-a07c-f4c9906622e3_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_cc7d4099-2479-421f-b8e1-e735772fc1cf_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_67009bfa-558d-4fa1-b568-05615f3d577e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less allowance for depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_aa58174e-3fdc-415c-a2f3-d6ad86576fd4_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a3a2a08d-4bbc-4ff1-bdd9-48450059e78e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b5730d6e-2e9d-4c6d-bdfc-fa852395e6a4_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_43b55a89-69bc-45af-b0e7-47cf76a0530c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Structural optimization and other special charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_c7094d1f-fe63-45a8-a67b-2df43aed9255_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_372a5296-3e38-4e1e-8e8e-b02479aa4432_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_10a6149c-d3a5-4adb-9284-87d1122fa7fc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recognized actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_24a3f430-5815-4353-ad4b-dfe4c60030d0_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Balance [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_c777ca06-83ca-4136-ba61-54733150e3ef_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_7829a209-5379-41b2-a432-f6cea1fd562d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_e9982fdb-58f7-4db8-ae02-20b22d1f4d89_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_fc8eb3b1-2779-43ff-9467-637432bceb44_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current maturities of debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_ac3cec00-fdf0-461c-a13c-ebc67cbb7204_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_cd06a7e8-5ebf-4f35-91fc-dea612e247f4_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, less allowance of $213 ($182 in 2023)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cd91d8a7-50ba-4c5d-812f-4a695893dd91_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_444f7042-ebcc-44c7-a200-6eea96dd9fc1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and other impairments</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_2e7ad399-2ceb-432f-baab-29c2aef3fbba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and other impairments</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_89a6e4cb-f546-4cc5-80df-6557aa8cb863_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_958b5764-a50d-4456-88b7-8c998af8fbb2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_031877a1-4686-4de3-bfec-8fda9c550a59_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_dfeee483-58e1-4df7-b675-afb0258c2b7e_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_89ce2c94-773f-494f-9821-9cb6cccf51ad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercised during period, exercise price range, lower range limit</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3cb2a7c4-4af2-43c9-b170-bafcaf136151_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares, Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_cba447c7-6da1-4a0a-b234-65b8d069c911_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_OtherOrthopedicsEnablingTechnologiesMember_372f345e-a451-4d51-bf81-7ddec2ba8787_terseLabel_en-US" xlink:label="lab_syk_OtherOrthopedicsEnablingTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Orthopedics - Enabling Technologies</link:label>
    <link:label id="lab_syk_OtherOrthopedicsEnablingTechnologiesMember_label_en-US" xlink:label="lab_syk_OtherOrthopedicsEnablingTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Orthopedics - Enabling Technologies [Member]</link:label>
    <link:label id="lab_syk_OtherOrthopedicsEnablingTechnologiesMember_documentation_en-US" xlink:label="lab_syk_OtherOrthopedicsEnablingTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Orthopedics - Enabling Technologies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherOrthopedicsEnablingTechnologiesMember" xlink:href="syk-20241231.xsd#syk_OtherOrthopedicsEnablingTechnologiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_OtherOrthopedicsEnablingTechnologiesMember" xlink:to="lab_syk_OtherOrthopedicsEnablingTechnologiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_4468b409-39ab-4d0b-b40d-dd658aa2262b_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_7b464924-5ddb-4443-b72c-1198b890a6c8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_8b851a93-a4ae-470d-9b10-be3efcec8e2b_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_253ab0d8-e758-4595-b3b2-e8647136e107_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_6c55dec2-ba2a-42f9-9c41-4aff6b47eb8e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_1f3a262b-924e-4ee7-a4a9-ddb49086f267_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_9113b034-52f4-4b4c-bca5-77ff7e836787_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_c67f8ae9-9c89-4430-9683-5713d8c6990d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_dcb99eac-e1e8-43b1-9833-e46ff3b28027_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_ddc9fd3b-7055-4c78-bd31-ba8914e9947a_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_ef6ae03b-38be-4bcf-8020-809800cbceea_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance&#160;at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_647c88f9-e7bd-4bf1-9943-1a758feccfb1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at End of Period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes5.200DueFebruary282035Member_8b64228a-fda2-4e5c-b888-dcee7ee70afd_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes5.200DueFebruary282035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 5.200% Due February 28, 2035</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes5.200DueFebruary282035Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes5.200DueFebruary282035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 5.200% Due February 28, 2035 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes5.200DueFebruary282035Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes5.200DueFebruary282035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 5.200% Due February 28, 2035</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes5.200DueFebruary282035Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes5.200DueFebruary282035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes5.200DueFebruary282035Member" xlink:to="lab_syk_SeniorUnsecuredNotes5.200DueFebruary282035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_98e8d6e2-55b3-4882-9aa0-599eac24fce6_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_dd13dbc0-ae30-4eb4-8710-98e1597567ad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued under the ESPP</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_d87fef2a-424d-4bf2-bee3-83913c41c96f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4cf77083-c081-4793-a7ed-0de142591c9c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_feff57c2-c4cb-4e22-a79c-dfc9d1b12742_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_aae25105-92ba-489b-80b0-72d0cab3bc85_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock under stock compensation and benefit plans, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_38218e9b-d4a3-4a69-837c-f3184d60dd8d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_c777b4e3-aae9-4bf9-aac8-73d2fd648fb5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncurrent deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_5a66fa57-aff7-4bf9-8345-29d07eaed7bd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-lived intangible asset, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesDebt_eaf3718d-ade0-4f7d-8621-48551aeac795_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading marketable securities</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Trading</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradingSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesDebt" xlink:to="lab_us-gaap_TradingSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_9910ce30-4b9b-4aff-b203-21961c3b76b1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_63098657-ee69-4c6b-bb5d-4a1b431415be_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_2070ac30-84e3-4fd1-a706-6f873f957931_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_186f1e16-a3d6-4e9f-9ebb-4b567979e396_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d185a4f3-21dc-401a-89f2-067da54d0bc2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_dcf9d6f0-c0ab-460c-a4f3-5415e81d7975_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_18980c7e-d22c-4189-a0c9-dadedcbb6097_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements Not Yet Adopted and Accounting Pronouncements Recently Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_0e7e76aa-013c-47f0-b2a1-6428bc1cecde_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0874fe02-996d-46ce-a477-b43b156a928d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a6b2cbc8-16ef-44a3-8ab9-370a56b4c145_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Less Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_4b43f3d8-f2b4-4dd5-a999-4e98dfe81303_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_e667b99d-1edb-4928-80c4-06da5a2c66da_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_9d0472ae-b68a-4c50-8461-a46dfddb1112_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e0885801-203e-4443-b8b2-e29171a6e8cb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_397fb7f2-5b40-42a0-a752-44900a9b32b1_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_AuditorInformationAbstract_label_en-US" xlink:label="lab_syk_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_syk_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_syk_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Auditor Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AuditorInformationAbstract" xlink:href="syk-20241231.xsd#syk_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_AuditorInformationAbstract" xlink:to="lab_syk_AuditorInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_15ea00e7-63c9-432e-8b3e-601812b426a7_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_bdf27e2e-289c-46e9-95eb-e64eea2648ef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_04bdabe1-fbaa-49d8-a488-f9ad08f003d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of RSU and PSU Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_5a1e02c4-280a-4844-98d4-27d1e40006c7_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f328de70-d4d4-46ec-b83b-2b5d3fef60b0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_7f70fe75-600b-4ff0-a681-a63c6f6d89f3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_cba35c91-2d9d-459c-b69d-d8d9304a3506_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate and Other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_2b21ba81-fc3d-4f02-a5e9-45d3d89e9afe_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_673f94da-25b8-4b46-b681-e70cbeb42b32_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental cash flow disclosure:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_dabf623d-98bf-441e-8ae3-5016e85dde64_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_845a2d76-9e1e-4d67-b18c-2ca49ed7dadf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Settlements of income tax audits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_00f5e3b7-cef2-4aa8-a204-ce10f0156647_verboseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_e2445ac1-0527-493c-9193-fc388cd04adf_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_MedicalDeviceRegulationsExpense_61dd5796-2031-45fe-a94d-df21fb654d81_negatedTerseLabel_en-US" xlink:label="lab_syk_MedicalDeviceRegulationsExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Medical device regulation</link:label>
    <link:label id="lab_syk_MedicalDeviceRegulationsExpense_label_en-US" xlink:label="lab_syk_MedicalDeviceRegulationsExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical Device Regulations Expense</link:label>
    <link:label id="lab_syk_MedicalDeviceRegulationsExpense_documentation_en-US" xlink:label="lab_syk_MedicalDeviceRegulationsExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical Device Regulations Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalDeviceRegulationsExpense" xlink:href="syk-20241231.xsd#syk_MedicalDeviceRegulationsExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_MedicalDeviceRegulationsExpense" xlink:to="lab_syk_MedicalDeviceRegulationsExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_6c14685a-e335-4638-91e4-d89180fabbd1_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_a93d18e6-33b7-4c7a-a640-661f145a5fd5_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermDebt_52612663-1609-48f1-87eb-78495ffd11d1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term debt</link:label>
    <link:label id="lab_us-gaap_OtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebt" xlink:to="lab_us-gaap_OtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_1593aed8-94ff-4802-9cf2-9bbc4db56e54_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1862a370-abd4-47b6-b758-229dd02a4c90_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective income tax, percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_16d15324-213b-4f4a-b6f8-84e363816b5e_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_b3fc75da-0175-4011-88c2-cf006ed9307d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d519eeb7-d412-4849-8ecf-43bbf41250ae_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2ed19de2-c401-43bc-acc4-69bbc27e4843_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment net earnings (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_8ebaf748-4d52-42ec-9f76-4fb3c755f3a1_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_12a5aa10-9bf0-413a-8c55-2ea5d8baa530_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities &amp; shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_c6730b50-aa7d-4a8e-afc9-9c0355683f00_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_29404022-8612-49d4-a1f2-e0fc33efe75a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_0854770c-fbb3-4a60-823a-9d8d1e2726ae_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_19fe3bb3-3171-4383-beb8-acfcfacb9bff_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_b1ababe7-6a9a-40e1-b834-75ff68af9ff0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_2cbba75d-2eb5-4f80-b404-6ccf3ec3ce20_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments of dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70267f02-36da-43a6-8f0c-8c1ca4b5e8d3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.000due2031Member_fdcb6fb5-3fa1-4334-9e1b-7374164bc130_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">1.000% Notes due 2031</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.000due2031Member_095b1f29-8789-4b01-823d-549be65a9225_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 1.000% due 2031</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.000due2031Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 1.000% due 2031 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.000due2031Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 1.000% due 2031 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes1.000due2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:to="lab_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_88683fba-08ad-4c0e-a853-2975982c037c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_c58984a2-affb-45b6-8b2a-7642568bf08c_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Building and Improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375DueMay152024Member_2ab91a43-4dae-43b3-a5a7-898fea259083_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375DueMay152024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 3.375% due 2024</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375DueMay152024Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375DueMay152024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 3.375% Due May 15, 2024 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375DueMay152024Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375DueMay152024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 3.375% Due May 15, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375DueMay152024Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.375DueMay152024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes3.375DueMay152024Member" xlink:to="lab_syk_SeniorUnsecuredNotes3.375DueMay152024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_97e5e8bf-e948-4981-8aaa-fabdfdddec69_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_238c2e3b-56a0-4bc9-be8d-3ed32013df7d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, Cancelled or forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6e2bc700-6a6e-4765-906f-c4e203286e39_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected option life (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_49962332-7c87-4fc7-9c02-bba6ffd629ab_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a005bd39-d9f8-4224-a163-f10d83f62d94_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_ba86ffc3-f839-4536-8b7c-18d4c153a2bd_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_9e86d5af-178f-4109-b51f-fc0d653ab7cc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_fdd112e9-72dc-4d45-b439-c1fc8d0ba5ba_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_4f67f172-e1b3-42f5-823b-c508252843da_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.850DueFebruary102030Member_12504fad-5d27-4e6b-80dd-1ed2f4fb9fd4_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.850DueFebruary102030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.850% Due February 10, 2030</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.850DueFebruary102030Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.850DueFebruary102030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.850% Due February 10, 2030 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.850DueFebruary102030Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.850DueFebruary102030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.850% Due February 10, 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.850DueFebruary102030Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.850DueFebruary102030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes4.850DueFebruary102030Member" xlink:to="lab_syk_SeniorUnsecuredNotes4.850DueFebruary102030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_22f9b528-49e6-4b30-ae7b-8448c811bc4c_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_cbe2cf0c-1aee-4611-80cd-39088374976b_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_46402968-b4a6-423a-bbaa-92bcb19c5671_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate purchase price of acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_8ee75542-7b27-4917-a615-b06e38b6a7da_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative term (up to)</link:label>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_label_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTermOfContract" xlink:to="lab_us-gaap_DerivativeTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c5c28ad1-bbcc-490c-9736-930c3cb962ae_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3c6c5a00-9f88-4f88-a89e-7391c60b9a8c_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_eb5d6440-7eb7-4c1e-be49-ff5f3035b965_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_f228185e-50ea-4559-a319-2180ca77a6c3_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimate of possible loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_e0712ea6-6ed7-4b67-bffd-9c63c6a43228_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asia Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.375due2044Member_bf9901e6-fe48-405c-93b6-a6a3c80ae596_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.375% due 2044</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.375due2044Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.375% due 2044 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.375due2044Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 4.375% due 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.375due2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:to="lab_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_34ec0ce2-f466-4aac-bb5d-b92b00b3448e_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_2cd14cba-a47b-4928-8d6f-be0aa96188ec_verboseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue_ce20815e-a99c-4d44-b758-f445e289f4ad_terseLabel_en-US" xlink:label="lab_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase to fair value</link:label>
    <link:label id="lab_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue_label_en-US" xlink:label="lab_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Timing of Disposal, Potential Increase In Fair Value</link:label>
    <link:label id="lab_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue_documentation_en-US" xlink:label="lab_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Timing of Disposal, Potential Increase In Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue" xlink:to="lab_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_cc1d6c48-e319-4b8d-8962-5c2e2ce44c64_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_489db4bc-34b0-4bb4-90ce-e3baa01fd1d8_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_91af3c4f-c0d9-4f9d-8de0-7d523b166073_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_6252e885-c5dc-4c65-8b58-cfd969551d6c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_26bbb8e3-0de9-4b3d-bc3f-ae19aa760d31_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_40c0b86e-80c6-40cd-a81c-3879003a8456_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e6713ac7-7e7a-4a52-b77b-16e7ffecf92c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_326752ae-5b0a-4c39-84cc-407cd3260b56_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_e488f9ac-dbe0-41e9-98fd-0af4131e5876_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Tax Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod_1fed2172-d595-4ba5-bb41-643c9ee50b9c_terseLabel_en-US" xlink:label="lab_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net advance consideration received during the period</link:label>
    <link:label id="lab_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod_label_en-US" xlink:label="lab_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract With Customer, Liability, Net Advance Consideration Received During Period</link:label>
    <link:label id="lab_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod_documentation_en-US" xlink:label="lab_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract With Customer, Liability, Net Advance Consideration Received During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" xlink:href="syk-20241231.xsd#syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" xlink:to="lab_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_081e897f-e4c5-4e35-bf81-c5d72523c851_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Assets Held and Used, Asset Name [Domain]</link:label>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_label_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Assets Held and Used, Asset Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:to="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_a1b9d429-610e-4bf9-adc6-3241cae43697_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_ce75cf54-1609-4151-b26b-8e0c9ad41639_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_db660a71-4fdf-420c-aa8c-7c2dcef3bb83_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase obligations</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PurchaseObligationFiscalYearMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:to="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_30165fbb-200e-4507-90ab-4045740d1ca6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationPriceOfAcquisitionExpected_9b8d9445-f00d-40cd-92a5-969b73dcfe93_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationPriceOfAcquisitionExpected" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business combination, price of acquisition, expected</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationPriceOfAcquisitionExpected_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationPriceOfAcquisitionExpected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Price of Acquisition, Expected</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationPriceOfAcquisitionExpected" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationPriceOfAcquisitionExpected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationPriceOfAcquisitionExpected" xlink:to="lab_us-gaap_BusinessCombinationPriceOfAcquisitionExpected" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_3d31328f-b7ff-47fd-904c-302836b25c72_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_e2c67d25-9e79-45e0-9c12-e071b88eb523_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_f87ea050-8d52-425b-a24e-7a1c1f26ac12_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_9baf8791-705e-4bd0-af36-0f7055cf628f_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value of senior unsecured notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_045bc9dd-91eb-4729-ab9b-da27847c2298_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange impact</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_78d43bfd-3e34-4f3e-b145-042e87604fbb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_fddc8e81-8ae7-45bf-9c76-60547918d8d9_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other intangibles, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent_2e8b54a2-d418-4438-8ea4-c3ad223703ae_terseLabel_en-US" xlink:label="lab_syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent_label_en-US" xlink:label="lab_syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Expenses And Other Liabilities, Current</link:label>
    <link:label id="lab_syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent_documentation_en-US" xlink:label="lab_syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Expenses And Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent" xlink:to="lab_syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_3944feb7-4e36-429b-9727-2105a2b1b02c_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Undistributed earnings of foreign subsidiaries</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9d73584b-3cbb-4152-9554-7a1a552cd757_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_49711ab3-d25b-42b9-b87c-924f5bd522ff_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_04f6a079-4cf6-4bc0-84c1-33e9ba9e6604_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Assumptions Used in Calculations [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Assumptions Used in Calculations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation_b4e6aedb-cf6a-4c83-8a38-5da72e5a484d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9b347542-e840-478c-88c5-ce589f83ec46_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardValuationAllowance_4b20586c-d023-481d-80fc-da16f6498520_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credit carryforward, valuation allowance</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardValuationAllowance_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:to="lab_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_TraumaandExtremitiesMember_ad0a11ee-c680-4ba2-966d-994abbc75f0a_terseLabel_en-US" xlink:label="lab_syk_TraumaandExtremitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trauma and Extremities</link:label>
    <link:label id="lab_syk_TraumaandExtremitiesMember_label_en-US" xlink:label="lab_syk_TraumaandExtremitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trauma and Extremities [Member]</link:label>
    <link:label id="lab_syk_TraumaandExtremitiesMember_documentation_en-US" xlink:label="lab_syk_TraumaandExtremitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trauma and Extremities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TraumaandExtremitiesMember" xlink:href="syk-20241231.xsd#syk_TraumaandExtremitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_TraumaandExtremitiesMember" xlink:to="lab_syk_TraumaandExtremitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_09c5d188-2f89-423f-8a2b-7e9ca00abdd7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Noncurrent liabilities&#8212;Other liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_31ecce43-cdf6-46e1-bdf3-d256604d5602_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected stock price volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.150Due2025Member_50ba8207-14be-4b9b-9874-72cd3887af9b_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 1.150% Due 2025</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.150Due2025Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 1.150% Due 2025 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.150Due2025Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 1.150% Due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes1.150Due2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:to="lab_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_OrthopaedicsAndSpineMember_ec131c1b-365c-4c66-bb40-6aee35913d56_terseLabel_en-US" xlink:label="lab_syk_OrthopaedicsAndSpineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Orthopaedics</link:label>
    <link:label id="lab_syk_OrthopaedicsAndSpineMember_label_en-US" xlink:label="lab_syk_OrthopaedicsAndSpineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Orthopaedics and Spine [Member]</link:label>
    <link:label id="lab_syk_OrthopaedicsAndSpineMember_documentation_en-US" xlink:label="lab_syk_OrthopaedicsAndSpineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Orthopaedics and Spine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember" xlink:href="syk-20241231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_OrthopaedicsAndSpineMember" xlink:to="lab_syk_OrthopaedicsAndSpineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_20f51b8b-ae18-4bae-93a8-ddd0fd1bb680_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign income tax at rates other than 21%</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c5b94be7-20e4-4544-9b8e-8bcd6c4ad237_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_15a1795d-3b9f-4fea-be1e-af888ef886d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Pension plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c6caa202-8429-45f7-a408-055d3d0b8244_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d4660e24-3a15-4f3a-bacb-de0fce22900e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_b183bf48-b9d9-4d73-99ca-ed25b99e36e6_verboseLabel_en-US" xlink:label="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation arrangements</link:label>
    <link:label id="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_label_en-US" xlink:label="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Plan Liabilities</link:label>
    <link:label id="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_documentation_en-US" xlink:label="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Deferred Compensation Plan Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:href="syk-20241231.xsd#syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:to="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f8f1d356-70bf-4e03-90fe-ccb06ba537d0_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingencies and Commitments</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0226c9a9-b25c-4116-a502-b7eb625d1a59_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_35456608-b395-4dec-bfa7-d87bb667659a_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock under stock compensation and benefit plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_c0505f8b-a925-4a00-9594-acb588313a38_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increases related to current year income tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_8cb4bf43-47e8-491c-a88f-af94e63b7a7b_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Patents</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_74851b33-fba1-48ac-ac46-9ef9cddf1ff9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebt_92b7a58e-b5da-4e36-b510-693a6777fe9c_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unsecured debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebt_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unsecured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebt" xlink:to="lab_us-gaap_UnsecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_4ffddd73-452a-4077-9fd6-230d986386a2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_006483ae-9481-4435-b1cd-e86cafa05f95_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares, Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_955d6f30-1ce5-48a5-af47-758235712b1a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_bd82befe-484d-4a5f-9717-d702c02ed18a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_ae74abc3-0b3c-417c-ac93-d67d09d0e3df_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total liabilities measured at fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1b47866e-9f8e-45ae-a0ac-1cfb108d6729_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_bdab5bb2-aee2-4b14-b730-2760703d75b8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par per share</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_a5bdaf4a-a7a1-4298-9da0-5566dac49c78_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_1ed21291-a790-45c1-b671-b37ba14fb3ac_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_d086cd2c-00eb-4765-9724-b73a670ae84c_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_f0cb5352-6172-4e9b-9737-750031be209b_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_502504fd-9c38-46c9-a6ef-30b63c26d61c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_3fa35c46-d657-4863-b8ce-73cfaccdd3ed_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_25194960-00b7-4377-a2cd-46462e0526c0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_95d5c309-8894-4556-8b1d-a98f1557845b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense, debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_2f925990-4f46-42a8-8e43-706dbb01dcce_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_0556b57d-261d-4bd6-81c2-0ec671434329_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_62f2417f-4aa0-489f-b120-ff5fc7646d57_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Information about Plan Assets [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Information about Plan Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_492d9f03-437a-414d-9f8a-e15f8abdc5f3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for interest on debt</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_19d0c824-e6f5-48b0-a752-b03497d384cd_negatedTerseLabel_en-US" xlink:label="lab_syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_label_en-US" xlink:label="lab_syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Valuation Allowance, Current</link:label>
    <link:label id="lab_syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_documentation_en-US" xlink:label="lab_syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Valuation Allowance, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" xlink:to="lab_syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_ae0e5445-fffc-46d9-8b5e-49d37376e33f_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">(Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c684680c-2185-4f33-8050-fda08f545229_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial statement translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_07faac86-fe44-46c3-804d-c603dd270979_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_ef994c3d-b23d-4e01-8403-ef139dd85234_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_3535d2ef-9a29-4c4a-b684-440712460c54_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_6e235e53-e65c-4ecd-a092-d736bead2498_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_c15ff7f2-f1c5-4b36-a4c1-75f61aa5b44d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other intangibles, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1301d38a-03a2-475d-b509-69a29474e035_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares, Exercisable at December 31 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_8718dcab-2f04-428a-9834-68266bfa03f0_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits, interest on income tax expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Interest on Income Taxes Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5a24da81-316a-49f5-a920-6c62e2e9e7db_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_12dcf833-880c-4b59-b12e-a8a96242d802_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_7934c44d-4ca9-4c27-8a13-e5354cb9ac2f_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Quarterly Data (Unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5d7d33c8-181f-4792-8968-822ec45c11a1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average fair value per share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_1a56c79d-733c-491f-b7e6-ef9b44e4e8a9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Changes in Accumulated Postemployment Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Changes in Projected Benefit Obligations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5ec9db70-5100-4d63-abf3-b3e6cafdd746_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_d45b449f-8af9-4e86-b8d1-619302233043_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_239115b4-f293-4eaf-a5d6-05faf17c672e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_db3c01d4-cdb8-45da-8473-c1a8c931f76a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_83784318-de7f-4360-96a1-1cadc2e282aa_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.950Due2030Member_3a4e6aac-bdc7-467f-b3c8-f17e0d7e0ddb_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 1.950% Due 2030</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.950Due2030Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 1.950% Due 2030 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.950Due2030Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 1.950% Due 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes1.950Due2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:to="lab_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_66e9db40-db88-40ab-9ffe-7f2e1b1d2b73_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Long-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:to="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierFinanceProgramTableTextBlock_4078bd35-d301-4aeb-a75d-598aa5cb8ed7_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplier Finance Program</link:label>
    <link:label id="lab_us-gaap_SupplierFinanceProgramTableTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplier Finance Program [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierFinanceProgramTableTextBlock" xlink:to="lab_us-gaap_SupplierFinanceProgramTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_4fe82ea3-4a45-4cb3-8495-964006af4070_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_d3df0db5-d30b-4f1c-9a7d-d2e2b0afc920_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_369e563f-6406-4827-ba89-f55bb98d3987_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds (payments) on short-term borrowings, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_3f67c612-0493-4452-94d1-7fe2d278fa89_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_MovementInContractLiabilitiesRollForward_38f00ea9-dffd-46d3-b38c-95401e0694da_terseLabel_en-US" xlink:label="lab_syk_MovementInContractLiabilitiesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movement In Contract Liabilities [Roll Forward]</link:label>
    <link:label id="lab_syk_MovementInContractLiabilitiesRollForward_label_en-US" xlink:label="lab_syk_MovementInContractLiabilitiesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movement In Contract Liabilities [Roll Forward]</link:label>
    <link:label id="lab_syk_MovementInContractLiabilitiesRollForward_documentation_en-US" xlink:label="lab_syk_MovementInContractLiabilitiesRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Movement In Contract Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MovementInContractLiabilitiesRollForward" xlink:href="syk-20241231.xsd#syk_MovementInContractLiabilitiesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_MovementInContractLiabilitiesRollForward" xlink:to="lab_syk_MovementInContractLiabilitiesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375Due2025Member_fc3cb1b6-524d-4413-9993-f55ede6ae1a2_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375Due2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 3.375% due 2025</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375Due2025Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375Due2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 3.375% Due 2025 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375Due2025Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375Due2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 3.375% Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375Due2025Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.375Due2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes3.375Due2025Member" xlink:to="lab_syk_SeniorUnsecuredNotes3.375Due2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_2ec9a606-7d2a-4e12-9b48-4685652fd5f4_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_8bca2936-d5e8-45c1-9503-c28c2ea10d3d_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_b09ea1ce-bf5f-4898-821d-293d003ded7c_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_138d9d15-90be-442d-b6e0-ab71cd5d6469_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_c8d7dd8d-7d3c-4e64-88c1-435fa86f3e49_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_ee2f35f9-2865-4f9f-bf4d-7b3987790653_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States state and local</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_dd701e10-63f3-4aa0-8226-97fc7bdb3da7_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_12a225a0-868a-4f5d-848d-476b96657975_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_40194a44-d124-425b-827a-3381b21beba6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value, Options expected to vest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_d83f532d-2b63-4d44-b897-99d5a5cc72c7_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">(Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_604988de-9f66-4b26-8b9d-a69e34c9298b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_3212276c-1495-42e2-bdaa-22ff5dbfc02a_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_d583a83f-f042-468a-9b69-e5170843efa4_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Disaggregated Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_98970bb0-6387-44d2-b821-5943663a602b_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_9bb3b35a-c26a-4ca8-a894-4a8c70095b2f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_f6505a44-f549-495b-ac61-ead3f7748034_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_e9f86856-9934-489e-9948-8b5a44a5ae3f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated future employer contributions in next fiscal year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_0e15a23f-2218-4dd5-97e7-a827e459fe49_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_MedSurgAndNeurotechnologyMember_32b3f554-24f4-4429-bf7b-0c05b624a4ab_terseLabel_en-US" xlink:label="lab_syk_MedSurgAndNeurotechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MedSurg and Neurotechnology</link:label>
    <link:label id="lab_syk_MedSurgAndNeurotechnologyMember_label_en-US" xlink:label="lab_syk_MedSurgAndNeurotechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MedSurg and Neurotechnology [Member]</link:label>
    <link:label id="lab_syk_MedSurgAndNeurotechnologyMember_documentation_en-US" xlink:label="lab_syk_MedSurgAndNeurotechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">MedSurg and Neurotechnology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember" xlink:href="syk-20241231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_MedSurgAndNeurotechnologyMember" xlink:to="lab_syk_MedSurgAndNeurotechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_e68f4265-727b-4b71-84a2-014f3f483be8_negatedTerseLabel_en-US" xlink:label="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_label_en-US" xlink:label="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:label id="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_documentation_en-US" xlink:label="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:href="syk-20241231.xsd#syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:to="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dcf6bfb7-22b1-4aee-9c19-838e2d40530a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States state and local income taxes, less federal deduction</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.750due2029Member_ee5b3ed9-c837-4fe3-8c34-12b31f32b653_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">0.750% Notes due 2029</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.750due2029Member_6254ebe0-8c90-4769-8790-d4abd5934fc7_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 0.750% due 2029</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.750due2029Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 0.750% due 2029 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.750due2029Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 0.750% due 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes0.750due2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:to="lab_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_4f76200d-02a3-4bb3-ba20-d7691517def6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bd546c80-4d41-49d7-a7c9-4e1f7f0c332d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_9bcf901b-b1a9-416b-b204-2c058b1905da_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_d2b99bdf-bb72-4871-a264-490b82388db8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_dd8bdf47-0f04-4335-90dd-29617a61f4b2_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_6a580265-b9ce-4067-898d-264a192b89d5_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_6585775c-a001-41cd-b61c-6b64b3163d96_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_730de925-ff9b-4334-893c-25f6a0d56fbd_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic net earnings per share of common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f9338aef-c7e2-43e2-8676-a5d2e660a66c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialDataAbstract_68d58fc3-780d-4109-9b90-a481a45645bc_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialDataAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Quarterly Financial Data [Abstract]</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialDataAbstract_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialDataAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Data [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialDataAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QuarterlyFinancialDataAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract" xlink:to="lab_us-gaap_QuarterlyFinancialDataAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.550DueFebruary102027Member_bd7aa09c-9f01-4905-8423-082713d499eb_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.550DueFebruary102027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 4.550% Due February 10, 2027</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.550DueFebruary102027Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.550DueFebruary102027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 4.550% Due February 10, 2027 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.550DueFebruary102027Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.550DueFebruary102027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes, 4.550% Due February 10, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.550DueFebruary102027Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.550DueFebruary102027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes4.550DueFebruary102027Member" xlink:to="lab_syk_SeniorUnsecuredNotes4.550DueFebruary102027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_8d5dab85-2988-420f-a0c6-5e5bd1762ff0_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_26b6255d-9f9c-4ec1-8c53-87fcae173598_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Actual plan asset allocations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_62358d69-4db8-4150-b1f0-08876067d34f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_b28f652b-a110-42eb-948a-aae50264d478_terseLabel_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Embedded Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_label_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Embedded Derivative Financial Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:to="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_91c9ba6f-ff50-4e88-aec6-129ff1ed7f43_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group, Held-for-Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Held-for-Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3ba8166c-499e-410c-acb3-d2aadb1854ad_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_360c7be6-2ee3-4d91-9044-200f28ad969b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_372936f2-dd46-475d-bd10-08281052bea9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_1402e981-e8d5-448b-8c6a-4a9416334844_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit facility outstanding amount</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_6f5b9c59-8ffc-41f5-b39d-820304021dd2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business acquisition, future milestone payments (up to)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_42c28614-99be-442c-a86b-5e54664a42cd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares, Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_8bdcc7f5-a354-459e-8909-5e0708ff46d8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net actuarial gain (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_ShortTermInvestmentsPolicyPolicyTextBlock_f4dbd8f5-dc09-4918-9cc8-93dffbd8b4a9_terseLabel_en-US" xlink:label="lab_syk_ShortTermInvestmentsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term Investments</link:label>
    <link:label id="lab_syk_ShortTermInvestmentsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_syk_ShortTermInvestmentsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short Term Investments, Policy [Policy Text Block]</link:label>
    <link:label id="lab_syk_ShortTermInvestmentsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_syk_ShortTermInvestmentsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Short Term Investments, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ShortTermInvestmentsPolicyPolicyTextBlock" xlink:href="syk-20241231.xsd#syk_ShortTermInvestmentsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_ShortTermInvestmentsPolicyPolicyTextBlock" xlink:to="lab_syk_ShortTermInvestmentsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_2b188530-c3d0-4aaf-bd82-accebfe66dcc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_444ef0f8-58a7-4aa4-94c8-e261b431c069_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_ec1fa439-d1b7-4681-b41e-95b5515d04bc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0f171633-53ce-493f-97a8-3f3899100d23_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_5c5b3c10-cebf-48ac-b282-10e367c6c457_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9535128c-74ae-4709-b386-e84b55aa495a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_3b9db1d4-bedb-4d25-b69d-35e72666e4cc_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets Held for Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_51fb6b08-ecd8-4b10-827c-12fd6765ed94_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits, income tax penalties and interest expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fb40e345-1fe0-4f8d-8bf8-b7a8bd11013f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_369a9caf-19d3-437d-80d3-92d1b2361107_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income (AOCI)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_8b550fd9-5455-4d0f-915c-0fc5f07e0f4f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expense funded with Stryker common stock</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_fd67b3e6-1e69-4029-9fd6-12ca17e56c8e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares, Cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_561faf62-5efc-4c03-95e0-c9db459f5a0b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_d101dfc8-9801-4b4b-961f-f556045ba227_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_21fcda11-c65a-4158-8174-f9cb4138be3e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of the Company's Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_5e6140d7-0a49-4e90-a4b2-7cfcdd46492f_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Tax Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_1342d744-71d0-4a9d-8425-c288b9c33bf6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_7f005fdd-a708-405c-8788-8c2daf877103_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_e77ea90d-75a0-4e7f-b610-3d01d3d0fac8_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_7350f3dd-ac5c-4846-a82b-35e7cac35b7d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_5ef73555-bf11-4538-8a66-970567662212_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total assets measured at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7d6cf483-ef42-4c0b-8ac4-7132ad263b67_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d94e83d4-59a6-4b92-97b4-5221ce312b0b_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_fe9c9b40-80d5-4db9-ac6a-5c909ce5a2ad_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.500Due2026Member_3151cab7-1f0e-47a0-a6b9-a627bdc42d2c_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.500Due2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 3.500% due 2026</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.500Due2026Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.500Due2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 3.500% Due 2026 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.500Due2026Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.500Due2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes 3.500% Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.500Due2026Member" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.500Due2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes3.500Due2026Member" xlink:to="lab_syk_SeniorUnsecuredNotes3.500Due2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_f3486c92-15d8-40d6-92de-79317646bfd7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_508da9f5-44f9-4971-a6ac-bec9ebd7997d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Shares, Nonvested at January 1 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1d6c6dd4-041b-414d-8be2-61f1e556e1c8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Shares, Nonvested at December 31 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_29014b97-0ecc-41e9-90cc-bb22c0f6481f_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_3f54813d-6cf2-4111-a0ad-f2217dbf0e9d_terseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">After-tax gain (loss) recognized in AOCI related to designated net investment hedges</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:to="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_922364a7-8700-4388-a800-c05357abfce7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_bf97beb9-e4c5-4880-9688-9dbbebf75972_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_a1ef7bb5-b04c-48f1-971a-86579f75527d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ending accumulated benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany_2e7fabc7-10d9-4bf4-b301-1b74452c5bcf_terseLabel_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stryker common stock held by plan, shares</link:label>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany_label_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Retirement Plans Common Stock Held by Company</link:label>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany_documentation_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Defined Contribution Retirement Plans Common Stock Held by Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:href="syk-20241231.xsd#syk_DefinedContributionRetirementPlansCommonStockHeldByCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:to="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany_3dcf7c2d-7a9a-47e0-ab11-64d947448ed1_terseLabel_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stryker common stock held by plan, amount</link:label>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany_label_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Retirement Plans Common Stock Value Held by Company</link:label>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany_documentation_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Defined Contribution Retirement Plans Common Stock Value Held by Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:href="syk-20241231.xsd#syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:to="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_6e3c1631-4cbb-4f51-982b-d44588b2082c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8ccb5261-57c6-431c-87d7-2c568cee0807_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognized from beginning of year contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_b4f05b29-dacb-49c2-8094-ce9cdbad695b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency exchange forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_22fee0a2-f586-48b7-ade1-258436d65b72_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_CustomerAndDistributorRelationshipsMember_17532c14-bb23-4612-8214-c848d1ef4c12_terseLabel_en-US" xlink:label="lab_syk_CustomerAndDistributorRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_syk_CustomerAndDistributorRelationshipsMember_label_en-US" xlink:label="lab_syk_CustomerAndDistributorRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer and Distributor Relationships [Member]</link:label>
    <link:label id="lab_syk_CustomerAndDistributorRelationshipsMember_documentation_en-US" xlink:label="lab_syk_CustomerAndDistributorRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer and Distributor Relationships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CustomerAndDistributorRelationshipsMember" xlink:href="syk-20241231.xsd#syk_CustomerAndDistributorRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_CustomerAndDistributorRelationshipsMember" xlink:to="lab_syk_CustomerAndDistributorRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_8dfa9d36-aa1e-4a69-92fd-483b55ffb09c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DeferredTaxAssetsOutsideBasisDifference_8a643fea-8efe-4dc6-b740-772e01c9d307_terseLabel_en-US" xlink:label="lab_syk_DeferredTaxAssetsOutsideBasisDifference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outside basis difference related to the anticipated sale of the Spinal Implants business</link:label>
    <link:label id="lab_syk_DeferredTaxAssetsOutsideBasisDifference_label_en-US" xlink:label="lab_syk_DeferredTaxAssetsOutsideBasisDifference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Outside Basis Difference</link:label>
    <link:label id="lab_syk_DeferredTaxAssetsOutsideBasisDifference_documentation_en-US" xlink:label="lab_syk_DeferredTaxAssetsOutsideBasisDifference" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Outside Basis Difference</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsOutsideBasisDifference" xlink:href="syk-20241231.xsd#syk_DeferredTaxAssetsOutsideBasisDifference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DeferredTaxAssetsOutsideBasisDifference" xlink:to="lab_syk_DeferredTaxAssetsOutsideBasisDifference" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_66f41ba6-49e2-41ba-b19e-7f788c520994_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_c6be0d73-6966-4b27-b053-2fc5a9108407_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_fe9d9ff4-3bb9-4999-877a-717b0b6efda4_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_90bf6fc7-646b-4608-97d0-2a929230cc62_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercised during period, exercise price range, upper range limit</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_24c6c865-760f-4c2c-a144-39e80cb316fd_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_0ea2f5a0-83f7-4d57-8ae7-a500f4cb5fee_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e4484bfb-26df-4d0f-896c-2a471288c92b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligationRollForward_95071279-8fad-4d00-b5b9-7cfcb0e1f7b1_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplier Finance Program, Obligation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligationRollForward_label_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplier Finance Program, Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierFinanceProgramObligationRollForward" xlink:to="lab_us-gaap_SupplierFinanceProgramObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_feccd542-0fb3-43df-82d7-79d9a2473dc6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on disposition of assets</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_e0091429-8966-48fe-bfd5-7dc0ab0fedc8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_4518ba3b-9471-4655-907e-8d8add0499ac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_b58a0ff4-b09c-4380-a5d1-76a01eb0f148_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets, operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_3c143ee5-42c7-4eb6-b02d-f40b239a5f85_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>20
<FILENAME>syk-20241231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:66138c84-a1f4-4bd1-9e3f-a7dda17467bc,g:664b5418-33ef-4591-a7dd-ebf51b747252-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.stryker.com/role/COVERPAGE" xlink:type="simple" xlink:href="syk-20241231.xsd#COVERPAGE"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/COVERPAGE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ce8efe06-a322-4ac6-8e5c-cd30025bff8e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_667ff751-0521-4b9e-904a-db5b499cc366" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce8efe06-a322-4ac6-8e5c-cd30025bff8e" xlink:to="loc_dei_EntitiesTable_667ff751-0521-4b9e-904a-db5b499cc366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_84a74645-7e64-4dd8-a20d-80dff99945cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_667ff751-0521-4b9e-904a-db5b499cc366" xlink:to="loc_us-gaap_StatementClassOfStockAxis_84a74645-7e64-4dd8-a20d-80dff99945cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_84a74645-7e64-4dd8-a20d-80dff99945cc" xlink:to="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_549f7d37-7618-4f1a-bf03-8b714d64bcb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:to="loc_us-gaap_CommonStockMember_549f7d37-7618-4f1a-bf03-8b714d64bcb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.125Due2027Member_b6efb38d-8018-4fc7-9297-1a5314ed2878" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes2.125Due2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:to="loc_syk_SeniorUnsecuredNotes2.125Due2027Member_b6efb38d-8018-4fc7-9297-1a5314ed2878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3375Due2028Member_4fe5bfdc-1db4-4b3f-af6e-6d9fccba74b0" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3375Due2028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:to="loc_syk_SeniorUnsecuredNotes3375Due2028Member_4fe5bfdc-1db4-4b3f-af6e-6d9fccba74b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.750due2029Member_047e2c92-defd-458b-9cdf-8d7ea525b936" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes0.750due2029Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:to="loc_syk_SeniorUnsecuredNotes0.750due2029Member_047e2c92-defd-458b-9cdf-8d7ea525b936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.625Due2030Member_78cea75f-7cf8-4b48-a917-88dbc85b4f50" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes2.625Due2030Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:to="loc_syk_SeniorUnsecuredNotes2.625Due2030Member_78cea75f-7cf8-4b48-a917-88dbc85b4f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.000due2031Member_565759f3-ace9-4547-ba8c-db7771e20f57" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes1.000due2031Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:to="loc_syk_SeniorUnsecuredNotes1.000due2031Member_565759f3-ace9-4547-ba8c-db7771e20f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375Due2032Member_57f37077-21af-4818-b30b-34a2bbac52cd" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.375Due2032Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:to="loc_syk_SeniorUnsecuredNotes3.375Due2032Member_57f37077-21af-4818-b30b-34a2bbac52cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.625Due2036Member_a66a4047-826b-4998-8a4c-e048d18ca433" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.625Due2036Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_54fc76a0-1a76-40dd-87ef-6001053c7f81" xlink:to="loc_syk_SeniorUnsecuredNotes3.625Due2036Member_a66a4047-826b-4998-8a4c-e048d18ca433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_667ff751-0521-4b9e-904a-db5b499cc366" xlink:to="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_5cca9174-913f-4393-8383-a73a8c5d4817" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_DocumentType_5cca9174-913f-4393-8383-a73a8c5d4817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_af909778-8f1e-4462-8508-de5a6e8ddf08" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_DocumentAnnualReport_af909778-8f1e-4462-8508-de5a6e8ddf08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_1841f264-6411-4ce6-b4d7-2f766cc54093" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_DocumentPeriodEndDate_1841f264-6411-4ce6-b4d7-2f766cc54093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_921b1532-0a29-47e1-9ce8-d15274b7af04" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_CurrentFiscalYearEndDate_921b1532-0a29-47e1-9ce8-d15274b7af04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_86b20622-1863-4fc1-9572-405c6f22a3bf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_DocumentTransitionReport_86b20622-1863-4fc1-9572-405c6f22a3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_08679748-2475-4d21-9569-2da7ad373d64" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityFileNumber_08679748-2475-4d21-9569-2da7ad373d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c58d8289-bc24-4729-8113-90ad150ea584" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityRegistrantName_c58d8289-bc24-4729-8113-90ad150ea584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1d6b23b6-b56f-4591-ad21-01c5b159274b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1d6b23b6-b56f-4591-ad21-01c5b159274b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4adbe232-2382-4e4c-b8de-f19d94f1c6a7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityTaxIdentificationNumber_4adbe232-2382-4e4c-b8de-f19d94f1c6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7ddc87c6-ce4c-4939-9893-0a00838dfd7b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityAddressAddressLine1_7ddc87c6-ce4c-4939-9893-0a00838dfd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_969b53a6-a60e-48bc-94cb-41e9328c1467" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityAddressCityOrTown_969b53a6-a60e-48bc-94cb-41e9328c1467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_533544e4-efe8-4e31-9c92-be840a752fd3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityAddressStateOrProvince_533544e4-efe8-4e31-9c92-be840a752fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_dcde48e8-772a-4dce-9cc5-0c86ff5a99db" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityAddressPostalZipCode_dcde48e8-772a-4dce-9cc5-0c86ff5a99db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_9fc312f1-b5d5-4fcf-b1af-d85b70bf9ab2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_CityAreaCode_9fc312f1-b5d5-4fcf-b1af-d85b70bf9ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b1fe90da-6af0-43d2-9e46-d4f683acba50" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_LocalPhoneNumber_b1fe90da-6af0-43d2-9e46-d4f683acba50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4058775f-beab-4f45-8e95-2c8b8c1c9cb7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_Security12bTitle_4058775f-beab-4f45-8e95-2c8b8c1c9cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_068bc70d-9877-4b0e-ae1b-a14a25f1294a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_TradingSymbol_068bc70d-9877-4b0e-ae1b-a14a25f1294a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_43033a52-6297-4cd4-8949-fba80aaf8642" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_SecurityExchangeName_43033a52-6297-4cd4-8949-fba80aaf8642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12gTitle_9ae50063-433d-449b-9334-3d73a636fd88" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_Security12gTitle_9ae50063-433d-449b-9334-3d73a636fd88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_8c52fe34-621c-4674-9a77-7265b463088f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_8c52fe34-621c-4674-9a77-7265b463088f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_e5119625-528b-4cc6-b11a-61eec0742f64" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityVoluntaryFilers_e5119625-528b-4cc6-b11a-61eec0742f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_967d11ee-469e-4e70-928a-bb57b9e0f37d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityCurrentReportingStatus_967d11ee-469e-4e70-928a-bb57b9e0f37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_d1d42b4b-f68a-4763-aa76-e0a54f890815" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityInteractiveDataCurrent_d1d42b4b-f68a-4763-aa76-e0a54f890815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_9313ad85-ab10-4685-a8a3-97f014b13f6d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityFilerCategory_9313ad85-ab10-4685-a8a3-97f014b13f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_dc5d5c45-5568-4c7c-84d7-4ea67657e031" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityEmergingGrowthCompany_dc5d5c45-5568-4c7c-84d7-4ea67657e031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_83f52156-a82e-4063-a556-8846ff8abb6b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntitySmallBusiness_83f52156-a82e-4063-a556-8846ff8abb6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_d1a04456-9553-4c6d-87cd-5e3420316471" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_IcfrAuditorAttestationFlag_d1a04456-9553-4c6d-87cd-5e3420316471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_d090f724-2064-430a-ac4c-67e05d5c9bf0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_d090f724-2064-430a-ac4c-67e05d5c9bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_9dc033a4-c70c-4300-9542-85258c3150d7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityShellCompany_9dc033a4-c70c-4300-9542-85258c3150d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_025c209a-e01b-4981-b01f-94375f8b7206" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityPublicFloat_025c209a-e01b-4981-b01f-94375f8b7206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_cd258874-599b-4c25-bcb6-de679ed88fa7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_cd258874-599b-4c25-bcb6-de679ed88fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_dfe3ab9c-87b4-45fb-9b11-f33e3f065645" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_dfe3ab9c-87b4-45fb-9b11-f33e3f065645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b1dec1f0-ee0d-451d-941c-a264960b4149" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_AmendmentFlag_b1dec1f0-ee0d-451d-941c-a264960b4149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_80816bb7-b0ba-436e-99b5-1a3647b6f375" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_DocumentFiscalYearFocus_80816bb7-b0ba-436e-99b5-1a3647b6f375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_087ac581-d37b-4bac-ac7b-c1c3c16c355c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_087ac581-d37b-4bac-ac7b-c1c3c16c355c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_d235a12a-89b5-48af-a05b-0b57b9168f37" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_758bd36e-95e9-458e-93bb-42e966f2cf4c" xlink:to="loc_dei_EntityCentralIndexKey_d235a12a-89b5-48af-a05b-0b57b9168f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AuditInformation" xlink:type="simple" xlink:href="syk-20241231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_AuditorInformationAbstract_1bb1b24a-0600-4b31-a68c-db819b579108" xlink:href="syk-20241231.xsd#syk_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_d8da03b8-b704-4f63-ab93-de47ccad7bd5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_AuditorInformationAbstract_1bb1b24a-0600-4b31-a68c-db819b579108" xlink:to="loc_dei_AuditorFirmId_d8da03b8-b704-4f63-ab93-de47ccad7bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_e3069819-64f5-4f6f-8c91-b2953810a4c0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_AuditorInformationAbstract_1bb1b24a-0600-4b31-a68c-db819b579108" xlink:to="loc_dei_AuditorName_e3069819-64f5-4f6f-8c91-b2953810a4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_99af485e-55d8-4810-801e-9e2ee635da26" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_AuditorInformationAbstract_1bb1b24a-0600-4b31-a68c-db819b579108" xlink:to="loc_dei_AuditorLocation_99af485e-55d8-4810-801e-9e2ee635da26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfEarnings" xlink:type="simple" xlink:href="syk-20241231.xsd#ConsolidatedStatementsOfEarnings"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_5ef15a68-87f0-479f-ad10-1774b4a272bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_aa6d9eca-f5ce-4412-8287-60dad879a425" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5ef15a68-87f0-479f-ad10-1774b4a272bf" xlink:to="loc_us-gaap_Revenues_aa6d9eca-f5ce-4412-8287-60dad879a425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_18d6bf36-8b2e-4655-8c0d-632dd6a13034" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5ef15a68-87f0-479f-ad10-1774b4a272bf" xlink:to="loc_us-gaap_CostOfRevenue_18d6bf36-8b2e-4655-8c0d-632dd6a13034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_b96e8c4a-ce16-41f7-9291-34cff7a48e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5ef15a68-87f0-479f-ad10-1774b4a272bf" xlink:to="loc_us-gaap_GrossProfit_b96e8c4a-ce16-41f7-9291-34cff7a48e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d157b7e2-8179-4aa1-974a-3898124c0fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5ef15a68-87f0-479f-ad10-1774b4a272bf" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d157b7e2-8179-4aa1-974a-3898124c0fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0a1179d4-8bd9-4ae5-bafb-d7318fb979fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5ef15a68-87f0-479f-ad10-1774b4a272bf" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0a1179d4-8bd9-4ae5-bafb-d7318fb979fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_bada7cc8-b696-483d-92d9-72d87827b77c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5ef15a68-87f0-479f-ad10-1774b4a272bf" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_bada7cc8-b696-483d-92d9-72d87827b77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_1eee163f-b1e2-483e-8393-6f52f8e3b5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5ef15a68-87f0-479f-ad10-1774b4a272bf" xlink:to="loc_us-gaap_AssetImpairmentCharges_1eee163f-b1e2-483e-8393-6f52f8e3b5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_085101aa-2fb0-4530-90df-cf059fe28260" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5ef15a68-87f0-479f-ad10-1774b4a272bf" xlink:to="loc_us-gaap_OperatingExpenses_085101aa-2fb0-4530-90df-cf059fe28260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1a0f8929-763c-43b8-93a3-b4559473fc71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5ef15a68-87f0-479f-ad10-1774b4a272bf" xlink:to="loc_us-gaap_OperatingIncomeLoss_1a0f8929-763c-43b8-93a3-b4559473fc71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_88373ba1-c397-4d07-9427-ff6808df2940" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5ef15a68-87f0-479f-ad10-1774b4a272bf" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_88373ba1-c397-4d07-9427-ff6808df2940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ec95e977-6beb-42a5-a1a7-bed974469e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5ef15a68-87f0-479f-ad10-1774b4a272bf" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ec95e977-6beb-42a5-a1a7-bed974469e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c7effe6a-6052-428f-83d2-a14370fbeaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5ef15a68-87f0-479f-ad10-1774b4a272bf" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c7effe6a-6052-428f-83d2-a14370fbeaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7173a1b6-5c2f-4eb5-ae3d-3972b2053541" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5ef15a68-87f0-479f-ad10-1774b4a272bf" xlink:to="loc_us-gaap_NetIncomeLoss_7173a1b6-5c2f-4eb5-ae3d-3972b2053541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_14dd0b4b-6dbf-4ce7-8f16-2a90cc7c6b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5ef15a68-87f0-479f-ad10-1774b4a272bf" xlink:to="loc_us-gaap_EarningsPerShareAbstract_14dd0b4b-6dbf-4ce7-8f16-2a90cc7c6b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_506c1e83-f329-4b86-b2d0-78b25733375d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_14dd0b4b-6dbf-4ce7-8f16-2a90cc7c6b4a" xlink:to="loc_us-gaap_EarningsPerShareBasic_506c1e83-f329-4b86-b2d0-78b25733375d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3f4e4abb-9ec8-4555-a21f-fce8378340da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_14dd0b4b-6dbf-4ce7-8f16-2a90cc7c6b4a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3f4e4abb-9ec8-4555-a21f-fce8378340da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1a261577-992c-4ebf-a6b1-6804fda4b34d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5ef15a68-87f0-479f-ad10-1774b4a272bf" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1a261577-992c-4ebf-a6b1-6804fda4b34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6dbf3faa-22ca-476e-9f61-733b23ba5a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1a261577-992c-4ebf-a6b1-6804fda4b34d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6dbf3faa-22ca-476e-9f61-733b23ba5a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_9059d82f-c59f-4ecd-a614-4cd7908a5395" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1a261577-992c-4ebf-a6b1-6804fda4b34d" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_9059d82f-c59f-4ecd-a614-4cd7908a5395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a48edeaf-7759-49b9-908a-0060a64b02f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1a261577-992c-4ebf-a6b1-6804fda4b34d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a48edeaf-7759-49b9-908a-0060a64b02f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfEarningsParenthetical" xlink:type="simple" xlink:href="syk-20241231.xsd#ConsolidatedStatementsOfEarningsParenthetical"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfEarningsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_467aada1-946d-408b-9afd-48fb81d808fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ecef27f9-f777-4173-9979-8a52b47fc8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_467aada1-946d-408b-9afd-48fb81d808fe" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ecef27f9-f777-4173-9979-8a52b47fc8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="syk-20241231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b8d437f1-f98b-4d71-9150-f82161416a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8061a908-fe97-4c3a-aec3-6b10e83a2cca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b8d437f1-f98b-4d71-9150-f82161416a7e" xlink:to="loc_us-gaap_NetIncomeLoss_8061a908-fe97-4c3a-aec3-6b10e83a2cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7623b73e-0d3c-4999-9e07-822765b51490" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b8d437f1-f98b-4d71-9150-f82161416a7e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7623b73e-0d3c-4999-9e07-822765b51490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_eedfd82d-31a2-4a9f-a560-c5a508cb9f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7623b73e-0d3c-4999-9e07-822765b51490" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_eedfd82d-31a2-4a9f-a560-c5a508cb9f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_8f35647b-efaf-4337-8d3b-4ef2273a9f89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7623b73e-0d3c-4999-9e07-822765b51490" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_8f35647b-efaf-4337-8d3b-4ef2273a9f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_15ce60b0-99a7-4da0-8aed-5716ff1e1377" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7623b73e-0d3c-4999-9e07-822765b51490" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_15ce60b0-99a7-4da0-8aed-5716ff1e1377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fce2e808-30da-4678-b06a-648c649a7d97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7623b73e-0d3c-4999-9e07-822765b51490" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fce2e808-30da-4678-b06a-648c649a7d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b4fc35f6-8264-47f6-8c54-6dc83a166b20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7623b73e-0d3c-4999-9e07-822765b51490" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b4fc35f6-8264-47f6-8c54-6dc83a166b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_71d68a76-abea-4727-9fbc-c0b1ec242835" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b8d437f1-f98b-4d71-9150-f82161416a7e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_71d68a76-abea-4727-9fbc-c0b1ec242835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="syk-20241231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_b05648bf-8deb-4adc-a056-88a808fb2aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_5cae5783-cb87-4cc9-963f-f614f530fdb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b05648bf-8deb-4adc-a056-88a808fb2aa9" xlink:to="loc_us-gaap_AssetsAbstract_5cae5783-cb87-4cc9-963f-f614f530fdb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_b9f3349a-ab12-4027-a313-5c5c9d5497e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5cae5783-cb87-4cc9-963f-f614f530fdb6" xlink:to="loc_us-gaap_AssetsCurrentAbstract_b9f3349a-ab12-4027-a313-5c5c9d5497e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f0c46ea4-e3ca-4c4c-8ea4-f6b68e2ea813" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b9f3349a-ab12-4027-a313-5c5c9d5497e0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f0c46ea4-e3ca-4c4c-8ea4-f6b68e2ea813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermInvestments_350dfb80-7c50-41b3-a0e3-0a3f36a7eab7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b9f3349a-ab12-4027-a313-5c5c9d5497e0" xlink:to="loc_us-gaap_OtherShortTermInvestments_350dfb80-7c50-41b3-a0e3-0a3f36a7eab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c072546d-2806-4ca3-93eb-73c321a76c16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b9f3349a-ab12-4027-a313-5c5c9d5497e0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c072546d-2806-4ca3-93eb-73c321a76c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_9ce2b8cc-a2fc-40e6-8737-a5764e88672b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b9f3349a-ab12-4027-a313-5c5c9d5497e0" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_9ce2b8cc-a2fc-40e6-8737-a5764e88672b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_61a76c3c-1ec8-471c-bf6c-d5475be2c942" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b9f3349a-ab12-4027-a313-5c5c9d5497e0" xlink:to="loc_us-gaap_InventoryNetAbstract_61a76c3c-1ec8-471c-bf6c-d5475be2c942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_33a87ba3-022d-420a-9aa7-4ec0d4d9135d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_61a76c3c-1ec8-471c-bf6c-d5475be2c942" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_33a87ba3-022d-420a-9aa7-4ec0d4d9135d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_02acadb2-532a-4a5c-8c6e-2dde1d742b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_61a76c3c-1ec8-471c-bf6c-d5475be2c942" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_02acadb2-532a-4a5c-8c6e-2dde1d742b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_099b116f-d135-4547-8993-087d31914be0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_61a76c3c-1ec8-471c-bf6c-d5475be2c942" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_099b116f-d135-4547-8993-087d31914be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_44e7ffea-e86c-40b7-bad5-622106ee5220" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_61a76c3c-1ec8-471c-bf6c-d5475be2c942" xlink:to="loc_us-gaap_InventoryNet_44e7ffea-e86c-40b7-bad5-622106ee5220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_44ea7720-9220-47c1-b150-7fe008cea68a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b9f3349a-ab12-4027-a313-5c5c9d5497e0" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_44ea7720-9220-47c1-b150-7fe008cea68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6be4dcdd-3558-420e-8ef3-c8fe2091e72b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b9f3349a-ab12-4027-a313-5c5c9d5497e0" xlink:to="loc_us-gaap_AssetsCurrent_6be4dcdd-3558-420e-8ef3-c8fe2091e72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_513859c8-1578-497c-b8b5-70ca87c89b63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5cae5783-cb87-4cc9-963f-f614f530fdb6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAbstract_513859c8-1578-497c-b8b5-70ca87c89b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LandBuildingsAndImprovementsGross_4e7629aa-a2e4-48b9-8bd5-cecf1cf07dfc" xlink:href="syk-20241231.xsd#syk_LandBuildingsAndImprovementsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_513859c8-1578-497c-b8b5-70ca87c89b63" xlink:to="loc_syk_LandBuildingsAndImprovementsGross_4e7629aa-a2e4-48b9-8bd5-cecf1cf07dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_82ce6eb0-060a-468c-b879-ed0d857f88c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_513859c8-1578-497c-b8b5-70ca87c89b63" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_82ce6eb0-060a-468c-b879-ed0d857f88c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8223a796-15aa-4c43-9086-d7c675511022" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_513859c8-1578-497c-b8b5-70ca87c89b63" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8223a796-15aa-4c43-9086-d7c675511022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_dcfbecf1-5e40-4d88-b4f4-e54f0f517c64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_513859c8-1578-497c-b8b5-70ca87c89b63" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_dcfbecf1-5e40-4d88-b4f4-e54f0f517c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a4076a4c-07ff-41ce-ab20-4ee8487941b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_513859c8-1578-497c-b8b5-70ca87c89b63" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a4076a4c-07ff-41ce-ab20-4ee8487941b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_06c9ef65-9013-4a9c-a84c-4435e2fd5e23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5cae5783-cb87-4cc9-963f-f614f530fdb6" xlink:to="loc_us-gaap_Goodwill_06c9ef65-9013-4a9c-a84c-4435e2fd5e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ff67cb93-c2b0-4e50-95f1-cfaf7227da54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5cae5783-cb87-4cc9-963f-f614f530fdb6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ff67cb93-c2b0-4e50-95f1-cfaf7227da54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_aabaa632-6b56-4750-b383-26ac287262c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5cae5783-cb87-4cc9-963f-f614f530fdb6" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_aabaa632-6b56-4750-b383-26ac287262c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_bebc17dd-8c42-4800-9035-16b0ee40162e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5cae5783-cb87-4cc9-963f-f614f530fdb6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_bebc17dd-8c42-4800-9035-16b0ee40162e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2643de55-b8db-4196-8824-333ac8550a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5cae5783-cb87-4cc9-963f-f614f530fdb6" xlink:to="loc_us-gaap_Assets_2643de55-b8db-4196-8824-333ac8550a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f9af416c-30cf-487d-a058-6a92eb8e974c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b05648bf-8deb-4adc-a056-88a808fb2aa9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f9af416c-30cf-487d-a058-6a92eb8e974c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_01092444-48e1-447b-9569-91d86ba03f43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f9af416c-30cf-487d-a058-6a92eb8e974c" xlink:to="loc_us-gaap_LiabilitiesAbstract_01092444-48e1-447b-9569-91d86ba03f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_a38a11e6-28c7-46f4-8e9d-e04c3187e97e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_01092444-48e1-447b-9569-91d86ba03f43" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_a38a11e6-28c7-46f4-8e9d-e04c3187e97e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_21ea72ab-ae24-4045-a46e-07e64b8dee6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a38a11e6-28c7-46f4-8e9d-e04c3187e97e" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_21ea72ab-ae24-4045-a46e-07e64b8dee6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ac66aad0-2e8f-44e8-b4a0-069d1982e518" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a38a11e6-28c7-46f4-8e9d-e04c3187e97e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ac66aad0-2e8f-44e8-b4a0-069d1982e518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_8726308c-5e95-4895-bfde-f6a67934ce32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a38a11e6-28c7-46f4-8e9d-e04c3187e97e" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_8726308c-5e95-4895-bfde-f6a67934ce32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_0a4d4182-005d-44e6-8547-cf609b771e83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a38a11e6-28c7-46f4-8e9d-e04c3187e97e" xlink:to="loc_us-gaap_DividendsPayableCurrent_0a4d4182-005d-44e6-8547-cf609b771e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_d4937fa8-63e9-4010-a53f-db38df0cabbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a38a11e6-28c7-46f4-8e9d-e04c3187e97e" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_d4937fa8-63e9-4010-a53f-db38df0cabbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_308403cf-af19-41e6-a614-c4f79b86ff2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a38a11e6-28c7-46f4-8e9d-e04c3187e97e" xlink:to="loc_us-gaap_DebtCurrent_308403cf-af19-41e6-a614-c4f79b86ff2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c20d433c-6219-46fd-8dcf-ebca1d762b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a38a11e6-28c7-46f4-8e9d-e04c3187e97e" xlink:to="loc_us-gaap_LiabilitiesCurrent_c20d433c-6219-46fd-8dcf-ebca1d762b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5bfccb54-2229-4ac6-b7e9-4c8a8ed654f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_01092444-48e1-447b-9569-91d86ba03f43" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5bfccb54-2229-4ac6-b7e9-4c8a8ed654f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_fa927edc-8550-47ae-a1c6-3d35cf3b238b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_01092444-48e1-447b-9569-91d86ba03f43" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_fa927edc-8550-47ae-a1c6-3d35cf3b238b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1218f9be-72e8-4d20-9399-8c8a4ac5be0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_01092444-48e1-447b-9569-91d86ba03f43" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1218f9be-72e8-4d20-9399-8c8a4ac5be0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_60d47f3c-1c15-4d41-8b39-47471015c4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_01092444-48e1-447b-9569-91d86ba03f43" xlink:to="loc_us-gaap_Liabilities_60d47f3c-1c15-4d41-8b39-47471015c4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_7a66308e-c9f7-41ec-8e7c-16d4f9ef2ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f9af416c-30cf-487d-a058-6a92eb8e974c" xlink:to="loc_us-gaap_StockholdersEquityAbstract_7a66308e-c9f7-41ec-8e7c-16d4f9ef2ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_dd7fb57f-250b-4ca1-aad7-c28598943bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7a66308e-c9f7-41ec-8e7c-16d4f9ef2ff5" xlink:to="loc_us-gaap_CommonStockValueOutstanding_dd7fb57f-250b-4ca1-aad7-c28598943bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d9626e9a-2903-4268-98c7-9a7c1abfe749" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7a66308e-c9f7-41ec-8e7c-16d4f9ef2ff5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d9626e9a-2903-4268-98c7-9a7c1abfe749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_908397a9-eea6-49f3-a791-2bb58cfa3911" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7a66308e-c9f7-41ec-8e7c-16d4f9ef2ff5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_908397a9-eea6-49f3-a791-2bb58cfa3911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1e446e31-29d6-42ed-8a89-f930815f13d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7a66308e-c9f7-41ec-8e7c-16d4f9ef2ff5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1e446e31-29d6-42ed-8a89-f930815f13d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a7374be6-c69d-4499-92b1-c91cd64e3c56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7a66308e-c9f7-41ec-8e7c-16d4f9ef2ff5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a7374be6-c69d-4499-92b1-c91cd64e3c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c108daad-f5b4-470b-8fe7-88932c386c72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f9af416c-30cf-487d-a058-6a92eb8e974c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_c108daad-f5b4-470b-8fe7-88932c386c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_44be517d-2632-4f4e-85b3-1bb2671688a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b05648bf-8deb-4adc-a056-88a808fb2aa9" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_44be517d-2632-4f4e-85b3-1bb2671688a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals" xlink:type="simple" xlink:href="syk-20241231.xsd#ConsolidatedBalanceSheetsParentheticals"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_86619f08-d5f4-4801-a1b5-c29b1c80d1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_4c32106a-ac39-476b-a206-c5fbadb5e31e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_86619f08-d5f4-4801-a1b5-c29b1c80d1e4" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_4c32106a-ac39-476b-a206-c5fbadb5e31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0ecb6102-abd4-43f6-8906-7a123092a68e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_86619f08-d5f4-4801-a1b5-c29b1c80d1e4" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0ecb6102-abd4-43f6-8906-7a123092a68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:type="simple" xlink:href="syk-20241231.xsd#ConsolidatedStatementsOfShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_fd42306f-10d6-437d-8554-cb08156d8cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6abb7195-06e5-4f78-a73d-7d71da8b05f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_fd42306f-10d6-437d-8554-cb08156d8cb2" xlink:to="loc_us-gaap_StatementTable_6abb7195-06e5-4f78-a73d-7d71da8b05f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2bb3c894-dbb5-4660-a96a-90c366d183e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6abb7195-06e5-4f78-a73d-7d71da8b05f7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2bb3c894-dbb5-4660-a96a-90c366d183e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_299e3c40-00f4-42f9-bd47-e4054a82892e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2bb3c894-dbb5-4660-a96a-90c366d183e9" xlink:to="loc_us-gaap_EquityComponentDomain_299e3c40-00f4-42f9-bd47-e4054a82892e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bfce9d55-6ee2-431a-8e2e-5a27aa2d9737" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_299e3c40-00f4-42f9-bd47-e4054a82892e" xlink:to="loc_us-gaap_CommonStockMember_bfce9d55-6ee2-431a-8e2e-5a27aa2d9737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_3f0a0c29-6e8b-4aea-b496-c970a4014046" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_299e3c40-00f4-42f9-bd47-e4054a82892e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_3f0a0c29-6e8b-4aea-b496-c970a4014046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_17152498-de17-4a3a-9a2d-c2c37dd596c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_299e3c40-00f4-42f9-bd47-e4054a82892e" xlink:to="loc_us-gaap_RetainedEarningsMember_17152498-de17-4a3a-9a2d-c2c37dd596c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef6f37e0-d0e8-4587-ab1a-9b5be7705853" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_299e3c40-00f4-42f9-bd47-e4054a82892e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef6f37e0-d0e8-4587-ab1a-9b5be7705853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_55077951-e88d-49e5-a516-7e6cb6b09044" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6abb7195-06e5-4f78-a73d-7d71da8b05f7" xlink:to="loc_us-gaap_StatementLineItems_55077951-e88d-49e5-a516-7e6cb6b09044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55077951-e88d-49e5-a516-7e6cb6b09044" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f1999a4c-a0e1-4023-95fc-4142890bc4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f1999a4c-a0e1-4023-95fc-4142890bc4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ca758e87-9d76-40d1-bee0-5c55b6e18de7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ca758e87-9d76-40d1-bee0-5c55b6e18de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_bcfaae49-9050-4121-b905-401d17b6b9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_bcfaae49-9050-4121-b905-401d17b6b9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_68a03a1e-cb58-461a-ba56-0f55519634b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_68a03a1e-cb58-461a-ba56-0f55519634b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_216b0aa0-2a8e-4acd-be82-a4fdc22e4089" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_216b0aa0-2a8e-4acd-be82-a4fdc22e4089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0ada7af8-0c06-4618-8bf3-2c3046f7c600" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_NetIncomeLoss_0ada7af8-0c06-4618-8bf3-2c3046f7c600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_4efd0ce1-39f0-4e11-9770-750e51da52e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsCash"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_DividendsCash_4efd0ce1-39f0-4e11-9770-750e51da52e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_83e8f3eb-5544-4041-9d4e-a7b8b34529f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_83e8f3eb-5544-4041-9d4e-a7b8b34529f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1db110f6-5d04-4fd6-949c-74d9bb4813b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1db110f6-5d04-4fd6-949c-74d9bb4813b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d73b1a71-1d7d-4863-b461-b26c8e87b67f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb74c2f7-e49d-4100-a248-a32867a2b092" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d73b1a71-1d7d-4863-b461-b26c8e87b67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="syk-20241231.xsd#ConsolidatedStatementsOfCashFlows"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_00926087-7951-4d54-bca1-720f1331373c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1afcef5d-d0a9-4bb9-b234-675342ac5baa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_00926087-7951-4d54-bca1-720f1331373c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1afcef5d-d0a9-4bb9-b234-675342ac5baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9675baa3-f9d2-4087-91ef-4e1449a03493" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1afcef5d-d0a9-4bb9-b234-675342ac5baa" xlink:to="loc_us-gaap_NetIncomeLoss_9675baa3-f9d2-4087-91ef-4e1449a03493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce46c95c-50a2-4a14-add7-9833f524df7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1afcef5d-d0a9-4bb9-b234-675342ac5baa" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce46c95c-50a2-4a14-add7-9833f524df7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_0eeda0ce-40ad-4591-ae29-a4a4b13a90c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce46c95c-50a2-4a14-add7-9833f524df7b" xlink:to="loc_us-gaap_Depreciation_0eeda0ce-40ad-4591-ae29-a4a4b13a90c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_5e641615-e752-487e-be0c-8afa63316b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce46c95c-50a2-4a14-add7-9833f524df7b" xlink:to="loc_us-gaap_AdjustmentForAmortization_5e641615-e752-487e-be0c-8afa63316b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_e77f63b0-ee0d-44f9-8380-502094cb1943" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce46c95c-50a2-4a14-add7-9833f524df7b" xlink:to="loc_us-gaap_AssetImpairmentCharges_e77f63b0-ee0d-44f9-8380-502094cb1943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b1532f76-5d8d-4c61-92bb-9ddfa8345b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce46c95c-50a2-4a14-add7-9833f524df7b" xlink:to="loc_us-gaap_ShareBasedCompensation_b1532f76-5d8d-4c61-92bb-9ddfa8345b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InventorySteppedUpToFairValueAtAcquisition_8da70c17-a13d-4b9d-ad5d-9c4955d6cdc5" xlink:href="syk-20241231.xsd#syk_InventorySteppedUpToFairValueAtAcquisition"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce46c95c-50a2-4a14-add7-9833f524df7b" xlink:to="loc_syk_InventorySteppedUpToFairValueAtAcquisition_8da70c17-a13d-4b9d-ad5d-9c4955d6cdc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_01fa1bfe-874f-4f9c-ba62-284fe1411744" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce46c95c-50a2-4a14-add7-9833f524df7b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_01fa1bfe-874f-4f9c-ba62-284fe1411744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_65ec6eb1-0c11-408e-a64a-625c820df882" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce46c95c-50a2-4a14-add7-9833f524df7b" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_65ec6eb1-0c11-408e-a64a-625c820df882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5ed8b2ea-5d23-4fde-a994-9ea5ab05f049" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_65ec6eb1-0c11-408e-a64a-625c820df882" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5ed8b2ea-5d23-4fde-a994-9ea5ab05f049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_81fbf960-1304-4998-a79f-192a29b82c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_65ec6eb1-0c11-408e-a64a-625c820df882" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_81fbf960-1304-4998-a79f-192a29b82c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_bc796b33-ea1d-4a71-9ae1-21b85770594e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_65ec6eb1-0c11-408e-a64a-625c820df882" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_bc796b33-ea1d-4a71-9ae1-21b85770594e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c64cb567-ada7-4de2-a847-23ddfdbecf8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_65ec6eb1-0c11-408e-a64a-625c820df882" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c64cb567-ada7-4de2-a847-23ddfdbecf8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_d5a48b8b-3307-4a26-a7aa-b6a0139e4062" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_65ec6eb1-0c11-408e-a64a-625c820df882" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_d5a48b8b-3307-4a26-a7aa-b6a0139e4062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_e43fca22-d63c-4e79-b22e-d02ff6468a58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_65ec6eb1-0c11-408e-a64a-625c820df882" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_e43fca22-d63c-4e79-b22e-d02ff6468a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a07acfd4-71dd-4639-94e5-c727f862d13b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1afcef5d-d0a9-4bb9-b234-675342ac5baa" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a07acfd4-71dd-4639-94e5-c727f862d13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df3da461-92e5-4282-94fa-5cd4ecf553f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_00926087-7951-4d54-bca1-720f1331373c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df3da461-92e5-4282-94fa-5cd4ecf553f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_74058767-6502-4c5e-94cd-c951659a9b04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df3da461-92e5-4282-94fa-5cd4ecf553f9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_74058767-6502-4c5e-94cd-c951659a9b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_b9b7804b-1aee-4d67-b6be-f51dc9bd80ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df3da461-92e5-4282-94fa-5cd4ecf553f9" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_b9b7804b-1aee-4d67-b6be-f51dc9bd80ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_51cff704-ed08-4058-9906-f20620fd82b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df3da461-92e5-4282-94fa-5cd4ecf553f9" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_51cff704-ed08-4058-9906-f20620fd82b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_dbcb03d0-b90b-4207-a5c9-ec137b047f08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df3da461-92e5-4282-94fa-5cd4ecf553f9" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_dbcb03d0-b90b-4207-a5c9-ec137b047f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_996d0349-1f0f-43e7-a62d-3dd47d592666" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df3da461-92e5-4282-94fa-5cd4ecf553f9" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_996d0349-1f0f-43e7-a62d-3dd47d592666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_f603c5c7-be02-4ba1-b62a-99455bcbdfc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df3da461-92e5-4282-94fa-5cd4ecf553f9" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_f603c5c7-be02-4ba1-b62a-99455bcbdfc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6db51537-d0e2-41d2-9c5e-7c5078fcb872" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df3da461-92e5-4282-94fa-5cd4ecf553f9" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6db51537-d0e2-41d2-9c5e-7c5078fcb872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_291e7b7c-48c9-4628-b221-976a2699edf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_df3da461-92e5-4282-94fa-5cd4ecf553f9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_291e7b7c-48c9-4628-b221-976a2699edf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ccd2e26-5f6d-403c-a055-d22cd97d33bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_00926087-7951-4d54-bca1-720f1331373c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ccd2e26-5f6d-403c-a055-d22cd97d33bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_b8766bd5-81a1-4114-8375-3b844346d9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ccd2e26-5f6d-403c-a055-d22cd97d33bd" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_b8766bd5-81a1-4114-8375-3b844346d9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2f07b74b-0ece-4265-97d1-f647c4518593" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ccd2e26-5f6d-403c-a055-d22cd97d33bd" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2f07b74b-0ece-4265-97d1-f647c4518593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_e67cc0a0-8b5f-49c6-8729-8ac2b49daf16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ccd2e26-5f6d-403c-a055-d22cd97d33bd" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_e67cc0a0-8b5f-49c6-8729-8ac2b49daf16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_948c9d79-6c8d-4dcb-a544-5bdc82285481" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ccd2e26-5f6d-403c-a055-d22cd97d33bd" xlink:to="loc_us-gaap_PaymentsOfDividends_948c9d79-6c8d-4dcb-a544-5bdc82285481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9c7d648f-2944-4f59-b5d0-39858455f0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ccd2e26-5f6d-403c-a055-d22cd97d33bd" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9c7d648f-2944-4f59-b5d0-39858455f0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_c49f08cf-9b76-43d2-bd30-949e81000aff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ccd2e26-5f6d-403c-a055-d22cd97d33bd" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_c49f08cf-9b76-43d2-bd30-949e81000aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26e9ccee-7a2b-4178-ac0a-c45bf51fc716" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ccd2e26-5f6d-403c-a055-d22cd97d33bd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26e9ccee-7a2b-4178-ac0a-c45bf51fc716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1825336b-d273-419c-8c39-e9cfa3c950f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_00926087-7951-4d54-bca1-720f1331373c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1825336b-d273-419c-8c39-e9cfa3c950f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7a2c92fb-21d4-42a1-b091-41b8aecc4c60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_00926087-7951-4d54-bca1-720f1331373c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7a2c92fb-21d4-42a1-b091-41b8aecc4c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0a398668-fd65-46d0-ad89-97dc679d3ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_00926087-7951-4d54-bca1-720f1331373c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0a398668-fd65-46d0-ad89-97dc679d3ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_415c0341-49f8-48d7-a6ad-05f40dcd9427" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_00926087-7951-4d54-bca1-720f1331373c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_415c0341-49f8-48d7-a6ad-05f40dcd9427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_51b5b91c-89eb-42da-80b5-e97380653a56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_00926087-7951-4d54-bca1-720f1331373c" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_51b5b91c-89eb-42da-80b5-e97380653a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_4f3610b4-0906-4cfd-9e3b-9297a9ec063f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_51b5b91c-89eb-42da-80b5-e97380653a56" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_4f3610b4-0906-4cfd-9e3b-9297a9ec063f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_280822c2-1b2f-4c3d-bb9d-fcdc8a647a47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_51b5b91c-89eb-42da-80b5-e97380653a56" xlink:to="loc_us-gaap_InterestPaidNet_280822c2-1b2f-4c3d-bb9d-fcdc8a647a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="syk-20241231.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d358a10e-48a5-495f-9cde-ba419a409365" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_a5b6735e-28f2-40b4-b1be-6a613e7a91ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d358a10e-48a5-495f-9cde-ba419a409365" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_a5b6735e-28f2-40b4-b1be-6a613e7a91ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognition" xlink:type="simple" xlink:href="syk-20241231.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_a0597caa-1fd7-4a20-b5ec-2fcb54daacd5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_effb0cce-332e-4ed8-8ee7-acb99ad569ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_a0597caa-1fd7-4a20-b5ec-2fcb54daacd5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_effb0cce-332e-4ed8-8ee7-acb99ad569ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="syk-20241231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f18ee1c0-cefb-4426-849f-703ac09d3c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_45ee2c03-9662-4127-a775-c98f4a556a26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f18ee1c0-cefb-4426-849f-703ac09d3c4e" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_45ee2c03-9662-4127-a775-c98f4a556a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstruments" xlink:type="simple" xlink:href="syk-20241231.xsd#DerivativeInstruments"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DerivativeInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_93198694-3f0e-4265-89f4-716656816e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_c80fdc5b-dcc7-4e2c-a46e-ec394e093c60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_93198694-3f0e-4265-89f4-716656816e5d" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_c80fdc5b-dcc7-4e2c-a46e-ec394e093c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI" xlink:type="simple" xlink:href="syk-20241231.xsd#AccumulatedOtherComprehensiveLossIncomeAOCI"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_3fea8887-1ab4-4a18-9267-29fce3005f08" xlink:href="syk-20241231.xsd#syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_23d5cc14-c941-48ae-86fc-ea6e2c35c620" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_3fea8887-1ab4-4a18-9267-29fce3005f08" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_23d5cc14-c941-48ae-86fc-ea6e2c35c620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/Acquisitions" xlink:type="simple" xlink:href="syk-20241231.xsd#Acquisitions"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_95e7c2f4-2fbb-4e36-b674-2a8b85ef478e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_d5fbd2c1-2daa-4c25-ab11-1128d51c6457" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_95e7c2f4-2fbb-4e36-b674-2a8b85ef478e" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_d5fbd2c1-2daa-4c25-ab11-1128d51c6457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ContingenciesandCommitments" xlink:type="simple" xlink:href="syk-20241231.xsd#ContingenciesandCommitments"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ContingenciesandCommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_20467e9c-8f43-4671-b5d6-25d646927e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_68e38d2b-0516-4524-aeae-06cb5287eb73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_20467e9c-8f43-4671-b5d6-25d646927e2f" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_68e38d2b-0516-4524-aeae-06cb5287eb73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="syk-20241231.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8c335908-619d-4293-8030-56ea86106ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_99a12e61-b2b8-4f13-a7e5-059e0e3522d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8c335908-619d-4293-8030-56ea86106ecd" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_99a12e61-b2b8-4f13-a7e5-059e0e3522d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStock" xlink:type="simple" xlink:href="syk-20241231.xsd#CapitalStock"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_552a2dd3-c709-4f0e-b785-6cf4532152f7" xlink:href="syk-20241231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b9caafa4-3368-4602-92d2-f84c69ffbf28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_552a2dd3-c709-4f0e-b785-6cf4532152f7" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b9caafa4-3368-4602-92d2-f84c69ffbf28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilities" xlink:type="simple" xlink:href="syk-20241231.xsd#DebtandCreditFacilities"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_01cee5e0-f4c9-493d-bd4f-94be61e1301e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_1c95c621-6e77-48d2-b2b2-aac719e4a9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_01cee5e0-f4c9-493d-bd4f-94be61e1301e" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_1c95c621-6e77-48d2-b2b2-aac719e4a9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxes" xlink:type="simple" xlink:href="syk-20241231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_08079089-3df8-4da9-a73b-04a652b3dd07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_6d3ac4c0-0005-4196-9e75-63302311c6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_08079089-3df8-4da9-a73b-04a652b3dd07" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_6d3ac4c0-0005-4196-9e75-63302311c6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlans" xlink:type="simple" xlink:href="syk-20241231.xsd#RetirementPlans"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bad78acf-d979-4cfa-8966-225a0ac94655" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1c591d27-e5b6-4bb3-9a4c-315c36e4523f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bad78acf-d979-4cfa-8966-225a0ac94655" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1c591d27-e5b6-4bb3-9a4c-315c36e4523f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited" xlink:type="simple" xlink:href="syk-20241231.xsd#SummaryofQuarterlyDataUnaudited"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialDataAbstract_3aad044c-c81b-462a-a00b-679717156942" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QuarterlyFinancialDataAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_295d4f82-4f7d-41dd-92aa-77683df19e02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_3aad044c-c81b-462a-a00b-679717156942" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_295d4f82-4f7d-41dd-92aa-77683df19e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicData" xlink:type="simple" xlink:href="syk-20241231.xsd#SegmentandGeographicData"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SegmentandGeographicData" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c4957edf-feac-4955-88e9-82f32418f8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_1026b985-f719-4c16-beb5-bfcfb95d6d42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c4957edf-feac-4955-88e9-82f32418f8a1" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_1026b985-f719-4c16-beb5-bfcfb95d6d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AssetImpairments" xlink:type="simple" xlink:href="syk-20241231.xsd#AssetImpairments"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AssetImpairments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_77a2f36e-eb25-48c0-9441-eee287157c58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentChargesTextBlock_3ac7c4cf-ba08-44a9-ada7-603eaaf9be3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentChargesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_77a2f36e-eb25-48c0-9441-eee287157c58" xlink:to="loc_us-gaap_AssetImpairmentChargesTextBlock_3ac7c4cf-ba08-44a9-ada7-603eaaf9be3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AssetsHeldforSale" xlink:type="simple" xlink:href="syk-20241231.xsd#AssetsHeldforSale"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AssetsHeldforSale" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6efe8935-7925-400a-a11b-9c94a3cd3b85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_7f15a379-d246-478c-9a47-7286c013af92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6efe8935-7925-400a-a11b-9c94a3cd3b85" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_7f15a379-d246-478c-9a47-7286c013af92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SubsequentEvents" xlink:type="simple" xlink:href="syk-20241231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_1d646225-5232-41a3-baab-26df752d9602" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_b110d8c2-b9b7-4208-af59-0687b0db359d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_1d646225-5232-41a3-baab-26df752d9602" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_b110d8c2-b9b7-4208-af59-0687b0db359d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsNotes" xlink:type="simple" xlink:href="syk-20241231.xsd#ScheduleIIValuationandQualifyingAccountsNotes"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_2d90099a-9eeb-4d10-bb55-f5b4b8ce1775" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_67c381fc-75dc-49ef-8821-73d8e26b20f0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_2d90099a-9eeb-4d10-bb55-f5b4b8ce1775" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_67c381fc-75dc-49ef-8821-73d8e26b20f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="syk-20241231.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_30f5411f-898a-4e7a-ab38-92e2b2b92f81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_NatureOfOperations_30f5411f-898a-4e7a-ab38-92e2b2b92f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_b761b2ef-ff21-4dd2-9455-4afbdbebc26a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_b761b2ef-ff21-4dd2-9455-4afbdbebc26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_34e1bbc2-74bf-46fd-8eac-f7a1cd77aa86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_UseOfEstimates_34e1bbc2-74bf-46fd-8eac-f7a1cd77aa86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_b2ff59f9-b528-4690-85b7-2b08ddb2d2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_b2ff59f9-b528-4690-85b7-2b08ddb2d2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_4d746f87-7346-48bc-8436-7195afa2abd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_4d746f87-7346-48bc-8436-7195afa2abd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_22ab783c-f31f-4c4b-a94f-3aa120336e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_22ab783c-f31f-4c4b-a94f-3aa120336e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_6f111c32-63e9-40b4-b4e3-9a5ba1082481" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_6f111c32-63e9-40b4-b4e3-9a5ba1082481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_b6bab3cb-435a-4e1d-8a34-641794b3b8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_b6bab3cb-435a-4e1d-8a34-641794b3b8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_894468ad-b49d-4c70-bdbc-fd7c2e27a6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_894468ad-b49d-4c70-bdbc-fd7c2e27a6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ShortTermInvestmentsPolicyPolicyTextBlock_e009631f-d3b4-4362-bdfc-3f63fbfd423e" xlink:href="syk-20241231.xsd#syk_ShortTermInvestmentsPolicyPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_syk_ShortTermInvestmentsPolicyPolicyTextBlock_e009631f-d3b4-4362-bdfc-3f63fbfd423e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_354d5b62-fe76-45c1-a7ea-92a127044e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_354d5b62-fe76-45c1-a7ea-92a127044e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_5ccf4d3d-9db9-43bc-bfe1-01be518b7b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_5ccf4d3d-9db9-43bc-bfe1-01be518b7b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_dca0a425-4f91-4acb-b589-98cabc8793e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_dca0a425-4f91-4acb-b589-98cabc8793e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionTextBlock_8b5569b7-bc40-4832-8fd1-c994ddf3bcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOptionTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_FairValueOptionTextBlock_8b5569b7-bc40-4832-8fd1-c994ddf3bcb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_813a1930-d965-4069-b424-0b28644316ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_813a1930-d965-4069-b424-0b28644316ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_b38b7cb8-1d14-4d56-bacb-d78d6595aa92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_b38b7cb8-1d14-4d56-bacb-d78d6595aa92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_a951c8ee-51b5-4d86-a6fd-6d245efce66a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_a951c8ee-51b5-4d86-a6fd-6d245efce66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock_25e813f2-3379-4d98-8192-6a334d20eefb" xlink:href="syk-20241231.xsd#syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock_25e813f2-3379-4d98-8192-6a334d20eefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock_c560ca63-0484-4333-a8c6-31caad9ada12" xlink:href="syk-20241231.xsd#syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock_c560ca63-0484-4333-a8c6-31caad9ada12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7ad089bf-bf79-4943-a04c-f50084e38847" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7ad089bf-bf79-4943-a04c-f50084e38847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_d1f66200-8e56-4e82-8606-21b450436394" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_d1f66200-8e56-4e82-8606-21b450436394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_53b36ca7-ec4a-4ceb-b0a4-4272def64dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeac259c-dcf3-49e8-92d9-c53c3742ad7f" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_53b36ca7-ec4a-4ceb-b0a4-4272def64dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="syk-20241231.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_01ea984d-480b-4b58-b85a-3fe09200709f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_bf91e2c0-9a59-4582-adf5-932425fa89cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_01ea984d-480b-4b58-b85a-3fe09200709f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_bf91e2c0-9a59-4582-adf5-932425fa89cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_758b375a-9360-40ab-9e5f-99acc3ca5876" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_01ea984d-480b-4b58-b85a-3fe09200709f" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_758b375a-9360-40ab-9e5f-99acc3ca5876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="syk-20241231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8bd24b92-a183-411c-8697-8b83909a3076" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_ac401b7e-43fd-4bd1-9201-ba71470763e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8bd24b92-a183-411c-8697-8b83909a3076" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_ac401b7e-43fd-4bd1-9201-ba71470763e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_f3f6938f-28cf-4d71-b51e-12de6eb21e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8bd24b92-a183-411c-8697-8b83909a3076" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_f3f6938f-28cf-4d71-b51e-12de6eb21e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsTables" xlink:type="simple" xlink:href="syk-20241231.xsd#DerivativeInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f985b4e6-07ef-4900-b049-ad002df9b55c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_a3d336ea-408b-4dc5-a16d-1804643b500a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f985b4e6-07ef-4900-b049-ad002df9b55c" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_a3d336ea-408b-4dc5-a16d-1804643b500a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_fa6df1f9-87dd-43ec-9f57-029ae56345fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f985b4e6-07ef-4900-b049-ad002df9b55c" xlink:to="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_fa6df1f9-87dd-43ec-9f57-029ae56345fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables" xlink:type="simple" xlink:href="syk-20241231.xsd#AccumulatedOtherComprehensiveLossIncomeAOCITables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_f1928d72-b379-46a0-93a7-a3193d5dd4ce" xlink:href="syk-20241231.xsd#syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_9833578d-b83f-476f-b116-00c09a15b5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_f1928d72-b379-46a0-93a7-a3193d5dd4ce" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_9833578d-b83f-476f-b116-00c09a15b5b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="syk-20241231.xsd#AcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1f67a2e8-d6a8-4807-aef7-2aa5bb81744f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_cf43f1e2-5820-431a-98c0-7e48f28369a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1f67a2e8-d6a8-4807-aef7-2aa5bb81744f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_cf43f1e2-5820-431a-98c0-7e48f28369a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsTables" xlink:type="simple" xlink:href="syk-20241231.xsd#ContingenciesandCommitmentsTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ContingenciesandCommitmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6daefa3f-2d70-40f8-bd76-b0efd7ab11e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_be173126-a112-4b7a-9303-ee81544487dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6daefa3f-2d70-40f8-bd76-b0efd7ab11e0" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_be173126-a112-4b7a-9303-ee81544487dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_f893272a-e3f6-483f-83bc-dd9e518bc531" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6daefa3f-2d70-40f8-bd76-b0efd7ab11e0" xlink:to="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_f893272a-e3f6-483f-83bc-dd9e518bc531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramTableTextBlock_e7d752fe-aa63-4bfa-af2b-8bbe67016030" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6daefa3f-2d70-40f8-bd76-b0efd7ab11e0" xlink:to="loc_us-gaap_SupplierFinanceProgramTableTextBlock_e7d752fe-aa63-4bfa-af2b-8bbe67016030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="syk-20241231.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_36718ab6-f39f-46b5-a61e-67187a7a048b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_f5922dca-e574-46e0-852a-127dce7e04be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_36718ab6-f39f-46b5-a61e-67187a7a048b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_f5922dca-e574-46e0-852a-127dce7e04be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_6a6604cb-c874-41ed-84b2-35ad79df73e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_36718ab6-f39f-46b5-a61e-67187a7a048b" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_6a6604cb-c874-41ed-84b2-35ad79df73e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_8bb98c03-07ba-4663-a0eb-b10408906d48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_36718ab6-f39f-46b5-a61e-67187a7a048b" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_8bb98c03-07ba-4663-a0eb-b10408906d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockTables" xlink:type="simple" xlink:href="syk-20241231.xsd#CapitalStockTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_92722de9-085e-49b4-b4ed-a69be65056d0" xlink:href="syk-20241231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_8119967b-bd3c-48fc-b458-3ca6d03286ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_92722de9-085e-49b4-b4ed-a69be65056d0" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_8119967b-bd3c-48fc-b458-3ca6d03286ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0c09dd64-4416-4b8a-b294-bd950f2f448a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_92722de9-085e-49b4-b4ed-a69be65056d0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0c09dd64-4416-4b8a-b294-bd950f2f448a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_0cea607f-d560-46fe-8d18-8dfb75d1c1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_92722de9-085e-49b4-b4ed-a69be65056d0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_0cea607f-d560-46fe-8d18-8dfb75d1c1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesTables" xlink:type="simple" xlink:href="syk-20241231.xsd#DebtandCreditFacilitiesTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_c4e82157-86d2-478c-af5c-554dcfcf569a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_e0986a10-a89f-41ba-9fa5-92fa54f3f97b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_c4e82157-86d2-478c-af5c-554dcfcf569a" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_e0986a10-a89f-41ba-9fa5-92fa54f3f97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="syk-20241231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_89591222-0708-4f3b-b634-3e37f8a735f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1a16b1a8-3027-43b6-a0cb-8e52175efaae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89591222-0708-4f3b-b634-3e37f8a735f3" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1a16b1a8-3027-43b6-a0cb-8e52175efaae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_5dd7ca87-35d0-4750-ac34-79881dbbd0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89591222-0708-4f3b-b634-3e37f8a735f3" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_5dd7ca87-35d0-4750-ac34-79881dbbd0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_847c99e4-511e-44db-80e4-827212374c08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89591222-0708-4f3b-b634-3e37f8a735f3" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_847c99e4-511e-44db-80e4-827212374c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_177d8357-d199-47ed-ba06-cf998b0b5dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89591222-0708-4f3b-b634-3e37f8a735f3" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_177d8357-d199-47ed-ba06-cf998b0b5dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansTables" xlink:type="simple" xlink:href="syk-20241231.xsd#RetirementPlansTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fd0bb23a-ea6e-4e9f-9a34-b128e4447fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_66521c30-029b-4eac-a849-7537d2897bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fd0bb23a-ea6e-4e9f-9a34-b128e4447fd6" xlink:to="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_66521c30-029b-4eac-a849-7537d2897bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_eb1446df-2696-45ef-8fde-a17082dfaeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fd0bb23a-ea6e-4e9f-9a34-b128e4447fd6" xlink:to="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_eb1446df-2696-45ef-8fde-a17082dfaeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_a8666485-fa0c-4e6d-b2ea-ac917dd855da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fd0bb23a-ea6e-4e9f-9a34-b128e4447fd6" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_a8666485-fa0c-4e6d-b2ea-ac917dd855da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_ae56b375-22a2-45a0-b252-35d326e32093" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fd0bb23a-ea6e-4e9f-9a34-b128e4447fd6" xlink:to="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_ae56b375-22a2-45a0-b252-35d326e32093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_e245883a-f146-44d2-8ef8-5813b1e26612" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fd0bb23a-ea6e-4e9f-9a34-b128e4447fd6" xlink:to="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_e245883a-f146-44d2-8ef8-5813b1e26612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_1289da17-ab64-4605-9d32-6cc61db46145" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fd0bb23a-ea6e-4e9f-9a34-b128e4447fd6" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_1289da17-ab64-4605-9d32-6cc61db46145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_a5ebb03f-fe92-486d-9861-da976c4a1fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fd0bb23a-ea6e-4e9f-9a34-b128e4447fd6" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_a5ebb03f-fe92-486d-9861-da976c4a1fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables" xlink:type="simple" xlink:href="syk-20241231.xsd#SummaryofQuarterlyDataUnauditedTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialDataAbstract_139054ae-6a29-443c-a834-c873548444d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QuarterlyFinancialDataAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_cbcadaa4-1db1-4290-8d07-b57728a7da5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_139054ae-6a29-443c-a834-c873548444d5" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_cbcadaa4-1db1-4290-8d07-b57728a7da5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataTables" xlink:type="simple" xlink:href="syk-20241231.xsd#SegmentandGeographicDataTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f693ce62-6af5-4930-bd0f-715aaac001c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6c506f54-ccf2-49f7-83c9-956756bcb8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f693ce62-6af5-4930-bd0f-715aaac001c3" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6c506f54-ccf2-49f7-83c9-956756bcb8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8b1074a9-7a69-49d7-a549-edc7a89d7835" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f693ce62-6af5-4930-bd0f-715aaac001c3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8b1074a9-7a69-49d7-a549-edc7a89d7835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_03953022-eab1-457a-bf03-82f0b418aa25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f693ce62-6af5-4930-bd0f-715aaac001c3" xlink:to="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_03953022-eab1-457a-bf03-82f0b418aa25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AssetsHeldforSaleTables" xlink:type="simple" xlink:href="syk-20241231.xsd#AssetsHeldforSaleTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AssetsHeldforSaleTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_98cfc734-dbd4-41cd-812e-3bbb3bed3407" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_e7c7e98d-1d39-41af-9400-5b92e3341c33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_98cfc734-dbd4-41cd-812e-3bbb3bed3407" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_e7c7e98d-1d39-41af-9400-5b92e3341c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#SignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5ecbf9c2-89fe-4dbf-8967-5ee2f2173767" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4a8c1842-5a5a-496d-aaec-cf6f0ecf74aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5ecbf9c2-89fe-4dbf-8967-5ee2f2173767" xlink:to="loc_us-gaap_StatementTable_4a8c1842-5a5a-496d-aaec-cf6f0ecf74aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dfe65178-1a99-4f9c-9cad-528b75b0540a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4a8c1842-5a5a-496d-aaec-cf6f0ecf74aa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dfe65178-1a99-4f9c-9cad-528b75b0540a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_863a0bdc-75e7-4e34-b382-555a460b9a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dfe65178-1a99-4f9c-9cad-528b75b0540a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_863a0bdc-75e7-4e34-b382-555a460b9a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_0a7a8182-8847-4e92-b1d2-0c206da89807" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_863a0bdc-75e7-4e34-b382-555a460b9a9d" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_0a7a8182-8847-4e92-b1d2-0c206da89807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_0af6f9ca-7a94-4799-9184-4e7008ee1e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_863a0bdc-75e7-4e34-b382-555a460b9a9d" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_0af6f9ca-7a94-4799-9184-4e7008ee1e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d2c77a04-fd39-45b5-a5ce-88bae5f5ef18" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4a8c1842-5a5a-496d-aaec-cf6f0ecf74aa" xlink:to="loc_srt_RangeAxis_d2c77a04-fd39-45b5-a5ce-88bae5f5ef18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b78e25c3-6110-4f0c-b0e3-5226f541c1e9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d2c77a04-fd39-45b5-a5ce-88bae5f5ef18" xlink:to="loc_srt_RangeMember_b78e25c3-6110-4f0c-b0e3-5226f541c1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0fef606c-35e3-4f03-b494-ebf1f779e65e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b78e25c3-6110-4f0c-b0e3-5226f541c1e9" xlink:to="loc_srt_MinimumMember_0fef606c-35e3-4f03-b494-ebf1f779e65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_adf9f59a-57f2-4218-8d4b-bea90f345040" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b78e25c3-6110-4f0c-b0e3-5226f541c1e9" xlink:to="loc_srt_MaximumMember_adf9f59a-57f2-4218-8d4b-bea90f345040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d82539d7-a499-4801-ae4b-55be1e1b9115" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4a8c1842-5a5a-496d-aaec-cf6f0ecf74aa" xlink:to="loc_us-gaap_AwardTypeAxis_d82539d7-a499-4801-ae4b-55be1e1b9115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03df3f95-ef9d-438c-871a-e0ff0a0be2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d82539d7-a499-4801-ae4b-55be1e1b9115" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03df3f95-ef9d-438c-871a-e0ff0a0be2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0d1fcfe6-e63e-4725-9998-292e49d0b3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03df3f95-ef9d-438c-871a-e0ff0a0be2b4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0d1fcfe6-e63e-4725-9998-292e49d0b3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_bab0658f-265d-44c6-8c1c-b7f97c9763a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03df3f95-ef9d-438c-871a-e0ff0a0be2b4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_bab0658f-265d-44c6-8c1c-b7f97c9763a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_66dbf80a-8d5f-40b4-820e-870a537d53c3" xlink:href="syk-20241231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03df3f95-ef9d-438c-871a-e0ff0a0be2b4" xlink:to="loc_syk_PerformanceStockUnitPsusMember_66dbf80a-8d5f-40b4-820e-870a537d53c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4a8c1842-5a5a-496d-aaec-cf6f0ecf74aa" xlink:to="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_42cb6785-7128-4a56-8557-f3c9f4fe60cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:to="loc_us-gaap_DerivativeTermOfContract_42cb6785-7128-4a56-8557-f3c9f4fe60cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_4e3b7cf1-efc8-41ff-841e-9d905944c0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_4e3b7cf1-efc8-41ff-841e-9d905944c0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d1e3cf29-430e-4dde-a010-97825f7dfc01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d1e3cf29-430e-4dde-a010-97825f7dfc01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_aed48c7d-da76-4c0c-a3f8-aef51e8776e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_aed48c7d-da76-4c0c-a3f8-aef51e8776e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4f942616-e91f-49ee-8609-2762cbc42092" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4f942616-e91f-49ee-8609-2762cbc42092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_f65d3eed-c442-48cf-830f-b500fdd4a084" xlink:href="syk-20241231.xsd#syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:to="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_f65d3eed-c442-48cf-830f-b500fdd4a084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_6cfd8340-77ec-4047-a5a8-13bf66e25403" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8975bc9-7c62-4f86-9975-37fc78b41687" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_6cfd8340-77ec-4047-a5a8-13bf66e25403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognitionNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RevenueRecognitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_7663cd0b-1daf-4655-93f8-852df4174580" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1a49ec32-4c64-4265-93be-7df4b4cbdb49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_7663cd0b-1daf-4655-93f8-852df4174580" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1a49ec32-4c64-4265-93be-7df4b4cbdb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_53d0116c-0b3a-4674-a8fc-866e761c6c27" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1a49ec32-4c64-4265-93be-7df4b4cbdb49" xlink:to="loc_srt_ProductOrServiceAxis_53d0116c-0b3a-4674-a8fc-866e761c6c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d72712dc-6496-4bd2-991c-e6de5d19d0b1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_53d0116c-0b3a-4674-a8fc-866e761c6c27" xlink:to="loc_srt_ProductsAndServicesDomain_d72712dc-6496-4bd2-991c-e6de5d19d0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeuroCranialInterventionalSpineMember_ac3b57ec-c907-46e0-8882-08968f0f6f7f" xlink:href="syk-20241231.xsd#syk_NeuroCranialInterventionalSpineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d72712dc-6496-4bd2-991c-e6de5d19d0b1" xlink:to="loc_syk_NeuroCranialInterventionalSpineMember_ac3b57ec-c907-46e0-8882-08968f0f6f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherOrthopedicsEnablingTechnologiesMember_b52077f7-0965-42c8-b526-a34bbce9c92c" xlink:href="syk-20241231.xsd#syk_OtherOrthopedicsEnablingTechnologiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d72712dc-6496-4bd2-991c-e6de5d19d0b1" xlink:to="loc_syk_OtherOrthopedicsEnablingTechnologiesMember_b52077f7-0965-42c8-b526-a34bbce9c92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_fb81d231-e7fd-4d75-8310-d435eb2062f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1a49ec32-4c64-4265-93be-7df4b4cbdb49" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_fb81d231-e7fd-4d75-8310-d435eb2062f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PercentageofServiceRevenueRecognizeoverTime_fd5bcdd1-ad62-4455-9099-501add2e961b" xlink:href="syk-20241231.xsd#syk_PercentageofServiceRevenueRecognizeoverTime"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_fb81d231-e7fd-4d75-8310-d435eb2062f5" xlink:to="loc_syk_PercentageofServiceRevenueRecognizeoverTime_fd5bcdd1-ad62-4455-9099-501add2e961b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_04a52c96-5114-4ef1-8074-de3a0bc7b018" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_fb81d231-e7fd-4d75-8310-d435eb2062f5" xlink:to="loc_us-gaap_Revenues_04a52c96-5114-4ef1-8074-de3a0bc7b018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_47e4ec9f-6aae-4363-8f7e-cd6d5053afc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_fb81d231-e7fd-4d75-8310-d435eb2062f5" xlink:to="loc_us-gaap_ContractWithCustomerLiability_47e4ec9f-6aae-4363-8f7e-cd6d5053afc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RevenueRecognitionDisaggregatedSalesAnalysisDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_f5c0eda3-61da-4f25-93d5-d05041098316" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a2d30cff-17b0-440d-bf36-b2502ebe3d16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_f5c0eda3-61da-4f25-93d5-d05041098316" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a2d30cff-17b0-440d-bf36-b2502ebe3d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f430ee38-b4b5-42bc-bb6f-987eba6be9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a2d30cff-17b0-440d-bf36-b2502ebe3d16" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f430ee38-b4b5-42bc-bb6f-987eba6be9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9e3f354b-e6d7-42b2-81f2-5c98fdabcf0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f430ee38-b4b5-42bc-bb6f-987eba6be9f1" xlink:to="loc_us-gaap_SegmentDomain_9e3f354b-e6d7-42b2-81f2-5c98fdabcf0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_543d4187-f028-4017-971e-394587fee2dd" xlink:href="syk-20241231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9e3f354b-e6d7-42b2-81f2-5c98fdabcf0f" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_543d4187-f028-4017-971e-394587fee2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_03290f5d-3c59-47fc-af02-378fa9beafff" xlink:href="syk-20241231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9e3f354b-e6d7-42b2-81f2-5c98fdabcf0f" xlink:to="loc_syk_OrthopaedicsAndSpineMember_03290f5d-3c59-47fc-af02-378fa9beafff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2939a106-19a6-44a7-9936-76bb16934ec9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a2d30cff-17b0-440d-bf36-b2502ebe3d16" xlink:to="loc_srt_ProductOrServiceAxis_2939a106-19a6-44a7-9936-76bb16934ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_2939a106-19a6-44a7-9936-76bb16934ec9" xlink:to="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InstrumentsMember_701df64e-8516-453a-b7d4-8185e6c46d35" xlink:href="syk-20241231.xsd#syk_InstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_InstrumentsMember_701df64e-8516-453a-b7d4-8185e6c46d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EndoscopyMember_3adbd311-e8d3-408e-97ad-0c390ded18ab" xlink:href="syk-20241231.xsd#syk_EndoscopyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_EndoscopyMember_3adbd311-e8d3-408e-97ad-0c390ded18ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalMember_8dca1936-631c-4362-968a-b994908a4eb3" xlink:href="syk-20241231.xsd#syk_MedicalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_MedicalMember_8dca1936-631c-4362-968a-b994908a4eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeurovascularMember_bc5e5f0c-e406-4a15-ae21-52bf5c420796" xlink:href="syk-20241231.xsd#syk_NeurovascularMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_NeurovascularMember_bc5e5f0c-e406-4a15-ae21-52bf5c420796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeuroCranialMember_045fc08e-10cd-4d98-8bf2-0ffaae39bb23" xlink:href="syk-20241231.xsd#syk_NeuroCranialMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_NeuroCranialMember_045fc08e-10cd-4d98-8bf2-0ffaae39bb23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherOrthopaedicsMember_66dbdbb0-fd50-4071-a4e7-c253db261ff8" xlink:href="syk-20241231.xsd#syk_OtherOrthopaedicsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_OtherOrthopaedicsMember_66dbdbb0-fd50-4071-a4e7-c253db261ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_KneesMember_aa4edf4f-58d6-4a87-bc24-ec8501e42f3e" xlink:href="syk-20241231.xsd#syk_KneesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_KneesMember_aa4edf4f-58d6-4a87-bc24-ec8501e42f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_HipsMember_e2813fc6-3486-4a21-ae0a-0e148bedf39b" xlink:href="syk-20241231.xsd#syk_HipsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_HipsMember_e2813fc6-3486-4a21-ae0a-0e148bedf39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TraumaandExtremitiesMember_b5b6ae5f-0721-44f4-b1aa-71f414de0c10" xlink:href="syk-20241231.xsd#syk_TraumaandExtremitiesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_TraumaandExtremitiesMember_b5b6ae5f-0721-44f4-b1aa-71f414de0c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpineMember_7b7130d4-6840-4f1d-a294-a76d3fb0e6ee" xlink:href="syk-20241231.xsd#syk_SpineMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_315121ce-00d1-40bc-b7c6-c8739ee5fab2" xlink:to="loc_syk_SpineMember_7b7130d4-6840-4f1d-a294-a76d3fb0e6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_64cc9542-c8c8-4c46-b087-ff699ca40dee" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a2d30cff-17b0-440d-bf36-b2502ebe3d16" xlink:to="loc_srt_StatementGeographicalAxis_64cc9542-c8c8-4c46-b087-ff699ca40dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_52c869ee-a4c2-48f4-936d-001ad7777040" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_64cc9542-c8c8-4c46-b087-ff699ca40dee" xlink:to="loc_srt_SegmentGeographicalDomain_52c869ee-a4c2-48f4-936d-001ad7777040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_21b13814-a033-40c6-82d1-3d750e1c3cf6" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_52c869ee-a4c2-48f4-936d-001ad7777040" xlink:to="loc_country_US_21b13814-a033-40c6-82d1-3d750e1c3cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_692f9982-9224-4e29-9019-b6cf8fb826fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_52c869ee-a4c2-48f4-936d-001ad7777040" xlink:to="loc_us-gaap_NonUsMember_692f9982-9224-4e29-9019-b6cf8fb826fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_218e426a-55e9-4d7a-86f0-4c5d503568e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a2d30cff-17b0-440d-bf36-b2502ebe3d16" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_218e426a-55e9-4d7a-86f0-4c5d503568e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fec97489-5e07-4250-ab3c-94c498b4434c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_218e426a-55e9-4d7a-86f0-4c5d503568e1" xlink:to="loc_us-gaap_Revenues_fec97489-5e07-4250-ab3c-94c498b4434c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RevenueRecognitionChangesinContractLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e8001736-e021-498c-92d7-0f7053b63f39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MovementInContractLiabilitiesRollForward_9fb72fde-6019-4fab-b11a-2c074950ca58" xlink:href="syk-20241231.xsd#syk_MovementInContractLiabilitiesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e8001736-e021-498c-92d7-0f7053b63f39" xlink:to="loc_syk_MovementInContractLiabilitiesRollForward_9fb72fde-6019-4fab-b11a-2c074950ca58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_95cbedf3-94f9-4293-bc76-193d63022ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_MovementInContractLiabilitiesRollForward_9fb72fde-6019-4fab-b11a-2c074950ca58" xlink:to="loc_us-gaap_ContractWithCustomerLiability_95cbedf3-94f9-4293-bc76-193d63022ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_4568e353-0cfb-4336-b95a-efeda2f97d53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_MovementInContractLiabilitiesRollForward_9fb72fde-6019-4fab-b11a-2c074950ca58" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_4568e353-0cfb-4336-b95a-efeda2f97d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod_1767ffdc-dadc-458b-8deb-62145a946236" xlink:href="syk-20241231.xsd#syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_MovementInContractLiabilitiesRollForward_9fb72fde-6019-4fab-b11a-2c074950ca58" xlink:to="loc_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod_1767ffdc-dadc-458b-8deb-62145a946236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_d070e342-3037-4c21-a645-e476d35fabbc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_MovementInContractLiabilitiesRollForward_9fb72fde-6019-4fab-b11a-2c074950ca58" xlink:to="loc_us-gaap_ContractWithCustomerLiability_d070e342-3037-4c21-a645-e476d35fabbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0379c1e7-1f1d-442f-8a98-a3cfdda0592a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b5974d0e-547e-4915-b3f5-567687e160da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0379c1e7-1f1d-442f-8a98-a3cfdda0592a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b5974d0e-547e-4915-b3f5-567687e160da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4c048e61-e62e-4abc-a918-3167bae318ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b5974d0e-547e-4915-b3f5-567687e160da" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4c048e61-e62e-4abc-a918-3167bae318ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_06f93b7e-3ac2-4eb4-9166-4b134e052f72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4c048e61-e62e-4abc-a918-3167bae318ca" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_06f93b7e-3ac2-4eb4-9166-4b134e052f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d7a6d02c-fd86-4b01-bf85-32e0d08ce422" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_06f93b7e-3ac2-4eb4-9166-4b134e052f72" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d7a6d02c-fd86-4b01-bf85-32e0d08ce422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ea733d33-d7c2-444e-93cf-06588b7bfe8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_06f93b7e-3ac2-4eb4-9166-4b134e052f72" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ea733d33-d7c2-444e-93cf-06588b7bfe8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ee2dde33-0e56-4157-aae8-18c357794469" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_06f93b7e-3ac2-4eb4-9166-4b134e052f72" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ee2dde33-0e56-4157-aae8-18c357794469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_76fdcb97-3e6c-4203-9db7-a49873d16c94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b5974d0e-547e-4915-b3f5-567687e160da" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_76fdcb97-3e6c-4203-9db7-a49873d16c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c903efa2-e939-4d65-9fa6-93cae7d2097c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_76fdcb97-3e6c-4203-9db7-a49873d16c94" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c903efa2-e939-4d65-9fa6-93cae7d2097c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_5a765a95-28bb-48c8-acfc-176bed34e431" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c903efa2-e939-4d65-9fa6-93cae7d2097c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_5a765a95-28bb-48c8-acfc-176bed34e431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_73e56938-9300-4d9b-bf88-f106eff87fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b5974d0e-547e-4915-b3f5-567687e160da" xlink:to="loc_us-gaap_FinancialInstrumentAxis_73e56938-9300-4d9b-bf88-f106eff87fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23373417-a5c3-4c77-9abb-37473584b7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_73e56938-9300-4d9b-bf88-f106eff87fe4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23373417-a5c3-4c77-9abb-37473584b7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_912ace3c-2c15-4810-b04b-db8b0dfcb9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23373417-a5c3-4c77-9abb-37473584b7dd" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_912ace3c-2c15-4810-b04b-db8b0dfcb9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_fbf567c0-1e57-4054-9ab9-c3fdb17afd77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23373417-a5c3-4c77-9abb-37473584b7dd" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_fbf567c0-1e57-4054-9ab9-c3fdb17afd77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_517ccf29-a049-4b49-a48d-6e6ddf9603c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23373417-a5c3-4c77-9abb-37473584b7dd" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_517ccf29-a049-4b49-a48d-6e6ddf9603c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_6dcd895d-e75e-45f6-b51f-28eb18efbc52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23373417-a5c3-4c77-9abb-37473584b7dd" xlink:to="loc_us-gaap_CertificatesOfDepositMember_6dcd895d-e75e-45f6-b51f-28eb18efbc52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_340f2564-41a1-4536-81bb-ef72b1d00dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b5974d0e-547e-4915-b3f5-567687e160da" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_340f2564-41a1-4536-81bb-ef72b1d00dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_cc79a5b4-7cc7-4ddf-b2e3-06ec3e67b3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_340f2564-41a1-4536-81bb-ef72b1d00dd6" xlink:to="loc_us-gaap_AssetsAbstract_cc79a5b4-7cc7-4ddf-b2e3-06ec3e67b3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6cabd616-d2c5-43a1-8a76-b496770ce2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cc79a5b4-7cc7-4ddf-b2e3-06ec3e67b3eb" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6cabd616-d2c5-43a1-8a76-b496770ce2c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_4574c22e-5761-40f7-990d-de1e760b7440" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cc79a5b4-7cc7-4ddf-b2e3-06ec3e67b3eb" xlink:to="loc_us-gaap_ShortTermInvestments_4574c22e-5761-40f7-990d-de1e760b7440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebt_8601b5f2-9710-45de-9cd4-adda5b37da27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradingSecuritiesDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cc79a5b4-7cc7-4ddf-b2e3-06ec3e67b3eb" xlink:to="loc_us-gaap_TradingSecuritiesDebt_8601b5f2-9710-45de-9cd4-adda5b37da27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_643a8973-65ec-4acb-bec3-6354ee51968c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cc79a5b4-7cc7-4ddf-b2e3-06ec3e67b3eb" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_643a8973-65ec-4acb-bec3-6354ee51968c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_d5d01bf1-c538-482a-ac30-8490d67a7022" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cc79a5b4-7cc7-4ddf-b2e3-06ec3e67b3eb" xlink:to="loc_us-gaap_DerivativeAssets_d5d01bf1-c538-482a-ac30-8490d67a7022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_b902137c-9633-4283-a974-a576c1f45b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cc79a5b4-7cc7-4ddf-b2e3-06ec3e67b3eb" xlink:to="loc_us-gaap_DerivativeAssets_b902137c-9633-4283-a974-a576c1f45b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_8c1c0b94-482c-461a-a484-59a579164672" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cc79a5b4-7cc7-4ddf-b2e3-06ec3e67b3eb" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_8c1c0b94-482c-461a-a484-59a579164672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_180b0708-05b3-4887-97af-ffa87e1cdee7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_340f2564-41a1-4536-81bb-ef72b1d00dd6" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_180b0708-05b3-4887-97af-ffa87e1cdee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_3a3dab68-d87c-4135-ac5d-886c88a009d3" xlink:href="syk-20241231.xsd#syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_180b0708-05b3-4887-97af-ffa87e1cdee7" xlink:to="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_3a3dab68-d87c-4135-ac5d-886c88a009d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_46414d27-6972-483b-ad06-f31f7db39c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_180b0708-05b3-4887-97af-ffa87e1cdee7" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_46414d27-6972-483b-ad06-f31f7db39c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_5512d22b-7095-49a3-98d2-a1f1febdd7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_180b0708-05b3-4887-97af-ffa87e1cdee7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_5512d22b-7095-49a3-98d2-a1f1febdd7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_20396f2e-109b-42eb-84e1-e812e57c2805" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_5512d22b-7095-49a3-98d2-a1f1febdd7dc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_20396f2e-109b-42eb-84e1-e812e57c2805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_81b2d6e4-7f37-464c-b835-e62486245d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_5512d22b-7095-49a3-98d2-a1f1febdd7dc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_81b2d6e4-7f37-464c-b835-e62486245d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_5d9b4252-275f-440a-90f6-2dc417079a11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_5512d22b-7095-49a3-98d2-a1f1febdd7dc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_5d9b4252-275f-440a-90f6-2dc417079a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_430ce507-4331-4d15-9043-7f400f2e9a10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_5512d22b-7095-49a3-98d2-a1f1febdd7dc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_430ce507-4331-4d15-9043-7f400f2e9a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ae4ed353-0984-4b51-ab97-c8b5ab35e494" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_5512d22b-7095-49a3-98d2-a1f1febdd7dc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ae4ed353-0984-4b51-ab97-c8b5ab35e494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_a5ce70be-3a6e-4d2a-83d3-8e3c7d40b8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_180b0708-05b3-4887-97af-ffa87e1cdee7" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_a5ce70be-3a6e-4d2a-83d3-8e3c7d40b8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#FairValueMeasurementsAvailableForSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4378c3ee-170e-48e9-8bf4-9ff87fb56cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0d82e68b-15a8-4dd2-b45f-478b4b55a719" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4378c3ee-170e-48e9-8bf4-9ff87fb56cf8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0d82e68b-15a8-4dd2-b45f-478b4b55a719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_c5247da3-7705-43a8-9e5d-f0c9f4746af0" xlink:href="syk-20241231.xsd#syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4378c3ee-170e-48e9-8bf4-9ff87fb56cf8" xlink:to="loc_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_c5247da3-7705-43a8-9e5d-f0c9f4746af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b9b43945-60f7-4095-8e6e-c539a4f017f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c6d10db6-b314-4fad-bfb5-8bca4571ab8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b9b43945-60f7-4095-8e6e-c539a4f017f4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c6d10db6-b314-4fad-bfb5-8bca4571ab8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cd6d76f5-82c4-4710-9bd6-92ac9993c230" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c6d10db6-b314-4fad-bfb5-8bca4571ab8e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cd6d76f5-82c4-4710-9bd6-92ac9993c230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_57df5ae7-bfdb-42ca-ae71-df052ccd440b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cd6d76f5-82c4-4710-9bd6-92ac9993c230" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_57df5ae7-bfdb-42ca-ae71-df052ccd440b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CerusMember_22f74b73-bafb-4a60-9f11-60a11774b428" xlink:href="syk-20241231.xsd#syk_CerusMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_57df5ae7-bfdb-42ca-ae71-df052ccd440b" xlink:to="loc_syk_CerusMember_22f74b73-bafb-4a60-9f11-60a11774b428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_733fd1f1-94a8-4ac8-9134-0601d03e9490" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c6d10db6-b314-4fad-bfb5-8bca4571ab8e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_733fd1f1-94a8-4ac8-9134-0601d03e9490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_52dc4bf5-6000-43b8-98f9-744ea52c17fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_733fd1f1-94a8-4ac8-9134-0601d03e9490" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_52dc4bf5-6000-43b8-98f9-744ea52c17fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_09be0f7e-1e86-409a-bdb6-9949bc18d4de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_733fd1f1-94a8-4ac8-9134-0601d03e9490" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_09be0f7e-1e86-409a-bdb6-9949bc18d4de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeInterestEarningAsset_aa28bd07-7f51-445d-8361-8183fd10a0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeInterestEarningAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_733fd1f1-94a8-4ac8-9134-0601d03e9490" xlink:to="loc_us-gaap_InterestIncomeInterestEarningAsset_aa28bd07-7f51-445d-8361-8183fd10a0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_992c6587-e952-4ca1-9552-50ef9acacb38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_b410da04-d1b4-4cc9-bb91-08d216345cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_992c6587-e952-4ca1-9552-50ef9acacb38" xlink:to="loc_us-gaap_DerivativeTable_b410da04-d1b4-4cc9-bb91-08d216345cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3478222f-c007-48ea-9c5e-04dd38140fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b410da04-d1b4-4cc9-bb91-08d216345cbb" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3478222f-c007-48ea-9c5e-04dd38140fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_45641076-0140-4387-8c3d-e397d00f8f38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3478222f-c007-48ea-9c5e-04dd38140fe0" xlink:to="loc_us-gaap_HedgingRelationshipDomain_45641076-0140-4387-8c3d-e397d00f8f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_55d6e4be-39ec-4c1e-9ecc-c1c76dfbd411" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_45641076-0140-4387-8c3d-e397d00f8f38" xlink:to="loc_us-gaap_CashFlowHedgingMember_55d6e4be-39ec-4c1e-9ecc-c1c76dfbd411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_3fb7e9cd-f248-4d5e-ab11-85440d50284f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_45641076-0140-4387-8c3d-e397d00f8f38" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_3fb7e9cd-f248-4d5e-ab11-85440d50284f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c1f8f041-31a0-4b6f-9f41-58569f95ec57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b410da04-d1b4-4cc9-bb91-08d216345cbb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c1f8f041-31a0-4b6f-9f41-58569f95ec57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d2473141-e05b-43d9-a968-f71c39da5dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c1f8f041-31a0-4b6f-9f41-58569f95ec57" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d2473141-e05b-43d9-a968-f71c39da5dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_430d7fc9-f7c3-416e-82b6-25b1063a2114" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d2473141-e05b-43d9-a968-f71c39da5dc5" xlink:to="loc_us-gaap_ForeignExchangeContractMember_430d7fc9-f7c3-416e-82b6-25b1063a2114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_3d06094b-f08d-46c3-a8c6-cca05a819ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b410da04-d1b4-4cc9-bb91-08d216345cbb" xlink:to="loc_us-gaap_HedgingDesignationAxis_3d06094b-f08d-46c3-a8c6-cca05a819ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_86e9ae30-5cc0-4a64-ba51-47e350d82a25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_3d06094b-f08d-46c3-a8c6-cca05a819ffd" xlink:to="loc_us-gaap_HedgingDesignationDomain_86e9ae30-5cc0-4a64-ba51-47e350d82a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e29d179e-490c-4005-8785-34f8c4ae2bec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_86e9ae30-5cc0-4a64-ba51-47e350d82a25" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e29d179e-490c-4005-8785-34f8c4ae2bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_b3ec6855-bb83-4d8a-adb2-6e8ec64e4b95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_86e9ae30-5cc0-4a64-ba51-47e350d82a25" xlink:to="loc_us-gaap_NondesignatedMember_b3ec6855-bb83-4d8a-adb2-6e8ec64e4b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f90d0821-d8a2-41b2-89be-e1dabb9f1e48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b410da04-d1b4-4cc9-bb91-08d216345cbb" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f90d0821-d8a2-41b2-89be-e1dabb9f1e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b8d8b437-71a5-4ded-98bf-4477be876962" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f90d0821-d8a2-41b2-89be-e1dabb9f1e48" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b8d8b437-71a5-4ded-98bf-4477be876962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_641365dc-4174-4ee7-96d0-9cb741ff168b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b8d8b437-71a5-4ded-98bf-4477be876962" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_641365dc-4174-4ee7-96d0-9cb741ff168b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_40ee74c2-04fb-4ce9-b9ba-bea35bc2d062" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b8d8b437-71a5-4ded-98bf-4477be876962" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_40ee74c2-04fb-4ce9-b9ba-bea35bc2d062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b44b4f48-c95a-4b61-b450-a9a7d9cf6b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b8d8b437-71a5-4ded-98bf-4477be876962" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b44b4f48-c95a-4b61-b450-a9a7d9cf6b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_14a50e29-2bce-4743-b622-12e282bc0227" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b8d8b437-71a5-4ded-98bf-4477be876962" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_14a50e29-2bce-4743-b622-12e282bc0227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_343140ee-0a39-40ab-9f32-4e6ab6b93673" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b410da04-d1b4-4cc9-bb91-08d216345cbb" xlink:to="loc_us-gaap_DerivativeLineItems_343140ee-0a39-40ab-9f32-4e6ab6b93673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_5929ce78-a2b1-4348-ad17-cc7c3c77568e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_343140ee-0a39-40ab-9f32-4e6ab6b93673" xlink:to="loc_us-gaap_DerivativeNotionalAmount_5929ce78-a2b1-4348-ad17-cc7c3c77568e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_1d4304aa-12b3-42cb-a250-72ac6fce6e53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_343140ee-0a39-40ab-9f32-4e6ab6b93673" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_1d4304aa-12b3-42cb-a250-72ac6fce6e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_70ccb687-f5c4-4095-afb8-2d0f0be9bcc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_343140ee-0a39-40ab-9f32-4e6ab6b93673" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_70ccb687-f5c4-4095-afb8-2d0f0be9bcc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_afbca11b-f9e0-4444-be12-5e63267fa0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_343140ee-0a39-40ab-9f32-4e6ab6b93673" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_afbca11b-f9e0-4444-be12-5e63267fa0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_77cb1642-1a9d-47ed-b42c-c587c896808a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_343140ee-0a39-40ab-9f32-4e6ab6b93673" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_77cb1642-1a9d-47ed-b42c-c587c896808a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#DerivativeInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_21d81d8e-c26e-4804-af7a-6b0b4db57917" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_431bcaf1-9af6-4668-91c9-1f60550ea766" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_21d81d8e-c26e-4804-af7a-6b0b4db57917" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_431bcaf1-9af6-4668-91c9-1f60550ea766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_8cbb7a30-c916-47ab-ae84-945e857c47ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_431bcaf1-9af6-4668-91c9-1f60550ea766" xlink:to="loc_us-gaap_HedgingDesignationAxis_8cbb7a30-c916-47ab-ae84-945e857c47ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c9eb5d6a-21a6-4a7d-b32e-f8df59c4187a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_8cbb7a30-c916-47ab-ae84-945e857c47ea" xlink:to="loc_us-gaap_HedgingDesignationDomain_c9eb5d6a-21a6-4a7d-b32e-f8df59c4187a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_05a0eb85-a739-469b-9f4f-61e4d2b22bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_c9eb5d6a-21a6-4a7d-b32e-f8df59c4187a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_05a0eb85-a739-469b-9f4f-61e4d2b22bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e1e39c73-c228-4de9-9b97-9af50f8e4070" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_431bcaf1-9af6-4668-91c9-1f60550ea766" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e1e39c73-c228-4de9-9b97-9af50f8e4070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e4d09c9b-884c-4360-bde8-c76486569bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e1e39c73-c228-4de9-9b97-9af50f8e4070" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e4d09c9b-884c-4360-bde8-c76486569bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a59085c8-02c7-4b1c-afaf-43802a02b8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e4d09c9b-884c-4360-bde8-c76486569bcd" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a59085c8-02c7-4b1c-afaf-43802a02b8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_cd6265a4-a334-4f64-80e0-fb92f51b1e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e4d09c9b-884c-4360-bde8-c76486569bcd" xlink:to="loc_us-gaap_InterestRateSwapMember_cd6265a4-a334-4f64-80e0-fb92f51b1e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_f2211354-fdec-4ea4-8d63-3242b757fcb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e4d09c9b-884c-4360-bde8-c76486569bcd" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_f2211354-fdec-4ea4-8d63-3242b757fcb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_756d4ccd-b948-4e20-b5f5-1d14bc1d4aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_431bcaf1-9af6-4668-91c9-1f60550ea766" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_756d4ccd-b948-4e20-b5f5-1d14bc1d4aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_08838301-9e5d-434c-b814-159400cf2705" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_756d4ccd-b948-4e20-b5f5-1d14bc1d4aa5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_08838301-9e5d-434c-b814-159400cf2705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_7d1858ef-5b4e-4054-bd3b-1c2393d5d3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_08838301-9e5d-434c-b814-159400cf2705" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_7d1858ef-5b4e-4054-bd3b-1c2393d5d3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e90b55da-bb33-4a1e-8e37-bcd20badbded" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_431bcaf1-9af6-4668-91c9-1f60550ea766" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e90b55da-bb33-4a1e-8e37-bcd20badbded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e0fd0e20-dfcc-4609-aa6b-6b7ac78f2711" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e90b55da-bb33-4a1e-8e37-bcd20badbded" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e0fd0e20-dfcc-4609-aa6b-6b7ac78f2711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_2b337797-c220-4d99-8f82-db1c7caffbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e90b55da-bb33-4a1e-8e37-bcd20badbded" xlink:to="loc_us-gaap_DerivativeTermOfContract_2b337797-c220-4d99-8f82-db1c7caffbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_27217e60-2fde-4da6-8742-c804b7f87469" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e90b55da-bb33-4a1e-8e37-bcd20badbded" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_27217e60-2fde-4da6-8742-c804b7f87469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_fe77c023-493f-41f4-891f-999486a9de6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e90b55da-bb33-4a1e-8e37-bcd20badbded" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_fe77c023-493f-41f4-891f-999486a9de6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b1193b73-0d75-4f33-960c-a641324843dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e90b55da-bb33-4a1e-8e37-bcd20badbded" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b1193b73-0d75-4f33-960c-a641324843dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_e45afa04-108f-488c-b622-810b77484461" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e90b55da-bb33-4a1e-8e37-bcd20badbded" xlink:to="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_e45afa04-108f-488c-b622-810b77484461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#DerivativeInstrumentsMovementsoutofOCIDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e9b8cf2e-864a-4267-86ea-4a6a5b026d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c178efa7-a23e-4738-b01d-ba20aff0efdc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e9b8cf2e-864a-4267-86ea-4a6a5b026d9f" xlink:to="loc_us-gaap_DerivativeTable_c178efa7-a23e-4738-b01d-ba20aff0efdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_8939722f-a6a4-45bd-9c47-e3e293336687" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c178efa7-a23e-4738-b01d-ba20aff0efdc" xlink:to="loc_us-gaap_HedgingDesignationAxis_8939722f-a6a4-45bd-9c47-e3e293336687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_01413e24-8909-43e1-9245-6697219827ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_8939722f-a6a4-45bd-9c47-e3e293336687" xlink:to="loc_us-gaap_HedgingDesignationDomain_01413e24-8909-43e1-9245-6697219827ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_da7c8f24-0613-4634-9666-5a00c24e37dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_01413e24-8909-43e1-9245-6697219827ee" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_da7c8f24-0613-4634-9666-5a00c24e37dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_550659af-12ba-4f3c-a6e1-c99f091f4ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_01413e24-8909-43e1-9245-6697219827ee" xlink:to="loc_us-gaap_NondesignatedMember_550659af-12ba-4f3c-a6e1-c99f091f4ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_982ab895-0973-4cc9-92e4-5e4f8f155919" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c178efa7-a23e-4738-b01d-ba20aff0efdc" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_982ab895-0973-4cc9-92e4-5e4f8f155919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_efc6fe27-1751-410e-8ede-7d53c7ce4f97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_982ab895-0973-4cc9-92e4-5e4f8f155919" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_efc6fe27-1751-410e-8ede-7d53c7ce4f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e26f6db8-d8f5-4ec8-b9ca-fdd96103ccab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_efc6fe27-1751-410e-8ede-7d53c7ce4f97" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e26f6db8-d8f5-4ec8-b9ca-fdd96103ccab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_176f05e2-1dcd-44c5-b83a-86bad6630482" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c178efa7-a23e-4738-b01d-ba20aff0efdc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_176f05e2-1dcd-44c5-b83a-86bad6630482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9013e47c-c02b-434e-905a-37b96cd03dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_176f05e2-1dcd-44c5-b83a-86bad6630482" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9013e47c-c02b-434e-905a-37b96cd03dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d96bafcd-0cb2-48e5-bc30-582081806fae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9013e47c-c02b-434e-905a-37b96cd03dfe" xlink:to="loc_us-gaap_CostOfSalesMember_d96bafcd-0cb2-48e5-bc30-582081806fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherIncomeexpenseMember_f046b409-4662-42fa-90bb-708b03f29bfb" xlink:href="syk-20241231.xsd#syk_OtherIncomeexpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9013e47c-c02b-434e-905a-37b96cd03dfe" xlink:to="loc_syk_OtherIncomeexpenseMember_f046b409-4662-42fa-90bb-708b03f29bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_1bed0401-c301-493f-a082-5f0a9143fbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c178efa7-a23e-4738-b01d-ba20aff0efdc" xlink:to="loc_us-gaap_DerivativeLineItems_1bed0401-c301-493f-a082-5f0a9143fbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_0287c24f-87c9-42a2-93f0-7085379e9985" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1bed0401-c301-493f-a082-5f0a9143fbdd" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_0287c24f-87c9-42a2-93f0-7085379e9985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_d631ceee-622a-4d70-9a62-fb917416f03c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1bed0401-c301-493f-a082-5f0a9143fbdd" xlink:to="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_d631ceee-622a-4d70-9a62-fb917416f03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_c6f49b37-3423-421b-b50b-09c86e1842d7" xlink:href="syk-20241231.xsd#syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_3bc98e0c-e669-404d-be74-f817a50a7d05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_c6f49b37-3423-421b-b50b-09c86e1842d7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_3bc98e0c-e669-404d-be74-f817a50a7d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1cb1ed3c-f30f-42c5-aaa3-d198bb258063" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_3bc98e0c-e669-404d-be74-f817a50a7d05" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1cb1ed3c-f30f-42c5-aaa3-d198bb258063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e154da4c-0c92-480a-88e8-085b2c5cf097" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1cb1ed3c-f30f-42c5-aaa3-d198bb258063" xlink:to="loc_us-gaap_EquityComponentDomain_e154da4c-0c92-480a-88e8-085b2c5cf097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_08403766-ea40-490b-8c05-9166e35b8f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e154da4c-0c92-480a-88e8-085b2c5cf097" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_08403766-ea40-490b-8c05-9166e35b8f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d5630b4b-036f-463c-8ccf-cc8e1781c79e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e154da4c-0c92-480a-88e8-085b2c5cf097" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d5630b4b-036f-463c-8ccf-cc8e1781c79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_b3e32f4f-917b-4344-9452-4543f541402a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e154da4c-0c92-480a-88e8-085b2c5cf097" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_b3e32f4f-917b-4344-9452-4543f541402a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d169a709-45b2-4be8-acf6-ecefba86b1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e154da4c-0c92-480a-88e8-085b2c5cf097" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d169a709-45b2-4be8-acf6-ecefba86b1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_34bf3749-ad80-4950-9d39-672d1f724b59" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_3bc98e0c-e669-404d-be74-f817a50a7d05" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_34bf3749-ad80-4950-9d39-672d1f724b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_c0dd19b9-b621-4f23-abdb-8706de107b64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_34bf3749-ad80-4950-9d39-672d1f724b59" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_c0dd19b9-b621-4f23-abdb-8706de107b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_5ac16570-2691-4013-b47b-7e5c50ef41f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_c0dd19b9-b621-4f23-abdb-8706de107b64" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_5ac16570-2691-4013-b47b-7e5c50ef41f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7712bb9c-478a-4e12-b170-27979d210803" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_3bc98e0c-e669-404d-be74-f817a50a7d05" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7712bb9c-478a-4e12-b170-27979d210803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7712bb9c-478a-4e12-b170-27979d210803" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1533b411-e2b8-4f72-bdb1-27f239ba09ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1533b411-e2b8-4f72-bdb1-27f239ba09ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_6387048a-960b-4766-be75-2a1d465a1efb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_6387048a-960b-4766-be75-2a1d465a1efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_b562a152-8f01-4b95-b0b4-5bab29835b79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_b562a152-8f01-4b95-b0b4-5bab29835b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_1b81970c-7593-4ea6-9361-031a9f6998e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:to="loc_us-gaap_CostOfRevenue_1b81970c-7593-4ea6-9361-031a9f6998e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f4c84a8a-7da8-4e10-9833-5540513b20f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_f4c84a8a-7da8-4e10-9833-5540513b20f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f6b32df6-d321-4033-b5bc-dd5691abd35c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f6b32df6-d321-4033-b5bc-dd5691abd35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c56116ee-8638-4cce-beb5-4c555250a2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c56116ee-8638-4cce-beb5-4c555250a2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c5bf6438-32ac-4caf-8a82-6503847e843f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_380ade72-9379-4a8d-a334-ee042d21d20f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c5bf6438-32ac-4caf-8a82-6503847e843f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#AcquisitionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b0092c15-4749-4eeb-86f7-6b8d1316d256" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_541c91bd-8ff6-49e6-a1bd-91652271af18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b0092c15-4749-4eeb-86f7-6b8d1316d256" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_541c91bd-8ff6-49e6-a1bd-91652271af18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8bada6c6-d2ba-486f-8a6b-e9e1abfff1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_541c91bd-8ff6-49e6-a1bd-91652271af18" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8bada6c6-d2ba-486f-8a6b-e9e1abfff1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34edde6d-472d-4ae2-b48e-c073e3b9d584" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8bada6c6-d2ba-486f-8a6b-e9e1abfff1c3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34edde6d-472d-4ae2-b48e-c073e3b9d584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_VariousMember_004281ba-9bf9-4768-803f-b84d2ecda601" xlink:href="syk-20241231.xsd#syk_VariousMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34edde6d-472d-4ae2-b48e-c073e3b9d584" xlink:to="loc_syk_VariousMember_004281ba-9bf9-4768-803f-b84d2ecda601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CerusMember_4c03ba41-4f30-4841-b4cd-dee56ebb1284" xlink:href="syk-20241231.xsd#syk_CerusMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34edde6d-472d-4ae2-b48e-c073e3b9d584" xlink:to="loc_syk_CerusMember_4c03ba41-4f30-4841-b4cd-dee56ebb1284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5f620c31-9261-4174-9f1d-69527491e571" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_541c91bd-8ff6-49e6-a1bd-91652271af18" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_5f620c31-9261-4174-9f1d-69527491e571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b03c4f18-5919-4b2c-b244-a5c2daf493df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5f620c31-9261-4174-9f1d-69527491e571" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b03c4f18-5919-4b2c-b244-a5c2daf493df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_8bdc4957-42f7-48f2-bd12-36d27af571e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5f620c31-9261-4174-9f1d-69527491e571" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_8bdc4957-42f7-48f2-bd12-36d27af571e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b92eddfb-6b7b-43b7-ba8f-2cb81d9c7377" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5f620c31-9261-4174-9f1d-69527491e571" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b92eddfb-6b7b-43b7-ba8f-2cb81d9c7377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5be98638-2ffa-4d2b-8ae9-8cb08f98c82d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5f620c31-9261-4174-9f1d-69527491e571" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5be98638-2ffa-4d2b-8ae9-8cb08f98c82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_d763cdcb-791a-47ab-9acd-03d8b14b9e12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5f620c31-9261-4174-9f1d-69527491e571" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_d763cdcb-791a-47ab-9acd-03d8b14b9e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_24e41f54-f344-47d7-9e0f-8a194a16f3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6f323eb-a596-4c50-8279-e362fde7e7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_24e41f54-f344-47d7-9e0f-8a194a16f3d0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6f323eb-a596-4c50-8279-e362fde7e7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c6621a7d-186f-4be8-baa3-0f59be4a8368" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6f323eb-a596-4c50-8279-e362fde7e7e5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c6621a7d-186f-4be8-baa3-0f59be4a8368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4dc776c9-c1bc-48bc-8bbe-bbef5e560be2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c6621a7d-186f-4be8-baa3-0f59be4a8368" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4dc776c9-c1bc-48bc-8bbe-bbef5e560be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_VariousMember_82ea2bba-9e39-49ad-81e1-ffa04ad02265" xlink:href="syk-20241231.xsd#syk_VariousMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4dc776c9-c1bc-48bc-8bbe-bbef5e560be2" xlink:to="loc_syk_VariousMember_82ea2bba-9e39-49ad-81e1-ffa04ad02265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CerusMember_0275306c-d4d6-4b6b-9566-68fa036ef91d" xlink:href="syk-20241231.xsd#syk_CerusMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4dc776c9-c1bc-48bc-8bbe-bbef5e560be2" xlink:to="loc_syk_CerusMember_0275306c-d4d6-4b6b-9566-68fa036ef91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_778f68a1-cbd8-4480-b188-d62c32c28f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6f323eb-a596-4c50-8279-e362fde7e7e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_778f68a1-cbd8-4480-b188-d62c32c28f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_778f68a1-cbd8-4480-b188-d62c32c28f1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CustomerAndDistributorRelationshipsMember_7a8b9211-c427-4eca-9e25-52932a96f8f6" xlink:href="syk-20241231.xsd#syk_CustomerAndDistributorRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:to="loc_syk_CustomerAndDistributorRelationshipsMember_7a8b9211-c427-4eca-9e25-52932a96f8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_a58a4c4c-af72-4631-b009-7d621f4bb1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_a58a4c4c-af72-4631-b009-7d621f4bb1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_9a037099-56cb-449d-a9d0-3cdb3d4f6925" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:to="loc_us-gaap_TradeNamesMember_9a037099-56cb-449d-a9d0-3cdb3d4f6925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_23f34f2d-fc47-4533-ad74-f0fe7c00a952" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:to="loc_us-gaap_CustomerRelationshipsMember_23f34f2d-fc47-4533-ad74-f0fe7c00a952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_2a6a86d9-7cf0-42ab-b755-76a72b12dd51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:to="loc_us-gaap_TrademarksMember_2a6a86d9-7cf0-42ab-b755-76a72b12dd51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_53ac51e2-c482-44c0-8021-f982af820855" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:to="loc_us-gaap_PatentsMember_53ac51e2-c482-44c0-8021-f982af820855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_f45ef898-1099-4820-a730-6ef5d0458a09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_439cfd19-bb66-4e1e-bd11-8560d560d8e2" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_f45ef898-1099-4820-a730-6ef5d0458a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f6f323eb-a596-4c50-8279-e362fde7e7e5" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a5aec1d4-01ef-4cdc-bab8-5e23ac2c2c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a5aec1d4-01ef-4cdc-bab8-5e23ac2c2c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_7a029da2-93d2-4346-8a9e-980ed00b42b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_7a029da2-93d2-4346-8a9e-980ed00b42b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_177e7d8d-b5b5-4644-87d9-d9783463a6da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_177e7d8d-b5b5-4644-87d9-d9783463a6da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_12bb35e5-f89f-499a-9ea6-3bf95d0a7c87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_12bb35e5-f89f-499a-9ea6-3bf95d0a7c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_6191251e-413b-4830-8245-8f4e94608b72" xlink:href="syk-20241231.xsd#syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_6191251e-413b-4830-8245-8f4e94608b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f336e235-57c9-4972-8245-6f4fc28adcde" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f336e235-57c9-4972-8245-6f4fc28adcde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_e4e86d7c-6045-40e1-9c06-21613ba98726" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_e4e86d7c-6045-40e1-9c06-21613ba98726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_8ed368a5-7158-42cb-b5d3-068fb413afdf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_8ed368a5-7158-42cb-b5d3-068fb413afdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0be612d5-e273-4dcb-a1c1-53275a83e4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_Goodwill_0be612d5-e273-4dcb-a1c1-53275a83e4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_21ed114e-ce16-482f-8629-b7652b30cb80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_21ed114e-ce16-482f-8629-b7652b30cb80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_8c1fed0e-0025-4797-a68c-1ebe0d186bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_8c1fed0e-0025-4797-a68c-1ebe0d186bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_f10a0202-b1cf-4ee0-9797-ef175486cdab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d5bc0e3e-71ca-4381-9be3-09c3e5786168" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_f10a0202-b1cf-4ee0-9797-ef175486cdab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#ContingenciesandCommitmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d7429b50-12de-42f2-a941-87a92add027e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_2357e6ab-6839-46a0-9715-ace0622131b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d7429b50-12de-42f2-a941-87a92add027e" xlink:to="loc_us-gaap_LossContingenciesTable_2357e6ab-6839-46a0-9715-ace0622131b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_41938610-ff1a-4f9d-8d65-318dcd311532" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2357e6ab-6839-46a0-9715-ace0622131b2" xlink:to="loc_srt_LitigationCaseAxis_41938610-ff1a-4f9d-8d65-318dcd311532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2f9529bd-4a86-4af3-bcbb-f88c9cbef172" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_41938610-ff1a-4f9d-8d65-318dcd311532" xlink:to="loc_srt_LitigationCaseTypeDomain_2f9529bd-4a86-4af3-bcbb-f88c9cbef172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_RecallMattersMember_15b665ca-55e4-4a67-8443-62cb4adb4ec6" xlink:href="syk-20241231.xsd#syk_RecallMattersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_2f9529bd-4a86-4af3-bcbb-f88c9cbef172" xlink:to="loc_syk_RecallMattersMember_15b665ca-55e4-4a67-8443-62cb4adb4ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_617b2286-b797-4563-93d0-6a8ee9ff93ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2357e6ab-6839-46a0-9715-ace0622131b2" xlink:to="loc_us-gaap_LossContingenciesLineItems_617b2286-b797-4563-93d0-6a8ee9ff93ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_24c1aa55-b7ae-400f-b63b-2afb849fe05d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_617b2286-b797-4563-93d0-6a8ee9ff93ef" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_24c1aa55-b7ae-400f-b63b-2afb849fe05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_c714edc5-bd5b-496b-a643-f0f68ba0c7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_617b2286-b797-4563-93d0-6a8ee9ff93ef" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_c714edc5-bd5b-496b-a643-f0f68ba0c7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_2e60277d-f514-4831-88f0-a485a0401dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_617b2286-b797-4563-93d0-6a8ee9ff93ef" xlink:to="loc_us-gaap_OperatingLeaseExpense_2e60277d-f514-4831-88f0-a485a0401dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationCurrent_524cab76-e38d-40d7-bd2e-45e2b59fc7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_617b2286-b797-4563-93d0-6a8ee9ff93ef" xlink:to="loc_us-gaap_SupplierFinanceProgramObligationCurrent_524cab76-e38d-40d7-bd2e-45e2b59fc7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration_8ba992d8-1f70-485f-aee4-2329e164736c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_617b2286-b797-4563-93d0-6a8ee9ff93ef" xlink:to="loc_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration_8ba992d8-1f70-485f-aee4-2329e164736c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#CommitmentsandContingenciesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a15cc0d4-1010-44f6-8ea1-f071cde38ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9ef938a7-eb15-4908-8192-908eac87eab3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a15cc0d4-1010-44f6-8ea1-f071cde38ec6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9ef938a7-eb15-4908-8192-908eac87eab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_6c36896a-e24d-422f-9084-348881279a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a15cc0d4-1010-44f6-8ea1-f071cde38ec6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_6c36896a-e24d-422f-9084-348881279a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5fa25f20-b67e-42d4-83a2-61f3eb7f38f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a15cc0d4-1010-44f6-8ea1-f071cde38ec6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5fa25f20-b67e-42d4-83a2-61f3eb7f38f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_fe72e1bd-25a6-49f0-9dc9-6b0f1d6a1e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a15cc0d4-1010-44f6-8ea1-f071cde38ec6" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_fe72e1bd-25a6-49f0-9dc9-6b0f1d6a1e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_a731c386-9b30-4a4a-ac82-e2b0a36f03fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a15cc0d4-1010-44f6-8ea1-f071cde38ec6" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_a731c386-9b30-4a4a-ac82-e2b0a36f03fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_ee520f97-b89b-46c4-828a-a96d432b3cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a15cc0d4-1010-44f6-8ea1-f071cde38ec6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_ee520f97-b89b-46c4-828a-a96d432b3cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_3c985782-5ede-4bc8-bc53-cc57712f8476" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a15cc0d4-1010-44f6-8ea1-f071cde38ec6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_3c985782-5ede-4bc8-bc53-cc57712f8476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_1db9a98e-a25d-4cd0-85f0-480a162ee250" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a15cc0d4-1010-44f6-8ea1-f071cde38ec6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_1db9a98e-a25d-4cd0-85f0-480a162ee250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7b8a7a20-1f7c-4b59-bd30-7c682ed143be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_a17a4f72-2e71-406a-b452-fb9020ba695b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7b8a7a20-1f7c-4b59-bd30-7c682ed143be" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_a17a4f72-2e71-406a-b452-fb9020ba695b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_09a0b57a-2c5d-46ee-8c18-cea04ede0874" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7b8a7a20-1f7c-4b59-bd30-7c682ed143be" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_09a0b57a-2c5d-46ee-8c18-cea04ede0874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_85839c59-3255-44c0-85e5-17c2f0de4a73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7b8a7a20-1f7c-4b59-bd30-7c682ed143be" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_85839c59-3255-44c0-85e5-17c2f0de4a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_b88cd7df-adb8-405c-8f31-049de2556870" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7b8a7a20-1f7c-4b59-bd30-7c682ed143be" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_b88cd7df-adb8-405c-8f31-049de2556870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_ee6a711e-e654-4138-9760-565c479008a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7b8a7a20-1f7c-4b59-bd30-7c682ed143be" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_ee6a711e-e654-4138-9760-565c479008a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_8a83c823-2e63-4928-a20a-c8b16fe8e32e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7b8a7a20-1f7c-4b59-bd30-7c682ed143be" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_8a83c823-2e63-4928-a20a-c8b16fe8e32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_e55aeb0f-8f37-4e00-bcbf-8a36cbc768f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PurchaseObligationFiscalYearMaturityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7b8a7a20-1f7c-4b59-bd30-7c682ed143be" xlink:to="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_e55aeb0f-8f37-4e00-bcbf-8a36cbc768f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_7260b623-0e78-4823-b39e-97a33d07b2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_e55aeb0f-8f37-4e00-bcbf-8a36cbc768f6" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_7260b623-0e78-4823-b39e-97a33d07b2ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_1cdc91d4-cea0-4240-9b17-5464fb576d23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_e55aeb0f-8f37-4e00-bcbf-8a36cbc768f6" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_1cdc91d4-cea0-4240-9b17-5464fb576d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_fc9b82bc-f675-462b-accf-67e9ab1c3237" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_e55aeb0f-8f37-4e00-bcbf-8a36cbc768f6" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_fc9b82bc-f675-462b-accf-67e9ab1c3237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_0ddc5f3d-1faf-4243-b34e-191a26a865f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_e55aeb0f-8f37-4e00-bcbf-8a36cbc768f6" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_0ddc5f3d-1faf-4243-b34e-191a26a865f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_ca0d9efb-1c46-400f-bcdc-89c96fd8288c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_e55aeb0f-8f37-4e00-bcbf-8a36cbc768f6" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_ca0d9efb-1c46-400f-bcdc-89c96fd8288c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_66c5399a-de6d-483f-97c6-9ce4717a9b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_e55aeb0f-8f37-4e00-bcbf-8a36cbc768f6" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_66c5399a-de6d-483f-97c6-9ce4717a9b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_836d3556-fd38-45b2-97bb-4acc87e5aeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7b8a7a20-1f7c-4b59-bd30-7c682ed143be" xlink:to="loc_us-gaap_LeasesAbstract_836d3556-fd38-45b2-97bb-4acc87e5aeb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_17529a5e-1d72-4d0b-987e-d5090385c5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_836d3556-fd38-45b2-97bb-4acc87e5aeb2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_17529a5e-1d72-4d0b-987e-d5090385c5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3484ea43-5eae-4277-9b01-e8cf29a5379a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_836d3556-fd38-45b2-97bb-4acc87e5aeb2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3484ea43-5eae-4277-9b01-e8cf29a5379a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9dbccbd5-828e-4c58-9f10-90c79b3326ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_836d3556-fd38-45b2-97bb-4acc87e5aeb2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9dbccbd5-828e-4c58-9f10-90c79b3326ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ef7cf033-6ad0-4b87-ba2d-95b360eb8cac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_836d3556-fd38-45b2-97bb-4acc87e5aeb2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ef7cf033-6ad0-4b87-ba2d-95b360eb8cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_da0ea7a7-4fda-40d8-bc4f-f95d03c96498" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_836d3556-fd38-45b2-97bb-4acc87e5aeb2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_da0ea7a7-4fda-40d8-bc4f-f95d03c96498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_df47ff8b-229b-40ad-bfa0-025b3a09d8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_836d3556-fd38-45b2-97bb-4acc87e5aeb2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_df47ff8b-229b-40ad-bfa0-025b3a09d8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsSupplierFinanceProgramDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#ContingenciesandCommitmentsSupplierFinanceProgramDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ContingenciesandCommitmentsSupplierFinanceProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f55b4848-bc0b-4127-b812-1dbeed6e17db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationRollForward_31a72c9e-2a6b-4e25-bf51-75a5cf3d4841" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f55b4848-bc0b-4127-b812-1dbeed6e17db" xlink:to="loc_us-gaap_SupplierFinanceProgramObligationRollForward_31a72c9e-2a6b-4e25-bf51-75a5cf3d4841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligation_212684aa-78db-482b-b526-512d3221b8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplierFinanceProgramObligationRollForward_31a72c9e-2a6b-4e25-bf51-75a5cf3d4841" xlink:to="loc_us-gaap_SupplierFinanceProgramObligation_212684aa-78db-482b-b526-512d3221b8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationIncrease_2ec66777-4973-4b68-88c7-d42b4b4c9077" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplierFinanceProgramObligationRollForward_31a72c9e-2a6b-4e25-bf51-75a5cf3d4841" xlink:to="loc_us-gaap_SupplierFinanceProgramObligationIncrease_2ec66777-4973-4b68-88c7-d42b4b4c9077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationDecreaseSettlement_d95a58ae-92a2-415c-9b0a-8a7dadb15098" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationDecreaseSettlement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplierFinanceProgramObligationRollForward_31a72c9e-2a6b-4e25-bf51-75a5cf3d4841" xlink:to="loc_us-gaap_SupplierFinanceProgramObligationDecreaseSettlement_d95a58ae-92a2-415c-9b0a-8a7dadb15098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligation_254cf614-e1d0-4cc4-a3f7-086a5e253600" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplierFinanceProgramObligationRollForward_31a72c9e-2a6b-4e25-bf51-75a5cf3d4841" xlink:to="loc_us-gaap_SupplierFinanceProgramObligation_254cf614-e1d0-4cc4-a3f7-086a5e253600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration_0f61d856-89d5-439f-bbaa-fe987cd9543b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f55b4848-bc0b-4127-b812-1dbeed6e17db" xlink:to="loc_us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration_0f61d856-89d5-439f-bbaa-fe987cd9543b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#GoodwillandOtherIntangibleAssetsGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_09ecc8e5-9063-4966-94d7-824e4d6e5055" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_33b40116-46b0-4635-9441-8b4f7bff585d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_09ecc8e5-9063-4966-94d7-824e4d6e5055" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_33b40116-46b0-4635-9441-8b4f7bff585d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_57219b17-53c8-4e55-857f-6738d147b5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_33b40116-46b0-4635-9441-8b4f7bff585d" xlink:to="loc_us-gaap_ReportingUnitAxis_57219b17-53c8-4e55-857f-6738d147b5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_6f1ff2cf-5726-4c30-9145-6581478ccdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_57219b17-53c8-4e55-857f-6738d147b5bd" xlink:to="loc_us-gaap_ReportingUnitDomain_6f1ff2cf-5726-4c30-9145-6581478ccdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpineReportingUnitMember_e8b7b880-55d7-4506-aec5-2cbeb7d8f862" xlink:href="syk-20241231.xsd#syk_SpineReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_6f1ff2cf-5726-4c30-9145-6581478ccdf0" xlink:to="loc_syk_SpineReportingUnitMember_e8b7b880-55d7-4506-aec5-2cbeb7d8f862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_1d306e1f-ded3-4f3b-8f73-58e244c2a17e" xlink:href="syk-20241231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_6f1ff2cf-5726-4c30-9145-6581478ccdf0" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_1d306e1f-ded3-4f3b-8f73-58e244c2a17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsMember_eeb0b493-38cd-45be-ab74-0f673ffb3fdb" xlink:href="syk-20241231.xsd#syk_OrthopaedicsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_6f1ff2cf-5726-4c30-9145-6581478ccdf0" xlink:to="loc_syk_OrthopaedicsMember_eeb0b493-38cd-45be-ab74-0f673ffb3fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1d52c770-7f3f-44ee-bb37-cf9bbf09c380" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_33b40116-46b0-4635-9441-8b4f7bff585d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1d52c770-7f3f-44ee-bb37-cf9bbf09c380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_692475a5-c3b0-43af-bf35-24d4a6de1b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1d52c770-7f3f-44ee-bb37-cf9bbf09c380" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_692475a5-c3b0-43af-bf35-24d4a6de1b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpinalImplantsMember_d387c26c-4ec8-489b-88aa-921f53ae25bb" xlink:href="syk-20241231.xsd#syk_SpinalImplantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_692475a5-c3b0-43af-bf35-24d4a6de1b3c" xlink:to="loc_syk_SpinalImplantsMember_d387c26c-4ec8-489b-88aa-921f53ae25bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4d613e06-b423-4174-945d-3887cf5b4213" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_33b40116-46b0-4635-9441-8b4f7bff585d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4d613e06-b423-4174-945d-3887cf5b4213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e541b5d9-f94b-4e27-9be6-1c8159696e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4d613e06-b423-4174-945d-3887cf5b4213" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e541b5d9-f94b-4e27-9be6-1c8159696e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2d0bf4f7-f567-46aa-89f7-3c4de33b0c39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e541b5d9-f94b-4e27-9be6-1c8159696e2b" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2d0bf4f7-f567-46aa-89f7-3c4de33b0c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_56006251-36e1-4a99-b3e1-3ac09879b919" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_33b40116-46b0-4635-9441-8b4f7bff585d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_56006251-36e1-4a99-b3e1-3ac09879b919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_99166100-30ee-4605-ad67-620450475501" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_56006251-36e1-4a99-b3e1-3ac09879b919" xlink:to="loc_us-gaap_SegmentDomain_99166100-30ee-4605-ad67-620450475501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_9afacfeb-5ee4-4e20-9e82-be77dc5490ef" xlink:href="syk-20241231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_99166100-30ee-4605-ad67-620450475501" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_9afacfeb-5ee4-4e20-9e82-be77dc5490ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_1754fe02-b201-47fd-9693-7f3e2f4c29aa" xlink:href="syk-20241231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_99166100-30ee-4605-ad67-620450475501" xlink:to="loc_syk_OrthopaedicsAndSpineMember_1754fe02-b201-47fd-9693-7f3e2f4c29aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_1d8a5e47-d1ed-4097-bcec-6c4d384e8ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_33b40116-46b0-4635-9441-8b4f7bff585d" xlink:to="loc_us-gaap_GoodwillLineItems_1d8a5e47-d1ed-4097-bcec-6c4d384e8ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2cbf4af9-6ffd-4dea-a33c-c461ef7a02ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1d8a5e47-d1ed-4097-bcec-6c4d384e8ab8" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2cbf4af9-6ffd-4dea-a33c-c461ef7a02ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_42c927ad-0183-4f02-a793-5c37a231e9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillTransfers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1d8a5e47-d1ed-4097-bcec-6c4d384e8ab8" xlink:to="loc_us-gaap_GoodwillTransfers_42c927ad-0183-4f02-a793-5c37a231e9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_8be7aa99-0715-4fe0-bcbd-db3c631f52f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1d8a5e47-d1ed-4097-bcec-6c4d384e8ab8" xlink:to="loc_us-gaap_GoodwillRollForward_8be7aa99-0715-4fe0-bcbd-db3c631f52f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c08dc27b-2c50-4e76-ad4b-86d0e2e4d3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_8be7aa99-0715-4fe0-bcbd-db3c631f52f7" xlink:to="loc_us-gaap_Goodwill_c08dc27b-2c50-4e76-ad4b-86d0e2e4d3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_9db06b6c-6c2a-45a0-a0f7-9f8850826a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_8be7aa99-0715-4fe0-bcbd-db3c631f52f7" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_9db06b6c-6c2a-45a0-a0f7-9f8850826a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_f86b5c79-e698-4037-9914-7cd77a96c68d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_8be7aa99-0715-4fe0-bcbd-db3c631f52f7" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_f86b5c79-e698-4037-9914-7cd77a96c68d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_0583d4c5-aa5f-4b06-8b88-3a253c7c7d90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_8be7aa99-0715-4fe0-bcbd-db3c631f52f7" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_0583d4c5-aa5f-4b06-8b88-3a253c7c7d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_40b57520-c89c-4201-a468-bef2db4f0a99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_8be7aa99-0715-4fe0-bcbd-db3c631f52f7" xlink:to="loc_us-gaap_Goodwill_40b57520-c89c-4201-a468-bef2db4f0a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb844776-64ea-48b8-a4f0-f8f9128a8519" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_92a420b9-cb66-41a1-ae44-d45dacd4f79f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb844776-64ea-48b8-a4f0-f8f9128a8519" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_92a420b9-cb66-41a1-ae44-d45dacd4f79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7ca911df-e8d0-44d0-854a-83df556b619f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_92a420b9-cb66-41a1-ae44-d45dacd4f79f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7ca911df-e8d0-44d0-854a-83df556b619f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4047882b-6a9a-4326-b3be-4bb75fcdbf25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7ca911df-e8d0-44d0-854a-83df556b619f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4047882b-6a9a-4326-b3be-4bb75fcdbf25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_746254ee-619a-400e-adab-cd864776be4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4047882b-6a9a-4326-b3be-4bb75fcdbf25" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_746254ee-619a-400e-adab-cd864776be4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_bd9d2a55-5e42-4f4c-bd0f-11bb4087e128" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4047882b-6a9a-4326-b3be-4bb75fcdbf25" xlink:to="loc_us-gaap_CustomerRelationshipsMember_bd9d2a55-5e42-4f4c-bd0f-11bb4087e128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_f6ebdaa3-56b5-4c04-bb53-feb317a30d58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4047882b-6a9a-4326-b3be-4bb75fcdbf25" xlink:to="loc_us-gaap_PatentsMember_f6ebdaa3-56b5-4c04-bb53-feb317a30d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_7b5d9755-cc92-4fe2-8c98-dcb2704d8365" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4047882b-6a9a-4326-b3be-4bb75fcdbf25" xlink:to="loc_us-gaap_TrademarksMember_7b5d9755-cc92-4fe2-8c98-dcb2704d8365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_c069221f-555b-4323-9567-934249f188bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4047882b-6a9a-4326-b3be-4bb75fcdbf25" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_c069221f-555b-4323-9567-934249f188bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_b94c5e77-a776-49b8-a825-bd41743a291e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4047882b-6a9a-4326-b3be-4bb75fcdbf25" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_b94c5e77-a776-49b8-a825-bd41743a291e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fe03aefb-058a-41c5-b55e-2e41b16d8c34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_92a420b9-cb66-41a1-ae44-d45dacd4f79f" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fe03aefb-058a-41c5-b55e-2e41b16d8c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3d77323e-5a4f-47da-9f50-22cf4c280dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fe03aefb-058a-41c5-b55e-2e41b16d8c34" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3d77323e-5a4f-47da-9f50-22cf4c280dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ea26e071-0ce6-491a-b144-ab225affe529" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fe03aefb-058a-41c5-b55e-2e41b16d8c34" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ea26e071-0ce6-491a-b144-ab225affe529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c2b67de9-e91d-4efe-a2d4-8be3541c2e04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_fe03aefb-058a-41c5-b55e-2e41b16d8c34" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c2b67de9-e91d-4efe-a2d4-8be3541c2e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_21e86b60-ad53-420f-9c84-01fce9c49663" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_e23045be-36b7-4fae-88e8-da3e9ebbdf58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_21e86b60-ad53-420f-9c84-01fce9c49663" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_e23045be-36b7-4fae-88e8-da3e9ebbdf58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_156bd7ee-ffb9-4e9e-af98-7aabc5cff7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_21e86b60-ad53-420f-9c84-01fce9c49663" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_156bd7ee-ffb9-4e9e-af98-7aabc5cff7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a8226212-d8b8-49ac-bda5-ee4eeecc050f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_21e86b60-ad53-420f-9c84-01fce9c49663" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a8226212-d8b8-49ac-bda5-ee4eeecc050f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e3e81836-46e0-430a-bec1-7e634b86ebc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_21e86b60-ad53-420f-9c84-01fce9c49663" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e3e81836-46e0-430a-bec1-7e634b86ebc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d7056c57-1e8a-464f-a428-0899c9faa2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_21e86b60-ad53-420f-9c84-01fce9c49663" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d7056c57-1e8a-464f-a428-0899c9faa2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#CapitalStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_5d5a0d32-8d65-4907-861c-8af017569792" xlink:href="syk-20241231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_34e51eed-b865-44e6-84b0-9d42b5ec6e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_5d5a0d32-8d65-4907-861c-8af017569792" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_34e51eed-b865-44e6-84b0-9d42b5ec6e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d6bbce6a-981b-4cca-ab59-c89246805d97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_34e51eed-b865-44e6-84b0-9d42b5ec6e9a" xlink:to="loc_us-gaap_AwardTypeAxis_d6bbce6a-981b-4cca-ab59-c89246805d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8065569-d571-44e3-92b8-bf215e6559c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d6bbce6a-981b-4cca-ab59-c89246805d97" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8065569-d571-44e3-92b8-bf215e6559c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2677a993-c81b-4145-b9ab-3043c17a0c77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8065569-d571-44e3-92b8-bf215e6559c8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2677a993-c81b-4145-b9ab-3043c17a0c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_ab347379-a878-4e70-855a-c838a4eb3346" xlink:href="syk-20241231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8065569-d571-44e3-92b8-bf215e6559c8" xlink:to="loc_syk_PerformanceStockUnitPsusMember_ab347379-a878-4e70-855a-c838a4eb3346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_3e1d2ae4-94a8-4825-bdd4-f15ae696e45a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8065569-d571-44e3-92b8-bf215e6559c8" xlink:to="loc_us-gaap_EmployeeStockMember_3e1d2ae4-94a8-4825-bdd4-f15ae696e45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_34e51eed-b865-44e6-84b0-9d42b5ec6e9a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CommonAndPreferredStockSharesAuthorized_a6be202d-eaf0-4024-8f11-25ba64190c41" xlink:href="syk-20241231.xsd#syk_CommonAndPreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_syk_CommonAndPreferredStockSharesAuthorized_a6be202d-eaf0-4024-8f11-25ba64190c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_64c74ee7-1f22-48ec-bf21-f8d66def70b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_64c74ee7-1f22-48ec-bf21-f8d66def70b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9c949877-f8e9-40b2-9631-667c198b00d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9c949877-f8e9-40b2-9631-667c198b00d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_19b22191-04a0-42cb-a345-619e4b77004c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_19b22191-04a0-42cb-a345-619e4b77004c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8d1dfa3d-d6e0-46cb-9269-5716e404ad37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8d1dfa3d-d6e0-46cb-9269-5716e404ad37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_ee3ff28e-7bb0-4b34-bac0-2e0142e2dac7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_ee3ff28e-7bb0-4b34-bac0-2e0142e2dac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_4cc4cc9c-245b-44a0-9573-891e648e7a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_4cc4cc9c-245b-44a0-9573-891e648e7a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_abc9e33e-1962-4e75-bc93-25f4b978efc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_abc9e33e-1962-4e75-bc93-25f4b978efc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0a3dc5da-d08c-4fe5-a8fc-cbbb410ffc70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0a3dc5da-d08c-4fe5-a8fc-cbbb410ffc70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_f8529ed6-9025-426e-8a12-2410ca08970a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_f8529ed6-9025-426e-8a12-2410ca08970a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_25450403-05a9-49c6-97a7-93c4ab829f86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_25450403-05a9-49c6-97a7-93c4ab829f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_40ce7b5f-9759-4dd6-8939-a350b9d7810f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_40ce7b5f-9759-4dd6-8939-a350b9d7810f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f6f4285e-cd9c-42ab-9d6f-102b1e68c310" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f6f4285e-cd9c-42ab-9d6f-102b1e68c310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_404c87b5-fc53-4f14-8392-4a4e6cc51de0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_404c87b5-fc53-4f14-8392-4a4e6cc51de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_5f829154-4caa-476e-8af6-2f313c18bb3e" xlink:href="syk-20241231.xsd#syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_5f829154-4caa-476e-8af6-2f313c18bb3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_0811a6aa-cf4f-499b-bf42-db4626ff83dd" xlink:href="syk-20241231.xsd#syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_0811a6aa-cf4f-499b-bf42-db4626ff83dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1ab9397d-302f-4b33-a764-af79f4e1eed6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b62cc8f-ff84-4dbb-9b5b-c2e6b12e75eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1ab9397d-302f-4b33-a764-af79f4e1eed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#CapitalStockOptionGrantAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_d33f721b-64bd-40ee-8d56-852dfe180796" xlink:href="syk-20241231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_20f83dac-1830-4f28-8666-3edbc34e4155" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_d33f721b-64bd-40ee-8d56-852dfe180796" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_20f83dac-1830-4f28-8666-3edbc34e4155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_03f7815f-2e70-4e04-8215-9c18a34c56a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_d33f721b-64bd-40ee-8d56-852dfe180796" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_03f7815f-2e70-4e04-8215-9c18a34c56a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_145719e5-2cda-411d-913e-6006b10f4bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_d33f721b-64bd-40ee-8d56-852dfe180796" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_145719e5-2cda-411d-913e-6006b10f4bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0c8992ab-a354-4729-88a7-70e429d13a29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_d33f721b-64bd-40ee-8d56-852dfe180796" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0c8992ab-a354-4729-88a7-70e429d13a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b2ee22b7-cafc-467e-8598-6be852db01ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_d33f721b-64bd-40ee-8d56-852dfe180796" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b2ee22b7-cafc-467e-8598-6be852db01ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#CapitalStockSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_129d00fc-4afd-48ca-b981-21ec88686716" xlink:href="syk-20241231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_77779abd-53da-431a-81c8-3ceca36e6f04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_129d00fc-4afd-48ca-b981-21ec88686716" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_77779abd-53da-431a-81c8-3ceca36e6f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b2b06e85-9aa2-4e14-a943-a1a4358ef66b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_77779abd-53da-431a-81c8-3ceca36e6f04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b2b06e85-9aa2-4e14-a943-a1a4358ef66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_897d76af-af4b-4511-a412-46d2778784d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_77779abd-53da-431a-81c8-3ceca36e6f04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_897d76af-af4b-4511-a412-46d2778784d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d446e078-0822-47c5-a33f-eca01f810193" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_77779abd-53da-431a-81c8-3ceca36e6f04" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d446e078-0822-47c5-a33f-eca01f810193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_99c3458c-0027-4fe5-b4ea-c15471f784bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_77779abd-53da-431a-81c8-3ceca36e6f04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_99c3458c-0027-4fe5-b4ea-c15471f784bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_eb807600-3f54-44be-bc0f-be9ae23e8d72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_77779abd-53da-431a-81c8-3ceca36e6f04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_eb807600-3f54-44be-bc0f-be9ae23e8d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_513497ac-46ca-4748-9de6-e19b9df8ce2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_129d00fc-4afd-48ca-b981-21ec88686716" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_513497ac-46ca-4748-9de6-e19b9df8ce2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_cf22eaa8-fccb-4b14-879a-6251505cbd9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_129d00fc-4afd-48ca-b981-21ec88686716" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_cf22eaa8-fccb-4b14-879a-6251505cbd9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cf48825b-c8dc-44d6-b034-29fa0561e843" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_129d00fc-4afd-48ca-b981-21ec88686716" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cf48825b-c8dc-44d6-b034-29fa0561e843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b18be430-cc6b-4ab8-a0b8-ceec5d612c70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cf48825b-c8dc-44d6-b034-29fa0561e843" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b18be430-cc6b-4ab8-a0b8-ceec5d612c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7dae80e3-4af8-4ae8-bc9c-d7e506e10718" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cf48825b-c8dc-44d6-b034-29fa0561e843" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7dae80e3-4af8-4ae8-bc9c-d7e506e10718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_e1238287-f0a1-4669-96d0-63cb967e15cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cf48825b-c8dc-44d6-b034-29fa0561e843" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_e1238287-f0a1-4669-96d0-63cb967e15cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_208d7dee-4161-47cf-b8b1-68be98bc2105" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cf48825b-c8dc-44d6-b034-29fa0561e843" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_208d7dee-4161-47cf-b8b1-68be98bc2105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12724013-02b5-4c40-b8a8-7bce8d92bbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cf48825b-c8dc-44d6-b034-29fa0561e843" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12724013-02b5-4c40-b8a8-7bce8d92bbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5c0a0f11-2f7d-4f10-850f-6d1d75afcd2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_129d00fc-4afd-48ca-b981-21ec88686716" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5c0a0f11-2f7d-4f10-850f-6d1d75afcd2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c9eeb392-afe4-431c-873c-9a6bc3969db2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_129d00fc-4afd-48ca-b981-21ec88686716" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c9eeb392-afe4-431c-873c-9a6bc3969db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_0c1c0097-1243-49d2-b675-444a7b9a2d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_129d00fc-4afd-48ca-b981-21ec88686716" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_0c1c0097-1243-49d2-b675-444a7b9a2d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_57d1c276-cbf5-4e04-a303-f1ab9a501a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_0c1c0097-1243-49d2-b675-444a7b9a2d3f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_57d1c276-cbf5-4e04-a303-f1ab9a501a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_6e039407-637a-4b9b-9d9a-508864c65d56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_0c1c0097-1243-49d2-b675-444a7b9a2d3f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_6e039407-637a-4b9b-9d9a-508864c65d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_db125cf3-75c5-453b-a9f1-7d7e0ad46094" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_0c1c0097-1243-49d2-b675-444a7b9a2d3f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_db125cf3-75c5-453b-a9f1-7d7e0ad46094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_52727075-6d92-4edb-8efc-e166cf84a20f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_0c1c0097-1243-49d2-b675-444a7b9a2d3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_52727075-6d92-4edb-8efc-e166cf84a20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_11781a6c-2f13-4960-b2db-118945985006" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_0c1c0097-1243-49d2-b675-444a7b9a2d3f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_11781a6c-2f13-4960-b2db-118945985006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_ae37ac8f-c1c2-4c05-bf00-2cab44bfe35d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_0c1c0097-1243-49d2-b675-444a7b9a2d3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_ae37ac8f-c1c2-4c05-bf00-2cab44bfe35d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#CapitalStockSummaryofRSUandPSUActivityDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_5c562056-1cf0-4d59-abbf-fe2bbf744067" xlink:href="syk-20241231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_a8fd5c21-989b-4ac2-a256-e3fa0f1d5c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_5c562056-1cf0-4d59-abbf-fe2bbf744067" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_a8fd5c21-989b-4ac2-a256-e3fa0f1d5c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_67b5bc21-2658-4855-acdd-2223ce52dc12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a8fd5c21-989b-4ac2-a256-e3fa0f1d5c2d" xlink:to="loc_us-gaap_AwardTypeAxis_67b5bc21-2658-4855-acdd-2223ce52dc12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_97fffc06-ed71-408b-9a65-a7dbb1057fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_67b5bc21-2658-4855-acdd-2223ce52dc12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_97fffc06-ed71-408b-9a65-a7dbb1057fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e4bd45e5-3f85-4f30-a73b-d7304118a336" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_97fffc06-ed71-408b-9a65-a7dbb1057fbb" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e4bd45e5-3f85-4f30-a73b-d7304118a336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_a59e0926-4885-43c4-97ba-b9f66ab9cb70" xlink:href="syk-20241231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_97fffc06-ed71-408b-9a65-a7dbb1057fbb" xlink:to="loc_syk_PerformanceStockUnitPsusMember_a59e0926-4885-43c4-97ba-b9f66ab9cb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_afc42930-055b-413b-a6e3-e531e2c26ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a8fd5c21-989b-4ac2-a256-e3fa0f1d5c2d" xlink:to="loc_us-gaap_ClassOfStockLineItems_afc42930-055b-413b-a6e3-e531e2c26ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51c9cfd-708f-42b3-abcc-25c8ee784a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_afc42930-055b-413b-a6e3-e531e2c26ad8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51c9cfd-708f-42b3-abcc-25c8ee784a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_42cdeac1-91c0-4080-b1b1-95ccf83b178c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51c9cfd-708f-42b3-abcc-25c8ee784a6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_42cdeac1-91c0-4080-b1b1-95ccf83b178c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1155ac2f-2596-4a3c-93aa-0b55f11a37a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51c9cfd-708f-42b3-abcc-25c8ee784a6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1155ac2f-2596-4a3c-93aa-0b55f11a37a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ffd67d0d-8e21-4843-8542-6039496c6526" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51c9cfd-708f-42b3-abcc-25c8ee784a6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ffd67d0d-8e21-4843-8542-6039496c6526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b8cba498-b4b0-4da0-b37b-36e6ff38ff07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51c9cfd-708f-42b3-abcc-25c8ee784a6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b8cba498-b4b0-4da0-b37b-36e6ff38ff07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_165df5ad-d83a-4418-ab3e-13d47818083c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51c9cfd-708f-42b3-abcc-25c8ee784a6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_165df5ad-d83a-4418-ab3e-13d47818083c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12f9acbf-6805-485b-aa5c-eaaa140e2391" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_afc42930-055b-413b-a6e3-e531e2c26ad8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12f9acbf-6805-485b-aa5c-eaaa140e2391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_fc56468c-323b-4541-9044-5b2998508152" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12f9acbf-6805-485b-aa5c-eaaa140e2391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_fc56468c-323b-4541-9044-5b2998508152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b2b5f638-85e4-4c19-96c3-1bdb5bf3064f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12f9acbf-6805-485b-aa5c-eaaa140e2391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b2b5f638-85e4-4c19-96c3-1bdb5bf3064f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1d7dc7e4-9030-42bb-bdb1-9904e7b7a339" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12f9acbf-6805-485b-aa5c-eaaa140e2391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1d7dc7e4-9030-42bb-bdb1-9904e7b7a339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5cc261eb-224f-4fb0-9a02-d75d72fa9026" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12f9acbf-6805-485b-aa5c-eaaa140e2391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5cc261eb-224f-4fb0-9a02-d75d72fa9026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0286404f-c6db-460a-8b91-907eec146697" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12f9acbf-6805-485b-aa5c-eaaa140e2391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0286404f-c6db-460a-8b91-907eec146697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#DebtandCreditFacilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_d1755332-580e-45df-9f5b-7b707f74564e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_7acd197e-c4c6-4961-861a-a82bbee58af2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_d1755332-580e-45df-9f5b-7b707f74564e" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_7acd197e-c4c6-4961-861a-a82bbee58af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_a2103eb3-c818-473d-8e43-779ccfe46272" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7acd197e-c4c6-4961-861a-a82bbee58af2" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_a2103eb3-c818-473d-8e43-779ccfe46272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_268c6e4b-0f41-45fc-b727-c6568b748deb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_a2103eb3-c818-473d-8e43-779ccfe46272" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_268c6e4b-0f41-45fc-b727-c6568b748deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_8de45ba3-0bbc-4856-a536-6483c595fc65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_268c6e4b-0f41-45fc-b727-c6568b748deb" xlink:to="loc_us-gaap_CommercialPaperMember_8de45ba3-0bbc-4856-a536-6483c595fc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1c2c6de8-dc56-400e-990d-6f340ffeafc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7acd197e-c4c6-4961-861a-a82bbee58af2" xlink:to="loc_us-gaap_DebtInstrumentAxis_1c2c6de8-dc56-400e-990d-6f340ffeafc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1c2c6de8-dc56-400e-990d-6f340ffeafc5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_FloatingRateSeniorNotesDueNovember162024Member_eda7bfd3-f27d-42c6-99cb-e6e61a847ee0" xlink:href="syk-20241231.xsd#syk_FloatingRateSeniorNotesDueNovember162024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_FloatingRateSeniorNotesDueNovember162024Member_eda7bfd3-f27d-42c6-99cb-e6e61a847ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.850Due2028Member_c5334f58-7dba-4ef8-8990-30f948d532cd" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.850Due2028Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_SeniorUnsecuredNotes4.850Due2028Member_c5334f58-7dba-4ef8-8990-30f948d532cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3375Due2028Member_fd4c1d6f-3630-4dbc-b364-b3cae6632be4" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3375Due2028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_SeniorUnsecuredNotes3375Due2028Member_fd4c1d6f-3630-4dbc-b364-b3cae6632be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.250Due2029Member_9282e95e-e0a6-450f-8b9a-1d965171c5b4" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.250Due2029Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_SeniorUnsecuredNotes4.250Due2029Member_9282e95e-e0a6-450f-8b9a-1d965171c5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.250Due2024Member_1812b921-f78b-457b-9ac8-3ae7268f7ede" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes0.250Due2024Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_SeniorUnsecuredNotes0.250Due2024Member_1812b921-f78b-457b-9ac8-3ae7268f7ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375DueMay152024Member_cb184f89-e67b-47a2-bc80-d541b6affc5e" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.375DueMay152024Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_SeniorUnsecuredNotes3.375DueMay152024Member_cb184f89-e67b-47a2-bc80-d541b6affc5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375Due2025Member_724d5870-6ef4-493c-9c55-23f23b5d7169" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.375Due2025Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_SeniorUnsecuredNotes3.375Due2025Member_724d5870-6ef4-493c-9c55-23f23b5d7169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4625Due2046Member_c990a7ef-846c-4194-b8f2-9ad03c115d58" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4625Due2046Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_SeniorUnsecuredNotes4625Due2046Member_c990a7ef-846c-4194-b8f2-9ad03c115d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.625Due2036Member_a7cffcfa-cb61-46da-a662-ebd753b6db4f" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.625Due2036Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3c74d34-f149-4385-b08c-55c9c5c7a5e4" xlink:to="loc_syk_SeniorUnsecuredNotes3.625Due2036Member_a7cffcfa-cb61-46da-a662-ebd753b6db4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7acd197e-c4c6-4961-861a-a82bbee58af2" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_20566385-1043-485e-bd63-9455e68bc229" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:to="loc_us-gaap_CommercialPaper_20566385-1043-485e-bd63-9455e68bc229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_aab5b4f2-265a-45e6-bb7b-68c0f62d10a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:to="loc_us-gaap_LineOfCredit_aab5b4f2-265a-45e6-bb7b-68c0f62d10a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_3b8aa3da-0e4c-4db7-aaef-4c35373df509" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:to="loc_us-gaap_DebtInstrumentTerm_3b8aa3da-0e4c-4db7-aaef-4c35373df509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_55e7daca-a2a6-4e16-8622-32e07bca0d67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:to="loc_us-gaap_RepaymentsOfDebt_55e7daca-a2a6-4e16-8622-32e07bca0d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_adee6fd1-408b-4130-87a9-b156b835ad37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_adee6fd1-408b-4130-87a9-b156b835ad37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_30d4e5fb-825f-480d-9584-ff75372518c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_30d4e5fb-825f-480d-9584-ff75372518c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_f071c63f-f387-46ca-8a1d-02840b0cff67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_fd81b337-8eda-4eb8-b98f-ea84df81170c" xlink:to="loc_us-gaap_InterestExpenseDebt_f071c63f-f387-46ca-8a1d-02840b0cff67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_ba6ece0e-765c-4671-9ec2-308301f7ffab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_9683bf09-c526-4936-8307-80831596cf37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_ba6ece0e-765c-4671-9ec2-308301f7ffab" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_9683bf09-c526-4936-8307-80831596cf37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6fbd9056-a6bd-4e06-8f29-64baf6f572f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_9683bf09-c526-4936-8307-80831596cf37" xlink:to="loc_us-gaap_DebtInstrumentAxis_6fbd9056-a6bd-4e06-8f29-64baf6f572f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6fbd9056-a6bd-4e06-8f29-64baf6f572f8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375DueMay152024Member_22b2d083-c314-4db2-b988-b7727652212d" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.375DueMay152024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes3.375DueMay152024Member_22b2d083-c314-4db2-b988-b7727652212d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_VariousMember_09098de6-0436-41df-80fc-ffa460067150" xlink:href="syk-20241231.xsd#syk_VariousMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_VariousMember_09098de6-0436-41df-80fc-ffa460067150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.250Due2024Member_ec9d2560-106a-4bdb-842e-897a39458d56" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes0.250Due2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes0.250Due2024Member_ec9d2560-106a-4bdb-842e-897a39458d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.150Due2025Member_99fe7680-d818-4f91-ab9a-6f800cb423ed" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes1.150Due2025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes1.150Due2025Member_99fe7680-d818-4f91-ab9a-6f800cb423ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375Due2025Member_3d393fa0-c803-4f2b-80dc-22d84b644445" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.375Due2025Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes3.375Due2025Member_3d393fa0-c803-4f2b-80dc-22d84b644445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.500Due2026Member_ccace28c-6d80-4332-92c5-8cbf665833a2" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.500Due2026Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes3.500Due2026Member_ccace28c-6d80-4332-92c5-8cbf665833a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.125DueNovember2027Member_5b04ddc5-d9df-4fa9-ba77-b336cb7e9dee" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes2.125DueNovember2027Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes2.125DueNovember2027Member_5b04ddc5-d9df-4fa9-ba77-b336cb7e9dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.650Due2028Member_bf8cbc5a-ffce-4192-9c54-5507fc6ba141" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.650Due2028Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes3.650Due2028Member_bf8cbc5a-ffce-4192-9c54-5507fc6ba141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.850Due2028Member_f2057d67-b878-4e45-a893-6b456a013330" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.850Due2028Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes4.850Due2028Member_f2057d67-b878-4e45-a893-6b456a013330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3375Due2028Member_a20496ab-f758-4ab2-961a-46ba4bc4bf7b" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3375Due2028Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes3375Due2028Member_a20496ab-f758-4ab2-961a-46ba4bc4bf7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.750due2029Member_d5d910c7-28b0-439e-a03d-9d0d50a1731d" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes0.750due2029Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes0.750due2029Member_d5d910c7-28b0-439e-a03d-9d0d50a1731d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.250Due2029Member_f758d256-87e2-4609-b3b3-d5f30fe460a3" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.250Due2029Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes4.250Due2029Member_f758d256-87e2-4609-b3b3-d5f30fe460a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.950Due2030Member_519c6c20-684e-411c-9cc4-62f4f26f68b4" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes1.950Due2030Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes1.950Due2030Member_519c6c20-684e-411c-9cc4-62f4f26f68b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.625Due2030Member_23b615fa-30e1-4fac-82b8-d79a8549f398" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes2.625Due2030Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes2.625Due2030Member_23b615fa-30e1-4fac-82b8-d79a8549f398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.000due2031Member_b23bbb62-14cc-4a03-8d16-797406ce7821" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes1.000due2031Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes1.000due2031Member_b23bbb62-14cc-4a03-8d16-797406ce7821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375Due2032Member_fe2057da-d908-4dd8-aa18-f2a8589a248c" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.375Due2032Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes3.375Due2032Member_fe2057da-d908-4dd8-aa18-f2a8589a248c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.625DueSeptember112034Member_f67fda6a-5a5a-4b6e-81b2-6a40ce41ec3f" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.625DueSeptember112034Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes4.625DueSeptember112034Member_f67fda6a-5a5a-4b6e-81b2-6a40ce41ec3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.625Due2036Member_327d58fa-3a14-408a-b08a-0a82c7c9d35a" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes3.625Due2036Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes3.625Due2036Member_327d58fa-3a14-408a-b08a-0a82c7c9d35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.100Due2043Member_9df9d1c4-9611-4a9c-a3e1-2cd48bec0e91" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.100Due2043Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes4.100Due2043Member_9df9d1c4-9611-4a9c-a3e1-2cd48bec0e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.375due2044Member_47442691-2096-4dd9-9000-953666f00916" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.375due2044Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes4.375due2044Member_47442691-2096-4dd9-9000-953666f00916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4625Due2046Member_6d3c338f-17e6-4e71-91e7-14efebbb773c" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4625Due2046Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes4625Due2046Member_6d3c338f-17e6-4e71-91e7-14efebbb773c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.900due2050Member_f329ee26-4678-4c41-a6c3-f24b9fec1d60" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes2.900due2050Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_670104b9-65e6-4abb-b22a-0070ca19f312" xlink:to="loc_syk_SeniorUnsecuredNotes2.900due2050Member_f329ee26-4678-4c41-a6c3-f24b9fec1d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_9683bf09-c526-4936-8307-80831596cf37" xlink:to="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_20a60a93-8433-4e0a-9713-f51f3e641f08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_20a60a93-8433-4e0a-9713-f51f3e641f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_f9f53617-f7d7-4c3c-893c-25ce422c6716" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_UnsecuredDebt_f9f53617-f7d7-4c3c-893c-25ce422c6716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_5e21ecd2-a5a1-40cd-a449-ef9acd1599bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_OtherLongTermDebt_5e21ecd2-a5a1-40cd-a449-ef9acd1599bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_df6b8dbd-74f9-488a-b58b-7460da5f42cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_df6b8dbd-74f9-488a-b58b-7460da5f42cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_1d7d4fda-2ead-494a-8247-5b9d41cb51bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_DebtCurrent_1d7d4fda-2ead-494a-8247-5b9d41cb51bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_eb2f07ff-0a63-40b9-b7e0-dc6141185e60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_eb2f07ff-0a63-40b9-b7e0-dc6141185e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_67c2a95a-99f7-40be-b605-d1ed3f6d1684" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_67c2a95a-99f7-40be-b605-d1ed3f6d1684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_8cd0135a-9d05-4bf0-b8f2-cade91f6d98d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_8cd0135a-9d05-4bf0-b8f2-cade91f6d98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_eb5ec9d9-6cb5-43f0-96fe-3d5de11b0785" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e0569087-346c-4e1e-bef6-9f056d90af48" xlink:to="loc_us-gaap_DebtInstrumentFairValue_eb5ec9d9-6cb5-43f0-96fe-3d5de11b0785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e175e90d-eb68-49b0-8ed5-4675059749a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_80c54c40-a9bf-4e22-852d-396b6c50e874" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e175e90d-eb68-49b0-8ed5-4675059749a0" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_80c54c40-a9bf-4e22-852d-396b6c50e874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_0c230b83-0a7b-452a-bc40-b77e44db8b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_80c54c40-a9bf-4e22-852d-396b6c50e874" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_0c230b83-0a7b-452a-bc40-b77e44db8b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_3ab24095-adb1-4d8f-9965-3feb8b974e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_0c230b83-0a7b-452a-bc40-b77e44db8b9e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_3ab24095-adb1-4d8f-9965-3feb8b974e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_5d98aa80-6d6f-4cc8-9a50-f7b127b7dd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_3ab24095-adb1-4d8f-9965-3feb8b974e1c" xlink:to="loc_us-gaap_DomesticCountryMember_5d98aa80-6d6f-4cc8-9a50-f7b127b7dd2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_0c1f5b0d-14a7-412c-9cf2-ecf6247a1e40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_3ab24095-adb1-4d8f-9965-3feb8b974e1c" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_0c1f5b0d-14a7-412c-9cf2-ecf6247a1e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_19ead102-ec1c-4b4c-b7cb-0cb57b8411ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_3ab24095-adb1-4d8f-9965-3feb8b974e1c" xlink:to="loc_us-gaap_ForeignCountryMember_19ead102-ec1c-4b4c-b7cb-0cb57b8411ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_80c54c40-a9bf-4e22-852d-396b6c50e874" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8a1acc73-9d1d-4235-bffc-8f290659e9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8a1acc73-9d1d-4235-bffc-8f290659e9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_04ce496f-70f7-4523-92d0-cb7418fcccf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_04ce496f-70f7-4523-92d0-cb7418fcccf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_a69504dd-abcf-4741-854a-ee77ac5a4085" xlink:href="syk-20241231.xsd#syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_a69504dd-abcf-4741-854a-ee77ac5a4085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_00c31669-a209-420d-8915-37c03cc9223d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_00c31669-a209-420d-8915-37c03cc9223d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_e6ccbadc-c718-4e96-bc10-495cb0fc13e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_OperatingLossCarryforwards_e6ccbadc-c718-4e96-bc10-495cb0fc13e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_81ed6f20-4442-45b9-9cfb-bcd2925d1d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_81ed6f20-4442-45b9-9cfb-bcd2925d1d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_d7ca5d42-4bce-4396-a5ba-3df05a64c73a" xlink:href="syk-20241231.xsd#syk_OperatingLossCarryforwardsSubjectToValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_d7ca5d42-4bce-4396-a5ba-3df05a64c73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_5a72032b-a26c-44c6-b162-53a3cf8bef49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_5a72032b-a26c-44c6-b162-53a3cf8bef49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_c96544c5-9c02-49d9-b9ee-58963ce8356e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_c96544c5-9c02-49d9-b9ee-58963ce8356e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_8a1ca1d4-9b63-4165-ab5c-6286e7b0d3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_8a1ca1d4-9b63-4165-ab5c-6286e7b0d3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_842ebfab-e095-40d1-ab05-191d7771ad52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_842ebfab-e095-40d1-ab05-191d7771ad52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_bc961102-506e-490c-ac19-b94228a06dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_bc961102-506e-490c-ac19-b94228a06dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_973db278-8d11-4c82-8df0-cfb1b7410d57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_973db278-8d11-4c82-8df0-cfb1b7410d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest_b8a2d372-c6ed-4b63-be8e-42aaba42b230" xlink:href="syk-20241231.xsd#syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_d060d357-864e-4117-9333-02f220a30530" xlink:to="loc_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest_b8a2d372-c6ed-4b63-be8e-42aaba42b230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_103e8692-e924-4259-8ae6-d6aa3657f3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1cc7c62f-a7b4-4c22-8fde-aaa88177a300" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_103e8692-e924-4259-8ae6-d6aa3657f3c3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1cc7c62f-a7b4-4c22-8fde-aaa88177a300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_15a15733-4539-4dff-8684-2850aff3bce2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_103e8692-e924-4259-8ae6-d6aa3657f3c3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_15a15733-4539-4dff-8684-2850aff3bce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_ce82853b-4239-4f0d-8db9-14b9db442a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_103e8692-e924-4259-8ae6-d6aa3657f3c3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_ce82853b-4239-4f0d-8db9-14b9db442a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_797d92a8-29a3-469f-9222-6ee0755919c7" xlink:href="syk-20241231.xsd#syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_103e8692-e924-4259-8ae6-d6aa3657f3c3" xlink:to="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_797d92a8-29a3-469f-9222-6ee0755919c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_3a8dd05a-fa05-49d2-98a1-5890c4842e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_103e8692-e924-4259-8ae6-d6aa3657f3c3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_3a8dd05a-fa05-49d2-98a1-5890c4842e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_b4060ead-b107-4d4e-89ce-70436137af06" xlink:href="syk-20241231.xsd#syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_103e8692-e924-4259-8ae6-d6aa3657f3c3" xlink:to="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_b4060ead-b107-4d4e-89ce-70436137af06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_7fe71ab4-64d3-4afc-b5bb-7a6ff46d73c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_103e8692-e924-4259-8ae6-d6aa3657f3c3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_7fe71ab4-64d3-4afc-b5bb-7a6ff46d73c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_eb57193f-82b6-40aa-b5f4-6c41c9c4e7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_103e8692-e924-4259-8ae6-d6aa3657f3c3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_eb57193f-82b6-40aa-b5f4-6c41c9c4e7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference_118d7b46-8741-4c91-bd4b-cb2663b5dc15" xlink:href="syk-20241231.xsd#syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_103e8692-e924-4259-8ae6-d6aa3657f3c3" xlink:to="loc_syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference_118d7b46-8741-4c91-bd4b-cb2663b5dc15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_61b44c8c-f7c9-4a56-8b47-71e958f029e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_103e8692-e924-4259-8ae6-d6aa3657f3c3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_61b44c8c-f7c9-4a56-8b47-71e958f029e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_247a7e9d-2d33-469e-b49a-997a33795f70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_103e8692-e924-4259-8ae6-d6aa3657f3c3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_247a7e9d-2d33-469e-b49a-997a33795f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6b33564e-e462-499d-aeeb-af99489b80cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_edc3538d-4c8c-4ed5-83ed-79f5294e6afe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6b33564e-e462-499d-aeeb-af99489b80cf" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_edc3538d-4c8c-4ed5-83ed-79f5294e6afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_ab18c56d-0afa-4b1e-ac95-c7c386e12262" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6b33564e-e462-499d-aeeb-af99489b80cf" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_ab18c56d-0afa-4b1e-ac95-c7c386e12262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f0b3a789-70ca-4f8e-8ce0-360deb7c7d83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6b33564e-e462-499d-aeeb-af99489b80cf" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f0b3a789-70ca-4f8e-8ce0-360deb7c7d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fe262fb9-4f68-4bf8-ace4-95566fc87371" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6e05bb4d-b116-425b-aa4b-ff0b7727537a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fe262fb9-4f68-4bf8-ace4-95566fc87371" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6e05bb4d-b116-425b-aa4b-ff0b7727537a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ee927def-0b97-43d0-b056-961d1ff7638f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6e05bb4d-b116-425b-aa4b-ff0b7727537a" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ee927def-0b97-43d0-b056-961d1ff7638f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_710f26b3-4816-4f37-a843-f9c06156b5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6e05bb4d-b116-425b-aa4b-ff0b7727537a" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_710f26b3-4816-4f37-a843-f9c06156b5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c1504c97-1868-410a-8246-aae23b8e4de0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6e05bb4d-b116-425b-aa4b-ff0b7727537a" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c1504c97-1868-410a-8246-aae23b8e4de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_7d70ea15-54d6-469a-869d-84e6762b1a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6e05bb4d-b116-425b-aa4b-ff0b7727537a" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_7d70ea15-54d6-469a-869d-84e6762b1a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1817766c-d631-43a0-b5c0-f9282da6e01e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fe262fb9-4f68-4bf8-ace4-95566fc87371" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1817766c-d631-43a0-b5c0-f9282da6e01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_9319616b-d598-4a24-a835-99463994e22a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1817766c-d631-43a0-b5c0-f9282da6e01e" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_9319616b-d598-4a24-a835-99463994e22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_de62a885-8204-44d1-895f-433bb1f2d5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1817766c-d631-43a0-b5c0-f9282da6e01e" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_de62a885-8204-44d1-895f-433bb1f2d5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1802940d-1b5d-433f-865f-ae8c59222086" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1817766c-d631-43a0-b5c0-f9282da6e01e" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1802940d-1b5d-433f-865f-ae8c59222086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7d2b1d33-d559-4260-a6c2-407a4e1106f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1817766c-d631-43a0-b5c0-f9282da6e01e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7d2b1d33-d559-4260-a6c2-407a4e1106f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d499a7b6-4531-4a69-8d64-77d3600f1016" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fe262fb9-4f68-4bf8-ace4-95566fc87371" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d499a7b6-4531-4a69-8d64-77d3600f1016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0b0a3d34-aac8-4058-9e48-3f9d54ea70dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_df168e8c-af75-44d5-b5ce-38979088971b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0b0a3d34-aac8-4058-9e48-3f9d54ea70dd" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_df168e8c-af75-44d5-b5ce-38979088971b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_ce98a5a0-07a5-4c28-82c9-8fa72ea1aef6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_df168e8c-af75-44d5-b5ce-38979088971b" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_ce98a5a0-07a5-4c28-82c9-8fa72ea1aef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_1f7cf4b9-d1a6-487b-be1e-5f54428bc561" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_df168e8c-af75-44d5-b5ce-38979088971b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_1f7cf4b9-d1a6-487b-be1e-5f54428bc561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsDepreciationAndAmortization_6d4c1784-d978-4c08-a8a2-fd2f79f62bac" xlink:href="syk-20241231.xsd#syk_DeferredTaxAssetsDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_df168e8c-af75-44d5-b5ce-38979088971b" xlink:to="loc_syk_DeferredTaxAssetsDepreciationAndAmortization_6d4c1784-d978-4c08-a8a2-fd2f79f62bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes_cc227cc2-f51e-454a-9fbf-58b3d55d16a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_df168e8c-af75-44d5-b5ce-38979088971b" xlink:to="loc_us-gaap_DeferredTaxAssetsStateTaxes_cc227cc2-f51e-454a-9fbf-58b3d55d16a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_a14c22df-35e0-483e-acc1-60f13a7fa996" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_df168e8c-af75-44d5-b5ce-38979088971b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_a14c22df-35e0-483e-acc1-60f13a7fa996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization_57b921e0-0aea-4669-bbba-80e3e3c67e7e" xlink:href="syk-20241231.xsd#syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_df168e8c-af75-44d5-b5ce-38979088971b" xlink:to="loc_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization_57b921e0-0aea-4669-bbba-80e3e3c67e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward_9b43c055-8230-42e7-8af5-585feddcac01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_df168e8c-af75-44d5-b5ce-38979088971b" xlink:to="loc_us-gaap_DeferredTaxAssetInterestCarryforward_9b43c055-8230-42e7-8af5-585feddcac01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_66a0c244-d578-40db-8f29-db84fa34a063" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_df168e8c-af75-44d5-b5ce-38979088971b" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_66a0c244-d578-40db-8f29-db84fa34a063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsOutsideBasisDifference_80325a9e-65df-411a-b88b-9d1cccb8cb9f" xlink:href="syk-20241231.xsd#syk_DeferredTaxAssetsOutsideBasisDifference"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_df168e8c-af75-44d5-b5ce-38979088971b" xlink:to="loc_syk_DeferredTaxAssetsOutsideBasisDifference_80325a9e-65df-411a-b88b-9d1cccb8cb9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_283d3de1-bfe6-46c8-9cdf-94d754167100" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_df168e8c-af75-44d5-b5ce-38979088971b" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_283d3de1-bfe6-46c8-9cdf-94d754167100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_93b1d42f-2e94-4023-a08f-33eff4a00ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_df168e8c-af75-44d5-b5ce-38979088971b" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_93b1d42f-2e94-4023-a08f-33eff4a00ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6e5572fe-a028-4096-9c6b-d6cb50a3e607" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_df168e8c-af75-44d5-b5ce-38979088971b" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6e5572fe-a028-4096-9c6b-d6cb50a3e607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_594e80f6-d31b-4a0a-925e-a3cd43c96bac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_df168e8c-af75-44d5-b5ce-38979088971b" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_594e80f6-d31b-4a0a-925e-a3cd43c96bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_a852be47-b89b-4fc6-b4d4-520bead5f18f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0b0a3d34-aac8-4058-9e48-3f9d54ea70dd" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_a852be47-b89b-4fc6-b4d4-520bead5f18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_3e744ce1-df9d-499b-ae27-8b736d5b0dfd" xlink:href="syk-20241231.xsd#syk_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_a852be47-b89b-4fc6-b4d4-520bead5f18f" xlink:to="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_3e744ce1-df9d-499b-ae27-8b736d5b0dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_a1583ff2-7620-42d9-9a79-8fc07810d429" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_a852be47-b89b-4fc6-b4d4-520bead5f18f" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_a1583ff2-7620-42d9-9a79-8fc07810d429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_58d17e61-3a92-43de-8b12-f83130c00b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_a852be47-b89b-4fc6-b4d4-520bead5f18f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_58d17e61-3a92-43de-8b12-f83130c00b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_0de0e0dc-05fc-4132-a1de-887d6fe61fad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0b0a3d34-aac8-4058-9e48-3f9d54ea70dd" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_0de0e0dc-05fc-4132-a1de-887d6fe61fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_498a270f-2304-419d-a0c7-fc77046b9956" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0b0a3d34-aac8-4058-9e48-3f9d54ea70dd" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_498a270f-2304-419d-a0c7-fc77046b9956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_c506d60d-585c-469d-ac50-c263015e31c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0b0a3d34-aac8-4058-9e48-3f9d54ea70dd" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_c506d60d-585c-469d-ac50-c263015e31c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f0ef6db2-3193-4292-9183-d822e48a9ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_beb222ae-b223-4a7a-99e1-9c1cb8caf777" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f0ef6db2-3193-4292-9183-d822e48a9ccd" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_beb222ae-b223-4a7a-99e1-9c1cb8caf777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_b83e6731-6d58-429d-b48d-743362382289" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_beb222ae-b223-4a7a-99e1-9c1cb8caf777" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_b83e6731-6d58-429d-b48d-743362382289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5577bbd3-5746-422a-827e-c688f3701f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_beb222ae-b223-4a7a-99e1-9c1cb8caf777" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5577bbd3-5746-422a-827e-c688f3701f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_0659294d-0a60-4422-866d-1f2596b675c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_beb222ae-b223-4a7a-99e1-9c1cb8caf777" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_0659294d-0a60-4422-866d-1f2596b675c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_7954da59-1f0c-43d1-835a-aab63f9b9d45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_beb222ae-b223-4a7a-99e1-9c1cb8caf777" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_7954da59-1f0c-43d1-835a-aab63f9b9d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_07d04f55-4807-4c63-b252-1bfd2222601a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_beb222ae-b223-4a7a-99e1-9c1cb8caf777" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_07d04f55-4807-4c63-b252-1bfd2222601a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_cd7caa0f-2b4f-49e6-ab1e-1b6947ec77eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_beb222ae-b223-4a7a-99e1-9c1cb8caf777" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_cd7caa0f-2b4f-49e6-ab1e-1b6947ec77eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_f454ad6e-349a-4ff5-81e6-d418ff2acba5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_beb222ae-b223-4a7a-99e1-9c1cb8caf777" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_f454ad6e-349a-4ff5-81e6-d418ff2acba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation_165465e2-ae22-4d34-8e12-7fef70a7ab26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_beb222ae-b223-4a7a-99e1-9c1cb8caf777" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation_165465e2-ae22-4d34-8e12-7fef70a7ab26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_7cd60c93-642b-42bf-9cae-b1acc5a928fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_beb222ae-b223-4a7a-99e1-9c1cb8caf777" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_7cd60c93-642b-42bf-9cae-b1acc5a928fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3adebaa4-af1f-4829-85a2-10fa14f7033d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_a39831d9-d25f-4a36-a0a0-a1eb42eed5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3adebaa4-af1f-4829-85a2-10fa14f7033d" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_a39831d9-d25f-4a36-a0a0-a1eb42eed5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_fab2c06e-7d44-473d-838a-2f2169b08f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3adebaa4-af1f-4829-85a2-10fa14f7033d" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_fab2c06e-7d44-473d-838a-2f2169b08f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany_7d59f208-559a-4873-ae14-a34de4acf934" xlink:href="syk-20241231.xsd#syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3adebaa4-af1f-4829-85a2-10fa14f7033d" xlink:to="loc_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany_7d59f208-559a-4873-ae14-a34de4acf934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany_9d28f3bd-320e-4775-b5de-12ea87179577" xlink:href="syk-20241231.xsd#syk_DefinedContributionRetirementPlansCommonStockHeldByCompany"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3adebaa4-af1f-4829-85a2-10fa14f7033d" xlink:to="loc_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany_9d28f3bd-320e-4775-b5de-12ea87179577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany_10c699bb-c15f-4579-829c-d953e6e8d7a3" xlink:href="syk-20241231.xsd#syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3adebaa4-af1f-4829-85a2-10fa14f7033d" xlink:to="loc_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany_10c699bb-c15f-4579-829c-d953e6e8d7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3fd281de-3a37-4ca4-9067-a185dc98a04b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_33c92905-a5d5-4c4c-a3e9-2f646a03ab08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3fd281de-3a37-4ca4-9067-a185dc98a04b" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_33c92905-a5d5-4c4c-a3e9-2f646a03ab08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_9fe7c689-2561-4b82-8fa1-f59b4a1a7d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_33c92905-a5d5-4c4c-a3e9-2f646a03ab08" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_9fe7c689-2561-4b82-8fa1-f59b4a1a7d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_2039b1e4-b440-439c-969d-591fb515edbb" xlink:href="syk-20241231.xsd#syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_33c92905-a5d5-4c4c-a3e9-2f646a03ab08" xlink:to="loc_syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_2039b1e4-b440-439c-969d-591fb515edbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_0025a836-e7d4-41ae-b94f-d72cc11e85ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_33c92905-a5d5-4c4c-a3e9-2f646a03ab08" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_0025a836-e7d4-41ae-b94f-d72cc11e85ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_87883e7f-9a1f-4e2e-896a-a905520a80c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_33c92905-a5d5-4c4c-a3e9-2f646a03ab08" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_87883e7f-9a1f-4e2e-896a-a905520a80c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_f464176f-2730-44ef-b14f-c1608e3ac816" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_33c92905-a5d5-4c4c-a3e9-2f646a03ab08" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_f464176f-2730-44ef-b14f-c1608e3ac816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_5dda5cc2-eec8-4489-8441-3b63138eaf95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_33c92905-a5d5-4c4c-a3e9-2f646a03ab08" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_5dda5cc2-eec8-4489-8441-3b63138eaf95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_94e19430-cfeb-4aa4-b58d-7b5791e33040" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_33c92905-a5d5-4c4c-a3e9-2f646a03ab08" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_94e19430-cfeb-4aa4-b58d-7b5791e33040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_9c0ebd62-0774-4f45-9eb3-b4af48491dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3fd281de-3a37-4ca4-9067-a185dc98a04b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_9c0ebd62-0774-4f45-9eb3-b4af48491dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_c79cef91-09a9-4d65-bfee-75163c514f34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3fd281de-3a37-4ca4-9067-a185dc98a04b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_c79cef91-09a9-4d65-bfee-75163c514f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_b86c1127-8e7a-4765-aef0-433188fe1315" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3fd281de-3a37-4ca4-9067-a185dc98a04b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_b86c1127-8e7a-4765-aef0-433188fe1315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_cf4e3d7d-991e-426a-83a3-13a285bf4c83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3fd281de-3a37-4ca4-9067-a185dc98a04b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_cf4e3d7d-991e-426a-83a3-13a285bf4c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_dfef20aa-6f5f-4924-baab-bb2d59777511" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3fd281de-3a37-4ca4-9067-a185dc98a04b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_dfef20aa-6f5f-4924-baab-bb2d59777511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_9f976a4a-8348-4c15-9a62-72a109af7bda" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3fd281de-3a37-4ca4-9067-a185dc98a04b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_9f976a4a-8348-4c15-9a62-72a109af7bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_8bfe7d59-f3c3-4965-9b79-606170ec0c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_9f976a4a-8348-4c15-9a62-72a109af7bda" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_8bfe7d59-f3c3-4965-9b79-606170ec0c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_9d3ad114-b199-48ff-b111-fd7dce12e4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_9f976a4a-8348-4c15-9a62-72a109af7bda" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_9d3ad114-b199-48ff-b111-fd7dce12e4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_e3ac1775-3a19-4a45-bf84-d0d3fac6b99b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_9f976a4a-8348-4c15-9a62-72a109af7bda" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_e3ac1775-3a19-4a45-bf84-d0d3fac6b99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations_3c294487-e156-4116-bef1-2f3633fde6a8" xlink:href="syk-20241231.xsd#syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_9f976a4a-8348-4c15-9a62-72a109af7bda" xlink:to="loc_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations_3c294487-e156-4116-bef1-2f3633fde6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5f6ff722-fad9-4e19-baee-25fbb7491c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3fd281de-3a37-4ca4-9067-a185dc98a04b" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5f6ff722-fad9-4e19-baee-25fbb7491c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4782f63d-2595-4234-90a7-f7d8f6067937" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5f6ff722-fad9-4e19-baee-25fbb7491c3b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4782f63d-2595-4234-90a7-f7d8f6067937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e1eb0268-6dea-424f-82fd-94b8f94bb4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4782f63d-2595-4234-90a7-f7d8f6067937" xlink:to="loc_us-gaap_EquityComponentDomain_e1eb0268-6dea-424f-82fd-94b8f94bb4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_ee69da25-6ea3-4ca7-81e5-bbb72256b1ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e1eb0268-6dea-424f-82fd-94b8f94bb4d2" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_ee69da25-6ea3-4ca7-81e5-bbb72256b1ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3e425ad0-10d8-43bc-811f-50bba00480de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5f6ff722-fad9-4e19-baee-25fbb7491c3b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3e425ad0-10d8-43bc-811f-50bba00480de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2cc41458-d456-44d4-b0c3-38ecf4912828" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3e425ad0-10d8-43bc-811f-50bba00480de" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2cc41458-d456-44d4-b0c3-38ecf4912828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AccruedCompensationMember_7523e927-5170-43d4-8894-85c7a9c42041" xlink:href="syk-20241231.xsd#syk_AccruedCompensationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2cc41458-d456-44d4-b0c3-38ecf4912828" xlink:to="loc_syk_AccruedCompensationMember_7523e927-5170-43d4-8894-85c7a9c42041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_86e09d24-acc8-45bf-accb-2b63032713d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2cc41458-d456-44d4-b0c3-38ecf4912828" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_86e09d24-acc8-45bf-accb-2b63032713d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_1b7589dc-63a8-44e7-b409-fed53c989d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2cc41458-d456-44d4-b0c3-38ecf4912828" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_1b7589dc-63a8-44e7-b409-fed53c989d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f2a0f270-306f-41ab-81ed-232e6ab04e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5f6ff722-fad9-4e19-baee-25fbb7491c3b" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f2a0f270-306f-41ab-81ed-232e6ab04e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_38ca1bc4-e4c8-483c-8ced-1ae6a5b10958" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f2a0f270-306f-41ab-81ed-232e6ab04e8c" xlink:to="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_38ca1bc4-e4c8-483c-8ced-1ae6a5b10958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0edc222e-8751-487b-b90f-fdbcb6087307" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_38ca1bc4-e4c8-483c-8ced-1ae6a5b10958" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0edc222e-8751-487b-b90f-fdbcb6087307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7f079f2e-0c14-4717-a3b9-d6bdcd65d4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_38ca1bc4-e4c8-483c-8ced-1ae6a5b10958" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7f079f2e-0c14-4717-a3b9-d6bdcd65d4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_32015bc0-27ee-4564-9f03-e337fb4e9400" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_38ca1bc4-e4c8-483c-8ced-1ae6a5b10958" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_32015bc0-27ee-4564-9f03-e337fb4e9400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_13edd5c4-d980-42e7-8ff4-8b3ccfa3bf9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_38ca1bc4-e4c8-483c-8ced-1ae6a5b10958" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_13edd5c4-d980-42e7-8ff4-8b3ccfa3bf9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_d63ecec1-7b99-424f-9dcc-d014f80ccd2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_38ca1bc4-e4c8-483c-8ced-1ae6a5b10958" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_d63ecec1-7b99-424f-9dcc-d014f80ccd2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_f9456991-fa77-441c-a6b3-3c5930522652" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_38ca1bc4-e4c8-483c-8ced-1ae6a5b10958" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_f9456991-fa77-441c-a6b3-3c5930522652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RetirementPlansScheduleofChangeinBenefitObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0bde2dc7-de6b-44fe-ba5d-c36763b32d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10ff7122-b6b2-4b0c-9094-b7c99ecba1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0bde2dc7-de6b-44fe-ba5d-c36763b32d9f" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10ff7122-b6b2-4b0c-9094-b7c99ecba1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_6ce29f9d-fb68-44ad-9dce-80f314e49fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10ff7122-b6b2-4b0c-9094-b7c99ecba1eb" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_6ce29f9d-fb68-44ad-9dce-80f314e49fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_cf4621cc-4d6f-4c8c-bbe4-71efeb5adfe6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10ff7122-b6b2-4b0c-9094-b7c99ecba1eb" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_cf4621cc-4d6f-4c8c-bbe4-71efeb5adfe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_81188b97-b2a5-4ec4-8760-abaeecce015a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10ff7122-b6b2-4b0c-9094-b7c99ecba1eb" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_81188b97-b2a5-4ec4-8760-abaeecce015a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_892f5ee2-f0b3-46ed-ac02-c7a036836782" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10ff7122-b6b2-4b0c-9094-b7c99ecba1eb" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_892f5ee2-f0b3-46ed-ac02-c7a036836782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_2f50fc2d-920b-4bb4-b7e9-7533add88960" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10ff7122-b6b2-4b0c-9094-b7c99ecba1eb" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_2f50fc2d-920b-4bb4-b7e9-7533add88960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_1ae536ec-e12b-46ed-87c2-1717ad33a515" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10ff7122-b6b2-4b0c-9094-b7c99ecba1eb" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_1ae536ec-e12b-46ed-87c2-1717ad33a515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_29a2c4ca-f007-4fc2-9253-f7495d074b54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10ff7122-b6b2-4b0c-9094-b7c99ecba1eb" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_29a2c4ca-f007-4fc2-9253-f7495d074b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_48d6a244-46c6-4bcb-af35-c694ec4fdf01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10ff7122-b6b2-4b0c-9094-b7c99ecba1eb" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_48d6a244-46c6-4bcb-af35-c694ec4fdf01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_f4af863f-d9c7-4a26-bce1-d39ed736d49c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0bde2dc7-de6b-44fe-ba5d-c36763b32d9f" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_f4af863f-d9c7-4a26-bce1-d39ed736d49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RetirementPlansChangeinPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4ff40c14-d279-4804-9f59-46ae2f5272a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_6624610f-efb3-4b2d-a2b3-63103c16e69b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4ff40c14-d279-4804-9f59-46ae2f5272a6" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_6624610f-efb3-4b2d-a2b3-63103c16e69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_3b587352-6757-403f-8e39-f2636866f2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_6624610f-efb3-4b2d-a2b3-63103c16e69b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_3b587352-6757-403f-8e39-f2636866f2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_516567a1-1a3b-4232-b9ad-1c9b21d8865a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_6624610f-efb3-4b2d-a2b3-63103c16e69b" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_516567a1-1a3b-4232-b9ad-1c9b21d8865a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_ed982ccd-17cf-43e1-a8c3-205590ff3387" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_6624610f-efb3-4b2d-a2b3-63103c16e69b" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_ed982ccd-17cf-43e1-a8c3-205590ff3387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_9b20b009-f2a1-43ae-8407-bf89463de201" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_6624610f-efb3-4b2d-a2b3-63103c16e69b" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_9b20b009-f2a1-43ae-8407-bf89463de201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_ac72cb0c-7205-4abe-ab87-301a9d09fc02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_6624610f-efb3-4b2d-a2b3-63103c16e69b" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_ac72cb0c-7205-4abe-ab87-301a9d09fc02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_64322861-7749-4aae-96d1-46c46763733a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_6624610f-efb3-4b2d-a2b3-63103c16e69b" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_64322861-7749-4aae-96d1-46c46763733a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_f74c9a6d-78b3-4a03-a667-7f76d0d3998f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_6624610f-efb3-4b2d-a2b3-63103c16e69b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_f74c9a6d-78b3-4a03-a667-7f76d0d3998f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e0607d31-9778-410d-ba36-14365b2dfda4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2048ba05-5a40-4c0c-a3e3-32cd2e00e0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e0607d31-9778-410d-ba36-14365b2dfda4" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2048ba05-5a40-4c0c-a3e3-32cd2e00e0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c67a85d0-d95c-49fd-947e-fbba9246bc31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2048ba05-5a40-4c0c-a3e3-32cd2e00e0b8" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c67a85d0-d95c-49fd-947e-fbba9246bc31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_1d70604b-aa1e-4224-9d6a-732cf260b340" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c67a85d0-d95c-49fd-947e-fbba9246bc31" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_1d70604b-aa1e-4224-9d6a-732cf260b340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_837e2833-1873-4174-9ff5-9fac078c2a30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1d70604b-aa1e-4224-9d6a-732cf260b340" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_837e2833-1873-4174-9ff5-9fac078c2a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_ef4a18ca-fb9b-481e-9142-ae31eeaae0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDebtSecurityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1d70604b-aa1e-4224-9d6a-732cf260b340" xlink:to="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_ef4a18ca-fb9b-481e-9142-ae31eeaae0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_08de8023-a603-4e52-a524-895ae9193c38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1d70604b-aa1e-4224-9d6a-732cf260b340" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_08de8023-a603-4e52-a524-895ae9193c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b475a5-3b6a-4794-bc92-e12165f74c87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2048ba05-5a40-4c0c-a3e3-32cd2e00e0b8" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b475a5-3b6a-4794-bc92-e12165f74c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_57ebf49b-3b92-4288-b410-b31d052ec627" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b475a5-3b6a-4794-bc92-e12165f74c87" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_57ebf49b-3b92-4288-b410-b31d052ec627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_00eceb66-1ea5-4927-b40c-02b5dc9f1983" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b475a5-3b6a-4794-bc92-e12165f74c87" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_00eceb66-1ea5-4927-b40c-02b5dc9f1983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b54f7089-0937-4aa6-8043-cfe92944b0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b082d5c6-d97b-4c5a-9d79-c31fe1ba364d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b54f7089-0937-4aa6-8043-cfe92944b0c7" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b082d5c6-d97b-4c5a-9d79-c31fe1ba364d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_98e2a133-1df1-438f-a1c6-acc5f2aa57d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b082d5c6-d97b-4c5a-9d79-c31fe1ba364d" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_98e2a133-1df1-438f-a1c6-acc5f2aa57d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_7008bbf1-ae39-4545-ad9b-ee0ea9c93f68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_98e2a133-1df1-438f-a1c6-acc5f2aa57d8" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_7008bbf1-ae39-4545-ad9b-ee0ea9c93f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_8292b333-761e-49f3-bea9-82d7074f4ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_7008bbf1-ae39-4545-ad9b-ee0ea9c93f68" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_8292b333-761e-49f3-bea9-82d7074f4ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_bac7f16f-67a2-4f02-b795-9b11a4236aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_7008bbf1-ae39-4545-ad9b-ee0ea9c93f68" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_bac7f16f-67a2-4f02-b795-9b11a4236aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_459489a4-f922-46b6-9591-734034081c16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_7008bbf1-ae39-4545-ad9b-ee0ea9c93f68" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_459489a4-f922-46b6-9591-734034081c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_4abd179a-4902-4ae0-abc7-e092e092f6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_7008bbf1-ae39-4545-ad9b-ee0ea9c93f68" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_4abd179a-4902-4ae0-abc7-e092e092f6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7d4803c-96f4-4476-8d4d-a8473706413d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b082d5c6-d97b-4c5a-9d79-c31fe1ba364d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7d4803c-96f4-4476-8d4d-a8473706413d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2548b-861b-417c-8924-820d38d151d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7d4803c-96f4-4476-8d4d-a8473706413d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2548b-861b-417c-8924-820d38d151d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c73f2fc9-4952-4f6e-9a77-6c342681b140" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2548b-861b-417c-8924-820d38d151d7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c73f2fc9-4952-4f6e-9a77-6c342681b140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b0934d3b-8456-4bb8-9273-fe3e5dc2c6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2548b-861b-417c-8924-820d38d151d7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b0934d3b-8456-4bb8-9273-fe3e5dc2c6d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ad4e7400-001b-4f4c-8de7-22326e23c4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2548b-861b-417c-8924-820d38d151d7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ad4e7400-001b-4f4c-8de7-22326e23c4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_94df0f98-b9b0-4912-852d-7031555ab274" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b082d5c6-d97b-4c5a-9d79-c31fe1ba364d" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_94df0f98-b9b0-4912-852d-7031555ab274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9e81ed97-48df-49a5-ba0b-2d5a1579ccef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_94df0f98-b9b0-4912-852d-7031555ab274" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9e81ed97-48df-49a5-ba0b-2d5a1579ccef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansNarrativeDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RetirementPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_db0a57ee-5af0-42ae-bc8e-66ae94f99aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5c587658-cc54-4294-b3a4-4e3057c6e848" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_db0a57ee-5af0-42ae-bc8e-66ae94f99aa5" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5c587658-cc54-4294-b3a4-4e3057c6e848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_783d177e-140f-4a4f-ad26-eb76f503bef4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5c587658-cc54-4294-b3a4-4e3057c6e848" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_783d177e-140f-4a4f-ad26-eb76f503bef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2ec80dd-1746-497a-9f7d-a6b68ebe2db5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_783d177e-140f-4a4f-ad26-eb76f503bef4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2ec80dd-1746-497a-9f7d-a6b68ebe2db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_da88a6af-4a49-4cbf-8cbc-b0f5b30cbead" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2ec80dd-1746-497a-9f7d-a6b68ebe2db5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_da88a6af-4a49-4cbf-8cbc-b0f5b30cbead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_742c6276-7753-4fe4-b266-700537a6a6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5c587658-cc54-4294-b3a4-4e3057c6e848" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_742c6276-7753-4fe4-b266-700537a6a6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_067d8a43-44fc-450b-84dc-48038ea5aa7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_742c6276-7753-4fe4-b266-700537a6a6cb" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_067d8a43-44fc-450b-84dc-48038ea5aa7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_c307b72c-8665-42c8-a213-82558c95b348" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_742c6276-7753-4fe4-b266-700537a6a6cb" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_c307b72c-8665-42c8-a213-82558c95b348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#RetirementPlansExpectedBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cd8de048-caf9-4d7a-a4d2-4965b6992f25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_ee293eac-c0b9-4864-89ce-5ea3dcf4611d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cd8de048-caf9-4d7a-a4d2-4965b6992f25" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_ee293eac-c0b9-4864-89ce-5ea3dcf4611d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_9da43b65-67e6-4845-9b86-b0b012d0041e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cd8de048-caf9-4d7a-a4d2-4965b6992f25" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_9da43b65-67e6-4845-9b86-b0b012d0041e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_131320d2-6b49-4ce5-b26a-b7a8ee802a17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cd8de048-caf9-4d7a-a4d2-4965b6992f25" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_131320d2-6b49-4ce5-b26a-b7a8ee802a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_de9ed9fa-dbc5-40fb-865e-4cbefdaac741" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cd8de048-caf9-4d7a-a4d2-4965b6992f25" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_de9ed9fa-dbc5-40fb-865e-4cbefdaac741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_7972de0e-7268-49fc-9f39-e1d60e70bf22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cd8de048-caf9-4d7a-a4d2-4965b6992f25" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_7972de0e-7268-49fc-9f39-e1d60e70bf22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_a27195b8-1be3-4f45-a75c-970c95bcc044" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cd8de048-caf9-4d7a-a4d2-4965b6992f25" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_a27195b8-1be3-4f45-a75c-970c95bcc044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#SummaryofQuarterlyDataUnauditedDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialDataAbstract_55707031-601e-4cc7-a8a3-d05f96bb9cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QuarterlyFinancialDataAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_f3fd4c3d-7670-467a-a5cc-7c8c39d8ee6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_55707031-601e-4cc7-a8a3-d05f96bb9cc6" xlink:to="loc_us-gaap_Revenues_f3fd4c3d-7670-467a-a5cc-7c8c39d8ee6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_9e6b07a4-e8d6-47be-a42e-52cf2e9c887d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_55707031-601e-4cc7-a8a3-d05f96bb9cc6" xlink:to="loc_us-gaap_GrossProfit_9e6b07a4-e8d6-47be-a42e-52cf2e9c887d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3d9ed2e0-c554-43e5-9720-fdef34b38d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_55707031-601e-4cc7-a8a3-d05f96bb9cc6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3d9ed2e0-c554-43e5-9720-fdef34b38d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6cdc4322-c959-4280-94fa-c1381a32d14e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_55707031-601e-4cc7-a8a3-d05f96bb9cc6" xlink:to="loc_us-gaap_NetIncomeLoss_6cdc4322-c959-4280-94fa-c1381a32d14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e17e0b1b-8898-48d0-a0d3-3c944037b330" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_55707031-601e-4cc7-a8a3-d05f96bb9cc6" xlink:to="loc_us-gaap_EarningsPerShareBasic_e17e0b1b-8898-48d0-a0d3-3c944037b330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_cb9fcb2a-2e2f-48bd-87e7-07ee6576ed11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_55707031-601e-4cc7-a8a3-d05f96bb9cc6" xlink:to="loc_us-gaap_EarningsPerShareDiluted_cb9fcb2a-2e2f-48bd-87e7-07ee6576ed11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_1b1881a3-8010-42d7-9413-6f7926458342" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_55707031-601e-4cc7-a8a3-d05f96bb9cc6" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_1b1881a3-8010-42d7-9413-6f7926458342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bcf5729f-7e47-49f9-b8bf-fe5ce43998a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_f9810e73-a5c4-4082-b89e-8ac2aebaef22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bcf5729f-7e47-49f9-b8bf-fe5ce43998a0" xlink:to="loc_us-gaap_NumberOfReportableSegments_f9810e73-a5c4-4082-b89e-8ac2aebaef22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5a94bf71-b8c8-4cca-ab3b-0807ef48b4a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bcf5729f-7e47-49f9-b8bf-fe5ce43998a0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5a94bf71-b8c8-4cca-ab3b-0807ef48b4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_fa59ed6d-4a5e-429f-9564-4bd77a35bd6a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5a94bf71-b8c8-4cca-ab3b-0807ef48b4a2" xlink:to="loc_srt_ConsolidationItemsAxis_fa59ed6d-4a5e-429f-9564-4bd77a35bd6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6338a198-4d7c-48bd-8ac9-c238dfcb08b4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_fa59ed6d-4a5e-429f-9564-4bd77a35bd6a" xlink:to="loc_srt_ConsolidationItemsDomain_6338a198-4d7c-48bd-8ac9-c238dfcb08b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9c5f4329-2306-4174-9761-01960a6d36a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_6338a198-4d7c-48bd-8ac9-c238dfcb08b4" xlink:to="loc_us-gaap_OperatingSegmentsMember_9c5f4329-2306-4174-9761-01960a6d36a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_fc9770ef-e08a-4541-a234-6e2fd94e7114" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_6338a198-4d7c-48bd-8ac9-c238dfcb08b4" xlink:to="loc_us-gaap_CorporateNonSegmentMember_fc9770ef-e08a-4541-a234-6e2fd94e7114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_48e3e5d3-a47b-460b-83c0-05583c0531b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_6338a198-4d7c-48bd-8ac9-c238dfcb08b4" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_48e3e5d3-a47b-460b-83c0-05583c0531b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3fbcafa5-8118-4663-b3d5-7cc8a745f081" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5a94bf71-b8c8-4cca-ab3b-0807ef48b4a2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3fbcafa5-8118-4663-b3d5-7cc8a745f081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_388d8ee5-355c-47b9-923a-ca9e76a89a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3fbcafa5-8118-4663-b3d5-7cc8a745f081" xlink:to="loc_us-gaap_SegmentDomain_388d8ee5-355c-47b9-923a-ca9e76a89a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_d3b49a34-d82c-4a2e-a87a-5f71bb941427" xlink:href="syk-20241231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_388d8ee5-355c-47b9-923a-ca9e76a89a3a" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_d3b49a34-d82c-4a2e-a87a-5f71bb941427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsMember_f8b8a430-38e3-47b5-bd7b-daf23e43d87d" xlink:href="syk-20241231.xsd#syk_OrthopaedicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_388d8ee5-355c-47b9-923a-ca9e76a89a3a" xlink:to="loc_syk_OrthopaedicsMember_f8b8a430-38e3-47b5-bd7b-daf23e43d87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5a94bf71-b8c8-4cca-ab3b-0807ef48b4a2" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_3b2b29fa-f493-4e1e-b38d-fc2234d894c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_NumberOfReportableSegments_3b2b29fa-f493-4e1e-b38d-fc2234d894c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_cf10fc1a-75d4-4134-b0c6-a49cf8eb5bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_Revenues_cf10fc1a-75d4-4134-b0c6-a49cf8eb5bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_f2b57212-338c-4a3c-93d4-10eb7eb73734" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_CostOfRevenue_f2b57212-338c-4a3c-93d4-10eb7eb73734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_541c8ee4-dbec-4b4b-9768-5688a8930462" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_541c8ee4-dbec-4b4b-9768-5688a8930462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_48b58a36-52d3-496f-8c1c-fe290828a733" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_48b58a36-52d3-496f-8c1c-fe290828a733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d9cfffb8-33db-44eb-8e83-e6f19ba5202a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d9cfffb8-33db-44eb-8e83-e6f19ba5202a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_883e784c-673d-46a2-b3e5-8f207f2a6e26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_883e784c-673d-46a2-b3e5-8f207f2a6e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6e13cd2b-888d-4b7c-b7a8-21c8851e5cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_OperatingIncomeLoss_6e13cd2b-888d-4b7c-b7a8-21c8851e5cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_229009ba-e9cf-441c-b652-73886209aa58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_229009ba-e9cf-441c-b652-73886209aa58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InventorySteppedUpToFairValueAtAcquisition_74c6d638-93be-481d-b4b8-7bf0d54cedd6" xlink:href="syk-20241231.xsd#syk_InventorySteppedUpToFairValueAtAcquisition"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_syk_InventorySteppedUpToFairValueAtAcquisition_74c6d638-93be-481d-b4b8-7bf0d54cedd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_3bbcc407-466a-410d-875d-d1fe9502d6db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_3bbcc407-466a-410d-875d-d1fe9502d6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_e5f8ea48-024d-4349-b3c4-e68c0a1c8727" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_RestructuringCosts_e5f8ea48-024d-4349-b3c4-e68c0a1c8727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_539a2c86-168a-4738-9845-2201eb11e777" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_AssetImpairmentCharges_539a2c86-168a-4738-9845-2201eb11e777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalDeviceRegulationsExpense_1955e7e3-57f7-4059-b6cc-fa7e63a94b7d" xlink:href="syk-20241231.xsd#syk_MedicalDeviceRegulationsExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_syk_MedicalDeviceRegulationsExpense_1955e7e3-57f7-4059-b6cc-fa7e63a94b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_RejuvenateABGIIHipRecallCharges_5720dd38-6a9a-4f38-8607-b0ee10172860" xlink:href="syk-20241231.xsd#syk_RejuvenateABGIIHipRecallCharges"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_syk_RejuvenateABGIIHipRecallCharges_5720dd38-6a9a-4f38-8607-b0ee10172860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_3cb801c3-50c5-4a80-a297-b3c19294be3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_LegalFees_3cb801c3-50c5-4a80-a297-b3c19294be3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dd7b8751-1c4f-48c1-a772-150ab6b0730f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9a0c507b-015f-487d-a450-b843dd409f44" xlink:to="loc_us-gaap_NetIncomeLoss_dd7b8751-1c4f-48c1-a772-150ab6b0730f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#SegmentandGeographicDataSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4c91e3a0-6c76-4d16-8c21-1c23ca2ccefb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c2f188e8-ac04-4997-b322-c60e4ee5173c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4c91e3a0-6c76-4d16-8c21-1c23ca2ccefb" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c2f188e8-ac04-4997-b322-c60e4ee5173c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b1c256f7-a1c2-44f0-b2aa-814da980140f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c2f188e8-ac04-4997-b322-c60e4ee5173c" xlink:to="loc_srt_ConsolidationItemsAxis_b1c256f7-a1c2-44f0-b2aa-814da980140f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e197f2f3-07f3-4d17-a21c-5dbfd2cb34c1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_b1c256f7-a1c2-44f0-b2aa-814da980140f" xlink:to="loc_srt_ConsolidationItemsDomain_e197f2f3-07f3-4d17-a21c-5dbfd2cb34c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_273accef-e808-4919-b6e4-0c12187c90f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_e197f2f3-07f3-4d17-a21c-5dbfd2cb34c1" xlink:to="loc_us-gaap_OperatingSegmentsMember_273accef-e808-4919-b6e4-0c12187c90f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_4c42e973-bb44-4590-b963-30d2d1405aef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_e197f2f3-07f3-4d17-a21c-5dbfd2cb34c1" xlink:to="loc_us-gaap_CorporateNonSegmentMember_4c42e973-bb44-4590-b963-30d2d1405aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3440e691-3480-4c03-8b7f-abea3291ae86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c2f188e8-ac04-4997-b322-c60e4ee5173c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3440e691-3480-4c03-8b7f-abea3291ae86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_abbb9aa6-c1b1-45fa-aa42-a0077723876b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3440e691-3480-4c03-8b7f-abea3291ae86" xlink:to="loc_us-gaap_SegmentDomain_abbb9aa6-c1b1-45fa-aa42-a0077723876b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_3190bcca-3080-4346-9407-7b89527d96d1" xlink:href="syk-20241231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_abbb9aa6-c1b1-45fa-aa42-a0077723876b" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_3190bcca-3080-4346-9407-7b89527d96d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsMember_b434693c-a3f3-405e-ae0e-ad6c9b1eb3d6" xlink:href="syk-20241231.xsd#syk_OrthopaedicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_abbb9aa6-c1b1-45fa-aa42-a0077723876b" xlink:to="loc_syk_OrthopaedicsMember_b434693c-a3f3-405e-ae0e-ad6c9b1eb3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_771e32d4-25cf-4e96-aa95-a1cc69b9e506" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c2f188e8-ac04-4997-b322-c60e4ee5173c" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_771e32d4-25cf-4e96-aa95-a1cc69b9e506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_849c95a6-0e75-431e-b153-086415e6dece" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_771e32d4-25cf-4e96-aa95-a1cc69b9e506" xlink:to="loc_us-gaap_Assets_849c95a6-0e75-431e-b153-086415e6dece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalExpendituresDuringPeriod_a451d9bb-42f5-4a5d-a6c3-6300c48ec821" xlink:href="syk-20241231.xsd#syk_CapitalExpendituresDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_771e32d4-25cf-4e96-aa95-a1cc69b9e506" xlink:to="loc_syk_CapitalExpendituresDuringPeriod_a451d9bb-42f5-4a5d-a6c3-6300c48ec821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5afcb971-53a3-4021-915f-71bc0f8ecfc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_18876f2d-a8a8-4400-8cb6-01538f9a94bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5afcb971-53a3-4021-915f-71bc0f8ecfc3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_18876f2d-a8a8-4400-8cb6-01538f9a94bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_5d7fb061-440d-46f2-b02a-17d3c7042dc2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_18876f2d-a8a8-4400-8cb6-01538f9a94bf" xlink:to="loc_srt_StatementGeographicalAxis_5d7fb061-440d-46f2-b02a-17d3c7042dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d2b85de9-ac16-420d-8635-2cce0fc9b5c4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_5d7fb061-440d-46f2-b02a-17d3c7042dc2" xlink:to="loc_srt_SegmentGeographicalDomain_d2b85de9-ac16-420d-8635-2cce0fc9b5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d9cac9cc-096b-44b2-8530-741049676fe4" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d2b85de9-ac16-420d-8635-2cce0fc9b5c4" xlink:to="loc_country_US_d9cac9cc-096b-44b2-8530-741049676fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_44a68391-7517-40c3-99f5-fddd4fe161cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d2b85de9-ac16-420d-8635-2cce0fc9b5c4" xlink:to="loc_us-gaap_EMEAMember_44a68391-7517-40c3-99f5-fddd4fe161cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_bb9d459c-1bd9-4c45-bf5b-8bb4833c86e3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d2b85de9-ac16-420d-8635-2cce0fc9b5c4" xlink:to="loc_srt_AsiaPacificMember_bb9d459c-1bd9-4c45-bf5b-8bb4833c86e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherForeignCountriesMember_ad881456-3e2b-4806-83d1-72266acd2d49" xlink:href="syk-20241231.xsd#syk_OtherForeignCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d2b85de9-ac16-420d-8635-2cce0fc9b5c4" xlink:to="loc_syk_OtherForeignCountriesMember_ad881456-3e2b-4806-83d1-72266acd2d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0f72132e-acdf-4f36-aa26-79924d2f238b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_18876f2d-a8a8-4400-8cb6-01538f9a94bf" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_0f72132e-acdf-4f36-aa26-79924d2f238b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_acbb563c-0ae6-4f4d-94d1-1830320145a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0f72132e-acdf-4f36-aa26-79924d2f238b" xlink:to="loc_us-gaap_Revenues_acbb563c-0ae6-4f4d-94d1-1830320145a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_393bfd6a-8edc-47b1-a840-9effbe2f969e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0f72132e-acdf-4f36-aa26-79924d2f238b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_393bfd6a-8edc-47b1-a840-9effbe2f969e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AssetImpairmentsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#AssetImpairmentsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AssetImpairmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c9c839eb-41a8-47d7-bb34-330594f8171c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_234860f3-6d89-4a87-8f6b-3aac6dd71d86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c9c839eb-41a8-47d7-bb34-330594f8171c" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_234860f3-6d89-4a87-8f6b-3aac6dd71d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_88986512-5c65-4ee3-8cff-24e2c55a378b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_234860f3-6d89-4a87-8f6b-3aac6dd71d86" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_88986512-5c65-4ee3-8cff-24e2c55a378b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_ed0399e3-c0ba-45ac-89d8-a566ef2e6394" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_88986512-5c65-4ee3-8cff-24e2c55a378b" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_ed0399e3-c0ba-45ac-89d8-a566ef2e6394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LongLivedAssetsAndIntangibleAssetsMember_29d851b3-4930-472a-9125-a9f60157eec2" xlink:href="syk-20241231.xsd#syk_LongLivedAssetsAndIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_ed0399e3-c0ba-45ac-89d8-a566ef2e6394" xlink:to="loc_syk_LongLivedAssetsAndIntangibleAssetsMember_29d851b3-4930-472a-9125-a9f60157eec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_009676b5-5b9b-4b9d-9751-198e68957749" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_234860f3-6d89-4a87-8f6b-3aac6dd71d86" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_009676b5-5b9b-4b9d-9751-198e68957749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_470205b4-208e-4c47-80f5-04a238692099" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_009676b5-5b9b-4b9d-9751-198e68957749" xlink:to="loc_us-gaap_AssetImpairmentCharges_470205b4-208e-4c47-80f5-04a238692099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AssetsHeldforSaleDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#AssetsHeldforSaleDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AssetsHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_bcbd8ac6-5b6a-4bed-b0aa-dbc3be469e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a93ffe6d-e0e4-4c65-a493-70caaf989df7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_bcbd8ac6-5b6a-4bed-b0aa-dbc3be469e7c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a93ffe6d-e0e4-4c65-a493-70caaf989df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b91466aa-82e6-4a20-b5de-7b5a5dbc4afe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a93ffe6d-e0e4-4c65-a493-70caaf989df7" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b91466aa-82e6-4a20-b5de-7b5a5dbc4afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9c744ede-cdc2-4fb8-9ee8-763f4174f590" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b91466aa-82e6-4a20-b5de-7b5a5dbc4afe" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9c744ede-cdc2-4fb8-9ee8-763f4174f590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e6014033-0345-45e4-a771-4b90ddb96333" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9c744ede-cdc2-4fb8-9ee8-763f4174f590" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e6014033-0345-45e4-a771-4b90ddb96333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fabdac5f-feec-4e64-a047-e462efbcd146" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a93ffe6d-e0e4-4c65-a493-70caaf989df7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fabdac5f-feec-4e64-a047-e462efbcd146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b2c5d0be-767e-4c19-aca1-5d3d5d1ba0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fabdac5f-feec-4e64-a047-e462efbcd146" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b2c5d0be-767e-4c19-aca1-5d3d5d1ba0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpinalImplantsMember_1e3ff412-c8c4-455d-82b7-544e9e6fd207" xlink:href="syk-20241231.xsd#syk_SpinalImplantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b2c5d0be-767e-4c19-aca1-5d3d5d1ba0b2" xlink:to="loc_syk_SpinalImplantsMember_1e3ff412-c8c4-455d-82b7-544e9e6fd207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_49a75b6b-8051-4c69-9c3b-523a9799461d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a93ffe6d-e0e4-4c65-a493-70caaf989df7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_49a75b6b-8051-4c69-9c3b-523a9799461d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_396e5781-dcd5-4968-9496-cbd552282c09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_49a75b6b-8051-4c69-9c3b-523a9799461d" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_396e5781-dcd5-4968-9496-cbd552282c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue_2d94c84d-9513-4f2f-b417-c6368763ff0a" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_49a75b6b-8051-4c69-9c3b-523a9799461d" xlink:to="loc_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue_2d94c84d-9513-4f2f-b417-c6368763ff0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue_45e0d0c6-f2db-4e91-9c3f-edf131dd4d46" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_49a75b6b-8051-4c69-9c3b-523a9799461d" xlink:to="loc_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue_45e0d0c6-f2db-4e91-9c3f-edf131dd4d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_49a75b6b-8051-4c69-9c3b-523a9799461d" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_0bbcc035-63fb-4aa8-862d-1be5494e2c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_0bbcc035-63fb-4aa8-862d-1be5494e2c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_0008907d-981a-49a1-8110-42fc40652e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_0008907d-981a-49a1-8110-42fc40652e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_dbbda89a-7420-433e-bbfa-c0965bc960f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_dbbda89a-7420-433e-bbfa-c0965bc960f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_f75f0778-4a7c-4c14-af42-0e8340cf7c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_f75f0778-4a7c-4c14-af42-0e8340cf7c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_3d80c562-1aef-4a01-aa03-e9f3ec57d7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_3d80c562-1aef-4a01-aa03-e9f3ec57d7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_bc00bcb3-72b3-4d60-a5a5-85ae117a8c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_bc00bcb3-72b3-4d60-a5a5-85ae117a8c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_5a947b6a-2267-48d6-94f9-2560e8c4b50d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_5a947b6a-2267-48d6-94f9-2560e8c4b50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_982e2126-efcc-4979-8e80-8d2fed2fa8eb" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_982e2126-efcc-4979-8e80-8d2fed2fa8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_c4085b0f-f2d3-4f26-918a-4a3b14a0216c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_e50dae3e-ad41-4a90-84c8-c722bd26f763" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_c4085b0f-f2d3-4f26-918a-4a3b14a0216c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_bd7afd5f-e988-4cdf-82f1-60158febbb81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_49a75b6b-8051-4c69-9c3b-523a9799461d" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_bd7afd5f-e988-4cdf-82f1-60158febbb81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_796306b2-fa2a-4f22-8c67-00d8bfb35534" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_bd7afd5f-e988-4cdf-82f1-60158febbb81" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_796306b2-fa2a-4f22-8c67-00d8bfb35534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent_f8edaea5-32b3-4542-8a4e-7c55f76b0e8b" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_bd7afd5f-e988-4cdf-82f1-60158febbb81" xlink:to="loc_syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent_f8edaea5-32b3-4542-8a4e-7c55f76b0e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent_d539f95d-cc7d-4685-a99f-4e9b7185b289" xlink:href="syk-20241231.xsd#syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_bd7afd5f-e988-4cdf-82f1-60158febbb81" xlink:to="loc_syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent_d539f95d-cc7d-4685-a99f-4e9b7185b289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_44220358-95b0-4bfb-b180-35dcd463c62b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_bd7afd5f-e988-4cdf-82f1-60158febbb81" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_44220358-95b0-4bfb-b180-35dcd463c62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_176e06dd-15f4-47a7-8fcd-1d3a64b28fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_bd7afd5f-e988-4cdf-82f1-60158febbb81" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_176e06dd-15f4-47a7-8fcd-1d3a64b28fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_f20c332f-e7d2-4d30-a9cb-d95b701e41ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_ec02878f-e9df-4db6-992f-797618bfc9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_f20c332f-e7d2-4d30-a9cb-d95b701e41ff" xlink:to="loc_us-gaap_SubsequentEventTable_ec02878f-e9df-4db6-992f-797618bfc9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5ba0d24a-93df-4be9-a578-8de9592fa751" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_ec02878f-e9df-4db6-992f-797618bfc9fd" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5ba0d24a-93df-4be9-a578-8de9592fa751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_46841459-6485-4a8e-b003-c3039fff836d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5ba0d24a-93df-4be9-a578-8de9592fa751" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_46841459-6485-4a8e-b003-c3039fff836d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c9734c23-2699-46ad-be50-965c5e99cdfb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_46841459-6485-4a8e-b003-c3039fff836d" xlink:to="loc_us-gaap_SubsequentEventMember_c9734c23-2699-46ad-be50-965c5e99cdfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_50da3f07-6e12-451b-a343-39342ec2e35f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_ec02878f-e9df-4db6-992f-797618bfc9fd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_50da3f07-6e12-451b-a343-39342ec2e35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bd409da6-a433-429a-8d0c-169363f3ae95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_50da3f07-6e12-451b-a343-39342ec2e35f" xlink:to="loc_us-gaap_EquityComponentDomain_bd409da6-a433-429a-8d0c-169363f3ae95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_87f0c239-7707-4dfd-bf01-f9b54a2d231b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bd409da6-a433-429a-8d0c-169363f3ae95" xlink:to="loc_us-gaap_CommonStockMember_87f0c239-7707-4dfd-bf01-f9b54a2d231b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0a2d7b8e-d5e2-4d01-a3d1-5080fec63206" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_ec02878f-e9df-4db6-992f-797618bfc9fd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0a2d7b8e-d5e2-4d01-a3d1-5080fec63206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea360b52-6737-4e60-851e-d3501333e15d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0a2d7b8e-d5e2-4d01-a3d1-5080fec63206" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea360b52-6737-4e60-851e-d3501333e15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InariMedicalInc.MergerMember_f5752750-f5f4-4a85-a3f9-db95e94e9b3a" xlink:href="syk-20241231.xsd#syk_InariMedicalInc.MergerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea360b52-6737-4e60-851e-d3501333e15d" xlink:to="loc_syk_InariMedicalInc.MergerMember_f5752750-f5f4-4a85-a3f9-db95e94e9b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cf1563ed-3f30-4e1e-b2d4-c2bee64a03a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_ec02878f-e9df-4db6-992f-797618bfc9fd" xlink:to="loc_us-gaap_DebtInstrumentAxis_cf1563ed-3f30-4e1e-b2d4-c2bee64a03a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5a890692-e17e-489e-bfba-13abb47f09b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cf1563ed-3f30-4e1e-b2d4-c2bee64a03a0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5a890692-e17e-489e-bfba-13abb47f09b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.550DueFebruary102027Member_6c0524bf-08b2-42ec-9dd1-c25c69a360b7" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.550DueFebruary102027Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5a890692-e17e-489e-bfba-13abb47f09b9" xlink:to="loc_syk_SeniorUnsecuredNotes4.550DueFebruary102027Member_6c0524bf-08b2-42ec-9dd1-c25c69a360b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.700DueFebruary102028Member_d7437674-8e85-45e2-bca4-7c7294bf10f2" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.700DueFebruary102028Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5a890692-e17e-489e-bfba-13abb47f09b9" xlink:to="loc_syk_SeniorUnsecuredNotes4.700DueFebruary102028Member_d7437674-8e85-45e2-bca4-7c7294bf10f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.850DueFebruary102030Member_7bc9a3f6-bf86-4cb8-b7ce-63f48f3f8ad8" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes4.850DueFebruary102030Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5a890692-e17e-489e-bfba-13abb47f09b9" xlink:to="loc_syk_SeniorUnsecuredNotes4.850DueFebruary102030Member_7bc9a3f6-bf86-4cb8-b7ce-63f48f3f8ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes5.200DueFebruary282035Member_bf46fb8b-7b05-4d06-8e22-2d5a9b91fe4f" xlink:href="syk-20241231.xsd#syk_SeniorUnsecuredNotes5.200DueFebruary282035Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5a890692-e17e-489e-bfba-13abb47f09b9" xlink:to="loc_syk_SeniorUnsecuredNotes5.200DueFebruary282035Member_bf46fb8b-7b05-4d06-8e22-2d5a9b91fe4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5ed9aa1c-7b81-4f3c-970d-33bf600b625e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_ec02878f-e9df-4db6-992f-797618bfc9fd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5ed9aa1c-7b81-4f3c-970d-33bf600b625e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_89d5892c-3759-42ae-b959-e4d90ad97c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5ed9aa1c-7b81-4f3c-970d-33bf600b625e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_89d5892c-3759-42ae-b959-e4d90ad97c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c32916bd-dfd4-4814-ad93-0c39abb6e217" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_89d5892c-3759-42ae-b959-e4d90ad97c9a" xlink:to="loc_us-gaap_SeniorNotesMember_c32916bd-dfd4-4814-ad93-0c39abb6e217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_27730b12-36c2-4648-b7eb-c187a9c61841" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_ec02878f-e9df-4db6-992f-797618bfc9fd" xlink:to="loc_us-gaap_SubsequentEventLineItems_27730b12-36c2-4648-b7eb-c187a9c61841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_78c31291-3f0e-4d78-b155-479cd22c4b58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_27730b12-36c2-4648-b7eb-c187a9c61841" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_78c31291-3f0e-4d78-b155-479cd22c4b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationPriceOfAcquisitionExpected_2169f69c-90dc-454c-8bf2-566fa194c648" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationPriceOfAcquisitionExpected"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_27730b12-36c2-4648-b7eb-c187a9c61841" xlink:to="loc_us-gaap_BusinessCombinationPriceOfAcquisitionExpected_2169f69c-90dc-454c-8bf2-566fa194c648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2734d83f-abdb-4a66-b0c6-edf8c4aadf61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_27730b12-36c2-4648-b7eb-c187a9c61841" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2734d83f-abdb-4a66-b0c6-edf8c4aadf61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_59a24d20-6fec-449f-9a38-d3f999da7f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_27730b12-36c2-4648-b7eb-c187a9c61841" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_59a24d20-6fec-449f-9a38-d3f999da7f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="syk-20241231.xsd#ScheduleIIValuationandQualifyingAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_ee4bdea8-05b6-4908-8303-846696757f4b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_2f0d8dea-ba20-41a3-a532-f4cd76a0217f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_ee4bdea8-05b6-4908-8303-846696757f4b" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_2f0d8dea-ba20-41a3-a532-f4cd76a0217f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_35e6903a-f732-4de7-8dda-20e941e96ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_2f0d8dea-ba20-41a3-a532-f4cd76a0217f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_35e6903a-f732-4de7-8dda-20e941e96ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_069663f1-a4f8-4784-baf7-0c2d84649f14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_35e6903a-f732-4de7-8dda-20e941e96ee5" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_069663f1-a4f8-4784-baf7-0c2d84649f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForNotesReceivableMember_8dde1499-c52d-444f-bd57-970607465778" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForNotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_069663f1-a4f8-4784-baf7-0c2d84649f14" xlink:to="loc_us-gaap_AllowanceForNotesReceivableMember_8dde1499-c52d-444f-bd57-970607465778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c1c783a0-7ccf-46c7-8685-acce0e156a90" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_2f0d8dea-ba20-41a3-a532-f4cd76a0217f" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c1c783a0-7ccf-46c7-8685-acce0e156a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_0f45643e-b813-44c1-a70e-e821e3210394" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c1c783a0-7ccf-46c7-8685-acce0e156a90" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_0f45643e-b813-44c1-a70e-e821e3210394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_c1229862-2893-4565-9c2a-707e3088003b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c1c783a0-7ccf-46c7-8685-acce0e156a90" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_c1229862-2893-4565-9c2a-707e3088003b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_fa2db0c7-e5e6-4cc0-9476-e3d475bc1160" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c1c783a0-7ccf-46c7-8685-acce0e156a90" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_fa2db0c7-e5e6-4cc0-9476-e3d475bc1160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_8444c129-a9f9-4087-9ce5-0f6001201fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c1c783a0-7ccf-46c7-8685-acce0e156a90" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_8444c129-a9f9-4087-9ce5-0f6001201fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_1880d517-cdd1-4706-bbfe-1af464451267" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c1c783a0-7ccf-46c7-8685-acce0e156a90" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_1880d517-cdd1-4706-bbfe-1af464451267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ex19icorporatepolicy6_as001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex19icorporatepolicy6_as001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **\H\?_%ZX\.^(X_#OA_2QJ.I
M\>8'!(!(X50IR3ZU@?\ "U?B;_T(R_\ ?B7_ !H ]=\2>*=(\):>E]K-R;>W
M=Q&K"-GRV,XP ?2M&QO;?4K""]M7WP3H'C;!&0>G!KY>^)7C7QCXC\/0VFO^
M&QIMJLX=9A&ZY;!X^8UV_P /_'OC:631-)F\+B/2=JQF\\I^$ ^]G.* /<J*
M^<[/X^^,=1+_ &+PU:7.S[WDQRMCZX-;D/QSU&_\'7^H6>D0+JNFNC7<$F[R
M_*8E=R\YR#@$'UH ]PK+\0>(=,\+Z4^IZM<&"T1E5G"%L$G X S6)X6\;Q:Y
M\.5\4W*I&8X))+A$Z*R9R!D^U>-^(O'VL>/OA-KMUJ%C:VUM;7-O'$8=V78O
MDYR>PQ^= 'T-I&K6>N:5;ZGI\IEM+A=\3E2NX=.AYJ[7C%C\0[/P%\$_#TN$
MGU.>UQ:VQZ-\QRS>BBMK3_B7?Z7X(/B;QI90V23L!96EJ"991CJ0QP,]>O2@
M#TVBO!%^-?C6YM)-6L_!R/I"$YFVR'CZ@XKN=+^*FG^(? FJZ[I4>V^TZW:2
M6TG_ (6"Y'0\J?6@#T*BOG6V^/?C*ZMVNH/#%M-;)G?)''*5&.3R#Z5ZK\/O
MB-I_CK24E51;7ZLR26Q/< $E?48(H [6BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJMJ%O)=Z;=6T,QAEE
MA=$E'5"00&_#K0!XU\0_AOXL/CM?%O@V1#<N!N7S%5XV P2-_!!%8UVWQXL;
M2:[N)RL,*%W.;8X Z\"MO_A3OC;_ **3?_G+_P#'*9-\%O%]U"T%S\1;R6%Q
MM='$K!AZ$&3F@#CO%OCF[\<?!N&;4$47UIJ212N@P),H2&QV/K7OO@UE;P!I
M)4@C[$G(/^S7+6_P7T6'X?3^%S<RM)-*+AKS:-WF@8!"^F.V>_6LSPM\(?$/
MAK5[&8>-;B;3K:3<;((ZHZ\\8WD?I0!S_P"S6 ?^$@R >8O_ &:N\'PGTBS_
M .$DN+>29YM9MY8Y$<C:I;)&..QQ2?"_X:3_  ]_M'SM3CO?M>S&R$IMVY]S
MGK6A\1?B%#\/;&RNIM.>]%U(T85)0FW SGH: /GG2O%4OA_X:>*/"D\C)=R7
M:(D?H#D2?^@#\Z[36]"_L+]F6W1XPDUS)%<R<<G>X(S^&*X"VL3\3/BDSZ9I
MTMM:WMRLT\8._P E,C>20![_ )U],^._!O\ PEW@U_#]K<I9+NCV.8]P4(00
M, CTH ^5XM,\0VFD:3XMOK1[C2+>988/.Y7:IR!M_NGD9[G-=_\ ';5D\0:7
MX5U;3W#:7/ Y4#HLGRY4^X''X5[18^!K9?AM#X.U*1;J%+?R6E";<G.0P'."
M#@_A7,>'?@XMCX8OO#>NZDFIZ9-)YUOMA*26TG<JQ)QG X_QH XO2K3XU7>D
MP-IE_926#1CRQ$]J4VXX&,55T+X?>+?"NG>+M2URVBAMKG1[A6,<R,&D)!'R
MJ>/XJZ&#X%>(-++Q:-X\N[2V8Y$:(Z?GM< UZ#9^#]13X;W/AB_UE[V\G@EB
M-]*&8_/G!()).,^O:@#D/@';1W?PON[>0?++=S(3WP445U'@WX8Z1X)N#-87
M%S(Q+']Z0>H ]/:I_AOX*E\!^&GTF6]2\9KAIO,6/8.0!C&3Z5V% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5'+;PS@":)) .@=0<5)10!%%;00$F&&.,GKL4#-2T
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ"LO,****ZC(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<A9,HX^964]?<&MS0=6M8++[-/((V5B02."#5'Q!J$-]<1+ =R1@C=C&2?\
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MK^'_  =+D8SW\,IS5I&]1117VAXH4444 %%%% !1110 4444 %%%% !1110
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M %IVA#5!H5D-:,1U/RA]I,7W-_?'M0!H45BZ/XFLM;UC6--M4F$NDRK#.SJ
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MPE%_Z"U>B.P:)\$' (XH X[X4Z[J7B3X>V&J:M<_:+R5Y0\FQ5R%D8#A0!T
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M )))K'^_!_Z.2@"6ST_Q)XQM(M2FU^\T+3)D#6=G8H@F,>/E>61@<,PYV@8
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M8B_: \4+/Q+-IEO);Y[Q@*&Q_P "KTN@#B/!OBG4]6NM6\,Z\D5KXBTL /)
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M,7PS_P"1H\?_ /8;;^1KG/ ^D^);S7_&W]E^)XM*===G\Z%].6X9LG*MN+#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHIDSF."20#)52<?04FTE=C2N[#Z*YJ/Q#?R1/*EDC1I]YESQ6SIM^FH
MVOG*I4@[64G.#7#ALSP^)ER4WKOJFK^AO5PU2DKR1<HHHKO.<**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSLYS)P/WJ\GT/ME\.G:H^K>%2-&N[:&STN>TN)=\/[AG6-5X#Y('ED\9ZC\
M#J[37])OKW[':W\,L_S%54_?VG#;3T;!X.,X[U6O_%.G:=XBL=$G=A<W<;R*
M=IVJ%*CDXZDM^E<OX3\.WEE_PCEM?V.HF?2(F1II;A!!&PC,>8PO+ALY .,#
MD\C!V?$D&I0^)M&U>PTV2_%M;7<)C214P\GEE-Q)X4E""><>E #+'Q?!::GK
M-CKVHV<36=\L$+*ACRC11N"V2<<R$9) .*V[_7])TN<07U_#!)M#D,?N*3@,
MW]U<\9.!7#ZMI6L7FE^/8(M NC-K! M"9(?G'D)&"3YG&&4GGL?7BI-2T/49
M]4UZXFT[59K?6+2%4MX)XD&1&4:*4DG:.<[AD?,>_4 ]!N;F"SM9+FYFCA@B
M4O))(P554=22>@K/A\2Z-/!=S+J,*QV:JUP9"4\I6^Z6#8(!P<'OVK.\5:)=
M7_@Y+"PC$LUO);2K TG$PBD1S&6..H4C)QSUK.UVRU#7[*XN+;0FMY(KBRG"
M3E%FO!#+YC1G!(  ^[N/WB>@Y(!T!\4:(ME<W;ZC%'#:X\\R94Q9Y!8$9 (Z
M$BHCXP\/*TJ_VM;%H@"R@DD@YP5'5AP>1D<&N6\1:9J^M-XDO[72+I1=Z&=+
MMX':-9)I&+G<06P%7<!DG/)P/70@@OX_&&G:E_PC]XMO;Z,]J6#0Y60LC! /
M,]$(STR1VYH W9?%6A0+;&35+8"ZB$UOAL^<AZ%,?>^@YJ0>(]';38]174(&
MM9)/*1U.=TF<; !R6R#\N,\'BN T^/4-&7P+;W>C3B[M7O$:VWQE\>6QW(0V
MT\'ID=_;-H:9KT9FU%--N(8+W76O)+>$0M=00^0(PR[B55F906P=P5CWS0!V
M;^)]$CL8[V34[=+:27R5E=MH$F=NTY^Z<\8.*C_X2[P_]CNKMM6MD@M65)W=
MMHC+?=W9Z ]CT-<.VC:[_P (KJ^GOH-]--<ZY'>HKS0,6A$L4A+'>!G"$$>I
M[CFM]=)GU7Q9X@&H:1<1Z5J>F06AED:/#%3+N& Q(XD&#CL?:@#9O/$EDL<\
M%C/%<ZE]D>YM[13\\H"Y&!Z'@?C0VNV^CV-I%KU[;QZ@UN))UB5B,@#>X49(
M0'N>/>L3X>PZA<V<^JZLZ2W0 TZ&53D20P%D\SZN^]OIM]*9XPTJ\NM9^V6%
MIJD=XE@8X+VPDC(=BQ/DRQR':4^Z<D=SR* .KN]7T^PTS^TKJ[BBLMH?SV/R
M[2,@Y]*BL=?TG4KJ2VL[^&::-/,**W)3.-P]5SW&16%XHCNHOA#JT=\D*7BZ
M)(LZPC$8<0G<%'IG./:LS4=*U7Q1>V0BTV72TM=*N[=IY73:SS1JBJFUB2H(
MW9('0=^  =;;>(-,U1VMM.U*![AXV>$X)#@<;EZ;U!(SM/XU@Z9XGO;OPYH]
MQ<WVG6U]=Z@]N_F1,$F5)VC*QC=PY &,D\U7M[+5+F?PINT:XM/[#C=[G+1X
M8B!HA%'AOFR6SG@849P>*SH--UV+PAHUBWA^]^TVNM?;)8Q+!Q$+EI<Y\S!.
MUNGJ#]: .XN/$FC6M]]BGU"%)_,6(J3PLC?=0GH&.1@$Y.14"^+_  \UE]L7
M6+0VWF^3YH?Y?,Z;<^N>,5A:58ZAIIOM+GT)KS[1K#7T=S(4,/EO*) [$G(=
M!P!CJJXXY$-OI-P/B-=:8FPZ,LB:XZ@\I<,&C"$>A=#+_O+0!VU[?VFFVIN;
MRXC@A! WN<9). !ZDG@#J:I)XDT9[&2]&H0^1'-]G<G(*R\?NRIYW<CY<9YJ
MAXMT^\N9-$OK2W:Z&FZ@MS+;(P#2)Y;IE<D LI<, 2.GKBLV_L=0N[S3=:AT
M,PI::JUS):J4$T\;6YB\UAG&\$\#.=JCOQ0!OOXHT..T6[DU.WC@:;R-[MM"
MR9 V-G[IY'!QUJ2T\0Z/?07<UOJ,#1V?-PS-M\H8SELXP,<YZ5P^KZ-K%]!K
MMW%HMS(-3U*QECM=\081P-$7=\N "P0@#)/ SCL_Q#H>LZUJ7B0V^DS1QWEG
M8B%II(@LSP2O(T9PQ(W!@H)&.N>* .SM_$NBW,=U)'J,(2UC$LYD.SRT.<,=
MV/E.#@]#BFGQ3H:V,]X^HPI!;L%F9\J8R1D;@1D9'(SUKG?$5AJ/B?1]1^S:
M)+93;;5D>9HTGN/*F\QHL@D   @$G&YCVY-'5]$OKW0/%+6>DZI->ZE8+91-
M=W$6^4XDQE<A552_4G)R>, $@'4#QMX9-RUO_;5IYJML(W]6P3@'H> >G7%,
MU/Q/9-X8NM2TS5["+8QB6XN@QBBD'57 P1]..U9VN65U<S>%I+30+AEM+Z.X
MN%!A!B18I$ .7Y(+@C&>,UCZII>MW.@^.;2'0;OS=6N=]H/,A <&&-,G]YQS
M&3SSR/? !VEYXFT;3KE[2]U&"*ZC0.\7.[![A>I'TS4LGB#28[6VN?MT3Q72
M&2 Q9D\Q  2RA<DJ 1D]!GFL)AJ#^/H=6.@WOV9-)>#S"T.1(75]N/,S_#C/
M3/?'-<GH5OK6FWNAV=MILT.JV.FW$=W"PBEV123 QG'FJN"4;!#D_*05Q@@
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M *&HZ+INK/;O?V<=PUNV^$N/N-ZCW]ZOT44 %%%% !5+4](T_6K86VI6L=S
M&#^7(,C(Z'%7:* &11)#"D48VHBA5&>@'2GT44 %4+'1=-TRYN;BRLXX)KEM
MT[H.9#ZGU-7Z* ,^]T/3-1O+>\O+..:XMCF&1LYC/MZ5H444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %(2%4L3@ 9)I:;(@DB>-NC @_C2=[:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDU/1770P-"A+FIQL_5_@NGR,9UZE16DPHHHKK,@HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#H&&,'\:1M"T=[%+%]*L6M$?>MN;=#&K>H7& >3S6A10!%;6UO9VZ6]K!%!
M@PD<2!54>P' J&/2M.AEN98["U22Z_X^'6%09O\ ?./F_&K=% %6QTRPTR-H
M]/L;:T1SEEMXEC!/J0 *CN-%TJ[NS=W.F64UR4,9FD@5GVGJNXC./:KU% &=
M_8&C;]_]DV&[9LW?9DSMV[<=.FWC'IQ5FTL;33XC%96L%M&6W%(8P@)]<#OP
M*L44 41HFE+//.NF60FN%*S2"W7=*#U#''(/?-1CP]HH55&CZ> C%E'V9."<
M<CCKP/R%:5% '-Z]X2AU+1I[#2Q9:6UQ)&\TRV88L$<.!A67N.I)ZGUS6A;>
M']*@LGMVTO3?WQ#W BM%1)7'\17GOTR21ZUJ44 9\VA:1<6L5K-I5C);PDF.
M)[="B$]< C JGXBT*YUFPMK&TN[:TMHYHY98Y+4RB01LK*G#KA<J,]<CCCON
M44 5[RPL]1@\B^M(+J'(;RYXPZY'0X/%13Z-I=U:16EQIMG-;0X\N&2!61.,
M<*1@<5=HH H76A:1?&(W>E6-P85V1F6W1]B^@R.!["KDD,<L+0R1H\3*59&4
M%2.F"/2GT4 9B>'-#BB6*/1M.2-5*JBVJ  $Y(QCIFGKH.CH\3)I-BK1',9%
MN@*'.>...>:T** ,U_#NAO+/*^C:>TD[;IF-JA,AZY8XY/UJW=V5KJ%J]K>V
MT-S;O]Z*:,.C?4'@U/10!F_\([HF,?V-I^-H3'V5/NCH.G0>E/BT3289XYXM
M+LHY8\;)$MT#+CI@XXJ_10!3ETK3IK]+Z73[62\CQLN'A4R+CIAL9%!TG36U
M$:B=/M3? 8%R85\T#&/O8STJY10!533;".]FO8[*V2ZG7;+.L2AY!Z,V,D<#
MKZ5##H.CV\$T$&DV,4,^/-C2W15DQTW #G\:T** *+:+I3V/V%],LFM-V_R#
M ICW>NW&,U8M;.VL;=;>SMX;>!?NQPH$4?0#BIJ* *?]D:;_ &A_:']GVGVW
M_GY\E?,Z8^]C/3BBUTG3K&9IK33[6WE889XH51B,YP2!ZU<HH S[W0='U*X6
MXOM)L;J=1A9)[='8?0D9J:?3;"ZN(+BXLK::>W.89)(E9HO]TD9'0=*M44 4
M[;2[+3XY?[-L[2SDD7!:* *"1G&0N,@9Z9K.T/P\^GZ;>VFIS6NHM>74ES,P
MM?+5RYSAE+-G' 'L!Z9.[10!GQZ%H\,D4D6E6*/$<QLMN@*'.<@XXYYIT>BZ
M5%)<21Z99(]R"L[+ H,H/4,<?,#[U>HH I)H^F1V<EFFG6BVLIW20+ H1SQR
M5Q@]!^0J[110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !2,P52S'  R2:6H;K_CSG_P"N
M;?RJ9OEBV-*[L1#5+ G NX?^^Q5L$$9!R#7GT;VPL94>%FN"PV.#PH[UT]OJ
M$6G^'X)6<3$#8 IZGT_"O!R_.O;N7MK)*-[J^FMK/_@'?B,%[.W)=MNQM45S
MK>(KN*!99=/*H_W&R0#^E6[W6S:VUJRPAI;A P4M@+D#O^-=T<VPCC*7-M9O
M1]=NG4P>$JII6W\T:5Q<1VL#S2MM11R:+>XBNH%FA;<C=#BLZ:[F.C7$U[:1
MX&!Y8?(89'.14*ZQ#9:-;RI;A3)N"0J>!@G)S_GK2EF,(5+SE:/+S:II[V_I
M;@L/)QT5W>W2VQN450TV[N[H2?:K4P8 *]?FSFC5M1;3;=)5C$FY]N"<=C73
M]<I*A]8=U'S3_+<S]C+G]FMR_17/MXBN(C'+-8,EL_1CG)^E6;_7$MFBBMHC
M/+*H90.F#TK!9MA'&4N;:W1WUVLMW<T>$JW2MN:]9\>LVDAN/OJ+?[Y8<=<<
M56L]<>2\%I>6Q@E;[OU_&LRQD6*35W>,2* <H>A^8URU\U3<'0>CYKW3TLKZ
MK<TAA6E+G7:WS9TUM<Q7D"S0MN1N^,4^:9+>%Y96VH@R36-%K$%GHL,RVX3>
M65(E/H>3FGKJ%S-873WE@%18]P#9PX]*WCF5-P4>:\^6^B=EI?7LOQ(>&DI-
MVTO;=7W-.UNHKR 30MN0\=,5-6!%K,-II,+Q6H5I&8)$K<<'J34UOK4HO([>
M\@2,R\(R.&&?0T4LTH-1C.7O-*]D[:[>E^EPGA:EVXK37M?0V:*Q)=;G>_DM
MK.V20QD@EW )QP<5M(6**7 #8Y .<&NNABZ5=R5/6WD[??U,JE&5-)RZBT44
M5TF04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQYF,Y$>=V,<Y_KQ0!ZE17FFK?%U=-U^^T>+PS?W5Q;0-=!HIH]DD &[S <\
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M=?\ AOK^CWNH6\&L7<:RPBX=%9!)'A60';GYF!]??B@#VVBL+Q9XE3PKHO\
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M3\K D DD<CBNA\0?$B70KG[/_P (UJ$TL5C]MNF:1(HX5"Y9 Y.'<>BY]LT
M=Y17FFI?&2PL='T35X=#U"ZL=7&V%XV0,) Q5HRN<[ACZ'/6HX/C'NU*RTZZ
M\(:Q:7=]<&WM4G,:"1@0#RQ&.H_/C- 'I]%<UX.\7KXQL;J\@TN[M(()3"K3
MLA$KKD-MVL<@' ST.>.E<!X:\8/IU_X_UF2VUNXDL)DDN=/N;F-A;C+[A'SC
M"A3T/(  SB@#V2BO,M&^,MIJVJZ+:R:!J%I;:R62SNI70AV4[2, YQNXS^E<
M-I?B#5-5^)VO:UK=SK-A8Z%()I((KA3';QH&_=.@;#;BH'RYYZ]: /H:BO-=
M/^,$%U=Z7%=>'K^RBUE6.ES221D7+ X"G!^0DX'/]X=N:K:=\9GU:^^R6/@[
M5YI%NUM)65D*1N3C#,.!R#U...M 'J=%>1-\>+1;&6_;PQJ8LK>Z%K<S>9'B
M)SD@#GYCPWMP.>:W]!^*-MJ^N7^D7FBZAIUU:V?VY8Y0':6+ ;@+_$0P.WGN
M.HH [ZBO-[#XN0W&L:397OA^_L$U:5X;22:1"Y93MP\8.Y,DCKZ^G-4?"GQ'
M\1Z]XU\0Z>_AVX:VLMJ+;)+$&MG"OD.Q(W%V7 QD#Z<T >K45XAX-^(NF>&?
M!>JZI=SZU?O)J[6\-O=R+)*TA4':IS@ =S^G.*ZR'XJKYNM6%UX>OK;6=)M_
MM4U@TT9+P\%F5\[3A6!(].F: /0Z*\NTKXU66I7VB)+H&H6EEK$YM[:[D9"K
M2!@I& <X!91GW]JZ[P]XM'B#7-<TP:7>VATJ<0F:=,)-RPRO_?.?H0>] '1T
M5A^+M0U#2_#5S=Z9"\MPC1@^7%YC)&7 =U3^(JI8@>U<\/$MQ:>']=U[3-97
MQ'8VMEYL,9\I9895#E_,"JF%P%."-W#<=* .]HKF;GQ?_9UAI,]]I&H*^HR+
M!&L8B;$K*2JD"0XW8.#T'<BDLO&8N]2&G2:#J]I=FWEN1'<K"F5C8H<'S,'Y
ML8[893G!S0!T]%>?7'BI/[:T/75_M"VTZ[TR\N'M9Y0/,">3Y;!-Y4$ASCD$
M[AFND?Q.B0:=NTO4%O=0+>18NL:S;5&69LOM4 8ZG/(&,\4 ;M%<M)X[L8[;
M3YAI^HR"]NGL51$0M'<IOS$XW\',;#(RO<D#FDBU::UM]3\6:L+ZRTZ&TPNG
MS+\\7EL_F.5!(+,<8()&T YYH ZJBLK2-;.JRRQMIUW:;(HYE>8QLDBONQM9
M&8$C:<CMD>M4M3\86>F3:@&M+N>#30AOKB%4*6^X!N<L"<*0QV@X!'TH Z*B
MN4O?'=M8RZLC:1J<BZ2JR7DD:Q%4B*[A(/WGS#:"<#YN.0*N6GBJ.\U![%=,
MOXYS:&\MA((Q]IB! RGS\'++P^T_,* -^BN5L?'-G?P:;<-INI6UCJ4@@@NI
ME0+YIR A"N67)! .,$]^032T+7AI.DZC]MEO+QAKD]A9QE_,ED._"1@L>P!Y
M)X ))H [>BN6O?'5II]M=O<Z9J"S64T45S;@1%HA+_JW)W[2A/&0>#G.,&K%
MSXPM+*?4X[NRO84T^*.264JC*S2'"(NUR2Y/&,#MG&1D Z&BN;D\9V=JUS#>
MV5Y:WL!A LW"-)-YS%(]FUBIRP(ZC&#G YIEQXXL+.*=;JTNX;R&ZBM&M'\O
M>7E&8\-OV;2,\ENQ'7B@#IZ*HZ7J+:E!*[V5S9O%*T317 7.1CD%200<\$&L
MX>*X1?6\,VG7\$%S=M9PW4J*J/*N[^'=O .QL$K@_0@D WZ*Y*?Q]:VR:C)+
MH^J+#IEP(+Z0K$5@R%(;B3YAAP?ER0.H%1>*_$B'3M?L+*VU*273[4O/=V;A
M!;2%-Z\[PS$##$*#P>>N* .RHK'M=5AL/!UOJVHSD10V"7$\K<G 0%C[FN>7
M6[NZ\=:(19:M8QW-C<R-:W$B[9@OEE"%5RH8;CUP>1F@#N:*XNR\66>D^'?[
M1FBUNY@DU.6UD-QY<DMO(9S'L(5N4#_*-NXXQ5^/Q?YMPMF-"U5=1/F-]C=8
ME<1H5!DW%]FTE@!ACDY]#@ Z6BN9C\;6-Y';G2[2\U"6:T^VF*!45HHLE?FW
MLH#%@P"@DY4^F:AL_%]S?^*K/3X-(NA8W.FK>B9_+5QN9<$J7R H)!&"<]!@
M9(!UE%<V/&ED0+C[)=_V:;O[&-0PGD^9O\OINW;=_P N[;C/MS4!\=VXN+R(
MZ+J^VPN/(O9!%&RV_P @<.VUSE=IS\N2.X'&0#JZ*P]#\3)KIA:+3;V"">V%
MS!/+Y;1R(2!C*.V&Y!P<5E7NJ7.F?$&6"W@U&_6?2Q/]CAE!4,LFTL!(P5>,
M#@C.>G6@#L:*P(?%4%[8:9=Z;I]_>KJ,)GC6-%78HQG>SL%4Y(&,Y)SC@$U#
M%XULI_[#,%C?21ZR2MO(%0*CJ"65\N,$!6.!G.TXS0!TM%<RGC6U=Y(ETW4/
MM O380PD1YGE52S["'QA54DDD =.O%:NCZQ!K5M-)%'+#);SO;SPS ;XI%ZJ
M<$@\$$$$@@B@#1HK A\5PR7]G;RZ=?VT5[/);VUQ.BJLCH&8C;NWJ"$8@E1G
M'N,LB\7VUQ/%]GT^_FLI;PV2WR*AB,@)4G&[=M#*5W;<9'IS0!T5%<U:^-+.
M[:TF2QOAIUVTBPZ@RIY+!%9BQ^;<JD(V"5&>/44D/C>P9(IKFTO;2WN+22]M
MIID7$T4:AF("L6!VD-A@#CW!% '345RG_">6<6D2ZK=:=?V]DEJETDS")EE5
MF"J 5<@-DC@D8SUZULZ5JS:D]Q')I]W9O#M_U^PJX89!5D9@1^- &E17,:;X
MIN+C7?$%I>Z=):V>ELO^DLT9 7RPY+8<GD'(P.G7!XJ>P\66][<Z=%)8WMHF
MIH7LI;A4"S87?C"L2I*Y8!@. >XQ0!T%%9.HZ]%9:G#ID%I<WM_+"T_D6^P%
M8U(!9B[* ,D <Y)^AQ3B\7V]U]BCLM-O[BZNK7[9]E"HDD46<9?>P ).0!DG
M@]AF@#HJ*Y5O'EBW]E_9=/U&[.II(;40HGS21YWQG<XVLN#G.%X/-);^.#=3
M2V\?AK7/M<-M'=26[QPJZQONP>9.N48;>O'2@#JZ*YV/QC8WOV)=*MKG4I+N
MT%ZB6X12L). S%V4 DY&,YR#Z&J[>/+%O[+^RZ?J-V=320VHA1!NDCSOC.YQ
MM9<'.<+P>: .JHKEY_&T5M827UQHNKPVT$,<UT\L*)]G#C."&8%BHY;:#CZ\
M5+!XBO9?'5YH)TN86L%I%.+@-'U=I!N/SYV_)@ #.0<C&* .CHKG;+QC97UQ
M8A;6[CM-0D>*RO'">5.RAC@88L,A&() R!],OUF]CA\2:!:R-J41GGD$36[(
M()&$3L4E!.XC"DC QD#F@#?HKDG\?6L4=Y-+H^J)!8W0M;R5EBVP,=N"<2$L
M/G4_+G /-4[J\O=6\;:KILSZE8V>GVMO+'/#.B(A+2,SN ^6#",* 0<<Y SF
M@#N:*YNT\96UU_9[_P!GWT-OJ0/V">41A;@[2Z@?/E2R@D;@N<=CQ52'X@0W
M%G)>0>']:DMHO/6601Q8C>$D.I)DQGY3@]#T!SQ0!U]%<K#XYAN+BS@BT753
M)?VQN;$%(A]H0;2V"7^3 93\^WKQSQ5NW\507ND6%_9Z??W#7DK0I;I&H>-T
M+!PY+!5"E&&=W7&,Y% &_17':CXXECT_3KG3M*N9FGU0:?<1N8PT+A]KJ?G
M+'!P02O<GUO'4XAXTC@N#J=K(NF27'ER/']E9 Z;F(#$[U+ 9Z8SC/6@#HZ*
MYJW\9VUPEA*--OT@U($V$KB,"Y.PNJCY\J64$KOVYQV-1:=X[L]1_LN4:9J,
M%IJ4S6\%S,D83S0&.P@.6'W&&<8R.M '5445SJ^+[>;5;FRMM/O;E+6\2RN)
MXA&5BD;;U4MOVC<,MMQUZX- '145S9\:604W'V2\_LT7?V,ZAA/)\S?Y?3=N
MV[_EW;<9]N:J2?$&SA@N;B;1]6CMK2\%E=3&.-A#*2J@$*Y+ EEY4-U% '7T
M5SR>,+)(]7;4+6ZTYM*B6>X2X"$^6P8JR[&8'.UAC.<C&*LZ=X@COM3?39[&
M[L;Q8%N5BN=F7C)VY!1F'!&"#R,CUH V**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#G/#FBZGI>K:Y=WLMH\>I7(N56'=F,A%3!SU&$!SZFMC3%
MU!=.A&J/;O>@'S6ME*QGDXP"2>F*MT4 %8'C7PO#XR\)WNAS3&'SP"DH&=CJ
M0RG'<9'/MFM^B@#RRQ\,?$<OX<TV\U'2H-)TET6=[.>57O(5P-KKMP?E&,=.
M:Q#\&O$,>A3^$8-5TX>')M1%[]H97^U*, ;-N-IZ#G/;\*]INKF&RM)KNXD$
M<$$;22.>BJHR3^0K/TC6UU=I +"]M0L4<RM<HH$B2;MI4JQ_NG(.",C(YH \
MZOOAEXAE\7ZAK%K>:4EM/ILFF0POYFY(3'L4DX^]P">U9+_![Q4_@[2_#G]I
MZ,(-/O6O$EVR[F8YX/&,<FO<*SM=U>/0=%NM4FMIYX+6-I95@"E@BC);#, <
M >N: .#U#P)XFU;XCZ7XJN[K1U2TMA:O;Q^;\R,KB0@D=?WCX^@SWKE'^#?C
M.+PK>>$K;6-&.BO>?:XI)%D$S'@8; P!@ ]^1UQ7NID A,@5F&W=M Y/M]:@
MTZ\_M'3K>\^S7%MYR!_)N4V2)GLR]C0!X_??"'71J5SJ-G_PCMS<7]FD$ZW\
M#2+;2* OFPY5LG"YP1U)ZBM2]^&>O-J_A*[M+[2O+\/QK@-"T?G.2"YVH-JC
M(X KT2YUF*UUVRTJ2VN-]XCM%. ICR@RRGYMP./;'/6M*@#QNV^$OB >&/%F
MD7.HZ83KDJW*/&)/W<JR!\'(^Z>1W/UJ"_\ A;XYUCPIIFAW^M:.(=/EB>!%
M1SY8CCV !MH)SDDY[].*]@M+_P"U7=Y;_9+J'[+($\R:/:DV5#90Y^8#.,^H
M-6Z /&/$'PF\1Z[XDU;4KFYT2Z&I6JQ*]T)6:R?:,^2N,8R#@DY .<9SE9?A
M;XNELO"=L=0T0+X;E\V XES*=ZM\W'^R!Q7JFDZS%J[7R);7%O)97)MIDG"Y
MW;%?(VL000Z]ZG%_G5VT_P"R70VP";[28_W)RQ&P-G[W&<>AH Y'XG>#=4\:
M^';2RT^\@AE@N5FDAG9A#. #\K%><9]JY*P^%/B73;OQ#/:3>'K9-:L6LWMH
M4E6.W5@ =F!SCGD]3S7K][<FSLIKD02S^4I;RHMNY@/3<0/UJ/3M1BU32+34
MK9)/)NH$N(U8 -M90P!YQG!]: /((OA+XI@L_"5NFHZ.?^$<N'N(BPE_>LTH
MDPW'3Y0.*9=?"7Q?;VOB/1-(U;25T/69_M#?:!)YR$-NVC P!T!// Z"O6]$
MUJ'7;2:>&"> PW$EM)'.%#*Z-M8?*2.HZ@UI4 <KIMM/X7^&RV>MW-FIT^P,
M+31,1'L5-JD[N_ _&O"/ 7AG7O'G@#_A'++5](ATJ/4!<74<@<W47&!@#@J>
M2,XY!YKZ@(!&" 1Z&D5$3[JJN?08H \YT;P#K6E?%&X\4?:M.-C+;"R$ W^8
ML*JH0YQC=^[7/;DUF:I\,_$<&J>*_P"P+[3/[/\ $_-U]LWB2 DL6V;00V=[
M=<=1Z5ZW61J_B"#29X[86MU>73P27 M[55+^7'C<WS,!U90!G))X'6@#P/5K
M4^$OBWX4TC0M7TX7FEZ6+8SWY(A\UO.8JX4Y7=OX'4;EKHV^#'B";PAJ>GRZ
MIIO]HZO?B\O),/L4+DJJ<9/+,3D>@]Z]?TR_CU59Y?[/NK;RI?+!NH=ADX!W
M+ZKSC/J#3;/6HKS7-0TG[-<0W%DD<K-(%VR)(7"LI#'^XW4 T <=XU\$Z_XK
M\!:?X=2[TV"5-ANI2)-I*#"[/KWS7.:E\)-<?59M5M/^$>NKJ^L5MKE+^!G2
MWE5542PY5N<*#@CJ3U%>ST4 >4^(/ACK4MIX.DT2_P!.%_X?+,QGB\F*1F*L
M658U('S*>,=_SS=;^$OB;6-?FU"^U/2=6-UIJVCRW\;@VTFT!I(D4;<Y!(Z<
ML>*]8N]7AM]'?4[>&?4(AC:EDGFO)EMORC/.._L#6A0!XFWPD\6'P[X>T;^T
MM%\K1+IKF&3$NZ1F??AN.F?2KOQ[:R'@[36N;N.WUR*Z22R\ML$MP)"#U"C(
M.?4+7ID.MQ2^(KC1&MKB.XAMUN1(X79(A8J"I#$]01@@=*T61'^\H;'J,T 8
MWA'2+70O!^E:;82)+!#;)ME7[LI(W%_^!$D_C7GD'PV\71?\)@3?Z(3XF4B;
MB7]R26^[QZ.W7N!7KP&!@=** /%K7X3>*;,>$_+U'1R?#KN\>X2_O2\OF'/'
MX<5?T_X7:ZVH>*WU6_TTVWB1&$_V99-\+?,4*9X(!(R#UQ7H^E:U%JMSJ-NM
MM<6\VGSB"9)@OWBBN""K$$%74UIT >.V'PM\3377AF/6+_2C9^&0S67V<2%Y
MWW!D\S( 495,XSP#ZYK?^'O@G7_!IUUKJZTVX.HRM<Q^4)!ME.>#G^'GZUU.
MK>);?2KI[46=Y>W$=N;J6.U16:.+.W<0S#.2#@#).#Q6U0!X8WP9\3OX4U'0
MFU32-E]J"WS2 294@$%1QTY%:\GPT\57'BJ]ULZMIEO)=Z6=.8P"3=&/+"[U
M]\J#UZ5ZY10!X3I?P8\26%QH%VDGAV"ZT>X\[S(UE+79WA@9&P#QC  Z<^M=
M)8^ ?%NB^/M;UG2-6TZ+3]4NA=2"16:1MH<B(C;@*6?E@<X''I7J55+^_P#L
M'V;_ $2ZN//G2#_1X]_E[OXWYX08Y/:@#Q>+X(ZZ?#ESI\NJZ:+A;_\ M&UE
MC5\"7 4HV1]W !R,G(K<3X<>)+W5_$?B+4[S2EUG5+$V$,,'F&WA1E5&8D@,
M3M7CCJ?R]$U_6HO#VC3ZI<6UQ/! -THMPI95[MAF&0/;GVK3H \3B^$7BF'2
M_"UFFI:.?^$?NI+J)B)?WI:19,-QTRN.*]'\.:7XEL=:UNXUO68KVRN9@]A!
M&F/LZ9.0>!V*COTSWKI:* ,[6[?4KG3PNDW4=O=I+'(K2@E'57!9&QR P!&1
MZUSDW@Z\U2Y\07U\UG9W.JZ6=-$=IN=5!#_O'8A2[?-CH, 8YKH=%UN+6XKM
MH[:XMWM;EK66.<+N#J 3]UF!'S#O1I^MQ:AJ^I:8+:XAN-/,?F>:%VN'R592
MK'@A3UP?:@# N= \1WD&CB>?30^GWJ700%RNU(C&$!P"<EF;)'&0,'&:J_$>
M*TNI]"M?[12SU">[-NK;@&-O*I68>P*XP?[X3O7>44 <9XH\&S>(=4T]U%K'
M8V5O+%&H=DD1G,95T8#Y2AB4BF7/A35=2AT6ZUG^R=4U+3/-C99HB(;E'502
M00VQ\JIR 1P>!GCMJS+K6XK/7K#29;:XWWRN89P%,>47<RGYMP./;'/6@# E
M\+:D(=#2V&DP#3]0:_DCAA,2$E9%"*%'99/O'DE<XYKI=8M[J[T>[M[*2&.Y
MEB98VF0.@)'\2G.1ZBKM% '*^%_"TFA:K?WB16EA:W,<:+IUB[-"CJ6+2<A0
M&;(& H&%[U4U'P29M9U:\@L]'N1JC([2W]N)'MF"!"5!4AP0H(4E<'/7-=A<
M7$-I;R7%Q*D4,:EGD<X"@=R:EH XJ_\ "VL77_"5I'+8)%K=L+:+._,($9CR
M>.?E).!CD8]ZMQZ7J5IX@L=:OKC3HK2RTV2TG^=AP2C%\D  #RQU[$\UU58<
M7B[1IKJ"".XF87$Q@AF%M+Y,D@S\JR;=AZ'OV- '%>#].U#Q'X0\/P?;+!M.
ML;M;F0H6\[?&Y=(F7HO.TDYSC''.:V(?!^K?9G:6YLA=Q:R=7MMF_86;<&C?
M(SC:Q 8>N<<8/:0W$-P91#*DAB<QR!3G:P .#[X(_.I: .0N-$@BM_$FJ^)Y
MK:*'4[9+>>.-R8X845@ &(!9B9&.<#D@ <<Y>@^&V\1_"E8+J^CN+[5!'=S7
M3J'#2HR% Z@\[1&B,,_PFNPU[6X?#VEMJ-Q;7$T".JR>0%)0,<!B&8<9(Z9/
M/2M.@#A;OP(=1LYP^GZ'8R"6WFA@MK8-&S1.6(E;:I96SMQCY1SR:L/X5NCI
M]Q%'IGAZ)+BXC:;3UMU\F6%5(*._EY+;CN#;>, >N>RHH Y_PCX?E\.Z;<VT
MDJ[);IYXK>-V>.U0@ 1H6Y*C!/0<L< 5SB>!-52\LIR^E23V>IM??;71C<7*
MEG(1VQ\N ^."1\HZ8Q7H=% '"7WA'7+W2/%%C]HT]#KD_FA_G/DCRTC(QCGB
M,'MU-3W'AG71-KHL[G3TAUR,&X,@<M;R^4(F*<?."%7&<8/KTKKKN=K6TEG6
M"6<QKN\J+;N;Z;B!^9%0:1J<&M:-9:I;*ZP7D"3QB0 ,%8 C(&><&@#+G\.R
MZGX"D\.:C+&DDMB;1Y8,LH^7:&&<>QQ^%44TCQ/-K>D:G>S:47L(I87CB,@$
MN\+E\D<'Y!\N..>3VV=7\0VFDZ)<ZOY<MY:VS,)OLI1BFPE7^\P^Z001U]JU
MJ ."/A'73H+:=Y^F[SK']J;\OC_CX\_9C'K\N?3M6GKOA8ZEKMIK(LM-O98[
M5K66UOUS&06#!E;:V""".G(;M7544 <?:>%]3T6_BU#2FTUII+!+.YA:(P1!
MD9F5XP@. #(P*]^.0>L\V@ZTFNZ?J=OJ%O+,E@ME=S31[6;$BNTBJHQDX88X
M R#VQ74T4 <2/!NH?V,OALSVO]C+?"Z\[+>>8Q/YXBVXQG=\N_=T_AS6AI6B
M:O92>(Y'N+-)-4F-Q T8+>2_E)&,AAA@-@/XGBNFK/L]7ANK**YFAGL?-F:%
M(KQ/+=F#%1QGOC(]1B@#G_#7A&?1]??4_)L=/C>U\F6TTYF\J>7<#YS*555(
MP0 !_$>:NS:3JW_"9/K4#61@%B;1(G9PQ.[>&) QUXQZ<^U:-OK,4^OW6CFV
MN(KBWA2?>X79(CEE!4AB>J,,$#I6E0!Y[:>!]6MK'1+>=]*OX].@EMVMKE7,
M+%V4K,%P<NN",'L3@BKEMX,O[?P%::(+JU&HZ=.MQ97*J0@=9-ZEE[ @E2!V
M)KMJS=9UF+1+>"XGMKB6&6XBMR\(4^69'"*6!8'&Y@.,_2@#GKGP/YFBZ%"1
M:7EWIDS7$JW:9ANI)%82[N#C+.6!P<$#BM[P_I;:38R1-;V-NTLS2F&QA$<:
M9P . -QP!EB 3Z#@5JT4 >>67@35;6^TBY=]*DN-.OGN)+PHQN+Q661?G;&5
M(#],L#@=,8K9T;0-8T:&/2;>[M1I,=U),LN"9FB=V<Q%2-O5L;\YP.@/-=51
M0!Q^E>&-6LM$M_#DMY;?V-;Q20>9&#YT\)5E5&!&$(W E@3DJ.!DU!I/@V\T
MRTBA@M]#M;BUL7MHKV"T4RS2%=JR-E?DZ9*@MN)ZXX/;T4 <!;>!]0M9;^YL
MHM)T[[3:I"]A &>UG?S SNZ%0!E0R8"GAB<GBMCPGX9D\/7&IRA;>UMKMHS%
MIUJ[/#;[00Q4L!RQ/("@<"NGJIJE^-+TRXOFMYKA+=#(T<.W>5')QN(' R>O
M:@#GKCPO?3ZSK?\ I,"Z5K*@7(P?- $!A*#C&/NMNSG@C'.:2S\-ZI)<>'QJ
M<UH8-$!:-H"Q:Y?RC$K," $ 5F. 6Y(YXYZ6QNX]0T^VO80PBN(EE0,,$!@"
M,^_-2S2-% \B1/,RJ2(T(#,?09(&?J0* ,'4=&OU\3Q:_I;6SS_8S9S07+,J
MLF_>K!E!((.>,<@]L57&A:S::Q;ZS#=6M[?M8+978GS"DA5BZNNT-C!9AMQR
M".>.=G1-7@U[1[;4[:.6.&<$JDH 88)!R 2.H]:T* .)T_P=J.F77AYH;FTE
MBTU[B6X9PRM+).S&0J!D* 6.,D^GO59[^\?XG:W#HUWIK7!TVUC\FZD(!=7G
M)(*Y)*AAE<?Q#D5W]5+2_P#M=S>0_9+J'[+*(]\T>U9?E!W(<_,O.,^H- '*
MZ3X.O?#,FGSZ5/;W4L.FKI\ZW3-&)-KEQ(I4-CYG?Y<=".1CE-/\':CIEWX>
M:&YM)8M->XEN&<,K2R3LQD*@9"@%B0"3Z>]=M10!Y_XH\!ZAK]QKH$FFR1ZE
M$BP7%W&SRV6U I2,8Q@D%L@@@L>#Q6T^BZP/%2ZQ!/9QK<6EO;7:G<Q7RY'<
M[..0P<KSC'7GI7344 <3X<\#G07TZW6RT;R+!V*WBVP-S,N&" DK\A&1E@Q)
MV]!DUK:[I&HZAK>AWMH]JL.FW#3NLI;<Y:-XR!@<</GZBN@K 'C/1FN[JU1M
M0>>T($\::9<L8\C(SB/N.1ZB@##NO".NW6A^(=/,^G*^KWHN@^7(B&$!&,<_
MZM>>.I]*TK?0-3E\0:M>W[6?V74[.*UECA9]Z!!)R"1@Y\P^F,5T&GW]KJNG
M6]_92^;:W$8DBD (W*1D'!YJS0!QMMX7U;[-H%E>3V;6VA,LD+QEM]RZ1-''
MO!&(QALG!;)':I=.\.ZM9>#-2T9Y;)KFY>Y:.1=X0">1W.1C/&\X]<#I76UF
M6&MQ7^L:EI@MKB&XT_RS(90NUU?=M92K'@[3UP?:@##M?#VMV]_X>N3)I[#2
MK&2T=0SCS"P0;AQQ_JUX]SZ503P9K":3IUK-)IMT+2_N+J2UEWB"X65G8!N#
MRC/D9!!QV/3OJ* .#M?!.IV>B?8XYM/,L&LC5(%C5HHB/,W&,@ [!R0",]JO
M-X<U>\U^"^U"XLY8?[,ET^X$897;S"C,R\8&"F /3FNNHH XN#POK'V30;*Z
MFL7@T(B2!T9PURZ1-''O&/W8PV3@MDCC%06WA'7+?1- T\W&G,VE7_VMG^<"
M0?/A0,<']XW//0>O'=T4 9ND3:E<-?OJ$211B[=+1%4AO)7"AFYY)(8CV(KF
MM0\'7VH^(4U!AI\$\=\D\>I0;DNO(4@^2P50&! *Y9CP>E=O2,2J$A2Q R%&
M,GVYH XD^#=0_L5O#?GVO]C&^^U>=EO/\OS_ #_*VXQG=\N_=T_AS4<WA+79
MM&U:Q,^G*]_JB:@'RY" .CE<8YYC S[GTKJ=$UF'7+&2ZA@G@\N>6W>.<*&5
MXW*,/E)'4'H:TJ .+U/P??ZW=>(/ML]I%;ZMI\5H/*W,T31ERK<@!AF0\<=!
MZUI:!H,FG7\EW+IVBV), B"Z=  7.<LQ?:I .!A><8ZGMT5% !1110 4444
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M\17=I--]L;<(U1VAB:7=NVEL#D\X S7J(TZR4J19VX*_=(B7CG/''K0=.L3
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M^O'%,:RM6ACA:VA,48PB&,;5'L.U 'F>L:E-HD_C&ST;4IV$6G6ES&K733O
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M]S,IG<JQ/?(YSWZUV-1Q6\$#.T4,<;2'+E% +'U/K4E !1110 4444 %%%%
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M)^#<J>#M'-"^&-4T^]U&31]2MX(]2CB$S26^7AD2,1^9& 0O*JORD8!&>G%
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ML6I6QEMM2FU2Y9[=OWTLHD5@H#?*H$A ZG@5J7&BZFWB\ZW!>6BQ+8M:)#)
MQ/)#;BP8?Q#ICI0!6TOQQ!JLNCLFF7L-GJX86EQ+L&75"Y5E#$CA6P>^WTP3
M.WBQ8M1MK>YTRZMX+J\:RAFE*J6<;L,4SN"-L.&[\'&#FLS3_!VK65EX9M3J
M=DZZ),TF[[,P,P,;QX^_\O$C>O(%54^']_'<6LBWNG%[75&U!;EK0F>XRS';
M(^[L'QD?W5Z8P0"S#XGU"_TCQ4U[I=U%#8330 VD\:R*BQH3M;</G&YFST'
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M1Q/"]O</;31N0=KH<'!!((Z$'T-5/%&@3ZXNG-!);G['<^>UO=QEX9QL9<,
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M\FTZYN7MHKQ-I!9=V7*YR(\H0&/MQ@@U2L?!3:=?M]G_ +-^RM?M>^<]FK7
M#.9&C#'C&XG#=0. ,C-6=%\.ZKHD-MIEOJ4 TFUF>2,"$^<R,6(B8YQ@%OO
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MG'(.54@\].G-8DW@O4GC22/4K1;N35UU:Y=[=F5G4*JHH# A0J@9.2>O&<4
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M!,H!+^620#MQ@YQSQ42:N]QXKME>PU6"\;29;F*U>X00N \8*LH8@2 LHR>
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M5=XIXRZ(P"MD9!4YX!!!!]Q7'1>)[FPT#29M,LK^Y6]UF2TF%]<J\L9$SJR
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M:Z>*,N(( "\A ^ZN2!DU9KF/B))!#\/]<EFG\ADLY6A?S3&1*$.S!!'.<8%
M'21.9(4<HT9902C=5SV..]/KS>YN-$U+QOHT=QJD36T^BS23HMZ525E:'9N
M;'3>?P)[5C:+J&G0:3X.U'^VO,O9=4DM)I9;XL7@VS*$8%L8 $7;K@]3D@'L
M-%>-W<^GV>@>(VMM0F77[/5I8],B-TYE#>8/+CC4GYD))!&"#R#TXT]8N8C;
M>-9]2O'AUNUE8:6HF*R(ODH8/)4'G=(6Z#YCD'.,4 >HU#;W<%V)#;RK((I&
MB?:?NNO4?45YS:V-AK_CO5=-U"^D$ATVTEDM8+UEVW.Z7S&"AOO#"\=!GIS5
M&SO-'\/^&/%EM&9H[M;V])AMIV21(1,JABV#Y8Q(IW8SC)&<4 >M45Y/;:E8
M1:AXJL)-0L(K+^R(9T2UNV\H29E!9&)'S<1@E>IQGFI-#N=-@U+P.8M5$DVJ
M:;(E[OO"YN#Y:XW MUWA@,=.0/2@#TZVNX+R)I;:59461XRRG@,C%6'X,"/P
MJ:N$^&ATNSTNXTVV95ODNKLS0@L3&BW4BKGLO!X'!/7G%5]5LM*UCXH3:1<W
M\@2?2"9;6&]:,M+OX. WW@G('T..!0!Z'17E&AM=S7=C+=:G;V^K)K,L<RM+
M*]Q(@D<>28QP$\L @_=  ;WIOAUXCXBTRWGN(=6CU"2[,=[;73K<;<,2MS$<
M\#[H((P0HP,T >LT5X]HMY9KH7A6?3]1EE\0/J4<$L;7+/*\/F,)%="?N"/)
M!(P, ]3DV3=G_A'FO/M;_P#"8?VUY7E><?-_X^MOE[,_ZOR><8QM^;WH ]8H
MKQBXN])@\.^(=2M]8'VFQUU5LG%^3Y2>9'\JC=C:1YF>N1GL.-#7KV*'Q-?Z
MBMY;ZI;B^LXQ;QW317ELV(BH@'*R(VX,0 ,[G&3B@#M]6\4'1[>^N)](OVM[
M.:*,RCRPL@?'SKEAD L >^>QK=E<Q0O((VD*J6")U;'89[UY%K^IZ8MAX]L$
MU1-IO;00Q)<;W!*Q%Q&,DYW;N!WS6M]HT9?$M_!IFHI)HIT9Y;]DO"\4<WF+
MY3%]WRN1O[Y.!GM0!UL/B7=J6D6-QI=[:R:G \R&;9^[*J&9' 8D,,CMCWJY
M#K$9@GFO+>:P2*[^RJ;D >:2X1&7!/RL6 &<'VKSS1-:L+B3X:B;4[>2<Z9(
MLN^<%MY@08;G.2P(YYR#5&=M+U#PE??Z5'<P6'BJ(JWV@N(83=1C.<\+MS@^
MF<4 >Q45YOXCNK32KC3/%&G+<WNF302Z:T$<LFQI""L+*N>[*8]W?S%.>]=C
MH6B+I?AJWTJXEDN6$.VXDDD9C(Y'SG).<$YQZ"@#1M;N"]@$]M*LL19E#J>"
M5)4_D014U>/:5=6=A\/+6QLKAH'2_B75O)=@T%L;MT;<P^YP"#T(&3[UV'AZ
M2)/&^K6ND2B31DLH'98Y-\4=R6DR%.2 2@0D#V/>@#<M=;2Y\17VBM:SQ36D
M,<_F.5*2([.H*X)/5&Z@5JUY%XTU:WA\<ZH&NT^P1V-D-2^S7.RX2)9IRWEX
M.<@LFX#YMI..2*L:M=6]]K%^BZG91Z.FD1/IL\UY(JJ,R"26,J?F=2$!.=P^
M7U- 'JM%>3ZG)>3W]_!K&J6T0BT:V>UN;F26 ABK>9-$@P=^\#/\0^4=^;"K
MHT?B?5K?Q)JC1H=)LYRTMP\"&4^;YDB@D;7^4$#J.<=Z /4**X_2KR]D^$<5
M[JUW<6MW_9#23704F6/]V3YF/[V,-CUKBU5QHOB33%6&>\BT!IXKW2;QWBE9
M0VQF7[R3$\_>.X#VH ]DJ*YE>"VDEC@>=T7(B0@,WL"Q _,UYQ/K]M+XHLIM
M%U**>[G\.W1B59]R2W ,)B7&<%_O<=<&K7AJX\.I;Z-J"ZO(=0_LYWO"UR2'
M)";VN,GY6#\#.,$D>P .TT;5(M;T2QU6!'2&\@2=$DQN4, 0#CC/-/O[V2R6
MW,=E<77G3I"P@ /EACR[9(^4=\9/M7E/A6ZTS3K'X<W$&IHMS=*;>ZW7>=Z?
M9WPC*3C"NJ #'!P.]=?X_O+2Q/A^>>\2VE&KVX4M/Y>8RXWY&1E<8SG@4 =E
M6+K'B)-+NA9PV%U?WGV:2[,%L%W"-" 3\Q&220 !R37FFLW&E+IGC^[@U?$]
MA<"33]E\?W+^1&V4&[J9-P]\$5TRW&AW?Q<MIDO+62:32-Z;+@'<_F+MP ><
MKSCN.: .]1MZ*V",C.#U%.KR>RNR=#T:[2[=O%DNL)'=1^<3*?WY$L;)GB-8
M]QQC  !'8U<\,6&@:K<:_<W&IM+#IVK2F+&H-Y<,/EK_ +6-I)?D^G7B@#TR
MBO&-#DTN32_ 4LNLN;B^=X+YFOVW3)Y,C!'^;H'6,8]\=^;\6LV$/AV_L8KW
MS[2/Q']EB'VXK'%$Q#*))/F(BR&&._"YQ0!ZE=7<%E;M<7,JQ0J0"['@9( _
M4BHI;V2/5+>R%E</'-&[M<J!Y<97&%8YSDYXX[&O([N:TU'PEXLM99[>:'3]
M8MI8$AF8QPQGR"S)DY"9,ASTZXKI3JVD?\)]HBZ1J$3+)87L/E_:#MD='B5!
M@GGD28/<9P2* /0J*\HTNZB.D>$;F"]=_$%S=HNJ*TY,C*5;[0)5SPJG/484
MA<8J@E[I5KX?FU2'61]JM?$WE6\AORVR W84H 6P4,98^XY[4 >S45@>,M-E
MUGPAJ$-E+(MT(3-:O#*R$R*,J,J0<'I]#7#3>(BMLGC&-IY-%O(9--@M/,;:
M5$6Z,XS]XS))'GJ=ZT >FS7LD6IVMF+*XD2='9KE /+BVXP&.<Y.>, ]#5'5
MO$EKIFA3:O%%)>VT,C1R?9RN5VN48_,1G# @XYKD8+.RT#Q9X3T6;4C)<2:=
M<Q78ENV9IWQ%@D%NI)?'XXZ5SXNM&TSX1:WIT=U%;7X:Z5XRYRF+J0(.> <#
M@=3@G!Q0![*[%$9@I8@9VKU/L*KZ==O?Z=;W<EI/:/*@8V]P )(_9L$C/XUP
MD5QH5EXXO-/CU6$6%UHPGF1[XLK.'X?);ABAR2#R,&L73[_3K[0_AN+G5QYT
MY$-T1>E6D7[/)E7PW.7"@Y[G'>@#U^J%WJL-O;WSPHUU-9*&EMXF4.,C('S$
M#ISR:YSP!>6LA\0V%I>K/!9ZK(D""?S/+B*(P Y)V[B^/H1VK%2;0]#\5^,O
MM4T5K<7#IY(>0C=NM=S'&<8RK<GC/'4@4 >A:9?QZII5GJ$2LL5U DZ*_4!E
M# 'WYJU7DWARZT[3Y?A^]IJ:?:;[3VBN5:[W>:?(&U64G'$B[0,<=!Z5+X-D
MNKFX\.75QJ=M'JDC2_;X5EDDGG;8^])4Z(%?&"<!<!1]X @'JE%<?XKG0>*/
M#UMJ4WDZ),+@S;WV1R3@+Y2.>!C!D(!X) ]!6.ATU=2\/V;7T\OAJ1;]DDNI
MCLEG$HV(6.-R!3)L!X(4'G - 'I%%>/VMS:W.LZ%;76IN+.76+V"VW7C*9[,
M1OY8SNRR>8-H/.0 ,G-1?;-*M-!O;Z'6@9]/\1QPV;F_+>5 ;E 4 W<H4,G7
M/&>PX /9:*\SOCX>7Q9XHCU?4FM[?[)!<0;KQT5699"SQ_-C=PO3D=NIK*N=
M6FNM*M(]:98]33PY%.YOKIH]TCAN88U&3-E1DYR"5 ')H ]AHKRG3;[2=:\0
M>'CJ&K1RK<^'3->)]M*K)*/*Y<!L9 \P_@3VIMG.+CX=:-XCCOI[LZ'=N;D)
M<LWF6RRLK!\'YBL>UQGGY1ZT >L45SG@NS,>COJ3B99-3E:[$<LC-Y4;$F-
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MGK>RVL\\/FQQ/Y)7*;W" G<1D98=,FLOQW<30:!;M'-)%:/?6R7LT;E2EL9
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M3RB+G/RMDK@=6]\&MU;S3M0\20C6;Z(Z3_8L,MFSW&V&23<XF<-D NH$?/4
M\8R: /0Z*\BTNXAOK[P9%K>HR":YLKL3QS73(T\89?(,BY&25YYY//7FNO\
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MCS@K;,D9#QME6# 9&>_<9J]X0N)KGP1H-S<2O+-+IMO))(Y+,[&-223U))H
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MBH8->MSXEEGO8M6T]HM'^U/#<R)Y"Q;LEBBLV)!R"?04 =5Y:#^!?RI&BC<
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M+71\R)!Y<A 4[2!TPHK!U>:_U?QQ=:)C5+>VBTQ9HI+.Z6(K(SN/,X<%ON
M'/.<C!S5F+XA6SV<U_-H^IP:?;-<1W-U(J%89(2P92%8DY*X! ()(&<] #KF
MBC=U=HU9ESM8C)&?2D:WA92K0QE2,$%1@BN<N?&0L!(E[H]]!<"T>]B@+1%I
M8TQO ._ 90P)!/?C-10^-_M%S96\>A:D9-0MC=6(/E 3(-I;)W_)@,I^;'7U
MXH ZK8F -JX' XZ4;%&?E'/7BJ&AZQ#KVCP:C!%+$DI93'* '1E8HRG!(R&4
MC@]JR'\;01Z/<ZD^F7P2UO\ [!/'F/=&^Y5W??P5RPZ$GVH Z588DC$:Q(J
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M MQ/>>')C--)/;+>W,=G-(Y9I+82L(SN/+#;P&[@ UT+6EL]N+=K>)H!TC*
MJ/PZ5* %    '  H \A6;1M)^'_CC3Q<)#>.=6"PO,QP@=@O!. 3O3'=L]^:
MT3>QZ7X@@CT34C/=7GAVYF$;79E\^X0QF)MI)&XY?IU&>PKTG[-!O=_(CWO@
MNVP9;'3/K3A#$I!$2 CH0HXH \[\&-+)J6B3QZI;,9]-=[F&.[EN'N3\G[R0
M,,(RL2.>?F([<:FN30R>/+2QUBY\C2#ILDL*O,8HY9PX#9((R53! /J3VR.O
MCMX87=XH8T:0Y=E4 L?4^M$T$-PFR>*.5,YVNH89_&@#SVS:QEUO2[&^U.ZF
MT,:();.6\G:,W$GF$.['(W,$V$9Z!B1ZUDZ==)?W/@R/5-4G!NOMJ,KWC(US
M;JS>07&X9R ISU;U.37K$UO!<($GACE0'(5U# '\:5HHV8,T:$CH2HH \@MK
MZPM-&MM0377:>U\3?9(7?4&8+;?:BFSEL%?+)/.>.<\"K&I2Z7;1>.A-J]S!
M>V,WF:<IOI T3&VB=?+&[DF0GCG.0,8->K?9X,8\F/\ [Y%8ND^&_P"SM4U&
M]GNUNS>W N2CP*/*D"*@*GM\J** ///%NMS?8=?FEE^S:K8Z; ^9[YHWCF,6
M_-O$H]3RQ/)!'05NW,NCZG\0Q!<ZL#:S:-Y\L*7[)&SAAAL!AC"9/';GL#7H
M#V\$DHE>&-I I4.5!(!ZC/I1]GA_YXQ^GW1]* /)[34_(\'>%?&-QJ%W>6]B
M/LVI".Y=@\9RBNRJ<,ZMLSD9(8Y[5V_AQ8O#VAZ=!JEV\=_J,I;9<3M(?.<%
M_*4L3PH&T#_9]35S7]"?6K&*SAO39PK,DTBI"K"78P8*<]LJ,^HXK7**VTNJ
ML5.5)'0],C\S0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKIIU(WD'V$1^<;GS!Y>S&=V[IC'>N7T'XH>%M>BU&9-4MK6*RG:,M=3I'YB
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN!HY9)))!;3#F.-CPK ],\G'^U7F?@B74=!\+>)_#MSX3U*:YG-V9)TM&/E
MQHD:J-IW[GST/ &[I7T910!X+X5\+BU^#-]<IX09_%%M%-"4N[-TDE5WSP#@
MN AZ>V*P- M-9_X33PEJ26.L26]O9FWEF31S!':R,CKL&Q1E59QEC[^E?3-%
M 'R?-I&I+\-I_"A\'ZJ_B"WU,W,EPEB6'EXVY#CDY/&!P1SFNYT^ZGC^,4'B
M!O#NNKIG]E+;2.=*FR9 F#D;>>F,U[O10!\FOX=U-OASJ5@OA75QJLNM+<1G
M^S)-WD>6P^]MZ9SQ[UJ>([I]6\;^*Y+2WN%T^[TZWCU&YEM'G>T4",L2HP4(
M\O!#>A/T^GJXS5/AAX?U/5-0O]^H6CZDNV^CM+IHH[D?[:CK^&.I]30!SWB?
M13K'P"CTWPE/+J,*VL'DLH(>XC1EW<=<_*3M]L5RNAP3ZE\0O#NLZ;H6HVFF
MZ+H@AU(O9,F]EC<&-5Q^\8Y P,D_A7N>F:99Z-IEOIVGP+!:6Z!(HUR0H'UY
M/U-6Z /DL^&]4_X5K/8+X5U<:PVMBY1AILFX0>41][;TW=J]C^,'GZY\+8X;
M#2M1N;J\>%XHDLW:2/!#'>N,H<9'/TKU&B@#YKM])E3QQH]Z_A35/L%OH"VU
MP/[)DP9Q;LIXV\G) SZU5L[/7+/X9:/I\WAR]C:VU=GN9[G3'D:VC;&'1&&&
MZ-G@XP!WKZ>HH ^==$TK57@^(]O<:/J\SZK:F:RFN--,7GE5D.<!0JN0XPHY
MYQUK.N;37=;^$-AIEEX<U"&+1KF&2Z<0$/=9\S<50KEMF5SU^][5]-T4 ?-9
MTF[FTKQM>V>F:_?1ZE#%;P3RV.QKF7(8L(40;0NUANZ<^IK<NO#-G#\"2UGX
M5O$\075M%9RJFGN)V=7#,67&<?*?FQZ<\U[Q10!\[W<NKH/ 8;1=0L;:RTX6
M\U]_8YN+B*95(*+&X( )"X..=V>U<S)I.O?\*MN/#Y\-Z[_:#:]]M"?V=)M\
MKRMN<A<9SV%?5U% '#Z%\0'USQU-X;M-%N$M[6S2>XNYR8VB9E4A#&5R#\P'
M7/!XXK@/%EE-<?&Z34W\.ZE<Z;%ITL$DBZ;)(CR^5(!C"X;E@,U[9;:98V=Y
M=W=M:Q17-XRM<2JN&E*C W'O@5;H ^7+/0=?7P)X<%QH6JFWT;66N+^SDM'#
M/&Y0AE4CY@ K@XZ;O>M:XTW4=0D^(6MV&AZDNDZM"MO96XLG#S394AQ'C( V
MN=V.-_UKZ-HH ^:M#TZ^L->^'MR/#6KQ?V=$R7[KID@PS2/C)V\\'/T-9D<M
MNJ?$K31X?N]0N[W4#%:2VUIYHB<2R<$C[GJ,=<5]3.N^-DRPW C*G!'T-<OX
M8\ :/X2U*[OM,FU S7>?M GNFD61B<[F!ZMUY//)]: /)9M&U3PIXH^'^KZE
MHE[=P6VD_9;M;6W,S^9MD4(P'<!U'/H<=*YN#3-;C^#VI>'6\-ZXNI3:NMTD
M8TZ7;Y>Q1G.W'537U110!\YK%=:EXYTW4])\+ZKIUII&C-;7RFQ9&:3RY%VJ
MJ_?)+J/7@GH*S?[/U5O@:/#;>&];.K+J/G*ATV7 3.<AMOX5]/44 >"2)-I?
MQ(M?$FMZ%JEWHEYHR6L(%D[M XC561DQE22'_P"^\^M=M9P/8_!&:WD\-S6#
MR64R1Z5;I)<.AD+;1@Y;)+!CG[N3TQ7HM% 'RW-INI2_#OPIH[>%];>]T[4)
M)KH'2Y2!$SDX!V\Y!'%7;JROHM4^(0B\,:S]GU="M@$TN7:6WY!QM^7@GFOI
M>B@#YU?3+^+1/AWJ4V@ZD;'1+@IJ=LUBX=7RC>9L(RRX'WL8^7%9=_HFL77A
MSQO=VF@ZH+/6]2C?3;9;)RQ"RLY<H!E!M.,]\X[5]/44 ?/?CCPQ:'X4Z-%H
M7A.^35[SR&N5@TZ0.#"A1C( /E)9LC/WLD\U4NM)5_'?B"]C\):I_9MSH+6U
MH/[)D %P8448&W@Y##-?1]% 'S/:1ZW:>$?!5E<:'?VB:?>3BYO9M*:>6V+2
M;UV(RD$$$<X/(QVYI1Z'K3> O&MG-H6K_:9KV*\@,VGLA=!)AB,# ;!!(7L#
MV%?4M% 'SIXMN=0\2>!O#EM9>$-6ADL+U,&.Q=O-B2,!I.%&W+'H>N,U%JEG
M>V.I>/EU+0=3O)_$4:OI,JV3R9#,652<?(5!3(/(*8]*^D** /G#3M"U'3/'
M7@QM:\/ZE=V^F:8(+YUT]YD#D2LBY (;:)(USR 5]J[;X!VM]I?A34=-U'3;
M^QG6^,ZK=6SQ!D9% VE@,\H<@=./6O6:* "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M..98[5F""0X5R1QM/K]?0X .CHK-U;7+72'M8I4FFN;MS';V\";I)"!N; Z
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M[F.YC3C8 I& 2#_$"<C@5<N/%NF6UW+$XG,,-PEK/=+'F&*9L!49O7+*"0"
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M><4RP\2O>^+]3T0Z?<QI9)$1.RC:Q?>23SPORC'KS0!T%%%% !1110 4444
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M^ @WY4#Y3C&.#R37HM% ' 67A?Q%IFE>%1;KISW^C64MFP>=_+.Y%59,[ 2
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M:9R2.F/>L&]\+^([O0O%-B(-+636;S[1$QNY"(U*1H0W[KK^[!X_O>W/H%%
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M1M,N);>9]X=LEG5"F,9) !;..?:G0Z%KD\WA]KV&Q0:&C.IBN&/VF7R3$O\
M!\BX8D]3T&#UKLZ* //[;POXC@T#0; P:69=.U,WDC"\DVLFYV '[KK^\/7^
M[[\=#XTTJ_USPI>Z7IRVQGNE$>ZXD9%49R3PK$].F._6K]IK%M>ZK?:;&LRW
M-D$:421E05?=M*GN#L;\JT* .3USP[=:EK.EZS]DMIY;>VEMY[1KET7#E&W(
MX7D@ICD#(/;%5AX;U:";PP;:STJ*+3+B6XN(XII$7,BR*50%&SCS,[B1N(/
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M@^A+!"DC2)$BNW5@H!/XU)0!P5YX,NI=1UF3^S].NX]6E28FZGDVP-Y:(ZE
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MK?6K6YUNZTA5F6[MHDF</&0I1B0&4]QE6'X5HT %%%% !1110 4444 %%%%
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M"^,K),B-D'@\$]17/ZIJNI>'X/&=M9ZA<2+916DMN]P_G-;^;E9&RV20 NX
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M@578>A8#)' _*FSZ)I-U>&\N-+LI;HKM,TENC.1C&-Q&<8XH \[TG6-;U?\
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M=_)<NA**%R"0#SC/3O0!F:-XVM;_ ,,2:W?6\]E"DKQ[7B)+'S6C15QG<Q(
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MX! 0!<9!W9/2M:32-<M-2UR[LK:TF.LPQ$K)<%1;S+'Y9S\IW)@*<C!Z\<T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$=Q=WEU=OI8U2WAANK&X!2V!,:F"6 XSN)(+C<?G!XQB@#T9)$D+!'5BAVL
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M5CCCJ?I6S/!#=6\EO<1)+#(I1XY%#*RGJ"#U%8UUXJL8&C2VANK]WM!>E;5
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M?V86UQ&OF1RL$"PQA>H)88)/<Y..:L2^--.@BE$\%W%>1W4=F;)E7S3+(-R
M$-LP1SG=C@\Y% &O/I.G75_#?SV-O+>0#$4[Q@N@Z\'J*CBT+28+\W\6FVB7
M99F\Y85#[F^\<XZGN>].TO4UU2WED%M<6SQ2M"\5PH#*R]>A((YZ@D5F#QCI
MS.K^3=?8&NOL:W^P>09M^S;G.[&_Y=VW;GO0!J:CH^FZN(AJ-A;77E$F,S1A
MBA/4J3T_"F'0M);2QIATVT^P @BV$*^6"#D$+C&<\Y]:YK1[W4_$'B;5F>74
M+*+3=06*./\ =^4T8BC9D8!B2S&0G/. !CN*TY/$<Z^-QX?&FW!A-GYYN5VX
MR7"Y'S9VCG/&<]* -&'0-&M[R*\ATFQCNHD"1S);H'10-H ;&0 .,>E4WT:]
MF\9P:S-<6K6EM;2000^2?,0N5+-NW8R2@'3I]:P=$\6+IL5]!J1U&ZA@UB2R
M^VL@9(<R!8U<Y!_B49 .,C.*W+[Q=86,M_F"[FM].(%]<PQ@QVQ*AOFR0QPI
M!.T-@'F@"W-X;T*XGGGGT73I9K@8FD>U1FD'7#$CGIWHE\-:%-%!%)H]@T<"
ME(D-NFU%)R5 QP,\XZ53?Q?8_P!H3VMO;7=TEO/#;SW$"J8XGEV[0<L&(PZD
MD @9]C2MXNT];SRO*N3;?;/L)O0@\D7&=NS.=WWOESC;GC- &B-&TL:G_:8T
MVS%^!C[5Y"^;C&,;\9Z<=:EOM/L]3M_L]]:PW,.X-LF0, PZ'GN/6H=6U>UT
M:WBEN/,=YY5@@AB7<\LC=%4>O!/.  "20!6:/&%D(',EK>QW2WOV!;-HU\UY
MM@?:N&*D;3NW;L8!YXH V;*PL]-M_(L;6&VAW%MD2!02>IX[GUJ"/0]*BU)M
M1CTVT2]8EC<+"H<DC!.<9R1QFLBX\<:;:(3<6M]'*EVEG-#Y09X97 *!@"<A
MMPP5W U%-X^T^WBOWFT[5(VTTC[>A@4FV0@,'8AL%2#GY2QP#Q0!JS^%] N9
MYY[C1-/EEN"#,\ELC&0@@@MD<G('Y#TIZ^'=%6]%ZNDV0N0P<2B!=P8# ;..
MH  SUJK>>*8+363I*:?J%S>&#[1&L$:D21Y +!BP P2!SCVS3(?%]E>6UI+I
MUI?7S7,<DHC@B 9 C;7#[RH!#?+MSG(. <4 :::-ID=]/?)I]JMU<*5FF$2[
MY 0 0QQSD ?D/2J\?AG08K>:W31K 0S*%EC^SIM=0<@$8Y /0=!5&3QKIHBT
MB6&"\N8]7CWV30Q ^8=I;9R05; )YP!W(P:IZKXHM+WPI<7D4FJ6 BNQ:W#P
MQ)Y]K()%!#!B1@D@9&>&S[T ;2^&= 1H671--#0KLB(M4S&O/"\<#D\#UIR^
M'-$2Q:Q31[!+1I!*84MT5-XZ-@#&??K5._\ %VGZ?<7:217,D%DZ)>74: Q6
MS. 0&)()X92=H. 03BC_ (2VS;49K2&TO)T@NTLIKF-%,<<S;<*<MNQ\RY(4
M@9ZT 6Y?#>AS6]O;RZ-I\D-N284>V1EC).25!'&3SQ3[GP_H][>?;+K2[.:Y
M.W,LD*LQV_=R2.<=O2M&B@"C9:5;V-]J-['N,]_*LLS-_LHJ*H]@%_,GUJ]1
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!QGB_PM>Z_?220V>GR$6@CM+M[B2"XLYLOEU9%)9<%#MR.5/K3YO#^
MNV^L27=G/9W7VO2H;"XFN79'62,N?-"A2&SYARN5Z=:["B@#S"8WOAZ[\ :1
M-/I:ZG9PR0>4UT0DRK!L!W%0R[B./E//'-1ZW;W.@3:;=WU[IL&JZEXD6],3
M3'RD46[1A=Q )&%4%]O5NG0'U$HK')4$^I%#(K?>4'ZB@#@]2\):]JFG>))'
M_LZ*_P!:\F$1B=S%!%&#@[MF78DGC:!SUXYLZSX7U;7]6NI+I;&"SN]'ETV0
MQW#O(ADPQ< Q@$ C&,C(YXZ5VM% '&Z;X;O[+=,NDZ'!<QV36ZO"[EI78KEB
M^S*+A<[0&R2.>.4C\,ZBO@#2/#]S9Z5>M9I#!<03NQBGC1=N0Q3*MD!AQP1U
MKLZ* .-T73M<\-VUK80JDT=WJ;.8VEDGCL+78245VP2<J ,\ OTP*U?%>E:A
MJVGVT6GR1YBNDFF@EE:)+F,9S&S*"0"2#T(.W!&#6[10!YQ_PA>O1:;JUG;P
M:-%'?:I;ZBBI/(JQ",PDQX\OGF'&[C.[.!TJ]J_A'5=<O/$1N&LK>#5=.AM8
MVCF:1XGB9V5B"@!!+\C/1??CN:* .3AT[Q+<^*-*UB_@TJ-+6UGM98H+F1C^
M\:,EU)C&?]7]TXQ_>/:[JND7Q\2:?KNFBWEFM[>:UE@N)#&KQN4;(8*V""@[
M<@GI6_10!PJ^$=7M%L;^VDLI=3CU6YU&:*21DBS-&Z;58*3\H9>H&<'IFIVT
M'Q"U[XAN'73';4[&*U1OM#KAD#KN(\LX!\PG )Q@#)SD=G10!Y_'X)OH9;.[
MEL=)OKA=*BT^:&XF<(C1%MLBMY9)!#'*D#MR:U+3P]J5GXET:\CBTT6-AIKV
M#+$S1G+&-BR1[2% ,> N[H>O%=910!B>*-%FUO3(4M98X[NTNX;RW,N=C/&X
M8*V.<'!&1TSGM6?J>C:[K=JDMR]E!<VM[!=V=NDC/&#&<D/)M!^;)'"_+P>:
MZNB@#@];\)ZWK<.OW#"PAO=3LHM/BB\]VCAB0NQ<MLRS%G/&  !UK4_L[7O^
M$M;6A;:;L.G"U\K[6^=X8OG/E=,G'TY]JZBB@#RN".^\-:MX&T1KC2FU*RL+
MFW,37159AB(+SMW*6QD?*>A'N-7_ (0_6UABG=[*XDGU.>_OM/:XDC@DWIM5
M=X4EMF%/*X8YX'%=Z44MN*@GUQ3J /.[3P?X@LK*SM8X](*6VMOJ@VSR(I5B
MQ$87RSC&_&<GI5K4?#&O7EMXQ@5--4:\NR)C<R?NAY(BRW[ODX&[ ]<>]=U1
M0!P]YX1O9M6?5&T_2;R>YL(K66&YF?9$\9?#*VPEE(?D$#H.:J:EX%U&ZE M
M8-+M+B%;>.SU2TD>WFMHT5 R^6JX=<JV%+8PV.U>AT4 9OB#2EUSP]J&ELVW
M[5 \:O\ W&(^5OP.#^%<E>>"=7O-'L]]W:KJLTLZZI*I8*\$XQ*J'&<@+&%S
MC[@Z5W]% '.ZAI&I3>+]&U&VCLQ8V$4T3JTS*Y$FP?*H0CY=GKSGM6!/X3\1
MMX1U3PY$^F?9[A[CR97E<,1+,\FY@$X(#!=HSGDY&,'T&B@#FX=,UAO&T6LS
MQ6*6O]G_ &1TCN'9PQ8.2,Q@$9&.HXY]J9XP\-WFO?8'T^XB@FB>2&=W)&;:
M5"DH7 ^]]UAVRHKIZ* .5MO"UQ;>-7U%9(!I"@W$5NN0R71C6(MC& OEJ>_5
MS^.5<^%O$5QH&O:?LTM9=3U$7B-]JD*QKE"5/[OD_NP/^!'ICGOZ* .%UCPC
MJ^O7^M/<&QMH=1T^"V1HYGD:*2%WD5B"BA@6?!&1P/?B]J^G>)];\/ZM83II
M<#7EBUI'&EP[J&=65I"WE@\ C"X[')KK** .6@T?6O\ A*=(U.:+3U@M-/DL
MY52X=F)=HVW+F,# \H<''WO;F7QAH-_K5I9OI-S%;:A:S,8YI"0%1XVC?H#S
MA\CW45TE% '(Q>$);;Q=;W=L\$>B1)'-]FR=_P!I2-H5.,8V^65[YR@JG#X)
MEMM1N@+#2;BWN-3-]]KN=S2HK2"1DV;<$@Y"MN&,@XXP>ZHH P?%.C7>JP:=
M-I[PB]TZ]2\A2<D1R$*RE6(!(RKMS@X..*P;WPGKNL/KYO6T^W&IQ6S0^3*\
MGD2P-N4'*+O4G!)X/48[UWE% '.V>DZE<^*HM=U-+6W-O9/:0P6\S2Y+NK.Q
M8JO]Q0!CU-07VG>($\7R:U80Z;+ MD+1(9[ET9SOW[B1&=N#QCG/J*ZFB@#A
M+'PCK&C#0;JT>RN[RR-X;N.61HD<W+B1BC!6(VL, $<CTJ./PCJYT-=,U&RT
M74H/[2N+N1)9742+(\C@J?+)C=6<=,\ \UW]% '!V_A7Q!:VN@1>?:7/]FZC
M)>D7%W(Q1&61%A5BA+!5D'S-R=N,4RX\+>(I_#VLZ?LTM9;_ %,7RM]JD*HO
MF*Y4_NN3\@&?]HGC&#W]% '"7O@NYFU/5[D:?H]T-5,<CO>%G^S.(UC<!=O[
MQ<*" 2O.<T:GX/U&^U]K^WAL+.X%Y%)%J=M.\<XMUVYC>-5"R9 9?F8C##TQ
M7=T4 <+HOA#4K'Q%9:FT5AI[)YIOS83OMORP(4M%M5%.2&)Y.1COFM/Q%H>I
M:CK=E=PI9WEC'!)$]E>3/'&)&*D2X56#D $8..O!%=/10!P.F>$]?T[3_"EH
M1ID@T2=Y)'%PZ^:&CDCX'E\'$F>O;'O2'PEKWVF>_7^S1=QZW_:MM'Y[E'!A
M\EHW.S*_+R& /)Z<<]_10!S>@Z9K-KXAU?4=22Q6+4!$RI;S.S1,B[=O*#<#
MUW<>F.])J&DZN/%\>L:8UF8WLTM)A<.P*!9=Y*@*=V5+#DC!P>>E=+10!P$O
MA;Q%)X>OM/V:6);G5QJ(;[5)M5?/6;;_ *KK\H7/OGMBI&\$SC4-2;^S]'N8
MM0O%NVGNBSO!D+O0)MP_*DJ<K][D<<]W10!R/Q-NHK7P'?%[F&W=I(5C:4@#
M=YJ'H2,]"<>@-5+WPUJ7BB;4;V]FL($N=&FTVT^R3-,K";!,K,57CY5P!GOS
M7<,JL,,H/U%*  , 8 H XVUTGQ,/$.FZO<P:4/LNG2V3P1W4AR6:-MX8Q=S'
MC;CCKD]*A@\'ZI)X%ET2ZELXKQ+UKVWEB=I(R_V@W"A@54XR=IQGCGVKN**
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M6678M= MMVXQP0P"X&>77UKH9]1DTSPY-J>J1HDEK:M<7"0$L!M4LP4G&>E
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MDED=II%)N3)N.),*,A2W &,8'I6Q110!A:SX9&L:OI^HG5K^UDT]F>". 1;
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MKJ-;.!"[R@Y&!V&.I]J6[O+F.ZL8[6UCN(IY2L\GGA#"FTG<!_'R ,#USVH
MP+CP*MQ_:JG7M46/5Y-U\B^4!(NQ4VCY/E&U0,C!(ZGH18?P5837U_--=74E
MO>V(T^6S/EB(0+NVJ,(&&-[<[L\_2NC\Q,9WKCZTAFB$BQF1 [#*KN&2/84
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M1G3[RA@2OU% #Z*C6XA>5HDEC:1?O(&!(^HJ2@ HHHH **** "BBB@ HHHH
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M?2H)M)L1?^-]*T_2R(9='AAMXQ:MLDDC288#$89@2G.2>E>H4A(4$D@ =2:
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M:/S-A..#M8\\UVG@RTC@?6)[><RP7%TKCR[3[/!N$:AC$I8Y!P,GH6#5U-%
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M_P!G2(%MF<,S!<':C DD>Y!J?6M,TL6GQ 2VTE_-*JVGJED^!*(5&8<+@'S
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MR3]]C8ZL8R/XBN&SZD<^E=+5/5=,M=9TV;3[U&:"8#<%8J000001T((!'TH
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M])K-K+]YM3;&PPQPH +GCYCZ< 9.8+?PI=6L=L8O$-^9H R9D5&1D*(FW9C
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MY>LWY718C#;*RQ89"NS#?)S\H XQT]:@/@)3;/!_;VI;7U$:F3L@SYP<./\
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ME^Z6-%\O]VD;EU4 J1G)&6QDA5':@"2ZU_7-.>*'4X-'LVGG=8YFNRR% BD
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MDJ,EMIZYI^JV\NI7WB_^P--OK=M2T2&.WE^Q20K/(AFW@$J IVLJC=C/;UH
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MZ9D'S*!G(YY&.<UY7IUG>QVWAZ0V]]9V-A?:D'6339&\GS)6:!_+9<[=A(#
M87=CCFK<FE6T-MX5A.FZG<P1ZU-=MYNFN3%$PGQE44[$+LI"G! (R!@X .\U
M'Q'I.F:2-4N+Z#[&SJB2)(K!V+;0%.>3G^M6IM4T^VBCEGO[6*.7_5N\RJ'^
MA)YKS6\L6G\/^,K>#2;P1G6(;RWC:PD0/&/L^]HP5&>4EX'/Y\S>),7U^=2T
MZVO[.==-D@BAN-*>>WO(_,<>7L4;D+;00002KC(XH ].!#*&4@@C(([UG2Z_
MID&NPZ+)=Q+?2PM,L1<9"AE7GGJ2XP.^#Z56\/ZJMRB:8]G):WEG9V[W,0YC
MA9USY8;/)&W\B/6L?7%%A\0=-U233)[J)M-G@5H+<R$S&6$J"0,*<!B"Q P#
MS0!J:+XC%[)>6^HFTM+J"^>T2-9\^;M56RNX D_-TQ6Q+>VD$\4$UU#'-+Q'
M&\@#/] >37E>I6JW&@>,94T747OKG5DEM&.F3>8Z@1%63Y,X!1_I^(S8UC39
MKS4O$ZW@U+R]4\AK,6^G%Y)(_*0*JLP_=LL@8X;;M)W'&: /1M6O)+#2KFX@
M$#3HA,27$PB1WQP"QZ9-']JV<,.Z\N[2"1$5IE,ZXC) [G''/!XS63XZA,W@
M'6[86TUW--8S111Q0-*[2,A"X503UQST%<];I97/CBTO;G1[YX$T/RGDETJ8
MKYFX':<IRVT$>O.!R<4 =C?>(=*TV\L+6ZO88Y;]B( 7'(",Q;K]W"XSZD#O
M5F34["(L)+ZV0HX1MTJC:QZ \]3@\5YCIMN]KX>\#W5YI%\4TV:>*YB>PD,D
M8\F4(-A7<5R5 .,9(K9LM,T_5_B%K,^H:%/Y4]C:K&US8N$\Q6D,@WE=NX9C
MY!Y[$XH [<7UF;PV8NH#= 9,(D&\#UV]:Q_$OB4:) C6QM+B9;B".:W>?;(J
M22+'N"@$\%P><5QD%A=?\(UI^CBPN1XBBUE9Y9S;. ,7)=YC+C:5:/(Z\[MO
MM52XM1#X6N=-NM$OY]<AUL7<LL=A)(77[6'\Y9 I##RL# )/&,<4 >K-?V:B
M4M=P 0D"4F0?(3TW>GXTEQJ%E:0I-<W=O#$^-CR2!0WT)/-<#JRBWU;Q>ATJ
M[F76-,A:T6.R=A-($E!4X7"L"5SNQC(J/3-EOJ5G>ZQIM_+82Z!#:0!K"5C%
M(I;SHRFW<I8;.2!N"\'B@#N/^$ATO^W%T<7D)O6A\\1AQ]TD =^ISP.XI=-U
M&6Z2^FN!:);PSLL,L-P) T84'<QP IY/':N0AMXM'\6:-<KH-U';MHL5K##'
M"96AD$B (S\@%5/+$]%//%9C6D\^GZTD.EWPM!XEAOIK=K&6/S[4>5N*JRC>
M,H25&2=O3D9 /25U33WM1=)?6S6Y;:)1,I3/IG.,U)!>6MS)+';W,,KQ';(L
M;ABA]"!T->8^*;5]1@\876GZ9>/97FE0VT*)8R;I[L&0[U3;GA2B[\8Z#/%;
MNGQVT'Q&M)+#3+NWM'T8PM)_9\L4>\.K(K,5 !"[NO3IU.* .QNKRUL8A+=W
M,-O&3C?*X09],FLC7O$L.E3Z9:0O;-<ZC*8XC-,$1%",Y<GDXPN!ZDBL_6$^
MR^/;'4[^VFFTU=.E@C=(&F$,Q=2<A02-RC ..Q'?GE["RFLYO"OVO2;[R(M3
MOKA8Q822?9K603"%7VJ=OWE^4\KD9 Q0!WMQJ>HVWAG[;/:6D.J>7Q;3702+
MS/[OF8Z=^E7I-4L;=6^TWMK"R8$@:91L)Z YK ^(\+77P_UBVCM)[N>>W:.&
M*&W:9C(1Q@*#CZ]JQ;J.POO'&HWTVC7LMM)H:0B232IL,^^0LO*<MM9??MZB
M@#O5OK1[B2W6Z@,T:[WC$@W*OJ1U IB:GI\LL<4=];/)*"8T6527 ZX&>>AK
MS?P]:K9_\*_ TB_AN(+-X;YSITR[&:(*1(VSO(.I.._3FJ'D6]QX:UC2].TF
M?^V)/$-PUI+%:,55ENR1()0-J!0"#DC@=.1D ]9DOK.*Z2UDNX$N).4B:0!V
M^@ZFF2ZII\.[S;^UCV.(VW3*,-_=//7@\5YUJME.-'\9:;-IUU-K.H7DDEA(
MEL[;PRJ(&$@&%"$#J1MVD]^='3M%L-0\?:^=2TB297MK54FGL76)Y$+^85=E
M"YSL.0><#&<4 =9I7B#2]:M9KFQO(I889)(W8.,#8Q4GK]W*G![CFK":KITE
ML;E+^U:W#;3*LRE0?3.<9KS=!+8^$-=TJ/P]/<7(O[F656LW,9B:\RI^7!E_
M=N7"J3D(0<9 -+4H[BXM?'4?V'4[Q=0TJ!+*0:3*HFE"RJ=JA.""R#)P<8/3
MF@#U8:E8D7!%[;D6W^O_ 'J_NO\ >Y^7\:BT;6;'7M,AU#3IUEMY5#*01D?4
M=JY*R@M4\?:<UKI5U%9R:+);R.=/E2/=OC9%<E  =H?KTZ=35OX;$V_A.RTR
M33KFUN+*VC2X:6W,0:3+!E&0"Q&T$GI\PP3S@ Z:75-/@W>;?VL>QPC;YE&U
MCT!YZ\'BI+F]M+,(;JZA@$AVIYL@7<?09ZFO/]0L[.;Q1XPFGT:[E6;2XH(7
M_LV5UE<>:'"D)AC\T?(Z_@<9EM9W;&UGU2/4([:;P[;V@5M,>9Q(N\31E2N5
M8DH>1\V."<4 >J_:K?[1]G\^+SO^>>\;NF>G7I33?6@$1-U !+_JSY@^?Z>M
M>=ZIHMYI1T&YTVSNI+N[TO\ L6:=XPTT+,$\N60KD IB3)SCGZ5/H_A\P^*;
M?0Y--8:3H<\U]9RR190^8J^6BL1@[6DGX[;$]J .^FN[:W95GN(HF8$J'<*3
MCKC-1KJ=@]LMRM[;-;LVU91*I4GT!SC-<O\ $)+;R?#\MS9FY1-8@RBQ[V(V
MOG ZGUP.N,8-<MKUHU]I7CB?3])OC97\=O':1)82AI;E5;?(L>W<.-@WD $K
MUH ]1.IZ>L4TK7UL(X&V2N95Q&WHQSP?K2R:A916@NY+NW2V;&)FE 0YZ?-G
M%<;J6DV%AKOAW5;/2FCTI7E:Y6*T;*R&(+%(\87<, ,N2,C<,XK"MK*>T\3V
M^LW>FW9\.G4[R6"$6CN82\42I*8@I9076?'R\>9GC=0!W.@>(O[3M[QK\6MM
M);WSV:[)]R2D!2"I(&<[NE;4=S!+))''-&[Q?ZQ5<$I]1VZ&O+6LB_A37DMM
M$O8O(U^+4(8&L75C")H7+1@KS\JN=J\CH0#Q3]:CNM6O?&']DZ;J"_VAIMF(
M7^QR1"Y$;RF50Q488JVT!L$YXXH [Z^\3:-I^DWFIRZC;-;6:%I6CE5B,#.W
M@_>., =S6C#<1W5N)K:2.5&'RLK94_B*X'Q#9V&N^&O$AT;0KG[2^C&!)&M7
MAWD!RD2HP&67)Z#C(&>U=CHU]!=Z:9;>TGM[>-BJ"2 Q%P "65",XR2.0,X/
ML2 8]GXGO[O1+JX%I8I?P:C)9"&2[V1OLDVL0Q7.<9(&/:M^;5-/M]_G7UK'
MY;!7WS*-I/0')X)P:\RNA)/X+UJ'^R=4>XD\0&Y@0Z9/N,9NEDW@;,XV G].
MIQ6M=06%UXYUJ\GT:\EMY=%BA61M+F*N^Z4NH^3EMK)[]NQH [NYOK2S1'NK
MJ"!'.U6ED"ACZ#--N-2L;.2..YO;>"23[BRRJI;Z GFO+-*M+Y(]"N-3COX+
M9?#D5BPETQYF2=3B5"A7*EAMP<8;;P35>\TBXTVRD6PM]2GN_P"S+6V?3]2T
M\SK?*J_*@D3_ %3KDAB&P#R?6@#V2BJ%EJT-]J-_8QI()K$QK.Q'R;W7?M![
MD J3_O"K] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !17'^*/&<N@ZTFFK%9Q>9:&>&>_F,,4\F2!"KXVAN >3_$
M.#3)]7BT_P 5ZG>W>DQBXM="%UY\,Q>1XE9B8MN ,[@<$9SD4 =G17(V_B36
MKC5K6P6PTYFN=..H*PN7P@RHV'Y#GEA\W&1GCBH=$\9ZCJ(\-7-WI=O;V>O(
M?*V7!>2)Q$9!N&T @A6Z'CC\ #M*3(/>O,=7O;A/ WC%[&PMK&Z74GANVBN'
M(D)6/=(#MR"0P&..AK4L[#3]!\=6JG0["TFN;*XN?M%K*V(]GDHZA-H&"-G/
M^R?6@#NZ*Y72O$FLZI::=JD6C1'2[^-YE(N,2Q)L+1LP("_/@# /R[AR>:KZ
M-XSGU/5H--V:;)<7-C)=1_9;OS5B="@,;L!@_?'S+Z'B@#LJ*XC3?&NJ75MH
MU_=:3;0V6HWK6)V7+-(C@NH;&T J2A'7."#[5=\)ZEK6H:KXBCU'[*8+746@
MB\IVR@$,)"@%>1\Q).<Y)XQ0!U5%<KJ^I:U!X]T33[3[*;&YMKB217=@S%#'
MR<*>@?@=\G.*HP?$)+F_A$45J]K+J1T\1K.3<##F/S2F,!=XZ9^[\V>U '<4
M5RMAXCU36%CO;#2H)M*DOGM"6G(E\M79&FQC&-RGY<Y(YSVKG]&U>Z\-:?JD
MEKI=K_9$'B"6VD"R%'423JF40+MPI<<$C.#TXR >E45Q&H^,=:LAXD=-(LWB
MT'$DS&Z8&:,QB3Y1LX8*3UXSCKGC4E\07MWK=QIFCVEO*]K:Q7,TES*4&9-V
MQ!@'DA"2>W'![ '1T5Y_:ZG9:UXO\)>((+98#>Z7>M(64;QM,/RL1UVG</S]
M:NVWC6Z;3M(UFXTZ--*U698H-DI::,/GRF9=N#NP,@'C<.M '9U2U32[36+/
M[+=HS('61&1RC(ZD,K*PY!! -<UIWB[4]0G\/E+"S$&MV[W,7^D-OA10K8;"
MX)PP] #QSUJII'B%;*V6RL=(MX=2U#6KNV\I9V,1D0LTLQ8C.,*3@#J0..H
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M,\J+(NTM$Y1A]&'(-<8?'XCTA;PMI=PMQ?QV5I<6]YF!RR;RSG!*;0'R",G
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MS=XV8]<]* ,"X\)23O977]LW?]HVEQ)<+<LJL"738R[",!=N  .F,Y.3FH?
M0_LN33UUR_$3ZC_:)<I$7\WS!+UV]-X!Z>W2M37->ETM=*FMH(+JVO;V&U>3
MSL%!(P4,N%(;\Q6Y0!C^(-!_X2'1QILU]/!$SQO*\(4,^Q@P&2..5'(J@?",
MDUQ?7=WK-U/>W-I]B2?RHU\F$G+!5"X)8]21V& ,5H>)=>7PUHLVJRV-U>00
M?-,MML+(G=B&8<#OCZU%-XD\K5M*TY=,NYI=0B,P>)XF6%1C<7._H-R\C(.0
M!F@"(^%(CX=TS2C?7!DTQXGM+O:N]&C&%)&-I^4E3QR">_-,O/"LM]! \^LW
M37T%\M]%.54K&X0IM$9X";2>.N23G-;RWEJ\\D*7,+2QC+H'!91[CM0+NV*Q
ML+B(B0[4.\?,>F!ZT <F_@'?;W<)UZ_VW>H1ZC(3'$3YR%""/EX7,:G'MBI8
M_ EO'I.M:3_:5V=/U02?Z,%0);,_4Q87Y>><<C/:NJEFB@3?-(D:YQEV &?Q
MJ%M1LE21VO+<)$VR1C*N$;T//!H PSX4N)=2TW4+C7;R6>QE>8 I'M9G4JPP
M0<+M.  >.O6JC^ S)97%JVNWVV?45U)SY461*KJXQ\OW=RJ<>U=5/>6MK&LE
MQ<PPHQPK2.%!/L33FN(4=4::,.PR%+#)% &5?Z"USJ=KJMM>O:ZA! UN91&K
MK)&Q!(93[J""",<]CBJ'_"%00VFG+9:A<07EC=2W:W;*KM+)+N\TNI&#NWGI
MC'&.E=+'-%,I:*1' X)5@:B%_9L\:+=P%I"0@$@RQ'7'/- '":SX2N+&P%FM
MQ?7VG7NJ?;+YQ"DLL7!;*QA<."X3(*L .B\<3VN@WFN:5JFBR2W-CHOFQ-:3
M"SC@FD_B<%-@  <+@[%)Y^I[:6[MH)8XIKB*.20X1'< L?8'K56/6].EUN?2
M$NHVO8(DEDC##(#%@!]?E)QZ8]: ,B[\(S7>IW.H'7;Z*XGLELRT21KM"DL&
M'RYSN)/7'.*AF\*7L5W=7]KJ3#4K^2VCN;E(UC"P1.6(50#\Q!9<G)^;MBM[
M4]:T_2'M$OKE(FNYA!"&(!9C_3CDU/)?V<0<R7<"! "Q:0#:#TSZ4 5];T>V
MU[2)].NFD2.7:P>,X>-U8,K*?4, 1]*S;CPJ=1LKJ'5-5NKF6;R2DJA8Q T3
M;T9% P&W<DG.< =!BMO[9:_:A:_:8?M!&X1;QOQZXZUD>)O$7]A6)GMTMKF6
M.2(2P/<;'".ZIN  .<%AUQ]: *&I>!QK,5^;_5KE[F]MEM'FBC1=D )8HJD$
M#).23D\#I5T^&KC^W&U?^VKK[2UF+0CRHMNT'.[&WKN.?3MBMN2ZMX9HX99X
MDEDX1&<!G^@[U#JEU+9:9<W%O'%+<)&3%'-*(E=\<*6/3)[T <[I_@?^S3H8
MAUJ\9-&A:"W5HXOF1@ 0WR\\ #C'2FCP*1IR60UV]V)J)U(-Y46?-,AE_NXV
M[R3C\*Z47\$<(:ZGMX)!&'E0RC"=,\\<9/6K".LB*Z,&1AE64Y!'K0!@CPPT
M-Y=/::K=6MK>7*W=Q!$%!,@V[MK]5#;1N'UP1FJUUX,-U_;X?6;L+K<?EW"B
M./Y%V;,)\O'R\<Y]:Z);VT>Z:U6ZA:X7[T0D!<?AUIT-U;W#R)#/%(T9VNJ.
M"5/H<=* .<_X0]X99)K/6KNVFN;:.UNY$1"9@@(5QQ\C@$C(XZ<<5,WA3RKJ
M\>QU6\LX;YHVNHXR"S,JJFY7/S*2JJ">>F1@\ULC4+(M*HO+<F+B0"5?D[<\
M\5)]I@W[/.CWE=^W>,[?7Z4 <_=>$6N;S6[C^U[M/[7MUMI46./$:+N VY7K
MAV'.>OM3!X,1[C3I+G5+FXCLK*2Q\IXXPLL4@4,&PN<D(O(QT]ZVY]3M8X"T
M=S:O*R,T2-.JAR/?TSQGM5*'Q%;1MI5IJ4EO:ZG?P^8+=)A(%(4%L-QD<X!Q
MS0!%IWAV[T^&&$:Y>216MN;>V4J@VC@!GP,.P"@ D8Z\9.:HVW@86MAH=FFM
M7IBT:?SK?,<66.UEPWR\C#L.,=?:MVUOKB?4[^&2*W6TM]GE3)<!V<D'>&7'
MR8(QU.:LQWMK+;M<1W,+P+G=*L@*C'7GI0!E:;X<_LS6+R]BU"X-O<S23_9#
M@()'V[B2.3]W@'IN/MA]_H+3ZR-7LKZ2RO3;_99&$:NLD>XL,@]U).#_ +1R
M#6I;W5O=Q>;;3Q31YQOC<,,_44"ZMV5F$\15/O$.,#ZT <Y:^"8+"ZT66TU&
MZCCTE9!'&51O-,AS(SDKG+'GC&">*V]6L)-2T\V\-Y-9R^9'(DT.-RE'#@8/
M4';@CN"15/Q+K;Z)H.H:A;1V]S/90/<-;R3>6655+'D G.!Z5HPWUM,CE;B$
MM& 95$@/E\9^;T_&@#G/^$&MFDN;Q[V7^TY[R*]^U1QJH26-=BX3&,;2P.<D
M[CSTQ:N_#$E_IK07.JW,EU]LBO4N"!B*2-E*A4Z!/D&1WR3G)S4,_B34[2ST
M.>ZTVU5M0O5M)ECO-XAW,0K*0N'X&3TQGO71-=6ZW*VS3Q"=AE8BXW$>H'6@
M# ?PFS7]E>KK-\MQ#!]GGDR"TZ>8).3CY>1CC^$D>E0+X(C\B_275;N22[OD
MU%92D8,%PFW#+A<8^11@YXSZUN:Q>W%AIKS6<,$]UN41PSSB%7R1GYB#C R>
MG.*GEO[.#?YUW!'LP'WR ;<],YZ4 8.H>%+C5;)X+O7;TN]S%<ED1 JF)E9%
M52"%&Y03W)SD]J2X\'O<SZU*VLW8.KVRVTX$<>$100-OR]<,PYSU]JZ5I$2,
MR,ZJ@&2Q. !]:BCO;66;R8[F%Y2N_8L@+;?7'I0!S\?A"2U;S++6;JWGDLX[
M.XE$:%I4CW;&'&%<!B,CCU!P*L'PU(NOC5XM7NTD6S^QI&RHX"<'))&XMN .
M2:V?M=M]J^R_:(OM&-WE;QOQZXZT@O;0W1M1=0FX')A$@W_EUH YF'P,MKH^
MDV-OK%VDNERR26UR40N Z.C*0  >'.#C@XK;U/1;75M FT>[:9X)8A&S[_WG
M&,-N_O @'/J*MQ7MI<3/##=0R2Q_?1) 67Z@=*6&[MKCS/)N(I/+.'V.#M/H
M<=* .<O?!K:H+F34-8N);F:R>P65(HU\N%\>9@8(W-@9/L, 5NZ=9/I^EPV3
M74DYA01K,ZJ&( P,@ #]*='J5A+#)-'>VSQ1_?=95*I]3GBJUYJK".S?3?LE
MX)[A(V)NE0",GYF4\[B./E[^M &'_P (*?[.-G_;E[M.I?VGO\N+/G>;YO\
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M/TK'_P"$"MW;54FU.[:UU6,"ZME6-$,@4#SEPORR9 )(X) R#73&^LPP4W4
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M1VJ&76-.ATZXOVOK<VMNI:659 57'7)S0!=HJG;:I976F1ZC'<QBUD19!(S
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M=H3R#O8O@ #<I!YSEAQS7;44 </XO&GP^-_"UU?67GH%NPS+ 92H"*02H!)
M/L<9SVS7-QZ=>[+:\AMYK;01XAN+F*)[-G$<30[4D,. 0GF[V''&X-BO1[[0
M+6_UFRU66:Z6XL@1"(YBJ#=][*]#D  Y]*TT=9$5T8,K#(93D$4 >5:AI=HN
MAZ=&UGJ%Y#)XA%T0=-<!8MP\TJB@E8B<G!QNR>"*D\6:'9Z;JEZ^D6OD2'3"
MOV)]-:>UO0[R,T2;,-'(6Z[3_&IQQ7J=% 'FDD*Q7'B0Z[I$S27]C MG"MNT
M_P @@P848 \B3=QQ]X'WJIIFF1)JMV-<TJ>XN%\-VMM/*UA)(LMROF^;A@I#
MM\R<C.>W>O5J* /*[""*Z'PZ&H:5>236MGY=V9M/E/EMY.P"0E./W@[\9P?0
MU5@M;DK;>3;75KI=IXBNIW273I"B1NK^5((R!E Q[?=)!XQ7KU% 'E]Q MCH
M5@((=3GCD\1QW@ TYP%C$BEV5$!*QYRPS@G)(%>BV6HQWTMW''%<(;6;R6,L
M10.=H;*D_>'S=?4&K"2QR,RI(K,G# ')7ZT^@".X$36THG3?$4(==N[<N.1C
MOQVK@?A[:-%:ZS&JZ@ES%*]I8R7UM)'LLT)\@*749'S$^OKT%>A44 >7:59%
M]*\&:?;:=/#K-C<HVI.]NRE (W$Y=R,,'8^IW;@><9%4*EGH-CI;:5>?:M-\
M2F=ECL9&$,!O&<.I"X*E&7[N?IP<>MT4 <G\1XA=_#[584M9KF:: K!'%;M(
M^\]" H)!]^U8QL=$'CN67^Q)?L!T58_^07+Y98,6QC9@OL./7DCKQ7H22QR,
MRI(K,G# ')7ZT^@#R329+A=,\,V]YIMQ"T.B?9VGN-,FGD,N55H AP$)"@[B
M.1T. :<EL^F?#_PEXHDTR634M"BCAN()H"DSQ,/+= & .02K#_=XZUZS69K6
MAVVO00PW<MRD<4JS*()C'EU8,I..N" 0/44 0>%M$30?#\%J8HDN7S/=&)0
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M869M@0ODH2I*@ [2 <=* ,J\\:W%B]U8V,$+OIEC#*\<J2,UR[)N$:;1A?E
M^8YY;&.,UW-K.+JTAN CH)8U<*XPRY&<$=C7/_\ "'JC2/!K.I02W%NEM=21
MF(-.J9"DG9\K ,1N7'&.X!K8AT\PZD]V+RZ:-H$A%L[YC3:2=P&,[CG!.>PH
M NT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1110 4444 %%4K#5;/4K4W%M(WE"9X,R(T9WJQ4C# 'J/QJ[0 4444 %%%%
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MQEBNC666B\EB802R9)VD]QDGK3X_"V@1/:-'HU@C69S;%;=1Y/.?DX^7GTH
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M@;3VCDV;'@-T\.& 49; !W=>*[4>%/#P%N!HFG@6PQ!BW7]T/1>/EZGI3?\
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M/3S#(XD>,VZ[68="1C&10!S-^-9T[Q-8Z''J.IW]O=QW%Z7\R*.7Y/*41A\
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M!C*\K LY8# 4;1CN<G@4[^Q-:FNO"XEL$CAL+.6VNG6Y!*ET6/*\<XVY[=:
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M.!T1PPRBA<@^AQF@"GI7BVUU/4]9M&M[BV33)O+::>%T0J(T<L6( 7[W0G)
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M!U<:G:PPFZOY+N,Q2[U*N!QT!R,<G'- '24444 %%%% !1110 4444 %%%%
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MUW$JH 3A200<8K+C\1:AIUKJMKJ=]J^G:FEI;D07$4-R=[RF/S(74A6WLRJ
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MBANK$Q216X)CW13Q'#Y8L1N&<!U/&.0#T6BN;\=WEWIWA6:^LKR2UF@FA.Y
MIW*955@=P/&&/3!]ZS]1O;]?$WB*PAU:X2*+1XKR)5$>8)"\H.W*]"$7AL]Z
M .TJK?:C:Z=IUQJ%S+MMK=&>5U4OM"]>%R3C!X%<3H][JXO/"3W.LW-P-;T^
M1[E&6,*CB)'#1X7Y2,D<YSWK-TR6ZTSX4Z[=6VN7:7\']IW,.YHV8&*>;YL%
M<D$XW$YY/&* /04UW3Y-6@TP2R"[G@-S$K0.JO&-N2&(VG&Y<C.1FM LJE06
M +' !/4]:Y&=VD^('AAW.6;2;TD^I+6U1>+K9Y?&'A)O[1NK6/S[@'RV4*N+
M>0[OF!&<9&3V)H Z:SU>SO[Z]LK=Y#<63*LZ/"Z;=V<$;@-P.#R,BKU><:B+
MN;7?&=[I^K36GV;3K:XA:V"$.XCD92Q8'*\#@8SD^V'2ZYKFL:E]DMS>1!-%
MM[U39M"F99=_SMYIY5=@&!QR<]J /1:*Q$O;YO! OI;BS@U Z=YS3[PT"2^7
MG=N'!0'G/I7 3>)]>TBUFM;J74X-8:"V4PW'D2H=\Z1/<12+\O\ 'C:P !QQ
MC- 'K5%><7FK^(=-N'L&N)H(+N^LK>*6YDADN+992XD)"9&#L 4MGECUQBKV
MK7.HZ1+'I\&O23B^U:WM=[!&FLHWC+,,XP2Q7@L.-X]J .YHKS77]6UG3(?%
M%E::M<9TN.TN;:X=49E,I96B?Y?F7Y<^OS=>E2>(-;UCPK/XACAU&:]$.C+?
M0FZ1"89?,9"PVJ/EQAL'^[0!W!UBR76TT=I)%O7A:=$,+A612H8A\;3@LN0#
MGFDN-8LK75[32YI)%N[P,8!Y+E7V@DC?C:" "<$YKEHK*6R^)&A))JUQJ&[2
M;PYGV%@=]OEAM X/IVQQ5CQ;"]QXJ\)0I>/:,US<#S(\;L>0^0N01D_3]: .
MPHKS:36M7MC<6XU:>1-.\26MB)RJ9GAE\HLC_+R5\PKD8/3/-7;[4M96\\9V
M=AJR">V2U-F;DHJP/*#E =O?@#=GDCK0!V.I:G::19&\O9&C@#HA949SEF"C
MA03U(JW7EUQKNIPZ7JNV_P!7L=1L;FQ\RSO!"YC664(<2*"'1ANQC!!':MJ^
M&JW/C'6M.BUV]MK2+2X;N)8ECS'*SS+P2A^7Y!P<_7M0!V]%>:67B+7=>?1[
M=3>*9O#]OJ$C6)A1FFDR"3YAQM7;T'][GM4.IZSXF73XKVYNI3;1Z-'-=2Z-
M+#(UK.=Y,[(W^LC(7("G^%N#UH ]1HKS74]>U2WU6?4);^[_ +#^T6@@O;'R
MGCMPPC+)/$</E]WWAG =>!BNE\9:A>6=OI-M9W+6IU'4HK.2X0 M&C!F.W((
M!.T*"0?O4 :]GK%E?W][8V\DAN;(J)T>%TV[L[2"P 8'!Y&15ZO-GN7T'4O'
M$K:Q/OBM[)4N3"DLL98.%7;\JLV6&,XZC.><R)<^([V]\1Z)8W]]97D&GV]U
M9FZ,$LB3,905) 9=K;%X/(YQVH ]%HKBO"&KW/B74?[1M]2NVTN"SACD@E6/
MFZ9=SAB$!!0%<@'&YCP,59\17]PWB"#3;6ZOPPLI+B2"R$2%1N"B1Y)#T'("
M@')Y/ H WM1U>RTH0_:I'#S,5BCBB:5W(!)PJ@DX R>*K:39>'YUBUC2K"P#
M7""5+F*W5'974,"3@$9!!Y]:X?2[F\U_4OA]JEW?SK<76FW$DOE! I8)'D@;
M>-V>?TQ2VM[/X9TSQ[J4-]-/<VUW.;>WN&4J[+;0L#@ $[0.@.-HZ=Z /0[O
M2]/OW1[RPM;ETX1IH5<K],CBK=<';2Z\LMQ%)?7D5O)I3SB2XFMFF$RE</&J
M9^0@G.1@<8QFM/P5%JESHVFZSJ.LW%X]]IT,CV[QHL:.RAMR[0#T..<^M '4
MT5YOKOB+4;>?4+^QO+Z2.TU:WM,[8DMD!>)'BVDEW/SMEL#DC' -=+X\N[O3
M_!6IW]C>O:7-K$9DD4*1D=F!!X]>_O0!T=-=Q'&SL&(4$D*I8_@!R:XB]GU/
M3?$4>EQ:W=W,-_I=S<[V$9>"2(QX=<+C:V\C!!' Q4>E:UJ-PWP_FDU*1SJM
MB6NX<)MF86^\OTR#N(Z$#VH [#2M5L]:L%O;"1I(&=T!:-D(9&*L"K $$,I'
M([567Q)I;1ZJ_G2J-*!-X&MY%:,;=V0"N6^7D;<Y[5P%E<7VC>#YM:L]6F+Q
M:]/&++"&)U>^9&C(QNW$,2#G(X[5J7DMQ;W7Q%N;2ZDMKBWABFCEC"DAEM0P
M^\",9'I0!WMO/'=6T5Q"Q:*5 Z$@C((R.#R*DKA+6_U/7M5N-/;5IM/2UT>V
MN4DB"AI)90^9&R#E5V#@<9)SVK=U'4CIW@6;49=43=%8>9_:$<(D#-LXD5 0
M#D\@9QS0!O45P>DWVJOXEO-%GN=2MXVTE+I3=/ \T<F\J6!3*C/H<C(XJGH&
MI:T]OX'O;K6KFX;7(62[C9(P@_T9I590%X8%!WYR: /2**\RAU'7(-)CU237
M;J9X/$7]G^4Z1A)(#=^3AL*,MM.<C'0>^;FH:OJDNF^,M735);231)94M;=5
M3R\10I)\X(RV\L>_0C&#S0!Z#17 G5]2D?Q<'U*XMQ;:9;7MN"(\VK,DK,!E
M>1E /FSWHAN=6U'6?#-M_;5W#!J.BR7-RL:QY+IY&&4E25),AS^F* .^HKSK
M3M>U>^L/#&G3:A(CWU]>VUS>JJB1UMVE"J.,!FV#) [-C':2ZO\ 5[;7;#08
MM3N]1BE:\FDEMC"DP$9C"0EFP,J),D_>.!VS0!Z#17GB7?B"9O"EO<:Q)!->
M7=U:71@,+^8D:3,I) ($F(U!P< YXJL;_7+71[W4&UVZE?3-=2QC1DCVRP&X
MC0B3"Y9MLA&1CH.^20#TRBO.9M:\17EWK-U:-/$;#55M85>6".U$:E-PDW'>
M2X8G/^TN/>OJ=_KEII?C'4(]?N\Z)>#[+&4BP5$44A5_D^8'>1VQ]: /3=R[
MMNX;L9QGG%+7%)%Y'Q9OYI=3N(XO[+M6$;NHC+--,@3D="0, '))[]*[6@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#-O] TG5+N.ZOM/@GGC38KNN3MSG:?49YP>,U$_A?0WLK:T_LRW6"UR+=4
M7;Y0/4*1R >X'!I^H:]:V%\ECY=Q<WCQ&;R+:(NRQ@XW'L!G@=SSC.#7/:KX
MJ^WZEX=M-)GNQ9:F)96N;6$%BJKPHW X(8_-D9&,<4 ='<^'M'NTLTGTVV=+
M,;;==@ C7CY0!_#\J\=.!Z5:OK"TU.RELKZWCN+:48>*1<JPZ_SYK#UW6;KP
MCX.2\NA+JEW D44DJ1!?,<X4NP'"@GGCUQ535=>GL?%&A.)+[[)?07 :P%N"
MS.@0J0-NX'EL\XQZ4 7;SPG81Z?>C2+"SM[^XMFMA.X(^4Y'S$9)QN)YH\,^
M%++1+2SDDL;)=2@MQ UQ IP0  2,_=W8!..I]:EC\7:5-IEM>Q-.YN9VMHK<
M0GSFF4L'38>05V-G/  SG%:&EZK:ZQ:-<6K/A)&AD212KQR*<,K ]"#_ (CB
M@"O%X9T6"=IH]-MU<AP,+PN_[^T=%SDYQC.:A'A#PZ+>*W&C60AAD,L<8B&U
M'/5@.QXZUFV_BJRT_3M9U2^O;Z>UMK\PRK):;39_(AV8 R5&X'<?[U7&\7V;
M)J"16]X+NSMA<^1+;LC21G(#J#U&0<]QW H U=2TG3]9M?LVI6<-W!N#>7,N
MY<CH<&JO_",:']I:Y_LNV\]HO):39\QCQC:3Z8[5SOAW7KA-(TO5M4U&]N9-
M5MXEBL#:J&:<J9&,6T [-I[\ +DFM:?QMHUM9BZG:Y2,70LY0;=BT,QQA' &
M03N&.N<C&<B@"POA'P\B6R+HUFJVN?LX$0 BSUV^G7M4]UX>TB]O#=W.GP2S
M,5+LR\.5^[N'1L=LYQ66OCK3&N(;8VFJ)<SM(L,+V3AY&C^\ ,=<$'GMS3K7
MQSHUX;0Q?:Q'<W'V42O;.J)/DCRF)'#9!'IGC- &K'H6E1:C/J$=A MY.I66
M<+AW'H3W%5/^$/\ #GV<0?V+9>2)?.">4,"3^_C^][]:2X\6:;:W<D,@N?+A
MN4M);D0GRHY7VA5+?5U&1D D9(J"Q\5?;/$6LZ6=.NU&G;,2>43YA*EC^>!C
MUH N-X7T)S>EM)M&-\-MT3&#YPSD;O7! QZ4MMX8T.T:5H-+MD::$P2MLR9(
MSG*L3]X<GKZUF:1XDM(?#FGW$VH7>I2WL\L5N6M@DTS!WRNP  ;0I!)P,+DF
MII?&^CPI"TGVM3)=&R*"V<M'/C(C8 9#$<CUR,9S0!9_X1'P_P"1#"=(M6C@
M?S(PR;MKX W GG. !GK@ 5/-X>TB>_-[+I\#W!=9&8KPSKC:Q'0L,#!(R,#T
MI=(URTUI;H6ZS1RVLWDSPSQE'C?:& (/JK @C@YK!NO$$VC^.-0M+B6^O+4Z
M;%=Q6L-N)#&?,D5R-J@XPJ]2>>G7% &S)X6T&62\>32;1FO1BY)C'[X9S\WK
M^-+8>'K#3=5DO[:(1L;6.TCC486*)&9L*.V2_/T'I43>*M.:&QDM!<7OVZW-
MU MM$6+0@#YSG&!\R\'DD\"F'QAI;QV#6GVB]>^MC=P1VT19C",9<@XQRP&#
MSDXQ0 GBK1[[7+:SM+?[&;5;J*>Y2Y#'S!&X=5&!QDJ,GVQWK3O]+L=42-;V
MV27RFWQL>&0XQE6'(.#CBLS6]1:Z\"7FKZ7=S6Y;3VO+>9$7</W>]<AP1Z9!
M%1:'XLL[Z+3;:Y-Q%=75H)HY+B QI<;5!<H3QQG....1Q0!HS>'='GTN+39-
M.MS9Q.)(X@F C YW#'1LD\]>3ZU)I^AZ7I,LTNGV,%L\V/-,2[=^  "?? %9
M]KXQT>Y:,F26&&>![BWN)XBD<\2#+,K'L 0><9'(R.:6W\6Z=<DJL-ZLAMOM
M<4;V[!IH<@%T'4XRN1P1D<<T 6G\-Z/)J#7SZ?"UPTHF9B,@R  !RO3<,#!Q
MG@5"?"'AUK>>!M&LS#<.))D,0*R..C,.YYZFH-,\::1JUQI\5M]J"ZC$9+.6
M6W9$FPNX@$CJ!D_@<9Q5W6M?LM 2V>^$X2YF$"-%"TGSG[JG:"<D\#UH 2Y\
M,Z+=NKW&FP2$1K$<KPR+]U6'\0'8'-27V@:3J5W%=WFGP3SQ)L1W7G;G.T^H
MSS@\5CR>/M'ABNWFBOX_L+A;U6M'S:@@$,_'"D$'(SQSV-7]4\3V&DSSQ2I<
MRFVM_M5P8(2XABYPS'_@+<#)X/% "P>$O#]M):20Z1:(]G_Q[,(^8?\ =]/P
MILO@_P .S332R:/:,\TGFN3'U?(.X#LV0#D<FJ^K^)K%5GLK:XO#<"U%R\UE
M!YOV>-L[78D$<X.!@G )Q5;0/%(/A3PY)?&>\U34-.CN6C@BW.^$4NY P ,L
M/3D@"@#?U#2-/U:R%GJ%G#=6P(/E2KN7(Z<&HHO#VD07XOHM.MUNQ%Y(FV#=
MLQC;GTQVJ>PU.SU/2X=2M)A):S)YB/@CCW!Y!'<'I7(V7C:XCT[PQ/<65S<M
MKLCRAHHLB*(I)*BC'5@H4?0$F@#I[#P_I.ES^=96$,,@3RU91]Q,YVK_ '5X
M' P.!3],T73=&21-.LH;99#EA&N,XZ#Z#)P.@R:YI_$[:+XJU^WOYK^[M+>V
MM[J.**W#FW1O,WGY5'R_*O4D\'&>:VKOQ3IML81'Y]VTMM]L"VL1D(@_YZ'T
M![#J>< X- %B30-)EU'[?)80M=;UD+E>KKPK$="PP,$\C J!_"?A^070?2+1
MA=G-P#&#YQ_VO7\:MOK.G)H9UIKN,::+?[3]H_A\O;NW?E7-6WB*:]\>Z=;Q
M2W\%G<:=<3O:7=N(QE6B".I*[N0SY&>.X% %>[\#2^9JB6]II4ZW@VVUU<;E
MFL4V!51 %/"D%AADY)[\UOGPGI%S'"VI6<-_=);I;RW$Z M.%&,OV/.3SG!/
M%-LO%VFW\UO'$EVHNH7FM'>!E%RB8R4[]"" <$@Y%16_C;2;JQLKR%;UH;VY
M:T@/V23+2 D$$8R.0W)_NMZ4 9%SX&D6?4UMK+2;B.Z4):SW.Y9;! @4)'A3
M\H(+#!3EC]:Z#_A&-.N+*SBU.%=0N+>V6W>YF'SS* ,[_P"\"1DJ<C)JYJFK
MVND0Q27)<M/*(88HT+/+(<D*H'? )]  2>!7-^)/&8M_#5Y/IBW*7T-U#9RH
MT'SVS2.@R5/'W7RIY!..M '5W-G;7EF]I<0));NNUHF'RD>F/2LV+PEX?@DM
MY(=(M$>V4K RQ@&)3U"^@]A3;>6YT?0[R^N[B]U%%+3Q1O"JS(FT?NR!@$@A
MCDXZ^U<]>>*[FY\*^&_$*275@MQ=6@N8!"&$JR[2P *EF'. 5P3[T =?IND:
M=H\+Q:;90VL<CEW6%=H9CU)]ZAF\.Z/<7TU[-IT#W,Z[9)"O+#&WGWP ,]<<
M=*JQ^+M*:SU"XF:>V_L]UCN8IX6616;&P!>K;MPQC.2<=:N:9K5KJD]S;1I-
M#=6NWSH)TV.@894^A!P>0>Q'44 ,'AS1AHYT@:9;#3L@BV" ("#D$#L00",=
M*KMX-\-O')&^B63)+CS T0/F8Z;O[QY/)I=4\5:=I,UTEPMRZV<2SW<D4)9+
M>,YPS'Z G R0!G%17GC#3K/4KC3S!?37<, N3'!:L^Z(DC>I'!&010!9?PMH
M4DLDKZ5:M))!]F=VC!+1;=NPGNN.,4+X7T-;6YMCID#Q7**DPD&\NJ\J"6R<
M \@=NU5YO&.DQ+I;J;F9-5C$EDT-NSB;*[@!@<' S@X]^].C\7:3)I)U'?.J
MBY^QF!H6$WG[MOE[.N[/X8YSCF@":'PKH, F\O2;3]_#Y$Q,88RIUVOG[PY/
M7-21>'='AL+FQ33X/LUTNV=&&[S!C&&)Y.!T].U47\9:5$WESK=0S+=16DD3
MP'=$\I CW8XVL2,-DCKSP:L2>)[".75HC'=&32T22Y00,3M;=AE_O#Y6/'I0
M X>%M"#VK_V7;%[4EH'*9:,DDD@GG))))ZG-2#P]I U#[<-/@%QYGG;MO'F=
M-^.F[_:QGWJIIOC#2M4N[2W@^TI]L@-Q:R30,B3H "Q4GK@,#].1D4EGXPTJ
M^N;6*(W BO!(;6Y>$K%,$&6*MZ8!()P".1F@"5O"/AYX;B%M&LVCN7#SH8@1
M*P[L.Y^M.7PMH:7(N!ID'F!T?H=NY0 K%>A8 #!QD8%5[?QCI=R8O*2[(N(&
MN+5C;L!=1KC)C]>"#C@D'(R*K6_C_1;I;%H5OF74(S)9-]D?%P0 2J<?> .3
MG P"<X!H Z*\L[;4+.6TO((Y[:92DD4B[E8'L164/!WAT9_XE%J2T?E,Q7)=
M/1B>2/K1'XMTJ72$U$-.%>Y-HL!A83&<,5,>SKNR#[8&<XYJ"7QOI%O"DDPN
MT)N_L3I]F8M%/@$(P /)!&,9SD8S0!=B\+Z%#+9RQ:5:I)9#%JPC&81G.%].
MO:FOX4T&078DTFU=;MBTZLF1(223D=.223ZDYK*U;QW:V7AK6=3MK.[DN=,R
MDMI+"4='*AE+ _P$$'(SQ[UT]M<"ZMEG$4L0;/R2IM8<XY% %"/PUHL-W;W<
M>F6RW%LNR"4)\T:^BGL/:K&IZ1I^L0QQ:C:1W*1MO0./NG!&1^!(]P2*P=/\
M46=M8WEU<WU[=&356M(8)+79)'(<8@50!D#D[C[Y/%;NEZI#JUO)-#'-&8I6
MADCF3:RNO48_J.* *S>%=!9[ISI-H6NUV7!\L?O5SG#>H]J)?"^AS6\$#Z9;
M^5!&8HU5=H6,\E./X3_=Z>U9Z^/-'.]F2^2.*Z%I<2O:N$@E)"A7..,EE_,9
MP"*N:AXJT[3KF[A=;F7[%&)+QX(6=;=2,@L1[#.!DXYQB@#5EM+>:S>SDAC:
MV>,Q-$5&TH1@KCTQQBL^#PQHEO#/"FFVY2>,0RB1=^^,=$);/RCTZ52L_%:7
MOBZXT6*SG:&.UAN$N@F4?S"_.1_#A!@]SFM/4]9M=*-M'-YDEQ=.8[>"%-TD
MK $G ]  22< >M $:>'='2QN+/\ LZ!K>Y(,R2+O\PCIN)R3C QZ8XIR>'M(
M33I; :? ;:5Q)(C+NWL,88D\EA@8/48'I5*/Q?IDUM;21+<R37,\MO%:K"?.
M,D1(D!4]-I!R2<=.>13K;Q=I5W>65I$T_G7<LL"!H679+&"SH^?NL I.#UZC
M(- $S^%M"EL9+*72[:6WDD\V1)$W^8^,!F)Y8XXR<]!3U\-Z*MTUT-+M3.T/
MV=I#&"6CQC8<]5QQCI5&7QII,&D7>J2BZ2UM+DVMP6MVS$XQG<.H'S#GWIQ\
M7V)3456UOOM-C;BY:V>W9))(SD*R@XR"5(]L<XH GM/"6@6$T$UKI5M%-;Y\
MJ15^9.G /7' XZ58U#0-)U:=)[^P@N)8U*(\BY*CV]/J*S=.\76]QX9TO5;N
MWGAFOUC6*V6(EY)&0/A!W&,G/3 )/2GGQEI1AA*?:9+F:X>U6T2$F;S4&74K
MVP.23Q@CGD9 +B^'-&71GT@:;;?V>YW/!L^5FSNW'U;/.>N:A'A'P^JS*-)M
M<3QB.7Y.9%!R-Q[\\Y/.:Y:S\37\'A;7=5:^N+A=,U?9FYA5'-NICWHP"K@@
M,_8'(%>AT 8S^$M EMW@ETFVFCD<22"5=Y=AT+$Y)([9Z4\^%]#,\LYTNV,T
ML?E22%/F=/[I/<>U:U% &.WA70C:P6PTNV2&W5DB1%V[%;[RC'\)P,CH<4ZZ
M\,:)>2![C3+=R(E@V[<*T:YVH5'!49. 1CFM:B@#*D\-:-+?->2:= T[.LC$
MCAG4 *Q7H2 !@XR,#TJYJ&G6>JV3V=_;17-N^-T<BY!(.0?J#SFK-% &*GA'
MP\B3HND6FV>+R9@8\^8F<X;/7DDY-/M_#NFZ8[W6EZ=:Q7WDF-96!!8<D!FY
M)&3[UKT4 8GA31[C0]%-K=FV:Y>>6>62W!"R/(Y<G!Z<G&/0"K>H:%I6JW,-
MQ?6$$\T(*H[KDA3R5]P<#@\5H44 8L/A'P];R6TD.CV<;VO^H98P#%SGY?3\
M*M#0M*&I3:C]@@^USJ5EE*9+@@*<]N0 ">X %:%% &3#X8T2WMYH(],MQ%,@
MB=2N04!R$YZ*/[HX]JNV&GVFF6<=G8V\=O;1C"11KA5'L.U6:* ,:Z\)Z!>W
M,]Q<Z1:32W!#2EXP0[#&&(Z;N!SUXJ/Q9HUSK?A2\T:P>")KF+R=\V=J+ZX'
M4UNT4 96D:#8:8S7,6G6EM>3($F: 9&!SM4GD+GMP/:J\?@SPW%L\O1K1?+8
MO'A,;"<_=_NCD\#CDUNT4 8L'A#P]:W$$\&CVD<D#^9$5C^Z^2=V.F[D\]:<
M_A709&NV?2;1FO!BY)C'[[_>_O?C6Q10!CS>%="GA@ADTNV,=NABB4)C:A.2
MG'53_=Z>U:4]I;7-G)9SP126TB&-X74%&4C&TCIC':IJ* ,6+PCX?@.8](M0
MQC,1;9EBAZJ3U(Z<'T%*OA+P\J6R+H]F%M<FW C \K_=_N_A6S10!B?\(?X<
M^S&V_L6R\@R^=Y?E#;O_ +V/7WJ>Y\.:/>77VFXTZ"24[=Q9>'V_=W#HV.V<
MXK4HH S+[P[H^IW@O+W3K>>X$?E;W7)*9R%/J 22,]#4,/A/0()(9(M)M4D@
M0QQ.$Y1#U4'L/:MFB@#(7PMH2:>;!-*M4M#+YPB2,*!)_?&.C>XYI[^'='>S
MAM#I\(A@<R1!1M*,<Y8,.03DY.<G)S6I10!EMX:T1FLV.EVN;(8MCY8_<_[O
MI4!\'^'3!) =&LS#+()9$,0P[CHQ'<^];=% &8_AW1Y+U;Q]/@,X*-N*]2GW
M"1T)7 P3R,#%0-X1\//%<Q/H]FT=TP>=3$")6'=AW/UK:HH S7\/Z2]U:W+:
M? 9K1%2!RO**IRH_ \C/0\BM*BB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#F[W3-2M?%SZ]I\$-TL]@MG+!)-Y
M94H[.K X((.]@1[#&:QM,\*:WI-UX:,:V,\>G?:GNG-PR$O<,68(NPY"DG&2
M,^U=[10!B^+=)N-;\+WVGVAC%Q*JF/S#A2RL& )P<9VXS67+I_B2\\2:+JD]
MIIJQV?VD2(MTX8+)@*!\A!(51DY&23CI7744 ><Q^#-89+>XN[>S>:VU>ZOA
M;Q7C@2Q3[\KOV*59=PQV.#TS77>'-,?2["9)+2VM7GN'F,=N[.!G !9FY9L
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M+<Q0+:*R?97C<EW&WYMX(P/FSC&>*MT4 %%%% !1110 4444 %%%% !1110
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M9C2]MH[A48Y*AU#8_#-7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_FL'D9CC)8NH;C ]JZKO10!RUAX:U#1[73=/LM5F>TCU"2[NI)%0.R-O<QC
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M>"Q?G[/<ZG-)IPNXKM+=D!>-H]I55D/*KE 3@9Y//-=35:_U"UTRS:[O)A%
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MX1$A6*&/=LQD9)&]N3US7444 9N@:0-!T&RTE+F2XCLXEACDD #;%&%!P .
M!6E110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!P^MKIW_">,_B5+=M)_LM19F\4&$3>8_F@;N-Y7R\=R,X[US.F
MVEI-?>"X]=MPTQMKM9ENHR6:$L/LZ39'/RXP&[CUKUZB@#R);ZSA\!&SBDVQ
M0>)%^SQ!3\ENM\KC:,?<$?([8%7O$VCQ0>)Y[.TL8I8?%T"P^<(PWD2(P:1\
M]LQ$N/\ ;C!ZFO3ZRI]"2X\16NLO?78DMHWCCMP4\H!L;N"N[)VCG.>/0D$
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ME:R)25538Y1F& P)P#T(YP<9&U%X0&F3+)H5\VGG[%%8NK1"4-'$"(V&2,.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHILDB11M)(ZHB@LS,<  =R:
M '455L=2L-3B:6PO;:[C4[6:WE60 ^A(-)>:II^GLJWM_:VS.,J)IE0D>V30
M!;HJ.">&YA2:"5)8G&5>-@RL/8CK4E !15*ZUC2[&;R;O4K.WEQG9-.J-CUP
M35:7Q-HD4:R?VG;R(TJ0[H6\P!W.%#%<[<G@9Q0!K4444 %%%% !1110 454
MOM3LM-^S?;+A8?M,ZVT.[^.1ONJ/<X-6Z "BHYYXK:WEGF<)%$I=V/15 R3^
M5,LKRWU"Q@O;242VUQ&LL4B]&4C(/Y4 3T444 %%%% !1110 4444 %%17%Q
M':V\D\Q81QC<Q52QQ] "35&#Q#I-R=,$-[&YU1&DLL9_?*J[B1QV!SS0!IT4
M44 %%%% !112.ZHC.[!549+$X % "T5GZ;KFG:N\J6-QYK1*CM\C+\CYVL,@
M94[3@C(.*T* "BBJ>FZK9:M!)-8S>:D<C1/E&4JXZJ0P!!&: +E%5[Z^MM,L
M)[Z\F6&VMT,DLC=%4#)-2Q2I/"DT3!HW4,K#H0>0: 'T454U+4K32;"6^OI3
M%;1#=))L+!1W)P#Q[T 6Z*:CK)&KH<JP!!]15;3=3LM8L$OM/N%N+:0L%D3H
M2K%3^1!'X4 6Z*:[I%&TDC*B*"S,QP !U)-4[;6M*O)A#:ZG93RGHD4ZLQ_
M&@"]1164WB32(X]3>2\5%TL;KS>C+Y(P3DY'(P">,YH U:*9%*D\*2QL&C=0
MRL.A!Y!I] !115)M6LDU>/2GFVWLD;2I$48;E7&2#C!QD9Y[B@"[1110 444
M4 %%%% !1110 452M=6L;V_N[&WGW75GM\^,HRE-V=IY'(.TX(]*NT %%%%
M!1110 452O\ 5K'3);6.\G\IKN40PY1B&<D +D# ))XS5V@ HHHH **KWM];
M:=;&XNYA%$&"Y.22Q. H Y))(  Y)IEGJEE?V'VZWG!M@7#.X*;2C%6!#8((
M*D'/3% %NBJ=CJVFZGO_ +/U"TN_+^_]GF63;]<$XJY0 4452GU:QMM4M=-F
MFV7=T&,"%&Q)M!)P<8R "<9H NT444 %%%% !1110 4444 %%%% !1110 44
M44 %%4M0U:QTK[/]MF\D7$JPQDHQ!=B JY P,D@#-7: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHJI;ZG975_>6,%PCW5GL%Q&.L>\;ES]1S0!;H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ K-\06NFWFAW46KNJ:> ))V9]BA58-R?3CD=QQ6E5+5M)L-<TZ33]2MUN+
M60J6C8D D$$=#G@@&@#GO#5O+=^(]3\27$0LTOH(H;2T8;9#!&6(ED7LS%^
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M#*A61AL=   RC"G P2,]ZYA/$6LGPO:^*3J#D3ZDL!TX11^6(FN?(V@[=^\
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MH>J@[N!T_(>@J./P;H4$$$,%K+ ENSO#Y-U+&T9?[^&5@0#CD9P3S0!)X4U
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MNWY3A5YX/:M^^\)Z'J-S+/=6"N\T(@E59'5)4&=H=00K8R<9!QVILG@_0IC
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MSR0BXB6-'D,L9P=R;0=PP0>,TZS\6:%J%U:VUIJ44SW2EK<H"4EPNXA6QM+
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MQ2T:&<;H(M+NIH0W3S?,A4D>X5B/HQ]: -Z;6=.@N;*WDNT$EZ<6V,D2G!.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ5+;(;%X?(,"_*OEXQM&.@QQQ5%/"NC"*[CDM&N/M<:PS-=3R3NR#)"[G8D
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MYS?:F+*6BR0&8Y7Y2/NGC/&* /5:KO=QAIXXOW]Q @=K>-EWX.=O4@#.#C)
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MV?*'*!QN8'I][J:73O%<&FZ+9S)8ZS=+>ZG/9@3S1R2QS^:Z["2WW=RL!@D
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M2.30!T2V%FEXUVMI MRXPTPC <CT+8S2P6=K;,6M[:&(D8)C0+D?A7-?\)U
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MQ6*33K+%'?ISPNR1"<  %2S\GA1GYO4[*Z2^L;>[C5E2>)95#=0&&1G\ZGH
MQ-&/]N^#;9;S3S8+=VGER6@!7RU(VX (! QT! QQ67;>%=3\O0[>\OK62#0_
MGMBD3!IY%B:.-I.?E #$D#.3Z=*Z^B@#"\)Z->Z!I+6%Y<V]P!/+,CPQ%/\
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MI>6G]Q?RI0 !@# ]J /---EL3H%G?:-J5S<^(SHT\AC28R&:;RU),RG.&$F
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M(\H6*YA,$K#<BN>I"L-PS@?45UNKZW#I,EG 89;F[O93%;6\.-SD*68Y)
M!))/YD@5S-OX5\10VGA^S?4-.>'0IE:$^4X:X18GB7?S\I"MVR">>.E;NO:+
M<7]]I6IV,T4=]ILKO&LP)CD1T*.IQR.""",X(Z&@" >+HREM$=+OEU"XN9;:
M*R<('8Q@EWW;MNP#G=GG(P,G%03^.K2"V21M,U!I!?C3IH4$9>&<XVJWSX(;
M<I!7(P><4ZXT#5Y[K3-6DO;:75+&:9UC9"L)BE&TQ CYAC"D,022#QS@4)_!
MVJ2(9TO+,7L^KQZK<EHV*9C"*D:\YQM0 L>^3CL ">?Q]':P:G)/H>IH=)8?
MV@O[H^0A4,'!WX<;3G"Y(P<@<9O7/BIXM;NM)M]#U&ZNK>!+G]V80LD3%@&4
MEQSE",'!_#FLO4O"6L7\/BN$7EBB:[&(P?+<F$",1^OS':,]N:I"ZU+_ (61
M=0V-YIIO1HUO#)',&\MY%DF8[2#G*A@=OHW;K0!T4?BR*]LK*ZTO3;Z^BN[=
MKD,BJBHH(!5F<@!\G&WKP>@&:A;QO:LFB/::=?W2:U%YEFT0C )V%]K;G!4A
M03GI[UD1?#ZXLTTJ*.XL;Z&ULGMG2_MRZK*[[VG1<XW$DC![8&>M3:7X0UC3
MH?"D'VVQ=-"1D8^6X,P*&/CGCY3GOS0!=/CNV6SMIVTG4=TNH'398QY6;><-
MM <EP,$]""1R.Y K7TO6UU2_U*U2QNH?L$WD/-+Y>R1MH;Y"K$GAEZ@=<=00
M.2U;2#H_@CQ2-<NX62]FEO(3:HP=)2 R!02<L&12/>MW1-!LKKP;9V6II;ZD
M+A?M-R[J&2:9SO=A[;B<>@Q0 _6KZ.#Q-H%K(-35II9?*:WD18)&$3L4E!.X
M\*2.,9QS6?\ \+!MQ!]I?1-52W6^;3Y9"L1V3A]@7 <ELM@9&1\PYZXM7_AJ
MX&HZ!)H_V&TLM(D>1;=HV^;?&Z$#' &')^M9G_"(:V=)>S^VZ?O;61JN_P I
M\9$XFV8S_>&,^G:@#0N/',%E8:M<W>D:A%)I3)]J@'E,ZHZ[ED!#X9<=@<Y!
MXJ<^,+6UNKB#5;.ZTQHK-[Y6N-A$D*8WD;&;E<C*GGD=:YCQKIM]IVA^+]2N
MKJUV:I;1Q011(V\.@(4#/WB02<8[5J7/A:X\62276K:A:2VCZ9/8VS6*GYA-
MMWRDDGG"+A1D#GDT :#>-;:U1'U/3[VP26TEO(3,$;S$C7>XPC$APISM/]#3
M8?&UL=+FU*ZT^\M[)+5+F.;,<BRASM5%*,1OS@;?<<U7N/#6MZA):3W=_9PW
M.G6<\5I+!&6W3R1[!*RMP !GY.>O6LU_AO\ :X]55Q8:9'?6L<1M;",F!IDD
M$@F9#@$Y4# '3.2<T ;5SXWM+#[5%?V%Y;7L"PLEI\CO/YSE(PA5BI)<%3DC
M&/3FJVAWUW/\0M7@FBO[6,:=;RFUN9_,57:24%DPS* 0JCC'3I4-SX)N+NTF
M*)I&FW22V\]J+*U&Q987W[G.%9@QP-O8>IK2TW1]:C\53:U?W%BRSV<=L\$"
MO^[V,[ JQZY+G.0/TY )M7\50Z9K"Z3%97%Y?&U:[\J%D4F,''&YAN8G/ S[
MXXJ'4/&,>G0374VDZB+*W2)Y[AD5 @< \!F!;:"-VW..G)&*@\6>%[GQ%*Z-
M#IES:M;>7$+N,^9:RY/[V-E&<X*\9'W1R*PM2^&VH7MIJ-HVH65V;NWAB2_O
MH#)<0F.-4(7G #%2Q((.6;KUH Z>]\5M:ZY<Z/#HFHW5W#;"Z'E&(+)&25R"
M7'.01@X)[#&321>,;2^CTW^R[2YOI]0L_MT<*;4*0\?,Y9@!R0,9/.>P)I@T
M;6QXGFUGS]/_ 'FGK:"+8_#*S-NSGIN8\>@K,T7P=J_A]-)GM+NRFO++3_[-
ME61'6.6(,&1@1DJP.<CD'/:@"S!XQO+SQ)HUG!HMXEG?V$MTQF\M94*O$O*E
M^ N\YZDY&,X-.@\1V6G2^);VZ_M56M+N**2VN'20!V1!&L 5B &WKP2.6.<5
M)=^'M:>_TK4(-4@:_MK.:TN)Y8<;O,:-C(BCC(,?"GCGD\<U+GP;J%^^OFXO
M;5#J-U;WENT<;$PRP^7LW GY@?*&>G4T 7[KQE'8)J"WFDWT5U96GVY[8-$S
M20#.74[]IQ@Y&0>F,Y%/LO%]O<W\-M/I][9K<6;WMM+,$(FB7;NP%8D$;U."
M <'UXJAJ7A;5M8DU.\N;BRAO+K3&TR%(P[QQ1N27<DX+,3C P -O4YJ4>'-:
M.J:->&]LD.G6,UH=L;$L9 GSC)XQY:\'/4T 7/#_ (K3Q%]FEM]-NX[2ZMC<
MP7+-&R,H*C:VUCM?Y@=I]#W!%;ER[QVTCQPR3.%)$<94,WL"Q S]2*X2#PKJ
MVB2W&MV,&G1:FFGR0>18H4COKAMNV65> ,$= "?F/S5W!6[6P"J\3W8C WLI
M"%\<G Y SVH Y+3/%EK8>'/#;16NM7\6J8BMIIWC>8N59@LA+CDA3ST'<BKZ
M>-;3[!-++97<5Y%?C3OL)"&1K@@,%4AMI!5@V<XQG/2LRQ\'ZS9Z3X9L?MM@
MPT2X\[?Y;CSAL= ,9XXD)[\@4K^#-4DN;R\:^LUN6U:/5;7$;;5=8A$4?GD%
M >1R"<]L4 )K^L7%W'8R+!J6F7-IKMG:2HTI595D>,M]QBLB%6 YZ'(XYK6N
M?&$%K#K\C:9?,=$ :X1?*RZ%-^]/GP1MYP2#[9JKJVA>(=7M8!+?V*RQZC#>
MB/RV*1K$598U/!;)4DL?[W XJ+5_"FK7EQXA6SO;2*WUVT6&8RQL7A81F,E<
M'!!!'7IUYZ4 7;WQ)!=SR:9;:?J-V_V1+FY-I((V@C?.WYMZG<=K$!>>/IG#
M\/:N\^B> ?M\^K/<7L*L+B.9?+FD\AV*S9.YAA21QU YK1M/#FN:=J;7]E>6
M EN[.&VNUDC<JK1;@DB<\\,<J<=!S5>Q\(ZS9V7A:U-Y8,N@ONW;'S,/*:+U
MX.UR>_(H LR>/H(8[Z:31=32WT^Z%K>RMY6(2=N#PY+##J3MS@'\*LZGXSMM
M.&HR+I]Y=6^G31V]U+"8P%D<*0 &89P'3)Z#/?!QEW?@_6KK1?$-@;W3U.L7
M?VG>(G/E#:BD8SS_ *M>>.IKGKZX\J_\0ZA>O9-=)<JXT.9Y$>[>%%"LBJP#
M!RH*DH_\.3P H!Z5JNLV^BZ'-JM\DL<4,89XP SY. $ !P6)('7&3UKEHM4O
MW\>RJ]AJUOOT:29K%KE6#L)$4,@\PQJV"0>1^N3T/B'1SXE\,3Z>9&M)9U1T
M<KN,4BL'7([X91D5EKHWB5_$$6LS76E^:ME)9F!$DV#<RMO!SD\KT]/SH @T
MKQ;9V^C^';2SCU*_GU*S-Q;"[FC$SHH7)=V8 O\ ,.!GOV&:NMXQ/VS3[./0
M=4:ZO[(WD$3")#@;-RMEQM9=X!SQGH363'X(U!?#FDZ+>1Z-JEK8VK6YBNH6
M +?+LE4X+*P 8$ C.>HJWIOA35]+O]%G74H+L:9ILEB7N%??,7,9+$Y.,&,
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MN;#3)#!<74(CV^:,955+AC@D G& ?8$C4T#27TN&Y\R"P@,\N\0V, C2-=H
M&0 7/!.2!UQC KA_&6E:AH'A+Q%#%>VG]G7]R]RBM&QGWR,&>)1G!R=QSU S
MQQF@#L4\3;]2O=..D7Z7=K:1W9B8P_O$<L %(DQD%&!R1TJ"#QE;7UMICZ?8
M7=U/J%D+]+=2BM'"<<N68*"2P  )R<]@33;O2;Z[\0?V[H]]9^3>:>MI(95+
M84,S+(F#AOOMP<=N:QK+P#<VEOHSS1Z3J%QI^G#36CNH28W12"CC()5@0<C&
M"&[4 :?_  G]A<&T33;*[OIKFP.H+$A1'\L$C&&89?((VC/3G'&9;+Q/?7?C
M*YTDZ1<+:QV,%RDA:,,"YDY8%\@?( !@G(.<#%9VK>";O4=/BL)(]'NH4LA"
MC2VHB-K/EBTT0097.5^4$?='/6KT/AK5;'7+>]L]3CD4V%M97,EPI:1_)=FW
M#ME]Y!STZC- $6F>);.STF:XV:M-//J\MG':W4B/+Y^\YC0AMH0;6(^; 4&I
M;SQW;6"3BZTO4%GM;F&WN(4$;-&9B!&_W_F5B<#;DY!R!BJ<'@W4TM=TE[9F
M\@UA]6MF6-@FY]^Z-N<XVNP!'L<<8INH>#M6U"6]O3=V45[>7=G,Z['9(TMG
M#H@/!)+;LMQUX'% &C+XXM+.TUF;4;"\LY-)2.2>&3RV9DDSL*E6*\D$<D8(
M.>.:U=)U>34VG233[BU,01E:1D9)589!1E)!QCFL.X\.:W)JNMWT5WIZG4;>
MWA6-X2ZJ(F8X;/!#!V!XXXJSX5\+GP_>:G<*EM:P7K1E-/L\^1 5!!9<XY;/
M. !\H^M $VI>*X]+FG,^F7WV*WGB@ENRJJFYRH!4%@SJ"Z@D#UQG!K'CU:\T
MKQMXD@AL]3U*!+:UN!#',&6'/F[]HD< $X&%7T[57UOP#?ZI<:L5N--8WMU'
M<Q7=Q;EYX0FPB('/"90\@_Q'C)S6D^B>)HM9U;4[.\TQ9+^&*$1R1N1'L#8?
M(/)^<\=#QR.X!<C\86EZ]K'I%I<ZE)<62WX6$HFR%CA2Q=AR2" /]DYQ26/C
M*RU*\T^"UM;MUU"TENH)2$"GRRJO&06R'!8#D8]ZHZ9X/NO#4MG+HEQ;RF+3
M(M.E2[#*'\LL5D!7/.7;*]\CD8IEMX-OM'70)-,O+>6XTR.XBF^TH0LWGLKN
MPVY*D.N0.>#C/>@ OO'%P=)TF_T[2+EQ>:H;"6.5HP\965HV'W\$DHV"#CN3
MZ])JVL6^B:#<ZO?)*D%M"9I44!G  SC@XSVZX]ZYB#P?JT'A^"Q:]M)KFTU8
MZE#(49%DS,\A5QSC[Y&1GM7175EJ<_AI[,7D!U)X=IG>$&,OWRG]T\C'I0!E
M7/C5;'2KO4;K1-16WMDBE9XC%(K1ON&Y6#X;!7D#)Y& <U)/XVM-/ENHM6L;
MS3I(+4WB+,$?SHPP4[=C'Y@S*-IP?F%<CXC\.#PYX3\37:FTT]-0ABBAT^P!
M\I9%8DNH(&7;/0*.$[]:V=2\(77C'S;K4]1LFA;3WM;-K.,LI+NCF5MQYYC3
MY0<8SR<T :D_C:SL/M<>IV5W97-O#%,MNVQWF61]B!-K$%B_RX)&"1VYJKK_
M (E*^'M=%[I>MV(LK=9)I+22)9!&P8[XGWXRNTY'4<<'-13^");VRN4:/2=-
MG_</;FPM  LL4@D#N< L"54;.P!Y).1;UG0]?U[P[J^G75]8PM?P"V2-$9HX
M5(8,^>&9CD<'@;1[D@%+7+F^OO&-GH"+JB6;:9--YMI<K$Y?=&JR%@X8A=S<
M'J3G!Q4NC>(K33= :5CK%S/+JDMDD%Y(DD[W&\@HI#;0@VL1\V  >:NC1=9/
MBJTUI[BPVPV+6;Q!'RVYD8L#GCE.![UFP^#-46SW/?6?VV#6'U:U98VV;G+[
MHW&<XP[#(YZ''&* .GTG56U,7:R6%S92VL_D.DX7YCM5@RE20RX8<^N1VK%T
M?Q5J%])XA-QHER$TV[:&-8WB)95CC;:<O]X[V;L,8&<UNZ9%J*).^IW$4DLL
MNY(X5PD*;0 H)&6Y!8D]V[ "L.+P_K-GJ&M-9WMH+34+A[H+)&Q;>T21[3_L
MC86R.3D"@!+'QQ_:-C!?6WA[67M;F&*6VD$2$3%V"[>&^7&<DM@8!.2.2^Y\
M;VUGI&K7UQIUZ&TB4)>0(8V9 45PX._#+M8'@Y]JJOX1U!O >E: ;NU>73S;
M@AD;R;J.+ V2+G.& YZC/8BJ$G@35#I/B2PAN-+MTULH=L-NRI;XC"$*H//W
M1SQDY/M0!O+XPMXKF^@O]/O;%K2Q.H?O@C>9 ,Y(V,>1C[IP>13+7QA]JL&O
M%T34FB:".> PB.;S@[;0JE&(# X)R0 .2< U%>:!KMUKTNJ1WUC!(VE26*;8
MF8I(WS"3G@@,!P1TK%F^'5W*;Z6V?3M+-S%"KV5DC?9KADE$C-(OR_> V$ =
M&.2: .B/C*RM[;5I;^WN+232_+\^)MKEO,'R;-I(.X_*!QS^=9_B'QI?Z7H.
MLW$6@7D5[8VJ3J)S&8R'W '<KG.TJ<J.>G8YJF/A_<RQZ[')-I]G'J:6[QQV
M5N56VF@;<A XW+D GH3[=M?4]"UK7]!U?3]2OK6(WEKY$,=NA9(VYS(2<,<D
MCCH O<G- #[K4]_BC0(+FVU>REF6=HXQ+%Y+D(<K*%<DD !EQP,]<Y 2+QI:
M2I;W7V*[73+FZ^R0WYV>6SERBG&[<%+#:"1U(['-12:'K]WKNCZG=WE@?L,D
MKM$D;?=D7;M5N.@YR1R2>@JK!X,O8]*L= >ZMSH]G>K=(X5O.=$E\U(R.@PV
M 6SR!T&: )F\?01Q7<\FBZG';6-X+.\E;RL0N2H!P')8?.I.W. ?PJY/XOA3
M6KW3+;3KN[DL9(4NC"4RGF;2"%+!F # D@8'/7!K(N?!^MW.AZ[IYOM/5M5O
MA=[Q$Y$8^3*XSS_JUYXZFG:WX,O]=OWGN&TU)O.AEM]0CC*W5HJA-Z(P + L
MKD$MQOY!Q0!T^LZS!HEI%--'+*\TR6\$,0!>61SA5&2!ZG)(  )K&OO'-KIE
MEJ<UYIM\DVF>6UW OELR1OG;(#OPR\$<'.0>*TO$>BR:S;69MYEANK&[CO(&
M=<H73(VL!S@JS#CIG/:N?U?P=JFL6VN2R7=G#?:M%#;$!6>."&,L0!T+,68G
M/ Z>G(!TVDZI-J1N1-I5[8>2X5?M07]ZI (9=K$8YQCJ#P:X_6O$[:K%HM[I
MUOJ<%HVM6]O%>I,$BG7SPCAD5\E#A@"RX^F1GOX?-\A//V>;M&_9G;GOC/:N
M%3P;KMMHUGHMMJ%A]AT^^CN[5GB?S'5)O,6-\' QTW#K@<#F@#8O/&=K:#4I
MQ8W<UAIDGE7MW&$V1, "V 6#,%# L0/7&2#3YO%\$*ZZ?[.O7;1D6654,698
MV4L&0[\$;03R0?;-9UWX1U&2PUW2K>[MDT_6Y7EG=E8RP>8H655'1LX)!)&-
MW?%.U+PGJ3W>M+IMY:Q6FKV*6LGG(S/"41D!7!P<JW?H1GGI0!#?ZM/%XUT"
MYL8M0N8]1TRXD-FDV$)4P%&*LP12 S<^_?BG77CJ9WT4Z=I-S*+O49+&ZB<Q
MK)#)&DA:/!<#=E,YSMP.O(J1/#WB&*_T>^BN]-\S3+"2T\LH^V;>8\DGJH_=
M ]^:B3P;J%O864T5Y;2:K#JTFJS,Z,L+O(KH4 &2  XQUSM]^ #2F\80KK-Y
MIMOIMY=2V+PQW7E&/,9EVD$*6W, &!) QUQG!K7U34#IMJLJV=S=N\BQ)%;I
MN8ECC))("J.I)( %<CJO@G4M8N0]Y<:>]RDL#PZJD/EW=N$5-ZKM R&97/+8
M&\C!P*WO%>B7&O:;;V]O+"##=1SO#<*3%<*N<QN!_"<Y[\@<&@"G/XYL;73[
MFXN;6XBGMKY-/>W9DSYSA2OS;MNTAU.21^?%;6E:C)J,,S2V-Q9R12F(I/M^
M; !W*5)!4@]?K7)VO@S4[*#5(D.C26^H7L=U)9M:X@*"-4:(C!&/E!#8SGG'
M-;?A'PZ_ANPN[<O&(Y[IIX[:'/E6JD >6F><<$]AEC@"@#-TWQO*=-UO4-7T
MV>T@T^\>W3:4<L0558P Y)<LP]!R.:VK#7UNM6?2KJRN+&^6 7*Q3%&#QYVD
M@HQ'!P"/<=0:P+KP5J-U#J]C_:4$5C>7C7\)$19Q-OC=-P/&U6C/0_,&[8YV
M+'1KY_$QU[4Y+<3I9FSAAMMQ4*SAW8LV"22JX&.,=3F@"2Y\2);>)!HATV]:
M=K5[N.8&(12*N 0"S@[LE1C'<'IS5.T\:0ZA#IOV32K][G4(&N8;9_*5Q"I
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MYD&T,&4JQ!'..O!!%:-,B\SR4\[9YNT;]GW<]\9[4^@ HHHH **** "BBB@
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M7JC?8[Y[JVTM)Q$+H>3)'O;E5S@/D-R>P%1VWCB:[DTM(] NQ_:UL;BP+2H
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M33:6QD>0V\1>3 =B@RV.F3WK F\6264<R7VD7,-V+N*SMXE8,MS)(,KL<X&
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M>'A[Q%#K4NK0:QIWVAK*.R$;6+^7A&=MQ_>9SE_7&,CW'744 <9:^"KS3O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/[-9?9KZ1Y;J+[-\LSM]YF&>2<"I;K1H;[2VTRZCM9K%D"&W>WRA48P,9Z#
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M<!Q]UAT(/8CU%0C1-+73&TT6%O\ 8F)9H2@*LV<[CZG/.>N>: /,O&S7(O\
MQDMH$,+KI"S[_N;C,0V[V*; W^SBNRTRZO(/'=UIE^MC<SOIR7"7EO;>4ZH)
M&7RGRS9&22O/][ZUMPZ+IEO8SV4=C!]FN,F>-D#"7(P=^?O9&!SGBC3=%TS1
M_,_L^RAMS+CS&1?F;'0$]2!V':@#F/$_VS_A8GA?^SVMA<_8[_'V@$KC]SZ<
MUSVG:G?6&D6MA;++%J-]XBN(-52!D7RY-KRE8BW"JP5,$\X8_P 1KT2X\.Z-
M=ZDFI7.EVDM\A!2X>%3(N.F&ZCI1<>'=&NIKF:?3+5Y;HH9Y#$-TA3&TD]<C
M P>HQ0!Q=_=^(K/P[=7\VIW$,6E:F#,D<D,LK61"%UD(! = S,.^T#/7-='X
M9FN]0U#6=2;4)Y].:[:"RA;9L54^5V! !(,@<#)/"CUK8@TJPMM/DL(;2%+6
M0,)(@ORON^]N]<Y.<]:ELK*UTZRBL[*"."VA7;'%&N%4>@% 'GFKI?7>M>.4
MT@VJH+**&]^V9)9O))_=XZ#8_5LC=VQG-CQ%>6EW\([5K%G^RM#I[.DK R+;
MM)%G?_P#.?QKK[[PYH^IW#3WNG6\TKH(Y&9?]8HZ*W]X<G@Y'-3#1]-5[IQ8
M6VZ[C6&X_=C]ZB@A58=P 2,>] &!+N'Q:M?*Z'0Y?/Q_UW3R\_\ D3'XUUE4
M=/T?3M*,AL;2.%I,!V4?,P'0$GG R<#H,U>H **** "BBB@ HHHH **** "B
MBB@ KG?%MA:KX=\0:CY>+IM(G@,FX_<".P&.G4FNBJK?Z=9:K:-:ZA:0W5NQ
MRT4R!E/U!H XW58/L?PQ?7K*:6UU.UT &*XB;G"Q[PI!R",CTS[TZ^74=.ET
MV&37=3O+C59E(M84B5FV1.SA'.T1I]TGJWRX'4UU!\/:,=)_LHZ7:'3\Y^R^
M2OE_]\]*+GP_I%W8V]E/IUN]M;L&AC*#$1'&5]."1QZT <):>(=6O+#3-/DO
MYH/M/B"XTZ6[RAE6*,2,J;@-NX[ FX#/X\U7U&2\TBR^(%Q9ZO<?:K.6WDCN
M/D+\0)A6XP>OIGIWKOCX6T'[%-9#1[);:9Q))$L*A6<=&P.X]>M1'P;X:9'1
MM"L&20 .K0*0X'3/K^- &7?QW]W\0#I::S>VUC+IAN6BA* JXD" JQ4D#!R?
M?VR#AZ5XCU'4+7PXFI7MX8[K3)Y97T^$M-).CHH9E120N"3T"[C@]A7;_P#"
M,:$+G[3_ &19^?Y7D^9Y(W>7C&W/7&.,5A77@BW@U6.XT_2](GL4M_*33[J+
M9% ^XEI(\*P!8$ _+GY1S0!K^&+?51X3LDUJXG.IR0 W#L5WHY'.-HP,?CSZ
MUQ\>IZS/X.T*Y76;E+J36WL9)MJ$R1FZ>/D%<9"J,<=>N:[/P_HKZ3X>CTN[
MN!=_ZS=D':%=F;8H))VJ&VC)Z 4W_A$/#?V=+?\ L+3_ "8Y#*D?V==JN>K
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M+6.5(=+M526/RG'E@@Q]=GLO^R.*8GA3P_$+41Z+8*+4[K<"!1Y)]5X^7\*
M.(N+[6K71==U,:]>O)I>LBW@C81[&BWQ J_R_-D.PSQCC'.<SWNL>(KN]\03
MV;RPMIM^EO;[YX8[=4"QL?,#?,=^\\]@5Q@BNN_X1#PX;>6W.AZ>89G$DL9M
MUVNXZ,1CD\GFIY/#NC2W4=R^FVS3($ 8H/X/N9]=O;/3M0!DZ-_R4/Q3_P!>
M]C_Z#+5K7/\ D8_#'_7W-_Z3RUH6^BZ7::C/J-MI]M%>SY\VX2,!Y.<_,>IJ
M/4=.EO-6T>[1D"64\DD@8G)#1.@Q^+"@#3KD?A__ ,>.N?\ 8=OO_1QKK757
M1D8 JPP0>XJCIFB:7HRRKIFGVUFLK;I!!$$#GU..IYH OT444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
K 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>ex19iiinsidertradingguid001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex19iiinsidertradingguid001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBJ>JZK9:)IL^HZC.(+6!=TDA4M@?0 DT 7**@L[N*_L;>\MV+0SQK+&2,9
M5AD<?0U/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5D>*5)\*ZLRR2Q/':2NCPRM&RL$)!!4@]:
MUZR?$^X^%M5CCBEEDEM)8TCBC9V9BA   'K0!Y#\,-1M?$7A2SLM9\0:M+K>
MH7D\,;1ZQ.LT:+&7W[0^,#;CD8R1UK8^)^MZWX8\+^%](BGO&GFGMX+R\B?!
MGVKAD#DAMS$9[9'?DU2^%^GGPYX1M!K?A[5TU73[V:X@2/3I'=@\>S 8#&"&
M/!(Y JQ\1K?7?$OAWPI.-%OC=KJ0O)[>.!F:WBR<!L#J 0#WH SO$ESJ7A_Q
M1X8\-P7/B"73M1NI;J:*69?-<,%Q"C!ONID_*3C)[\5W4'B33/!EE-H3W6JZ
MS+H]K]HOKEBLDD,3$D&1B5R<'( R=J_GB^.;"_OOBAX*U&TTZ]GL[%W>YFCM
MG*QABN,\>W3MWK)NM#O-&^*OB&75- U;5M"UZ-=LFG^8P! QLD"L!MY8?-QT
M]30!Z)J'CC2;-K*.V$^HW%[:M>P0V84LT 7<9/F*@#TR<D\"N3\3_%F&+PUH
M6H^'[:XN%UFZ6&.5D \H!\.N">7X(';OGIG+U;1M6\'_ !&T'Q+IOAZ[N=&&
MG"PGLK%3/):CG@ =0,J<].",]*M_$K2-2UC1?"]]I>@74<-CJBSR6<42^:D>
M<[MB]#QG R1GGO@ TM:UB"7XE^$X[B\UW3;B6.1H[ *GDSY!_P!9AS@C'H>V
M,=:W-'\?Z9K6HZSI\%I?176CJ3=1SJB$$$\#Y^>AYZ=.>17*^*;+4M0^+G@S
M5X=)O_L=K&_VB3R&(AW9P&(R,\C..G>IO$'@G4'^+=CK&F IIVJVKVVLD#@H
MH'!_WP%7\#0!UDOC.RC.E0+9WLFH:I$9K>P54$WEA=Q9LL%48]6Z\=<BM#P_
MK]AXFT:'5=-D9[>7(PZ[61@<%6'8@BO./'VD:I8_%'0_%<.EZCJ>E):&SNHM
M.+^=%RYW (0V/G!]/E(/45WWA73K'3=&V:?I+Z7;RRM*MO*27YQ\S#)VDXZ9
M/;.#D  \QTY[N^_:"UWP_/JNK'2HK3S8[9-2G0(Q2(Y!5P1RS?G6EX2\6:II
M'Q5U;P'J]_)?VJ*9K&ZN"#*B[!)M9OXAM)Y/.5]^*.G6NHV/Q]UKQ'-H^J?V
M3/:^5%<)92,&8)$.@&>J-SBM+PWX1U>\^)FL^/\ 5+$VH>,Q:=8R.OF, @0,
M^"0N57IZL?3D W4^*?A^1],D5+LV&I736EK?A4,32@XP0&WKD]"5'KTYJKJ'
MC^[B^*EOX6M]*NY((K9IIS&$+2DXVE<L,(.<G.2>W'/F-YHWBK5=*T2[N/"F
MHV]Q::WYTMM;VZQP119! BB4Y[$ER.21\Q[=[>Z9JUG\>+77QI-Y/I]QIGD"
M6% P23T<YPOU/'UH Z?4OB%HNF3ZBKK<S6^ER1QZA=0HICMF<X ;)!.,C.T'
M&>:L77C72K3QEIOA=Q</?:A ;B&1(\Q;0&/+9[[3T!_6O,],\.W.D>,O%6DZ
M_P"&=6U;3-8O#=6LUH7,#[F+;9<,%'4<MT*^F*]$?5-3T_QAHVA6WAEWTM[,
M^9J2.2EL0#\F2/\ 94<D$[AZ4 =77E'_  L"]MOC9!IEWNCT+4;<VMDQ/RO*
MCL-_XN&3W&T]#7?>*-0NM/T24V-O=37<Q$,1MX&E,98X,A '102WOC%>:?$_
MP#=W'A#3)]%N]6OM0TMX_L$!MTW*G (^2-2",*?F/\)[T >AZ[XRT[P]KNCZ
M1?177GZO+Y5J\:*4W9 (8YR,;E[=ZH1_$OP^6\0"X-S:#02!>F>,8!)*@+M)
MW$D8_$5Q7BY=<UV;X>>)7T'4O,TZ\W:E;1VS&6)B8B2$QDK\C8(XZ5BOI$Z+
M\4;[Q!X>U1-/OU2X@0)M9]CLP(< J""5)Z\ ]<&@#TR#XD:?-J6E:<=*U6.Z
MU6!;FS1HXSYD9YW<.<8')!Y JJOQ;\/-X5NO$8M]1^P6MW]CF_=+O63 /3=R
M/F XKB?!_B3P5JOBWPW+=^(9;G5-/M%L-/C-BUNA8KMRQRV7(..H'MFN>D\-
M>)+?X:^)?"X\.:I)?2:T+E72 ^6T?RC<K?Q?=[9ZT >T7?Q TR"]N+."TO;V
M>ULEOKA+94+11,,CY68%CCG"@XR/6LBT^(5U?_%:Z\-0Z7=FSL[0&0JJ%F=V
MCQ(<L,(%;MD_-T].0\9>%KG43;ZSHUEK.G^)[&WMDMIH+60I=C8H*N<81E)(
M); P,'/;:T+2M=TKXW:CJNH:7<2PZCID$0NK=,Q"0+"'R>B@%'.#SP,9R* .
MW\<S7UKX*UB\TZ_DLKFULY9TDC16)*H6Q\P(P<?6LOX27UWJ7PPT:\OKF6YN
M91,TDTSEF8^<_4FM3QRLLW@?6[6"WGN+BYL9H(8H8F=F=D( X'')ZGBN+\)W
MVO>#_@M8);^&[V[U>S9DDL9(VC8!IG.[I\PP0>,]><4 >G7J7,ME-':3+#<,
MA6.5EW!&/1L=\=<=Z\@@T[Q!X3^-&BZ;9^)-4U:SU*"2>\BOI=^Q1NRV.@&0
M,$ <\5Z=9:^+WPA;:^ME<MY]FETMK$N^0[E#! !U/.*\V\+^(?%D_BII[SP#
M?6]YJ5PD=QJ5RYV6]L&X15V# "Y[\L<GTH YV7QGJ^H^ _$GC>&_N8KVSUI(
MK)5E81QP H!&4SM((<YR.372_$.QU75?!,GC6V\4ZCIWE6L5U:6=K*8X0K!3
MAL8+.23SGC@8KGYO FM6'@CQ%X'M]/N);B]UE)[.<1,86@)0[VDQM7 3D$YS
MT!K?\5ZAK%A=Z7X?L_!6J:WH>DQ1!MH,<=S*@ 3/RMN1<9QT+8[#D V;N"[U
MCX::;?>*?$MYH0%@DES);2"!FE*\%SC)XQ\@QDD]>,8/ABXUG7/V>M2%Y=2Z
MM?7$%Q#;B(F>7!&%1\9.[.>O0$9KJ;7QAJ%PEG9^(_!VIQ0W]NTDKQ6K744)
M+L!%(JJ3G:%R2.IZ 4[X9>$'\)V.L?NVM[>_U&2XM;5CS##T0-Z-@=.PQGG-
M '2>&$>/PII$<L<D4D=E"CI(A1E8( 00>1R*U:** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=P.00=JY'-2ZKXTU'Q!J'C#1-'MK/[%HMFZ74MP6WS.RL"J8X7&UN2#DCWH
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MUQ5]XXCTC4O#OAJ&:SMKJ[L!<RW5ZV(H8PI"\;EW%F4CJ,8[UP/Q!\5#QAX
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#AOBGX0U7QOX8CT?3'LX3]H29Y;F1EQM## "J
M<]:S?%?@37_$.C>%+2%M-BFT:6*68O<.5?8%&%(C[X/7I7I=% 'GFG^"]>L?
MB-XF\3K-8)'JEIY-NJ2L7B<*H5B"F#RF3SQGO5?3/AW>6?C9_$T=IINGS&QD
MAF@LYW\JZG;^,@H-B]\#//TR?2Z* /%X/@WJS_"I_"UU>V*:A!?_ &ZTGB=V
MC+;<;6RH(X)Y&>U;P\'>*M0^)FA^+]2;2(A8VAMY;>"61B21("02@S]_/;T]
MSZ510!YIX=\%>*?!_B+6$T>[TR30M3N#<@W&_P ZV8]=J@8;@XY(S@=.]Y?!
MVKK\7SXN,ED; V?V3RS*WF]/O8V8Z]LUWM% !7G7Q3\#:SXYCTJ'39+"%+*<
MS,]S*X+' X 5#Z=<UZ+10!@>*]*U#Q!X*U+2H%MHKR]MVA^>5O+0MP3N"Y/Y
M52\.^'M6T?X;1>'_ +5;P:G!9O;Q7,+%T5R#M?D \$@XQVKK** /&+/X5>*H
M7\)W$^H:,]SHMY)<3$"7=/O=6+LY&7?Y<<A>@YK9;P#KVE>*/%5YHDVG26'B
M.!A*+IW5[>4AN0 I##+-W'7VY].HH \=F^%?B&3X/VW@L7.F?:H[KSC.99 F
MW<6Q]S).6Q6[J?@K7+_QYX6\0*VGI!I%OY4T1G?<Y((.WY,8&>,XS[5Z+10!
MY!%X9U;P+X0\>W^H-I$HU)GN849FD0%B0$960 _> 'J:H>'M4U'PWJFAOK'P
MXN;128M-AOWU W#0!SM 5&SL!)Z#'''M7M-S:V][;26UU!'/!(NUXI4#*P]"
M#P:HVOA[2+*:.:WTZW22+_5MMR8^,?+G[O'IB@"36]'L_$&BW>DZA&7M;J,Q
MR '!'H1[@X(]Q7*^$]!\2^#-$_L&)+#5;"!G^R3O<-!(J,2=KKL8<$GD'\*[
MFB@#S#P=\+;SP_\ #O7O#E[J%O)<ZLL@\R%24B+1[!UP6P>>@K(@^&/BUK3P
M5#<3Z,%\-71EV)++F9?,5\[MG!^7&,<=<G.![-10!YX/ FI3?%/5O$ERUD=+
MU#3S8-$LS^:%*J-V-F/X>F>_6N7E^%7BS_A7EQX)CN](:S2]\^WNWDD#LF[.
MUD"X4YR<Y/I[U[710!YIKW@7Q"WB'PYXHT*YT]=7TRU6TN(+EG$,T8!'#!<_
MQ-U'IZ<R^//!?B3QCHVD0?:-,2ZM;T7DVYW6-< @(F$)/7[QQSV'0>C44 <
MO@_6O^%NGQ@38?8S9?9?)$[^9G'7[F.OO_A7+K\*/$G_  @WB703<:5YVKZ@
MEVD@GDVQJ&#$']WDGY0/Q/IS[/10!YCK?@#7WN_">O:+<V$>N:);+:RQ3NYA
MF0+@@,%SW;M_%VQST.KZ+K6M:5#;:I:Z1J$4I?[;8R.R1!2!M$;[2VY2"=Q
MZGIQCK:* .3^'7A.;P9X472I[@2N9Y)MJL66(,>$4D D =\#))XKK*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZQ']VQ;?R ?E!X.2#V% '745RT7CS3;C5YM,MK'59YX+Q+2<QV;%8689#O\
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M%O:WY1?(ED.=H!W;@&P<$J >QQ5E?$]K).!#:7<MN;LV7VI%4QB4-L(/S;@
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MYA;PW;VV(ED8E55CGJ2.V1V)!H ["BBB@ HHHH **** "BBB@ HHHH ****
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M '":>EWX;\?>(;N[L[R?3M9$%Q;W%O;O-L=$V-&ZJ"RGH02,>^:@TOP-+/\
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MNAW+G<IXR* .9US0I_&'B<7=K'<6EO;Z1=V?VF>%XB\LX"J K ,0HRQ.,9(
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M]>PT4 (I#*&&<$9Y&#2T44 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQMZY[5<T'Q+:>('OH88+JUNK&417%M=1A)$) 93@$C!!R#FO/]-\-:CX?M/
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MP,UWM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*7OV=FC3(8K)M.!Z'FN!\9Z7-XU\,)97'A>Y@\183R)V";;23()<3*Q&P<G
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ME>/E'3J<FNCTR+5=!U[Q6S:-<W)U*Z6YLVB*F.3]TJ;68GY.5YW <=,UW=%
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MY!(()[@D$4 <EJ^LZ9I/Q U*W\<VCBPO#&-(OY5+6\2!!N0$?ZM]V26Z^I
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M;<>,+D@X!YYR:[#QYH=YXB\&7^G:<ZI>MY<L&\X4O&ZN ?J5Q^- $L'BF/\
MMK^R[_3[NPE:T:\22;:8S&IPV64D*PXR#^=56\<V<5MIU_<65W!I.HR)';WS
MA=F7^X67.Y5;L2.XSBJT5SK?C'0KW3+[0KG0UN+.6WGDN71B9'0KB,*22HSG
M<<=  #DD8DFC:QKOPXL/!E]I<]K>1&VM[FY)4PK%"ZDR(V?FW*G '.6Y  S0
M!T<WC91JNLZ7::'J=W>:6L3RQQB,!U<,05)<#&%Z'DYX'!Q7A^(UA/:Z/?QZ
M9J/]E:G+'!'?,B*D<KG"JR[MW7@L 5SW--TNUO[3Q_XMU&73KD6EY!:K;2 *
M?-,2N& &<CEAC.,US,.@ZW%\*?#&CG1[HZA97]O+/""F52.;>QSNP>.F#0!V
M4WC0#6=5TBTT34[N^TZ..1XXQ&!(K[B"K,X&/E[X)SP#S5.+XD6$]AI.IQZ9
MJ7]E:C+'"+UD14BD<[0K*6W'YN"P!7/<TNEV]];?$7Q'JDNFW0LKJTM4@EPO
M[QHP^X 9R/O#&<5R\.@:Y'\(-$T0Z/=?VE:WT4DL *954N/,)SNP?E]Z /0+
MKQ&J7][8V%A<ZC<V,:O<I 4&S<"57+$9<@9QZ8R1D9S9?B'I(T[1+^V@O+JV
MU><6\#PQ@[).<JPSD,-K# !Y%4]-M=1\-^--?NVT^ZO--UDQ74,ENH9HI53:
MT;J2",X!!Z>I%8D?A/5=*TKPK MC+/-#KS:I>K"5*VZ/YF5R2,XWJ.,YP: .
MWT'Q/'K>H:GI\EA=V%]IS()K>YV$[7!*,"C,"" >_&*L7^N)::K!I<-N]S?3
M0O<")'5?W:E03EB.<L !_*L31+*^A^)/B6_FL9X[*\@M4@G;&US&'#=\C[PZ
MCFF^,]$M-=OK:&_TN^9(8FDMM4T]BL]K+G& 0<\C'8CCGM0!'?>,[]?$'A>S
MM='NO(U6*:=U9HQ)\D>?+P6P""RDG/; SS6I>>+8H!J4EII]W?P:6Q2\DM]G
MR,%#,JAF!=E4@D#UQR>*Y=-,\4P77@74]1LY=2O+".ZAOC$\8=3*H$9;+ =%
M&X@GG/6KFB6>J^%;OQ+8R:7<7UOJ%]-J%C-!M*N90-T3Y(V$$=3P0>O:@#H$
M\66-Y]B324?49KRU^V1)"0H$.0-[%B-N2< =<YXX..1\0ZO:>(AX&UFW@N("
MVOI"T=PI1T(64,I&<?>7J,]*I:1X:U[X=7NBWEKITVM6HTI=/OHK1E\R*02-
M('0,1N7+L.WK6KXTTK5?%%AX?AN](G\O^TQ<7<,$B[K>W\MT(+!AE_F!.W/4
MXSC) .QTO65U:6X,%G<+:QN4CNW*>7/CJ4PQ)7WP <<4:IK4&F7-G:>7)/>W
MKLMO;QXW/M&YF)) "@=2?4#DD"L7P4=<TZ&?0=9M9Y8K!_*LM3.W%S"/N[@#
MD.!P>,'&:C\4Z7J,7B_P]XFL+9[R*P$UO=VT9&_RY0/G0$C)4@9'4CI0!8?Q
MU8PV&MS3V5Y'=:(OF7MGA#(J;=P=3NVLI4$@Y[=,\5>T#Q&=?+NFDW]I;^3%
M-#<7**$G5QGY<$GCOD#J/6N3UCP_J&I?\)GK,-A.)=3TC^S;*V.!)(=C_.P)
MPH+, ,G.%.>M=GX;2:+PSID-Q!)!/%:QQR128RK*H!'!(ZB@#-U/QG%IWB)]
M!BTC4KS4/LANXT@1-LB[@N 2P YSRV!QW) -.#XD:7<:##JJV5^$-^NG7$#(
MHEM9RP7:ZEAW(Z9ZU2OKLV?QM@D^S3S(?#K*WDIO*#[0.2.I&>.,]?3-9>H^
M$M6/AC6KZ&Q=KZ]UV+5EL59=_E1NF%SG&\JI;&>IQ0!VESK5I=Z_=^%I[6X$
MWV W9<[?+>(MLX(;.<]B!7"^!?&\'A_X?>&4U#3-273Y$6%]3\M?(CD9R!N^
M;=C)QNQC/<UNVD6KWWQ,_MI]#N[73YM#^RAYGC#(_G%@'4,<<=AGMG&>,:R\
M.ZM?_"JS\"W.EW%M=#RX+JXDV^5'&LH<NK G=D#  YR1G% &W:1I;_&C5FC1
MB6T*&1E!R6;SG'&?8 58\/>(= M/"TE_I]A<6=M)J,L"VK &66Y:4J0!N(RS
MY[X'L!2P6=]'\5K[5&L+C^SWTF.V2XP"K2+(SD8SGHPYQ7*Q>&O$7_"$(;;3
MGCU73?$#ZM!:3NJBX3S'(7<"0,JYZ]Q0!Z#IGB%;_6;W29["ZL[VTC25A* R
M.CYP5920>001UJ;4M;BL=0M=.BADNM0NE9XX(R 0BXW.Q) 502!ZDD8!J#0M
M5U/6-UQ=:-<:5;JF!%=LAE=^YPI("CWY.>@QSA:]9ZKI7Q%T_P 46>GSZE8O
MI[:==0VY7S8<R;UD"L1N&>#S0!F>!]5MM*_X3.\N;>:U1=<\L6[X:3S&2-50
M<D$EB .<<CG%:6M^)K/5++7_  [>6DUI?KI4MW&CNK++'@C<K(QY##D'!^HK
MGI_#7B'4]/\ %30Z0]O=2:S#JMC'=O&4N/+$?[ML,<9VD<\>]=#9+?Z]I&HQ
MKX1&A/)8RP_OQ&'DE9<!5*?P#NQQGC ZT 4/"GC>WTKPYX1T^_TO4;>UN[.V
MM8=1DC40-,8U 7KN&3P"0 >W'-;GA[Q-?ZOXK\0:=/ILL-OI\T<*-OC(7*;\
MMALY;<. "!Q[UAPZ+J6M>#/#7AJ?3+FS>P>T-]+.%"H(,$A""=Q8J ". "2<
M=#K^'[+4M-\>>*&FTZ7['J,T-Q#>!T\O"PJA7&=V[<.F.G.?4 WM4UJ+3;JQ
MLQ&TUW?.R01!@N[:NYB23V'X\]*J_P#"3Q"TM7>RN8[RZFEABLY"@DS&S!B3
MNVA1MSG/0C&20*I^,]*M-:2RLM1T>XO;(L[M<6I(FM)!C8ZD$-W8?+GMQC-<
M?-H'BJSL=!U:>T?7Y-)N;N(V=VR&XFLY2 C,3P9%"*?7G'7- '86GCW2[FTO
M7DBN(;RSNULI;)@K2-,YPBI@[6#9X.<8R3C!HN/&T5DNLK>:3?Q3Z3;"[FC
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MW/VW_2XX2'C*SF65V4I\W3##);'XUT'B71+W5O -H;*%XM:TU8;RS1\;EGB
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M)K"+;V4.$:5C"A.WL.I))X'4D4 >ET5S^I^*$TRXM["5;1=2FA:<Q378BC1
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M%E'$BPQS1W$,_FQ2ABW .T<C:,\?Q"F:AKHMM8M]&LX!<ZE/"]P(VDV)'$I
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M+FP^S:A=&Z:$/-&ROYC%E&58XZXYKU"B@#.T)KQM%M1?V7V.X6-5:$RK(5P
M.2O'7/0GM7*6NEZU;:QXUO#H@GCU)X'M89Y8BEPJ1K&Z,-QQG!Z\8/X5WE%
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MD4:DB,$<@,00<<X^IKH/#][KNHEKC5M%31T5-HMS<).[MW8LG 48P.<G)SC
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M@"VU"3C/+8Z#-="VGZG)\4;36O[.E73UTA[-Y3)'E9&D5_NALX 4C([_ )T
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MG(^4X[GG('&0"73/%>CV&B^(=4CTG^S5MM8:UN49D4RW#&-/,=AD $NN3DX
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MS1QI(K%L'<2<#Y>_/MC)KD=9\.>+-4TS4HKK14O-1354N(+U[N/$ENLRLJ1
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M0)M"L-0>Y"K=:GJ,^H31J<B(R-PF>^%"@GUS0!T=%%% !1110 4444 %%%%
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MMC#;W%]"\MC-#.9(Y609>,DJ"K $'H01^5<[X2MI_$.H>+K?7-.L;FU.LE9
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M,"RATZ2U?,J[P[LK<#T&W'6NGM+RVO[9+FSN(;BW?.R6%PZM@X.".#R"*FH
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MME=:;X3TG3[R(1W-I:16\@5@P)1 I(/H<5R.@7.HV_C?QX+'3Q=%KN#8QF5
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M1^SHFH:S8#3[:W:4?ND",-SL.,EF)(&< #DU)=:%K$LW@F1;)<:,=UV#,O\
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M3(K/--*H4]#@*%!QDY);H,<@&=H_Q O-0T7^WKS0A9:)%'<M<W)NU=HS$[*
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MA"WEL]N\@'(W*5W8_'-<YX5A\96]I9Z1K5M816]BJQO?P7!=KI5&% C*C9G
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MZ5J^DS10:UH\YFM6FSY<BL,/&^.0& ZCI5ZWO->OHQ%+I*Z:YXDF>Y24+Z[
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M'0\'W/YU?AABMH(X((TBBC4(B(,*J@8  '05R\/B358_'#>&KBQM)@MC]O\
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M!U-S=6]E;27-U/%!!&-SRRN%51ZDG@54_MW2O(L)_P"T+?RM095M'WC$Y(R
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M2VMQ#JL$27MK-,T926,;4=&"G(VG!! ]?:NNIDDT41022(A=MB;F W-Z#U-
M'GTG@35+>/2&LVL9+B+7'UJ^:25T#R/N!1 $/ #  G'W>G/&YK^A:I>>+- U
MO3'L\V"7$,T=RS#Y90HW+M!R05Z'&?45NW.J:?91R275_:P)&P5VEF50I(R
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ML5&#@  8/<]\#H-3T;3M82)=1M4N%A<2QAR<*XZ,/<=CVJHOBSPRJA1XATK
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M"]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ]GN+NUDACEY^5F4@=.U>>Z9XFLYYM(\)^--'.B:Q9SP-8R% ;>9XV7:87'
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M!) SG)!Z<9J+X-UU/"7A#21_9QGT2]M[B9S</MD6($87]WG)SWZ8[U/!X?\
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MGH\-U-%?::\;)=6R*'"MDO\ -E@F2%Q\WM70>(+[4+#3TETZWADD:>-)))W
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M#*2Q!&T@\\^U '2:;=Z?J]K!J]@R3Q7$0,4X4@LAY[\@>U..K6(UI='-PO\
M:#6YN1!@Y\H-MW9Z=>*\[O\ Q'K>J^%_ >HV]Q:V9U74+=;B)8&922&< ?.#
MM!09'4\<CH>G77=37X@CP])#9M$=(:]690RLT@D5,'D[5Y)QR>G- '4T5Y@/
M'OB9?!Y\3RVFE"TM;]K:Z@42%Y$$_E90YPI&1USGG@5U-SKU_<^+[KP[IOV:
M"6VL%NVFN8V<.78JJ@!EX&WDY/7% '35#=W=O8VDMU=3)#!$I9Y'. H]ZPO
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M,>_UH W**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K)\07VH6%A'+IT$,CM/&DLL[@1V\1/SRL"1D*.P(S6M7.>,=!O]>LM
M/&G74$,]E?17?EW"EHIPF?D<#G&2#]5% &!_PG6I#2/&,L26%U<: HEBF57C
MBGC,7F#Y<DYZC@X/!%6K3Q3KT>O^&8-1@T_[%KL+E%@#^9#(L7F9+$X8$9X
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M5IX'U*P\+W_A"WO+8Z'<&1(IVW>?!!(27CVXVL?F8!LC&>AQB@!;KQ7X@O\
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M*PDC/[RWC=E;+YR'(4L,# X&#UI\U]%J?Q+\':A!GR;K1[J9-W7:WE,,_@:
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M.^M-#,6Q[J*0PPI ?+V(!N!(&T=1P>M3V&EZ?I4;QZ=86MFCG<RV\*QACZD
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MJP2RVD]K T1B>, LC LV1@C!SF@#IM%UNP\06!O=-F:6W$KQ;FC9/F4X888
M]16A7EOA;77T+P43#'ON;WQ#<V<(*E@&:=R3@$9PJL<9&3@9%=5H&H>(9/$%
M]9:C:2/I@A66UOGA$3;LX:-E!.?4$ <9H Z"]OK;3K1[J[E$4*D L03DD@
M#DDD@ #DDXJII.OZ?K4MY#:/*)[*01W$,T31O&Q&1D,!P1R#T-<M\4$NVL]
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ML\&GO:^2?, D+ 2>9NZ@@<;<>YH ]>I&8*I8YP!G@9/Y5PFH>)M=U!=:?P]
MS2Z;<O;00FV\Q;B1 "P=MPVY)*C'3&23G [2PGFN=.MI[BW:VGEB5Y(&()B8
M@$J2.N#Q^% %+2_$>E:S-=1:?<-.]HYCG A<>6XZJ<@?-[=:--\1Z5K%Y=6E
MC<M+/:-LN$\EU\IO1L@8/M7$> [N]M]7\:K:Z8]TA\03DNLR)@[5XPQJ'PK>
M7D%Q\2;Z)%MKN&\,RI(!(%98<X.#ST[&@#U*BN#/BW5?[%\"Z@#;9UR6WBNX
M_*.!YD1<E#GCD=\U"^O>*KR\\86MM>:;;G174PN;1F\P&$2;2-_'7!;)]@*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_>/>M^B@#EH_"U_:^)==U2TU2%(-62,O!);%BDB1^6#NW#Y<<XQG(Z@=<Q/
M-_'X4\.:(NKV_P#Q);R&Z68VC?O?+)*J1OXSGDY-=Y10!Q+^#=;L/$5_?^'_
M !$EA9ZG()KRUEM!,%EP TD9)&"0.^1GUZ5V,,'V>TC@B9F\N,(K2$L3@8!)
M[U+10!R_A7PO>^';O6YIM0@NEU2]DO=J6YC,;M@8SO.1@#TJ#1O!UUI][XDD
MO-1AN(-=D:22..W,;1979@$N<\>U=?10!Y]!X!UL:;X<L;CQ!:M'H-U'+;%+
M$C?'&C* ^7Y;! R" .>">FI;^$[^"\\47/\ :5LQUS;@?9F_<$1B,?Q_-P/;
MFNMHH XAO U^?#OA?25U6V']@W,%P)3:M^^\I2JC&_Y<@G)YJGJ7PZU*^TWQ
M)IB:_%'8ZQ=F]&ZSW2QR%E.TMOP4&P8& >G/'/H=% ',0>&]2C\9GQ%+J=O*
MYTT6!B^RE<X<OOSOXY/3'3OGFI_!_AZX\,:,^GSWD=WFXEG5TA,>/,<N1@LW
M0DUT%% '+W?A>^N/'UEXF74+=([6U>U%L;<DLK')._?UZ=J;9^$)=*\2:C>Z
M;?11:5J9WWFFRP%E,IX:1&##:6'48.3^G544 </X>\%ZWH'EZ8OB4S>'8'W0
M6S6P$ZIG(B,N?N_ADCCBK-[X/N]7GLAJEY:SI9:C]NM[A8"MPBB0NL0;<>.B
MD]P.F>:Z^B@#C+?P7>Z;!K.FZ9J<4.DZI+)*8Y("TEJT@Q((SN (/4 CY3Z]
M*DO/!DUOJ&@7GA^\@LGTFV>R6.Y@,R/"P4=F4[AL!SGGO77T4 >>S_#G4)O#
M.OZ+_;L175M2-^9GL\M&2ZOCAP#G8.PZFMOQ3X5N?$-OIMS;:D+#6M,F\^VN
MTBW(&(PRE">58<$9KIZ* .0U'P;>:]X<GL]9UEGU.22.:*\M8?*6VDC.4,:9
M/0DY).3D\CC$MGH7B=M.N!J?B6.;4#"8K::"T\M(CD'>R[OG;@=P,9 ZFNJH
MH YO3/##6_BN?Q'=-:K>RV8M'6TB*+)\P8N^2<MP /09Y/;I*** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KC?BO_ ,DM\0_]>W_LPKLJP?&.
M@3^*/"][HL-Y':"[38\KQ&3:,@\#<.>* %GTRRUGP0-/U&-'M)[%5DWC@#8/
MF]B.H/;%<!\/O%VI3>!O"FG,97O;N&Y/G^7YK"&!]@P"1D_,HR>RG@UV-WX9
MUK4]$71KS7H8;%HA#.;&S,<LB8P5#M(P7(X.%S[BH=;\"K-:Z*WAR]&C7NB
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M(L>#P20",YQ6P?\ 3O%H'6+3;?/L9I?ZJBG\):K6/AJZT31=(TO1=2%O%:W
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MM/"%]I=OK$NCW]MIVH:G=QW#&*U#0Q!0H8*A/)8 Y;CD]!0!U]%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M 07-E:7@475K#.%^Z)8PV/IFID141410JJ,!0, "EHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ JO%I]E!.T\-I;QS-G,B1@,<^X%6** "BB
MB@ HHHH **** "BBB@ HHHH *C>"&22.1XD:2/)1F4$KGK@]JDHH **** "B
MBB@ HHHH **** "BBB@ HHHH *KQ:?907#3Q6EO',V<R)& QSUYQFK%% !11
M10 4444 %07-E:7@475K#.%^[YL8;'TS4]% "*JH@1%"JHP !@ 4M%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM0N4B5;-2)4B56V-G. 1GISD]>U>FVL4D-I%%+(LDB(%+JFT''?&3C\ZY-?
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M7E_AO5KOP_\ "KP@EO>RF;6+BUL(FD5"MJ'9MS*-HR< XW9YQ[@@'K=(0#U
M/UKBY[_4]%\?:;H3:A/<V&LVL[0O*J&2VFB )((7!4AAP0<'VXJO\.)-?UO1
M-.U[4]?FG#BXCDM/(C5'(F958D#((V]N,8XZY .POM0:RN;*$6-W<"ZF\HR0
M(&6'@G<YSPO&,^I%7:Y+Q;J6HZ?XB\*1VEZ\5M>Z@;>YA"*1(OENW4C(Y4=#
M6')<^(;_ %KQQ9)XCN;:+2EADM#%!%N4M"9-I)4@KGKQD\<^H!Z35*^U!K*Y
MLH197=P+J;RC) @98?E)W.<\+QC/J17!3^,-3C\->%]<U".^&DW>G^;J-SIL
M09H9BJ%79<$B/[^<#KC/H;-SKE^A\#RV6O\ VZTU&\,,\R1IMNEV.P8_+E3E
M1D#&.10!W&H7J:=IUQ>R1RR)!&9&2)<L0!DX%0Z+JL&NZ'8ZM;)(D%Y"LT:R
M !@K#(S@D9KCVU&]\5V/C"6+49[*#39Y]/MXH57EHXP7=\@[LLQ&.!@>O-9O
MAC6;S^P?!OA^S$Z^=H8NY6MV19&"^6H4%^ /F)..>![T >HT5YAJU_XTT;P]
M:B[U%8;DZ[#;0RE8W::UDD 42@# 8<@[<9KO]'L+S3K22&]U6;4I&E9UFFC1
M&53T7"  X]<4 7ED1W=%=69#A@#RIQGGTX-.KRW1!J-I9_$2]@UJ]%Q:W]P8
MVD$;C<L$;*3E.V ,# QVJ[92^(5\"VNO3^*T22^L+-C]I@0) 6VEV3"DL[*2
M "#ECTZ  'HM8^L^(K71+[2[2X@N';4KD6L+QJ"BN02-Q)&. >F>E<7_ ,)I
M?:%<^,WN/M5Q::78P7EI%>*JR;G#C!(YVDJI^;D9/TIOB.TODN? 5Y=ZK/=/
M-J\)F1E01ES$YW*  5 Y &>AYR1F@#T&VU!KC5+VR-C=Q"U$9%Q(@$4VX$_N
MSGG&,'@8-7:X.'5=8?Q#X[L3JDFS3[>WDLCY4>8"T3N?X<-R!USQ618ZSXA@
MT?P'KEQKDUR=7N+>TNK5H8UB998V;<,+NW J#G./8#B@#U.D(!QD XZ5YQK7
MB/4EE\9J^IOIMWI42OID "?OAY>X-A@?,WOE,=L8&#S7;>'S?-X?L'U.21[Z
M2!9)_,559789*X4 <$XZ=J -*J5WJ#6E_8VHL;N<7;LIFA0&.#"YS(<\ ]!U
MYKCX-=U'1O$_B32=6U">[VVR7NE I&K/&WR%!M4982%5&<_>6I=0N];TCQ+X
M)T^75Y;A;QYHKX&*,"=EA9MW"@CYNPQT% '<5CWOB*UL/$FEZ'+!<&XU(2M#
M(JCRQY:[FR<YSC';O7-V6I:KXJT[Q'?V.J36,MA>SVEE'&B% 80.9 RDMN;.
M1V&,8/-95GKK^)O$'PQUF6(12W=O?.Z#H&\D X]L@X]J /4:;YB>;Y6]?,V[
MMN><>N/2O,M<\0ZSIH>]BU5[F6/7([9EMHU-K';M($$3%@"9,'G:20W<"M'2
M[:Y?XO\ B3_B9W@1+&T98R4*@,9/EP5X4'GC!R3DF@#L=,U!M2AFD:RN[0QS
MO#LN4"E]IQO7!.5/4'O5VO+K7QCJ]IX1FDN+SS[^X\2/H\-U)&H$2F;8&*@
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MFTXQZ<UU-9NOZU!X=T.[U:ZAGE@M8S)(L"AFVCJ<$@?K0!B+X!LY=2U*[O\
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M. $.]I.(U;*]1MD)QCD#UKF+;QCJ]IX2NWGO/M&H3>(WT:VN98U C!EV!BH
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MY<>(W8^6K.=N5_?!AQC(!Z8J?QY)=7?P[UF^>[>2"?4K86<;JNV.-;F-01@
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MH1)DCC0OY>& "N/E'(S@$]2#4.O1^(K?P%XXAUE_,L?L3OI[RNC3A3&=ROL
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M_+>1WMS"H!86V0=F1@%CC)QP V,<8O3:UXDL-8\3>'+-VU&[@T]+_3)) HD
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MI88 W/@XW-GVQDYEG\'+?2K/J.I3W-S%9364%PJ+&Z+* &<D#E^!@\ <\<T
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MH^:@0-#.FW:R\8Q\HX.: ,N+5M3N=1\8:.;W48K:WTV*ZM9)@B3Q%E?=@XR
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MT\N"'+!(5D"OE""OT /)R3TKJ&\=Z?8:=IDFHPWQN+RRBNC]EL9ID&\=,HI
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!) P 2?PK1KR))+W1_@;H-_I^IWD$Q6QW8DR"KNBE1D$J,$],5UB7\NO^/\
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MM-J*^:VX2)F,QOSWD#-SVC/8U2L+V^N=#^(L%[?3W8M+BYAA:;&43[.I"@
M 9)[4 =QHVI)K.A:?JD<;1I>VT=PJ,<E0ZA@#^=7JP/ O_)/O#?_ &"K7_T4
MM<5XBUG4;&VO-3L]5N[N>#6XXO/A8I:Q1&5$^SE"<.P!.6 /.>01B@#U2BN
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M&(5L-M+%0O [\<X- 'KU%>::Y!XJT'P]XKNFU<06:V1N;!$NVN)X'1?G&^1
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M@Y  &T     8Z=:WJI:I>W%A9B:UT^:^D,B)Y,+*K ,P!;YB!@ Y_"@##MO
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M@T3P;0X=UC*1A55,]#C^=:'ASP_#/I.@7=Y=7MT;&!&MX+H*H@DV;22 H8L
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M56=G(&"S8R?<XP*YJX\#V,FMWNJ6M_J-A)J"!+V&UE58[C P&8%20V.,J0:
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MED,D1R<R(Y.2IR!D'L.!FMQ_"EI-'J+3W5W+=W\:12WA=5E5%Y54VJ H!)/
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M"OMB@#EKK_A*[6Y\%:7JGB$B\N+FXMKV2Q*E)56-V5CE =^,>V><5-K]U?\
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M< !00>@XXK5\6W#PV^FQIJ+V@FO41XH5)FNEPQ\J,CE22 2W& #R!S5A?#<
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ME7X?Z8EIKEJE[J0BUK/VH&XW=5"MMW \L ,DY/IB@#9\/?\ (M:5_P!></\
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MSUI;.VFN I$"/Y*YP !A=Y.,8)ZUW5QX;MKCQ-9ZZ;FY2XLX6@BB0H(]C8W
MC;GG []N*IQ>!]*%IK=I<R7-Y;:U*9KN*=EP7( RNU01PJX],"@">TT:[T_Q
M!'=1ZU<2:?);F*2SNG,I>8'(D5F/R\9RH&/:LWXD7M]IWAJ&[L+Z>UD6^MD;
MRL#>KRJI!)&<8/8BK_A[PC;^'BK#4]4U!HT\J$W]QYGDIQ\J@  =!R<GCK5K
MQ'X=MO$VG)8W=Q<PPK*DW^CE02R,&7)*GH0#0!S5ZNHWWQ4N-&_MN_@TY]%6
MY\J!E0JYF*?*VW(X YZ^]<KK5U>:Q^S[JD^HWMQ/<VCS0>:7P90EP44OCAN
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M[:UI]CQF/9Y>[=TV==QSG/Z<4 <9H^LZA=>"-/6\UN99DUF2R=PI:XO8XY'
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MYX],<8R<@'I%%>*64VI1?#'0O$S:WJLNI1ZFL>Y[MRCQM=M&RLF<,"#U;)[
M@#%>UT 86N^(VT75M$LC8M,FJ77V;SO,"B([6;IR3PI]/K6[7"?$2 W.J^#8
M5FEA+ZP%\R(@,O[F3H2#@UB7L>H>'M8\5:';ZMJ=QIY\/OJEN\UV[2VLP+KA
M9,[L';NP3VH ]6HKS:2_OOLGPSN1?W?F7IA2Z_?OB<&V+'>,X8[AG)YI6U*X
M\(>*-=TR[N;R[34K<76C"XNI'S(2(VMU)/!WLA&.<-[4 >D45YUKR:MX;&FE
MX=3US2+6Q\N]^RWC_:TE)_UY&X,X.#QGY><8KL/#5U;7OAC2[BSO9+VW:UCV
M7,F=\H"@;FSSN..<]\T :M%>76=W>>)/ASK/B;^T;RUU:&2[E@,5PRK;>2S;
M(RF=I&%&[(.=QSVQ#8F_\7>++&&\U35+&#4?"T5]-!:731;)6D )3^[V_+G@
MD$ ]7HK.U>*\'AR^AT^Z$-[]E=+>XF;A)-I"LQ^N"37FI\73:3IFMO)9ZGI?
MB*PTEY#87D[W$,F" )XF+$, 3SZ_@: /6B2%) )('0=ZXU?'KGPAKNO'2),Z
M1<W%O);>>N6\K[S;L8'?IFF6&DZJFMZ/J]MJD<6GO&4N8WU"6Y%Z&7*,H< *
MP/.5Z@XZ5S*?\DK^)'_81U3^9H ]5L;G[986UULV>=$LFW.<9 .,_C4]>=:U
M=:II]IHEZFGWFIZ-%IRB[MM/N&CN(6(7;*%4@N,*PQGCDUUWA>[M;[PMI=Q9
M7LE];-;($N9<[Y<#&6SSNR#G/?- &O17F5MJMUIWBFULO$::C;RW&I.;'5(+
MAY+2\5F;RX74-A#M( 4CJN?7,5E_;OB_PP=<L=2CL-02\E<7+WTH2!8Y2#&\
M 79MV#!!/.=QH ]2HK@;(3>-+KQ9;2ZG=V5U8WALK3[-,Z?9@(U*R[5(W%F+
M'GJ!CIFGV<UTOQ0L[%M4N;JVE\.&63$S".602HOFA =JDC/W?6@#NZI:E<WU
MLMJ;'3_MADN$CF'G+'Y41^])S][;_=')KRBYO]4/PYO)X]8U!+B#Q*UM'-]I
M9F\O[4$"DDY("G&#70>*=.F\.0Z!]BUG5W%SXDM?-\^\9]R.WS1_[GR@[>G)
M]: .^%U ;QK,2J;A8Q*T?<*20#^)!_(U!IES?74,S7^G_8I$G=(T\Y9-\8.%
M?(Z;ASCJ*XO2=-@;XQ>)I/,N5865I)\MS(!EO,!R-V"/0$8'8"L:R\0:CI_@
MZ</?32O/XHDTTW-Q<-NCA,Q7&_DKP-N1TSD4 >M45P4^B>);&;638:M!;)>Z
M>RVEG+>R3F.Y! $BO( 5!# $#N0:?X+UF*\UV]L;FUU32M7BMD,^F7L[S)@,
M1YL3EB&!)P2,9P* .ZHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=W7[W/6I]+\/-8>*M3U=9[KR[N-$>.:<N'=<#>%Z* !CCKD\# KH:* ,S6M
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M*,[OE&3DD!<_B*W:H:W_ ,@#4?\ KUE_]!- &#HOC.ZUJPTS48O#]TEAJ/\
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M[.,[FSS@8S72Z5#>:!X^U;P_'J-]>Z5-I U!%O)VF>WD\PH5#MDX8 G!/8T
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M99%(.7?.YLX&<GH!TP,;U4M3EU&&WB;3+6&XE,R+(LLOEA8R?F8'!R0.U7:
M,ZXT:&YUBVU-Y[E9[962((^$"MC<",<YVCKZ<8I^HZ/8ZK+9RW<"R2V4ZW%N
M_1HW'<'W'!%7J* ,2Z\+V,^L2ZM#+=6=[/$(;B2UEV>>@Z!QR"1SAAAAV-:=
MA86NF6$-C90K#;0($CC7HH_SWK'\.>(;C6M2UVSN+..V;2[L6P\N4R;P4#;L
MD#'WNF*Z"@#!?PAI;:EJ5^ANHIM20+<B.X8(QV[-P7. VWC.,TQ_!>CR^$D\
M,RI.^FQA1$#,=\6T@KM?J,$#'^%=#10!SMMX)T:WU1]2*74]S):_9)FN+EY!
M,G/WPQPQ^8CGH.E48OAKH,5M:6@DU-K2SN5N;6W-_)L@9<D!,'( )]<CUZUV
M%% &(OA:Q35M0U-)KM;J_B6&=A+P47(4 8XQD\CGFJ@\"Z0NC:;I*O=BSTR=
M+BT03G,;J<J<]3@YP#GK]*Z:N>T?Q#<:CXMU_1)[..%=+6W9)$E+^:)0QR1@
M8QM''/?F@#C;_2S/XIU:?4=.\6VES/.!#/HURXAGB5%5&8HV W!SD#''UKO?
M#=G>6.B16]]/<S2JSE3=2"254+$JKL.&8# )Y^IZFSJ,NHQ&T_L^UAG#W"+<
M>;+L\N$YW.O!W,...,UF:/XAN-2\5^(-%GLXX1I0MRDB2E_-$JLV3P,8VCCG
MOS0 Y_".FR7VL7;M<M)J\'V>\_?'#H%*J /X<!C@CGFK-EH%M:7\=\\US=W4
M4)MXI;EPS1QD@E1@#.2HR3DG YJQ?RZC'-9"QM89XWG"W322[#''@Y91@[CG
M'%217]M-?W%C'*K7%NB/*@_@#[MN?KM/^30!QWC2RGOO&GA!HX;_ ,BUGN))
M[BUA<^3NB*H2P!'WL<<C'48KHD\,Z6;/4+:YA-V-2_X_7N#N:?C: <8P . !
M@#M6Q6%XQUVX\,^%+_6;>TCNGM(_,,4DIC!'U /Y?K0!6T/P-I7A^.1+*;4&
M)C,,37%V\OV>,]5C#$A!P.@SP*GMO!^F6?A.3PS"UR-+>-H3&9B6$;9W*&ZX
M.3^=;<$AFMXI",%T#8^HKF;SQ+JD][JEOX?TR&_DTJ6.*XBEG\II690Q"$C
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M5A+K.LV^K:;9:CHT"17TC1BXM;LRK$5C9\,&13SLP,9'TXST% 'G'PZ\+!_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0+I(N"-@C\V3/)')QC&0<\4 ;OC>:WCT>UAN+NZA^T7T$*16V-]TQ?/DY)
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M.\9Z8-,\3^5J/P_\::_&VZ&\M9(K4AB5,,:[=P'3YF#'(ZKL]*Z?Q)/JTO\
MQ(]/T9[B"^MGBDOWF3RK?/RG>I^9N#G'?IZD7[GPYI=YX>709[=CIBPK!Y"2
M,@**,!25(.,"@#E?!5Y#K>K7 U6)X-8TV..**R9OD6WP"DR]GW?WB/EZ8');
M%TFTOO%_A*#Q"NMV^GZC%=//+>>6[2P%)#NB8;P-FT8VXQC!QDY/??\ "):-
M_:5CJ/V>87EC#]GMYA=2AECZ[3\WS#_>S54> /#*Z^^MKIBK>R2"9]LKB-Y
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX&B4^9$=Z[3O+$D#.=N3P*[?PY";?PY80'47U+RH1&+QQ@S <!O?..O?KWH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$2%Y)'.%51R230!+14%E=Q:A86][!GR;B)94W#!VL 1G\#4_6@ HHS1G/2@
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MCM((84,$;,L*!1N*@DD#N:\XL_"^C:_:^/9M5C8M;ZQ<M%-YK+]G(BC.]<'
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M>[MX3<2H/FF(7@L>YY//7FN=EMK%?C@9)8+8,= 616=5YD^TX#9/\709Z]*
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M\N,=>?K0N@:,EXEVFE62W*1"%)A;J'6,# 4'&0OMTJ['<0S/(D4T;M&=KJK
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MAS1(M,FTV/2+!+"<YEMEMT$;GKDKC!YJ[+=V\ 8S7$487&XNX&,],Y]:FZT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.W9Y>T;=N,8QTQCM7D>F+HFG_##Q==7]NR6QU.]MY&L]L<I1I]JH&[#)4<\
M5Z\8T,1C*@H1MVXXQZ5G0^&]#M[.XLX=(L8[6YSY\*6ZA),]=PQ@_C0!YU//
M>:?\0=8-HUC'?GPHSPV]G]T2K(?+4_WV&1@X&01Q6GX73PIK/AOPCJ*SHU]
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M-7F4,I5@"I&"#T->+SZ5J+:/JW@K3HB+KP[>MJFGS%,@1?ZV! ?[Q9F3Z(U
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU=+OHI/C'.)=2L;B2?P^BXM<!"PF;"CD[B!SZX/0"N^&CZ8IF(TZS!G4K,1
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M#<H= MF:.[C5V9O,<%G'0OC&3_C6_P#$J2YM_A]JDMHLA\L1M*L0!8PB1?-
M!X^YNZ]JZ)=,L%O3>K8VPNCUG$2[S_P+&:M$ C!&10!P>DGPQJGB:QUVQ\1R
M:E>K9/'B.2':MN>3YJHBD '&-W0]NM8?A\6GAOQE:K+&R>&M5FDET$NPV6\[
MCYAC'RB09,?/ )'&XUZ5;Z+I5G#/#;:990Q7'^N2.!563_> '/XTZ72-,GAB
MAFTZTDBAXB1X%*I_N@CC\* /(O'&I:?<^'_B!':26]HZ3+'<I.^^>YF5$P44
MGY$  Q@'.">,5T8BTW4?C#IDX2UN%E\/2/O 5@["9 #GN1S^5=T^D:;+---)
MI]H\LT?E2NT*DR)_=8XY'L:/[)TWSUG_ +/M/.50JR>2NX #  .,XQQ0!X])
MING#X5?$)UM+?,&IWR1-L&8PL@*JOH 3D >M=$UCIM]\7=(^VVUM,9_#C/B5
M0?-<2I@D'[Q SUST]J[P:'I A>$:78B)R&=!;IM8CH2,<USESX1EN/'UMJCZ
M?I<FC0Z:UD('.6#&0/N";-O&,=>] ' :I8KIOPO^(\5H FC_ -I-]B4?<7YH
MPX3_ &0^1QQD&NLUG5K>P^*(AU?5WTRTN=*1;&X;RA$S"1O-3=(K $@QGMD
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M^)9; D'/(B7/XYH Z"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?O&I=&T&:VU#^T[^/3DO1"T"K86_EJ%8J3DDY8Y5?0#TYS0!@>,-7B\/^/\
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M.P0*R./XLH1CN O'2NQ%M (EB$,8C3A4VC ^@HDMK>:+RI8(GCQC8R C'TH
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MV2[<#&0"^!@9[G('0TZXURRB\3Z#;LRV8GT?,>IQQ>9)-\RYMXS@C/&X\$]
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M;2E,?V>'?+J@,#$-NP<QKG;\ON20.* /0KSQ3H6GW45M=:K;1S31&:-"^2R
M9W<=NF/7/%/LO$FC:CH\NK6NHPM80EA+.QV",K]X-NP5(]Z\\T^_LKGQ+\,W
M$J'R]*G4EQC:QBB Z^I# >N#BJ%S]AO?!WQ+ADNFCC.KM<*\"^8>!"5?:.J[
MEY/H&H ]/B\4:)+J*:?_ &A'%>R -';3AHI'!Z%5< D>XI7\3Z-'?PV3WRK-
M-*8(BR,(WD'5%DQM+<$;0<Y&*XK1->T7Q+XYAU*/7]-_M1=->R@M+=WRY+!V
M?+JI.-HPH!QR<UC>%KKP[?Z%IOAC7+74G\1Z=*B-ILDUQ_KD/$HP=H7^+=T
MS^(!ZC)XATN*[%L]R?,,PMPPB<IYIZ)O V[N>F<U8U2X@M=+NIKF\%E"L3;K
MDL!Y7'WLGC(KS.6XETKQ!)<^']4COK6YUKR[[P_=@-(DOG8::$_>4 CS.?EQ
MDUZ'XDDCB\+ZJ\KJJ?9)02QP.5(H HV?B/1-,T;1TN_$$<_VN!?L]S<L ]R-
MN=YX&,@9)P!6AH_B#2M?2=]+O$N/L\GER@ JR-C."" 1Q^=>81W-I_PC'PJ2
M26+,-Q 9 Q'R;8&4Y],-@<]ZZ?PS<0-\5/&JI*A+I8[0"/F*QL&QZXX!].*
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MC%O.DP0[5QDR#;E<?WLYR/K6UJ=W9'XG^#6@G@\O[#=KE&& &6/8./7!Q]*
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M1',PMRY5O+64]$+XVAO]DG/->?>%-0\+:]:Z!I\]KJ+^(-+>(M8327 -G+&
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M],E\SRF\DH),?*7&1GWQ6+>^,O#NGW%W;W.K0+/:!3/&N79,YP,*"2>"<#D
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MN'B,T2&)U\Y!U:/(_>#_ '<TZU\3:/>Z//JUM>K+86^[S9U1MJ[?O=NW?TH
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M$,LJLH\J'<,@L3N('XUTGC'P]=>)M(BL+:[AM=MS%<,\D1?/EN'  !'4BM]
MPC7?MWX^;;TSWQ0!XOIVLV=SJ7P[OXYV$,<DT;VMO;,(;)FMV A'RY+ \'))
M.,X -3F>T?P)\4 )(3)-J-X8QD9D!C0(1ZY8''OFO8Z* /.O$<;P^$_#_C#3
M1Y]UH<23.(SDS6S(%G3_ +Y^;V*UN)>V7A?P=+JWB+]T)W^TWO[LR$22L $P
M 2=N50<=%%6M2T/4M3UI'EU@+H@5#)IRVR[I'5MW,F<[20,KCD#'<ULW=O\
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MM0\,\@4L(W-LRA3CH<\8KV)6W*& (!&>1@TM% !1110 4444 %%%% !1110
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MTL FVE9FCY89*G(Z@'GDXH TO&_B:&]\%OJ6BZK<0-::G!;7&PM"Z-YR*Z2
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M@ 8*59HVE)(R03M'0$\ %SQWXB2^^&VH:KH6IW,$EM<QPLT6Z)T<3HCHP(#
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M'%N! YW';NY^7Y> 3\V*Y+0= 35-:\;7EQ$W]CZXT,,2,I7S56'9)( >S%L
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M5+&*\M'9X)<[2R%#P2#D, 1R#U%6:P/!=UJEYX4M)]9@CAOF,GF>7&8Q( [
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MDTRZ8J4NHXED*8()^5N#D<?C3M)TQ-*L%MQ-)/(6:26>7&^61CEF. !R>P&
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M4.P/YX;;NQC.T9QZ5QKJY^!U]9BWN/M;:HSK!Y#>81]M$@(7&<;.<^E>UT4
M5KJ6-],GEV>?$86;8/\ EH,=/QKR[2M/U""6/1_#NIW%]HE]IUPBP7T9\[2&
M\O"#>1N )(78W(QQG!->M44 >5>$[O2=3M-&TG4- U7^WM,:+S(+L3F*V>/
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MIZCT)JE<V_A?5]$O[R'3=4@LK^>V634E69+AI$)V2C>"^(SM^8C')["O2J*
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MD<O(K7"L"  >, \]..M=?=-+)\6-*OTL[XV:Z1-$T_V278KLZ,JD[>#A3UH
MV+;QGHUSX<?7?.DBM(Y3!(DL165)0VSRRG7=NP,>]/A\6Z:^MOHT\=W;:@D7
MGM%+;L0L>#\Y=<H%X(R6ZC'6O.Y;.3_A _%"76FZHDK^(WNK0);,LOS3H8Y$
M5P-_KM')Z<9S6SI.L:??>*+G4KVWU,ZQ<:>;*WANM*EM(I$3=(R+NW98G)Z]
M!P.N0#L-/\1VNHW%K%%;W:)=P&XMII(P$EC&WY@03C[RG#8//2MBO-?"FG7>
MC^(M/BT*35?^$=G@D>YT[4H'']GL "JQNX!Y)QM!/&3SP:[O1=4&M:3#?BRO
M+(2[OW%[%Y<JX8CYER<9QD>Q% ''_$'3KC3?"7B378=7U1+Q8_-MQ%>RQQP
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M,KMC1W 8@C/R\XV^XS?^(,<\TGA?[/:7=QY&N6]Q+]GMWD\N-0X9CM!P!D4
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M3].] ';T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5D>(/#\>OV]LIO;NRN+6<7%O<6K@-&X!7
M.""K##$8(/6M>B@#&T[0Y[::.XU'6+O5)XLF(SI'&L9(()"QJHS@D9.>"<8R
M:V:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q-?\.#6Y[*
MZBU*\TZ^L6<P7%JRG&X ,&5@58$ =16W10!E:9HTEG,+F]U.ZU*["E%EN%1
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!0O]1ELI$6/3+V[##)
M:W$>%]CN854_MZY_Z%W5_P H?_CE;5% &+_;US_T+NK_ )0__'*/[>N?^A=U
M?\H?_CE;5% &+_;US_T+NK_E#_\ '*/[>N?^A=U?\H?_ (Y6U10!B_V]<_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH ***P_&,LL'A'4IH)I898XMR/$Y5@01W% &Y1
M2,P12QZ 9-<P/&]NU[96?]CZL+F]A:>WB:) 71<;CR_&-PX.#S0!U%%86G^*
M;74-9ATM+6\AGELVO 9HPH"JX0J><A@QZ8[5NT %%%% !15#6=6AT/1[K5+F
M.5[>UC,LOE %E0#)."1G J>PO%U"P@O$CDC2=!(JR !L$9&<$]J +%%%5OM;
M_P!I_8_LEQL\GS?M.!Y6=V-F<YW=^F,=Z +-%9E]KD%AK>EZ5+#.TNHF18I%
M V*40N0W.>@]#6G0 445S5]XTM;":%)=-U(K/>FQ@=8DVRS L,+E@<?(W) '
M% '2T52TW45U**5Q;7%L\4AB>*X0*P( /8D$8(Y!J[0 45F>(=;@\.:'=:M=
M0SS06R[G6  MCUY('ZU96[=M2>S^R7 185E%R0/*8DD; <YW#&3QC!'- %JB
MBB@ HJCJNKV>C6BW%[(55Y%BC15+/+(W"HJCEF/H*K+KP6\L[6ZTV_M'O',<
M+2JC*6"LV"49@O"GKC- &O115:UNWN9[J-K2X@$$OEJ\H 68;0=R8)R.<<XY
M!H LT5F0:Y!/XDNM#$,Z7-O;QW+.P&QD=F4;2#GJIZ@4_7-7AT#0[S5KB&:6
M"TB::180"VT#)QD@=/>@#0HJDFH%[JUA2SN&CN(6E\\ >7'C;A6.<Y.[C /0
MU=H **** "BBB@ HHHH **** "BBLQM<@7Q/'H)AG%Q):/=K+@>645E4C.<Y
MRX[4 :=%%% !1110 4444 %%%% !145S,;>UFF6&29HT9Q%$ 6? SM7) R>@
MYI;>4SVT4S120F1 QCD #)D9P<9&10!)1110 44V1BD;,L;2$#(1<9/L,D"L
MSP]K]KXFT>+5+**=+64L(S,H4MM8J> 3CD$<T :M%%5KB[>"ZM(5M+B87#LK
M2Q@%8<*3E\D$ XP, \D4 6:*S-<UR#0+2"YN89Y(Y;F*V!B .UI'"*3DCC+#
MIFM.@ HHKGM<\7V>@17L]W97[VMB%-Q<11*47< 0.6!)^8= >M '0T5G:=JP
MO[FXMVL;RTEA1'(N$4!@VX J5)!^Z<^G'K6C0 44UV*(S!2Y )VKU/L,UC:/
MXEBURRTR]L["]-M?^9B1E4"#82/WGS<9(P,9_"@#;HHHH **KWU]:Z;8S7M[
M.D%M A>25S@*!WK*?Q/'#9K>SZ5J<5FQ7;,\2]&( )0,74<C[RC'?% &[115
M8W;C4UL_LEP4:$R_:0!Y0((&PG.=QSGIC /- %FBLS4-<@TW5]*TZ6&=I-2E
M>**1 -BLJ,YW<YZ*>@-:3'"D@$X'0=30 M%8>F>)HM7TJSU"ST^^>*YNGMBN
MU=T.QW1G?YL!04/0D\CBMR@ HHHH ***J:GJ5MI&G37UVY6&(#.!DDD@ #W)
M( ^M %NBLZQU;[6EXUQ8W=A]E<J_VI5"L,!MZLI*E<'KGC!!J-]>MD\1VNB^
M5,9KFU>ZCE 'EE4*@C.<Y^<=J -6BBB@ HK$@\2V][YSZ=9WE];0NT;W-NJ^
M7N4X8+N8%\'(^4'D8ZUHZ;J$&JZ;;W]MO\BXC$B;U*M@^H/(/M0!:HHHH **
M** "BBB@ HHJ&[N/LEI+<&-Y!&I8I'C<0/3) H FHK.T+6;?Q#HUMJMI',EM
M<KOB\U0&9>QP"<?C6C0 45D:YXBL]!TJYU&9);B*VD2*9;?:S(S%0,@D?WE_
M.M>@ HHHH **** "BBF&:,3K"77S64N$SR5! )_4?G0 ^BBB@ HHHH ****
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M/39+6!MT,#6J%(SW*KC _"@#A]8O-6TW38;N:_GUO3K;2T^V7%A.UM<0\O\
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M[1*9I S#<2>%RV/\:F\00&/PIXJN8/$:7]E=:%*Z6B.\H5@I_>AV=B P.-O
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MKDQI$6,0>%(QPZX9B6;'7C.W(Z?P_P"%5L-0U:\U&TL)IKO46O89$&]HP0H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *IZEJ=OI<,3SEBTTJPPQ(,M+(W15]^">>  2< 5<KG?%
M>BWFJ?V3>Z<T?VS2[Y;M(I6*I,NUD="<'!*L<'!YH K:OXQ2'PUXBNK&WG&I
M:1;R-+:RJH:)O++HS?-@H0,Y4G//<$5<\,6LPM5U&6YU$FZ@B+6UW,)%5P.7
M7D[=V>@...@K'U/POJ&H6GBV[2**.^URP%C# TORQJ(W4,[ =<R$X&> *ZK3
M8KB'1[:"95CN(X51@#N 8#'7N* ,NS\9:=>SVL<<-V%O()9[21HLBX2,@-M
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M7#W"S&%(UV RL%#,5)8# ##))')QUXKF]7\!7&H7'B!8KI([6[VWMB@ZPW^
M#+[8,:'_ (&]2ZOX9U=8]"U&PCL;[4-/\[[5;71V1W/G8:4JV#M.]01QTXH
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MV <^A 8#J.*ZG4M7ATV6T@:*::XO)#%!#$!N<A2YY)  "J3R17)6&B^)WO\
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M RMRP'L/NCV45A/X?U:RO_$R64<%Q::X/,1I)=IMY3&(VW#!W)A5(QSU&.]
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MJX!#$X4YX R034]CIUM??$&YU#3;^&?36BCN;J*%@Z&[ :-&R#C.S.1ZHAH
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M "BBB@ HHHH **** *]W86=^L2WEI!<")Q)&)HP^QQT89Z$>M6*** "BBB@
MHHHH **** "BBB@ HHHH *KV=A9Z= 8+&T@M8BQ8QP1A%R>IP.YJQ10 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %,EBCGB>*:-9(W!5D<9# ]0
M0>HI]% &=8:!I&E.&L-.MK<@87RXP-H]%]!["G#1=+6_:_&GVPNF;>THC&XM
MC&X_[6.,]<5?HH S)/#NBS)=))I-DZ7;!KE6@4B8CN_'S'ZU7U?P[:W6GWQL
MK&S349[-[2.X= I564@*6 )VC.<5MT4 8/A[PW::5H5I:3V-G]ICM%M9VC7<
MK@ !@,@?*Q&2,5/!X5\/VRJL&B:?&%B:%=EL@PC?>7IT/<5KT4 99T'3(4MW
MM-,L8[BSC9;-C ,09'1<<J/4#%1Z'I]_ 9K[6)+235+E424VB,L:(F=JKN.2
M,LYR>['TK8HH S=#T2TT&Q:ULXHHHWE:4I#&$0,W]U1T' _GU-)-X<T2X-T9
MM(L9/M;K)<;[=3YS#H6XY(]ZTZ* **Z-IBW,MR-/M1/-'Y,LGE+N=/[I..1[
M&J]KX6T"QT^>PM=&L(;2X8/- ENH20@Y!(QSC QZ5K44 9EQX=T:[T^2PN=,
MM9[25]\D4L08.W3<<]3@#GKQ5RSL[;3[2*TL[>*WMHEVQQ1(%51Z #I4]% %
M&\T;3;^X2XNK*&2X1=J3%<.J^@8<@>V:8=!T@Z7+IATRT^PS$F2W\E=CG.<D
M8Y.0#GK6C10!D?\ "*^'_*EB.B:>8YE5)%-LA#JOW0>.0/2I+SP[HVHS02WF
MEV=Q) GEQ/)"K%%_N@D=/:M.B@#'N?"GAZ\L;:QN=#T^6UM3F"%[9"D7^Z,<
M5<.D:<;U+TV%M]J2/R4F\H;U3^Z#U ]JN44 9:>&]#CA@A32+%8K>4S0H(%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ***QM>\2V?AY]/6[BN7-]=Q6D1BB+
M*'D;:-S= /QS[4 ;-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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1** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>ex19iiinsidertradingguid002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex19iiinsidertradingguid002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M *X?XP211_"S6_-=%W)&%W'&3YB\#WKN*1E5QAE!'N* /.O%DDB>(9M5\/\
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M_"@?,>I^OO0!Y;>W5QH^K75_HNHV^J:9/K*I?:)<@>=#<>:HWPD<YW!7"GC
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M$02.)(AU*H, &@#S+PWJ7A+Q*/#SQWEY/J^GX9+%I&5[-@NV3>,#"@ CG@\
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M<QQ(A<Y8JH&X^_K6=J/B+2]*:87EPR^1&)9BD+R")#G!<J"%'!ZXZ5HS3)!
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MF+;P+.TZPQB5AAI HW$?6N/UCXG^'=/T.^O[.[^W2VULEPL,,3G(D_U9)Q@
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MW/D.Y:-8BV\[5Y8D+P!W)P!6NGB/2I!J.RY8MIV/M:>4^Z'(R,KC/3GITYH
MTW19$*.H92,%6&0:2*&*",1PQI&@Z*B@ ?@*YG4?'>EV=WH$4/G7,>LDM%-#
M [KY0C9]PP.2< 8ZX.>@K2U+Q-I&D;S?71C6,*TK"%W6$-T,A4$(#_M8H U?
M+3.=BY]<4"-!T11^%9M[XATNPR9[DD+")W,43RA(SG#L4!VJ<'!. <'T-: G
MB-N+C>!$4W[SP-N,Y_*@!WEIM*[%VGJ,<&B.-(HQ'&BHB\!5& /PKG?^$_\
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MD?6M+Q/JMC?^)O EY;SAH#?2R!V4K\AA=0W., D@ ]Z]"HH \MTG6]-T>_\
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M6I='A;:/MD) D0Y'W>#DGIT/6MRN)^+A!^&&LQ]9)$C5$')8^8IP!W/!/X4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MWL[-PEU&$7$[R*OSG@C!/ 4#!- '>W/B^*#QU;^&_LERV^S:Y:9;=V7.]%4
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MXE,F&'S<JNXX&< 5LZ?XLT_4-?DT98KR"[6#[1']HMVC6:,':60GJ 2.N.M
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M,EXI82((0K LQ)))SQR1WQTJ;P)H>IZ7/<:?J,;?8=%EDMM+D8Y,L3D.&/\
MNJ50'_>%=U10!XWJ?]M:GIEM+>Z%K']I6?B"*>:&&W801PK/D&)1@297!+88
MY)R0,5UMD+@?%G4+^2QO8[5]'AA$K6[[/,61V9=P!!(##H3GMFNWHH \ETU]
M;TKP#''!I&H"0Z](]THLF,\5L\SOYL2,O+8V\@$C)/44G]DZC<R?$:UM=&U1
M5U73HOL3W0/[TB!EP7=B=Q8C@G(SSBO6Z* //)K2;Q-8^#[&"RO(&TN[M[R[
MENK9X1#Y*$%!O W,S$#Y<C&3Z9SKS1-3UD?$>SM;2XBFU"2&2R>>!HXY_+C0
M$!F '+*5_'/2O5** .$\+W5GK%_9S+X%ETF^M0QGN+NP6(0$J05B?JQ)[CC;
MG.. ;WQ-L+O4OA]J=M8VTMS<9AD6&)=SN$F1S@=SA3Q76T4 <#<->6GQ%L/%
M3:??MI5[I9L)%%NS2VSB4NK-&N6"L..F1QG%:/A'29X-=\3ZW)%)!!JUW&]O
M#(I5MD<83>5/*ECN.#S@#-=;10!Q?BJ*[@\>^$M5BT^[N[6W2\AF-M%O*-(B
M;,^@)4C)X'<BLB*&Z#?$@G3[\"^R;7-I)^__ -'$?R_+S\PQ^O2O2Z* /(5M
M;S1U\):Q>^&KO5=/CT.+3;VU6S,D]K*NT[_+89(R"IQZ9],^B>&8K=--DFM=
M$31X;B8RK;^0L4C9 &^15X#$@^^,9YX&U10!YEKU[)H_C[6)[*RU?_3+""*Y
MEM-/-XCL-^UL*P*,JG'.0<].,FC=6MK;Z1X4U'0M%O-6TC0C-9WFG36Q^U*'
M5?G,;@9<$!L8Y#<<<UVLWA&1=8N]1TSQ!JFFF]D$ES##Y4D;N%"[@)$;:<*!
MQZ"MRPL8M/MS%&TCLS%Y)96W/(QZLQ]>![   8  H \V\46R:E\/=7;1?"=Q
M8->S6NR%-/\ +N)RDRLS.B#( 4'&[G@^HSK:M;7&H?$JREBMKU+:31;BU-U]
MED"1R2,I4$XX. 3[5WM% 'E?A")4L--\/:IX"==8T\QQ/>2V*&V_=X G68]3
M@9&.=WYC<\&+=P:EXP<V-U&UQJ;W-M]H@>)9E\M%!!8#NIKN** /'(CJ]ZO@
M_4+K0M;-_::ENOH_LQCB@RDB[8X\A0F2/G QC&YLUU_AJ*XC^(OC*XEM+J*"
MZ:T,$TENZI+LBVMM8C!P?S[5VE% '"_$R86Z>$YBDCA/$5JQ6-2S$;9.@')/
ML.:9<Z//KWC74=9M;>:*W70I--1YXFB,TKN6X# ':H YQC+<=#70^(?#B^(9
M-,9[V:W&GWB7L0B53ND0$#=D'CYCP*W!G R<F@#Q^!]1G\+^ +%= U<3:/J%
MJMZ'M&79Y<3JQ&?O+WW#CISDXKHM+EGT+Q-XO-WI=_+]ON4GM!%:O(EPODJN
M-Z@JIR,?,1Z]*[ZB@#RJ+P[?^'M)^'FER6UQ<2:;>F:[>W@>5(0R29R5!X#.
M!^&:NWND7NK>*_'-K%;W4":GH\5I;7,D#K$T@20'YL8XWCZ]J](HH XCPAK^
MHWMAINE7?AK4;/4+*-(KJ6Z@VP1[%VEHWS\^['&W/7G@<]/H^J'5[%KDV%[9
M8E>/RKR+RW.UB-V,G@XR#6A10!P/BQ+B3XF^"[N*QO9K:P-Y]JFBM9'2/S(@
MJ9(&#D^G3O3M/6>#QWXVNI;&^%O<VUJL$OV20K*4C<,%.WG!8?7M7>44 >0?
M8]0C^$7A/3CI6I&]M;VT:>!;.0O&(Y0SDC;T _/M72WB7>E?$V+Q"]K=W&DW
MVEBR9X8'D>VD60NNY -P5@3SC@]<5W5% 'D'B#0=0;PIXQO(=/O'DUO5+>:U
MM([=VD\N.2++LH&5+;6;!P<8SSQ74^/!->CPK):V=Y.L6MV]U+Y=K(QCB4/N
M9@!D8W#@\UVU% '$V0FB^*VLWSV=Z+1],@B2?[+)L9T9RP!V\G##Z]JY?0GU
MK2?!GABS?2-4CMUU"Y&H&&S<W,",\C1E!C(#;@"R\@$C(->O44 >,W&BZM/X
M&^(6EP:)J2376H-=6R3+N,J$1$!6))=OD;H3TZYKJ?$,\^I^(/!=_#IFI+##
M>R33;K1\Q(8F0%P =N21P>?45WM% 'GN@B[\,7?BK3=1T^]N4O=0FO[.6"V>
M5+A)0/W9*@A6!&/FQUSTK+TCP]J'AZ\^&]A/;74YTR*[^V310O)'"TL9PI8
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MYTM]EV(K-R8AMW%CG&% YR>O.,XK7F\0V2K9"V$EY-?1>?;0VX!:2, $O\Q
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M4'22.)W*R#RG('ECACG&.":UK?QQH\NFZO>W!N;)=(.+V*ZA*2194,IV\Y#
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M$\3ZEJ&F:_\ ;)!9?Z7)!&8,XB,."$/&,@@ECG.>@]0BBC@A2*) D:*%55&
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MR]M=7C%K:3&2W<1PB%TW2B7&PC:A(P223CUH ]5HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH ***Q?$WB6T\*Z8NH7L%S) 94B)@0-M+,%!.2.,D4 ;5%<]!XK29 KZ1J
M5O=R7#P06L\:I).%4,9%RV-F#U)'/'7 JO;>.],N;>?,%S%>P7RZ?)92;!()
MV^Z,[MI!&2#NQ@>O% '4T5S5]XS@TRS>YOM+U"%8[Z.Q<8C)5WV;6X?E3Y@Y
M&3UXJ[_;UK-XHE\-/;W*77V(W8D.T1O'NV<$-N!R?04 ;%%>1Z-XAN_"OPGN
M;ZRM9+F0:M<6ZL74^5NN2@8[CD]1@<\XSQDUZO;2O/;I));R6[MUBE*EE^NT
MD?D30!+17)VFKZ-%XJ\3R0:=>KJ=G!;M>OC/G)A_+V#=C@!NPZU%9?$73[U-
M%G&FZG%8ZPZPV]Y+$HC$K E4/S;LG!Y *Y[T =C137=8T9V.%4$D^@KF=/\
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M\EO%I]I=W\T^GC4E2%50B \ G>5Y)X Z\'.*RM3\>LT'A6YT:PGNK37+A0)
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M$K1JX8#\6'7&:Q(])U:/P!X$T\Z5>?:],U*TFNXA'S$D9.YL]#U'3.:]6HH
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MB\Q2N^/&Y<^F01^E 'DFBV4_BOX*:'X;@LKE)+A8!).\>(XHDE#F0/T.0N
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M!2UC_D"7_P#U[2?^@FO,=*LI_%?PC\,Z!!97,;NMHTT\D>$BBC97+ANC$A<
M#)^;G&#CU.^M1?6,]H99(EF0H7CQN /!QD$?I5;0=&@\/:+:Z5;332V]J@CB
M,Q4L%'09 &<4 <_X<MKR#X@^+KN>RN(K6^:U-M,Z863RXMC?3GUQFN;\.Z=J
M.AQR>&KWP4E]/'/(+35C%$T$D3.65Y6)W C/( ).*]5HH \RU_0KR?6[K5M!
ML]1TOQ(ETB+-"#]EOX@P&91]W 7/7#?+QGBC6="O)==GU?0;/4=*\1"]1&>(
M'[)?PAP-TO\ #C9GKALC@'BO3:* "BBB@ HHHH **** "BBB@ HHHH ****
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MS1YV_(2_)SQR!COVJOI_C2TU/PW!K=K87S13W(MD@(C$N_S/+Y&_ PV<Y.0
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M'W*Q3J5(..,D'M0!J:I9P2^.-#D9#GR+EB Q 8KY>TD=#C)QGIFI/'']L?\
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MR;PN-V\9 ."5P>Q[TRTUK0+7Q)XLN?LES:WFGV\$NI7$H.V2,(Y0J-QZ*K=
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M3S"FY=X&=N><>M.K@+!/L?Q8\4RV=JCS-I=K)Y:D)YC[I.I]\#FM?X?Z]?\
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MZ1(SR.J(HR68X %<EH?B/2X?"GAW^RM.:$:G'MT_3U(!4!2QR>@50,D\_B2
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MP9$DC$D8'&X$9'6O)M=UJ]\4_![Q7=:KI\2>3+<+$0X<(8Y-H XSD8^]WYH
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M2KVI:7K,_C'P??G3_-BT];DWLL#QJD;2QA0%#,&(!]NE=H[K&A=V"JHR6)P
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M$/B3X?ZU;'1F@N[V#R;:Q\^,NOJSOD*,^@)P .Y(';22)$A>1U1!U9C@"G4
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MYQG\:S?"EEXJ\/V<?A:;P_!/!:N8[?6O/C\OR<DAF3[V\ XQCD@<@<UZ110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %8?BKQ+'X5TE=1FLKBYB,T<)\G;\A=@H)R<
MXR1T!-;E<G\1=-U'6/"IL=,LGNKAKJWDVJZ)A4E5R268=E- "'QI<KX@ET-_
M#M\M\UM]JM$\V(B>,-M)+!L)@D9R?S. 5M/',-WX?_M :;=K=#4/[,>RX9DN
M-^S!8<;03DMTQ^51SV.IR?$^QUA=,G^P1Z5):O+YD7RR-(K@8WYX"D9QUKG8
M=)\6V.AZFEII=PC7/B22^F@2YB22XLG;+*CA\*W SR.,X- '3MXW2"U\1M<:
M9/\ :M 4/=00R*X9#'Y@9&)7(V@]0#QT-<IX]UJ3Q)\--1N9M!N+2W5+*YM+
MFX*$2;Y4SM .5(!QR!D'MFI/^$=UR)O'B6WAP6]OK6GQQV<<5Q$ '\AH]I&0
M <MD]NN"W?1\1Z-K.I?""#0[?2I6U,V]K$T!EB&TQM&6RV_;CY#C!]* .K@U
MHW6JW-M;VI>SMAB6^\P",/SN0=R5QSC@=,Y! P6^)&FQS:7*\0_L[4YUM[>X
M2=&<,_W"\?55;'!Y(R,@57T+1M7T2]U#P^MA<R>&+N,O:3&:/?8M)G?"1ORR
M@DD$9QG'/6H?",7BS2[*R\-W_AZW"V(6!=86=#%)"G 8)]_>5&,'OR?2@";3
M/&NID>+;S4-)D:UT>YD0)!*C,J)$C$<D9)R6Z]\#.*E@^(R&YT0WNAW]GIVL
M^7':W\K(4,KKE4*@[E!Z D#/7IS6;<Z=JNDZ;\14N; BRODN;R&[$JE64VX7
M;MSNW KW 'O18Z;>^*?!O@NP;3Y;:WM?L5Y/<2LA4K$@("88DECCL,#.<'@@
M$VB3VNB>./B->F$K;VZVEQ(D$>2<6Y9L*.I//U)K?T_Q9]HURUTJ]T][.:[L
M3?0,9 X* @,K\#:PW#CD=>:P7TOQ/#K/CR]TRR:VN-1A@_LRXDDC(9XXBAXW
M$@YZ9&/6J=GX>U>;Q3HNH-X=DL[=M-GL[Z26\C>8.^S+NP)+]#@Y)/?;0!TJ
M>,Q*FFWL.E74VE:C<BV@NHOF;YB0LC(!D1G'WLYY!(&:K:S\1-/TB"\O!"+B
MQL9_(N72X02 A@K%(SRP4\'H>#@&J/@R/Q?HNF6GA>\T:,1V)$*ZN+A#%) I
MX(3[V_;Q@C&>2>U0Z5:>*?#.IZEI,/AV#4["YO9;JRU W*(L(E8N5E4_,=I)
MY4'- 'H<,L<\,<T3!XY%#(PZ$$9!K#U;Q))8ZC<6-IILMU-;69O9F+^6@3)
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MLDH/S8!YRH)/\F:_I'B34=3URSNM,_M2SN-.6+39C.B0P2^6PD+H3G>6((8
MX&!D<F@#:NO',$5[H-M;:7>W7]MVS7%H\>P A4#X.6X.&7K@<]:O^&?$@\0P
MWRO92V5W8736MS;R,K%7 !R&7@@A@<UR6G:/KZ7_ ,/I;C198TT>RE@O")XF
M\LM"D8_BYY4GC/&/I6WX0T[4K'7/%$][82VT-_J'VFW=Y(VWIY:KT5B0<J>M
M %KX@P17'P[\1+-&D@73IW4,,X81L0?J#6)H?C4Z=;^&M-U'1;VTL[^"&VM-
M0D*&.27RQA2H)9-V.,CGT%=3XHTZ?5_">L:;:[?M%W9301[S@;F0@9/IDUS
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M;$!_J6G59)5^BY 7'9V% '>4444 %%%% !1110 4444 %%%% !1110 4444
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MOIEQI]PT@@N8VBE$;;2R,,$9[9!HTO3H=)TRVT^W:0P6T:Q1>8VXA5& ,]\
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M1SW"EH+6.3<L1<GYF"\>G;. ,^FT4 </;Z5K^@>.=7U+3["*_P!-UL12.K7
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[9^<;#C;STSGVQSIS^'M:GU[P??^59"/1HYEN5^T-EB\0C^3Y.<8SSBNSHH
M\_T'P_XQ\.>9H%G/ILF@^<[6UY(S_:+>)V+%-F,,PR<$G'KZ5V^H+</I]PEJ
MD;SM&519'**21CD@''Y59JK#J=A<7\]C!>02W< #30I(&>,'IN Y'3O0!A?#
M_0]1\,^"]/T74A;&>T5DWV\A=7!8G/*@CK5>+0=5T3QIJVLZ7';W=GJZ1&XM
MY9C$T4T:[0RG:05(ZCJ#TSTKIK'4+/4[47-A=0W,!9E$D+AERI((R/0@BK-
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M(Q(6&WY5##G_ &<>^.:UCX-UB;P-8>#-32S2QMVC6XNH9BYGB1PX"J5&TM@
MY/ SC- $\4\%C\7-?NYB(X8M"@EE;'0"20D_D*D@\=W<MYHKC31-8ZI(L9$
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MA>]<A 0$/E CJYW_ /CIZ\"F6WAW6X=6\8WCQV+#6HXEMP)V&TI#Y?S_ "<
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MU#L^8_-G) ]/>@"TWB74-0;66T*RM[F/29FMW$TI4W$RJ&=$P#MQN R<Y.>
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MO=3MMMT93$_V=LKDL=X]\+TZ<\ '8>(+#1+JTCN-=$0MK5Q,KS2E$C<<A\Y
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MS6R!MV#$RR9^;N"#R.U8WQ&NFNO$O@[PS*2-.U6]=[M>TJQ!6$9]58D9'?%
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ME<0,SFWE79M!! S]SK[FM!O#GB'Q'H%_IGBV^L MQ;-;JNF(X7)Q^\;>>6!
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M$)6+,9-I)!V=!M_'/:I?".A7^A-K9O6MF&H:G+?IY+L=@?;\ARHZ;>O?/04
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ML$AB\DN9(9$B\SYB3@@C/ Z>IZT_3_%VH"#Q1#JR6L6H:*Y"10QL1+&R;HG
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MQ,[ OM5EVC"G'WNOMTH RY?$WB:YU[Q/I6GVFE(VD1P212SO(P<.C-@@8Y.
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MI,$;E(R#@\\BO%?&GBC6/&?@K3;:%(+2U\3ZFEG96Q0F<VZN,RLV['+ 9 '
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MT! \Q7W@%O7C'(XY&>(E\6W5GXE^('CBPAMYWL#'IUL]P3Y:(K!3TY8LP4@
MCJ22,8(![]17"7WCZ;3=*\-6UQ!;CQ!K4"2&%WV0VXV!I)')Y"KSQG)QC/>K
M_@;7M8\0V^IW>HP0K9+>-'IUQ'$T7VF$?\M-K,>#V/>@#K*R],\1:3K-]>V>
MGWJ7%Q8L%N413^Z8YP"2,9^4\>U<[K'C65/%5UH6EFW1=,LFOM4O+A2Z0(!E
M4"@C+'@]>!Z]N&\&>)7\*^ AK]Q:_:]?\6ZK)):VH;;YCLVU<GL@.3_P(>M
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M3O#,YZ98X/Z=J[*B@#AO%'P[75OA^?"^EWQM SQ&6><&1I@F/OD8R?E7V&T
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MS+RP"&YCV,-F_.WDC!SM/3--U?Q#I6@K"VJ78MDF<1QLZ,59ST4$#&3@\=:
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M8(FW)&QPK(2QQQM)//WAC&*OZG\(]2O$\710>(5BM]>N5N1&8,E2'W$,V<D
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M+%+2>.6V,DD04, 8FW  '>200>>:U_"FCW.@>&-/TFZNH[J2TA6$21Q[ 54
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M_P!%N;48#1[%X<9.&#;@>G;@5C:IK7B1_'S^&],DTV*)]+-ZD\\+NT9\T)R
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M00<#TYZUDP>,-:F\ >$-=-Q&+K4;^VM[I1$-CI)(5; Z@X'&#0!Z517!I?\
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M*J#P< DXJ\OBZ5M/TT:=J<>K_P!K:@T%I=0*@98EB+ME3M7S!M(P<<D''\-
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M.!Z 5WM !2,P52S$  9)/:N8N-9N=1\;3>&[.Y:S2UL5NYYT16D9G8JJKN!
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MG:898;@0B)BLL$A*D#C@KP?>H;75?$OAK2?!^H37UK=:/??9+&6R6VV- )$
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M\!G7/*Y!!Z\9- 'IU%<O9ZO?M\2=1T228264>G17<:E &5F=E(R.H^7O744
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M&-K7&X;]^[(8<[NV.G'7FNFJEJVIPZ-IDU_<17$L46W<EO$97.6 X4<GK^5
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M_9&B&:&083''+^9\A[9QQ6Q?>&[J_P#$VAZU)J,2OI22KY2VQQ+YBA6.=_'
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MY/\ %O\ F^IH H:CJVJ^'/$^AV5U?-?6&L.]JSM$B26\X7<K+M !4X(P02,
MY/2L2Z\7ZY#\,O$>MK=1_;]*O[B")_)7:Z1RA!N7Z>F.:ZNW\-W<]_IEYK>H
MQ7\NF!C;^5;>2&D9=ID?YFRVW.,8 R3CIC#OOAO=7>E:]HT?B!H=*U:YDNA"
M+0%XG=@S#?N^9<@D# /N1P0#O@<@&O.%\5:U::EX?%S>Q7$M_J3V5[;P1!K:
M'(<J(Y0H)==HR"QYSD"O0HH76S6":9I7V;6DP%+''7CI7"6WPVO;?2M%T_\
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M ^8X// K'\)RZNEKXWN_[6::XM]5N4C-Q"K+E(X]I(7!X  P"!6KX<\$ZAH
MAL&\2W%UH=J^ZULGMU5U .55I<Y95/(&!T Z<59L_"%Q82^(/LVKD6VKS27
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M*PH%&<*J+P!R3G))SUQ@  UJ*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBN;\8Z[/H]OI=K:.([K5=0BL(YBH;R=V2SX/!(53@'C)&<B@"ZOB*T
M;Q8?#GE7 O!:&\WF/$90,%X.>3D^G:K6EZC_ &I:-<?8[NTVRO'Y=W%Y;G:Q
M&X#/W3C(/<&N*@L[FU^-01]1GN0_AUS&\RINC/GJ#]T $9YY'KVQC)F\4>(U
M^%-SK*:K_P 3*#56MO-,"8=/M0B QC ^4]AF@#UBBN'OKW6M%U73M%EU6YU&
M?5IYYEEC@ABDABC128TW?*?F;.3DXR.O-4YM;\4:#:M::FP'V_5[>QTV[G\M
MI4CESN,BI\I90IQZDC/>@#T2FQR)+&LD;JZ. RLIR"#T(-<5XAL=?L=#\3NV
MO2/I_P#9CRVK (MS%*J,6&X(!L.![C)P1Q6?INJ7NFZ!X*T:WN+N>75+(2EU
M$(DCCC@0E$W!5ZL.6R<!N^" #T>LA_$5HGBJ+PZ8KC[9+;-=*_EXCV*0#\V>
M3EAT%<A=:[XI\/6$EMJ1!>_U:WL-*NKCRVD1)CR9%C^4E &QZ\9[U+]CN+/X
MSZ6)=0GNT;1;@KYZIN0^9'GE5'!X/3CGMP #JM;\16F@RZ;'=17#G4+N.SB:
M*/*B1S@;CD8'7\JUZX;XFK*UKX86!UCE/B&S".R[@IRV"1D9^F14%M/XDT_Q
MM/X8NM?ENX;_ $Y[NSO3;1++:R*P4K@+M9?F!Y'M[T =_M4L&(&X< XY%+7G
MNA>(=7U7PY9:;-J$D7B1-2-C?2+''E/+.Z1@NW;M,8&TXZNM=EK=MJ%SHMU#
MI5\;/4#&?(GV*P#XXR&!&">O% &A17"Z#XCO?$6D>'(X+V>'4'9SJF8X]Z>3
M\LJL-N!F0H!@ X.>U5H-;UGQ#X1UGQ)IVIO:2VLUS]CMA$C1%(20%DRI8E]I
MR01C(QTY /0Z*X#1_%6H:QXI\.%)WBL-6T1[V2T*(1'("F-K;=W\1ZG%:O@;
M5;_4X-=74+IKEK+6;FSA=D53Y:$;0=H )YZXH ZJBN135+O7O&FN:';WTUA!
MI$%ON:!4+R22JS9RZL-J@# QR2<^E<K)XP\27'AVSV7L4&I6GB9=$NY! I2X
M D +8/W<@C.,=\8[ 'K%%9^CV5]8630ZAJDFI3&5F6>2%(R%)X7"X!QZUP6L
M>)-:TV2.Z35?M,@UV.TEBMHE:U2W>0((V8J"9 ""=I)#=<#B@#TVD95=2K $
M'J"*X'S?$FJ^/?$&CVWB)K*ULXK2>';:1N5WERR\CD$+R3STQWS7.L>*O$6D
MW6I^'OM"7,=[+%;0L8/LS)'*4*R;CYF6"DY&,$C'') /1Z*S]4FU!/#]Y-IT
M"/J0M7:WB8Y4R[254GTS@5PVG^*WU33-8>SUS4(-1L=-DDGTZ_MXTN+:91D/
M@QX93T/4=.F: /2:R-$\16FO7&I0VL5Q&^G7/V:;SH]F7VAN!G.,$=<5RA\1
M:Q_8_P /+W[<V_5WMH[Y?*3;+O@+L?NY4[A_"16=ING:[?ZMXY.BZZ=,FBU4
MM&%MTD$CB&/ <L#\OT /N>E 'HU[J/V*\L;?['=S_:Y#'YD$6Y(<*3ND.?E'
M&,^IJ[7FMEXPU?5;;X?ZBLXMX]8E:.]MUC4ARL;G()R0-RYX-3SZOXE\06^M
M3>'VN8KFROI;2U5?L_D$Q,%(EW_.=QSTQ@$8YR2 >AU%,(&*+,(R6;"!\<G!
M.!GO@$_A7(6VIZMXCUK6=)2];2I],M;<,+<(Y-Q+&7))93E%X  Z_-GM63J=
MOK3>-O D&HZQ(EX\%Y]H-D$\KS$B&7570\G<1R..V* /20%10  J@=!P!2(Z
M2QK)&RNC ,K*<@@]P:YOXB></AWK\D%U-;21V,L@>$@-PI.,D'@]\8/N*Q[?
M5+RUF\(^&H=0G#ZC:-<2W3)'O2..-2$3"A>21R02 #W(( .^HKD/#^KZC%XU
MUGPQJ%PUXEM!%>6ERZJKF-\@H^T $AAP<<CK2>*M3U/0?$6A:@=0D709[C[)
M?0>7'B-W&(GW%=P7=@'GN* .PHK@M:\3ZAIFFW^I0W1>.\U2+3-.62--D.6$
M;R' !/S"0C)(.U?6K%]J.J:!XUT/2Y-1GO=/UI)H<S)'YEO-&F\.I50"",@@
M@X(S[4 =K17E<GBK7U^$5UKHU-_[2MM0:$3>3%\Z"[$6&7;C[I[ <UK:G-XC
MO_B+>>'['Q VGVITA+R-UM8Y&B<RE.-PY&%[^IQCJ #NKB7R+:6;RY)/+0ML
MC7+-@9P!W-1:?>?VAIUM>?9[BV\^-9/)N4V21Y&=K+V([BJVMR75OX=OY;:X
M\JZBMG=)M@;#*I.<'CM7"MX@\02Z!\/;F'5!'-J[0QWC- C"0M"SEN@QR.@Q
M0!Z82 ,G@5Q6J_$W2=(L8M0FT_59=.G0O;WL$"O%* 0."&RN<Y!8*".E4[&Z
MU>6\\:^'[O6;FX73HH9;>[,42RA98F8H<)M(RIYVYP:YN[@DB_9H1WNYIEDL
M+4JD@0",>8G"[5!Q]23[T >RT5R<NIZA'\4;?1Q>/_9\^D2W)A*)\LBR(H8-
MMST)X)(K L_&&K1Z+)'/<27-W/XFFT>"8)$KK&K-C PJ%MJ$ GC)&<]* /2B
MJMC< <'(R.AI:\\U*Z\8Z3I7BBZ:XECL8-/>ZL)[H0//'*BDLA"?*5.,@D9'
M2DM=5UZSUOP7+<ZP]W;ZY"R7-LT$:HC"#S%9"!NSD<Y)!SP!T !Z)17":;?>
M(/%GAYM<T?5DLYS>R+!:RQJ8!#',4*R?*6W,JEL@C!(QBFWFK:]KUSXBM]$>
M\@FTV?[+:F#[/L,HC5]TOF?,06?& .@]>@!WM%9UG=W</AZ*\U>)(KR.V$EU
M'"=RAPN6"^HR#BN#N/$FN_\ "LX_'<%^3,%%X^GE$\AH2^#'G;N!"_Q9SD>G
M  /3:*\\FO/$6M^.;W2-/\0/IUFVE07T+"TC=HF=V&,,.>%YS^&*Z+QCKDV@
M:'%+;E!<W5W!9Q22#*QM*X7>1WP"3CVH Z&BN.UB[UGPA;ZQK4^HC4=(M].,
ML<%PJB87"GL451L(QGN#TXK/U;6=:\/:3X?UY]2>]BN[BWAO[9XT"%9L#=%M
M4,I5B, DY'7)YH ]!IK2(C(K.JESM4$XW'!.!Z\ G\*\UFO_ !+>7/CF&/Q%
M+;+HS*]J8K:(G_4"0*VY3E<GGC)]145Q=W^NZ_\ #2_;4KJU;4;.:XDC@V;%
MD^S!BP#*1GYR.<X'3'- 'J-%<!I\OB35O&WB/3E\1-;VFE7=HT:K:1L9$>,2
M-&<C@')&>O3GC!JQ>(=;UGX=7OC73]2:"6+[1<V]D8T:$PPNPV/D;B65"20P
MP3Q@"@#LKCQ%:6WB>RT!XKC[7=Q231N(_P!WM3&[YL]>1TSUK7)P,FO/'U%=
M7^('@/4UC,:WFDW=P$/50Z1-C]:T/BKJ$^G_  [U(VTC1RW!CM?,7JJR2*C'
M_ODF@#J;"_AU*W^TVVYK=C^[E(^64?WE]5]#WZC(P:M5S/B/5'T7^P='T]EM
MFU&[6S24*#Y,:HS':#QNPH49!&3G!QBLOQ!JNN^"]&UO4+C4(;^W9X(],\]!
MYD3N0C>9M"AE#$,.^,@GI0!W5<[!XSTZXT_6[U+>]$>C3/#<J8?G)50Q*KG)
M&#WQ69JFHZIX8\4>'H9-0FU#3]6G:SF2=$#1R[2R.A15X.""#D>F*R-,_P"0
M3\4/^OVZ_P#29* /0=*U&'5]'LM3MU=8+R!+B,. &"NH89QWP:MUYQH^M7<.
MA>!]"LUN UWHB7$CV_EB3;''$ J^8=O)?)/)PO'7(D_MKQ1I$-IIFK.$GU'6
M!9V5[)Y9E6W*L^75?D\P!2HXP20<'!! /0R0!D\"J%]JBV:V3):W5VEW.D*M
M:Q^8(PP)\QSGA!CEO<5QOC"SU^Q\'^+VFUR22Q%B9;)E"K<(0A\Q&(4 J3C!
M'/)&:-1O=5T/1O!0M=5F:.\U&TM;@2Q1DO&Z$E<A1@#;CCGGK0!Z#17%2:W?
M:'\0[BRU?4W;1[S3WNK'?'&HC>+F5,A03A2&&3TSUJ.;6-9MI]!T::6[DOM3
MCGNYFC6!98D3:1$NX!,CS "<$_*?7( .B\2^(K3PKH5QK%]%<26T !<01[FY
M./4#J1U-:]>4>,?^$AC^$_BZ#7OG1&!LII#'YKPEUP)!'\NX'C(ZUTWB#4]3
MT+QCH5Q+J$@T"_D-G-#Y<>(IR/W1W;=VUB".O!QZXH [ JI8,0"1T..E,N+B
M&TMI;FXD6.&)#)(['A5 R2?PK)\/7%W?_;[^6Z>6TFN6%E&RH D2?+D$ $[F
M#,"2?E*UI7UE;ZEI]S8W<?F6US$T4J9QN5A@CCV- $8U*(R6T6R43W"-(D17
M#!5QEB.PY4<]R*Q[7QK87M[?6=M9:E-<6$GE7*);$^6V,XSG!X]*;#X#T2 :
M)M6[+Z,S&U=KERQW'<0YS\PS@X/ICIQ7): ^NIXL^(7]B0V+R_;$VFYD9</Y
M(Q@!3G]* /1]*U.#6-/2]MUF2-V=-LT9C=65BK J>005-7*Y?6[J]MKC184O
MULX)_,^TQ01[KJ=]N0(UVL,9)+'C''(&:Y!_%GB)OAW_ &@FH&*^MM;_ +/>
M1X(RTD?V@1_,!\H.#R5QTXH ]7JEJVH?V5I<]]]CN[SR@#Y%G%YDK\@?*O?K
MFN.:3Q!'\0W\._\ "1SM:7>F&]\TVT/F6[K*$(B^7 !W#[X;&.YYK'O/%/B&
M#X3>(=035/\ B::/?SVBW?D)F58Y0@)7&T'![#M0!W]WXCM+/Q'IFARQ7/VK
M44D>%Q'^[ C7<V6SUP1TSUK7KB?$O_)4? W^YJ'_ **2JMMXAU/1M3\4:3K&
MH37=U!&MUI1,<2-+"_R(J[5 +B7"$GC)7B@#OG8I&S!6<@9VKC)]AFL;P]XK
MTKQ/]N&FRR&2QG-O<Q2QE'C<=B#^//L:T=-ANK?3;:&^NC=W:1@33E57>^.3
MA0 !GVKRNS_XI+Q;I_B-?DT[6KZ[TS4?19?M4I@D/ZKGL* /0]<\5Z7X?OM-
MLKV20W>I2^5:PQ(6:1N/R'(Y/K6TIRH)!!(Z'M7D?B3_ (F7BCPIK[<K=:_'
M#:>UO&KA2/\ ?8N^>X*^E=#>ZMKFN7OB*TT5[R"7391;6S0?9]AE\M7W2>9R
M02V, = >_0 [RBO/FU'Q1-XOT'2;O45L&O=)EENXK>*-_+F0H"49@?[QQG('
MH:R?[5\4-X-\57G_  D<JW'AR\NHH9%M8LW(B4./-RN.AQ\H7UYH ] ?Q%:1
M^*H?#K17'VR6V:Y5_+Q'L4@'YL\G+#H*UZ\TU WNL_$3PY):WO\ 9\]SH$TC
M31QAV0,T1.T-QGGJ0?I4-MXPUW2H]1T'4;@7VI6VL6^G0WR1(C21SKO5BIPF
M\*"/3)&<\Y /4:*X"[G\8:;!XAG,\R:=%IKW-I/=B!YXIT!)7"?*R$<Y/(Z5
M!%=>+;?P1;>(1J-SJDEU:6<LEG;6L8DB0[3*T7'S.5)X/?)'8  Z_P 1^(['
MPOI@U'45N#;^8L;&"%I"N<_,0.B@ Y-0?\);IQUV]T9(KQ[RT@6X95@.)(SM
MR8S_ ![=ZY YYP,GBL_PQ?V'BW2;_P O6)=3L7F"&&9!'+"-HW0R *IZYZ]0
M<9(KIA90B_-Z06G\ORE8G[BY!(4=LD GUP/08 'VMU!>VL5U;2I+!*H>.1#D
M,IZ$5+7$?#^Y=-3\6Z03F"PU>1H!V1)0)"H]@Q8_C5KQ'>:@FN?98-4>"$V#
M216UDBO<M-N^^VY2JQ@8Y) ))![4 =;17E\/BCQ#J.A^ +R+44MY=8E$-X!;
MJRN?+<[N>G*YP,?EQ3Y_&&J>%+;QRM_>/JO]B"V>TEN$1&)G7A7V!00'QR #
M@T =MJ7B*TTO6M*TJ>*X,^IR-' Z1Y0%5+'<V>. >F:UZ\XU^POK3QKX#>ZU
M:>\+7DPD61$5=_D/\R[5! ZC!SV]\^CT %%%% !1110 4444 %%%% !1110
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MUK*^E@%O<@QB2.= <J67(^9>Q!Z<'-4[SP':SZ396$%]/!]FU :F\VQ6DGN
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M $.[N?M-PEO_ *-%O\K=GYWYX08Y/;(H KZ7H:6%_>ZE-,;G4;T(LTQ4* J
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MMI#+&H;*?ZOS&'WPO&.!R!G-=.DB2H'C=74]"IR*=0!RZ>#S'-XCE&IR%M=
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MO_$.BZS+J#"?2EE5$6(;9/,4*Y;OT QCI[UBHVC^./%^F:C:07#KH;3>;/+
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M&YE9<#<.00O.?PQ4,VK>)?$%MK,N@O=175C?26EJ%^S^0S1$ ^;O.\[CGIC
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M8N5DDL3 L);=\Y(P0^?[VX!L^M4])\)7VGV[I>^);_4Y%B,-L]TB8@4C!.%
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M@#R <#@$=^178CP?'9:V=6T6]?3YY+9+6XC,8ECF1!A"02#O4< YZ=0:AN?
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MX=5TJTU&WW>1=0I/'N&#M8 C(]<&@#F]"^'UCX?N$%MJNK2V$+E[;3I[G=!
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MW+W<Z7/ED>8^ Q&U1P0!QTK+T7X>:?H-VIM-3U5M.CE\Z'2Y+G-M$V<C QG
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[EWE5C\J;-PRN <9]N>  !B&;X?:;+H>CZ<E]?Q2Z,0=/OD=!/#@8QG;M((
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBL?5-?6QU2
MTTFUM7O-2NHWF2%7"!(T(#.['H,L!P"23TZX -BBLC2-;?4KZ^LI]-N;&XLQ
M&9%F*D/OW8*%2<K\O7CTP"*UZ "BHK>Y@NE=H)%D5)&C8KV93AA^!!%9^KZV
MFFW6GV,<:S7^H2/';1,^Q3M0NQ9L'  '8'DCB@#5HK.T34+O4M/\Z^TR73KE
M9&C>"1P_W3C<K#JIZ@X'TK1H **BDN8(KB&W>15FFW>6G=L#)Q]*Q_#OB/\
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MB::5L9PJC)/Y"LO2=<U'4+^.*XT22WLY[474%VLPD7G'[MQ@%7P0<#<.O/%
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MNT %%%86H>(_L'BW1]!:RD;^TTF9+G> J^4H8C'4GD>G6@#=HHHH ***B-S
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M#;FVB99]^8SC@APP/W1CCCMB@#D[G6;G^Q]#U?3?[3U_PZ+607)M+AX[M6+
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M;3O"P,L9<RG:06.<  \#;[USOBZ_OO#6L>"KMGDUV]L+341))&@5IV6- S$
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MQ4FC>';70KG4)[6:Y=K^<W-P)7#!I" "PX&. !@<<4 :]%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3R>9;LOW2C[MPQ]>G'2KEMH.GVT%Y'Y)F-Z-MT\[F1YAC;AB>V,C'09-:5%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*T+R^7N4=<'!Y_"G^%M<_P"$D\+Z=K1MQ;_;(1+Y6_=LSVS@9_*O"K5(M?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_4UMT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM!_X1Z[U:U34X[B*65;A+.*$QQV>X'*H"S8#8SM[>G- &T[:G_;42I':G2S
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ME%>6023:+XEL1KFFQ7EI>:JQT_7[-@7WR,VR*<'G W;!V&U>...V\8VEW?\
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MEL #).3BN073K>#X1C7XPXU.SUEFMIQ(V8LW^TA1G !!.?7/- 'N,[2K;R-
MB/*%)178JI/N0#C\JQ?!>O3>)_"&GZS<0QP2W2,S1QDE5PY&!GZ5NM]T_2O!
M[;0;:#X':9XFLFN(O$%F%>SN$F?=N,^T1A<XVMG&W')/UH ]YKG-4\07>G^-
M= T5;:!K74UN"TQ<[U,2;L!<8YR.<GOQ7*M:MXR\1>+-'U"YLH[FV>.*".>V
M,DEO$T*D21'S%VG>6.X#.<9/0"66-H?&'PWB?4&U%H[>^3[8RX,^(5&_J>O7
M.3GK0!Z117D-F(]?^$&K^([TF/Q#!]LN&NP<36LT3N416ZJ %4;1Q@^]7K^X
M&C:KX6\7ZQ"L<6IZ>+'5E9,JDKQAU;;Z[E9#[$"@#U"BO)/"T#J]YX$U"T5+
MC[<E\5/S$6;_ +W!8_>VL/))_P!H5ZPCQ;FB1DW1@ HI&5]..U #Z*Y/Q>UG
M-JWAZPF$EQ<SW,CP6!8+#<;(SN,Q(/RJ"&X!.<<'M2^&+2)8^(K1V0):Z[=0
MQ11D[(D 0[$!Z*"QP/>@#:USQ,NFZI8Z-96WVS5[X,T4!?8B1K]Z21L':HZ=
M"2> *2XU37-.N;%+O3K6>WN;A89)[:9AY&[H65AR,X&0>I'%<O-G3?V@(;F]
M.V#4M$-M92-T,BR!F0>^ 3^->B33Q0A/-<+O<(@/5F/0#^?X9[4 245Y)8I%
MXB^%FO:]J!\O7X)+V5KH'$MI+$S&-%;JH553Y1V)]35K4)I=,;P9X[U*-8F>
M&*VUC(P$\Y %E(Z J^ 3UPV* /4:*\T\07!TK0=-OV,5E'KNLQ-?22QG:D+A
MBBR %<#Y8PW(&2V>IJ+7_#*Z+H?B^>/5(E2ZTB6<:=90M!%&Z*<2@!SC/0C@
M-COB@#U"BO*-1L[/PSX0T+4;9S;-J\UA;ZI=SR.ZF+83EQN "YPIQC@XZ4[Q
M/9W?@?1_$NM:3JD"37&GJRZ?96IBBB;>J&X4;V (5SZ9QGM0!V>O>(+O2?$?
MA[3HK:![;5+AX9)6<[T*QL_"XQVZY_"KWB35)]$\.:AJL%O'<-96[W#1/(4W
M*BEB 0#SQZ5P^LZ1I%CXJ^']UID,2B2ZD7SDZS*;=B&8_P 9[[CD\GUKK/'7
M_)/O$G_8+N?_ $4U &&/B#=V-CX?U/6='AM],ULQ)'<6UV93 \J[D$BE%XQW
M!.,&N\KSSP_X17Q#X2\'3:MJ$LUE8VMK=0V2(J(T@C&TN>K 9/''OFL^/3SX
MW?Q7;7>HV=M>V>HRPK+);EKBSC3'E/&_F+L! W9 P3NSGF@#U.BO+&T"QUWX
MDKI^ISSW]K/X8BEE/FO&)W\[&_ .5S@' X!QW%-UDR:!K,]_JNFQZGH$FHPO
M%JEL^;G3V1T41N#R8PRXX/0G.2: /5:*\YT.VM?&$_C*/7$5KNVU.6TB+_?M
M8%1?+:,_P9Y?(QD_2N>TF2\\0?\ "KKK69+AKF[CO%G(F=?-186VL<'JRX)/
M4[C0![/17"^ ;>/3M>\8:3:@QV%IJ,9MX,DK%OA1F"YZ#)SBH_%EC#=?$[P=
M%*TICN(KY9465@KA8UP, ^YZ=<X- '?45X]!X=TR72_B%8/"[6>FSRO8P&5M
MELQMU?*#/!W<CT[=36M930:XOA"WN@VI:E)H2W3VETP^S;66,--)D$L^<@
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M#7VG2Z<[7%L%\UC*8T(F:,9+@9(S@X+CUH ]%HKR*>VO_"/@VYN+EY+*WO\
M7T3,TCO]ET]I?E5@&^48X(!!"MC.1QUVA^'$T?Q;+?0:G:I%>V?.FV=J8H7*
ML/WX&]@#A@O&,Y% '1:BVIK]D_LV.U?-R@N?M#LNV'G<4P.6Z8!XJ[7#_$9
M)?"4P9U<>(;1.'(!!+$@C.#T'7TK.AT#3]9^)OBZRU".2XM6LK-C"\SE-S"3
MG&>W;L.U 'I-%<A\+;J>]^&6@3W,KRRFVVEW.20K$#)^@%=?0 4444 %%%%
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MP?X?CT0:.FEPBP#B18LG*L.C!L[@1V(.1VJ_8:59Z9YIM8F$DI!EEDD:223
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M7]Y:O;_:X+:2:))R=KE%+8P"">G:G>'=1DU7PUI6H7'EBXN[.&>14X 9D#'
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MDVHB!/MC0B S8^8Q@E@OTR2:R['PU:V7BS4->BACAGO(ECD\MV)FQCYGSP"
M  ![G)SQN AE# @@C(([US$GB.['Q"L=$B-I)I]S8S7!=,F0.C*,9SC'S>E
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MD'1Q@CD=CVJ-/#NEQZC=:@D$BW=V@CGF6>0,ZCH#\W;MZ=JT1-$S;5D0M@G
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M-575'L+=M05=HN2@\P+Z;NN/:K=S:P7ML]O=0I-!(,/'(NY6'H0>HH \JO\
M0]0^&%S9:EX8U.6?0+F]B@FT6X;S OF,!F!NH//3\3FMC2=-TQ_BUXM\^SM"
M3:V17?$O5Q*&(XZGOZUUEMX8T2SNHKBWTRVCDAR8<)Q%V^1>B\>@%2W6C:/)
M?G5KJQM#=I$8_M4D:[UCYR-W4#D_F: //?AOX,\/:O\ #JQGOM,AGGE2[MC*
MXRPC,\@V@]L8R/0Y(Y)IWA*-M06Q\%:C:H\GAFX)NBT0VR(@_P!&8?[X8/\
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M3    Z"@#S34_"$.J37?B[P3K#Z-K&^5;C:P-O</&Q5EE3H#E3S^.">:I?\
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M=.GY#TH YCQ586-]\3_!AE@BF2X@OED[B5!&A /]Y>3P>.3ZUS\'AS1I-/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV#3K M];&9W9%C$J[F91E@!G.0#DCM5/7/$FF>'S9K?W,<4EY<);PHS@%BQ
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MZ[9^*]%\3Z^]A<C4YC<V[F%'*!\PNA9"Q^0(!@GIQU% 'KSLJ(SNP55&22<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "HKFUM[VVDMKN"*>"08>*5 RL/0@\&I:1F
M5%+,P55&22< "@"F='TMIH)CIMF9;=0L+F!=T8'0*<<#Z4P:#HZQS1KI-B$G
M.95%NF)/]X8Y_&G0ZUI5RK-!J=E*J EC'.K  8R3@]LC\Q4AU*Q"0N;VVV3G
M$3>:N)#TPO//X4 0G0M(80 Z58D6_P#J0;=/W??Y>./PITVBZ5<:E'J4VF64
ME_%_J[IX%,J?1B,C\Z?<ZII]G/'!=7UK!-)C9'+,JLV>. 3DTZYU"RLR1=7E
MO 0AD/FR!<*.K<GH,CF@"I'H5JGB237/)@6[: P!XX0KLI*D[VZM]Q<>@SZU
M?N+:"\MWM[F&.>"0;7CE0,K#T(/!K*M_%>CW?B&71;>^@DNXH4E8+(I'S$X4
M<\G SCT(]:T%U.P:_-BM];&\ R;<2KY@'^[G- #(-'TRULY+.WTZTBM9/OPQ
MP*J-]5 P:C.@:,8(H#I%@88FW1Q_9DVH?4#'!J9]3L1+Y'V^U6=I/*5#*N?,
MQG;C.2<<XZXKG/"/B:>]L-6EUR\LXWM-7N;%' $*%8R , D\]3U- '6,B-&4
M904(P5(X(]*H?\(_HHB@B&D6'EP',*?9DQ&<Y^48XY]*M-?6B& -=0 S_P"I
MS(/WG^[Z]1TJ2::*WA>:>5(HD&6=V"JH]23TH KPZ7I]O=R7<-C;17,O^LF2
M%5=_JP&33+#1=*TJ2:33M,L[-YCF5K>!8S(?]H@#/XU+!J-C<V9O(+RWEM0"
M3-'*K(,=?F!QQ26VI6-[ \]K>VT\2'#R12JRK]2#Q0 M[I]EJ42Q7UG;W4:M
MO5)X@X#>H!'7DTT:7IXL&L!8VPLW!#6_E+Y; \G*XQS31K&F%78:C9E8XQ,Y
M$ZX5#T8\\*>QZ5+%?V<]U):PW<$EQ$ 9(4D!= >A(!R* &66EZ?IUE]CL;&U
MM;7G]Q!"J)SU^4#'-)IVD:9I$;QZ9IUI9)(VYUMH5C#'U(4#)JM87,L*:E-J
M&JV4\,=T^QHP$%M'@$(YR?F'4DXZCBKD6H64]T]K#>6\EQ&H9XDE!=5/0D Y
M H BM]%TJTO'O+;3+.&Z<DO-' JNQ/7+ 9.:3^Q-)WSO_9=ENN!B8_9TS*/]
MKCG\:E?4K"*Z%K)>VR7!Z0M*H<\9Z9STHN=3L+(QB[OK: R#*>;*J[OID\T
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M2SH]M?65UI1TEKM3;@,PD$JI@N&(/!/IUKI(=5TZYN)+>"_M99X@3)&DRLR
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M5;5M!CN+"_;2H[2PU:X@:..^%NI="1C)/4U'J'B!/#'A>/4?$=Q:I<I&JRB
MD)+,1C;'NYY/3/;KTK/OO$MS!X[T6QBO+-M&O;.YG=U R#%MY\S=C'S>@Z4
M95MX(>\2.WU#PEX5T\IMS?6)+S#&.8P8E*GC@ECCWKT)E5U*L 5(P01P14,%
MY:W5J+JWN89K8@D31R!D('4Y'%-L]1LM11GL;RWND0[6:"57"GT.#UH JVOA
MO0K%T>TT73K=D<R*T-JB%6/5A@<'WIQ\/Z*QG)TBP)N'$DV;9/WK@Y#-QR0>
M<FK4]Y:VK*MQ<PPEPQ42.%R ,G&?0 D^PJ&;5],M[2*[GU&TBMI<>7,\ZJCY
MZ88G!H R4L->O_$!?5O[.32;.X,UFEN7,LIVD*9-W VY)P.^#QCGHZY;Q1KF
MH:7JOAE+*:W-IJ.HK;3@Q[F*E&;*MG 'R^GXUOW6IV%E-%#=WUM!+*<1I+*J
M,Y]@3S0!%+H6D3S7,TVE6,DMTFR=WMT+2KZ,2/F' X-+)HNE33QSRZ99O+$H
M6.1H%+(!T ..!4EYJ=AIVS[;?6UMO^[YTJIN^F3S3KJ_L[*)9;N[@MXV.%>6
M0("?8F@ ^P6?V_[?]D@^V;/+^T>6/,V_W=W7'M4%OHFDVE]->VVEV4-W.")I
MX[=%DDSUW,!D_C4TNHV,%F+R:\MX[4])WE4)_P!]$XJ6">&Y@2>WE26)QE)(
MV#*P]01UH @L]+T_3C(;&QMK4R'+^1"J;C[X'-27EC::C;FWO;6"Y@)!,<T8
M=21T.#Q52)[K_A(;A6U&U>U^SH4LU0>:C9.7)S]TC Z=JL6^IZ?=SO!;7UM-
M,F=T<<JLRX.#D \<T ,_L?2_M3W7]FV?VAUVM+Y"[V7&,$XR1BD71-)2PDL%
MTRR6SE_UEN+=!&_U7&#5J:X@MPAGFCB#N$4NP7<Q. !GJ2>U1VM]9WIE%I=P
M7!B;9)Y4@?8WH<=#[4 %C86>F6JVMA:06ENGW8H(PB#Z <5R^J>&KG4_B'8Z
MM<6%E<Z7!8R6K+.P9MS.K!@A4CC;CKGFNFBU.PGO'LX;ZVDNH_OPI*I=?JH.
M15&P\3Z3J6N7VD6MY#)<V6Q9 L@Y8@DJ/4@#GTS[&@"__9]E]@-A]CM_L10H
M;?RE\LJ>HVXQCVJ*UT72K%H6L],LK=H4,<1A@5#&I.2JX' SS@5:GN(;6!I[
MB:.&)!EI)&"J/J33(+VUN;475O<PRVY!/G1R!DP.IR.* *\.B:3;WS7T.EV4
M=XY):X2W42$GJ2P&:>^DZ;)>&\?3[5KIEVF=H5+D=,;L9Q2P:KIUU;R7%O?V
MLT,7$DD<RLJ?4@X%*=2L!'#(;VVV3'$3>:N)#TPISS^% #(='TRWM);2#3K2
M*VFSYD*0*J/GKE0,'\:?I^F6&DVPMM.LK:SMP2WE6\2QKGUPH I+C5=.M!*;
MF_M81$5$GF3*NPM]W.3QG!QZU2U7Q1I.C7^FV5Y>0QSZA(5A5I . I8N<]%^
M7&?4B@"[<Z5IUY<1W%U86L\\7^KDEA5F3Z$C(INHZ/IFL1I'J>G6EZD;;D6Y
M@60*?4!@<&G7.J:?9/$EU?6L#S?ZI99E4O\ 3)Y_"G7M]:V$'FW=W;VJGY5>
M=PJY_$C- #+G2=-O!"+K3[2<0?ZKS85;R_\ =R./PIMYHFDZC<PW-[IEE<W$
M'^IEF@5VC_W21D?A7*>'_$NM:AX7U359#;W<^GZA<Q&*&/8L\,38PG)PV!D9
M)!/!ZY'8:??VVJ:=;7]G();:YB66)Q_$K#(- #9M+T^YO8KV>PM9;N)2L<[P
MJSH#U 8C('-0-X>T1X((&T?3S#;@B&,VR;8\]=HQQGVJ>35-/BO5LI+ZU2[?
M&V!IE#G/3"YS2W&I6-IYGVF]MH?*0/)YDJKL4G )R>!GO0 VZTC3;W3UL+O3
MK2>R4 +;RPJT8QTPI&.*GMK:"SMX[>UAC@@C&U(XD"JH] !P*0W=L+3[6;B(
M6VS?YV\;-OKNZ8]ZY?1/$ESJ?CW5],6\L[K3;>SAGMWMESR[.""VX[C\O;'T
MH Z*^TC3-4,9U#3K2[,6?+-Q"LFS/7&1Q2W6EZ??6Z6]W8VUQ GW(Y85=5^@
M(P*GGN(;6!I[B:.&)!EI)&"JOU)J%-3L'LA>I?6S6AZ3B53&><?>SB@">&&*
MWB6*&-(XU&%1%  ^@%59=(TR::XFETZTDEN$"3N\"EI5'0,<<@8Z&I8+ZSN9
MYH(+N"6: XECCD#-&?1@.1^-<MX\\52:'I0;2]0L!?)<P1RV\F'DV/(JG"[A
M@X;.2#0!T)T'1RD*'2; I <Q+]F3$9_V>./PIT^BZ5=:A%J%QIEE->PX\NYD
M@5I$^C$9%1[[K_A)-O\ :-K]C^R9^Q;!YWF;_P#6;L_=P0,8Z]ZF&KZ:9(8Q
MJ%IOG8I$OG+F1@<$+SR0>#B@"Y6;?^'M%U2X6XU#2+"[F0862XMDD8#T!(S5
MJ[U"RL IO+NWMPWW3-($S],FID=)%W(ZL/53F@",VMNUH;0V\1MBFSR2@V;>
MF-O3'M4%IH^F6%O);V>G6EM!(,/'# J*PZ<@#!ITFJ:?%>K927ULEVV-L#3*
M'.>F%SFJ2^)])?Q*^@+>0F^CA$LB>8/ER<*O^\>3CTQZT 3?\(_HOV46O]CZ
M?]G#;Q%]F38&]<8QFGR:581SB]ATNT:\C3;')Y2JX &  V,@5=D+B-C&%9\?
M*&. 3[G!KG?!&O7WB+1)[O4(X([B.]GMBL .T"-RHZ\GI0!1\ >$!X>\.65M
MJFFZ?_:ELTA^TPJ'+;G8@ABH/1L5TLVC:7<7;W<^FV<MS)&87F>!6=D(P5+$
M9*X[=*QH->U%OB1<>'IX;9;)-,%[$Z%C(29=GS$X Z'@#OUKH5N;=KE[99XS
M.BAWB#C<JGH2.H!P: *JZ)I*2PRKI=DLD"A(G%N@,:CH%..!]*H:EIU[IMGN
M\)Z;HT5Y+,IG%PAB1DYR<QC);IU]ZPM*\4:UXFU^4Z#J/AN31X+CRY8G:22[
M"*VUFPK;1NP2N>Q&:T%UO5-:U77+/1)+2$:2RP9N(F?SYB@<@X8;5&0,\G.3
MVY -S1M..EZ:D$D@EG9FEGE"X$DKL68@=ADG [# [5<FABN(7AGB26*12KHZ
MAE8'J"#U%9/A3Q#%XJ\,6.LPQ&(7"'?$3DQNI*LN>^&!&:NSZOIMKG[1J%I#
MB01'S)E7#D9V\GKCM0 MEI>GZ;N^P6%K:[@ WD0JF0.F<"EO=,L-2$0OK&VN
MA$V^/SXE?8WJ,C@^]6JIS:OIEN&,^HVD063R27G5</C.WD_>P1QUH CDT'1Y
MED672K%UEE,T@:W0AY#U8\<M[]:<VBZ4\_GMIEDTVSR_,,"EMN,;<XSC'&*F
M%_9M?&Q%W ;L+O, D'F!?7;G.*L4 9O_  CVB_9EMO['T_R%;>L7V9-H;U Q
MC-2RZ/IEQ>6]Y-IUG)=6Z[8)G@4O$/16(R!]*N,&*D*0&QP2,@&N(\,:YXE\
M1SZZAN]*MQIFJ36"XL9'\P)C#']\,$YZ4 =.V@:,]G!9OI-@UM;MNAA-LA2,
M^JKC /TI[Z)I,L<\<FF63I<2>;,K6ZD2/_>88Y/N:CL;V>#1DN=;N+..0,P>
M:,[(67>0C#<QQE=IQD]:M1ZA9361O(KNW>U ),ZR I@=3NSB@"6&&*WA2&&-
M(XD&%1% "CT %5#HNE'43J!TRS^VD@_:?(7S,C@?-C-4=7\7:)H^@W.L3:C;
M26T ZQ2JV]^R#!^\:T9-5TZ*R%[)?VJ6A.!.TRA,_P"]G':@ _LK3OM_V_[!
M:_;.GVCR5\S_ +ZQFK=5_MUGY,,WVN#RIB%B?S!MD)Z!3WS[4R/5=.E2-X[^
MU=)=WELLRD/MSNQSSC!SZ8H MT5#:7EK?VXN+.YAN(6) DA<.IQUY'%9NH>)
M])TW7++1[F\A2\NU9U1I -JJ/O'/3)P!Z_@: -BBLRUEN%U?5#<:E:2VJ"(Q
M6Z*%>V&T[C(<\[B,C@8 JQ'JNG2SQ01W]J\TR>9%&LREG3^\HSDCW% %NBJ]
MI?V=^)#9W<%P(VV.89 ^UO0X/!]J;!J=A=74MK;WUM-<1?ZR*.56=/J <B@"
MU1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5Q'Q*OA86.A-=-LTE]8@346;[@B^8C?_L;
MPF<\?G7;U%<VUO>6TEM=01SP2#:\4J!E8>A!X- '!P36%W\;!)926\P/AUUD
M>%@P)\]< D>Q_(UQMK?64?P7\(6[W,"S1:M;[HRXW)MNCNR.V._UKT.V\,W&
MG_$*WU2PL;*VT>'2VL5BA;858RB3(0+C'&.M;P\.Z('F<:/IX:>02RG[,F9'
M!R&;CD@]S0!Y?XTU#3KO2_B$MG);0.L4:737$F^2XD$0*")20$4#&#SDYP!U
MK1>RTG6OB1X<:X@M+R.XT&;S=P5UF(:,?-_>QSUSC'M7H<NBZ5/<RW,VF6<E
MQ-&89)7@4LZ8QM)(R5QVZ4BZ)I*7$-PNEV2SPJ%BD%N@:,#@!3C( ]J .'M(
M[;3?B;XBMK..VMY5T>T6RBPJC</,"A1]<#BLCPR/#WB+PMX9:[\0W0U.PN(G
M^QHT*7"W@X=2-F\AF+%LGD<D]Z]6:PLWODOGM(&NXU*).8P9%4]0&Z@>U0Q:
M+I4&IOJ46F6<=_(,/=+ HE;ZMC)H X;P/H6CS^(O%LLFG6CRVNNEX"8E/DD1
M(04_NG)/(_I47AO0K3Q1X3\:Z/=!3%<Z]J"!L9V-O!5A[@X/X5Z!:Z3IMC)+
M)::?:6[R_P"L:*%4+_4@<UGZAIUWIFGN?">G:/#>R2J9%G0Q1NO\1)C&=WI0
M!SO@K4+SQ/-:S:K;M'=:"CVER&7AKW.QV7Z(H(([3>U2?$+41INI>%Y[V[DM
M-(^WNMS<*JE8W,;"(MN!&-V>2.#@]A75:+ISZ;I_ESR++=2R-/<2JN \C')P
M/0=!Z  5:NK2VOK:2VN[>*X@D&'BE0.K#T(/!H \OU>+PMI>GZW>1ZA/JZ:G
M?67V@"YC2V6?>-A+1J HX#/UXQQR*C26VN/%GCVWN[NPNVGTB LL2@([JDO1
M23DJ .<YX[5Z6FB:3'I9TM-,LET\\&U$"B(\Y^YC'7VH_L/2,$?V58X,(@(^
MSIS&#D)T^Z#VZ4 >4:EH6CQ_L\#44TZT^V/HD&ZY\I3(3A3][KU-='=V%EIW
MQ.\&_8K>& W%C?)*8U ,H"QL-Q_BY)//O7:G1=*-@+ Z99&S!W?9_(7R\^NW
M&,T?V+I7G0S?V99>; ,1/Y"[HQZ*<<?A0!Y'=VEH/AI\3HA!"(H=8NVC0(,(
MP6/! [&NCGL;+3OB%X":RMX8'N+2]65HU"F4")&^8_Q<Y//?FNRGT;P_:65P
MT^FZ9#:M^\G,D$:H<?Q-D8_$U*FCZ1(;>XCTZQ9HE'V>58$.P=1M..!]* /*
M);6#6?#GB#PLVH:=+/<:Z\JW\MU&-H$RLQ9&._>H5D VX.!@X-;WBFTO=,O]
M4O\ 0!IUY9P:='!J>AW"^6#;J'*F)APO#.,$8X/>G6G@S4RK6VK^&_">J2L[
ML^K3J3))N8G<T9B.6YZ!P.P(KKK7PMH\%E9P3:?:W3VL"0+-/ KN54 #)(SV
MH L6%S]O\.6UU:1O%Y]HLD*2?>3<@*@^XR*XOX>HK_ ZTC*9;['<*ZL,G>'D
MSGWW9KT6LG2M'_L>ZO$M2G]GW,K7 B/!AD8Y<+ZJQRV.Q)Z@X !Y>S65S\*/
M $"/"^=2TM)E1AG);!!QT/!K2U:"73/&/C&'0(%M[E_#"2Q1VR!<RAI0I '\
M0& /PKT(^'M$-ND!T?3_ "4<R)']F3:K'JP&, GUJ>/2M.AO3>Q6%JET1M,Z
MPJ'QZ;L9H \]T!?"^N_\(KJ=IXAFFO+10+2TA:!73*8='54#;0 <Y]/<9U/B
M=>FQT_0FN#MTE]9MUU%C]T0Y)^?_ &-P7.?IWKJ[31=*L+R:[L],L[>YG_UL
MT,"H\G?YF R?QJS<6\%W;R6]S#'-#(-KQR*&5AZ$'@T ><ZC?:59_%ZZO&DC
M*?\ "+2M,8'&]PLRG P>6VCCO6-IU]8KKWPTFAN;&WLO(N1#;I+N>&)K<[1)
M(3\S$@9X W CG&:]4L]!T?3F1K+2K&V9$,:F&W1"JDY(&!TR3Q20:!HULL2P
M:381"*4S1B.V1=DAX+# X;WZT <#=07'AKQ7J?ANQA9+/Q5_I%F\:\03'"W/
MTPG[P=LC'>N]U*&>R\,W<.CQ!+B&S=+.-1P&"$( /J!6=HUAKT^I?VCXC.G+
M-;J\5K%8[RH5B,NQ?^(A5&!T&[UP.CH \>O/*U#X$:)<Z6?^)Q UK]E=?]:+
MWS563WW$F3/U)-=/!% ?C?=@QQ%QH$+]!][[0_/UZ5UD6BZ5!?O?Q:;9QWCD
MLUPD"B0D]26QG-*-(TP7QOAIUH+PG)N/(7S#_P "QF@#E?BXJ?\ "M]0=PN$
MEMCDC[H^T1Y/Y55UN+3]1^*'A*/9;W-K]COB%&&0D&/MT."#^(]J[RXMX+NW
MDM[F&.:"0;7CD4,K#T(/!JJ-$TD30S#2[(2P*%B?[.FZ,#H%.. /:@#R*6X&
MD^&/$?E[X-*M?&.+L0("(;;,9;"X(V[B"1C'7BNZT"TT&;QA/K.FZ]+J=[<V
M(CG$4D+0[ P*,XC4?/R0">H#>E=+!I&F6J3I;Z=:0K/GSA' JB3/7=@<_C2Z
M=I.G:1"T.FV%K91,VYDMH5C4GU(4#F@#B_&6GV%Y\2_ ZW5K!*)6O5<.H.\"
M#(!]1GL>*HO)I>E?$/4-$O[Z/1K)],@338]D*0O%E_-0>8A .XC(&,@#.<"O
M0[C2M.O+F.YN;"UGN(O]7++"K,GT)&13=1T?3-72--3TZTO5C.Y%N85D"GU&
MX'% 'G%U8:=I.F?#VQTN\N+NPAUT+;S7#AF=-DV""  5Y^4@=,8J,2Z1JNI>
M-="\3ZZ=.EENVWPRM"F^U*+Y;(TB$\ 'H>#SU->F7.DZ;>&$W6GVLYA_U1EA
M5O+_ -W(X_"FW>BZ5?W<-W>:99W%S!_JIIH%=X^_RDC(_"@#SB^N=,6XU>PM
MY_+N+?P[##<76JONDEA*OL54R!N.?F;U(&TTS1UU*^\->#KWPWJED^LV>BA&
ML;SYH[F(K%O7(.48%4Y]QGBO39M+T^XO8[V>PM9;N-2B3O"K.JGJ Q&0.34#
M>'M%>&"%M(L#% "(4-LF(P>H48X_"@#S*Q\1VDFK^%+B[>3P]I=QIUQ%;*QC
M,<-TLH5DW.I4#:IVGC@X'4BNY\$Z9I.EZ=?1:+?S7MI)?23&1V1HP[8++&4
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M<!C_ *,"<#KV/Y&NNM]%TNSO'N[;3;.&YD)+S1P*KL3UR0,\U,+"S%\;X6D
MO&3RS<",>85_N[NN/:@#C?&6J1:5XY\(2:G(L6CN]RK2R'$27.Q?*+$\#C>
M3W)K%\5MH^GZ;'<Z,0^DS^)+:?6Y8Y"\)#'Y\G)&W<(]P''./45Z9>V%GJ5J
M]K?VL%U;O]Z*>,.A^H/%)'I]E#8"PBM+=+,+L%NL8$>WTVXQCVH X^_MF3XP
M:+<:<!B?3;@:GLZ-$I7R2WON) /H#7"6][91?!+PS;27$"SQ:M"&C+C<FV[.
M[([8!_7WKVFPTO3]+C:/3[&VM$;&Y;>)8P<=,X%0?\(]H@>=_P"Q]/WSR"69
MOLR9D<'(9N.2#SDT <!9Z3I-YXQ^(WF65I-&(+5E!C4J-UNQ)'8$]<UFZ=+#
M_9?PEN;QX]@1T>24C&/LS  DUZI_8>D[YW_LNRWSC$S?9TS(/1N.?QH.B:2;
M2.T.EV7V:)Q)'#]G38CCHP7& ?>@#S9;C1]5U;QGHOB/7?[/:>?_ %<C0(LE
MH8E$;(TB$X'S'@\$YZFKN@7=O:?$F/3KZXF,,>@VZZ2]\0'D3GS2<@?O#A=W
M?"UWMYHNE:C=0W-[IEG<W$',4LT"NT??Y21D?A2ZAH^F:L(AJ6G6EX(FW1BX
MA638?4;@<4 <;\*WLAH&MPVSP_9XM9O0$C8%53S#MZ=L=*F^#RS+\*M$$V<[
M92F?[AE?;_X[BNCO=%C?3+C3]-C@L8[PL+B6% C -]]E &"YR>3T)SSC!T+.
MT@L+*"SM8EBMX(UCBC7HJ@8 'X4 >,^*=2T^?PMXAEL);>UC3Q"AD2:3?<2W
M"SQAW&3^[4 <#!X';I73VNG:3J'QCU1VM;2YBDT6WEY175V,D@WXZ$XP,^E=
MK)H.CS27,DNDV+O=8%PS6Z$S8.1OX^;D#KZ4[^QM+^TO<_V;9^>Z[&E\A=S+
MC&"<9QB@#QW0]06R\+?#N.]D"Z&=5NTN&<_('5Y1;ACZ!N1GCY1Z5V.BR62_
M&CQ&L$D DFTVU9@C#+N"^?J<;?PQ77C0M(&GR6 TJQ%E*<R6XMT\MOJN,&GV
M6C:7IKA['3;2U8((P8(%0[1R%X'3D\4 <AX\U)--\3^%)+Z]>QTEYKA9+H!-
MD<Y0>46+J5''F $CC/:N7\7Z/H%MX&\27&FZ@^H^?J-I/+*6C:.*9IHPWEE%
M 5BN-V/4>M>NWEE::C:O:WMM#<V[_?BFC#JWU!X-5CH6D&PCL#I5B;*(YCMS
M;IY:?1<8% '$7]JFD?%-!HUI#!._ANY*1Q(%$CK*A3('7FN8N[W2KSX$Z/.9
MH'NX[RU:=I&'F+<^>OFEL\[CER?8^E>PC2-,6[2[73K07,:A4F$"[U X #8R
M!4#^&M">XFN'T73FGG(:60VJ%I""""QQD\@'GN* .62"TD^-LI2.%EN/#6Z3
M"@B4&XQD^O''TKADT[3X/@<;^*U@2[AU;,4X4;TQ?X&UNH !/ ]3ZU[2VD:8
M]V;MM.M#<E=AF,"[RN,8W8SC':HO^$>T3[-]F_L?3_L^[?Y7V9-N[UQC&: .
M-U2^MM,^)>I/=36MW'=:/'$;:6YCB:'YWX_>, 5?G.,D8Y'(K=^'N@Q^&_!&
MFZ<DMK/*D>Z:>V V2.3R<C[V.%R>2%%9>J^&-3E\075RVA>'=;T^58TMH[_]
MT]HJKC8/W;@KG+<8//L*Z+PWH46@6$T,4%K;^?,9V@M$V0Q$JJ[4'I\H)/&2
M2<#.* /+/%&I:?/X6U^:PEM[6-/$2%TFDWW$MPL\8=QD_NU ' P?E'4=*ZVS
MGL1\9=0D,MOB?1K9H6++^\)FD&5/?J.E=?)H.CS27+R:38N]UC[0S6Z$S8.1
MOX^;D#KZ5.VGV3W<-VUG;M<PJ4BF,2EXU/4*V,@>PH LUQ/PO(/AO4,'/_$X
MO?\ T<U=HZ)(C(ZJR,,,K#((]#5>RTRPTU76QL;:U#G+"")4W'WP.: .30C_
M (7?*,C/_".)Q_V\M70(=!AUZ^G5K%-66W0W;;E$JPC.TOW"]>M6AI.FB^^W
M#3[07A_Y>/)7S/\ OK&:D%C9B[ENQ:P"YF01R3",;W4=%)ZD#)XH X77M%T2
MYU3P[KGAK[''JIOHBDUB5 N+8M^^#;>&4)DY/? SS4WB#33X4OM5\1:5J4T,
M^J!5;3E@64W5R%VIY6?NL>_!&,DCBNNT_1=*TCS/[-TRSLO,.7^S0+'N^NT#
M-3"QM%O#>"UA%T1M,WEC>1Z;NN* ,/P#X>F\+>"=,TFY</<Q(7G(.1YCL78>
M^"Q'X5Q6D>'_  Y?2?$2+4[*S,,-_)DNB_N$,*$LO]SD$Y&.5]J]9KB_#WA%
MX-;U^]UK2].F%]??:K9SB5D7:J[3E1@Y7/&: )? -ZUIX(\,6&L721ZI<V8\
MJ"9P)9 HSP#R2%VY].]<;%I&EOX8^*1:QM6\F[O/+S&/W>+=&&W^[\W/'<>U
M>M2V5K-=074MM#)<6^[R960%X]PPVT]1D=<=:K#0=&6.:-=)L D_,JBV3$G^
M\,<_C0!YT]G:6C_#"\@@BCNII5$DZJ \F^U8MN;J<GKFO0Y/$&C0V5Y>R:I9
MK:V4IAN9C,NV&0$ JQSP<D#!]13CH.CL( =)L2+?_4@VZ?N^_P O''X4R\T.
MQN--O+.*RL42[?S9E>V5TD<D$NR]&;@')[@4 :,<B31)+$ZO&X#*RG(8'H0?
M2O,/ ND66JW?C?S[F\C)\0W2?Z-?S0 #"\X1P,]>2*]'LM/M[#2[?3H4_P!&
MMX5@16Y^15V@'UX%4SX5\.DDG0=+R>2?L<?/Z4 <IJ^I:/#'X5TZ.1+F:"^^
MS6=U+(4MUEBA(9VP?FQD@+W;C(QFN?T=8-2TWQ=IZ:];6MU)XC6:VN(U4QF4
M>2R'9DY1G '4\GO7J4FAZ3-81V$NEV3V<3;H[=K=#&AZY"XP#R?SI9-%TJ5;
MA9-,LG6X*M.&@4B4J, MQSCMF@#R;Q1?WMUX#\;V6MZ7:VVL6?V1KFXM"6AN
M0S+MD7/*G:N"#SC%=!K>L6-O\1]+2YU9;#2Y]-D2SN4,7E&X\S]XNYU902NW
MT].^*[R/2M.ALY;.*PM4M9<^9"L*A'R,'*XP>/6H[G1-)O-/CT^YTRRFLH\;
M+>2!6C7'3"D8% 'EFL:#X?LM(\-V^G7#7]D_BR+;-,49?GW%TC* #R]V1@<9
MR.U;6O\ A[1+7XC^"+6WTNRAAE.H%XHX557_ '0;D <\G.*[J;1=*N(8(9],
MLI8K<8A1X%98Q_L@CC\*?-I6G7%S%<SV%K+/",1RO"K,GT)&10!R/@"**UUW
MQI:VZ)%!'J^Y(D&%4M#&3@#IDTSQ*]I;_%7PG-=-#'&;.^!>7 !($9ZFNQM=
M+T^QEDEM+&UMY)?]8\,*H7^I YI]S86=X\+W5I!.\#[X6EC#&-O5<]#[B@#S
MJWL[,^)_BA;FWA\EK:U9X]@VDFW8Y(]<\_6L4Z7IW_" ?#*?[) )IM0L(Y)
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M, #\,G)S6G0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW3UCC802LH8!&7#+C)!#ECQ71ZAKFE:4RKJ&I6EHS8($\RIP3@'D],\9K,\
MR))\//#91E8#3+8$@YY$:@BN*EU+28O$_C#0_%>M2:8+R4/&LK1I'<VK0J@"
MLRDDC## /4G'.: /2;[6M+TP*;[4+6VW*77S90N5'5N>PR,GH*DFU&QM[-+R
M:\@2V< I,T@"-GI@]#GMCK7FSWFCV&LC2+=O[-EB\/QQK<W[%IYX"6V0QHQQ
MN!ZD@GD#'IB^'/$%II>G_#C4+^Y0:-%93VDEP6S';W15=N\]%.W<HSTR>G-
M'<^,_$LUOX7MM5\/:I;M&;^"!Y(@LH96E5&7/(!Y/O\ 2NFL-:TK5)[B#3]2
MM+J6V;;.D$RN8SZ, >.A_*O-_&C>'9/!-Y/HP@-G>:Y;2S3H^Z*YE,R;V4DX
M88')'&0?0UMQ?9H/C>(H?*CW>'.43 SBXXX'H,_A0!V5YJ-CI_E?;;R"V\YQ
M'%YT@7>Y. HSU))' JM'XAT6:P-_%JME):"0Q>>DZE-XZKD'K[5ROQ56U;1M
M$%T(MAURR!\S&-OF?-U[8SFJGBRZL_#7C70+JYF.E:+-#<QFZMXT6..Y<H0S
MDJ0-RJ1NQGKSC- ';)K^CO:6]VFJV36]RXC@E$Z[9')P%4YY.>,#FETW7-)U
MAYTTS4[.\:!MLHMYED*'WP>.]>5^)++PW#X;@N].N#=Z?<^)[6XN+N5U:*1V
M<>:R$ #;C@D<9!]#6IXATF;_ (3ZYG\+1I%>KX=N4N#;@*-[?\>X..-Q()'L
MOH* /0(]=TF:_%C'J=H]V2P$*S*6)7[P SR1W':H[CQ+H5I,\-QK.GQ2QR)$
MZ/<H"KMG:I&>"<' ]C7FE]);ZQ\&O#=OI#*-8AELHK2->)(KI'59,CJ" )"<
M]LDUNZ%9Z9>?%?QJD]O:SNL=@0KHK8(1B3@^X4_4"@#=TWQGHVNKJ\5CJMM$
MUC*\/G-(O\**3* ?X0SXST.WKS5S3M6L[32-,6_U^SO)KB-1'=EDC%VV/O(H
M..>O%<9X<N[);3XA6%Q-"+C^U;V9H'8;O+,28<C^[[]*Q46SG\$_"E9Q!(&O
M;9"'P<CR7!'TSCB@#UC3=9TS689)M,U&UO8XW*.]O,L@5O0D'BHD\1Z))*L2
M:O8F1AE5^T+EAG&1SSSQQ7"-':2>+/B9:&[%G%+I=MYDL0R8_P!S*&? Y) Q
M^E4_#UUI7B.[\$>9J^AK-HUN5\B*]CDEG=H@@54Z@<;B#R" !GK0!ZE>W]GI
MMJ]U?74%K;I]Z6>0(H_$\57M==TB^U&?3K35+.>]@YEMXYU:1/JH.17-?%M$
M?X6:]N4-M@!&1G!WKS6=J^F6$WC/P-<:%';K<1M+(\EL!C[)Y1R6(ZJ6*@9[
MM]: .V?7=)CU%-/?4[1;QVV+ 9E#EL9V@9ZXYQUJ.3Q+H4-Q]GDUFP2;SE@\
MLW"!O,;HF,_>/IUKRSP]<Z%K/A2VT+Q%J]XNMV=X?.TL,B3M=+(6#(-NXY)W
M;LXY.3UKI?#%GIEW\2O'(DM[6:2.XLF4,BL4(A!R!V.X=?4>U '5Z-<B:75)
M/[=M]2B6Z.U8E0"T&T?NB5/)'7)YYJQ9:WI6HW#066I6EQ,J[S'%,K-M_O8!
MZ>_2O)-0%P_A#XFQ:2OF2+K.Z2*#[S18A\P #U4./SKJ?$$MMK?B#P+?:!/%
M+,+LRB2$@XLS&?,SCHI^0<]R!UH T?B#XI30_"NJOI^L6EKJUM 7C1RKMG&0
M-I[D=,C\*ZBQD>;3[:60Y=XE9CZD@5XQ_;%D_P %O%6F:K<0)K\<MW]MMYF
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MZ'\J2/7=)FU'^SX]3M'O3NQ LRESM^]@9R<=_2N'U5#%\5+B#2O*BNW\)S+
ML>%^<3#9^7:LSPO=^&/$.C^%[>?5KN35M-EA\O3 R)-!.@VOE0H;8/F)).".
MO- 'K=%9^F:YI>M-=KIM[#<M:3&"<1G)C<=0:T* "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4JL0IZ-@'I[]* )HM/LK>.2.&SMXTE.9%2)0'/N .:/[.L2H7[';[0<@>4N
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MVXDECM4>@ [Y-=#7'>/_ !A/X2M+.:UMC< 3+->X&?*M ZK(_P!<NH'XGL:
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M(C,K@9('.!WQU-<OX(\4->^%Y]1UK5+=]NHW%M'<'9&KJLA5 N.#D#CJ3[T
M=A#!#;J5ABCB4G)"*%&?PILUG:W,D<D]M#*\1S&TB!BA]03TJBWB30X]/74)
M-9T^.R9S&+A[E%3>.J[B<9]NM6I-2L(GMDDO;9'NCBW5I5!FXS\G/S<<\4 3
M/;PO,DSPQM+'D(Y4%ESUP>U,:RM7M3:M;0M;$8\DQ@IZ].E1W^JZ=I4:2:C?
MVMG&[;$:XF6,,WH"Q&334UC3)-2.FIJ5FU\%W&V$ZF7;Z[<YQ^% $S65J\21
M/;0M'&,(AC!"CV':A;*U242K;0K(.C", CC'6N2\3>)I8+_PY)I&K6SV=SJZ
MV-X(MD@(V.S MSM(VC(X-=-IFM:7K,,DVEZC:WL4;E'>WF60*WH2#0!9FMK>
MYV^?!%+MZ;T#8_.B6UM[BW-O-!%) 1@QN@*D?0\53MM?T>]GE@MM4LYI8D\Q
MT2=253^]UZ>_2HD\4^'Y)K2%-;TYI+PE;9%N4)F(8J=O//((X[B@#-\8>';S
M6]/TRTTU+.-+._@NRLS%%VQ-NV *IZ]/;WKH;2TM[. 1V]M#;J?F9(5"KGOT
M I]Q<0VEO)<7$JQ0QJ6=W. H'4DUY]KOCS^T/ 2Z_P"&M1BC9;R&-UPLC^6\
MXC&X'[FY?FY&: .^2RM(KI[J.UA2X<8>58P';ZGJ:5+2VCF,J6\2R'.75 "<
M]>:K6.MZ5J=S<VUAJ5I=3VQVSQPS*[1GT8 \=#^5)'KNDRZB-.CU*T:].[$
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MI%1_VWI/VV&R_M2R^USJ'B@^T)OD4\@JN<D>XJ>VO[.\DGCM;N"=X'\N98I
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MM6G42D8SD)G./PIT.K:;<V#WT&H6DMG'G?<),K1KCKE@<#% $@L;1;9+86L
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MW^H6UL=N_P#?2A<+ZG/0>]7597174AE89!'<4 +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %8OB?4M+TW2T&M)"VG74RVL_G@&,!\@%L\8SC.>F<]JVJ1D5\;E
M!P<C(Z=J /*K+15\%>/=%M?"6IR2Z3JKR?:](,OFQP(%)\Y#R5&<#GJ2!DYP
M*&GW>@ZEHFL>&?%>KW4&HIJ,YGT[*+)<,9C)&T7R[VSE,8/;TQ7KMMI]E9,[
M6EI! 9#ES%&%W?7 YIS6=L]TMTUM"UP@PLI0%U'H#UH \\TBUTAOBGXRBU&&
MT)^Q61VW(4_)Y;^83G_@.37-:=%_8OA+P))>2?9["/Q%(\#SMM$=NPF\LDGH
M""",]B*]!L?"]POC77-8U"WT^>SU!;<1(27>(PJP!P4QD[NQXQWKJI(8IDV2
MQI(N0=K*",CI0!Y;+K.DQ^+_ !5IGB76GTV#45BEMFE*)%<VK0JNU6=3T._C
M(Y8X[U+;V6EV?Q \$6EM&P@BTFY$"W7,NT&/RR<\YP.,\CVQ7I4]G;731M<6
MT,K1'=&9$#%#ZC/2A[6WDE$KV\32#HY0$_G0!Y)%%I__  AOQ68);9^V7PR
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M7/7![4 >'Z--IU[X)^%\<CV\Q34Q%(K$-C"2_*?S7CW%:/B-KI;[XJPZ,?\
M3#8V+!(3\Q&QA(0!WV9_2O6S86955-I 57[H,8P._'%/2UMXY3*D$2R'.75
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MZ/*@[3[CI4DFG6,S1M+96[M'C86B4E<=,<<59H **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3.PL;2TCC:5T!QOD>16[@X  Z=ZL?%_1M0U[X:ZG9Z9&\UP#'+Y*#+2*K@D
M=S@9QWQ4/@/QEX</@C1+&WOHC?06<5N^GIS<"15"L/+^]U!YQCOG% &]I$U_
MHNG7;^)]6CE/VQDMYY%2/=&<"-<* "Q.>!R2>!T%66\5Z!'ILNHR:Q9Q6D4I
MADDEE"!)!U0@X(;_ &3S7GVN7Y?XVVTFNN;?2M&TEKZUBD/RRS'"DJ/XG&[
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MR"S>=44@NO!VD@@@9; &>">*K_#F[UC4? FF:CKMT;B_O$-PS>6J (Q)0 *
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M2$U:'/SV@/)W?W0?ESZ-CJ#741Z,E]\0/#JZ;\OAOP?8MOO%^Y)*4P45APQ
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MI9L8#.WS.1ZC<3@]Z\\\/:ZBZ]\3/&,FXW-L'M;9=IRB1# !]-Q$>!W(;T-
M'J5IXN\/7\MM%::S9SO=2/%;B.4'S6098+ZX'I2W/BWP_:3O#<:O:1R)*(6#
M2#_6<?)GNW(XZC(]:\KTCP^GA?X'Q^)?L*R>(+>Q>YM;@KF2W$N>1]%<L<]R
M?2L/29;'4-8^&6@112FSMX?[4GD:)MUQ<'YC@$9($BD;NG7L,T >[ZIKVEZ1
MA+^_BMG:-I I/S;%'S/C^Z.Y/ [UR?PR\0ZGJO@B;Q%XDU%?*N+B1X'F5(EB
M@4[1D@ =0W)KRK5_%$_]G?$?49XIGUBZNQI2AXVVVMKN*A=V,#(R,=21FMW7
M)X](\1^ /#]Q>16&@6=B+A+B[A;R9KE0P4N,KG!"L,D??]Z /9],UO3=9^T#
M3KR*X-M)Y4RH>8V]"#R*P=9U.YF\;:+INE^)+"V,1>34--=0\T\>T$8X)7&#
MZ=>_2K'@S0]/TC3;FXLY+BXEU"X:YN;RY3:]PYZL!@87T&.GKG)X'1M9@D^*
MOCSQ-=*[+HUJ;2%-I^5(P2Y]LLG'<[^.] 'HC>-_"Z6MW='7K#[/:.(YY1,"
MJ.<X7/<\'@<\5N12QSQ)+$ZO&ZAE93D,#R"#7S+/HTL?PLTG[:KMJ/BS61))
M)Y18PQELDC )R=JMQU'':OHZ:YM]&\/R77EF*VL[4R>6>"J(F<?@!0!P&H>+
M=1O?C(?!S:K)HUA':"6)X8XS)=RD*0H:16  !;@#DH:TYO%3^!-'U&Z\:ZPE
MQ)]J<:>J1*DD\05=N$7JV2<GH/85P_Q$O_#?C;X=66OQW<,'BBW6(V\,+8N1
M,2-T6S[Q&<D>F,@X)S/XINK_ %34?AGX?U\.MP^W4-04KDR21H,+@=6)W@@=
MVH ],A\:Z ;>%KC5K&&=[,7CQ"X#>7'M!+$_W>>#QFK%KXL\/WQE%KK5C,8;
M?[5*(YU;RXL9WMSP,$'GUKSW3M)M_&OQA\5W.HVZW&E:?;Q:<(Y!\LAZL#Z@
M,&/U"GM5>]B31OCS'9:?91LMSX<6VAM]F8\;]H#?[ "#/L,=<"@#;^(GB^[C
MT/P^?"6JJ+O6KZ.WMIHD2170Y#-\P/0[?IFNXT_5]/U 3)9WT5R;9O+F*L#L
M8=0WH?:O$O$NE7Q\:1Z1X9;R4\':%+/$QBW9N'7/RCIO(*D>A'2G>)O$]Q>_
M!CPPD0GL[*_GAMM5NS$RC;C]X>Q(9LDGOR,G)H ]AB\6>'YKB>"/6+,O! ;B
M3]Z !$#@OGH5SQD<4^P\4:'JEQ;V]CJMK<37,330HD@)>-6VE@/3((S[&O,?
M$:Z5I7@OQ/XHL+S^T;ZZL4TVWN8(?+MXXF(010#)X Y)R>1UZBNU\#^"M/\
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M*\\\%67AU]%T76GU/^TDT+3WN5AMX2L=O*R[I7E))W2DYX)'J%[UP=QIL_\
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M@\$@D ]2*IVGQ TK4?'1\+6!>::&-WN9MC!$88P@XY)&3GI@=230!UM( !G
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MS58\ 0J=SR2$X!W@%<$X49XSS7=V/BO1-1OX[*UOU>XFA^T0J49?.CSC>A(
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M],X<=RF[@'N#BOH2B@#S&WL_"ZV=SK,R7NHPW-K%I(G^S-%%#;.0ACA0C<%
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M)&!G-=+I6HW#?$GQ?XCDTBZC_L?2OLVGV_V=OE14+^F <KC Y^?C(!->TT4
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MMI7CC9]B9W$D $]5''?FO2J* /'[O2CK_P 6K"-["ZCT3PUI 986B.)'9?\
M5CL?E*@@9^X167X7O[C0/@YXO\2WMM/;:EJ4TTS-+&4^>0[$"YP3@MG.,?-C
M/!Q[I7)ZWX,E\1WTB:MJ\EQHK7$-PNF^0J@&,'Y2XY9&8[B",\  B@#S?6]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0:%%9B:*!A )5E+%%..!@\=NW6LG5M'O/[?GU?P[;ZIIFO&_5)H1&YL[^(.
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MXURU[>+J5L8)'>8D[P.FTE2!CIMKKZHZ;I<>FHY\^XN;B3'F7%R^Z1\9P.
M ,G@ #D\<FKU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %<UXX\27/A?0!>VME)<R23Q0 J5 CWN%
MW')&>O &><9P.:Z6N2^)-A>:CX-ECL+62ZGBNK:?R8AEV5)D9MH[G /% &/J
MFH/9_%71[MK74-TVD7!-DK>8Q8.@ "AB@.,\Y ]372Z?XQTS4=#_ +4C2YC
MN39FUECQ,)PVWRMN2-V??'<G&:QIC=7/Q.T;5#IM]%:)ID\4CO 2(W=T*@D9
M&2%)]NAYKEY-"UF?P_JD]OH\L]Q:^*I=6CL;F(H+RW)(P-PQDJQ.#SQTZ4 >
MCZ7XFM-3UB\TAK>YL]2M$622VN0NXQMT=2K,K+VX/!ZXJ'6?&&GZ+K%MI,UO
M?37EU$\L,=O;E_,VXR >YY'3IU.!S5;PK+;WUQ)?6OA-]#3RO+9[JT2">1L@
M[0%).P8ZGJ2,=#67XGNUL_BKX1E>*:1/LE\&\F,R,O$?.U<DCZ T ;&E>.M'
MU72KN^475L]G.+:XM+F';/'*2 J%!G)8D 8)SF@^-K"&]O[&]L[ZSO;*U^VM
M;R1J[R0YP73RV8, >#SD5QNL^$]6U)?$VOV%@&FNM0LKNUL+E=GVE+8 '>I^
M[ORV >>!G&:U[6:+4](U*YL_!-QH[_8)86:>Q2.>21A@1QA,L5SG).!T]\ %
MFX\;Z+K7AB_N+C3-:_LA]-^TR3BV95>)A\RJZG[P&<\C&,YK9BUW3[+3]'M[
M2&YF>]MU:SM$(,K1J@))+-@8!&26ZD#))KG8[2\_X46=*-C=C4!HALOLQA;?
MYOE;,8QTSWZ57CL=2TS6O"7B(6-W-:0Z3_9M] D+&6W)"D/Y>-S#<N#@$XP1
MF@#J;;QCI$VG:G>3R26?]EN4OH;A<20-C(! )SD$8*DAL\9KF=2U"6Z^*_@X
M-9:C9>9#>,R7#C9(/*&,*KL 1DYS@\BLSQ%X1U?6XO%VM:;;NDU]+8O9VLP\
MMK@6V"2P/*[CD -@_*,XS6I<WU_KOC?P=JD/A[5X+>U6[%T;B 1^27C50#DC
MOWZ'MGG !=^+@*_#75)EEEC>(Q,K1R,G65 <X/(P3P:TK'QOIUYXC30Y;34;
M*[F1I+5KRV,272K]XQDG/ YP0#CM47Q(TN]UGP!JMAIUNUQ=2+&4B4@%MLBL
M0,D#. :J7]G)XL\3^'[V"UN[6TTOSII9KF!H7WO'L6-58 GJ23TX')S0!H7'
MC?3;5K.6:"[73KRX%M!J.U?(:0D@?Q;@"00&*[3US@@T_4/&>G:>NJ2>1=W,
M&E8%]-;HK+ 2 Q!RP+84@G:#@&N+\(V5QIUA:^&-3\""74K)A$NIM:1M:R(I
M^68R'G.WG;U)],\1:H[0ZWXNT^/2-?;3=4E$5RVG6:W*N3$HD9&W#8Q!VD%6
MQC/!.  =;>ZYH5_J7A:2XM]0,UW.[Z<VQXU#;&Y?D @KD@'/4'%%U\0M-MY-
M7BCT[5KF326'VM8;7E5*[MWS$<8YYY/8'FLG46CU*[\"W6CV%ZVGV5T_F#[,
MX-NBQO%M<$9!#?*1UX-)!;WB:G\0Y6T^]"7ZI]D/V=_WV+<1G;Q_>X_7I0!T
M%UXXTFVN-&A5+RX.L0M-9M!;EE=0F_\ ,C''OS@<U7E\6Z/J_A37I[RTU&&"
MQ$MOJ%J\96>,;,M]PG^$Y# _C7-Z997\4_PR\S3;Y1I=G+%?$VSX@8VXC /'
M=ACC/KTJ1K.^:U^)*C3K[.I!OL0^SO\ O\VXC&WC^\._UZ4 =$OB[1](MO#M
MC';Z@4U.V!L56%I#M6+>%8Y.6P .I.3SQS5BQ\:Z5=Z7JU]<+<Z>NDNR7L5Y
M&%DAPH;.%)!!!!&"<US(M;W[9\-W_LZ]VZ="XO#]G?\ <$VWE@-Q_>XX^O3F
MJ][9.T?Q*>^TJ[EM+Y8WMT93#]HVPJF%9A@'>..YXP#0!UR^,K-=8L-+N+#4
M;>ZOX_-ME>$,'7C<<HS;=N1G.,9K1UG6[70X+>2Y$CO<W"6MO%$ 6EE?HHR0
M!T)R2!Q7":+J<4GB'1;G7-.\11W5G#]BM+B[TSR85:3:I9V5F&]B%7/"\].:
MZ7QO<:M;V>FG3;2YN+=KU!??8T#3I!@Y*#J#G )'(!.,=0 5]5\>1VOAGQ!J
M-IIUT][HVY+BTEV*T;;0P8D,05P0?E)..V:Z'1;R;4-(MKFXMI8)9(U+++LR
M3@<_*2,&O,SH6JSV'Q&L;?0[Z :E"LEF9F4^8?("[=VXY8D'U]SFO1_#L\MQ
MH%DTUG<6CK"B&*X4*XPH!R,G'.: .>\127,'Q-\&+'>W*P7!O!+;B0B-ML&5
M)4<$@D\GUK8UWPS'XBF5;Z^OH[-(\)!:7#P9<DY=BI!; Q@=!SP<\9/B6*XD
M^(7A"ZBL[J6VLFNS<S1P,RQ^9%M3) YR?3..^*F\7:Y>VD\6FVNB:S=V\RDW
M-SI\(8JO]Q267#'N1T'3D@@ H>#M5O\ 2O =_=ZF]_JT5A>7,5I+&GFW%U;I
M(51L?Q$X//H,U-J>IR:Q\0])\-YFBL1IKZI=19*-+\PC1&QS@$DD=R!GI5^Q
MU^:/PS=7L'A;4[6&R41V^GM&BSR@ ?=0$@#G Y['CUJZEI]Q:^.]*\6QVL[P
M/8/87D:1EY(E+"1&VKDG# J<9QD'IF@!/!^I7$FL^*/#DT\L@TFZ06\K-N=8
M9DWJN3G.T[@"<\8]*3X<2W$EGX@CN;NXN3!KMW"CSR%V"*0%&3V J;PEI%Q:
M:GXC\07L+PRZO=K(D+#YUAC39'N Z,1DXZC('7(J+X?07-K'X@6ZM+FV:XUJ
MZNHO.A9-\3L"K#([^G7VH Z#6=;M=#@MY+D2.]S<):V\40!:65NBC) '0G)(
M'%,T77[;6Y+^"*&>WN;"?R+F"=5#(VT,/ND@@@@@@UF>-[C5K>TTTZ;:7-Q;
MM>H+[[&FZ=(,')0=0<X!(Y )QCJ,'PW]OT#5O&=Z?#FJ>1*\5U;1@*[S 0J-
MH.XEG)!SU]SF@#J=6\5V.CZU8:3/!>275^LC0"& L&V+N(SZ]/SYP.:RQ\1M
M/:PO[E=)UEI=.D9+VU%LOFVX4;BS?-MQ@Y&&)(S@<&H=:6ZO/'G@O4$T^\%O
M;QW37+>23Y!EB4*&(R,YR#C.._%4+6VO$D^(;-I]Z!J#%K3-L_[X>0(_EX_O
M#'Z]* ._LKR#4;"WOK63S+>YB6:)P/O(P!!_(U/7(^$;RZT_0/"NBSZ1?K)_
M9J1SS-%M2W>*-05?/.2<XQUK5T/Q!_;5SJ5N^FWEC+8S^65ND"^8O.UUP>5.
M#0!R'C*>WM/B=X6CO-2FL]/NH+LW*_;7@C<HB[,X8#()K?T:;01>ZAJ&E:M+
M/;6D7EW7^F/<0@X#Y!9F (7.<>H]*R?$R70^*'A?4HM.OI[.P@NEN9H;9G"&
M1 %' YZ=LXK8GU2]N)+_ /L71;A;DV<DOG7D#1)+*JXBCPV"22>3T 'OP 2:
M=XTL-1O=+MA:WD U6!KBPEF1=EPB@,<;6)4[2#A@./RJ:V\4V]Y+:_9[&]EM
MKJ:2&"Z4(8W9 Y/\6X#]VP!('./6N$L(-6N/$7@G5I="UEIK=+B/4);E0"LC
MQ!>%W82,-G& !CIDU:TO1[RS\1Z=J'AZWU33/M5VQUC2[B-_L@4ABTJ%AM#$
MXQM/.X<#!H W?#GC9M3T_6-0U.PGL;:RO9H SE& V,$V?*Q)<MG@ C)P">*O
MCQC9IJLVEWEE?V=\EL;N.&6-6,\8."4\MF!(/4'![XQ7$-X?URZ\(>*M$ATN
M5;T:S+J-L;@*(;E?/65%!SSN (]!WQ6]HEW#?H]W%X&GT:6"!Q-)/9(LA8C&
MR+9\S G^+ &![\ $\/Q-TF?2'U9--UDZ<MFUY]J^QDQE5."H8'&X=<=.#SP:
MOV7C;3[W6;#3?LFH0-J,+2V<\\ 6.?:H9E4YSD YY !'0FN8L=/U!/@%)HSZ
M=>+J8TR2T^RF%M_F$$ 8QTY'/2K5S;W<FN?#Z=;"],5@DOVMOL[_ +G=;^6-
MW'][C]>G- '2>--?F\,>$=1UBWM&NI;:(LJ J I[,V2/E!ZXR?:L[4M7TV6;
MPS_;-AJ,5W<7B_9 #@+-L;!<H^W!&XX)/TJWX_TZ[U?P!KEA8PF:ZFM76.,=
M6/7 ]ZPM>-[J8\%W$>D:B@M=2CN)T> EHHQ&REF SCEAQU]J -BX\=V,5]J]
ME!INJW=SI00W$4%MR0RE@5W$ C SSC.>,TR+XA:1/_9,L=O?FQU62.*WOC!B
M'S''RH23G)/&0",\9JCID=S;>-O&UY+8WBVUW%:BVD^SN1,8XF5@O'8D#W[<
M5SL6F:E'\,/!FG-I=]]LL-1M)+F$6[EHTCDW.3QTQZ=>W>@#O=6\66FDQ7TW
MV.]NX-.&;V6V1&6W^4,<[F!)"D,0H) (K9L[N"_LH+RUE66WGC66*1>C*PR"
M/P->:_9IM"\5ZW#J/@R?7;/5+K[79W=O:QRE2RJ&BDWD; "O!/'-==I^M-:Z
MW;>')M&FM"+,2I/#&!:[@!NC0_[.?0?AQ0!IZKJ]KI$,+W&]GGE6""&,9>61
MNBJ.F>"<D@  DD 5E-XUTZ#^U([NWO;6[TR#[3/:21!I##S^\786#+P>0>#U
MQ5+QSINHR7WAW7-/MY+LZ1?&6>UC^^\3J48J.[*#D#OS63KVF7.M:UJ_B"VL
M[P0)X>FTZ!'MW26XED). A ; X&2 ,MZ F@#>L?'NF7UYI$ L]1ABU>,/9W,
MT 6)VV;]F<YW8SVP<<$UI^)M8D\/^&M1U:.S>[:T@>;RD95R%!.221P,9.,G
MT!/%<0]G??V3\.(O[.OB^FR0F\46S_N0MN8SGC^\>WUZ5VGBZRN-2\&:Y8VD
M?F7-S83Q1)G&YF0@#\S0!Q.O:M/<KX U>[BO+>62_C$L8;(E!@9LA$9@<GIQ
MFNNT[QEIM]%JS3Q76GR:21]LBO(PKQJ5W*WRD@@CI@Y]JY2Y6_O+'P$W]C:E
M$=/NXGN5>W):-%A*%B!G'S'&.O&<8J#6/#^J:WJ?Q!M[6UFB.HV]G]BEFB*Q
MS/"I++DC&,X'/7/<4 =K;^*[637X-%NK.\L+RZA::U%RJ8G5?O;2K-@@')!P
M?:KVI:O!ILMI T<LUS>2&.""+;N<A2S?>(   )Y-<OX5N4U.]M93X$;1;NW!
M^T7%S:1QA&*D%86'S-DGK@#;GU%7O&VF6.KQ6%IJ-A?30&1G6\L _G6<@'RN
MI3+#J1P#VR,4 0Z]KVBW.D:=-JUCJ21R:I'!%$%*NEPLNU2Q5L;=PSU((Z9J
M_>^,=/T[7VT>\@N8)_LLEVDL@18I8T&6VL6Y(].HZG YKB[ZQ\1R>"M.M+]+
M[4IX->BEAE-N?.>TCE!$DH X; /7D\<9S6QXUTBX\6[XK:*:UFT95O;*ZDM2
M?-N.H49'*8&&'4EA_=Y +OB'QC=Z9I^A7%MHUZ3JM_!;[9?+5XU9LX*EOO,H
M( [=R,8.1)J;:9\6KR;[)J5PTV@Q2BRB/FN',S9 !;8O  /(''7GE^OW&K:_
MX8\-:HVA7T5Y9:O:W5[8B(^8@3<'*@_>'((QV_&KEL+H_%6XU673[V*T?1(X
M/,:!F E$K.4RN02 1TR,\ F@#IM!URS\1Z);:M8&3[/< [1(NUE()5E8=B""
M/PK)LM2;7O&NJ688_8=$$2% >);AQO)/J$7: /5B>H&*_P ,K6ZL/!L=I>VD
M]K<)=7#&.:,J</,[J>>O#"H/"%J^F>.O&=G,"#<7,-_"3_'&Z;21]&1A0!E'
MQI8:KK>JW6JWEU:^'=+NC91B&&4QS2C >2:1%(" D*H) /).>,2>+-*:>X\1
MRV.FR3B^\/1P6DMM 75W!F!4,HX.'C^H]@<)8Z/=Z+X7\4>%Y=-N+IKN:Z>Q
M>.(M'.DX.T,_1"I)!W8Z9&:[;P[ICZ+X:TO2I)?->SM(H&D_O%5"D_I0!B:=
MI+RZGXAM4^VVMM(\,UI,=X*2&/#.A;OD#([\Y!R:O^#-??Q)X:@O9U5+R-WM
M[I%Z+-&Q5L>Q(R/8BMXD $D@ =2:XKX6VDD/A:YOG4JNIZC<W\2G_GF[G8?Q
M !^AH Q--\1Q>&/$_C<R6>KZA%%>Q.5M8VG,*>0K%B6/ R3QG/7 XKL8/&6E
M75YHD%N9I8]:C>2RN$4>6P1=S \Y4@>HZ\5B::UYH/B[Q;+<:5?3+J$T4]D8
M(#(DX6%4*[APAW#'SE1WK%M_#6H^$+3P!(UE<7R:0]TMZME&9&C,Z-]U>I4,
M<9]* .T7QEIOE:L\L=Q"VEW"6TZ2*N3(^W8%PQ!SO4#D=><5%K&O6#:%KD>K
MZ=J4%M;6NZZCV@NT3JV2AC8]E;G(Q7*V]C<S-XV&K^%[ZXL-1OK=Q 5!,D16
M-&*[6R64 MQW7@YI$TG6+/PQXOTJWFU74=(ET\Q:6M["YN!*Z.&C&X!B@RF"
MPP,^QH Z?_A+M(TB+P]8);:@5U*VS9*L+2':L>X*QR<MC ZGD\\<U8T[QGIE
M_IVHW<D=U9'3IO(NK>ZCQ+&_&T84G.[<,8)SFN:^RWG]J?#F7^S[W9I\$BWA
M^SO^X+6_E@-Q_>XX^O3FLW4] U?5E\=)9V$HFN+^TO;);F(I'="$1DKEACDH
M1@^W:@#MQXST^'4[G3M1@NM-N8+1KW;=*F)(5^\RE&8'&.1P?:I5\56JQO-=
MV=Y96ZV3WWGSJA0Q)C<<HS<X8''6N=TVXBU*PN[J#X?/I\L-G*)4N[..-IF*
M']S'CE@QX+<#'UXSM,T>[T:>^AT:VU2\\-2:7.TFD:E&_P"ZFP-D,1<9(8;@
M0"5'KR* .[L-;%]>I:MI]Y;-)!]HC>8(5=,@<%6;GYAQ4NJ:Q;:2+995DEN+
MJ7R;>WA ,DKX)(&2!P 222  .37'^#]'N]%\2&#29=4_X1A[,L;34D<&TFW#
M:D1<;BN-V0,@8Z\BK/C6UU*U\3^&/$EE8SW]MICSQW=M;KNEV2H%WJO\6TCD
M#GF@#,T'6X-/\;^/M1U 7EG:V=M9RRQW3%VC 24MMPS#!Z@*<<UU5IXLM[K4
MFTTZ??07ILOMT4,JQYFBSC*E7(SD@8)!YKC9G\1_VSXXU71]"O!->6%J+%KJ
M%5#LBN&&UCDG#< CJ,''2K&D6UY_PL?2]6CT765M)M)DMY;B]P7$AD1LOEOE
M& >./88H Z>R\9Z?J'A23Q%!;7GV1'9/*9%$I97V$;=W7=Q@X/MR*Z 2 0B6
M0>4-NY@Y'R^N2#CCZUP-MH-U;?$B]L("AT*Y:/6IH\\I< E=N/1G59,^L9KL
M]:L&U70=1TY)?*>[MI(%D_NEE*Y_#- &1_PG&FK%8W4L%W%IM]*L5MJ#HODN
MS?<_BW*&[%E /'/(K$UJ^DU3XEP^'KW2KJZTL:5+*8,Q[7<RHGF_?'"C('\0
M)) [UF2Z9J>O?"ZR\%7&F7=KJD0MK29WB/DQI"Z9E67[K JF0 <Y.,=:WI([
MA?C!#??8KLV0T9K0W(@8H)3,K!<X]!G/3WH G\2Z@_P_^'5Q/80W5\;&#9$T
M\H=ESP&=F() )'3)Z#WK(\1:@\/C[P3?2V]_"TBWP>TW;V<B(;?D1F7/)Y]^
M2,<;OQ&TR\UCX>ZU86$#3W4L'[N)>KD,#@>^!65J+W>I>-?!6I+I6H16]L+L
MW!D@.81)$%3=C.,D=.W?% &YIWC+3-0TJ^OGCNK3[#<&UN;>YCQ*DO&%VJ3D
MMN7&"<Y%2V/BBUN]?DT.>UNK'4E@%RD-R$_>Q9QN4HS X/!&0?:N OM UC4K
M7QE]CTZ4W#ZO;ZC9Q7412.[6(1DKEACDH1@^W:NK\*SP:E>+=0>"Y-#:*,K+
M-=VD<4A8X^2/;R5ZDL<#@=<\ $'Q,!73]"E225&77+)?DD90P,HR" <'\:U-
M5\9V&E3ZG%]EO+K^RH4GOFMU0B!&!()W,"?E4G"@\"J/Q%MKJ[TS2([2TN+E
MXM7M;AUAB+E8XY S,<>@_/M6'XJ36]6N/%FG3:/J-Q!+I^W2?LZ[87)B.XR'
M(RX<X"MG&!@9Y(!VDOB2U$\,%G!<7\TUJ+Q8[?9D0DX#?.R]3T YXK&F\:7#
M^*-!TZTTF[>VU*R>]\PF,,5PN!@N,8W_ #9]L9YK NM'35=,T87FGZYI&IV>
MEQ"UU*RB<RQ2 $-$X3/'RJ<-V)Y4U9BM_$</B#P7JVK:;-<W2:;/;7IM54B.
M9_+(W<@ ':<D< _A0!W.M:O;Z#H]UJEVLS6]K&99!#&7;:!DG'TK"'Q TP7>
MGP2V.J1)J,1DLYVMLI,0N[8N"6W8]L'L35[QM#-<^!M<M;:"6>XN+&:&**)"
MS,[(0!@>YZUR]W;7CR?#UET^](L&#7>+9_W(\@Q_-Q_>./UZ4 =)I_C/3+VW
MU:6Y2YTUM(/^FQ7J!&B4KN#?*2"".1@T^/Q;:?VE8V-Y9WM@^H FS>Y10LQ
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MO?#4-]XGT_7GOKQ+BQCDCBA3R_+*OC=D%"QSM'>MNB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHKF/$'C:#09IT&CZOJ$=JH:[FLK<.EN,9^8EADX() S@$$T =/1573=1M-7
MTRVU&QF$UK<QB2*0?Q*1Q]/I5J@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *RM<NFM;"2WLXDDU"\#1V\79G(P6;_97@L?3CDD ZM<KJ7@=-2U
MF;5/^$BU^UFE4)LM;I8T51T51LX&>?K0!K^'=%A\.>'=/T>W8O'9P+$'/5B!
MRWXG)_&M.J.D:7'H^FQV4=Q<W.PL6GNI/,ED)))+-W//Y8%7J "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
@* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>ex19iiinsidertradingguid003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex19iiinsidertradingguid003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;B\M9L &6$MM(('&Y6X..H93ZUK7E]:Z=;FXO+B."($+OD; ))P /4D\ =Z
M+%%98\2Z)_9]Q?MJEHEK;N8YY))0@B<?PMG&T^QYI+3Q+HE_J9TVTU6TFO1'
MYA@24%]OKC\10!JT5QGQ"\4QZ/X3UAM/UB.TU2UA+(0%<J^,A3N! )'0'D]J
MZNPD>;3K620[G>%&8^I(% %BBLR3Q#H\.H1V$FHVZ7,DGE(C.!N?^X#TW?[/
M6J]UXQ\-V0G-SKEA&+=Q'+F=?D<_PGGKQT[4 ;=%5+G5+&TM8[F>ZB2&4@1/
MNSYA/("X^\2.@%<5H?B634)?&@N?$<<=E9S+%:7SB-5M@T0.>@!*L3PW<8-
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M_A R0/P!%=/Y:;MVQ=WKCFE(#*00"#P0>] '&ZS>VJ?!^XN&FCCAET7]VS,
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MY2<E5.,C;M X&3G%>TV-E#IUC#9VZE884"*"<GZGWJ4PQDL3&A+XW?*/F^M
M' 6-YIEQ\9]0N%GMF_XD4!5RPS_K')Z_[)!^A%<9H>IQ:?X2\ W\\JG0[/5K
MP7K*<I"S/*(&?'106SD\#(]J]S,<9))1<GOBD,,91D,:%&X92HP: //]!U33
M;SXQ:X]E>6TPGTJVVO$X82%6?.".#@8Z4GQ:O+6VM_"HGN8HBOB*SE;>X7"
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M#% '"_$JZMX'\)+-/%&?^$AM7P[@?* ^3]/>NG\1SQ1>%]4EDE1(_LDOSLP
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M58H.K8'5@O.0,C)Q@=ZY?P+XG-WX.;4]:U6.;-_/ ERVU1(!*RH%"@ D@#
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M]8'A75++_A:'B1FU:.[%Q86DB3X54D"^9N92!@H,@9R>H&2: *L?CMIO#/\
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M1M[F*V)6=XG#",CDAL="/2N,\.2:7J/Q6\8'-M.SV]@4# %B C$\'G@A<^A
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MI'M_/!Q]#6)8W5QI&LV#:3J-OK.@WVL/&=/F ^TZ?.SN79&!Y56WD@]!]<T
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MI3LAAW!@CYP 2<D \\&N(T?4DT[X:?#_ %6::8:197,JW\EL<M 6$B([ 9P
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M(Q1W+;0,XX)/'.* -GH,"F^7'C&Q<9ST[UDZAXJT72IIXKR]$9MPAN&$;NL
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M1;236I;:\8RM%81D8NAL.=XP3A0"1R.: -F4R")C"J-)CY0[%03[D _RKG?
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M<8(ST)K4HH Y.#P]J]\\2ZZ=$,,4B2YLK-ED=D8,OS,QVC(&< GW%=60&&"
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M,#:2,^E87A.[\.ZGH^B^'M4T_4V\1:6\*MITLEQB*:+Y1,.=@4#+9Z8. #D
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%>/0^.-0L_C=;QWY,>A:W:BWT\Y^4[78(_U9MV/]F1*[[Q9XPM/"HTZ%[>6
M[O\ 4K@6UG:Q$ R.2!DD\!1D9/N* .CHKQWPA>SGX_\ BE+B*2RA335=K5Y
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MEQICQ6=C.EJJB5"+8KY@);GYF8C^'(&!Z9H ](HKR#]H=FM?!6GWEN[0W/\
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M /%4?\*3\%?\^E[_ .!TO_Q5 ')Z)X+\3:;X+\>Z1)H;+-J4SM9K#/&4<-D
M*21@ >H'TSQ7I'P^L+W2/ &D:?J-H]O>6MOY<D3,K'()Z%20?SK#_P"%)^"O
M^?2]_P# Z7_XJC_A2?@K_GTO?_ Z7_XJ@#"\+:/XCT'XC^+M=N/#-[-9ZD6-
MLL<T&7^?(!!D&,BL;3?AGXGTOX8^++)[-6O]:EB:WTV"92L 5]Q)8D+T..#T
M4?AVW_"D_!7_ #Z7O_@=+_\ %4?\*3\%?\^E[_X'2_\ Q5 &3<:7XRCT[P+I
MMOHSR:=:6B1:I"MS'%)O5 NTODD)QD[?O#(/I6#I7PT\1S_#+Q5X;N;!;.[F
MU'[79DS(8YL;<*,'(!"GD@=1[X[3_A2?@K_GTO?_  .E_P#BJ/\ A2?@K_GT
MO?\ P.E_^*H M>';_P 37WA!K+5O#<]G=P6+0.SSQGSY NT; #WZDL0!VSU'
MF?A_X?\ C3POI&A:WIFFW/\ ;UA=217-@]U&8YK9SG@[]H]#[D'M7H7_  I/
MP5_SZ7O_ ('2_P#Q5'_"D_!7_/I>_P#@=+_\50!6DT+5-.^*P\:QZ9=3VE]I
MA@FMT*&6WE 7 (W8(.P#()&2<\<URK?"WQ!;? R[T585EUFXOQJ#VJR#Y?NK
ML#9P3M7/7VYKL_\ A2?@K_GTO?\ P.E_^*H_X4GX*_Y]+W_P.E_^*H Q]-T3
MQ'=?%W1O$ESH%Q::=%I0M7:2:)F1MK#YE#9')[9XQTY T? 7A_6_#GCOQ@]Y
MIK?8=5O?M4%XLJ;-F9&QC.[=\X&,>O/3,_\ PI/P5_SZ7O\ X'2__%4?\*3\
M%?\ /I>_^!TO_P 50!5^-OAW6O%?A:RTS0]-EO)TO5N'(D1%50CKU9ASEA7H
MMB[O80-)#)"^P!HY,;E/H<$C]:X3_A2?@K_GTO?_  .E_P#BJ/\ A2?@K_GT
MO?\ P.E_^*H YGPEX,U+P[?ZOH&J^#;;6;*XO&GL]1F\IHU4X'[P-\P P#@
MG.>.];]AX?UB'X\:CXADTR5=)FT\6L=SOCQO CYV[MP'RD=*G_X4GX*_Y]+W
M_P #I?\ XJC_ (4GX*_Y]+W_ ,#I?_BJ (-<T#6;GXY^'?$$&F2R:596;P3W
M >, ,RRCA2VX@;USQZURI\ >(=.\">)_!5MI\EP^I:FD]I>!U$1AW1DLY)RI
M CY&,Y/&:['_ (4GX*_Y]+W_ ,#I?_BJ/^%)^"O^?2]_\#I?_BJ ,>3P=K'A
M3XA^'==L+&?5M/M]*33;A8&02HR)M#8=@,'Y>_'/M4'A#PQKVG:=XV75_#/V
MA-6OO.CM6GC*SQF0[U!W @[6)!..@-;_ /PI/P5_SZ7O_@=+_P#%4?\ "D_!
M7_/I>_\ @=+_ /%4 97@CPKKO@R;Q0^BVUVVE- 'TS3]0D4,UQM)(X) &?ES
MQGCTS7:^!]<U77_#:W>M6$=EJ,<\L$\41RFY&*DKR>XQU/(-<_\ \*3\%?\
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M<^#?$[^%/A[9+H<YN-%O/.O4\V+Y%$@/!WX.1Z5V/_"D_!7_ #Z7O_@=+_\
M%4?\*3\%?\^E[_X'2_\ Q5 &5I_@_6;GQ_X[GN["6UT[7+)K:VNF=",E0N2
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M"V8VM[8[/,M91@*FUF&Y& ' Z8[=0O\ PI/P5_SZ7O\ X'2__%4?\*3\%?\
M/I>_^!TO_P 50!T?@:QUC3?!6E6>O3&74XH=L[%]Q')P"W<A< GVKH*S="T.
MQ\-Z/#I6FHZ6L)8HLDA<_,Q8\GD\DUI4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M++Q[+<R^'9+C0YK:PUU5$%RTZL5E:/S I0<X(! ;VZ"@#LV940N[!549))P
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M8V<KPQRK$I;$F27(ZGITR?;K6_#X^TZZT'1=1A\N.35T+V\5U,(E7:,OO?G
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M8&[G!4YQV]:[6@C(P>E 'D5M:ZI<Q:AY/A*;4]"O=2DO5CM-3A2WG DRKA'
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MI(ERR."IP,_Q>G;I5D^,=1-W-I:Z;9IK=O8I=2:?+>8:5F#$I$0IW8VXW>I
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M;:[#7V"RQ[=QC^3D\DX.T8QR3TZ.X\1-<ZU%HVEP17%RUH+R9IW*I%$QP@.
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MP7EM%<VTT<T$JAXY(V#*ZGH01P17G]KJNL:P_CJTU."S>TM"\"*LS-Y8$ 8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !61XBM;F\L8;>&PM=0MWF
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M1RW88X[GM6EJ/A_Q!=>*];U.Q:*S%YHHL+6?S<O%,"[!R .!ENH)/'2NYHH
M\YTSPQXBBUOPI?OIVF6L>FP3P721W3.S&14!ESL^9B5)P>?5N>-SP9HNJZ#_
M &K9WL=K]DDU"XNK>:.4L[K*^X KM&W&<=3G^?554M]3LKJ_N[&"ZBDNK/9]
MHB5LM%O&5W#MD<T <[K6E:Y-XVL-2M8;.]TR.U:+[/<S%!;S[\^< %.X[?E[
M$<X(R:D^'NBZGX=\(6VDZHMN);9Y K02%@ZM(S!CD#'WNG/3KS@=310!R$>E
M:SI/C;7=7M+."]MM5AMU0?:/+:%XE9?F!!RIW=1DC'0UEW7@C4;3PWH&G6/D
MW-Q::S'JMY*[^6KL)&D<*,'NV![#FO0Z* /.->\+>)=3N?%<0AL+B+5+3RK&
MZN)R'M5,>TQ!-IQEN<@CKDYQBG'P_P"*])UC3/$&EVVGW-T=-33]0T^2Y9%(
M0Y1TDV]1D@Y'TKT6B@#A/$WAG6/$4.@QW]M97:V]]]JOHO,Q'Y91T\I,C+8#
M=3C.">,X%:+P7K%UX0UGP7J4R/I+@QZ9>F7=-'&"&19%QSM(&"#R..*]$HH
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MW8*B@EF8X 'J: .871[W6/%FDZ]J5JED-+@F2& 2B1FEE"AF) QM"K@=SNY
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MOC%_ 5OX3:TTV4V$\'D7QNRJS11RJRY382IVK@\GIQFO4EWM$/,"JY7Y@IR
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MM$<95_-;Y7"Y . ,]10!W50W5W!8VTES<R".&,;G<@X4>I]JFJIJG_()O?\
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M^H01":6$ Y1"< D].O;-<AIGC^ZO_#.C3?9[==8U2_DL(UVL(E:-W#R%2=V
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M+,!@YZ-Z4 6I/%V@Q:-=:O)J,:6%K,\$TS*P"NAPRXQDG/H*V(Y%EC61#E&
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M<L0#D@  8X&>3GC+@\#ZBWA.'PA?WMM<:+"Z+YX#">2!'#K$R_=!X"E@>@Z
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MET\4DMG;1VY>+.'"*%!P>F<=*RY_#VI1>.I/$-A=VPBGL4M9H)HV+$H[,"K
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYM@Y+,D3!@N,DX)!QGH:O>(/"$WB6WU6/4)("[H$TR1&8&T(P0^?[^X*21U
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MFMRSQ,Z2HT0C+8!!!P <9Q[TJ>%/$FD>(-1N/#VM64.F:I.;FX@O+9I'@E8
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MGAG0$E3\I!##)Z?ISD Y^\UWQ1J4W@EKB--'N+N^ECNK26W9@72-R&^\I*$
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M+1J944Y"OCD#VSF@">BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]<I:V^V)F#2,< $@8'XD=#2ZIK$>C^'+K6;R)TCM;9KB2+(+#"Y*^F>U>?\
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M<MA@,C QG@GD:K>"_M.M^([N^O8Y[/7;6.UEME@*,B(K*"'W')PY[>E=91D
M@9Y- 'GX\!:[)I6C:7<^);>6WT:]AN;63[ ?,98L[5D/F8/&!D =,\UV>JV4
MNH:-=V,4RQ27$+1"5H]X7<,$[<C/7UJ[4=Q.EM;R3R;MD:EFV(6./8 $G\*
M../@>]_L;PMIPU> #0)HI5<V9_?>6A0 CS/EX)SUYJQ!X1O=*O-9_L;5(K>R
MU>5KB6&6W,C03,,.\9##[W!P0<$>G%;^C:Q9:_I%OJFG2&2TN%+1.5*[ADC.
M#R.E7J .0G\"K _AEM%OA8_V"DD,0DA\WS(W0*V>1AN,YY&>H-='JNGIJVC7
MVFRNR1W=O);LZ]0'4J2/?FKE% ')V?A&[:ST6QU;4(+JST=XY($@MS&97C7$
M;2$LW3K@8R0#TXJI#X)U?3-9OY-%\2M9:1J$[7-Q9M:K(\<C??,3D_+N]P<>
ME=O10!2U#2K74]%N=)N4)M+B!K=U!YV%<<'UQWKC/^$"UV32M%TRY\2V\MOH
MU[#<VLGV ^8RQ9VK(?,P>"!D =,\UZ!10!RO_"*7P\0:]JT>KI&VJ626J!+8
MAH"BL%<-OY(+$]!T'2H9_ Z:OJC7^MR6TTSZ?+I\K6D!A,Z28!9R6/0#Y1VR
M3D\8Z+^U[4:O+I>)OM,5N+EL0L5V$D<-C!.1T'-9;>.-!7PU<^(3<S?V;;R/
M%))]FDR&4[3E=NX<\9(% %/PUX6UO1DMK/4/$AU#3;(!;6$6HC<@#"B1\G=M
M'3 &2 3Z56'P\6YT/Q%I6I:B)H=8OGOP\,!B>WE.TC:2S9P44]N]=JCB2-77
M[K $4Z@#FX?#M[=ZCI5[KM_!=R:7N: 06YB#RLNWS'RS<XS@# !)//&*J^#K
MJ[O-$N-7OK>ZETB4RQ7,=L8YI?E*A68L?EYR?[Q Z5UU% '#:+X%U;09&TZS
M\2N/#?FM)'8FV!EC4G)B67/"9)[9P>".M./@?4;.[UY-(UF&WTS6VDFN+:>U
M,C13.N'>-@XQNZD$'&*[>J4FJVT6LP:4WF_:9H6F3$3%-JD Y;& >1QF@"OX
M:TB70?#>GZ3+="Z-G D E$>S<J@ <9/8>M8H\#+)>>)([F_$NDZZ2\UH(<.C
MF,(2),]. 0-H(..?7KZ* .1MO"%[+9:1IVL:G%>V6E31S1;;<I),T8Q'YAW$
M<<$X') Z<@ZWBG0AXF\,:AHIN7MOM<6SSD&2IR#T[CCD=QFMBB@#C[;PGK">
M*+37[C7H)+J*P:RDC2QV1L"P8%1O)'*C/)SSC;VHI\/+Q/ EEX8&M08M;M;D
M7!LCEL3>:!M\S^]QG/2N^HH X'Q4NB>,M0L?#D=X)M5LKU'N1;Y5H(PI\W=Z
M*Z$IC/5QZ5O>)/#']M7&EW]I="SU/2IC+:3F/>N&&UT9<C*L.#@@\"MU8HTD
M>18T5WQO8#!;'3)[T^@#E;CPE/>_VS=W-[#_ &IJ5C]@$RP'RX(<-PJ[LDY<
MDDGGC@8JNW@J]-CX4MAJT _X1]HV5OL9_?[(S&,_O/E^4^_-=E10!Q$'@C5]
M,UF_?1?$KV6CZA<-<SV;6JR/'(W+F)R?EW>X.*UK6+68?&DRB^$NA?9 JVIM
M]OV>4;<?O.KEAO)'; ]1GH:"0,9/7I0!S_BWP[/XEL;.VAOH[3[/>1799X#+
MN,;!@/O+CD<TR+PY>Q>-+OQ$-1@/GV*68@^RGY=K%@V[?SRQXQT_.NCHH \]
M3X:7$/A?2]/@USRM4TF[DN['4([7&TNS,RLA8[E.XCJ. /?.O>^%M4U7PIJF
MF:CK:37VI0^1)<K:[8XTP1A(PWN3DL22?0 #JZ* .1U'PEJ,\OAR]L]5MX=2
MT9'B$DEH7BE1T"ME-X(/RJ1\U9\GPU:[TO7[*]UF23^U+T7\4R0!'MYE"X8$
M'!^X.,#C/UKOJ* ..B\*Z[<>(M$UK5-=M)I],BFB*06)C$HD"@DYD.#\N>..
MF!ZUI? %Y+X;\3:.VLP8UV\DNFE%F?W._;N4#S.?NC!XKNJ* .7N?#%[<>(/
M#^KOJ4 _L>*6,Q+:-^^\Q0K'._Y>%&.#^-<#IEX+R:?6K/Q?X;CN9[N29;;4
M].1KR([B%C8AP^X+A0 ,CH,U[-4/V2V%Q]H^SQ>?T\W8-WY]: (M.DN+O2+6
M2_MUBN9H$:>$<A&*C<O/8'(KDK;P#/:^')_"JZHC>'I7;;&83Y\<+-N:$/NQ
MCJ-VW(!QZ&NXJEINJVVJBZ-MYO\ HUP]M)YD3)\Z]<9 R.>HX- &/-X7G7QG
M#K]AJ"6R"P6QEMC;[PR*Y==K;AMY.#P>.F#S6-+\/+R7P/JWAIM:@QJ-V]RU
MP+(Y3?)YA4+YG/(P#GI7?44 <;J?@_5V\1_V_H6OIIM]<0)!?H]IYL-P%^ZV
MTL"K#) Y/'XYGN/"5Y+K?A[4EU<,VD>>S>=;[VN&E7#DD, O4D # ^G%=%?W
M\&FZ=<WT^\PVT;22>6A=L 9. .2:EMYTNK:*XCW>7*@==RE3@C(R#R#[&@![
M#<C+ZC%<>?"NNR>%/^$;N-<M9K-[;[))<M9'SS%MVD#Y]N[' 8CWP378T4 <
MM=^#F&K>'[W2K\60TBV>S$;P^;OA8*, Y&&&P8)R/4&IM!T"?P]J&NZA=:C#
M-#J-P;ME6W,?E$*%ZESD84=A71,P52S$!0,DGH*Q;'Q9I.H:I!I\$LWG7,!N
M+9G@=4N(QC+(Q&&'(_ @]* .?TN'1/%?CV/Q3I%Q]IMK6S\J2:,GRI9B2$^K
M(C29]/,6K6L>!%UWQ%J&H7]U!+:7FFC3C:FV.5 <NKA]_P!X,<]!T%==%%'#
M&(XHUC0=%08 _"GT </=^!M4O_#FF6EUXD9M9TJ59;+54M=K@@%<2*6(<$'!
MY&>_?,NI^#M8USPEJ.E:KX@CEO+]%B>X6SVQQ(ISA(PXY)ZL2<_@*[.B@"*V
M2:.VC2>1))54!G1"H8^H!)Q^9KD+KP;J]MXGO=7\.^(1IL6HE6O;66T$ZLZC
M;YB9(VM@>X/?/2NTR!C)Z]*S-)U_3];DOH["21VL9_L\X>)HRLF 2,, >A%
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M"_M=*T^>_OIU@M8$+RRMT51WH XW1?%&IZSX7TK;-'%KL]\;.\C,0(A>,DS
MKG@!5.#GJR>M6+;6M8\1Q^()]%NH;;^R[N6RMXI(=XGEC4%C(<Y"ECM&W!&,
MY.<!OA33M,OO%6L^*],=I+.\"1P,"?+D?:/-E0>C;8U)[F,U:@\)WVDZGK$^
MB:G%;6NK2FXFAFMS(89R,-)&0P^]P2"#R/PH R=)\=7>MW_@FXME2.RUZ"Y:
MX@=,M&\29^5O3=GJ.@'2MOPMK-_J6K>)+*]>.1=-OQ;PNJ;24,:M\W/)^;VJ
MG<^!/LMOX:'A^]CL9M WI;FXA,R2(Z;7# ,IR>N01S5[PUX9NM!U36KR?4_M
M@U.X6X*F (48(%Z@\CCICCWH @U/5]3T[Q[I6GRW$:Z3JD$R1$1?.ER@#!2V
M<8*[B!CJM8^@>+M4U?1M2@:[@.LPZFMG 5M\(\;$-'*%)R5,>Y^O13BNF\5^
M&H?%.E0V<D\EN\-U%<Q3Q<.A5N<'L2I9<_[511>$+*W\9CQ#"3&19K;?9U&$
MW+D+)]0C,@]B: (+36=3_P"%DW>@7$L#V4>EQWD92(J^YI"AW')S]T] .M<'
M)_R0OQC_ -?M_P#^CS7H:>'+I/'5QXD%_"5EL%LA;?9SE0KEPV[?R<L>W2L?
M_A7]X? VK^&FUB$C49Y9C<"S(\L2/O8;?,YYZ'/YT =G;;C81!" WE#!(R <
M>E>?Z-XF\23Z3J/B'4;RP_L[2+B^2YMH;9@\Z0[MI5BQVG*CCGOSSQZ!;130
MV,44DD;S(@4NJ%5) Z[<G\LUSN@>$#IFA:MI&HW<5];:C/<2R!(#%@3$EU^\
MV1R<4 4+/5_%<FHZ+<+9/<V%X/\ 3D:)(UM@RY5XVWY8 \$')(Y&*=IFL>(_
M$>A:?XBT:2T,-S<Y%C,N%^R[RI)?KYF!N].V#U,OAOPEKFBBWLKSQ.]_I%GC
M[- ;4)*57[BR2 _,%XZ 9P,\<5!HO@74]"DDTZS\1,OAMIFE2P-L/-C#'<8U
MESPA)/;."<$'F@"*^\2>(=3CUF7P[ [2Z==/:P0^0CQW#QXWAV+ KDY QC'!
MR<X%U=?UEO'.D:5.D-M;7VE27<D&S,L,JE 5+Y(."QZ ?C43>"]7L?$5_?:!
MXD.G6.I2^?=VCVBS8E( 9XR3\I..X(SZ\"M!_"\__"7Z9K<5^BP6-DUFMN\)
M=G5BI),F_K\H[>M &3IOB;5Q;^)]/U":%M9TVZ6&U6.':LBR@?9VQD_>)P>>
M,&K-WK>JW&LWNAV,LHGT^UA>:YAMD<O+(&(^5F "X7/<G/48YTKKPI;7/C:S
M\2^:RRP6S0/"/NRG.49O]W+X_P!X>E4-;\(:E-XG'B'P]K@TN]EA6WNTEMA/
M%<(I)4E<C##)YS_7(!L>&+S5K_P[9W&NV L-492+B!6# ,"1D8)X( .,\9Q7
M(^)?%NLZ''J%Z]Q;![748HH["*/S5:V=T4-*XYC=MS$9(' &#7=Z=:/8V,<$
MMS)<RC+232  R,3DG X R> . ,#M7#WWPXU"ZTK6]*C\0K'9:A?_ -H1AK,-
M)'(9%D*LV_YERO& #TYP,$ [G49Y[;3+N>U@^T7$4+O%"#_K'"DA?Q.!7"Z3
MX]BGTB^UC^U4O(M/TZ6>^T^2$0W,$ZX.W;U"_>'.><?,:[>ZM+FXT:>S6\:.
MZDMVC%TJ8*N5(W@#T/.,USDW@=-6U5M0UN2VFF?3Y=/E-I 83.DF Q<EB> .
M!VR>3Q@ @MM4\6MJNE.EHUQ8W:$7A>!$6U)7*NA#Y9<\$')QSD5SW_"4^-YO
M!5]XGAN=**Z9<7 FM/LS?Z1'%(0WS;ODPHX'/3D\X'3^&_"NNZ,+>TU#Q.VH
M:79X%M#]E$<A ^Z)),G<%XZ 9(&?2N;\$Z3=^(? VJ:;_:,":;=ZE>1S!(B9
M1&9FW*K;L?,.Y'&>_% &QK7B?4Q:SWUK=0V=J=*6]L8UC\^:>0J6.]!DK&HV
M@D8^]]ZH9_%7B"^N/!"Z?+8VR^(;-YI1) S^4X@$F0=PR 6Z<=.O-7[KP-<M
MK&JW%AJZVECJEC'9SVYM1(T81&5?+8MA1ACD$'O]1'9>!M1M)?";MK<$A\/0
MO"H-D1YRM&(^S_+A0/7GGIQ0!'JNJ^(]*@DAO=2LXYH--\Z.2VM_,>ZN!NW9
MBY*Q@!<D8^]U'2LNZU?5M<U3X;7L5\+-=3BEN)($BW()/LK-GDY(^8@#MUYK
MH=0\'WMSXDU/4K361;V^J6:6ES"]L)'4*& ,;%@%^\<@@_X5(/ 5];:;X6CB
MUQ!>^'R5CF:SRCQF/RRNS?P=O?)Y[=@ 1WWB/Q!J2ZVWAZ%VFTVX:V@C\A'2
MXD15+!V+ J"3M&,8ZY.<#LK6[E;2(;R^MS:S&!99X20QB;;EER.N.1^%<J_@
MO6+'Q%>ZAH'B0Z?:ZDXEO+66T6;][@ R1DD!6('/!&>QX%=?#;1PV<=J-SQI
M&(_WAW%@!CD]S0!R.E:IXEUW2-&\0:<]H;>]G5YK&5<".U8GD/U,@&#Z'D8I
ML.O:SX@L->U#1KF"W&FW4UK:P20[UN&B W&0YR S9 VXP.>>E)X?\#ZIX?QI
MD/B-W\.12F2&R-L/.52V[RC+GE,^V2.,BK,'A"]TNZUD:/JD5O8ZO*UQ+#+;
MF1H)G&'>,AAUZX(.#^5 &1!XVU;6KWP:^EM:6]IK]M<22)-"7:)XT!/(8;AD
MGC SCKS44>N>+IK#Q5 -3L%N= E?;<_8R?M*^4)%4KNPG7!(SU[8YW!X(%KJ
MGAB?3KN.WL] AEABMW@+M*'0(27W#!P,].I-)#X/OHO^$I/]JVY.O$G_ (]#
M^X)C$?\ ST^;Y1[<_E0!G1^*M>U+5_"<-I)96\&N:4]XX>!G:)PB-UW?,/GX
M''3DFJ(\1>+I/#GBB==1T];GP[<3H939D_:Q&@D *[L)P<'&?PQSM:;X)O;#
M4/#-RVK6\BZ'8M9*@LRIF5E522?,.#A!V/>EC\%7R:7XILCJUN?[?EED9Q9D
M>3YB!" /,^;@#TYH (?$]_/XI\,6RF-;+6=-ENY(RF6C950C#>GS]QVK$U+Q
MGX@M/!GB_489K0W6C:H]I"SVY(>(>6!D!A\WSGGIQTK<F\&ZBI\-7-CJ]O%J
M&B6[6OF26A>.:-E53E X(/R CYNM4;CX<WMQX=\1Z0=>4KK=Z;MY7L\M&24R
M.& .=@],<\4 7XM7UVQ\?V>CZA<VEQ:ZE933Q+% 4-N\97C.X[P0W4XY';I6
M;:>-]3AT#5I[P6LM_%X@;1K39&4BR75%9ADG R6//;&:W[GPY?77B[2M>?4;
M<&QMY8#"+4_O/,V[CG?Q]T8X-9)^'7VGP[KFDWVJ;_[2U%]2BGMX#&]M,S!@
M1ECG!4>G&: -9O\ A*K"\U':UIJ%F+$RVKRXB?[4,_NVQQY9X.>H]^M8ND^)
M]2E\5Z=I#W\-Y'?Z;).TR6^$BG0KGRV&!(GS'N>GWJO'PEK.IZ!J&G^(/$9N
MY;FT>UCEMK80+&&'+E<G<QP.X&,@ 9-1V?@W5H]<T/5;O7HI9=,MGM7CBL1&
MLD;;>GS':?EY/(] M '/^']5UZP^%NOZXNI17%W;37TRFYM]V3'(^<X8=<<#
MH/2NC3Q+>7^K:%H5O*L-U>:9_:-U<; 2J#:H" \9+,>3D  \<\10^!+V#PMK
MGA^/6H_LFHM<>26M,M"LQ);)W_.1N.#\ON#VL3>#;A9]!U*TU&*+5])M_LIF
M,!,5S"0 49-V1T!!#<'UH P=5\;:[INC>,;3?:'5O#PCE2X: E)X9%W(=H88
M<<@]LCI6O%K6O6/C;1-/U"YM+BSUFUGD6** H;=XE5OO$G>"&QR!SS@=*=JG
M@5]4T;Q! ^H1IJ.N[%NKH6Y*HB*%5$3=T !Y)/))]A<N/#%]<^(O#^K/J5N#
MI$4L9B%J?WWF*JL<[_E^Z,=: +/C99SX(ULV\_DNMC.Q;9NR!&V1[?6N/75=
M=T#P#X*DLKJSE:]FT^S*S6Y&V.15& 0WMR<'KVKO=>TZ;6-!O]-AN$MVNX'@
M,KQF0*&4J3C(R>?6N=O/!=_=>'/#VDC5[=&T:XMIUF^QD^;Y  4%?,XSCGG\
MJ &VVJZ[_P )/%X4NM2MGO1:2:A/>P6VS$/F;(T5&) ;.<DYX&.IS6)JWCK7
MM.\,^+4#68UGP[-&K3& F.>*3!1MN[Y6VGGJ,CISQUFJ^&9KGQ)8>(].O([;
M5+:!K67S(B\5Q"QSL8!@1AN00>.^:SM6\ OJGA[7;$ZC''?ZY*DEY=_9RP 7
M:%5$W#  4 9)ZD]Z ([[5/$]CXVT[1_MVGO#J]M.\9-JW^B-%M)Q\W[S(;'.
M.>>.E:'@K6=1U)=:LM5EBGNM+U%[3[1%'Y8E4*K*Q7)P?FQQZ5+>>'+Z]\5Z
M+KCZC;J=-BFC,(M3^]\P*&.=_P OW1C@_C3_  WX=N="O]:N9KZ*Y&IWANRJ
M0&/RV*A<9+'(PH]* ,;77U-OBMX>MH=2,5J]E<RB'R@RAEV D\\DAB,]NW4U
MS\5SK>GCXBZEI%W:VYL=0DNF6: RF8I C%.HVC Z\GGMCGN-9\-W&H>)M(UN
MSU$6DUC'+"ZM!Y@DCDVYQR-K#;P>1[&LY?!-\+#Q7:G5K<_\) \C,WV0_N-\
M8C./WGS?*/;F@!'\5W>IWNGZ?8QS0R7&EQZE,\,2RL@D.$4!B!C(;).>@]<C
M8\)WFN7FB!O$-BMIJ$<KQG;@"50?ED !.W([9ZYK!NO >I(=%OM(UY;'6=-L
MEL'N/LN^*Y@&/E>,MQR,\'KGVQUFDV5Q8V02[O7O;IV+S3L@0,W3A1PH   '
MMR2<D@'$?#Z5M2\;^.M1N_FNXM1%C'NZQP1@[ /0'K[GFNM\07-CHEC=>);F
M'?)IUG,05X9D.UBOXE%K-NO"=S;>)KCQ!X?U".QN[Q%2^MYX#+!<[>%8@,I5
MP.,@_A6A+HDNJV-U;:[<1W,=S ]NT-O&8HU1AAC@LQ+>Y/'8#G(!SFH^)-:T
M+1]#\07DT%S9WLL$=[;)%M\A9L8:-LY.TD ALY]J6SU/Q9JWB[7M+MM0TVW@
MTJ[M@&:T9C)&Z!V7&_@X/7/..@JW:^#+QM*TO1M4U2.\TS398Y(@+<I+,(N8
MUD;<00,#. -VT=.<W]&\.W6E>)M=U>6_AF357B<PK;E#$8T"#YMYSP.>.M '
M'?\ "2^-[KPMK6NVMUI0.C7ETCVQM6_TF.%B&YW_ "?*#CJ2>];^F^*I_%6L
M)8:7-]AB33(+^:4H'?=,,H@!XP ,DXYR ,5@^#M,O==\.>)].BU*"*PO-9OH
MI2L6Z54:0A@K;L?,IX)'&<\UU#^#S8^(;?6M!N8K.5+-;&:WEB,D4L2_<Z,"
M&7IGGCB@#F;OQYKZ>&+N6-;)-5TS6DTN[S$WES R*H=/F^3(8'G=CFNANKCQ
M+I9M(M1U6P,$]W+YMW#!LD2/9F...,EM[ELCOP.F>:@U#P ]UH$MA;ZE'#<W
M.I+J=W<O;%_,E#A@ H<;5^51C)X'KS6CKGAN_P!2UO1=8LM4BM;S31*C+);&
M6*19% ;Y=X*GC@Y_.@#A]:\2:SK/PTNK@W@MY[;6QI\KQP;#.BW"H,J>4R",
MCVQP,BNNO=:U(Z[)X?M99C/;6:7$]U!;(S%G9@@"LV !L)/7.1TJ@?AS<-X:
MUG1VUTM]NU(ZC!,UJN87\T2?, 1OY';:/:K>K>#M7N-8L]>TKQ MEK4=O]FN
MI&M \-S'N+ &/=Q@DX.2<<$GK0!L^%;S6K[0()?$%@MEJ8+)+&A&UL'AQ@G
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MY &PL"K80Y;)P>0/6LV_\0:G;V'A"YLM:M[VWU'5DM9KB*)2)XF,A!!Z*<*
M0!G.>: .^#J7*!AN !*YY .<']#^5+7G^B6]]/\ %#QDAUJ^"0PV01<1$!62
M4A1E#@*22,=<\YJA;>+M<G^&OA77FO0+V]O[>"YQ$FV1'F*$8QQQZ8H ]/I"
MZA@I8!FZ GDUYWXS\0ZUI$/B*ZMM45'L(8YK.UM85E 4*"QN"RG9N.0 &7('
M&33[DWE[\6-$8:G=PPRZ++<"!!&44[XL@94]>Y//'!% ':V>I)>WM]:K;743
M6<BQM)-$523*ALH?XAS@GUJ[7G%QXVU+0[7QY>7\B7:Z)-&MI&(P@^>-2H..
M2-SC))Z5?UC5=9\+7OAVYN-1;4+34KV/3[J)X47RWD!VR1E5! ##!#%N"._-
M '<45Y;/K?BR;1?&U['KL<+:#=S^0$LT/F+'$K[&W9^4Y//WLGKVKT?2KQM0
MTBRO64*UQ!'*5'0%E!Q^M %NBBB@!&571D=0RL,$$9!%106EM:AA;V\4(;KY
M:!<_E4U% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %(RJZE6 *D8((X(I:* (
M8+2VM=WV>WBAW?>\M N?KBIJ** "BBB@ HHHH **** "BBB@ HHHH **** "
MF211S "2-7 (8!AG!'0T^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/B72HK 7GV1([B.?<(MY)C8,HZC R!FMVB@#FM6\,7>KPZI:3:I&;#4XA'/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ J*YN8+*UENKJ9(8(E+R22-M55'4D]A4M>5?M!37D7PT"VQ8127L27.W_G
MGAB,^VX)^E '7:=XVM]8M&OM*T?5KW3@2%O(X45),'!**[AV'T4TRZ^(6A6O
MA"Z\3YNY=.MY3"VV B0L&"D;6P1ACCG'2G:-?VF@_#33+]89)+*UTN*5A  2
M(UB#%L$C/ )]:XGQ9XT@O/A'J?B7PD;O3P+M")F15\UVD57^7)]><@<\T =W
MJOC;2=)BTHR_:);C51NL[:*/][(-H8G#$ 8!'4CKBKFA>)=.\065I<VC2QM=
M0M.D$Z%)0BMM)*]N>/?MFO(O%,,]_P#$7X:3S:A=B:\M@[.K*#&VQ<E>.,GD
MYS6CX;MKBZ_:%\4I)JE\1:V\3)^\7YE_=MY9X^YECP,?6@#V.BO&?!WC/4Y?
M'*:!XHN[_3]<6\E8PR$&VO(BK[$08^3&05(X;;R22*]FH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ KE_&VKZ=8Z8MAJF@ZIK%I?JZ216-F9P ,?>P1MZ\'U'
MM7444 >)0:Q#9^'I_#UI8^/4T>6)X!!+HJR/%&P(*(YYQ@G&<XJ"9O#C^ 1X
M-A\.>/8=-\P2.ZZ7F5SNW<D@CJ!T KW2B@#P^YOM*N]4\/ZC)H_C_P _0HQ'
M:XTA<$  9<8Y) '3%6X];T>#QS<^*[;P_P"/(+J[C6.Y@32_W<NW;C.?F'W5
MZ$9QZ$@^RT4 >/:-<:9J'B7P\+K2?&4S:<Y2R>_TI8TA+<9>0 ':O;/3OFO8
M:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5K#P[<V,M\T][_PDYT&VOID4NJ,PQ(P "E@I;M@D#(H [M_$5O'XNA\.-;7
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MF.(HGCCCC!,2$+@9)SG&0,@<\T =U6/+XBMXO%MOX=:VN!<3VSW*387RRJD
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MUC5[F[@L[A+E(UBCBWR(<J7(&3]!MJVWAN-O& \2?;KD7(LS9"$!/+\O=O\
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M-/U:T4I#>VI7?L/5&# JZGT(^F*M:IK<6E6MF\\3?:+V=+:"#<,M*P)VD]
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M:9:7JH4%Q"DH4G.W< <?K0!SMQX#LM1\/7&EZKJ%_?S3LDC7\L@$R.ARA0@
M+M.< #N<YR:=:>#7BU^PUJ\U[4;V]LX'MU,BQ*KHQ!(8*@]!SU]ZT_$VNKX:
M\.WNL/:374=K&9'CB*@X'?YB./S/M6C;3"YM89PNT2(KX],C- &;XF\/Q>*-
M!N='N+J>WM[E=DK0;=Q7(.,L#CI5W3K,Z?I\%H9Y)Q"@C$D@4,0!@9P /TJU
M10!QH^'EK#K-Y=V6L:I9V5]*9KS38)0(97/WCTW+N[[2,^U:UGX9BLO%5]KZ
M7URTMY$D,EN0GE!4SMQA<C&3W[UN57:[1DNOL^)Y;<E7B1AG?M#!>> 2&7KZ
MB@#"?P?'<>7#>:C<W5E%?_VA'!*J?+)O,@4,!G8&/ Z]LXXJ/_A"+>%]5CLM
M1N[2PU5VDN[2+9M+L,.R$C*;AUQ^&#6_IUS/>:;;7-S9O9SRQAI+>1@S1$]5
M)'!Q5J@#GW\)6O\ ;^EZK!=3V_\ 9ELUK;VT03RA&P (.5S_  KW[5+X?\-Q
M>'I-2>*]N;C^T+M[R43!/ED; .W:HXX'!S6W10!SFK>$8K_Q#;Z_9:C=Z9J<
M4/V=YK8(PFBSG8ZNI!P>0<<?E5 ?#JP_X1[5M'?4M0DCU&]:_,K,F^&8N'#(
M0OJ!UST]Z[*B@#E[7P:8/$$>NRZYJ,^HK9&S:1Q$%=2V[)4)@<@8  Z<YR:L
M:'X4BT#PJ?#]KJ%V]N%D5)90AD0.23C"@'ECU!KH** .03P!:QZ-H.F+JM^(
M=$N$N+9L1;F900H;Y.0 Q'&*;K6A/I/_  D?B.T?4;Z^O;(0M9P; 2%!"[,+
MN!&XGJ3^E=C10!Y5H2W""SA\/>,-=O)(?+3['>:8%C"# (D8Q*4 &?XL\<9/
M7O\ Q+X?MO$^AS:7=2S0H[(ZRP, \;HP96&01P0*UJ* .;L/""67B8:_)J^H
MW5ZUH+6;S60)* Q()"J,8R>%P/8G)JYXA\/0>(8+-9+F>VFLKI+RVFAVY250
M0"0P((PQX(K8J!;J.:T^TVI%RA4LGDLIW_0DX_6@#-M?#Z07-W?2W<TVI74(
M@:[95!CC&2%1<8 R2>AR3SGC&)#\.;2UT?1+&UU?48)=%E:2RNE\LR*&!#*0
M4VL""1R*V_"OB"/Q3X<MM9BMI+9)VD BD(++LD9.<<?PYK9H XYOAOI,UEKE
ME=7=_<V^KRB>59)1F.4!?WB$#.[**><@8P!C(-JQ\'O;Z=<V]WK^J:A/- UL
MMS<LA>*,]0H"XR<#+$$G KIZ* ./M_A[:6;Z%+:ZI?P7.C0&VAG3R]TL/'[N
M3Y,,HQZ#DYZU:_X0Z*#4-3N=.U*[L8]4.Z\AB"%6?&#(NY3L8CJ1UZXSS734
M4 <SJ'@JSN(]$_LZZN-*ET4%+.2U"-L1E",A#A@00!U'49JNOP]T_P#L[Q!8
MS7]_-!KC%K@22*2K%0NY3MSG@=<CVKI=1NSI^G7-X())_(C,GE1E0S #.!N(
M'ZU6\/ZPGB#P]I^KQQ-"EY LRQL<E0PS@F@";3;-M-TZ.WFO9[MHU^:XN"NY
ML=SM  _ #\^:\]\':4=9@\7VC:G<0VEYK=V9((U4&2)B/F1B,@,,C(STXP>:
M].JDUY=#6H[(:?*;1H#*;W>NQ7# "/;G.2#G/3B@#!UKP'9ZC?6&H:=?WFC7
M]C!]EBGL&49@[1LK @J.WI4EUX*M[DZ.W]IWZ/I=P;I)"R.TTI!!:0LISD,1
M@8 [8P,/U#Q7)!<7T6FZ3<:I_9TL<5XMNPWJ7 ;"*?OD*P)&1UXSSCI* ,34
M_#<>I^(=(UE[VYBFTLR&&*,)L;S%VMNRI)X]"*I?\(5!#/JHL=1N[.SU9VDO
M+6+85+L,.R$@E"PZX^HP>:ZBB@#E]0\$64]]IE_IEU<:1>Z;!]E@EM I!@_Y
MY,K@AE]/0\U;\.^&(O#DNI2Q7]Y=-J%RUU-]H*8$A !(VJ.H4>WH!6[10 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %<;\3;J_L?":W6G:A/9SK>6R;HL?,'E52#WQ@
M]B*[*LCQ'X>MO$VFBPO)[F* 2I*?(95)96#+R0>A - ',:@+[1M>TCP]#JE[
M>C5I;JZ=[V\,;XC1/W22(F57+%L  \$9 JI=7?B3PQ;Q:9?:G$RZKK,%I92K
M.T\UI!)N+!G=1N/R,%)!Z\YQ75^(_"6G^*+"VM[^6Z6>U<2V]Y;R>5/$XXW*
MP& 3],>W JK<> ])O/#LNCWLU]=^;(LS7D]P6N?,7[KA^Q7M@8Z\<F@#-2.>
MS^*<&CQZAJ#:=/HTL[02W<CXD$J+N#$E@<'UX[8R:YV#6]6D^#V@:NVI71U!
MM1CB>?S2&D0W10ANQ&WCFM>QTI](^+%C^\U:]B71I8)+Z[5Y<R&5&52^T*.
M>!C\S6BWPRT=M/?3C>ZI]@^TBZAMA<X2W;?OPF!D#=ZY(R<$9H 47-\?BY<Z
M;_:-S]B?0A<+#E=L4AFV[E&,9P.^>]<MHM_J]G\-KGQE<:YJ5Y>6,=\J6\K@
MPR8E=5+KC)*D9SD<<=*]!_X1BW7Q*=>2]O%O#9_8A\R%1%G<!@J23NYR23^'
M%-T;PGI^C:!-HB//=:?-YF^*Z*MQ(27' '!+'\Z ,>QTWQ#%KFDZE#J4(TUX
MRM]'-J,EP+G<HV/&K1A4;//RX!!QBG?$6ZU&SLM$?3M1GLGFUFUMW,8&'5WP
M0V1DCVR,]ZM>'O FG>&YXVMK_5;F&#(M;:[NS)%;9!'[M>W!(R<D GU-9_Q/
M@EN]+T6WABO)&&LVLKM:0N[1QJ^6?Y0<8'.: *,<>KZ#\06T-==U*\T_4],E
MN5:Y=9);::-@"R';@*0PXQC-5O#$.K7GPS3Q-<>)=6>^ET>4[?,4QJPRP<*5
M/S?+C.>YZ<8[:#P] +F>_>\NY[ZXMQ;BZEV!XXLYVJ H4<G)^7).,]!B/3_"
M=GIGA(^&K>ZN_L/E-"K,RF1$;.5!V^YZ@GF@#E-.U^]O8OA]HT]W.O\ :VFF
MZN[@2%9)BD*MM#CD9+;B1@\=>369XFU?6=%3QKHUMJMZ(;+38]2L;CS-TL.X
ME6B+MDD9!().X#O7;OX(TUM'TFP$]VCZ05-A=JZB:# V@ [<$;>"""".N:=>
M>"]/U#3-3L[JYNY'U0*MY<[D$LJ*,!>%VJH'90.I/4G(!8\.Z7/90R7=QJU]
M?/>)%(R7+@I$P7GRP!\H.>F3TKC_ !IJ%[#%XLN;/5+V:XL+1)8$LY#%'IY5
M"Q\P[@)&8\[<,0,< '->B65M]CLH;8323") @>7&X@=,X 'Z5SE_X TG4+O6
M)I+G4(X]7CV7EO#<%8G;;M#XQG=CWP<<@T 8=U-JNK>-]#L/[;OK2TO]$>XG
MCMBJX<&/E3C@G=U.2!G&.M<]?ZMXBTKPSXHTS^W+R2?1=6M8;:]<@R20S/'\
MDC8R2 _4$'FMZXT5K7XD^'[6UFU:.VLM*E@^VK&TF'+)M5G9"AR >#P,#&.*
M?\0=!BLOA[?6%A!>W5U>WT$\SQ1M+-,_G1L[G8.,*O8    4 /EBU?P[\1]&
ML4UW4;ZPUV&Y29+IU<P2QIO$D?RX4'.,8Q^E8VBZCJUC\-;CQI<ZWJ5[=V,=
MZJ6TD@,,F)G5"ZXR2I&<Y&!QT%>A6NA0F]35);V[N[P0&&">X"!H$;!;:H0
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MKJ%)AL!D $A4$'!8 9/..V*D;P=:.^AN;Z^SHHQ:?,G]W9\WR<_+Q_\ 7YH
MY2WE\3>+= FUC2+Z&SOEO91#))?R+%$D<Q7RY( A4@HO)))R<Y P!T_Q -VW
MPWUYK//V@Z?(1Y9SQM^;'X9J _#K1QK=UJ,%UJ=M%>2>;=V$%T4MKASU+H.N
M>XS@]ZZT@$$$ @\$4 <_X#:W;X?>'C:E3#_9T &WUV#/XYSGWJAXFU5K;Q-X
M=T&VD-NFL7<WVN:$[7Q'%NV9'*EOD&1S@<>M6K'P7;Z0\B:-JNI:;9R.7-E
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MADV-@[6&#@]N*R)?",%W'!;W^J:E?6,$B2+:7#H49D.5WL$#N 0#AF.2.<T
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MT_Q-K+^'O#=_JZ6ANOL<+3-$) F549/.#Z>E7=/NOMVFVMV4V>?"DNW.=NX
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M220YQD<$@;1GN1GO0!YMX%U%;N:T\.W\EU86KWM[<VTL4S1_;9%N)-T6]2"
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M0R/DG>&SG=DDELY.3G.34<'@K2(=!N]')O)8+U=ES+-=.\TJXQM+DYQ@D8&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5FZ]H5
MCXDTB;2]261[.;'F(DA3=@Y R.>H%:5% &/<>&K&ZU;3M3F>Y>[TY66VD\YO
ME###9'0Y  .:H2^ ="N-/U.QGBN);?4[@7-TKSL2\N0=X.<J?E'3'2NGHH Y
MK5_ NC:Y'8_;/MGVFQ!%O>1W3I<(#U'F Y/XYJ>Y\':/=:=I]@T<ZV]A.MS
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MJ:[;I4N75&.W:6"YP&*\;@,X^III\%Z0;/2+3_2O)TAUDLE^T-^Z91A3G/.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO]W&[&.!QC'%6M7N/'6O000ZG\-;&YC@F$\:MK*#;( 5##'<!CCTZ]17J=%
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M]'VR+=1W^J)<A_D.W"C!'S8YQ_6O<*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=JQA@H"J,%F))[C !-4? OAR71I-:NYK;[,E[?R26D!/,4!QM7 .%!(9@HZ
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M\LD,C[R6W,2",<\$8%=EX^GL(O"DL6HO<K#<3PP*ELX5I7:1=J$G@*QX;/\
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MR)*<$OELEA_LYZ"@#M=/U6SU1KP6<HE%I<&VE9>1Y@520#[;@#[@U<+!02Q
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MR"ZXW 'O@\?4&O-M+631M?T:#6],M;^SN[R4Z;KUIC?(TJ2'9<*1GE6;D''
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M+JRN--N[:XDD,0W2*\>W@L&(_BZ8S76D@#). * ,,^#?#AM!:_V1;"#SC<;
MN 9<YWGU;T)Y':KE_H>FZH;4WUJ)S:N)("[-F-QT8'/WO?K6$OB:XG^(UKHU
MM<V5QI<VGRW&Z$;G61'1<%@Q&/FZ8%;6FS745I=2:I?64NRXDVR0#8L<>?E5
MLD_,!UH 67P_I,VJG5)+"$Z@8O)^T@8DV\\;AST)&>O-1)X6T)-#?1!I=N=+
M?.;0KF/DYX!Z<\\=^:T1=VQ25Q<1;825E;>,(1U#>GXTL%S!=0B:WGCFB/1X
MW#*?Q% &3:^#_#UEHKZ/;:1;1:?(XD>%5X9@00Q/4D$#GV%:%CIEGIQE:VB*
MO*09)'=G=\# W,Q).!TR>*0ZMIJV<]X;^V-M;@F:42J5C ZY.>*CTK6K+6-%
MM]5MIE^S3PK,"S ;%90WS>AP: $O=!TW4+P7EQ;9N?*\GS4D9&,>2=A*D97)
M/!XIO_".Z0+ZVO5L8TN;6/R8)$RIB3IM7!X7V'%7H+JWNH?.MYXIHC_'&X9?
MS%-2^M),[+J!MJ"0XD!PA_B^GO0!1A\-:+;VE[:IIT'V>^8O=1,-RS,>K,#G
M)/<]34EEH.FZ<KBUMMA>,1%S(S/L'10Q)(49X .!5NWN[:\3?;7$4Z_WHG##
M]*FH S]-T/3-'LGLM/LXK>U<DM"H^0D]>#QSW]:=I6C:;H=G]CTNRAM+?<6\
MN)<#)[U>KD_"'C2/Q1J6MV9@\A[&=3!G_EM;.H,<H]0V&/T(H T=2\'^'=8U
M2'4]1T:SN;V+ 6:2,$\=,^N/?-6VT/36UE=7:U4Z@J>6+C)W!/[O7[OMTK0J
MK]M@N#+;VEY;&Z3*[=P?8W^TH(/X<4 9NK>#O#FNZA#?ZIHUG=W4. DLL>3@
M= ?4>QS4]YX9T34-3CU*[TNUGO(X_+662,$[>N#Z@'IGI67X%\2RZ_X2TV_U
M2:UCU"[:8>7&=@;9*Z_*I)/ 4>M=%<WMK9A#=7,, <[5\V0+N/H,]: ,O_A#
M_#ATNVTTZ-9FRMI/-AA,0VH_]X>_\Z35?!OAO7+^"^U/1;.ZN80 DDD8)P.@
M/J/8Y%;,DT<07S)$3<0J[F R3V'O65<>*-'M]3L-/-] \]\':(+(I&U0<L3G
MID8^OT- $EWX=TJ^NGN;BT#321B&1E=E\R,9PC8(W+R>#D<FM)$2.-8XU544
M *JC  '8"G$@ DG %06]]:7:LUM=03*OWC%(& _*@#)/@SPV;2XM/[&M1;W$
MOG31*F%D?.02!UP>1Z&KG]@Z;_:<6IFV!OH8_*CG9V+JG]W)/3V[U8AO;>^B
MD-C=V\S+\NY'$@5NV<'].*PO VNWNO>&#J&IF 7"W-Q$YA4H@$<C*, DXX7U
MH M6O@WPY8ZX^M6NC6<6I.23<)& V3U([ GG)')R:T=3TNPUK3Y;#4K6*ZM)
M<;XI5R#@Y'ZU+;7=M>1>;:W$4\><;XG##/ID55U(WRSV'V2[M((S< 7"SJ29
M4P?E3D8;./6@#(U/PGI5MI=_+I.B6_\ :+V,EI"T2JKX8' W,0.K')SGZU'X
M+\,0:5X;T5+W3C#J-E:I&RO+YBQR! KN@#%5+<\C!.3GK71M?6B7/V9KJ!;C
M@^49 &YZ<=:L$@#)X% '!Z'X5:;Q-XHN]8TF1(-1N5DA9IUVRQB-5*.J/R,@
MG:P(YKJ-9\.:-X@L4LM6TVWN[:,@HDB?<(X^7'(X]*NVU[:7H8VMU#.$.&,4
M@;:?0XKG_&.MZCH;:$UD;?R[W5K:RN!+&6;9(V"5(( /'<'K0!>F\)>'[C2;
M72Y=(M#8VC![>$1X6-AW7'0\GZYJ-_!GAMX[N,Z+9B.\V_:$6/:)=H 4$#J!
M@<=.,UL075O=!S;SQ3!&VMY;AMI]#CH:;'>VDMQ);QW4+SQ<R1K("R?4=10!
M2O\ PYH^J:?!87]A%<VUNRO"DN6\MAT(/48Z57;P;X;9+M/[%LU2\"K<*L>T
M2!0 H('88''3@58T;Q!INO"Z;3KF.=+>=H"RL"&*XR1[9.,^U%_XATW3=6L-
M+N;F-+N]+F.,L 0JJ6+'T'&/J: %/AW2FN[.[:T#7%DI6VD9V+0@\$*<\ C@
M^HXJNG@_P['K[:ZFC6:ZFQW&Y$8W;O[WIN]^M9VA>)+F?7_$UEJ]Q9QPZ;=0
MPP2*/*!#QA^=S')YQ^'2NFN;NVLXO-NKB*"/.-\KA1GZF@#)U+P;X<UC58M4
MU'1K.YO8L;9I(P3QTS_>Q[YK<K+U;Q#INBV]I->74:K=W$5O!\P_>,[ #'J!
MG)/H#6FCK(@=&#*PR"#D$4 95MX8T6SN_M-OI\4;^:9@JYV+(>KA,[0QR?F
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MDEL9R+@2#<95VGY8R#PV<'OTK(TS6M5O/&WB3197M1#8P6TEJRPMD&0.3O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MNK6QMH+BY;=/+%$JO*?5B!D_C1>Z7I^I- U]8VUT8'\R$SQ*_EM_>7(X/N*
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MW85U]UK>DV)G%WJEE;F!0TPEN%3RP> 6R> >V:N0S17$"3P2I+%(H9)$8,K
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/2+;3HK$166HP7<B7$C(I2,YV *C=>E=%96-K80>7:6EO:J3N9($"KG\ ,T
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MF>*XXI/"&LK,B-']BF)#@$<(:\W^SV=SH7PD$\4,F_R$.]0=R_93\I]1G'%
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M0M'LO^?A9E,?7'WLXZ\5YA.MKX/@\ PS:LL>C11303:G:B,Q?:2BA')967!
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MEC38BPBUE6EA@&"8<0^: !ZH'S^- 'K=GJ^F:C+)%8ZC:7,D8!=(9E<J#T)
M/%):ZUI5]<M;6FI6=Q.H+-%%.K, #@G .<9XKE+C6?!>I"37;)H]1N8-)F#?
M8927CM=NYE95(VDD8 /.3QT..5T_4]/?Q-\.)$OK!+3['<QQ6L,@86Z- NR-
MW)RS< <XR1TH ]1?Q%HD90/K&GJ9)3 FZY0;I!C*#GEN1QUYJK<>+M&M?%,/
MAZ6]@2^D@:8JTH&SYE55.?XFW9 ZX!KRRYL=/_X59\1IEMK?>FKWH1P@RNV1
M2H![8/0>]==)>V]O\7-(GNKB.-9_#KI&\C >8YFC.!ZD^@H [F\OK/3X//O;
MJ"VASCS)I BY],FD.H60O%LS>6XNG7>L'FC>R^H7.<5S/Q3C:7X7^(552Q^R
M%L =@02?TK%U'5]*OOB1X',-]:SQM:7B$K(K*2T<>%STR?2@#MW\1:(DD,;Z
MQIZO-(8HE-R@+N#@JO/)![5/?:G8:7&LFH7UM:(V<-/*J XZ]37CUKI&A7?P
MG\9&:TM6N(KZ_2)@@,B2B1O)5>X.XK@#^][UMZ-K$>B>-I[/QC=16\UQH=FE
MM-=R!8VVJPG4,>,ESDCO@>@H ](FU&RM[-;R:\MX[9@"LSR (<],'.#FF+JV
MFOIQU%=0M6L0"3<B9?+ '7YLXKSR%M/TGQEX+BLXF@\-&UNH=/,C$H)R?E.Y
MB?O(&V$GD,<=:S/$=D%@^*<D2H=*:UC=1@%!=^4?,*]@W*9]R* /4TUW2)+J
M2U35+)KB*/S9(A<*71,9W$9R!CO5>XU:SU'P]>7>E:[8QIY;HFH*Z2Q0OCJ>
M=IP<<$UP^I:?IW_"2_#5?LMMMD6X!&P8<?9MW/K\V#]:S]3AM5M?B];K'"(8
MXDD6, ;5<VGW@.Q)[^M 'IT>JV-K;6Z7FK6;3&W$ID:14\Q0/FD SPO?T&:G
MMM2L;VP%_:WMO/9D%A<12JT>!U.X''&*\XBM;&Y\<> C+#!(7T29CN4'<0D6
MTGUQSBLF:& _#[X@P)>0V4,/B&4H6XC!#PD(<=%9OE/8;CGC- 'K5MK&EWDG
MEVNHVDTF0-L<ZL>F>@/IS4]S>6UE&)+JXB@0L%#2N%!8\ 9/<UP^C_V;XB^(
MB^(H[S2V>'3/LBVT-W%/*7W[B_R$X"C@'J=QZ=W?%R.V;P9%+<JFV/4;0EVX
MV S+N.>W% '7VFL:7?R7$=GJ-I<26QQ.L4ZN8C_M 'CH>M0C7=)N08K;6+ S
M/$\B;9T8[5)4OC/*@@@GID8KC[O0[&#XM:%)I-I;PI_9MR-22&,*AA^41;@.
M.6SCUVGTJI\-M)TB3X46UXUC9O-Y5VK3-$K,!YKY&[J!A5X]A0!W.EWBV_AV
MVN=0UFUO L0,FH+MCBE/3<,': ?K5NVU.PO+-KRVO;::V3.Z:.561<=<D' Q
MWKR+2M5CTCPS\+K[4'":(BR)<RM_JXYC&5B9NPP2_)Z=>U:OBVZT6UT6[U?0
MF9[)M8M;G6;NS;SD90?F(SN4E<(6 &/7O0!Z/8ZKIVJ+(VGW]M=B)MLA@E5]
MA]#@\4^XOK.TEBCN;J"&28D1+)(%+D#) !Z\5RGAV/P]>^+9]:TK7)=6OIK$
M13R121-$J!@4WB-0 _7&><!O2JWCVVM9O%?@CSX8G+ZFZ'>H.Y?)?CW&<<4
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M@1;?5WM;5KDI%\@CC(' '0MR??FNSO=3LM/2-[JY2,2'$8)RSG&?E Y/'/%
M$\%O#:P+!;PQPQ)PL<:A5'T J :5IRWGVQ;"U%UDGSQ"N_)Z_-C/<U6D\2Z'
M%I*ZK)JUDM@YPMP9EV,>F <\G/&.M9.J?$/PYIPA5-2M[F22_CL2L4@;RW+
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MH;)8TD26U1]F",;@S 9W9X)Z8KL[_5;'3/+%Y<I$TN?+0\L^!DX4<G ZXZ4
M6V570HZAE88((R"*J0Z78V:1_8]/M(FA#>2$B5 F[J 0.,X&<57;Q)HB6MG<
MMJUD(+Y@EJ_G+B9B< )SR<^E/TO7](UMKA=+U*VO#;L%E$$@;83TSCUYP>]
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M->M'YH@24%RN,YQ]"#3KOQ%H]A*\=WJ5M 8V5)&D<!8V/(#-T4GL"1F@"?\
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M$X 'K0 V>WANH'@N(8YHG&&CD4,K#W!J&QTS3],C:/3[&VM$8Y9;>%8P3[@
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M#J?6KM5+'4[+4TE>RN$F$,GE2A>J/@':PZ@X(.#ZU;H **** "BBB@ HHHH
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M1E1]1BO0=!\-W6G^(==U&^%G*FI7*7$03+-"50)CD<\#.1BNF*(QR54GU(H
MX*WN(M#^+=]'J!BM;.\TN%-,=L)&!&S&2-3T#9;=CT%<=J,$=GX*U-IGC32[
MWQ:DU@DA 1H/.3<5!_@)#D=L<]#7MLL,4Z;)HTD7.<.H(S^-*45@ R@XZ9%
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MKQB$<'@RL0?H00:?XFUBPLO'ND6MP\&GW$EE,T>IS]=I9 88@?E+G /(/ P
M<UVRHB_=51]!0R(Q4LJDJ<J2.A]J /"+.\TY_AKX7M)YXF,/BI%E2; VC[3(
M2&!QCY3DCL#[UT>ORS2^./&%OHTR'49?#*"%(7&]I TG3'\6",?45ZGY4>,>
M6N,D].YZTHC0-N"*#ZXH \=U#Q'X?OO"7P_%G>6JM::M8"6#< ]MM4JP=>JX
M/'-=O\3+?4+WX;:W#I2O)=/ "$C^\Z!@74>N4W#'?-=2MO"KEUAC#%MQ(49)
MZ9^M24 >=:]=V7B>^\#77AZ>*6XCU!+G,+ M%:^6WFAL?=!^52#W(%8VF_V&
M_AOXD6U^+4ROJUZK1L!YC9 \L*.I.[.W'\73FO6DACBWM#%&KORV!C<?<BN<
M\*>&[G19M6DOA:2M>ZE-?Q/'DF+S,93D=MO4=?2@#D-.\SP_XH\!1:Y,(9UT
M"6U8RG[TW[K]V/5N,8')K+U_S[Y/BG;Z.5GN3-9.T,+9:2-8T\T #KP&!_$5
M[255B"5!(Y!(Z4@1%.0J@^H% 'GVNW5GXEUOP1>>'[F*>:*\-RSPL"8[3RSY
MF['W0?D7![\5R\LVG/\ #?XGLLEJ7?5KWD,N6^Z4^O.<>]>SQP11%S'$B%SE
MMJ@;CZFE\J/&/+7\J *ND3)<:-8S1R+(KP(0ZG(/RCO7D;ZA91_##XA:?+<1
M+=QW^HLT+-AEW2?+D=LYX]><=#7M  48  'H*0QH<Y1>3D\=: //?$&H:-I7
MA7PQ="UL3%/=VB17S_ZFU94.V5RI&0N" "0,GDBN.U6ZEN+'XEV^F74M_<22
M6<YV* \]N$C\P@* -I7<,@<CUSFO<VCC9-C(I3^Z1Q2A5#%@H!/4XZT >8ZK
MXDT#5O'7P_O--U&TFA$ET-T;C]V&@(56_NDG P<'(K.EO+(Z'\6E%Q <O-@;
MQR3; #_Q[(^M>N1V\,1S'#&G)/RJ!R>M+Y4?_/->?:@#RZ2YT^'4OA68IK9
M$D VLHX:U(/YM@?6LB_O=(-MXS\)W/B#2K6/4-5DD::^G,4L);87PA&&"D84
M[AG'8 9]H\J/CY%XZ<5QUGX;\261DM&U#1KVT>9Y!<7EBSW'SL6(;#A6(S@'
MC@#B@#KK1H7LX&MY5EA**8Y%8,'7'!!'7/K7DFFW$#_!OQ!X?UAE.O1&\BN+
M9_\ 6RW+N[Q,J]6W%DVD=<<=*]6TS3X=*TVWL;<?NH$VKD 9]\#@<]AQ5@PQ
M&83&)#*!@.5&X#ZT >::6%M?BEH%OJL\#ZC;^%=DS.P+><)(\G/J?G/TS6I\
M+)[>71=92WEC=$UN]VJC A5,I(Z=B.17<&-"VXHI/KBE5%3[J@9]!0!P_B:U
M\(>+M1O- \0B"&\LMK6\S2B*4*RAMT;GT.<CD< D<UQEX^JR?!;Q=:7=]+JM
MG97/E6%^_+7$"/&2V?X@#N&[O@^E>T2V\,Z%)H8Y%)R5=003^-/"J$V!1MQC
M&.,4 ><7FHZ-JWQ<\.2Q75G=12:7="-MRL')9 ,>N1NQZ\U9\8QW'A7Q!IOB
MK2;(SK)&-+N[6(8\P,?W!]!B3"Y]'KO?+C!!"+D=..E8)T?6+OQ$UQJ.I6\F
MD0RK-:6<5N5?>%P/,<GD DL !UP>V* ./\>6?]DZ%X.TR/4HK>^_MJ%OM3@'
M]ZRREI2IZ_.VX]N:@CU6;4_AOXD\-01I#XKLH)8KNVCDW/<.1DRH3R_F+D^N
M3CTKU5D1OO*I^HH"(&W!5!]<4 >=:#JG@_Q/JFBZG9W]U=ZE9([I$\I!LE9,
M2>8,  <!>>"<8J?X1K83>#$E@6V>:.]NR70*67=,^.>V5"_ABN\2")"Y2)%+
MG+D*!N/OZT]45?NJ!]!0!S_BF_T6)+32_$$5N^GZDSPL;@#RPP&X;B>!['C!
MQ7%>'M*E\-^-KC1/">K27>A3Z?+,]L\WFII\V<1[7[;B3\O7 ).<9KU4JK?>
M4'C'([4R&"&W39!$D29SM10HS^% 'D/A6\\,ZUH&@Z+J=S?MKVF31 Z6TC++
M%<Q<;\ ?=ZL3G&"<U:T/6M!2P\0>%/%B*^I-JD[O92H2]Z'DWQ-&/XLC:!CI
MM'05ZJ(8A,91&@D(P7"C)'IF@PQF593&AD48#E1D#ZT <!!J=EHWQ;UK^TIX
M[1KS3+0VR.W,Q5I 50?Q') P.?:N+TN\TZ3X;_#>.:>W.S7HQ(DC#Y<--G(/
MU7\QZU[FT4;2+(R*73.UB.1GTH$,855$:!5& -HP!0!P?B)[&U^*7@:)&MX3
MMU [%(7EHU[>YS]357PU?V5M<?$"QN;B*.X_M.XG:%S@B(PQX<CLIZ9Z5Z.4
M0G)521WQ1L0DDJN6Z\=: /%;'4XM,\%_#C5;JXFCT6VBDAO;BW.?L\C1[49L
M9P =RD]MWO6W<VGA2]TV^O-+UJZM1?ZA;N-:$F^,7:!BA&[Y2!@!L<'<!G(.
M/3S%&8RA12C<%2.#2"&(1"(1IY8& FT8 ^E ')>!M0U2YEUJSU=+.6[L[E$?
M4+(8BN\QKAL=G"A0P' XK&\2ZO8+XPUK3FDBTZ\.D*//8;IKY3O(CB4Y&%.<
MX4L=W;&:]'CCCAC$<2*B#HJC 'X4%$+ARJE@,!L<B@#QO2]4LH=&^%%_-=1I
M:6P>":=VPB/]E90I8\9SQ]>*].\47<%MX/U:ZGLGO;=+*5I+894RKL.5]1D<
M>U:WEIM5=B[5Z#' IU 'D.F:Q83>//!5Q'JMM/%)IMQ"B6RXAA.V+;$IY)('
M4,21C.%S1:7UHWP^^*&VZA.=0U+&''.Z,!?S/ ]:];6*- H6- %^[@=/I1Y4
M>"-BX/M0!E>%)8YO"&C/$ZNAL8<,IR/N"N)\/:A96]E\0[&XN(H[D:G>SM"Y
MP1&T:8<CLI['O7IH4*,* !Z"DV(2QVKENO'6@#QM;FP?P3\*EEGMV OK4,&9
M3C$+@Y^AP/KBNETB?3A\7_%KO+:AA86@8LRY& ^_/X;<_A7?>5'C'EK^5+Y:
M9)V+D]>* /"]"U6+3/!'P_U2ZN9DT:UDNX;R>W.?LSN66-FQG ^\/8-[UTMS
M9^%+W3;V\TO6KJU^WZA;NNM"3?']K0,4(W?*1P%.."6 SD''IQBC*,AC4HW!
M7'!H$,0B$0C3RP,!-HP!]* .%\.^*9-*LM>D\5S6,?V"[BCEU2T4^5=%T0*<
M#.' V*P' XKO:C$$*PB$11B(=$"C:._2I* "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKF/B'
M?WVE>!-6U+3;R2UN[2 RQR(JMR"."&!&* .GHKP:[^('BK0O WA+Q1_:[ZC-
MJ<S1W-A/!$%D +<H40,#QCJ>2/Q]7U#QUX;TC4IM.U'4TM;N&#[1)'+&XPGJ
M#C!]."<GCK0!T5%<^GC?P]+8:;>0WYFCU/=]B2*&1Y)]N=VV,+NXP<\<5@^.
MO%V/A9J/B/POJH$D!3RYHT5L'S%1E974X.&/! (H [ZBN,\(>/M(U>TT33+C
M5%EUVZTZ*=T,3*)7\L%]K8"D@AL@'C!]#65#KM]-J?CGR/%*W'V.V,EM9I:%
M)+%E5CR73!Y'OGKQ0!Z117E_P]^)EG=>#M&D\3ZN?[3O99(O.>W*1L_F,%4N
MJB-6V@<$@XY[UM7>L3+\6+/3U\21PVPL6:31VM6WRMACY@?;C&!V/\)&.30!
MVU%<%X?^)=CXCU/7K:!;B""Q;RX939RL6*JQ=F 7Y<$<*<$X]3@.\%^)H;;X
M?MK.N^*K;5(89I!)J(B,2@9X7!4$GGT[X&: .[HK%M?%>CWGVU8KF03648EN
M()+>1)8T(R&\ME#$$=P*RHOBAX,G%F8M;C9+N7R(G\F3;O\ [K-MPI_WL4 =
M?117/0>./#EQ=Q6\6I*3+<&UBE,;B&28=464C8S>P/- '0T5Y)K7B[5];^*5
MUX0TO59]*ABLCY4Z6;.3<[EY8%>4QD9X7OD\5VOC&XU'2OA]J5Y;Z@\>HV5D
MTHN8XT&]U7.2K C!(Z4 =-17@<_Q \5Z/\,?#/C$ZTU[=7UV\%Q8SP1!)%#R
M %=B!EX0#J?O5V7_  DVM#XX66@_;)%TJXTS[4UH\:?(^&XW;=W&!WH ]*HK
M#'C#06U%;$:@IE:Y-F'\MO*,^,^5YF-F_'\.<]NM9/C#QKING:=K5A::I)%K
M%I9//F"!I! VTE/,;:R+DXX;&<^] '945Y_X'\;H?A7I7B'Q3J:B:X:1&F:,
M!I'\UU551!R< < =JVSXVT.ZDO["VOY8[^UB9I8VLY=\'RY!92OISCN.E '2
MT5YYX8\;:?I'@.SU/Q)XJBU%9KB2$:C':R*C-DD)P@Y !Z@9Q[5TVD^,M US
M5[G2M.U!9KVV0221>6R_(<?,I8 ,O(Y&1R/6@#=HKEYOB)X5@221]4_<)<?9
M3<);R-$9L9V!PI4MCL#71PW$5Q:QW,;?N9$$BLP*_*1D$@\CCUH EHKG8?'7
MAR>_LK./4?GOV9;21H9%BN"IP0DA7:W/H:;?^/O#.EZI=:9>:EY5];1^;)!Y
M$A?;@'( 7YN#GC/&3V- '245@KXT\.MX7'B7^U81I!'%R01SG&-N-V[/&,9K
MBK;QK?WOQML=%LM1N&T:XL&GDM9[41,DF'XPR!QP%.#Z^AH ]3HKDOB7J6H:
M+X!U35=+O9+2\M45XW148'+J,$,".A-<N/$.O'X#?\)/_;-Q_:_V7[1YWE18
MSOQC;LQC'M0!ZK17#>!?$KM\,+'Q)XEU;<98VDGGF5$5?G90 %4>PQR2:Z"#
MQ7HL]OJ$YOEA73@#>+<(T+P C<"RN 0".0<<]J -FBO)==^(4]QX_P#!MOH&
MJW']F:I+BY@EM/+$B97:R^8@;:P)^8'!QQ7=:AXW\/:7=WEK=7Y$EBBO=^7#
M)(MNK=/,95(7/O0!T%%>?>(_%<5W?^%)=(\4QZ=;7EZ 4ELI&%\FY1L4E.#S
MCG'W@<\"MB]^(WA33[N_M+G5-ES8#=<P_9Y2Z#UP%R1CG(R,<]* .IHK"F\8
M^'X-&LM6;4HS9W[*EHR*S-.S' 54 W%L\8QD4_2O%NBZUJ5QIUA=O)>6V1/"
MT$B-&0<$-N48/M0!M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5QWQ3D1?AIKL18>9+;%(T[NQ(X [FNQK!\2:+JVL+;#
M2O$=QHQB+>888$D\W.,9W=,8/3UH Y'X2>']$F\#:%?S:?;2ZI;1L#),NZ2!
MM[= ?N'ITQ69J$4,_P"TM82RHKQ1Z9Y8=AE1(0^%STSANGO71?\ "$^+O^BD
M:C_X 0T?\(3XN_Z*1J/_ ( 0T 8OB&P.B?&[PSK4ZQVV@I826J2X"0V\FV3Y
M2>BYW#&<9_"N+73K^'X.>/+N6*5+?5=3$MA$RD-*OG*=RKUP0/R7/2O3O^$)
M\7?]%(U'_P  (:/^$)\7?]%(U'_P AH X*)E_P"$Y^%,B_<@TB..9@.(V,97
M:Q['/&#WJSHQ!\<_%-QG;/9R>2V.),(P.T]\>U=I_P (3XN_Z*1J/_@!#1_P
MA/B[_HI&H_\ @!#0!Y4]G/J7P*T'PG;P.VOOJ1Q8LI$L8+R-O93RJ[6!W'C!
MKLKQ3#^T;H!=RZ0Z1]GDF/3S,2\$]B<CCW%='_PA/B[_ **1J/\ X 0T?\(3
MXN_Z*1J/_@!#0!RWPXD_LG5/B#97\<MO.]]-,!)&P'E_.0V<8P>,'OD>M<19
MZ3J-Y\![%;>"9_[/UO[3>6ZH=XBP1N*]2!G/YGM7L'_"$^+O^BD:C_X 0T?\
M(3XN_P"BD:C_ . $- ',R*^J_&#6_$&GS+)HUMH;037<;9B=RN0@8<$]#[8K
MSR6*0? K0;41/]JC\0&1X@AWJH5\L1UQRO/N*]I_X0GQ=_T4C4?_   AH_X0
MGQ=_T4C4?_ "&@#KM6AEU#0+Z&RE"S7%K(D$@;@,RD*<_4@U\\OIU[>_"'PY
MX1LXG3Q'#KC>9:8Q+!@RGS&'4* R_-TKUC_A"?%W_12-1_\  "&C_A"?%W_1
M2-1_\ (: ,&R=1^TI?S%AY3:4(1)_"9!LRN>F>#Q[5V7Q(E1/ASKZ,P#RV,L
M<:YY=BI 4#N3Z5E_\(3XN_Z*1J/_ ( 0T?\ "$^+O^BD:C_X 0T 9'P<\/:)
M<^ -%N[O3K>;5;0RY,Z;I(&,KD8#?<.,'@"JVH$M^TE9R(VU!I)A\W'RK(0Y
M"YZ9Y'%=!_PA/B[_ **1J/\ X 0T?\(3XN_Z*1J/_@!#0!YSX LK"XTI_!WB
MA]7BUBPU0W,5C%'CS'!XD#;,]2V26 Q@]*L6DY\.ZQ\5M.UA94O=4BEFLOW;
M-]HC*S8VX'( =<^G/H:[[_A"?%W_ $4C4?\ P AH_P"$)\7?]%(U'_P AH \
MS2WL(_@EX,FU&[?3[RQU;,'GQ,(]YE=L2=PNWG<,_0YKL-"DT.^UWQAXFB\1
M:;=7U_8[#96D^Y88D0+DE@"Q) YV@#..]6]:^%_B#7;);6_\?7=S$CB18I].
MB:,L.FY> P]CQ6=I7P4U#2M1CU.W\7BUOXU9%ELM)AA 5NH('!^IH \YO(Y&
M_9WTNQ$;F[76F9H IWA</R5ZXY'/N*]&M&CG_:/NYD;=;3:0(EE4_*S$(<!N
MF<<UT7_"$^+O^BD:C_X 0T?\(3XN_P"BD:C_ . $- 'E>E0^&+_P>OA-_%NG
M6FE+K+72S7+F.Z,:DJ%*$;5)(R'W="/E!X'T+J$L0T:ZF\DW</V=V\J/YC,N
MTG:/7(X_&O(9?@)<SR2K/XJAEAE+-(\FC0M.Q8Y),I.[.3UZUT]G\/O$]A90
M6=K\1-0CM[>-8HD%C"=JJ, <^PH \E6Z^UQ> ;V#3KJRLK36VW645K*8;1?.
M1@ [ M(S %B<GT '?M9Y(T^/VOW+G;!_8;1B1AA=X1"5SZX!X]C75_\ "$^+
MO^BD:C_X 0T?\(3XN_Z*1J/_ ( 0T >-Q:?J$GP+TF6.VFDCTW7#<7ENJ'<L
M>#ABO7'/ZUW0U2UUC]HC1M3L#)-8MI1C%PL3;"3YF.<=.<9]<BNJ_P"$)\7?
M]%(U'_P AH_X0GQ=_P!%(U'_ , (: )?B\Z_\*PUJ'<#+-$JQQCEG.]> .IK
MST:/H7_#._G_ -G6/]L?8]F[R5\_S?,Z=-V['Z5WO_"$^+O^BD:C_P" $-'_
M  A/B[_HI&H_^ $- 'F^IVFH7?[.WATZ=')++IEVL]Y;QC,BHK2=5Z\$J>1T
MYZ"K_B[3-/\ %G@C7M?\+3:MJ-]=P0&[>6/:&2-U.S:%4%U S\N>![C/<_\
M"$^+O^BD:C_X 0T?\(3XN_Z*1J/_ ( 0T >?ZIK%GK/BGX6W&GB66&T11.R0
MMB(@1@J3CJI'/IQZT[4GT.P\3?$'2(_$-A:+K31QW#:B61H)#N+F, $2+ASU
M*X/J!D]]_P (3XN_Z*1J/_@!#7-ZC\$]3U'4I;VX\81W4TY!EDO=&AG<X&."
MQX&!T'% &9XTM]/LE^%EKI=\M_8V-Y&?M2,'!C5XAO)' 'RGZ8([5%*R?\+#
M^*4Q_P!7/HTD<+XXD;RE4JI[G/&!WKK='^%^N^'].33]*\?7UK:(S,L26,1
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4C+_ &.238P+J!D?=VGCBNP_X1Z3_H/:Q_W^3_XBC_A'I/\ H/:Q_P!_D_\
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M8.I^'UT;4O"6H:Y'8V)UF28O<P2K<(BW'F%?N[<EE.'W?=/(SQ7JQ\/2$?\
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M_:8C#Y:W0"$' +$':<<''%>R44 <GX0/AZ^O-1UCP_!<.EV(UGOYGF/VAE!
M \WD[1CD<<X['&-XCU.+_A,M3TV2*2RD?21Y4\%L7FO\E_W88*<*N>0.?FSD
M 5Z+10!R?PRG6;X;Z"%#@Q6<<3!T*_,J@'&1SZ9'%<E;W%J?#_Q2'F1[I[BZ
M,8R,R VZJNW^]EL@8[UZS10!Y5<7-LMA\+MLL8\F6(R8(_=C[.RG=Z?,0#GO
MQ6-XCU:*^\/ZTGDRV4UKKR/+IUO:L  +A,SRL%RQ<?-G('( !(S7MU% ' :3
M=6ES\8M7E5E/FZ3;)&77!)#.S+SSD J2O4=ZYK6=4TC3M2\;Z!=:M'90:M-B
M1[RWE+1,\*AV3:I5UP1MR5P0>HP3[)7*6OASQ#IMW="P\20FQN+A[@QW=AYL
ML9<Y(60.H([#*G P.U &#K-UIG]K_#HZ?>QW%E%._ESAPP,?D,@8GW.!]:KP
M7%I]N^*#&2+$JKL)(_> 6P7CU^;(X[\5Z/I]C%IMDEK"695+,S-C+LS%F8XP
M,EB3P .:M4 <[X"=7^'_ (> ;+)IT"..ZL(U!!]"",8KBUEFTSQ"LWAW4Q>6
MEWK31WV@7:AGB<S'?/$?O* 09.?EQSFO5J* /$-<U:&^T*[/DRV,MKXBC>;3
M;>U8+$!<#,TC!<LS?>SD#G !(S75SS"]^+%^MI-Y<L_AD0PNV5*RF5V"\\A@
M"#CJ!7HE% 'D7A.[\.ZII6AZ!J6G:HWB+2GA5M/FDN<02Q87SASL50,L/8X'
M4 ]9\3K2_NO!CMI\$EPUM=07,UO&,M-%'(&90._3..^*[&B@#@-2GM/$WC7P
MEJ>BW4<\6G_:)[NXC/$431[=CGL2V/E//!..*D^%CP/H>J",IYG]L7<A '.&
MD)5OH5Q@]Q7=T4 <-\5)XHO#5DCN YU.T<+W*K*K,<>@ R:BO[T:3\5[76+Z
M95T6]T@VD%X6_=13"7>59NB[AC!/4C':N^HH \4\2V93P=X_OD'^@:KJ5N]E
M%C_7;6B\R11W#$,<CJ%STYKJ_'URME<>&M?\NXN-$M+B3[8]B[[HUDC*+*/+
M(.U>^.QKT"B@#R36X]-NM!NO$?A/3KV\A34;&]O929F:^2%R2JK)RVT;3D<'
MISMKKM/\1>'M?:ZUC2X5D"6;)/J3VYBVC.1%N903R22!TP,]176T4 >+:,\]
MEX/^&^KLKOIVE3.FHHJDF NC(LCCJ I8Y/;=6YJEO8ZKXNU[7!NNO#__  CC
M6=[):G<)W+EL(1]YE3/(SC<!7IM% 'E=@-79=9T*'5(_$FFOHDYL[\*#/"Q&
MU8)&7ABW49Y^7D5GPZY97FC?#2*V,\KV-U!%=!('/DNMNRE3QU![?CZ5[)10
M!P7@J2";Q;XX$4D?FRWZ/&PQ\RB)5W#U ;(^M<QX7GT&ZT.Q\*:_8:I+XBL)
M%1M/DEN=KR(WRS @[ G\6[H.>O&?9** ,'QI%I\_A.\AU5ITLI#&DDEN2'BS
M(H5P1_=.&_"O/KK5]5T[0O$5O?\ V/Q58VT5J8=3%OO#*9#\LH3AS']_Y>><
MG&>/7Z* /,]!U&V'Q7N[DWMS=07&AQ%+R>$HC[97+$$*%"@8YZ>Y-<YIDLMI
M\+_"6I>3=3VFEZI-+J,%JSK-'&S3J'PI#?+O#?0^E>WT4 <CX1?PYJ6HWNL^
M'X;F;[1&B3ZA.\Q\XK]U!YO)VCJ1TR!ZXIZK- OQCT$NZ IIERA)/W69DVC/
M8D XKNJ* /'XY[8^ _B>BO&7GU"^:)1C,@:)0A7U!8'&.IS6E#K5L-<T6T<-
M:B708]E_!;F2:Y.<&W1@IQ@C)&-V2,8QSZ=10!Y-X:T>7Q#\#=,M;,20ZMIP
M\^T=XRICN8G9E'([_=)Z?,:[/P5//K&EGQ)>6[6]QJJHZPMUBA5<(OT)+O\
M]M*MZ_I&JZM+;)9:Z^G6>'2[BCMU=YU8 ?*YYC(YY&>OM6Q##';P1P0H$BC4
M(B*.% & !0!PVI7+:'\6X-4U-_*TF\TG['#=.<1PS"7>59NB[AC!/7&.U<KJ
M5AJ-M!K?B.PM9KC21XDM=2%M$I)GAB $LBKW!?Y@>^S/3FO9J* /-?$EY8^-
M_"&OS^$[0W5Y-8>6UZ+=HVD 8-Y +*"V1OR!TR!WK:\/^*=!\6WEA<6%@TM_
M;QL)6EM61K %?F0NRX!) 7:#SR>@KL** /"8]2@A^$=AH;+.=2T_5XQ=VZPN
M6AQ>%OFX[@C'KVZ&NYTFXM9OC%KC!D)DTNV1"PP20SEEY[C*DCJ.]=[10!S'
MQ"O1I_@J]N&TZ._16B#12Q&1%'F+^\91RP7[V!_=[=:Y72KJ.X^)>IM#<WE\
M+W0(Q#<20%1*0\F=N%"A>F#T]R:]1HH XSX5W4<WP[T>V42"6TMUAF5XV78X
MR"O(ZCO7)>,]22[A\>Z;Y$ME<K;C;!;VQ+WP$0Q*[[3E1]T8(QMY)SBO8**
M,[0;B.[\/Z?/%NV-;I@LA4G@#H1FM&BB@ HHHH **** "BBB@ HHHH ****
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M'S;6,P>[/VRY:T2,6KEDF7.Z-ACA^/N]3QC-7+7Q?:WL,1M]/U)KAX6G>U>
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MUTD0MV8M']J$A8;<\!0>>A[9H ]&L_%]C?:G>:;'::@E[;6_VE8)K<QM/%G
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MY4TJ[LJ.=PSL;!( ..*S_""7,7BGQC))974275ZDUN\T#QI*HB520Q&.H/\
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MMS<_97NGB0) _F&,;_FS@L.J@@9YYXH [:BJU_>)IVGW%Y)')(D"&1EB7<Q
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M5O?C>/KVIOA+^T)$L=.O_ Z:?J%F%6YU!HHO).WC?&P.YF;'''&<D\8/HE%
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MCGVQS7HE% 'DMG9:]<ZGX+U:Z\/:FU]9S2C4IKAX]V]X64E!NPL08YX  &,
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M?HM% &?HL<D6E1"6QAL&8EOLL(&(@22 =O!;&,XXSG&:T*** "BBB@ HHHH
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M1110 4444 %%%% !1110 5C:5X;@TG6=4U2*\NY9]29'N%E*;<JNU2 %!&%
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ML:R1LKHPRK*<@CU!IU !1110 4444 %%(2 0"0,]*6@ HHHH **** "BBB@
MHIJ.D@)1U8 D'!S@CJ*=0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 44C,%4LQ  &23VH5E=%=&#*PR"#D$4 +11
M32Z*ZHSJ&;[H)Y/TH =1110 44UG1-N]E7<=HR<9/I3J "BFM(B,BLZJSG"@
MG!8XSQZTZ@ HHHH **** "BBB@ HHHH **** "BFF1%=49U#OG:I/)QUQ3J
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M])NH9T%O=V@D.3(H8[B8\<;0VX^G( /2JRO$VL?\(_X8U/5]@D-G;/,J'HS
M<#\3BI=.O+^ZN;^.\TPV<4$_EVTAF5_M"8!WX'W><C!]*?J^F6^M:->Z7= ^
M1=P/#)CJ PQD>_- '+>"_#]GJ/A33]7URWAU/5-2MTNI[B[C$A_>#<$7/W5
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M\UA?Z;*L<\$CJ_#KN1@R\$$&N<\4E;+XK>%+NWL6N+J2SOEV1!0\F%CV@L<
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M)+"2]LX&&'SX# J#C(/IST .YTR^N;PW:75BUK);S>5]\.L@V*VY3@9'S8Y
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M8-<(/M$,S-NVMG 8 C&??\0"Y\1M476_AKXG@O-*EM;O3)8D(E7<A)="'B?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MLKS]Y!/YOF?*GRDE%.5_$?-]: /1JJV^IV%W=2VMM?6TUQ#_ *V*.56=/]X
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MX .Y7*CC##^'(.>*N/XOO;6#S+_0GMFNKB&WTR/[4K-=M("?F '[O: 2V<\
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M((Q^)JH?'=TB>'IFT3=!KP'V0I=C<A*;U#@J "5YX)Y&/>@#M:*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KCOB/ITUUH>GZC C2/HVIV^I
M,BC)9(V^? ]E+'\*[&B@#E/%>F7NJ7/AW5=*CBNUTZ\^U-$)0IEC:-E^0GY2
M?F!Y(!]:JW?A:\UR\\0:I=(MI<:AI#:3:PLP8QQG>2SE<C)9^@)P%')SQU]M
M:PV<(AMXQ'$"2$7HOT'8>PJ:@#S6#1/%=R/!?GZ3:6_]AR!9PUX&W@0F/>"%
M.!SD#D\\XQSO>&M(U;1_$OB,SV\!T_4+[[;%<";YCF-5V;,<$%>N:ZRB@#E/
M%>E:CJ&N^&;FRM/.ATZ]-S.?,53M,;)@ GD_-G\*PM5\$ZCX@O/'%O<1?9;;
M6XK46D_F*VUX5X+ '(!8#UXSTKTBB@#B[C2=8\3_ /".QZS8+9'2[R.^N9!,
MKK-+&K!1'@YVEFW$L 0!C!SQ8\+:1JNC:[XB2XMX#8WVHO?0W"S98[T0;-F.
M,;3DYKK*BN;FWL[=[BZGC@@C&7DE<*JCW)X% ',^*=*U&_\ $7AF[L[7SH-.
MNWGN&\Q5.TQLF%!/)^;-5[?2=5M_&7BG4S8%K;4+6"&V(E3+-&K@Y&> 2W'T
MYQ79@@C(.110!YDGA;78_ 'A+1OL -YI-_:SW $Z;2D+[CM.>2>W3OG'??33
M=33XEW.O&P8V+Z2EFI$J;S(LC/TST.[&<]?;FNNHH \OA\'Z^OPMM=%-I$-3
MLM16\6(SC9*!<F7 8=#@XY'45J7^G^+-+\6?\))H^G6E\M_:1V]_ISW?EE&0
ML4=)"N#@,0>/Y\=Y10!P>KZ)XE_MO0?%-M#;7>HV:S0WE@LNQ3%)@XC<@9*8
M')QN]NE7/"^EZU;>,/$VJZA906UMJ;6[PA;CS'!2(*00!C]>HXR.:["B@#D_
M$&D:K+XU\/ZWIUO!<16D5S;SI)-Y902!,-T.0-IR.M9^EZ%KGAN+Q!I5I9)>
MV>H7,UU97'G*HA,H^9)0><!N05#9!Z5WE% 'G?B;PV=.^$UKX+L7,US<B#3X
M6(^\Q8-(^.P"AV/H!7>[#:V.RWC\QHH\1Q[L;L#@9[?6E-M +G[6R#SE38'8
MYVKU('IG SCK@9Z"H_[3L!9"]-];?9"<"?S5V9SC&[..H(^M '%>'-+\0Z=-
M?ZKJ&E"?Q!J4@$MP;A/*@B!PL:<YV*.<8RQZTW2-.\9>&+R^T>PL;&\TBXNI
M;BTOI;G8UHLC%V5X\$O@DD8(SZC/'H-% '):9I6IVWQ&U;59K4_8;JS@MXYC
M(FXM&6))4'@'=Q_(50TO0M<\-P^(-)M+)+VSU"YFNK*X\Y5$)E'S)*#S@-R"
MH;(/2N\HH XRU^&/AG^Q-*L-3T^*_ET^T6V6:0L"0,D\ ]V+'\:J)I'B;POX
MMU2YT+3;34M)U8QR&.6[\AK254"$D[3N4@#H,_U[ZB@#BIM"UG3?&MIXFMT7
M43-IXL=1@1EC;(;>LD>X@8R2-I(XQR344?AF]@AU>\GTNVOWUO4%EO-/D=2H
MMPFQ5RWREQ@-Z9.,XYKM;FZM[.+S;J>*"/(&^5PHR>@R:/M5O]K^R>?%]I\O
MS/)WC?LSC=MZXSQF@#S.;P#JD7@W7=*TM&BMIKVWN=,TZZN-WD+&R.Z;\L%#
M%6P,D#CGDUZ5:/<26D;W<*0SL,O&C[POMG S4]% 'GOA?2?%_ABW?PS#:6<N
ME1S.;753<X:*%F+;3%M)9QDXY Z>G-W2])UCPOX@U][.Q&H:?JUQ]NA*S*C0
M3LH#J^XCY3@$%<D>AKM:* /-V\$ZCI7ASP=I-C$MVVDZFE_=R!U0'_6%PH8\
M_-(<#T'6M271];;QUK6J6L*P176DK9VMPSJ=DREV#%<YVY8>O3I7:44 >7Z=
MX:\31WWA"^ET>SCN-+>87\C7N^2Y=X3&9F;;SD\X))YQP!FN@\)Z7K&E0>)A
M<6@AEOM2N+ZT/F*PPX&T-@\$%>>WO7844 >?:3X4NK+Q5;:[I^DC1G:WE_M.
MUCN%\B\E*C9M52<8;)W$*?8Y-=/X6U74-7T87&JV,=E>I*\4D44OF)E3C*MW
M';Z@ULL%*D, 5(Y!Z8JE9ZGI4]M(;*^LI(+8;9##*I6( =#@X7B@#D[O3_%.
M@>--2U;0M/M=5T_5Q$T]O+=?9WMY40)N#$$%2H&1C/'YMO\ 2/%&G^+K#Q-8
MV]KJDTEA]@U"U\[R H\PR*T;$<A2Q'/) '<\=?:ZSI=\\:6FI6=PT@8H(9U<
MMMQNQ@\XR,^F:NT >1VFB:AXE\*_$32HA!'J%QK+E5WDH'5(7"[L=/EQG ]<
M"NC6P\2:AXYT37[K2;:TM[>SG@FA-V'="Y0YR!@GY>!T]3S@=-I7A_3=%GO)
MK"&6.2\E,UP7N))-[GJV&8@'@=/2M.@#S"?P?KMWX*\5Z9]DCBN]0UAM1M5>
M9=KH98W"DC.UL(1Z<CFMWQO9W&J>!GGF5+/5[5X[NR"/YGEW*M^Z4' R6)"?
M\"-=E61<>&-%NO$4.OSZ?')JD$8BCN&))5021@9QD9/.,T 6-%TXZ5H]M:.X
MDF52TTG_ #TE8EG?\6+'\:YCQGX</B.>:WN]"%Y$ENIL;V"9(I[:?+9^8D$+
M]P\9Z'@UVU% '$ZUX5UJ]\/>'#!J"'Q#I,D.Z^;^(,OESGGKE26]RHIVE>"F
MTCQQ->VKJFB-!%*MMGD72(8MWT\L\^IY[5VE17%U;V<8DN9XH(RP4-*X49/0
M9/>@#S3Q)X5\3ZO#XMLVLK2[:_'_ !+KV:YP88MJ_N53'RG(.3D YR3Q5A9]
M0MOBY8.^G>;/_P (T1-!!,I*?Z0.A;:&YQZ=37I%99\/::?$ UTQ2_VD(?($
MWVB3'EYSMV[MN,\XQUH Y>+PO>0:?J#W>DVVI?VSJC76H6+NI"0%"JJI; +J
M50]N2<'H:T_ WAZX\-V-_:L9H[![HR6%I-+YK6L6U1L+9/\ $&( )P".<YKJ
M:* //]?T#Q%J.M^(%^QVM[97UAY&G33W&T63&-E<;,'YF8YW#M@$XIFGZ!K\
M>H^!)[G3HT31;*6WNO+N%;!>)(P1G&>4R?3/&:]#HH \NOO!.N:G8>)T2*.T
MNKG5X]5TYY)%92T80!7VDD9V'UZBM8V7B;5O&GAO6KK1;>RAL8+F.Y1KT.09
M @RNU3D?+Q^N._=T4 8WBRTNM1\):MI]E#YUS=VDMO&I8* 70J"2>PS7,WGA
MG6)=)\(W]K;HFK^'M@:VDE&V=#$(Y55AD D="?QQ7=075O=>9]GGBF\IS')Y
M;AMC  E3CH>1Q[U+0!Q5UH-_J6N:GXBDLFAG?2&TRTM&D0N=S%F9R"5')4
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M-C^X#L01)Y8ZCD9/&< U7G\'^))/A_XKT(V-K]HU+499[8QW(VE7D#Y.0-H
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MI)%(H964]B#61IO@S0=(FCEM+)P8SF-9;F65(SV*J[$*?H!0!O4444 %%%%
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M:)"T5RAC)493_3L<>G'%=IHVB:S8>.)M8_L6SM=/FTN.W%O;W +1LCNVT#:
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MGPGI>I:=KGB6XO;3R8=1OOM5NWF*QV[%3# '@_+GN*=XV\/WNLP:7>Z6T?\
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MX-G=1[9&1D(8(W\2]&]>,XQS4^H_$&>*RFU/3=/6^LX+IH&MX]YN)563RW=
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M=@6/'+';] /QJ+3?&L46@ZK?SZ9;VDT&LR::L$#Y6:;>J;BVT=6.2<9P.A-
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M#XK>"6P,F'4 3_VSCK5\;>(;CPIX2O=;MK..[:U4,T<DICX) SD YZCCCZT
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M@Y;;U/3 ISZ#K5GXQ3Q/:1VDTEW9"UU"S\XJ 5;<CQN5Y(SM.0,CGCI7944
M>=:KX%U6X\.:G#:_8CJ>J:K'J-P9)F6.,(Z,J*0A+85 ,X'))]JZ7Q#J6MZ>
M=)?3K6QE6:Z2*\BED;?M8@?NL#DC)))XP,^N.@I"JE@Q4;@, XY% "T444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !6/XBUZ/0;6U;RO.N;VZCL[6(MM#RN>,G!P
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M10!Q,WCB\?PO<>*['3X;C1;=Y"4\PB:6&-RKRKQM'W6(4]0.H)Q4::_JE_\
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MOVAMRF.,I\_R<9SGC- $\'BRZU+2-"O["Q6*WU.V-S-=7+?N;-0H.'(QDDG
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MEA((9?NMSR".,<<UPK?#_5K+2[F'11:V]I+JT-ZNC2W#& PJN'B+ ' =OFP
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M593U!%1Z=I=CI%J+:PMH[>$8^5!UP !D]3P .>P%6Z* "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
/"BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>ex19iiinsidertradingguid004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex19iiinsidertradingguid004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPI_2/^@_XF_\&;?X4?\ "G](_P"@_P")O_!FW^%>AT4 >>?\*?TC_H/^)O\
MP9M_A1_PI_2/^@_XF_\ !FW^%>AT4 >>?\*?TC_H/^)O_!FW^%'_  I_2/\
MH/\ B;_P9M_A7H=% 'GG_"G](_Z#_B;_ ,&;?X4?\*?TC_H/^)O_  9M_A7H
M=% 'GG_"G](_Z#_B;_P9M_A1_P *?TC_ *#_ (F_\&;?X5Z'10!YY_PI_2/^
M@_XF_P#!FW^%'_"G](_Z#_B;_P &;?X5Z'10!YY_PI_2/^@_XF_\&;?X4?\
M"G](_P"@_P")O_!FW^%>AT4 >>?\*?TC_H/^)O\ P9M_A1_PI_2/^@_XF_\
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M+10!YY_PI_2/^@_XF_\ !FW^%'_"G](_Z#_B;_P9M_A7H=% 'GG_  I_2/\
MH/\ B;_P9M_A1_PI_2/^@_XF_P#!FW^%>AT4 >>?\*?TC_H/^)O_  9M_A1_
MPI_2/^@_XF_\&;?X5Z'10!YY_P *?TC_ *#_ (F_\&;?X4?\*?TC_H/^)O\
MP9M_A7H=% 'GG_"G](_Z#_B;_P &;?X4?\*?TC_H/^)O_!FW^%>AT4 >>?\
M"G](_P"@_P")O_!FW^%'_"G](_Z#_B;_ ,&;?X5Z'10!YY_PI_2/^@_XF_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ZK2=575X)IH[::&..>2 &7;^\*,5++M)XR".<=*QM?UV&YL];TZUL+J_%G
M1=M RJ(V*;@H)8%FQ@D#L1W.*Z#3K&'3--MK&#/E6\2QJ6.20!C)]2>IK@K&
MUUKPYJ_BO3VT:[O[35[F2^L[NV*%0SH%:-]S#;C P><C\J *WA^]TJW\"?#R
M+5=/N+EYI+=;.5#\L5QM;:S?,#TW=C71S>.HEUW4-'M]#U:ZNK!X%F$,2$!9
M<X<?-]T #WYZ<''+0:/K2>#?A_92:-=K<Z5?V\UVF4/EQHCJ6X;G[PXZ]>*Z
M30K2^@^(_BF]FL+B.SO8[1;>=@-KF-&#=\CEAC(YH GU3QYI^E6DFHRVMS)I
M,-Q]FFOHRA2-M^PG;NW%0_RD@=1QD<U9U/Q;!8C43;6-UJ"Z9&)+QK;9^[&W
M?M&YAN;;AL#L1W(%<?H>GZOH$MUX>N/!T>H_Z3*]EJN(C$T<CEP9B?F!7<<@
M DXP/4WK0:_X1\6ZY'%H-SJVFZO<+=VT]H\:^5*45620,PVK\HP>>/7L :#>
M,KJ?QKI.F66FSRZ?>::U\)045G!*!3M9@5"ACG/))X'%7;SQK:VMG?ZA%8WE
MUINGRM%=7< 4JA7AR%+!F"\Y('8XS@UGWMEK,'Q!T/6&TYKN,Z9+9W#VS*%A
ME9T;)W$'9\IY&3QTS67I.EZQH7A;7_"DFEW%T\TES_9]RF#%,DV2-[9^0J6.
M[/;IF@#H-2\=V=EJ5K86VG7^HS7EFUY:FT166=  ?E)8<X8'G _' J4^,8VC
MNFATJ^E:RBBDO(AL$D!= X4J6R2%()Q^&2"*P-.\/7VB>+?"<,=K<7%EI>CO
M8S7:@;!(=F#@G./E/;C(J+Q=H%SJ.K:AJ&DV&HZ?XC@V+I^HV;8CNUV*=LW.
MW:&+ [@. ,9Z4 >BW$\=K;2W$S;8HD+N<9P ,FN<T_QK;7U[I-N]A>6ZZQ;/
M<V$DFPB554,00&)5MK X/\^*V=1.HKH5T;$1-J8MG\@-]PS;3MSGMNQ7G%CI
M^MR^(/!NL3>'=1^T6J7$>I3W,L9D,CQ!=WWC^[#;L 8P#POJ ;LOQ-LHM-OM
M1_L75C9Z?>/:WLOEQ@6Y1@K,1O\ F&3T7) &3CBN@OM=ACU%-*M;:6^O9(#<
M-%"RJ$BS@,S,0!DY [G![ FN FT769?AWXVTU=(NA>:GJ=W-:1$+F1)7!4YS
M@< YR>*U8X-7T+QVVN)I%Y?:=JFGPV\JP!3+:RQYP&4L/E()Y!ZT 3?"=@_A
MS5&6*2%3K-YMBE^\@\SA3R>1TZ]JZ*[\1+'J-WI]C8W.H75G&LMRD!0>6&R5
M7+,,L0"0/3KC(SD?#NRU&PT[5X]2TZ:R>;5KJYC$K(=Z.Y((VL?U_#-0V5GJ
M/AKQYX@O7L;F\TS61#/%+;*':*5$V%&7.<$8(/0=#0!2\:>,!>_#%M7T$7$D
M-XT<1F0JC0YF1'5@6!#<LO&<'TZU0\3VL.AW>D2:;X?NK-=:U6VAOK:.2(1R
MJGF'R]@DV[FV@D]".">HINH^%-6LOA9<Z7!82W&I7^I"^>WA*D19N%E*[B0.
M%&.O)SBNA\:P7VHW'A:2RTZZG6UU>*\N-J@>7&JNI)R1S\PX&: (/#]EX:T?
MQ_=V=CHESI^JSZ>;R1G<>4D3.H*( Y5?G!)P,9!P<&M0>-K0G39UL;UM.U*Y
M%K:WRJI1W.=K%0=P1L'#$>G0$&L^ZTR\O?B=->&SN4TZ?0&L3=;0 LC2[L8S
MG[IZXQGBJO@FX\3Z5I-CX6OO#\T<U@%@.I>8AMG@4X#+SN+%> N.O)Q0!L:O
MXYL=(M;J_>TN9M-LY_(N;N+85C8-M8A2VY@K'!('8XS@U'>>/8+?6+O2[71=
M5O[JVABG*VL:,)(W. RG=R./KZ#KCG-*L-6\/:EJ6C3^#DU:.>]FN+'4@(O+
MV2N7Q,6^9=I8\@$GL.F=W2K&_@^)VIWLMC,ME-IUO;1W(4"-GC+E@!G('S<<
M8H U$\4Q3SO]FL+F>VCOOL$EQ&4PDH8(V5W;@H8XSC\,<UI:OJMMHFDW&I7C
M$00+EL8R<G  SQR2!S@<UP%WH%XWB4:OH=C?Z1K1U/;=[#_HE[;"0@R2#)7)
MCY[-N/3O7;^)(_.\/W41TP:FD@5)+/C]ZA8!@,D#.W)'(Y% %#4/%PTFPU2[
MOM'OD33H$N)=AC;?&V_E#OP<;#D'!Y'6IY_$UK'J^C:7);7.[68Y'MY1MV#8
MF]@WS9!QZ UQ*^$-470O%.BZ.]^=#NM,*6%KJ+G=%<$-E(RWS!,;>O&3QGDU
M:1=;U+Q#X'OO^$<O[>#34GCNO.:-60M"$SC=]W/OD\X% &=X8\51>$M)\0N^
MCZI=6-OKMYY]Q;1ADMXP^ 3N8%L <[<X YQ77W6JZ'=>,O#8:SFGO;JVGFTZ
M^4_NA&44O_%SD%>J]ZPK'3]7L=$\6:&='N'NM3O[R6UD^7R&CG^ZS/G@#.2"
M,\< U))I8T7QI\.-+1S(MEI]Y!OQ][;%$N?QQ0!M:IX\T_2K234);6Y?28;C
M[--?1E"D;;]A;;NW%0_RD@?3(YJSJ?BV"Q&I-;6-U?IIB![QK;9^[^7=M&YA
MN;;AL#L1W.*X[0M.U?0'NO#UQX.CU _:97LM6VQ&%HW<L#,2=P*[CD $G&!Z
MF_9_V_X1\6:Y%%H%SJVFZO<B\MI[5XU\J4HJLDFYAM7Y1@\\>O8 T3XQNI_&
M^E:79Z=/+I]WIK7PE!16<%HPIVLP*A0QR#R2>G%:GC/7+GPWX0U+5[2U-S-;
M0LZKN "\?>.>P]!R:Q[RRUF#XA:)K#:<UW&=+EL[A[9E"PRLZ-D[B#LX/(R?
M:M?QQIEUK/@;6].L8_,NKBTD2),@;FQP,GCF@!L7B7RK32XKBRN3J=^I\FUS
M'O<*H+.2&VA1D=^X&,G%6=$\1VNM7%_9K%-;7^GR".ZM9P-\>X95N"058<@@
MURD]EK"ZWX7\4QZ3=".TMI+*]L24,Z1N%Q( &(.&7D YQCC/ V- TB<^,M=\
M2S0R6\=]'!;P12##LL8.78=LEL 'G YQF@"UKOBZ#0M8T_2WTZ_NKG4%E-N+
M=%(<QKN*\L.>G7CGDC!IH\6>9;KY&D7TEZ+9;F>R;RTD@5L[5;<P&X[6P 3T
MYQD51\1VE]-\0/"5];V%Q-:6)NOM,R 8C\R,*O4Y//IG%9>M6.HZ+X\O-7'A
MHZ_I>IP0HZPK&TUM+'D# <@%6!ZYZC\P#33XE:1<1Z))96FH7:ZS'*]IY,()
M+1@[D(+<,#QZ=R< FIM.^(.E7>G:O<WD-UILVD,%O;6Z0>;&6^Y@*2&W=L'F
ML'6I)['QIX EFTT0ONU!FM+10WE*T0XP.&(!&<=2#C/%0:_X*U3Q(GBO5+6,
MVMS?_9/L$,_RF3[.=V7'\.X\ 'D8!.* .Q7Q5%%K5II6H:?=6%Q>QL]IYQ1E
MF*C+)E6.' YP?P)K/L/'HU6>6+3_  ]K$YBNIK25]D:K%+&.0S%\#)& ?IG&
M14%]:WGBS6/#5W)IEW81Z7.UY<_:% 8.$*B)<'YLDY)'&%ZY-3^ +.^L8->2
M^L9[4W&LW5W#YH'SQ2-E3P3^1YH Q/\ A+[;6OA%-KGBC0[N?3YP6FBA9,.I
ME.T+AP<*0H).#WYYKJ-1\6P:;X@@T)=,U"YO)K9KB$0(FUPI *@EA@\]6P/>
MN%70]?\ ^%%7'A=M#NEU.)/LZ)NC(E/G%BRD-]W;CDXKJ;FWO9OB9HVJKIUU
M]ABTR:"68J,([LA (SG^$]!B@"Y;^.],E\,7&MSPW-L+:Y:SFM9%!E6X#A/+
MP#@DL1CG'/4<U/;^*XY/%'_".S:;>0W_ ) N<_(T?E$XW;@W]X;>G7VYKAKG
M2[R/P3XJMKS1[DSWVOO<V46]4D<22H4>,YQO&"VTXZ<\5M^']123Q>EYJNBZ
M_;:I=V_V*&ZOX(EB"+ND*#RV(!."Q)ZXXQP* .HUSQ#!H,VF)<VUQ(NH7D=E
M')$%(21\[=V2#C@\@&JTGBRVBU;5M-:QO#/IMLMU)M5")8VSC9\W7Y3P<51^
M(.GWUWIND75A9R7CZ;JUM?201$;WC0G<%R0"<'.,]JR8X-8G\8^(-5?0;V*U
MO='C@A+-&6WJ9/E8!N"=PZ9 [D=@#3LOB)9W@T.8Z5J4%CK++';7DJ($\UE+
M*A&[=S@C.,9Z$]:=XGUV&[T7Q#8VMA=7R65N\=U+ RJL;[-VT98%F (8@=,]
MSQ7.+H^KIX(\!6!TF[-UI=_:RWD8"_NDC5@QSG!ZCIG-3V=IKF@/XOTAM%O+
MZ#5;FXOK*[MRA7]ZO*/E@5*D>^>W;(!J^$-9CL? ?A2S2&2YO9]*BD2"-E4[
M%1 S$L0 ,LH]<GIUIS?$O25TJ*^-G?\ .I#2YX5C5GM[C<%*N W(YSE<YKEX
M-%UW1['PCJS^&GU$6.E#3-0TUS&TJ#Y2)(P25)RO3.<'\M;Q#9:GJ.A:2]KX
M;>U9=:MKPV<*QAXX8V!9I,';N.#P">P]: .VT?4Y=5LWGFTV\T]UE:/R;M5#
MG!^\-I((/8YK0I%;<H;!&1G!&#2T %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;33YO)NBMTBRY! <QQGE]I.#DCD'&:ZEI3?:49K"9=T\&ZWE(X^9<JWTY!H
ML[UW$;AD#)&>E+7BNAW/AZ\TY?"/B?3QHGBY5V_:[E<-=2_\]5GZON/4$\YP
M,BO2M8\4P:=J#Z= +>6]C@%PZ3W2P*%)(4;CG+$JV!C'')'&0#H**Y/2O'MA
MKVFZ3/I,$DUUJ8D,5M(P0QB,XD,C<X .!D Y+# J.7QTUMIT=U=:+=0,-472
MYHY#@K(S!0Z$C#QG(.X8^E '856U"TCO].N;2:66**:)HWDBD*.H(P2&'0^]
M93^)3'XINM!_L^62XAL!?HT;J?-0N4VC=C#9!ZG'O6+IOCE_$/A]M3'A>^?1
MYK"6<R-)$0^TE3'M+ \C/)XX.,]2 =)H&CV.C:8D%A++/')B1KB:8S23' &Y
MG/WN  .V  .*T?-C\[R?,7S=N[9GG'3./2O/9O%-Q9Z'X''A_28H+#5I(46$
MRA3&GEEQ&./0<GV]^-R'5-/;XASV<VD?9]4CTD3/?NRG=!YF-@(.<!LGG'3I
M0!U-%<2?B5IJ3Z5(T<9T_5)UM[>=+E6D5G^X7BZJK>N21D9 K3L_%+:C,SV5
MB)[-+Y[&25)QYD3JQ1F9,<+D<<YP0< &@#HZ*R?%$$-QX5U6.>))$^R2G:Z@
MC.PX->;^%(O"5Q\-]"M]0T02W5[##:O/_9C@EY&";O.*8R-V=V[M0!Z]17-:
MUXLC\-ZSIEAJ%J8[&])C347E B1PI.U^."<<=C4I\3^1H5KJ-]I\UO->3)#:
MVFX&25W.$'. N>3ST YQR* -]F"J68@*!DDG@4(ZR(KHP96&0P.01ZUP?BS5
M'U3PGXPTG4]'>":STR2=9"/-@D!C8JR.5'S*1R, @],U)X<\5/;)X7T:[TFX
M@AU"Q5+2[9U(=TB#$% <J" 2"?R% '<T5R-QXY%LT=Q+I<R:=)J@TL3N^V3S
M"VS?Y9'W-W&<Y[XI;CQI<_VYK.CV/AZ\NKO3(XI2/.C19%<,0023C[O ZG/0
M8)H ZVBN7A\<6-WHV@WUI#))+KC!+2!R%(;:6;>><!0IR1GV!S4<'CNV$^NP
MZAI]Q9G0QF\EWH\?(#($Y#-N4Y&5'IUH ZRBN3LO'5K/XGL]"N88HY[Z)Y;5
MX+I)U;8,LC[?NL!SW!YP:ZLD $DX ZDT +GG'>L6/PQ8IXDEUUYKR:Y?!2*6
MY9H86"[=R1YPK$9&?<^IKB=/U>_L?B/8ZS>3,='\51-;6R'I"T1)@_[^(6;'
MJY]*[O4]:6QO[/38(?M&H7@=HH=^U0B8W.[8.%&5' )RPXZX -6BO/\ 7_&^
MJ0^'5N;/2);6[&KQZ;.MRVT+F106C./G5@<!N.N>V*[R!Y7@1YHA%(1ED#;M
MI],]Z )*CFGBMHFEGE2*->KNP4#\37*7'CR*'1'\0II\DV@1RF-[M) 7VA]A
ME$>.8P1USG'.,5F:U?W=]\3=$L18Q7FGG3[B>.-IEV2Y,:^8001P"0/9CZT
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M,H8_*%/(&#SD:QT34++Q[H5Q:Z=-+I>G:6]B;CS8P<DIM.TL"1A.>.]=O10
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MJHFQCD9)))QT'J<<Y<>&?$$_PT\5:*-(E%]J6HW$]NAGAP4DE#@D[\# '/\
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MT4 <7\2=*U36]$LK32M/>ZECOX+E\21H B-D_>8<UUCK));22PQB&[>(A?-
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M>AZ+=:G+!/.ENF_RK=-SOV  ]<FN,DT76F@\ J-*F)T<H;T>=%\F(#&<?/\
M-R<\=ORKI?&,.M7'A._B\/-MU1E7R?G"$C<-P#'A25W 'L2* (K3Q4/[?O-&
MU.U6RN;:R6_+K-YD9A)*DEL @@CD8_&N.\:ZJ^N:5X5U-=(VV4^MV4EI=.X,
MJJ9!ABF/E##D8)/3(%2'PGJE_P")+V1="32].U+P^^G2/]I1Y(9&9B6<*3N8
MYZ@G/=L\5#-IGBZ[\'Z!H<_ATB[T>^LV><7<7E3QP,/F3YMV2 "00/QZ4 =M
M8^)6N_%FH^'Y;$V\]G EPLCR@B>-R0&08S@$$'/0^M1)XIN)XM*6#2G:XU,R
M- #(?*6-!G>[A3M##&T8).1TYQ1\7>&M0U36-&U32W6"Y3?97S;L$VDJ_/@]
MV4@%?<YI_B>QUAM7T-;'3OM^AQ"1+RRCF2+)P!&6#$!D'.5_'!P* (9?B-;Q
M>%EUO^R[IPM__9\\2,I\J42>6><_,,], Y]!5^R\7^9XAO='U/39M,E@L_MZ
M/+*CJ\&XJ6)4D*0>HR?K7%?\(KXE3P;J&D#0T$KZ_P#;HA#<QE3%YXDR,D8&
M!@9P?85T.J^']0UCQU=7$EC-%IEWX?ETQ[CS(R4D=]WW0V< =_7\Z -.W\6S
M3RZ1+_8UU_9VK-BVN4.]D!7<K2H!\BL.0<G'<"L[5/B9IFF6[:@RQ2Z7'<_9
MI9DND\U3OV%Q%U*!N^<XY (YH\'MXPL]/L-!U31H;=+!4A?4UND=)XDX&Q!\
MVY@ #NQCD]>*I>'K/Q?X:6;PW'HMO=V*SR-9ZN;E L<3N6_>1GYBR[CP.#TR
M.M '8^(X(;KPQJD4\:2Q-:2Y5P"#\I-<'X4\:/H7@_PE#J&B7D6E7%M;6JZG
MO0HLC* N4!W!2>-QQ^6*]&U*V>\TJ\M8R!)- \:ENF2I S7!6WAS5]3\#:'X
M2OM,DLULS;+>7,DL;(R0E6_=[6+$L5 &0, G/(P0#I]+\3'4-?UC1YK(VEQI
MBH[&24$2HX)5UP/N\')['C%:&B:D^KZ/;:@UL;<7""1(V;<=A^Z3]1S^-<KX
MVT":^\2:'=:?<""YN_,TV] ZRV;*7?IT*[>#V+UW*JJ(J(H55&  , "@#DM1
M\<C38[N\DTN;^S+2_6PFG=]CEV95WHA'S("X&<@G!P#4MWXON(_$U[H%EH-W
M=7MO:I<J?-C1)%9B =Q/ R#UY]L<UQ_B#P[XKU?2M?MKC1%O;]M12:RO'NXP
MIMEF1ECB4G*$*I!!V@\G)-=/9V.KI\1[W6Y]*D2TFTJ*V#)-&W[Q79R,;@<?
M-@' Y]* &'XAPMX:T77HM,F-EJ5PMJ[/(%^RR%S'^\_V0P(R/;CFND_M-V\0
MMI26^Y4MA<23;^$#,552,=3M;'^Z?QY/PSX5E?X63>&?$-H;4R"Y63=(C!0\
MKNK@J2,C<#SW%:?P_M+^/PO;W^K3"?4KY$EFE (W*%"Q]>>54,?]IF]: &^,
M]?U/1KSP_;Z?:QR)J&HI;R.TFTXPS;0,=]IR>WX\20^+KB2_US3VTAEO=)@C
MG,/GC_2%<$@QG'^R1SCGCWJ/QQI>I7YT"[TRT^V2:;JL=W+ )%1FC".IP6(&
M1N!QFH/$/AG4-3\2Z1J=KY<(FMWL-74-G-LV'P#QGYE*@]?WF: +^F^+!JVB
MZ%J5I9AUU=P$C\X9C7:S$L<=@I!'KQS5>Z\;K%I5[K5KILEWHUC*\<]Q'( Y
M"';(Z)CYE4@Y.X$[3@'C,/A'PK=Z#K>K>:R?V7'<2-I4:_\ +-)MLDHQV <8
M'T/K63IF@:[HOA#6?!Z::US%,;F.POA*@B\N8L?W@+;P5+G.%.>U 'H=K<PW
MMI#=6TBR03QK)&Z]&5AD$?4&N6N?'4<.BS>((M.DN-!@E:.2ZCD&_:K[&E6/
M'S("#SD' ) (K?T72X]&T"PTF-R\=G;1VX<\%@JA<_I7!:=X;U[3?A]J/@7^
MSS,K+/:VFH^;'Y1AE+$.XW;PRASD!3G P>X +GBG4[R?QOX/M;:UCN["X-S<
M*IF 2X*P_*2"/X=Q(ZUTT=A;>%O#MTNBZ=&BQ"2X2U$A5"YRQ&3G:,YX P.P
MK OM!U"T\4>"VL-/FN-.T2">&6;S8P<-"L:8#,"?N\_UKLKV%KFQN(%(#2Q,
M@)Z D8H \GUC4[K7/AWX/UO5+-#=MJUA,DB8=FW2 G:,97/3'TKN+'QBCZKJ
MNG:MI\NERZ?:B])EE617MSN^?*YP05.1S]37)KH'B5OA]X9T:30W6ZTN^M'E
M5;F([DA?+,#N Y &!G/7..^KJWAK4=;\8ZV\EG+!IVHZ =,%R7C.V0LYSM#9
MQAQVZB@"Y!\0[)M8TFRGAC2+5B5M98[I)65\9"RH/N$CI@L,\'%,^)VO7NB>
M&K:'393!?:K?0Z=#..L)D)RP]P <>YH\*W'C#R;/2]9T&WM#:*J3:DMTDB7"
MJ, H@^8%L#.[&.3UP*T/'7A9O%OAPV4$ZV]];S)=6<S#(29#E2?;DC\: )D\
M%^'TTW[$--A^[@W&/WY;'W_-^]O[[LYJ*VU!M):P\+V,8O\ 4K73T>0O)Y2+
M&N$#,V"<L0<  ]#G%.L-:UZ:W2*\\,7$%\!AW%S";;=_>#!R^W_@&?:LR72-
M7TCQ\/$4%NVI6U[8):7L<+(DD<B'*R*'8 J<D$9R.O- !<_$BSM_#4^K_P!F
MWC/:7HL+RU!7?;3;PN&YY&6&"N<Y%/O/'5WILUG#J'A;4H)+V]:TMU$L3^9A
M-RGAN,X(P>!@Y(K!UCP?K$GAG7&MK!I=1UC5XKXVZRQ@0QQR(0K,6 +;4).,
MC+8Z#-:?C^>9-5\$S1VDDDHU<'R RAS^YDR,D[<_CCWH N6'Q!MC+K5MKEA/
MHUWI$(N9XIG60-">CHR\-Z8'<@5:?Q<UE>Z3'JNF265OJSB*UF\T/ME(RL<H
MP-K$9Q@L,C&:PM>\$W?C"[\07MQ&VGF\TI-,M$E92WRR&4N^TD %MHQG. >F
M:LW.EZSXILO#MGJFEO8/IU[#>7DS2QLCM$#@1[6).YL=0,#/?B@"Y8>-KK4]
M8NK"T\-WSBSOQ9W4K2Q@0@J#YA^;YAST7)Q]0*6V\<B6?1FGTN:WL]8G>WM)
M)'Q*&4,1YD9 VA@IQ@GMG%-\*:;JMCJWBJ6YL'MEO[XW-K))(C CRU09"L2#
ME<_2N5B\/^+)X?#5U>: LFKZ?J8FO[J6]C+W VN-RGG$8W#Y>".@4T ='H_B
M^]DU7Q7)J]O%;:;I$VTR++N\M%B#DD8Y)SGCITYQFK%MX^M)/$.FZ5<PQ1G4
MU<VLD5TDQ#*-Q24+]QL=,%AVS65-X3U:]N/'&E2VRQ66NGS(+[SE*J3"J;2@
M^;(91V QGGM6IX9O?%]S]FM-;T""P:W %Q>K=)(MQ@8_=HO(W'!.[&!GOT +
M'Q!M=6N_!MW'HT33W(:-WMU?8T\2N"\8/;<H(]\X[US_ (4U#P=XFUFPNM%M
MX](UC3F?[3IK0BWEVF-D*L@P&P6!!YQ[9Q7::^^JQ6,4FC0+<7*7$9:)I @>
M/=\XR>GRYQ[XKE]3T"?Q%XRT#6(]#FTN?39S+<7L[1;Y8]I'DCRW8MDD<G
MSC.<4 3ZS\2-/TB"[O1'%/8V5P;>Y9;I!,"&VLR1'E@K9!Y!X. 1S6E=^*R6
MU!=(L&U(Z?"LUSLDV9W+O5$X.YRN#C@<CGFN>T>T\7>&+[4-&MM#M]1TV>\E
MN++4&ND18%E<N5E0_,=I8_='/\I$LO%'A?QEJUUIVD+K6FZP8IB5N4@>WF5
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M2:+?%, NV6-@XX)W="",_F :[^*7C.FVLMB+?4M0FGBBM[B<(O[HD,=X!SD
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M.(B<@.%R 2.HS0!H7&H65G(D=S>6\#O]Q9954M] 3S5A65L[6!P<'!Z&N/\
MA]I$!\&:?J-ZB7>HZI;I=WES,H9Y6D&[!)_A ( '0 5.38^"8XM.T^ /+JVH
M,+.T#;%5F7<_/.U %9N <9  Z4 =517*#QA/!JFIZ/>Z:L>J6=G]NACBGW1W
M,.<%E8J,$$8((^F:R#\1=67P>_BA_"Q&F"P6[1_MR[F8D H5VY YR&YR.PH
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M+][>N]L8!!XY%=RUQI^CVT,$UW%;Q@;(_M$_)QVRYR:EGU"RM8#/<7=O#""
M9)) J@GIR3WH Y+1_#=[I'CI+N&V']DPZ+#ID4AE!?,;$@E?0@X]<]JP=?\
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M74&L84EF*W*'+!7:(J/E)7LW 93SFEC\8:S>>(M4T?3_  V)WTVY@BGD>^5
M(Y%#;Q\O) (.T>_/0'FT\)^+GTW2$N;#3YM2L-:COKF]>\.^]56?!SLRH <#
M'.,8 KJO#NE:I9>,_$^I7EJL=KJ;V[P,LH8CRXA&=P[9(R.OO0 W3O&DMUI/
MB"YO--CM+O19GBEM?M)<N54,ISL'# C;P<UU%J\\MI%)<PK#.R R1*^\(>XW
M8&?KBN+U+0%O/B;97=I<A;>>U$NJ6Z\B7R9 ;=B?7>3]0A%;MSJNJV_C&RTT
M6$#Z5<P,3<B;]ZDBY)RG]S 49]7% &XS!5+,0 !DD]J\LM]1O=+^(6E>)KJ9
M_P"RO%(-B(VX6#:2;4_5UR<=B[5W'BJ#4;W1FL=.MO-^U,L5PWFB,K 2/,VD
M_P 17<![G.>*P_&7@/3M4\)W5KHNB6-KJA"/:S0Q1PM%(K!@=P' XP<4 ;>M
M^(X])U;3-+ M_M6HB4PM<S^5&=FW*YVG+'>,#'8^F#3F\636]UI.G7-G;VFI
MZBL[+%=712,&)@NU7V'<S;@1QTR?0&KJ>FZAK^E:=:>(O#=M?V[0.+^%)DW)
M-\FUXF)''^L[J1D5G0^$+P>&=.T'7M,37M/2.;S \RF> E\Q!78KG:A*D@CH
M,<4 :FJ:^T5SX774_#T1GOK[R5,D@;['*%?YE)7).%/(QP:L)XLFO-5O[/3;
M.WN6L+R.UN(FN2LZJQ3=((]I^4!L]1G::P5\*:_;Z5X.M')OI-(OS=7$DDX+
M"/$@5 3]YE5U&> =M2>(?"5[KVH?:UTQ+/6;>\5K+6K>95(@#@XD PS';N7;
M@@\<C)H MZ1XBUN7Q;XMAO+2&2STKRE2.VE9I,>49!M79\[-N /(QP!G&:LV
M7C*YDU[2M*O]+CMI]4LGNH8TN=TD14!BDJE5VG#=>>01VS51] \1V_B'QA/I
MQMH8]9AC>UO#*=T,J0>6 4V_W@#G/3U/%9VG>&_$<.L^%-1;2+"W&FPSQ7BK
M>%WD:1$!E+;?F)*D\DDYY([ $TOQ)U"/P_?:X?#@%CIUZ]K>$WHWJ$D"%D&W
MYB"<D';[$]M*76];/Q5BT6*&U.G+I1NL&=E9@944N1L(+#! 7IR?FYP,*?PC
MK\WPY\2Z%]BC6]U._GN(<SKL"22AQN/8@#'0]OPZ"72-87X@V&OV]K UM)I?
MV"X66?:T!\T/N  .[C(P".>XH O>.M,U+6/!6J6&D.JWTT0$89MH<!@60GMN
M4%?QKD_#^O\ AGQ-KNEVEWI8T#Q1I4FY;&>$1N1L92L;  ,F#G'MG'&:[K7X
M]4DTAQHIB%^)8GC$SE$($BE@Q ) *AAP.]<WKF@WWBS5M!EN-(33VTN^2\>\
M>9'<A.?+CV\D,<9+;>!T)H =K/Q!BT^/4IK*"SNTTV4Q30M>B.>5EQO$4>T[
ML9QR1D@CT)O_ /"52ZA-/!H-BMY+;VD5U*)Y3"!YBEHXQA6.\@9/  R/6L>T
MTSQ?X:U_58=(LK#4=(U.[>\CEN+DQ-:22<N& 4[USR ,'W%+/H_BCP_XQNM9
MT6WM=7M]4MX8[V&XN/L[)-$NT2 [2,$=0!0!8N?'.H1W/AZVB\-7'VG6H972
M&YF$+PO&FXHX(.!TY].Q/%2S>-)XLV<EII]KJT-JD]U:WFI+&L;/G$:N%.\_
M*>< #(]:9J&CZY<>*_"FI/#%<+IOVEKQTD"#,R;0(P>2%]\' '4U%JFF>)M&
M\:7.O>'K2UU*UU*".*\LY[CR&1X\A9%?!&,'!&/_ *P!0;QQJNKZEX*ETFRC
MAM-6:Y:6"ZF:.3?'$^4;"'"@\@X.2!P!6IX@\<W.@VFIZA-H^W3].N(X'>><
MQ27&[;N:%2N' W>HSANF*36-%\0W&J>%=8C2SNKS39KAKF$RF) )HRORMM)(
M3('3) Z<U@>(/"/BK5K#Q98O:V-U+J$FZROY;@AHX?D(@5-IVX*GN 2<G- '
M2:OXNU2T\52^'],\/_;[H:>;Z)FNUB5QO";3D';W_''3DBSI/BBZO/%&I:%J
M&FQ6$]I;QW,;?:O,\^-\C</D& I&#SU]>M5+?2]:;XCP:[<6,26O]D?89/+G
M#%9#+YF1D E0.,\'/:H/'.A?VMK&@R65W]GOGGDLIBG62T="9E/I@*"#V8CN
M: .FT'4IM8T:WU":U6V^T#?&BRE\QG[K9*CJ,'&.,UE2^*;NY_M=]%TR.^BT
MJ5H)B]P8VEE50SI&-IR0"!DD9/'O72HBQHJ(H5%&%4#  KB]*T?6O"VJ>($L
M+..^L=4NWO[=S,$,$S@;UD!YV9 (*Y/7B@!)?B&+AO#;:/I37\.O1RM;NTXC
MV,B%BK#!QR,$]L'KC!Z./4KN'PTVIZE8?9+J*W:::U642;"H)*AAP>G6N-LO
M!-_H,_@:VL(EN;701/\ :I3($+M*A4E5/^TQ.#CC'6O1)(TFB>*10R.I5E/0
M@]10!PGPNMAJOA2+Q-J:I<ZMJS2333NNXJF]@L:Y^Z@ ' XZUG?$;PYIVB^!
M=;N+.V1%N+ZSN!$J#$<GG1(Q3TR .![^M:GAC2->\#VKZ';V*ZKHT<KO8S1W
M"I-"C,6\N17P#@D_,#^%3^--'UWQ#X/N;"*& W=Q/ Z0B4!(4CE1SER,L3M/
M;'(';) +ECXHOI/%LV@:AI"VLK61O;5TN1)YB!PA5AM 5@2. 6'/6L[1_&.G
M6_A>XU+^R[?3,ZI+9+;+(JJ\_F;2S-@ 9.6)P> >M6Y=,U.3XD6FO"R(LH]+
MDM'S*N_>SJ_3/0;<=>OM7/Q>"]??PA<VL?D6>KV^MOJ]BSR;XF8R%PKXYZ,0
M?K0!T&E^,9]3UJ_T:.SLWO(+=;F"6"\,EM,A."#($RK ]MI[&LGX8VIUGP5H
MVH:M8VLLT,LUS;7)D+R^8TLF]B"HVGGU.?;%=%HUWXGN8I+G6=+MK)HXRB6=
MO<B8ROQ\Y8@!1Q@#GJ<GI5?X>:1J.@>"['2-3@6.YM0X9HY Z-N=F&#UZ$=0
M* .IHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *KWE_9Z?#YM[=P6T6<;YI @S]2:L5Q_
MQ5 /PN\0Y&?]%/\ ,4 =5:W=M>P">TN(IXCTDB<.I_$5-5#1 %T#3E4  6L0
M ';Y17,ZOXVNH?[6;2+..Z.ER&)X620O<NJAF5"JD*1G SG)SP!@D [6BN5C
M\5S:EK=EI&GVWV>YN-+&J.;U&!C0L%5"@P=V<YYXQWS5/1_&>KZUX:M]3AT*
M))9[W[&52Y,BP!699)9/D7"KM/ SG(Y% '7W=Y:V%K)=7EQ%;V\8R\LSA%4>
MY/ IUM<PWEK#=6TBRP3(LD<BG(92,@CV(-<-)XF/B#PKXVLI5MG?3;>:$SVS
M[HIU: L&'IUP1D].M=#X*_Y$/P[_ -@RV_\ 12T :E[J-CIL2RWUY;VL;':K
M3RA 3Z#)ZTMG?V>HV_GV-W!=0Y(\R"0.N1U&17!^!+A]>\;>,-7O?GGL;]M,
MM%;GR(H^NWTW'D^N*/$,[Z!\7O#$UC\B:['/:WT2\"7RU#(Y']X%L9ZXXH [
M/4->TG29$CU#4;:U=RH ED"]3@9STR00,U'?>)=$TVY%O?:K9V\IR-LLH7G&
M['/?'..N*XSPY!J&K>)/&]MJ-KIMU"]W''+%-N="1 FQ0".5S@G\:J>%GNY/
M!OB"^U#3=-U%+74[VZ6*=CS+'(3U*D# '!QGITH ]-M+NWOK2&[M9DFMYD$D
M<B'*NI&00:FKD-/\5-=:7X8M[.T@CO\ 6+(7*19(BMXU168X') +*H'&<]1B
MED\6:AIVGM_;&EBVOGU'[!:X<F.YX+"48!8+M#'&"?EQ0!UU%<%/XZU6SL_$
M32:.LS:5:_:X;@"2&"YC )89920ZX^[SGU%=!X;U+6M4B-UJ6GVMK:3012VI
MBG+N=RY8.,  CCH3UZF@#:FFBMX7FFD2.*-2SN[ *H'4DGH*R_\ A*_#O_0?
MTO\ \#(_\:T+VS@U"RFL[F,203(4D0]&4]0?8UPFJ6\*_&OP[&L,83^RKGY0
MHQ]Y>U '8#Q!HS26D::K9.]XQ6V5)U8S$9SMP><8/3TK2KSSQG91:7K?@U=-
MLX]S:S+(L0(12[12$\XX!/)X/?@]*NV_CF>SA\2IKMG#%<Z&T6X6DA=)A*H,
M84L 023M.>] ';4$@#)X%<EI_BG4)/%-MI-UIXEMKJ%I$N[:*4) Z\F.0NH'
M(Z-QG&,"LOXEWDL^H^%?#0=DM-9U#9>%3CS(4 9H\^C9 /L* .MC\2:%,[)'
MK.GNR E@MRA( Z]^W?TK4K-U;0=.UG09]&NK:(V4L7E",( $&, J.Q'48Z8K
M-.NWM_K6IZ1HR6SS:7'']HENBVUI'4LL8"]. "6[9'!YP =)17 'XCSW&BZ'
MJ%EI*E[_ %1=+N8)9\/;398,!\N&^Z><CJ..U6K?Q-XEG\0:IX>_LO3!J-M#
M'<Q3?:G\@Q/N&&^3=N!7' P>3QC! .B7P_IJ:\VN"&3^T6B\DS>?)S'G.W;N
MVXSSC'6EU?0=.UU;==1A>5;>59X@LSQ[9%^ZWRD<CM7(CXB7TOA?PWJ]OHT<
MCZM?BPDA-S@Q2;G4[?EP1F-N21C(ZU:L?&6L0Z[JFA:UHL0U*WL&U"T6PF,B
MW48.-JEE4A]V!TYS^8!VJ@*H49P!CDY-+7&Z?XOOG\3V>AWD%D;F\L7NMD,I
MW6TB[<Q2=?[WWN.A^6L@_$36U\+R>(Y-%LDL+2^:VNT^U,9"HF\K,?RX.,@\
MXSSP.I /2:KWM_9Z;:M=7]U!:VZD!I9Y B#)P,D\=:PCXBO8/'T7AZ[MH(K6
MYM7N+2Y#DM,RD!H\8P& .[J>*!"?&7AV]@O[6R:UFG>.W,D7FJZ(Y DVMQDX
M)7J.AYZ4 =("& (((/((I:Y;5->MO#5]HOA^.:VLUN('6"XO6/E_N]BB,'(R
MQ#=SV[DXK>TZ:\GTR&6]MT@NV7]Y$K[E5O0-CD>^* +=%><2>//$\ND:SJEG
MX=L9(-&O9X+I&O6W2)%C<8_DY.,GG'8 $U=G\<:I>ZOIMEH.EVMPFIZ4=1M9
M;BY*?W<!P%.W[W;.3CIR: .ZHKB;[QGJ")J$5E9V[WNFQH+B B5Q+.8Q(T4;
M*O& P 8]2>@ZUOZ=XALKS2K.\N773Y;F%93;7;".2//4$'!X.1^% &O51]5T
M^/4X]-:]@%](I=+;S!YA4=3MZX]ZP+KQ)J=W_;1\/V,%W_9#^2Z2N0US,$#M
M&F/NX#*-QSDG&.,UFZE*UQ\3_!5Q) T$LNGWK/$^-R$K$=IQW&<4 =Y17 WG
MQ!N5L?[5TW3C?6*W)A-O%%*UQ)&'V&1"%V]03M[CN#P)_%'C74/#UKJU^]C;
MQ6>GL@B2YD*27P(4N8CVV[L=#D@]* .WHKC=6\5:W%XK30=(TFSN))M-:^@E
MGN60$AE7# +QU[9R2.@R:@\0^,]6T'3]2O[G3K2WBT^.,B.>8@WK%0T@A;T7
M.,X.2#P* .YHKD;WQ5JH\6VFAZ?IEK*+S3GO(9YK@KC#*,. IP!N[9SQTY(K
MZ?X\EGT%9;JQC35CJSZ,+>.4^6UPK$$AB,A-H+=,X!ZT =M17*W/B;4=#BUB
M77--'V6QCCDM[NW.$N2YVB,*22K!L#N.<\4S3_%.H2^*;?2;K3Q+;74#2)>6
MT4H2%UY,<F]0.1T;C.,8% '6T5S/BSQ+>^'KC1HK33H[P:C>K:?-/L96*LPX
MQC'RGG/'H:R8/&VLVNH:WH^KZ19QZK86!U&W$%TQAN8!D'YBF001C[O/M0!W
ME%<';>.=6C\,P>(=3TFUBL;NTMVLXXKDF66XE( 0@KA5)8'.3@=><@:DGB6\
MTGQ/INCZU!;"/5$D^RW5NS;5D0;FC<-[<AL\XZ"@#5O_  _INI:G9ZC=0R/=
MV18V\BSR)Y9(P2 K <C@\<BM.N0MO%&L:EI^G:UIFDI=:7>7(C$:N1.L!8J)
MSGY<< [?0]>U5=5\=7<4.I7.D6*WJ:=<- UOLD,MRR$"3854A2#D#.<X[4 =
MN[I%&TDCJB*"69C@ >I-5]/U&RU6T6[T^ZANK9F95EA<,I()!P1P>016'%XE
MN=8U:?3=&@B62UM8KBY>\##8TH+)%M'(; ))_AXX.>.-\%>(+K0? /AUA9PL
MNH:[+8RQER#$9+F3E2!@XQTXS0!ZQ17+2>*+Z/Q)K>D)96\C6%@E["QF*>8&
M+#:WRG&-IY&:RM.\=:M)X9A\2ZCI-K!I=Q:1/ ([@M*T[NJ*A7;@*2W4$D#G
M'8 '?45Q2>-+^VU6ZM;O2WN;:.PDO([JSAE"[D!)A;>OWB!P<\^@K0\,^(;C
MQ MO=0R:?=:=/;F7S[20DQ297]TP/?#'G@\'@4 =+16-K>J7UC=64%K;1B*?
MS&GOIS^YM55<@MR,EB0!R._I7+/\1KS_ (0M-=@TNWGD34O[/G1+@[2?-\O?
M&<?,#D$ D=>IH ]"HKD9O$^JZ?+;V&JV=E;ZC>33&W\F22:-8$"DR-A0Q.7
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MS7S69O+&6.1DBN%!PR-D,48''][(.?:@#JJJ7.JZ?97=M:7-[;PW-RVV"%Y
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M3!E;!(.".O(-6*XGX0_\DLT3*[?EEX]/WKUVU !1110 4444 %%%% !1110
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M>&8QKM*L=H(##/0''O6N-#U&]\2+XBO;>UBN;:Q>UM+59RR[G(+LS[!CH
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M0RLTD+PKA692@'WL'@]L5W]% '*Z#'XVP@\0/I'^C(0#9N^;M\8!?*X1><D
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M.1G,?[GROF!4>F>#[4 5--\5:SH<'A:+5-)MDT74DM[*&XAN"\L4K(-GF+M
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ML5$P(7:?7;Z'K6C<^)M5N[?5[K0--AO8]+N&MC"[D274B8\P(>BXR0"<Y(/
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M1M9=BC(&?FY)XXY .IHKSN/XAZAJ5AX5O-+T^V UBYDM9XKF1MT,J*^X @=
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MIUM<:?%=6E^UO/IL\;+<>0K8\U6+@,"N'X7&#U)Z]K0 4444 %%%% !1110
M53U32=/UNQ:RU.SAN[9F#&*9 RD@Y!Q5RB@!D,,5O"D,,:1Q1J%1$4!5 Z
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]EDF=[G;O,%O$\TBKV8J@) ]R*DTW5;'6+4W-A<+/$',;$9!1QP593RK#N"
M:Q? >D/I?A6UENG,VIWZB[OKA^6DE<9.3Z $*!V %<%9>(;[2U^(/B?2$ADB
MFU:&VL89$+)<3+B)MH##[S,O(/8T >QTV21(8GEE=4C0%F9C@*!U)/85R?\
M;VM6GC32=&O4L7BU*TFF*PQL'MFCV\LQ8AE.['0<^M<S;>(M>3P1JOB:2XL;
MZ34;[[/I]M-:MLDC,OD1K@2?=;EL<GD\GL >GV]S!>6T=S;31S02J'CEC8,K
MJ>A!'!%2US(U=UU^/PMHMO;1O9VJ2W<OEXAMD/"(J*1EFP2!D  9YZ5S]Y\0
M-0@\/W<\:V?V^VUW^Q@6B<QSMN7YE4-D84DXR>5(H ]&HKE-*\0:O=^+M8TR
M>UMC;65I#.JQ9\Q))"V(W8G:3M4'@ #..>I9X-\1ZCXGM;6_+69M6BD6[A2)
MDEM+E64>2V6.< MS@?=![T ==1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'($;<N]0<'U&>] '"^$-5MK7^U]4O;;55NM5OY+C']E7+%81A(AD1X^XH/\
MP(U:U756N-9L=2T^ZU"W^RQ2QM;RZ%=NDX<J3DA 5QL&",]37:44 >97EG#J
M(\07MS=:BFK:M8?V?')#H=V([:+!X *98DL23D=L 8JU)'9AO#MU%)J)O-$W
MK$&T.[$3(\?EE  F5P ,')/'.<UZ'10!YM?:9H^JV6O?VC-K$FH:S +>2Y31
M;H""-?N)&OEG"@\G)^8YSVQJ6&M7J:>(;Z]NVGCA,<;VWA^[12VW =@5.?7
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MUE:+X@L=?-^++SO]!NFM9O-B,9$@ )P#SCYAVJ71$U!-%M/[5F\V_:,-.=H
M5R,E1@ 8'3\*\YTNV\1RS>.)M U:"QD@UJ:18Y+82^>XBC.UB3\JG ' SS0!
MZM17GFF>-K_Q0FD064%S;RW6DKJ%P;,0EU+.4 7SCMVY5CT)^[TKI_"<VORZ
M*1XDMDAOXYG0,I3]]&#\KD*2%)'49Z@T ;E%<!=ZYXEUJ/6Y?#L=P)]/O)+2
MVC5;<PRO'C<)2[!^3D?+MP,=:;XH\2:]X6FTC6+U@NE7:""[L@8@UM<LF4Q(
M1@INR">V,\CB@#T&BN1U35=4T2ST+3)+A[W5-2G,+W$4<:XVQM(Y16(7^' W
M'ODYQ@XFLZQXUT3PUXINY1Y<-G$L^G7EW'"TKC'SHZ1MMR#T;'3J* /2:AO+
ME;*RGNG22188VD*1(7=@!G"@<D\<"N,N-4U_27TV"[U6"XFUV[BAMMMJ$%DO
MEL\F#GYS\N%SW/((XJWJ#^*-&T?Q-<OJ-M/!;VIN--GEB!E!6,EUD50JD9 P
M1V/.: .GL[I;VQM[M$EC2>-9%25"CJ&&<,IY!YY%3UYY?>,+S3M \+:CJ<UW
M;Z;?6*RW^I6MNLAAF*1E=PVL%0[GR0O4 <5:7Q'?W-SI&D6EXU]+=64M[)?:
M>(<O&KJJ%!(0@SNYZXQC'.0 =S65#X@L9_$D^@)YWVZ"W%RX:)E786V@@GKS
MGID<&N27Q'XHT^UL-)U>!(-4U'56L[2Z81DM; %_-9$)4/M!&WIG!QCBGZ7;
MW-M\:M02YO7N\Z#$8WD158+Y[\': #SGG X(^M '?TC,J*69@J@9))P *PO$
MU[>V::?]FO(;.WEN0ES,PW2[-I(6)"#N<L ,8/&>/3SSQ!K^K:K\*_&?FW]Q
M'+INH/9K*(ECDFA_=_+(,<$B0@X"].W- 'L-%0VL4D%NL<US)<.,YED503SZ
M* /TKSS6_%.M:3(UR=0CDD36H[5K2WB$D"6[R! 'DVY67!#8W<$CC% 'I-%<
M*;WQ)J?CG7]"MM8AL[>VM;>:"1;17="^_CYB0?NC)/IP!G-90\7Z[+\._#GB
M\W(BM]\8U>..%3F'>4:1<@D$$ D>A/3% 'I](S*N-S 9.!D]36-8WES?^)+\
MPW1;3;6..+8%4AIV&]B&QG 1H^_5CZ5S_CD7C>*O!L5OJ5Q;137[JR1A""1"
MY#'(.2.F#QSTSS0!UJZG&^M2:6(+D2QP+.93"1$06(P'Z%N.GI5VN,.KZT/'
MNJZ(+V$V\6CI=VY:W'RR%V7+<_-]WU YZ5S=OXH\5'P=X4\2-JEN[:A=06T]
MHUJH1Q*Y7<6'S @X/&!VP>I /5Z*X+_A(]5\.^)]<L=6O1J5I:Z*=8C80+$R
M;6=6C&WJ/ER,Y/N:?8ZAXPN+O0KZ&WGGL;O:=0BF^S)%$C+D/"5;?P3T;=D>
MAH [JBL'QG+K%MX3U"[T*81ZA;1&:-3&'$@49*X([C.,=\5SA\8RMXN\,B'4
M7?1-8M Q!B3]W,REH@SX_C"2#'7*]AQ0!VFJZG'I-F+J6"YF7S$CV6T)D?+,
M%!P.PSR:MM(J<$\X+;1R2!UP.IZC\ZX'7M>US3_!J:W:Z@O^D:C$(A) I/V:
M28(F,8Y*D-D@]<=JE*7K_&MH?[4N1;IHBSK#M0JN9\,HRO0[!D]??&* .GT+
M7['Q%:3W5AYOE0W$ELWFQE&WH<-P>1SZUJ5XQ;:CK>A>"O%&O:;J$4,=AKUY
M(;9H XN!YX#!F/(&#QMP?<]N\_MBZUKQEJ.@6=X]C%IMI#+++$B-(\DN2H&\
M, H5<GC))ZC'(!U=%>7GQMK9T6,R2QQZA8>)(]&O"D0\NX0R*-X!R5)5AT/!
MS[5K:UJ^JKXLUS18=0DAMTT#[?"Z1IOBD\QUX)'3"]\]: .Y5E=0RL&4]"#D
M4M<M\.$G'P]T*2>[EN#+8PN/,"_)E!P" ,_4Y/O67=7OBG4?'FL:#8:U;6,%
MO9V]S#(;(2%=SL"I!/.0O)S]!0!WM%>>7&O>*=;L=2OO#<,YFM;V6WMH"+?R
M)A$^QA(782 MACD;<9'7J="77-3O?%=YHKW)T<6^E)>(VU'+NQ(8DL""B8 .
M/7KTH [.BO/-(\0^(=0\%^']6U"]M;)M0F#7++!ME6,JVU84.[>[$ CCHW3O
M6;=^,_$$7P]\5:A!=J+W1]3>UBFGM@'>+,>-R\ -B3KCMTH ]5K*MO$%C=>(
MKO0XO.^VVL*S2AXF5=K$@8)^]T/3BN=U#4M=T;4-/TJXU:&XN]<OBENZVH06
M<*Q[Y .3O/&%+?WN<XQ5?0[>YMOC%K:7-X]W_P 2BV*22(JL%\Q^#M !YSR
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M3_#_ /:%ZITV;S[&^0JL\#Y)!! P?O$=.GYUT&B:-+I44C7>I7.I7DN!)<W
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M3E3ND 5?EPH)8XZ#CT Q76Z;HD=[)I.J7>HMJ LHB;/"JJAF7:7;'WGQD9X
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MGG.<T >O45P,YU'3_$=AX5CU*\OEN+>XOGENKOR97 =%6,2(F0!N8X&#P.<
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M3!>RB&0QO,[/L4;A@A5 )X(R2,],4 :WASQ%%XCCU%X[2>U-C?26,B3%2Q=
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M608'JN<8YQ5;P9KRWVN#3[U]5T_6(+,_:M,U%V<2-N7]]$Q)!7AA\N!\W04
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MW,5JAD>.$J&QZ_,1Q^OL: ,WP]X'M/#K1B+5-5NX;<%;2"\N?,CM01CY!@=
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M23N*XVYZ@<YK&@^&>EP66FV@U36&ATRY%Q9J;H?N<9&P87[N&/)RP[$5VM%
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MK$L,;2D%MJC !P .@':L-? FG1Q7]I#=WL.EW\K2W.G(R>2Q;[X!*[U5NX#
M=>F:ZBB@##N_"]M=>(K#6OMEW#/8Q/#!%%Y8C5& ##!0GG []N*TM3T^WU;2
MKO3;M2UM=PO!*%."58$'![<&K5% '+#P-:>3HT;:KJCG2)1+;N\B,2P78-V4
MQ@+Q@8]>O-3'P7ILM]KES=2W%TNMQI%>03%?+*HI5=N%!& 3SGWZUT=% ',^
M'/!5KX<="NJZM?I"I2VCO[GS$MUZ80 #MQDY(' QDUTU%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5QOC'PO<ZWJ5GJ6A:Q_9GB+3XV\ER-T
M<D3'E)%[J2O7G'H>*[*L?4?#Z7VK0ZI%?WMG>0PF%'MW7!4G)#*RE6Y ZCC'
M&* .,LO$6H:SIGB?1/$.GG2_$5EI^Z66TE(2>+#%'C8<@9)XSW^H&=&VHZ9\
M-_A^VFZO>6S7MUIT$HW!U*2(,C!&0..@('KFO0;+PQ9VTFH7%S-/?7>H1B&Y
MN+@KN:, @( H4*HR> .IR<FLM?A[8KHVEZ6-5U8P:9<1W%L6E0LK1_ZL<IC"
M^F.>^: ,OQ!;:CX-72-8;7M4O=+MKW;J2W,H/[F0X5SM XC8K]1UX%1>,9);
M[P)XWU+[1*UFT$EO;1ER4Q&-KN![N&'T4$=36_XLU 26\GAI=)OKZ?4[1XTD
M%N6MUW?+F1Q@+C.X^W3DBK=WX3L+OP<OA?S)X-/%NML?)*AR@&,9(/7N>M &
M/X.U(>)+J:X:YN;9M,VVC:87*%2!D2R ==PY7'RX]3TQ]/N?%7BGPW8^)-)O
M;>VN9)S.?.OG$'DAR&B:(1E1A1C.=V1G-=7'X-M(=>M-:AO[^.]@M1:.R-&!
M<1@Y D&SYC[\8QQ5.U^'6EV.K3W5K?:I#93S&>72X[G%H\A.22F,X)ZKG!Z8
MQQ0!EZ=;ZMK'CSQ/92>(]2AM=-NK.2".(HN0T>]D;Y>5/(Q^9.*ZCQ:^K1^&
M[A]$B,UZK1D1*X1Y$#J9%5CT8IN /J?6ETWPW!I>OZIK$5Y=R3ZD4-Q'(4V9
M1=JX 4$8''7GOFKFK:8NK60MFN;BV(D259K=@'5D8,,9!'4<@@Y% 'E'B?5[
M+7?AEXK>SO\ 5HI+80^=IUZ[I/:-N *-DDLK<GDD'GTP.PN+R4^.=-\(B[ND
MM/[-EOYI/.82S'S BIO'S #+$X(/ [9SHW?@G3=1LM8@OY;BYDU>-(KJX)57
MVI]P+M4 8))Z=3SFG7/@ZUN&TVX-_?KJ6G;O)U#S%,Q###*V5*LI]-N!VQ0!
MQEUXNU;09?$FAR7CR_8]0L;>TU"8!FBBNB,[B>&*#=@GKQG-=9=:1>:=-J<Z
MZQ-+IDVFN@LKEC(XF ),BNQR 5X*],\\58N/!FD7NCZGIU_')=KJ;;[R:5AY
MDK  *V5  VA5P  !CIUJ/3?!D.GV-Q;OK.KWLLL)MUN;RX622*,]53*[1G R
M2"3@<\"@#C_AEJ0US2]'TI[FYL3I6FP.;57*->*Z#$F1UC!XXYSUQT/=>,(S
M+X,UI1++$193,'B<HP(0GJ.>U9L/P]TZV70S;W^HPS:*ABM9T>,.8R -CG9A
MEXZ$=ZZ:ZM(KVQGL[@%X9XVBD&<;E88/3V- 'E-W:-'\/_AJD5S,'FU'36#N
MV\QDP'[H/  [#I6S:WNHZ5KOC/2FUZ3R+6PAN[:[U%@XM7=9 Q)P,J"H..U:
MZ^ +)=+TC3SJNJM%I-Q'<6I>6-F#1C:@.4Q@#C  ]\FIK[P+INI7NL7-Y<WD
MO]K6JVMS$60+L7.W;A<@C).<_7- &!I&H7R^.-,TP76IFQO]'EDD:[D.99%9
M )D#$M'D,>/E_P!T8JU\);7RO!YF-Q<RL][=J1+*7'$[\\]SW/>M.T\"V=KJ
MNF:F^J:M<WFGPM DD]R#YB''RN H&!M'3&>^:O\ A_PS:>&UN8[*XNW@GF>9
M89I=R0EV+,$  X))/.3[T 8>MWL^B?$#3I+S4+A=$U2UFMRAE*I!<(-X;/;<
M@8?49K%\+:QJ.HZ7-X?O+R_36DU-5:660B86S#SE<@<+F(%/3=BN\UWP_I_B
M.SAM-1B,D4-Q'<J ?XD;(_ C(/L31'H&GQ^)IO$"Q8U":U6U9^VQ6+?GR.?8
M4 <UI=Q=>+[[Q/%_:-W9?V;>M868MY2AB*(I\UA_&2S'ALC ''4G$T/Q7J^L
MM\/KZ>>2&749;NWOHD.(YC$D@#;>@^9-W&.M=I+X3MQK-[JEC?WNG3WR*MVM
MLR;9BHP&(96PP'&5Q4=_X*TR[T[2;.TDN=-_LEP]E-9N \7RE2/F# @@G.0<
MT 8"WMW+)\2+":ZFFMK.("W21MWEA[;<P!/.,DU6T75IVT[X>>&HII+>*_TE
M;BXDC;:[)'"F(U;J,DY)'.%X(S720>!K"V;7&COM1WZRBI=,TP8\($RN5/)&
M>3GKQCC#+GP#IT^DZ-9+>W\,^C "POHI$6>$!0NW.W:00 ""#G'- &;X,M39
M?$7QS!Y\TRAK$JTSEV ,+$ L>3CID\_6M#6]6FF\>:/X96:2WMKBUFNYWB8H
M\NPA5C##E>26.,'@<]<W]&\*6VC:SJ.K)?7]S=Z@(Q<-<2*0Q1=H.%4 'K[<
M\ 5-K7ANTUNYL;QY9[6_L'+VMW;D"2/<,,OS @J1P00: /.?$U[J T7XA>&[
MF]NI[?3K)+JTN#(1($D1B8G8<L 5/7DC@YK1UNR=-0^'=O#>7",]Q(1,S;W7
M-LV<;LCZ9R!Z&NO?PEIT^F:M9W337#:LA2]N)& DD&W:/N@  #H ,#KU)S6_
MX0FV+Z+(^JZI))I#%[=Y)$8L2NPELI_=XP,#OUYH Y.3Q)J?AFT\<6O]H378
MTN[M([2>\<,T0N%CSN;'(4N2,@].]:UWIWBFPO+F[BU1;;37L)1)&UZUQ*)U
M4LLD6^/ Z$%>F.0.*V#X(TN:?7I+N6YNX]<5%O(9BFP[5VJ5VJ"" !W[9Z\U
M!I?@*VTRREM3K6M7:M"T$+7=R)#;(1@B,%< XXR03C@8H YW2]*\1:O\-H=:
MM_$^JMJ]UI"20QAU$8F W @8SD_=.2<YSZ8B7Q@9]:\'ZO!=W8T>^A2&_B,Q
M,<,\@(ASDYSO1U;MT)Z\^@Z#HT/A[1+72K:>>:WM4$<1G*E@HZ#( SBLM_ 6
M@OX;U#03;,+&^N7NIE!P=[.'X/8 @ >PH YWQ1>ZI9_#NXURTU2\@EN+V*:(
M!P<023JJKR"0"C \8.3C.!BIO&FM7>C:Q<2:F-4@T*2U5(-2TYF(L9LMN:9%
MY(Y3!((XZ<FNJ\1>'+7Q+HQTJYGN+>U+HY%L54G8P91RIP 0#QZ5#>^&%O9;
MQFU74$CO8!!<Q*8RDBA2N<%#M8@D$C'Z# !S[:AJ'B77M4TJPNLP6-G;-%+#
M?-;LS2H6$N51MPZ8!XX.0<\=1X935XO#MG%KUQ;7.J1J4N)K8DH[ D9Y YP!
MG@<YK(U+X>:5>7UE>V-WJ.CW5I;K:++IL_EEX5^ZC9!! [=_TKI;&RATZRBM
M+<-Y<8P"[%F8]26)Y)))))Y))H \PTS1M0U1_',MAKU]IDT&M3O#]F*A3((H
MR#)D$LO08R!U_"SHGBG5O%KZ)8LHCDGT1=0N%2Z:V,KLYCR&52P VDX&/OC.
M<5U3>#+07.IO!J&H6]OJDAEO+6)TV2,0%8@E2ZY  .UA[8IFN>!-+UDZ=+#-
M=Z7=::GE6ESITHB>./&-G0@K@="/ZT 6?"5OKEGHS6OB"\M[N\AF=4FB<N3%
MP4#G:OS@'!XYX/>LE+[4U^*.JZ<M_));#14N8()<"..0R,N> ./E'7)ZUT^E
M:9#I-BMK#)-+R6>:>0O)*QZLS'J?Y  #  %9TOA6UF\17>M/>7AN+JS^Q21Y
M3RQ%DD #;G(+$YS0!R?AK7KJ;4DTO4)=1TWQ-%8R^;9Z@Y:"[DP/WT39*[00
M>%Q@,>.,T>&];:]U#^RM5FUC3-=CL)!<V5W*Q6X?Y3Y\+@[< AN%P,,>,"NG
M'@ZUE^SF]O[Z^:UMY;>W>=DW1+(NQCE5!+;>,G/Y\U/:^&((;^RO;N]N]0GL
M8GAMFNBA,8< ,<JHW$A0,G/ZDT <-;Z]JTOPZ\":JVHW'VV\U.SAN9 W^N1Y
M"&##H<@"M*:?7O%<_B6+2KH6L^GW;6=FPO6A\EU16#N@1@X+,?O9&!@ ')-V
M/X9:7'IUII_]IZN;.RNTNK.$W"XMRK%@JX7D9/\ %DCH".<VK_X?Z?=Z_)K-
MMJ6K:;<W"JEV+"Z\M;D*,#?P3G'&00: *&FZEJ&N>+'T'4KORSIVEP377V"9
MHQ<7$F<LKC#;%V\#CEN<X%+\*XF@T'6(GE>9TUR]5I7QN<B0C)QQD]:U;[P3
M87&K6>JV-U>:5?6L M1+9,H\R$=(W5U92!VXR*M^'/#-IX8M[N&SGNY5NKF2
MZ?[1+O(=SDXX_P#KT 9,=W=?\+7O-*-W.;!]%2Y\@R'"R&9D+*>HX Z5R$>N
M:]+X'\/7,>MW,=U-XD%C)(0K>9$;AT ;(R<!1T(SWKT#4_"EMJ/B"WUM+Z^L
MKR. VTAM9 HFAW;MC9!/7)RN",]:XOQ5X6MO#_AW0])TV34I(SX@@NG9<RO"
MOF%G<87"@$YR1]<T /OM7U?P)XIU*"34[S6-.DT6XU*-+PJSQ30]0"H&$.1Q
MCBI-5U+5-%\$Z%XNM]2N;FYD:U>]A=]T5RDQ4,JIT0@N-I7'3G-=G;>'K3[9
M<7]W++J%S<V_V9I+D+@0]2@55  ).3QD\9Z#%*P\$6-C:VEC]LO;C3;*836M
ME.ZM'$RG*#.T.P4\@,QQ@>@P <VRZMJ?B3QS8MXBU*&WT^.WDM1 R(T9:$OC
M(7IGMW[DUUO@K4[G6?!&B:C>.'N;FSCDE<#&YBHR<>YID?A*WBU+6[]-0OA-
MK"(ESS'A0J[5VC9QA3CO^=7M!T:#P]HEKI-M--+;VJ".(S%2P4=!D 9Q0!PL
M4_BCQ;HEUJNBWL-I?)?2I;M)>NL4212E=DD(C(;*KDDDG+9! P OC/4]4\,Z
MY9WZ:J_]F:I";:>-IF*6$C%0+E<<E 6 .< $KR,\;C?#K2QK=WJ%O?ZI:07L
MGFWFGV]SLMKASU++C//?!&:U+GPS:7JZNMU<7$R:G"()%<(1%& 1M3Y>!\Q/
M.>>: ,C7+V[L-4\-^&[2XDE^W+.TDTUT8Y)A$JG;Y@4D$E\_*!PN!@5SOB3_
M (2[P[X*UN6;6Q&8KRW>P,4_G2I#)*J,DC,BD@9."#GU/%=/=_#[3;[P[8:1
M<7^ILVG.'LKX3A;FW(&!M<*.W'(/Z"GW7@.ROO#LNC76IZI,L\B27%U),K3R
ME&#*"Q4@ %1@* .OJ<@&=>F\T;Q'HOA]];O[B/6[JXFEGG=0Z+'$&\J,J!M#
M,<\<@ @8ZU%XIAUKP[X%\4S0^(KAFB4W-B>#-;QX^XSMDL,AL'K[UT7B+PG8
M^)M/MK:^GNDN+2036][;R".>*0?Q*0, ^HQCVZ5!/X+L[KPU>:+<ZAJ,ZWHV
MW5W+,K3RCTW%< >P QSW)R 8OB;6;_29=.O;VWU.?0#8_P"D3Z;(?-MICC]X
MZJ0S)C/J!SD'BH[?6+K6]5L-#L;_ .VVR:)#>&Y2\>V>Z9F*>9N52W&S...7
MYSC%=.?#A6>.>#6-1AD6U6U;;Y1$B*206!0C<-QY&*R[WX;Z-<6^E+93W^E7
M&EQ>1;75A/LE$?=&)!# GGD=2?4T :GA*WURTT-;7Q#>6]W?PR,GG0N6+)U3
M>=J_-@C/'/![UQ]D_P#9'COXA:J9KN;^S[6VN1"9V(?]S(VW'IZ#MFO0-,TV
M'2K%+6%Y9 "6:6=R\DC'JS,>I/\ ]8<5GCPM8KXEN]<6:Z$MY$D5S;B0>3-L
M!52RXR2 Q'7'M0!Q6IZOJVF_#32_'$&I7$]]LMKJ[@+DPSI*RAHA'T7&_ (P
M?EY)YKT36#*-%O6@G>WE6!V26,*64@$@C<"/S%8EEX%T^RLX=.%W>RZ3!.)X
M=.E=6B0AMRC.W>5#<A2Q' [5M:U(L>AWS-N(\AQA5)))4@  <F@#RIKWQ'I_
MP^\.^-E\0WUS<C[+]JLI-ODS1R,J$;<9WY8'=D]^G &AXTUG4M/TSQ-J5CJM
MU<76GW$9@:U;9!9J-F8I 3MD8Y8D88C</N\5H^ O#:7?@3P['J5Q?2)9I'*;
M"X146.9>1N&T,0IY )QTZX&-&^^&^DW\>M0/?:G'::O(9[BUBN L8E.,R*-N
M<G X)(]NE $6LWMUX?\ 'NCWUS?7!T/4U:S>)Y/W=O=$9C;Z, RX/ .#6WX7
M,]QILFHS33.M]*UQ DCD^7"3^[ !Z97#'W8CL*PO$,-OKR'P.^F:G=+F!IKV
MXB/D^6&#LPE[O@$ #N>F <=NJJB!5 55&  . * .!BLMWQOO&-U=X&BPS!/.
M;;GSG&,=-ORCCUYKD8Y-1TKX<:WX@L=6N[>:PUNX>*"(@1.#=88.,9;()[X'
M''7/J5UX8M;GQ/%X@6ZO(+Q+86S"&0!)4#%U# @YPQ)X(ST.1Q68_P /-.D\
M,7WA]]1U(V-[<-<3?/'OW,^\X.S@%N: *E[=ZGK_ (JUW1;24Q)IL$ 3R[UK
M=P\BEO,^5&W <  \<'(.>.D\-)J\?AZSBUZXMKC5(U*7$UL24=@2,C('. ,\
M#G-96L>!++5M6@U=-3U33]3CA$$EW8SK$\\8YVN-NT_@!^@KHK&RAT^RBM+<
M,(HQ@%F+,3U))/)).22>230!YZDWB?Q;I-_J.BWD5I?0ZA-#;,]ZZQQ+%*5V
M21",AMRKDY)/S<$# I/&>IZIX9U>PU1=4+:=J,!MKF$S,8[*1MH%TN.3&I8
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M:-;_ &;8K1L\;-@';]W/;J>,GBNYTO3(=)L5M89)I<$L\T\A>25CU9F/4_\
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M7XC=R!(RS& -(N>2)58\]ASG(H ]6U6YO+/2Y[C3[ W]VBYCM1*L7F'/3<W
M_&I6NX8YX()75)YP3'&3RV!EORS^M>>>,);R/X9>)->M-2O[>6X8W%JT=TX\
MN(,$39S\H9?GXQ]_V%6-6T^&X^,'AYW>Y#/I=RQV7,B<JT>,;6&!SR!P>^:
M.E\.>(SK]QK$+6+VC:;>FS8-('+D*K;N.!][IDT7?B,VGC+3?#[6+D7T$LRW
M/F# \O&1MZ_Q#TKSN:RDDTGXF:A%J-_:SV-]<7$'V6X:("1+=&!.W&[H!@Y'
MMFM6^$FM^,_ CSW$T3W6D74DKP/L8[DA) 8<KG/48/H10!Z92$D*2 20.@[U
MY%'XAU+1_#&J6"W]TZQ^*QH\5W-*9)8+=RA)WMDD@,P!/3(]*Z6\>Z\._$;P
M[9V-Q=2Z?K$=Q%<V\\[S!&B0.LBER2#V/.#QWH W?"_B(^)+6_F-FUHUG?S6
M31M('),9 )R..OUI+KQ&;7QEIWA]K%R+VWEG6Y,@P/+QD;>O\0]*\\M];N-#
M\)>(&M93!+>>+Y[+[0,?N%DF 9^>X7./?%;MYI<.G?%WPUY$UTRR:=> K-</
M+@CR^07)()SSZX% ';:==7MS]K^VZ>;/RKAXX?WRR>=$,;9./NYY^4\C%7:\
M>O;_ %./X8^/9UU?4!<6&L74=O/]H;S$12@"ANH&#T%='LN=&^)7AZ*+4[^>
M+5;*Z-U'<7#.C-&$965#\J'YB/E &* .^HKR2ZGU[4/#^H)%<ZBGBR/63%''
M!+($\KS0, #Y/*$1))[$<_-7JJ6RK9BU:25U$?EEVD.\C&,[A@Y]QS0 6]U!
M=H[V\JR*DC1,5[,IPP_ @BIJ\B\+10Z?\*I)$U:[T]Y]2E@$B222N_\ I; 1
MQKNX=Q\NX8/.2>,UN^'3=W7C+Q3HES)?V]E]EM9HH&O7>2 N'#%7#$J3M!P&
M(S]30!Z!17F/@:ZNY_$+Z%JVKW<\ND"22SF-Q*/[3B:0CS7R<.$QLQR,G/3%
M=7X^URZ\-^!-7U>R4-=6\&8LC(5B0H;'?&<_A0!T9Z>M87AGQ&?$7]JAK)K1
MM/U"2Q96D#EBBJ=W' ^]TYZ5S>O&Y\-7/A34=+O[RX6\U""PNXYKAY4N8Y0?
MWF&) 8$;@5QW'3BL73]!EU:T\<W$6M:EI\]MK=U) UI<&)%=8T.Y@/OCH"#D
M8Z8Y- '?:GXC.F^*M#T0V+NNJF8+<^8 (S'&7(V]3G ';K6A975[/=7T=UIY
MMH890EO+YRO]H3:#NP.5Y)&#Z5YW;:G=:UJOPJU*^&+JYANI9>,98VIR<=L]
M?QJWIUWK:P_$2.PNY[F^M+AEL!<2;_+;R%8!<\ 9/3I0!Z-17FFFB\U/6_"4
MNE7NK&S>S>75]\TN-P13'OW<!RY(('49[ 51U;4KR"&VU33]4OKPGQ%'"U]Y
MS1PM&TVPP)%N(=5'REL $@D$F@#U-;J!KQ[195-Q'&LCQ]PK$@'\2K?E4&EW
M5[=VTDE_IYL95F=%C,RR;D#$*^1TW#G':N+T/38#\7/%SB2Z5EM[)P1=28RR
MR9R-V"/0$$#L!6'9^(]2LO ]LCW]R\E[XH;2WO)9"TD4)G8$ACT.U=H/;/%
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MP;N2Z9[AI%& 2[9) '&.F.,<FM'3='MM-FN[A&DENKQU>XN)2"\A50JYP
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MC=RFT%MI4Y ;KD>O:N@E\):1<:%?Z1<0O-;Z@S/=N[GS)7./G+>HP,8X&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG5D2,G#KAB7+[1P?4@]JZVB@#"\4>'+7Q%X;DT>6W5XFV[%\QHUC*_=/RX)
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M]I'=-:1&0Q/*8P0.O(!_+]:LM=ZC)+I;6MG#):S@M=R/+M:$;,KM&/FR>.U
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M)&LKQ[AZ$J0<>U5G\,:5)J6GZ@\4[76GHR6LC7<I\L,,,,;L'( SG.<5L44
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M.GGR!IGR#N=@VYCD#J>P]*GU?PUI.O:-_9.J6GVJS&"%ED8L".C!\[@??.:
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MPL\?7:Q0C</3/3MB@#RZ&[U34_#?@[[?J-\9E\1MIS7"7#(;F%#* S8."?D
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MR97A9OO;7#[@#DY&<&I%\"^&DL=3LETM!;:FV^ZB\Q\.>.1S\OW0?EQR!Z4
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MICYU^H@WK)*@R 2<,,DD9QQTKO(/">CP+&AMY)TB@>WB2YG>81QL,,J[R<9
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MN^1.?O-NR6P2-Q^;!QG%78/#>D6_A[^P%LP^E^7Y7V::1I1L_NY8DX].>.U
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M<8YSZ167I7A[3=$GO)["&6.2]E,UP7N)) [GJV&8@'@=/2M2@ HHHH ****
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MM8894FU0*\(\M@J,Y497!P,#CITJZEXTUWX'T6ZFM([*ZT/?&EY"98I[@+$
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M)0\D0\V,C(R1\P^G6O//!&CZ;]@\:%+*&-EUF^@5XE",L8"_*&&"!["@#O\
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M@#UG/.**\ATBP_X2_P (KK5SK-G8:I:WCRW%XEH3=6TJ2',9;S.F,*%Q@J0
M*]'\51K+X2UA6+#_ $.4@HY4@A"1R.: -?-%>+/H4&G^"/ OB;3#,NO%]/B\
MX2L6G2155HB,XVX/3L!]:UXHH([?XI0.D:PQ,61" %0FU# @=N>?K0!U^I>(
M+RQ\<:'HBV\!M-2BN':8L2ZF)0<8Z#[P]?PJ[XGU2YT7POJ>JVD,4TMG;27
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M1IHTRL>>%W,0.PY/2M+3+3[/\3-5TU[6VL;:YT&.62SLG(0-YK*"2 OS8XR
M.,#GK0!Z71FO$])LX-&^"-OXLM5F&L'3U@DO/,=F6!IQOP <<+D@C!&,YZFN
MLC\/VMIJ<&N6>O6-C%<V$L6W3K7RX[A=A82M\[ E.H;\,\T >@9HKS7PBTVC
M^*K#1]=T2"TU0V,L5KJ5BP,%_&I0L6&-P<;5//J?6M_QF]G+=:#87'FS7%Q?
M$V]D'"Q7#)&Q(E)!^11\W0G(& : .KHSFO%?[4N-#\,^)H?.%O91>*([>X^S
M,56VMG,7FA/[J_,1QC[QZ5U7B>UL?">FZYK_ (>D-OJ#Z.YCM+?:("$(Q/L
M^\-P^;."* /0,BBO+M;L-(MD\ WVFK$9+G5;8-=*<R7*&-F)=NKY(4Y.>:;'
M%!'9_%.!DC6&)V9$( 5#]E# @=N>?K0!Z->MJ8NK$6*6C6YE(NS,S!A'M.-F
M."V<=>U7:\K90UM\)[@NYD81*QWG!'V0GD=,Y[U9T/PWIFJ?$3Q?]NBEF6RO
MK.>W5IWQ')Y(?<,'DY]?<=S0!Z7GG%5-4N9K/2KJYMHXY)HHF=$D8JK$#."0
M#_*O+-&L/^$O\(1:W<ZS9V&J6MV\UQ>):$W5O*LAS&6\SIC"A<8*D #I6E8B
MT\4-X\;6(8Y[NRNYK2&.09-O L8\MD_N[CN;<.2?H* .T\*:O-K_ (3TK5YX
MTCEO+9)G2/.U2PS@9K8KE_AO_P DU\.?]@^+_P!!%<I'%!'9?%.!DC6&)V9$
M( 5#]E# @=N>?K0!ZG17D4=A!J>I_#&&Z>9XKK1I1.@F8"4+;Q$ X/N<XZY(
M/%9FHR77@VV\;Z7I,L\.AV]Y8!2LC'[(DV//"-U'!'TW ^] 'N%&:\_UK3XM
M%\=^%'T*%+9-0::VO8+<;$FA$>X.P'=2.&Z\XS7$7>E6D?PJ\4:LJR&_T[6+
MEK.<RL6MRMP "G/''4]3W[4 >[T4#D44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !6;J&@:7JEU'=7=HKW42[8IU9DDC!Z[74@KGO@C-:5% %#
M3]%T[3(YTM;8*;@[IWD8R/*<8^=F)9N..2:H:-X+\-^'KZ:]TG1[:TN900SQ
M@\ ]0N3A1[#'2MZB@#!M?!?ANRUR36K;1[:+478N9E7^(]6 Z G)Y SR:=>>
M#?#U_J%W?76EPR7-W%Y5PY)'F+MV\@'&=IQNZCUK<HH QH_"FAQ7%A/%I\<4
MFGJ4M#&S+Y*G@A0#@9[^O>K,FAZ=+K,>L/;YU"-/+2?>V53NHYQCVK0JEIK:
MF4N?[32U5A<.(/LS,08<_(6S_'CKCB@"F/">@A=15=-A4:D6-WLROG;OO9P>
MA[COWIM_X0T#5-%@T>^TR*XL+?'DQ2%CY6.!M;.1@<<'IQ6W10!C+X5T./3;
M33XM/2&VLY/-MUA9HS&^""P92#N^8\YR<FM"QT^UTV!HK2(1J[F1SDLSL>K,
MQR6)]2<U9H) &3T% &=-H.E7&M0ZQ+8POJ,,?EI<$?,%SG'O@DD>E0)X5T2*
M\DN8[!%:2;[0\8=A$TO7S#'G9NR =V,YYK+T'Q!K7B"/2]7L[6S;0[XR;U8L
ML\" L$?.2'W;1E0!C/4XS764 (P#*0<X(QP<5E6?AK2=/BO(K2U:%+QF>X59
MG_>,WWF//WCCD]:UJ* ,0>$-"%E968L +:QD$MK$)7 A<=&7G@CG'ID^M22>
M&-&FNKRYFL5EFO8O)N6D=F\V/IM8$X(YX';M6O10!@6W@GPW9R6DMOI$$<MH
MK+!(,[T!Q_%G/88)Z8XQ3O\ A#?#_P#9#:3_ &<O]GO)YK6WF/L+YW9QGUY^
MO-;N<#)K';5)]6\.RW_AIK2XG8NMLURS"%RKE225YQ\IP1UXH BU?P9X=UZ>
MVGU72H;N:V79')(6+;?0G.6'L<]34NM>%="\164%IJNEV]S! <PJ1M\OM\I7
M!'0=/2M=<[1NQG'..E+0!6L-/M-+L8;&PMX[>UA7;'%&N%453NO#>CWFJ'4Y
M["-KYHO),X)5]G/&0?<\]>36K10!A_\ "(:#_9UIIXL +2SE$UO")7VQ..0R
MC/!!Z>F3CK3-5\$>&M;U.+4=3T:VN;R(!1+(#E@.@;GYA_O9K?HH   !@<"L
M"'P3X9M]?;78=&M4U)F+F<+_ !'JV.F[D\XSS6_10!EOX<TF73[RPDM ]K>N
M9+F-I&(E8XR3SWP*K:AX-\/:MI%MI=_I<5Q9VO\ J$D+$Q?[K9W#TX-;M% &
M+)X2T*33[*P.G1K:6+B2VB1F58G'(< $?-DDYZ\GUJ76_#6C>)+..UUBPBO(
MHFW1^9G<A]0P.0?QK5KG(?$%XWQ$G\.R6\"VJ::M['*K$NQ,FS!Z =#Z]N:
M+<WA;0Y]'@TA].B_L^ AH[=250$'(. >3GG)[\]:6Y\,Z1=W$T\]L[23QK%.
M?/D F0# 60!L.,9X;/4^IK7K+\2:E<Z/X:U+4[2&*::SMI)Q'*Y56V*6/(!]
M* *VM^#/#GB.2WDU;2+>YDMAMB8@J57^[D$<>W2MJ&&*W@C@@C2.*-0B(@PJ
MJ.  !T%4]$OI-3T#3K^5562ZM8IG5.@+*"0/;FK] &/<>%M%NKZ>\EL5,UP
M+C:[*D^.GF("%?\ X$#4VH:!IFJW-K<7MMYLMHV^W;S&7RF_O+@C!]^M:5%
M#&B1XC$ZAXV7:RMR"/0YZU@6_@/PM:K;+#HEJHMI?-AR"=C<],GIR>.GM714
M4 8H\):&+2^M18_N+]S)=Q^:^)V/4MSR3W]:U+2UALK2*UMU*0Q*$12Q.T#H
M,GFL3QQKUYX8\'ZAK-C;P3S6J!]D[$+C(';KUZ<?6M]&W1JQ[@&@#)7PKHB7
MDETM@BO+,+B1 [")Y1R',>=A;(!W8SD9KGF\/7-[\4KS5;K3KI+!M-CM8KN.
MY$9WJ[,WW'#[2&';MTKN:I6;:F;V^%ZEHMJ)%^QF%F+E-HSYF> =V<8[4 07
M7AS1[S1H](GTZ!M/C*E( N%4J<@C'(.>]"^'=)74K?44LU6ZMHO)AD5F'EQ_
MW0 <!?:L?0_$&L^((],U>QM;-]$O7E5U8LL\**6"/G.&SMY7 QN')ZUOOJEJ
M-6&E+(K7S6[7(BST0,%R?3);CZ'TH J'PKHC7LUW]@023R":9 [".60=':,'
M8S< Y(SQ4[Z%ILFL'5VMS_:'E>1YXE<-Y?7;P>F><>O/6L[P=K]WXAT^_FO8
M(8)K749[/;"Q*XC;;G)Z_D/I714 4-*T73]$ADATZW$$<DAD=0[$%SU;DGD]
M_6F:AH&F:G>0WES;'[7"I1+B*1XI IZKN0@[?;.*TJ* ,BX\,:-=1644M@GE
MV+![5$9D$+#HRA2,'WZUK]!17-6OB"_G\<ZIH#VMLL5K91W4+AVW.79AACCC
M[O8'\: +DGA/0I9]0F;38?,U%=MVRDJ9@1@@X/< 9]>^:4^%]&(T\&T)&G?\
M>?[U_P!QQCY>>../IQTJMX*U^Z\2^'1J-Y!#!-]HGA*0DE1Y<C(.3U^[70T
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MYSMSCWQ0!=QQBLBP\,:-II@^RV>U;=2D"/([I"",$(K$A<CC@#BM>B@#G(?
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MZ=@V8\Y_W&!@;?FXXX^G'2G7/A?1;N^GO)K%3-< +<;795G Z"100LGI\P-
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M]RW<5JQC9.J#@%AZ84D_A7+ZU;:(FH?#>[TN.V$37H6"6,#+1F%CU[\XS[T
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M O8+"S348HC';W+P M'QP,]<>P-:=% 'EEGX"DN+9;35?!'A]KW;B;5EN/\
M6.>LNT(&W$\[<CTR*].MH/LUI#!YCR>4BIO<Y9L#&2?6I:* (%L[99+B18(P
M]QCSFVC,F!M&[UXXJ*?2-.NM,73;BQMYK%4""WDC#1[0, ;3Q@5<HH S1X>T
M87%K.-*L_.M%VVTGDKNA'HAQ\H^E-3PWH<<-W$FD6(CO?^/E! N)O]\8^;\:
MU** ,>P\*>'],FAFL=%L8)H5*QR) H9 >N#C(J:+P]HT-^U]%IEJERTGFF18
M@#OZ;_\ >_VNM:5% $4UM!<-"TT*2-"_F1%ESL;!&X>AP2/QH2V@CN);A(46
M:8*)) N"X7.,GOC)J6B@"K9:;9:=]H^Q6D-O]IF:>;RD"^9(W5CCJ3CK5JBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH2I&F)GP3&'"8Z$@C![]:U_$#:9K7C[P#>)%#-#<M>[7= ?-00DJ?=3U'U%
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M"DD:NCDRO\V.A.,<U3TK4/#UY#XST'Q=/!%</JDIGAN)?+>6#Y?(*<AB H4
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M!FFQZ+I40 CTRR0";SP%@4?O/[_3[WOUJ.U\0Z->O(MMJ=K*T<7GL%E'$?\
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M?$\D/@#4-9\.:M#YMK)&ADB"R8)D5&4@YP<-W&>E ':1QQPQK'$BHBC"JHP
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ!H.I?$+P!=Z?J-E-$?M@#QR+\H:#"J?[N3Q@]^*],J"*SM;<@PVT,9!)&Q
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M(Q.PVM($&XCT)ZT >6Z)K'A\Z=XC\+^+O+.H/JL[RV4V?,O TFZ)HP.7R @
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MKA]%FBN+Z%\H!L;9&3TW<DXZC'/45BB2R@L_A.T3V\9W(,J0/O6I#?FV,^]
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MF_\ '[J-M;@()"9)  J'HQ] <'D^E0&Z1_%L<":[""MHQ?20$+L=RXE)^\
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MPW&DV[+,FU8WVO)NV8ZJ/7+8Z$T =)\.M6OM=\!:7J6I3^?>3K(9)-H7)$C
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MCUUXIVAE==-  ^T*0/F=2-PVXXZ=:M7?B?1K"9XKJ^2/RY!%)(58QQ.<85W
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MT?*/;TJ*^OK33;*6\OKB.WMHEW22RMM51[FLRR\8>'M0,XM=6MI/(@2YE.[
M6-QE6)/^1WH V)(HY0!(BN!SAAFHY+*TE*&2UA<I@INC!VXZ8]*HVOB32+MK
MQ([U4DLT\RYCG5HFB3&=S*X!"X!YZ4P^*=%C2X>>^6W6WB$TIN4:':A. WS@
M<$@X/?% &P0""",@]0:A^R6V,?9XL=<;!6/9^-?#=_JL.EVNL6TE[-&)(H@Q
MRX(W<'H3CG'7VJQ?>)M&TR?RKR^2$B18G=E;RXW;&%=P-JDY'#$=1ZT :$MI
M;3Q+%-;Q21J<JCH" ?8&I'C22,QNBLA&"K#(/X5GZEX@TO2"PO;KRRD?FR!4
M9S''_?;:#M7@_,<#@^E9EYXVTNU\0Z7I".TS7\+7"S1HSIY8 P00"#DD=.@Z
M]10!TA (((!!XQ47V2VQC[/%CKC8*J:[K-KX>T2[U6]\PV]M&9&$:%F.!T '
M_P"H=^*K6'B:PNM L]5FD\E;A4 0HV3(R@[%&,L>>, YQ0!JBW@#!A#&&'0A
M1D5@>--!OO$6F6EI9-;(8;V&Z9IV8 B-PVT8!ZXQGM[UKZ;J]AJZ2M8W*RF%
MS'*F"KQO_=92 5/L0*AU+Q%HVCW,-MJ.I6UM/,K/''(X!*JI9CCT !YH NVU
MO%;0A(K>*#/S,D0 7=W[#/UI5M;=+AKA8(EG88:0( Q'N>M96G^+= U32KG5
M+/5;:2RM21/*6VB+'7<#@C\:EM_$FD7+W*+>K&]K&)9DN$:%D0]&(< [3@\]
M* +[6ELUPL[6\1F7[LA0;A]#UH-I;&X6X-O$9E^[(4&X?0]:YJZ^)'A:"QN+
MF+5$NC#:->>5;JSLT8.,@ >N/P.>G-)+XAT_5-*T&ZDUI]*EN[J I$@PUPY
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M:>'&AF9V!(ES'QGU.&^HS6O\,IX9+?Q,L4B,/^$@O'4*?X&8%2/8]CWKNJ*
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MXVQGM8?@YX%0R1))%K%H[KD H5G)8D=L Y/L:]QHH Q/%TT2>"M:=Y$"-83
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M<:Y<.0^5QUR3CCOQ2:UJUA=^#? ,L-RC)'J^G;F.0 $'SGGLN<$] >*]7HH
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MHRP81'S#C<3DX[8/3C/<4  =!0!P'Q%TZ[BU?PQXKM;:6Z31+IS=00J6?R)
M%9U4<DKC.!Z^U=';^+]"OX5;3-2MK^9Q\EO;2!Y2?0KU7W+8 [XK<I  "2
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MI"K;HSY<8"]!SG))&.30!WGBSQ/:^$]$?4;E))"76*-$0G+L0!D@<#)ZG^9
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M0/9&6^"Q1H,&[9<J8B&&=N>I'0CK4]YXU\-V$MY%<:O;K)9%1<(I+M&6R0"
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MYMV!6-'C"Q(S#C.\Y ]B: .N_P"$GT;^T(;$WR":=VBA+*P25QU17(VLPP>
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M/.-Z,P =<\94D5LT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5T/@-A_;?C'Y642ZNTT19"!(GEH-RYZC((R*[>B@#S_5[R3P]\6(-7U**?\
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M!8H5!;H"<' -=U110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&WHNR,",)C(.XXV@9R>F:DUZ[ET#XJ:?K=_%.VC3Z4]@)XXVD6WG\T/E@H)
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MGRN5/^C_ +S.XL>"JY&,\],@'76/BW1M0NX+:&XE$ES;FYM_-@DC$\0QED+
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M4D\Y1N"L!_#CGGOSUK;\6^*8O"UK82/;3S/>7L-JGEPLX7>X!)VCK@G ZDX
M!YKGK#5+?5/C#%?V<=U)9R:!Y*W'V614+^?NQDJ,< \GC@CK5[XEI)_8FE7*
M0RRQVFLV=S/Y49<K&L@+-@ DX]J *=SXA_L[XI W%[?G3IM!-PEGY4C'S/.
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M)I"LP$#;08AU8-QC&<\5V.@^(['Q#'=&T6XBEM)C!<07,1CDC? ."I]000:
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M8[BUU*&(3FVN4VLT1. ZD$@C/'!X/7% &Q1110 4444 %%%% !1110 4444
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M]9;X<2:=#HUW)J&D:RUZ]K-$42Z07+2;$8\/E3D$9''KBO8(PZQJ)&#N!\S
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M'SS$6CCDX^;&0#Z<]:\ATZQU.V^&_A".71=3672-?2:ZA^RLTBQB27+*@RS
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MOXM1U"2]LI[6V\V*990,QNW1"N,?-@8]NH!>6^6+XN22B]E;3W\.?:]K3DQ
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M-S'*Y<*[GY4()P=W H Z_4?'VBZ=J%S8,M_<75O"D[QVUG)(3&QP&7 ^9?\
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M!]0UTJU]"#IJ.K;@Z0,RM)]7?)/LJUVE !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 445F:AK<%E?P:='#-=W\\;2I;0;=PC4@%R6( &2!R>2>,
MT :=%<G<_$+1[7PW>ZU)%>[+"?[-=VPB'G029 VL,XZD<YP<\&KEGXKM+[Q"
MVA/9W]I</;FX@>XB"+/&"%)0@Y!!(X8*>>E '045YEX8U^#PKX6\4:E=P7MS
M:6FOWBN8?WKQH' !.Y@2!QZUW4VM1Q7.F6XMIY'U#)3R]A$8"[B6.[H!W&>2
M/44 :=%</\60$\"R7&^1&AN[4@H[#@SH#D#KP3P<UIZ=XVL+_P 0MH<UEJ.G
MWC1&: 7T'EBXC'5D.3T[@X(]* .@N83<6LT*RR0F1&021D!DR,9&>XZUFZ!H
M*Z';.LE_=ZC=R[?-N[QPTCA>%'   &3@>Y/4DU0D\;Z=#+IKS6UW'8:G,L%I
M?LJ>3*[9V#AMP#8X)4 UM:KJ=MHVF3ZA>,5@A SCJ22  /<D@?C0!<HK$?Q/
M:VL6HRZG;7.G1V$*3RO<!2"C;@-I1FR<H1CKG'K3(O%-M_;-II5]97FGW-ZC
M/:?:0FV;:,LH*LV& YP<&@#>HKS_ ,(7MKHUSX[NKVY:.SM-59WDFD9]BB&,
MGDY)^E5]9U&2]^)?@5FL-1LO,>Z8?:& 21?L[8^57(##/< \_7 !Z11574]2
MM-(TVXU"^F$5M F^1R,X'L!R2>@ ZDUP6J:A+<?%;P>S:=J-HS07K%)W7;*!
M$,8"N5##)SG!Y% 'H]%<K+X^TR'PM?>(6M+[[)87#V]R@1/,1D;:W&[!&?0F
MGZOXXLM)UN31_P"S=4O+Y+,WBQ6EMO,B!@I"\C)Y^G'7. 0#IZ*Y#3M<T4^(
M?$=S!8:C'J-M;6TE]YB-EU*N4"(3U !S@#\:++XBZ9>C1I5L-3BL]7=8K:[E
MA58O-8$JA^;.3@\@$9[]: .OHKGM0\86-A)JJI;7=VNDQK)?/;JI$(*[L<L"
MQ"_,0H/'OQ6II.J0:SI<&HVR2K!.H>/S4VEE/(./0CD4 7:P[/PY]D\6:AK_
M -M=Y+V&.%X#& JJF=N#US\QSZ^U4[OQWIMG]JE:VO'LK.]6PN;Q%7RXIB5&
M""P8@%U!(4CFNAO;A[2QGN([>2X>-"PBC*AGQV!8@?F: )Z*X/2_B-&O@C3?
M$&LZ=>0K>R(BF)%=<R/A<8;(49 Y )]#6O'XS@>2VMVTG58;VZN)8;>TGA6.
M201J&:0;F"[,$<YY]* .EHKG;?QGI5QH!U?%Q&HN39_9W0>=]H#[/*"@D%MW
M'!QWSBN=L[UY/C7,TEG?6I7P\SM#.P?<?/3YD"LR]!CCN.E 'HE%<)IOB[PY
MH7@K^U[.RU&/3&OI(BC(7=96F*L3N8X!<^O?I6YIOBRUU'Q!/HC65]9WD=O]
MJC%U$$$T.[;O7!)X.!A@#STH WZ*Y.7X@Z7%8V>H"UOI-.O;G[+;744:LLLF
MXJ,#=NP2I )'./<9Z6>Y,-B]TMO-*53?Y,8'F-QG !(&?;- $]%<F/B!IKZ+
MHVK)97[VFK3K;V[!8_ED9BJA\O\ +D@_R.#Q5[6-;LHX=8L[RRO9+:ULO-N7
MA4$,CA@57#;MV%8]!@<YY&0#>HKC[?Q=HFC:-X8@M[/4!:ZG;QK8HL1D*KY>
MY58Y)+;1CJ3_ #J]IWC33;RVU>6ZCN=-;2#_ *;%>JJM$I7<&^4L"".1@T =
M%17F^N:D]]\0? LAL-1LQ+/.RF=@$D7R&/*JYPW(/S 'GV..DO?&EC9VU[>"
MTO;C3["5HKN\@162)E^_QN#,%[E5.,'T. #I**PO^$KLF\06FCQP7,DEY:-=
MVTZ;/)FC &=K;LD\CC'?/3FH+/QI9WVBW^IQ6-\$L;EK66!EC$IE5@I4#?C.
M2!R1G/&: .DHJM>7\&GZ9/J%X3#;V\+33%ADHJC+9QG. #TS6-8>,+2]U&VL
M7LKVUFN[,WMMYRH1-&,9QL9L,-PX.#S0!T5%<4OQ-TEM-34O[/U4:?\ :C:S
M7+6X"6[>9Y>7RV<;O0'&><5NW^N01W\NE06EU?7:P>;-%:E5,2-D EF90"<'
M !SP3[T ;%%</\))?.^'MM)F4AKJZ(\TDMCSWQG/.?K78WEW!86-Q>7+^7;V
M\;2ROC.U5&2?R% $]%<[IOC"SU#4K"Q:SO+634+4W=FTZIMFC&,XVL<$!E.#
MCK5>\\?:79V$NI&VO9=-CNS9M>1(K)Y@;9P-VXC?\N<8S[<T =517-WWC.SL
MI+J-+"_N);.S6]NXXD0-!&P)&X.RY;"M\HR>/I5?4]:T"\OO"DT\-W.U],)M
M-FC#*BLT9(+\C^$G@Y^E '645R5U\0;&WN-8MXM*U:ZFT@K]J2&W'"E=^X;F
M QMY]3V!YKI-.O[?5--M=0M'WVUU$LT38QE6&0?R- %FBJ]]?6VFV$]]>3+#
M;6\9DED;HJ@9)K&7Q?:)J%A:7ME?6)U '[')<(NV9@,[/E8E6QR P!/3KQ0!
MT-%<5+\3=*BT^\U#^S=6:SL;MK6\F%N,6Y5@I9LMTR>V2.I XS'K(V?%SPQ)
M&\C"6PO2RB0E6VB/& 3@'D_G0!W-%<]IGC"RU/3M7O%M+R!=)EDBN8[@(KAD
M7<P W$8QCDD ]JVK*Z^V6,-T8)H/-0/Y4P =<\X(!//XT 3T5QVDZSIJ:;XG
MOM#TV^,]O?RBZBE.&><(I9@'? 7&...AP/6A\/M-AU;1M"\2W5K=PZL+7=+=
M&50+WS%RQ<*QW $Y&X#'&!0!Z!17)Q>);N\\?:AX<;2[E;2WM(W,RR(,[RPW
MY#A@N%P,?-G/ XKEO OBVV\/^"[-+VUU&2W;4KBWDO0FZ.%FN75-[,VX]1R
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M-%8KEPS!1DCCGGJ.AQ':>.-(O](LK^S\^9[V=K:"T" 3&5<[T*D@ J%)))P
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MMU&)(RPP<'L1ZCI0!?K*UW1YM9MH(8-7O],,<PD:2R959Q@@J<@\<_H*U:*
M(+*S@T^R@L[9-D$""-%SG  ]3U/O4]%% !1110 4444 %%%% !1110 4444
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M:>*:1-SPDF/).%)&,@=,XR,]>3ZT 8?CS0;GQ-X'U;1[.0)<W,.(BQP"RL&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BJD&IV5SJ5UI\%PLEU:*C3QKD^7OSMR>F3@G'7&#W%5+?Q+I=S
M<Q0Q3LRS2M!#-Y;"*6102RJ^,$C:W3KM.,X- &M169K'B#3M"^R"_DD0W<Z6
M\&R%WWR,<*N5! )]\5HR2)#$\DKJD: LS,<!0.I)H =16,?$UB-6TW3=ESY^
MHK(]N3$0K+&,LQ)Z#D=?45IRW,4-Q!#(2&G)6,]BP&<?7 )_ T 3445SS>-M
M$74+ZQ#WSW-AM^U)'I]P_E9&1DJA'(Y'M0!T-%8=]XLTFRT*WUI9FNK"X9$B
MEM5\S>78*H'U8@5N4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %<SXF\6:?I-Y#I#ZM8Z?>W
M*>89KN9$$,6<;P&/S,2"%'J"3P.>FKF_$L\%Q:7VG?8[T7,MNT27<6G-.(RR
M\,".N,YQGK0!YS9ZE#9?"GQ3K6A7*27FK:D\$3I+OD3?(L$>\]=^S]YSSE\]
MZZ?Q%9QZ??\ P_\ "NGC AOEG&.T5O$=Q/UW#\35J6#2G\)6_A^/3-7B@MUA
M\IUTV3(>(JR,1CGE!GUYJQ:7-M'KLVMWEEJUQ?M"+>-AIDJ)#%G)51SR3R23
MS@= * $U_P#XFWQ$\-Z0/FBL4EU:X7W4>5%_X\['_@-)K5S+K?C[3_#"Y%A:
MVW]IZ@.TOS;8HC[;@6([[15?3'>R\5ZGKMRNJ7+WT,4(B&CRIY*1[L!3D\$L
M2<]3Z4ZUU*"U\<ZEJ3:=JQ%]8VZ)_H$F08FDW\8Z8DCH R[O6A=_%>_@M+F)
M-0M[5-,T_P U"\8E<&>9FQZ*J#&03@@8Y(V_%MW<V#>%;9IQ-?7&M0IN1-F5
M"N9"!DX&W(Z]ZQ)M*M(].#(^LPWL6L-K)O6TISAR3N4K_=V'9UZ#-7+>Z74/
M%5MK=[I^LO;Z=;F'34>PD+,S@>9.W'!(PH'89/?  /0&8(I9B H&23V%>9^!
M9M<O-&U?7].T^V>?7K^:Y@GN;@HJ1 ^7'N4*20 N0!USU%=#KVJ-J^B7>G6T
M.KV;7,31-/\ V7*Y56!!VCC!YZT>']0@T+P_8:4+'595LX$@5UTN5-P4  D<
M\\<\]: .>MO#D>C3^"_!4=P;E+2675KR4C&[RR2IQV!EE! _V:O:MXQU)O!^
MH^)]+,"6J/Y.FQ2)N-VQ<1AVYX#,?E YP 2><"2589_%MUKDB:YY<]BMG]G7
M3) 54%B?GQT);.,=5'..*P8_#K#0]#TN:^UN6/1[N*>W/]BN 4CSM5E[MR/F
M.?N_=Y.0#I)_$&MKXXA\/036<FS2A=7+M"<1R%MH9CN^[PQP,'[HR,Y&EX%U
M:_UWPA9ZGJ+1M-<-(R/''L#Q[V"-MR<94 ]>]81M[<#Q+*J:V+S6XA%]H.F2
M$P(L7EH!ZX)+=LDFNG\*VZ67ARRLX_M.RVC6$?:(#"V%  PAZ# X_F3S0!LT
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 445RNH>/]+TR"6XN;/4UMH[DVOGBU.QI
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MBEPQLKNT\FX>#%S'L,FTXWKR<H>Q[U=H **;)(D2%Y'5$'5F. *RO^$BM?\
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M&ZEV*UNIQRH P6R =S9/ ]\@'-1>(QKOA_Q"EIKFJ6UY:Z7(T^GWD:175K*
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M;4K4D2>7A5>1$9%PN54Y)P#_ /7;J.FS:K\8+ZUBU.[T]3H$):6S*K(?W\F
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M0#M(4CJ""1P0:LQ^"K*VU73M5AU"_BN["T%IYB&,>?$.BR#9\V.W3'UKIZ*
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M\'^S749C?RVPP'J#Z@X-9A\'P/J6CZA+JNIRW.E"00O(\;;RZ[7+_)SD8'&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
=HH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>ex19iiinsidertradingguid005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex19iiinsidertradingguid005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$T'4]8O4^T7=G"SR/@&61D!. .I/)P!0!TM%5;#4K+5+;[38745S#N*%XV!
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M]2TV :?>2G]SA"YDC#= 26#>_'M7HAC0J%*+@=!BFR012JJR1(ZJ00&4$ T
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M6_=PW95.&/120I49]Q7K[P0R.'>)&< @,R@D ]12O%')$8GC1HR,%",C'TH
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MOI/V=M52>QDA\C&^,J 9F..0  Q;/?'?%=/X>FM;CXJ^.+<R0R;X+%3&6!W
M1R!ACOC//UKH_"^COH?AW3["X6W-S:VT=LTT(_U@10H/(![=*NZC!=2:?<KI
MLD-O?-&1#-+'O57[$CC(H X'PO8WMKK;>"KB*0Z;HES]N@G;E9+=LFWC)[E7
MWG/_ $Q%=OIGB#2M9N]0M=.O8[B?3YO(NHU!!B?G@Y'L>1QP?2F:#I=W80S3
MZG=QW>IW+!KB:./RTX "JBY)"@>_4D]\59M--BM;Z[O1\UQ<[0[;0 %4G:H
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MXD??].,$^QKG/#*VE]\/_#<-KKZZ1J<%_>-I]R-KQA_,E_=NI."&1C@?EZ$
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MJ-QI]CJ5K<7=L,S0Q2!F09QR/KQ[&O%[^_LO^%:?$&U>\$LIU\R?O@%=E:2
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M@84 ;>>#P!UKFEU_2KK2O!5U;W-O9VT.O*6TV+D60(FXE8Y;>2>Y .3A3C-
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M4<R%)45U/\+#(KS;5]8-EX3\+7^E>*+N[LI-:@AFO964?:(FF8.';:.!@CC
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MCLKVUU&RAO+*>.>VF4/'+&V58'N#6;<>*]$M;IK>:^"LDZVSOY;F-)6QA&D
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MBC"*@10BC 4#@4I160H5!0C!4C@BN!UKQ+*NN>#+V/49[73[N69;N%T\M&Q
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MPO)]C6SXCGDT_6-8U7PUJJ/=M/&M[H%TH>/4"40!HA]X,5VC*Y!*\]*]7HH
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M1Y$6:SN(R,1RIAHW!'H0/PS6-X>O[G5O"VH>)]8@%G<7-I]G$;D#RUC4AO\
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MH ]/TW6M/U9KA+.XWRVS!)XG1HY(B1D;D8!AD<C(YJ6^U&TTV%);N81AW$:
M LSL>BJHR6/!X )XKDM+@74?BM>Z]ILBRZ8-'CM99XCF.:?S2PP1PQ5.I'3<
M!3?&CS:;XR\):Y.&_L>TDN(KN0#*P-+&%21O1<Y!8\#/O0!T*>*=$?3[R^.H
M1QP61*W1E!C:$@9PZL RG'J.:72/%.BZ[=2VVF7\=S-%$DSJJL,(X^4\C_\
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MMS;64LT<L07(94)'4'T^M4_#GC70[]=-TDZO%+J\EI&S1MG,C! 6PQ&&(YR
M21S5WQO!-=> _$%O;Q/+-+IUPB1HI9F8QL  !U-<;.MIXETKP+9Z.\4]YI]Y
M:W,S1=;6.)/W@?\ N$\+M."3VX. #N+KQ3HME,T=Q>B-4E$$DQC<Q1R'HK2
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MRM*3/( <.HD.?E^7#="1[4[P#)JVK1G4-=A,=[I\;:4"3D2.CXFE!]'*H/\
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MM"0GYX[?8ZGJK G@CL:[&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 5Q.O:A)%X^M;.>SNXK.73SLO+*U9Y9Y/,_U!D4$QJ
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M#UZ$8/2LOQ'I-T?"7CR_AM;DQ:S?V[65LL#%Y AC#2! ,_,0QZ=%SW%>R44
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MI;Q+F>3;8[/MDD<+NEOO^[O(''!!]@<G KC/"NJ/H^FW/@[6-#O+K4X;R9H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH&XY( '/H 2> 376WNOQ6;F%;.\NKI(1/+;6Z*SQH<@%OF Y(( !).#@'!H
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MQ17P0&%ILE=N<[L;@1NQMSWH Z.BO/M$U1-&\3^.Y;J:ZFMK:ZM1'&TC2O\
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MXUZ'H%M':Z+;Q0Z7#I<7S,EG$BH(@6) (7@-SDXXR3R>M:5% !1110 4444
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M&7346>?RI=&G=HC*QCW"2, A2< X]!6_XA\1Z?X8T];[4C,L#2+$&CB+X9B
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MUL5A:#KDFO2M<IHU_86ZQ[6?4(/)E=\\*%)S@<Y)XR1C/-;M !1110 4444
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M*V<X' .<GC\JVD35="^(-SK0TF]O=,UBQ@B8P(#);2Q9 5E)&%(8\^M>@T4
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M<.-Q5]X8!V0EE XR0".:]BKEK/P+9:<3%8ZKK-O8[BPL8[TB)<G)"\;U&2>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<)SVST/CI;_5/"L)TK3%U>SE99KJU%T;=YX I8*C 9R3M..,@8[T =A17->
MH="7PE:7?AVU>VL+T?:!')(SL&( ()8DY&W'7'%=#<2116TLD[!8D0L['H%
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M);.,?6K.F>*H-2\0WVABPO8KRQV_:"RJ8TW+N3Y@QZCIQV- &_1110 4444
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M(V&);*[2!CAB3P.:Z+_A$?#7_0NZ3_X!1_\ Q-'_  B/AK_H7=)_\ H__B:
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M/(K*\)6WBS0[&W\+W6@6\D5F?)AUD3IY;0 \,8_O;PO&.F>I KT:D)"J68@
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M'4]2\0Z^NGS1S7.BG2K.T9XQ(^2S%V.[:HRR@<YP#7?44 ></HFM_P!D_#^
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MQ+ TX"RJFX':W(_BSSZ&MM](U2?XC6^L3V:BR_L=[&9DF!Q(TBN< X)48QG
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MID%H?*&WGGGGMQ[\5A3^%?%MSIT27.G65SJ5MK45Z]^]W\UW$DV]5'R_(H7
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M9<6<WE1F638=J @%CCID\4 <+#\2;N31-#UQ_#KKIFJ31P;UNU,L;NQ5<)M
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M/X1LQ90OJ&AZDMS-";@!94_> [6Y[2#J!T/MGTZ(R&)#*%$FT;PIR >^#Z4
M<9I?B356\:^*K?44LXM+TF. EUN&)C0QO)OQL^8G(SR,8&-V.99O',EGI>F:
MW>Z7Y.B:@\:K<"XW2PK)_JWDCV@!3D9PQ(R.O:O)X6U&X\4>+4FAB.D>(+6*
M(W*S8>+;"T9&S')Y!!SC'Y53_P"$9US5? MCX,U6TCC2W:"&XOTE4QRP0NK
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MI%;R#<&!*(%)!!Z''?!K9H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MI7>KZ982".\U&TMY",A9IU0D?0FKM>=_$=X8O%7@66:-G1-2DR$B,C8\L]%4
M$GMT% '?6UY;7L7FVEQ#/'G&^)PP_,5-7FG@V,:Y\1M5\6:)%]ET"6T^QNI
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M,<=A'IW]HM<-<6=S(=X=(7.UBH^[SN'&2<=,4 >A44#.!GK7%S>-+V7P[?\
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M"9#?+@#IURP[T(?B7<W>CZ#>VNA[IM1OVTZ>W>YVO;SJ&ROW<$?+UR.#T[4
M=GK6AZ?XATR33M4A:>TD(+Q"5XPV#D9*D$\@&KL4:PQ+&I8JHP"[%C^)/)_&
MN'A\<:O;WFN:5JVC6L6K:=8G484ANV,-S!R"0Y3(((QRO7THMO'.J1^'(-?U
M+1[>&RO+:V:R2*ZW22SRD 1D%<*,L#G)P.>N0 #NZ*Y>3Q+?:;XFL-$U6UME
M;4XY#97,#L4\U!N:-P1D<<AN_/ JMIGC&]O=$UR>XL((-3TN[:S^QK,6$DG
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MW/4ZE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\DX&!UJ:ZL_$>NV6H:-JUIIMO8W)>%KFWN'=W@;C C*##E>,[L G(!Z5U5%
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M#B&>!O\ EDI"$X7"[3@8P2<DG/?51O=9TK3IXX;[4K.UED&42>=49NW )YH
MY(Z%XIT3Q;J>HZ"--N+#6"DMQ!>2NAMIE4*64JIW*0!D<'Z5=ET#63XXT;6"
M]K/;V5C+;32/*4DD=RI+! I &5Z9[^U=7%-'/'YD,B2(21N1@1D'!Y^H(I]
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M"_R?(0K ?Q=,# '/4:#HFJV'C/Q%JMXEI]EU3[.8_*E8NIBCV'*E0.>O4XH
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M\-:+K5EXM\1:OJ45E'#JGV=D2"=G9#''M(.5 (]^.G2@!?B5JFHZ-\/]6O\
M2WCCN(XL>8Y.4!(4E<?Q<\?G[58EU^\CU6PT%(;9M6N;>2YD/F,8H85(7<>
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M[>"."% D4:A$51PH P *?0 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^%[_ $G>(Y)X_P!S(?\ EG*#N1OP8 U;U/6=-T9(7U&\BMA/(L47F-R[DX
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M"3G')/<D^@%Z/0M1_P"%B'Q$YM1:MI@L#$LC%P1(9-WW0.^,?C[5TK,%4LQ
M &23VJGIFKZ?K5O)/IMW%=0QRM"TD1RH=>HSWZT 97C/0K_Q!HL-MIUS#%/#
M=PW/EW )BG"-DQR8YVG^E9-OX9\36VOZ[J\6H:8D^IV]NJJ(GQ')%N '7E<-
MR>I]!7<44 <GH7A,Z=XMO-?^S6>GM=6JP2VMDY:.5PVXRME5&[L..YR>:G\6
M:%J>KW&C76F7%L'TZ[^T/;7>[RIAM*C.W)W+G(XZUN7NHV6FQ)+?7<-LCN(U
M:5PNYB<!1GJ3Z5)<W,%G;27%S-'#!&NYY)&"JH]23TH \[O? 6OW6B>+=--_
MIKC7;@3J^QT\LE4#9'/ V8 YSG.>U;WB30=6UN'P\8OL4<NFZA%?3!Y7VN45
MAL4[>^[J>F.AK;77=*;3Y[\:A;BUM\^=*7 $>!G#9Z'!'7U%6+&]MM2L(+ZS
ME$UM<1B2*1>C*1D&@#GM6T'69_&FGZ[875D88;1[5X+M681%F!,L>.K8&TYQ
MD#K7/V?@+7K3PUH.D-=Z=+_9.L#4 _SIO02.^WH>3OZ]!CO7<ZIKVCZ&(CJV
MJ65B)<^7]IG6/?C&<;B,XR/SJY;W$-W;17-M*DT$JAXY(V#*ZD9!!'4&@#C-
M1M+K0-<\1>+KR>UBL7TQ8OEW2/&8]Q#;< -DMTR/K7/:+:Z]X=LM,O#!X5OH
M(%"1?9[J;S6WX#>0#N0,WHN ?85Z;J%]86-N#J-S;PPRL(AY[@!RW 49ZD^E
M4+30_#6AZA'+9Z3IEC=W!*I)#;)&SG&2 P YQDX[X/H: .?@\,>*M#UW4CH&
MJ::-'U.Y:[DCO8G:6UE?[YCVD!@3SAB!G\<Z,'A[4;?QV^NK);RVW]EIIZK)
M*WFL5<N'8[<<DX/Y^U=310!YS)X$UF3X<:EX8,]@)[R[><3^8Y50TWFD8VY)
M'3]?:K^H>'/$UKXID\0>'+S38Y+^".+4+.^#M$S("%=&4 Y .,8&?Y=O45S<
MPV=K-=7$@C@A1I)';HJ@9)/X"@#EKKPWJ\_B/PSJ;75M<?V5]H:X:0LC2M,N
MT[0 =JKV!)XP,]ZS[CP/J5]IWC.SGN+2(:^_F0LC,WE$(J@,"HR/E!R/6NWL
MKRWU"Q@O;259;:XC66*1>C*PR#^1J"TUG3;[4;S3[2\BFN[/;]IB1LF+=G /
MOP>* ,*XT?6[VRM[74[;1M1M7MS%=6<I=8R_&UE)5CP,]0.HZ8K1\)Z$WAKP
MO8Z.UP9S;(5WDGC+$[1GG SM'L!6U10!R\6@:I8^.=4URTGLWM-1MX4DBE#"
M17B#  $< '=R>2/2L"/P)K4?P[TWPSY]@9[.]6Y,_F/M8+,9<8VY!YQ^OM7<
MZGK.FZ-%%)J5Y%;+-(L4?F-R[DX  ZD\U>H \]U;P5K]_+XKBCOM/^SZ[ %6
M297:6 B/;Y8Q@;,Y(/;)X)-7_P#A%];36O#VJQWEA]HL;*2RNE,;[2K;3N3G
MDC;CG&>O'2NSHH S]>T^?5?#^H:?;7;6D]S;O%'<+UC9E(#5R-CX2\10ZMX:
MU"6?1X_[(M9;5X((Y I5@@RI]3L]!C/\5=Y++'#$\LKK'&@+,[' 4#J2>U9*
M>*M D4,NKV>TC*L90%?_ '2>&_#- &/H'A"XMO"NLZ%J[P/#J,URY:V=B0LY
M8D<@<C=U_E3?#.C>,=.2UT[5]7TZXTRR 6*:WB=;F=5^Z),G:O;.,DXQW)/9
M44 9?B33[C5_#.IZ9:F)9KRUDMU:4D*N]2N3@'IG.*YV3PKJ[_\ "'8:RSH.
M#-^]?][B(Q?+\O'!SS]/>NVHH X>R\(ZOHUEK>CZ9/9MI6I2RRPR3,PELS*/
MG4*%(D ))'S+Z'-2R>#+FPU7PS<Z'<6\<&D6<EBR7*LQ:-@@W#'5ALZ' .:[
M.B@"&[65[.9( AE9"%#L0N2.Y /\JX*#P/K,'A+PIHXFL&DT.^BNGD\QP)5C
MW8 ^7@G=^&.^>/0Z* .2_P"$8OYO%FN:E-);)::GIZ605'8O'MW?-@J <[SQ
MGM61_P (+KX\*:#;Q:I8V^MZ R_89TC8Q.@385DSS\R]<#CM7HE% '#ZUX;\
M3^(_!>IZ;J=[IJZA?HD06W$BV\"ALDC.69C^';TYNWWA_4K_ ,7:'J\@LUM[
M&VG@FB\UBS^:%!*_+VV]^N>U;>H:YI>E2)'?7T$$D@+*CO\ ,5'4XZX'KTJ>
MRU"SU*#S[&ZAN8<X\R%PZD_4<=Z /.)/A_XE3P)>^"[?4-,?3"V+.ZF\SSDC
M\P/L=0,9'/S ^V.XV+[PUXGLO%$NO^'M0TP2W\$<6HVM[')Y3L@PLB;22" <
M8/Y^G<44 <3J/A36TUW2?$6F:A;3:M:P/:W:W89(KF)VWD KDIM;[O7C /3F
M[X5\/ZKI&KZ]?:A<6<BZG<K<+';JV4(15P2?]WT]^.E=310!S?BS0+[6)]%O
M--GMX[G3+X7(6Y#;'78R$?+R#ALCZ55M?#FK:'XFU35=*DLKB'5EC>ZM[AVB
M\N=%V^8A56R&'53CIUKKJ* ,?POH$?AK08=.27SG#/+-+MV^9([%F;'89)P.
MPQ6*OAO7]*\9:EJ>B7MA_9VK%)+N&[1R\,BKMWQ[>&R ,@D<UV5,EBCFB:*5
M%>-QAE89!% 'E'A30+[6_A/X1FTR:W2^TR^:]B%SGRY-LDJE6*@D9#'D ]*V
M;KP3X@OKGQ3<2:M:6TFMV,5NK6Z/F)T5AP<_=^8@GDGKQTKMM/TNPTBU%KIM
ME;V=N"2(K>,(H)Z\#BK= '#6'A?Q!%XFT;6)Y](B6SL'LI+:VC<*%)4C83Z[
M>X&/0U"G@O6/^$)\2:$TMCYVKW5S.DHD?;&)FR0?ER2/U]J[JYN8+.W>XN9D
MAAC&7D=L!1[FI: ./UGPYJ^I0>&$B-BC:1=Q74VZ5\2%$9-J_+QD,3D_E5?Q
MW%8Z];V>DV^IQ0>(8;V![9;>56F@8GYVV]=OEESR.0*[BJB:7I\6I2ZE'8VR
M7TJA)+E8E$CJ.@+8R1P/RH FM;:&RM(;6W01P0QK'&@Z*H& /R%2T44 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %<%\03J/]O>#TMKBW2)]67:LD3-^
M\$4G)PPRN.W'/>N]KF/%&A:EK&JZ!<V36BQ:9>B[<3.P,GRLNT84XX8G/Z4
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M)<W$C1SX=0J-,9<D8.3SC' 'J: #X@6VI1P>&Y6ET[[3+K=C#)*EJP+#S=R
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M4RB(Q$\ $'!SC\,U>L= U>S\5Z_K#-92IJ5O!#&GF.I4Q*PR?E/7<3@=,=Z
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M&/\ R3+P[_UY)764 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+;3PO#*5'5@C@';[XQ6M0!Q\/A+48F\5L;ZU)UTY7]TW[@^6(^?F^;@9[<U
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MJLCY)VX#$[1GDYSQBC0?"UYI=KX@M[C4(W75[N>[#V\91H#*H! ))SC (/%
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MJZY->P31ZA!#"T2PE67R@P#9SCG<<C% &=8^*M1M;[Q18:[):K<Z6@N+7[/
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M=(RF])&8D$$G'WB.M '->*E&E>#_  %)9#;):ZGI\<.WNK(49?H5)!J'3/\
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MRK]UP RD, 2.O]<@!%XCUF74-$T"Z@M;+6[NTDN[TK^]2%$(7Y!GDLQ&,DX
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 445S.OWVH0ZU;VL=^MG9R6TC*8(Q-<RS@C 6,J
MV4 ))('IR* .FHKS"'QIXAOO"?@G5();.*?5[Y+2Z5H"0?\ 6?,/FX'R=/?J
M*U=.O_$EQK'BGP\VJ0RWME#!/8WAME4 RJQV.O0@%.O7!ZT =U17"Z)XEO\
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M9K=_-H[VTXE^SK<>5=VY"S0DX##/!&<<'D=Q7 :OJVJ>(OV?K_5+V["W3PW
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M8R4;\0><<$$<&MVN:^'\,T7@+03-<M.&TZV9 45?+7RE^48'/U-=+0 4444
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7">(1?O\
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MF"DCJ,]0:Q_B/]SPK_V,=E_-JZ?2;";3[+R[F]DO;IVWS7$BA=[8 X4<*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4:0
M1(VY(D5CW"@&I** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:O+;3W$5I$TLB0;=VT#)/S$"DCU>6:32?)TZYD@U"(R/.I79;#8& ?G/.<#
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M ;-%17,YM[62=89)BBEO+CQN;V&2!GZD5G^&]=A\2^';+6;:*2*&[3>B28W
M9(YQQVH U:*** "BL7Q1XCB\+:,=3GM+BXA61(V$.WY2[!03DCC+#IFKIOIA
MK:V'V"X,!MS,;SY?*#;L>7USNQSTQB@"[1110 444Q9HGF>%9%,B %U!Y4'.
M,_7!H ?116+XJ\1Q>%/#UQK$]I<7,,&W>L&W(R0H)W$<9(Z9/M0!M444R*:*
M="\4BNH9ERIR,J2"/P((_"@!]%%% !1110 445%=74%E:RW5U,D-O"A>21SA
M54#))/I0!+17/VWBDWEF+^VT359=/9=Z7 CC&]/[ZQEQ(1CD?+D]@:U-*U*#
M6-)M-2M=X@NH5FC#C#!6&1D=C0!<HHHH **** "BBB@ HIBS1/+)$LBM)'C>
MH/*YZ9I] !15'6-7M-#TV2^O681*50*B[F=V(554=R20!]:H1>)3_:MEIUYH
M^HV,]X6$+3"-D.U2QRR.P!P.AY],\F@#=HHHH **** "BF/-%')'&\BJ\I*H
MI/+$ DX_ $T^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^I$/-"KKY:R;0F]05/.!W)'M0!Q>B>*]3N_"W@*TGO9?M6O22"YO.-^Q S$
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M#T_'9\50:[H#:.UKXHOY'U+7;>"02QQ%$1P<JH"@A<KG&?8YZUO:AX&T[4M
MU#2)[J\"ZE,)KVY1D$L[#&,DJ0  J@  8 K'^(\#M9^%K47%T\D>N6TLD\:
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M+R-L2<@XZGOZT =/H'B&ZUN:5)_#^I:8L29+WBJH9]S*57!.<;<YZ$$&MVN
MN-?U#2/&/BTRW4UW9Z=HT=]#;/M 5OWA(& .NT<G)J]H]IJM[9>'=>CU]_W\
M237\<GS17"R("%1<X3#$8(Y]<]P#L:*\RL[OQ5XH\.6_B'1KJ*WNFN6D037A
M$ B60J8GC"$?='+?>SSD#@6[.'6-8\?>)]/;Q)J%O::=+92P)$(Q]Y"S(?E^
MZ>1ZGC).* /0J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXBE4 *R,J@+@#  &.3ZUU5% '":]X??1_!&IP++K6MW%VJ03SM+YERL);#%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R/BCP7<:Q?G6-*U
M[4=+UB*$1PM%+F!@"2%>/&&&2<UUU8=QX<>XU:XO1KNKQ0W"JLME'.OD\#'R
MY4LF>^QASS0 OA#5[G7?">FZE>PK#=3Q9F1>F\$J2/8D9'L:VZCM[>&UMHK>
MWC6*&) D<:# 50,  >E24 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
+ 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>ex19iiinsidertradingguid006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex19iiinsidertradingguid006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]!M?*73[N>%HV.0247<,X7.".@/3J: /4**** "BBB@ HHHH **** "BBB@
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M,"SP;2V[<$."K=L@C(P#TKHJ* ,+0/"UCH%Y?WL"H;N_*&=XXEB3" A0J*,
M<GKDG/)Z8W:** "BBB@ HHHH *YVY\*FY\5G67U:]^SM"D<FGE@86*-N5L=N
M0,XZ_0D5T5% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH)P,FB@ H
MHHH **** "BBB@ HHHH ***,Y&10 4444 %% .1D44 %%)D>H]*6@ HHHH *
M*,\XHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BD9@JEF(  R2>U(CK(BNC!D8 JRG((]10 ZBBB@
M HHHH ***BDN;>&6.*6>)))#A$9P"_T'>@"6BBFK)&TCHKJ73&Y0>5STSZ4
M.HHHH **** "BBB@ HHH)P,GI0 44V.1)8UDC=71AE64Y!'L:=0 44R66.&)
MI99%CC499G. ![FECECFC62)U>-AE64Y!'L: '444R66.",R2R+&B]6<X _&
M@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %>:?%31[J\N-)U#2 $UBP6:\MV
M4<R&+8VP^H(R,>IKTNL+4HKU_%.D3PZ?-+:P),LLRO& N\*!P6!/0]!0!2E\
M3+K?@W3[W1Y-MQK2I#:D<F)F!WM]8U#L?=,5ROPPU'3_  W\*K:^N H>6]E@
M#$@/,YF94!8X[=R<  FMKPMX-N?#&MZO<%C<:8DSR:3:1E<Q"7:TH&2 /F
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MA\J5"H<E,8Z$H?F].W/"7^G>*-%\86_B2PTZ+5UNK!;/4+2&=83&ZL65XR^
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MZD<;3W&1S[;WAFVU.S\,Z;;:S<"XU**!5N)0<[FQZ]S[]^M &K1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.U[I!M;;5;]K&%)9BMRARP5VB*CY3L[,<!EZYH [.BN7A\637^IWMKIUG;W
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ML<BJP/F28/S$ CKGG/3@UZ!69#X?TV#79M:CAD&H3((Y)3/(0R#HNTMMP,G
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ML:* .2U/2=2E^(6BZM;V2MI]C:SP2,)5#$R;<;5]!M]NM+;:7J<?Q,OM:>S
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M%=_10!R/@KPP_ANZU?[/%+9Z3=21O::=)+YGV<@'S",$A0Q(X!/3WP.NHHH
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MFLY2R3[U5D(+#(X;GCC!^E '077A_3;W6;75IX9&OK0,()1/(OEAN& 4-CG
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MM_J-EI=M]IO[J*V@WJGF2L%&YC@#)]2:LUS7CC6I- T%+Q=/M[V,W4$3I.^
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML0N[DXYQG.1?TW1-7L?&_B'6F2Q:UU&&WC@47#[P8@P^8;,#.[L3C'>NJHH
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M1GE?Y<^CT4 >8WG@OQ7=-XAG272XVU*_M;L6_GR%)4C50\,C; =K!<9QSCD
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M 'GND^!-2T/6O#,UJ]E-:Z9%="ZD>5DDEDN"&9E4(1@$< MTKT*BB@ HHHH
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M#/K79:1/K,[79U:RM;51(/LP@G,A9",_/D## \<<?S/#W/@?Q!<>!/$FA?\
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M%C.5'R$Y)[C /. #KJ*\_/C^[@LM .M6T?AZ;45F6:74(7:**5"H"=5QO!+
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MHQYD8PDB,JM_"<%<<]<UU5% ' MX#O;9=$^QW%J\MGJLFJWDDNY//EDW;@H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML699&9V4!L9P&(XS6A\/]#DT+PA:0SR32W$JB21Y_P#6!=H6-6]"L:HOU4T
M/\6^*$\-'3/.FAM+>\G,,E]<1L\4'RDC< 1C<0 "2 .:BEUK6HM-TV5O[,"3
MSRBYU(-FWAA!;RW"[P27 08#<%JT]:L]0NY+<6R65Q:%72[M+S.R96QCD*V"
M".X/4CW'(VOP]U+21HTFDWEF@L+ZZNOL,X=K=%FX"ICG,8SM/&=QZ9Q0!0\0
M>(I_$GP=\7R74<0FLI9[)GA5E278RX<*Q)7((X)-=3?>(YH-3@T2Q(CN5L5N
MI)FLI;H*K$J@V1D'DJQR2,8[YXQ9/ 6M/X5\5:*VHV,AUJ\EN4E\IT\OS"I;
M(R<_=P /S-7]7\,>(#K6G^(=!OK&VU6*T%E=072N]O/$#N'(PP())!]_S *A
M\?W]II&DS:[9IH<MU=2VT]S=P2&",H,JV"5(#\8+$8P<YQ79:-/=W6EQ37S6
MSS,SX>U/[MTWG8R\GJNT]3UK)FTK7)+:V6YFT_4A(L@U"VN%9(9=VW:$&'VA
M=N.0<Y.>3D3^#_#@\+:#_9JN"GGRS+&A)2$.Y81IGG:N<9[]>,XH RXO$^JO
MK/C&R^R60;1H8);<[F_>;XW?YS_P$=!ZUFV/C7Q UGX1U6]M=-&GZ[)%;O%"
M'\V-Y(RRN"3C;E?NX)]ZU$\,ZI'KGBO4%DLRNM0111(7;,1C1D!;Y><[L\=,
M8YZU2_X0S5AX<\):6)K(OH-U!.[EWQ,(E*@ ;?ER&Z\XQWH CMDU*3XS:FCW
M=HT*Z3!E&MF/[HS2?*/WG#>K8P?[M*/%^HGP/+XLTBTL3HUMO>.Q\MED>VC8
MJ6#AMJG"E@NTC&!FMFWT'4HO'][X@=K0VMQ9QV8B#MO4(Q;=]W!SN/'ZUDV?
M@C4].\,:AX1MKNU.AW)E2&=BWGV\,I)>,+C:Q^9@&W#&>AQB@!'\6>(]5\1S
MZ7X?M]),;:9!J-K/>-)ADD8@!MO.2!VZ>IZ4/XG\4W-YXJM+.#2(I-$9"C3"
M1Q(#%YFTX(Y.<9XQZ'MIZ;X8NM-\;/JL/V5=._LV+3HX S;T6-B5;ICOC'ZU
M%;>&M4M]1\679>S;^VPGE+O8>45B$?S?+SP,\?3WH SXO&NMM;>%-8EM+!-*
MUR>"V:!2[3Q-*A*MOR%QD=-O3OZ.\4^--7\.6VIWTL-C%%9W$:P6<N7FNX24
M#2AE?Y!EB!E3]WGK2MX,U;_A%_">DK-9>9H5W;W#R%WQ,(00 !MXSGKSC'>J
MFK> =>U#3?%.FIJEA]GUFZ^UQS2Q.TRG*D1,<XV+L !YX[4 :+W>LO\ &'^S
MUOX!8QZ.+A86MR<!I@K#(<?,=@PV, <;>I,,/CVXL]"\3ZCJ5G;^9I6J-800
MV[$"9B(PF6/<L_)QP.W%:;>'=7'C:S\0I>V?.G"QO$,+<@2>9F/GC.2.3QUY
MZ5EM\/KC4-$\4:7J5S#&FLW[7\,MN6+6[_)MX(&<&,'MG)'% &C>>(=5T'Q#
MH]AJPLKBUU9F@BFMHVB,,X7<%8%FW*W(!&"".E<]/XZ\41^&M=UQ;/21%HNH
M36\T1\PM,D;!3M.1M."3DYSTVC&3TG]@ZKJU]HUUKS61.DN9D6U9B+B?:5#G
M*C8 "3M&[DCGCG(D\#ZO+X.\3:&UQ9"36KV>Y64,^(A*P)!&WDC'MG/;'(!W
M\;B6))%Z, PS[UD^(-0O]/@M6L8K?9).$N;JY8".UBP29&&Y<\@#&1RU:-FD
ML=E!'.$$JH%;825R!V) K!\5Z#J6KW.C7>F7-LDNG7?V@P72L8IAM*\XYW+G
M(/8T <W<_$'58O!7B?58(+">[T2\: /M=(IDPA#A<D@X<<;NW6MJ/Q%K-GXU
ML-)U6&P%GJ5K-/ ;??OA:+:6#L3A@0W4 5CWG@#7+K1?%FFMJ6GN-=N!.'\I
MT\LD(&XR>/DP![Y)[5NWOA_4K_Q9H6L2&S6'3[>>&:+S&)D\T*"0=O;;^.>U
M ''>.=;U+Q+\']4UJV^R1Z5<$>5 \;&5HA,%#E]V 21NV[>AQG->LR"0Q.(F
M59"IVLR[@#V)&1D>V17F4GP]\11^![_P7;:GIS:2S?Z'/,C^='&9 ^Q@.#CG
MYL^V!V]+A$JP()W1Y0!O9%*J3[ DX_.@#QF_O-5U'X!:_>ZI>17+R33<K"48
M$79!R=Q&..  ,#CFN\C\1:O9>-X-'U>*P%I>V<MU ]OOWPF,KN5R3AN&SD =
M.E8TO@#6F\ ZKX46_L#!<SR-;RE'#(CS>:2_7)[8&!WSVK>O?#^H7_C+2=;E
M^R+!:6DUO+#YC$OYNW)!VCIM_'/:@#)B\;:S>6VDZKI^F27=A?3('M4T^<2Q
M0/TE\X_(V!@D8QS@'C)NQ>)]5?5_&-G]DL@VC0PR6Y#-^\WQL_SG\ .!5;PY
MX5\4^'T31$UNRD\.0.?(<PO]L6+.1%NSM [;N3CICC%M/#.J1ZWXLOP]F5UN
M"**)"[ Q%(RF6^7G.[/'3&.>M $W@S5_$6O:=8ZMJ4.F0Z?>6,<T:0%_-$IP
M3G/&TCD=Q[T_Q%K6JZ=?21VXLK6T2T,J75VID\^?)Q"J*ZMG R3SUZ5>\)Z5
M<Z%X5TW2;MX9);*!8/,B)VN%& >1P?:LK4?#6L3>,9]7L[^T%M<V LW2YB9W
M@P22T>"!\V>0<=!UQB@""P\;SZQ8^%X[."&'4=<MVN6$N7CMXT4%S@$%N2%
MR.N<\<X%GJ6K:'K7Q.U-DL[B^LHK:?@,D;JENS#C)(. .,]>]6[/X?ZYIFF^
M&+BSU*P_MG0D>!=T;B">!P 48\L#QD,!U[5:D\&Z]<-XQEGO-.W^(;5( B(X
M$)$)CSD]<9/&.<?P]* !O%GB6"[\,M):Z7);Z['L2-3(KPR^5Y@8MD@J<'(
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MX?Q>'I=2@AO[.\^WV-];@G9-YA<90CI\Q'7H:](HH Y#^Q_%>H^']2MM:O\
M3&N[FSDM(4LTD2%=XP9'W9+-Z   <COD5IO"6K/IGA"U62RW:#+%)(Q=\3>7
M&8\#Y?ER#GOCWKN** .-E\(WUUK?BNYFN+>.UUVQ2S7869X=J.@8@@ YWDXR
M,8ZFBU\*ZE=:;H6EZQ)9_8]'>&0&V9BURT0Q&6# ; #AB 6R0.0.O944 <):
M>%?%&AZOJ$6AZQ81Z)J%R]TT=S SS6KN<OY6"%()R1NX'H><ZECX?O[3QY=Z
MXTENUG/8Q680NQE'EEB&)(P2=QR/U-=/4-W=PV5K+<W#%8HE+N0I8@>N!DF@
M#C]6\'WVO7-N=1%@7M-1%U:ZC&6%S%$)=XB VXZ?+G=C'."16WXM\.0^*_#5
MUI$LS0&7:\4Z#)BD5@RMCO@@<>F:OZ5JEIK6EVVI6$AEM+E!)$Y4KN4]#@\B
MKE '+KH.IZKJ>C7NO-9@Z4S2HMJS,)IBNW>=P&T %B%YY(YXY7P_H6I:7XEU
M_4KIK1H=5FCE5(G;=%LC"8Y7YL@ ]JZ>LNZ\0Z9:7S6+SR2W:*&>"V@DG= >
MA98U8J#VSC- %#Q=H%YKD>DRZ?<00W6FZA'>H)U)1]JLI4XY'#?I4%IH.K6W
MC:^U]Y+.5+BPBM @9D.Y"S;NAP"6/'./4U:N_&_AVRTVZU"740;>U=8YRD;N
M8G;HK #*GD<'&,C.*Z"@#S:W^'FLV?A70[>SU2UM]<T.XFFM;D*S12K*S%T=
M>H!#8XSTKL]#MM9CADFUV[M9KR3 \NS1EAB49^Z&)))R<D^PQQ5G3=5M-62Y
M>T9V%O</;2;XV3#H<,!N R/<<5=H X_7_#FM:AXUT77["6P1-+CF18IRY,OF
MJ <X'RXQ[U8O=#U?Q##=V.NSV<>F3VDD'DV>_>7<8WEF]!G QU.>PJ[)XMT:
M+4[>P>Y<27$[6T4GDN8GF7.8Q)C;NX(QGJ".HQ4VI^(]*T>[M;6_N6AGNFV6
MZ>2[>:W]U< Y/L* ,3P[I7BW3(H;;7M:L+G3K%?DDMX76>X51A?-). !U(49
M.!D]<\=I!U2:R;7[*\\(75G/=/?HUXTL;ABQ*EU5BBR!<#.W(QW.37L"L'4,
M,X(R,C!_(UFQ^'-#BU#^T(]&T]+W.[[0MJ@DSZ[L9S0!RDWAC7M5OM7U%+JU
MMH->TR*"2&ZB9YK(^6043! P2Q)]^<&I(_"&M+;^#D>YL)'T#!D(WJ)0(O*
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M2.\ANA*;5OWWE9VKC?QG/)R:E/@[7-/\0W][X?\ $*6-CJ<OGW=K-:";9*0
MSQ$D8)QWR,^O2@#J4N[AM$6]DM&AN3;B5K9CDH^W)0D=2#Q7&?!K_2?AW;ZK
M,_FWVIW$]S=S'J\GF,O/T"@5WD$*V]M% K,RQH$!=LL0!CD]S7)Z9X3U+PQ=
MW:^';^U72KJ9IS87D+,(';[WENK#"G^Z0<=B* *'Q6L+>W^'GB.\AC"SW*V_
MFD<;RLJ@$^^#C/H!Z5?@UC7+/Q_#HFHSV4UM?V,MS!Y,#(8'1E&TDL=XPW7
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M7ZSXJTN8RV5TJ1PLC9BDEP/-D3L<A8USZHU=M0 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y
MI9VFHZ[\5O%LT>IO8S:9;6UG:.L*2%%D3S"<.",%ASQDXZC%>EUCW7AV";66
MU>UNKFQO9(1!-);[,3(#E=P96!*DG!Z\D=.* */@+7[WQ%X72ZU.*.._AGEM
M;CRAA'>-RI9?8X_G7354TO3+71].AL+*/RX(@< G)))R22>I)))/<FK= !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
F444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>image_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0.jpg
MB5!.1PT*&@H    -24A$4@   L(   "V" 8   #3/NLG    "7!(67,  $SE
M  !,Y0%USO"5   Q04E$051XVNR<:U"691Z'F9T.GE&0#,^H@"=4P-3,\!#@
MN=)V#-LD4_%46K:YYB''\W$U#SF-HFX2E.(V*>-0[:Q'3"T!37/S )B@)+HN
M((@'U-\^]]W2A_W0S!:XO"_7-?/_R,O[O _\?M=SO_?S> C@?Z3&[QYZ( ,
M9 09 0 5B0<? 5!R $!&   B#$#) 0 9 0"(,  E!P!D!  @P@"4' "0$0"
M" ,E1\D! !D! (@P4'*4' "0$0" " ,E1\D!D!%D!  @PD#)47( 9 09 0"(
M,%!RE!P &4%&   B#)0<)0= 1I 1 ( ( R5'R0&0$60$ "#"0,E1<@!D!!D!
M (@P4'( 0$:0$0" " ,E!P!D!!D! (@P4'( 0$8  "#"0,D! !D! ( ( R4'
M &0$   B#)0< ) 1  "(,%!R $!&   @PD#) 0 9 0"(,  E!P!D!  @P@"4
M' "0$0" " -0<@! 1@  (@Q R0$ &0$ B#!0<I0< ) 1 ( ( R5'R0$ &0$
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MTB6[=Q 1=OU"K&SO"PE^,-C]O\7%]DD/Z:EIVK4S2:M6K-3$F+&*".NEH(!
MN^?3U?+*O&>S4FUDV.Q+7>T<DSFV8VEI/V^5,-*/"+MWSR#"#(,(E_O>+[,Z
M9!YU-&?6N_KXH_B?@BHWUS[.R)0J(NR^J\'N+L)5<278[@>^?%G?'C^N3>LW
M:,+H&+LJ]T3'3G:[P^-UO>P*JZOEE7G/OE[>]ABZ=@K6H(B^FCAFK'VRQ<D3
M)^P-627_V3>,"+MOSWAP<A@&$2[OD#)W>OLW;>:42XB]4<9\A9J>EJZ<[!S[
MR"+V"2/"B'#E/G:S1< \?[>PH$#GL[)T])MO['-^S7-\.[9N:_?@FJ^LW26W
MZE6O*=]ZWG:5\8V)K^G3[=N5GIJJ'\Z?MV)E<JNBGV=+S_Q_>@819AA$N$+'
M/"?RS=<GV2MV<W--]H4+]GF0YN8&5H7=\P9"=ST_546"S?[8(N=_U-R(E+)_
MO^+CXK1PWCQ[HU*?IYZV-Z&9KZ;-JIR[?=W>W#FV9WJ$:>RKH[5X_@+[A(G#
M7QU29D:&?4H!(NQ^/8,(,PPB7''S;P   /__[)UY=(WG]L>MV_:V:@@1)#%%
MB'F>2<R4("*&B'F6A$1I%37/\U1SHX8:BJ#(@"0E*$G0*XEYEJ!D4"))2:E^
M?^_>_9U>=]WV]HCSGG/><_9>:Z_5/Z3G?=[GG+T_SW[V\(]W4:Y$*;1NV@Q#
M^@_ XOD+$!X2A@N)YY&:D@+\!KWEPW^\:W0U9S'G=V&)^V.*[Y^QU_S;;[^Q
MOGKUBG^?T4>/8LW*E1CIZXN6KFYPLG>$?2%;V+R?%_G?_:?9O!-#*:V)UD9K
MI+6V<FN*T0&!V!"T'M\?/X&TM#1^-[KW9"V_?2WHV_B9/+(QHJ*&<S[RKOY;
M"_[S Q3)5P!.#B70P],+\V?/1=B!4%R[>O6-G8F L#8.!9:V/Y8.P01W+U^\
MQ+-GSW#_WCTDQ,<KO]$0+%VX"+Z#AZ!-L^9P5D##VFQ7^5*ET;Y5&P3X^6/%
MTF4(#PU#8D("[M^_CYSG.7CY\J5)@%C\BF']C("PJ*B L%&TT <?HGZ-6NCC
M[8-94Z=CSZY@7+QP 3\J3N7GGW\6$+:@ X& L+;6^N+%"V1G9W/$\TC4=UB^
M> D"AOO!JZ,'&M6NBPIERJ)8P4)69[.*VQ1&Q;+.:%*O </5QR,#L'+Y%SAV
M-!J/?_J)#PX$PP+"VO8S L*BH@+"1M$"[[V/4L7L4:-B97BT<\>X3S[%YJ\V
MX.2)$TBAZRM)CQ 0-L.]L=1H\!]I$+_^RA"<FI**Z]>N8\V*E0S %4H[P:%P
M$8M,@<A-RD3)HL51U:4BO+VZ(6CM.MR^=1N/'CUB&-:E2P@(:]//Y)%-$145
M$#:V.CDXHEV+5@CT\\?V+5MQZ\9- 6$+RI6VE+VQY)0(BF2FIZ?CYHT;G/_Z
MS=;M?)W<OU<?U*]>$R6*%.6KYGSOO&?U]BJ? L)%"]B@='$'-*I3#X/Z]L.B
M>?,1O&,GXF)BD9R<C,>/'^-7Y5 A(*P]/R,@+"HJ(&S\*\="MJA>H1+:-&W.
M#N5\0H+>!2@"PN:_?DO8&TO/"\[)R<'UJ]<0%1&)%<N68^B @6A8JPXJE2T'
M1UL[OF*FO$NQ5__.02W\87XX*@>$RL[E%2"N"_^AP[!^W9>(.7D2=V[?QB^_
M_"(@K$$_(R L*BH@;!*G8I>_($>=1H\,1,RI4QQ-,4<0-C<8%A!6?U\L/1),
MU_DI#U-P)"KJ#PAN4+.VV*8W5,H=IFCCAJ @MF%/'C_F?&M*E1 0UHZ?$1 6
M%140-JD.[C< WT5&<B$#153^#H8%A 6$K0&$U9+,S$S<NWL79^).8]47*]#?
MIS=<%:!S=BPI]B@7726:-VZ"88,&X^N-FW#KYDU^OVI'AN7=&];/" B+B@H(
MFU3)$8?LW\_YBME967I%4ZP5A+4"9%K>%TM/B4A-347\N7/8LVL71@[W195R
M+K#],#\7&8D]>O.(([V[FI6J8,KG$_'#F3-<D/5S=K: L(;\C("PJ*B L$FU
M=W=O!._8@>2D)+Y:U*?@1$#8O->MU7VQ9 @FQT]ZZ>)%?+-M&R:,'0OWUFTX
MYU7LT-LI%=&1':/A(]%'CN)N4O(?G3D$A,W?SP@(BXH*")M4NW3HR"V;SIX^
MPU>VE&,G><("PL;>$TN&8 (R<OSTVR)0F_C9.+[2I\(XBFB*'7H[I1[+U&^Y
M3P]O[L%,MDS-EFKRS@WK9P2$144%A$VJ'[5HB5G3IB,\-!17+E_F:G9+@D(!
M8?/?$TM/AR (IMQ(&@)!;:2Z=NIL]ETAJ'<O/1^-/+91GM7F_Y_7'/L:TW-1
M058E)V<,'SB(K^"I(%&?F@=A+M/[&0%A45$!81-77M?G*5;4ANAT;"R>R90Y
MS4?!!83-Z_N5E97%SC\J,A+3)T]!\\:N9@N5I 2_U,*M7,G2'+6NYE*1U<G>
MD;L F-NST[/HNA-X=>R$U5^LP/F$1)YF]EP!8@%A\_8S L*BH@+")M5J%2K"
MT[T#)HT;CT/AX<C*S!00UOAZM;0GEAX-)DE/2T/DX<-8,'<>^GCWY*E;Y@K!
M]%PTR(/&.C>N4P\M79OR4 32.E6KHU31XIS.86[1;"HV)(!W:] 0$SX=BWU[
M]B#A7#PR,C($A,W<SP@(BXH*")NVT*28/6I7K<8.FJYMJ9#!TB*D L+FN1_6
MD!+Q2TX.3X_;$+0> _KT1=.&C>'D4,)DD5[*IR68I4AOW6HU&'9=ZS=$,^6Y
M*&^YE0*^5,37NT=/!/CY8^SH,9S33#ILX&!T[>2!]JU:\Y"$%HU=^>_<E+^G
M82 U*E6&2VDGE"Q:S&2YS]2%P[N+%V9.F8JP R'X\?Z/>O=(%S]C&C\C("PJ
MJA$0UN7,T?4@-;^GG"=#:=OF+="F60NT='7C)O'U:]1"9<51T56?VKF$117'
MZ%RB)#NWH+7KD)Z6KG=#>@%A 6&!X+\6R@M^E)Z.N-A8SH^D:"7UOB48-<5:
M[0O9,B@2C/?U]L'G"MPNG#L/RY<LQ=I5J_CWOW']>FS=M!E[=@4C+"04AP\>
MPG<1D8@Z'($#^_9AQ[;MV+)Q$S8J8!^T9BT70'VA_/WLZ3,8G'LH$$K7X&44
M.VF*-3H6L4.MRE7AT:X]/]>EBY?P[.=G>/GBI<%@6,M^IC4=8)JX_N%G*CHY
MP\&V"&P^R*OJ+<7_\C-YK,U BVAGO^7=_+=QHB@'.;- OQ%L9 VCR[!LT1(L
M6; 0<V;,PN=CQR' UQ^>[AU16S'H#H6+\.>J9:3( !8M8(/&=>OS\SQ\^%"O
MSA'69'NTMD[)83;]]XF@Z\F3)TBZ<P>'PL+A.W@(@VB^=]XSV7K+.I1@"![0
MJX]B<Q8C^L@17+]V#??OW>-GS<[.Y@(SFGY'2I%47=LW^F^=DGV@W%OJU_OX
MT2/.Q:4TA."=.S%K^G3X=.N.JBX53)K>X6!KA]$C Q!S\A0RGF3@^?/GXF=>
M\S,3/OV,_4SG]NX\!KEH01L.NIC"SP@(BP@(:P2$R3A1)*=[9T]L^#((B?$)
M!M/X?YW##V?.XGCT,>S?^RTV?[61#95G^PZ<3TA7J454+E(A8SA_]AS<34[F
M2);8'@%A2P9AM87@\?*E2_AV]QY,FS09[FW:PC9? :.MC^P5]2BFB%_3AHW0
MS:,S_(<.YY0!BLA%'CJ,JU>N\("/IQF_@Z*^XXD)\E\I0,SCHA5;07FX]Q28
M/GOF#'=LH(EYXS_YE*_!.RCKIO0+2L6@0[VQUD_%<]T\/+%RV1<X=O0H[MR^
MK3RX^!EJ7W;L:/0??F:<LD\=VWZ$RL[E4:I8<13*FX^?PYA^1D!81$!8(R!,
M!21DR/OV],'NG;LX]\P0>O_>?<4HW$5R4C)N7+^!Q(0$Q)Z*84.U;M5J3!XW
M 3Y=NZ->C5HHZUB23]5JK+%J^0I<T7[QP@4\^/%'L3\"PJH\I[5$@RER&A41
M@8GCQJ-]JS;<=:'@^WF-F")0E'_3=!T^)B"0H8I:5U&$],JER]S+E:+ NC9C
MNNBOOND#].]("8;I[VE:6%I:&I*2DMB&?7_\./;MV8O%\Q? ?\A0OA(G&#;6
M^BFZV:!6;?3OU1M+%RY2UGW2[%,CC.%GDNXD_8>?H8,:'5S&C?D$73IT0A7E
M.T/?G<(JY7C_F9_1' B+" A;X[NA2"P!*!69#!LX"!$'#W$$Q9!*#HFN)C.?
M9G(AP<,'#W'GUBW$*HYKZ8*%G'M'.5U4=*#&&LE)4;5U[*E3W.I)0-ATX&:I
M-L(:()C D'L&*[_AS1LVP*NC!]_H4(ZDVITB"+2+V11"Z>+VG%]*U]ZC_$=B
MRZ9-/-&.NE?H>]OS-D)033:-P)ANN;Y<O8;3%"@Z[%*J#.?Q$JBJW47"R<$1
M]:K7Q-"! SGGF=K8Z:!?_,SO?H9@]-;-F[Q/,Z=.XQQBND4H;E/8:'Y&0%A$
M0%@C(*RKMO8;,A31WQU1?2VZZ\?TU#0<# OC8IN>7MWX:DF--5*U]TA?/[[:
M/!X=+2"LX?69X[-: P239&5FX;9R@(V+B>4"LI9-W!@J"N?-I_K:J+B6BJ!Z
M]_#F*^^5RY9SQ(^NPRDG4P>"QD@+H0,!?1YUS#CU_4F.;E)>\IC 47!OW99O
MM]0\&-#_F]Z[L_(Y'LJ!8,7290Q>]!Z>O65O84OR,[J]>O#@ 8)W[$2@_PBT
M;=&2_8&Q_$P>:S32(@+" L)Z7CTJ1BH[*QN7+U[BZNV94Z9Q7T^U"FGZ^?3"
MNM6KL7WK5K%# L(6U];0&)*6FLKI!]1YP7_H,-2L5$75G,O7M:)364X%6+-R
M)1^>*4?YIT<_,9#J\G_5&CO\5^DA%(7,?/J4"^HNG#^/HXKMG##V,^Y)K/9[
MX=["'^3E% GZS,B("(Z,4TJ(^)G7 B[*]X+RO,_$G<;6S5]C=$ @%[49R\]H
M"H1%!(0%A(UGH%Z_9J3KS">/GV#/KMWP[M)5E366*F:/SNX=,&WR9"R8.U=
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M]=9\%A4>B7FSYJ!G4#!JUZC%O5;H8SDG.WMXN+JA01UWQADC@3!%DB!,$*9
M$83U6Q9!C2_=O?]J\Q:L7?T%!O<; '=G5^ZU*NW3*EO);A$MFOH@T->?<<9H
M($RA) @3A"E0!&&",#7WM]O!??NQ?>LVC/QX*#QJU^$^*^(.-K9HYM4(W=[M
MA!Y=@QAGC C"%$MUA9D@3($B#)OG_=4C!%/;2_<,SB2=1FS,(4P8,T[V$^8^
MJ^&UJE5'FY:!^'#@(/DCAG'&H"!,P20($X0I4 1A@G!9[(->8/CJY2M(2DC$
MU#]/AG=]3TW7+OH4BP$0OHT:HZ6/'P)\_>EOZ)W:M<?P(1]AP=QYB(J(9)PQ
M,@@3A@G"!&$*E!%!6*]E$03ATCV']/1T7#A_'K.GST!CCP::KEUT-Q#=*<:'
MC<;,J=,P:]ITS)DQD_X&'CY_ 39NV( #^_;A4$P,XXS109A K!8,$X0I4 1A
MM4"86O[_]T$/,)R;FXN;R<E8,&\>FC;PTG3=;C6=9!9S^[9O<"+N.$Z=C$?B
MJ03Z&_@/9[['M:M7<?OV;=RY<X=QAB!,."8($X0I4,:"88*P9>B<ZB#\^/%C
MW+IU"Q$+%J)9PT::KKNNDPM&CQR%@_OWX]S9L[AR^0J2;]R@OX&GIJ1( ,[-
MR4%>7A[C#$&88$P0)@A3H C"!&%]GX,69_+LV3-DF8 J*CP"/E[>FJZYGHLK
M)HX=CY/'CR,M-0UWL[+P\.%#^AMX?GX^"@L+\?3I4^F,,P1AFD+ 21"F0/%>
MJ9.%9,*BG$6NUUSV\N5+/+A_'\N7+)4?856K5 4VY2MJLF9W)Q=9'WPD-E9F
M-%\WDTECG"$(TW0!G01A"A3O%4%8%1"VY/6:"X2SL[.Q8>TZ='NWLQRJX6AC
MJ\EZ74WZ,SBT'_[RQ1K$GSB!]%NW*":,,P1A&D&8($R!XCF]WGM,$#;VJ&MS
MGT]>;B[^]E4T!O?K#[_&3>&FT:CE6G;5\5['=S!ETJ?8&AV-RY<N44P89PC"
M-((P09@"Q7.R3! VPOZJ5O*EQ1D]>O0(?]^]1];O=NG04;/!&@[65>%O NW>
MP>\C8OX"V?U 9*2%TQAG",(T709L@C %BG=+W99=!&%CP+#H''',I F1"Q?)
MK+" 5:T&:@@-:N+9 *.&#I/CG9\_?XX7+UY04!AG",(TXV2%"<(4*-XK@K E
M@[!JZ_ZM]J2P4/:EW;)Q$R:,&8NV 8&:KM>Z7 4$=>J"Z,U;\.CA0Q0]>8(7
M)B"F,<X0A&D$88(P!8KWZE??98*P93^SBNLN*BK"I8L797F$F%HFQO=J#<*M
M_)MC^N0IB#EP$)<N7)0=)%@FP3A#$*81A G"%"C>*XL 8:/LK;F?6<6UBSZT
M*3=3$'_B))9%+4%PEZZ:K]>K;CWTZAZ,&9]-Q=Y=NY&1GDX09IPA"-/T%; )
MPA0HWBWSOLM&R :K#L(JKO_GH1I9,BLLRB-"0WK)K*UPK=;JXE #S9LT0TBW
M[G*JG1BRD9&>@8>O,L,TQAF",(T@3!"F0/%N_<_[3!!6XWE5 V'QL9JHU<W,
MS,3>W7LP9- ?Y6 -H1M:P;"]E0WJU'*&;Z/&^&# 0$0N"L=W>_;BZI4K\@,Z
M&N,,09A&$"8(4Z!XM\H$A(VTKUH]KTHP+#*PQ<7%\J.U$W%Q"!L^4K8Z$S"L
M9598_&V[RE;P\VZ"7L$],'?F;!P]?$2NA642C#,$81I!V( P3('B_5*U=1A!
M6.W,ML@*BQ*)"^?.8^GG4;).6)0N.-G9:_[AG!B]W-+'#X-"^V-IU&+$GSR)
M&]>O(S<G1ZZ+0,PX0Q"F$80)PA0HWB^"L&+/JEI66$"G&'O\CP,'$14>@0%]
M0C4;KE'B5G\H+\LD7!UJF&#8%Q\.'(SP!0OQW=Z]N)F<C&?%Q81AQAF",(T@
M3!"F0/%^&>?.Z.E953M'T<;LVM5K.'XL#C.F3$.@7W/85JH"F_(5-5^S4W4'
MF1GNW2,$B^;/QY%#L1+,[]^[)Z??B=(-D;6F,<X0A&D$88(P!8HP3! F")O]
MV9Z88/-NUEU<_^DZ5J]8B9"@[JCOZH::MG::U@N7?$#G4=L-+9KYH,_[/3!I
MW'BL6+(4WV[?@3-)IV6&."<[6P[?8 TQXPQ!F$80UB$,4Z!XQPC"^OLH4*6S
M%&4(HJ]PP>,"[-JY4^I%H*\_ZCF[PL:D(UK7"XN/YQQM;.%6HY8LRW@[L!7&
MA8W&I@U_Q8FXXTA+3959899+,,X0A&G*0J=1@SL%BO>,$$P05N4\!60FGDK
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M, " $ 8 HT(8 $ ( X!Q(0P ((0!P*@0!@ 0P@!@5 @#  AA # NA $ A#
J&!7"  !"& ","F$  "$,    #$B_ SK<JZ4O5I,N     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>image_0a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #  M # 2(  A$! Q$!_\0
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M_2YDT;J_GV^'_P#P4B_:!\ 3P>5X]NM:M(CDVFN0QW:./0L0)/R<5]M?L_\
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M?BQQ_P 7-\9>_P#Q4-Y_\=H _I?R*,BOYG_^&DOBQ_T4[QE_X4-Y_P#':/\
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M_P GC:O_ -@JQ_\ 0&K]E?V>CCX"_#?_ +%K3/\ TDBK\:O^"N'_ ">-J_\
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M01C]WK,%WIDONK0F09_X%""/>OD:OH7_ ()^S-!^V-\*V7OK"J?H8I ?T)H
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M91')CV,HF;_@6/K\S5;U/4;G5]0N;Z\E:XN[F5III7/S.[$LS$]R22?QJI0
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M%#_A4'[+7Q&\2QR^3>)I4EG9N#@K<7!$$;#W5I V/]FOYR"V10 E ZT4#UH
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M\_L__':TTK5KLQ>#_%31Z=?AF.RWF)Q!/T.,,=K'@;7))PHK]XUD# $'/N*
M"7_5-]#7\Y_[<UL]K^U[\6TD!W-X@N7&?1FR/T(K^C%L$8-?@G_P5.\(2>%O
MVRO%L_DF.WU>WM-1B8_Q;H%5R/\ @:./PH ^1:*** %VGTI*]%^ /PG'QS^+
M_AOP(=;M_#KZY,]M'J-U$94CD\MF12H()+LJH.>KBOO#_AR'XE[?%/2?QT>7
M_P".4 ?F517Z:_\ #D/Q,/\ FJ>D?CI$O_QRF_\ #D3Q3_T5'1O_  4S?_%T
M ?F917Z9_P##D3Q3_P!%1T;_ ,%,W_Q='_#D3Q3_ -%1T;_P4S?_ != 'YF4
M5^F?_#D3Q3_T5'1O_!3-_P#%T?\ #D3Q3_T5'1O_  4S?_%T ?F917Z9_P##
MD3Q3_P!%1T;_ ,%,W_Q='_#D3Q3_ -%1T;_P4S?_ != 'YF5^E?_  1(MI&^
M)OQ)GP?+32+9"W;)G)'XX!J<_P#!$7Q2/^:HZ-_X*9O_ (NOK[]@S]B&\_8_
MM/%W]I>(K3Q'>:W);^7+:6SPB*.,-E2&)SDL#GMCWH ]=_:T_P"3:/B=_P!B
M_>?^BS7\V;?X5_29^UI_R;1\3O\ L7[S_P!%FOYLV_PH 2E7[PI*5?O"@#^C
M;]B#_DT;X1_]BW9_^BQ7N->'?L0?\FC?"/\ [%NS_P#18KW&@ I",TM% "8I
M:** $(S0!BEHH **;N_'Z4Z@ HHHH ;MH*!J=10 W9[G\Z7'N:6B@!,>YHQ[
MFEHH 3'N:,>YI:3(]10 QXU="I 8$<@C(_*OSB_X*O\ [)7AO4?A7<?%GPYI
M-OI7B+198QJ;VD0C6\M78)ND P"Z,4PV,D,0>@Q^CY<8ZU\4?\%7?C1I'@']
MF+5/"DEQ"^N^+9([*UL]W[SR4D6267 !PJ[%7)X)8 <YP ?AA103DYHH 5&V
ML#Z&OZ&_^">FOR>(_P!C;X7W$K%FM],^Q G^[#(T0'X! /PK^>1/O#ZU_0=_
MP3@TF71_V+_AI%*I4RV<UP >ZR3R.#^3 T ? W_!;+GXZ> O^Q<;_P!*IJ_.
MFOT<_P""V5K*OQK\ W)4^2_A]XU;'&X7,I(S]&%?G'0 5]T_\$;^/VN+K_L6
M;W_T;;U\+5]0?\$Y?C9HOP)_:E\/ZSXCN$LM"U&WGTB[O7SMMA* 8Y&/91(D
M8)[*6/:@#^@BBJUK>0WMO%<03)+!,H>.6-@RR*1D%2.""""".M3A@>] #J**
M0G% "U^$_P#P5P_Y/&U?_L%6/_H#5^ZV[K7X4_\ !7#_ )/&U?\ [!5C_P"@
M-0!\7T444 ?HS_P1._Y+=X\_[%U/_2N*OV/K\</^")W_ "6[QY_V+J?^E<5?
ML?0 4444 %%%% !1110 4AZ4M% 'RK_P4N^%!^*W[(_BY8(&GU#0 FNVRKV,
M!/FGZ"%YB?H*_ $C%?U,:YI%IK^CWVF7\"W-C>P/;W$#_=DC=2KJ?8J2/QK^
M9KXP_#^Z^%/Q3\6^#[SFXT34[BP+#@.(Y" P]B "/4$4 <93D.&!!P0>M-HH
M _2W_@H5^TY_PM#]BWX"V<5WYNH>+(EU;52C#_66D?D2JWL;B20C/>$^E?FE
M6KJ?B34=7TS2-/O+N2>STJ![>RA9OE@C:5YF"CW>1R?4GVK*H *[3X.?#VZ^
M*WQ6\(^#K3(GUO5+>P#XR$620!F(] I+'V!KBZ^\?^"/GPJ_X3/]I6\\67$3
M-9>$M,DG1\ K]IGS#&#_ , ,S ]B@/O0!^U&D:3::'I=EIUA"MM96<"6\$*#
M"QQH J*!Z   5?HHH *^2/\ @JG_ ,F3>-_^N]A_Z5Q5];U\D?\ !5/_ ),F
M\;_]=[#_ -*XJ /P./6B@]:*  #)KZT_X)__ +&%[^U'\1UO]8BEM_A[HDJ2
M:K= $?:GX*VL9]6_B(^ZN>A(KY<T#3UU;7+"R=S&ES<1PEP,E0S!21],YK^E
MGX)_"'PW\#?AIHG@WPM9K::5I\( ;C?/(<%Y9".KL<DGZ 8  H Z[2-(L]!T
MRTT[3K:*RL;2)((+:% J1QJ %4 =   !]*_-W_@L!^R\/$/AFQ^,6A6F[4-(
M5+'7%B4YDM2<13' /*,=I)/W6'I7Z8[:R?%'AK3O%_AW4M$U:U2\TS4;>2UN
MK>0962-P58$>X)Y[<'M0!_+>RX^O<>E)7L7[5GP"U#]FWXVZ_P""[P-)8P2F
M?3;IAQ<6C_-$X.3R =IYX*FO': )$?YJ_>3_ ()J?M/_ /#0GP+MM,U>[\[Q
MAX4"6&H>81ON(<?N+CJ3\RJ020,LC8XK\%Z]\_8K_:1NOV9/CMHOB8NYT"X8
M6.M6Z$XDM'(W-@ Y:,XD'&?E(!&XT ?T5=>#7Y9?\%KOA-)-;> OB3;0LR1>
M9H5])QA 2TUOD>Y\\>V!7ZA:;J=KK&G6U_93I<V=U$DT,\;;ED1@"K C@@@@
M\5YM^TY\%+7]H/X'^*_ UQL2?4K0FRG?@0W2$/"^<$@!U ..2I8=Z /YK:*T
MO$.@ZAX6US4-'U6UDLM3L+B2UNK:92KQ2HQ5U(/0@@@UFT :GAOQ!?\ A+Q!
MIFN:3=/9:IIMS'>6ES$?FBFC8,C#W# '\*_HE_9)_::T/]J;X0Z;XITV6&#6
M(E6WUG2T?+V5V!\PQG/EMC<A/53@\A@/YQJ]._9__:&\9?LV^/H/%7@S4C:W
M('E75G*-UM?0YYBE3.&!Z@]5."""* /Z6 <FG5\@_LR?\%*?A9\?+&TL-7U"
M'P/XO* 2:7JTH2&5^<F&X.%8'&0&*MSC!QFOK>*XBF161PR,,JP/!'J#W'O0
M!/130P-.H **** "BFEJ49S0 8XI:** /)/VM/\ DVCXG?\ 8OWG_HLU_-FW
M^%?TF?M:?\FT?$[_ +%^\_\ 19K^;-O\* $I5^\*2E7[PH _HV_8@_Y-&^$?
M_8MV?_HL5[C7AW[$'_)HWPC_ .Q;L_\ T6*]QH **** "BBB@ HHHH ^0?\
M@IG\?_&O[.'P-\/^(_ FIQZ5J]UXCAT^::6UCN 86M;F0J%D4@'=$AR,' QT
M)K\SO^'JO[1__0YVG_@FM/\ XW7W9_P6K_Y-A\)_]CA;_P#I#>U^+5 'US_P
M]5_:/_Z'.T_\$UI_\;H_X>J_M'_]#G:?^":T_P#C=?(U% 'US_P]5_:/_P"A
MSM/_  36G_QNC_AZK^T?_P!#G:?^":T_^-U\C44 ?7/_  ]5_:/_ .ASM/\
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M+=G_ .BQ7N->'?L0?\FC?"/_ +%NS_\ 18KW&@ HHHH **** "BBB@#\_/\
M@M5S^S#X3_['"WZ_]>5[7XM5_1!^VS^RK-^UY\+](\(0>)(O"[V&LQZJ;N6R
M-T'"P3Q&/8)$QGS@<Y.-N,<Y'Q3_ ,..M0_Z*]:?^$Z__P E4 ?EK17ZE?\
M#CK4/^BO6G_A.O\ _)5'_#CK4/\ HKUI_P"$Z_\ \E4 ?EK17ZE?\..M0_Z*
M]:?^$Z__ ,E4?\..M0_Z*]:?^$Z__P E4 ?EK17ZE?\ #CK4/^BO6G_A.O\
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M'&3BOC']KK_@F->?M1?&:]\=Q?$*W\.I<6D%J+&31VN67RU()WB=0<YZ8XH
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M  '/@?X+:M\1=0M]FI^+[D1V9<?,MC 652.XWRF4GU"1GD$5^A &* %HHHH
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M:<\5]*4UE##G]* /Y8;FUELKB6":-HIHG,<B.,%6!P01Z@@C\*KU^RG[1?\
MP2,L/C+\7=>\9>'O'%OX0M-8D%S-I;:.UP%G(_>,K"9,!C\VW;P2<'FO-?\
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M,^B@#)_&MBDQ2T %%%% !1110 4444 %%%% !1110 4444 (!BEHHH ****
M"BBB@ HHHH 3&:3;3J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!"<5^;7_!;(
M@_"3X?#<,C6YL<_],!7Z35&8U8 $ @= 1F@#^5S:?;\Z-I]OSK^J/R8_^>:_
MD*/)C_YYK^0H _E<VGV_.C:?;\Z_JC\F/_GFOY"CR8_^>:_D* /Y@/"_PU\6
M^.)UB\.>%]9U^1CPFF:?+<D_A&IKZK^"G_!*3XV_%&YMI_$&FP?#O1)"&>ZU
MMPUSM/79;(2VX?W9#']:_=58POW0!]!BE*Y^GI0!X!^RY^Q5\.OV5-*SX;L6
MU+Q+/%Y=YXCU$!KN8$@E4P,1)D#Y%QG W%B,U[^%Q_\ 6I:6@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
F*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>image_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "0 ) # 2(  A$! Q$!_\0
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MHZ  < "K- !1110 4444 )C)S7S]^R_++JOB_P",VKF0F"?Q;-#%&PP4"11
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MC-IFJ6[6\R@X(!Y# ]B" 0?4"O#?@S\0M5^"_B2U^#WQ.U9;F\6//A?Q-/\
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%44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>image_1a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_1a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "0 ) # 2(  A$! Q$!_\0
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MHZ  < "K- !1110 4444 )C)S7S]^R_++JOB_P",VKF0F"?Q;-#%&PP4"11
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MC-IFJ6[6\R@X(!Y# ]B" 0?4"O#?@S\0M5^"_B2U^#WQ.U9;F\6//A?Q-/\
M)'J]L#@0NQX%Q&, @_> )'N ?2U%(#FEH XSXRZZGAGX3>,=5DD\I;72+J0/
MZ$1-@_GBN4_9)T.3P[^SCX#LIFWRC3Q,[>ID=G_]FK&_;2UAK7X#:QH]NIEU
M'Q#+#HUI I^:1YI%0X'< $D^U>N>"]$'AKPCHFDA0@LK*&W*CL50 _J* -NB
MBB@ HHHH *J76FVE[+;RW%M%/+;N7A>5 QC8C!*DC@X.,BK=% " 8I:** "B
MBB@ HHHH *X;XN?!OPK\;O"4OA[Q9IHOK(L)8948I/;2CE98I!@HX/0@UW-%
M 'R=%X^^,/[,3?V?XTT&[^*GP\MB$M?%.@QEM5M8> !=6XYDVC@NO)ZDDUVP
M_;H^!L>D?;[GXA:98_NO,:UNBT=RO^R8R-P;MC&<U[SL7).!DC!-<OJ?PM\'
M:UJ*ZA?^%](O+Y6#"XGLHVDR.AR1F@#YL\ :UKG[7WQIT7QM+H&H>'_A)X/:
M2;13JD;0SZY?,"HN!&<$1(,%<]2/R^O:C2%(PH50H48  P /I4E !1110 44
%44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>image_1b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_1b.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "0 ) # 2(  A$! Q$!_\0
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MHZ  < "K- !1110 4444 )C)S7S]^R_++JOB_P",VKF0F"?Q;-#%&PP4"11
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MC-IFJ6[6\R@X(!Y# ]B" 0?4"O#?@S\0M5^"_B2U^#WQ.U9;F\6//A?Q-/\
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%44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>image_1c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_1c.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" $[ 3\# 2(  A$! Q$!_\0
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M T'4-!UD/MC;5[0P;V)VCE\9Z5^J&E7]KJ5N+NRNDFB?E)(V!!'UH M4444
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M8EO:IE /]D5UPZ=*JVL2QV\<:/@"-0HS["K0&!B@ IDLT<.-[ %CA1ZT^H9
M%D,D@# #*CT- $GF'(&P\BJFL:QIVE:?-?:E=)!# NZ663HHJOK6L6>@Z=-J
MVH7\4*11L[F:0+A0,GK["O@3]KK]M_Q!\3M<O/A5\-EN(M(RT<NKJC*I'J7'
M'ZT <I^W%_P<$?"/X!_&*P^#'P[C_M2^GO8X+@VLZ'&3@\$>M??_ .SGX\E^
M*OP<\/?$@V[0G6=/6X>)\9!)([?2OPM_8E_X)1R_M:?MC2_'?7VDN]$TR_(D
M>9@2\L4IW8SUK]\_A]X.T?P%X6L_"WA]"EE9PB.",KC8H[ 4 ;(0@YS3J**
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M^@7[<?QFE^"'P&USQ)&BC-A*J,1T;;FOSJ_X(;_#CXE?%KXZ^,/V@OB#:/\
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M_P""S.@>*_VTW_97\(P)<20S.LLD<A. KA3QTKL_^"QG_!0+3OV+OV:=<O\
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M(WX)?M2/*(F43MN9CB-?>O+OVKOVI_AW^R[X!NO&_CK5(85BA)BC=^68#(%
M'9_%/XI^#OA'X3N?%OB_68;2VM8BQ,\JJ#P?4\U^0?[7O[:7[17_  4J^+L7
M[.O[-VG7%MX1>\\G5-6@5XR\;95@& VG!4=^]>;?&7]J3]L[_@LK\6O^%.?
M>PO[3P=#<^7=7,$F4=,A@<,/0FOU:_X)]_L-^!/V-?@YIWA.VT2*36LE[V\*
M89F8 G/XYH R_P#@GQ_P3N^&7['?@6VN-.TN.77)XU:]U!XP96<C#98>M?4D
M0_>%@!@U7BC-L[9;_6'./2K,*A%V 8 H 7=\VT"E&X-CJ*6B@ HHHH ****
M"BBB@ HHHH "2.@HHHH POB5+=0>"=0ELFQ*L)V'/>OR._X)L6DWBC_@IUXK
MN=6BWR0VMP06'I*U?K;\5'EC\ ZD\+[6$!P?2ORM_P""6>I65[_P4B\7%81Y
MHM+H,_\ VT:@#];55<)QC J4NJG!IK*",!OF]:CE#"(*P^;/RF@!LDS"8#M7
MYM_\%ROVQ+#3_#R_LK^![QF\0>(]]LJQ=58<]1TK[F_:5^./A[X"_!_5OB)K
M]W'']CM) A=L9DV,5'YBOQX_85^$_P 1/^"F_P"WY<?M9^.+"2X\,^'M36XA
M27YD=6^7^M 'Z,?\$I/V0?#_ .SC\#K/54LO+U34XO/NG" $F0!CS]2:^B/B
M]\0]#^%/@._\:^(IVC@L[=L,H_BVG'ZBMKP_IEIX?TR#1K$ 110JJ1 <*H&!
M7QK_ ,%4OBCXBUAM*^!?@O4'D758]U];1GNLF.?P- 'YR?M8>,K_ /;F\5^*
MO$_Q+END\/V,1.C*%.R1PY5A@\=/2OT@_P"",7[.7A'X2_ F/7M#A>,S$;49
M  5*GFODGXU?#OPEX3N_AG^SQH>EQ)+?:ZPUQ4ZM')$6Y'U%?JG^SQ\/M&^&
MWPMTSP[HL"QQ);)\JC'04 =NV&*S+D!>V* =X\Q%(Y[U(GW12T %%%% !111
M0!C^.+&XU/PY=Z?;Y#2V[JA'9BI _6OQ^^,'[ /_  4?UC]JA_$6B>/)3X4O
M+T>?9^1,3Y?S<9WX].U?LP5####-!1"0Q49'2@#Y;_99_P"":?P+^!&K6?Q,
M_P"$5BE\23V8^UW$RJQ\QAECRN1S[U].;9HH=A9 ^."%J:6-6&_'(Z&J&N7B
MV>D3ZE,Q'D0LV!]#0!^4'_!2^37?'O\ P4M\.>&=-4S6RRV.Y=N54E6!-?J5
M\,M+?2/A]I6C3H$%M9*C!1C)YZ5^8/PT\6VGQT_X*,W/B?4H5\O3KB)-\XP@
M$<CKG)KZ9_X*%_\ !4[X=?LC>'O^$9\*12:WK]W"8K2TTRW-R$9OE!/EY(P2
M* /4?VO/V]?@;^Q=X O/%'Q!U1);BTA9X=)2Y"W$I'\*Y!&:_+WPSX7_ &C?
M^"V7QL_X2'Q58:CHGPZM+K=#:S!HVE"-Q\Z-@Y4>E=7^RA^P+\>O^"C7Q*7X
M^?M97E[;Z!+.)K;2IY#\RDX(,<@!'!K]8O@Y\%/A_P#!3PM;^%? 7ARVL+:W
MB$8%O$%W8&,G'>@#COV5OV-_@Y^R;X/@\,_#/PU% (8@LDS*K2,1W+8!KUE0
M^2R[5'8,.:DBCV,QSU-/&UQDCH: (7E=!@1;F]0*D@8LOSGYN]/P/2D"J"2!
MR>M "T44C#CKB@!:*BDE9?WB\CO2J2%RC9+'.": )**** "BBB@ HHHH ***
M* .1^.]T+/X3ZS<E]NRU)W9Z<U^5?_!'9-2U#]OOQCJ,MHWE^7=@2%?^FK5^
MI/[2,9D^"FOH.]F?YU^9G_!&G6GN?VP_%FF"W"LANB7 Y(\QN* /UG.#N9C@
M9ZU!<SV\$1N;BX58H?F9R> *L2!2"7Z#MZU\L?\ !5']K/2OV6OV9]3O#J7E
M:AJUO-;Z>L+9D$@ ;H.1Q0!\&?\ !<?]KWQ'^T=\3]'_ &-/V=]8,UQ=WT#Z
MF+=B_"3*'Z$$?*QK]"/^"9/[(^C?LF?LYZ+X2BT_RM3DM1_:;L/]:>HZ\U^>
M'_!"?]@'QO\ $#XEZW^V=\='FO+R]U&5M(6[;<!!(N0><$<@5^R_G6L$*VX4
M[5 ",@SB@"GXFU:VT'0[G6;Y\>3&S<'&0.U?!GAOQ'X'^+G[1'B/XHZG9W*6
M_AF:>"6XN9\Q*S(&'';I7TA^WM\;++X0_"2>[G<$SQLB*O+DE?0<U\1_'3Q7
MIGP7_89G\8Z=.MO??$(07OS$++R6B.!U[4 8'[''A.;]K;_@HYXC^(<\S7>A
M^'DMI=-FC8^5YBNR-[=#7ZU:=8I9QQPA"/+3:N.F*^,?^"*OP#TOX6?LW6OC
M+R6EOM;GF\^>5?F(WAQS^-?:\8(DVN>>P[4 2)]T4M%% !1110 44UGQG'..
MH%)YC,-P^4=]U #Z*B,Y6,N"&P?X>U1B[WLK1S*5!^? Z"@":<X3._%<#^T#
M\3/#WPJ^%6K^+O$TR>1%;-P[8SE37'?M;?MU_!W]D[P^FJ>-O$%OYTLRHEL)
M@K'/3J*^'/\ @H'^T%\4_P!KK]G>7Q'\-H)K/PY=6^[SV3@J2<?,I% 'S3^R
MK\>_&GQ]_:9\0?#7X1^")+>6>\D)UN!R=JM,^#^&/UK]!/V6O^"4GA_P_P"+
M[SXH?'J4:_K NR]M)=QX**1D_J!7G_\ P0%^".G>"/A+<ZCXC\,Q'47O;AAJ
M4MNNY_WF0-Q&?UK](Y8D;Y<8'MQ0!0T?2M+T*PBL])@2&VB7$:(N M:"KE?E
M<X/-)%#&I8@=>W:GA0.E "@8&,TBC QBC SFEH **** "FR,$7)IU-D7<N*
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MT1&<JG.U\_E7@'_!7.[MM4_:6^&G[+OA"^W6.D6K6IM(ONX6X4]/^!5]!?\
M!+7]G#5O"GP^\2_M3?$ZR=]6U&.ZN(6N%R55F,BXW9Q][M7R[^QII=W^UO\
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M6MY>T<'B@!X&!BBA>@^E% !1110 ''4TPRC. *5R1C"YYYJ.2XCB;##&1P:
M.0_:"LQ?_!_6[1IPF^T(W,V .:_%#X7_ +>GPE_X)N?&OQ=XOUFY_M+4)DNA
M:VD$?G;I&9B!A"3UK](O^"Q?[6I_9;_9'\0>(88F-S=:?)Y+!L&,CO7Y!_\
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M0/#_ (%T:77O%E_'91QQDYE;KQ7"?M1?M??"G]F;P9/XG\7^)+-)X49DLGE
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MUKP\\IN5GDRP7S @SW[5]D?M"_"?P_\ &GX6ZOX*\4:5#=6]U92H$>,'YBA
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M[T ?+O\ P5SUAM"_8A\:B+<0^B2@[>W*]:X__@BS;:3<_LS6NH6RQB1RF\H
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M]!AB0!UROI5S ]*0CCI0!^?O_!7/_@F?HGQO\%3?&;X+:0FE^,-'1IH[BSC
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M%(44DDKUZT -BC55X.0>E/I%4*-JC %+0 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M(%P2?6CYMWM2.2#P:<>AH BE>*-OO?-Z4K'(#^62?0&E"(_S,H)]34)=A.R[
MC@'I0!(RQ-]\%<^]/"JJ_*,^E 4,HW#-)(2'&#VH 55)^9^M.IK_ 'E^M.H
6**** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>strykerlogoa72.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 strykerlogoa72.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_[@ .061O8F4 9      !_^$-M$5X:68
M $U- "H    (  <!$@ #     0 !   !&@ %     0   &(!&P %     0
M &H!*  #     0 "   !,0 "    )    '(!,@ "    %    ):':0 $
M 0   *H   $N  K\@   )Q  "OR    G$$%D;V)E(%!H;W1O<VAO<"!#0R R
M,#$U("A-86-I;G1O<V@I #(P,34Z,#DZ,C@@,3$Z-3DZ,S<   >0 P "
M%    020!  "    %    1B2D0 "     S P  "2D@ "     S P  "@ 0 #
M     ?__  "@ @ $     0   N2@ P $     0   ,@     ,C Q-3HP-SHQ
M-B Q,CHP,3HP,  R,#$U.C W.C$V(#$R.C Q.C P      8! P #     0 &
M   !&@ %     0   7P!&P %     0   80!*  #     0 "   " 0 $
M 0   8P" @ $     0  #"          2     $   !(     ?_8_^T #$%D
M;V)E7T--  +_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5
M#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,
M# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  K * # 2(  A$! Q$!_]T
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MW;6;BWWN^BQ>+9G^-7Z[=1S7'ICQB5:FO%HI9<0T'3U'WU7/L>UOTWL]*O\
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M68,&.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
M    4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P
M<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !
M   /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0
M=0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I
M;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0     0
M$G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B
M;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L
M  !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R
M8F]O;       0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O
M=6) ;^            !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M            0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M                4G-L=%5N=$8C4'AL0%(            *=F5C=&]R1&%T
M86)O;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT
M1B-2;'0               !4;W @56YT1B-2;'0               !38VP@
M56YT1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .
M8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M      UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M       X0DE- ^T      !  2     $  0!(     0 !.$))300F       .
M             #^    X0DE-! T       0    >.$))3009       $
M'CA"24T#\P      "0           0 X0DE-)Q        H  0         !
M.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &
M   ! #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M      !P  #_____________________________ ^@     ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@  #A"24T$"       $     $
M  )    "0      X0DE-!!X       0     .$))300:      -=    !@
M            R    N0    4 ', = !R 'D :P!E '( 7P!L &\ 9P!O #(
M,  Q #4 7P!W &4 8@    $                          0
M   "Y    ,@                      0                         0
M     0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T
M,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M
M;&]N9P   ,@     4F=H=&QO;F<   +D    !G-L:6-E<U9L3',    !3V)J
M8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R
M;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@
M  UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4
M26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L
M;VYG          !,969T;&]N9P          0G1O;6QO;F<   #(     %)G
M:'1L;VYG   "Y     -U<FQ415A4     0       &YU;&Q415A4     0
M     $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L
M;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R
M>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV
M97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT
M"V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M  QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
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M_P#8.G_WE24[WUD^O'UHP?K^_H^+F^G@#)QJQ3Z51]MC:'6-]1]3K?=ZC_\
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MSGL=^]753L=_QZL?X\OZ1T?^ID?EH24^>=3ZSG]39B593YIP*&8V+4T0QC&
M-W;?]+<YN^ZS\_\ XME5;/</\7E_1J_J5CW])KVLK8YV6R0;#DM'ZSZSF_GO
MVM]+=_VF^SK%Z-]0>F]0_P 6[,6AH&?U&MF:W)?H?M :XX['.]WZ"MMC\?\
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M &\ <P!H &\ <    !< 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '
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M P,# P,# P/_P  1" #( N0# 1$  A$! Q$!_\0 'P    8" P$
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M6[R[1[QWA/+/)%F.R=Y9O=!QB5#ZWHL!0Y&KEQFV\2G BHL?#34D* +'&J@
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M!72[E[SJ7W_CZ7*PZ5:+)[;V3E,1AI48:T_AH5O4#[]U[JZ3W[KW7P-NP?\
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M,=/245%1PI3TM)2T\2K%!34T$:HB* JJH %A[]U[J7[]U[KX&W8/_'^[W_\
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M*NT'6>V]UT\R)ZU^^B)(# /[KW7TVO?NO=>]^Z]U\#;L'_C_ '>__AW[E_\
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M#'+;4D4]1M&E9U'#&-2?TCW[KW7S,_?NO=>]^Z]T?_\ E._]O3?Y:?\ XO\
M_#?_ ."*ZY]^Z]U]OGW[KW7O?NO=?__2W^/?NO=>]^Z]U[W[KW53W\\[X[9'
MY3?RD_G3U%A*"3*;C?I/)=D;8QM/#YZ[);EZ0S.&[JPF)QB#UG(YNOV E%"
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MMCRD.W^F4D:]K#2TRC^O/OW7NOGD>_=>Z][]U[J[[_A-[_V^U^!'_B0.P?\
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M@GR%5-)'!$K"-?=>Z'W_ *#5OYIO_/@_@!_Z*SY%?_=5>_=>Z]_T&K?S3?\
MGP?P _\ 16?(K_[JKW[KW7O^@U;^:;_SX/X ?^BL^17_ -U5[]U[KW_0:M_-
M-_Y\'\ /_16?(K_[JKW[KW7O^@U;^:;_ ,^#^ '_ **SY%?_ '57OW7NO?\
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M8W;@-[8A:;.X2II,I0&'<&VJ25C%(ID1"C75F!]U[JCO_H$S_DI_\^([0_\
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M7[O=(F-'M[M3O;:L\X12L=3O':/7F7I(B]M2M-%L68@ V(C-_H/?NO=?.O\
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MH::HG8RSSIL3?=;3[RI@TQNE/1;KHJ&%#HB@1 H7W7NJ+>S_ /A$K\Y,/6U
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MQL__ -";"_\ U;[]U[KW^D/8'_/<;/\ _0FPO_U;[]U[KW^D/8'_ #W&S_\
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MX]OXF+)XRGC1YJC-X:DIH]"U4Q/NO=?)#]^Z]U[W[KW7O?NO=?1)_P"$<O\
M-%_OEL/>7\K_ +=W%Y-R];4^<[6^+M5E*J\V4Z^KZ]J_L_JZBDG9!)4;-W!D
M#G\=3J99Y:')Y&P2GQR@>Z]UO7^_=>ZK-_FF_P J_P"./\UWX[UG2O=] <#O
M# '(9CI?NO!XZEJM\=/[RJZ>*)LEBC-)3?QK:V;^UAAS>#FFCI<K31H0\%7!
M1UE+[KW7R1OYCG\L+Y8_RO.ZJOJ#Y+['FI,;D:BOFZT[;V]%6Y#JOMS 4<B
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MY961F5E*LI*LK AE8&Q5@;$$$<CW[KW77OW7NO>_=>Z][]U[KWOW7NOL,_\
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M?]K#Y*__  5W=_OW7NM@[W[KW7O?NO=>]^Z]U\G3_A7+_P!OF^S/_$(="?\
MO&^_=>ZUDO?NO=>]^Z]UN.?\(H?^WDOR5_\ %']W_P#O^>@/?NO=?3<]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_3W^/?NO=% ^:O
MP*^)W\Q+JS =*?,7JG_3!UEM?L#%=I8+;7]^>R>O_L=]X3;FZMIXS._QGJW>
M.R=P5/VVW][92G^UFJY*-_NM;Q-)'$\?NO=5@?\ 0+C_ "*/^\&?_9F?F'_]
MT%[]U[KW_0+C_(H_[P9_]F9^8?\ ]T%[]U[KW_0+C_(H_P"\&?\ V9GYA_\
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M23R?!B%7D8LRT_R1^7=)""?^.=/2]^PT\2_X*H'OW7NL/_0+C_(H_P"\&?\
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JW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>strykerlogoa72b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 strykerlogoa72b.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_[@ .061O8F4 9      !_^$-M$5X:68
M $U- "H    (  <!$@ #     0 !   !&@ %     0   &(!&P %     0
M &H!*  #     0 "   !,0 "    )    '(!,@ "    %    ):':0 $
M 0   *H   $N  K\@   )Q  "OR    G$$%D;V)E(%!H;W1O<VAO<"!#0R R
M,#$U("A-86-I;G1O<V@I #(P,34Z,#DZ,C@@,3$Z-3DZ,S<   >0 P "
M%    020!  "    %    1B2D0 "     S P  "2D@ "     S P  "@ 0 #
M     ?__  "@ @ $     0   N2@ P $     0   ,@     ,C Q-3HP-SHQ
M-B Q,CHP,3HP,  R,#$U.C W.C$V(#$R.C Q.C P      8! P #     0 &
M   !&@ %     0   7P!&P %     0   80!*  #     0 "   " 0 $
M 0   8P" @ $     0  #"          2     $   !(     ?_8_^T #$%D
M;V)E7T--  +_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5
M#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,
M# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  K * # 2(  A$! Q$!_]T
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MW;6;BWWN^BQ>+9G^-7Z[=1S7'ICQB5:FO%HI9<0T'3U'WU7/L>UOTWL]*O\
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M68,&.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
M    4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P
M<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !
M   /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0
M=0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I
M;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0     0
M$G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B
M;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L
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M8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M      UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M       X0DE- ^T      !  2     $  0!(     0 !.$))300F       .
M             #^    X0DE-! T       0    >.$))3009       $
M'CA"24T#\P      "0           0 X0DE-)Q        H  0         !
M.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &
M   ! #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M      !P  #_____________________________ ^@     ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@  #A"24T$"       $     $
M  )    "0      X0DE-!!X       0     .$))300:      -=    !@
M            R    N0    4 ', = !R 'D :P!E '( 7P!L &\ 9P!O #(
M,  Q #4 7P!W &4 8@    $                          0
M   "Y    ,@                      0                         0
M     0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T
M,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M
M;&]N9P   ,@     4F=H=&QO;F<   +D    !G-L:6-E<U9L3',    !3V)J
M8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R
M;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@
M  UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4
M26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L
M;VYG          !,969T;&]N9P          0G1O;6QO;F<   #(     %)G
M:'1L;VYG   "Y     -U<FQ415A4     0       &YU;&Q415A4     0
M     $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L
M;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R
M>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV
M97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT
M"V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M  QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
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M_P#8.G_WE24[WUD^O'UHP?K^_H^+F^G@#)QJQ3Z51]MC:'6-]1]3K?=ZC_\
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MSGL=^]753L=_QZL?X\OZ1T?^ID?EH24^>=3ZSG]39B593YIP*&8V+4T0QC&
M-W;?]+<YN^ZS\_\ XME5;/</\7E_1J_J5CW])KVLK8YV6R0;#DM'ZSZSF_GO
MVM]+=_VF^SK%Z-]0>F]0_P 6[,6AH&?U&MF:W)?H?M :XX['.]WZ"MMC\?\
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M &\ <P!H &\ <    !< 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '
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M P,# P,# P/_P  1" #( N0# 1$  A$! Q$!_\0 'P    8" P$
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M6[R[1[QWA/+/)%F.R=Y9O=!QB5#ZWHL!0Y&KEQFV\2G BHL?#34D* +'&J@
M>Z]T ?OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z^P
MS_PF6_[<<_!'_M0=W?\ P3?=7OW7NM8+_A<%_P S]^ W_B'^Z/\ WM-F>_=>
MZT8_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO='_ /A9_-(^>O\ +YS]
M%E_BO\DNPM@8.GK%J\AUG691]U]/[AO*'J8\]U9N<939=5/5QEXS614D.2@6
M1C!4PN=8]U[KZ+_\E7_A3;T5_,?R^W/CG\D\+M[XW?,/)I#0[;H:;)3KT[WI
MD] #4O6F4S=549/:V]*F0'Q[9RE3535(T_8UU=*TD$'NO=;37OW7NOF ?\+*
M_BC_ *(OYBG6OR<P^-^VVW\M^F<<^:KEBT+6]K=&G';"W,-:#QMX^N*[9QY]
M9=G)XL??NO=:@WOW7NO>_=>Z&_XS=X;A^,WR+Z(^1.T_*=Q]&]O===L8B"*7
MPFMJ]@[LQ.YTQLK'T-2Y1<::>9&!22&5E<%20?=>Z^['LK>&WNP]F[2W_M'(
MQ9?:F^=L8'>&V,M ;P9/;VYL529K"Y&$W-XJW&UL4B_X-[]U[I3>_=>Z][]U
M[KWOW7NO>_=>Z^-M_P *(?E!_LUO\W[YB[OH,C]_M/K/?D7QYV4(Y?/1TV'Z
M*H(.OLV^.F!99J#-;^Q.9RD;J2C_ 'Y9"5(/OW7NJ4/?NO=>]^Z]U<E_(!^*
M7^SA?S:_AYUSD<;_ !'9NR>PXN]^PUEA\^/7:71M-+V,E#EX[-KQFZ-SX/&X
M206LS915) )(]U[K[,WOW7NO@;=@_P#'^[W_ /#OW+_[N:WW[KW20]^Z]U[W
M[KW7UNO^$G__ &Y*^.7_ (D#Y$?^_OWO[]U[K8^]^Z]U[W[KW0<=O]N]:]!=
M7[\[I[BWCAM@=7]9;8RN\-\;QS]0:?%X' 8>G:IK*N8HLD]3.X41T]- DE35
M5#I##')+(B-[KW7Q\OYW?\X#LK^;;\HJO>9.9VE\:.K:C+[;^-_4];.$;#[<
MJ*B-,CO_ '=24\TU#-V1V#]E#45[(TD=!2QT^/BDE2F-1/[KW5+?OW7NO>_=
M>Z][]U[KZ3/_  EK_D1?[+MM3;?\R+Y<[-\/?F_L":WXU=:[DH--9TQU]N*@
M>,]F9_'U<>NA[.[ PM64H(&59<)@IV\EJRNEAH?=>ZW7_?NO=>]^Z]T2GYR?
MS#OB)_+GZKD[;^6?;^"ZZPU4*N':>UTU9KL7L7*TD:.^$Z^V+C?+GMRUJO-$
ML\T<:4% )DDK:BFA)E'NO=?/_P#YAO\ PL3^8/>-=G-C_ W9F,^)75TDE11T
MG8^YJ+!=@_(/<% 6:):R^2I\IUQUP*VE<ZZ6BH\Q7TDH#P9<$"WNO=:G/<_?
MW>7R-W?4=@=_]Q=F]U[WJC*)=U=I[YW+OO.K%*_D:EI\CN7)9*HHZ%" $IXF
M2&-5"HJJH ]U[H(_?NO=>]^Z]U[W[KW7O?NO=6X_!O\ GE_S-?Y?E9AJ/I/Y
M*;KW+UMB6@C/1W<]36]K=05&.@"@8C'[=W'7-E=D4<NA=;[9R&$JFTV\UB0?
M=>ZWYOY4_P#PJF^'7SJR&V^G/DO18_X<_)+,24F*Q4.Y]P1UO1/9&;GT4\-+
MLSLC(QT#[2SF5JK^##[AC@!>2*FI<CD:API]U[K:A]^Z]U[W[KW7O?NO=>]^
MZ]U\G3_A7+_V^;[,_P#$(="?^\;[]U[K62]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U;I\!?YX_P#,B_ETY7"T_2G?^XMV=5XR6G6KZ![DK,GV3TY7
M8V%U:3&XO;^7R*Y78(J HUU&V:[#53:0'D=+H?=>Z^E/_)R_GW_%O^;7MQMG
MXZ%>D/EAMK#')[V^/6Y\U3Y"7+X^E11D-W]1[D:#'#?^T:=C>JB^WI\KB2;5
M5,(#!5U'NO=7N^_=>Z][]U[KWOW7NO_6W^/?NO=>]^Z]U[W[KW7O?NO=?.<_
MX5I?SG=S;Z[-SG\KCXY[NJ<5UAUS)0/\L]R8"ND@E[$[%9*?*T'31K*1E\FS
M>OH)()\W )&6MS[_ &LZ)_"F$_NO=:-7OW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NOL,_\)EO^W'/P1_[4'=W_ ,$W
MW5[]U[K6"_X7!?\ ,_?@-_XA_NC_ -[39GOW7NM&/W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=2\?D*_$U]%E,76U>-R>-JZ;(8[(X^IFHZ_'
MU]',E11UM%64[QU%+5TM1&LD<D;*Z.H92" ??NO=?67_ .$T?\X++?S,_BCE
MNL>\L\F3^7/Q=AP&W>QLO5/&E?VSUYE8JBEV)VZ\9$?GW!4/C)\9N/Q!U&2I
MXJQS$,G# GNO=!U_PKP^*/\ I[_E5UO<^&QOW>[_ (A]K;/[42HIX?-D'Z^W
MA4#J[L#&0BS,M!'/NK$YFK86*0X/63I5K^Z]U\J+W[KW7O?NO=>]^Z]U]@[_
M (30_*#_ &:'^3M\6JS(9'^(;LZ'Q^=^,F[QY?,U#+T[7)C=B4;N3K\G^A[(
M;:F8, 09B!<6)]U[J^KW[KW7O?NO=>]^Z]T6CYF_(;$_$SXE?)+Y,YDTQI.C
M.E.Q^S*>EJF"Q9;,[5VMDLGMW +=D#U.XL_#34,*W77-4*MQ>_OW7NOA99S-
M9;<N:R^XL]7U.5SF?RF0S69RE8_EJ\EELK5RUV1KZJ0V\E365D[R.WY9B??N
MO=-?OW7NO>_=>ZW\_P#A$?\ %+75?,OYO9K&\00[6^+O764:&X+U#8[M3M^F
M65Q97B2'9971<D2.&MQ?W7NOH"^_=>Z^!MV#_P ?[O?_ ,._<O\ [N:WW[KW
M20]^Z]U[W[KW7UNO^$G_ /VY*^.7_B0/D1_[^_>_OW7NMC[W[KW6.::&FAEJ
M*B6*"G@BDFGGFD6*&&&)2\LLLKE4CBC1268D  7/OW7NOEL_\*9/YZ\OS[[0
MKOAM\7MVRM\,NF]SG^]&Z<)5LM'\D>T<!4O$=R-4P,$R/5.RJZ-DV]""U/DZ
MQ6RS^5?X;]K[KW6IC[]U[KWOW7NO>_=>ZW+O^$O/\B+_ &;+>^"_F$?+39OG
M^,76>XFFZ+Z\W'0:L?W]V9MNO*/N?+T%7'X\IU)UUF*4J\;*U+G<Y":1S)2T
M5?3S^Z]U],KW[KW7O?NO=4(?SQ?YZ?3G\HWJZFVWA*3#]K?,3LK!U5;U'TS-
M62#%[=Q;O44$7:G;<E!/#D,5L*AR,$D=)1120Y#<-7!)34KPQ15E=1>Z]U\H
M7Y6?+?Y$?-ON?<_?_P G>T-Q=J]F[IF83Y;.5(7'X/%)/-/0[7VA@*98<+M#
M:.)-0XI,9CX*>DAULP36[NWNO=%P]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW6Y!_((_X4T;\^)>8V7\0_GYN_-]A?%*KEH=L]>]T9N6NSV_/
MCBKE:7&4&<J]-7E]Z=,TI*1FG?S9+;U, :,RT<*4"^Z]U],3!YS"[GPN(W)M
MO+XS<&W=P8O'YO Y["5]+E<-F\+E:2*OQ>7Q&4H99Z+(XS)4,Z303PN\4T3J
MZ,5(/OW7NG3W[KW7O?NO=?)T_P"%<O\ V^;[,_\ $(="?^\;[]U[K62]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0C]0]N]E]!]G[%[HZ<WGF
M^O>T>M-R8W=NQ]Y[<JOM,O@<]BIA-2U4#,LD%1!(-45133I+35=/))!/')#(
MZ-[KW7V3_P"2_P#S-=L?S5?@[L/Y"Q08S!=L[>JI>M/D)LC&LRTNU^W-N4-!
M/E:O$TTTDM1%M3>N*R%+F\4&>;P4U=]H\LE12SD>Z]U;%[]U[KWOW7NO_]??
MX]^Z]U[W[KW7O?NO=%@^:WR.Q7Q"^(GR4^3^7BIZJGZ*Z6[#[)HL;5,4AS>>
MVUMNOK=L;<U!XK2;DW(E)01^I?W*D<CZ^_=>Z^&=O?>FZ.R-Z;O[$WQFJS<>
M]=^[HS^]-W[AR,@ER&>W1NG+5><W!FJ^4!1)693+5TT\K6%WD)]^Z]TE_?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M?89_X3+?]N.?@C_VH.[O_@F^ZO?NO=:P7_"X+_F?OP&_\0_W1_[VFS/?NO=:
M,?OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[J\#_A.G\N
M\G\/?YN'Q4W#_$Y*#97=V[H/C%V72^;[>CR.V>\*V@VO@'R<S$)%0;<[-_N_
MFI':RJ,9ZB%)/OW7NOKG?)'I#;'R8^/?>'QWWHJG:G>/4_8'5&>E,*SO1X[?
MNULIMJ;(TR,5TUN,&2%13NI5XYXD965@"/=>Z^%)V/L#='5'8>_.K=[X]L3O
M3K7>>Z-@;NQ3EB^,W1L[.5VW<_CV+*C%J/*XZ6,W4&Z_0>_=>Z1GOW7NO>_=
M>ZWV_P#A$9\H/M=T_-/X8Y?(W3-839?R8V#C&ET+%48"LAZP[6JDC9K2S5T&
M>V>/2 RI2,3<6T^Z]U]!WW[KW7O?NO=>]^Z]UJD_\+!_E!_H6_E94G1^*R/V
M^Y?EIW5LG8-31Q2^&L?KSKJ5NV=WY"%U(D--'N/:^WL?4*O$D64*-=&8'W7N
MOE>^_=>Z][]U[KWOW7NOLJ?\)[OBE_LH/\HWX@[$R.-_AV\NQMB?[,'V )(?
M!72[E[SJ7W_CZ7*PZ5:+)[;V3E,1AI48:T_AH5O4#[]U[JZ3W[KW7P-NP?\
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M,=/245%1PI3TM)2T\2K%!34T$:HB* JJH %A[]U[J7[]U[KX&W8/_'^[W_\
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M*NT'6>V]UT\R)ZU^^B)(# /[KW7TVO?NO=>]^Z]U\#;L'_C_ '>__AW[E_\
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M#'+;4D4]1M&E9U'#&-2?TCW[KW7S,_?NO=>]^Z]T?_\ E._]O3?Y:?\ XO\
M_#?_ ."*ZY]^Z]U]OGW[KW7O?NO=?__2W^/?NO=>]^Z]U[W[KW53W\\[X[9'
MY3?RD_G3U%A*"3*;C?I/)=D;8QM/#YZ[);EZ0S.&[JPF)QB#UG(YNOV E%"
M1K:HT$Z6/OW7NOBT>_=>Z][]U[KWOW7NK$_Y?G\U;YP?RQ]UYS<?Q*[?J=I8
M;=TE)+OKK3<F*H-X]6[XDH4,='5Y[9V9CEIJ?,TL1\<>4QTE!EHX;PK5"%GC
M;W7NKU*?_A:)_-9A@CBDZB^"U7(BA6J:CJ;NU9YC_JY%I/D?2TP8_P"T1H/\
M/?NO==S?\+1OYK$B%$Z?^"M.Q(M+#U-W>SBQN0!/\D9X['\W4^_=>ZB?]!GO
M\U[_ )]?\(/_ $4?<'_W0GOW7NO?]!GO\U[_ )]?\(/_ $4?<'_W0GOW7NO?
M]!GO\U[_ )]?\(/_ $4?<'_W0GOW7NLU/_PM"_FMPRK))U/\&JM!]8*CJ7NA
M8G_X,:7Y%TTP_P!@X]^Z]T:#J/\ X6\?)W%5E+_IX^$/0V_: O&M:>H]_P#8
M/4E8L9($LU*N\D[LA=T!U+&Y4,1I+K?4/=>ZOX^'/_"M+^5=\FJ_$;5[5S^_
M_AYOG)R14BQ]Z82DJ>M)\C*RVBI.U]E5F?PF*QZJQ+5NXJ;;U,I4AF'IU>Z]
MULN[4W9M7?>V\+O'8^YMO[RVAN3'T^6V[NK:F9QVXMMY_%5:>2ER>%SF(J:S
M&93'U*<QS02R1N.03[]U[I0>_=>Z][]U[K0^_P"%QDJ#K'^73"6M+)OOY)RH
MMCRD.W^F4D:]K#2TRC^O/OW7NOGD>_=>Z][]U[J[[_A-[_V^U^!'_B0.P?\
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M@GR%5-)'!$K"-?=>Z'W_ *#5OYIO_/@_@!_Z*SY%?_=5>_=>Z]_T&K?S3?\
MGP?P _\ 16?(K_[JKW[KW7O^@U;^:;_SX/X ?^BL^17_ -U5[]U[KW_0:M_-
M-_Y\'\ /_16?(K_[JKW[KW7O^@U;^:;_ ,^#^ '_ **SY%?_ '57OW7NO?\
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M8W;@-[8A:;.X2II,I0&'<&VJ25C%(ID1"C75F!]U[JCO_H$S_DI_\^([0_\
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M7[O=(F-'M[M3O;:L\X12L=3O':/7F7I(B]M2M-%L68@ V(C-_H/?NO=?.O\
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MH::HG8RSSIL3?=;3[RI@TQNE/1;KHJ&%#HB@1 H7W7NJ+>S_ /A$K\Y,/6U
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MQL__ -";"_\ U;[]U[KW^D/8'_/<;/\ _0FPO_U;[]U[KW^D/8'_ #W&S_\
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MX]OXF+)XRGC1YJC-X:DIH]"U4Q/NO=?)#]^Z]U[W[KW7O?NO=?1)_P"$<O\
M-%_OEL/>7\K_ +=W%Y-R];4^<[6^+M5E*J\V4Z^KZ]J_L_JZBDG9!)4;-W!D
M#G\=3J99Y:')Y&P2GQR@>Z]UO7^_=>ZK-_FF_P J_P"./\UWX[UG2O=] <#O
M# '(9CI?NO!XZEJM\=/[RJZ>*)LEBC-)3?QK:V;^UAAS>#FFCI<K31H0\%7!
M1UE+[KW7R1OYCG\L+Y8_RO.ZJOJ#Y+['FI,;D:BOFZT[;V]%6Y#JOMS 4<B
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MY961F5E*LI*LK AE8&Q5@;$$$<CW[KW77OW7NO>_=>Z][]U[KWOW7NOL,_\
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M?]K#Y*__  5W=_OW7NM@[W[KW7O?NO=>]^Z]U\G3_A7+_P!OF^S/_$(="?\
MO&^_=>ZUDO?NO=>]^Z]UN.?\(H?^WDOR5_\ %']W_P#O^>@/?NO=?3<]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_3W^/?NO=% ^:O
MP*^)W\Q+JS =*?,7JG_3!UEM?L#%=I8+;7]^>R>O_L=]X3;FZMIXS._QGJW>
M.R=P5/VVW][92G^UFJY*-_NM;Q-)'$\?NO=5@?\ 0+C_ "*/^\&?_9F?F'_]
MT%[]U[KW_0+C_(H_[P9_]F9^8?\ ]T%[]U[KW_0+C_(H_P"\&?\ V9GYA_\
MW07OW7NO?] N/\BC_O!G_P!F9^8?_P!T%[]U[KW_ $"X_P BC_O!G_V9GYA_
M_=!>_=>Z]_T"X_R*/^\&?_9F?F'_ /=!>_=>Z]_T"X_R*/\ O!G_ -F9^8?_
M -T%[]U[KW_0+C_(H_[P9_\ 9F?F'_\ =!>_=>Z]_P! N/\ (H_[P9_]F9^8
M?_W07OW7NO?] N/\BC_O!G_V9GYA_P#W07OW7NO?] N/\BC_ +P9_P#9F?F'
M_P#=!>_=>Z]_T"X_R*/^\&?_ &9GYA__ '07OW7NAUZN_P"$_?\ )HZ?K*:O
MVC_+[Z-RE122))".SH=V]VTVN,W0RT7<^Z-_452 ?J)(W!_-_?NO=6M;%Z]V
M#U?MNAV;UIL?:'7>T,6&7&;4V+MK"[2VWCE:P84.#P%%C\72!@HOXXEO;W[K
MW2O]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=$;^07\LO^7M\J:^MS7R#^&7Q
MR[0W-D6D:MWIGNJ]J0[_ *EI?\X9.P,3C\=O0ZSR?\O_ %<_47]^Z]U7UE_^
M$Q7\C/-U;UM9\%,5#-(Q9DQ'?ORHV_2 FP.B@P/>6-H8EXX"Q@#W[KW35_T"
MX_R*/^\&?_9F?F'_ /=!>_=>Z]_T"X_R*/\ O!G_ -F9^8?_ -T%[]U[KW_0
M+C_(H_[P9_\ 9F?F'_\ =!>_=>ZN&^,OQFZ0^'/1NP_C;\<-D_Z.NENLZ?.4
MNR-F?WDW=N[^"0;CW/FMY9E/[Q;[S^Y]UY+[S<FXJRIO5UU08_-XXRL2(B^Z
M]T6#YP?RF?Y?O\R#/[!W1\S^@?\ 3+G>K\/FL!L6N_TJ=U]>?P/$[AK:+(YB
MD^VZI['V-1Y/[RLQ\+^2LCJ)8]%D95+ ^Z]T1C_H%Q_D4?\ >#/_ +,S\P__
M +H+W[KW7O\ H%Q_D4?]X,_^S,_,/_[H+W[KW0^?&#^0A_*:^&G>FQ?DI\;/
MBC_HX[KZTDW#+LG>G^G3Y*;P_@LFZMIYW8^>;^[F_>X]T[3R7W^U]S5U+:KH
M)Q%Y_)'HF2.1/=>ZN"]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=$:_F5?,#)
M? ;X-_(;Y?8C8M#V7DNC]JXC<=+L7)9Z?;%%N)\GO';>UFI*C/4N+S4^.2&/
M/&8.M+,6,06P#7'NO=:5'_0<7VI_WKMZ_P#_ $H[<?\ ]J#W[KW7O^@XOM3_
M +UV]?\ _I1VX_\ [4'OW7NO?]!Q?:G_ 'KMZ_\ _2CMQ_\ VH/?NO=-^5_X
M7#=T38ROBP?\OGJ_'9B2DG3&5^5[[W7F<91US1L*:HK\32=:X*JR-)%+9GAC
MK:5Y%!42H3J'NO=:;/RO^47<'S2^1/:WRB[[SU/N+M?N'<K;DW174-'_  [$
MT:P4-'AL%M[ 8XS5#X[;>U=N8RCQF.@>6:2&AI(E>21PTC>Z]T7GW[KW7O?N
MO=>]^Z]UOD_\(N_Y?=7EMZ]Y?S(]^X1DPNTL?7?'GX_S5U/Z*[=6<BQV8[@W
MGC/*L<J';VW#CL%3546N&?\ C.4@)$E.P'NO=?0O]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW5!N0_X3 _R,\K7UV4K_@_YZ[)5E37UL_^S+?+^+S5=9,]14R^*'O^
M.&/R32$Z455%[  <>_=>ZA_] N/\BC_O!G_V9GYA_P#W07OW7NO?] N/\BC_
M +P9_P#9F?F'_P#=!>_=>ZMO^)_Q'^/7P>Z2VY\<_BYU]_HPZ:VED-Q97;VS
MO[U[WWK_  ^OW7G*[<F?G_O#V'N7=NZJO[_-9*:;3/72)%KT1A(PJCW7NC'^
M_=>Z][]U[KWOW7NO>_=>Z*'\S_@9\2OYA?6&(Z;^8G3N-[EZ\P&[J#?>"P]5
MN7?&S*_#;KQN.RF(ILOB]T]<[GV?NV@=L9FJF":**N2"IBE*RHX"V]U[JKW_
M *!<?Y%'_>#/_LS/S#_^Z"]^Z]U[_H%Q_D4?]X,_^S,_,/\ ^Z"]^Z]U[_H%
MQ_D4?]X,_P#LS/S#_P#N@O?NO=6@_"_X'_%C^7MUAE^F/B'UODNJ>L,WNZOW
MW6[0JNS.V>R<?'NG*8[%XK)9/%S]L[ZWUD,$E?1X:F\U/0S4]+)+'Y6C,KN[
M>Z]T;WW[KW7O?NO=>]^Z]TR[AVWM[=V&K]N;KP.%W/M[*PFFR>"W#BZ'-8;)
M4[$$P5^+R4%315D)(!*2(R\?3W[KW58G;'\CK^47W555-?OK^7S\:HJZL9I*
MRNV%L.GZBK:N9V+R5-35]2U&R*B>JE<DO*[&1SRS$^_=>Z*Y4?\ "7G^174S
M23R?!B%7D8LRT_R1^7=)""?^.=/2]^PT\2_X*H'OW7NL/_0+C_(H_P"\&?\
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JW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>strykerlogoa72c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 strykerlogoa72c.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_[@ .061O8F4 9      !_^$-M$5X:68
M $U- "H    (  <!$@ #     0 !   !&@ %     0   &(!&P %     0
M &H!*  #     0 "   !,0 "    )    '(!,@ "    %    ):':0 $
M 0   *H   $N  K\@   )Q  "OR    G$$%D;V)E(%!H;W1O<VAO<"!#0R R
M,#$U("A-86-I;G1O<V@I #(P,34Z,#DZ,C@@,3$Z-3DZ,S<   >0 P "
M%    020!  "    %    1B2D0 "     S P  "2D@ "     S P  "@ 0 #
M     ?__  "@ @ $     0   N2@ P $     0   ,@     ,C Q-3HP-SHQ
M-B Q,CHP,3HP,  R,#$U.C W.C$V(#$R.C Q.C P      8! P #     0 &
M   !&@ %     0   7P!&P %     0   80!*  #     0 "   " 0 $
M 0   8P" @ $     0  #"          2     $   !(     ?_8_^T #$%D
M;V)E7T--  +_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5
M#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,
M# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  K * # 2(  A$! Q$!_]T
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MW;6;BWWN^BQ>+9G^-7Z[=1S7'ICQB5:FO%HI9<0T'3U'WU7/L>UOTWL]*O\
MX*M)3[DDO"?^?W^,[_N1?_[!T_\ O*E_S^_QG?\ <B__ -@Z?_>5)3O?63Z\
M?6C!^O[^CXN;Z> ,G&K%/I5'VV-H=8WU'U.M]WJ/_P (O6%\S9_5.LY76CU+
M.<X]5]2MY>ZMK';V!C:?T#6,9]%E?^#79=!^NW^,3(Z[T[&S;[CBW9=%60UV
M+4P>F^QC+6N>W'8YGL=^\DI]G27B/UB_QB_73"^L74L'$Z@6T49=U5%?H4.(
M:VQS*V;G4.>[V_O*DW_&A]?:+&/NS=[09].S'I#71RT[*:[/\QZ2GWM)>4];
M_P 8?U@S/JC@_6#H]XP+JLAV%U.AM;+6FPL;=3=5]HKN=71M9_GW>C^F]+U%
MU/\ BT^LV9]8OJ^Z[J-@MSL:]]-KX:TN:0VZJPUU-8QGML]'Z'^!24]:O//\
M:OUKZ_\ 5Z[IK>D97V9N0VXVCTZ[-Q8:MG\_7;M^F[Z*H?XS/K[UWH_7V=-Z
M+EC'930UV2!778?4>7/#7>O7;MVT>D_V_P"D6-_C//43TKZLOZI:Z[/LQK;,
ME[FM80^ST+34:Z6LK;Z._P!'Z/YB2GU;ZK9N3G_5SIN;EO\ 5R<C'KLML@-E
MSA+G;6!K&_V5JKB\/ZSX/U8_Q=]+ZAECU'G%J9C8[3#K;"WVLG\QC?I6V_X.
MO_26;*G\M]3?K-_C!^MG6C0SJ)Q\"H^IF65T4176XG912ZVBS]+9'IT>KZG^
ME_2^DDI]=27GOU[_ ,:+>AY3ND]&K9DY]8C)OLDUU./%36M+?7OV_P Y[_3I
M_P"%L]6NGBA]?/\ &:[&/46WWG#$SD#$J]$:_P"E^S>DDI]W27GGU$_QI-ZU
MDLZ3UMM>/G60,;(9+:[7?Z%[7%WHY#O\'_@K_P";_16>E7=2_P :'US^LO0>
MOX^'TG,^S8]F(RUS/2J?+S9?6YVZ^JU_T*F)*?4$EX$?\9G^,%K=YZ@X-T.X
MXU$:\?\ :=>B?XN/K_?]9O6Z?U%C&=0QJQ:+*P0VVL$5O>YGN;78RQU>_P#,
M?ZOZ.M)3_]#OOK;TN_J_U;ZCT['UOOI<*6R!N>W])77N<6M;ZCV;/<O#_JG]
M;.H?4W/RR,1EMEH]&^F\%EC'5N/MW?SE>U_\[4O7_K-_C#Z)]6>H,Z?U"G)?
M<^IMP=2QCF[7.?6!-EU3MWZ+]U<UF_XRO\7'4+?7S^C695T >K=BX[WP.&[W
MW.=M24YO_CX=3_\ *NC_ +<?_<NB^J?^-CI_7,ZOIN?C?L_*O(9CO#]]5CS_
M (+<6UNIL?\ X%OZ3U/])]#?CCZ]?XJ9_P#$_P#^R6-_Z57"VOQ^J_6YKOJ_
MCNPZLK+K^Q42 6$N;M=[3LJ_2?I=C'>GC_0^A6DIV_KB3_XZKS.HR\.#\&8R
M]T7@_P#C#?;T[_&+D9ME1<UEF-D5M,M#VLKI^B^#^?4^K>O0>G_XW/JUU#/Q
ML"C'S&W9EU=%9?76&AUCFU,+RW(=[-SO<DI\XL__ "JC_P!/C?\ VZ"]A^NO
M0;_K#]7,GI>+Z3<FTUNI?=(:TLL98]VYC+7L=Z+;*_8S\]>/6?\ Y51_Z?&_
M^W07OR2GS;IG^+OJG3OJ7UWI&<^F^_, OQ1C.<Z;*1ZM3/TM=/\ .6UL8L+_
M !*]4&/US,Z8]P#,Z@/9/)LH,M8W_K-V0_\ ZVO9E\\=<;E?5#ZZ9PP-M3\:
MRW[-I(;5DUN],-_E,QLG;_QB2D[!_P \?\8NOZ:C.S2=?:3BU'=M_K?8*%T_
M^/+^D='_ *F1^6A5_P#$GTKUNJYW5GB6XE3::I'Y]QW.>QW[U=5.QW_'JQ_C
MR_I'1_ZF1^6A)3YYU/K.?U-F)5E/FG H9C8M31#&,8 W=M_TMSF[[K/S_P#B
MV55L]P_Q>7]&K^I6/?TFO:RMCG9;)!L.2T?K/K.;^>_:WTMW_:;[.L7HWU!Z
M;U#_ !;LQ:&@9_4:V9K<E^A^T!KCCL<[W?H*VV/Q_P#B[K[?YVQ<M_BO^L5O
M0/K#9T3J.ZK&SW_9[:[ 1Z62T^G5N9!V[W_JMW_6_5_F$E/)X'5&4]9;U3J6
M.WJGZ1UUU%SB&VV.W.W71._],[U7U_0N_F[/T:[T?X[^H 0.E4@#@>H[_P B
MN:ZOT[J/U$^M@>VMME=+W68;K6[Z[J'[F;+-S1N=Z3_1O_T=O\W_ (*U=MC_
M .-7ZCOI8[)Z/95<0/48RFBQH/@RUUE+GM_ZU6DI\RZIU2K*ZN_J?3\9O3"Y
M[;64T..VNQL$OH,,]/\ 2-]5K/\ !_F+J/\ &WE?;.M],RR-OVCI=%NWPWV9
M#X_Z2](^JO7OJI]:_M8Z=TX5C#]/U?M%%39]7U-FSTW7?Z%^[<O/O\=0 ^M.
M( ( P*P /^.RDE/JN%C_ &SZJX^*0U_VC 946O\ HG?2&19]+V>[W+D?\7W^
M+SK?U8ZW9U#/NQK*;,9](;0^QSMSGU6"1932W;^B_>7;="_Y#Z=_X5I_\]L5
MY)3_ /_1ZSZS_P"+OHGUGZ@SJ&?=DUW,J;2&T/K:W:US[ 8LIM=N_2_O+)_\
M97ZJ_P#<K/\ ^W*O_>9=^DDI\_\ _&5^JO\ W*S_ /MRK_WE6]]7?J#]6_J[
M:,C!H=9F-!#<J]V^P C:[T]&55>WV[JJF/71))*<7ZQ_5#H7UDK:.IT;K:QM
MJR*SLM8"9AKQ[7M_D6LLK6#T_P#Q1?5KI^?C9]&3FNNQ+J[ZP^RHM+JW-M8'
MAN.UVS<W]Y=PDDIY!W^+'H#OK!^W_7R_M?VL9VS?7Z?J"S[1LV^AZGI;_P#A
M?[:Z])))3Y[_ (PO\8?6/JOUJGI^#1C6U6XS;W.O:\NW.LNJ@>G;4W9MI_=7
MF/UB^L'4?K;U>K*NQJVY;V,QJZL5CIL.YWI^QSKK++GNM]/_ +;8O6_KK_RK
M5_XFOYAO_+G])^G;_-?]U/W/^&]=2^I?]/M_\3?T/^\/^>_Z[_P22F_]0/JW
M9]7/JY3AY C,N<<C+ (<!8\-;Z8<WV_HJF55NV>SU-ZE]:OJ/TGZU/QG]1MR
M*CB!XK%#F-!W["[?ZM5W^C71))*:G2NG4=+Z=C=.QW.=3B5MJK=807%K1M&\
MM:QN[^PN:Z[_ (KOJWUSJ=W4\A^3CWY$&UN.ZMK"X#;ZFRRFWWO_ ,(NP224
MYN=]7^E]3Z;7TWJM7[0IK:UOJ7_SI<T;?7]:KTG5WO\ \)93Z2Y2W_$Q]4WV
M.>V[-J:3I6RRLM']7U*+'_YSUWJ22GG_ *J?4KI7U4^U?LZV^W[9Z?J?:',=
M'I>ILV>E53_IG[E7^M'^+SHOUGZA7U#J%V37;52*&MH<QK=K766AQ]6FYV_=
M<[\Y=0DDI#B8U>)BTXM9)KQZVU,+M26L 8W=Q[O:C)))*?_9_^T5=%!H;W1O
M<VAO<" S+C  .$))300$       L' %:  ,;)4<< @   @  ' (W  @R,#$U
M,#<Q-AP"/  +,3(P,3 P*S P,# X0DE-!"4      ! #%M'!JU@13,IV2@$W
M68,&.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
M    4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P
M<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !
M   /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0
M=0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I
M;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0     0
M$G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B
M;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L
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M8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M      UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M       X0DE- ^T      !  2     $  0!(     0 !.$))300F       .
M             #^    X0DE-! T       0    >.$))3009       $
M'CA"24T#\P      "0           0 X0DE-)Q        H  0         !
M.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &
M   ! #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M      !P  #_____________________________ ^@     ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@  #A"24T$"       $     $
M  )    "0      X0DE-!!X       0     .$))300:      -=    !@
M            R    N0    4 ', = !R 'D :P!E '( 7P!L &\ 9P!O #(
M,  Q #4 7P!W &4 8@    $                          0
M   "Y    ,@                      0                         0
M     0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T
M,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M
M;&]N9P   ,@     4F=H=&QO;F<   +D    !G-L:6-E<U9L3',    !3V)J
M8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R
M;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@
M  UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4
M26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L
M;VYG          !,969T;&]N9P          0G1O;6QO;F<   #(     %)G
M:'1L;VYG   "Y     -U<FQ415A4     0       &YU;&Q415A4     0
M     $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L
M;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R
M>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV
M97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT
M"V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M  QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
M #A"24T$*       #     (_\        #A"24T$$0       0$ .$))3004
M       $     SA"24T$#      ,/     $   "@    *P   >   %"@   ,
M(  8  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(
M" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1
M$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\  $0@ *P"@
M P$B  (1 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,  0($!08'
M" D*"P$  04! 0$! 0$          0 " P0%!@<("0H+$  !! $# @0"!0<&
M" 4###,!  (1 P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3
M\.'Q8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2E
MM<75Y?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%
M-0$  A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T? S)&+A<H*20U,58W,T\24&
M%J*R@P<F-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U
M5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:  P# 0 "$0,1 #\ ]525;J6?C]-Z
M?D=0R211BUNMLB)(8-VUFXM][OHL7BV9_C5^NW4<UQZ8\8E6IKQ:*67$-!T]
M1]]5S['M;]-[/2K_ ."K24^Y)+PG_G]_C._[D7_^P=/_ +RI?\_O\9W_ '(O
M_P#8.G_WE24[WUD^O'UHP?K^_H^+F^G@#)QJQ3Z51]MC:'6-]1]3K?=ZC_\
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MSGL=^]753L=_QZL?X\OZ1T?^ID?EH24^>=3ZSG]39B593YIP*&8V+4T0QC&
M-W;?]+<YN^ZS\_\ XME5;/</\7E_1J_J5CW])KVLK8YV6R0;#DM'ZSZSF_GO
MVM]+=_VF^SK%Z-]0>F]0_P 6[,6AH&?U&MF:W)?H?M :XX['.]WZ"MMC\?\
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M &\ <P!H &\ <    !< 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '
M( !# $, (  R #  ,0 U     0 X0DE-! 8       < "     $! /_A#ZUH
M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTB
M[[N_(B!I9#TB5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^#0H\>#IX;7!M
M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!8
M35 @0V]R92 U+C8M8S V-R W.2XQ-3<W-#<L(#(P,34O,#,O,S M,C,Z-# Z
M-#(@(" @(" @("(^#0H)/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W
M+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX-"@D)/')D9CI$
M97-C<FEP=&EO;B!R9&8Z86)O=70](B(@>&UL;G,Z>&UP/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O(B!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+VUM+R(@>&UL;G,Z<W12968](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B('AM;&YS.G-T
M179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R
M8V5%=F5N=",B('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N
M=',O,2XQ+R(@>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O8F4N8V]M
M+W!H;W1O<VAO<"\Q+C O(B!X;7 Z0W)E871O<E1O;VP](D%D;V)E(%!H;W1O
M<VAO<"!#0R R,#$U("A-86-I;G1O<V@I(B!X;7 Z0W)E871E1&%T93TB,C Q
M-2TP-RTQ-E0Q,CHP,3HP,"(@>&UP.DUO9&EF>41A=&4](C(P,34M,#DM,CA4
M,3$Z-3DZ,S<M,#0Z,# B('AM<#I-971A9&%T841A=&4](C(P,34M,#DM,CA4
M,3$Z-3DZ,S<M,#0Z,# B('AM<$U-.DEN<W1A;F-E240](GAM<"YI:60Z839D
M.&4P8S,M-3DR-"TT-#AC+3DR-V4M-#(V,&1D83,Q,F0W(B!X;7!-33I$;V-U
M;65N=$E$/2)A9&]B93ID;V-I9#IP:&]T;W-H;W Z-3$U-C$Y-#@M838X."TQ
M,3<X+3EF.&4M83DQ9&8Y9C)B9F5E(B!X;7!-33I/<FEG:6YA;$1O8W5M96YT
M240](GAM<"YD:60Z,D4Y,SA%034R,S S,3%%-4%".#1"-D8P,D4R-S$X14,B
M(&1C.F9O<FUA=#TB:6UA9V4O:G!E9R(@<&AO=&]S:&]P.D-O;&]R36]D93TB
M,R(^#0H)"0D\>&UP34TZ1&5R:79E9$9R;VT@<W12968Z:6YS=&%N8V5)1#TB
M>&UP+FEI9#HW,35B9C(P92TY,3=A+30U.6$M.3,P-"UC9F0R964W960Y,S0B
M('-T4F5F.F1O8W5M96YT240](GAM<"YD:60Z,D4Y,SA%034R,S S,3%%-4%"
M.#1"-D8P,D4R-S$X14,B('-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#TB>&UP
M+F1I9#HR13DS.$5!-3(S,#,Q,44U04(X-$(V1C R13(W,3A%0R(O/@T*"0D)
M/'AM<$U-.DAI<W1O<GD^#0H)"0D)/')D9CI397$^#0H)"0D)"3QR9&8Z;&D@
M<W1%=G0Z86-T:6]N/2)S879E9"(@<W1%=G0Z:6YS=&%N8V5)1#TB>&UP+FEI
M9#HW,35B9C(P92TY,3=A+30U.6$M.3,P-"UC9F0R964W960Y,S0B('-T179T
M.G=H96X](C(P,34M,#DM,CA4,3$Z-3DZ,S<M,#0Z,# B('-T179T.G-O9G1W
M87)E06=E;G0](D%D;V)E(%!H;W1O<VAO<"!#0R R,#$U("A-86-I;G1O<V@I
M(B!S=$5V=#IC:&%N9V5D/2(O(B\^#0H)"0D)"3QR9&8Z;&D@<W1%=G0Z86-T
M:6]N/2)C;VYV97)T960B('-T179T.G!A<F%M971E<G,](F9R;VT@:6UA9V4O
M<&YG('1O(&EM86=E+VIP96<B+SX-"@D)"0D)/')D9CIL:2!S=$5V=#IA8W1I
M;VX](F1E<FEV960B('-T179T.G!A<F%M971E<G,](F-O;G9E<G1E9"!F<F]M
M(&EM86=E+W!N9R!T;R!I;6%G92]J<&5G(B\^#0H)"0D)"3QR9&8Z;&D@<W1%
M=G0Z86-T:6]N/2)S879E9"(@<W1%=G0Z:6YS=&%N8V5)1#TB>&UP+FEI9#IA
M-F0X93!C,RTU.3(T+30T.&,M.3(W92TT,C8P9&1A,S$R9#<B('-T179T.G=H
M96X](C(P,34M,#DM,CA4,3$Z-3DZ,S<M,#0Z,# B('-T179T.G-O9G1W87)E
M06=E;G0](D%D;V)E(%!H;W1O<VAO<"!#0R R,#$U("A-86-I;G1O<V@I(B!S
M=$5V=#IC:&%N9V5D/2(O(B\^#0H)"0D)/"]R9&8Z4V5Q/@T*"0D)/"]X;7!-
M33I(:7-T;W)Y/@T*"0D\+W)D9CI$97-C<FEP=&EO;CX-"@D\+W)D9CI21$8^
M#0H\+W@Z>&UP;65T83X-"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(#P_>'!A8VME="!E;F0]
M)W<G/S[_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$" @(" @(" @(" @,# P,# P,# P/_VP!# 0$! 0$! 0$! 0$"
M @$" @,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P/_P  1" #( N0# 1$  A$! Q$!_\0 'P    8" P$
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M6[R[1[QWA/+/)%F.R=Y9O=!QB5#ZWHL!0Y&KEQFV\2G BHL?#34D* +'&J@
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M!72[E[SJ7W_CZ7*PZ5:+)[;V3E,1AI48:T_AH5O4#[]U[JZ3W[KW7P-NP?\
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M,=/245%1PI3TM)2T\2K%!34T$:HB* JJH %A[]U[J7[]U[KX&W8/_'^[W_\
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M*NT'6>V]UT\R)ZU^^B)(# /[KW7TVO?NO=>]^Z]U\#;L'_C_ '>__AW[E_\
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M#'+;4D4]1M&E9U'#&-2?TCW[KW7S,_?NO=>]^Z]T?_\ E._]O3?Y:?\ XO\
M_#?_ ."*ZY]^Z]U]OGW[KW7O?NO=?__2W^/?NO=>]^Z]U[W[KW53W\\[X[9'
MY3?RD_G3U%A*"3*;C?I/)=D;8QM/#YZ[);EZ0S.&[JPF)QB#UG(YNOV E%"
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MMCRD.W^F4D:]K#2TRC^O/OW7NOGD>_=>Z][]U[J[[_A-[_V^U^!'_B0.P?\
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M@GR%5-)'!$K"-?=>Z'W_ *#5OYIO_/@_@!_Z*SY%?_=5>_=>Z]_T&K?S3?\
MGP?P _\ 16?(K_[JKW[KW7O^@U;^:;_SX/X ?^BL^17_ -U5[]U[KW_0:M_-
M-_Y\'\ /_16?(K_[JKW[KW7O^@U;^:;_ ,^#^ '_ **SY%?_ '57OW7NO?\
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M8W;@-[8A:;.X2II,I0&'<&VJ25C%(ID1"C75F!]U[JCO_H$S_DI_\^([0_\
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M7[O=(F-'M[M3O;:L\X12L=3O':/7F7I(B]M2M-%L68@ V(C-_H/?NO=?.O\
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MH::HG8RSSIL3?=;3[RI@TQNE/1;KHJ&%#HB@1 H7W7NJ+>S_ /A$K\Y,/6U
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MQL__ -";"_\ U;[]U[KW^D/8'_/<;/\ _0FPO_U;[]U[KW^D/8'_ #W&S_\
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MX]OXF+)XRGC1YJC-X:DIH]"U4Q/NO=?)#]^Z]U[W[KW7O?NO=?1)_P"$<O\
M-%_OEL/>7\K_ +=W%Y-R];4^<[6^+M5E*J\V4Z^KZ]J_L_JZBDG9!)4;-W!D
M#G\=3J99Y:')Y&P2GQR@>Z]UO7^_=>ZK-_FF_P J_P"./\UWX[UG2O=] <#O
M# '(9CI?NO!XZEJM\=/[RJZ>*)LEBC-)3?QK:V;^UAAS>#FFCI<K31H0\%7!
M1UE+[KW7R1OYCG\L+Y8_RO.ZJOJ#Y+['FI,;D:BOFZT[;V]%6Y#JOMS 4<B
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MY961F5E*LI*LK AE8&Q5@;$$$<CW[KW77OW7NO>_=>Z][]U[KWOW7NOL,_\
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M?]K#Y*__  5W=_OW7NM@[W[KW7O?NO=>]^Z]U\G3_A7+_P!OF^S/_$(="?\
MO&^_=>ZUDO?NO=>]^Z]UN.?\(H?^WDOR5_\ %']W_P#O^>@/?NO=?3<]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_3W^/?NO=% ^:O
MP*^)W\Q+JS =*?,7JG_3!UEM?L#%=I8+;7]^>R>O_L=]X3;FZMIXS._QGJW>
M.R=P5/VVW][92G^UFJY*-_NM;Q-)'$\?NO=5@?\ 0+C_ "*/^\&?_9F?F'_]
MT%[]U[KW_0+C_(H_[P9_]F9^8?\ ]T%[]U[KW_0+C_(H_P"\&?\ V9GYA_\
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M23R?!B%7D8LRT_R1^7=)""?^.=/2]^PT\2_X*H'OW7NL/_0+C_(H_P"\&?\
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JW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>syk-20241231_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 syk-20241231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_[@ .061O8F4 9      !_^$-M$5X:68
M $U- "H    (  <!$@ #     0 !   !&@ %     0   &(!&P %     0
M &H!*  #     0 "   !,0 "    )    '(!,@ "    %    ):':0 $
M 0   *H   $N  K\@   )Q  "OR    G$$%D;V)E(%!H;W1O<VAO<"!#0R R
M,#$U("A-86-I;G1O<V@I #(P,34Z,#DZ,C@@,3$Z-3DZ,S<   >0 P "
M%    020!  "    %    1B2D0 "     S P  "2D@ "     S P  "@ 0 #
M     ?__  "@ @ $     0   N2@ P $     0   ,@     ,C Q-3HP-SHQ
M-B Q,CHP,3HP,  R,#$U.C W.C$V(#$R.C Q.C P      8! P #     0 &
M   !&@ %     0   7P!&P %     0   80!*  #     0 "   " 0 $
M 0   8P" @ $     0  #"          2     $   !(     ?_8_^T #$%D
M;V)E7T--  +_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5
M#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,
M# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  K * # 2(  A$! Q$!_]T
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MW;6;BWWN^BQ>+9G^-7Z[=1S7'ICQB5:FO%HI9<0T'3U'WU7/L>UOTWL]*O\
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M68,&.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
M    4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P
M<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !
M   /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0
M=0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I
M;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0     0
M$G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B
M;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L
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M8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M      UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M       X0DE- ^T      !  2     $  0!(     0 !.$))300F       .
M             #^    X0DE-! T       0    >.$))3009       $
M'CA"24T#\P      "0           0 X0DE-)Q        H  0         !
M.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &
M   ! #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M      !P  #_____________________________ ^@     ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@  #A"24T$"       $     $
M  )    "0      X0DE-!!X       0     .$))300:      -=    !@
M            R    N0    4 ', = !R 'D :P!E '( 7P!L &\ 9P!O #(
M,  Q #4 7P!W &4 8@    $                          0
M   "Y    ,@                      0                         0
M     0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T
M,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M
M;&]N9P   ,@     4F=H=&QO;F<   +D    !G-L:6-E<U9L3',    !3V)J
M8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R
M;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@
M  UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4
M26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L
M;VYG          !,969T;&]N9P          0G1O;6QO;F<   #(     %)G
M:'1L;VYG   "Y     -U<FQ415A4     0       &YU;&Q415A4     0
M     $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L
M;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R
M>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV
M97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT
M"V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M  QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
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M_P#8.G_WE24[WUD^O'UHP?K^_H^+F^G@#)QJQ3Z51]MC:'6-]1]3K?=ZC_\
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MSGL=^]753L=_QZL?X\OZ1T?^ID?EH24^>=3ZSG]39B593YIP*&8V+4T0QC&
M-W;?]+<YN^ZS\_\ XME5;/</\7E_1J_J5CW])KVLK8YV6R0;#DM'ZSZSF_GO
MVM]+=_VF^SK%Z-]0>F]0_P 6[,6AH&?U&MF:W)?H?M :XX['.]WZ"MMC\?\
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M &\ <P!H &\ <    !< 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '
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M P,# P,# P/_P  1" #( N0# 1$  A$! Q$!_\0 'P    8" P$
M    !P@&!00) PH" 0 +_\0 M1   @$#! $# P(# P,"!@EU 0(#!!$%$@8A
M!Q,B  @Q%$$R(Q4)44(6820S%U)Q@1ABD25#H;'P)C1R"AG!T34GX5,V@O&2
MHD14<T5&-T=C*%565QJRPM+B\F2#=).$9:.SP]/C*3AF\W4J.3I(24I865IG
M:&EJ=G=X>7J%AH>(B8J4E9:7F)F:I*6FIZBIJK2UMK>XN;K$Q<;'R,G*U-76
MU]C9VN3EYN?HZ>KT]?;W^/GZ_\0 'P$   8# 0$!            !@4$ P<"
M" $)  H+_\0 M1$  @$# @0$ P4$! 0&!@5M 0(#$00A$@4Q!@ B$T%1!S)A
M%'$(0H$CD152H6(6,PFQ),'10W+P%^&"-"624QAC1/&BLB8U&50V160G"G.#
MDT9TPM+B\E5E=58WA(6CL\/3X_,I&I2DM,34Y/25I;7%U>7U*$=79CAVAI:F
MML;6YO9G=X>7I[?'U^?W2%AH>(B8J+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ
M>HJ:JKK*VNKZ_]T ! !=_]H # ,!  (1 Q$ /P#?X]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=?_]#?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]UJ2_\*J_YG'SA_EM[1^$^4^%O=O\ H8KNW-Q]\T'8
M4_\ HVZB[$_O!2;+QG4U1MJ+Q=K[!WU#B?X;-N:N.JA6F:;SVE+A(PGNO=:;
M_P#T%'?SU_\ O.;_ -EF^'G_ -S[[]U[KW_04=_/7_[SF_\ 99OAY_\ <^^_
M=>ZM._DF_P __P#FX?+G^:/\1OCG\AOEG_I!Z:[/WAO#%;YV=_H'^,^U/XY0
M8KJO?FY*"#^\.R.F=M;JQG@S6%IIM5'74[MX]#$QLZM[KW7TK/?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7R*-X_\*?OYYF*W=NG%T'S
M@\%#C=QYR@HH/]EI^($OAI*/)U5/31>6;H"2:3QPQ@:G9F-KDD\^_=>Z3G_0
M4=_/7_[SF_\ 99OAY_\ <^^_=>Z]_P!!1W\]?_O.;_V6;X>?_<^^_=>Z^B9_
MPGO^7'R%^</\KCI7Y&?*/L'_ $G]R[MWAW-BMP[Q_NILC97\0H-J=J;IVW@(
M/[O=>;:VEM6D^PPN-AAU04,;RZ-<A>0LQ]U[JZ[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U__T=_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6AE_PN
M/_X\+^6__P"'?\HO_=-T1[]U[KYZGOW7NO>_=>ZN^_X3>_\ ;[7X$?\ B0.P
M?_?(=H>_=>Z^QU[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z^!MV#_P ?[O?_ ,._<O\ [N:WW[KW20]^Z]U[W[KW7UNO^$G_ /VY*^.7
M_B0/D1_[^_>_OW7NMC[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__TM_CW[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6AE_PN/_X\+^6__P"'?\HO_=-T
M1[]U[KYZGOW7NO>_=>ZN^_X3>_\ ;[7X$?\ B0.P?_?(=H>_=>Z^QU[]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z^!MV#_P ?[O?_ ,._
M<O\ [N:WW[KW20]^Z]U[W[KW7UNO^$G_ /VY*^.7_B0/D1_[^_>_OW7NMC[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U__T]_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW6AE_PN/_X\+^6__P"'?\HO_=-T1[]U[KYZGOW7NO>_=>ZN
M^_X3>_\ ;[7X$?\ B0.P?_?(=H>_=>Z^QU[]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z^!MV#_P ?[O?_ ,._<O\ [N:WW[KW20]^Z]U[
MW[KW7UNO^$G_ /VY*^.7_B0/D1_[^_>_OW7NMC[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U__U-_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TC]]=A; ZNVW7;R[,WQL
M_KK:&,"G);JWUN;"[1VWCPP8J:[.;@K<?BZ0,%-O)*M['W[KW54_9_\ PH#_
M )-/4-;44&[/Y@G1F3J*5Y(YCUG/NSNJFUQFSB&NZ:VQOVBJ1?Z&.1P?Q?W[
MKW0$_P#04;_(H_[SF_\ 99OF'_\ <^^_=>Z]_P!!1W\BC_O.;_V6;YA__<^^
M_=>Z]_T%'?R*/^\YO_99OF'_ /<^^_=>Z]_T%'?R*/\ O.;_ -EF^8?_ -S[
M[]U[KW_04=_(H_[SF_\ 99OF'_\ <^^_=>Z]_P!!1W\BC_O.;_V6;YA__<^^
M_=>Z]_T%'?R*/^\YO_99OF'_ /<^^_=>Z]_T%'?R*/\ O.;_ -EF^8?_ -S[
M[]U[KW_04=_(H_[SF_\ 99OF'_\ <^^_=>Z]_P!!1W\BC_O.;_V6;YA__<^^
M_=>Z]_T%'?R*/^\YO_99OF'_ /<^^_=>ZU)?^%5?\U;X$_S)-H_"?%_"WOC_
M $SUW4>X^^:_L*#_ $7]S==_W?I-Z8SJ:GVU+Y>U^N]BPY;^)3;9KAIH6J6A
M\%Y0@>,O[KW6F_[]U[KWOW7NK3OY)OR/Z8^(W\T?XC?(SY#;R_T?=-=8;PWA
ME=\[Q_N[NO=?\#H,KU7OS;=!/_=[9&#W+NK)^?-9JFATT=#4.ODUL!&KLONO
M=?2L_P"@H[^11_WG-_[+-\P__N???NO=>_Z"COY%'_><W_LLWS#_ /N???NO
M=>_Z"COY%'_><W_LLWS#_P#N???NO=>_Z"COY%'_ 'G-_P"RS?,/_P"Y]]^Z
M]U<-\9?DSTA\QNC=A_)+XX;V_P!(O2W9E/G*K9&\_P"[>[MH_P ;@VYN?-;-
MS+_W=WW@-L;KQOV>Y-NUE-:KH:<R>'R1AHG1V]U[HL'S@_FS?R_?Y;^?V#M?
MYG]_?Z&L[VAA\UG]BT/^BONOL/\ CF)V]6T6.S%7]SU3UQOFCQGV=9D(4\=9
M)3RR:[HK*&(]U[HC'_04=_(H_P"\YO\ V6;YA_\ W/OOW7NO?]!1W\BC_O.;
M_P!EF^8?_P!S[[]U[KW_ $%'?R*/^\YO_99OF'_]S[[]U[KW_04=_(H_[SF_
M]EF^8?\ ]S[[]U[KW_04=_(H_P"\YO\ V6;YA_\ W/OOW7NLD7_"HG^15-(D
M2?.>,,[!5,OQK^7T$8)_U<T_0$<4:_XLP ]^Z]T;7I?^=A_*;[_K:3&=9_/S
MXVU.7KW6/'X3>>_*7JC.Y&=R E+CL)VO#LG+5]8]^(887E(!.FP/OW7NK.Z&
MNHLG1TN1QM92Y#'U]/#5T-?0U$571UE)41K+3U5+50/)!44\\3AD=&*LI!!(
M]^Z]U*]^Z]U[W[KW5,'?O_"A/^4'\7NY.POC]WQ\M*KK_M[JK<,^UM^;.J_C
MQ\J,S+@\W3PP5+4Z9C;72&:V]EZ6:EJ8IH*JAJZFDJ(9$DBE=&#'W7N@@_Z"
MCOY%'_><W_LLWS#_ /N???NO=>_Z"COY%'_><W_LLWS#_P#N???NO=#5\=?^
M% W\H?Y8=U; ^._0?R\IM[]P=HY6IP>Q-IU71_R2V5%GLO2XK(9J3'KN7?W3
MNUMI8^IEH,7,85JZ^#[B8+#%KFDCC?W7NKE/?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U6)\U?YRG\MG^7=V9M[IWYB?)2FZB[*W3LBA['PFUH^JN\.Q*JIV7DLYGM
MMX_.5%9U5UGOC%XR.LS6UZ^&.&JGAJ6^V9Q'H*LWNO=$\_Z"COY%'_><W_LL
MWS#_ /N???NO=>_Z"COY%'_><W_LLWS#_P#N???NO=2*3_A4'_(RKZJFH:'Y
MNSUE;6U$-)1TE+\8/F/45-555$BPT]-301?'MY9YYY7"HB@LS$ "Y]^Z]U?H
MCB1$D4,%=5=0Z/$X# , \<BI)&P!Y5@&!X(O[]U[KX''8/\ Q_N]_P#P[]R_
M^[FM]^Z]TD/?NO=>]^Z]U];K_A)__P!N2OCE_P") ^1'_O[][^_=>ZV/O?NO
M=>]^Z]U[W[KW17OEY\T?C!\#.GZKOKY:]N87ISJRESN'VPFX<IB]R[CKLGN/
M/RR1XO!;>VGLK";EWEN?+314\U0\&.Q]5+!14T]5*$IJ>:6/W7NJHO\ H*._
MD4?]YS?^RS?,/_[GWW[KW7O^@H[^11_WG-_[+-\P_P#[GWW[KW7O^@H[^11_
MWG-_[+-\P_\ [GWW[KW2BVA_PI?_ )*/8&Z]M;$V/\Q,QNW>>\\]B-K;3VMM
M[XK?,S+9[<>Y,]7P8O"X/"XNB^/,U7D<IE<C51P00Q*TDLKJJ@D^_=>ZO:5@
MZJXU ,H8!E9& 87&I'"NC6/((!'Y]^Z]UR]^Z]U[W[KW7O?NO=(/L;M3K#I[
M;53O/MSL?8?5NSZ(Z:S=?8V[]O;(VU2-I9[5.=W-D<9BX#H0GU2C@$^_=>ZJ
M)[>_X48_R7.EJFJH-R?._K/=.1IC(B4O4.W^QN[*:KEC)!CI<]U/LS>&UR'(
M],CUR0L/H_(]^Z]T2W-?\*]_Y.&*J7@H=V?(;<D2OI%9A>B\I!32#G]Q%W%F
M\!5A./[42MS]/K;W7NEELK_A6?\ R5]UU,-/F^[^U.MTE.DU>]?C_P!HUE-"
M20!YO]'V#WW4 &_U6-@!];>_=>ZM)^/'\V/^6M\K*NAQ70OS:^.^^=QY1XX\
M;LN7L3#[1[!R#R6TK1=>;XDVUOBIY8 Z,>VEB ;$@>_=>ZL)]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=5.?+G^>/_*W^"7<^3^/?RK^4'^BSM_#X/ ;DR.T
M?]"GR(WQ]MA=ST7\0P=9_'^N.I-W[8F^^H_7XXZUI8OI(J-Q[]U[HLG_ $%'
M?R*/^\YO_99OF'_]S[[]U[KW_04=_(H_[SF_]EF^8?\ ]S[[]U[KW_04=_(H
M_P"\YO\ V6;YA_\ W/OOW7NO?]!1W\BC_O.;_P!EF^8?_P!S[[]U[KW_ $%'
M?R*/^\YO_99OF'_]S[[]U[J70_\ "H#^1=D*J*DI_G321RS,%1Z[XZ_+7&4H
M)(4&6MR70U)10+<\EY% ')-O?NO='IZ'_FR_RT?DU746(Z2^<?QKWGN+)/%'
MC=H2=H[<VMOG(23,%C2AV+O*KV]N^L<N0I$=$Q5F -B0#[KW5A7OW7NO>_=>
MZ][]U[KWOW7NO>_=>Z__U=_CW[KW7O?NO=>]^Z]U[W[KW35G<[A-KX3,;FW-
MF<5MW;FWL7D,YG]P9W(4F)PF#PN)I):_*9C,96OFIZ'&8O&T,$DU1432)%#$
MC.[!03[]U[K0E_FX?\+ *S"9W=/0_P#*MQN%KDQ<]9A,W\O]]X*+-4%760LT
M,\W1G7>:@.,KJ*FF6T6>W'3U--5C7X,4T/@K9/=>ZT<OD)\I_DC\L=YU'87R
M6[R[1[QWA/+/)%F.R=Y9O=!QB5#ZWHL!0Y&KEQFV\2G BHL?#34D* +'&J@
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M!72[E[SJ7W_CZ7*PZ5:+)[;V3E,1AI48:T_AH5O4#[]U[JZ3W[KW7P-NP?\
MC_=[_P#AW[E_]W-;[]U[I(>_=>Z][]U[KZW7_"3_ /[<E?'+_P 2!\B/_?W[
MW]^Z]UL?>_=>ZT/O^%4O\]W^Y>.WC_*\^(6\K;OS5%+A/F%VEMJOLVUL%7P6
MJ?CWMS*4<FH;ASU)*/[W31.!14+C$DM/49&*D]U[KYY'OW7NO>_=>Z][]U[J
M^[^0A_)>WI_-E^2*UN\Z3-;:^'/2V5Q64[]W_2>>@FW-4L4K\9TML;) +KWE
MO"G3575,1(P6(9ZN0BHEH(*OW7NOKN["V'LOJW9&TNMNN=L8796P=A[<P^T=
MF;1VY008O [:VSM^@@QF%PF(Q],J04F/QU!3)%$BBP51^??NO=*WW[KW5;_\
MUC^8]UA_*W^&_8?R?[ CI,[N.E";0Z9ZXEK/LZOM'M_/4E:^U=IQ2H?/3XBF
M2BGR>8J8PSTF&H*J6-9)EBBD]U[KXS/R4^1_<7RY[R[(^1G?N\:_??;':NXZ
MK<FZ]P5S%8_-,$@H,/AZ$,:?#;;V]C((:'&4$ 6GH:"GB@B54C4>_=>Z WW[
MKW7O?NO=>]^Z]T[8+ 9W=&7H-O[9PN6W%GLK.M+B\)@L=69?+Y*J8$K34&-Q
M\-165D[!20D:,QM]/?NO='_VC_*'_FG;ZQD6:VQ_+N^9M=B:B,34F0J?CIVG
MB*2M@9!(L]!-FMLX]*^"13Z7AUHQX!)]^Z]T"'='P:^:?QQHILIW_P#$CY*]
M+8>G_P YG>T>C^RMCX KJ""2'/;CVUC\/40EV"AXYV0MQ>_OW7NBL^_=>Z][
M]U[KWOW7NO>_=>ZWN?\ A)O_ #LLGM3=FW?Y67R>W=)6;+W;45$7P[WMN"N+
M2;2W=.\U;6= UU?5-9MN[O=I:C:X=PU)EM>,B\JU]%#2^Z]U]#_W[KW7O?NO
M=?)T_P"%<O\ V^;[,_\ $(="?^\;[]U[K62]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=;>'_"-_Y>9/I[^8OO3XKY/*NFQ_EYU/G(\?
MB'FT0-VUTG0Y3L+:V4C60F,.O7B[LIG5 KS/-"23XE4^Z]U]0CW[KW7O?NO=
M?__0W^/?NO=>]^Z]U[W[KW6N;_PJR[!K=C?R4/DAC*":2GF[)WKT/U])-%J$
M@HI^X=H;NR,(=2-$=;0;0EIY+\-%*R_VO?NO=?(Y]^Z]U[W[KW7O?NO=?37_
M .$T_P#(B^+W7GP^ZA^<?RAZ?V9W9\A_D7MVA[0V!0]G[=QF\=G].]4YXM6]
M<OM3:N>IJW S;SWAMTTV<J<W/3R5E)%6P4E&8!%42UGNO=;;L74/4T$4<,'5
M_7<,,2*D446RMM1Q1HHLJ1QIC B(H^@ L/?NO=9/]$W5?_/M.O\ _P! W;G_
M -;??NO=>_T3=5_\^TZ__P#0-VY_];??NO=>_P!$W5?_ #[3K_\ ] W;G_UM
M]^Z]U[_1-U7_ ,^TZ_\ _0-VY_\ 6WW[KW7O]$W5?_/M.O\ _P! W;G_ -;?
M?NO=>_T3=5_\^TZ__P#0-VY_];??NO=>_P!$W5?_ #[3K_\ ] W;G_UM]^Z]
MU[_1-U7_ ,^TZ_\ _0-VY_\ 6WW[KW7O]$W5?_/M.O\ _P! W;G_ -;??NO=
M>_T3=5_\^TZ__P#0-VY_];??NO=:,'_"V[:&T]L=7_R]9-M;7V[MYZS?OR*2
MK?!X3&XEZI(=O=0M"M2U!34YG6(R,5#7"EC;ZGW[KW7SYO?NO=>]^Z]U=A_P
MG/QF-S/\Z?X(8S,8^ARN-J]_;_2JQ^2I*>NH:E$Z3[-E1:BDJHY8)E65%8!E
M(# 'ZCW[KW7V"/\ 1-U7_P ^TZ__ /0-VY_];??NO=>_T3=5_P#/M.O_ /T#
M=N?_ %M]^Z]U[_1-U7_S[3K_ /\ 0-VY_P#6WW[KW7O]$W5?_/M.O_\ T#=N
M?_6WW[KW2QQF*Q>$H8,7AL;08C&4H<4N.QE'3T%#3"65YY!!24L<5/"))I6=
MM*B[,2>2??NO=?.R_P"%P7_,_?@-_P"(?[H_][39GOW7NM&/W[KW7O?NO=72
M_P#">/ISJCY ?SBOAQU%WAUULWMGJ[=]=W@FZ>ONP-OXW=6T-PIA?C7W)N/$
M+F,#EZ>JQU>N-S^'I:R 21MXZFGCD6S("/=>Z^I)_P ,R_RF/^]<'PP_])YZ
MT_\ L>]^Z]U(@_DW?RG*?5X_Y;WPH;7:_G^-W555;3>VG[G;$VCZ\Z;7_/T]
M^Z]TU[A_DK_RDMSXNJP^2_ER?#RFI*R&2&6;;W16P]HY1$D&EFI<YM3$87-T
M,P'Z9(:B.1#RI!]^Z]UH;_\ "EG^0'U=_+?Q>R_E]\.H,_C/C/O_ 'I%UWO[
MJK.9C);IEZ:WWEL?DLOM2NVON3,3UVX\CUYNNCP]73,F5J*JJQ>3AB3[N>.O
MAAI?=>ZU"O?NO=>]^Z]TI]D[LRNPMY[1WS@IFI\WLO<^ W9AIT8H\&5VYE:3
M,8^97'*M'5T:,#^"/?NO=??$QM?3Y7'8_*4C%J3)45+7TS'3=J>L@CJ(6.AF
M6YCD'T)'^/OW7NOD@?\ "ICXH_[+#_-][MSV*QO\/V9\H<#M7Y-;8\<.F!\G
MO:*MV[V86G0"*6NK>V-H9O(2IQ(D=?$6!U*[^Z]UKI^_=>Z][]U[JZC_ (3S
M?*#_ &5#^;W\.-Z5^1_A^T^QNP&^/N]A)+X**HPG>U!4==8F7)S$A8<=@M\9
MG$961V(1#CPSD*#[]U[K[*'OW7NO>_=>Z][]U[KYB_\ PL[^4'^D_P#F#=.?
M&7%9'[G _%KHVER.;HA*3_#NSN]J^GW=GH7A4E%\O6^W]H3*QLY\QXTV)]U[
MK3O]^Z]U[W[KW1R/Y>?Q@K?FA\XOBQ\7*2"HFH^Y^ZMD;4W/)2%Q48_8 RT6
M5[(S<1B(DU8#8&-R5=P5-J?ZCZCW7NON2T%!18NAHL9C:2FH,=CJ2GH,?0T<
M,=/245%1PI3TM)2T\2K%!34T$:HB* JJH %A[]U[J7[]U[KX&W8/_'^[W_\
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M*NT'6>V]UT\R)ZU^^B)(# /[KW7TVO?NO=>]^Z]U\#;L'_C_ '>__AW[E_\
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M#'+;4D4]1M&E9U'#&-2?TCW[KW7S,_?NO=>]^Z]T?_\ E._]O3?Y:?\ XO\
M_#?_ ."*ZY]^Z]U]OGW[KW7O?NO=?__2W^/?NO=>]^Z]U[W[KW53W\\[X[9'
MY3?RD_G3U%A*"3*;C?I/)=D;8QM/#YZ[);EZ0S.&[JPF)QB#UG(YNOV E%"
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MMCRD.W^F4D:]K#2TRC^O/OW7NOGD>_=>Z][]U[J[[_A-[_V^U^!'_B0.P?\
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M@GR%5-)'!$K"-?=>Z'W_ *#5OYIO_/@_@!_Z*SY%?_=5>_=>Z]_T&K?S3?\
MGP?P _\ 16?(K_[JKW[KW7O^@U;^:;_SX/X ?^BL^17_ -U5[]U[KW_0:M_-
M-_Y\'\ /_16?(K_[JKW[KW7O^@U;^:;_ ,^#^ '_ **SY%?_ '57OW7NO?\
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M8W;@-[8A:;.X2II,I0&'<&VJ25C%(ID1"C75F!]U[JCO_H$S_DI_\^([0_\
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M7[O=(F-'M[M3O;:L\X12L=3O':/7F7I(B]M2M-%L68@ V(C-_H/?NO=?.O\
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MH::HG8RSSIL3?=;3[RI@TQNE/1;KHJ&%#HB@1 H7W7NJ+>S_ /A$K\Y,/6U
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MQL__ -";"_\ U;[]U[KW^D/8'_/<;/\ _0FPO_U;[]U[KW^D/8'_ #W&S_\
MT)L+_P#5OOW7NO?Z0]@?\]QL_P#]";"__5OOW7NE)C\CC\M215^+KZ/)4,_D
M$-;CZJ"LI)O%(\,OBJ:=Y(9/'+&RM8FS*0>1[]U[J9[]U[KWOW7NO>_=>Z^3
MI_PKE_[?-]F?^(0Z$_\ >-]^Z]UK)>_=>Z][]U[K<<_X10_]O)?DK_XH_N__
M -_ST![]U[KZ;GOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[K_]#?X]^Z]UJ!?\+5O^W670?_ (O_ -6?_ Z_*KW[KW7S!/?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW3]M7:^X=\;HVWLK:.'KMP[LW?GL/M?;& QD)J,EG-P[@R%/
MB<+A\?3K9IZ[)Y*KBAB0<M(X'Y]^Z]U]R#X#?&.B^&7PK^+_ ,6J1Z6>HZ1Z
M6V+L?<%=16%)E]Z4.%IZC?F?IP%4"+<&]:JOKAQ?_*.;GGW[KW52_P#PJ2^*
M^0^3_P#)\[RKMO8R7+[M^-.X]G_*# 4<$9>7^'=>-E,!V16%E5G2'#=0;UW#
MD'X(;[0 V^H]U[KY%/OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NOL,_
M\)EO^W'/P1_[4'=W_P $WW5[]U[K6"_X7!?\S]^ W_B'^Z/_ 'M-F>_=>ZT8
M_?NO=>]^Z]U?=_PF$_[?G?!7_M8?(/\ ^!1[V]^Z]U]@KW[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6K#_ ,*\OBC_ *>OY5M5
MW1AL;]WN_P"(?;&S^TEJ((?-D&Z\WG4#JW?^,A4*S"A2JW3B,Q5L+%(<)K)T
MJWOW7NOE2^_=>Z][]U[KWOW7NO>_=>Z][]U[K?+_ .$27Q2_B.^OF+\VLWC;
MT^UMN[6^,_761EB\D,N4W364?97:H@9QHIZ[$8W;VU$#K>0P921;JK$/[KW7
MT+??NO=>]^Z]U[W[KW7O?NO=? V[!_X_W>__ (=^Y?\ W<UOOW7NDA[]U[KW
MOW7NOK=?\)/_ /MR5\<O_$@?(C_W]^]_?NO=;'WOW7NO>_=>Z9-R[;P&\MN9
M_:&Z\-CMQ;6W5A,KMO<NW\Q20U^(SN SE#/B\SALI0U"O!6X[)XZJD@GB=2D
MD3LI!!/OW7NOC _SI/Y;N?\ Y7GSU[4^/:TN1FZDS<Y[-^.VY:XS3G</3&[J
M^O?;U'/7R^JNSFQZ^DJMOY.1@C3UV+>H"+%/$6]U[JJ#W[KW7O?NO=6!_P K
MSY[[Z_EJ_-KI?Y7[,^_R&+V?G!A.TMGT4XA'8/3VYGAQW8>S9%EDCI)*RKP_
M^5XQY]4-)FJ.CJBI, ]^Z]U]KCJSL[8O=76FP.X.L-Q4&[NN>T-G;<W]L;=&
M,<O09[:F[,32YO!92FU!9$2LQU;&Y1PLD9)5U5@0/=>Z"GY??%'I[YO_ !O[
M8^+?>^"_CO6O;FV*C;^6$'@3+X'(QR19#;F\-M5=1#418_=6SMPTE-D\;.T<
MB1U=*FM)(]:-[KW7QD/YDG\O#O7^61\I]\?&3O'&R32XB9\UUQV%1T-12[7[
M;ZTKZJHCVUO_ &O),94$-?% T-?1B667%Y.&HHY69X2S>Z]T0GW[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U]>K_ (2R_P#;C'X8?]K#
MY*__  5W=_OW7NM@[W[KW7O?NO=>]^Z]U\G3_A7+_P!OF^S/_$(="?\ O&^_
M=>ZUDO?NO=>]^Z]UN.?\(H?^WDOR5_\ %']W_P#O^>@/?NO=?3<]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_1W^/?NO=:@7_"U;_M
MUET'_P"+_P#5G_P.ORJ]^Z]U\P3W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UN\?\ "37^
M3!N3M+M?;W\S_P"16TJC&]/=49"KF^*^WL]1/"_9W:]&\^/E[9BI:I09=E]6
MRB48NH"::S<H2:&0?PJ59?=>Z^D![]U[IHW!@,)NS 9O:VYL50YW;FY<1DL!
MN#"92FCK,9F<)F:*;'97%9&DF5H:JAR%!4R0S1N"KQN5(L??NO=?&5_G6?RN
M=]?RJ_FIO;IZJQF6J^B=\UN6W[\9=_U<<]11;JZMKL@7@V[599P8JG>O6LU6
MF(S<3%)VDCAK?$E-7TK/[KW51'OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K[
M#/\ PF6_[<<_!'_M0=W?_!-]U>_=>ZU@O^%P7_,_?@-_XA_NC_WM-F>_=>ZT
M8_?NO=>]^Z]U?=_PF$_[?G?!7_M8?(/_ .!1[V]^Z]U]@KW[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0)_)3H[;'R:^//>/QVW
MHJ_W5[QZF[ ZISLK0K.]'0;\VME-M2Y*F0E2M;BSD14T[J5>.>)&4A@"/=>Z
M^%+V-L'<_578.^^K][8]\1O/K?>6Y]@[NQ4FK7C-S[/S==M[/X]]2HVNBRN.
MEC-U!NOT'OW7ND;[]U[KWOW7NO>_=>Z][]U[K[%7_"<#XI?[*7_*"^*> R6-
M_AV\^Z=O5WR8WUJB,$]5D^[9HMR;1-9 P$L%=C.J$V[CYD?UK)1D$*?2ONO=
M7G>_=>Z][]U[KWOW7NO>_=>Z^!MV#_Q_N]__  []R_\ NYK??NO=)#W[KW7O
M?NO=?6Z_X2?_ /;DKXY?^) ^1'_O[][^_=>ZV/O?NO=>]^Z]U[W[KW6N'_PI
MH_E<_P##A_P*S&_NM]N_Q3Y-_$B'<';'52T%+YLUO/90H8)NV^J:<1I)45<^
MX]OXF+)XRGC1YJC-X:DIH]"U4Q/NO=?)#]^Z]U[W[KW7O?NO=?1)_P"$<O\
M-%_OEL/>7\K_ +=W%Y-R];4^<[6^+M5E*J\V4Z^KZ]J_L_JZBDG9!)4;-W!D
M#G\=3J99Y:')Y&P2GQR@>Z]UO7^_=>ZK-_FF_P J_P"./\UWX[UG2O=] <#O
M# '(9CI?NO!XZEJM\=/[RJZ>*)LEBC-)3?QK:V;^UAAS>#FFCI<K31H0\%7!
M1UE+[KW7R1OYCG\L+Y8_RO.ZJOJ#Y+['FI,;D:BOFZT[;V]%6Y#JOMS 4<B
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MY961F5E*LI*LK AE8&Q5@;$$$<CW[KW77OW7NO>_=>Z][]U[KWOW7NOL,_\
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M?]K#Y*__  5W=_OW7NM@[W[KW7O?NO=>]^Z]U\G3_A7+_P!OF^S/_$(="?\
MO&^_=>ZUDO?NO=>]^Z]UN.?\(H?^WDOR5_\ %']W_P#O^>@/?NO=?3<]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_3W^/?NO=% ^:O
MP*^)W\Q+JS =*?,7JG_3!UEM?L#%=I8+;7]^>R>O_L=]X3;FZMIXS._QGJW>
M.R=P5/VVW][92G^UFJY*-_NM;Q-)'$\?NO=5@?\ 0+C_ "*/^\&?_9F?F'_]
MT%[]U[KW_0+C_(H_[P9_]F9^8?\ ]T%[]U[KW_0+C_(H_P"\&?\ V9GYA_\
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M23R?!B%7D8LRT_R1^7=)""?^.=/2]^PT\2_X*H'OW7NL/_0+C_(H_P"\&?\
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JW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>syk-20241231_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 syk-20241231_g2.jpg
M_]C_X  02D9)1@ ! 0$ ;0!N  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (/ ]4# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFQ_^2:]NHH \1_X:+\1?]$/^(7_?FQ_^2:/^&B_$7_1#_B%_WYL?_DFO;J*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR])K5\[3Z,IPRGV(!J_X@\'Z%XJTZ>PUC1[+4[.9#')#=0*ZE2,$<CBOS/\
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M21(8VDD94C4%F9C@ #J2:^6_BA_P4:^%/P_UR;0M(?4_'6N0L4>U\.6WGHC
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MR*'Q=X+\7>#H96"B\O;#,*Y/5B2IQ] 3[5]:>"O'GAWXC:%!K/AG6+36],F
M9;BTD#@9[,.JGV(!J7Q%X+T#Q9IMQI^LZ-8ZG9W$;1217,"N&4C!'(X_"OS9
M@T&Z_P""=G[8^C1V]W<GX4>,', 660E($=@I#=LQ.R-NQDKD4!N?=/QV_:8\
M$_LZPZ5+XQGO(4U)V2W^R6QFR5&3GD8KC?A=^WE\*/C!XXL/"7AV^U*36;W=
MY,=Q9F->!DY.>*]ZO]'TS78XFOK"UU!%^:/[1"L@&>XW XK\V?L5MIW_  5T
MGM[2WAM;=%@VPP1A$7_08>@ Q0!^FM>'?&S]LCX<? #Q5!X>\6W.H0ZE-;+=
MHMK9F5?+)('.>N5->XUG:AX;TG5IA-?:797LRC:)+BW21@/3)% CR;X%_M>?
M#O\ :*U[4M'\&W=[<7NGVPNYUNK;R@(RX7@Y/.2*V_CK^T9X._9UTO2]0\8S
M7D-MJ4[6]N;2W,Q+JNXY&1CBOBG_ ()WQI#^V1\<8XT6.-8)0J(H50/M:\ #
MI7Z,ZEHVGZRB)J%C;7R(<JMS"L@4^HR#B@9\[> _^"A'P@^(_C31_"NC7VJ/
MJ^JSBWMHYK$HI<@GD[N!@&F_&?\ ;\^''PF\03>&["/4O'/B>$XFTWPY!]H\
M@^DCC@'V4-CH<5\9?MW+=^%_VYO"8\)V<%GJ;Z?:P6J6T(0+)*TT6_"@<@.3
MGVK]%/@?^SYX2^"'@VQTG2=)MFU#8)+[4YD$EQ=W!&9)'<C)RV:!Z&+^S1^T
MU9_M(:?KTT'A;6O"MSHTT44]MK$/EL_F*S*4R 2,*<\5[544-K#;N[Q0QQO)
MC>R* 6QTSZU+02%4]7UBP\/Z;/J&IWMOI]C N^6YNI!'&@]2Q.!5ROS=_;5U
MK7_VIOVHO#?P#\*:C-!H^G*)M;>%B$21AND:3'WA''LVCINEQ0,]=\8_\%/?
MAOI>MW6D^$]#\1^/;FW<H\VCV>8#C^ZV2Q_[X%:_PW_X*-?#OQ=KEMHWB;3-
M<^'5_=.([=_$5H8K>5CP%$G8_4 >]>Z_"WX+^$?@_P"$M.\/^'-%M+2VLXA'
MYWDKYLK8Y=FQDDGFKOQ ^%7A/XH>&[W0_$VA6>J:?=QF.1985W#/=6QE2/44
M!H85O^T%X.NOC-%\,(;N:;Q3+I_]IQK''N@:#:K;A(#@\,*X?XM?MR?"[X*^
M-[SPIXFN]3BU>U1'D6VLC(F'4,N&SZ&OC[]ESX?ZQ\)O^"C]QX)U:_FU./0]
M%O;?3[JX;=(]DRQO!N/J(V4>V,=J_2?7/#&C:A%=7-WI%A=7!B;,L]JCL<+Q
MDD4 <'\!?VFO _[2%OK4W@NYN[E-(>)+K[5;^5@R!RN.3G[C5ZO7Y\_\$GU"
M:M\=E4!5&N6X"@8 &^[XK]!J 9\O^)O^"CGP:\)>(M4T74;[5TOM-N9+2X":
M>2HD1BK8.[D9'6O9?@S\:?#/QZ\&KXH\)S3SZ4T[VX>XB\MMZXSQD^M<;^UA
MX6T6+]G/XF7::/IZW?\ 8ET_GBU3?NV$[MV,Y]Z\I_X)6_\ )K,/_86NO_9:
M Z'V'7S?\;/V^?A9\%=8_L.2[O/%7B+.UM,\/1+<-&?1VW!1]!N([BNL_;$\
M87_@/]F7XA:UIDC0WT.G>5')&<,GFR)$6![$"0G-> _\$O\ X)^%K'X(KXZN
M+6WUCQ+KES)Y]Y<JLK0HAXC&0<-GECU/% %G3O\ @J-X:6X5M:^&?C?2-.)Y
MO/L'F*H_O$';Q^->YZG^UW\,M/T'P9K,6N'4M-\6W1LM-GL8_,!F 4E)!D%"
M-XR#S7K4VCZ?<PF*:QMI8L8V/"I7\B*_-W]L[]GNQ^&/[1/PL\1>%+62RT+Q
M#KBR7FDVH)MX;Q&4O,J#A-ZE<X[J?I0&A]F_'7]JSP%^SK?Z59^,;B^AFU.-
MY;?[):F8%4(#9Y&.HK\X/%/[3_@;5/\ @H%H/Q7@N+T^$;2%$EE:U(FR()D.
M$SSRZ]Z_7'4M TS661M0TZTOF084W,"R%?ID'%?FWXXT73H_^"L'A:P73[1;
M%K>/=:B!!$?]&N.J8P?RH&CZ!_X>=? __G_UK_P6G_XJOI_PSX@M/%OAS2]<
MT\NUAJ5K%>6[2+M8QR*&7(['!%5O^$'\-_\ 0OZ7_P" 4?\ \32>+O$^E?#O
MP;JFNZB\=EI&DVCW$K8VJD:+G QTZ8H$8OQ5^-/@OX*>'Y=8\9:_:Z-:JNY(
MY&S-+[)&/F;\!CU(KY;N_P#@J5X5O9BWAKX;^-?$-@#C[7'8[5/N-N_(_$5Y
M%^RO\';S]MWXS>(?C;\28Y[KPG:Z@4TG2+AR8I'7!2/'39&FS./O,?8U^E-C
MH.F:7 (;+3K2TA P(X(%10/3 % ;'S;\*_\ @HI\)_B-K46AZC<:AX'UV0A%
ML_$EO]G5F/8/D@?5]M?3T<J31I)&ZR1N RLIR"#T(/I7C'[1W[*/@G]HKP7=
MZ9J>F6UAK2HS6&LV\(6:VFQ\I)'WESC*GJ,]*^=?^";?QZUMKWQ%\$?&]R\G
MB#PO)(E@]P^Z0Q1L5D@)ZL8R#@_W2!0![C\6?VY_A;\%O'5_X1\2W>IQ:Q8K
M&TRV]D9$ >-77#9Y^5A71?"']J[X=?&OP[XBUW0-4D@TG0-G]H76I1BW2(,&
M(.2>GR&O0O$OAC1M0LM0NKK2+"ZN3 ^9IK9'<X4@9)&:_*/]B/X2ZA\=OB9X
MS\(WTLD'PYT[6CK&MVT+%/MTJ2RI:VS8Z(=TK$="$QZ4 ?6GBK_@IMX(LKR6
M+PGX.\7>-K6)BK:EI^G,MJ^#C*/R2/JHKJ/@?_P4+^&'QFU]?#TKWOA#Q$[;
M(['7(UC65O[J.#C=[,%]LU]':;X<TK1K..TL-,M+.UC4(L,$"HH4# & *_/?
M_@JY\#]&TWPSH'Q.T:TCTW5K2\2RO7ME$8F1C^[8XQ\X;'/I0&A]E?&W]I'P
M'^S_ *9'<^+-7\N\N.+72K-?.O+IO1(QZ^IP/>OG&7_@J;X7TVY\W5OAGXWT
MO1L_\?\ /8A<#U*L0O\ X]73?L6_!6/Q)X8L_C+\0((]?\>^*+>.:&:]7S5L
MK,*%A2(-P"R*KD^K?B?J?4?#VEZO9O:7VFVEW:NI5H9H5="",$8(H Y3X/\
MQN\'?';PK'K_ (.U>/4K,G;+$?EF@;^[(G53^A[$UW=?EUX)TH?LK_\ !3*/
MPMX?+V/A;Q'\K:<K'R_*GC<HN/\ 9F0$'TXK]1* 9D>*_&&B>!=%GU?Q!JMI
MH^FP*6DN;R41H,#.!GJ?8<FODOQ%_P %0OA_'J5Q:>$/"OBKQPD#E#>:;8$6
M[X[J>6Q]5%>/_$BUO?\ @H!^V1<^!X;R>+X8>!R4OFMW(6=E8JY]"SNK*K<_
M*N:_0GP?\._#7@'0[/2/#^B66EZ?:1B***"%1A1ZG&2?<T ?+_@W_@IU\-M4
MUJWTOQ9HGB/P#-<-M2YUFR(M\^A8?,/^^#[XKZUT77-.\2:9!J.E7UOJ5A.N
MZ*YM95DC<>H8'!KEOB=\&/!WQ@\*W_A_Q1H=K?6-XA0OY:K+&>SH^,JP/(/M
MWKXH_8LUC6/V8OVF/%7[/7B*\>ZTB\#7V@SS,><*77:,X4.BMQ_>4>M 'TW\
M:OVROAO\ O%47AWQ9<ZC#J4L N56ULS*NPG YSUI?@W^V9\,OCIJ>K6/AK4K
ME'TNU^V7<NH0"WCBBSC<6+8'3O7L&H>&](U:837VE65[,!M$EQ;I(V/3)%?D
M%\)_A;>_&3]M#XG> +:XDTSPS?>(-0N-:-F?*+6<%Y+^X7' #EP,>@]J /L_
MQO\ \%,/ >C:Y=:9X1\->)/B"+5S'-?Z+9EK7<.H5^2V/]T#T)KZ3^$_Q&M/
MBU\.-!\865E=Z;::O;"Y2TOD"31#)!5QV.0:M^#_ (>^&O .AVFC^'M$LM*T
MZUC$44-O"J@*/4]3]37DG[<GBJ\^'?[)OCW4-%)LK@6D=FC6_P AC6>>.%RN
M.AVR-R* ,+XR_P#!0?X5_"/7&T"&>^\9>(%)#V/AV$7 B;T=]P'_ 'SN]ZX/
M2/\ @J)X4^V(/$7P[\9^'=.9L-J$M@7CC']Y\[<#UQFKW_!-?X'^%/#GP TK
MQ=]CM=4\0^(=US=7TR+(T8#$+$I.=NWOZFOKJZT/3;Z!H;G3[6XA88,<L*LI
M'I@B@-#S#4OVJOAO82>!/(UP:K!XVGDM]'N=/3S8Y'0(6#G(*$>8O!&>>E>N
MU^:G[17[/EG\(/VR/@[J/A>VFM/"VO:LUU_9<()M[2\4J)W1>B!U,1(]0:_2
MN@ HHHH$%%%% !1110 4444 %%%% !1110 5^<'[>G_)\/P/_P!VT_\ 2N2O
MT?K\X/V]/^3X?@?_ +MI_P"E<E T?H_1110(_.;]C^%=<_X*(_'?4K\;KVQO
M+Z*W+=54W3I@?\!517Z,U^;GB;4(_P!E3_@I9_;>I-]C\)^.X]S7#G"*\V [
ML>P6;?\ @:_2)6#*"#D'D$4#8M?"?_!7;1[>[^!OA:_8 7-IKJA&QR5:&0%?
MIT/X5]V5^<'_  50\77?CWQA\.?@]X?7[;J]W=B]DMX^6$K_ +F!"/0^8Q_"
M@%N>Z_&+5+FZ_P""<FJWC%O/N/!,9D/?YH%W?SKGO^"4MC;6O[,<DT('G7.M
M7,D^/[P"*,_\!5:^B?$WPELO$7P*OOAS(<6-QHATG<.P\K8#^@KXD_X)>_$0
M_#7Q)XY^"GBV4:7K]OJ+75K;7!V^9*H$4\:9]/+5AZ[LB@.A^CM%%8GC3QGH
M_P /?"VI>(M?OH].TC3H6GN+B4X"J!G ]2>@'<D4"/@KX16L-K_P53\>+  %
M>UGD;']]HR6_6OI+]O/4)=._9)^)#0_>ETUH2P[!F )KXG_8?\<WGQ-_;[\2
M>+;VVDM&UJVO+Z&"08*0N"8Q]-N*_0G]IGP1)\1_@#X[\.0IYD]]I4R1KWW
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M>"?^NNH?^EL]?3] /<^'?^"NO_)N>@_]C%#_ .D]Q7UW\,?^2<^&?^P=;_\
MHL5\B?\ !77_ )-ST'_L8H?_ $GN*^N_AC_R3GPS_P!@ZW_]%B@.A^7GQIUS
MQ+9_\%.=3U7PUX9'C#7]-FMY+/2'F\H2>7:QJ#N[8'-?47_#3'[3G_1N$?\
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M!:_.[_@E?JD.F_$/X[>'[AO+U%M52Y6%N&*1S7".<>QD3\Z_1&@&>2_M:?\
M)L_Q,_[ -U_Z :\6_P""5O\ R:S#_P!A:Z_]EKM/^"A'CR#P/^RKXS5V_P!(
MUB :3;J#\Q:8[<@>PS7&?\$K_P#DUN'_ +"]U_[+0'0^F_B=X L/BG\/M?\
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M9_\ HT4 MSWO]FE0O[.GPN &!_PB^F?^DL=>DUYO^S7_ ,FZ_"[_ +%;2_\
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M*^P_@7\$/#?[/WP]L/"7AFW*6T WSW4@'G7<Q^]+(1U8_D!@# %>@T4 >?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]1?L]_'30OVAOACI?BW1)5!F41WMH3\]I< #S(F'L>A[@@C@UZ50!^>'Q$^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **^3OV6?VL_$GQ^^.OQ
M'\,ZCIECI6C>&_,AMH[<EY)&2X,>]F('4#H..:^L: "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "O,OCM\?M"_9^T&PU;7M/U;4;>\N#;
MQII%K]H=6QG+#(P/>O3:CFMXKA0)8DE Y =0?YT ?,_PU_X*"?#KXH?$C1O
M^GZ9XCL=;U5F6!=1L%A7A&?)^?(&$/:OIROSQ^+\,<'_  5D^&2QQK&O]CQ?
M*J@#_57U?H=0,****!!1110 4444 %%%% '$?&3XM:5\$? EUXKUJSU"^L+>
M6*%H=+M_/G)D<("%R,@$\^U?._\ P\^^%4>I6=E<Z/XKLI[N1(HA=::L>2S!
M0>7Z9-?7DL,<Z%)$61/[K#(K\Q?^"JEO%;_&SX3"*-(QY<?"*!_R]4#1^GM%
M%% @HHHH **** "BBB@ HHHH **** "OEKQM_P %$?AYX#\2:UHNI:!XM:;2
M;J2UGN(=*W0ED8J65RXRN1P:^I:\B_:JLK=?V=_B%(+>(2?V5*=VP9[=Z!FM
M\!?COX=_:)\"MXK\+QWD6F"[DL]M]$(Y-Z!2> 3Q\X[UZ/7QG_P2?_Y-7?\
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M/B?X,_\ !0_5?$?P:\5^*_%F@6LOB&TU:+1M%T'1MQFU&ZD0E8P#DG!!)(Z
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M -A]?_0&K[[H&SXC_P""N?\ R;#8_P#8?M__ $7+7U9\'?\ DD7@?_L!V/\
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M/"?^"3__ ":NW_8>NO\ T7#7V97QG_P2?_Y-7;_L.W7_ *+AK[,H&]S\[O\
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M<QG\^/QH*/CGX*_L:_%_Q9\)O">LZ-^T/J>AZ7?:=%/;Z;#9RLELC+GRP1.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLO\ Y$H_X4EJ7_15O'G_ (%67_R)7J-% 'EW_"DM2_Z*MX\_\"K+_P"1*/\
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MLO\ Y$H_X4EJ7_15O'G_ (%67_R)7J-% 'EW_"DM2_Z*MX\_\"K+_P"1*/\
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M_DY3X*_]<=:_]%VU &]_PI+4O^BK>//_  *LO_D2C_A26I?]%6\>?^!5E_\
M(E>HT4 >7?\ "DM2_P"BK>//_ JR_P#D2C_A26I?]%6\>?\ @59?_(E>HT4
M>7?\*2U+_HJWCS_P*LO_ )$H_P"%):E_T5;QY_X%67_R)7J-% 'EW_"DM2_Z
M*MX\_P# JR_^1*/^%):E_P!%6\>?^!5E_P#(E>HT4 >7?\*2U+_HJWCS_P "
MK+_Y$H_X4EJ7_15O'G_@59?_ ")7J-% 'EW_  I+4O\ HJWCS_P*LO\ Y$H_
MX4EJ7_15O'G_ (%67_R)7J-% 'EW_"DM2_Z*MX\_\"K+_P"1*/\ A26I?]%6
M\>?^!5E_\B5ZC10!Y=_PI+4O^BK>//\ P*LO_D2C_A26I?\ 15O'G_@59?\
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M% &S_P *3U+_ **MX\_\"K+_ .1*/^%):E_T5;QY_P"!5E_\B5ZA2T >7?\
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M]:7_ .D,=>W5XC\(_P#DXCXX?]?6E_\ I#'0![=1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5XHG_)YEU_V(EO\ ^E]Q7M=>*)_R>9=?]B);_P#I?<4 >UT444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5XA\5O^3E/@K_UQUK_ -%VU>WUXA\5O^3E/@K_ -<=:_\ 1=M0
M![?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %>*_MB?\D US_K\TW_TN@KVJO%?VQ/^2 :Y_P!?FF_^
MET% 'M-+24M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"HYH8[B,QRQK*AY*NH(XY'!J2B@ HHHH **** "BBB@ HHHH **** "BBB@
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M([4 0_\ !,WPGXP7X-^'=:_X3+_BD!+<K_PC?V&/[V,!O.QOZX.,]J\WTO\
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MR[%B)' )&. >!BK^D?&[5O%'[+8^)=E_9^FZQ;Z3)J-[:W,;RPQ20J6FA(#
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M]* /6J*\R'[2'PZ7Q)%H+>)%^VR78T]+C['.+-[GIY(N=GDE\\;=_7CK7IM
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M\#W7@O\ :&^#_AS1O$6G^%-/TGPA-IVCWVK:<MW 9XVC5T16DC E,8C.0V<
M\5Z+^S3X1L?#OCCXKWMOXZC\9:EJ6IVKZK%9:2;&SLKI8,,(OG=79D,9?:QP
M5&>37M'B+POI'B[3S8ZUIMMJ=H3N\FZC#KGU&>E3:'H.G>&M-BT_2K*#3[*+
MA(+= JC\!0!\_?':ZTK3?VH/@G>>)Y+>#P^J:HD,U^RK;)?F#]SEF^4.5\P+
MGG)XYK'L-?\ "K?MSZD^DZAIHNKGP:(IG@G3$TXN/E4$'YF"]AS7TIXB\,:3
MXNTQ].UK3;;5+%R"UO=1!U)'0X/>LVR^&?A336L6M?#VG0/8C%LT=NH:(9SA
M3CCGF@#Y<^$^I>#K3]A_Q-:>))K!+Q8]5CUZWNG43F^-Q-N\U3\V\O@C/."N
M.U>W_LFP:[:_LV_#N+Q*)AK*Z1")A<@B0+SY8;/.=FSK7:WWPU\*ZEKR:U=>
M']/N-50[A=R6ZE\COG')KI  H  P* /CGXR:V/@+^T1XFU&U6*Q7XB^%6M-.
MDCC +:W#(L4'/JPN>G4[?:N-^(/A^3X ZAXG^%7ANU6VLOB1I-C;:-"R;Q'?
MR3):W+#/&=LK2G_=S7W+K'A?2/$-Q8SZGIMK?S6$PN+5[B(.89!T=2>A]ZDO
M_#^F:IJ%C?7EA;W-Y8N7M9Y8PSPL1@E2>AQZ4 ?)O[57AGP?X-F_9X\&LNGZ
M?H%IXHM8/L,TB1K]G1 NY@2..!ECWZUJ:YK'AW2_^"@/A&6RN]/BDG\"7<,J
M6LL8,K"Y1HD(!Y;&2HZD=.*^E]8\(Z+X@N$GU/2K2_FC78DEQ"KE1G. 2.*A
M3P+X>CO([M=%L1=1[=D_D+O7:,#!QG@ 4 ?GKXN\5#Q)^RM\8-5T[5_"_@GP
M[<ZA?Q_\(A#8BZU"ZN!* TDLK2AEE8C=@(=JC/05Z_\ $_5-.U#_ (93U1[J
MTN;(ZY;Q27C2(\>[[&XVL_3KV)ZU]1_\*U\*'5KW5#X=TTZA>H8[FX-LN^53
MU#<<]*DOOA[X9U30/[$N]"L+C2 XD%E) IB# Y!"XX/TH L^$_%&D^,M#@U3
M0[A;O3)"R13)&R*VTE25! R,C@C@]J^0OB)I=_HOB;XR>*_AEXST)%6X\GQ=
MX6\80#R+B1+6,GR9MVY0\3(HR,9!Q7V=8V-OIEG#:6D$=M:PH(XX8E"JB@8
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ML>2J,D;!E5=O%?7^H>"=!U6\>\NM'LI[UO\ EXD@5I/;YL9KQ'P=X!\7^ ?
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)BB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>syk-20241231_g3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 syk-20241231_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_!3GX4?$GQ9JEQKO@[X-+9W)NKV5FL[R/2/$@E"%F)4K(N,C!^0&D_X*,_\
M!.7X\>,_^"^GAG]GSPGX(U]_A)\?_$W@3QIXX6STF5]/(L()[>[,\H78KJ%U
M*38S#FZ4D<K7O/[)/PK^)^G?$?\ X+,3ZA\.->@3Q-I^MCPV\VCSJ-5+6_BD
M*+8E?W^?,CQLW9WKZB@#XY_8A_8@_P""7/Q8_P""2LW[7G[17_!57Q)\._C7
M;Z3KUS!X=A^+VGQO!<VMS<I9*-*=#>2F5(X?D1P\GF90C(Q^K?\ P;Q_MQ_%
MOQ3_ ,$0?^&I?VX/'&IZA9_#^;7S_P )=KDK2W5_H.G)YOGR2N<SM&1<0!R2
MS?9P"2V2?"O^#?\ _P""''_!/;X[?\$R_ 'QF_;%_8?M-2^(MWJFLC5KGQ0V
MHVT[I%J=S' )+8S(F!"L8&4P0 ><YKU3_@Y7U3QU\-_^"=_@K_@FW^P[\%+F
M*]^,'B>R\,6&B^#= :.RTG1+>6)Y(\6Z;+:-YVLX<$*K1R3=@U 'YE_L1?M9
M_M>_LX_MS_"3_@N;^T;XHOK?X6_M-?%_Q-X;UVQFO)6M-,TR2>*%7;<=HAAE
M9VB51G;H[]<XK[Y_X/*]:U#2/V.O@PEKXHO=(@NOC+'#?W=C>M P@.GW6XEE
M/0#GGCBO*OVQ?^#8_P#;RTW_ ()WZA\((/\ @K!JWQ(\+_##0)M<\%_!U_A.
MEK:W%Y9V\SI;VTRZC(T<KK),BOL8LTQ##YB1Y;_P4E^*GQY_X*!?\$(?V2M2
M\8?!KQ??>-_"WQ9M_#GC[3+GPS=/<M)8V$\ NY8S'N*SP-;S,Y&W?,R]J ."
M_P""DO[/G_!'W]B_]FF[^./_  3%_P""P_Q*\0?&O3-9T[_A$M#T?XJPZF;S
M?=1K-DV%M$\!2$R2B0R ;HE3!,@KZ@_X*S?$K]H?7?C)_P $AO$GQTN-1T;Q
MSXB\6:9<?$#3E9K5GU*2\\)-<I-$N K>8\FZ,C"EF6NE_P""UW_!).[_ &"O
M&'@G_@KI_P $@/@/H^@>)_AEJL'_  F_PZ\->&TEL-4L6D"K=QV,:D J6\N9
M8E#>7(LRF-X"YS/^"MGQ3U_]O;]HS_@EM^U5\*O@_P"+8=.OOBO)?^(],N=!
MN?/\.2C6?#(G@O!Y8\KRY(9EWL%5UB+KE2#0!X]_P6D\<?!S7_\ @N9KWPK_
M ."V'C?XN:%^S?%X.LI/@_;>!WE&ERS&"U,US-&B.TJ^>;Y9'A1I@Z0H?W:K
M7UK_ ,$%?A)\/?V=OB1\7/B+^QE_P4WT;XO_ +*2Z%]KT3P!>ZQ<W.O^%+M5
MBE$T]O-%%]D4HM['@(GG*L+,-T9QE?M\?\%$/VB/V,/V]/'7PG_X*L?L277Q
MM_9.\36:7/PPU+PY\+['5XM.F(4^3<"XQ%)*I:6%UED63"1R(K*_/BO_  1,
M_9TTK]HO_@LG\1OVT/V-OV,O&/P1_9>OOAQ=Z%<Z7XEL9+"+7[BYBAC:&&'>
MZ#=*K7!CA=XX1"N61I%2@#._X)Q_L-^(?^#G#5/B1_P4,_X*2?'CQW'X'MO'
M-QH'PW^%WA371:V6E1Q0PSGATD4(D=S"@**LDLB2/(YX!],_8UN/CA_P1'_X
M+F^%?^"3J_M ^*?'_P !?C5X2?5? UGXSO\ [5=>&[D)>&-4< *K>=8RPNL:
MI&Z7,3E-Z5Y[_P $^/VI_CE_P;'^(/B1^PE^W)^R3\3/%GPKU+QK<:_\./BA
M\//#ZWT-YYL44!5O,DBBQ)%;V[&/S1)#)Y@*,'##TG]B7P=^T_\ \%F?^"W?
MAW_@KK\1/V:_%'PM^"?P?\*OI7PXM/&MD;:^U^4QW:Q.(S]\^;?3SO)&6B3R
M8H0\AW-0!\6_L0?\%+/C+_P3>_X+4_&WXW?$O4=9N_@'XK_:$U_P1\1KRXN7
MEM-'GEU2]FL;K!)\MX0DT@ 'S0+=*H+ 8_0_]C[Q9J6L_P#!W+^TYIMMXFGN
M]'_X9ZTJXL8$O6DMOFM_"I$B*"5Y#$[AUW'UKRO_ ()B?\$Z-&_;7L?^"D?[
M+O[2'@'5M'T?Q[\=KN;PYK.HZ/)$]M<I?:K):ZC:F15$GE2&-\J<.I*$[7(/
MF?\ P;*_L]?MF_ ?_@M5\7/"'[87@_Q$FK^$?@=<>$O^$AU'3YOL=U%IVHZ'
M:6:6]RR!)H_LEM'Y1!):)%/8T ?J?_P7)_;N\9_\$Y_^":7Q _:1^%ZP_P#"
M71I:Z1X3FN8A)';7UY.D"W)5@58PHTDP5@59HE5@037P1^R+_P &PGPN_:^_
M9/\ "W[6_P"VM^U]\8]8^.?Q'\,VOB5O%]GXJ4_V'+>0K<P1*LT;R3-&LB"0
MF0!B&$?EC!K] /\ @MI^P;XH_P""D'_!-WX@?LQ_#RYMXO%=U%;:IX2-W,(X
MI=0LYTG2!V/""95>'<>%,H8\*:^ /V3O^#C?QG^Q7^RCX:_8Y_;*_P"";?QV
M7XW_  [\.6_AK3M'TCPJ/L?B'[)"MO;3&61UDB+I&F]HX9U)R\9<,% !P_[*
MW[<'[5/C'_@DY_P4 _X)\?M9_$^^\4^._P!F?P[K6C:=XVN+J1[R_LP+ZUVO
M,Q+RF*:R<K*[%REPBDG9FOF__@GC^RW_ ,$#/B_^QMX(^(_[;?\ P56^(O@W
MXI:G:73^+?#-C\1H[>*QE6\G2)5C>PE9=T"POS(W+D\9P/I[]E#_ ()[_M??
M#[_@DO\ MY?MO?M:_#'4-&^*G[3?AS6-7M_ B6,GVZQMR+VY :W&7BDFGO9,
M0,-Z)#%D!F*CZ>_X(.?\$Q?V(_&?_!);X.>)OVDO^">OPKU;QM=Z7J)U[4/'
M'PFTV?59G&JWBH;B2ZMC,Q$0C WG.T*!QB@#]!/V;/@YX._9Z_9^\%_ OX>Z
M[JFJ:%X2\,V6E:/J6MW:SWEU;00K'')-(J('D90"S!5!)S@5^/7Q \%_$/\
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MQ \-_P#!P!^W7XO\1>!=9L-)U:_0Z5JE[IDL5M>#[:3F*1E"R<<_*30!Y_\
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MXL*^/?&G@:'P TZ3[9_^$BD+:;?3*<Y20117=ZG? 0CJ#7P__P %5?V9K_\
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M'_!'OPQKEEXE\,_\$)/C5IVI:==QW.GZA8_LP>'X9[6>-@\<L<B7H9'5@&#
M@@@$'(K]DZ /P-^&_P"VEX\_X->OVL_C=^QI^T;)XB\8_!_Q=H-YXU_9]U&]
MGEN7EOPA6'3WE.2@D*+;3N?N/;12A LY)Z?]G#]C3X^?#K_@B)^U;_P4[_;"
M\4:O=?&KX_\ PNUW746[N94;0-'FB>X@BBCW?Z.T[%)BBXV1K;1X4QL#ZC_P
M=E_!SQ'\6/#?[,(\,?"R^\2O9_&39J'V#0WO#!9R)#YJR;$;;$VQ=P/RG8,Y
MP*^XO^"RF@:QXA_X)0_M!>&_"^B7-]>W7PFUB&RL+"V:669S;.%1$0$L3T
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M+NA>-OGSG(!'Z3T %%?//_!63XT_$[]G/_@FS\:?CI\&/%+Z)XK\+> ;W4-
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M4 >UT5G>$?%>@>//">E^./"E_P#:M+UG3H+[3;KRGC\ZWFC62-]K@,N58'#
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M_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM/_Y\8?\
MOT*FHH R/%EG:0^&[R6&UC1EA)5E0 BKEA86+6,+-91$F)228QSQ4'C'_D6+
MW_K@:N:=_P @^#_KBO\ (4 ']G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0
M_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^
M,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% &'XBM;6+5=)2*V
MC4/=D.%0 ,-O0^M:W]G:?_SXP_\ ?H5F^)?^0OH__7Z?_036Q0!#_9VG_P#/
MC#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H5-10!#
M_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\
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M[_UP- $]A86+6,+-91$F)228QSQ4O]G:?_SXP_\ ?H4:=_R#X/\ KBO\A4U
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M *_9O_0JV*Q_ _\ R")?^OV;_P!"K8H **** "BBB@ HHHH *S?&/_(L7O\
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M,P2@PJ@S7Z .Q5"RH6(&0HQD^W-?F]^S;X%_X*?VG[4US^UA^UW_ ,$ZM/\
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M4^ZFO=_^$EU?_H4+W_OI:\C_ .">_P#R1/5O^Q[UG_TI->Z4 8__  DNK_\
M0H7O_?2T?\)+J_\ T*%[_P!]+6Q10!C_ /"2ZO\ ]"A>_P#?2UF>%=<U&UTZ
M2.'PW<S@W,C%T9< ENGX5U=8_@?_ )!$O_7[-_Z%0 ?\)+J__0H7O_?2T?\
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MZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\
MPDNK_P#0H7O_ 'TM?D!_P7,_; N/C3\=+/\ 9[\.2O%HG@$M_:<0D!$^K2 >
M9G'!\I,1CNK-,*_3O]N3]J/0OV0/V:_$7QCU&YM_[1AMC:^&[*=A_IFHR@K#
M&%ZL <R,!SY<;GM7\\NN:WJWB76KSQ'K^H2W=_J%U)<WMW.VYYII&+.['N2Q
M))]37W'!N6^UKRQDUI'2/J]W\E^?D?FOB%G'L<-'+Z;UGK+_  K9?-Z_+S/M
M_P#X(:?M@7'P6^.EY^SWXCE>71/'Q7^S(C( (-6C!\O&>!YJ9C/=F6$5^O\
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M@_ZXK_(4 34444 %%%% !1110 4444 8_B7_ )"^C_\ 7Z?_ $$UL5C^)?\
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M[Y5EN!HYO2KP3A)/[-DG?2S5FK/9VL_,^O****_H$_30HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KY#_ ."B7P/_ &K+/XW^!/VU/V0O
MA)I'Q*UOPGX+\1^#_$/PYU7Q%%I4]]INK-8R_:]/NYP8(;J&:PBW++M66*1T
MWH0,_7E?%?\ P5TD_P""+J7W@'_A[=K'AZUG\K4_^$"_MW4M4MRR9M?MFS[
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MZ1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4 ;%%8_\
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M6T'BSQ-I5CINNZVK.9KNTLVG:VA;)*A8VN9R-H&3(<YXQYQ\>?\ @G)^Q/\
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M";5OBG/\.;F_32_(S:27JP!_,GCA^^%?;CS,_=.<8XSD?-W_  ^+_P"K=/\
MR[O_ +DH ^PK+_D=[W_KRB_F:V*^&8/^"NODZW/K/_#/F?.A6/R_^$LZ8[Y^
MR5<_X?%_]6Z?^7=_]R4 ?;5%>;? /X_ZC\<_A-I/Q3@^'-S8)JGGXM([U9PG
MESR0_?*INSY>?NC&<<XR>Q_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\
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MOHHQ_NQ48KL?>4L/"D^;>7=[_P!>2T-BBL?_ (275_\ H4+W_OI:/^$EU?\
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MQ9I\7XJ4U#'XRN?[@J_J^$Q6N'ERR_EDU^$M$_GR_,CZWCL%IBH<\?YX)_\
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MS](T_P"V?:[O^V;*7R_,LIXT^2.9F.7=1P#UR>,F@#[UHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *_*C_@H=^W'^SI^T[KO@;X/
M_'S_ ()?_MR>&_'1UG4!\*?$WP_\.:;I?B*&80;;Y]/GAU@N;=H"OGAT:'88
MS( 0A'ZKU\B?\%(?A[\9/AY\5OA]^WW^SM\7/A9H'B?P%HVL>&=3T/XSZV^F
M:'KVDZF]G<2Q)>IN:SNTFTZ%XW",KC>KX44 ?,O_  2-T/\ 9$_9Y_;+T/\
M9TLOV5_VPM*^)*?#.>S\%>*OVH)=,FM](\,V9@$MAI7V6^:**(.;=76V@)!*
M"1E#<_JK7Y\_LB^._BI^VS^VUX)^/O[3W[1/[.=E<_#;1-97X?\ PJ^"OQ+C
M\1:C=W=_#'!=WU]<MY9,<=NC*D,,9&92[O\ (JU^@U !117':Q^T#\&=!^.&
MB_LUZK\0]/C\=^(="N]:TGPNK,]U-I]L\<<URP4$1QAY44,Y7>=P3<4?: =C
M17@_Q(_X*;_L*?"/XLW7P4^(G[0VFZ;KNG:E;:?K+MI]Y)I^D7EQL,-M?:A'
M"UI8RN)(R([B:-B'4X^89N_M _\ !17]C+]EKXCQ?"+X[?&ZVT3Q+-HT.K+H
MZZ3>W<PLI99H8YV%M#($5I+>91N(),;<4 >UT5G>$?%>@>//">E^./"E_P#:
MM+UG3H+[3;KRGC\ZWFC62-]K@,N58'# $9P0#6C0 4444 >%_P#!/?\ Y(GJ
MW_8]ZS_Z4FO=*\+_ .">_P#R1/5O^Q[UG_TI->Z4 %%%% !6/X'_ .01+_U^
MS?\ H5;%8_@?_D$2_P#7[-_Z%0!L4444 %%%% !1110 445C>.?'_A'X;Z&_
MB+QEK,=G;*=JELEI&[*BCEC[#Z].:RKUZ&%HRK5I*,(J[;=DEW;>B)E*,(N4
MG9(G\8_\BQ>_]<#5S3O^0?!_UQ7^0KYW\9?MX>'+ZWN-)\/_  ^O)X)5V"XN
M[Y86QZ[%5_YUVWPD_:V^&?Q N+;PU>^?H^HNJQPQ7Q!BF;& J2#C/LP7/09-
M?*8/C[@_'XM8:CC(N;=E=2BF^RE)*+OTL]>AQPS/ U)\D9J_S/6**Y[XH_%C
MX:_!/P9=_$/XL>-=/T#1;)<W%_J,X1,]D4=7<XX1068\ $U\R-\9OVN_V^V.
MF?LPZ?>_"CX73G;/\3M?LB-8UF+H?[,M21Y*,.D[D'!!4JRE#]WA\'5KQ<VU
M&"WD]O\ -OR5V&*S"CAIJFDY5'M&.K?GV2\Y-+S/3_VE?V[/A3^S[K<'PQT3
M3K_QQ\1=1&-'^'OA2/S[Z5B,AIBH(MHL8)=^=N6"L :\ZT3]C7XZ_M<:O;?$
M+_@HCXMC31HIEN-(^"_A:\9-*M"#E#?SH=U[*.X!V @X8JQ2N[^'WPG_ &0?
M^"=/@:?58KJ#3[W4B6U7Q'K5P;O6M=FSN8O)@R3$M\VQ $!).T9)J"3QA^T_
M^TK&1X#TV7X7>#)!EO$&M0AM8O8O6&#.VW!'\3'/1E8]*W>,HX16PBL^LW\7
M_;O\J^^7GT.58"OCGS8]IQZ4U\/_ &\]YOUM'^Z]SL_B'\=?@7^S-HMCX&BB
MABNHX4@T+P7X8L5>Y=<82.*WB $:^A.U?0YXKCO^$+_:@_:9_??$O6)OAGX/
MFZ>'-$N0^KWT9[7%QC$ (ZJHS@E67O6EX T+]DC]F-9[VP\5Z?/K=QDZEKM_
M??;]3NF/WB[J&89[JH4'KC/-=!_PTA;ZW\GP[^%GBG7L_<N8]--O;'_MI)C'
MY5\GB>),CP]5PGB(N?\ +%\\_P#P&-Y?@=[Q.%I^[S+T6OX(Y+X__L^?";X?
M_LD^(_ /@;PS:Z-82?8I+EX8=\MTT=Y!(!*['=(6*[=S$[0W XQ7RD % 50
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M^WMX'^$?[-7@[X&?"CP?J?Q)^*$\=^;?P1X9&YK7=?W#+)>W!!2TCPRL2V6
M96*A3NKM=+_8I^)O[0NHP_%K_@I5\2[74[*RD%UIWPKT"Z:V\.Z3CE6N7W!K
MV1>[.=H.X9=#BNN^#.C_  )_9VT&3X1?L5_""+5+O</[2U.U.8I)>?WMW>OE
MIFY) R1U"E>!7;V7P(UOQO>1Z[\?/%K:U(CAX= L2T.G6Y[?*,-*1_>;Z'-?
MI53BNFY.AP_2=62T=5NT%W]_5+SC34YK:32.[V%;'ROB;5/[BTIK_$]YOY6_
MNK<K6GQ>BO;2/P!^S%\/(+^WL(Q;17R6XM-(T]5& J[0-P4?P(!QTS5[1_V?
MQKNHQ>)_C=XFE\4ZC&V^&RD7R]/M3Z)".&],MU[C->A:?I]AI-E'IVEV,-M;
MPKMA@MXPB(/0*. *FKS8Y%+&357-:GMY;J-K4HORA=\S7\U1R?5<NQZ\<*I6
M=5\UNFT5\O\ ._R&P006L*6UM"D<<:A4C10%4#H !T%.HHKZ%))61UGB7[8W
M['/_  UG_P (Y_Q<7^P/[ ^V?\PC[7Y_G^1_TVCV[?)]\[NV.?$O^'.G_5Q?
M_EH__==?;5%,#X9T/_@D5_;-HUU_PT'Y>V9X]O\ PB><[3C/_'V*N?\ #G3_
M *N+_P#+1_\ NNOL+P/_ ,@B7_K]F_\ 0JV* "BBB@ HHHH **** "LWQC_R
M+%[_ -<#6E6;XQ_Y%B]_ZX&@"YIW_(/@_P"N*_R%35#IW_(/@_ZXK_(5-0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?G;_P %
MB=#^$ND?MF?L]?%_]I;]C_QC\>OASI>A^*]-U+P'X<^%MWXJM]*O[G^SFM]8
MFM4A>VDVK%+!LF(?$_F1*YC?;^B5?"VI?L ?\%HKK49[G3_^#@/4+6"29V@M
MA^R[X6?RD))";B<M@8&3R<4 '[!OC_\ X)E>(?VA[+3?V7O^"3OB'X1^+6TV
MZ:V\9ZC^RFWA**"$)^\B.HFTBV%U^4)N^?I@U]TU\L_LI?LD_P#!2OX0?&&V
M\:_M.?\ !7"[^,'A2*RGBN/!4WP+T'05GF=<1S?:[(^:OEM\VT<-T-?4U !7
MPCXE_9J^"_P-_P""X'P<\>_#?P<+77OB#\._B9JWC'7;J\FNKS4[C[5X<,:/
M-.[N((1(Z0P*1%"C%8T4$Y^[JYO6OA!\-?$7Q2T'XUZWX2M[CQ5X8TN_T[0-
M9=F\VSM;UK=KJ)0#M(D-K;DY!/[H8QSD ^)_VKO#?A']JT?$S_@E'^PG\/+&
MTM/&FO7%S^TK\38[?=I?A8ZBR3WT*,V1>ZY<Q$!($^6V$B2RLFU$9?''[._Q
M9;]JG]HSX]_LM?\ !2_1_!&LZ!X4\-:7J?A8>"K'4SH::9I<]U:P:O-?[W%M
M*+R>XS;^0^V8MYK%<5ZQXG_X(M?\$Q/&7C'6_'_B/]E'3+C6/$FLW.K:[?+K
MFI1M>WUQ(99IW"7(!=W8L3CO78?&?_@FI^PU^T)XNB\=?%_]GG2M7U1=)M]+
MO+C[9=6ZZG8P']S:WR02HFH0ID@1W(E4 D8P2* -O]A#]H/Q+^UC^Q=\+/VF
M?&/A)-"U;QWX#TS7-1TJ(-Y=O-<6R2.(]Y+>42Q9,DG8RY)/->L5#IVG:?I&
MGP:3I-C#:VMK"L-M;6\02.&-0%5%5<!5    X %34 9/CKP=I?Q!\(W_ (+U
MNXNX;348##/)8W+0S*I(.4=>5/'45Y#_ ,.]_@G_ -#;X[_\+*Y_QKW2B@#Y
MP_X)X^ M&@^!NI6Z75\5B\::K$I-XQ)"3;!D]SA1D]SDU[O_ ,(/I'_/S>_^
M!;5Y'_P3W_Y(GJW_ &/>L_\ I2:]TH Q_P#A!](_Y^;W_P "VH_X0?2/^?F]
M_P# MJV** ,?_A!](_Y^;W_P+:LSPKX5T[4-.DFFGN01<R* EPRC :NKK'\#
M_P#((E_Z_9O_ $*@ _X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:MBB@#'_ .$'
MTC_GYO?_  +:C_A!](_Y^;W_ ,"VK8HH Q_^$'TC_GYO?_ MJ/\ A!](_P"?
MF]_\"VK8HH Q_P#A!](_Y^;W_P "VK\^[CQY\1?'FE6%_P#$KQ3/JE]';#+R
MQI&(]WS%0L:JH[#.,G S7WEXZ^-WPI^&SM;^,/&]E;7"%0]E&QFN%W#()BC#
M. ?[Q 'O7P#:2B:UCE&WYHP<*P(Z>HX-?@_C7F[6#PV HU%:4I.I%-7]U+DY
MDM;.[:ONU?H?-9_B$X1I1EWNO3:Y)1TZ445_.Y\P7_ 'A#X->)_BMK'QO_;&
MU/7_ !G;Z%;6(\%:3J$_G6&DMB19V\EBL6XE(F#R=2QZE01]"V7Q)^*7QVT1
MC^SKX%O-.L'.Q/$VM7G[O;@C,*G".01U7S5'0K7%_L:_!WX6?%OQ?K6H_$+P
MS#J\_AJ*RFT^UNR6@5IS< N\7W9"/(XW @9/'.1]A11101+!!&J(BA41!@*!
MT '85_7G!\N),_X5P=;&8Z<4H<J48P3Y8MQ5Y34[W23;2BW>][ZOZ_*<(UA%
M44N5RU=DKO7=MW;_ $6B/F;P3^P7XOM_$W_">^._BLMUKS'+:M) U]<KZ"-Y
MMJPX[%$! XZ5Z7'^R?X!OB)/&?B3Q%X@?J?[4U=BF?94"X'MDUZA17T:X7R>
MIKB8RK/_ *>SE47_ (#)N*^44CT_J=!_&G+U;?X/3\#CM#^ WPN\-,'T#PS%
M:..DL( ?_OK&?UK9_P"$'TC_ )^;W_P+:MBBO:P^&PV$I^SH04(]HI)?<CHC
M"$%:*L8__"#Z1_S\WO\ X%M7D/QK_8OTWQE>2^)OAYJJ6.HRL6NK6]),-PQZ
ML& )1CWX()].2?=J*\W/,@RKB/!/"X^GS1W71I]TUJG^>SNC+$8:CBJ?)45T
M?$UU^R/\<[+4H=.N/#-N!<2^7%.-2A*$_P#?6X?E7L?P4_8OTWP=>1^)OB)J
MJ7VHQ$-;6MD2(;=AT8L0"[#MP #Z\$>O>)?^0OH__7Z?_036Q7R.3>%G"F38
MV.*C&5247>/.TTGT:2C%.W2]^^YPT,FP5"ISI-M=S'_X0?2/^?F]_P# MJ/^
M$'TC_GYO?_ MJV**_1SU3'_X0?2/^?F]_P# MJIZK\)_!6NIY6MZ:;Q<8VW3
M>8/_ !X&NDHJ*E.G5@XS2:?1ZH32DK,\WO\ ]D[X'W[^<OA5[:4<K+97;PE3
MZC:0/TJI/^S'+8+_ ,4=\9_%FG8^[%<WPN8E^B,!_.O4Z*\2?#&03FYQP\82
M?6'[M_?#E?XG.\'AF[J*7II^5CYY^-/@CXX_#_X9:QJU]\2;#6=.6V$5TTME
M)!<;)'6/Y0C%,_/SGMFOF&ON_P#:.T_Q-JWP,\3Z9X+\#3>)=7GTITTS18+V
M"V:XG) 3]Y.Z1H%;#DLPX0XR< _#>O:!K?A?5Y_#_B32Y;*^M7V7-K-C=&WI
MD$@^Q!((Y!(.:_ O&'),1EV-PV(C*<J,HN*YYRFU)-MJ\FY)--6N];.VSM\Q
MGE)TZ\;7:MUN^KZO\KW*E%%6]!T#6_%.KP>'_#>ERWM]=/LMK6'&Z1O3)( ]
MR2 !R2!S7X[3IU*U14X*\F[)+=M[)'B)-NR/L7]F7PWI>M? W0-3E6>%Y()%
M=8)2BDI,Z;L#N0H.>]=Y_P (/I'_ #\WO_@6U87[.6G^)=)^!OAC3/&?@:;P
MUJ\&EHFIZ+<7L%RUO."0_P"\@=XW#-EP58\.,X.0.UK^Z\EPE? 9/AL+7^.G
M3A&5K-<T8I/5:/5;H_0\(FL+33_E7ET[/5&/_P (/I'_ #\WO_@6U'_"#Z1_
MS\WO_@6U;%%>D=!C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'
M_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 <IX5\*Z=J&G2333W((N9% 2X91@-
M6G_P@^D?\_-[_P"!;4>!_P#D$2_]?LW_ *%6Q0!C_P#"#Z1_S\WO_@6U'_"#
MZ1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\
MP@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\ X%M5'Q+X2TRQ
MT&ZNX;BZ+1Q$@/<L1^(KIJS?&/\ R+%[_P!<#0!4LO!>E2V<4K7-YEHE)Q=-
MCI4O_"#Z1_S\WO\ X%M6EIW_ "#X/^N*_P A4U &/_P@^D?\_-[_ .!;4?\
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M+:QB=!G)<G:1_LN\35YGXX^,UG?W/D_'3]KS3=/1Y /^$6^'8>[F8,F&@9X
M=K9XVR&9>O->CVO["7PVUMX[KXR>._%WCN9""(=?UZ1;5".FR&$H$7_9R17I
MO@;X1?"WX9PB'X?_  \T;1\+@R:?I\<<C#_:<#<WU)-']B5L5KC\1.I_=C^[
MA]T7S->4YS0?4Y5/X]1R\E[J^Y:OYMGSEX!NK2U6(_L]_L-^(=9F79Y7B+X@
MRQ6$893D3QK-N'XQ*A-?G1\(OVX_"_A[QG>_#_QT3%H<<_EZ5K$:E_*8<,)
M,DQELE6 X[C!RO[C5^7'_#NC]LG_ *([_P"7#IW_ ,D5OBN&>%\QR>IEN+PJ
M=.7P\C5-PE_/&T6N;IJK--IIIG#F>45<91A2PU14E%W?N<U]+6WCW?F:6A>+
MO"GBBQ&J>&_$MAJ%LRY$]G=I*F/JI-<1\8OVJ/A)\'M+F>_\16^I:HJD0:/I
MUPLDKOV#E<B(>I;MG )XKH+S_@GG^V#I]J][=_"'9%&N7;^W]/.!]!<5)'_P
M3K_;'EC66/X/95E!4_\ "0:?R#_V\5^89;X*9%A\Q57&8B=6BG?D5H-KLY^]
MIWM&+[-/4\^IPU7E3M"ND^_)?\.8]._X(9_&.]^-FG_$[Q3K7EIJ*W.DI=P1
M9VQC_33'M!YV[<#ZJ:^^J^7/^":_[.?QE^ '_":?\+;\'?V3_:W]G?V?_P 3
M"WG\WROM7F?ZF1]N/,3KC.>,X./J.OVB4,'2?)A::ITUI&"U44MDM%HNGD?0
MX&A5PN#A1J3YY127-:U[=;7?YA1112.L**** "BBB@#'\2_\A?1_^OT_^@FM
MBL?Q+_R%]'_Z_3_Z":V* "BBB@ HHHH **** "N+^+'P$^'?QBA63Q/ISQ7L
M2;8=2LV"3(O]TD@AA[,#C)QC-=I17)CL!@LSPTL/BZ:G"6ZDKK_A^SW70BI2
MIUH.$U='S3!^PCI,WBB?2?\ A9%P+>&)9/\ D&+O()Z9\S'XX_"O8OA/\ _A
MW\'86D\,:<\M[*FV;4KQP\SK_=!  4>R@9P,YQ6Y9?\ ([WO_7E%_,UL5X&5
M<$\*Y)B?K&#PL8SZ-N4FO3F;M\K'-1R_!X>?/3@D_O\ S"BBBOJCL"BBB@ H
MHHH **** ,?P/_R")?\ K]F_]"K8K'\#_P#((E_Z_9O_ $*MB@ HHHH ****
M "BBB@ K-\8_\BQ>_P#7 UI5F^,?^18O?^N!H N:=_R#X/\ KBO\A4U0Z=_R
M#X/^N*_R%34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/#?QPTO3)]!U&_\ &D&F#P=K=MHT.C2/>QS*7N;1H;6TN UOOEWK-'Y8#(X
M/J+]D#]H&P_:O_93^&_[3>FZ3_9\7C_P1I>O_P!G%]WV1KJUCF>#=_%L9V3/
M?;FO1J\Z_9#_ &?M._90_96^''[,FE:L=0A\ >"-,T :B8]ANVM;6.%IRO\
M"79"^.V[%>BT 9/CKQ#JGA3PC?\ B/1/"MWKEW:0&2#2;%E$UTV1\B%N,_7T
MKR'_ (:P^-G_ $8_X[_\"K;_ .*KW2B@#YP_X)X^*=9E^!NI2OX+OD9_&FJN
MR%ERA:;<5/NI)4^ZFO=_^$EU?_H4+W_OI:\C_P"">_\ R1/5O^Q[UG_TI->Z
M4 8__"2ZO_T*%[_WTM?&/[4ES]L_: \27+V;V\C2VGFPR$;E/V* #./;!_&O
MN:OS1_;>_:$\%_"_]N[Q+X"\;:JMK%K+V#VUU(<1VSC3K4 R'^%7Z!N@*\X&
M2/SWQ-R#,^(>%Y4L#!SG3DJG+%7<HQ4E*RZV3YK=;::V/$X@<(9<YSDDDUOY
MZ?J6J*2.1)4$L3AE8 JRG((]:'=(D,DCA5499F. !ZU_(5G>Q\<=1\&?!OAK
MXA?%'1_!GB_2+C4-/OI)A<6-M=R0//LMY9 N^-E8#* D C(!'>OKGP#\+OAC
M\+E7_A7_ , K'2Y$&!<VUE%YY^LIR[?B37PM^Q#^T)X+^)_[=WAKP#X)U5;N
M+1VOGN;J,YCN'.G70/EG^)4/!;H2W&1@G]+:_KKPQX<Q_#O#2CCJ;IU:LG4L
MU:2BU%13ZZI<UGM?6SN?7\/*E+ >T@T^9O5>6EOP,?\ X275_P#H4+W_ +Z6
MC_A)=7_Z%"]_[Z6MBBOT4]TQ_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI:V*
M* ,?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI:V** .9\2Z]J=SH-U!-X8NH5:
M(@RNRX7W-6;+Q'JJ6<2+X2O& B4!@RX/'6K?C'_D6+W_ *X&KFG?\@^#_KBO
M\A0!F_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_
M -]+1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM
M;%% &/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!RFN:YJ,^HZ;))X;N
M8S'<ED1F7,AV]!6G_P )+J__ $*%[_WTM'B7_D+Z/_U^G_T$UL4 8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 <I:ZYJ*^*;JZ7PW<L[VT:M &7<H!
M/)K3_P"$EU?_ *%"]_[Z6BR_Y'>]_P"O*+^9K8H Q_\ A)=7_P"A0O?^^EH_
MX275_P#H4+W_ +Z6MBB@#'_X275_^A0O?^^EH_X275_^A0O?^^EK8HH Q_\
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MIW_(/@_ZXK_(53\8_P#(L7O_ %P-7-._Y!\'_7%?Y"@":BBB@ HHHH ****
M"BBB@#'\2_\ (7T?_K]/_H)K8K'\2_\ (7T?_K]/_H)K8H **** "BBB@ HH
MHH **** ,>R_Y'>]_P"O*+^9K8K'LO\ D=[W_KRB_F:V* "BBB@ HHHH ***
M* "BBB@#'\#_ /((E_Z_9O\ T*MBL?P/_P @B7_K]F_]"K8H **** "BBB@
MHHHH *S?&/\ R+%[_P!<#6E6;XQ_Y%B]_P"N!H N:=_R#X/^N*_R%35#IW_(
M/@_ZXK_(5-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MKX'_ /0W>.__  KYZ/\ AW5\#_\ H;O'?_A7ST >]45X+_P[J^!__0W>._\
MPKYZ/^'=7P/_ .AN\=_^%?/0![%9?\CO>_\ 7E%_,UL5\9>$_P!CCX9ZK^US
MXM^%%UXJ\7C2]*\*V%[:LGB:83&65V#;GZLO' [5ZG_P[J^!_P#T-WCO_P *
M^>@#WJBO!?\ AW5\#_\ H;O'?_A7ST?\.ZO@?_T-WCO_ ,*^>@#WJBO!?^'=
M7P/_ .AN\=_^%?/1_P .ZO@?_P!#=X[_ /"OGH ]ZHKP7_AW5\#_ /H;O'?_
M (5\]'_#NKX'_P#0W>.__"OGH ]ZHKP7_AW5\#_^AN\=_P#A7ST?\.ZO@?\
M]#=X[_\ "OGH ]B\#_\ ((E_Z_9O_0JV*^,OV1/V./AG\6/AEJ'B3Q3XJ\7K
M<0>*M2LD%EXFFB3RH9RB9 ZMCJ>]>I_\.ZO@?_T-WCO_ ,*^>@#WJBO!?^'=
M7P/_ .AN\=_^%?/1_P .ZO@?_P!#=X[_ /"OGH ]ZHKP7_AW5\#_ /H;O'?_
M (5\]'_#NKX'_P#0W>.__"OGH ]ZHKP7_AW5\#_^AN\=_P#A7ST?\.ZO@?\
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M"@L3U.!R>] %BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSP3^T!IE]XHEU2ZTRR@6SNDL]0O[8.;FSM;YXA:W=Q$(Y-\,,KR)Y;Y4;3@
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MPRZGHRZC/;0WZQ.)%AG\AT,T#,HWPL3'(!M=64E3\4_\$\'_ &3/AS_P1/\
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M2D;G@@_\+$_X)9?L-_LFVW[QOBKH'PZM]9@'?1-*T6WUW4-_I'+%IJVC'O\
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MG0TTS0= TZ*PTC3TE>06]O&H5$#2,S-@ #+$GU-;= 'PC_P<'_LU?!?XG?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^YX5/B"HZWOP7+^/]?(_0.BO-_\ AJ3X>?\ 0#\2_P#A/S?X4?\ #4GP\_Z
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2*>&0<QS12I'*CC[KQJ<'&*[^B@#X5\3_P#!(7]I#XS^"(/V=OVI_P#@J_\
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%?-6N?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<%!9F[LS*JJ,LS,JJ"2 <?X0?M%>!_C7J5YI?A/2-?MI+&!99FUC19;564G
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M!^'MSJ_Q#U#6QY*-;6UC-IE^]GI\;B<F=H/,9O+0D#<1\\_$K]K#XV_M%_\
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M](-V=.%AY7DG6PRM: F#;]FS=>5@>90!^IM%)&NQ FXM@ 98\GZTM !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
A44 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771225275984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COVER PAGE - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-13149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">STRYKER CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">38-1239739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1941 Stryker Way,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Portage,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">49002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">385-2600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12gTitle', window );">Title of 12(g) Security</a></td>
<td class="text">None<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 123,147,898,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">381,579,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Portions of the proxy statement to be filed with the U.S. Securities and Exchange Commission relating to the 2025 Annual Meeting of Shareholders (the 2025 proxy statement) are incorporated by reference into Part III.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000310764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock, $.10 Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.10 Par Value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.125Due2027Member', window );">2.125% Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.125% Notes due 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes3375Due2028Member', window );">3.375% Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.375% Notes due 2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes0.750due2029Member', window );">0.750% Notes due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.750% Notes due 2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.625Due2030Member', window );">2.625% Notes due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.625% Notes due 2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes1.000due2031Member', window );">1.000% Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.000% Notes due 2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes3.375Due2032Member', window );">3.375% Notes due 2032</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.375% Notes due 2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes3.625Due2036Member', window );">3.625% Notes due 2036</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.625% Notes due 2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12gTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(g) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection g<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12gTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.125Due2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.125Due2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes3375Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes3375Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes0.750due2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes0.750due2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.625Due2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.625Due2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes1.000due2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes1.000due2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes3.375Due2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes3.375Due2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes3.625Due2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes3.625Due2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771225329424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_AuditorInformationAbstract', window );"><strong>Auditor Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst&#160;& Young LLP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Grand Rapids, Michigan<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_AuditorInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Auditor Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_AuditorInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771223955632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements Of Earnings - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 22,595<span></span>
</td>
<td class="nump">$ 20,498<span></span>
</td>
<td class="nump">$ 18,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">8,155<span></span>
</td>
<td class="nump">7,440<span></span>
</td>
<td class="nump">6,871<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">14,440<span></span>
</td>
<td class="nump">13,058<span></span>
</td>
<td class="nump">11,578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research, development and engineering expenses</a></td>
<td class="nump">1,466<span></span>
</td>
<td class="nump">1,388<span></span>
</td>
<td class="nump">1,454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">7,685<span></span>
</td>
<td class="nump">7,111<span></span>
</td>
<td class="nump">6,386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">623<span></span>
</td>
<td class="nump">635<span></span>
</td>
<td class="nump">627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill and other impairments</a></td>
<td class="nump">977<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">10,751<span></span>
</td>
<td class="nump">9,170<span></span>
</td>
<td class="nump">8,737<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">3,689<span></span>
</td>
<td class="nump">3,888<span></span>
</td>
<td class="nump">2,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(197)<span></span>
</td>
<td class="num">(215)<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">3,492<span></span>
</td>
<td class="nump">3,673<span></span>
</td>
<td class="nump">2,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">499<span></span>
</td>
<td class="nump">508<span></span>
</td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 2,993<span></span>
</td>
<td class="nump">$ 3,165<span></span>
</td>
<td class="nump">$ 2,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net earnings per share of common stock:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net earnings per share of common stock (in dollars per share)</a></td>
<td class="nump">$ 7.86<span></span>
</td>
<td class="nump">$ 8.34<span></span>
</td>
<td class="nump">$ 6.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net earnings per share of common stock (in dollars per share)</a></td>
<td class="nump">$ 7.76<span></span>
</td>
<td class="nump">$ 8.25<span></span>
</td>
<td class="nump">$ 6.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares outstanding (in millions):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">381.0<span></span>
</td>
<td class="nump">379.6<span></span>
</td>
<td class="nump">378.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive employee stock compensation (in shares)</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">385.6<span></span>
</td>
<td class="nump">383.7<span></span>
</td>
<td class="nump">382.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224081200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements Of Earnings (Parenthetical) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares excluded from calculation of dilutive employee stock options (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771222597008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 2,993<span></span>
</td>
<td class="nump">$ 3,165<span></span>
</td>
<td class="nump">$ 2,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension plans</a></td>
<td class="nump">32<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Unrealized gains (losses) on designated hedges</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Financial statement translation</a></td>
<td class="nump">99<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="nump">123<span></span>
</td>
<td class="num">(195)<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 3,116<span></span>
</td>
<td class="nump">$ 2,970<span></span>
</td>
<td class="nump">$ 2,668<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224439568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 3,652<span></span>
</td>
<td class="nump">$ 2,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">750<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less allowance of $213 ($182 in 2023)</a></td>
<td class="nump">3,987<span></span>
</td>
<td class="nump">3,765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Materials and supplies</a></td>
<td class="nump">1,147<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">336<span></span>
</td>
<td class="nump">330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">3,291<span></span>
</td>
<td class="nump">3,271<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">4,774<span></span>
</td>
<td class="nump">4,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,593<span></span>
</td>
<td class="nump">857<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">14,847<span></span>
</td>
<td class="nump">12,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_LandBuildingsAndImprovementsGross', window );">Land, buildings and improvements</a></td>
<td class="nump">1,627<span></span>
</td>
<td class="nump">1,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and equipment</a></td>
<td class="nump">5,056<span></span>
</td>
<td class="nump">4,652<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property, plant and equipment</a></td>
<td class="nump">6,683<span></span>
</td>
<td class="nump">6,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less allowance for depreciation</a></td>
<td class="nump">3,235<span></span>
</td>
<td class="nump">3,129<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">3,448<span></span>
</td>
<td class="nump">3,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">15,855<span></span>
</td>
<td class="nump">15,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangibles, net</a></td>
<td class="nump">4,395<span></span>
</td>
<td class="nump">4,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Noncurrent deferred income tax assets</a></td>
<td class="nump">1,742<span></span>
</td>
<td class="nump">1,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other noncurrent assets</a></td>
<td class="nump">2,684<span></span>
</td>
<td class="nump">2,673<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">42,971<span></span>
</td>
<td class="nump">39,912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">1,679<span></span>
</td>
<td class="nump">1,517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">1,403<span></span>
</td>
<td class="nump">1,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes</a></td>
<td class="nump">539<span></span>
</td>
<td class="nump">391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividend payable</a></td>
<td class="nump">320<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">2,266<span></span>
</td>
<td class="nump">2,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current maturities of debt</a></td>
<td class="nump">1,409<span></span>
</td>
<td class="nump">2,094<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">7,616<span></span>
</td>
<td class="nump">7,921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, excluding current maturities</a></td>
<td class="nump">12,188<span></span>
</td>
<td class="nump">10,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Income taxes</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other noncurrent liabilities</a></td>
<td class="nump">2,184<span></span>
</td>
<td class="nump">1,930<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">22,337<span></span>
</td>
<td class="nump">21,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common stock, $0.10 par value</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,361<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">18,528<span></span>
</td>
<td class="nump">16,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(293)<span></span>
</td>
<td class="num">(416)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders' equity</a></td>
<td class="nump">20,634<span></span>
</td>
<td class="nump">18,593<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities &amp; shareholders' equity</a></td>
<td class="nump">$ 42,971<span></span>
</td>
<td class="nump">$ 39,912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_LandBuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Land, Buildings and Improvements, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_LandBuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of common shares held by shareholders. Excludes common shares repurchased and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224020688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance</a></td>
<td class="nump">$ 213<span></span>
</td>
<td class="nump">$ 182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771222897584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements Of Shareholders' Equity - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 1,890<span></span>
</td>
<td class="nump">$ 13,480<span></span>
</td>
<td class="num">$ (531)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">377.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 2,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,073)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">378.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">16,616<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">2,034<span></span>
</td>
<td class="nump">14,765<span></span>
</td>
<td class="num">(221)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">3,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,159)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(195)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(195)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, shares at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2023</a></td>
<td class="nump">18,593<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
<td class="nump">16,771<span></span>
</td>
<td class="num">(416)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(68)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">2,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,236)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, shares at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">381.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2024</a></td>
<td class="nump">$ 20,634<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 2,361<span></span>
</td>
<td class="nump">$ 18,528<span></span>
</td>
<td class="num">$ (293)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477787/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224362512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements Of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 2,993<span></span>
</td>
<td class="nump">$ 3,165<span></span>
</td>
<td class="nump">$ 2,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">427<span></span>
</td>
<td class="nump">393<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization of intangible assets</a></td>
<td class="nump">623<span></span>
</td>
<td class="nump">635<span></span>
</td>
<td class="nump">627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill and other impairments</a></td>
<td class="nump">977<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">229<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_InventorySteppedUpToFairValueAtAcquisition', window );">Sale of inventory stepped up to fair value at acquisition</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax (benefit) expense</a></td>
<td class="num">(370)<span></span>
</td>
<td class="num">(206)<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(321)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="num">(579)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(206)<span></span>
</td>
<td class="num">(797)<span></span>
</td>
<td class="num">(762)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Accounts payable</a></td>
<td class="nump">192<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">290<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">516<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="num">(116)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(238)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other, net</a></td>
<td class="num">(306)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="num">(107)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">4,242<span></span>
</td>
<td class="nump">3,711<span></span>
</td>
<td class="nump">2,624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="num">(1,628)<span></span>
</td>
<td class="num">(390)<span></span>
</td>
<td class="num">(2,563)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
<td class="num">(750)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(58)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales of marketable securities</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(755)<span></span>
</td>
<td class="num">(575)<span></span>
</td>
<td class="num">(588)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeInvestingActivities', window );">Proceeds from settlement of net investment hedges</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing, net</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(3,000)<span></span>
</td>
<td class="num">(962)<span></span>
</td>
<td class="num">(2,924)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Proceeds (payments) on short-term borrowings, net</a></td>
<td class="num">(32)<span></span>
</td>
<td class="nump">540<span></span>
</td>
<td class="num">(375)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">3,011<span></span>
</td>
<td class="nump">1,241<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments on long-term debt</a></td>
<td class="num">(2,039)<span></span>
</td>
<td class="num">(2,058)<span></span>
</td>
<td class="num">(653)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payments of dividends</a></td>
<td class="num">(1,219)<span></span>
</td>
<td class="num">(1,139)<span></span>
</td>
<td class="num">(1,051)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Cash paid for taxes from withheld shares</a></td>
<td class="num">(195)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing, net</a></td>
<td class="num">(51)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(525)<span></span>
</td>
<td class="num">(1,594)<span></span>
</td>
<td class="num">(749)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash and cash equivalents</a></td>
<td class="nump">681<span></span>
</td>
<td class="nump">1,127<span></span>
</td>
<td class="num">(1,100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of year</a></td>
<td class="nump">2,971<span></span>
</td>
<td class="nump">1,844<span></span>
</td>
<td class="nump">2,944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">3,652<span></span>
</td>
<td class="nump">2,971<span></span>
</td>
<td class="nump">1,844<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow disclosure:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes, net of refunds</a></td>
<td class="nump">989<span></span>
</td>
<td class="nump">693<span></span>
</td>
<td class="nump">505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest on debt</a></td>
<td class="nump">$ 396<span></span>
</td>
<td class="nump">$ 356<span></span>
</td>
<td class="nump">$ 324<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_InventorySteppedUpToFairValueAtAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory, Stepped-Up to Fair Value at Acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_InventorySteppedUpToFairValueAtAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771325711840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Nature of Operations: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker (the "Company," "we," "us," or "our") is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Our products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and artificial intelligence-assisted virtual care platform technology; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the fourth quarter 2024 we changed the name of our &#8220;Orthopaedics and Spine&#8221; operating segment to &#8220;Orthopaedics.&#8221; </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis of Presentation and Consolidation: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Consolidated Financial Statements include the Company and its subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. We have no material interests in variable interest entities. Certain prior year amounts have been reclassified to conform with current year presentation in our Consolidated Financial Statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our reportable segments and related disclosures reflect certain reclassifications of prior year amounts from our Orthopaedics segment to our MedSurg and Neurotechnology segment due to changes in our internal reporting structure.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of net sales and expenses in the reporting period. Actual results could differ from those estimates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Revenue Recognition: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales are recognized as the performance obligations to deliver products or services (including services under extended warranty service contracts) are satisfied and are recorded based on the amount of consideration we expect to receive in exchange for satisfying the performance obligations. Our sales are recognized primarily when we transfer control to the customer, which can be on the date of shipment, the date of receipt by the customer or, for most Orthopaedics products, when we have received a purchase order and appropriate notification the product has been used or implanted. Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales represent the amount of consideration we expect to receive from customers in exchange for transferring products and services. Net sales exclude sales, value added and other taxes we collect from customers. Other costs to obtain and fulfill contracts are generally expensed as incurred due to the short-term nature of most of our sales. We extend terms of payment to our customers based on commercially reasonable terms for the markets of our customers, while also considering their credit quality.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A provision for estimated sales returns, discounts and rebates is recognized as a reduction of sales in the same period that the sales are recognized. Our estimate of the provision for sales </span></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">returns has been established based on contract terms with our customers and historical business practices and current trends. Shipping and handling costs charged to customers are included in net sales.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cost of Sales: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of sales include direct materials and supplies consumed in the manufacture of product, as well as manufacturing labor, depreciation expense and direct overhead expense necessary to acquire and convert the purchased materials and supplies into finished product. Cost of sales also includes the cost to distribute products to customers, inbound freight costs, warehousing costs and other shipping and handling activity.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Research, Development and Engineering Expenses: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research, development and engineering costs are charged to expense as incurred and include research, development and engineering activities relating to the development of new products, improvement of existing products, technical support of products and compliance with governmental regulations for the protection of customers and patients. Costs primarily include salaries, wages, consulting and depreciation and maintenance of research facilities and equipment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Selling, General and Administrative Expenses: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Costs include selling expenses, marketing expenses, administrative and other indirect overhead costs, amortization of loaner instrumentation, depreciation and amortization expense of non-manufacturing assets and other miscellaneous operating items. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Currency Translation: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial statements of subsidiaries outside the United States generally are measured using the local currency as the functional currency. Adjustments to translate those statements into United States Dollars are recorded in other comprehensive income (OCI). Transactional exchange gains and losses are included in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash Equivalents: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Highly liquid investments with remaining stated maturities of three months or less when purchased or other money market instruments that are redeemable upon demand are considered cash equivalents and recorded at cost.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Short-term Investments: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Short-term investments that have a maturity greater than three months and less than a year from the date of purchase primarily include time deposits, certificates of deposit, commercial paper, bonds and notes, substantially all of which are denominated in United States Dollars and are stated at cost plus accrued interest, which approximates fair value. We expect to hold all of our short-term investments to maturity.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Marketable Securities: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities include marketable debt securities and mutual funds. Mutual funds are acquired to offset changes in certain liabilities related to deferred compensation arrangements and are expected to be used to settle these liabilities and are recognized in other noncurrent assets. Pursuant to our investment policy, all individual marketable security investments must have a minimum credit quality of single A (Standard&#160;&amp; Poor&#8217;s and Fitch) and A2 (Moody&#8217;s Corporation) at the time of acquisition, while the overall portfolio of marketable securities must maintain a minimum average credit quality of double A (Standard&#160;&amp; Poor&#8217;s and Fitch) or Aa (Moody&#8217;s Corporation). In the event of a rating downgrade below the minimum credit quality subsequent to purchase, the marketable security investment is evaluated to determine the appropriate action to take to minimize the overall risk to our marketable security investment portfolio. Our marketable securities are classified as available-for-sale and trading securities. Investments in trading securities represent participant-directed investments of deferred employee compensation.</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounts Receivable: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable include trade and other miscellaneous receivables. An allowance is maintained for doubtful accounts for estimated losses in the collection of accounts receivable. Estimates are made regarding the ability of customers to make required payments based on historical credit experience, current market conditions and expected credit losses. Accounts receivable are written off when all reasonable collection efforts are exhausted.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Inventories: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value, with cost generally determined using the first-in, first-out (FIFO) cost method. For excess and obsolete inventory resulting from the potential inability to sell specific products at prices in excess of current carrying costs, reserves are maintained to reduce current carrying cost to net realizable value.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Financial Instruments:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Our financial instruments include cash, cash equivalents, marketable securities, accounts receivable, other investments, accounts payable, debt and foreign currency exchange contracts. The carrying value of our financial instruments, with the exception of our senior unsecured notes, approximates fair value on December&#160;31, 2024 and 2023. Refer to Notes 3 and 10 for further details. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All marketable securities are recognized at fair value. Adjustments to the fair value of marketable securities that are classified as available-for-sale are recognized as increases or decreases, net of income taxes, within accumulated other comprehensive income (AOCI) in shareholders&#8217; equity and adjustments to the fair value of marketable securities that are classified as trading are recognized in earnings. The amortized cost of marketable debt securities is adjusted for amortization of premiums and discounts to maturity computed under the effective interest method. Such amortization and interest and realized gains and losses are included in other income (expense), net. The cost of securities sold is determined by the specific identification method.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review declines in the fair value of our investments classified as available-for-sale to determine whether the decline in fair value is a result of credit loss or other factors. Impairments of available-for-sale marketable debt securities related to credit loss are included in earnings and impairments related to other factors are recognized within AOCI.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivatives:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> All derivatives are recognized at fair value and reported on a gross basis. We enter into forward currency exchange contracts to mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, thereby limiting our risk that would otherwise result from changes in exchange rates. The periods of the forward currency exchange contracts correspond to the periods of the exposed transactions, with realized gains and losses included in the measurement and recording of transactions denominated in the nonfunctional currencies. All forward currency exchange contracts are recorded at their fair value each period.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. These nonfunctional currency exposures principally relate to forecasted intercompany sales and purchases of manufactured products and generally have maturities up to eighteen months. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">earnings and is included in cost of goods sold. Cash flows associated with these hedges are included in cash provided by operating activities in the same category as the cash flows from the items being hedged.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts are used to offset our exposure to the change in value of specific foreign currency denominated assets and liabilities, primarily intercompany payables and receivables. These derivatives are not designated as hedges and, therefore, changes in the value of these forward contracts are recognized in earnings, thereby offsetting the current earnings effect of the related changes in value of foreign currency denominated assets and liabilities. The estimated fair value of our forward currency exchange contracts represents the measurement of the contracts at month-end spot rates as adjusted by current forward points. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate derivative and non-derivative financial instruments as net investment hedges of our investments in certain international subsidiaries. For derivative instruments that are designated and qualify as a net investment hedge, the effective portion of the derivative's gain or loss is recognized in OCI and reported as a component of AOCI. We have elected to use the spot method to assess effectiveness for our derivatives designated as net investment hedges. Accordingly, the change in fair value attributable to changes in the spot rate is recorded in AOCI. We exclude the spot-forward difference from the assessment of hedge effectiveness and amortize this amount separately on a straight-line basis over the term of the forward contracts. This amortization is recognized in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate forward starting interest rate derivative instruments as cash flow hedges to manage the exposure to interest rate volatility with regard to future issuance and refinancing of debt. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into earnings and is included in interest expense within other income (expense), net. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest rate derivative instruments designated as fair value hedges have been used in the past to manage the exposure to interest rate movements and to reduce borrowing costs by converting fixed-rate debt into floating-rate debt. Under these agreements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Property, Plant and Equipment:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Property, plant and equipment is stated at cost. Depreciation is generally computed by the straight-line method over the estimated useful lives of <span style="-sec-ix-hidden:f-409">three</span> to 30 years for buildings and improvements and <span style="-sec-ix-hidden:f-411">three</span> to 15 years for machinery and equipment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Goodwill represents the excess of purchase price over fair value of tangible net assets of acquired businesses at the acquisition date, after amounts allocated to other identifiable intangible assets. Factors that contribute to the recognition of goodwill include synergies that are specific to our business and not available to other market participants and are expected to increase net sales and profits; acquisition of a talented workforce; cost savings opportunities; the strategic benefit of expanding our presence in core and adjacent markets; and diversifying our product portfolio.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of other identifiable intangible assets acquired in a business combination are primarily determined using the income </span></div></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">approach. Other intangible assets include, but are not limited to, developed technology, customer and distributor relationships (which reflect expected continued customer or distributor patronage) and trademarks and patents. Intangible assets with determinable useful lives are amortized on a straight-line basis over their estimated useful lives of <span style="-sec-ix-hidden:f-414">four</span> to 40 years. Certain acquired trade names are considered to have indefinite lives and are not amortized, but are assessed annually for potential impairment as described below.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations IPRD is considered to be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions IPRD is expensed immediately unless there is an alternative future use.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Goodwill, Intangibles and Long-Lived Asset Impairment Tests:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We perform our annual impairment test for goodwill as of October 31 each year. We consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill and periodically corroborate that assessment with quantitative information. In certain circumstances, we may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. Indefinite-lived intangible assets are also tested at least annually for impairment by comparing the individual carrying values to the fair value.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows. Undiscounted cash flows expected to be generated by the related assets are estimated over the asset's useful life based on updated projections. If the evaluation indicates that the carrying amount of the asset may not be recoverable, any potential impairment is measured based upon the fair value of the related asset or asset group as determined by an appropriate market appraisal or other valuation technique.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Assets and Liabilities Held for Sale: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">classify assets and liabilities or disposal groups to be sold as held for sale in the period in which all of the following criteria are met: management, having the authority to approve the action, commits to a plan to sell the disposal group; the disposal group is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such disposal groups; an active program to locate a buyer and other actions required to complete the plan to sell the disposal group have been initiated; the sale of the disposal group is probable, and transfer of the disposal group is expected to qualify for recognition as a completed sale within one year, except if events or circumstances beyond our control extend the period of time required to sell the disposal group beyond one year; the disposal group is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We initially measure a disposal group that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held for sale criteria are met. Conversely, gains are not recognized on the sale of a disposal group until the sale is completed. We assess the fair value of a disposal group, less any costs to sell, each reporting period it remains classified as held for sale and report any subsequent changes as an adjustment to the carrying value of the disposal group, as long as the new carrying value does not exceed the carrying value of the disposal group at the time it was initially classified as held for sale.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Upon determining that a disposal group meets the criteria to be classified as held for sale, we cease depreciation and amortization of the assets and disclose the major classes of assets and liabilities of the disposal group in the Notes to the Consolidated Financial Statements. Refer to Note 16 for further information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Share-Based Compensation:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Share-based compensation is in the form of stock options, restricted stock units (RSUs) and performance stock units (PSUs). Stock options are granted under long-term incentive plans to certain key employees and non-employee directors at an exercise price not less than the fair market value of the underlying common stock, which is the quoted closing price of our common stock on the day prior to the date of grant. The options are granted for periods of up to 10 years and become exercisable in varying installments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We grant RSUs to key employees and non-employee directors and PSUs to certain key employees under our long-term incentive plans. The fair value of RSUs is determined based on the number of shares granted and the quoted closing price of our common stock on the date of grant, adjusted for the fact that RSUs do not include anticipated dividends. RSUs generally vest in one-third increments over a three-year period and are settled in stock. PSUs are earned over a three-year performance cycle and vest in March of the year following the end of that performance cycle. The number of PSUs that will ultimately be earned is based on our performance relative to pre-established goals in that three-year performance cycle. The fair value of PSUs is determined based on the quoted closing price of our common stock on the day of grant.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Compensation expense is recognized in the Consolidated Statements of Earnings based on the estimated fair value of the awards on the grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized associated with such grants will be reversed.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Deferred income tax assets and liabilities are determined based on differences between financial reporting and income tax bases of assets and liabilities and are measured using the enacted income tax rates in effect for the years in which the differences are expected to reverse. Deferred income tax benefits generally represent the change in net deferred income tax assets and liabilities in the year. Other amounts result from </span></div></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">adjustments related to acquisitions and foreign currency as appropriate.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We operate in multiple income tax jurisdictions both within the United States and internationally. Accordingly, management must determine the appropriate allocation of income to each of these jurisdictions based on current interpretations of complex income tax regulations. Income tax authorities in these jurisdictions regularly perform audits of our income tax filings. Income tax audits associated with the allocation of this income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period of time to resolve and may result in significant income tax adjustments if changes to the income allocation are required between jurisdictions with different income tax rates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Tax Cuts and Jobs Act (the Act) was enacted in 2017 in the United States. The Act also subjects a United States shareholder to tax on Global Intangible Low-Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to account for GILTI tax in the year the tax is incurred.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2024 the Financial Accounting Standards Board (FASB) issued ASU 2024-03 (Subtopic 220-40): </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which requires disaggregation of certain expense captions into specified categories in disclosures within the Notes to the Consolidated Financial Statements. The new disclosure requirements are effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. We are currently evaluating these new expanded disclosure requirements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In December 2023 the FASB issued ASU 2023-09 (Topic 740): </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes: Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which expands the existing rules on income tax disclosures. This update requires entities to disclose specific categories in the tax rate reconciliation, provide additional information for reconciling items that meet a quantitative threshold and disclose additional information about income taxes paid on an annual basis. The new disclosure requirements are effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating these new expanded disclosure requirements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 1, 2024 we adopted ASU 2023-07, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Refer to Note 14 for further information.</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 1, 2023 we adopted ASU 2022-04, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Liabilities - Supplier Finance Programs: Disclosure of Supplier Finance Program Obligations</span>. Refer to Note 7 for required disclosures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771226268160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">REVENUE RECOGNITION<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We disaggregate our net sales by business and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time. In 2024 less than 10% of our sales were recognized as services transferred over time. Refer to Note 1 for further discussion on our revenue recognition policies. </span></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the fourth quarter 2024 we reorganized our Spine business to align with certain updates to our internal reporting structure. The spine enabling technologies portfolio (Enabling Technologies) was reclassified to Other Orthopaedics and Spine, the interventional spine portfolio was reclassified to Neuro Cranial and the remaining Spine business was renamed to Spinal Implants. In addition, we changed the name of our &#8220;Orthopaedics and Spine&#8221; operating segment to &#8220;Orthopaedics.&#8221; Neuro Cranial includes sales related to interventional spine of $413, $327 and $282 for 2024, 2023 and 2022. Other Orthopaedics includes sales related to Enabling Technologies of $152, $149 and $131 for 2024, 2023 and 2022. In the first quarter of 2024 a product line previously included in Instruments has been reclassified to Endoscopy to align with a change in our internal reporting structure. We have reflected these changes in all historical periods presented. </span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,834&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,518</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,163</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,893</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spinal Implants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,077</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,335</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,556</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,595</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,498</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">United States Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,016&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,517</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,328</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,248</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spinal Implants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,426</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,929</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,390</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16,943</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15,257</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,638</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">International Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,001</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,835</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,645</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spinal Implants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,651</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,406</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,166</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,652</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,241</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,811</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></div><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">MedSurg and Neurotechnology</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">MedSurg and Neurotechnology products include surgical equipment, patient and caregiver safety technologies (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical), minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke (Neurovascular), cranial, maxillofacial and chest wall devices as well as dural substitutes and sealants; a comprehensive line of products for traditional brain and open skull based surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products (Neuro Cranial). Substantially all MedSurg and Neurotechnology sales are recognized when a purchase order has been received and control has transferred. For certain Endoscopy, Instruments and Medical services, we may recognize sales over time as we satisfy performance obligations that may include an obligation to complete installation, provide training and perform ongoing services, generally performed within one year.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Orthopaedics</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries, and cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. Substantially all Orthopaedics sales are recognized when we have received a purchase order and appropriate notification the product has been used or implanted. Substantially all Spinal Implants sales are recognized when a purchase order has been received and control has transferred. For certain Orthopaedic products in the "other" category, we recognize sales at a point in time, as well as over time for performance obligations that may include an obligation to complete installation and provide training and ongoing services. Performance obligations are generally satisfied within one year.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Costs to Obtain or Fulfill a Contract</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We typically do not incur costs to fulfill a contract before a product or service is provided to a customer due to the nature of our products and services. Our costs to obtain contracts are typically in the form of sales commissions paid to employees or third-party agents. Certain sales commissions paid to employees prior to recognition of sales are recorded as deferred contract costs. We expense sales commissions associated with obtaining a contract at the time of the sale or as incurred as the amortization period is generally less than one year. These costs have been presented within selling, general and administrative expenses. On December&#160;31, 2024 and 2023 deferred contracts costs recorded in our Consolidated Balance Sheets were not significant. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets and Liabilities </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our contract assets primarily relate to conditional rights to consideration for work completed but not billed at the reporting date. On December&#160;31, 2024 and 2023 contract assets recorded in our Consolidated Balance Sheets were not significant.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our contract liabilities arise as a result of consideration received from customers at inception of contracts for certain businesses or where the timing of billing for services precedes satisfaction of our performance obligations. This occurs primarily when payment is received upfront for certain multi-period extended warranty service contracts. Our contract liabilities of $978 and $860 on </span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2024 and 2023 are classified within accrued expenses and other liabilities and other noncurrent liabilities within our Consolidated Balance Sheets based on the timing of when we expect to complete our performance obligations. Changes in contract liabilities during the year were as follows:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.658%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning contract liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">860</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Revenue recognized from beginning of year contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net advance consideration received during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending contract liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">978</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771223657040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">FAIR VALUE MEASUREMENTS <div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets and liabilities carried at fair value are classified in their entirety based on the lowest level of input and disclosed in one of the following three categories:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.107%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted market prices in active markets for identical assets or liabilities.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unobservable inputs reflecting our assumptions or external inputs from active markets.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Use of observable market data, when available, is required in making fair value measurements. When inputs used fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement. We determine fair value for Level 1 instruments using exchange-traded prices for identical instruments. We determine fair value of Level 2 instruments using exchange-traded prices of similar instruments, where available, or utilizing other observable inputs that take into account our credit risk and that of our counterparties. Foreign currency exchange contracts and interest rate hedges, when outstanding, are included in Level 2 and are primarily valued using standard calculations and models that use readily observable market data as their basis. Our Level 3 liabilities are comprised of contingent consideration arising from recently completed acquisitions. We determine fair value of these Level 3 liabilities using a discounted cash flow technique. Significant unobservable inputs were used in our assessment of fair value, including assumptions regarding future business results, discount rates, discount periods and probability assessments based on the likelihood of reaching various targets. We remeasure the fair value of our assets and liabilities each reporting period. We record the changes in fair value within selling, general and administrative expense.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2024 we recorded $208 of contingent consideration related to various acquisitions described in Note 6.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2023 we recorded $192 of contingent consideration related to the acquisition of Cerus described in Note 6.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were no significant transfers into or out of any level of the fair value hierarchy in 2024.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"></td><td style="width:64.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.253%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Assets Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trading marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,661</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,180</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Available-for-sale marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and asset-backed debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States agency debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States treasury debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total available-for-sale marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">316</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">198</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,977</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,378</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"></td><td style="width:64.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.253%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Liabilities Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred compensation arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">259</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">209</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">77</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contingent consideration:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in estimate and foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ending</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3 - Liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">452</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">289</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">788</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">595</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"></td><td style="width:64.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.253%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Fair Value of Available for Sale Securities by Maturity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due after one year through three years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2024 the aggregate difference between the cost and fair value of available-for-sale marketable securities was nominal. Interest income on cash and cash equivalents, short-term investments and marketable securities income was $139, $75 and $25 in 2024, 2023 and 2022, which was recorded in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our investments in available-for-sale marketable securities had a minimum credit quality rating of A2 (Moody's), A (Standard &amp; Poor's) and A (Fitch). We do not plan to sell the investments, and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost basis, which may be maturity.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224082768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments</a></td>
<td class="text">DERIVATIVE INSTRUMENTS<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use operational and economic hedges, foreign currency exchange forward contracts, net investment hedges (both derivative and non-derivative financial instruments) and interest rate derivative instruments to manage the impact of currency exchange and interest rate fluctuations on earnings, cash flow and equity. We do not enter into derivative instruments for speculative purposes. We are exposed to potential credit loss in the event of nonperformance by counterparties on our outstanding derivative instruments but do not anticipate nonperformance by any of our counterparties. Should a counterparty default, our maximum loss exposure is the asset balance of the instrument. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign Currency Hedges</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.661%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash Flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Investment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Designated</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,588</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,338</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,164</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,090</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">78</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">148</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash Flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Investment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Designated</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,650</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,662</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,315</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,627</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(20)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We had &#8364;2.3&#160;billion and &#8364;1.5&#160;billion at December 31, 2024 and 2023 in certain forward currency contracts designated as net investment hedges, for which the maximum term is 9.7 years, to hedge a portion of our investments in certain of our entities with functional currencies denominated in Euros. In addition to these derivative financial instruments designated as net investment hedges, we had &#8364;5.0&#160;billion and &#8364;4.9&#160;billion at December 31, 2024 and 2023 of senior unsecured notes designated as net investment hedges to selectively hedge portions of our investment in certain international subsidiaries. The currency effects of our Euro-denominated senior unsecured notes are reflected in AOCI within shareholders' equity where they offset gains and losses recorded on our net investment in international subsidiaries.</span></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2024 we settled certain foreign currency forward contracts designated as net investment hedges resulting in cash proceeds of $99. The amounts in AOCI related to settled net investment hedges will remain in AOCI until the hedged investment is either sold or substantially liquidated.</span></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The total after-tax gain (loss) recognized in OCI related to designated net investment hedges was $325 in 2024.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:28.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.440%"></td><td style="width:0.1%"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Currency Exchange Rate Gains (Losses) Recognized in Net Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recognized in:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net Investment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-Designated</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">106</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">98</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">92</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pretax gains (losses) on derivatives designated as cash flow hedges of $14 and net investment hedges of $43 recorded in AOCI are expected to be reclassified to cost of sales and other income (expense), net in earnings within 12 months of December&#160;31, 2024. This cash flow hedge reclassification is primarily due to the sale of inventory that includes previously hedged purchases. A component of the AOCI amounts related to net investment hedges is reclassified over the life of the hedge instruments as we elected to exclude the initial value of the component related to the spot-forward difference from the effectiveness assessment. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Interest Rate Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pretax gains of $4 recorded in AOCI related to interest rate hedges closed in conjunction with debt issuances are expected to be reclassified to other income (expense), net in earnings within 12 months of December&#160;31, 2024. The cash flow effect of interest rate hedges is recorded in cash flow from operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-5C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/815/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771222532128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive (Loss) Income (AOCI)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract', window );"><strong>Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive (Loss) Income (AOCI)</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME (AOCI)<div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:26.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Marketable Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedges</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial Statement Translation</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(303)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(221)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(28)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(427)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(416)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(328)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(293)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/220/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224390672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">ACQUISITIONS<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We acquire stock in companies and various assets that continue to support our capital deployment and product development strategies. Cash paid for acquisitions, net of cash acquired was $1,628 and $390  in 2024 and 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2024 we completed various acquisitions for total consideration that includes $1,628 in upfront payments, net of cash acquired, and $400 contingent upon the achievement of certain commercial or clinical milestones. The combined acquisition-date fair values of the contingent milestone payments totaled $208. The acquired companies expand the product portfolios of our Instruments, Endoscopy, Medical and Neuro Cranial businesses within MedSurg and Neurotechnology and our Trauma and Extremities and Joint Replacement businesses within Orthopaedics. The purchase price allocation for our acquisitions are based on preliminary valuations, primarily related to developed technology </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and customer relationships. Goodwill attributable to the acquisitions reflects the strategic benefits of expanding our market presence, diversifying our product portfolio and advancing innovations. This goodwill is not deductible for tax purposes. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 2, 2023 we acquired Cerus for net cash consideration of $289 and up to $225 in future milestone payments that had a fair value of $192 at the acquisition date. Cerus designs, develops and manufactures neurovascular products used for the treatment of hemorrhagic stroke. Cerus is part of our Neurovascular business within MedSurg and Neurotechnology. Goodwill attributable to the acquisition is not deductible for tax purposes.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The purchase price allocations for the acquisitions completed in 2024 and Cerus are:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.956%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.463%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.465%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Purchase Price Allocation of Acquired Net Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cerus</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tangible assets acquired:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price, net of cash acquired of $57 and $7</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,836</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">481</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average amortization period at acquisition (years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The purchase price allocation for Cerus was finalized in the second quarter 2024 with no material adjustments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771325449472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies and Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies and Commitments</a></td>
<td class="text">CONTINGENCIES AND COMMITMENTS<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are involved in various ongoing proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor, intellectual property and other matters, the most significant of which are more fully described below. The outcomes of these matters will generally not be known for prolonged periods of time. In certain of the legal proceedings the claimants seek damages as well as other compensatory and equitable relief that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief. For legal matters for which management had sufficient information to reasonably estimate our future obligations, a liability representing management's best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, is recorded. The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those estimated by management, additional expense may be incurred, which could unfavorably affect future operating results. We are self-insured for certain claims and expenses. The ultimate cost to us with respect to product liability claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.</span></div><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are currently investigating whether certain business activities in certain foreign countries violated provisions of the FCPA and have engaged outside counsel to conduct these investigations. We have been contacted by the United States Securities and Exchange Commission, United States Department of Justice and certain other regulatory authorities and are cooperating with these agencies. At this time we are unable to predict the outcome of the investigations or the potential impact, if any, on our financial statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have conducted voluntary recalls of certain products, including our Rejuvenate and ABG II Modular-Neck hip stems and certain lot-specific sizes and offsets of LFIT Anatomic CoCr V40 Femoral Heads. Additionally, we are responsible for certain product liability claims, primarily related to certain hip products sold by Wright prior to its 2014 divestiture of the OrthoRecon business.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have incurred, and expect to incur in the future, costs associated with the defense and settlement of claims and lawsuits. Based on the information that has been received related to the matters discussed above, we recorded charges of $17 in 2024 and our accrual for these matters was $202 at December&#160;31, 2024, representing our best estimate of probable loss. The final outcomes of these matters are dependent on many factors that are difficult to predict. Accordingly the ultimate cost related to these matters may be materially different than the amount of our current estimate and accruals and could have a material adverse effect on our results of operations and cash flows.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Leases</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment under operating leases. We evaluate our contracts to identify leases, which is generally if there is an identified asset and we have the right to direct the use of and obtain substantially all of the economic benefit from the use of the identified asset. Certain of our lease agreements contain rent escalation clauses (including index-based escalations), rent holidays, capital improvement funding or other lease incentives. We recognize our minimum rental expense on a straight-line basis over the term of the lease beginning with the date of initial control of the asset. Right-of-use assets are recorded in Other noncurrent assets on our Consolidated Balance Sheets. Current and noncurrent lease liabilities are recorded in Accrued expenses and other liabilities and Other noncurrent liabilities, respectively.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have made certain significant assumptions and judgments when recording leases. For all asset classes, we do not recognize a right-of-use asset and lease liability for short-term leases. We also do not separate non-lease components from lease components to which they relate and account for the combined lease and non-lease components as a single lease component. The determination of the discount rate used in a lease is our incremental borrowing rate which is based on what we would normally pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"></td><td style="width:58.493%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.376%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.253%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.378%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-816"><span style="-sec-ix-hidden:f-817">Right-of-use assets</span></span> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-820"><span style="-sec-ix-hidden:f-821">Lease liabilities, current</span></span> </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-824"><span style="-sec-ix-hidden:f-825">Lease liabilities, noncurrent</span></span> </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;text-indent:-0.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.5</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease expense totaled $190, $172, and $149 in 2024, 2023 and 2022.</span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Future Obligations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have purchase commitments for materials, supplies, services and property, plant and equipment as part of the normal course of business. In addition, we lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment under operating leases. Refer to Note 10 for more information on the debt obligations.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2029</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt repayments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,823&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Minimum lease payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Other Contractual Obligations and Commitments</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We participate in a supplier financing program that enables our suppliers, at their sole discretion, to sell their Stryker receivables to a financial institution on a non-recourse basis in order to be paid earlier than our payment terms provide. Under this program, we agree to pay participating banks the stated amount of confirmed invoices from its designated suppliers on the original maturity dates of the invoices, generally within 90 days of the invoice date. We or the banks may agree to terminate the agreements with advance notice. Separately, the banks may have arrangements with the suppliers that provide them the option to request early payment from the bank for invoices confirmed by us. Our outstanding balances of confirmed invoices in the programs were $71 and $51 in 2024 and 2023 and are included within <span style="-sec-ix-hidden:f-856"><span style="-sec-ix-hidden:f-857"><span style="-sec-ix-hidden:f-858">Accounts payable</span></span></span> of the consolidated balance sheets. </span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning confirmed obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(372)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending confirmed obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">71</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771226312080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In our annual impairment tests of goodwill as of October 31, 2024 and 2023 we performed a quantitative assessment of the Spine reporting unit using a discounted cash flow analysis to estimate the fair value. Significant inputs to the analysis included assumptions for future revenue growth and operating margin. The analysis also included a rate to discount the estimated future cash flow projections to their present value based on the reporting unit&#8217;s estimated weighted average cost of capital. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2024 the carrying value of the Spine reporting unit exceeded its fair value and a charge of $273 was recognized in goodwill and other impairments in the Consolidated Statements of Earnings. The impairment charge for the Spine reporting unit was driven by a decrease in future product demand due to the competitive environment and an increase in the Spine reporting unit&#8217;s weighted average cost of capital. Subsequent to the annual goodwill impairment test management committed to a plan to sell certain assets associated with&#8239;the Spinal Implants business (disposal group).&#8239;Goodwill was allocated to the disposal group based on the relative fair values of the disposal group and the portion of the Spine reporting unit that will be retained. Goodwill allocated to the disposal group was tested for impairment which resulted in an impairment charge of $183 recognized in goodwill and other impairments. Refer to Note 16 for additional information on the assets classified as held for sale. For our annual impairment test in 2023 we also elected to perform a quantitative assessment. As a result of that assessment we concluded that the goodwill of the Spine reporting unit was not impaired in 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For our other reporting units, we considered qualitative indicators of impairment as it was considered more likely than not that the fair values of those reporting units exceeded their respective carrying values. No impairment was identified for those reporting units in 2024 or 2023. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill, including discount and tax rates and future cash flow projections, could result in significantly different estimates of the fair values. A significant reduction in the estimated fair values could result in impairment charges that could materially affect our results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill of $117 previously reported within Orthopaedics was reclassified to MedSurg and Neurotechnology to reflect the reclassification of the interventional spine reporting unit from Orthopaedics to MedSurg and Neurotechnology to align with certain updates in our internal reporting structure. Goodwill recorded in the first three quarters of 2024 related to interventional spine is presented in the additions and adjustments line within MedSurg and Neurotechnology. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.132%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Changes in the Net Carrying Value of Goodwill by Segment</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,935</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,945</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,880</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,270</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,973</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15,243</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,208</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,647</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15,855</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.394%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:23.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.132%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Other Intangible Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less<br/>Accumulated<br/>Amortization</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Developed technologies</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Customer relationships</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,055&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Patents</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Trademarks</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">In-process research and development</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,416</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,021</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,395</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,549</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,956</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,593</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:19.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.787%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Amortization Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2029</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771227931760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CapitalStockAbstract', window );"><strong>Capital Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Capital Stock</a></td>
<td class="text">CAPITAL STOCK<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate number of shares of all classes of stock which we are authorized to issue is up to 1,000,500,000, divided into two classes consisting of 500,000 shares of $1 par value preferred stock and 1,000,000,000 shares of common stock with a par </span></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">value of $0.10. No shares of preferred stock were outstanding on December&#160;31, 2024.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We made no repurchases of shares in 2024. The manner, timing and amount of repurchases are determined by management based on an evaluation of market conditions, stock price and other factors and are subject to regulatory considerations. Purchases are made from time-to-time in the open market, in privately negotiated transactions or otherwise. On December&#160;31, 2024 the total dollar value of shares that could be purchased under our authorized repurchase program was $1,033.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares reserved for future compensation grants of our common stock were 18&#160;million and 20&#160;million&#160;on December&#160;31, 2024 and 2023. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We measure the cost of employee stock options based on the grant-date fair value and recognize that cost using the straight-line method over the period in which a recipient is required to provide services in exchange for the options, typically the vesting period. The weighted-average fair value per share of options is estimated on the date of grant using the Black-Scholes option pricing model. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Option Value and Assumptions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average fair value per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118.22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">83.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68.08&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected option life (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.9</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The risk-free interest rate for periods within the expected life of options granted is based on the United States Treasury yield curve in effect at the time of grant. Expected stock price volatility is based on the historical volatility of our stock. The expected option life, representing the period of time that options granted are expected to be outstanding, is based on historical option exercise and employee termination data. </span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:22.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.196%"></td><td style="width:0.1%"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">2024 Stock Option Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares <br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Term (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding January&#160;1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">189.70</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">339.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">134.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">274.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding December&#160;31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">214.87</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,572.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercisable December&#160;31</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">175.39&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,223.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options expected to vest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">275.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">331.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options, which represents the cumulative difference between the fair market value of the underlying common stock and the option exercise prices, exercised was $362, $318 and $218 in 2024, 2023 and 2022. Exercise prices for options outstanding ranged from $92.24 to $339.77 on December&#160;31, 2024. On December&#160;31, 2024 there was $159 of unrecognized compensation cost related to nonvested stock options granted under the long-term incentive plans. That cost is expected to be recognized as expense over the weighted-average period of approximately 1.5 years.</span></div></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.405%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.405%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.129%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.135%"></td><td style="width:0.1%"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares<br/>(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant&#160;Date Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">246.98</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">250.17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">332.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">305.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">244.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">233.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">276.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">233.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on December 31</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">290.58</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">287.51</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2024 there was $90 of unrecognized compensation cost related to nonvested RSUs. That cost is expected to be recognized as expense over the weighted-average period of approximately one year. The weighted-average grant date fair value per share of RSUs granted was $332.64 and $257.09 in 2024 and 2023. The fair value of RSUs and PSUs vested in 2024 was $81 and $23. On December&#160;31, 2024 there was $23 of unrecognized compensation cost related to nonvested PSUs. That cost is expected to be recognized as expense over the weighted-average period of approximately one year. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Employee Stock Purchase Plans (ESPP)</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Employees may participate in our ESPP provided they meet certain eligibility requirements. The purchase price for our common stock under the terms of the ESPP is defined as 95% of the closing stock price on the last trading day of a purchase period. We issued 173,708 and 190,524 shares under the ESPP in 2024 and 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_CapitalStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Stock [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_CapitalStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224784368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Credit Facilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-Term Debt, Unclassified [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt And Credit Facilities</a></td>
<td class="text">DEBT AND CREDIT FACILITIES<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have lines of credit issued by various financial institutions that are available to fund our day-to-day operating needs. Certain of our credit facilities require us to comply with financial and other covenants. We were in compliance with all covenants on December&#160;31, 2024. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2024 there were no borrowings outstanding under our revolving credit facility or our commercial paper program which allows for maturities up to 397 days from the date of issuance. The maximum amount of our commercial paper that can be outstanding at any time is $2,250. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In May 2024 we repaid the outstanding $600 principal amount of the 3.375% senior unsecured notes due May 15, 2024. In September 2024 we issued $750 of 4.250% senior unsecured notes due September 11, 2029, &#8364;800 of 3.375% senior unsecured notes due September 11, 2032, $750 of 4.625% senior unsecured notes due September 11, 2034 and &#8364;600 of 3.625% senior unsecured notes due September 11, 2036. In November 2024 we repaid the outstanding &#8364;500 of floating rate senior notes and in December 2024 we repaid &#8364;850 of 0.250% senior unsecured notes. The following table summarizes our total debt at December 31:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:0.1%"></td><td style="width:2.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:57.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.460%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.463%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Total Debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Due</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Senior unsecured notes:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 16, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.250%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.150%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 1, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.500%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.125%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.650%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 7, 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.850%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 8, 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 11, 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.750%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 1, 2029</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.250%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 11, 2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.950%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2030</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.625%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.000%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2031</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 11, 2032</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.625%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 11, 2034</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.625%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 11, 2036</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.100%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 1, 2043</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.375%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2044</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.625%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2046</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.900%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2050</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,597</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,995</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less current maturities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,188</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,901</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="12" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Borrowing capacity on existing facilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of senior unsecured notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of the senior unsecured notes was estimated using quoted interest rates, maturities and amounts of borrowings based on quoted active market prices and yields that took into account the underlying terms of the debt instruments. Substantially all of our debt is classified within Level 2 of the fair value hierarchy.</span></div>Interest expense on outstanding debt and credit facilities, including required fees incurred, that were included in other income (expense), net, totaled $396, $356, and $337 in 2024, 2023 and 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771227929232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES<span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our effective tax rate was 14.3%, 13.8% and 12.1% for 2024, 2023 and 2022. The effective income tax rate for 2024 increased from 2023 due to the 2024 deferred tax benefit on the outside basis difference related to the anticipated sale of the Spinal Implants business partially offset by the 2023 tax effect related to transfers of intellectual property between tax jurisdictions. The effective income tax rate for 2023 increased from 2022 due to the 2022 effective settlement of the United States federal income tax audit for years 2014 through 2018 and the 2022 reversal of deferred income tax on undistributed earnings of foreign subsidiaries partially offset by the 2023 tax effect related to transfers of intellectual property between tax jurisdictions. Additionally, the effective income tax rates for 2024, 2023 and 2022 reflect the continued lower effective income tax rates as a result of our European operations and certain discrete tax items.  </span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Effective Income Tax Rate Reconciliation</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local income taxes, less federal deduction</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign income tax at rates other than 21%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax related to repatriation of foreign earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intellectual property transfers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal audit settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Outside basis difference related to the anticipated sale of the Spinal Implants business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Earnings Before Income Taxes&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,969&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,972&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,276&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,492</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,673</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,683</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Income Tax Expense (Benefit)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current income tax expense (benefit):</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total current income tax expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">869</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">714</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax expense (benefit):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(30)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax expense (benefit)</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(370)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(206)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">58</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">499</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">508</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">325</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest included in other income (expense), net was expense of $13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$1 in 2024 and 2023 and income of $71 in 2022. The United States federal deferred income tax expense (benefit) includes the utilization of net operating loss carryforwards of $9, $189 and $56 in 2024, 2023 and 2022.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Deferred Income Tax Assets and Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development capitalization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International interest expense carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Outside basis difference related to the anticipated sale of the Spinal Implants business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,090</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,889</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less valuation allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,862</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,666</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,012)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Undistributed earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,202)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,059)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,660</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,607</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent deferred income tax assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,660</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,607</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued interest was $71 and $67 on December&#160;31, 2024 and 2023 which was reported in accrued expenses and other liabilities and other noncurrent liabilities.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">United States federal loss carryforwards of $335, with $70 of associated deferred tax asset and with $2 being subject to a valuation allowance, begin to expire in 2025. United States state loss carryforwards of $3,480, with $85 associated deferred tax asset and with $49 being subject to a valuation allowance, begin to expire in 2025. International loss carryforwards of $269, with $69 of associated deferred tax asset and with $63 being subject to a valuation allowance, begin to expire in 2026; however, some have no expiration. We also have tax credit carryforwards of $204 with $83 being subject to a full valuation allowance. The credits with a full valuation allowance begin to expire in 2025. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We recorded deferred income tax on undistributed earnings of foreign subsidiaries not determined to be indefinitely reinvested. In 2022 it was determined that, based on our revised capital plan, certain cash outside the United States would no longer need to be repatriated during the period previously contemplated. As a result deferred taxes of $71 that were recorded on the associated earnings were reversed. The amount of undistributed earnings of foreign subsidiaries determined to be indefinitely reinvested at December 31, 2024 was approximately $10&#160;billion. Determination of the total amount of unrecognized deferred income tax on undistributed earnings of foreign subsidiaries is not practicable.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Uncertain Income Tax Positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning uncertain tax positions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">371</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">286</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to current year income tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to prior year income tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Decreases related to prior year income tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(33)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements of income tax audits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Statute of limitations expirations and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending uncertain tax positions</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">349</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">371</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our income tax expense would have been reduced by $224 and $248 in 2024 and 2023 had these uncertain income tax positions been favorably resolved. It is reasonably possible that the amount of unrecognized tax benefits will significantly change due to one or more of the following events in the next 12 months: expiring statutes, audit activity, tax payments, competent authority proceedings related to transfer pricing or final decisions in matters that are the subject of controversy in various taxing jurisdictions in which we operate, including inventory transfer pricing, cost sharing, product royalty and foreign branch arrangements. We are not able to reasonably estimate the amount or the future periods in which changes in unrecognized tax benefits may be resolved. Interest incurred associated with uncertain tax positions is included in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the normal course of business, income tax authorities in various income tax jurisdictions both within the United States and internationally conduct routine audits of our income tax returns filed in prior years. These audits are generally designed to determine if individual income tax authorities are in agreement with our interpretations of complex income tax regulations regarding the allocation of income to the various income tax jurisdictions. Any income tax audit assessment or draft income tax audit assessment received at the conclusion of an audit is reviewed and evaluated for proper financial statement treatment. We have not received any audit assessments or draft assessments that have not been reviewed and evaluated.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income tax expense in 2022 decreased $162 due to the effective settlement of the United States federal income tax audit for years 2014 through 2018. In addition 2022 other income (expense), net includes a benefit of $50 related to the release of accrued interest </span></div></div></div>associated with this settlement. Income tax years are open from 2019 through the current year for the United States federal jurisdiction. Income tax years open for our other major jurisdictions range from 2010 through the current year.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224096768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Retirement Plans</a></td>
<td class="text">RETIREMENT PLANS<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide certain employees with defined contribution plans and other types of retirement plans. A portion of our retirement plan expense under the defined contribution plans is funded with Stryker common stock. The use of Stryker common stock represents a non-cash operating activity that is not reflected in our Consolidated Statements of Cash Flows.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:61.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expense funded with Stryker common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stryker common stock held by plan:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dollar amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares (in millions)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Value as a percentage of total plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain of our subsidiaries have both funded and unfunded defined benefit pension plans covering some or all of their employees. The majority of our defined benefit pension plans have projected benefit obligations in excess of plan assets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Discount Rate</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The discount rates were selected using a hypothetical portfolio of high quality bonds on December 31 that would provide the necessary cash flows to match our projected benefit payments. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Expected Return on Plan Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected return on plan assets is determined by applying the target allocation in each asset category of plan investments to the anticipated return for each asset category based on historical and projected returns. </span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:61.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Net Periodic Pension Cost</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(41)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(32)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(59)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Changes in assets and benefit obligations recognized in OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net actuarial gain (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized net actuarial (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prior service credit and transition amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in other comprehensive income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">43</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">252</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in net periodic benefit cost and OCI</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(104)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">193</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-average rates used to determine net periodic benefit cost:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate used to determine projected benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The actuarial gain (loss) for all pension plans was primarily related to a change in the discount rate used to measure the benefit obligations of those plans.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Investment Strategy</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The investment strategy for our defined benefit pension plans is to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk </span></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">tolerances.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(782)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(826)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(290)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(341)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent assets&#8212;other assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current liabilities&#8212;accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pre-tax amounts recognized in AOCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized net actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(28)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Benefit Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning projected benefit obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">826</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">673</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial (gains) losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending projected benefit obligations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">782</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">826</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending accumulated benefit obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">748</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">790</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">485</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">420</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actual return</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending fair value of plan assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">492</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">485</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:33.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Allocation of Plan Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025 Target</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024 Actual</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023 Actual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Valuation of Plan Assets </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">404</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">57</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">492</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">378</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">485</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Level 3 pension plan assets primarily include guaranteed investment contracts with insurance companies. The insurance contracts guarantee us principal repayment and a fixed rate of return. The $8 decrease in Level 3 pension plan assets is primarily driven by the change in the corresponding pension liability. We expect to contribute $21 to our defined benefit pension plans in 2025.</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Future Benefit Payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2029</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2030-2034</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/715/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480126/715-20-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480266/715-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224089536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Quarterly Data (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialDataAbstract', window );"><strong>Quarterly Financial Data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Summary of Quarterly Data (Unaudited)</a></td>
<td class="text">SUMMARY OF QUARTERLY DATA (UNAUDITED)<div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024 Quarters</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,243</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,422</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,494</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,436</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,043&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">788</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">825</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">834</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">546</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023 Quarters</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,778</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,996</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,909</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,815</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">592</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">738</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">692</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,143</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 270<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/270/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771222712928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Data<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment and Geographic Data</a></td>
<td class="text">SEGMENT AND GEOGRAPHIC DATA<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 1, 2024 we adopted ASU 2023-07, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which expands disclosure requirements to require entities to disclose significant segment expenses that are regularly provided to or easily computed from information regularly provided to the chief operating decision maker. We have updated our disclosures to include our significant segment expenses that are regularly provided to our chief operating decision maker (CODM).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We segregate our operations into two reportable business segments: (i) MedSurg and Neurotechnology and (ii) Orthopaedics which aligns to our internal reporting structure and how our CODM assesses the performance of and allocates resources. The CODM is the Chief Executive Officer. The CODM makes decisions on resource allocation, assesses performance of the business, and monitors budget versus actual results using segment operating income. Our reportable segments and related disclosures reflect certain reclassifications of prior year amounts from our Orthopaedics segment to our MedSurg and Neurotechnology segment due to changes in our internal reporting structure.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Corporate and Other category shown in the table below includes corporate and administration, corporate initiatives and share-based compensation, which includes compensation related to employee stock options, restricted stock units and performance stock unit grants and director stock options and restricted stock unit grants.</span></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Results</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,595</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,498</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,876&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,637&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cost of sales </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,720</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,130</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,557</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment research, development and engineering expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,324</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,210</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,159</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment selling, general and administrative expenses </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,314</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,856</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,172</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">641</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">567</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">528</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,426</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,341</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,278</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,595</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,735</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,033</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Items not allocated to segments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(780)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(649)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped up to fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(623)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(627)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Structural optimization and other special charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(295)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill and other impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(977)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(270)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,689</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,888</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,841</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.949%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.949%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Assets and Capital Spending</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23,115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">41,622</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">38,827</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42,971</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">39,912</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchases of property, plant and equipment:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">506</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">362</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">348</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">755</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">575</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">588</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We measure the financial results of our reportable segments using an internal performance measure that excludes acquisition and integration-related charges, structural optimization and other special charges, goodwill and other impairments, reserves for certain product recall matters and reserves for certain legal and regulatory matters. Identifiable assets are those assets used exclusively in the operations of each business segment or allocated when used jointly. Corporate assets are principally property, plant and equipment and noncurrent assets. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The countries in which we have local revenue generating operations have been combined into the following geographic areas: the United States; Europe, Middle East, Africa; Asia Pacific; and other foreign countries, which include Canada and countries in the Latin American region. Net sales are reported based on the geographic area of the Stryker location where the sales to the customer originated. </span></div></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.762%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.949%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.949%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Geographic Information</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Property, Plant and Equipment</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16,943&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,946&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,595</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,498</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,448</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,215</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771222471376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Impairments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentChargesTextBlock', window );">Asset Impairments</a></td>
<td class="text">ASSET IMPAIRMENTSDuring 2024, 2023 and 2022 we recorded impairment charges of $159, $36 and $54 to write off long-lived and intangible assets excluding long-lived assets held for sale which included charges related to certain product line exits<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentChargesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentChargesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771223657040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets Held for Sale<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Assets Held for Sale</a></td>
<td class="text">ASSETS HELD FOR SALE<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the fourth quarter 2024 management committed to a plan to sell certain assets associated with the Spinal Implants business and such assets were classified as held for sale beginning November 2024. As a result we recognized an estimated loss of $362 to record the disposal group at its fair value less cost to sell within goodwill and other impairments in our Consolidated Statements of Earnings. The fair value of the disposal group was measured using a discounted cash flow analysis based upon unobservable inputs, such as estimated selling price derived from Company-specific information, market conditions and the rate used to discount the estimated future cash flows to their present value based on factors including the disposal group&#8217;s cost of equity and market yield rates, which are Level 3 inputs. Future changes in the judgments, assumptions and estimates that are used in our fair value estimate, including discount rates and cash flow projections, could result in a significantly different estimate of fair value. In January 2025 we entered into a definitive agreement to sell the Spinal Implants disposal group as further discussed in Note 17. The terms of the definitive agreement were materially the same as those considered as inputs to the valuation of the disposal group at December 31, 2024. A change in the amount or timing of consideration received could increase the fair value by up to $84 or decrease the fair value by up to $218.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A valuation allowance was recorded to reflect the estimated loss on the disposal group. The assets associated with the Spinal Implants disposal group are reported in our Orthopaedics segment. The assets and liabilities held for sale are classified within prepaid expenses and other current assets and accrued expenses and other liabilities in our Consolidated Balance Sheets and included the following as of December 31, 2024:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total inventories </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">183</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Property, plant and equipment, net </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangibles, net </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">326</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent deferred income tax assets </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Valuation allowance </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets held for sale </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">450</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts payable </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued compensation </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">104</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205-20/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771226331920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">SUBSEQUENT EVENTS<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In January 2025 we announced a definitive merger agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. (Inari). Pursuant to the agreement we commenced a tender offer to purchase all of the outstanding shares of common stock of Inari for $80 per share in cash, or an aggregate purchase price of approximately $4.9&#160;billion. The boards of directors of both Stryker and Inari have unanimously approved the transaction. We expect the acquisition to close in the first quarter of 2025, subject to completion of the tender offer and other customary closing conditions. Inari&#8217;s product portfolio includes mechanical thrombectomy solutions for peripheral vascular diseases such as deep vein thrombosis and pulmonary embolism. Following closing, we plan to integrate Inari into our MedSurg and Neurotechnology segment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In January 2025 we announced a definitive agreement to sell our United States Spinal Implants business to Viscogliosi Brothers, LLC. The definitive agreement includes a binding offer to sell our Spinal Implants business in France, subject to required consultations with employees and employee representatives. We expect the sale of the United States business to close in the first half of 2025, subject to customary closing conditions. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In February 2025 we issued $500 of 4.550% senior unsecured notes due February 10, 2027, $700 of 4.700% senior unsecured notes due February 10, 2028, $800 of 4.850% senior unsecured notes due February 10, 2030 and $1,000 of 5.200% senior unsecured notes due February 10, 2035. We intend to use the net proceeds from the notes due in 2030 and 2035, together with cash on hand or other immediately available funds, to consummate the Inari Tender Offer and to pay related fees and expenses. We intend to use the net proceeds from the notes due in 2027 and 2028 for general corporate purposes, which may include working capital, other acquisitions  and repayment of indebtedness.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771226613456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II Valuation and Qualifying Accounts (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:4.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.254%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.754%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial Statements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The following Consolidated Financial Statements are set forth in Part II, Item 8 of this report.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Report of Independent Registered Public Accounting Firm</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1442ddc197954361b38cabd10df2e256_79" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">25</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Earnings for 2024, 2023 and 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1442ddc197954361b38cabd10df2e256_82" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">26</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Comprehensive Income for 2024, 2023 and 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1442ddc197954361b38cabd10df2e256_88" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">26</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Balance Sheets on 2024 and 2023</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1442ddc197954361b38cabd10df2e256_91" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">27</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Shareholders&#8217; Equity for 2024, 2023 and 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1442ddc197954361b38cabd10df2e256_94" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">28</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Cash Flows for 2024, 2023 and 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1442ddc197954361b38cabd10df2e256_97" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">29</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes to Consolidated Financial Statements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1442ddc197954361b38cabd10df2e256_100" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">30</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) 2.</span></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial Statement Schedules</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Consolidated Financial Statement schedule of Stryker Corporation and its subsidiaries is:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Costs &amp;<br/>Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Uncollectible Amounts Written Off, Net of Recoveries</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Changes in Foreign Currency Exchange Rates</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance<br/>at End<br/>of Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DEDUCTED FROM ASSET ACCOUNTS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for Doubtful Accounts:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other schedules for which provision is made in the applicable accounting regulation of the United States Securities and Exchange Commission are not required under the related instructions or are inapplicable and, therefore, have been omitted.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771226404032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 546<span></span>
</td>
<td class="nump">$ 834<span></span>
</td>
<td class="nump">$ 825<span></span>
</td>
<td class="nump">$ 788<span></span>
</td>
<td class="nump">$ 1,143<span></span>
</td>
<td class="nump">$ 692<span></span>
</td>
<td class="nump">$ 738<span></span>
</td>
<td class="nump">$ 592<span></span>
</td>
<td class="nump">$ 2,993<span></span>
</td>
<td class="nump">$ 3,165<span></span>
</td>
<td class="nump">$ 2,358<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771222373840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771226489584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771226587296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text">We review cybersecurity risk as part of our overall enterprise risk management program. This ensures that cybersecurity risk management remains a top priority in our business strategy and operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text">Primary management responsibility for assessing, monitoring and managing our cybersecurity risks rests with our chief information security officer ("CISO"). Our current CISO has over 30 years of experience in information technology including over 20 years in cybersecurity and oversees a team of cybersecurity professionals with over 140 security, risk, and compliance certifications. The CISO is regularly informed about recent developments in cybersecurity, including potential threats and innovative risk management techniques.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text">Cybersecurity risks are overseen by the full Board of Directors and the Audit Committee. The Audit Committee is central to the Board of Directors&#8217; oversight of cybersecurity risks and bears the primary responsibility for overseeing cybersecurity risk. The Audit Committee actively participates in strategic decisions related to cybersecurity, offering guidance and approval for major cybersecurity initiatives. This involvement ensures that cybersecurity considerations are integrated into our broader strategic objectives.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">Cybersecurity risks are overseen by the full Board of Directors and the Audit Committee. The Audit Committee is central to the Board of Directors&#8217; oversight of cybersecurity risks and bears the primary responsibility for overseeing cybersecurity risk. The Audit Committee actively participates in strategic decisions related to cybersecurity, offering guidance and approval for major cybersecurity initiatives. This involvement ensures that cybersecurity considerations are integrated into our broader strategic objectives.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our CISO provides comprehensive updates to the Audit Committee quarterly and the full Board of Directors periodically. These briefings include a range of topics, including:</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Current cybersecurity landscape and emerging threats&#894;</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Status of ongoing cybersecurity initiatives and strategies&#894;</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Incident reports and learnings from any cybersecurity events&#894; </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Metrics demonstrating company and industry-standard prevention of common threats; and</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Regulatory changes impacting cybersecurity requirements and strategy.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Primary management responsibility for assessing, monitoring and managing our cybersecurity risks rests with our chief information security officer ("CISO"). Our current CISO has over 30 years of experience in information technology including over 20 years in cybersecurity and oversees a team of cybersecurity professionals with over 140 security, risk, and compliance certifications. The CISO is regularly informed about recent developments in cybersecurity, including potential threats and innovative risk management techniques. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CISO implements and oversees processes for the regular monitoring of our information systems. We use various tools and methodologies to manage cybersecurity risk that are tested regularly. We also monitor and evaluate our cybersecurity posture and performance on an ongoing basis through regular vulnerability scans, penetration tests and threat intelligence feeds. In addition, we engage third-party consultants to conduct annual cybersecurity assessments and to conduct audits for compliance with regulatory, Sarbanes-Oxley Act, Service Organization Control Type 2 and</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">International Organization for Standardization standards. We also engage third parties to assess our cybersecurity maturity and risk management programs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use a cross-departmental approach to addressing cybersecurity risk, with our cybersecurity, product security and legal teams presenting quarterly on key topics to a committee of leaders in finance, regulatory, and corporate affairs functions. This leadership committee meets quarterly to ensure that we have input and oversight from critical stakeholders into our cybersecurity program and evolving issues.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CISO oversees a training and awareness program for employees to take part in protecting the Company against cybersecurity risks. We have implemented annual mandatory security education to help employees understand cybersecurity risks and comply with our cybersecurity policies. Additionally, we provide frequent communications around pertinent cybersecurity topics and policies to all employees. We also provide additional </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cybersecurity and data protection training to employees in certain roles. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As part of our cybersecurity risk management program, we also conduct cybersecurity and privacy assessments on all third parties who integrate with Stryker&#8217;s data, network, systems and products. We use a combination of internal and external tools to confirm that these third parties meet our security requirements. We leverage standard industry threat model and privacy impact assessment concepts to confirm that data minimization and adequate data protections are in place. We perform supplemental reviews as necessary, commensurate with the risk associated with each vendor.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the event of a cybersecurity incident, we have an incident response plan that includes immediate actions to mitigate the impact and long-term strategies for remediation and prevention of future incidents. The cybersecurity and product security teams routinely practice this plan with functions across the organization. We conduct tabletop exercises with senior management, during which we practice the procedures in place to ensure that potentially material cybersecurity risks and incidents are escalated to management and the Board of Directors where applicable.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text">Primary management responsibility for assessing, monitoring and managing our cybersecurity risks rests with our chief information security officer ("CISO")<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text">Our current CISO has over 30 years of experience in information technology including over 20 years in cybersecurity and oversees a team of cybersecurity professionals with over 140 security, risk, and compliance certifications. The CISO is regularly informed about recent developments in cybersecurity, including potential threats and innovative risk management techniques.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CISO oversees a training and awareness program for employees to take part in protecting the Company against cybersecurity risks. We have implemented annual mandatory security education to help employees understand cybersecurity risks and comply with our cybersecurity policies. Additionally, we provide frequent communications around pertinent cybersecurity topics and policies to all employees. We also provide additional </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cybersecurity and data protection training to employees in certain roles. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As part of our cybersecurity risk management program, we also conduct cybersecurity and privacy assessments on all third parties who integrate with Stryker&#8217;s data, network, systems and products. We use a combination of internal and external tools to confirm that these third parties meet our security requirements. We leverage standard industry threat model and privacy impact assessment concepts to confirm that data minimization and adequate data protections are in place. We perform supplemental reviews as necessary, commensurate with the risk associated with each vendor.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771225158784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Operations</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker (the "Company," "we," "us," or "our") is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Our products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and artificial intelligence-assisted virtual care platform technology; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties.</span>During the fourth quarter 2024 we changed the name of our &#8220;Orthopaedics and Spine&#8221; operating segment to &#8220;Orthopaedics.&#8221;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation and Consolidation</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Consolidated Financial Statements include the Company and its subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. We have no material interests in variable interest entities. Certain prior year amounts have been reclassified to conform with current year presentation in our Consolidated Financial Statements.</span><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our reportable segments and related disclosures reflect certain reclassifications of prior year amounts from our Orthopaedics segment to our MedSurg and Neurotechnology segment due to changes in our internal reporting structure.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of net sales and expenses in the reporting period. Actual results could differ from those estimates.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales are recognized as the performance obligations to deliver products or services (including services under extended warranty service contracts) are satisfied and are recorded based on the amount of consideration we expect to receive in exchange for satisfying the performance obligations. Our sales are recognized primarily when we transfer control to the customer, which can be on the date of shipment, the date of receipt by the customer or, for most Orthopaedics products, when we have received a purchase order and appropriate notification the product has been used or implanted. Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time.</span><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales represent the amount of consideration we expect to receive from customers in exchange for transferring products and services. Net sales exclude sales, value added and other taxes we collect from customers. Other costs to obtain and fulfill contracts are generally expensed as incurred due to the short-term nature of most of our sales. We extend terms of payment to our customers based on commercially reasonable terms for the markets of our customers, while also considering their credit quality.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A provision for estimated sales returns, discounts and rebates is recognized as a reduction of sales in the same period that the sales are recognized. Our estimate of the provision for sales </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">returns has been established based on contract terms with our customers and historical business practices and current trends. Shipping and handling costs charged to customers are included in net sales.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Sales</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of sales include direct materials and supplies consumed in the manufacture of product, as well as manufacturing labor, depreciation expense and direct overhead expense necessary to acquire and convert the purchased materials and supplies into finished product. Cost of sales also includes the cost to distribute products to customers, inbound freight costs, warehousing costs and other shipping and handling activity.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research, Development and Engineering Expenses</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research, development and engineering costs are charged to expense as incurred and include research, development and engineering activities relating to the development of new products, improvement of existing products, technical support of products and compliance with governmental regulations for the protection of customers and patients. Costs primarily include salaries, wages, consulting and depreciation and maintenance of research facilities and equipment.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">Selling, General and Administrative Expenses</a></td>
<td class="text">include selling expenses, marketing expenses, administrative and other indirect overhead costs, amortization of loaner instrumentation, depreciation and amortization expense of non-manufacturing assets and other miscellaneous operating items.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Currency Translation</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial statements of subsidiaries outside the United States generally are measured using the local currency as the functional currency. Adjustments to translate those statements into United States Dollars are recorded in other comprehensive income (OCI). Transactional exchange gains and losses are included in other income (expense), net.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Highly liquid investments with remaining stated maturities of three months or less when purchased or other money market instruments that are redeemable upon demand are considered cash equivalents and recorded at cost.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_ShortTermInvestmentsPolicyPolicyTextBlock', window );">Short-term Investments</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Short-term investments that have a maturity greater than three months and less than a year from the date of purchase primarily include time deposits, certificates of deposit, commercial paper, bonds and notes, substantially all of which are denominated in United States Dollars and are stated at cost plus accrued interest, which approximates fair value. We expect to hold all of our short-term investments to maturity.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities include marketable debt securities and mutual funds. Mutual funds are acquired to offset changes in certain liabilities related to deferred compensation arrangements and are expected to be used to settle these liabilities and are recognized in other noncurrent assets. Pursuant to our investment policy, all individual marketable security investments must have a minimum credit quality of single A (Standard&#160;&amp; Poor&#8217;s and Fitch) and A2 (Moody&#8217;s Corporation) at the time of acquisition, while the overall portfolio of marketable securities must maintain a minimum average credit quality of double A (Standard&#160;&amp; Poor&#8217;s and Fitch) or Aa (Moody&#8217;s Corporation). In the event of a rating downgrade below the minimum credit quality subsequent to purchase, the marketable security investment is evaluated to determine the appropriate action to take to minimize the overall risk to our marketable security investment portfolio. Our marketable securities are classified as available-for-sale and trading securities. Investments in trading securities represent participant-directed investments of deferred employee compensation.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable include trade and other miscellaneous receivables. An allowance is maintained for doubtful accounts for estimated losses in the collection of accounts receivable. Estimates are made regarding the ability of customers to make required payments based on historical credit experience, current market conditions and expected credit losses. Accounts receivable are written off when all reasonable collection efforts are exhausted.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value, with cost generally determined using the first-in, first-out (FIFO) cost method. For excess and obsolete inventory resulting from the potential inability to sell specific products at prices in excess of current carrying costs, reserves are maintained to reduce current carrying cost to net realizable value.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionTextBlock', window );">Financial Instruments</a></td>
<td class="text">Our financial instruments include cash, cash equivalents, marketable securities, accounts receivable, other investments, accounts payable, debt and foreign currency exchange contracts. The carrying value of our financial instruments, with the exception of our senior unsecured notes, approximates fair value on December&#160;31, 2024 and 2023. Refer to Notes 3 and 10 for further details. <div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All marketable securities are recognized at fair value. Adjustments to the fair value of marketable securities that are classified as available-for-sale are recognized as increases or decreases, net of income taxes, within accumulated other comprehensive income (AOCI) in shareholders&#8217; equity and adjustments to the fair value of marketable securities that are classified as trading are recognized in earnings. The amortized cost of marketable debt securities is adjusted for amortization of premiums and discounts to maturity computed under the effective interest method. Such amortization and interest and realized gains and losses are included in other income (expense), net. The cost of securities sold is determined by the specific identification method.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review declines in the fair value of our investments classified as available-for-sale to determine whether the decline in fair value is a result of credit loss or other factors. Impairments of available-for-sale marketable debt securities related to credit loss are included in earnings and impairments related to other factors are recognized within AOCI.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives</a></td>
<td class="text">All derivatives are recognized at fair value and reported on a gross basis. We enter into forward currency exchange contracts to mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, thereby limiting our risk that would otherwise result from changes in exchange rates. The periods of the forward currency exchange contracts correspond to the periods of the exposed transactions, with realized gains and losses included in the measurement and recording of transactions denominated in the nonfunctional currencies. All forward currency exchange contracts are recorded at their fair value each period.<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. These nonfunctional currency exposures principally relate to forecasted intercompany sales and purchases of manufactured products and generally have maturities up to eighteen months. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">earnings and is included in cost of goods sold. Cash flows associated with these hedges are included in cash provided by operating activities in the same category as the cash flows from the items being hedged.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts are used to offset our exposure to the change in value of specific foreign currency denominated assets and liabilities, primarily intercompany payables and receivables. These derivatives are not designated as hedges and, therefore, changes in the value of these forward contracts are recognized in earnings, thereby offsetting the current earnings effect of the related changes in value of foreign currency denominated assets and liabilities. The estimated fair value of our forward currency exchange contracts represents the measurement of the contracts at month-end spot rates as adjusted by current forward points. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate derivative and non-derivative financial instruments as net investment hedges of our investments in certain international subsidiaries. For derivative instruments that are designated and qualify as a net investment hedge, the effective portion of the derivative's gain or loss is recognized in OCI and reported as a component of AOCI. We have elected to use the spot method to assess effectiveness for our derivatives designated as net investment hedges. Accordingly, the change in fair value attributable to changes in the spot rate is recorded in AOCI. We exclude the spot-forward difference from the assessment of hedge effectiveness and amortize this amount separately on a straight-line basis over the term of the forward contracts. This amortization is recognized in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate forward starting interest rate derivative instruments as cash flow hedges to manage the exposure to interest rate volatility with regard to future issuance and refinancing of debt. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into earnings and is included in interest expense within other income (expense), net. </span></div>Interest rate derivative instruments designated as fair value hedges have been used in the past to manage the exposure to interest rate movements and to reduce borrowing costs by converting fixed-rate debt into floating-rate debt. Under these agreements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, plant and equipment is stated at cost. Depreciation is generally computed by the straight-line method over the estimated useful lives of <span style="-sec-ix-hidden:f-409">three</span> to 30 years for buildings and improvements and <span style="-sec-ix-hidden:f-411">three</span> to 15 years for machinery and equipment.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">Goodwill represents the excess of purchase price over fair value of tangible net assets of acquired businesses at the acquisition date, after amounts allocated to other identifiable intangible assets. Factors that contribute to the recognition of goodwill include synergies that are specific to our business and not available to other market participants and are expected to increase net sales and profits; acquisition of a talented workforce; cost savings opportunities; the strategic benefit of expanding our presence in core and adjacent markets; and diversifying our product portfolio.<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of other identifiable intangible assets acquired in a business combination are primarily determined using the income </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">approach. Other intangible assets include, but are not limited to, developed technology, customer and distributor relationships (which reflect expected continued customer or distributor patronage) and trademarks and patents. Intangible assets with determinable useful lives are amortized on a straight-line basis over their estimated useful lives of <span style="-sec-ix-hidden:f-414">four</span> to 40 years. Certain acquired trade names are considered to have indefinite lives and are not amortized, but are assessed annually for potential impairment as described below.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations IPRD is considered to be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions IPRD is expensed immediately unless there is an alternative future use.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock', window );">Goodwill, Intangibles and Long-Lived Asset Impairment Tests</a></td>
<td class="text">We perform our annual impairment test for goodwill as of October 31 each year. We consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill and periodically corroborate that assessment with quantitative information. In certain circumstances, we may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. Indefinite-lived intangible assets are also tested at least annually for impairment by comparing the individual carrying values to the fair value.<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows. Undiscounted cash flows expected to be generated by the related assets are estimated over the asset's useful life based on updated projections. If the evaluation indicates that the carrying amount of the asset may not be recoverable, any potential impairment is measured based upon the fair value of the related asset or asset group as determined by an appropriate market appraisal or other valuation technique.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock', window );">Assets And Liabilities Held For Sale</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">classify assets and liabilities or disposal groups to be sold as held for sale in the period in which all of the following criteria are met: management, having the authority to approve the action, commits to a plan to sell the disposal group; the disposal group is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such disposal groups; an active program to locate a buyer and other actions required to complete the plan to sell the disposal group have been initiated; the sale of the disposal group is probable, and transfer of the disposal group is expected to qualify for recognition as a completed sale within one year, except if events or circumstances beyond our control extend the period of time required to sell the disposal group beyond one year; the disposal group is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.</span><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We initially measure a disposal group that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held for sale criteria are met. Conversely, gains are not recognized on the sale of a disposal group until the sale is completed. We assess the fair value of a disposal group, less any costs to sell, each reporting period it remains classified as held for sale and report any subsequent changes as an adjustment to the carrying value of the disposal group, as long as the new carrying value does not exceed the carrying value of the disposal group at the time it was initially classified as held for sale.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Upon determining that a disposal group meets the criteria to be classified as held for sale, we cease depreciation and amortization of the assets and disclose the major classes of assets and liabilities of the disposal group in the Notes to the Consolidated Financial Statements. Refer to Note 16 for further information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text">hare-based compensation is in the form of stock options, restricted stock units (RSUs) and performance stock units (PSUs). Stock options are granted under long-term incentive plans to certain key employees and non-employee directors at an exercise price not less than the fair market value of the underlying common stock, which is the quoted closing price of our common stock on the day prior to the date of grant. The options are granted for periods of up to 10 years and become exercisable in varying installments.<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We grant RSUs to key employees and non-employee directors and PSUs to certain key employees under our long-term incentive plans. The fair value of RSUs is determined based on the number of shares granted and the quoted closing price of our common stock on the date of grant, adjusted for the fact that RSUs do not include anticipated dividends. RSUs generally vest in one-third increments over a three-year period and are settled in stock. PSUs are earned over a three-year performance cycle and vest in March of the year following the end of that performance cycle. The number of PSUs that will ultimately be earned is based on our performance relative to pre-established goals in that three-year performance cycle. The fair value of PSUs is determined based on the quoted closing price of our common stock on the day of grant.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Compensation expense is recognized in the Consolidated Statements of Earnings based on the estimated fair value of the awards on the grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized associated with such grants will be reversed.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">Deferred income tax assets and liabilities are determined based on differences between financial reporting and income tax bases of assets and liabilities and are measured using the enacted income tax rates in effect for the years in which the differences are expected to reverse. Deferred income tax benefits generally represent the change in net deferred income tax assets and liabilities in the year. Other amounts result from <div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">adjustments related to acquisitions and foreign currency as appropriate.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We operate in multiple income tax jurisdictions both within the United States and internationally. Accordingly, management must determine the appropriate allocation of income to each of these jurisdictions based on current interpretations of complex income tax regulations. Income tax authorities in these jurisdictions regularly perform audits of our income tax filings. Income tax audits associated with the allocation of this income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period of time to resolve and may result in significant income tax adjustments if changes to the income allocation are required between jurisdictions with different income tax rates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Tax Cuts and Jobs Act (the Act) was enacted in 2017 in the United States. The Act also subjects a United States shareholder to tax on Global Intangible Low-Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to account for GILTI tax in the year the tax is incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements Not Yet Adopted and Accounting Pronouncements Recently Adopted</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2024 the Financial Accounting Standards Board (FASB) issued ASU 2024-03 (Subtopic 220-40): </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which requires disaggregation of certain expense captions into specified categories in disclosures within the Notes to the Consolidated Financial Statements. The new disclosure requirements are effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. We are currently evaluating these new expanded disclosure requirements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In December 2023 the FASB issued ASU 2023-09 (Topic 740): </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes: Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which expands the existing rules on income tax disclosures. This update requires entities to disclose specific categories in the tax rate reconciliation, provide additional information for reconciling items that meet a quantitative threshold and disclose additional information about income taxes paid on an annual basis. The new disclosure requirements are effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating these new expanded disclosure requirements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 1, 2024 we adopted ASU 2023-07, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Refer to Note 14 for further information.</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 1, 2023 we adopted ASU 2022-04, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Liabilities - Supplier Finance Programs: Disclosure of Supplier Finance Program Obligations</span>. Refer to Note 7 for required disclosures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Goodwill and Long-Lived Assets Impairment Tests Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_ShortTermInvestmentsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short Term Investments, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_ShortTermInvestmentsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 705<br> -Publisher FASB<br> -URI https://asc.fasb.org/705/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a company's election to apply the fair value option for measurement and reporting of eligible financial assets and liabilities (as defined), as well as certain other eligible items (as defined) included in the statement of financial position, whether such option is elected for a single eligible item or a group of similar eligible items and is in addition to other disclosures concerning fair value which the company may be required to provide. Such disclosure might be expected to include: (1) for items included in the statement of financial position: (a) the reasons for electing a fair value option for each eligible item or group of similar eligible items; (b) if the fair value option is elected for some but not all eligible items within a group of similar eligible items: (i) a description of those similar items and the reasons for partial election and (ii) information of how the group of similar items relates to individual balance sheet line items; (c) for each line item in the statement of financial position that includes an item or items for which the fair value option has been elected: (i) information of how each line item in the statement of financial position relates to major categories of assets and liabilities presented in accordance with other fair value disclosures and (ii) the aggregate carrying amount of ineligible items included in each line item in the balance sheet, if any; (d) the difference between the aggregate fair value and the aggregate unpaid principal balance (assuming contractual principal amounts and fair value option elected) of: (i) loans and long-term receivables (other than securities otherwise reported at fair value) and (ii) long-term debt instruments; (e) for loans held as assets for which the fair value option has been elected: (i) the aggregate fair value of loans that are 90 days or more past due, (ii) if the policy is to recognize interest income separately from other changes in fair value, the aggregate fair value of loans in nonaccrual status, and (iii) the difference between the aggregate fair value and the aggregate unpaid principal balance for loans that are 90 days or more past due, in nonaccrual status, or both; (f) for investments that would have been accounted for under the equity method if the entity had not chosen to apply the fair value option, the information required for such investments, if material either individually or in the aggregate; (2) for items included in the income statement: (a) the amounts of gains and losses from fair value changes included in earnings and in which line in the income statement those gains and losses are reported whether or not combined with gains and losses from items required to be accounted for at fair value; (b) a description of how interest and dividends are measured and where they are reported in the income statement; (c) for loans and other receivables held as assets: (i) the estimated amount of gains or losses included in earnings attributable to changes in instrument-specific credit risk and (ii) how the gains or losses attributable to changes in instrument-specific credit risk were determined; (d) for liabilities with fair values that have been significantly affected during the reporting period by changes in the instrument-specific credit risk: (i) the estimated amount of gains and losses from fair value changes included in earnings that are attributable to changes in the instrument-specific credit risk, (ii) qualitative information about the reasons for those changes, and (iii) how the gains and losses attributable to changes in instrument-specific credit risk were determined; and (3) certain other disclosures as required or determined to be provided.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 825<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/825/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478411/912-330-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224101408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregated Revenue</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,834&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,518</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,163</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,893</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spinal Implants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,077</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,335</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,556</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,595</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,498</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">United States Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,016&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,517</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,328</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,248</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spinal Implants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,426</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,929</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,390</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16,943</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15,257</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,638</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">International Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,001</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,835</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,645</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spinal Implants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,651</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,406</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,166</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,652</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,241</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,811</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Changes in Contract Liabilities</a></td>
<td class="text">Changes in contract liabilities during the year were as follows:<div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.658%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning contract liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">860</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Revenue recognized from beginning of year contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net advance consideration received during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending contract liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">978</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224387280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"></td><td style="width:64.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.253%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Assets Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trading marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,661</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,180</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Available-for-sale marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and asset-backed debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States agency debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States treasury debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total available-for-sale marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">316</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">198</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,977</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,378</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"></td><td style="width:64.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.253%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Liabilities Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred compensation arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">259</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">209</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">77</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contingent consideration:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in estimate and foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ending</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3 - Liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">452</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">289</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">788</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">595</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Available-for-sale Securities</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"></td><td style="width:64.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.253%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Fair Value of Available for Sale Securities by Maturity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due after one year through three years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224064864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.661%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash Flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Investment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Designated</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,588</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,338</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,164</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,090</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">78</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">148</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash Flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Investment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Designated</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,650</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,662</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,315</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,627</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(20)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:28.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.440%"></td><td style="width:0.1%"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Currency Exchange Rate Gains (Losses) Recognized in Net Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recognized in:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net Investment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-Designated</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">106</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">98</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">92</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771227926976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract', window );"><strong>Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:26.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Marketable Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedges</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial Statement Translation</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(303)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(221)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(28)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(427)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(416)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(328)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(293)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771222334816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The purchase price allocations for the acquisitions completed in 2024 and Cerus are:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.956%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.463%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.465%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Purchase Price Allocation of Acquired Net Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cerus</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tangible assets acquired:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price, net of cash acquired of $57 and $7</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,836</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">481</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average amortization period at acquisition (years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224390176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies and Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"></td><td style="width:58.493%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.376%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.253%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.378%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-816"><span style="-sec-ix-hidden:f-817">Right-of-use assets</span></span> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-820"><span style="-sec-ix-hidden:f-821">Lease liabilities, current</span></span> </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-824"><span style="-sec-ix-hidden:f-825">Lease liabilities, noncurrent</span></span> </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;text-indent:-0.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.5</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock', window );">Future Purchase Obligations and Minimum Lease Payments</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2029</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt repayments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,823&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Minimum lease payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramTableTextBlock', window );">Supplier Finance Program</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning confirmed obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(372)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending confirmed obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">71</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Subparagraph (a)<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplierFinanceProgramTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplier finance program.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477128/405-50-55-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplierFinanceProgramTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771226266864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in the Net Carrying Amount of Goodwill by Segment</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.132%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Changes in the Net Carrying Value of Goodwill by Segment</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,935</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,945</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,880</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,270</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,973</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15,243</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,208</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,647</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15,855</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Summary of the Company's Other Intangible Assets</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.394%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:23.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.132%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Other Intangible Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less<br/>Accumulated<br/>Amortization</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Developed technologies</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Customer relationships</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,055&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Patents</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Trademarks</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">In-process research and development</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,416</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,021</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,395</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,549</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,956</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,593</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Estimated Amortization Expense</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:19.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.787%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Amortization Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2029</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771222430032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CapitalStockAbstract', window );"><strong>Capital Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Fair Value Assumptions</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Option Value and Assumptions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average fair value per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118.22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">83.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68.08&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected option life (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.9</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:22.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.196%"></td><td style="width:0.1%"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">2024 Stock Option Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares <br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Term (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding January&#160;1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">189.70</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">339.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">134.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">274.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding December&#160;31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">214.87</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,572.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercisable December&#160;31</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">175.39&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,223.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options expected to vest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">275.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">331.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Summary of RSU and PSU Activity</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.405%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.405%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.129%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.135%"></td><td style="width:0.1%"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares<br/>(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant&#160;Date Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">246.98</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">250.17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">332.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">305.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">244.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">233.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">276.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">233.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on December 31</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">290.58</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">287.51</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_CapitalStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Stock [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_CapitalStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771324699504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Credit Facilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-Term Debt, Unclassified [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Maturities Of Long-Term Debt Disclosures</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:0.1%"></td><td style="width:2.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:57.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.460%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.463%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Total Debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Due</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Senior unsecured notes:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 16, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.250%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.150%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 1, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.500%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.125%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.650%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 7, 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.850%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 8, 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 11, 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.750%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 1, 2029</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.250%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 11, 2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.950%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2030</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.625%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.000%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2031</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 11, 2032</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.625%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 11, 2034</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.625%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 11, 2036</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.100%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 1, 2043</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.375%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2044</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.625%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2046</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.900%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2050</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,597</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,995</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less current maturities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,188</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,901</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="12" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Borrowing capacity on existing facilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of senior unsecured notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-8<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771350541920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Effective Income Tax Rate Reconciliation</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local income taxes, less federal deduction</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign income tax at rates other than 21%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax related to repatriation of foreign earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intellectual property transfers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal audit settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Outside basis difference related to the anticipated sale of the Spinal Implants business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Provision for Income Taxes</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Earnings Before Income Taxes&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,969&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,972&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,276&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,492</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,673</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,683</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Income Tax Expense (Benefit)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current income tax expense (benefit):</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total current income tax expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">869</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">714</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax expense (benefit):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(30)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax expense (benefit)</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(370)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(206)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">58</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">499</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">508</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">325</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Deferred Income Tax Assets and Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development capitalization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International interest expense carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Outside basis difference related to the anticipated sale of the Spinal Implants business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,090</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,889</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less valuation allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,862</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,666</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,012)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Undistributed earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,202)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,059)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,660</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,607</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent deferred income tax assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,660</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,607</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Roll Forward</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Uncertain Income Tax Positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning uncertain tax positions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">371</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">286</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to current year income tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to prior year income tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Decreases related to prior year income tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(33)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements of income tax audits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Statute of limitations expirations and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending uncertain tax positions</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">349</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">371</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771222457440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock', window );">Defined Contribution Plan Disclosures</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:61.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expense funded with Stryker common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stryker common stock held by plan:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dollar amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares (in millions)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Value as a percentage of total plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock', window );">Schedule of Costs of Retirement Plans</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:61.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Net Periodic Pension Cost</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(41)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(32)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(59)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Changes in assets and benefit obligations recognized in OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net actuarial gain (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized net actuarial (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prior service credit and transition amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in other comprehensive income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">43</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">252</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in net periodic benefit cost and OCI</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(104)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">193</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-average rates used to determine net periodic benefit cost:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate used to determine projected benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock', window );">Schedule of Defined Benefit Plans Disclosures</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(782)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(826)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(290)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(341)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent assets&#8212;other assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current liabilities&#8212;accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pre-tax amounts recognized in AOCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized net actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(28)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock', window );">Schedule of Changes in Accumulated Postemployment Benefit Obligations</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Benefit Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning projected benefit obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">826</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">673</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial (gains) losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending projected benefit obligations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">782</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">826</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending accumulated benefit obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">748</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">790</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock', window );">Schedule of Changes in Fair Value of Plan Assets</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">485</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">420</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actual return</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending fair value of plan assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">492</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">485</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Valuation of Plan Assets </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">404</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">57</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">492</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">378</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">485</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of Allocation of Plan Assets</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:33.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Allocation of Plan Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025 Target</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024 Actual</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023 Actual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Expected Benefit Payments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Future Benefit Payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2029</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2030-2034</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (d)(5)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (b)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (a)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the costs related to the various types of retirement plans including defined benefit pension plan cost, defined contribution plan cost, other postretirement benefit plan cost, and net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 715<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 715<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (f)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771222526640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Quarterly Data (Unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialDataAbstract', window );"><strong>Quarterly Financial Data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Summary of Quarterly Data</a></td>
<td class="text"><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024 Quarters</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,243</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,422</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,494</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,436</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,043&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">788</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">825</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">834</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">546</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023 Quarters</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,778</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,996</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,909</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,815</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">592</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">738</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">692</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,143</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224079632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Data (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Operating Profit (Loss) from Segments to Consolidated</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Results</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,595</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,498</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,876&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,637&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cost of sales </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,720</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,130</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,557</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment research, development and engineering expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,324</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,210</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,159</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment selling, general and administrative expenses </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,314</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,856</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,172</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">641</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">567</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">528</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,426</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,341</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,278</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,595</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,735</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,033</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Items not allocated to segments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(780)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(649)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped up to fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(623)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(627)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Structural optimization and other special charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(295)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill and other impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(977)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(270)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,689</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,888</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,841</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Sales and Other Financial Information by Business Segment</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.949%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.949%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Assets and Capital Spending</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23,115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">41,622</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">38,827</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42,971</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">39,912</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchases of property, plant and equipment:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">506</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">362</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">348</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">755</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">575</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">588</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock', window );">Geographic Information on Net Sales and Long-Lived Assets</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.762%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.949%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.949%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Geographic Information</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Property, Plant and Equipment</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16,943&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,946&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,595</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,498</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,448</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,215</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771325466160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets Held for Sale (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposal Groups, Including Discontinued Operations</a></td>
<td class="text">The assets and liabilities held for sale are classified within prepaid expenses and other current assets and accrued expenses and other liabilities in our Consolidated Balance Sheets and included the following as of December 31, 2024:<div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total inventories </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">183</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Property, plant and equipment, net </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangibles, net </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">326</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent deferred income tax assets </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Valuation allowance </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets held for sale </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">450</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts payable </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued compensation </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">104</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5D<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771226405952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Derivative term (up to)</a></td>
<td class="text">18 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</a></td>
<td class="nump">33.33%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember', window );">Performance Stock Units (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod', window );">Performance period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">40 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">30 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Performance Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771223413664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_PercentageofServiceRevenueRecognizeoverTime', window );">Percentage of sales recognized as services over time (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 6,436<span></span>
</td>
<td class="nump">$ 5,494<span></span>
</td>
<td class="nump">$ 5,422<span></span>
</td>
<td class="nump">$ 5,243<span></span>
</td>
<td class="nump">$ 5,815<span></span>
</td>
<td class="nump">$ 4,909<span></span>
</td>
<td class="nump">$ 4,996<span></span>
</td>
<td class="nump">$ 4,778<span></span>
</td>
<td class="nump">$ 22,595<span></span>
</td>
<td class="nump">$ 20,498<span></span>
</td>
<td class="nump">$ 18,449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">$ 978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">978<span></span>
</td>
<td class="nump">860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=syk_NeuroCranialInterventionalSpineMember', window );">Neuro Cranial - Interventional Spine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">413<span></span>
</td>
<td class="nump">327<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=syk_OtherOrthopedicsEnablingTechnologiesMember', window );">Other Orthopedics - Enabling Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
<td class="nump">$ 149<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_PercentageofServiceRevenueRecognizeoverTime">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Service Revenue Recognize over Time</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_PercentageofServiceRevenueRecognizeoverTime</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_NeuroCranialInterventionalSpineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_NeuroCranialInterventionalSpineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_OtherOrthopedicsEnablingTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_OtherOrthopedicsEnablingTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771218552864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Disaggregated Sales Analysis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 6,436<span></span>
</td>
<td class="nump">$ 5,494<span></span>
</td>
<td class="nump">$ 5,422<span></span>
</td>
<td class="nump">$ 5,243<span></span>
</td>
<td class="nump">$ 5,815<span></span>
</td>
<td class="nump">$ 4,909<span></span>
</td>
<td class="nump">$ 4,996<span></span>
</td>
<td class="nump">$ 4,778<span></span>
</td>
<td class="nump">$ 22,595<span></span>
</td>
<td class="nump">$ 20,498<span></span>
</td>
<td class="nump">$ 18,449<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,943<span></span>
</td>
<td class="nump">15,257<span></span>
</td>
<td class="nump">13,638<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,652<span></span>
</td>
<td class="nump">5,241<span></span>
</td>
<td class="nump">4,811<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,518<span></span>
</td>
<td class="nump">12,163<span></span>
</td>
<td class="nump">10,893<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,517<span></span>
</td>
<td class="nump">9,328<span></span>
</td>
<td class="nump">8,248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,001<span></span>
</td>
<td class="nump">2,835<span></span>
</td>
<td class="nump">2,645<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,834<span></span>
</td>
<td class="nump">2,534<span></span>
</td>
<td class="nump">2,245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Instruments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,267<span></span>
</td>
<td class="nump">2,016<span></span>
</td>
<td class="nump">1,776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Instruments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">567<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="nump">469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Endoscopy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,389<span></span>
</td>
<td class="nump">3,068<span></span>
</td>
<td class="nump">2,759<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Endoscopy | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,792<span></span>
</td>
<td class="nump">2,513<span></span>
</td>
<td class="nump">2,245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Endoscopy | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">597<span></span>
</td>
<td class="nump">555<span></span>
</td>
<td class="nump">514<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,852<span></span>
</td>
<td class="nump">3,459<span></span>
</td>
<td class="nump">3,031<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Medical | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,191<span></span>
</td>
<td class="nump">2,785<span></span>
</td>
<td class="nump">2,422<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Medical | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">661<span></span>
</td>
<td class="nump">674<span></span>
</td>
<td class="nump">609<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neurovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,307<span></span>
</td>
<td class="nump">1,226<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neurovascular | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">506<span></span>
</td>
<td class="nump">483<span></span>
</td>
<td class="nump">446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neurovascular | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">801<span></span>
</td>
<td class="nump">743<span></span>
</td>
<td class="nump">754<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neuro Cranial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,136<span></span>
</td>
<td class="nump">1,876<span></span>
</td>
<td class="nump">1,658<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neuro Cranial | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,761<span></span>
</td>
<td class="nump">1,531<span></span>
</td>
<td class="nump">1,359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neuro Cranial | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,077<span></span>
</td>
<td class="nump">8,335<span></span>
</td>
<td class="nump">7,556<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,426<span></span>
</td>
<td class="nump">5,929<span></span>
</td>
<td class="nump">5,390<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,651<span></span>
</td>
<td class="nump">2,406<span></span>
</td>
<td class="nump">2,166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">712<span></span>
</td>
<td class="nump">658<span></span>
</td>
<td class="nump">606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics | Other | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">504<span></span>
</td>
<td class="nump">468<span></span>
</td>
<td class="nump">455<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics | Other | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics | Knees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,447<span></span>
</td>
<td class="nump">2,273<span></span>
</td>
<td class="nump">1,997<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics | Knees | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,788<span></span>
</td>
<td class="nump">1,676<span></span>
</td>
<td class="nump">1,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics | Knees | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">659<span></span>
</td>
<td class="nump">597<span></span>
</td>
<td class="nump">504<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics | Hips</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,704<span></span>
</td>
<td class="nump">1,544<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics | Hips | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,059<span></span>
</td>
<td class="nump">988<span></span>
</td>
<td class="nump">896<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics | Hips | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">645<span></span>
</td>
<td class="nump">556<span></span>
</td>
<td class="nump">517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics | Trauma and Extremities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,507<span></span>
</td>
<td class="nump">3,147<span></span>
</td>
<td class="nump">2,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics | Trauma and Extremities | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,586<span></span>
</td>
<td class="nump">2,297<span></span>
</td>
<td class="nump">2,035<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics | Trauma and Extremities | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">921<span></span>
</td>
<td class="nump">850<span></span>
</td>
<td class="nump">772<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics | Spine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">707<span></span>
</td>
<td class="nump">713<span></span>
</td>
<td class="nump">733<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics | Spine | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">489<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">511<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics | Spine | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 218<span></span>
</td>
<td class="nump">$ 213<span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_InstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_InstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_EndoscopyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_EndoscopyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_NeurovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_NeurovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_NeuroCranialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_NeuroCranialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_OtherOrthopaedicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_OtherOrthopaedicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_KneesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_KneesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_HipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_HipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_TraumaandExtremitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_TraumaandExtremitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_SpineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_SpineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771218616656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Changes in Contract Liabilities (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_MovementInContractLiabilitiesRollForward', window );"><strong>Movement In Contract Liabilities [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Beginning contract liabilities</a></td>
<td class="nump">$ 860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized from beginning of year contract liabilities</a></td>
<td class="num">(553)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod', window );">Net advance consideration received during the period</a></td>
<td class="nump">671<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Ending contract liabilities</a></td>
<td class="nump">$ 978<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Net Advance Consideration Received During Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_MovementInContractLiabilitiesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Movement In Contract Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_MovementInContractLiabilitiesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771217316320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">$ 91<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">4,977<span></span>
</td>
<td class="nump">3,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">788<span></span>
</td>
<td class="nump">595<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">(Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Available-for-sale marketable securities</a></td>
<td class="nump">3,652<span></span>
</td>
<td class="nump">2,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">750<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesDebt', window );">Trading marketable securities</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">4,661<span></span>
</td>
<td class="nump">3,180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities', window );">Deferred compensation arrangements</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">316<span></span>
</td>
<td class="nump">198<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Corporate and asset-backed debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | United States agency debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | United States treasury debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Foreign currency exchange forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Foreign currency exchange forward contracts</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate swap asset</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency exchange forward contracts</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">(Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning</a></td>
<td class="nump">289<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Additions</a></td>
<td class="nump">208<span></span>
</td>
<td class="nump">192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in estimate and foreign exchange</a></td>
<td class="nump">8<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Settlements</a></td>
<td class="num">(53)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending</a></td>
<td class="nump">452<span></span>
</td>
<td class="nump">289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">$ 452<span></span>
</td>
<td class="nump">$ 289<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Liabilities Measured on Recurring Basis, Deferred Compensation Plan Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-12<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 30: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-10<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771225918736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Available-For-Sale Securities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue', window );">Due after one year through three years</a></td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the fair value of debt securities which are expected to mature after one through three years of the balance sheet date and which are categorized neither as held-to-maturity nor trading securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771226520544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>May 02, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1', window );">Reduction of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeInterestEarningAsset', window );">Interest income</a></td>
<td class="nump">$ 139<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_CerusMember', window );">Cerus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 192<span></span>
</td>
<td class="nump">$ 192<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of right to a contingent consideration asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeInterestEarningAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income from interest-earning asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph b<br> -Subparagraph (1)<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeInterestEarningAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=syk_CerusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=syk_CerusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224257376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Forward Currency Exchange Contracts) (Details) - Foreign currency exchange forward contracts<br> $ in Millions, &#8364; in Billions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 9,090<span></span>
</td>
<td class="nump">$ 7,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1', window );">Maximum term</a></td>
<td class="text">9 years 8 months 12 days<span></span>
</td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="num">(70)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Designated as Hedging Instrument | Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">5,164<span></span>
</td>
<td class="nump">4,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="nump">78<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Not Designated as Hedging Instrument | Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Not Designated as Hedging Instrument | Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Not Designated as Hedging Instrument | Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Not Designated as Hedging Instrument | Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">1,588<span></span>
</td>
<td class="nump">1,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">2,338<span></span>
</td>
<td class="nump">1,662<span></span>
</td>
<td class="nump">&#8364; 2.3<span></span>
</td>
<td class="nump">&#8364; 1.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="num">$ (4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-7<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-7<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771220218512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Narrative) (Details)<br> $ in Millions, &#8364; in Billions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Derivative term (up to)</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeInvestingActivities', window );">Proceeds from settlement of net investment hedges</a></td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency exchange forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 9,090<span></span>
</td>
<td class="nump">7,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Derivative term (up to)</a></td>
<td class="text">9 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign currency exchange forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax', window );">After-tax gain (loss) recognized in AOCI related to designated net investment hedges</a></td>
<td class="nump">$ 325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Cash flow hedge gain (loss) to be reclassified within twelve months</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax', window );">Net investment hedges expected to be reclassified to cost of sales and other income (expense)</a></td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign currency exchange forward contracts | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">2,338<span></span>
</td>
<td class="nump">$ 1,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2.3<span></span>
</td>
<td class="nump">&#8364; 1.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Cash flow hedge gain (loss) to be reclassified within twelve months</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Embedded Derivative Financial Instruments | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5.0<span></span>
</td>
<td class="nump">&#8364; 4.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification from other comprehensive income (loss) to earnings from the sale or complete or substantially complete liquidation of an investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771226504032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Movements out of OCI) (Details) - Foreign currency exchange forward contracts - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gains (losses)</a></td>
<td class="nump">$ 106<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gains (losses)</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax', window );">Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax</a></td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gains (losses)</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gains (losses)</a></td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification from other comprehensive income (loss) to earnings from the sale or complete or substantially complete liquidation of an investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=syk_OtherIncomeexpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=syk_OtherIncomeexpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224467920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Beginning of Period</a></td>
<td class="num">$ (416)<span></span>
</td>
<td class="num">$ (221)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">OCI</a></td>
<td class="nump">305<span></span>
</td>
<td class="num">(196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="num">(128)<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">8,155<span></span>
</td>
<td class="nump">7,440<span></span>
</td>
<td class="nump">$ 6,871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(197)<span></span>
</td>
<td class="num">(215)<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">499<span></span>
</td>
<td class="nump">508<span></span>
</td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">123<span></span>
</td>
<td class="num">(195)<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), End of Period</a></td>
<td class="num">(293)<span></span>
</td>
<td class="num">(416)<span></span>
</td>
<td class="num">(221)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">123<span></span>
</td>
<td class="num">(195)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Beginning of Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">OCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), End of Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Marketable Securities | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Beginning of Period</a></td>
<td class="num">(28)<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">OCI</a></td>
<td class="nump">43<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), End of Period</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension Plans | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">32<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Beginning of Period</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">OCI</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), End of Period</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Hedges | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Financial Statement Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Beginning of Period</a></td>
<td class="num">(427)<span></span>
</td>
<td class="num">(303)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">OCI</a></td>
<td class="nump">236<span></span>
</td>
<td class="num">(157)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="num">(110)<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), End of Period</a></td>
<td class="num">(328)<span></span>
</td>
<td class="num">(427)<span></span>
</td>
<td class="num">$ (303)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Financial Statement Translation | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">$ 99<span></span>
</td>
<td class="num">$ (124)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771223204224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 02, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,628<span></span>
</td>
<td class="nump">$ 390<span></span>
</td>
<td class="nump">$ 2,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_VariousMember', window );">Various</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh', window );">Future milestone payout</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_CerusMember', window );">Cerus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">$ 192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price of acquisitions</a></td>
<td class="nump">289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business acquisition, future milestone payments (up to)</a></td>
<td class="nump">$ 225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any change recognized during the period in the high-end of the estimated range of outcomes (undiscounted) of a liability assumed in a business combination arising from an item of contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=syk_VariousMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=syk_VariousMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=syk_CerusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=syk_CerusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771218334288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 02, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,855<span></span>
</td>
<td class="nump">$ 15,243<span></span>
</td>
<td class="nump">$ 14,880<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_VariousMember', window );">Various</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred income tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt', window );">Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(102)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase price, net of cash acquired of $57 and $7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash Acquired from Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_VariousMember', window );">Various | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_VariousMember', window );">Various | Developed technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average amortization period at acquisition (years):</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_VariousMember', window );">Various | Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_VariousMember', window );">Various | Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average amortization period at acquisition (years):</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_VariousMember', window );">Various | Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average amortization period at acquisition (years):</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_VariousMember', window );">Various | Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average amortization period at acquisition (years):</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_VariousMember', window );">Various | Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_CerusMember', window );">Cerus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred income tax assets</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt', window );">Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income tax liabilities</a></td>
<td class="num">(60)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase price, net of cash acquired of $57 and $7</a></td>
<td class="nump">481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash Acquired from Acquisition</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_CerusMember', window );">Cerus | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets:</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_CerusMember', window );">Cerus | Developed technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets:</a></td>
<td class="nump">$ 240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average amortization period at acquisition (years):</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_CerusMember', window );">Cerus | Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets:</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_CerusMember', window );">Cerus | Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets:</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=syk_VariousMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=syk_VariousMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=syk_CustomerAndDistributorRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=syk_CustomerAndDistributorRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=syk_CerusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=syk_CerusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224720880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies and Commitments (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Lease expense</a></td>
<td class="nump">$ 190<span></span>
</td>
<td class="nump">$ 172<span></span>
</td>
<td class="nump">$ 149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramObligationCurrent', window );">Supplier finance obligation</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration', window );">Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accounts Payable, Trade, Current<span></span>
</td>
<td class="text">Accounts Payable, Trade, Current<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=syk_RecallMattersMember', window );">Recall Matters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyLossInPeriod', window );">Charges during period</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="nump">$ 202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483359/720-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482395/460-10-55-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483359/720-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482395/460-10-55-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyLossInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyLossInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplierFinanceProgramObligationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation for supplier finance program, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplierFinanceProgramObligationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes obligation for supplier finance program, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=syk_RecallMattersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=syk_RecallMattersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771225503696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Lease Cost) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">$ 516<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities, current</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities, noncurrent</a></td>
<td class="nump">$ 379<span></span>
</td>
<td class="nump">$ 356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (years)</a></td>
<td class="text">5 years 1 month 6 days<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">3.87%<span></span>
</td>
<td class="nump">3.87%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other Assets, Noncurrent<span></span>
</td>
<td class="text">Other Assets, Noncurrent<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other Liabilities, Current<span></span>
</td>
<td class="text">Other Liabilities, Current<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other noncurrent liabilities<span></span>
</td>
<td class="text">Other noncurrent liabilities<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771216395248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 1,410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2026</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2027</a></td>
<td class="nump">779<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2028</a></td>
<td class="nump">1,823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2029</a></td>
<td class="nump">1,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">7,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationFiscalYearMaturityAbstract', window );"><strong>Purchase obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear', window );">2025</a></td>
<td class="nump">2,610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear', window );">2026</a></td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear', window );">2027</a></td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear', window );">2028</a></td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear', window );">2029</a></td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear', window );">Thereafter</a></td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Minimum lease payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 73<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224077888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies and Commitments (Supplier Finance Program) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramObligationRollForward', window );"><strong>Supplier Finance Program, Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramObligation', window );">Beginning confirmed obligations</a></td>
<td class="nump">$ 51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramObligationIncrease', window );">Additions</a></td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramObligationDecreaseSettlement', window );">Settlements</a></td>
<td class="num">(372)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramObligation', window );">Ending confirmed obligations</a></td>
<td class="nump">$ 71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration', window );">Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accounts Payable, Trade, Current<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplierFinanceProgramObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation for supplier finance program.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477128/405-50-55-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplierFinanceProgramObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplierFinanceProgramObligationDecreaseSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in obligation for supplier finance program from settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477128/405-50-55-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplierFinanceProgramObligationDecreaseSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplierFinanceProgramObligationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in obligation for supplier finance program.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477128/405-50-55-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplierFinanceProgramObligationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplierFinanceProgramObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplierFinanceProgramObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes obligation for supplier finance program.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771223799904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Goodwill) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="nump">$ 456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning balance</a></td>
<td class="nump">15,243<span></span>
</td>
<td class="nump">$ 14,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions and adjustments</a></td>
<td class="nump">1,152<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign exchange and other</a></td>
<td class="num">(84)<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="num">(456)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending balance</a></td>
<td class="nump">15,855<span></span>
</td>
<td class="nump">15,243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning balance</a></td>
<td class="nump">8,270<span></span>
</td>
<td class="nump">7,935<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions and adjustments</a></td>
<td class="nump">852<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign exchange and other</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending balance</a></td>
<td class="nump">9,208<span></span>
</td>
<td class="nump">8,270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="nump">456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning balance</a></td>
<td class="nump">6,973<span></span>
</td>
<td class="nump">6,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions and adjustments</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign exchange and other</a></td>
<td class="num">(170)<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="num">(456)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending balance</a></td>
<td class="nump">6,647<span></span>
</td>
<td class="nump">$ 6,973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=syk_SpinalImplantsMember', window );">Spinal Implants | Disposal Group, Held-for-Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="nump">183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="num">(183)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=syk_SpineReportingUnitMember', window );">Spine Reporting Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="num">(273)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill transfer</a></td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=syk_OrthopaedicsMember', window );">Orthopaedics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill transfer</a></td>
<td class="num">$ (117)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from transfer into (out of) asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation and measurement period adjustments of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 16<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479405/805-10-25-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=syk_SpinalImplantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=syk_SpinalImplantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=syk_SpineReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=syk_SpineReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=syk_MedSurgAndNeurotechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=syk_MedSurgAndNeurotechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=syk_OrthopaedicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=syk_OrthopaedicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771216381744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 9,416<span></span>
</td>
<td class="nump">$ 9,549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">5,021<span></span>
</td>
<td class="nump">4,956<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">4,395<span></span>
</td>
<td class="nump">4,593<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">5,698<span></span>
</td>
<td class="nump">5,769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">2,931<span></span>
</td>
<td class="nump">2,815<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">2,767<span></span>
</td>
<td class="nump">2,954<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">3,055<span></span>
</td>
<td class="nump">2,907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">1,636<span></span>
</td>
<td class="nump">1,504<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">1,419<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">302<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">413<span></span>
</td>
<td class="nump">427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771226511488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2026</a></td>
<td class="nump">550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2027</a></td>
<td class="nump">528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2028</a></td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2029</a></td>
<td class="nump">$ 465<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771222367360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Narrative) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Capital Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CommonAndPreferredStockSharesAuthorized', window );">Common and Preferred Stock, shares authorized (in shares)</a></td>
<td class="nump">1,000,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par per share</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining shares authorized to be repurchased</a></td>
<td class="nump">$ 1,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Capital shares reserved for future issuance</a></td>
<td class="nump">18,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of options exercised</a></td>
<td class="nump">$ 362<span></span>
</td>
<td class="nump">$ 318<span></span>
</td>
<td class="nump">$ 218<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options exercised during period, exercise price range, lower range limit</a></td>
<td class="nump">$ 92.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options exercised during period, exercise price range, upper range limit</a></td>
<td class="nump">$ 339.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Compensation cost not yet recognized</a></td>
<td class="nump">$ 159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost not yet recognized, period for recognized</a></td>
<td class="text">1 year 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Capital Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Compensation cost not yet recognized</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost not yet recognized, period for recognized</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Granted (in dollars per share)</a></td>
<td class="nump">$ 332.64<span></span>
</td>
<td class="nump">$ 257.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue', window );">Shares vested during the period</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember', window );">Performance Stock Units (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Capital Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Compensation cost not yet recognized</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost not yet recognized, period for recognized</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Granted (in dollars per share)</a></td>
<td class="nump">$ 305.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue', window );">Shares vested during the period</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Capital Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp', window );">Percentage of closing stock price under ESPP</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued under the ESPP</a></td>
<td class="nump">173,708<span></span>
</td>
<td class="nump">190,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_CommonAndPreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common And Preferred Stock, Shares Authorized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_CommonAndPreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Closing Stock Price Represents Purchase Price Under ESPP</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771223750480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Option Grant Assumptions) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CapitalStockAbstract', window );"><strong>Capital Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value per share</a></td>
<td class="nump">$ 118.22<span></span>
</td>
<td class="nump">$ 83.59<span></span>
</td>
<td class="nump">$ 68.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">29.90%<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected option life (years)</a></td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">6 years 2 months 12 days<span></span>
</td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_CapitalStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Stock [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_CapitalStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771217264896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Summary of Stock Option Activity) (Details)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Options outstanding at January 1 (in shares) | shares</a></td>
<td class="nump">11.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Shares, Granted (in shares) | shares</a></td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares, Exercised (in shares) | shares</a></td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Shares, Cancelled or forfeited (in shares) | shares</a></td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Options outstanding at December 31 (in shares) | shares</a></td>
<td class="nump">10.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares, Exercisable at December 31 (in shares) | shares</a></td>
<td class="nump">6.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Shares, Options expected to vest (in shares) | shares</a></td>
<td class="nump">3.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise&#160;Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Options outstanding at January 1 (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 189.70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">339.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">134.86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Cancelled or forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">274.74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Options outstanding at December 31 (in dollars per share) | $ / shares</a></td>
<td class="nump">214.87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, Exercisable at December 31 (in dollars per share) | $ / shares</a></td>
<td class="nump">175.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Options expected to vest (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 275.67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual term, Options outstanding (in years)</a></td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual term, Exercisable (in years)</a></td>
<td class="text">3 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual term, Options expected to vest (in years)</a></td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, Options outstanding | $</a></td>
<td class="nump">$ 1,572.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, Exercisable | $</a></td>
<td class="nump">1,223.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value, Options expected to vest | $</a></td>
<td class="nump">$ 331.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771223446288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Summary of RSU and PSU Activity) (Details) - $ / shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Nonvested at January 1 (in shares)</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares, Granted (in shares)</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares, Vested (in shares)</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Shares, Cancelled (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Nonvested at December 31 (in shares)</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Outstanding at January 1 (in dollars per share)</a></td>
<td class="nump">$ 246.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Granted (in dollars per share)</a></td>
<td class="nump">332.64<span></span>
</td>
<td class="nump">$ 257.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Vested (in dollars per share)</a></td>
<td class="nump">244.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Cancelled (in dollars per share)</a></td>
<td class="nump">276.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Outstanding at December 31 (in dollars per share)</a></td>
<td class="nump">$ 290.58<span></span>
</td>
<td class="nump">$ 246.98<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember', window );">Performance Stock Units (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Nonvested at January 1 (in shares)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares, Granted (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares, Vested (in shares)</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Shares, Cancelled (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Nonvested at December 31 (in shares)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Outstanding at January 1 (in dollars per share)</a></td>
<td class="nump">$ 250.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Granted (in dollars per share)</a></td>
<td class="nump">305.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Vested (in dollars per share)</a></td>
<td class="nump">233.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Cancelled (in dollars per share)</a></td>
<td class="nump">233.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Outstanding at December 31 (in dollars per share)</a></td>
<td class="nump">$ 287.51<span></span>
</td>
<td class="nump">$ 250.17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224467920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Credit Facilities (Narrative) (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Credit facility outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 396,000,000<span></span>
</td>
<td class="nump">$ 356,000,000<span></span>
</td>
<td class="nump">$ 337,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_FloatingRateSeniorNotesDueNovember162024Member', window );">Floating Rate Senior Notes Due November 16, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.850Due2028Member', window );">Senior Unsecured Notes 4.850% Due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.85%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3375Due2028Member', window );">Senior Unsecured Notes, 3.375% Due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.250Due2029Member', window );">Senior Unsecured Notes, 4.250% Due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.250Due2024Member', window );">Senior Unsecured Notes 0.250% due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="nump">$ 850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375DueMay152024Member', window );">Senior Unsecured Notes 3.375% due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375Due2025Member', window );">Senior Unsecured Notes 3.375% due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4625Due2046Member', window );">Senior Unsecured Notes 4.625% due 2046</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.625Due2036Member', window );">3.625% Notes due 2036</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.625%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">397 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_FloatingRateSeniorNotesDueNovember162024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_FloatingRateSeniorNotesDueNovember162024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.850Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.850Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3375Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3375Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.250Due2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.250Due2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.250Due2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.250Due2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375DueMay152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375DueMay152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4625Due2046Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4625Due2046Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.625Due2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.625Due2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771223282288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Other long-term debt</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total debt</a></td>
<td class="nump">13,597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current maturities of debt</a></td>
<td class="nump">1,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">12,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance costs</a></td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Borrowing capacity on existing facilities</a></td>
<td class="nump">2,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of senior unsecured notes</a></td>
<td class="nump">$ 12,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375DueMay152024Member', window );">Senior Unsecured Notes 3.375% due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_VariousMember', window );">Various</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.250Due2024Member', window );">Senior Unsecured Notes 0.250% due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 940<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.150Due2025Member', window );">Senior Unsecured Notes, 1.150% Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">648<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375Due2025Member', window );">Senior Unsecured Notes 3.375% due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">749<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.500Due2026Member', window );">Senior Unsecured Notes 3.500% due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">997<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2.125DueNovember2027Member', window );">Senior Unsecured Notes, Due November 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">828<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.650Due2028Member', window );">Senior Unsecured Notes 3.650% due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">598<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.850Due2028Member', window );">Senior Unsecured Notes 4.850% Due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">596<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3375Due2028Member', window );">Senior Unsecured Notes, 3.375% Due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">661<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.750due2029Member', window );">Senior Unsecured Notes 0.750% due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">883<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.250Due2029Member', window );">Senior Unsecured Notes, 4.250% Due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.950Due2030Member', window );">Senior Unsecured Notes, 1.950% Due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">991<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2.625Due2030Member', window );">2.625% Notes due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 669<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">713<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.000due2031Member', window );">Senior Unsecured Notes 1.000% due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">823<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375Due2032Member', window );">3.375% Notes due 2032</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.625DueSeptember112034Member', window );">Senior Unsecured Notes 4.625% due September 11, 2034</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.625Due2036Member', window );">3.625% Notes due 2036</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.100Due2043Member', window );">Senior Unsecured Notes 4.100% due 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">393<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.375due2044Member', window );">Senior Unsecured Notes 4.375% due 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4625Due2046Member', window );">Senior Unsecured Notes 4.625% due 2046</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">983<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2.900due2050Member', window );">Senior Unsecured Notes, 2.900% due 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 642<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375DueMay152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375DueMay152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_VariousMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_VariousMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.250Due2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.250Due2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.150Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.150Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.500Due2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.500Due2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2.125DueNovember2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2.125DueNovember2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.650Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.650Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.850Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.850Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3375Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3375Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.750due2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.750due2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.250Due2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.250Due2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.950Due2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.950Due2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2.625Due2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2.625Due2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.000due2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.000due2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375Due2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375Due2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.625DueSeptember112034Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.625DueSeptember112034Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.625Due2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.625Due2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.100Due2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.100Due2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.375due2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.375due2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4625Due2046Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4625Due2046Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2.900due2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2.900due2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771223339264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax, percent</a></td>
<td class="nump">14.30%<span></span>
</td>
<td class="nump">13.80%<span></span>
</td>
<td class="nump">12.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Unrecognized tax benefits, income tax penalties and interest expense</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized', window );">Net operating loss carryforward recognized</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Accrued interest and penalties</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward, amount</a></td>
<td class="nump">204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardValuationAllowance', window );">Tax credit carryforward, valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings', window );">Repatriation of foreign earnings reversed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed earnings of foreign subsidiaries</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense', window );">Unrecognized tax benefits, interest on income tax expense</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">$ 248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxSettlements', window );">Tax settlement amount</a></td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest', window );">Tax settlement, release of accrued interest</a></td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Deferred tax assets, operating loss carryforwards</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_OperatingLossCarryforwardsSubjectToValuationAllowance', window );">Operating loss carryforwards, subject to full valuation allowance</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">3,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Deferred tax assets, operating loss carryforwards</a></td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_OperatingLossCarryforwardsSubjectToValuationAllowance', window );">Operating loss carryforwards, subject to full valuation allowance</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Deferred tax assets, operating loss carryforwards</a></td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_OperatingLossCarryforwardsSubjectToValuationAllowance', window );">Operating loss carryforwards, subject to full valuation allowance</a></td>
<td class="nump">$ 63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Expense (Benefit), Tax Settlement, Release Of Accrued Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax expense (benefit), Portion of Net Operating Loss Carryforward Recognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_OperatingLossCarryforwardsSubjectToValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Subject to Valuation Allowance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_OperatingLossCarryforwardsSubjectToValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to repatriation of foreign earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from tax credit carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482620/740-10-25-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 740<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 740<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense for an underpayment of income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224427472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">United States federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">United States state and local income taxes, less federal deduction</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign income tax at rates other than 21%</a></td>
<td class="num">(4.10%)<span></span>
</td>
<td class="num">(6.80%)<span></span>
</td>
<td class="num">(4.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent', window );">Tax related to repatriation of foreign earnings</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="num">(2.40%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">United States research and development credits</a></td>
<td class="num">(1.40%)<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
<td class="num">(1.50%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent', window );">Intellectual property transfers</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(3.30%)<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic', window );">United States federal audit settlement</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(6.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses', window );">Goodwill impairment</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference', window );">Outside basis difference related to the anticipated sale of the Spinal Implants business</a></td>
<td class="num">(4.90%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.50%)<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">14.30%<span></span>
</td>
<td class="nump">13.80%<span></span>
</td>
<td class="nump">12.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Foreign Earnings Repatriation, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Outside Basis Difference</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Transfer Of Intellectual Property, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to domestic income tax settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771337077840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Earnings before Income Taxes) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 523<span></span>
</td>
<td class="nump">$ 701<span></span>
</td>
<td class="nump">$ 407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,969<span></span>
</td>
<td class="nump">2,972<span></span>
</td>
<td class="nump">2,276<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">$ 528<span></span>
</td>
<td class="nump">$ 1,043<span></span>
</td>
<td class="nump">$ 998<span></span>
</td>
<td class="nump">$ 923<span></span>
</td>
<td class="nump">$ 1,226<span></span>
</td>
<td class="nump">$ 869<span></span>
</td>
<td class="nump">$ 899<span></span>
</td>
<td class="nump">$ 679<span></span>
</td>
<td class="nump">$ 3,492<span></span>
</td>
<td class="nump">$ 3,673<span></span>
</td>
<td class="nump">$ 2,683<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771223990400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Provision for Income Taxes) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current income tax expense (benefit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">United States federal</a></td>
<td class="nump">$ 490<span></span>
</td>
<td class="nump">$ 236<span></span>
</td>
<td class="num">$ (76)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">United States state and local</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">International</a></td>
<td class="nump">289<span></span>
</td>
<td class="nump">430<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income tax expense</a></td>
<td class="nump">869<span></span>
</td>
<td class="nump">714<span></span>
</td>
<td class="nump">267<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred income tax expense (benefit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">United States federal</a></td>
<td class="num">(462)<span></span>
</td>
<td class="num">(212)<span></span>
</td>
<td class="num">(179)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">United States state and local</a></td>
<td class="num">(76)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">International</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">267<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income tax expense (benefit)</a></td>
<td class="num">(370)<span></span>
</td>
<td class="num">(206)<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax expense</a></td>
<td class="nump">$ 499<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="nump">$ 325<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771222190848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventories</a></td>
<td class="nump">$ 551<span></span>
</td>
<td class="nump">$ 521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther', window );">Other accrued expenses</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_DeferredTaxAssetsDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">715<span></span>
</td>
<td class="nump">918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsStateTaxes', window );">State income taxes</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization', window );">Research and development capitalization</a></td>
<td class="nump">408<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetInterestCarryforward', window );">International interest expense carryforwards</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss and credit carryforwards</a></td>
<td class="nump">410<span></span>
</td>
<td class="nump">385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_DeferredTaxAssetsOutsideBasisDifference', window );">Outside basis difference related to the anticipated sale of the Spinal Implants business</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred income tax assets</a></td>
<td class="nump">3,090<span></span>
</td>
<td class="nump">2,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowances</a></td>
<td class="num">(228)<span></span>
</td>
<td class="num">(223)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred income tax assets</a></td>
<td class="nump">2,862<span></span>
</td>
<td class="nump">2,666<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred income tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_DeferredTaxLiabilitiesDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(1,141)<span></span>
</td>
<td class="num">(1,012)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Undistributed earnings</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred income tax liabilities</a></td>
<td class="num">(1,202)<span></span>
</td>
<td class="num">(1,059)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred income tax assets</a></td>
<td class="nump">1,660<span></span>
</td>
<td class="nump">1,607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Noncurrent deferred income tax assets</a></td>
<td class="nump">1,742<span></span>
</td>
<td class="nump">1,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Noncurrent liabilities&#8212;Other liabilities</a></td>
<td class="num">$ (82)<span></span>
</td>
<td class="num">$ (63)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DeferredTaxAssetsDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DeferredTaxAssetsDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DeferredTaxAssetsOutsideBasisDifference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Outside Basis Difference</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DeferredTaxAssetsOutsideBasisDifference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Research And Development Capitalization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DeferredTaxLiabilitiesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DeferredTaxLiabilitiesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetInterestCarryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetInterestCarryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsStateTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsStateTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771337012688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Unresolved Income Tax Positions) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Unrecognized Tax Benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning uncertain tax positions</a></td>
<td class="nump">$ 371<span></span>
</td>
<td class="nump">$ 286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases related to current year income tax positions</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increases related to prior year income tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decreases related to prior year income tax positions</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements of income tax audits</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Statute of limitations expirations and other</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation', window );">Foreign currency translation</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending uncertain tax positions</a></td>
<td class="nump">$ 349<span></span>
</td>
<td class="nump">$ 371<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771225969104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Plan expense</a></td>
<td class="nump">$ 376<span></span>
</td>
<td class="nump">$ 327<span></span>
</td>
<td class="nump">$ 305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Expense funded with Stryker common stock</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany', window );">Stryker common stock held by plan, amount</a></td>
<td class="nump">$ 781<span></span>
</td>
<td class="nump">$ 649<span></span>
</td>
<td class="nump">$ 522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany', window );">Stryker common stock held by plan, shares</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany', window );">Stryker common stock held by plan, value as a percentage of total plan assets</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Retirement Plans Common Stock Held by Company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DefinedContributionRetirementPlansCommonStockHeldByCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Retirement Plans Common Stock Value Held by Company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Percentage of Defined Contribution Retirement Plan Assets Value Held by Company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771223816848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Components of Net Periodic Pension Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="num">$ (39)<span></span>
</td>
<td class="num">$ (32)<span></span>
</td>
<td class="num">$ (56)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement Of Income Or Comprehensive Income, Extensible List, Not Disclosed Flag</a></td>
<td class="text">Interest cost<span></span>
</td>
<td class="text">Interest cost<span></span>
</td>
<td class="text">Interest cost<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="num">$ (21)<span></span>
</td>
<td class="num">$ (23)<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service cost and transition amount</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Recognized actuarial loss</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Net actuarial gain (loss)</a></td>
<td class="nump">43<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Recognized net actuarial loss</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax', window );">Prior service cost and transition amount</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Total recognized in OCI</a></td>
<td class="nump">43<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="nump">252<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax', window );">Total recognized in net periodic benefit cost and OCI</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">$ (104)<span></span>
</td>
<td class="nump">$ 193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract', window );"><strong>Defined Benefit Plan, Assumptions Used in Calculations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Expected return on plan assets</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations', window );">Weighted-average discount rate used to determine projected benefit obligations</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract', window );"><strong>Defined Benefit Plan, Information about Plan Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 492<span></span>
</td>
<td class="nump">$ 485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligations</a></td>
<td class="num">(782)<span></span>
</td>
<td class="num">(826)<span></span>
</td>
<td class="num">$ (673)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="num">(290)<span></span>
</td>
<td class="num">(341)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=syk_AccruedCompensationMember', window );">Accrued Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract', window );"><strong>Defined Benefit Plan, Information about Plan Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract', window );"><strong>Defined Benefit Plan, Information about Plan Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract', window );"><strong>Defined Benefit Plan, Information about Plan Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="num">(335)<span></span>
</td>
<td class="num">(359)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember', window );">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract', window );"><strong>Defined Benefit Plan, Information about Plan Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Unrecognized net actuarial gain (loss)</a></td>
<td class="nump">6<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Unrecognized prior service credit</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement Of Income Or Comprehensive Income, Extensible List, Not Disclosed Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Used in the Determination of the Projected Benefit Obligations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-17A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=syk_AccruedCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=syk_AccruedCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224523200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Schedule of Change in Benefit Obligations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Beginning projected benefit obligations</a></td>
<td class="nump">$ 826<span></span>
</td>
<td class="nump">$ 673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign exchange impact</a></td>
<td class="num">(52)<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Employee contributions</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gains) losses</a></td>
<td class="num">(40)<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Ending projected benefit obligations</a></td>
<td class="nump">782<span></span>
</td>
<td class="nump">826<span></span>
</td>
<td class="nump">$ 673<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Ending accumulated benefit obligations</a></td>
<td class="nump">$ 748<span></span>
</td>
<td class="nump">$ 790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480266/715-60-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224055280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Change in Plan Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Beginning fair value of plan assets</a></td>
<td class="nump">$ 485<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Employee contributions</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign exchange impact</a></td>
<td class="num">(31)<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Ending fair value of plan assets</a></td>
<td class="nump">$ 492<span></span>
</td>
<td class="nump">$ 485<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480266/715-60-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771221119376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target plan asset allocations</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target plan asset allocations</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDebtSecurityMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target plan asset allocations</a></td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherLongTermInvestmentsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target plan asset allocations</a></td>
<td class="nump">32.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">32.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDebtSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDebtSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherLongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherLongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771217277120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 492<span></span>
</td>
<td class="nump">$ 485<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">(Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">404<span></span>
</td>
<td class="nump">378<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">(Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents | (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents | (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents | (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Debt securities | (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Debt securities | (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">185<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Debt securities | (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other | (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other | (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other | (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771227260608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">(Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Estimated future employer contributions in next fiscal year</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771223422432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Retirement Plans (Expected Benefit Payments) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2026</a></td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2027</a></td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2028</a></td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2029</a></td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2030-2034</a></td>
<td class="nump">$ 171<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224509056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Quarterly Data (Unaudited) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialDataAbstract', window );"><strong>Quarterly Financial Data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 6,436<span></span>
</td>
<td class="nump">$ 5,494<span></span>
</td>
<td class="nump">$ 5,422<span></span>
</td>
<td class="nump">$ 5,243<span></span>
</td>
<td class="nump">$ 5,815<span></span>
</td>
<td class="nump">$ 4,909<span></span>
</td>
<td class="nump">$ 4,996<span></span>
</td>
<td class="nump">$ 4,778<span></span>
</td>
<td class="nump">$ 22,595<span></span>
</td>
<td class="nump">$ 20,498<span></span>
</td>
<td class="nump">$ 18,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">4,174<span></span>
</td>
<td class="nump">3,517<span></span>
</td>
<td class="nump">3,416<span></span>
</td>
<td class="nump">3,333<span></span>
</td>
<td class="nump">3,703<span></span>
</td>
<td class="nump">3,158<span></span>
</td>
<td class="nump">3,181<span></span>
</td>
<td class="nump">3,016<span></span>
</td>
<td class="nump">14,440<span></span>
</td>
<td class="nump">13,058<span></span>
</td>
<td class="nump">11,578<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">528<span></span>
</td>
<td class="nump">1,043<span></span>
</td>
<td class="nump">998<span></span>
</td>
<td class="nump">923<span></span>
</td>
<td class="nump">1,226<span></span>
</td>
<td class="nump">869<span></span>
</td>
<td class="nump">899<span></span>
</td>
<td class="nump">679<span></span>
</td>
<td class="nump">3,492<span></span>
</td>
<td class="nump">3,673<span></span>
</td>
<td class="nump">2,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 546<span></span>
</td>
<td class="nump">$ 834<span></span>
</td>
<td class="nump">$ 825<span></span>
</td>
<td class="nump">$ 788<span></span>
</td>
<td class="nump">$ 1,143<span></span>
</td>
<td class="nump">$ 692<span></span>
</td>
<td class="nump">$ 738<span></span>
</td>
<td class="nump">$ 592<span></span>
</td>
<td class="nump">$ 2,993<span></span>
</td>
<td class="nump">$ 3,165<span></span>
</td>
<td class="nump">$ 2,358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net earnings per share of common stock (in dollars per share)</a></td>
<td class="nump">$ 1.43<span></span>
</td>
<td class="nump">$ 2.18<span></span>
</td>
<td class="nump">$ 2.17<span></span>
</td>
<td class="nump">$ 2.07<span></span>
</td>
<td class="nump">$ 3.01<span></span>
</td>
<td class="nump">$ 1.82<span></span>
</td>
<td class="nump">$ 1.95<span></span>
</td>
<td class="nump">$ 1.56<span></span>
</td>
<td class="nump">$ 7.86<span></span>
</td>
<td class="nump">$ 8.34<span></span>
</td>
<td class="nump">$ 6.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net earnings per share of common stock (in dollars per share)</a></td>
<td class="nump">1.41<span></span>
</td>
<td class="nump">2.16<span></span>
</td>
<td class="nump">2.14<span></span>
</td>
<td class="nump">2.05<span></span>
</td>
<td class="nump">2.98<span></span>
</td>
<td class="nump">1.80<span></span>
</td>
<td class="nump">1.93<span></span>
</td>
<td class="nump">1.54<span></span>
</td>
<td class="nump">$ 7.76<span></span>
</td>
<td class="nump">$ 8.25<span></span>
</td>
<td class="nump">$ 6.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share of common stock (in dollars per share)</a></td>
<td class="nump">$ 0.84<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224169088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 6,436,000<span></span>
</td>
<td class="nump">$ 5,494,000<span></span>
</td>
<td class="nump">$ 5,422,000<span></span>
</td>
<td class="nump">$ 5,243,000<span></span>
</td>
<td class="nump">$ 5,815,000<span></span>
</td>
<td class="nump">$ 4,909,000<span></span>
</td>
<td class="nump">$ 4,996,000<span></span>
</td>
<td class="nump">$ 4,778,000<span></span>
</td>
<td class="nump">$ 22,595,000<span></span>
</td>
<td class="nump">$ 20,498,000<span></span>
</td>
<td class="nump">$ 18,449,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,155,000<span></span>
</td>
<td class="nump">7,440,000<span></span>
</td>
<td class="nump">6,871,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research, development and engineering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,466,000<span></span>
</td>
<td class="nump">1,388,000<span></span>
</td>
<td class="nump">1,454,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,685,000<span></span>
</td>
<td class="nump">7,111,000<span></span>
</td>
<td class="nump">6,386,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,426,000<span></span>
</td>
<td class="nump">1,341,000<span></span>
</td>
<td class="nump">1,278,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(623,000)<span></span>
</td>
<td class="num">(635,000)<span></span>
</td>
<td class="num">(627,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment net earnings (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,689,000<span></span>
</td>
<td class="nump">3,888,000<span></span>
</td>
<td class="nump">2,841,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_InventorySteppedUpToFairValueAtAcquisition', window );">Sale of inventory stepped up to fair value at acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(12,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill and other impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(977,000)<span></span>
</td>
<td class="num">(36,000)<span></span>
</td>
<td class="num">(270,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 546,000<span></span>
</td>
<td class="nump">$ 834,000<span></span>
</td>
<td class="nump">$ 825,000<span></span>
</td>
<td class="nump">$ 788,000<span></span>
</td>
<td class="nump">$ 1,143,000<span></span>
</td>
<td class="nump">$ 692,000<span></span>
</td>
<td class="nump">$ 738,000<span></span>
</td>
<td class="nump">$ 592,000<span></span>
</td>
<td class="nump">2,993,000<span></span>
</td>
<td class="nump">3,165,000<span></span>
</td>
<td class="nump">2,358,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,518,000<span></span>
</td>
<td class="nump">12,163,000<span></span>
</td>
<td class="nump">10,893,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,595,000<span></span>
</td>
<td class="nump">20,498,000<span></span>
</td>
<td class="nump">18,449,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,720,000<span></span>
</td>
<td class="nump">7,130,000<span></span>
</td>
<td class="nump">6,557,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research, development and engineering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,324,000<span></span>
</td>
<td class="nump">1,210,000<span></span>
</td>
<td class="nump">1,159,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,314,000<span></span>
</td>
<td class="nump">5,856,000<span></span>
</td>
<td class="nump">5,172,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">641,000<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
<td class="nump">528,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(623,000)<span></span>
</td>
<td class="num">(635,000)<span></span>
</td>
<td class="num">(627,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment net earnings (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,595,000<span></span>
</td>
<td class="nump">5,735,000<span></span>
</td>
<td class="nump">5,033,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | MedSurg and Neurotechnology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,518,000<span></span>
</td>
<td class="nump">12,163,000<span></span>
</td>
<td class="nump">10,893,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,320,000<span></span>
</td>
<td class="nump">4,876,000<span></span>
</td>
<td class="nump">4,637,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research, development and engineering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">784,000<span></span>
</td>
<td class="nump">702,000<span></span>
</td>
<td class="nump">682,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,203,000<span></span>
</td>
<td class="nump">2,934,000<span></span>
</td>
<td class="nump">2,564,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208,000<span></span>
</td>
<td class="nump">181,000<span></span>
</td>
<td class="nump">178,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment net earnings (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,004,000<span></span>
</td>
<td class="nump">3,470,000<span></span>
</td>
<td class="nump">2,831,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Orthopaedics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,077,000<span></span>
</td>
<td class="nump">8,335,000<span></span>
</td>
<td class="nump">7,556,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">2,254,000<span></span>
</td>
<td class="nump">1,920,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research, development and engineering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">540,000<span></span>
</td>
<td class="nump">508,000<span></span>
</td>
<td class="nump">477,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,111,000<span></span>
</td>
<td class="nump">2,922,000<span></span>
</td>
<td class="nump">2,608,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">433,000<span></span>
</td>
<td class="nump">386,000<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment net earnings (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,591,000<span></span>
</td>
<td class="nump">2,265,000<span></span>
</td>
<td class="nump">2,202,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,000<span></span>
</td>
<td class="nump">139,000<span></span>
</td>
<td class="nump">123,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Segment operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(880,000)<span></span>
</td>
<td class="num">(780,000)<span></span>
</td>
<td class="num">(649,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_InventorySteppedUpToFairValueAtAcquisition', window );">Sale of inventory stepped up to fair value at acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Acquisition and integration-related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(108,000)<span></span>
</td>
<td class="num">(20,000)<span></span>
</td>
<td class="num">(138,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Structural optimization and other special charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(138,000)<span></span>
</td>
<td class="num">(170,000)<span></span>
</td>
<td class="num">(295,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_MedicalDeviceRegulationsExpense', window );">Medical device regulation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(58,000)<span></span>
</td>
<td class="num">(96,000)<span></span>
</td>
<td class="num">(140,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_RejuvenateABGIIHipRecallCharges', window );">Recall-related matters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,000)<span></span>
</td>
<td class="num">(18,000)<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Regulatory and legal matters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,000)<span></span>
</td>
<td class="num">(92,000)<span></span>
</td>
<td class="num">(76,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,689,000<span></span>
</td>
<td class="nump">$ 3,888,000<span></span>
</td>
<td class="nump">$ 2,841,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_InventorySteppedUpToFairValueAtAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory, Stepped-Up to Fair Value at Acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_InventorySteppedUpToFairValueAtAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_MedicalDeviceRegulationsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Medical Device Regulations Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_MedicalDeviceRegulationsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_RejuvenateABGIIHipRecallCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rejuvenate / ABG II Hip Recall Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_RejuvenateABGIIHipRecallCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224528176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Data (Segment Information) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 42,971<span></span>
</td>
<td class="nump">$ 39,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CapitalExpendituresDuringPeriod', window );">Capital Expenditures During Period</a></td>
<td class="nump">755<span></span>
</td>
<td class="nump">575<span></span>
</td>
<td class="nump">$ 588<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">41,622<span></span>
</td>
<td class="nump">38,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CapitalExpendituresDuringPeriod', window );">Capital Expenditures During Period</a></td>
<td class="nump">506<span></span>
</td>
<td class="nump">362<span></span>
</td>
<td class="nump">348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | MedSurg and Neurotechnology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">23,115<span></span>
</td>
<td class="nump">20,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CapitalExpendituresDuringPeriod', window );">Capital Expenditures During Period</a></td>
<td class="nump">276<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Orthopaedics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">18,507<span></span>
</td>
<td class="nump">18,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CapitalExpendituresDuringPeriod', window );">Capital Expenditures During Period</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">1,349<span></span>
</td>
<td class="nump">1,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CapitalExpendituresDuringPeriod', window );">Capital Expenditures During Period</a></td>
<td class="nump">$ 249<span></span>
</td>
<td class="nump">$ 213<span></span>
</td>
<td class="nump">$ 240<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_CapitalExpendituresDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Expenditures During Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_CapitalExpendituresDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771224505488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 6,436<span></span>
</td>
<td class="nump">$ 5,494<span></span>
</td>
<td class="nump">$ 5,422<span></span>
</td>
<td class="nump">$ 5,243<span></span>
</td>
<td class="nump">$ 5,815<span></span>
</td>
<td class="nump">$ 4,909<span></span>
</td>
<td class="nump">$ 4,996<span></span>
</td>
<td class="nump">$ 4,778<span></span>
</td>
<td class="nump">$ 22,595<span></span>
</td>
<td class="nump">$ 20,498<span></span>
</td>
<td class="nump">$ 18,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Property, Plant &amp; Equipment</a></td>
<td class="nump">3,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,448<span></span>
</td>
<td class="nump">3,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,943<span></span>
</td>
<td class="nump">15,257<span></span>
</td>
<td class="nump">13,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Property, Plant &amp; Equipment</a></td>
<td class="nump">1,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,997<span></span>
</td>
<td class="nump">1,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe, Middle East, Africa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,897<span></span>
</td>
<td class="nump">2,618<span></span>
</td>
<td class="nump">2,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Property, Plant &amp; Equipment</a></td>
<td class="nump">1,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,260<span></span>
</td>
<td class="nump">1,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,020<span></span>
</td>
<td class="nump">1,946<span></span>
</td>
<td class="nump">1,885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Property, Plant &amp; Equipment</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=syk_OtherForeignCountriesMember', window );">Other foreign countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">735<span></span>
</td>
<td class="nump">677<span></span>
</td>
<td class="nump">$ 578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Property, Plant &amp; Equipment</a></td>
<td class="nump">$ 116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=syk_OtherForeignCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=syk_OtherForeignCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771220153024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Impairments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill and other impairments</a></td>
<td class="nump">$ 977<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_LongLivedAssetsAndIntangibleAssetsMember', window );">Long-Lived Assets and Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill and other impairments</a></td>
<td class="nump">$ 159<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_LongLivedAssetsAndIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_LongLivedAssetsAndIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771226682848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets Held for Sale (Details) - Disposal Group, Held-for-Sale, Not Discontinued Operations - Spinal Implants<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax', window );">Loss on disposition of assets</a></td>
<td class="nump">$ 362<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue', window );">Increase to fair value</a></td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue', window );">Decrease to fair value</a></td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Disposal Group, Including Discontinued Operation, Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Accounts receivable, net</a></td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Total inventories</a></td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent', window );">Property, plant and equipment, net</a></td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent', window );">Other intangibles, net</a></td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets', window );">Noncurrent deferred income tax assets</a></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets', window );">Other noncurrent assets</a></td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent', window );">Valuation allowance</a></td>
<td class="num">(362)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets held for sale</a></td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract', window );"><strong>Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent', window );">Accrued compensation</a></td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities', window );">Other noncurrent liabilities</a></td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities held for sale</a></td>
<td class="nump">$ 104<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Accrued Compensation, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Accrued Expenses And Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Timing of Disposal, Potential Decrease In Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Timing of Disposal, Potential Increase In Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Valuation Allowance, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred tax assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=syk_SpinalImplantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=syk_SpinalImplantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771217364672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - Subsequent Event - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Feb. 12, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Senior Unsecured Notes, 4.550% Due February 10, 2027 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.55%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Senior Unsecured Notes 4.700% Due February 10, 2028 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Senior Unsecured Notes 4.850% Due February 10, 2030 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.85%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Senior Unsecured Notes 5.200% Due February 28, 2035 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Inari</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationPriceOfAcquisitionExpected', window );">Business combination, price of acquisition, expected</a></td>
<td class="nump">$ 4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Common Stock | Inari</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Business acquisition, share price (in dollars per share)</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationPriceOfAcquisitionExpected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of expected business acquisition prior to consideration being transferred. Excludes asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479455/805-10-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationPriceOfAcquisitionExpected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.550DueFebruary102027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.550DueFebruary102027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.700DueFebruary102028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.700DueFebruary102028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.850DueFebruary102030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.850DueFebruary102030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes5.200DueFebruary282035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes5.200DueFebruary282035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=syk_InariMedicalInc.MergerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=syk_InariMedicalInc.MergerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45771325339472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II Valuation and Qualifying Accounts (Details) - SEC Schedule, 12-09, Allowance, Notes Receivable - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance&#160;at Beginning of Period</a></td>
<td class="nump">$ 182<span></span>
</td>
<td class="nump">$ 154<span></span>
</td>
<td class="nump">$ 167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged&#160;to Costs &amp; Expenses</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Uncollectible Amounts Written Off, Net of Recoveries</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">Effect of Changes in Foreign Currency Exchange Rates</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Period</a></td>
<td class="nump">$ 213<span></span>
</td>
<td class="nump">$ 182<span></span>
</td>
<td class="nump">$ 154<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br> -Paragraph Column E<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br> -Paragraph Column D<br> -Publisher SEC<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br> -Paragraph Column C<br> -Subparagraph (1)<br> -Publisher SEC<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br> -Paragraph Column C<br> -Subparagraph (2)<br> -Publisher SEC<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br> -Paragraph Column B<br> -Publisher SEC<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForNotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForNotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>135
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( .-=3%H'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #C74Q:QWF&O>\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M3L,P#(9?!>7>NLU8#U&7"XC3)B$Q"<0M2KPMHFFBQ*C=V].&K1."!^ 8^\_G
MSY);'83V$9^C#QC)8KH;7=<GH<.&G8B" $CZA$ZE<DKT4_/@HU,T/>,1@M(?
MZHC JZH!AZ2,(@4SL @+D<G6:*$C*O+Q@C=ZP8?/V&68T8 =.NPI05W6P.0\
M,9S'KH4;8(811I>^"V@68J[^B<T=8)?DF.R2&H:A'%8Y-^U0P]MN^Y+7+6R?
M2/4:IU_)"CH'W+#KY-?5P^/^B4E>\751\:+F^[H1]XU8\_?9]8??3=AY8P_V
M'QM?!64+O^Y"?@%02P,$%     @ XUU,6IE<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M4,G@G'R;MI.T$Z>;4(P+[:BTP["BYHO&!]#^4FOW,O'UW;?SX@]02P,$%
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M(]$_ =B_47S7/1.WXDKQ;?=RPXJ*"2/0WZ\Y5R]OS \<GL-<_!]02P,$%
M  @ XUU,6G*?8[P3(0  C&0  !D   !X;"]W;W)K<VAE971S+W-H965T,3 N
M>&ULY5UM<]M&DOXK*&W5KE5%RK+L37)RDBI9CK/:BF.7Y5SJZNH^#($AB1C$
M,!A ,O?77S_=/2\ 25G9N[TO]\662&"FIZ=?GGZ9T;?WKOODU];VQ>=-T_KO
M3M9]O[U\^M27:[LQ_LQM;4O?+%VW,3W]VJV>^FUG3<4O;9JG%^?G7SW=F+H]
M^?Y;_NQ]]_VW;NB;NK7ON\(/FXWI=J]LX^Z_.WEV$C[X4*_6/3YX^OVW6[.R
MM[;_9?N^H]^>QE&J>F-;7[NVZ.SRNY.K9Y>O7N!Y?N#?:WOOLY\+K&3AW"?\
M<E-]=W(.@FQCRQXC&/KOSE[;IL% 1,;O.N9)G!(OYC^'T=_PVFDM"^/MM6M^
MK:M^_=W)-R=%99=F:/H/[OYO5M?S5XQ7NL;SO\6]//O\XJ0H!]^[C;Y,%&SJ
M5OXWGY4/V0O?G!]YX4)?N&"Z92*F\K7IS???=NZ^Z/ TC88?>*G\-A%7M]B4
MV[ZC;VMZK__^MEZU];(N3=L75V7IAK:OVU7QWC5U65O_[=.>)L&C3TL=\)4,
M>'%DP&<7Q5O7]FM?_-!6MAH/\)2HBR1>!!)?73PXXFM;GA7/G\V*B_.+%P^,
M]SPN^3F/]_S(> >66?SGU<+W'8G(?QU:L8SWXO!X4)M+OS6E_>Z$],+;[LZ>
M?/_G/SW[ZOSE ]2^B-2^>&CT?V:#OC#@S8\_W[RYN;[Z^6-Q=7W][I>?/][\
M_&/Q_MU/-]<W/]P6/YM^Z&SAEL6[K>T,=,=?%C3"[I/MBB?]VA8GUVZS->UN
M=E*<W%O\.WCZUW7%B1NZD].B]H4I5HU;F*9HR%30BW5;;&Q%ZVB*WI;KUC5N
M!<Z;MIH5O5M9&K@CX>_7!8VAHF\[/RON;6&(H*HC]6WI41+_3[986]/TZQ+?
M+&S?V^ZL^!54+WFNUMT9J'NQ[5PUE#W/4V!OZI(F)6+>VNIVZ%:SXF<[="Z2
MM.,'WW7]VFT-Z/5%OS8]3==LBWI#PV%0&MO2?N#1C ZR>271[,^*=[2".'/=
MELU06;)[W8K7;W\?ZNTF#! _;LU=O6)^%W[G>[OQ+PO;5LZ7;EN7_"P-OQE:
M>IIW)3T6"%K30[3?M"I+O%O9MMQ%KH]GK=L>EI46PZ17M=\Z;Q9-XMC+HJ2A
M^-71M/RZZ7H(94U?8J2FJ3&9G1OO:Z*I*N[JKA_P*D;?-J:'_T@[OWM9M.![
M7#P&Y4_NC"^'QG1D6GFO7H+K#4F_+P9O07CQFZ,YR2/0QZ6-*R+U'3:&V6F[
M&B^^-9]<\<$M7%^7\RN:_BI0E]/AMW5+!,3IC">):QK\[U@FXT:&^4UQ9VB&
M?@<E">SU6PMVT#[0_K\>.B@I=&5)TDPR_?M +*/!8,,@T25MU0J4T".MV;"^
M0>[__*=O+B[.7XX$$*N[)2HM?_GL9>%$,6D&;U?, -** V^>A1=>&5HXIG@/
M ]7V:2.O28[(E%3\R67QD<A)'Q%];X@Y+>_S+;W%W$X2W?/3; I$J.@[/RQ\
M7=5@$#'BBACI,PL&8>G*\(J8,Q^VK_6F%,&&T-BF)G_'1!#/RYQ.5O6U(>%M
M80UHR""(M#RFCW>(Q3E\2JK4U[([U[;K":[0QM9DLG:6A,ULA!(>=&$M $?9
M0)J7-7;)@0 68;90Y=!U8#N_N\UY2L-B&[_(0[$1),..: &=NI/"C,XV_":I
M9=E 2<AF$5H!E"E*I3X1&,P![>^!)2T[MV&:1C*5"0Z^4VO(DT\-8GBT&BPS
M@B77AY4R?Z% LA86RKXC?2&BSXI?/$OV#[ZOL4]>)(PXMC7B6O#M,O+'YS(6
M6%Z3HC'737)_M$YZ8]L0'61X2!N:AN7);E5>()J_M#5^8Z;[XLF/5U?O3XE,
MLH/@Y\:TA#H#$]BGV$"FV#A/2'4KK&4?8,BYT 9@:%DL#1ZX3,N@YZWN7T.R
M5S<L;OQ[VD<\2.O"(MAP'7['R0(@/GB![<@A)K'B'"&G)43O3:,4V,\$X[UL
M6WJ#64G:XRI2U9(--K&& *TG(H<&A+-#91DBZ?$9C\Z*#Y8<,@G%!ULZ4G&Q
M(+<R98<I^.-_@"S/D])4'$:0IRC<HE%OY\'_BM3]+C>V),;173\1@R,&3S\;
M6J *^YG<&,',XMYT9$#Z77B F0Q YT^9&$]3>=9E<5]"7H=7 >JKP')AH.X2
M&3)%0##98&')PD*O6KA.XJ7]+/I =K[327;!]!]9KJB^/\0G$FL*C6J2Y?NU
MY4G9+&(+>#T4'M#T&#O@(X)'Z[HDBV1:LEM3P?%K<?FST:=,_K8O%KO14,3R
M&2]CX\A<CJQ%V)59I(L-I?*!^%ELAXX8 6WOL"_,Y"V]1BO"K*WKHZ$2WLB(
M-(X7>\O.E297;V])(M\?Q&X,*"*? G\ZM=(!-A;0UV++2 $B3X'D3*R(I^_C
M:ZPI<>C>?&*- *XH',01[YVI3)/*B*7_XX+"^I-HF\I-7(28M@.K/B.K'-29
M7A4\B=]FY.D:TD%352K; EIZ\]EZ!AJN8;<Q)H%DD!\K'?PEG,""G0H&6 [-
MLFZ:I$',\F1FU92P5I-B#LQ[=0[@C%^399F35]@0L@FQ!,N48APFG'VXJ&^!
M9\5]F5WNE1+'HHX"BA*"J)F2SAKO6G:?,@0SDT@@X?ADQ0Q.@XEU34^;QKNX
M;ZJN-3U'*ZE[8#6RPSLRB=B,NYH3$!@ZV+Y*=Z*SM+R61H5]3U"FLPMV(K6?
MV$!#OV-OU>_)(&J0/4"@V&+Q-O+AOI$0\Q%(">YA3.B(O*1C]!(QJ_;KW.J%
M;586[D=@$N80<'8=(]W%X F+>E@%X+52/4S 1#W]6]'VWI+MV8*W_+H&)BIP
M)/O=:D]C.QN0);OPZ, (L:GTL")>QE\# T4?*G+KM(R !U6!ANVV@4O%;@^;
M! [(+ ]+4P;Y5*V;Y? _/0+*&[. @:Q@!4C^>!-5%=3'\_0P&Q031H]+RR .
M>=/ML%I3,OK08*ZE9V6C@_FLCI%/=LP! \CF*;5G$TZP6"L[Q.."W>Q>:?NZ
M>C'T642<,W]&KRU(@DG[.TYDR4;-X%?MVF''P]XE&^,/[C#GV5A]/I"U-+2N
M6?&:D$+C4O3Y0[LB$1+5^T&1R67V?#5YWF;/*Q6=S:4H;D1FDB3,%=GH'C6T
MDEZS[C028:E1RU]C<'6?.47-"X0O[6?B=F[*9Q)P2IQ(.TKV,9,Y'T)[VFG&
M"JR"*PA2BR$9E*V&1L%2L'%;!NG!EHRU5?,!JCD^\Y<Q&6$:#M&PPRO\Q_K1
M]&$[1V*.#Y#@)6,M8&89&5J0@N1(-V89R  @+8!<Q(_B.OC[JVH#(>X[2<^D
MS1="(WGR;H2M,S7IX\_,>+ DF74[U4859_+:A'K_$4./QIF6GT?,L@E1W&Q_
M^:,7@[1!$%P[']N)#-(+,1MR#K0<FHCT*(O=:^1N:(?8;I:[XB-00*.!^)M#
M<!^*GH772#C!@QT(=K*@B!1E0WYR@$J('N/QQG%B)\RM 'TYM"Q1V5?D!:O?
M2+B$ FB#DFDU(!C%;/3]F)#7!#],Y\>(&Z&CP@_2'+O63!1M/K#9DW?7-Z=G
MP@X3R(EX:45RJ &3\][NNXT@ 3*6;M7I#.Z$F&W\NOB!9)10$TB^+/Y&UH[8
MU-3T(=Z_LV&MK(:=A>!+5,N>?P-(HU$:7&]GB;^2\";%;. 7&2,GBTX?JR"X
MUNY4D#.1"]$E<ZBR-"$ S; E0:OH%PU7 EJA 4LLPJ9%*.A0YAJQW7# $8?=
MI&5=YI_GRY4T)V"]"8O<%2N"6$A;T9?M>+&\ U@M?V4DYZ!Q8@HU8EBP;X$
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MIF :)B#D+P@/PA?/M%&HJ)>YK1P9R(7=.?4<X4!M.(.8I!.$(I^6\^T8B\*
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M:+F<BQ]UXW YGV;XSC/Z!H?%)RO;G60777_QB&9$)*1@1:B91C$DP1FXOA?
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MB? _ZHS/^F*:(NE'5(C0\HC&%0!X=M(3;_X81?WHO?B.[DRP".V#Z\@I],&
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M_.DO/'BSY,]M,^.]R?EGBJ5=62+ ^[G!7E$]D(+-]]>K_P%02P,$%     @
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MB7A8M0#4^2$UJ1F5_UG$OAE1DV\#^\0$0GY7P9Z&XVXRK?BF<!N%.G/8(;0
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M#%]79'D"?I\9E'?SPANTWVL7_P)02P,$%     @ XUU,6LX:K5!N#   >QX
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MP"Y(@^I).)*YJA0B9;RFW8V+V*<>&[=I%!B5]*K@,8B#>M:5(@*L=ZAN&U5
M9?!J$IN\.#2?GK(G-<$Y&/.H2EV#3.%9' [[Z;_8"PW!Y$%'Y\4-YE-KHYY5
MAKQH#9VA(_F^*O$D@-9R6%9Z2]@B/88^RC&$K&!BK$R754<PC3;:>N6"9?K%
M7MO\WC8) U@@:CW5XE"!;9.IV8OD*8D&#(5UK,Q2X]AV#ETL?;2-5"@Z"VA
M@0JN@=RM,@$.!4H0)H\H1DIN-ZOL@A<# %I55L]L98$/;S@'.,$&I_T](&Z
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MI*<%^'[N0,3I QW0_=Y\^1]02P,$%     @ XUU,6KOH<'D5"   \Q,  !D
M  !X;"]W;W)K<VAE971S+W-H965T,3<N>&ULG5AM;]LX$OXKA+=8= &?;<F2
M7]HD0)IDNP':I&ARNQ\.]X&1:)NM+*HD%3?[Z^^9H20K:>+>W1>;DC@SSSSS
M1NEH9^Q7MU'*B^_;HG3'@XWWU9OQV&4;M95N9"I5XLG*V*WTN+3KL:NLDCD+
M;8MQ/)G,QENIR\')$=_[9$^.3.T+7:I/5KAZNY7VX9TJS.YX$ W:&Y_U>N/I
MQOCDJ))K=:/\/ZM/%E?C3DNNMZITVI3"JM7QX#1Z\RZA_;SA3ZUVKK<6Y,F=
M,5_IXC(_'DP(D"I4YDF#Q-^].E-%08H XUNC<]"9),'^NM7^._L.7^ZD4V>F
M^$OG?G,\6 Q$KE:R+OQGL_M#-?ZDI"\SA>-?L0M[T^E 9+7S9ML( \%6E^%?
M?F]XZ DL)B\(Q(U S+B#(49Y+KT\.;)F)RSMAC9:L*LL#7"ZI*#<>(NG&G+^
MY+TQ^4X7A9!E+J[]1EEQ67I9KO5=H<2I<\J[H[&')=H_SAJM[X+6^ 6M42P^
MFM)OG+@H<Y4_5C &Q YGW.)\%Q_4>*ZRD9A&0Q%/XN2 OFGG]Y3U3?\;OW_P
M6)QKEQ7&U5:)?YW>.6^1/?]^CH=@)7G>"E74&U?)3!T/4#).V7LU./GUEV@V
M>7O AZ3S(3FD_?^.W4&MSV-^?WU]_M?EAP_B].I<7-_^<?%97%[=GEZ]OWSW
MX4*<WMQ<W-[ N#"U!9JREH70VTIJB_KUPBL'3LU*K#O$?'F=>7,'U&U<V1$L
MIF*G1*4L]1R5"RF^U;+TVDNJ8,@ZY1PKA@ZX+6XJ^( 641GK=;D6=:F]J!TM
MI<@12E.7'HHRZ39BA3X$0[)X<-H);P3 :92W8E4K8!;WLJC52-SH=:E7.H-M
MH<NJ]KR==G7BNLR*.B>,#FVMHD;C!&"+5>TI>:RZ5V6MQ!JA]1OV#_W42H:)
M+KC6Y4C<]C7*PIF>6F$9F>G<8/LMY+RUL_>LLN9+Z'@M6CC$@80L.\9=##A*
M5O68M5]_6<31_*WK6=AQ8R,L]P"^ABWCF/E,5@A),:*X<_1(72:M?2!MP=2A
M *GOF5+DI :Q>]Z9)"FR#=AA!:_B.1("&6-59A"1OTFD[.42D<K9OT\YB@Q;
M/@,/IM YNW*##%+A,?1>2%L"C L!Z*5K8YK"^")XPI-;I&,I[AXHRU2&F>@4
MV6UB@DCD=>;Q:$L0\UJUZ9.9;:60SY3-JKS7UI1LF#TO*?J=KI< =('Z>7AN
MZCNGOM5<B&WZ<H5V##XI521F"4V!"[/=:D_Z(2M%50 ?5ABKA<B4]1C[7)"@
M%'\FTR%GM-\0PNGR;>L [%UN21P[[Z@V4</B-;*Z,HZP6%-7OXT:H:ZS$<VR
M*$PF&PBD[K'0TW0N0I?8)Y1KL_")'+%-MYE6B!_*5;^1B#DANJ-GY+;*1V+?
M@7^"D?P@:JEB33]1Q6ZCLPU4.APC0F)3!OR0C%0'T6+Z/]7 2'Q6*]P"I"N#
M+A+-V+C,<TT.4X\NP[&.W0\$-L',"BS0_+BUB8TJ G!XA,:(\]"!3D_ VB;.
MW8R/8(&:IJF_W-)'F%O4]9B/$!(PWVOY.\KPMCWR0T+=$7$HB!2$TO@&;V"0
M@.X="A0^%G/#QJ;3N2(I("]:X+K,,1^\L9QD/2)@JK'8D]P:M(5"?U7% T$O
M&4WGPP\9:]Q3%]R^:8;&#IXJQ0?;)YT7P;\RC_*,$.58A:"&YO:<!=UT<VQH
MR&E&# "O5==8O]3YFK-L^&CV42*VL\,UP8-P[0+=1/*3="'+A*8-X;"9?G2_
M&WI<J_([3\-@Y-#@&X+T&AG;9!'LNOTH!_>Y7J$N", >:I,XO2 @%?MRT$;M
MG$JEH: WA7NA>VKZAUIN: G[2-YJM \,$8#"N""*@C2#:HX+\*K7;K@;1'.:
MZ_?:U [2(8Q-[X79:XOP5E(A/UT[/?<UC5+\J/*;VJZ9S"M56W2(;%.:PJP?
MZ#%>CJALFZ;:BF:RWRHU3E4X'I9--W'/%=W*FNUC,#^WC?I:E^Q(-V/J*N<P
MM3E$ELGFWAH.Z0@/<J+'$W5+FX?4X^AJZ\@EJQ25,?@*A<L)SZ,C</.L8SB<
M->>HO<*VEX:<E/D7O+&% P8=J]M8''!W),X>U]457L3/VE+^LSU$=1[AL'&C
MN/ .DOB(\%N#<P#Y&(M78CY<3E/\SX;+A/ZC9+A83,3IBXY,)Y'@TT;\EM?H
ME8K"@T[$R'NS9YJ(>"%F<6C_K\1B&,\GP=:<KJ-T&"?3O3.]TF@MO$[2V6_-
M[\N8%FD,+!,1#2.L#B!:S,3K:#Z!QD7R6PCS*[$<QI,%PYHE\P!KD:8X)_%W
M"7XQ>?YE2KRW!J>6#W1TH3B=XW1?H$"1,RWU&I%LS*3#V9+,Q& \XO_Y;!ZH
M2;%<XL8B2NEQFH@S?M7GX5.$<M_HJE,U'4Y2#M9P-IWQ?Q(M@RJ(3^:XD4X2
MNCV9BD_(8B*ID8U2IC[(-?:G\1+\(4YS<6LE'5#MUTX@B4@@3ED@;202;(V3
MF8@6$7CY!YIM1BQ0/4B;A3>;/-#!\6R!TT\;6[X,H/<IA65@NY&8D?$996H4
M]BYG8K$4\WT6AQ FT8PYGL3$;3*<+M-F_S!-EKBQA /),%U.Q477IT^WU"S^
M#DWLXGNE2@Q 2+'HC'[8W07]+ G'A%A/4TKB-*9@)@M:)[-4//<"/^Y]B$$P
MU_RYB4="Z<,WF>YN]T7K-'S(V6\/G\,^\LLA^HA:070RFJ<#8<,GIG#A3<6?
M=>Z,1^;P<J,02TL;\'QET!":"S+0?><[^0]02P,$%     @ XUU,6DRL-!J"
M"   3Q4  !D   !X;"]W;W)K<VAE971S+W-H965T,3@N>&ULQ5C;<MLX$OT5
ME,8SE53)%"^Z9FQ7.9G,[NSN3%2QDSQL[0-,0A+6),$!0,O:K]_3 $A3CAU/
MS</N@RA>T(V^G#[=Y-E>Z5NS$\*R^ZJLS?EH9VWS9C(Q^4Y4W$2J$36>;)2N
MN,6EWDY,HP4OG%!53M(XGD\J+NO1Q9F[M]879ZJUI:S%6C/35A77A[>B5/OS
M43+J;GR4VYVE&Y.+LX9OQ96PGYJUQM6DUU+(2M1&JIIIL3D?729OWDYIO5OP
M68J]&9PS\N1&J5NZ^*4X'\5DD"A%;DD#Q]^=>"?*DA3!C-^#SE&_)0D.SSOM
M/SO?X<L--^*=*K_(PN[.1\L1*\2&MZ7]J/9_%<&?&>G+56G<D>W]VG0V8GEK
MK*J","RH9.W_^7V(PT!@&3\CD :!U-GM-W)6_L0MOSC3:L\TK88V.G&N.FD8
M)VM*RI75>"HA9R_>\49:7K(KJ_+;LXF%2GHPR8/X6R^>/B.>I.Q75=N=8>_K
M0A3'"B:PI3<H[0QZFWY3XT\BCUB6C%D:I]-OZ,MZ!S.G+_LC#K)_7MX8JP&%
M?SWEJ]<T?5H3E<<;T_!<G(^ ?R/TG1A=_/!=,H]__(:=T][.Z;>TOYR(%\0O
MU[]<7_Z#75U_>/=W=KT3C&^W6FRY%:QNJQNAF=HPL^.PG,YX6;*\Y,;X2^.B
ML]_)?,?VD-7XM7:GM/R/*)A53!K3"AQ9V]!E,H[C>#S#C_Y9(>\DTL]DC6=V
MKWK5N4+Y&BOK+>T2U@_,.$E8PS6[XR6T(ZH;H37T>'-X782-XJ\$<U55*.I@
MM[0[Q@>:2',<)7'$?E,#H<<;[ 7\!%,9BZV<C34#_H0+5X?!B'T1J+@"<52@
MH:;5^8YW8?.J91U64MPK7M="CYF5%:DD)WBEVMJ2P%">@EP(*S36P:2; XF"
M"$%YUC%-0?;PF@ERBCL2@PIPYRW(&I$M)-TSX^!-HV4NW'[*[N# !C!7VG@+
ML)=I;_X-+J3T 1AMR?'TX#-4".WTFXBMC^QS?F^TJL@=<6K5*?V3P]B"46L(
M]HSI'BRX ^#* ZO%5EF)<X!'\]IPQ\&(F?;&[:41$?OP1+B=8JNH% I5EL.4
MAFC;'2?WVQ(Q VB"O05KP4!0W^HA=!\"#NO45O.*[;D![L9QED7LRJL,Y5PP
M=#FV:6T+UX$PN&=\W"%86Y=RTG\,/@)1L@0YEZ7K,PAW&O>73T$JK$G) *?C
M0^/#0T@3W-#V%(9<&8<:436E.@@1=E1A=8\16NLL/"VHWC=<=E&CC;3(U;9&
M-+K(06EK")LD1W1(G>N4& 6[(W+0>0=KZ6DCM%14UX$;.&F3C22(2HK;[ZW4
MGB$07B(!1I$$$%U5B'N$OMX*%U>/F !9>VAD#A(ZN-MWPG.$W\[7T=XU5%&<
M<AC#MT=N89U'@\M(" ?L(3650UV(BHL'UKCH#+Q^6_+\]O0JWZF2*MEI< 5$
M"RI5B#(*26&?^T!>@@.KL)E+(Z60#BD2]T>,/6%)LHRP_(0MLVBVPO]\&<7+
MH>8W[*,TMZ<;+:C,P [PB6ER8QIE['L<8QR3:(GC^_L&!0UO/?_"Q(,4*(LD
M2MR:U!WCX<HA5=PI<( LI3VP=!6ML Q_M#I=' N%^)1R(]BK@^#:O&9S6#/'
M#C,(4KKT,U93YGU:C>/I0!VBT^V4#K+H,D6MY!&^/]62;E]9*#7L6KLR.02'
M\Q;5ZP"WV1#% >:.1HBKNNQ'+P;A\98[="[0"& Z7!4XP.GP2!5/Q&E,S$.T
M4ML.<Z&6(._L<L7XV&M"2:\.175SU)_&1R8.S L;BWNA<S"K0VM/&K[#>!Y#
M/?#(@W?(/.R2AF/R+A!BC^?+@.>O;ESVX\6'00/]&Z];S/8L =*C&0%^N8H6
M,?M+\"\!:K(,MU)DPQM;L%=)M'C-DFP:+>?L':]SS.P%M0I@9R-<VE_%4?8:
MN)Q&B^G1A@-N9>CW2VR9)E"T # SVG\\6Z31O-N-WY3B2&:.9UBUP.H5RU W
M))*"F;.>E(?Y(*+",JK<%#+S!5M$"UQD&57D\=B%.M 2S35_Z& ]_7DV[2%B
M/-VW%75EO*6@H %D+1 *0,#NA?"(=*P2!H!>*3UPO:\\4$2.FA,!X8%W'P#B
ML \[1)\$UQ6S>3K&$=V,!$]2G(399NS)+C2N-.K3%U2Y.N_0/!RI-/%_X6>(
MDU4:48=7V(- L'AFX'IN+D!Q^.8-ZH3C;=VWMN*X7;L>IT7)0]IJ55/F^M)_
M7'9^=*! E:K>GE+%P/&<BA?):$I.D]%UWSVE>5RD T.X?U@C-'T;_:J7/7 !
M;] X[UW70C.DHG$$&[&/,!BA]:1'1A,#&O;JX]4GT"\E8BVT>RLGE!PM6;LE
M+]8T:6*T=G#V6Q\IA/&AFF.@/(ZH<:73>;1R93;#A+WH*QL%BE^"2D"Y35D6
MHS&LV&>ORY<OC@F*>#J-@*L4X]=J]DRY__#=,DW2'_O_=(%6DW4R1S8.BWE@
MY2J.9L[*Y2*:)2\B:A7_64!1Z/XWV%"8SP@;SXQ'?L1Y/  >34HNS1WF?<'[
M;/EJGZ'MK[J"'\RHU[LCE9TB!T$Z"9'H!)WB91*49B^7,S+[)X.__C\$_WW7
M5WW)=>]+;$TLP5Z]OUJO7_>+#-CZ0"^F%J-EX[N"&Q]H63<R.XK&VQ]]@\N%
MMIP&F5)NY8V?.,*43>^%QF=C\$Y#,XSCWL?O)0^<1G1FND[A-D:<"K%QKYV(
MRFKV??<T+Y6;D8<34IB&\$9OZ67.L7K!W2#$!Y:$T?V+\-\*T.L7V7@1^U:2
MK.+Q#%D/KW /MGES'D/NJ>\ID\%'KDKHK?N41U\8\&KMOW?U=_NOA9?^(]G#
M<O^I\5>NM^C,K!0;B((U9B/,K^[SG;^PJG&?S&Z4M:IRISN!5V%-"_!\HY3M
M+FB#_AOJQ7\!4$L#!!0    ( .-=3%I> 1N_0 8  -D.   9    >&PO=V]R
M:W-H965T<R]S:&5E=#$Y+GAM;)57VW+;.!+]E2Z-=YX4B3=1E&.[RI>DUEN9
MF53LF7G8V@>(A"Q42$(!0"G>K]_3X$6T8WMV'BCQTGWZ] 6-QME!FZ]V*Z6C
M[U59V_/)UKG=Z7QN\ZVLA)WIG:SQ9:--)1P>S</<[HP4A5>JRGD4!.F\$JJ>
M7)SY=Y_-Q9EN7*EJ^=F0;:I*F,<K6>K#^22<]"^^J(>MXQ?SB[.=>)!WTOV^
M^VSP-!]0"E7)VBI=DY&;\\EE>'J5L+P7^$/)@QW=$WNRUOHK/]P6YY. "<E2
MYHX1!/[V\EJ6)0.!QK<.<S*89,7Q?8_^T?L.7];"RFM=_JD*MSV?9!,JY$8T
MI?NB#_^4G3\+QLMU:?TO'5K9))A0WEBGJTX9#"I5M__B>Q>'D4+VFD+4*42>
M=VO(L[P13ER<&7T@P]) XQOOJM<&.55S4NZ<P5<%/7=Q(]>.1%W0M9&%<O11
MY*I43DE[-G? 9ZEYWF%=M5C1*UAA1+_HVFTM?:@+63P%F(/8P"[JV5U%;R+>
MR'Q&<3BE*(B2-_#BP=O8X\6OX'W2]<.[>VDJ8K^G]'N=E\):M5&RH']?KJTS
M*)/_O.1Z"YR\#,Q+Y]3N1"[/)U@;5IJ]G%S\_%.8!N_?H)T,M).WT-LD7?Z_
M2?H+K ]7]W3YZPU=?_EP<WM/'R^O;S_=WM]^N*,_)6W%7A*K6-(;REMSRMH&
M\5D_TEX8I1M+&U6+.E>B)%5;IUS#*\R2VPH4DY$D]D*58EU*<IHV#9CKQE A
M'M\Y_0Y_A*9BA%/U ]52%G9&U](XM!"VRJ*=Y<W@*!K MT8!&M:!F>MJ5SYB
MK;CMB S7L79;"7V]EWB+?L5>'204 >ZU%(1EJRG*\BA)Z!&H-UFMH=_7W(Q^
M>^$ML8T.MM:TU@8)A3/ :)QUH,&>P6WHL#=&[G6YYW=/_4(<6@$0JZ3Q/NP$
M0D,[HQ^,J.BP5;GGJ0^(.J31AQK31J39<23BU9(#BZ]&5TP,3TYR'#EM[.N,
M[O$6/4-5346BTDWMAC@_-^Q3F(N:UO*),YS8^I$<&C* Z22:1HM@1K<U_8)T
M^J <)!S="55X%F/EDS0(X))"EG:<IH$""\:S>+GX!UE9*_C7U%;F#:*$P#HX
M63326P@7?4)@\D[N7)N1WG!7HB?+1<"XR0SLWL0\0H1M4E=3^OFG+$Z3]UG@
M,?Z:UW.,.)J.&*31W]1.?/UV)-*>Q-^&27V(?D59/XG0*ZGIS"U:<YM2MZO2
M< UU5EM;S$V-UL(SW#YVK??!6_%OZW&CN:C9EO.-HIT*U'^Y\Z PG7:HE,+O
M3FZ\ D_IKIT?V,Z]E_+M\0LSOD% /#'\Q C-2^9/^\R.RXI.V(,HC-[CCF/_
M1]?IACB&:2?9RRT62>_GD=XSF5424#@+6>9?32U[<PM*DQ6NK*=RM-)]YRI:
M0B:>(3-,U: -=-HIK589KB5%LS ::\>!%UC2<KFD+&+X=#&H+_W'C!:K]DIF
MV1/RV? ]]5?';?C>+92,TBBD- WA_?*(WJTB;S;+XGX)_KC.X%<\!"B<K9X%
M)P[@6HPKA'OI"^Y!($V!$L;0#H(?PA^'<#\"C[CWX,=UBJ_')'5+]87UN$3Z
M>JGX%:F4TC >887,Z!+-KFQ# F?C57LES^LN2? ^]5='8ISH!(G.$EPQ(K$*
MGH8)]9$".DTB^LWO>.&1ZOUQ[9Q0&$\7*!7<1-/5:D&?I+48+(V1:,&CW22<
M)L&*HFFP2CJ DH<EQ\-2#Q5-PRSCFV"Z"D),3^CDQF'-%JU(O^-@6['84+&2
M8OR ZE6_0V)KP93D=[Z:Y'=E?;<9;?,GH("I:?C_*)3!V%$V?DM[I0]Z:LLL
M:&^B1=1VF">JW/A>43\(2Q),$ V\:RQ3^M9H?E U H!OOB':Z3A@W!#;G<S/
M2J,A@$\)!3O8@;0G#^B:KSAEH33R3OU1R;+HQB:'@PN;TQ#/_?[(C/T,43[Z
M-HE,V-Z3-MR8O4R#$Q*/.7?-FINZPU:.P8@GFVZ+[S)#HTF7AQ_T\D]R+TN*
M>LQ1O+8*XQDJ\7'VTO0Z'QTW,#T\^$,5###K]N0QO!W.;9?M<>4HWA[Z4.\/
M<(-*N8$J-Y0)F?8@U3XXO?.'E[5V. KYVRW.GM*P +YO-$+</;"!X31[\3]0
M2P,$%     @ XUU,6L;$U<O'"P  ,B(  !D   !X;"]W;W)K<VAE971S+W-H
M965T,C N>&ULQ5IM;^,V$OXK1)HM',#GZ,6OV]T R6YZ%Z OB\WV>L#A/M 2
M';.5)9>DXKB__IX94HKLV$F*7G$?8LL29SBOSPQ'>;>IS*]VJ903#ZNBM.]/
MELZMWYZ?VVRI5M(.JK4J\611F95T^&GNSNW:*)DST:HX3Z)H?+Z2NCRY>,?W
M/IF+=U7M"EVJ3T;8>K629GNEBFKS_B0^:6Y\UG=+1S?.+]ZMY9VZ5>ZG]2>#
M7^<MEURO5&EU50JC%N]/+N.W5T-:SPO^J=7&=JX%:3*OJE_IQTW^_B0B@52A
M,D<<)+[NU0=5%,0(8OP6>)ZT6Q)A][KA_BWK#EWFTJH/5?&SSMWR_<GT1.1J
M(>O"?:XV_U!!GQ'QRZK"\J?8^+5I>B*RVKIJ%8@AP4J7_EL^!#MT"*;1$8(D
M$"0LM]^(I?PHG;QX9ZJ-,+0:W.B"565J"*=+<LJM,WBJ0><N;LJL6BGQ13XH
M^^[<@2/=/\\"]96G3HY0QXGXOBK=THKK,E?Y+H-SB-+*DS3R7"7/<ORHLH%(
MX[Y(HF3X#+^TU2]E?NF+^HF/VF9%96NCQ+\OY]891,1_#NGL.0X/<Z0L>6O7
M,E/O3Y &5IE[=7+Q]5?Q./KF&7F'K;S#Y[B_Z(]GJ0_+=O/#AQ^_OQ9?+O]U
M?2M^K(U0BX7B9! .9C'2*;&15L3#0?JF+^)T,'TC9)F+.!G$;P02GYW!+DGY
M 2Z2@?BR5!U6V@O><FS(Z '0PJI<+$RU\DSR&BLKX<"!UR"-E#%80N1S5:J%
M=@(Y2PN )%;GBG)/6Y%K[&A4F2E 0H&-\H:1+)W.])IO65F <,'W;]>ZE(6X
M6:T+++%B7EM8S5JQEL9I611;K%Q8X-]\VTB4LB!>N9U]C"PM]K?$7)<.8((5
M-=BO#7#2N"VD=QNE2F;P2VVTS37CCWVEP=(#!DOV#)9TV$!P5RC I&L4_JG4
M).ZM U<K%BI7!@)VMI-U#O/2?ELEH4L2Q4-0FJJ^6]*/*3NYW<NH>V@,%N#?
M.JK##GZJRUPCH?2\IIW!M-3E'1L)NP 82X#^'%[4TFCU?[#\90Z-<4E[]GFK
MHWZPQP*>2A#MR>094$^7-61#55/F.7;(+ E:BS)!LE=(P.N:9):E(,DER\C;
M9- #=11!;A$"SG.!,U=0X;K=H0-IGREP/BM(D^E",R>?4"PY2WTX&BQ^UJXR
M6Q][23R(Q)N]KUU*HE L95%E._&D;%\4E% -<U2"VM?<>!#S7P*&WX9(Z :B
M"S:J8%,#P\(D"2"G-QS$9Z(W'DS/PC4IVXD&HY#G)BC<B;(V\J)!BHT3T4L&
MP[,]30@8I<F6K$R.X"ZJ-></;(XPL:(7$Q$^$_X<G<'DAP+N,2:__FJ:Q,DW
MHI<.TC-L'A\QN\^\3LHVA"V#,6G[]ZK*-[J D5=KJ0VO3 ;3=E4\F #(_R)8
MA,%G9T\$^Y$]U(O(&C%$@8DZ(;F/951*$$$1%Q-<4"7!UW7CGBM%'A/=8O=\
MW)Z*$1Z<BDD4XW,83=@EII0^JT72GXUG]#E)\)E,QN)+Y7#_5*3]X2SA[_&$
M."3]\305'ZK5NBH5*0Y[=#+J^@'MKE6B=^6KT)GX4 /PX(".CJI9%$K5V=O7
M91TDGT4D0SK&9V\RW@_-_23#ZN%4C(?[VDYG8IA&(IG,@I[9<2%/Q12F@>D
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M4 1JC?\[3>"GRFH_M'CL[:XH!8@_=FU(2(QUNQ:MPX0ZO@0=UTT8<=EN+]/
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MIQ#F@=_G[7 CEK;_&JU $N!PQ3ZYY$/DT/])$_1AX,\GNY$..*]9E[#?Q*.
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MD,],K#QB4.@',,-U'A'I!4%Z(2 _"\ 5H^88(-'I0#$T.@/6BP!CT,G6Q+_
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M-QQSWI=H?0#[-\;0P? )V@T\_@502P,$%     @ XUU,6O#)\D7T!0   @X
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M@&^&>+G 1QH[,<#[F<4(;6[$P?JS[^(?4$L#!!0    ( .-=3%J]_*!0304
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M41ZFEX5Q+H1QP2/!?,7 '9ZCN88?E_.V4V)@BIR+Q)U]XCVGU+&/HFO@VM^
M8SF>9D"WY?@,K05N7<3[Y?AX@TOQNW+\$=+2P0^JY^YJ\/OJN>OP8?7<=?BH
M>NXZ?/Q_\_[P?Z]N4AUW2E:Q6Y2OJ_S<?RE?79EF=I[>3G[QVVP-(]0UQ">=
M(;I%1OCYDQU8/W0E4J=9OTZSNSK-!G6:W==I-JS3;%2GV;A.LX<ZS28UF1V5
MJU>4JU?F'OX4NVH$*8[Q4OL1S6A?T7+[O U]+^B8V\.B.]<T7>]8T]=H'/]8
M<W>N:32;QYK!N<:V/?=8='\N"EK.L6:H">:>!!MIDC_U&9]KG%;K9$ /YR+7
M#D[2GVB<7/]C2-GTF@<;JQ31I3HN,!"1#>;9GW316YQ(;M3&[*2_9[='MJ9_
M+$XPV8'CPSX[_HC/W#+&#"1H(4)9UPTQ5)H=*;(&)VNUK7LA7&P3U>U*G,(0
ME0+Q?$$(WS=D@.)<%_X%4$L#!!0    ( .-=3%HL=6B^0P(  (H&   9
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M6.J?!0@3H)_GG*OCQ&PP_'Z2-U!+ P04    " #C74Q:/*4S.!$"  #=!
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M9$*V9PN3:#6BO3BNPD^Y=\;O<H]SY8T_7@8&?3*4<56CG1:\XF 150SMC*Z
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M'Z\)[;&-,HU#W'!6@D\MBGJ3FFL28GVRQ'-4B%A<Q(XGX)"H@8#'?<LDW:5
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MGQ-IU4/W.G-?-6?$"[8D8998!H_CH/6CF_<?7I].JK0=@O:]+]\@<).2XC(
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MW%K2\ETR.A'):8L>8T.%CP,",KMR,X$F=9_,/ASB\,7.YBP<ZY #(%9OF,&
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M#>F7_E^KI+3)ELPI9A#BZ2R'G_MIA.]TX#L=I>RA-;8@-JTJ#M:GC]N*[UT
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M"E!U#:O;&-FX)K&5AEJ.6QZHQZ.R O1])Z4Y;:R!X5_#ZC]02P,$%     @
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M?E65J)X33%#A(#/>R;R(WV2\$N48&!U!3.+D#3XVA,TZ/O8*WR>M5K\\"-.
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M.[PKN^X:?TZ$\0!<7VH4W@^\@^%W9_X_4$L#!!0    ( .-=3%KZ-Z(&S08
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MZ=H3%EYGQ\MTZ<:,86192KXJB_<?2'R<+)F_IIE#8,?I(O;%1M7"Q0F&#PK
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M=B,X^B W ?^OE;+;![= ?S)U_G]02P,$%     @ XUU,6E(3(L\2!P  -A0
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MJW<RP?K$B/1 HZ?&;)3\IU:I*XV\DZEEW=K1@RR3%EDF+T:6+?@W?:IISL\
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MAHCZZ#5'O\&*.==KVZP3.A'?J@SB[-P(%*&QO0&\@S,\N,).\P 0 D;6  @
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M66PQIO.,FSW_,O"3"_PI@0]*VJV!M[+E[?<$,29[S)@<,EZ2JXQWO)E"EDZ
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MZ81--A\^F\4RX(?9V4FO%OI&AZ_]M8.WV:BE-JWNO+$=<7I^.CEGQQ<2Y:/
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MTG@51ZP/ S.N[@S<LDHM186.758H494$]_YF1$<14L1[#, \)?<CGR^TH#?
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M>XE0-21J7R$+GK927Y>(1NI;5QV0, <2YD+")I"P*21L!@GS(&$^)&P."5L
MP4JI[16I[?V@_7\/,K>0, <2YD+")I"P*21L!@GS(&$^)&P."5L P4JY[1>Y
M[7_[KJ+1^M9H0L(<2)@+"9M PJ:0L!DDS(.$^?V3):EE5':3\U--V^Q6EJVG
M&K-GUN_'#/WU'97>F)"/8D,8^LC$AF[),@RX7).Z"7Z6NC7ZG02;A$9T?6:;
MULQ^:X1 :0XHS06E34!I4U#:#)3F@=)\4-H<E+: HI5S?/2NV?A!*]0<#!5B
M2)H#2G-!:1-0VA24-@.E>: T'Y0V!Z4MH&CE$)NO(3:_?;G:['US3B%I#BC-
M!:5-0&E34-H,E.:!TOR<5GH#T*F\*IG7B:S*"XY%G:AM5%:NVM%!JYBP=7I\
MD*. [A*1'=0H2HLCBN_3@UJ5\COCUC-JRGUUI#$]V/6*S\Y#WF.V#A..(K*2
M5>DW7=E2EATQS&X$W:;'O)ZI$#1.+S<$+PE3 OGYBE)QN%$5% <]1_\!4$L#
M!!0    ( .-=3%K(U_TLN!8  &:F 0 9    >&PO=V]R:W-H965T<R]S:&5E
M=#0Y+GAM;+7=;6_;5IK&\:\B> >+&6"W%I^I;!J@+<\CV9FBV>Z^6.P+U69L
MH;;DD>2D!?;#K^3(ID@>'8G57V]F$N><G^PX5W/#N<S[_9?%\K?5?5VO1[\_
M/LQ7WU[=K]=/[ZZO5S?W]>-T]<WBJ9YO?N738ODX76]^NKR[7CTMZ^GMRZ7'
MA^MP/$ZO'Z>S^=6']R]O^VGYX?WB>?TPF]<_+4>KY\?'Z?*/[^N'Q9=OKX*K
MUS?\/+N[7V_?</WA_=/TKOY8KW]Y^FFY^=GUFW([>ZSGJ]EB/EK6G[Z]^BYX
M5P5!OKWQ<N2_9O67U=Z/1]N/Y=?%XK?M3\SMMU?C[;M4/]0WZZTQW?S?Y_J'
M^N%A2VW>D7_NU*NW%]U>W/_QJRY?/OK-1_/K=%7_L'CX[]GM^O[;J_QJ=%M_
MFCX_K']>?-'U[B-*MM[-XF'U\K^C+[NSXZO1S?-JO7C<7=Z\!X^S^=?_G_Z^
M^YW8N[!QW!?"W86P>R$^<"':78A.O1#O+L2G7DAV%Y)3+Z2["^FI%[+=A>S4
M"_GN0G[JA<GNPJ1[(3WTB1N_?N;&I[Y&\/;)[GVV#UYY_70'+Y_OZZ]_L%[^
M5!;3]?3#^^7BRVBY/;_QMC]X^:/]<G_SAW$VW\;PXWJY^=79YM[ZP\_UYWK^
M7(]^KF\6=_/92S+^?53,5M.[NV5]-UW7MZ./TX=Z-?IN/GWX8S5;C?Y:U.OI
M[&'UM\W!7SX6H[_^Y6^COXQF\]&/LX>'S?W5^^OUYCW;^M<WN_?B^Z_O17C@
MO8A&/R[FZ_O52,QOZUO'?>N_'X0>X'KS6_+V^Q*^_KY\'WK%HK[Y9A0%_S8*
MQV'L>(=^\%__6#]MKH\/7B_\U^WSW'M=^*__.%UZWWEY^L<>.:ZKTS]VUW5]
M^L?NNFY._]A=U^UYG_?RO-^ZZO3KH>=/<?26[NC%BPYY38ZWP5Y\&KWF_7^J
MS=&16=>/J_]UY?6K&[O=[6SP;O4TO:F_O=K\Y;^JEY_KJP__^B]!.OX/5U9(
MK" Q06*2Q!2):1(S)&9)K"2Q"L):N8W?<AO[] ]_W\S?J^W?NJYH?KV:O%S=
M3MF?/Z1QE+Z__KP?N?ZA))[$[4.%Z]#VOSO[AX3C4!A'[4/2<2@/DO8AU3\4
M3\:3]B'M.C3I?'3&<2C+\O8AVS\4ALFD\TZ5CE/C>-*QJOZI((_CYGUO?9:3
MM\]RXOTL_[*9M[;CU7HS93D_T][K0_\C3&(%B0D2DR2F2$R3F"$Q2V(EB540
MUHIG^A;/]$+#4TKFEL0*$A,D)DE,D9@F,4-BEL1*$JL@K)7;["VWV9\?GKQ7
MAT:3Q H2$R0F24R1F"8Q0V+V*Y;N#XSII#LVEXY329ADG>'3<2I*H]P]?.9O
M*<F]*3'S=;V<O_S5-GUP)<5[?6A22*P@,4%BDL04B6D2,R1F2:PDL0K"6O&<
MO,5S<J'A<T+FEL0*$A,D)DE,D9@F,4-BEL1*$JL@K)7;8-S\@]KXSX^?_KM#
MTXEJ!:H)5).HIE!-HYI!-;O3]F?')$TZ7^(M7:?"..B,H8Y3<1X$[C$TV/L'
MZ,";EQ_KVX_/R[O1='X[^GO]O%RLZYO[^>)A<?>',T%>;7""2*U -8%J$M44
MJFE4,ZAF4:U$M8K2VLD-F^2&%YI1=S 58E(K4$V@FD0UA6H:U0RJ650K4:VB
MM':(FX9(X/V'["/C*EH#0;4"U02J2513J*91S:":W6GM+W4F0=Z=5QW'PB"-
MN@.KX]@XGT0')M:FG!'XVQF>B77T?Z.C_ZKOUP>'BM0*5!.H)E%-H9I&-8-J
M%M5*5*LHK9WDIH 3))>:8-%N#JH5J"903:*:0C6-:@;5+*J5J%916CO$34TG
M\+8)CDRP:!<'U0I4$Z@F44VAFD8U@VIVI[5GSB3(NA-L_]@D"KNM4\>I/(P/
M_,-_T/1C G]!QC^_'BT&^/7!D4)+-*@F4$VBFD(UC6H&U2RJE:A645H[R4V'
M)\@O-;^B]1Y4*U!-H)I$-85J&M4,JEE4*U&MHK1VB)NF3^ M)!R97]$Z#ZH5
MJ"903:*:0C6-:@;5[$[;'SFC\3CHCJ_]4V$>)=WQU7$JC1/W^!HV!9O07[ Y
M-KZNULOGQWJ^=N;);P_-$ZH5J"903:*:0C6-:@;5+*J5J%916CO'3?$G#"XT
MO(9H!PC5"E03J"913:&:1C6#:A;52E2K**T=XJ8#%'KK"?[AU7]W<$[1F@^J
M"523J*903:.:036[TSIC:>>I!Z7K5-(]5;E.A0>'UZ9N$_KK-B</KZ<T"?RO
M-3A?:#T'U02J2513J*91S:":1;42U2I*:^>ZZ02%\:6&6;0.A&H%J@E4DZBF
M4$VCFD$UBVHEJE64U@YQ4P<*_0_D\0^S:.,'U0I4$Z@F44VAFD8U@VIVI[4'
MT+1;)'"=&@=I=YCMGPJR+#TPS#;-F]#?O!DRS!ZM%?A?:W"^T*8.J@E4DZBF
M4$VCFD$UBVHEJE64ULYU4Q *LTL-LV@W"-4*5!.H)E%-H9I&-8-J%M5*5*LH
MK1WBIAL4^A_PXQ]FT?H/JA6H)E!-HII"-8UJ!M7L3FL_AZ WRSH.=;_WJW(<
MBM,##V(-FPY.Z._@^"=9,;]=K&X63\X'$OCEP5%"&SJH)E!-HII"-8UJ!M4L
MJI6H5E%:^V'W33,H&E]H;HW06A"J%:@F4$VBFD(UC6H&U2RJE:A645H[Q$TM
M*/(_#\@[M_KO#LXIVOQ!-8%J$M44JFE4,ZAF=UJK#AOEG9T%I>O4..U.KHY3
M898<&%VCIH$3^1LX)XZNI_0)_*\T.%UH7P?5!*I)5%.HIE'-H)I%M1+5*DIK
MIWIO<=/%-C>QJYO8W4WL\B9V>Q.[OHG=W\0N<&(W.+$KG-@=3I<H!45-*2CR
M]A6.C+)H[P?5"E03J"913:&:1C6#:G:GM<?/2?=1L*Y32=!]LI;KU,%R;-3T
M;R)__^;T4?9HF\#_2H/3A;9U4$V@FD0UA6H:U0RJ650K4:VBM':JFY90=*D]
M6A%:"4*U M4$JDE44ZBF4<V@FD6U$M4J2FN'N*D$16<LU?+?'9Q3M/6#:@+5
M)*HI5-.H9E#-1OV-6,FDVR9P'4JZCRAP'0KB W-L4[V)_-4;_QR[^=79S8&I
M%:WEH%J!:@+5)*HI5-.H9E#-HEJ):A6EM3/<-(*B2RW@BM!"$*H5J"903:*:
M0C6-:@;5+*J5J%916BO$<5,(BL_8Q>6_.S2GJ%:@FD UB6H*U32J&52S<7]_
M5I3W=G&Y3L5)IW%0N4Z-HP.[N.*F>Q/_Z5U<S>!Z2I/ _SJ#LX7V=%!-H)I$
M-85J&M4,JEE4*U&MHK1VIIM^4'RI+5TQ6@="M0+5!*I)5%.HIE'-H)I%M1+5
M*DIKA[BI \5G;.GRWQV<4[3Q@VH"U22J*533J&90S<;]O5I1,.D^(]9Q*LSR
M[A=@7:?B,#PPR#;-F]C?O#EUD#W:(_"_SN!LH2T=5!.H)E%-H9I&-8-J%M5*
M5*LHK9WIIAT47VI95XR6@5"M0#6!:A+5%*II5#.H9E&M1+6*TMHA;LI \1G+
MNOQW!^<4[?N@FD UB6H*U32J&52S<7^_5IKVYEC'H:S[M%C7H?&!;^V*F])-
M?,ZBKI>W?)ZN;IX?IDMGG-!:#JH5J"903:*:0C6-:@;5+*J5J%916CO)32,H
MOM2BKABM!*%:@6H"U22J*533J&90S:):B6H5I;5#W%2"XC,6=?GO#LXIVOI!
M-8%J$M44JFE4,ZAFX_YRK2 :=TNPKE-AV'T\K//4>.P>7Y.F?9.<LZBK-;Z>
MTBGPO]K0A*%:@6H"U22J*533J&90S:):B6H5I;63W?2$DDNM[DK08A"J%:@F
M4$VBFD(UC6H&U2RJE:A645H[Q$TQ*#EC=9?_[N"<HMT?5!.H)E%-H9I&-8-J
M-NFOVTK&G3FU=!R*\^ZS"5R'X@.K#I*F@).<L[>K.\L>K17X7VUPO-#*#JH)
M5).HIE!-HYI!-8MJ):I5E-9.=E,52N)+S;)H-PC5"E03J"913:&:1C6#:A;5
M2E2K**T=XJ8;E)RQN<M_=W!.T?H/J@E4DZBF4$VCFD$UF_2W;>7C;JW <2B+
M>[.LXU!RX/$$2=/!2<Y9V_7REM$/R^E\=F!V15LZJ%:@FD UB6H*U32J&52S
MJ%:B6D5I[20W!:'D4HNZ$K0;A&H%J@E4DZBF4$VCFD$UBVHEJE64U@YQTPU*
MSEC4Y;\[.*=H_0?5!*I)5%.HIE'-H)I-^NNUPB#J?2&V?RK(LVZMP'4J3?(#
MXVM3PTG.V=75&E]/JA6@Q1U4*U!-H)I$-85J&M4,JEE4*U&MHK16LM.F,)1>
M:G]7BG:#4*U -8%J$M44JFE4,ZAF4:U$M8K2VB%NND'I&?N[_'<'YQ2M_Z":
M0#6):@K5-*H95+-I?^=6D/6^Q<MU*HDZIRK7J>C0_JZTJ>&DY^SOZHZS1YL%
M_E<;G#"TN(-J M4DJBE4TZAF4,VB6HEJ%:6UD]UTAM)+[?!*T7H0JA6H)E!-
MHII"-8UJ!M4LJI6H5E%:.\1-/2CU-A>.C+-H PC5"E03J"913:&:1C6#:G:G
MM9Z\E27=:=9Q*.X^=\MQ*)P<FF6;&D[JK^'\8[F^7SQ-MX_7<N<%;>*@6H%J
M M4DJBE4TZAF4,VB6HEJ%:6UH]J4@-)+;>5*T?X/JA6H)E!-HII"-8UJ!M4L
MJI6H5E%:.\1-_R<]8RN7_^[@G*(5'U03J"913:&:1C6#:C;M[]*:C+/N$PD<
MI_(HZHVG_5-9DASX+JZTJ=JD_JK-_GQZ2C? SPV.$-J^036!:A+5%*II5#.H
M9E&M1+6*TMK1;5H_Z:7V<:5HP0?5"E03J"913:&:1C6#:A;52E2K**T5XJPI
M^&1G[./RWQV:4U0K4$V@FD0UA6H:U0RJV:R_0RN-N\_&*AVGDDG8W<?E.A5-
M#CQ!*VNZ-)F_2].95X_^X[^?&QPAM%Z#:@+5)*HI5-.H9E#-HEJ):A6EM:/;
MU'JR2ZW=RM &#ZH5J"903:*:0C6-:@;5+*J5J%916CO$38,G.V/MEO_NX)RB
M)1U4$Z@F44VAFD8U@VHV<ZS*2I-NE]5U*NX^2:MRG0K2 U]?S9JR3.8ORW3F
MU7^L[VOG9@(_,S@Z:&\&U02J2513J*91S:":1;42U2I*:T>VJ>QDE]JJE:%E
M'E0K4$V@FD0UA6H:U0RJ650K4:VBM':(FS)/=L96+?_=P3E%^SJH)E!-HII"
M-8UJ!M5LUM^%E05A=TQU+,S:>S3 +E6NK5J'AM2F-)/Y2S.N(?64,H"?'9PC
MM$^#:@+5)*HI5-.H9E#-HEJ):A6EM2/<]'BR2ZW3RM!&#ZH5J"903:*:0C6-
M:@;5+*J5J%916CO$3:,G.V.=EO_NX)RBI1U4$Z@F44VAFD8U@VHVZZ_ 2L9Q
M=VCM'XK3WM#J.)0D[J$U;YHSN;\Y<V!H/=H(\+-#<X1J!:H)5).HIE!-HYI!
M-8MJ):I5E-:.<%/FR2^U-"M':SVH5J":0#6):@K5-*H95+.H5J):16GM$#>U
MGOR,I5G^NX-SBC9W4$V@FD0UA6H:U0RJV;R_ZBH<=^;1TG$HV&NF[E+E.+17
M+6B'I:G/Y/[Z3&=H+>?U@=R@31I4*U!-H)I$-85J&M4,JEE4*U&MHK1V9)L&
M3QY?:DA%.SVH5J":0#6):@K5-*H95+.H5J):16GM$#>=GOR,;5C^NX-SBM9V
M4$V@FD0UA6H:U0RJV;R_PRJ,X^YC 5RGPJR[#\MQ*IA,L@-S:E.?R?WU&=><
M>DHCP,\.CA+:K$$U@6H2U12J:50SJ&91K42UBM+:$6Y*/?FE-F'E:*T'U0I4
M$Z@F44VAFD8U@VH6U4I4JRBM'>*FUI.?L0G+?W=P3M'F#JH)5).HIE!-HYI!
M-9L[ME=E>>^KJZX=5[U-6*Y3\20Z,+<V#9K<WZ Y,+<>+P6@Y1I4*U!-H)I$
M-85J&M4,JEE4*U&MHK16A"=-KV=RJ957$[39@VH%J@E4DZBF4$VCFD$UBVHE
MJE64U@YQT^R9G+'RRG]W<$[1\@ZJ"523J*903:.:034[Z:^I2I/.\ZI*QZ%D
MTOF:;.4ZM->);8>E:=!,_ V:SM"J9T_NV*!=&E0K4$V@FD0UA6H:U0RJ650K
M4:VBM'9BFQK/Y%)[K"9HL0?5"E03J"913:&:1C6#:A;52E2K**T=XJ;8,_%V
M#H[,J&AW!]4*5!.H)E%-H9I&-8-J=J>UO[;:^W8KUZDDCKM3JN-4'!SXVNJD
MZ=!,3E]EM1M33ZD$^-7!24+;-:@F4$VBFD(UC6H&U2RJE:A645H[P4VK9W*I
M#5<3M->#:@6J"523J*903:.:036+:B6J5936#G'3ZYF<L>'*?W=P3M'J#JH)
M5).HIE!-HYI!-3OI;Z4*QOVOK3KV8'5[ Y7C4#XY\&BK25.@F0S:;[4;6H_V
M ?SJX!RAU1I4$Z@F44VAFD8U@VH6U4I4JRBMG>"FTC.YU)JK"5KJ0;4"U02J
M2513J*91S:":1;42U2I*:X4X&#>MGNV/__38>N3RT*BR7,%R@N4DRRF6TRQG
M6,Z^<NV-5YW5JZ7KU/[JU:\)<YX*#GPG5C .]I(S:.75?RZGSX_3T71^.Q*_
MKY?UXVP].Y0JM&C#<@7+"9:3+*=83K.<83G+<B7+51C7"72X%^A++<)ZE;%$
MHR4@EA,L)UE.L9QF.<-REN5*EJLPKI/H:"_19VS%.G)Y>&C1T@_+"9:3+*=8
M3K.<83G[RNT/I%$R[CYGP'DLZ#Z.H'(="_/QP?DVW@N/OX=STGQ[2M/@R L-
M#QK:VF$YP7*2Y13+:98S+&=9KF2Y"N,Z 4_V GZIA5JO,I9HM#W$<H+E),LI
MEM,L9UC.LES)<A7&=1*=[B7ZC.U:1RX/#RW:%F(YP7*2Y13+:98S+&=?N=:$
MFN1I;]YU' M[W^KE/#:.#JPM",;97G@&;=LZ..\>+2D<>:'A04/K/BPG6$ZR
MG&(YS7*&Y2S+E2Q785PGX/E>P"^UB^M5QA*-%H]83K"<9#G%<IKE#,M9EBM9
MKL*X3J(G>XD^8S'7D<O#0XL6C5A.L)QD.<5RFN4,R]E7KE6K#8/>N-L_E2?=
M;0>N4UD6'AAV@[W:3S!H2]?'I\VO.T/D=P:'".4*EA,L)UE.L9QF.<-REN5*
MEJLPKI/?O?)1<*D57:\REFBV?81R@N4DRRF6TRQG6,ZR7,ER%<9U$KW7/@K.
MV-=UY/+PT+(%(Y03+"=93K&<9CG#<O:5:\V?_:J"ZU3078G@/!4=>/Q!$.RU
M?()!R[M>9MF3>@E^=WBHV (0R@F6DRRG6$ZSG&$YRW(ERU48U\GS7O$HB"\V
MV[)-(Y0K6$ZPG&0YQ7*:Y0S+698K6:["N$ZB]YI&P1EKOHY<'AY:MDR$<H+E
M),LIEM,L9UC.OG+[\VB<=Y^1X#J5C'M?IW6="@ZLI0V"O49/,&CAU^ML>[R#
MX'>'AXHM^Z"<8#G)<HKE-,L9EK,L5[)<A7&=/.^5C()+;?]ZE;%$LZTBE!,L
M)UE.L9QF.<-REN5*EJLPKI/HO591<,8JL".7AX>6+0ZAG& YR7**Y33+&9:S
MKURR-X^&07<EF/M4_^NVCE-AMX-PO;JOZW4Q74\_O'^LEW?U#_7#PVITLWB>
MK[=_'>Z]=;2L/VV#]>Z[\.JZ]_;O@W<F<+S=!N^JE[=?-_R']T_3N_K'Z?)N
M-E^-'NI/FY<:?Y-MWM/E[.[^[2?KQ=,FTU>C7Q?K]>+QY8?W]?2V7FX/;'[]
MTV*Q?OW)]@6^+):_O7PX'_X?4$L#!!0    ( .-=3%J(OU3UM (  *8&   9
M    >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;)6546^;,!#'OXK%JJF5UI*0
M!+HN06J25:NT3%6J;@_3'ARX@%5C,]N!=I]^9Y/0;$W0]@*VN?O?[\[V,:ZE
M>M0Y@"%/!1=ZXN7&E%>^KY,<"JHO9 D"OZRE*JC!J<I\72J@J7,JN!_T>J%?
M4":\>.S6[E0\EAO#F8 [1?2F**AZG@*7]<3K>[N%)<MR8Q?\>%S2#.[!/)1W
M"F=^JY*R H1F4A %ZXEWW;^:1M;>&7QE4.N],;&9K*1\M)/;=.+U+!!P2(Q5
MH/BJ8 :<6R'$^+G5]-J0UG%_O%._<;EC+BNJ82;Y-Y::?.)=>B2%-=UPLY3U
M)]CF,[)ZB>3:/4G=V$9HG&RTD<76&0D*)IHW?=K68<\A"(XX!%N'P'$W@1SE
MG!H:CY6LB;+6J&8'+E7GC7!,V$VY-PJ_,O0S\1(J$!L@2TAD)IBKU#F9Y51D
MH D39":%45@[\IG1%>-H@>NG<S"4<7U&3JS-@G&.CGKL&T2RPGZR#3]MP@='
MPO<#LL  N28?10KIGP(^YM(F%.P2F@:=BG-(+LB@_XX$O6!('N[GY/3DK$-W
MT!9JX'0'1W07L@(\C(;<'JG)]Z7DG.!1J:E*?QPJ11-@>#B O7U7NJ0)3#R\
M7AI4!5[\]DT_['WHP!^V^,,N]7@*&1."B8PD.WC^ G^(MM$;.3U[M:OX,NR-
M_>H Q*B%&'5"[ Z;:@[;+TC)6LF"K%HXN2;/0-4_0S;QPCW(\]%H<)@R;"G#
M3LHOV II6E&1@.70+ 5%3=.$$L >DI)THRRMR8&4H)A,#[&%K]C"J'\8+6K1
MHDXTO"3_LX71JRU\'UW^1>#O]8X"5.8ZI,80&V&:-M*NMDWXNND]+^9-!U]0
MA?NH"8<UNO8N(HRLFJ[83(PL72=:28-]S0US_)& L@;X?2VEV4UL@/;7%/\&
M4$L#!!0    ( .-=3%HI_[BK^08  &8K   9    >&PO=V]R:W-H965T<R]S
M:&5E=#4Q+GAM;,U:;6_;-A#^*X17#"G0U"9%OV6)@<19L (-%C1K]V'8!UJB
M;2)Z\4C:;H']^%&2(UHBQ<8V,_1+(LG'TW.\X]W#$R^W&7\22THE^)K$J;CJ
M+*5<772[(ES2A(CWV8JFZI=YQA,BU2U?=,6*4Q(5@Y*XBWJ]03<A+.U,+HMG
M#WQRF:UES%+ZP(%8)PGAWVYHG&VO.K#S_. 36RQE_J [N5R1!7VD\O/J@:N[
M;J4E8@E-!<M2P.G\JG,-+Z9XG \H)+XPNA5[UR W999E3_G-A^BJT\L1T9B&
M,E=!U+\-G=(XSC4I'/_LE':J=^8#]Z^?M=\5QBMC9D30:1;_R2*YO.J,.B"B
M<[*.Y:=L^QO=&=3/]859+(J_8+N3[75 N!8R2W:#%8*$I>5_\G4W$7L#X*!E
M -H-0,T!N&5 L!L0%(:6R JS;HDDDTN>;0'/I96V_**8FV*TLH:EN1L?)5>_
M,C5.3NX(X^ +B=<4W%,BUIPJ'TD!SO)GI)CIW^?@CJ4D#1F)P8=42+XN96Z^
M@0?.0I8NP)1(NL@XH^(M.+NEDK!879V#SX^WX.S-6_ &L!3<LSA6"L5E5RKD
M^?N[X0[E38D2M:"$"-QGJ5P*\&L:T:BNH*M,KNQ&SW;?(*?&6QJ^!P%\!U /
M80N@Z<N'!PXX0>6&H- 7M.B[%H)*Z\24X[!]7+[(+\2*A/2JHU:QH'Q#.Y.?
M?X*#WB\VHSPIJYF(*Q.Q2_OD>J."@LQB>JZ2S[D@,55QS)]4K*AG0-!PS9E4
M 71AFX52=;]0G6>FS60,+[N;?=M,D1&J1&J(^Q7BOA/Q'YE4$4\*UX"D7!T1
M(!+,\T6SR1>-#6NI=+ '!(^'PP9:4R@(AB,[WD&%=^ ,HJE:(FHQJK4)U*5@
M$>7E"K[FG*CGQ:I]!Z;+_"9?D-=)ME;"V1RT#OWK>J86O$JV?]M,'?@,3D_*
M:E,WK*9N^ )7QXS,6%Q$X0'^'AJN'(Y&#7>;,OUQW^[M405YY(1\]I%N: S@
M6QLFY]!#'>-)6<W*<67E^,C$./9IHB=E-1-A3]?@GI?4:"V</3.3#/JH$7\6
M*30>0GL$PCWR )W 'Y<9E^>2\D2EDPT5LD@Q5IC07"7]7A.E*=1K@8@T1.1>
MV9Q$.4-Y^80B<ZKZXR92BU!OW()5DP#H+,#'%IR=UEK%&0R:]=$B%<!1V_SJ
MJ@ZQ<X%^U#G36KFADQ4<NDY]::L;JPD!=#."6SJG//=)F"5J(R7*&DGVRJMU
M"LQB;XDHBU!K1&E& '\T2@"]<@)?VNK3IUD!?#U: ,V:;_&Z1:C5ZYH9P!=1
M V2E!NZQ!SOH-<@!U.P 'DL/H%=^X$M;?:^J"0+R0Q"L&1B9M=_8/%EDVG9/
M2+,#Y&8'1Y8S9+*   Z:@$TA.&[9/R%-%A#ZP=(E<K*70\/4E[;Z]&G^@E["
M7XY+E\BD)\:FV2(S'K;X7!,8Y.Y+5,D2_*L\QU>9\AL%)(W*R#V?D?!)&1#1
MF?P.<W2_Z&!?O@;509KJH/Z1F14Y.=+!9GK25C=3$R3D9! G9M:!N:T/FC%K
MRN"@)68U+T%N7K(?LY]3)E5\/DH5M@(0E8'";R^*5N<K#G:C)VWU"=&,!XV.
MC5:O=,>7MKJ9FNX@)\\X,5K'9LEL!JLI@NVQ&FCN$KBY2WNL2EY4AQ=%J_LE
M!_?!/6FK3XDF1@$\MMOO9%0'F^E)6]U,S:8"=^OEI&@-S Y+@!OA:I-IZ6D%
M>U]BW"2FQ@<HEVS.PB)<%<F+Z"H33%KQ^OU0\QI?:@+-B0)W4\<1H%XYCB]M
M=3,UQPG<[9S3 M3R":<9GY9/02WAJ0E+X"8L^^%YEW'*%BE0.'E1]NG7L-R:
M*'NVA.=]JK38>]A]Z;55XTM;?5XT)0J&QX:L5Z+C2UO=3$UT G=KYU27C\Q^
M$^HWP]84@GL;\#IRS5T"-W?YD$JJ9D2"8G\EMF15;K"L,$T>8H%IX3-M,+&F
M*[AW4C\;>R4BOK35C=5$!+L[-"=&$[9\U&GNV2TR;7MVK)D%=C.+71(,K U.
M]]B#/?0:+16LV0AV'PSY_SM2V"N1\:6M/GU[9T[<S9T;NF!IJF;!:BDVL\RH
MV:&W"$'40C*Q9A[X.\PCBIAL.PN%;9^"FB<*+$)PW-*RQ9I=8#>[T'&D,C5+
MGCMA\UV>>$X/5M1FH\/ ;(J<MT'6A1^[>R&/5,JX_>,;-K^PG!M-&IL0:D.F
M:S5VU^I?TZ@M\LP*BXUO]A:A_?"L@])E&+O+\"D]VIWJOANV*63"[NZ=6$PH
M7Q0'.86J-BIWE8?XJJ?58='KXHADX_D-O)B61SZUFO($ZCWA:NT+$-.Y4ME[
M/U2(>'FHL[R1V:HX%SG+I,R2XG))B<J2N8#Z?9YE\ODF?T%UM';R'U!+ P04
M    " #C74Q:*T8M6%L"  #3!0  &0   'AL+W=O<FMS:&5E=',O<VAE970U
M,BYX;6RM5%%OVC 0_BM65DU46DE(4CJQ)!(EJM8')%34[F':@PD'L>K$F>U
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MA,:9MF&.KRY(DX#W&R'T86,&NWO'DS]02P,$%     @ XUU,6J"DT3IN P
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M)D4_/$0_-*ZUJ"!OR7V<E.0I3C?-ZYQKM]^PMVDZ_DS9?#5MYLK&:QR3;?A
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M$-H W\\Y5_N&_D!U4SKY'U!+ P04    " #C74Q:LG FR+@(  #K2   &0
M 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6S%G&UOV[86Q[\*X3M<M$!=FT]R
MW)L$2,P[K,"Z!DVWO1CN"]5F8J%ZR)7D)!OVX4?)BFF1])&MT/";UG8.C\[_
M4")_I(YT_I3EWXNEE"5Z3N*TN!@LR_+APVA4S)<R"8OWV8-,U5_NLCP)2_4U
MOQ\5#[D,%W6C)!Z1\3@8)6&4#B[/Z]]N\LOS;%7&42IO<E2LDB3,_[R6<?9T
M,<"#EQ^^1/?+LOIA='G^$-[+6UG^^G"3JV^CC9=%E,BTB+(4Y?+N8G"%/XB
M5PUJB]\B^51L?4:5E&]9]KWZ\G%Q,1A7$<E8SLO*1:C^>Y0S&<>5)Q7'_QNG
M@\TQJX;;GU^\_UB+5V*^A86<9?'OT:)<7@S.!F@A[\)57'[)GGZ2C: ZP'D6
M%_6_Z*FQ'0_0?%646=(T5A$D4;K^/WQN$K'5  <[&I"F 3$;L!T-:-. [MN
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M<D\F)<YX<FP0Z%H,*"T"I<50M*Z3^_48>WA!IDVJ![;=H%7/?#53PT^@J[)
MDEWW&MNS!.)XQ\9"KMZ$H+0(E!9#T6ICS8,5]HSP=;47(E0Z+'-9+U>WI>U^
MRT.URW!4OK#OHWK79(^I-W$>,5_37*"4K!32NKU33O)Z7Z0^D:RHUO%?F)0L
MJPXW!*MDK"NHZRO&Y-N)#M#N3@7_ 5!+ P04    " #C74Q:6!*=D"4)  "D
M8   &0   'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6RUG5]OVS@6Q;\*X2T6
M+3"I+4IRG&YB(+&X.P4V,T';F7D8[(,BT[%0_?%(<M(.]L,/)2NF*,G7UN#X
MI;%EW1_I<V52AR+9ZY<T^YJOI2S8MSA*\IO1NB@V'\;C/%C+V,_?IQN9J$]6
M:1;[A7J;/8WS32;]91441V,^F4S'L1\FH_EU=>PAFU^GVR(*$_F0L7P;QW[V
M_4Y&Z<O-R!J]'O@4/JV+\L!X?KWQG^1G6?RR><C4N_&>L@QCF>1AFK!,KFY&
MM]8',;7+@.J,7T/YDC=>L_*K/*;IU_+-Q^7-:%+62$8R*$J$K_X\RX6,HI*D
MZO%'#1WMRRP#FZ]?Z?^NOKSZ,H]^+A=I]%NX+-8WH]F(+>7*WT;%I_3E1UE_
M(;?D!6F45_^RE_K<R8@%V[Q(XSI8U2 .D]U?_ULM1"/ L@\$\#J MP.F!P+L
M.L!N!S@' IPZP#DUP*T#JJ\^WGWW2CC/+_SY=9:^L*P\6]'*%Y7Z5;32*TS*
M"^5SD:E/0Q57S&^#/[9A'I9)R]G;VRA* [_*X,\K]F4MV4,FHU"5JRXB]K#-
M@K5*BCH8!I)]2:LS*D(FE^PG=5G?YKDL\C*X"7['WGJR\,-(O;I@OWSVV-LW
M[]@;%B;L/HRB\I3K<:&^35FG<5#7?+&K.3]0<XNS^S0IUCD3R5(N3<!8R;#7
M@K]J<<=)XKW_G4WX#XQ/N-U7'SK:D\%[9EM5N-,3[IT>WE>Z.#V<$UK8^^O"
MKGCV =[=-E='\KR91_;[?]4Q]K&0<?Z_GBK>[9!./[)L\C[D&S^0-R/5IN4R
M>Y:C^3__84TG_^I3&PGSD# !@AEY<?9Y<2CZ_#]INGQ1OYD^^<G(H?+O8&X%
M*WN;Y[GESESW>OS<U+7O+.[8YEFBYRQG-IOLSS*4</=*N*02O_I9F&[[&HX[
M,G"H$$B8AX0)$,Q0?[I7?XIO'Z;(O"!A'A(F0# C+Y?[O%R2OXK;($BWB>J"
M,QG(\-E_C&1?)DC(T$SL8-/&S]N9MMH)9'D"!#/TG>WUG9'Z>G(EL_)N)TR"
M-):L\+\QO[KIZ9.99 V5>=:1F<]:,B/+$R"8(?/57N8K4N:/R;-,BC3[WJ<J
M&3I4U:N.JI;%6[(B"Q0@F"&K-=&W^Q-2V)^+M<R(*Y8.'RIN33.NV<N6N- 2
M!8IFRMMP4]:1YN&QZ)65#!LLJ]61]<)I7[30(@6*9NK*M:Y\<+,;A?YC&*D[
M#]E_)9/$P9+SKN1\TKX=AI8I4#13<^T +=+(U$W%,96AGJ^F&2I;D\Z5#75S
M*)JILO9SUM\W='3H8'&=GJ[.==KB(LL4*)HIKK:(%NT1]R-6FW+$Z@>6R(*E
M*Q;X^9KYK^-6ZL ;]Y+YR9*]N>Q- ]1/UC0C#3.[?<,,+5.@:&8:M%>T2,LS
M7Y1Z[\<)5UD:-VUCK^10JUC3FI*[G=L0J 5$T4S!M0FT:!=8CXVP_[-%-82L
MVO%,1M7 ;KX.-_TM.=030FD>E"90-#,YVD%:,_S0B06UDE":!Z4)%,W,CC:>
MUC'G6?C)4_@8R=HE?>A-!]2#6ET3RJU.QPQUH2B:^:!%VU!.VU#=0'GR64;I
M1O4+A0S621JE3P=N-6GD4,VA- ]*$RB:F1QM8KF%;Z XU.%":1Z4)E T,SO:
M"G/:"I_60-&0P>G@G2<X[E7[EA5:I$#13)6U^>6T^?VMFF$@EQ?^L\S\)Z5U
MG&9%^.?NX?A&JN9KR?QBYR+JG\C;[]+/\G?]^8#ZY".5MSBKJM+[6X":9Q3-
MS)(VSYPVS[H;^9+Y2QG[V=?^K@-JI*$T#TH3*)J9$&VXN7N&K@/JKZ$T#TH3
M*)J9'>W#.>W#3^PZH-Z[IC6[CO9X'K1 @:*9&FOKS0=;[T]-Z\U^OY?QH\SZ
M?PE0#PZE>5":0-',+&D/SL_@P3G4@T-I'I0F4#0S.]J#<]J#PV^^H&[]2.4M
MA[CY@GIX%,V<(*@]O'VJAZ=OOFC,X&F!4-\.I0D4S4R(]NWV&7R[#?7M4)H'
MI0D4S<R.]NTV[=O1C1I=W.#$T95W#[=IT'H(%,U,4F/6,^V<=9OVX!<RZ9\C
M0S,&*X^=Z(R=Z7P.>V]K>V\[9VC0H%X?2O.@-(&BF=G17M^F'Z[#&S3H,,"1
MRE-#9-"*"!3-S)+V_#;M^4]KT:"6'TKSH#2!HIG9T*,#]N496C3HJ "4YD%I
M D4SLZ-'!6QZ<O=IXV,T9' Z9IWQL?:#%6B! D4S-=;>WJ;M\4)F_8MVZ+C!
MLB)I'I0F4#1S 9GV[<X$WP8Y4!,/I7E0FD#1S.QH$^_0,\A/7,!34XPU=6:S
ML: +&BPRU(NC:*;(VHL[PZ>3'UX3X73G?CMMK9$FV(/2!(IF:JTMM4-;:G(I
MC].=\,W;TD+],90F4#13VL9:8/KQ]['%/'7XE&HDH/X62A,HFJFN]K<.;1$/
MK>5QNA.X)VU5H<^@H32!HIFJ:C_JT'[T;ZSD<;K3MR^F'<FAIA-*$RB:*;DV
MG0[]2/JDA3Q.=Q7O!>^TQ5#O"*4)%,T467M'A_:.Y,8,W:6[MN6VM84^#X;2
M!(IF:JL]HT-[1LPR'J<[R]J9=?I#J&^$T@2*9FZWH7VC2S_O';Z*Q^TN_VTM
MNUG090[5&TH3*)JIMW:"+NT$JY&204MX:.!0DPZE>5":0-',U&C_Z'+\$(H+
M?6 +I7E0FD#1S.QHQ^D><YRG#..Z7>O9OJ>DRQFL,=1ZHFBFQMIZNK3U?&V<
M3E^^0P,'7_Y0WPJE"13-3$UC7ZPSS,%VL7MF83?-PNZ:=0[_ZVK_ZR+F8+L]
MLZ:=3O,$M;Q0FD#13)6UY75IRXN>FW"D.,L^.)M@08<.SA+4,Z-H9I:T9W9I
MS_S:B=#S1VG(X*8):K.A-(&BF>G0-MN].D/' 7UL"Z5Y4)I T<S]%K7]GM+V
M^[2.HX8T.XYVMT&7,U1C*$V@:*;&VG)/3[/<Q%0IFC#T>H?2/"A-H&AF+K3'
MGI[!8T^A'AM*\Z T@:*9V=$>>XKPV#6$;(V@'AM*$RC:3N-Q8Y?V6&9/U?;X
M.:NF>^PV;-\?W6_!?UMM/#_6I^_V[[_WLZ<PR5DD5RIT\OY2*9SMML3?O2G2
M3;7G^V-:%&E<O5Q+=9.5E2>HSU=I6KR^*0O8_\<$\[\ 4$L#!!0    ( .-=
M3%J\J7@CC@,  -0-   9    >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;*U7
M76_C-A#\*POU4"2 &WW8CN/4-I!8.=P!26O$O?;AT =&6MO$4:)*TG'NWW=)
M*3K;483DH!>;E':&NT-IM)SLI/JF-X@&GC*1ZZFW,::X]'V=;#!C^DP6F-.=
ME509,S15:U\7"EGJ0)GPHR X]S/&<V\V<=<6:C:16R-XC@L%>IME3'V_1B%W
M4R_TGB_<\_7&V O^;%*P-2[1?"D6BF9^S9+R#'/-90X*5U/O*KR,P\ "7,3?
M''=Z;PRVE <IO]G)YW3J!38C%)@82\'H[Q'G*(1EHCS^JTB]>DT+W!\_LW]T
MQ5,Q#TSC7(I_>&HV4^_"@Q17;"O,O=Q]PJJ@H>5+I-#N%W95;.!!LM5&9A68
M,LAX7OZSITJ(/4"__PH@J@#16P']"M _ H2#5P"#"C!PRI2E.!UB9MALHN0.
ME(TF-CMP8CHTE<]SN^]+H^@N)YR9S65N>+[&/.&H@>4IS&66<4-;:S2<_,&4
M8G9G3N$D1L.XT*?P&WQ9QG#RX10^ ,_AC@M!6Z@GOJ&$+*V?5(M?EXM'KRP>
M1G!'ZV\TW.0IIH<$/E52EQ,]EW,=M3+&F)Q!/^Q!%$2#AH3F;X?W&^#QV^%1
M2S7]>G/ZCJ__"M^MU!H.=^CK+<7 9X.9_K=)\))PT$QH3>12%RS!J4<NH5$]
MHC?[]9?P//B]2:PNR>*.R Z$'-1"#MK89[=(U@#X1&ZIL4FV$CYT<&N5C[-P
M'$S\QWTU&F)&T6%,W! S&-<Q![D/Z]R'K;DOMT4A."I8\9SE"8)\$'S-K&LV
M53)\D<$H/"KD9<CP*"1N3>DG-^N\+OC\;05_K I>*+E6+.O!GW7E/9AOE2*/
MZL'2,'H;: AR54$X$["0FKLOR]>;)V._4P\"R6:V&2K'T/CVM"=VE21R:VUQ
MP;XSHNO!7XJE6.?2] IUSABW,O[DUHSJK1FUYGN/"1,"[I@QJ!H-OQ7_7O_I
MDBSNB.Q MXM:MXNNC?RB2R&[)(L[(CL0<EP+.6Y] .<;IM:D7KI5)"44J+A,
MF^0;-YCUD0VVKO1>43HB.Q E#'XT<4&K+#?:<.J!T5I@0<^:,SM!@\:>+'BA
M#?4K1^*T+_A>=;IB*^7Q]]I=LO.U.S9H<%9:MHKUU?IH<N4:\J/KU_;(XMKH
M'S3E>>>.'C.>:Q"X(LK@;$1JJ?((44Z,+%Q3_2 -M>ANN*%C%RH;0/=74IKG
MB5V@/LC-_@=02P,$%     @ XUU,6GT',_!U P  OPL  !D   !X;"]W;W)K
M<VAE971S+W-H965T-C$N>&ULK59A;]H\$/XKIVQZU4JT"01"Z0M(7=BT2=U6
MK>J[#]/[P80#K#DVLPVT_WYG)TU#E])VX@O$SMWCYQ[?76ZX5?JG62):N,V%
M-*-@:>WJ/ Q-ML2<F5.U0DEOYDKGS-)2+T*STLAFWBD782>*DC!G7 ;CH=^[
MTN.A6EO!)5YI,.L\9_KN'0JU'07MX'[C&U\LK=L(Q\,56^ UVIO5E:956*',
M>([2<"5!XWP47+3/TW;D'+S%?QRWIO8,+I2I4C_=XM-L%$2.$0K,K(-@]+?!
M%(5P2,3C5PD:5&<ZQ_KS/?H''SP%,V4&4R6^\YE=CH*S &8X9VMAOZGM1RP#
MZCF\3 GC?V%;VD8!9&MC55XZ$X.<R^*?W99"U!PZ@R<<.J5#YZ4.<>D0^T +
M9CZL";-L/-1J"]I9$YI[\-IX;XJ&2W>-UU;36TY^=IRJ/.>6[L4:8'(&J9*6
MRP7*C*.!HTLDB6C3V&,XFJ!E7)AC.(&;ZPD<O3V&M\ E?.9"T)6886B)D<,-
ML_+T=\7IG2=.GV!V"G&[!9VHTVUP3U_N'N^ZAZ1#)4:G$J/C\>*_$F/"32:4
M66N$'Q=38S6EX/]-,1>'=)L/<75Y;E8LPU% A6=0;S 8__.FG43_-BEP(+ =
M/>)*CW@?^M@7]8F:GZPI"9@Q:!OON #I>1#7-C;C7CL9AIMZ&'_:= ?=RF:'
M7;=BU]W+KLA-P=F4"V[IAEI4,%K3[361++"2&H%VM_N(9)--W$RR5Y'LO9:D
M5'(/S]X?0L7]P2.>#3:]I)EG4O%,]O+\[OL=SD[8!C7U;VK1[B- V0_"AV!1
MYW!TATR;XR;>^^%[X#VA#3G5U!(2F+&[IF1*7X:3%#AF3Y+WJ\C[KXM\1G6N
MUM*"9A:;0BWP!C7YH],H/NL_NJ5GS7;HGE5TS_;2_;HBEJXK@4^M%E1%>D.W
M=.&*M 77EJB[/@9J#A^X9-3!F( K9;C_>/YX?VO=IW@J$-[+=>XAE6SL9L_0
ML4O4Q;&4VE_VI79Z"*0=S0:59H/7:799UN-="]+BE-=I=LE-<^M_AH</\;+>
M#-*GY3H,UHY@[>AA+(C^6K*'NSF0:L]Q\:$^M,UZ.VT<&@X%5V@7UJ8K-]I^
M9GK!I:&^."?\Z+1/C5@7TV*QL&KE!ZZILC2^^<<E3=BHG0&]GRME[Q=NAJMF
M]O%O4$L#!!0    ( .-=3%J'N&=J8@,  /X,   9    >&PO=V]R:W-H965T
M<R]S:&5E=#8R+GAM;+67T6Z;,!2&7\5BU=1)4\%. DF7(+6-JDU:M:A=MXMI
M%PYQ$JL&9[:3M&\_&PC088-4:3<!@__SG6-R?LSTR,63W!*BP'/*,CGSMDKM
M+GU?)EN28GG!=R33=]9<I%CIH=CX<B<(7N6BE/DH"$(_Q33SXFE^;2'B*=\K
M1C.R$$#NTQ2+EVO"^''F0>]TX9YNMLI<\./I#F_( U&/NX70([^*LJ(IR23E
M&1!D/?.NX.4U0D:0S_A!R5$VSH$I9<GYDQE\6<V\P&1$&$F4"8'UX4!N"&,F
MDL[C3QG4JYA&V#P_1;_-B]?%++$D-YS]I"NUG7EC#ZS(&N^9NN?'SZ0L:&3B
M)9S)_!<<R[F!!Y*]5#PMQ3J#E&;%$3^7"]$0Z$+M E0*\H7P"U">Y1PK'$\%
M/P)A9NMHYB0O-5?KY&AFGLJ#$OHNU3H5W_!,T6Q#LH02"7"V C<\3:G2"Z\D
M.+_=J[T@8+$7R5;7#KXM&=U@LY[%Y#N:T72?@J_$W%W@EUSW 9S/B<*4Z;,S
M0#,]C3&CF?I*YVS(?E+F=UWDAQSYS4ER 0;P(T !&H+'ASDX/_OP.HRO2Z[J
M1E7=*(\[<-9=5UE4W5R'.94)X]*4_NMJ*970?Y[?MN0+R- .,1UU*7<X(3-/
MMXPDXD"\^/T[& :?.DH85"4,NJ+'>D5&MIP*U2A7F:8\Q' (@ZE_L+"&%6O8
MQPIMK$(5-EE!X&"-*M:HCQ796*,6*XHF=E18H<(^U-B&"MMEC=' SHHJ5M3'
MFMA849LU&D,[:URQQIVL[UNB+7JMB+ 1Q^V%A(%C)2<5<=+93Y5#\-HA;.S)
M?V@8&-1F%[RI94I9<TE0Z.H9V/!6^*:N*66OGWGDH-6.!CO=QMDWI:Q)&SK^
MR[#V'MAK/M;.*66O2@L=L-I\8*_[6%L'6NQGZ(#5[@.[[:>[=V#;A>#(@:Q=
M"(:=S7-ZB[+\+;HKWZ)6?*>?O;5_:@N#O1YF[Q^;B;D>>VUBL-O%G.W3-C"(
M7+3:P&"G][C;9]*B31SVC&HC0KU&9&T?U#:BT 6K;0CUVI"U?5#;AES&@!K[
MJFX7ZFZ?4MS<G$3_(OW&;M9\&=QAL:%ZO\G(6HN"BTBK1;'9+@:*[_(-[I(K
MO5W.3[?Z X4(,T'?7W.N3@.S9ZX^>>*_4$L#!!0    ( .-=3%K;Z$?LTP(
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MKP>4:UUV[')A5>&[Y%)9ZKE^NJ%'#K4SH/.54O:X< 35LYG\!E!+ P04
M" #C74Q:OL4-A1 &   ?)P  &0   'AL+W=O<FMS:&5E=',O<VAE970V-"YX
M;6RU6EUOVS84_2N$5PPM$-<B*=M*YAC(Q]8&6-H@0;:'80^*1=M:)5$CZ;@%
M]N-'R8JH#YJ6#/HEL23R\![QZIXCBK,M9=_XFA !OL=1PB\':R'2B]&(+]8D
M]OE'FI)$7EE2%OM"'K+5B*>,^$'>*8Y&R'$FH]@/D\%\EI][8/,9W8@H3,@#
M WP3QS[[<4TBNKT<P,';B<=PM1;9B=%\EOHK\D3$<_K Y-&H1 G"F"0\I E@
M9'DYN((7-ZZ;=<A;_!&2+:_\!AF5%TJ_90=WP>7 R2(B$5F(#,*7_U[)#8FB
M#$G&\6\!.BC'S#I6?[^A_Y:3EV1>?$YN:/1G&(CUY< ;@( L_4TD'NGV,RD(
MC3.\!8UX_A=LB[;. "PV7-"XZ"PCB,-D]]__7MR(2@<XV=,!%1U0LX.[IP,N
M.N"<Z"ZRG-:M+_SYC-$M8%EKB9;]R.]-WENR"9-L&I\$DU=#V4_,/U$:;,,H
M GX2@*]B31BX2X2?K,*7B( KSHG@X/U;JP_@_2T1?ACQ#V (GI]NP?MW'\ [
M$";@7EZ6\\)G(R'#RL!'BR*$ZUT(:$\($(%[FH@U![\F 0GJ "/)IR2%WDA=
M(R/B+5E\!!B> >0@5Q/03??NV! .+N\QSO'PH7O\U^_R"K@3).9_Z^[3#L;5
MPV0/] 5/_06Y',@GEA/V2@;SGW^"$^<7'4=+8#7&;LG8-:&7C,] &*=^R.1S
M+T!$N38[=E#C'"JK.J]S=SR9C5ZK9(S#'4EF7)(9=YR^1RK_RNJQ]5F@G<"Q
MS0FT!%;C/"DY3SI.X#59A4D2)BM9+2,_61 =[QW8I#*%<(Q<W)C$26NBH>MY
M3MFJ%NFTC'1JC/0J",),$'A>P?S@'UDSLW33IMJT':<,M!%FNQ%VH#Y(KPS2
M,P8I<T;J20+(]\5:UE:2QTJS:JN+TFL%,/3<1I#M-A.DC_&\C/&\TY17'EE=
M<.?MX-J/JW&D(U,7.DK2G([)*P7E0.864/74]<;C!B%MLVJ&UT.MJ"\TAGI/
M@J<-6^7Y\(5L&!5DL4YH1%<_M-$:T?H6&%MH=>Y(<4=V9+' L<7:$EJ=M?("
MT"B\_:2QP*JFG=/,S%/H/%1"#UU;X@@MB7C!^Q26 "I/ (WRVU<@"[3J1'IH
MVIK+=JOI.1[O*3)*RZ%9S'M))&QKN=>22$VCO1H)E9)#LY3W4TG8UFFOJ4.:
M-MC=$Z;2<F@6\XY""=L2W9IOXT#'YK 2?-A-\3OI9%OWSY'C-0FU6]72O/XV
MIP0=F07]*Q-KFOHD"!?:G#5W[UM9;*'5R2I+@* =6416S8 MM#IK90:047;[
MR6*!54VSM@<U#W@L(:7SJ.M+_T%A1%;?^VVAU7DK0X"ZOOIW$L8"K?8B<SYM
MOCEJ6[E[A!$I$4=F$>\EC*@MSMAI5G1-HWW53\DW,LMW/UE$;6D>PI;3T+1"
MWIY E7XCLWYW%$;4%F7-*Z1YK&/36(D\ZB;R7;01:5[&)^ZT2<AK+7_4,KT>
MJ!)Q9!;QIS1,_ C<Q:F,3W#P'[@->4JY//>)T4UZ!CZ3*!@N*1L^^1$Y U^H
MR)HL:"+"9$,"\#4ES!?[UF[-P_<N3J=8&<#*2&#'TDJL54=A"ZW.6CD*;%YD
MZ*6M!59MI<-KUF/S@,<24F8!=UTY.*BMV.K:@2VT.N_*=X1N:P<'"BQNKQH,
M-7-X"I^ E4_ 9I^0U2T"'DE*F<CJZW,2ZLE8736PA58GK0P'[OHIX5#]L?HE
MP19:G;4R,+CKQX0N]4?C3%I^T#S@L824T<%3:_7'DHTI>)_"%&%EBK"5E0^L
M^8"AF<-3+'Y@Y9NPV3?U7'DWH_6>QU/8(%?9(->2#7*MVB!;:'76R@:YW6P0
M$,Q/^%+_^N1J[ ]L6GGS0,<24?;'-:^5'%H.,W?O/6NG\#RN\CRNI<T3KM55
M%%MH==:5_1/=5E',N=K>.3'4)*M5RS.J;#6*"5OE.[ X6-!-(G8;=,JSY2ZO
MJWQO4^/\-;RXV>W54C"[K6/W/EN%"0<164I(Y^-4$F2[W5B[ T'3?$/3"Q6"
MQOG/-?$#PK(&\OJ2RF)>'&0#E'OBYO\#4$L#!!0    ( .-=3%KDF9.>\ 0
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M,]^O:.YW)"OK1<%[)B7+Z\T-52_[O#)0YU>,R>>=:IVQ65=>_ ]02P,$%
M  @ XUU,6OI;?C5@ @  _04  !D   !X;"]W;W)K<VAE971S+W-H965T-C8N
M>&ULC51;;]HP%/XK5E9-5)J:$$A@'42BI=OZ4 VUZO8P[<$D!V+5L3/;$+9?
MOV,G1&R$LI?$E_/=G/A,*JE>= Y@R*[@0D^]W)CRVO=UFD-!]94L0>#.2JJ"
M&IRJM:]+!31SH(+[81#$?D&9\)*)6UNH9"(WAC,!"T7TIBBH^G4#7%93K^_M
M%Q[9.C=VP4\F)5W#$YCG<J%PYK<L&2M :"8%4;":>K/^]<W(UKN"KPPJ?3 F
M-LE2RA<[N<^F7F - 8?46 :*KRW< N>6"&W\;#B]5M("#\=[]H\N.V994@VW
MDG]CF<FGWM@C&:SHAIM'67V&)D]D^5+)M7N2JJD-/))NM)%% T8'!1/UF^Z:
M<S@ A.$)0-@ 0N>[%G(NY]309*)D192M1C8[<%$=&LTQ83_*DU&XRQ!GDD]2
M9A7CG%"1D2\F!T7NA:%BS98<R$QK,)KT[K1A> *0D5DAE6&_J3O2NQW^&QHN
M26\.AC*N+\D%88(\("'NZXEOT*(5\M/&SDUM)SQA9P[I%1GTWY$P"(?D^6E.
M>A>7?]/XF+"-&;8Q0\<[^)^8QP'G3*=<ZHT"\GVVU$;AS_*CRWVM,NQ6L1?H
M6I<TA:F'-T2#VH*7O'W3CX,/KV08M!D&K[$G>"11EZ<:%3F4O8/;) ZP<-LA
M-6REAN>DXBZI&A4?2$51T"T5M5+1.:E1EU1T+!6.NZ7B5BH^)S7NDHJ/I(;C
M$ZE&K=3HG-3[+JG1T;<:QO]^*__@-MO&^$#5F@E-.*P0%5R-$*[J9E-/C"S=
M!5]*@^W"#7/LSZ!L >ZOI#3[B>T9;<=/_@!02P,$%     @ XUU,6J&97V1_
M!@  P"@  !D   !X;"]W;W)K<VAE971S+W-H965T-C<N>&ULO9KO;Z,V&,?_
M%2L[3:V4)6#RLTLCM>%N.VG=HD;=O9CVP@4G00>8V2:]VU\_&PC$0-Q0N<N+
M-OSPU_8GYO'S-5Z\$/J5[3'FX%L4QNRVM^<\N1D.F;?'$6(#DN!87-D2&B$N
M#NENR!**D9\5BL(AM*S),$)!W%LNLG-KNER0E(=!C-<4L#2*$/U^CT/R<MNS
M>\<3C\%NS^6)X7*1H!W>8/Z4K*DX&I8J?A#AF 4D!A1O;WMW]HWK0%D@N^//
M +^PD^] =N69D*_RX+-_V[-DBW"(/2XED/AWP"L<AE))M..?0K17UBD+GGX_
MJG_*.B\Z\XP87I'P2^#S_6UOU@,^WJ(TY(_DY5=<=&@L]3P2LNPO>"GNM7K
M2QDG45%8M" *XOP_^E: ."E@3\X4@$4!6"\P.E/ *0HXEQ88%05&&9F\*QD'
M%W&T7%#R JB\6ZC)+QG,K+3H?A#+WWW#J;@:B')\N4))P%$(-IQX7\'5[XA2
M)'^):W#E8HZ"D%V#G\#3Q@57'Z[!!S $;(\H9B"(P5,<<-87)\7WAR ,Q>_(
M%D,N6B6UAU[1@ON\!?!,"VP('DC,]PQ\C'WLJP)#T9VR3_#8IWNH572Q-P".
MW0?0@J.6!JTN+^ZT%'<O+PXUO7'*7\C)])R+?J&_?A.7P6>.(_9W&^M<:]2N
M)8/(#4N0AV][(DHP3 ^XM_SQ!WMB_=S&R:28:TA,83@J&8YTZLL5B2(99&(?
MK$5<P91B/P?:/XYGE/(]H<&_XL*5&,_YV>LVQ'E5DZPJ&58/2]NRK+$E/XOA
MX12@ME5= 1H24P".2X!C+<"*&CM#K8W4N$&JE9*VZJZ4#(DIE"8EI4DW2@FB
M(,$TI]5&*-<;GXZE&AQMC5WA&!)3X$Q+.--+GL&"S.6/V[3U<;/:!I*V 5U9
M&1)36,U*5K,.K.0H.J PQ1DJGX0AHJP:5ZW4<OWI"35K4!]:%]SC:MOY1@KS
MDL*\V^,D\E;&11 /XMUKHV;>&#7UP:*MN^M@,22F8+*M*H>SM* >L<SP)97F
M9,8)>,8B0T]2ZNU%@MP:J M])0Y9CE,CIF]%5V2FU%1F)WFOK7_$BK2J(%94
MX0-AI< VY2G%(& L1;'7&K@+=24LS5J#4LN=L#5\N?H6OY4(K(A +9&[W8[B
M'>*BXS&G@;!V7A%VR!:01-HT!O W3+W@W#""C6'D3&"=1\M-]JR.HGD3/+E)
M[6&52=O:)'/Y1[T3P$^I?&Q$+ V(WR\O@(0&GGAJ4+S#?2"\L8BUV0$(@RC@
MK7UW&M%T#@?0F9]\ZB2,YM>FU%2V589MZU/L-[)-D^0"MJ,&6\>9#Z;3.E"C
M^;8I-15HE7';^I1;Y  )CAG*ED<\PCB("0??,1>QRB.[^%S27<@JL7S<&'I&
M<VY3:BJI*NNV]6GW):3ZQ3C,XOLK /6UV4)9)&03$&6K%FV^6:_0F>Y[9.UV
ME;;;^KS]$3,Q&WC\Z)CS91]P];AY:D^]]'I=UR",JKFFU%2655IOSPRNY=B&
MDN\"I$DUUY2:"K)R!K;>&KPY.,X;P7'>2-B,.@-3:NI*:&4-H-X:&(Z-K]26
MQ\;6)5>CWL&4F@JU\@Y0[QV^9&\31$!$!TR1R%QV(H'AP)>Y\Q8%A5OO@U_D
MZ6*%XS+;7E2L9CIP,!G5QFC+?7 \'5BU>=[5=^2MH"I+ ?668I.;JX.80JJ$
MD.]Q,>!:"30S_UE]X4)?:^?!9$A-9529$J@W)6M,L]=WPFBJ$^SZW 2K%^PZ
M+QA5<TVIJ3 K%P)'!B=8:-(OK(RJN:;45)"5^X#OXSY@TWW ^CJ2ONK.H-[#
M?,#*?,#_U7R\4IMF@C7J.4RIJ5 KSP'UGN,=)]AI<X*UQH/&VHR^@9UQOH?M
M@)7M@/K7"6^9AF<7/,=&'84I-951Y2B@WE%\C)*0?,?'.7A=+)>#=8C:=S7H
M]3I/'D9-ARDU=<-"93H<R^26!9/68&54S36EIH*LC(:C-QHB-_1PS&4$)%O@
MA81E+WDRK/DR:AK[(MY]W*S7K6B+S3^6\HYO/JX]R/I6=&;V'I[#J3R'<Y'G
MD"]O1+#+^<A8=Y81;+[)F3I3:U:'U'+?W!K#FC5S]<WKVOWAR=:N"--=MD6.
MB40CC7F^(ZH\6V[#N\LVG]7.W]LW;KZ9KI+)]_8](+H+8@9"O!62UF J@C[-
MM\OE!YPDV0:R9\(YB;*O>XP$5WF#N+XEA!\/9 7EIL7E?U!+ P04    " #C
M74Q:I<XIPS\#  !("@  &0   'AL+W=O<FMS:&5E=',O<VAE970V."YX;6RM
MEEUOXC@4AO^*E5FM.M*4?!+2+D1JR7SL1355J]VY&,V%FQS JA-G; /EWZ\_
M0I:F!G'1&["=\S[V>YS89[IE_%FL "1ZJ6DC9MY*RO;:]T6Y@AJ+$6NA44\6
MC-=8JBY?^J+E@"LCJJD?!4'JUY@T7CXU8_<\G[*UI*2!>X[$NJXQW]T"9=N9
M%WK[@0>R7$D]X.?3%B_A$>0_[3U7/;^G5*2&1A#6( Z+F7<37A>9CC<!_Q+8
MBH,VTDZ>&'O6G;^KF1?H!0&%4FH"5G\;F .E&J26\;MC>OV46GC8WM._&._*
MRQ,6,&?T!ZGD:N9E'JI@@==4/K#M-^C\C#6O9%287[2UL6GBH7(M)*L[L5I!
M31K[CU^Z/!P(HO$10=0)HG,%<2>(AX+TB"#I!(G)C+5B\E!@B?,I9UO$=;2B
MZ89)IE$K^Z31V_XHN7I*E$[F<]P2B2EZE*Q\1A??6[,;7SEN)+H1ZF4P ^(C
MNBA 8D)5ZQ+]@7PD5IB#F/I2+4*C_+*;\-9.&!V9,(S0'6OD2J#/3075:X"O
M5M];B/86;J.3Q +*$8K#3R@*HL2QH/GY\M@A+\Z71R?<Q/V&Q(87G[4A/V^>
MA.3JX_CERK0E)6Z2/C"N18M+F'GJ1!# -^#E?WX(T^ O5Y;>$U:\$^Q5!I,^
M@\DI>O[#?.M07>(-<'5TH04F'&TP70-J@=LWUY5.BYT8K#XN-WD89B.]JYO#
M1+T-R^+1^.IU5/$V*LU&0=9'O;(V[JV-3UI[(.+Y<L$!$&DDJ-1)Q+%TFK&@
MJX/Y@U&0Q ,O-BH,!F$#+TY6>,1+VGM)3WKY_-*JLQ\J5)$-J:"IT(X K5Q>
M4N?\X<"+.VJP>T7J=!RZO4QZ+Y/SO CSU;:<E( VC&))*)$[EZ>)8[71U> M
MFD]<JXV&[YH[:N+VE/6>LO,\,7LG4+( =+$#S,5'EZ'3M!09)8I1;4__,$,5
MWKDND/EYI*@G1<=(Q6G2N".%P1X5)0Z4S9Y_<,?6P)>F5A&H9.M&VKNJ'^W+
MH1M3!0S&;U699*N:_S&VQKK#?$D:@2@L%#(83=1WQVW=8CN2M>8F?V)2U06F
MN5*E'G =H)XO&)/[CIZ@+Q[S_P!02P,$%     @ XUU,6M;P0'GL!   HQ0
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M[C,ALJ3:?.3ADN?E"?+W52;'M,U.F<%FO;S9?U!+ P04    " #C74Q:+Y.
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MGDN ,U/@S&!PGC%?H;EL2/VA)ZBTS,QTA! CH1BF()A-+!^/O9,5]L@PLEJ
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M*9YF'[= (Q!F@'Z^YEP]7)@)RA,]JW\!4$L#!!0    ( .-=3%I+X?[]?@0
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MG,(>M;1$930DX:4P/!N8\-B!F05Q!]BU88O03[PX$2^>V,\&5%%1\0PG'N]
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M.T=W57\CJ6^,+*O/#+?2&)E7EUO@*2AK@+]OI#0/-_;+Q>E+U>I_4$L#!!0
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M970X,"YX;6R]6FUSVC@0_BL:KG.3SH2"92"02Y@AN+G+3-MDFN;ZX>8^"%N
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ML8ATS22SR#2-2\F:/">'F-Z\HO8+T\[2V4,F<,M4@97LQ7/3ER]4R!%AE=7
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M;+6;76_;-A2&_PKA%5L*;+7$#]OI' .MLV(%6BQHT.YBV(5BT[%0?;@BG33
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M*M;O0,UG78_V8V9#GZ,:0Y@;0SHFM5.H6V/TNOC8AV$::IC?QA0#91\H-?/
MOV:?&6!CJM9J/V+2.\1JB>D=8IVV'L(JGX#[&!7W<290PG=J4/!JKD87IX?*
M3C<R/U3/9=WE4N9I=;GGT98798!Z?Y?G\L=-^:A7\VC?ZG]02P,$%     @
MXUU,6J6XO@C? @  3 D  !D   !X;"]W;W)K<VAE971S+W-H965T.#4N>&UL
MM59=;]HP%/TK5E9-5%H;2"!E'40JT&F5V@FUZO8P[<$D-V#5L3/;@?;?[SJ!
M#%B(UHV])/XZQ^=<?UP/5E(]Z06 (<\I%WKH+(S)+EU71PM(J3Z7&0CL2:1*
MJ<&JFKLZ4T#C I1RUVNW S>E3#CAH&B;JG @<\.9@*DB.D]3JEY&P.5JZ'2<
M3<,]FR^,;7##04;G\ #F,9LJK+D52\Q2$)I)010D0^>J<SGNV_'%@"\,5GJK
M3*R3F91/MG(3#YVV%00<(F,9*/Z6, ;.+1'*^+'F=*HI+7"[O&'_6'A'+S.J
M82SY5Q:;Q=#I.R2&A.;<W,O5)UC[Z5F^2')=?,FJ'!OX#HER;62Z!J."E(GR
M3Y_7<=@"=((# &\-\/8!W0, ?PWP"Z.ELL+6A!H:#I1<$65'(YLM%+$IT.B&
M";N*#T9A+T.<">_!, 6X+(9,.16:M#Y3I:B-[2EI3<!0QO4I.2./#Q/2.CDE
M)X0)<L<XQT70 ]>@!LOD1NOY1N5\WH'Y.AZYD\(L-+D6,<2[!"Z*KQQX&P<C
MKY%Q M$Y\3OOB-?VNC6"QG\.]QOD^%5 _8+//\B78$M,1B"P5$:53)B.N-2Y
M O+M%KO)C8%4?Z\+7\G>K6>W9_I29S2"H8.'5H-:@A.^?=,)VA_JK!^);"<0
MW2H0W2;V\"HR.>5XTDVN1)W3$MXKX/:R68:>-W"7V_IKAKROANRHZE6J>HVJ
M6K>P!$[\TSI%C=#7QOY(9#LN@\IE\%\W87#,0!R);"<0%U4@+OYM$Y;P8&N'
MG?7W-F'C#'^IOU_I[S?JO]:&8:["I4QR8U<.THS+%U DPEM4L5ENDZ&V=[*
M9T,27&/T^P)4U;GM_WZ>.GMN&_6\UJV[E9A24/,B7VO4G@M3WO!5:_4DN"HR
MX5[[")\*96;_15.^,^ZHFC., (<$*=OG%^A.E;F[K!B9%>EO)@TFTZ*XP.<.
M*#L ^Q,IS:9B)Z@>4.%/4$L#!!0    ( .-=3%IT$57'5@(  #D&   9
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M5=!-4"[K0E4/M*AL<5@*C:7&=K=8VT&:#;B^%D*?!J;>M'^+["]02P,$%
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M%P8DK[Z/5#LBVY?OJ)\R(;*DW-PQ&K*\ .3OVRP3;SO% ,U7JO&_4$L#!!0
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MB4T<Y3$CZBQ;SCI%5!T[G5IA;6J%J5,K?^E@$+79NYN@V16HYD(U#ZKY4"V
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MB#KY(E$X,:AX&%$XMJS3%X4PVSR)J3YCR;-+:>KQ?9L'JCE0S85J'E3SH5H
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M:A%*ZW2XU>9.K-<\CXD%#:5 -0>JN5#-@VH^5 N@&H=J(52;0;4(I74;N<W
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M"NI_O\OSZNF7Y@X>\N+WW=.Y_C]02P,$%     @ XUU,6@FVL]QY!   $1D
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M#&1QG<%5'H7D+IQ&#]&4&PI"^<DW%23-@-),*,V"TFPHS8'27"C-@])\*"U
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#DR+GAM;+57VV[;.!#]%4);+%K
MB2SZ$B=K&\AENPV0M$&][3X4^T!+8YLH):HD;2=_OT-*EIQ(8OJP?;%%B3/G
MS'#FD)SNI?JN-P"&/*8BT[-@8TQ^$88ZWD#*]*G,(<,O*ZE29G"HUJ'.%;#$
M&:4BI/W^.$P9SX+YU+U[4/.IW!K!,WA01&_3E*FG*Q!R/PNBX/#B,U]OC'T1
MSJ<Y6\,"S)?\0>$HK+PD/(5,<YD1!:M9<!E=7%%J#=R,KQSV^NB9V%"64GZW
M@]MD%O0M(Q 0&^N"X=\.KD$(ZPEY_"B=!A6F-3Q^/GA_[X+'8)9,P[44__#$
M;&;!)" )K-A6F,]R_P'*@$;67RR%=K]D7\[M!R3>:B/3TA@9I#PK_MECF8@C
M PRTW8"6!BX180'D6-XPP^93)?=$V=GHS3ZX4)TUDN.9796%4?B5HYV97VH-
M1I,/(!*":TP63 !Y>P.&<:'?D1-RPW4N-1/D+R6W><_-/,&9)W9FCWR4QDZ)
M969XMH6$?,I!,9MPC<:+G&=H>IOF@F4(\X;PC-QS(>SW:6@P $LCC$NR5P59
MVD%V0.X19Z/)GUD"R7/[$ .OHJ>'Z*^HU^$-Q*=D$/4([=,A^;*X(6_?O//X
M'519'3B_@PZ_MUDL4R +PPQ@"9L>N6*8@1A?N59C64(NDX3;/&%^; *%U%L%
MFBR?7J1<]PBZ$]N$9^O.5'^[0P;D%M'TOVUY+>@.V^G:SK_0.8MA%F!K:U [
M".:__Q:-^W]XDC&LDC'T>9_?2:T)-F#BPG(Q$[DBS%5>&]G"W<BYLZJRFP_&
M=!KN6CB,*@XC+P?,(&J6!F(D63&NR(Z)+;2!%W[&1^"383OVN,(>>[&QR'X2
M>]S IM&D'?RL C_S5N++]GVME'JD5(1OETMM%(IF:SV=_8)ZFE0A3;SYO(QC
MN;5JHB &OF-+JT,9F#:>DT9&NRKIO$(_]Z+_+0UFDV<[;&NI.+16\'D#-IH,
MVG&C?JW4?2_R@X*<\83 (V[)&J7"JH@T&U"X42B%?#P]5?I^1JG?P>AH[XA>
M882G V6>>L3INR,$/[8\+S2O8TU*I\=41E$'%5I3H5XJGUP>>&98MN98$;H;
MGC;@!W3<@5\+?N25T/E'F1T6 <\$@$\)LG&[@&&/OH49-.B<=Y"I!3?R*VZ1
MC*RFY($?-NOBK&LU:K6-_'+[%16.%:<N@><^N_.U@C?%]J13ZJ-:;R._X!8M
M6L1,-H>3#8I@.XFFZ@Y'7:U1RV[T?^ON'6=++G![M+5[72Z<7X6C7R'#4:W#
MT4\*<<Z>K JW4FPJ,.W8TJ):@B._!B.PLMG#]K)2Z!+8"M[4X:Y.I[4,4[\,
M'\!;9%C42]A&AS8UF';T.JTUF/HUN-'KKY%HJB_MZ'=:JR_UJV_1<4?(K[==
MZ7'T;$-Z>=(*CRXV*:BUN[YIXLJNN.-4;ZLKXF5Q,:JG%_?+>Z;6'$_* E9H
MVC\]0V157-F*@9&YNR8MI<%+EWO<X#47E)V WU=2FL/  E07Y_E_4$L#!!0
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MS@1Z9]0[$^B=4>],H'=&O3.!WAGUS@1Z9]0[$^B=4>],H'>>'/8FT#NCWIE
M[X)Z%P*]"^I="/0NJ'<AT+N@WH5 [X)ZEY_4>QB_#G6X]7RO\?D_2?5X^6Z]
M/?ZZ_+XX>7NO.+O[BN'I+U!+ P04    " #C74Q:N.0S3$8"  ",-0  $P
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M_X_CEV<ZU-WXDB^6/V'=_@102P$"% ,4    " #C74Q:!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M .-=3%K'>8:][P   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( .-=3%J97)PC$ 8  )PG   3
M  "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ XUU,6C@>
M@?&]"@  0U\  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( .-=3%H,!V1M/P(  ,4%   8
M  " @0$3  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " #C
M74Q:$D+IOYX%  !B%P  &               @(%V%0  >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&UL4$L! A0#%     @ XUU,6LXC\UF< @  W@8  !@
M         ("!2AL  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0
M   ( .-=3%IJ7)M-G@,  ,L,   8              " @1P>  !X;"]W;W)K
M<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " #C74Q:0!;P&$8'  !B(0
M&               @('P(0  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L!
M A0#%     @ XUU,6J"H:QEV @  V@4  !@              ("!;"D  'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( .-=3%I9 @>:U 8
M )LU   8              " @1@L  !X;"]W;W)K<VAE971S+W-H965T."YX
M;6Q02P$"% ,4    " #C74Q:Z+V>&9((  "3*0  &               @($B
M,P  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ XUU,6G*?
M8[P3(0  C&0  !D              ("!ZCL  'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6Q02P$"% ,4    " #C74Q:;#L0NVP,  #*'P  &0
M    @($T70  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (
M .-=3%KSQ,IKL0@  (L5   9              " @==I  !X;"]W;W)K<VAE
M971S+W-H965T,3(N>&UL4$L! A0#%     @ XUU,6E<A) RM!P  )A0  !D
M             ("!OW(  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"
M% ,4    " #C74Q:K+E_XGH#   @"   &0              @(&C>@  >&PO
M=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( .-=3%H*],KXY@4
M +L-   9              " @51^  !X;"]W;W)K<VAE971S+W-H965T,34N
M>&UL4$L! A0#%     @ XUU,6LX:K5!N#   >QX  !D              ("!
M<80  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " #C74Q:
MN^AP>14(  #S$P  &0              @($6D0  >&PO=V]R:W-H965T<R]S
M:&5E=#$W+GAM;%!+ 0(4 Q0    ( .-=3%I,K#0:@@@  $\5   9
M      " @6*9  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%
M  @ XUU,6EX!&[] !@  V0X  !D              ("!&Z(  'AL+W=O<FMS
M:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " #C74Q:QL35R\<+   R(@
M&0              @(&2J   >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+
M 0(4 Q0    ( .-=3%I$\,U<,@D  '47   9              " @9"T  !X
M;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ XUU,6J[.3*9;
M P  \0<  !D              ("!^;T  'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6Q02P$"% ,4    " #C74Q:)-3-OHL)  "Y%P  &0
M@(&+P0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( .-=
M3%I4K: .E (  (T%   9              " @4W+  !X;"]W;W)K<VAE971S
M+W-H965T,C0N>&UL4$L! A0#%     @ XUU,6O#)\D7T!0   @X  !D
M         ("!&,X  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
M    " #C74Q:O?R@4$T%  !2#   &0              @(%#U   >&PO=V]R
M:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( .-=3%JC!H0.F@0  (D*
M   9              " @<?9  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL
M4$L! A0#%     @ XUU,6A01<5<A P  XPT  !D              ("!F-X
M 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " #C74Q:+'5H
MOD,"  "*!@  &0              @('PX0  >&PO=V]R:W-H965T<R]S:&5E
M=#(Y+GAM;%!+ 0(4 Q0    ( .-=3%H\I3,X$0(  -T$   9
M  " @6KD  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @
MXUU,6NB>4;[D"@  8"P  !D              ("!LN8  'AL+W=O<FMS:&5E
M=',O<VAE970S,2YX;6Q02P$"% ,4    " #C74Q:BZ/3J5LA   1;   &0
M            @('-\0  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4
M Q0    ( .-=3%I5/[,-ZP0  (\+   9              " @5\3 0!X;"]W
M;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ XUU,6J[MTZLX!
M.@H  !D              ("!@1@! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX
M;6Q02P$"% ,4    " #C74Q:I,S(=>\#  #\"0  &0              @('P
M' $ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( .-=3%J4
M/N5)80,  /D'   9              " @18A 0!X;"]W;W)K<VAE971S+W-H
M965T,S8N>&UL4$L! A0#%     @ XUU,6D#!C]EZ P  TP<  !D
M     ("!KB0! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .-=3%KZ-Z(&S08  *42   9              "
M@?PX 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ XUU,
M6E(3(L\2!P  -A0  !D              ("! $ ! 'AL+W=O<FMS:&5E=',O
M<VAE970T,RYX;6Q02P$"% ,4    " #C74Q:J%N_'T0#  #(!P  &0
M        @(%)1P$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0
M   ( .-=3%H*#'_==P8  ,</   9              " @<1* 0!X;"]W;W)K
M<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ XUU,6B8;(JY) P  F <
M !D              ("!<E$! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q0
M2P$"% ,4    " #C74Q:K]Z4E=T#  !\$   &0              @('R5 $
M>&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( .-=3%K(H&?V
M0@4  /0I   9              " @099 0!X;"]W;W)K<VAE971S+W-H965T
M-#@N>&UL4$L! A0#%     @ XUU,6LC7_2RX%@  9J8! !D
M ("!?UX! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " #C
M74Q:B+]4];0"  "F!@  &0              @(%N=0$ >&PO=V]R:W-H965T
M<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( .-=3%HI_[BK^08  &8K   9
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M970U-2YX;6Q02P$"% ,4    " #C74Q:(I?0>2 $   U%0  &0
M    @('2E0$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    (
M .-=3%JR<";(N @  .M(   9              " @2F: 0!X;"]W;W)K<VAE
M971S+W-H965T-3<N>&UL4$L! A0#%     @ XUU,6@@0 SH\!   J1H  !D
M             ("!&*,! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"
M% ,4    " #C74Q:6!*=D"4)  "D8   &0              @(&+IP$ >&PO
M=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( .-=3%J\J7@CC@,
M -0-   9              " @>>P 0!X;"]W;W)K<VAE971S+W-H965T-C N
M>&UL4$L! A0#%     @ XUU,6GT',_!U P  OPL  !D              ("!
MK+0! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " #C74Q:
MA[AG:F(#  #^#   &0              @(%8N $ >&PO=V]R:W-H965T<R]S
M:&5E=#8R+GAM;%!+ 0(4 Q0    ( .-=3%K;Z$?LTP(  $('   9
M      " @?&[ 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%
M  @ XUU,6K[%#840!@  'R<  !D              ("!^[X! 'AL+W=O<FMS
M:&5E=',O<VAE970V-"YX;6Q02P$"% ,4    " #C74Q:Y)F3GO $  !C'@
M&0              @(%"Q0$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+
M 0(4 Q0    ( .-=3%KZ6WXU8 (  /T%   9              " @6G* 0!X
M;"]W;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ XUU,6J&97V1_
M!@  P"@  !D              ("! ,T! 'AL+W=O<FMS:&5E=',O<VAE970V
M-RYX;6Q02P$"% ,4    " #C74Q:I<XIPS\#  !("@  &0
M@(&VTP$ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( .-=
M3%K6\$!Y[ 0  *,4   9              " @2S7 0!X;"]W;W)K<VAE971S
M+W-H965T-CDN>&UL4$L! A0#%     @ XUU,6MD)U/-4!0  &1X  !D
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M=#<T+GAM;%!+ 0(4 Q0    ( .-=3%HN(I%?S@,  &84   9
M  " @2S^ 0!X;"]W;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @
MXUU,6IB3/#J@ P  50X  !D              ("!,0(" 'AL+W=O<FMS:&5E
M=',O<VAE970W-BYX;6Q02P$"% ,4    " #C74Q:/6IU3=L$  "U$@  &0
M            @($(!@( >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4
M Q0    ( .-=3%K]$I!.AP,  ,P+   9              " @1H+ @!X;"]W
M;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#%     @ XUU,6H3S>_M$ P
M0@H  !D              ("!V X" 'AL+W=O<FMS:&5E=',O<VAE970W.2YX
M;6Q02P$"% ,4    " #C74Q:0+P9?ID'  "A*@  &0              @(%3
M$@( >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+ 0(4 Q0    ( .-=3%I>
M@ZUMM@,   <.   9              " @2,: @!X;"]W;W)K<VAE971S+W-H
M965T.#$N>&UL4$L! A0#%     @ XUU,6A8H-3 N P  J@D  !D
M     ("!$!X" 'AL+W=O<FMS:&5E=',O<VAE970X,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .-=3%JMMEN]:@4  +$:   9              "
M@3XQ @!X;"]W;W)K<VAE971S+W-H965T.#<N>&UL4$L! A0#%     @ XUU,
M6DN+WW];#P  UL(  !D              ("!WS8" 'AL+W=O<FMS:&5E=',O
M<VAE970X."YX;6Q02P$"% ,4    " #C74Q:";:SW'D$   1&0  &0
M        @(%Q1@( >&PO=V]R:W-H965T<R]S:&5E=#@Y+GAM;%!+ 0(4 Q0
M   ( .-=3%I,X V[^ 8  $1(   9              " @2%+ @!X;"]W;W)K
M<VAE971S+W-H965T.3 N>&UL4$L! A0#%     @ XUU,6HSV^:#< @  !0H
M !D              ("!4%(" 'AL+W=O<FMS:&5E=',O<VAE970Y,2YX;6Q0
M2P$"% ,4    " #C74Q:5)'26VT$  !$#P  &0              @(%C50(
M>&PO=V]R:W-H965T<R]S:&5E=#DR+GAM;%!+ 0(4 Q0    ( .-=3%I,2UN+
M900  (P8   9              " @0=: @!X;"]W;W)K<VAE971S+W-H965T
M.3,N>&UL4$L! A0#%     @ XUU,6GW?WJ1^ P  8@H  !D
M ("!HUX" 'AL+W=O<FMS:&5E=',O<VAE970Y-"YX;6Q02P$"% ,4    " #C
M74Q:$S_':FT#  "L%@  #0              @ %88@( >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( .-=3%J7BKL<P    !,"   +              "  ?!E
M @!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( .-=3%KS[5&IU@8  .0]   /
M          "  =EF @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #C74Q:
MMO4_!K8"  !1-P  &@              @ '<;0( >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " #C74Q:N.0S3$8"  ",-0  $P
M        @ '*< ( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     9@!F  $<
(  !!<P(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>491</ContextCount>
  <ElementCount>532</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>129</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - COVER PAGE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/COVERPAGE</Role>
      <ShortName>COVER PAGE</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952151 - Statement - Consolidated Statements Of Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedStatementsOfEarnings</Role>
      <ShortName>Consolidated Statements Of Earnings</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952152 - Statement - Consolidated Statements Of Earnings (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedStatementsOfEarningsParenthetical</Role>
      <ShortName>Consolidated Statements Of Earnings (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952153 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952154 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952155 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952156 - Statement - Consolidated Statements Of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity</Role>
      <ShortName>Consolidated Statements Of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952157 - Statement - Consolidated Statements Of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements Of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Derivative Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DerivativeInstruments</Role>
      <ShortName>Derivative Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI</Role>
      <ShortName>Accumulated Other Comprehensive (Loss) Income (AOCI)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Contingencies and Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ContingenciesandCommitments</Role>
      <ShortName>Contingencies and Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Capital Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStock</Role>
      <ShortName>Capital Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Debt and Credit Facilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DebtandCreditFacilities</Role>
      <ShortName>Debt and Credit Facilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Retirement Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlans</Role>
      <ShortName>Retirement Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Summary of Quarterly Data (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited</Role>
      <ShortName>Summary of Quarterly Data (Unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Segment and Geographic Data</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SegmentandGeographicData</Role>
      <ShortName>Segment and Geographic Data</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9952172 - Disclosure - Asset Impairments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AssetImpairments</Role>
      <ShortName>Asset Impairments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9952173 - Disclosure - Assets Held for Sale</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AssetsHeldforSale</Role>
      <ShortName>Assets Held for Sale</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9952174 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9952175 - Disclosure - Schedule II Valuation and Qualifying Accounts (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsNotes</Role>
      <ShortName>Schedule II Valuation and Qualifying Accounts (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RevenueRecognition</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/FairValueMeasurements</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Derivative Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DerivativeInstrumentsTables</Role>
      <ShortName>Derivative Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DerivativeInstruments</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables</Role>
      <ShortName>Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/Acquisitions</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Contingencies and Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ContingenciesandCommitmentsTables</Role>
      <ShortName>Contingencies and Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/ContingenciesandCommitments</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Capital Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStockTables</Role>
      <ShortName>Capital Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/CapitalStock</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Debt and Credit Facilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DebtandCreditFacilitiesTables</Role>
      <ShortName>Debt and Credit Facilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DebtandCreditFacilities</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxes</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Retirement Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansTables</Role>
      <ShortName>Retirement Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlans</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Summary of Quarterly Data (Unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables</Role>
      <ShortName>Summary of Quarterly Data (Unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Segment and Geographic Data (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SegmentandGeographicDataTables</Role>
      <ShortName>Segment and Geographic Data (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SegmentandGeographicData</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Assets Held for Sale (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AssetsHeldforSaleTables</Role>
      <ShortName>Assets Held for Sale (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/AssetsHeldforSale</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SignificantAccountingPoliciesPolicies</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Revenue Recognition - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RevenueRecognitionNarrativeDetails</Role>
      <ShortName>Revenue Recognition - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Revenue Recognition - Disaggregated Sales Analysis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails</Role>
      <ShortName>Revenue Recognition - Disaggregated Sales Analysis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Revenue Recognition - Changes in Contract Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails</Role>
      <ShortName>Revenue Recognition - Changes in Contract Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails</Role>
      <ShortName>Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Fair Value Measurements (Available-For-Sale Securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails</Role>
      <ShortName>Fair Value Measurements (Available-For-Sale Securities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Fair Value Measurements (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Derivative Instruments (Forward Currency Exchange Contracts) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails</Role>
      <ShortName>Derivative Instruments (Forward Currency Exchange Contracts) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DerivativeInstrumentsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Derivative Instruments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails</Role>
      <ShortName>Derivative Instruments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DerivativeInstrumentsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Derivative Instruments (Movements out of OCI) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails</Role>
      <ShortName>Derivative Instruments (Movements out of OCI) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DerivativeInstrumentsTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Acquisitions (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AcquisitionsNarrativeDetails</Role>
      <ShortName>Acquisitions (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/AcquisitionsTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails</Role>
      <ShortName>Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/AcquisitionsTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Contingencies and Commitments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails</Role>
      <ShortName>Contingencies and Commitments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/ContingenciesandCommitmentsTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Commitments and Contingencies (Lease Cost) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails</Role>
      <ShortName>Commitments and Contingencies (Lease Cost) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails</Role>
      <ShortName>Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/ContingenciesandCommitmentsTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Contingencies and Commitments (Supplier Finance Program) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ContingenciesandCommitmentsSupplierFinanceProgramDetails</Role>
      <ShortName>Contingencies and Commitments (Supplier Finance Program) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/ContingenciesandCommitmentsTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Goodwill and Other Intangible Assets (Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Capital Stock (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStockNarrativeDetails</Role>
      <ShortName>Capital Stock (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/CapitalStockTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Capital Stock (Option Grant Assumptions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails</Role>
      <ShortName>Capital Stock (Option Grant Assumptions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/CapitalStockTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - Capital Stock (Summary of Stock Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails</Role>
      <ShortName>Capital Stock (Summary of Stock Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/CapitalStockTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - Capital Stock (Summary of RSU and PSU Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails</Role>
      <ShortName>Capital Stock (Summary of RSU and PSU Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/CapitalStockTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - Debt and Credit Facilities (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails</Role>
      <ShortName>Debt and Credit Facilities (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DebtandCreditFacilitiesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails</Role>
      <ShortName>Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DebtandCreditFacilitiesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9955553 - Disclosure - Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails</Role>
      <ShortName>Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9955554 - Disclosure - Income Taxes (Schedule of Earnings before Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Schedule of Earnings before Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9955555 - Disclosure - Income Taxes (Schedule of Provision for Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Schedule of Provision for Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9955556 - Disclosure - Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9955557 - Disclosure - Income Taxes (Schedule of Unresolved Income Tax Positions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails</Role>
      <ShortName>Income Taxes (Schedule of Unresolved Income Tax Positions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9955558 - Disclosure - Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails</Role>
      <ShortName>Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9955559 - Disclosure - Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails</Role>
      <ShortName>Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9955560 - Disclosure - Retirement Plans (Schedule of Change in Benefit Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails</Role>
      <ShortName>Retirement Plans (Schedule of Change in Benefit Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9955561 - Disclosure - Retirement Plans (Change in Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails</Role>
      <ShortName>Retirement Plans (Change in Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>9955562 - Disclosure - Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails</Role>
      <ShortName>Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>9955563 - Disclosure - Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails</Role>
      <ShortName>Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>9955564 - Disclosure - Retirement Plans (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansNarrativeDetails</Role>
      <ShortName>Retirement Plans (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>9955565 - Disclosure - Retirement Plans (Expected Benefit Payments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails</Role>
      <ShortName>Retirement Plans (Expected Benefit Payments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>9955566 - Disclosure - Summary of Quarterly Data (Unaudited) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails</Role>
      <ShortName>Summary of Quarterly Data (Unaudited) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>9955567 - Disclosure - Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails</Role>
      <ShortName>Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SegmentandGeographicDataTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>9955568 - Disclosure - Segment and Geographic Data (Segment Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails</Role>
      <ShortName>Segment and Geographic Data (Segment Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SegmentandGeographicDataTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>9955569 - Disclosure - Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails</Role>
      <ShortName>Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SegmentandGeographicDataTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>9955570 - Disclosure - Asset Impairments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AssetImpairmentsDetails</Role>
      <ShortName>Asset Impairments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/AssetImpairments</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>9955571 - Disclosure - Assets Held for Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AssetsHeldforSaleDetails</Role>
      <ShortName>Assets Held for Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/AssetsHeldforSaleTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>9955572 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SubsequentEvents</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="syk-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>9955573 - Disclosure - Schedule II Valuation and Qualifying Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails</Role>
      <ShortName>Schedule II Valuation and Qualifying Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsNotes</ParentRole>
      <Position>94</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="syk-20241231.htm">syk-20241231.htm</File>
    <File>syk-20241231.xsd</File>
    <File>syk-20241231_cal.xml</File>
    <File>syk-20241231_def.xml</File>
    <File>syk-20241231_lab.xml</File>
    <File>syk-20241231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>syk-20241231_g1.jpg</File>
    <File>syk-20241231_g2.jpg</File>
    <File>syk-20241231_g3.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="1559">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="60">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>142
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "syk-20241231.htm": {
   "nsprefix": "syk",
   "nsuri": "http://www.stryker.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "syk-20241231.htm"
     ]
    },
    "schema": {
     "local": [
      "syk-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "syk-20241231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "syk-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "syk-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "syk-20241231_pre.xml"
     ]
    }
   },
   "keyStandard": 495,
   "keyCustom": 37,
   "axisStandard": 31,
   "axisCustom": 0,
   "memberStandard": 65,
   "memberCustom": 54,
   "hidden": {
    "total": 19,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 15
   },
   "contextCount": 491,
   "entityCount": 1,
   "segmentCount": 129,
   "elementCount": 928,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 1559,
    "http://xbrl.sec.gov/dei/2024": 60,
    "http://xbrl.sec.gov/cyd/2024": 15,
    "http://xbrl.sec.gov/ecd/2024": 5,
    "http://fasb.org/srt/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://www.stryker.com/role/COVERPAGE",
     "longName": "0000001 - Document - COVER PAGE",
     "shortName": "COVER PAGE",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.stryker.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
     "longName": "9952151 - Statement - Consolidated Statements Of Earnings",
     "shortName": "Consolidated Statements Of Earnings",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsParenthetical",
     "longName": "9952152 - Statement - Consolidated Statements Of Earnings (Parenthetical)",
     "shortName": "Consolidated Statements Of Earnings (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "longName": "9952153 - Statement - Consolidated Statements of Comprehensive Income",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.stryker.com/role/ConsolidatedBalanceSheets",
     "longName": "9952154 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals",
     "longName": "9952155 - Statement - Consolidated Balance Sheets (Parentheticals)",
     "shortName": "Consolidated Balance Sheets (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
     "longName": "9952156 - Statement - Consolidated Statements Of Shareholders' Equity",
     "shortName": "Consolidated Statements Of Shareholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-18",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-18",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows",
     "longName": "9952157 - Statement - Consolidated Statements Of Cash Flows",
     "shortName": "Consolidated Statements Of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.stryker.com/role/SignificantAccountingPolicies",
     "longName": "9952158 - Disclosure - Significant Accounting Policies",
     "shortName": "Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.stryker.com/role/RevenueRecognition",
     "longName": "9952159 - Disclosure - Revenue Recognition",
     "shortName": "Revenue Recognition",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.stryker.com/role/FairValueMeasurements",
     "longName": "9952160 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.stryker.com/role/DerivativeInstruments",
     "longName": "9952161 - Disclosure - Derivative Instruments",
     "shortName": "Derivative Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI",
     "longName": "9952162 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI)",
     "shortName": "Accumulated Other Comprehensive (Loss) Income (AOCI)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.stryker.com/role/Acquisitions",
     "longName": "9952163 - Disclosure - Acquisitions",
     "shortName": "Acquisitions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.stryker.com/role/ContingenciesandCommitments",
     "longName": "9952164 - Disclosure - Contingencies and Commitments",
     "shortName": "Contingencies and Commitments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.stryker.com/role/GoodwillandOtherIntangibleAssets",
     "longName": "9952165 - Disclosure - Goodwill and Other Intangible Assets",
     "shortName": "Goodwill and Other Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.stryker.com/role/CapitalStock",
     "longName": "9952166 - Disclosure - Capital Stock",
     "shortName": "Capital Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.stryker.com/role/DebtandCreditFacilities",
     "longName": "9952167 - Disclosure - Debt and Credit Facilities",
     "shortName": "Debt and Credit Facilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.stryker.com/role/IncomeTaxes",
     "longName": "9952168 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.stryker.com/role/RetirementPlans",
     "longName": "9952169 - Disclosure - Retirement Plans",
     "shortName": "Retirement Plans",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited",
     "longName": "9952170 - Disclosure - Summary of Quarterly Data (Unaudited)",
     "shortName": "Summary of Quarterly Data (Unaudited)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.stryker.com/role/SegmentandGeographicData",
     "longName": "9952171 - Disclosure - Segment and Geographic Data",
     "shortName": "Segment and Geographic Data",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.stryker.com/role/AssetImpairments",
     "longName": "9952172 - Disclosure - Asset Impairments",
     "shortName": "Asset Impairments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AssetImpairmentChargesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AssetImpairmentChargesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.stryker.com/role/AssetsHeldforSale",
     "longName": "9952173 - Disclosure - Assets Held for Sale",
     "shortName": "Assets Held for Sale",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.stryker.com/role/SubsequentEvents",
     "longName": "9952174 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsNotes",
     "longName": "9952175 - Disclosure - Schedule II Valuation and Qualifying Accounts (Notes)",
     "shortName": "Schedule II Valuation and Qualifying Accounts (Notes)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-429",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R29": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-429",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-429",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Significant Accounting Policies (Policies)",
     "shortName": "Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.stryker.com/role/RevenueRecognitionTables",
     "longName": "9955512 - Disclosure - Revenue Recognition (Tables)",
     "shortName": "Revenue Recognition (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.stryker.com/role/FairValueMeasurementsTables",
     "longName": "9955513 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.stryker.com/role/DerivativeInstrumentsTables",
     "longName": "9955514 - Disclosure - Derivative Instruments (Tables)",
     "shortName": "Derivative Instruments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables",
     "longName": "9955515 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)",
     "shortName": "Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.stryker.com/role/AcquisitionsTables",
     "longName": "9955516 - Disclosure - Acquisitions (Tables)",
     "shortName": "Acquisitions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.stryker.com/role/ContingenciesandCommitmentsTables",
     "longName": "9955517 - Disclosure - Contingencies and Commitments (Tables)",
     "shortName": "Contingencies and Commitments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables",
     "longName": "9955518 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.stryker.com/role/CapitalStockTables",
     "longName": "9955519 - Disclosure - Capital Stock (Tables)",
     "shortName": "Capital Stock (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.stryker.com/role/DebtandCreditFacilitiesTables",
     "longName": "9955520 - Disclosure - Debt and Credit Facilities (Tables)",
     "shortName": "Debt and Credit Facilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.stryker.com/role/IncomeTaxesTables",
     "longName": "9955521 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.stryker.com/role/RetirementPlansTables",
     "longName": "9955522 - Disclosure - Retirement Plans (Tables)",
     "shortName": "Retirement Plans (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables",
     "longName": "9955523 - Disclosure - Summary of Quarterly Data (Unaudited) (Tables)",
     "shortName": "Summary of Quarterly Data (Unaudited) (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.stryker.com/role/SegmentandGeographicDataTables",
     "longName": "9955524 - Disclosure - Segment and Geographic Data (Tables)",
     "shortName": "Segment and Geographic Data (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.stryker.com/role/AssetsHeldforSaleTables",
     "longName": "9955525 - Disclosure - Assets Held for Sale (Tables)",
     "shortName": "Assets Held for Sale (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.stryker.com/role/SignificantAccountingPoliciesDetails",
     "longName": "9955526 - Disclosure - Significant Accounting Policies (Details)",
     "shortName": "Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-51",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "span",
       "div",
       "div",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails",
     "longName": "9955527 - Disclosure - Revenue Recognition - Narrative (Details)",
     "shortName": "Revenue Recognition - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "syk:PercentageofServiceRevenueRecognizeoverTime",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "syk:PercentageofServiceRevenueRecognizeoverTime",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
     "longName": "9955528 - Disclosure - Revenue Recognition - Disaggregated Sales Analysis (Details)",
     "shortName": "Revenue Recognition - Disaggregated Sales Analysis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-429",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-171",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails",
     "longName": "9955529 - Disclosure - Revenue Recognition - Changes in Contract Liabilities (Details)",
     "shortName": "Revenue Recognition - Changes in Contract Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-15",
      "name": "us-gaap:ContractWithCustomerLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
     "longName": "9955530 - Disclosure - Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details)",
     "shortName": "Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails",
     "longName": "9955531 - Disclosure - Fair Value Measurements (Available-For-Sale Securities) (Details)",
     "shortName": "Fair Value Measurements (Available-For-Sale Securities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails",
     "longName": "9955532 - Disclosure - Fair Value Measurements (Narrative) (Details)",
     "shortName": "Fair Value Measurements (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
     "longName": "9955533 - Disclosure - Derivative Instruments (Forward Currency Exchange Contracts) (Details)",
     "shortName": "Derivative Instruments (Forward Currency Exchange Contracts) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-197",
      "name": "us-gaap:DerivativeNotionalAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-198",
      "name": "us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails",
     "longName": "9955534 - Disclosure - Derivative Instruments (Narrative) (Details)",
     "shortName": "Derivative Instruments (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-198",
      "name": "us-gaap:DerivativeTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
     "longName": "9955535 - Disclosure - Derivative Instruments (Movements out of OCI) (Details)",
     "shortName": "Derivative Instruments (Movements out of OCI) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-198",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-198",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
     "longName": "9955536 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details)",
     "shortName": "Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-15",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
     "longName": "9955537 - Disclosure - Acquisitions (Narrative) (Details)",
     "shortName": "Acquisitions (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-280",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
     "longName": "9955538 - Disclosure - Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details)",
     "shortName": "Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-281",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails",
     "longName": "9955539 - Disclosure - Contingencies and Commitments (Narrative) (Details)",
     "shortName": "Contingencies and Commitments (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails",
     "longName": "9955540 - Disclosure - Commitments and Contingencies (Lease Cost) (Details)",
     "shortName": "Commitments and Contingencies (Lease Cost) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails",
     "longName": "9955541 - Disclosure - Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)",
     "shortName": "Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.stryker.com/role/ContingenciesandCommitmentsSupplierFinanceProgramDetails",
     "longName": "9955542 - Disclosure - Contingencies and Commitments (Supplier Finance Program) (Details)",
     "shortName": "Contingencies and Commitments (Supplier Finance Program) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-15",
      "name": "us-gaap:SupplierFinanceProgramObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SupplierFinanceProgramTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-15",
      "name": "us-gaap:SupplierFinanceProgramObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SupplierFinanceProgramTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
     "longName": "9955543 - Disclosure - Goodwill and Other Intangible Assets (Goodwill) (Details)",
     "shortName": "Goodwill and Other Intangible Assets (Goodwill) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails",
     "longName": "9955544 - Disclosure - Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details)",
     "shortName": "Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails",
     "longName": "9955545 - Disclosure - Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)",
     "shortName": "Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.stryker.com/role/CapitalStockNarrativeDetails",
     "longName": "9955546 - Disclosure - Capital Stock (Narrative) (Details)",
     "shortName": "Capital Stock (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "syk:CommonAndPreferredStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "syk:CommonAndPreferredStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails",
     "longName": "9955547 - Disclosure - Capital Stock (Option Grant Assumptions) (Details)",
     "shortName": "Capital Stock (Option Grant Assumptions) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails",
     "longName": "9955548 - Disclosure - Capital Stock (Summary of Stock Option Activity) (Details)",
     "shortName": "Capital Stock (Summary of Stock Option Activity) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-15",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-15",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails",
     "longName": "9955549 - Disclosure - Capital Stock (Summary of RSU and PSU Activity) (Details)",
     "shortName": "Capital Stock (Summary of RSU and PSU Activity) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-321",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-52",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails",
     "longName": "9955550 - Disclosure - Debt and Credit Facilities (Narrative) (Details)",
     "shortName": "Debt and Credit Facilities (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:CommercialPaper",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:LineOfCredit",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:CommercialPaper",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:LineOfCredit",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
     "longName": "9955551 - Disclosure - Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)",
     "shortName": "Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:OtherLongTermDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:OtherLongTermDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.stryker.com/role/IncomeTaxesNarrativeDetails",
     "longName": "9955552 - Disclosure - Income Taxes (Narrative) (Details)",
     "shortName": "Income Taxes (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails",
     "longName": "9955553 - Disclosure - Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)",
     "shortName": "Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails",
     "longName": "9955554 - Disclosure - Income Taxes (Schedule of Earnings before Income Taxes) (Details)",
     "shortName": "Income Taxes (Schedule of Earnings before Income Taxes) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails",
     "longName": "9955555 - Disclosure - Income Taxes (Schedule of Provision for Income Taxes) (Details)",
     "shortName": "Income Taxes (Schedule of Provision for Income Taxes) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails",
     "longName": "9955556 - Disclosure - Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)",
     "shortName": "Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:DeferredTaxAssetsInventory",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:DeferredTaxAssetsInventory",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails",
     "longName": "9955557 - Disclosure - Income Taxes (Schedule of Unresolved Income Tax Positions) (Details)",
     "shortName": "Income Taxes (Schedule of Unresolved Income Tax Positions) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-15",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "div",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-43",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "div",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails",
     "longName": "9955558 - Disclosure - Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details)",
     "shortName": "Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails",
     "longName": "9955559 - Disclosure - Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details)",
     "shortName": "Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "syk:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "syk:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails",
     "longName": "9955560 - Disclosure - Retirement Plans (Schedule of Change in Benefit Obligations (Details)",
     "shortName": "Retirement Plans (Schedule of Change in Benefit Obligations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c-15",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails",
     "longName": "9955561 - Disclosure - Retirement Plans (Change in Plan Assets) (Details)",
     "shortName": "Retirement Plans (Change in Plan Assets) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c-15",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-43",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
     "longName": "9955562 - Disclosure - Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)",
     "shortName": "Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails",
     "longName": "9955563 - Disclosure - Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details)",
     "shortName": "Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-175",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
     "longName": "9955564 - Disclosure - Retirement Plans (Narrative) (Details)",
     "shortName": "Retirement Plans (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-191",
      "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails",
     "longName": "9955565 - Disclosure - Retirement Plans (Expected Benefit Payments) (Details)",
     "shortName": "Retirement Plans (Expected Benefit Payments) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails",
     "longName": "9955566 - Disclosure - Summary of Quarterly Data (Unaudited) (Details)",
     "shortName": "Summary of Quarterly Data (Unaudited) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c-429",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-429",
      "name": "us-gaap:GrossProfit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
     "longName": "9955567 - Disclosure - Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)",
     "shortName": "Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails",
     "longName": "9955568 - Disclosure - Segment and Geographic Data (Segment Information) (Details)",
     "shortName": "Segment and Geographic Data (Segment Information) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:Assets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "syk:CapitalExpendituresDuringPeriod",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails",
     "longName": "9955569 - Disclosure - Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details)",
     "shortName": "Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "c-429",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-459",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.stryker.com/role/AssetImpairmentsDetails",
     "longName": "9955570 - Disclosure - Asset Impairments (Details)",
     "shortName": "Asset Impairments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AssetImpairmentCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-474",
      "name": "us-gaap:AssetImpairmentCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.stryker.com/role/AssetsHeldforSaleDetails",
     "longName": "9955571 - Disclosure - Assets Held for Sale (Details)",
     "shortName": "Assets Held for Sale (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "c-477",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-477",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R93": {
     "role": "http://www.stryker.com/role/SubsequentEventsDetails",
     "longName": "9955572 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "c-481",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-481",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R94": {
     "role": "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails",
     "longName": "9955573 - Disclosure - Schedule II Valuation and Qualifying Accounts (Details)",
     "shortName": "Schedule II Valuation and Qualifying Accounts (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "c-485",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-490",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "syk-20241231.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableTradeCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Accounts Payable, Trade, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r126"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, less allowance of $213 ($182 in 2023)",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1341"
     ]
    },
    "syk_AccruedCompensationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "AccruedCompensationMember",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Compensation",
        "label": "Accrued Compensation [Member]",
        "documentation": "Accrued Compensation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income taxes",
        "label": "Accrued Income Taxes, Current",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r205"
     ]
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedIncomeTaxesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Accrued Income Taxes, Noncurrent",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r205"
     ]
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Plans",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r8",
      "r24",
      "r37",
      "r150",
      "r1309",
      "r1310",
      "r1311"
     ]
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive (income) loss related to prior service cost (credit) component of defined benefit plans attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r24",
      "r37",
      "r322",
      "r323",
      "r1309"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less allowance for depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r289",
      "r907"
     ]
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedges",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r313",
      "r322",
      "r323",
      "r754",
      "r1079",
      "r1309"
     ]
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable Securities",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]",
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r313",
      "r322",
      "r323",
      "r1309"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r321",
      "r322",
      "r801",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accumulated other comprehensive loss",
        "periodStartLabel": "Accumulated Other Comprehensive Income (Loss), Beginning of Period",
        "periodEndLabel": "Accumulated Other Comprehensive Income (Loss), End of Period",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r151",
      "r300",
      "r903",
      "r943",
      "r944"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r321",
      "r322",
      "r801",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r24",
      "r37",
      "r761",
      "r764",
      "r821",
      "r939",
      "r940",
      "r1309",
      "r1310",
      "r1311",
      "r1328",
      "r1329",
      "r1330",
      "r1331"
     ]
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedTranslationAdjustmentMember",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Statement Translation",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r24",
      "r37",
      "r148",
      "r149",
      "r322",
      "r323",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r1309"
     ]
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r485",
      "r486",
      "r487",
      "r489",
      "r1067"
     ]
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average amortization period at acquisition (years):",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r1067"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1222"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r955",
      "r1328",
      "r1329",
      "r1330",
      "r1331",
      "r1421",
      "r1494"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1235"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1235"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1235"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1235"
     ]
    },
    "us-gaap_AdjustmentForAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentForAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of intangible assets",
        "label": "Amortization",
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r74",
      "r659"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1280"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1193",
      "r1204",
      "r1214",
      "r1247"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1196",
      "r1207",
      "r1217",
      "r1250"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1281"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r1235"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r1242"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r1197",
      "r1208",
      "r1218",
      "r1242",
      "r1251",
      "r1255",
      "r1263"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r1261"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, allowance",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r417",
      "r454"
     ]
    },
    "us-gaap_AllowanceForNotesReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForNotesReceivableMember",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Allowance, Notes Receivable",
        "label": "SEC Schedule, 12-09, Allowance, Notes Receivable [Member]",
        "documentation": "Allowance for portion expected to be uncollectible of receivable from written agreement to receive, at specified future date, money consisting of principal and accrued interest."
       }
      }
     },
     "auth_ref": [
      "r1322",
      "r1323",
      "r1324",
      "r1325",
      "r1326"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of intangible assets",
        "negatedTerseLabel": "Amortization of intangible assets",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r484",
      "r491",
      "r1099"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Anti-dilutive shares excluded from calculation of dilutive employee stock options (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital Stock [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "srt_AsiaPacificMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "AsiaPacificMember",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asia Pacific",
        "label": "Asia Pacific [Member]",
        "documentation": "Region of Asia Pacific."
       }
      }
     },
     "auth_ref": [
      "r1300",
      "r1301",
      "r1302",
      "r1303",
      "r1496",
      "r1497",
      "r1498",
      "r1499"
     ]
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetBackedSecuritiesMember",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Corporate and asset-backed debt securities",
        "label": "Asset-Backed Securities [Member]",
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans."
       }
      }
     },
     "auth_ref": [
      "r1115",
      "r1141",
      "r1345",
      "r1346",
      "r1347"
     ]
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and other impairments",
        "negatedTerseLabel": "Goodwill and other impairments",
        "label": "Asset Impairment Charges",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r54"
     ]
    },
    "us-gaap_AssetImpairmentChargesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetImpairmentChargesTextBlock",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Impairments",
        "label": "Asset Impairment Charges [Text Block]",
        "documentation": "The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "terseLabel": "Assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r216",
      "r293",
      "r339",
      "r374",
      "r383",
      "r401",
      "r405",
      "r451",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r752",
      "r755",
      "r794",
      "r901",
      "r998",
      "r1091",
      "r1092",
      "r1140",
      "r1170",
      "r1393",
      "r1394",
      "r1446"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "syk_AssetsAndLiabilitiesHeldForSalePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "AssetsAndLiabilitiesHeldForSalePolicyTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets And Liabilities Held For Sale",
        "label": "Assets And Liabilities Held For Sale [Policy Text Block]",
        "documentation": "Assets And Liabilities Held For Sale"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r305",
      "r339",
      "r451",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r752",
      "r755",
      "r794",
      "r1140",
      "r1393",
      "r1394",
      "r1446"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total assets measured at fair value",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r772",
      "r773",
      "r1127"
     ]
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/AssetsHeldforSaleDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets held for sale",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r112",
      "r121",
      "r174",
      "r282",
      "r283"
     ]
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group, Including Discontinued Operation, Assets [Abstract]",
        "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.stryker.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r1176",
      "r1177",
      "r1200"
     ]
    },
    "syk_AuditorInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "AuditorInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Information [Abstract]",
        "documentation": "Auditor Information"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.stryker.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r1176",
      "r1177",
      "r1200"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://www.stryker.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r1176",
      "r1177",
      "r1200"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in one year or less",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r897"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Marketable securities",
        "terseLabel": "Available-for-sale marketable securities:",
        "label": "Debt Securities, Available-for-Sale, Current",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r460"
     ]
    },
    "syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Due after one year through three years",
        "label": "Available for sale Securities, Debt Maturities, After One Through Three Years, Fair Value",
        "documentation": "This item represents the fair value of debt securities which are expected to mature after one through three years of the balance sheet date and which are categorized neither as held-to-maturity nor trading securities."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1258"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r1259"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1254"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1254"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1254"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1254"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1254"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1254"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r660",
      "r661",
      "r662",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r1257"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1256"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r1255"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1255"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position Location, Balance [Axis]",
        "label": "Statement of Financial Position Location, Balance [Axis]",
        "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r504",
      "r1460",
      "r1461"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position Location, Balance [Domain]",
        "label": "Statement of Financial Position Location, Balance [Domain]",
        "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r100",
      "r504",
      "r1460",
      "r1461"
     ]
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BuildingAndBuildingImprovementsMember",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Building and Improvements",
        "label": "Building and Building Improvements [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r746",
      "r1119",
      "r1120"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Axis]",
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r76",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r746",
      "r1119",
      "r1120"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Line Items]",
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r746"
     ]
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionSharePrice",
     "presentation": [
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business acquisition, share price (in dollars per share)",
        "label": "Business Acquisition, Share Price",
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate purchase price of acquisitions",
        "label": "Business Combination, Consideration Transferred",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2",
      "r21"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Reduction of contingent consideration",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset",
        "documentation": "Amount of increase (decrease) in the value of right to a contingent consideration asset."
       }
      }
     },
     "auth_ref": [
      "r749",
      "r1315"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future milestone payout",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High",
        "documentation": "This element represents the amount of any change recognized during the period in the high-end of the estimated range of outcomes (undiscounted) of a liability assumed in a business combination arising from an item of contingent consideration."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business acquisition, future milestone payments (up to)",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of contingent consideration",
        "label": "Business Combination, Contingent Consideration, Liability",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r194",
      "r748",
      "r774",
      "r775",
      "r776"
     ]
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://www.stryker.com/role/Acquisitions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisitions",
        "label": "Business Combination Disclosure [Text Block]",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r747"
     ]
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Acquisition and integration-related charges",
        "label": "Business Combination, Integration Related Costs",
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationPriceOfAcquisitionExpected": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationPriceOfAcquisitionExpected",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination, price of acquisition, expected",
        "label": "Business Combination, Price of Acquisition, Expected",
        "documentation": "Purchase price of expected business acquisition prior to consideration being transferred. Excludes asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1286"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Debt",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax assets",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred income tax liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets:",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r78"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "documentation": "The amount of inventory recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r78"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Purchase price, net of cash acquired of $57 and $7",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combinations [Abstract]",
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "syk_CapitalExpendituresDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "CapitalExpendituresDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital Expenditures During Period",
        "label": "Capital Expenditures During Period",
        "documentation": "Capital Expenditures During Period"
       }
      }
     },
     "auth_ref": []
    },
    "syk_CapitalStockAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "CapitalStockAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital Stock [Abstract]",
        "label": "Capital Stock [Abstract]",
        "documentation": "Capital Stock [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAcquiredFromAcquisition",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Acquired from Acquisition",
        "label": "Cash Acquired from Acquisition",
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r287",
      "r1072"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Available-for-sale marketable securities",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1423",
      "r1424"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents at beginning of year",
        "periodEndLabel": "Cash and cash equivalents at end of year",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r164",
      "r335"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Change in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r164"
     ]
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow hedge gain (loss) to be reclassified within twelve months",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "us-gaap_CashFlowHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowHedgingMember",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flow Hedging",
        "label": "Cash Flow Hedging [Member]",
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "us-gaap_CertificatesOfDepositMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CertificatesOfDepositMember",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Certificates of deposit",
        "label": "Certificates of Deposit [Member]",
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r1162",
      "r1163",
      "r1164",
      "r1167"
     ]
    },
    "syk_CerusMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "CerusMember",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cerus",
        "label": "Cerus [Member]",
        "documentation": "Cerus"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1233"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1230"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r1228"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r297",
      "r298",
      "r299",
      "r339",
      "r366",
      "r367",
      "r369",
      "r371",
      "r377",
      "r378",
      "r451",
      "r527",
      "r530",
      "r531",
      "r532",
      "r536",
      "r537",
      "r567",
      "r568",
      "r571",
      "r574",
      "r581",
      "r794",
      "r948",
      "r949",
      "r950",
      "r951",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r985",
      "r1007",
      "r1026",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1285",
      "r1316",
      "r1332"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r297",
      "r298",
      "r299",
      "r377",
      "r567",
      "r568",
      "r569",
      "r571",
      "r574",
      "r579",
      "r581",
      "r948",
      "r949",
      "r950",
      "r951",
      "r1107",
      "r1285",
      "r1316"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r1234"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1234"
     ]
    },
    "us-gaap_CommercialPaper": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommercialPaper",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial paper",
        "label": "Commercial Paper",
        "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r203",
      "r1457"
     ]
    },
    "us-gaap_CommercialPaperMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommercialPaperMember",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial Paper",
        "label": "Commercial Paper [Member]",
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r526",
      "r1162",
      "r1163",
      "r1164",
      "r1167"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingencies and Commitments",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r176",
      "r515",
      "r516",
      "r1055",
      "r1379",
      "r1386"
     ]
    },
    "syk_CommonAndPreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "CommonAndPreferredStockSharesAuthorized",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common and Preferred Stock, shares authorized (in shares)",
        "label": "Common And Preferred Stock, Shares Authorized",
        "documentation": "Common And Preferred Stock, Shares Authorized"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital shares reserved for future issuance",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockDividendsPerShareDeclared",
     "presentation": [
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Dividends declared per share of common stock (in dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r183"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common Stock, $.10 Par Value",
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r1158",
      "r1159",
      "r1160",
      "r1162",
      "r1163",
      "r1164",
      "r1167",
      "r1328",
      "r1329",
      "r1331",
      "r1421",
      "r1492",
      "r1494"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r985"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance, shares",
        "periodEndLabel": "Ending balance, shares",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r140",
      "r985",
      "r1004",
      "r1494",
      "r1495"
     ]
    },
    "us-gaap_CommonStockValueOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValueOutstanding",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, $0.10 par value",
        "label": "Common Stock, Value, Outstanding",
        "documentation": "Value of common shares held by shareholders. Excludes common shares repurchased and held as treasury shares."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r985"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1239"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1238"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1240"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1237"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Benefits [Abstract]",
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax assets:",
        "label": "Components of Deferred Tax Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax liabilities:",
        "label": "Components of Deferred Tax Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r317",
      "r319",
      "r326",
      "r894",
      "r913",
      "r914"
     ]
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive (Loss) Income (AOCI)",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r325",
      "r893",
      "r911"
     ]
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Axis]",
        "label": "Consolidation Items [Axis]",
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r235",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r343",
      "r374",
      "r385",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r405",
      "r406",
      "r407",
      "r527",
      "r528",
      "r529",
      "r530",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r1091",
      "r1092",
      "r1304",
      "r1305",
      "r1393",
      "r1394"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Domain]",
        "label": "Consolidation Items [Domain]",
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r235",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r343",
      "r374",
      "r385",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r405",
      "r406",
      "r407",
      "r527",
      "r528",
      "r529",
      "r530",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r1091",
      "r1092",
      "r1304",
      "r1305",
      "r1393",
      "r1394"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation and Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r1080"
     ]
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in Contract Liabilities",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability."
       }
      }
     },
     "auth_ref": [
      "r1397"
     ]
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails",
      "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liabilities",
        "periodStartLabel": "Beginning contract liabilities",
        "periodEndLabel": "Ending contract liabilities",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r583",
      "r584",
      "r594"
     ]
    },
    "syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net advance consideration received during the period",
        "label": "Contract With Customer, Liability, Net Advance Consideration Received During Period",
        "documentation": "Contract With Customer, Liability, Net Advance Consideration Received During Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Revenue recognized from beginning of year contract liabilities",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r595"
     ]
    },
    "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future Purchase Obligations and Minimum Lease Payments",
        "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation."
       }
      }
     },
     "auth_ref": [
      "r1299",
      "r1321"
     ]
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CorporateDebtSecuritiesMember",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt securities",
        "label": "Corporate Debt Securities [Member]",
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment."
       }
      }
     },
     "auth_ref": [
      "r1115",
      "r1117",
      "r1127",
      "r1141",
      "r1156",
      "r1489"
     ]
    },
    "us-gaap_CorporateNonSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CorporateNonSegmentMember",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate and Other",
        "label": "Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]",
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r400",
      "r401",
      "r402",
      "r403",
      "r406",
      "r1337"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of sales",
        "label": "Cost of Revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r339",
      "r451",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r794",
      "r1091",
      "r1393"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of sales",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfSalesPolicyTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of Sales",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered."
       }
      }
     },
     "auth_ref": [
      "r1291"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States federal",
        "label": "Current Federal Tax Expense (Benefit)",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1289",
      "r1319",
      "r1417"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International",
        "label": "Current Foreign Tax Expense (Benefit)",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1289",
      "r1319"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current income tax expense",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r732",
      "r1319"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current income tax expense (benefit):",
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States state and local",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1289",
      "r1319",
      "r1417"
     ]
    },
    "syk_CustomerAndDistributorRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "CustomerAndDistributorRelationshipsMember",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer relationships",
        "label": "Customer and Distributor Relationships [Member]",
        "documentation": "Customer and Distributor Relationships"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Relationships [Member]",
        "verboseLabel": "Customer relationships",
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1372",
      "r1374",
      "r1377",
      "r1378"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1185",
      "r1274"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1185",
      "r1274"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1187",
      "r1276"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1187",
      "r1276"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1189",
      "r1278"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1187",
      "r1276"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1180",
      "r1269"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1181",
      "r1270"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1181",
      "r1270"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r1179",
      "r1268"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1179",
      "r1268"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r1179",
      "r1268"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1182",
      "r1271"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1184",
      "r1273"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1184",
      "r1273"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1185",
      "r1274"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1188",
      "r1277"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1186",
      "r1275"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1183",
      "r1272"
     ]
    },
    "us-gaap_DebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1": {
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current maturities of debt",
        "label": "Debt, Current",
        "documentation": "Amount of debt and lease obligation, classified as current."
       }
      }
     },
     "auth_ref": [
      "r295"
     ]
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Debt And Credit Facilities",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r337",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r525",
      "r526",
      "r538",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r554",
      "r561",
      "r562",
      "r564",
      "r809"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails",
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r128",
      "r129",
      "r204",
      "r207",
      "r343",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r545",
      "r550",
      "r551",
      "r552",
      "r553",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1138",
      "r1317",
      "r1380",
      "r1381",
      "r1382",
      "r1442",
      "r1443"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails",
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt face amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r539",
      "r809",
      "r810",
      "r1103",
      "r1104",
      "r1138"
     ]
    },
    "us-gaap_DebtInstrumentFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair value of senior unsecured notes",
        "label": "Debt Instrument, Fair Value Disclosure",
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable."
       }
      }
     },
     "auth_ref": [
      "r552",
      "r793",
      "r1103",
      "r1104",
      "r1424",
      "r1425",
      "r1426",
      "r1427",
      "r1434"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails",
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stated interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r540"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails",
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r343",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r545",
      "r550",
      "r551",
      "r552",
      "r553",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1138",
      "r1317",
      "r1380",
      "r1381",
      "r1382",
      "r1442",
      "r1443"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt term",
        "label": "Debt Instrument, Term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total debt",
        "label": "Debt, Long-Term and Short-Term, Combined Amount",
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States federal",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1319",
      "r1416",
      "r1417"
     ]
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1319",
      "r1416"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncurrent deferred income tax assets",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r702",
      "r703"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax (benefit) expense",
        "totalLabel": "Total deferred income tax expense (benefit)",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r230",
      "r1319"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax expense (benefit):",
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total deferred income tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r137",
      "r206",
      "r723"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Noncurrent liabilities\u2014Other liabilities",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r702",
      "r703",
      "r902"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States state and local",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1319",
      "r1416",
      "r1417"
     ]
    },
    "us-gaap_DeferredTaxAssetInterestCarryforward": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetInterestCarryforward",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International interest expense carryforwards",
        "label": "Deferred Tax Asset, Interest Carryforward",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward."
       }
      }
     },
     "auth_ref": [
      "r1414"
     ]
    },
    "syk_DeferredTaxAssetsDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "DeferredTaxAssetsDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Deferred Tax Assets, Depreciation And Amortization",
        "documentation": "Deferred Tax Assets, Depreciation And Amortization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred income tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsInventory",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Deferred Tax Assets, Inventory",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory."
       }
      }
     },
     "auth_ref": [
      "r1414"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred income tax assets",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1411"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred income tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1411"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss and credit carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1414"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets, operating loss carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates."
       }
      }
     },
     "auth_ref": [
      "r1414"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1414"
     ]
    },
    "syk_DeferredTaxAssetsOutsideBasisDifference": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "DeferredTaxAssetsOutsideBasisDifference",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outside basis difference related to the anticipated sale of the Spinal Implants business",
        "label": "Deferred Tax Assets, Outside Basis Difference",
        "documentation": "Deferred Tax Assets, Outside Basis Difference"
       }
      }
     },
     "auth_ref": []
    },
    "syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "DeferredTaxAssetsResearchAndDevelopmentCapitalization",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development capitalization",
        "label": "Deferred Tax Assets, Research And Development Capitalization",
        "documentation": "Deferred Tax Assets, Research And Development Capitalization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsStateTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsStateTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State income taxes",
        "label": "Deferred Tax Assets, State Taxes",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes."
       }
      }
     },
     "auth_ref": [
      "r1414"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1414"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other accrued expenses",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1414"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less valuation allowances",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "syk_DeferredTaxLiabilitiesDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "DeferredTaxLiabilitiesDepreciationAndAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Depreciation and amortization",
        "label": "Deferred Tax Liabilities Depreciation And Amortization",
        "documentation": "Deferred Tax Liabilities Depreciation And Amortization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Undistributed earnings",
        "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences."
       }
      }
     },
     "auth_ref": [
      "r1414"
     ]
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ending accumulated benefit obligations",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level."
       }
      }
     },
     "auth_ref": [
      "r624"
     ]
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax",
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r8",
      "r37",
      "r150",
      "r1401"
     ]
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unrecognized net actuarial gain (loss)",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r634"
     ]
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized prior service credit",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax",
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit)."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r634"
     ]
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actual return",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses."
       }
      }
     },
     "auth_ref": [
      "r609",
      "r1117"
     ]
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Actuarial (gains) losses",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recognized actuarial loss",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r600",
      "r631",
      "r649",
      "r1117",
      "r1118"
     ]
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Amortization of prior service cost and transition amount",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r600",
      "r632",
      "r650",
      "r1117",
      "r1118"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning fair value of plan assets",
        "periodEndLabel": "Ending fair value of plan assets",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r598",
      "r599",
      "r614",
      "r997",
      "r1117",
      "r1456"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected return on plan assets",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r637",
      "r652"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected return on plan assets",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Assumptions Used in Calculations [Abstract]",
        "label": "Defined Benefit Plan, Assumptions Used in Calculations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanBenefitObligation",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Benefit obligations",
        "periodStartLabel": "Beginning projected benefit obligations",
        "periodEndLabel": "Ending projected benefit obligations",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Benefits paid",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services."
       }
      }
     },
     "auth_ref": [
      "r607",
      "r655"
     ]
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee contributions",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation."
       }
      }
     },
     "auth_ref": [
      "r604"
     ]
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "documentation": "Information by defined benefit plan asset investment."
       }
      }
     },
     "auth_ref": [
      "r615",
      "r616",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r639",
      "r1115",
      "r1116",
      "r1117"
     ]
    },
    "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]",
        "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested."
       }
      }
     },
     "auth_ref": [
      "r1115"
     ]
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employer contributions",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets."
       }
      }
     },
     "auth_ref": [
      "r611",
      "r618",
      "r651",
      "r1115",
      "r1116",
      "r1117",
      "r1118"
     ]
    },
    "us-gaap_DefinedBenefitPlanDebtSecurityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanDebtSecurityMember",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt securities",
        "label": "Defined Benefit Plan, Debt Security [Member]",
        "documentation": "Debt instrument issued by corporation, government and governmental agency, municipality, and other institution; in which defined benefit plan asset is invested."
       }
      }
     },
     "auth_ref": [
      "r1400"
     ]
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanEquitySecuritiesMember",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity securities",
        "label": "Defined Benefit Plan, Equity Securities [Member]",
        "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant."
       }
      }
     },
     "auth_ref": [
      "r1115",
      "r1117"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2030-2034",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r625"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r625"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r625"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r625"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r625"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r625"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated future employer contributions in next fiscal year",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r626",
      "r1118"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected return on plan assets",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r600",
      "r630",
      "r648",
      "r1117",
      "r1118"
     ]
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of plan assets",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee."
       }
      }
     },
     "auth_ref": [
      "r608",
      "r616",
      "r618",
      "r619",
      "r1115",
      "r1116",
      "r1117"
     ]
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange impact",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Funded status",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r614",
      "r1117"
     ]
    },
    "us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanInformationAboutPlanAssetsAbstract",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Information about Plan Assets [Abstract]",
        "label": "Defined Benefit Plan, Information about Plan Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanInterestCost",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest cost",
        "terseLabel": "Interest cost",
        "label": "Defined Benefit Plan, Interest Cost",
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r600",
      "r603",
      "r629",
      "r647",
      "r1117",
      "r1118"
     ]
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net periodic benefit cost",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r627",
      "r645",
      "r1117",
      "r1118"
     ]
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of Net Periodic Pension Cost",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "syk_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement Of Income Or Comprehensive Income, Extensible List, Not Disclosed Flag",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement Of Income Or Comprehensive Income, Extensible List, Not Disclosed Flag",
        "documentation": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement Of Income Or Comprehensive Income, Extensible List, Not Disclosed Flag"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Benefits paid",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services."
       }
      }
     },
     "auth_ref": [
      "r613",
      "r1402"
     ]
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee contributions",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets."
       }
      }
     },
     "auth_ref": [
      "r612"
     ]
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange impact",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Target plan asset allocations",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan."
       }
      }
     },
     "auth_ref": [
      "r615",
      "r1117"
     ]
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanServiceCost",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Service cost",
        "terseLabel": "Service cost",
        "label": "Defined Benefit Plan, Service Cost",
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r602",
      "r628",
      "r646",
      "r1117",
      "r1118"
     ]
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actual plan asset allocations",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan."
       }
      }
     },
     "auth_ref": [
      "r1399"
     ]
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanCostRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan expense",
        "label": "Defined Contribution Plan, Cost",
        "documentation": "Amount of cost for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r656"
     ]
    },
    "us-gaap_DefinedContributionPlanDisclosuresTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanDisclosuresTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Contribution Plan Disclosures",
        "label": "Defined Contribution Plan Disclosures [Table Text Block]",
        "documentation": "Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expense funded with Stryker common stock",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "syk_DefinedContributionRetirementPlansCommonStockHeldByCompany": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "DefinedContributionRetirementPlansCommonStockHeldByCompany",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stryker common stock held by plan, shares",
        "label": "Defined Contribution Retirement Plans Common Stock Held by Company",
        "documentation": "Defined Contribution Retirement Plans Common Stock Held by Company"
       }
      }
     },
     "auth_ref": []
    },
    "syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "DefinedContributionRetirementPlansCommonStockValueHeldByCompany",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stryker common stock held by plan, amount",
        "label": "Defined Contribution Retirement Plans Common Stock Value Held by Company",
        "documentation": "Defined Contribution Retirement Plans Common Stock Value Held by Company"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r55"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r374",
      "r388",
      "r405",
      "r1091",
      "r1092"
     ]
    },
    "us-gaap_DerivativeAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Foreign currency exchange forward contracts",
        "terseLabel": "Interest rate swap asset",
        "label": "Derivative Asset",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r307",
      "r308",
      "r772",
      "r773",
      "r785",
      "r793",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r991",
      "r992",
      "r1038",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1078",
      "r1127",
      "r1131",
      "r1160",
      "r1425",
      "r1426",
      "r1427",
      "r1493"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r975",
      "r977",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1038",
      "r1039",
      "r1041",
      "r1043",
      "r1158",
      "r1160",
      "r1428",
      "r1429",
      "r1430",
      "r1431",
      "r1432",
      "r1433",
      "r1435",
      "r1436"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative asset",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r146",
      "r197",
      "r198",
      "r306",
      "r1078"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Derivative liability",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r146",
      "r197",
      "r198",
      "r306",
      "r1078"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeFairValueOfDerivativeNet",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Derivative, fair value, net",
        "label": "Derivative, Fair Value, Net",
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives."
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeGainLossOnDerivativeNet",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gains (losses) on designated hedges",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r1420"
     ]
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r101",
      "r102",
      "r199",
      "r975",
      "r977",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1038",
      "r1039",
      "r1041",
      "r1043",
      "r1078",
      "r1158",
      "r1160",
      "r1428",
      "r1429",
      "r1430",
      "r1431",
      "r1432",
      "r1433",
      "r1435",
      "r1436"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r759",
      "r766"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Axis]",
        "label": "Hedging Relationship [Axis]",
        "documentation": "Information by type of hedging relationship."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r98",
      "r101"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r98",
      "r101",
      "r102",
      "r106",
      "r107",
      "r758"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r758"
     ]
    },
    "us-gaap_DerivativeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLineItems",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Line Items]",
        "label": "Derivative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "us-gaap_DerivativeNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeNotionalAmount",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notional amount",
        "verboseLabel": "Derivative, notional amount",
        "label": "Derivative, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payment on derivative."
       }
      }
     },
     "auth_ref": [
      "r1418",
      "r1419"
     ]
    },
    "us-gaap_DerivativeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeTable",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Table]",
        "label": "Derivative [Table]",
        "documentation": "Disclosure of information about derivative instrument or group of derivative instruments, including, but not limited to, type of derivative instrument, risk being hedged, notional amount, hedge designation, related hedged item, inception date, and maturity date."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r90",
      "r91",
      "r92",
      "r95",
      "r99",
      "r101",
      "r103",
      "r105",
      "r107",
      "r766"
     ]
    },
    "us-gaap_DerivativeTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeTermOfContract",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative term (up to)",
        "label": "Derivative, Term of Contract",
        "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives",
        "label": "Derivatives, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r90",
      "r91",
      "r95",
      "r104",
      "r342",
      "r363"
     ]
    },
    "us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net investment hedges expected to be reclassified to cost of sales and other income (expense)",
        "terseLabel": "Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax",
        "label": "Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax",
        "documentation": "Amount, after tax, of reclassification from other comprehensive income (loss) to earnings from the sale or complete or substantially complete liquidation of an investment in a foreign entity."
       }
      }
     },
     "auth_ref": [
      "r1440"
     ]
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DesignatedAsHedgingInstrumentMember",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Designated as Hedging Instrument",
        "label": "Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DevelopedTechnologyRightsMember",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Developed technologies",
        "verboseLabel": "Developed technologies",
        "label": "Developed Technology Rights [Member]",
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1372",
      "r1374",
      "r1377",
      "r1378"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r593",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r593",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Disaggregated Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r1398"
     ]
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss on disposition of assets",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax",
        "documentation": "Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114",
      "r120"
     ]
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupClassificationAxis",
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Axis]",
        "label": "Disposal Group Classification [Axis]",
        "documentation": "Information by disposal group classification."
       }
      }
     },
     "auth_ref": [
      "r282"
     ]
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupClassificationDomain",
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Domain]",
        "label": "Disposal Group Classification [Domain]",
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group, Held-for-Sale, Not Discontinued Operations",
        "label": "Disposal Group, Held-for-Sale, Not Discontinued Operations [Member]",
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r29",
      "r282"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/AssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r112",
      "r121",
      "r174"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/AssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable, Current",
        "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r112",
      "r121",
      "r172",
      "r174"
     ]
    },
    "syk_DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/AssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Compensation, Current",
        "documentation": "Disposal Group, Including Discontinued Operation, Accrued Compensation, Current"
       }
      }
     },
     "auth_ref": []
    },
    "syk_DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/AssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Expenses And Other Liabilities, Current",
        "documentation": "Disposal Group, Including Discontinued Operation, Accrued Expenses And Other Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/AssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncurrent deferred income tax assets",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Tax Assets",
        "documentation": "Amount classified as deferred tax assets attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r112",
      "r121",
      "r174"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/AssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other intangibles, net",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Current",
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r112",
      "r121",
      "r172",
      "r174"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/AssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total inventories",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r112",
      "r121",
      "r172",
      "r174"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/AssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other noncurrent assets",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent",
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r9",
      "r112",
      "r121",
      "r174"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/AssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other noncurrent liabilities",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent",
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r9",
      "r112",
      "r121",
      "r174"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/AssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current",
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r112",
      "r121",
      "r172",
      "r174"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/AssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment, net",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current",
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r112",
      "r121",
      "r172",
      "r174"
     ]
    },
    "syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Decrease to fair value",
        "label": "Disposal Group, Including Discontinued Operation, Timing of Disposal, Potential Decrease In Fair Value",
        "documentation": "Disposal Group, Including Discontinued Operation, Timing of Disposal, Potential Decrease In Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "syk_DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase to fair value",
        "label": "Disposal Group, Including Discontinued Operation, Timing of Disposal, Potential Increase In Fair Value",
        "documentation": "Disposal Group, Including Discontinued Operation, Timing of Disposal, Potential Increase In Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "syk_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/AssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Valuation allowance",
        "label": "Disposal Group, Including Discontinued Operation, Valuation Allowance, Current",
        "documentation": "Disposal Group, Including Discontinued Operation, Valuation Allowance, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSale"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets Held for Sale",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r171"
     ]
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Name [Domain]",
        "label": "Disposal Group Name [Domain]",
        "documentation": "Name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r1119",
      "r1120"
     ]
    },
    "us-gaap_DividendsCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DividendsCash",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash dividends declared",
        "label": "Dividends, Cash",
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r183"
     ]
    },
    "us-gaap_DividendsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DividendsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend payable",
        "label": "Dividends Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r1176",
      "r1177",
      "r1200"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r1176",
      "r1177",
      "r1200",
      "r1243"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r1221"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r1173"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Domestic Tax Jurisdiction [Member]",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r706"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1232"
     ]
    },
    "us-gaap_EMEAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EMEAMember",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Europe, Middle East, Africa",
        "label": "EMEA [Member]",
        "documentation": "Regions of Europe, Middle East and Africa."
       }
      }
     },
     "auth_ref": [
      "r1496",
      "r1497",
      "r1498",
      "r1499"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net earnings per share of common stock:",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic net earnings per share of common stock (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r364",
      "r366",
      "r369",
      "r370",
      "r371",
      "r373",
      "r744",
      "r751",
      "r769",
      "r770",
      "r895",
      "r915",
      "r1084"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Diluted net earnings per share of common stock (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r366",
      "r369",
      "r370",
      "r371",
      "r373",
      "r744",
      "r751",
      "r769",
      "r770",
      "r895",
      "r915",
      "r1084"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails",
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective income tax, percent",
        "totalLabel": "Effective income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r706",
      "r1125"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States federal statutory rate",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r706",
      "r735",
      "r1125"
     ]
    },
    "syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax related to repatriation of foreign earnings",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Earnings Repatriation, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Foreign Earnings Repatriation, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign income tax at rates other than 21%",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile."
       }
      }
     },
     "auth_ref": [
      "r707",
      "r710",
      "r1125",
      "r1320",
      "r1406"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill impairment",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss."
       }
      }
     },
     "auth_ref": [
      "r1125",
      "r1320",
      "r1406",
      "r1408"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r1125",
      "r1320",
      "r1406",
      "r1407"
     ]
    },
    "syk_EffectiveIncomeTaxRateReconciliationOutsideBasisDifference": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationOutsideBasisDifference",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outside basis difference related to the anticipated sale of the Spinal Implants business",
        "label": "Effective Income Tax Rate Reconciliation, Outside Basis Difference",
        "documentation": "Effective Income Tax Rate Reconciliation, Outside Basis Difference"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States state and local income taxes, less federal deduction",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r709",
      "r1125",
      "r1320",
      "r1406"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "United States research and development credits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r1125",
      "r1320",
      "r1406",
      "r1408"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States federal audit settlement",
        "label": "Effective Income Tax Rate Reconciliation, Tax Settlement, Domestic, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to domestic income tax settlement."
       }
      }
     },
     "auth_ref": [
      "r1320",
      "r1406",
      "r1407"
     ]
    },
    "syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intellectual property transfers",
        "label": "Effective Income Tax Rate Reconciliation, Transfer Of Intellectual Property, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Transfer Of Intellectual Property, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmbeddedDerivativeFinancialInstrumentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmbeddedDerivativeFinancialInstrumentsMember",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Embedded Derivative Financial Instruments",
        "label": "Embedded Derivative Financial Instruments [Member]",
        "documentation": "Derivative instrument embedded in host contract."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation cost not yet recognized",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r689"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation cost not yet recognized, period for recognized",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r689"
     ]
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Purchase Plans",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "syk_EndoscopyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "EndoscopyMember",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Endoscopy",
        "label": "Endoscopy [Member]",
        "documentation": "Endoscopy [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entities [Table]",
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1172"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1172"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r1172"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Information [Line Items]",
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1283"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1172"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1172"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r1172"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1172"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1284"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1226"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1279"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r1279"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1279"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails",
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r279",
      "r321",
      "r322",
      "r323",
      "r350",
      "r351",
      "r352",
      "r354",
      "r359",
      "r361",
      "r363",
      "r376",
      "r452",
      "r453",
      "r496",
      "r582",
      "r733",
      "r734",
      "r741",
      "r742",
      "r743",
      "r745",
      "r750",
      "r751",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r768",
      "r801",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r811",
      "r813",
      "r821",
      "r911",
      "r939",
      "r940",
      "r941",
      "r955",
      "r1026"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1236"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1193",
      "r1204",
      "r1214",
      "r1247"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r1190",
      "r1201",
      "r1211",
      "r1244"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1242"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r772",
      "r773",
      "r785",
      "r1127"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r772",
      "r773",
      "r785",
      "r1127"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r552",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r771",
      "r773",
      "r774",
      "r775",
      "r776",
      "r784",
      "r785",
      "r787",
      "r828",
      "r829",
      "r830",
      "r1103",
      "r1104",
      "r1115",
      "r1116",
      "r1117",
      "r1127",
      "r1131"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r780",
      "r782",
      "r783",
      "r784",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r891",
      "r1127",
      "r1132"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "(Level 1)",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r552",
      "r618",
      "r623",
      "r773",
      "r785",
      "r828",
      "r1115",
      "r1116",
      "r1117",
      "r1127"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "(Level 2)",
        "terseLabel": "(Level 2)",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r552",
      "r618",
      "r623",
      "r773",
      "r774",
      "r785",
      "r829",
      "r1103",
      "r1104",
      "r1115",
      "r1116",
      "r1117",
      "r1127"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "(Level 3)",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r552",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r773",
      "r774",
      "r775",
      "r776",
      "r785",
      "r830",
      "r1103",
      "r1104",
      "r1115",
      "r1116",
      "r1117",
      "r1127",
      "r1131"
     ]
    },
    "syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred compensation arrangements",
        "label": "Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Plan Liabilities",
        "documentation": "Fair Value, Liabilities Measured on Recurring Basis, Deferred Compensation Plan Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r779",
      "r786"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in estimate and foreign exchange",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r1428",
      "r1436"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Settlements",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r779",
      "r786"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning",
        "periodEndLabel": "Ending",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r777",
      "r786"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r552",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r771",
      "r773",
      "r774",
      "r775",
      "r776",
      "r784",
      "r785",
      "r787",
      "r828",
      "r829",
      "r830",
      "r1103",
      "r1104",
      "r1115",
      "r1116",
      "r1117",
      "r1127",
      "r1131"
     ]
    },
    "us-gaap_FairValueOptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOptionTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments",
        "label": "Fair Value, Option [Text Block]",
        "documentation": "The entire disclosure for a company's election to apply the fair value option for measurement and reporting of eligible financial assets and liabilities (as defined), as well as certain other eligible items (as defined) included in the statement of financial position, whether such option is elected for a single eligible item or a group of similar eligible items and is in addition to other disclosures concerning fair value which the company may be required to provide. Such disclosure might be expected to include: (1) for items included in the statement of financial position: (a) the reasons for electing a fair value option for each eligible item or group of similar eligible items; (b) if the fair value option is elected for some but not all eligible items within a group of similar eligible items: (i) a description of those similar items and the reasons for partial election and (ii) information of how the group of similar items relates to individual balance sheet line items; (c) for each line item in the statement of financial position that includes an item or items for which the fair value option has been elected: (i) information of how each line item in the statement of financial position relates to major categories of assets and liabilities presented in accordance with other fair value disclosures and (ii) the aggregate carrying amount of ineligible items included in each line item in the balance sheet, if any; (d) the difference between the aggregate fair value and the aggregate unpaid principal balance (assuming contractual principal amounts and fair value option elected) of: (i) loans and long-term receivables (other than securities otherwise reported at fair value) and (ii) long-term debt instruments; (e) for loans held as assets for which the fair value option has been elected: (i) the aggregate fair value of loans that are 90 days or more past due, (ii) if the policy is to recognize interest income separately from other changes in fair value, the aggregate fair value of loans in nonaccrual status, and (iii) the difference between the aggregate fair value and the aggregate unpaid principal balance for loans that are 90 days or more past due, in nonaccrual status, or both; (f) for investments that would have been accounted for under the equity method if the entity had not chosen to apply the fair value option, the information required for such investments, if material either individually or in the aggregate; (2) for items included in the income statement: (a) the amounts of gains and losses from fair value changes included in earnings and in which line in the income statement those gains and losses are reported whether or not combined with gains and losses from items required to be accounted for at fair value; (b) a description of how interest and dividends are measured and where they are reported in the income statement; (c) for loans and other receivables held as assets: (i) the estimated amount of gains or losses included in earnings attributable to changes in instrument-specific credit risk and (ii) how the gains or losses attributable to changes in instrument-specific credit risk were determined; (d) for liabilities with fair values that have been significantly affected during the reporting period by changes in the instrument-specific credit risk: (i) the estimated amount of gains and losses from fair value changes included in earnings that are attributable to changes in the instrument-specific credit risk, (ii) qualitative information about the reasons for those changes, and (iii) how the gains and losses attributable to changes in instrument-specific credit risk were determined; and (3) certain other disclosures as required or determined to be provided."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r228"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461",
      "r462",
      "r463",
      "r563",
      "r579",
      "r766",
      "r792",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r912",
      "r1097",
      "r1127",
      "r1129",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1141",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1348",
      "r1349",
      "r1350",
      "r1351",
      "r1422",
      "r1425",
      "r1426",
      "r1427",
      "r1434",
      "r1437"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-lived intangible asset, useful life",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Less Accumulated Amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r469",
      "r490",
      "r1099"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r492",
      "r1067",
      "r1099"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2029",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r492",
      "r1067",
      "r1099"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r492",
      "r1067",
      "r1099"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r492",
      "r1067",
      "r1099"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r492",
      "r1067",
      "r1099"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r485",
      "r486",
      "r487",
      "r489",
      "r490",
      "r493",
      "r494",
      "r859",
      "r860",
      "r1067"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Gross Carrying Amount",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r469",
      "r490",
      "r860",
      "r1099"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r485",
      "r486",
      "r487",
      "r489",
      "r490",
      "r493",
      "r494",
      "r1067"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Carrying Amount",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r859",
      "r1374"
     ]
    },
    "syk_FloatingRateSeniorNotesDueNovember162024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "FloatingRateSeniorNotesDueNovember162024Member",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Floating Rate Senior Notes Due November 16, 2024",
        "label": "Floating Rate Senior Notes Due November 16, 2024 [Member]",
        "documentation": "Floating Rate Senior Notes Due November 16, 2024"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International",
        "label": "Foreign Tax Jurisdiction [Member]",
        "documentation": "Designated foreign jurisdiction entitled to levy and collect income tax outside country of domicile."
       }
      }
     },
     "auth_ref": [
      "r706",
      "r707"
     ]
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency exchange forward contracts",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into."
       }
      }
     },
     "auth_ref": [
      "r772",
      "r773"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency transaction gains (losses)",
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r796",
      "r797",
      "r798",
      "r799",
      "r1023"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency Translation",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "us-gaap_ForeignExchangeContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignExchangeContractMember",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency exchange forward contracts",
        "label": "Foreign Exchange Contract [Member]",
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates."
       }
      }
     },
     "auth_ref": [
      "r1078",
      "r1115",
      "r1126",
      "r1127"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r1197",
      "r1208",
      "r1218",
      "r1251"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r1197",
      "r1208",
      "r1218",
      "r1251"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r1197",
      "r1208",
      "r1218",
      "r1251"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1197",
      "r1208",
      "r1218",
      "r1251"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1197",
      "r1208",
      "r1218",
      "r1251"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1231"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "periodStartLabel": "Goodwill, Beginning balance",
        "periodEndLabel": "Goodwill, Ending balance",
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r470",
      "r892",
      "r1092",
      "r1098",
      "r1128",
      "r1140",
      "r1356",
      "r1363"
     ]
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAcquiredDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions and adjustments",
        "label": "Goodwill, Acquired During Period",
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination."
       }
      }
     },
     "auth_ref": [
      "r474",
      "r1098"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Other Intangible Assets",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1354",
      "r1366"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Other Intangible Assets",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1354",
      "r1366"
     ]
    },
    "syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill, Intangibles and Long-Lived Asset Impairment Tests",
        "label": "Goodwill and Long-Lived Assets Impairment Tests Policy [Policy Text Block]",
        "documentation": "Goodwill and Long-Lived Assets Impairment Tests Policy [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill, impairment loss",
        "negatedTerseLabel": "Goodwill impairment",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r471",
      "r477",
      "r482",
      "r1098",
      "r1128"
     ]
    },
    "us-gaap_GoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillLineItems",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Line Items]",
        "label": "Goodwill [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r1098"
     ]
    },
    "us-gaap_GoodwillRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillRollForward",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Roll Forward]",
        "label": "Goodwill [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillTransfers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillTransfers",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill transfer",
        "label": "Goodwill, Transfers",
        "documentation": "Amount of increase (decrease) from transfer into (out of) asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r1362"
     ]
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange and other",
        "label": "Goodwill, Translation and Measurement Period Adjustments",
        "documentation": "Amount of increase (decrease) from foreign currency translation and measurement period adjustments of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1355"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "terseLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r155",
      "r215",
      "r339",
      "r451",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r794",
      "r1086",
      "r1091",
      "r1334",
      "r1336",
      "r1338",
      "r1339",
      "r1340",
      "r1393"
     ]
    },
    "us-gaap_HedgingDesignationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingDesignationAxis",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Axis]",
        "label": "Hedging Designation [Axis]",
        "documentation": "Information by designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r758"
     ]
    },
    "us-gaap_HedgingDesignationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingDesignationDomain",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Domain]",
        "label": "Hedging Designation [Domain]",
        "documentation": "Designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_HedgingRelationshipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingRelationshipDomain",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Domain]",
        "label": "Hedging Relationship [Domain]",
        "documentation": "Nature or intent of a hedge."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "syk_HipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "HipsMember",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hips",
        "label": "Hips [Member]",
        "documentation": "Hips [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r1176",
      "r1177",
      "r1200"
     ]
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impaired Long-Lived Assets Held and Used, Asset Name [Domain]",
        "label": "Impaired Long-Lived Assets Held and Used, Asset Name [Domain]",
        "documentation": "The name of the impaired assets to be held and used by the entity."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairedLongLivedAssetsHeldAndUsedByTypeAxis",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impaired Long-Lived Assets Held and Used by Type [Axis]",
        "label": "Impaired Long-Lived Assets Held and Used by Type [Axis]",
        "documentation": "Information by type of impaired long-lived asset held and used."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InProcessResearchAndDevelopmentMember",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "In-process research and development",
        "label": "In Process Research and Development [Member]",
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process."
       }
      }
     },
     "auth_ref": [
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1374",
      "r1376",
      "r1377",
      "r1378"
     ]
    },
    "syk_InariMedicalInc.MergerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "InariMedicalInc.MergerMember",
     "presentation": [
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inari",
        "label": "Inari Medical, Inc. Merger [Member]",
        "documentation": "Inari Medical, Inc. Merger"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperations",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment operating income",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r154",
      "r166",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r368",
      "r371",
      "r751"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r705"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings before income taxes",
        "verboseLabel": "Earnings before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r211",
      "r215",
      "r896",
      "r909",
      "r1086",
      "r1091",
      "r1334",
      "r1336",
      "r1338",
      "r1339",
      "r1340"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r705"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Name [Axis]",
        "label": "Disposal Group Name [Axis]",
        "documentation": "Information by name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r1119",
      "r1120"
     ]
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r29",
      "r34",
      "r112",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r122",
      "r123",
      "r124",
      "r175"
     ]
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Income Location, Balance [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r504",
      "r512",
      "r778",
      "r781",
      "r786",
      "r936",
      "r938",
      "r1010",
      "r1067",
      "r1130",
      "r1462"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Income Location, Balance [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r504",
      "r512",
      "r778",
      "r781",
      "r786",
      "r936",
      "r938",
      "r1010",
      "r1067",
      "r1130",
      "r1462"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Axis]",
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r334",
      "r706",
      "r707",
      "r715",
      "r729",
      "r1125",
      "r1413"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Domain]",
        "label": "Income Tax Jurisdiction [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r334",
      "r706",
      "r707",
      "r715",
      "r729",
      "r1125",
      "r1413"
     ]
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxContingencyLineItems",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Contingency [Line Items]",
        "label": "Income Tax Contingency [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxContingencyTable",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Contingency [Table]",
        "label": "Income Tax Contingency [Table]",
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months."
       }
      }
     },
     "auth_ref": [
      "r1409"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r697",
      "r706",
      "r711",
      "r712",
      "r713",
      "r721",
      "r727",
      "r736",
      "r738",
      "r739",
      "r740",
      "r953",
      "r1125"
     ]
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest and penalties",
        "label": "Income Tax Examination, Penalties and Interest Accrued",
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations."
       }
      }
     },
     "auth_ref": [
      "r1409"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "totalLabel": "Total income tax expense",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r231",
      "r362",
      "r363",
      "r374",
      "r391",
      "r405",
      "r704",
      "r706",
      "r737",
      "r916",
      "r1125"
     ]
    },
    "syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Tax settlement, release of accrued interest",
        "label": "Income Tax Expense (Benefit), Tax Settlement, Release Of Accrued Interest",
        "documentation": "Income Tax Expense (Benefit), Tax Settlement, Release Of Accrued Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r320",
      "r700",
      "r701",
      "r721",
      "r722",
      "r726",
      "r731",
      "r947"
     ]
    },
    "us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationRepatriationOfForeignEarnings",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repatriation of foreign earnings reversed",
        "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to repatriation of foreign earnings."
       }
      }
     },
     "auth_ref": [
      "r1406",
      "r1407"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationTaxSettlements",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax settlement amount",
        "label": "Effective Income Tax Rate Reconciliation, Tax Settlement, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements."
       }
      }
     },
     "auth_ref": [
      "r1406",
      "r1407"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for income taxes, net of refunds",
        "label": "Income Taxes Paid, Net",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r334",
      "r728",
      "r729"
     ]
    },
    "syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforward recognized",
        "label": "Income tax expense (benefit), Portion of Net Operating Loss Carryforward Recognized",
        "documentation": "Income tax expense (benefit), Portion of Net Operating Loss Carryforward Recognized"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income taxes",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued expenses and other liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other, net",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1197",
      "r1208",
      "r1218",
      "r1242",
      "r1251",
      "r1255",
      "r1263"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1261"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1178",
      "r1267"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1178",
      "r1267"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1178",
      "r1267"
     ]
    },
    "syk_InstrumentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "InstrumentsMember",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Instruments",
        "label": "Instruments [Member]",
        "documentation": "Instruments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other intangibles, net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r1374",
      "r1376"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense, debt",
        "label": "Interest Expense, Debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r558",
      "r565",
      "r1105",
      "r1106"
     ]
    },
    "us-gaap_InterestIncomeInterestEarningAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeInterestEarningAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Interest Income, Interest-Earning Asset",
        "documentation": "Amount of interest income from interest-earning asset."
       }
      }
     },
     "auth_ref": [
      "r1292",
      "r1293"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for interest on debt",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r331",
      "r333"
     ]
    },
    "us-gaap_InterestRateSwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestRateSwapMember",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest rate swap",
        "label": "Interest Rate Swap [Member]",
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period."
       }
      }
     },
     "auth_ref": [
      "r1069",
      "r1165",
      "r1166"
     ]
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r1076"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total inventories",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r303",
      "r1073",
      "r1140"
     ]
    },
    "us-gaap_InventoryNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNetAbstract",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories:",
        "label": "Inventory, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Inventory, Policy [Policy Text Block]",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r286",
      "r302",
      "r464",
      "r465",
      "r466",
      "r857",
      "r1081"
     ]
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Materials and supplies",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r1307"
     ]
    },
    "syk_InventorySteppedUpToFairValueAtAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "InventorySteppedUpToFairValueAtAcquisition",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of inventory stepped up to fair value at acquisition",
        "negatedTerseLabel": "Sale of inventory stepped up to fair value at acquisition",
        "label": "Inventory, Stepped-Up to Fair Value at Acquisition",
        "documentation": "Inventory, Stepped-Up to Fair Value at Acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWorkInProcessNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Work in process",
        "label": "Inventory, Work in Process, Net of Reserves",
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r1077"
     ]
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available-for-sale Securities",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments."
       }
      }
     },
     "auth_ref": []
    },
    "syk_KneesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "KneesMember",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Knees",
        "label": "Knees [Member]",
        "documentation": "Knees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "syk_LandBuildingsAndImprovementsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "LandBuildingsAndImprovementsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land, buildings and improvements",
        "label": "Land, Buildings and Improvements, Gross",
        "documentation": "Land, Buildings and Improvements, Gross"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease, Cost",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1445"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesAbstract",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum lease payments",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LegalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LegalFees",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Regulatory and legal matters",
        "label": "Legal Fees",
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings."
       }
      }
     },
     "auth_ref": [
      "r1290"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r128",
      "r129",
      "r130",
      "r133",
      "r134",
      "r135",
      "r138",
      "r339",
      "r451",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r753",
      "r755",
      "r756",
      "r794",
      "r984",
      "r1085",
      "r1170",
      "r1393",
      "r1446",
      "r1447"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities &amp; shareholders' equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r208",
      "r905",
      "r1140",
      "r1318",
      "r1352",
      "r1438"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and shareholders' equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r285",
      "r339",
      "r451",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r753",
      "r755",
      "r756",
      "r794",
      "r1140",
      "r1393",
      "r1446",
      "r1447"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total liabilities measured at fair value",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r773",
      "r1423"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities:",
        "label": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/AssetsHeldforSaleDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities held for sale",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r112",
      "r121",
      "r174",
      "r282",
      "r283"
     ]
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract",
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract]",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit facility outstanding amount",
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r207",
      "r1458"
     ]
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityLineItems",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Line Items]",
        "label": "Line of Credit Facility [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r1317",
      "r1392"
     ]
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Borrowing capacity on existing facilities",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r132",
      "r526"
     ]
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityTable",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Table]",
        "label": "Line of Credit Facility [Table]",
        "documentation": "Disclosure of information about short-term and long-term contractual arrangements with lender under which borrowing can occur up to maximum amount. Includes, but is not limited to, letter of credit, standby letter of credit, and revolving credit arrangement."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r132",
      "r526",
      "r1317",
      "r1392"
     ]
    },
    "srt_LitigationCaseAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "LitigationCaseAxis",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Case [Axis]",
        "label": "Litigation Case [Axis]",
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim."
       }
      }
     },
     "auth_ref": []
    },
    "srt_LitigationCaseTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "LitigationCaseTypeDomain",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Case [Domain]",
        "label": "Litigation Case [Domain]",
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "syk_LongLivedAssetsAndIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "LongLivedAssetsAndIntangibleAssetsMember",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Assets and Intangible Assets",
        "label": "Long-Lived Assets and Intangible Assets [Member]",
        "documentation": "Long-Lived Assets and Intangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Unclassified [Abstract]",
        "label": "Long-Term Debt, Unclassified [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r343",
      "r1396"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Long-Term Debt, Maturity, Year One",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r343",
      "r556"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Long-Term Debt, Maturity, Year Five",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r343",
      "r556"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Long-Term Debt, Maturity, Year Four",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r343",
      "r556"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Long-Term Debt, Maturity, Year Three",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r343",
      "r556"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Long-Term Debt, Maturity, Year Two",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r343",
      "r556"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1": {
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt, excluding current maturities",
        "verboseLabel": "Total long-term debt",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r296"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r1380",
      "r1381",
      "r1382"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r58",
      "r1380",
      "r1381",
      "r1382"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Line Items]",
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r518",
      "r519",
      "r520",
      "r524",
      "r694",
      "r1101",
      "r1388",
      "r1389"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Table]",
        "label": "Loss Contingencies [Table]",
        "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation."
       }
      }
     },
     "auth_ref": [
      "r518",
      "r519",
      "r520",
      "r524",
      "r694",
      "r1101",
      "r1388",
      "r1389"
     ]
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimate of possible loss",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r520",
      "r523",
      "r524",
      "r694",
      "r1101"
     ]
    },
    "us-gaap_LossContingencyLossInPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyLossInPeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Charges during period",
        "label": "Loss Contingency, Loss in Period",
        "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates."
       }
      }
     },
     "auth_ref": [
      "r1387"
     ]
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MachineryAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery and equipment",
        "label": "Machinery and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery and Equipment",
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable Securities",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MaterialReconcilingItemsMember",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment",
        "label": "Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member]",
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r403",
      "r406",
      "r1091",
      "r1092"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r244",
      "r246",
      "r247",
      "r249",
      "r277",
      "r278",
      "r519",
      "r520",
      "r521",
      "r522",
      "r657",
      "r694",
      "r776",
      "r856",
      "r935",
      "r937",
      "r945",
      "r976",
      "r977",
      "r1031",
      "r1033",
      "r1035",
      "r1036",
      "r1045",
      "r1065",
      "r1066",
      "r1096",
      "r1107",
      "r1121",
      "r1131",
      "r1132",
      "r1136",
      "r1137",
      "r1151",
      "r1395",
      "r1448",
      "r1449",
      "r1450",
      "r1451",
      "r1452",
      "r1453"
     ]
    },
    "us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MaximumRemainingMaturityOfForeignCurrencyDerivatives1",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum term",
        "label": "Maximum Remaining Maturity of Foreign Currency Derivatives",
        "documentation": "Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1234"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1234"
     ]
    },
    "syk_MedSurgAndNeurotechnologyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "MedSurgAndNeurotechnologyMember",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MedSurg and Neurotechnology",
        "label": "MedSurg and Neurotechnology [Member]",
        "documentation": "MedSurg and Neurotechnology"
       }
      }
     },
     "auth_ref": []
    },
    "syk_MedicalDeviceRegulationsExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "MedicalDeviceRegulationsExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Medical device regulation",
        "label": "Medical Device Regulations Expense",
        "documentation": "Medical Device Regulations Expense"
       }
      }
     },
     "auth_ref": []
    },
    "syk_MedicalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "MedicalMember",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medical",
        "label": "Medical [Member]",
        "documentation": "Medical [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r244",
      "r246",
      "r247",
      "r249",
      "r277",
      "r278",
      "r519",
      "r520",
      "r521",
      "r522",
      "r657",
      "r694",
      "r776",
      "r856",
      "r935",
      "r937",
      "r945",
      "r976",
      "r977",
      "r1031",
      "r1033",
      "r1035",
      "r1036",
      "r1045",
      "r1065",
      "r1066",
      "r1096",
      "r1107",
      "r1121",
      "r1131",
      "r1132",
      "r1136",
      "r1151",
      "r1395",
      "r1448",
      "r1449",
      "r1450",
      "r1451",
      "r1452",
      "r1453"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1254"
     ]
    },
    "syk_MovementInContractLiabilitiesRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "MovementInContractLiabilitiesRollForward",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Movement In Contract Liabilities [Roll Forward]",
        "label": "Movement In Contract Liabilities [Roll Forward]",
        "documentation": "Movement In Contract Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1262"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1235"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Operations",
        "label": "Nature of Operations [Text Block]",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r232"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r165",
      "r166"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      },
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net earnings",
        "verboseLabel": "Net earnings",
        "terseLabel": "Net earnings",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r166",
      "r212",
      "r283",
      "r315",
      "r318",
      "r323",
      "r339",
      "r353",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r362",
      "r363",
      "r368",
      "r451",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r744",
      "r751",
      "r770",
      "r794",
      "r910",
      "r1006",
      "r1024",
      "r1025",
      "r1168",
      "r1393"
     ]
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetInvestmentHedgingMember",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Investment Hedging",
        "label": "Net Investment Hedging [Member]",
        "documentation": "Hedges of a net investment in a foreign operation."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "syk_NeuroCranialInterventionalSpineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "NeuroCranialInterventionalSpineMember",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Neuro Cranial - Interventional Spine",
        "label": "Neuro Cranial - Interventional Spine [Member]",
        "documentation": "Neuro Cranial - Interventional Spine"
       }
      }
     },
     "auth_ref": []
    },
    "syk_NeuroCranialMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "NeuroCranialMember",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Neuro Cranial",
        "label": "Neuro Cranial [Member]",
        "documentation": "Neuro Cranial"
       }
      }
     },
     "auth_ref": []
    },
    "syk_NeurovascularMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "NeurovascularMember",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Neurovascular",
        "label": "Neurovascular [Member]",
        "documentation": "Neurovascular"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Accounting Pronouncements Not Yet Adopted and Accounting Pronouncements Recently Adopted",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1234"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r1197",
      "r1208",
      "r1218",
      "r1242",
      "r1251"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1225"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1224"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1242"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1262"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1262"
     ]
    },
    "us-gaap_NonUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonUsMember",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International",
        "label": "Non-US [Member]",
        "documentation": "Countries excluding the United States of America (US)."
       }
      }
     },
     "auth_ref": [
      "r1496",
      "r1497",
      "r1498",
      "r1499"
     ]
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncompeteAgreementsMember",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patents",
        "label": "Noncompete Agreements [Member]",
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1372",
      "r1374",
      "r1377",
      "r1378"
     ]
    },
    "us-gaap_NondesignatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NondesignatedMember",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Not Designated as Hedging Instrument",
        "label": "Not Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other income (expense), net",
        "terseLabel": "Other (income) expense, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r1087",
      "r1095",
      "r1335"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating income",
        "terseLabel": "Segment net earnings (loss)",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r1086",
      "r1334",
      "r1336",
      "r1338",
      "r1339",
      "r1340"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease expense",
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r1444"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities, current",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities, noncurrent",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r818",
      "r1139"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term (years)",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r817",
      "r1139"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss carryforwards",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "syk_OperatingLossCarryforwardsSubjectToValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "OperatingLossCarryforwardsSubjectToValuationAllowance",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss carryforwards, subject to full valuation allowance",
        "label": "Operating Loss Carryforwards, Subject to Valuation Allowance",
        "documentation": "Operating Loss Carryforwards, Subject to Valuation Allowance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Segments",
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r406",
      "r1091",
      "r1092"
     ]
    },
    "syk_OrthopaedicsAndSpineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "OrthopaedicsAndSpineMember",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Orthopaedics",
        "label": "Orthopaedics and Spine [Member]",
        "documentation": "Orthopaedics and Spine"
       }
      }
     },
     "auth_ref": []
    },
    "syk_OrthopaedicsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "OrthopaedicsMember",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Orthopaedics",
        "label": "Orthopaedics [Member]",
        "documentation": "Orthopaedics"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other noncurrent assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r292"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prior service cost and transition amount",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax",
        "documentation": "Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r151",
      "r633"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total recognized in OCI",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r8",
      "r24",
      "r150",
      "r151",
      "r195"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net actuarial gain (loss)",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r151",
      "r633"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OCI",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r37",
      "r322",
      "r801",
      "r804",
      "r807",
      "r911",
      "r1309"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r321",
      "r911"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial statement translation",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r911"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other comprehensive income (loss), net of tax",
        "terseLabel": "Other comprehensive income (loss)",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r32",
      "r316",
      "r319",
      "r325",
      "r359",
      "r801",
      "r802",
      "r807",
      "r893",
      "r911",
      "r1309",
      "r1310"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss), net of tax",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Pension plans",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r8",
      "r150",
      "r151",
      "r911"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Recognized net actuarial loss",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r151",
      "r314",
      "r633"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total recognized in net periodic benefit cost and OCI",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax",
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable securities",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r312",
      "r450"
     ]
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCurrentAssetsMember",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "label": "Other Current Assets [Member]",
        "documentation": "Primary financial statement caption encompassing other current assets."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r106"
     ]
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCurrentLiabilitiesMember",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current liabilities",
        "label": "Other Current Liabilities [Member]",
        "documentation": "Primary financial statement caption encompassing other current liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherDebtSecuritiesMember",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Debt Obligations [Member]",
        "documentation": "Investments in debt securities classified as other."
       }
      }
     },
     "auth_ref": [
      "r1353",
      "r1400"
     ]
    },
    "syk_OtherForeignCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "OtherForeignCountriesMember",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other foreign countries",
        "label": "Other foreign countries [Member]",
        "documentation": "Other foreign countries [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "syk_OtherIncomeexpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "OtherIncomeexpenseMember",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense), net",
        "label": "Other Income (expense) [Member]",
        "documentation": "Other Income (expense) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherIntangibleAssetsMember",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Intangible Assets [Member]",
        "documentation": "Intangible assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r1099",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1374",
      "r1376",
      "r1377",
      "r1378"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued expenses and other liabilities",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r1140"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other noncurrent liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_OtherLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails": {
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term debt",
        "label": "Other Long-Term Debt",
        "documentation": "Amount of long-term debt classified as other."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r207",
      "r1458"
     ]
    },
    "us-gaap_OtherLongTermInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLongTermInvestmentsMember",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Long-Term Investments [Member]",
        "documentation": "Long-term investments classified as other."
       }
      }
     },
     "auth_ref": [
      "r1489"
     ]
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncurrentAssetsMember",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other noncurrent assets",
        "label": "Other Noncurrent Assets [Member]",
        "documentation": "Primary financial statement caption encompassing other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncurrentLiabilitiesMember",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other noncurrent liabilities",
        "label": "Other Noncurrent Liabilities [Member]",
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "syk_OtherOrthopaedicsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "OtherOrthopaedicsMember",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Orthopaedics [Member]",
        "documentation": "Other Orthopaedics"
       }
      }
     },
     "auth_ref": []
    },
    "syk_OtherOrthopedicsEnablingTechnologiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "OtherOrthopedicsEnablingTechnologiesMember",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Orthopedics - Enabling Technologies",
        "label": "Other Orthopedics - Enabling Technologies [Member]",
        "documentation": "Other Orthopedics - Enabling Technologies"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r1234"
     ]
    },
    "us-gaap_OtherShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term investments",
        "label": "Other Short-Term Investments",
        "documentation": "Amount of short-term investments classified as other."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r899",
      "r900",
      "r1308"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1195",
      "r1206",
      "r1216",
      "r1249"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1198",
      "r1209",
      "r1219",
      "r1252"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1198",
      "r1209",
      "r1219",
      "r1252"
     ]
    },
    "us-gaap_PatentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PatentsMember",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patents",
        "label": "Patents [Member]",
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1372",
      "r1374",
      "r1377",
      "r1378"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1223"
     ]
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other investing, net",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r1287",
      "r1312"
     ]
    },
    "us-gaap_PaymentsOfDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDividends",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of dividends",
        "label": "Payments of Dividends",
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash paid for taxes from withheld shares",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisitions, net of cash acquired",
        "terseLabel": "Cash paid for acquisitions, net of cash acquired",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireMarketableSecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of marketable securities",
        "label": "Payments to Acquire Marketable Securities",
        "documentation": "Amount of cash outflow for purchase of marketable security."
       }
      }
     },
     "auth_ref": [
      "r1344"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property, plant and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireShortTermInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of short-term investments",
        "label": "Payments to Acquire Short-Term Investments",
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1233"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1233"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plans",
        "label": "Retirement Benefits [Text Block]",
        "documentation": "The entire disclosure for retirement benefits."
       }
      }
     },
     "auth_ref": [
      "r597",
      "r615",
      "r617",
      "r623",
      "r638",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r653",
      "r654",
      "r656",
      "r1117"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1225"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1242"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r1235"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1224"
     ]
    },
    "syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of closing stock price under ESPP",
        "label": "Percentage of Closing Stock Price Represents Purchase Price Under ESPP",
        "documentation": "Percentage of Closing Stock Price Represents Purchase Price Under ESPP"
       }
      }
     },
     "auth_ref": []
    },
    "syk_PercentageofServiceRevenueRecognizeoverTime": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "PercentageofServiceRevenueRecognizeoverTime",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of sales recognized as services over time (less than)",
        "label": "Percentage of Service Revenue Recognize over Time",
        "documentation": "Percentage of Service Revenue Recognize over Time"
       }
      }
     },
     "auth_ref": []
    },
    "syk_PerformanceStockUnitPsusMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "PerformanceStockUnitPsusMember",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Performance Stock Units (PSUs)",
        "terseLabel": "Performance Stock Units (PSUs)",
        "label": "Performance Stock Unit (PSUs) [Member]",
        "documentation": "Performance Stock Unit (PSUs) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanAssetCategoriesDomain",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "documentation": "Defined benefit plan asset investment."
       }
      }
     },
     "auth_ref": [
      "r615",
      "r616",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r639",
      "r1115",
      "r1116",
      "r1117"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1226"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1282"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1225"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par per share",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r567"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r985"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r985",
      "r1004",
      "r1494",
      "r1495"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r467",
      "r468",
      "r1075"
     ]
    },
    "us-gaap_ProceedsFromHedgeInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromHedgeInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from settlement of net investment hedges",
        "label": "Proceeds from Hedge, Investing Activities",
        "documentation": "The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation."
       }
      }
     },
     "auth_ref": [
      "r332",
      "r1287"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of long-term debt",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r948"
     ]
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financing, net",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r1288",
      "r1313"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds (payments) on short-term borrowings, net",
        "label": "Proceeds from (Repayments of) Short-Term Debt",
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sales of marketable securities",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r276",
      "r408",
      "r858",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r1070",
      "r1108",
      "r1150",
      "r1151",
      "r1152",
      "r1155",
      "r1157",
      "r1306",
      "r1390",
      "r1391",
      "r1398",
      "r1459",
      "r1463",
      "r1464",
      "r1465",
      "r1466",
      "r1467",
      "r1468",
      "r1469",
      "r1470",
      "r1471",
      "r1472",
      "r1473",
      "r1474",
      "r1475",
      "r1476",
      "r1477",
      "r1478",
      "r1479",
      "r1480",
      "r1481",
      "r1482",
      "r1483",
      "r1484",
      "r1485",
      "r1486",
      "r1487",
      "r1488",
      "r1490",
      "r1491"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r276",
      "r408",
      "r858",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r1070",
      "r1108",
      "r1150",
      "r1151",
      "r1152",
      "r1155",
      "r1157",
      "r1306",
      "r1390",
      "r1391",
      "r1398",
      "r1459",
      "r1463",
      "r1464",
      "r1465",
      "r1466",
      "r1467",
      "r1468",
      "r1469",
      "r1470",
      "r1471",
      "r1472",
      "r1473",
      "r1474",
      "r1475",
      "r1476",
      "r1477",
      "r1478",
      "r1479",
      "r1480",
      "r1481",
      "r1482",
      "r1483",
      "r1484",
      "r1485",
      "r1486",
      "r1487",
      "r1488",
      "r1490",
      "r1491"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment:",
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r820"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total property, plant and equipment",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r288",
      "r908"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Property, plant and equipment, net",
        "terseLabel": "Net Property, Plant &amp; Equipment",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r820",
      "r898",
      "r908",
      "r1140"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r225",
      "r229",
      "r906"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r820"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment useful life",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PurchaseObligationFiscalYearMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PurchaseObligationFiscalYearMaturityAbstract",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase obligations",
        "label": "Purchase Obligation, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r1223"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1223"
     ]
    },
    "us-gaap_QuarterlyFinancialDataAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "QuarterlyFinancialDataAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Quarterly Financial Data [Abstract]",
        "label": "Quarterly Financial Data [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "QuarterlyFinancialInformationTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Quarterly Data (Unaudited)",
        "label": "Quarterly Financial Information [Text Block]",
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r375"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Range [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r244",
      "r246",
      "r247",
      "r249",
      "r277",
      "r278",
      "r519",
      "r520",
      "r521",
      "r522",
      "r615",
      "r657",
      "r685",
      "r686",
      "r687",
      "r694",
      "r776",
      "r831",
      "r840",
      "r856",
      "r935",
      "r937",
      "r945",
      "r976",
      "r977",
      "r1031",
      "r1033",
      "r1035",
      "r1036",
      "r1045",
      "r1065",
      "r1066",
      "r1096",
      "r1107",
      "r1121",
      "r1131",
      "r1132",
      "r1136",
      "r1137",
      "r1151",
      "r1160",
      "r1384",
      "r1395",
      "r1426",
      "r1449",
      "r1450",
      "r1451",
      "r1452",
      "r1453"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Range [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r244",
      "r246",
      "r247",
      "r249",
      "r277",
      "r278",
      "r519",
      "r520",
      "r521",
      "r522",
      "r615",
      "r657",
      "r685",
      "r686",
      "r687",
      "r694",
      "r776",
      "r831",
      "r840",
      "r856",
      "r935",
      "r937",
      "r945",
      "r976",
      "r977",
      "r1031",
      "r1033",
      "r1035",
      "r1036",
      "r1045",
      "r1065",
      "r1066",
      "r1096",
      "r1107",
      "r1121",
      "r1131",
      "r1132",
      "r1136",
      "r1137",
      "r1151",
      "r1160",
      "r1384",
      "r1395",
      "r1426",
      "r1449",
      "r1450",
      "r1451",
      "r1452",
      "r1453"
     ]
    },
    "syk_RecallMattersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "RecallMattersMember",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recall Matters",
        "label": "Recall Matters [Member]",
        "documentation": "Recall Matters"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesPolicyTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable",
        "label": "Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r415",
      "r416",
      "r418",
      "r1342"
     ]
    },
    "syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]",
        "label": "Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]",
        "documentation": "Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r53"
     ]
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized Tax Benefits [Roll Forward]",
        "label": "Unrecognized Tax Benefits [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RecordedUnconditionalPurchaseObligationDueAfterFifthYear",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, after Year Five",
        "documentation": "Amount of recorded unconditional purchase obligation maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1385"
     ]
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RecordedUnconditionalPurchaseObligationDueInFifthYear",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Five",
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RecordedUnconditionalPurchaseObligationDueInFourthYear",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Four",
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RecordedUnconditionalPurchaseObligationDueInSecondYear",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Two",
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RecordedUnconditionalPurchaseObligationDueInThirdYear",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Three",
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RecordedUnconditionalPurchaseObligationDueWithinOneYear",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year One",
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1190",
      "r1201",
      "r1211",
      "r1244"
     ]
    },
    "syk_RejuvenateABGIIHipRecallCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "RejuvenateABGIIHipRecallCharges",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Recall-related matters",
        "label": "Rejuvenate / ABG II Hip Recall Charges",
        "documentation": "Rejuvenate / ABG II Hip Recall Charges"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayments of debt",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r1314"
     ]
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments on long-term debt",
        "label": "Repayments of Long-Term Debt",
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r951"
     ]
    },
    "us-gaap_ReportingUnitAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReportingUnitAxis",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reporting Unit [Axis]",
        "label": "Reporting Unit [Axis]",
        "documentation": "Information by reporting unit."
       }
      }
     },
     "auth_ref": [
      "r481",
      "r482",
      "r1098"
     ]
    },
    "us-gaap_ReportingUnitDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReportingUnitDomain",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reporting Unit [Domain]",
        "label": "Reporting Unit [Domain]",
        "documentation": "Level of reporting at which goodwill is tested for impairment."
       }
      }
     },
     "auth_ref": [
      "r481",
      "r482",
      "r1098"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research, development and engineering expenses",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r696",
      "r1067",
      "r1091",
      "r1454"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research, Development and Engineering Expenses",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r695"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1191",
      "r1202",
      "r1212",
      "r1245"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r1192",
      "r1203",
      "r1213",
      "r1246"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1199",
      "r1210",
      "r1220",
      "r1253"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restricted Stock Units (RSUs)",
        "terseLabel": "Restricted Stock Units (RSUs)",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Structural optimization and other special charges",
        "label": "Restructuring Costs",
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Retained earnings",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r183",
      "r904",
      "r942",
      "r944",
      "r952",
      "r986",
      "r1140"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained Earnings",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r350",
      "r351",
      "r352",
      "r354",
      "r359",
      "r361",
      "r363",
      "r452",
      "r453",
      "r496",
      "r733",
      "r734",
      "r741",
      "r742",
      "r743",
      "r745",
      "r750",
      "r751",
      "r760",
      "r762",
      "r763",
      "r765",
      "r768",
      "r811",
      "r813",
      "r939",
      "r941",
      "r955",
      "r1494"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r596"
     ]
    },
    "us-gaap_RevenueRecognitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition [Abstract]",
        "label": "Revenue Recognition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1068",
      "r1082"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net sales",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r214",
      "r324",
      "r339",
      "r374",
      "r384",
      "r385",
      "r399",
      "r405",
      "r408",
      "r410",
      "r412",
      "r451",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r794",
      "r896",
      "r1091",
      "r1393"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1262"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1262"
     ]
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r1439",
      "r1441"
     ]
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "documentation": "Disclosure of information about acquired finite-lived intangible asset by major class."
       }
      }
     },
     "auth_ref": [
      "r485",
      "r486",
      "r487",
      "r489",
      "r1067"
     ]
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Allocation of Plan Assets",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital Stock [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r76",
      "r746"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r76"
     ]
    },
    "us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Fair Value of Plan Assets",
        "label": "Schedule of Changes in Fair Value of Plan Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements."
       }
      }
     },
     "auth_ref": [
      "r185"
     ]
    },
    "us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Accumulated Postemployment Benefit Obligations",
        "label": "Schedule of Changes in Projected Benefit Obligations [Table Text Block]",
        "documentation": "Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits."
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Provision for Income Taxes",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1415"
     ]
    },
    "us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCostsOfRetirementPlansTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Costs of Retirement Plans",
        "label": "Schedule of Costs of Retirement Plans [Table Text Block]",
        "documentation": "Tabular disclosure of the costs related to the various types of retirement plans including defined benefit pension plan cost, defined contribution plan cost, other postretirement benefit plan cost, and net periodic benefit cost."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Maturities Of Long-Term Debt Disclosures",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r61",
      "r64",
      "r110",
      "r181",
      "r182",
      "r1103",
      "r1105",
      "r1321",
      "r1442"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1411"
     ]
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan [Table]",
        "label": "Defined Benefit Plan [Table]",
        "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r65",
      "r66",
      "r67",
      "r68"
     ]
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]",
        "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r65",
      "r66",
      "r67",
      "r68"
     ]
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location",
        "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Groups, Including Discontinued Operations",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r29",
      "r34",
      "r112",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r122",
      "r123",
      "r124",
      "r175"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r708",
      "r1125",
      "r1406"
     ]
    },
    "us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographic Information on Net Sales and Long-Lived Assets",
        "label": "Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]",
        "documentation": "Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Expected Benefit Payments",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter."
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1423",
      "r1424"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of the Company's Other Intangible Assets",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r1099",
      "r1373"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfGoodwillTable",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Table]",
        "label": "Goodwill [Table]",
        "documentation": "Disclosure of information about goodwill, including, but not limited to, change from acquisition, sale, impairment, and other reason."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r1098"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfGoodwillTextBlock",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in the Net Carrying Amount of Goodwill by Segment",
        "label": "Schedule of Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule."
       }
      }
     },
     "auth_ref": [
      "r1098",
      "r1355",
      "r1356",
      "r1357",
      "r1358",
      "r1359",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r820"
     ]
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Quarterly Data",
        "label": "Quarterly Financial Information [Table Text Block]",
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r50",
      "r51"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and Other Financial Information by Business Segment",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r50",
      "r51"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of RSU and PSU Activity",
        "label": "Share-Based Payment Arrangement, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r189"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Stock Option Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r188"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value Assumptions",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShortTermDebtTable",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Short-term Debt [Table]",
        "label": "Short-Term Debt [Table]",
        "documentation": "Disclosure of information about short-term debt arrangement. Includes, but is not limited to, description of arrangement, lender, repayment term, weighted-average interest rate, borrowed amount, and description and amount of refinancing of short-term obligation when obligation is excluded from current liability."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock, Class of Stock [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64",
      "r179",
      "r181",
      "r182",
      "r183",
      "r297",
      "r298",
      "r299",
      "r377",
      "r567",
      "r568",
      "r569",
      "r571",
      "r574",
      "r579",
      "r581",
      "r948",
      "r949",
      "r950",
      "r951",
      "r1107",
      "r1285",
      "r1316"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unrecognized Tax Benefits Roll Forward",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r716",
      "r1124"
     ]
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsNotes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r349"
     ]
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated Amortization Expense",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1099",
      "r1375"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1171"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(g) Security",
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r1175"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r1174"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "verboseLabel": "Segment [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r216",
      "r374",
      "r380",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r405",
      "r406",
      "r407",
      "r412",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r495",
      "r513",
      "r514",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r1088",
      "r1091",
      "r1092",
      "r1098",
      "r1154",
      "r1459",
      "r1463",
      "r1464",
      "r1465",
      "r1466",
      "r1467",
      "r1468",
      "r1469",
      "r1470",
      "r1471",
      "r1472",
      "r1473",
      "r1474",
      "r1475",
      "r1476",
      "r1477",
      "r1478",
      "r1479",
      "r1480",
      "r1481",
      "r1482",
      "r1483",
      "r1484",
      "r1485",
      "r1486",
      "r1487",
      "r1488",
      "r1490",
      "r1491"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r245",
      "r248",
      "r250",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r410",
      "r411",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r969",
      "r972",
      "r974",
      "r1032",
      "r1034",
      "r1037",
      "r1046",
      "r1054",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1071",
      "r1109",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1153",
      "r1160",
      "r1398",
      "r1459",
      "r1463",
      "r1464",
      "r1466",
      "r1467",
      "r1468",
      "r1469",
      "r1470",
      "r1471",
      "r1472",
      "r1473",
      "r1474",
      "r1475",
      "r1476",
      "r1477",
      "r1478",
      "r1479",
      "r1480",
      "r1481",
      "r1482",
      "r1483",
      "r1484",
      "r1485",
      "r1486",
      "r1487",
      "r1488",
      "r1490",
      "r1491"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicData"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment and Geographic Data",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r374",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r395",
      "r397",
      "r398",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r412",
      "r1087",
      "r1089",
      "r1090",
      "r1091",
      "r1093",
      "r1094",
      "r1095"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative expenses",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, General and Administrative Expenses",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption."
       }
      }
     },
     "auth_ref": [
      "r1405"
     ]
    },
    "us-gaap_SeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeniorNotesMember",
     "presentation": [
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes",
        "label": "Senior Notes [Member]",
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors."
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes0.250Due2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes0.250Due2024Member",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes 0.250% due 2024",
        "label": "Senior Unsecured Notes 0.250% Due 2024 [Member]",
        "documentation": "Senior Unsecured Notes 0.250% due 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes0.750due2029Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes0.750due2029Member",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "0.750% Notes due 2029",
        "terseLabel": "Senior Unsecured Notes 0.750% due 2029",
        "label": "Senior Unsecured Notes 0.750% due 2029 [Member]",
        "documentation": "Senior Unsecured Notes 0.750% due 2029 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes1.000due2031Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes1.000due2031Member",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "1.000% Notes due 2031",
        "terseLabel": "Senior Unsecured Notes 1.000% due 2031",
        "label": "Senior Unsecured Notes 1.000% due 2031 [Member]",
        "documentation": "Senior Unsecured Notes 1.000% due 2031 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes1.150Due2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes1.150Due2025Member",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes, 1.150% Due 2025",
        "label": "Senior Unsecured Notes, 1.150% Due 2025 [Member]",
        "documentation": "Senior Unsecured Notes, 1.150% Due 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes1.950Due2030Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes1.950Due2030Member",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes, 1.950% Due 2030",
        "label": "Senior Unsecured Notes, 1.950% Due 2030 [Member]",
        "documentation": "Senior Unsecured Notes, 1.950% Due 2030 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes2.125Due2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes2.125Due2027Member",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2.125% Notes due 2027",
        "label": "Senior Unsecured Notes, 2.125% Due 2027 [Member]",
        "documentation": "Senior Unsecured Notes, 2.125% Due 2027 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes2.125DueNovember2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes2.125DueNovember2027Member",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes, Due November 2027",
        "label": "Senior Unsecured Notes, 2.125% Due November 2027 [Member]",
        "documentation": "Senior Unsecured Notes, 2.125% Due November 2027"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes2.625Due2030Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes2.625Due2030Member",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2.625% Notes due 2030",
        "label": "Senior Unsecured Notes, 2.625% Due 2030 [Member]",
        "documentation": "Senior Unsecured Notes, 2.625% Due 2030"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes2.900due2050Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes2.900due2050Member",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes, 2.900% due 2050",
        "label": "Senior Unsecured Notes, 2.900% due 2050 [Member]",
        "documentation": "Senior Unsecured Notes, 2.900% due 2050 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes3.375Due2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes3.375Due2025Member",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes 3.375% due 2025",
        "label": "Senior Unsecured Notes 3.375% Due 2025 [Member]",
        "documentation": "Senior Unsecured Notes 3.375% Due 2025"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes3.375Due2032Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes3.375Due2032Member",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "3.375% Notes due 2032",
        "label": "Senior Unsecured Notes, 3.375% Due 2032 [Member]",
        "documentation": "Senior Unsecured Notes, 3.375% Due 2032"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes3.375DueMay152024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes3.375DueMay152024Member",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes 3.375% due 2024",
        "label": "Senior Unsecured Notes 3.375% Due May 15, 2024 [Member]",
        "documentation": "Senior Unsecured Notes 3.375% Due May 15, 2024"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes3.500Due2026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes3.500Due2026Member",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes 3.500% due 2026",
        "label": "Senior Unsecured Notes 3.500% Due 2026 [Member]",
        "documentation": "Senior Unsecured Notes 3.500% Due 2026"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes3.625Due2036Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes3.625Due2036Member",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "3.625% Notes due 2036",
        "label": "Senior Unsecured Notes 3.625% due 2036 [Member]",
        "documentation": "Senior Unsecured Notes 3.625% due 2036"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes3.650Due2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes3.650Due2028Member",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes 3.650% due 2028",
        "label": "Senior Unsecured Notes 3.650% Due 2028 [Member]",
        "documentation": "Senior Unsecured Notes 3.650% due 2028 [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes3375Due2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes3375Due2028Member",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "3.375% Notes due 2028",
        "terseLabel": "Senior Unsecured Notes, 3.375% Due 2028",
        "label": "Senior Unsecured Notes, 3.375% Due 2028 [Member]",
        "documentation": "Senior Unsecured Notes, 3.375% Due 2028"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes4.100Due2043Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes4.100Due2043Member",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes 4.100% due 2043",
        "label": "Senior Unsecured Notes 4.100% due 2043 [Member]",
        "documentation": "Senior Unsecured Notes 4.100% due 2043"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes4.250Due2029Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes4.250Due2029Member",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes, 4.250% Due 2029",
        "label": "Senior Unsecured Notes, 4.250% Due 2029 [Member]",
        "documentation": "Senior Unsecured Notes, 4.250% Due 2029"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes4.375due2044Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes4.375due2044Member",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes 4.375% due 2044",
        "label": "Senior Unsecured Notes 4.375% due 2044 [Member]",
        "documentation": "Senior Unsecured Notes 4.375% due 2044 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes4.550DueFebruary102027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes4.550DueFebruary102027Member",
     "presentation": [
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes, 4.550% Due February 10, 2027",
        "label": "Senior Unsecured Notes, 4.550% Due February 10, 2027 [Member]",
        "documentation": "Senior Unsecured Notes, 4.550% Due February 10, 2027"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes4.625DueSeptember112034Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes4.625DueSeptember112034Member",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes 4.625% due September 11, 2034",
        "label": "Senior Unsecured Notes 4.625% due September 11, 2034 [Member]",
        "documentation": "Senior Unsecured Notes 4.625% due September 11, 2034"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes4.700DueFebruary102028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes4.700DueFebruary102028Member",
     "presentation": [
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes 4.700% Due February 10, 2028",
        "label": "Senior Unsecured Notes 4.700% Due February 10, 2028 [Member]",
        "documentation": "Senior Unsecured Notes 4.700% Due February 10, 2028"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes4.850Due2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes4.850Due2028Member",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes 4.850% Due 2028",
        "label": "Senior Unsecured Notes 4.850% Due 2028 [Member]",
        "documentation": "Senior Unsecured Notes 4.850% Due 2028"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes4.850DueFebruary102030Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes4.850DueFebruary102030Member",
     "presentation": [
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes 4.850% Due February 10, 2030",
        "label": "Senior Unsecured Notes 4.850% Due February 10, 2030 [Member]",
        "documentation": "Senior Unsecured Notes 4.850% Due February 10, 2030"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes4625Due2046Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes4625Due2046Member",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes 4.625% due 2046",
        "label": "Senior Unsecured Notes 4.625% due 2046 [Member]",
        "documentation": "Senior Unsecured Notes 4.625% due 2046"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SeniorUnsecuredNotes5.200DueFebruary282035Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SeniorUnsecuredNotes5.200DueFebruary282035Member",
     "presentation": [
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Unsecured Notes 5.200% Due February 28, 2035",
        "label": "Senior Unsecured Notes 5.200% Due February 28, 2035 [Member]",
        "documentation": "Senior Unsecured Notes 5.200% Due February 28, 2035"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r1122"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Shares, Cancelled (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value, Cancelled (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares, Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r675"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value, Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r675"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Shares, Nonvested at January 1 (in shares)",
        "periodEndLabel": "Shares, Nonvested at December 31 (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r672",
      "r673"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average grant date fair value, Outstanding at January 1 (in dollars per share)",
        "periodEndLabel": "Weighted average grant date fair value, Outstanding at December 31 (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r672",
      "r673"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Shares, Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value, Vested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares vested during the period",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value",
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r686"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected stock price volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r685"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares, Exercisable at December 31 (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r666"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, Exercisable at December 31 (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r666"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value of options exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r679"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Shares, Cancelled or forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r670"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares, Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "documentation": "Net number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r1404"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average fair value per share",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r678"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value, Options outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Shares, Options outstanding at January 1 (in shares)",
        "periodEndLabel": "Shares, Options outstanding at December 31 (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r664",
      "r665"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average exercise price, Options outstanding at January 1 (in dollars per share)",
        "periodEndLabel": "Weighted average exercise price, Options outstanding at December 31 (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r664",
      "r665"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Exercise\u00a0Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value, Options expected to vest",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares, Options expected to vest (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, Options expected to vest (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued under the ESPP",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Award [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r660",
      "r661",
      "r662",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, Exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r669"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, Cancelled or forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r670"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r658",
      "r663",
      "r682",
      "r683",
      "r684",
      "r685",
      "r688",
      "r690",
      "r691",
      "r692",
      "r693"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercised during period, exercise price range, lower range limit",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercised during period, exercise price range, upper range limit",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1403"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1123"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected option life (years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value, Exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining contractual term, Exercisable (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining contractual term, Options outstanding (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining contractual term, Options expected to vest (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Period",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-Term Debt, Type [Axis]",
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r1380",
      "r1381",
      "r1382"
     ]
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-Term Debt, Type [Domain]",
        "label": "Short-Term Debt, Type [Domain]",
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r1380",
      "r1381",
      "r1382"
     ]
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term investments",
        "label": "Short-Term Investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r210",
      "r1308"
     ]
    },
    "syk_ShortTermInvestmentsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "ShortTermInvestmentsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term Investments",
        "label": "Short Term Investments, Policy [Policy Text Block]",
        "documentation": "Short Term Investments, Policy"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r336"
     ]
    },
    "syk_SpinalImplantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SpinalImplantsMember",
     "presentation": [
      "http://www.stryker.com/role/AssetsHeldforSaleDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Spinal Implants",
        "label": "Spinal Implants [Member]",
        "documentation": "Spinal Implants"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SpineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SpineMember",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Spine",
        "label": "Spine [Member]",
        "documentation": "Spine [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "syk_SpineReportingUnitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "SpineReportingUnitMember",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Spine Reporting Unit",
        "label": "Spine Reporting Unit [Member]",
        "documentation": "Spine Reporting Unit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r706"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r216",
      "r281",
      "r374",
      "r380",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r405",
      "r406",
      "r407",
      "r412",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r495",
      "r498",
      "r513",
      "r514",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r1088",
      "r1091",
      "r1092",
      "r1098",
      "r1154",
      "r1459",
      "r1463",
      "r1464",
      "r1465",
      "r1466",
      "r1467",
      "r1468",
      "r1469",
      "r1470",
      "r1471",
      "r1472",
      "r1473",
      "r1474",
      "r1475",
      "r1476",
      "r1477",
      "r1478",
      "r1479",
      "r1480",
      "r1481",
      "r1482",
      "r1483",
      "r1484",
      "r1485",
      "r1486",
      "r1487",
      "r1488",
      "r1490",
      "r1491"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r297",
      "r298",
      "r299",
      "r339",
      "r366",
      "r367",
      "r369",
      "r371",
      "r377",
      "r378",
      "r451",
      "r527",
      "r530",
      "r531",
      "r532",
      "r536",
      "r537",
      "r567",
      "r568",
      "r571",
      "r574",
      "r581",
      "r794",
      "r948",
      "r949",
      "r950",
      "r951",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r985",
      "r1007",
      "r1026",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1285",
      "r1316",
      "r1332"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails",
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r140",
      "r143",
      "r144",
      "r279",
      "r321",
      "r322",
      "r323",
      "r350",
      "r351",
      "r352",
      "r354",
      "r359",
      "r361",
      "r363",
      "r376",
      "r452",
      "r453",
      "r496",
      "r582",
      "r733",
      "r734",
      "r741",
      "r742",
      "r743",
      "r745",
      "r750",
      "r751",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r768",
      "r801",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r811",
      "r813",
      "r821",
      "r911",
      "r939",
      "r940",
      "r941",
      "r955",
      "r1026"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r245",
      "r248",
      "r250",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r410",
      "r411",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r969",
      "r972",
      "r974",
      "r1032",
      "r1034",
      "r1037",
      "r1046",
      "r1054",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1071",
      "r1109",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1153",
      "r1160",
      "r1398",
      "r1459",
      "r1463",
      "r1464",
      "r1466",
      "r1467",
      "r1468",
      "r1469",
      "r1470",
      "r1471",
      "r1472",
      "r1473",
      "r1474",
      "r1475",
      "r1476",
      "r1477",
      "r1478",
      "r1479",
      "r1480",
      "r1481",
      "r1482",
      "r1483",
      "r1484",
      "r1485",
      "r1486",
      "r1487",
      "r1488",
      "r1490",
      "r1491"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r351",
      "r352",
      "r376",
      "r813",
      "r858",
      "r946",
      "r966",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r985",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1005",
      "r1008",
      "r1009",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1026",
      "r1161"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r351",
      "r352",
      "r376",
      "r413",
      "r813",
      "r858",
      "r946",
      "r966",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r985",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1005",
      "r1008",
      "r1009",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1026",
      "r1161"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1194",
      "r1205",
      "r1215",
      "r1248"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock under stock compensation and benefit plans, shares",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r139",
      "r140",
      "r183"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Shares, Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r139",
      "r140",
      "r183",
      "r669"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock under stock compensation and benefit plans",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r139",
      "r140",
      "r183"
     ]
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining shares authorized to be repurchased",
        "label": "Share Repurchase Program, Remaining Authorized, Amount",
        "documentation": "Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders' equity",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total shareholders' equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r86",
      "r89",
      "r279",
      "r280",
      "r322",
      "r350",
      "r351",
      "r352",
      "r354",
      "r359",
      "r361",
      "r452",
      "r453",
      "r496",
      "r582",
      "r733",
      "r734",
      "r741",
      "r742",
      "r743",
      "r745",
      "r750",
      "r751",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r768",
      "r801",
      "r803",
      "r807",
      "r812",
      "r821",
      "r940",
      "r941",
      "r954",
      "r987",
      "r1004",
      "r1027",
      "r1028",
      "r1052",
      "r1169",
      "r1318",
      "r1352",
      "r1438",
      "r1494"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.stryker.com/role/CapitalStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital Stock",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r338",
      "r566",
      "r568",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r580",
      "r582",
      "r767",
      "r1029",
      "r1030",
      "r1053"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r808",
      "r823"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r808",
      "r823"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r808",
      "r823"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r808",
      "r823"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.stryker.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r808",
      "r823"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.stryker.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r822",
      "r824"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental cash flow disclosure:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplierFinanceProgramObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplierFinanceProgramObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsSupplierFinanceProgramDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning confirmed obligations",
        "periodEndLabel": "Ending confirmed obligations",
        "label": "Supplier Finance Program, Obligation",
        "documentation": "Amount of obligation for supplier finance program."
       }
      }
     },
     "auth_ref": [
      "r505",
      "r506",
      "r507",
      "r510",
      "r511",
      "r1100"
     ]
    },
    "us-gaap_SupplierFinanceProgramObligationCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplierFinanceProgramObligationCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplier finance obligation",
        "label": "Supplier Finance Program, Obligation, Current",
        "documentation": "Amount of obligation for supplier finance program, classified as current."
       }
      }
     },
     "auth_ref": [
      "r505",
      "r506",
      "r511"
     ]
    },
    "us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]",
        "label": "Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes obligation for supplier finance program, classified as current."
       }
      }
     },
     "auth_ref": [
      "r506"
     ]
    },
    "us-gaap_SupplierFinanceProgramObligationDecreaseSettlement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplierFinanceProgramObligationDecreaseSettlement",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsSupplierFinanceProgramDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Settlements",
        "label": "Supplier Finance Program, Obligation, Settlement",
        "documentation": "Amount of decrease in obligation for supplier finance program from settlement."
       }
      }
     },
     "auth_ref": [
      "r509",
      "r1100"
     ]
    },
    "us-gaap_SupplierFinanceProgramObligationIncrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplierFinanceProgramObligationIncrease",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsSupplierFinanceProgramDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Supplier Finance Program, Obligation, Addition",
        "documentation": "Amount of increase in obligation for supplier finance program."
       }
      }
     },
     "auth_ref": [
      "r508",
      "r1100"
     ]
    },
    "us-gaap_SupplierFinanceProgramObligationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplierFinanceProgramObligationRollForward",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsSupplierFinanceProgramDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplier Finance Program, Obligation [Roll Forward]",
        "label": "Supplier Finance Program, Obligation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsSupplierFinanceProgramDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]",
        "label": "Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes obligation for supplier finance program."
       }
      }
     },
     "auth_ref": [
      "r506"
     ]
    },
    "us-gaap_SupplierFinanceProgramTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplierFinanceProgramTableTextBlock",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplier Finance Program",
        "label": "Supplier Finance Program [Table Text Block]",
        "documentation": "Tabular disclosure of supplier finance program."
       }
      }
     },
     "auth_ref": [
      "r1100",
      "r1383"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1241"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credit carryforward, amount",
        "label": "Tax Credit Carryforward, Amount",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "us-gaap_TaxCreditCarryforwardValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credit carryforward, valuation allowance",
        "label": "Tax Credit Carryforward, Valuation Allowance",
        "documentation": "Amount of valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from tax credit carryforwards for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r1412"
     ]
    },
    "syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stryker common stock held by plan, value as a percentage of total plan assets",
        "label": "Total Percentage of Defined Contribution Retirement Plan Assets Value Held by Company",
        "documentation": "Total Percentage of Defined Contribution Retirement Plan Assets Value Held by Company"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1233"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1240"
     ]
    },
    "us-gaap_TradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeNamesMember",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trademarks",
        "label": "Trade Names [Member]",
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1374",
      "r1376",
      "r1377",
      "r1378"
     ]
    },
    "us-gaap_TrademarksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TrademarksMember",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trademarks",
        "label": "Trademarks [Member]",
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r1099",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1374",
      "r1376",
      "r1377",
      "r1378"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1261"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r1263"
     ]
    },
    "us-gaap_TradingSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradingSecuritiesDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading marketable securities",
        "label": "Debt Securities, Trading",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading)."
       }
      }
     },
     "auth_ref": [
      "r294",
      "r772",
      "r1074",
      "r1343",
      "r1425",
      "r1426",
      "r1427"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r563",
      "r579",
      "r766",
      "r792",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r912",
      "r1127",
      "r1129",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1141",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1348",
      "r1349",
      "r1350",
      "r1351",
      "r1422",
      "r1425",
      "r1426",
      "r1427",
      "r1434",
      "r1437"
     ]
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "After-tax gain (loss) recognized in AOCI related to designated net investment hedges",
        "label": "Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax",
        "documentation": "Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r757"
     ]
    },
    "syk_TraumaandExtremitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "TraumaandExtremitiesMember",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trauma and Extremities",
        "label": "Trauma and Extremities [Member]",
        "documentation": "Trauma and Extremities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1264"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1265"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r1265"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1263"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r1263"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r1266"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1264"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "US",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "verboseLabel": "United States",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "United States agency debt securities",
        "label": "US Government Agencies Debt Securities [Member]",
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB)."
       }
      }
     },
     "auth_ref": [
      "r1083",
      "r1115",
      "r1455"
     ]
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "United States treasury debt securities",
        "label": "US Treasury Securities [Member]",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r1083",
      "r1115",
      "r1117",
      "r1127",
      "r1455"
     ]
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnamortizedDebtIssuanceExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unamortized debt issuance costs",
        "label": "Unamortized Debt Issuance Expense",
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Undistributed earnings of foreign subsidiaries",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r217",
      "r698"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r1260"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning uncertain tax positions",
        "periodEndLabel": "Ending uncertain tax positions",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r699",
      "r716",
      "r1124"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Foreign currency translation",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from foreign currency translation."
       }
      }
     },
     "auth_ref": [
      "r1410"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Decreases related to prior year income tax positions",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r717",
      "r1124"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Settlements of income tax audits",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities."
       }
      }
     },
     "auth_ref": [
      "r719",
      "r1124"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits, income tax penalties and interest expense",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r714",
      "r1124"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increases related to current year income tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r718",
      "r1124"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Foreign currency translation",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from foreign currency translation."
       }
      }
     },
     "auth_ref": [
      "r1410"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increases related to prior year income tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r717",
      "r1124"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits, interest on income tax expense",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Expense",
        "documentation": "Amount of interest expense for an underpayment of income taxes."
       }
      }
     },
     "auth_ref": [
      "r1409"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Statute of limitations expirations and other",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "us-gaap_UnsecuredDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnsecuredDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails": {
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured debt",
        "label": "Unsecured Debt",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r207",
      "r1458"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r47",
      "r48",
      "r223",
      "r224",
      "r226",
      "r227"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowancesAndReservesAdjustments",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of Changes in Foreign Currency Exchange Rates",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment",
        "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment."
       }
      }
     },
     "auth_ref": [
      "r1327"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowancesAndReservesBalance",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance\u00a0at Beginning of Period",
        "periodEndLabel": "Balance at End of Period",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "documentation": "Amount of valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r344",
      "r348"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Charged\u00a0to Costs &amp; Expenses",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense."
       }
      }
     },
     "auth_ref": [
      "r345"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowancesAndReservesDeductions",
     "crdr": "debit",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Uncollectible Amounts Written Off, Net of Recoveries",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowancesAndReservesDomain",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "documentation": "Valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r344",
      "r345",
      "r346",
      "r347",
      "r348"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "documentation": "Information by valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r344",
      "r345",
      "r346",
      "r347",
      "r348"
     ]
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348"
     ]
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "documentation": "Disclosure of information about valuation allowance and qualifying account and reserve."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348"
     ]
    },
    "syk_VariousMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "VariousMember",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Various",
        "label": "Various [Member]",
        "documentation": "Various"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1229"
     ]
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of dilutive employee stock compensation (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation."
       }
      }
     },
     "auth_ref": [
      "r1333"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r365",
      "r371"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average shares outstanding (in millions):",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r371"
     ]
    },
    "syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.stryker.com/20241231",
     "localname": "WeightedAverageUsedInDeterminationOfProjectedBenefitObligations",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate used to determine projected benefit obligations",
        "label": "Weighted Average Used in the Determination of the Projected Benefit Obligations",
        "documentation": "Weighted Average Used in the Determination of the Projected Benefit Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r1227"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "16",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-16"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-7"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-8"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-10"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(j)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-11"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-12"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-14"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-15"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478353/942-405-50-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "740",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "740",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-4"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(c)(2)",
   "SubTopic": "20",
   "Topic": "860",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4D"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "70",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-37"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-6"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-18"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "25",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480238/815-25-50-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-5"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205-20/tableOfContent"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-11"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3A"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3A"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4A"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5D"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-7"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/220/tableOfContent"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "270",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/270/tableOfContent"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-9"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-12A"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805/tableOfContent"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479613/805-30-35-1"
  },
  "r195": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r196": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/815/tableOfContent"
  },
  "r197": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r198": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r199": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r200": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/825/tableOfContent"
  },
  "r201": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r202": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r203": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r204": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r205": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r206": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r207": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r208": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r209": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r210": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r211": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r212": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r213": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r214": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r215": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r216": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r217": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "09",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "09",
   "Paragraph": "Column C",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "09",
   "Paragraph": "Column C",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "09",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "09",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "09",
   "Publisher": "SEC"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column C",
   "Footnote": "5",
   "Publisher": "SEC"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column C",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column C",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column F",
   "Footnote": "7",
   "Publisher": "SEC"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(C)",
   "Publisher": "SEC"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-17A"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-27"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1B"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-4"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-6"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-2"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715/tableOfContent"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-3"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-3A"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-8"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480126/715-20-S99-2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480266/715-60-50-3"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480266/715-60-50-4"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482620/740-10-25-3"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4CCC",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5C"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-17"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-2"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-12"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(1)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477128/405-50-55-5"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-18"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-17"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1249": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1250": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1251": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1252": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1253": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r1254": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1255": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1256": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1257": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1258": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1259": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1260": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1261": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1262": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1263": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1264": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1265": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1266": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1267": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1268": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r1269": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1270": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1271": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1272": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1273": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1274": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1275": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1276": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1277": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1278": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1279": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r1280": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r1281": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r1282": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r1283": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1284": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1285": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r1286": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479455/805-10-15-3"
  },
  "r1287": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r1288": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r1289": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1290": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1291": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "705",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/705/tableOfContent"
  },
  "r1292": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r1293": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r1294": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r1295": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r1296": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r1297": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r1298": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r1299": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Subparagraph": "(a)",
   "Publisher": "SEC"
  },
  "r1300": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Subparagraph": "(ii)",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r1301": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r1302": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "1",
   "Publisher": "SEC"
  },
  "r1303": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r1304": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(ii)",
   "Publisher": "SEC"
  },
  "r1305": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)",
   "Publisher": "SEC"
  },
  "r1306": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r1307": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1308": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1309": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r1310": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r1311": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1312": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r1313": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r1314": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r1315": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1316": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1317": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1318": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1319": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1320": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1321": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1322": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r1323": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r1324": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r1325": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r1326": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r1327": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r1328": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1329": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1330": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1331": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1332": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r1333": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1334": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1335": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1336": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1337": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1338": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1339": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1340": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1341": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r1342": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1343": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r1344": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r1345": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1346": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r1347": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r1348": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1349": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1350": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1351": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1352": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1353": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r1354": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r1355": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1356": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1357": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1358": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1359": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1360": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1361": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1362": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1363": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1364": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r1365": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r1366": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r1367": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r1368": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1369": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1370": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1371": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1372": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1373": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1374": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1375": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1376": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1377": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1378": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1379": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1380": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1381": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1382": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1383": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3"
  },
  "r1384": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1385": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-6"
  },
  "r1386": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1387": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r1388": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r1389": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1390": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1391": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1392": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1393": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1394": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1395": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1396": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r1397": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r1398": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1399": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1400": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1401": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1402": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480266/715-60-50-4"
  },
  "r1403": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1404": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1405": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r1406": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1407": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1408": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1409": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1410": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r1411": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1412": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1413": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1414": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1415": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1416": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1417": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1418": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r1419": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B"
  },
  "r1420": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r1421": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1422": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1423": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1424": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1425": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1426": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1427": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1428": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1429": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1430": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1431": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1432": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1433": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1434": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1435": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1436": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1437": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1438": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1439": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r1440": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r1441": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r1442": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1443": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1444": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r1445": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1446": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1447": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1448": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1449": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1450": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1451": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1452": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1453": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1454": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1455": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r1456": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1457": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1458": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1459": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1460": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1461": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1462": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1463": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1464": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1465": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1466": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1467": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1468": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1469": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1470": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1471": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1472": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1473": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1474": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1475": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1476": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1477": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1478": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1479": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1480": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1481": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1482": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1483": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1484": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1485": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1486": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1487": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1488": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1489": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-1"
  },
  "r1490": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1491": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1492": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1493": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1494": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1495": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1496": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1497": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1498": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1499": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>143
<FILENAME>0000310764-25-000023-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000310764-25-000023-xbrl.zip
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M@_T.G2X+EG?KD=KM]KY\I!YI3'@OO8GSH@S.PK$*WH;R5YL>[G=?[M]_!8%
M=Y?"JCI]K,(\L#WOM&GZ87>O;8>][AUT#^NK_\#928_3Y=,@' >31(4%Z%=E
M%L3I*,O'P3R;!N5-6-(?8:Z"+(7_C8(P*%2BAF5PG6?3"7X3I]##.)J&21'D
M:JC@ ^AH<%V9#3\%V:2,LY0V5JY &,9#U./XMVD:ET6P<7'YH=@,PEF81_ P
MVF;=X \%RIZ")BCX-_U68.MR19=-5(ZMA&T;S&ZR8*:"@4IB=:N"69PD\"'X
MI.8@WU-XX6!:9CG=G$US;/:LO($[X+(XA2_A#<%H6DYSU0VNX.\R*V'?]^DU
MQZ!T!O\(DZD*-OK'_]C$[L[Q*=*@N C"R23//L=CN#*9!Q\NCX/_]?ESY_/G
MS]V6"M1>==FOR;J "<!IIY[BA-(Z"-(L+<JPQ"&=^S,,\Q% MX/B!FXK<*0N
M^>@#@9I/LCRDJUYGXS'\YY+NA-45!A-8$K2R9.P^=^$A,+_\H&YP\GFH)G A
M/!*F*I_%L!Y@R&'%*5HN.']7*A\76GA',;ZIZ%"+Q^$\4)]5/HQI,<&$Z06)
MUL)_T(OFN.D'"N8DQ8["CQ6I?]"A9X/N3*M+?9[$M"'L=7MXW>Y^JSD'9? +
MY<6+1UT6S2K61QS4*<C'GWY\L;.S?=0?XO30A]X1309OY(QT_. V#NG+#[]<
M!N?P^1)V#TSW3 V"(H;-E61#,NQ@.O0H+.C+:/3 ?6'5.E)#69NOIBF8+7C5
M#S_/9K/N=%!TA]GXIQ_W#H] ^!74<OIT^?'WQV[L#S_?-3[?8*X'JIPIE0;O
MPGQX$^S1)N"_=WN^.O1X8HF%=*3*,$[PP**=#](#%YG>VK YEPJ&,)VCW$Y
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M[,;!6C@ 7YY/];0.F/=>;CZ[1>>.;]SWI^NL,[N!1W=8"]YIT,9RL% K=_W
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MS$_3'IB\0YG^7S(J1C(R&4S%I@,^(="PJ/]-*]P%]S<JXS5CH&:6V2-FF7N
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M5&PJK=//;YU;L->2%F%=T;B/GME71^/>'95Z(U D3!HIR=?8%VK@"P--7#E
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M<F].S][VSXX?EJ5A7?W':V$AW"6'_X#5IR4#[&'8X5L7LCM/X41>48F/!G/
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M8R8Z+F2TXW,/Y1[OMQF$_4/3_3=]#2;V2MV3JUX#@A!.2TG;TP&3UI7FJ'1
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M6;G!^9938!_[/'&RF;A.'0H>6:EI9>*;#L(+AMA] _?XBR)/CNF21D!'5#D
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M$VDI_;T8-!N'<6$V^EUF3/16147&1B/'66FHHUSR 7)&#!JK<8KC*S6BF(E
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MPJWAW7\=A.XM_&N<3/U__#]02P,$%     @ XUU,6BC10X^=EP  2[T# !X
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M+KBZ2(,K'0QU'.E+'5Q%<0P?@B_Z!HZX!%XXG!5I1C>GLPQ;>55<P!UP693
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M4&.I>.9 LP(YC[N/3[?2U/.6Z9YV\>M9%A41Z%"'UR,8K7,=]$=T5/5>;>_
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MN3VG\<6=2L2[68.02ZN<%@Y#W0WZB60_L\=IDH:>=I)5G5/EH2L)54E(1UV
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M1] 0MP'@(LP"%A'K8G+))>QY&4Z0=7+5X'U-LR'96P8%-P JR-I8L'H0TD)
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M1BE")L-L&DJ)56>1JM%H-IDQ=Q8E/!&R5F]PM1/)GA%VP9W= ,YAC6D4F'U
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MA XAJ[#ATDGF/]0:4$RG@Q+#EM8B<@CCY6PJ;ED_.OV3$HQ4T!#PK7A@GL[
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MUL=:HU6:2V-A<BK*U1SEV*N0+7F4%?;](?J,!'_KM87#7XZ^B5 T89BQXUJ
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MY??U\/CEX<G1GY9,>UN_[740B]5\[[V:^Y0SGG_^:?OIX_WV?]_  J]M0LE
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M>HTJ$_H'\_Q4^S3P7\5E9Y2?:<59:>=Y]A&@&)&7C8(W,AHB;.P+E[$'  >
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M6OCK*M[Y)_YP>T7$IS 1;M^*F=GUHX6 ]X 9_0FM\[LIB^T4_MN[V+=97H8
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MA 4?D%+8/%[!JE\M.;U(IL"TC9%JWR5*1(*FPB1<NSZQ:Q)>-!<2]6I?'[$
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M,E4Y%0W?5&HB$3)<9CNO%IQ6\@12Y^IR3*VE%9$."R3I[%+<2OUM"\-X%GM
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MS?X+3Z[3),W![VIYG\+A97@!1L'VF\W-;HO"U+TVK3,;XM-]6200$E+.&GL
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M3]QQ=*KV["F:I :>SP&[&NP2^8 I'>U01DZ[%^T;RNLT#43*/S5%I R=>.3
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M/@-BS\D92"3^JBEED^(V)KR=_CH_1B%%=\FJ=^=JR!F .Q(H[DM/5#-,;YF
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MM98FO3*=/KTJP[YU8YD=H!X@72NGF$GUFE +>#'P9C%3]3>^8U/K[=*K2D>
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M: \60@'2<N1D.9 A?X!DA"H7<0")9HZD??-W@"0B>!'LS$5,V="?U+A[OLG
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M2Q"D82:7#1/*E5 RX0/'F+U^0:1O<=+VMK9V#>D_+C>QK>M6O*99M85V?J+
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MHHJQ.)9/\&$H9OPG'-EPA[_AU(?3EHA[R?.6G^,!S<B,$?R+18AQ2A3"=SY
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M8"07'X,X% ?E,K23WO@L-_"LGWE6"JA_4C?A,.&)X9&3<FDUS$#C#S6==9:
M=27-M$$S_N9G*G =F8L$-E,+',]UFH#FQ6E: 0[TY%;E8<P&)LHB6.Y8RH"R
M"J5NI_!4W"[9K#69]L+UF5H;K#_5V#':A8-W^J.Z^VMH<?A.\9=YJNDJ+00;
M]WXS?(\U[&<&,S9. IL*0=\5>^NX[;KMJ,N/HS!AK8/W[%\PP+@J6YZV:%-L
MR@)GNOOXW%0G.+.BDRUNKW9MX=]S-E8]N+]39-.R!A%>A!?B>-,?_>OE<#B:
MSA9"SSA]&4S)1,,!KXMIA;( W_760=4T@FDJ%;872#" OH[1-L>V9(2_)&2P
MG;VQ'\;2=5J4(>DAN+?Y)88<V'4(W%^BX<7-(P5B'$NI"]7=,A=2AFFI20'G
MWS!RE%P;%LP$(6OEQU-KOC04J=R 0BR02E&R4]]EGA]@9$5RU\Y8.#]DRYP)
MQA $*4=V)<E--60#-?2ES1:K]QND^*'NH8X15-7T>DU+#Q'W38:(N(8D*(8\
M:\-D$O(0!7@UYO@Q%S0C;I<7C(_MTFT;;4.9 ?Y]R#V3G<9=,"$>2-@EW]N6
M[V#UYQ7F R>1/U3ZS'-^:">I5!$%,^8&[77V3) ;VEBSE4T&4&P/0>30HO<'
M-S0-3*LSCFZ9I)F^@=ZQSN;\Q$XWZ(:6V39B>[$<<;=B/2'VW!]0NA$4,B\%
MA?3@HO11N_EM+:ON?Q&%K8<WL"H)E;N!Y824>[@14-A4G+V4,V >*SS,B">&
MXCNRU4&%(7(&%7/*BJ6(0^0>1/(TF"X2C H<JM3 AY&>6!K.Y7-1$1,.Q_P6
MI-<.2S4,2DNEE<AI)O"<>EW[?$[A;]OK922B=W8V<O4LZ'QL?N:A#T)^H9VM
M%OL-KKN"7\*JAG&AYO.)'!@&#D+W7L0/L00BC$)L.E9*])GC**1R2%7:N:'L
MW*&S<TW\D0IYX"!03;X$%TP/<^(8(C_^W'CL%<^MU-Z=VTABKY>@_-1JP2DH
M\F$AIRI5O"*C$3>7PQSL!?M3^$< @@E?P,1+[A/K6I <2M.EMKQ!$L.AB?UP
M$I!R_;V/=3OP(0Y"7#NG0%3[DBT-F\M"D%4_=6[+^!"-RU WPZC(T,EUPY5E
M0?AVE^N>$<J'ZYRMN73.JGW-JGW-JGW--]UDU75EU77E130G6'5=^1X7<]5U
MY?L=R4JQS24+JZXK/UC7E>-#\"WZ6%9X]OTS;;T(#,5?/M+YH;=\[F1+^Q0O
M74PLK2?  PX1Z<A^#0O!X2&A![WV0^'UU 2F$O$5B@D;8TF]P!_[%TH #N40
M6R5A?%<>5S,U.\0894)'[_K2S[-$.*'C+!GY*3XWIP([&:(>0DJ)"_F+TO6(
M7,#'14E&-81!"*,SG*<FTD3Q;+D9AGGB/!3VO\;,$<55$$" \S>$<4K^A!)*
MI4 YYB/L]P.E;TV9$7I_"N0TIJ<JLTMC=*;W@7[A#M>(K/*I]]  NYW9&N#<
MO_$.%"8Z_,C[/"%@L@[&+48#?(Z)]KS<L83:B&"BDI)@0XI/GN7I[5?8>G'B
M42"<D=J]21I&)EQ3TA-.]+@HORG</[P(.9);(Y3D[%"I,JX 48@X+H^Q<HI^
M&M)-(L!WN%QAN 7EQP)XRI7.D+K=6 )E&W:\?)3D\>%?WO\<]AZ3/F"WO;VL
M4OXRSOE>'X/%B^4?&2A.03-(@ 2,#Q:'AU70>Y0>R:3'PLA(^GZ23N3M"(D(
M_T/=$ZB2HT074,18!P^WMQ5708C-*PHFIL*S.\R\:Q0/4 8M YB+\&S.4-;Q
M+ ?IIQ,^C*]4EJ-TM[UC=>W]C_(CO$7D7R,_UECXMPAOCG3IR024!.:_.7-O
M!\'9?C9-+D*"4MLR+,J?XX.2%)&"(ZX^4;?RJ0&*RV/8CC"I[.:'T+F.&2]\
ML:#\.%2$<,/0$-J/DM0909YPHRC*_>'/X/<Z6\B)IR*C:K0"%+9&/9IJ6DKK
M\>MK]$282SJ,/R:]9ZT'&^<BU@:F-T6^]_&$.<]ZUJBPZR6I>YS+F-:+N1#L
M6](8[>H$0BQFZW]IAD;J6HE.YBH7G,2< >ZZ0PE.E;,/'"R^GWWUB*^-LYI@
M_K$9JI$JF3>$5QH5, [.>69*?2VQQCN%@409KY??'P[5)->5WS1O)4K:?V;N
M2<.D=3DN0.H'%@^+6_9+DGX%0<)>(Z80RTY^'@Y1P++;\2")/**//?OR!_WO
MBF'M.\4A3CE2GYMBS5 2S*:/T@6_""RS=7%A9NK.6"+Q,D4ZG0COM>3H)^2,
M;AHJH_VBY%J;CGDU@^]V-'(*!0G4)= LOAEI$Y9F+7.!&N.K:8*#JKP^&;OK
M/?E+R[IDG%!/OR&S14NM,=4EK7'6G?DDZ/!Q?V?55Y:#04PZ;YV4O>E#![/]
M\T]O.G=U[WMH\O1>KSW+5+K,\TE&;54(+T+_9<[$=L:62!NL#RZ;TB^^X9PY
M]$VFAANC$#=@1G\':N3#R=7VL\E3U>;?<^EA.;;>6?/,=>]M8\AA,A&N'E.C
MUF(8$:)%8"M?J!9[4\B4]/^W]_5?;2-INO]*G>F]W;#'\00(27JRN^<XX!!/
M@N$:DYZ^O\E(!HUMB9$L,NQ??]_/JM*'#2$$[,#L3D]C6Z52J>K]?I]G'B4*
M7:JA&QLMF3_GS7]PWGR%?,#CH^]P_]KU*,_NZC+?K( #N-5^NZZ]]UJ&SN"3
MV$R4I2!@$8_,(E$J_+*%,-)F5:\DN09&N6DKZK#"/D5WK>4(<9K;@RO.6*F,
M7OOO>2C2\J[KGQW*$3J%9Q$AL'%[L#Y!E<R0OK6/XSV&,AH>?^Z;-P86?$JN
M3V]LI]N2B"_-.+>@(0@V0+/RH9%\_2MFB?*^BH6SX/':YD.1H3/4XM)'*88N
MX5H[GF /%.\"5IX@J3885(H\'N+.WL5>YTUVRC'\5<R]U=2GB,#!.>-&1+;P
M@A(H*=[63C!.>/0F5#]4UE'5!>..9>V1\*%-+71!Z95:"J4H.<?]&'.Y9. A
MH(]126)K=DZUMK,HR N<@D4:]W!AF-52>:0Y).YN1XP9V;T2+JX56L-ZR?P5
M".W?+//7 K !SS/VR#K0-97V=2%?Q6!R)=VJ1>@,6 !CAE5"V2";G(4#X;+\
MJX!MC(U65I+6.Z<J(A_1\23^"+>IXB<M5 9R_/WV&4O,P,0#'/J\A<9H&F.#
MO%/P1T;4&L2RS7(XUF&F-LLZQJ%0/&-+/++%/!B>'G0^W^U!WCRX".QC;AW>
M9N9HL7Q8PQ_W/D9C_+\?_SY.NX/AD1G<&?!C)0@,?O:W-#@Z[/3ODT+KN9SH
MIT)XT^ 6IHE*#@(F8-15$A;B_Y66*+7=:W; ()T%21R@\J$23APHO8P2XUD@
M'@RE[[F4V>%1X1%Q49UNB/PCO=$SQ]4-'%>;+A%8\>@%BH2ND>64-Z*NI8,9
MKK^$W.__M?Q$67I)_%C6J10RIJ?HL*V2#C@].;E/%;"J3N=:J(#>(1JRG?[0
M= ^//Q_]V>V:_M&P]Z&W1]'U1Y$C-C%8C_H)XYT-8'%,;L8^F&1!PD:^!:U?
M&11Y#J(ZP,[C-)%.:R&'Q>^Q\($K-4IC:ZFH--^VC(M?PGGWR@QZ#?1R)6((
MYH20L"!'YRB<!M[P/*;2!WCL,WCDV*-N</&U.N&=>&G4]FQU(\*$H/2$->(G
M;IO.>"Y96KXK\9;;F]K%LU>TN)A%7L28 XQ"X">>N:<Y\R88"!YH(9?@J<T;
M,U\*1N?Z9G?GS=:+4_7#=8B]"%NI1;EOX#=4[? 8Z9Z]]X/'.!9,$MQ:OKVT
MQH;K>O"$N)/2P$32?'X(T,2Y_Y)Y1UT)*CKS\,+>#Z0DS+.BJOF MCD!Q5N0
M?L10QJ5$:],;S@G6^N#3T).L2OJ];#I@96NSU8"/%R487&;2Q+@,C>*1)]:.
MAK<(B- 6\V H8#B,Y8'^N8!:4^V$%C_XU#5Z[3UBI*PLW\D*!'UO@8_5W3L=
M](:][HGYW/FCI'L?CQ&@&>D*F9 "P994J"LL)-"MJ7X;ZU+6$*/(U@_6\8SL
M<5 9_R$*HTP0*_2NS4 D-<02#Y/$=I5P2-5A+MD$D99++" MKC_^;6!'-K %
MG948IKE(6A_02(<Z Y;@6GKI(S^%U"5(S1N4LGJNX?LY:_@6",L'EHS8P'H6
MLSNLT/3-YY  X!J]U-(A:95*ARX"AC;+BY'8BMQDA;AV4@UNR\XH9D#F2)';
M-@O#A5B+!(1&>#(/9.X\A1.4D),_98@:ZY2/TO!Z^5,Z:5,YL!Y,E%>\#"Y"
MV!*:M"DY_0BCQG^U; 6A> JX1+. <?E\X>=D8J:P;V=QQF ^W-"FU8S+WT_'
MD;8LK<?4,@H/1S 5/KA1=!%,QW[]A;H,AV#4I10%LY48BM6'W6'J!Z#U4>Z1
M@=T=)<$\\CEE[()A&(Y>FCX/5W!305O,E-0>+MU]DN>NJ*6R'FAN_]C[V.D?
M=!%B:#@X^KP"MHI&BQ%#[&9"=<_H7NB7BMB@9(LYB9G4H]%(M[]3T.$Q%5)2
M-;^/.H8,D0C'=;V ^X?WOKH-UMXG+\$GI\PJH=3&0[[8ZY!6@_(#=DA.HS#C
M5H^R*V.7D]KLJOSO2UW[Y>ST)!,\)M&[TM/?DIG^YY<?K]9!?G3ZP]Z+O:/!
MX/08)<8*B(\.*)P7,-6LH)@$[18T1]@"U,")*&>$PPL(SVY.M(E,SVJ](_C$
M=0=9PE;:ING71%,'MD8&#MJ9SUH6@RN02>&;E,VX=CH;\J,SA =!R$S\D[4)
MST/1-Z0XNB[)&RY]*1W#V!$!GZ577DPGYT/#@U,).?;JYA*'S*J$N8MET?KG
M*4YZ_8/.\=&@^\"<B<^YB@42Y/^".0BKA8?IF)24Z6JWX>/%2L;@]:=?8Y\D
M5/K0LXCPF!'MF([+]BN-:3?%-*B%Y>Z5*S55M1*.9BF89..6399+G$N_,769
M5D.6%#BIO7YN=[0=I_RGH$;KFK_9V=C:W!AOVA:Q<DG>AP(!VI#I;6XV]BZ"
M2TR1;+_]'=$(7KXVW;"]:3:XO?)#A\,W_-I]:/?<(;M/T_"<\0(\C/> ,;JM
MF^LXY-*$R;4[G+694^L.F)WGP27(_%*F&@TUBF"U?+0.#_R #&%'KVE78/>-
M??8/'8UFE7PY,I6T>QAA3 C'%0PT-FBMX>D%ET$OVFD20DD<\V7<*FP+()<.
MXLW6X>]Z [?@91*V!(]% V1RASAOWBEV-^@V.T9\W7_T>CVS'\OQA!V!]F=H
M_WX%+SD54S5(W-*]?;GIK]V"#?(<2U\1_;"OQ/6N7KH/WI>2TCPN9R7V-T@(
M),4VC3Q/S[@X16>-+MY%$*9?O8^P6<,=M#/%"=<1O1.DYFKB/7$YE^3$KAMQ
MSYJ4( '!@IREG$3*H_*U@@-@2UGPCG2GZ\J 9VI@<H,A.=_:CFN[%!/*$638
M=2C&+IU]>&"M%8_+U%06IVD:*"0VH6F7V"DLD>?2B=G94-!*Z8Y=-K_Q>QM9
M"^8VW>%IM$WEIO 7W_7ZD*#2,-[7U(R*''W;W'*!\O 2#$0 VS27._!2REK=
M95&"\H8H34E!L_0&^>WNL/11"'B'@YVZBY^"?%R+"%Z/\_=FF 6A"L>SZ'%*
M?)IN6O?TQO2?>_3T%F?UFX@?U/8:,0J^LU^L5(EY25_,94D)6T4A[S%E@#QD
M6B00N$B:4AC;\^Y%]MK&*XRY\5:J"C1NH=UL6A%0PT2@H0S<$AG1Q8WWFV/.
MT@1T2:+5!'M6;A*> -NZMEG0!PS H"?]"&^#B\D:C5:0_B2;4[A7-2LK+83:
M[LCP#&H^RMQQ0OR!/T^82L,T[BAL7F$5X<H$'HY.AQ]-Y\.@MW=O99*[SXA<
MWX?(!3I/.]V&P;^C1X+;]'2[>CQEFB4--FSM+ LVB-A@?#UKR97!,=$32\$O
M-9TQ',I A^-B,;5-SM'DS"+845AQ6"H'\>PC:P5CQ)[$'Z8[HLH-Y8+;#5DJ
M)/<S!Y0WJ!)+E_-"E\&U!F019"S*B#'5IT1E"$!J?+.,,39'+"N 5A#VZ3V!
M_,):>'^U9I8C5WB_9NG)I>E&W(:@^Q&HQJN#K3W]P%TB94>5 TWI/P)R6W+I
M>B4WEST) @$N3D>B#33W6(>X/.V.>4FF[KI=<O)[FE&>B\1^SB*Q9C7PX#AO
M:]KIM$Z*=2W"!HLI?$D7[$<1(HUV"/E2ZX/11'L<I>M+>8HJ)E*/5R?JY32=
M3SSK,>).,7M#-7*4#2$@3KO3:ZITJ&B?!-!:+H"V[*Q>JD+-]-]?EZGO)!*K
M>+=21>EG2?+B$HGYU'.G6AIO*DFY$C+0Q%+[6VYOLTJ*_&I!BQ(QRUEI.\Q;
M\_HE3"$,KKU\J"NE1M!MZP-(]?-7F0HCIE;L^BH^$&Q,?-?^2_4QQ.\T@2SB
M9=4AO_V1ROA4(9^#^B/]/"&)3T>#[@/W[M\G5^.ZA".VWK9?KU[G_C=V2OVP
MCJVE=_T$AS=(/'0B!/5NS.0TTF"XABK-53'N#]8B1]@S*6%*&<P:.(I2%"@R
M'=OZ1J93LY2P8;*E/>^AAG&X=5X"M ZN[?1DG\#8S,9EE/G 102I5 (E0N$#
MPBUY(3<N0QIT='9>+;N5LO&X/(6EP]9[_'JN@+1>-[K ;2.8T:5>KZ9Q/<M2
M\,"?6O_^^LC/QP\6W4)^K@766DV8D1V&ME @:(FZ63TX>@4DD\3Z F& ;,\U
MX,Y-M3'E @Q_6@.2@3SK0LYK)JX@HB7F[T5B<V;.B&)@1?YT!LMP@2WOC+YF
M,S]V% 4_^S3XP^R"#!2(3;-!T1B#TNLJF%+#\$PA)ZLM\IMJQ=/=7F"C/]'
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M=^ PH^A<!DURMEDV??,?3AE*;".N1<X-S<&\11X%:U2DJ"CW)9[3MS# =4C
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M9&$LU@H=5[SFEXL,X\37,Y),"@8Q5!%V#\\MIY QH&2B8>)5#*NT8#,LE%4
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M/J1GV9R!8,D:EF.2K#J.Q-W 8.G*8FD,-VB4<#9=H1D>L08@&%@_U*0^\X$
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MPC_G^,6X>>WMF#,FI(-5V=/AJVDCD;'62,Q9U3<^M3KR].$JG<]^4'.5UP<
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MH^/!T8?WP<5I<'$\?'\>] ='T/'!T0EV^WQNORN=?/6*R95K)^%S@D!4>GA
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M*+A*ZBR)]O%"N$XL!9P<Q#4Q/4(SX@ZW7;769Y-O9#+!I S&KEM_!C;'\MM
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MPLT>U%K+ LBPMUI&;U>%IGY4FP(R(PV"<?)4ZOS;1&7..0<>6>C/X)S,.'^
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M1;<C**BQ\2F /!/P<?WEN(G695E) <5*#M887A6E*UE63]C6M5>/-Z*HXD:
M6_NVLJN%2I)3M2@S5\UT0N5BW=%D91J6Z#MEB#X7Q[,F)I^*GB"NIZXLD[%B
M7;&PUC ! IMI4U[(<J2?"?5*[S-T\&!X8SH7;0WA7N\P=)0NM!T#X3H&LQ1>
MOR:B$,^".S&67V4IH >#64JM'Y.&VBKNP9^@)^<A.W]1ZL@A1=4=C?IC!Y9Q
MN#IL1JEM;-J(R?C6U"CFVI QG4[BHL7E(@L/V>QAO3GTL><4?0)>KMR/>W[1
M#X8GA_?TY#Y^YNH HP PGW J2\F%L>=EW/P9.3H>O.\/?_\N<'9KX5J_"V=W
M@>F6)M>,"RLA=&W-RO>U(/$\NL<OJ359Q^YUX(PG,\RA;*><IPG=]IQP4Y6H
M2T[GN+E*#0>2Y]]6 ?G/,<=$0*GBH"_\$;9^/P8(+H('\D'&[U&2"^-JXUF4
MX"62E@G"52(0>?",AN' O/%()5%^%?2QMEDBX>W3F1'Z;G)!!S09?%MX'\4"
MX"X#7&IBNVX=M'A>52[L0\WSF94Q!P'8N3]EVD9X435_M!9B^:)IYF%Q28+W
MF@-<#U-T#$[4->P=4 )H2I.6X,_R+2,O+S>/&:]T(8E&TD$3QW5EB#I><"4/
M#!"GS\,)P]L/,0VWG#(LRZX<!K%(5E=8CS#CJW#(GP!5&P^HVK"#<2WB2'<=
MC.MA*'^AI=9=B94FQXNIQY;3"6F!98%R5@K:O,[IS"4[&S\2&->XK(]T@B[)
M1@Z_M7M2_X1#T[\&7U<YF3DBHZ/,>!;8:B./@CNT7#E?ZV^UAM8$*XN9['U,
M637\T]E41*X+]A G@PD&"2$/]"NA<%*%;$%Y3M8G>W'%ULF;D\&[_N#HV\_#
M7PO3Y"Y7Y1^P[HQ,@-T+>WMG*/OR!/2B=4L*PB+ULF.>+]0(&Q9(Y.?XL3@P
M&6Z4?1,EL+O"#FWQQB@X2P";Q00]24PY221(2<IP+5WR^&>!P?F 5+C!PLB$
M\V<DHF1 "*;%0Y6R3,Y88>>+;[SIF>KB*@US+\.(L_R*.;A; ?N KF]^YV[?
MO]CR/:GMOE_]YYL(%,C6@%-+[.0PG7'95\]_UNJ;%4YR<S;[!SUY[:G'<ECF
MGEEZZYW05QKL:#X8,[TC,4_4&IQJP27F)U$V=8#H]":!<_HJFOD<6;8VK@_@
M,4U"(D!0.&#YCK<%=&PBK:8:K,T4GD0)]U]G6<K)!ZF0YOM\/U/U20OVW:#/
MY:$DHVK,"XC(PYQ@%GG.,ZE@FP>6Q)]"T[2/<014"3*!>_*DV*Q:L1GV!X?W
M+)9S7P[U)\5F+IPY37;^"VP0+JCLP,WHE%H=2+%_ QN.W7E8@=K#(\_59-KK
MMPCIT!O,@+C:^9?IJ! 0L0&%WCP-2\<&UJQ,(='AH+@"VA6I>.MY\F"7OF$<
M+VL0UOGYKAOL[1WL]%Z]V.EAD[S/!T+;YU^YT]O=.7AE+\2/SW<MRQEU@@J/
M"$D<(Z\Q>Y3=EM\!:]=&Z"OKA\F[\+DP*0?)*-$>NG,JQ=R9_%)_EH^DM<OR
MQF,J+5EW0#(M0HQ.;-V;2)#]>'(U:L0;6P.^3V7_ZL_C",$)[G@.;HQ/VS;7
M,"@VVIO/)^MT^ ;!R6]Q&A2J*;#Y]Y\_>\T<C4]@)IL7M*Y;?B-@N)MAHO )
MXIRCOB?3LNN1P>), 3]5M\:ZRT+!1(0LK-)<2U;&C<Z(7"?188=]D7Y.#D%@
M@I#I?2@Z!D<NLM=UC+B0-M>T^$Y G";&@3I2.9;R2CR> :(<&YC:"J]ZS_&)
ME]JZ"VK;VS'_B;D$HZ6B&+4A9H$@9R]LE4LD*%24/XLZ JHET#D5%[??IV6Q
M42KY1L B/_"Y>IQ<4LCB'1P;I;K4JQ$9O][BFM,S$F"TBM RN#.5FT%O=/T-
M=L(Z'-IT]TXC<NSQHL!_V!EA\EC@<E#TH[&()\D*Y#1H:"12SYM<I2+M!)?1
MM4ZX;IMD'58-"J]/.N(7&9)@NLE\ZA!J+U,W25#."*K \W/_;?/5UGZ;W;UH
MP=$*PRF\C!6H8U]WH;4[!;HPG++0<%[BOZ%'EC,IJ79 FLL<7:<E1K%0OD%;
M<_WO0!=R(_RMKM,H^]I&T*/.VP^_Y&EYI:*":ZYP61?>1ECPI:ALHQB1(%*<
MA3 CL/050C:0Y3;BRB\X?G"0XNEN=Q1HIWS7N)3W(*O.-26/)8E\@R_#;<8?
MX<B&)_P)ISZ<MD3A2Y:WW(X'-$,S)O 7;R$&+)$+W_L"N8GV]IZ]7C#E>8J%
M(@+I6!A=V@8E9LUNR";\X9=?/P;G)V\')X.WP:_'[T[_Z 0?3S\$_</?!Z=_
MO#L^>GO<"3X,CHZ'YQ?]P5% _[P='A\'%Z?!Q6_'P=GP])\GYR>G@_/@] U]
MP\?WN_Z@0Q\OCH?OS^F^P]/!T<D%78H?+WX[@3^.CHX'1Q_>;\QPG;T[[I\?
MTY!1+X;'%Q^&@VIG@G^>](/C]_V3=\'@-'C7AR& "_IPP]D0OMM[V8%!VCO
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MSLM)Z]9Q<AH!7,/2N:ND>H:Y3K2[28DA\D[ R6W091C4"&NPR\X*87.E3WD
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M1Z5-5!<O&\9VKU>R86PWHH5N.+^/K.S.;M2OK#;>XWZ]I[_WA__;&Y#YU=W
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M!#?QZ4I#9PN]@8R_L0YAHYGH@26%!>GD8:8TK9,Z\+K3OTT+Z6E[;RTPR]=
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ML(/>648/TMM:;[CH.+O<NG8 S/F$8<V+N"@D*ZSR"&<X5=KHI24CG]-8P S
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M<G4[Q&GD>JA6%JN'Z<H<[&44AV_2S(@%Y'-IJ-F_5O7/];,ZD6@;2N2/'U.
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MT[^.LNB*_N=B/IO^\_\!4$L#!!0    ( .-=3%H'<>Q$UPD  ,4G   >
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M-?*ZH%]P2!/]<!PU@-&0Q[M-MD5J"+LRP 7=JHVU!V;;Y.4"UVR,=?!M#/-
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MVV*9LU*P0\Z\.YR$<I:!1B:?82@:^AO:B(17VISR4MK&U_LN&DSL36:YH1V
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M_9Y?@?56W9*J*-J4+>]&4EREV$[B6_%C+>^F\A&< 4E$P\%D,".:]]?OZ6X
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M4^*MB=V F?W9([29%BZ8D&^"#BLI=_%/LG0H% /Q=*AUAZAWK%!DSHS^0JB
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MF%=C&<DI83WO&6/59LDA=IH7+9,D@,R8+[=("FE:NI@Q2\G5NXJ@W4I]%W7
M^^\0'!?[]7R2$54F$ZXPX(RX2F? U5[ >$S14N"9Q'+^^"5T?MR"9Z/+I#H'
MJ:T+%_IL?W0OD4%U;J4P6)<^8<,B#R(MTB5>HYEZH2OFOHX0*]TD'N)F""D(
M*],9O18K#>[!^!]'U _)YF<D>C_\P#>M+G+5AP%2*&)'*2AEPUT;P6;^[ '1
MZ5 )F@<"..K_P :F!T7)6@&8E;%D/GNZ'MW)$6@@;N,+\NY^U\;!>@,243TM
M=(U0$BB?[@W?VEKZHKAC3L=*%\%=S25B:F^@4%?8QC+A[%5&T/"M$&?5E:9;
M!-%6 ,'![/K6'&!AY-[O7;B#"YYTNT(P4+>,<DGJ6[K.011 LBG5VT94&H,E
M5P45<S8'-NUYJH)Y++][9RZ7);8FAZ'+X\0W+X;;?49B>TXQOM,G]"<+$3(7
MN#<W7?3]=$W [E&:@NH94C*US"#"J-]::0<X\;*14SJ0>;_E8BG?NPDX\8SQ
M70D,W@5VAV[E@F+< )AR39 )BA[X2@F%EVY'RB!(N]=1L.<JPC#69TH=L$/?
M+Y=&+I[&UU9]@Q 0@B.F7F-.XD*@N*)P+9TC0<.XU%!GLN>-[V<'17LYP#+L
M/$5#=[C<[OANE6/8](#1O:M,N63),>,OX6?\><T=<BQH7P?'YF=IFA]-H9EQ
M4-)()P9 +"+B;[1Z_HS4[PI(PX)(N36DYH8F_(M.'YE 3OP!? R7XX'H.E8%
M3/;*AABB^&;W@/Z8+@V[5%JT,9:!-V$.ZIYJ^XKJZ#;TN6A5.8V$"HL&%!PY
M63XPD-JE,,:R -/1(9*8U,E7DF'+IV/Z(N7@"L9?AK:7G?DDNO&1<$"('1YX
M#';+R'&L+C:@:"0?1G7:,;T.Y<TJC!N5.8)@B,R<]QT/B$1>YT[5OTSKS@K"
MIZQ'NL:EQ(28XC>Z$:.$#C<$E=C<XKTO!$JV/%I/[CJ(0]$ID"$1A)N0Q#*G
MU 1SHCEMW?//;G,PRE"#A_0VQ/Z514^0P/H[$;(U)*/TWFUJJ&AEFW _&=H4
MRR%O1*D^(5;M8$B(B"V=:V+--0[2,1/#U%WHWMOE)F2JO[.Z>_(UJ[LG^]7=
MDV]1W3V!Z7.>ITC!?!\'4W/VO,H2*Z5G05LO1D3ZK30(J-G3>.W&^.V&0K,,
M^4)&WL71&5<Z<#A]70;+C*N%B)%-F5B7&\GYL^\?/TFL_FBDK)1SJ8$ZW*$^
M4WT#F'Y6D#J$_0>*9;T$VK[;N($OVT.0$W7CZ::;&Q6R3P_<6,8/?THM&#M?
MA*Q%&GD[^-"P*#$SQ"57U/3RMDX(38!NOJ,O$'8$XF7]L;A'ND:CKEA%W+=0
M<B\*$^%Y#RAW7YHU1*C+?BV$>T6Y;O_,WB=+H,.2CISWD8ZF%CDR@/>!VH7E
M)(LC/B[R=NFZ P\,QK=KQLD0!]85EN'J.5UG">;!EKSXR4O.=])*$V[ !AC"
MV"W#M2\_FK:P0JX*41C!+X%>:9%NAG#.=;6,*$?M:S$>QUK:[=!Z7P(U]FJC
M2::> ?F'XB\V2T9Y^"Q7IBHG SU9IE[R<(] 5Z"!:Z^">NFJ'<(S)M&*CW1@
M^=.A2;=X=X008?(G")3D(1UH*>+29X)-J7KRV+9?;-/:?*SZ(W)*E??88!(&
M?P%94$(KHR*8P)5^TM!0,Y7^1NGV#W5"JJRRW$R?I]OG2-E@%#=,(& =N,17
M4OKK'$P'_@ ^U1*23@VEO=C3Z*3Y!FQ44+:&#XH),P;J1WB:"?#B!C5DFU6)
M85J!PHNHD*P:'R$\%QK(S/@PI#8+R-ZUGYB8^]G:?9,;S<#PFZY&L@I<+CHH
M]D7X_&G"^U#),Q'-\WG1=5=(1'N467XML\O026"(B$;\^EWL*GY743\?$F3H
M-+&-YGXOEOZ3@]*60Y9C3,7H$>:R9OC.1V;IHIH:YF*%14Y)+9YTNZFWQ<H4
M=SE/A& OD55Z!0,JY)#%(%8FD^Y":)D_&\G^);H^V!2=W1=/AD[23.W9,EE[
MZ.'#.'X:/VK/W7'24M2W3 Z\O'WW3JYF3$T)DZ_R\[O$G6FH1S T_NW9WB<H
MJ('3ICLL*E+4R>SBE/AF=J&?S+SM.>^^UI1\Y<TE6O\-U=1T,169]RU2ZB1B
ME30IBI\3S#>Z\^"9#_/S(WI^-/4.,\JD[>@MA!"6DWLN@A>GVG&QKP7$2M^'
M\,+),1IR4J"G5'#DZ$(4%):>!]B(LD:K#!;XU^ZW=CH6\.?)H]G)W6ERT@\9
M)QM;.>(EUEYA6CKIFV@:(=&R*]XL5(H2@[_GRTF[$*W$3BNF"'FY\J.VJLB!
MKEUMMB.%_ITES\77+'DN]DN>BV]1\EPH-3)-A$6* 4.H2XC%3X\;02D=*]L\
M9SHU#)7@()7+[FEW[E*=Z-/4,9TW3,=+4+JX(HJ!$-T1<Q",%-KSJ?PO(@#F
MVFCDN(N>O.ED?BK@9&%2WB![)@Z@I6:O5%@=&ER<JKEK6[BF6"'[)@6LL>?$
MD!#<E:BA>)<P-/Y5%H&D3.U\WJV%M*PJ"27[ B#*Z8JA!46QD_*4:PW"?5H6
MYH7"HN&KM;R<,5Y;%!46YD&QO]H?U]WQNZV$E,B;EDYN<(8<0?<&G"1&;W -
M!0@U)46 ]I>SZ%<#++-'\XNS62I72)]<(<_.KV[JH<Z)^GF?>\*XS&%4O/-U
M7'"W_OMT"$VL\"$&(>$!=K/<G;7:M,2:$B-(^<:8]'9>N/^1YDJ:^'T/\!GV
M/KCJYUB%U)S+O&.HKOD:C[J[#M\C'>5-4L')%W#4BA6D#&]P&JZFN?P+'%?<
M7GJWJ6U)1-G52:0>1Y\F;8F5A:M*S"^=3%LUY'.(P\9%+*Q9F-K'();IZC0O
M:0YL]H:$U5BZ9 ?LW&3GU1/L>I(9(A\4-\LEF86JB*W+.0/S!6N'-CYY*RN>
MKUA#($#XI1,XI.6 P@^RBL.KRI',S!M33^B:;]QZ.KP4=QIZ%)@@Y3?=:!,I
MRK"XF1QR4?9?/5VO! : Y/XS?2#%?;!;;T)WG\]>'$N]AA2[C[3&4_5[@&B:
M_JV8X>G7Q Q/]S'#TV^!&9ZJO'N1O25_/7D_/HU[A/G/P0[CK*LL-AAKZ4N,
M+&3(R ?ZJ?-0D^C7DZ&V.Q!E<KI3EW!'FUX5TI'Z\VR,CF\U[UUU+ZQGR*K<
M Q"L.KQK&E@B*3/Y2GK);U  !U!)0JB(WI]P%>5[*AT2OSG*9/E_&W#PZ:PQ
MGFF=?KV6_U4!HGQVR.3_P<9+3?2RI+71NX-?)-J./8A' YK(&3.)GO4P<^^/
MU'?T JHTL/,[B9RO&J"*CF&)1-(#[\_P>S4'@LJWC1T[_]!_A,+_+PK]QRO_
M"U!+ P04    " #C74Q:>1*3+2T/  "@6 $ %    &5X,C%I,3(S,3(P,C0Q
M,&LN:'1M[9UK4^,X%H:_[Z_00FT/[';2$* OI(>J$&YI"*%PH&OFRY9B*[$:
M6_)(<B#\^CVR8R?<>KJKMKKL@Z:F&HCM6*\?ZW*DHW,^AR:.]CZ'C 9[__C\
MST:#'$@_C9DPQ%>,&A:05',Q(5\#IF](HS$_JRN3F>*3T)#61FN'?)7JAD]I
M?MQP$[&]XGL^O\O__OPNN\GGD0QF>Y\#/B4\^'V%!Q_&K:VQ3UOC#YO;6]LC
M^FE[Y+]_O^E_W!IMMW:V_[NY I?"Z?DUVLPB]OM*S$4C9/;^N^\WFA]V$M.^
MY8$)=S<W-OZUDIVZ]WDLA8'[*;@^__7)UQAV9QHTXA.QFXE9R2\J#OLRDFIW
M=2/[KVV/-,8TYM%L][>.XC3Z[:VF0C<T4WR<'];\GNU^@M)D?]WF)=R&BR,N
M6%'BS98MX^%=R$<<GM_F&E__V1(^(ZN\]">%^\"(J5^IW!M>_G%Z>$FZ@\N+
MP65GV!N<D[.>-R2#(^)=[7N]@U[GLG?H5;/T'4WDF!PPG\4CIMZL;K[?:&]M
MOK7U8/O%$L=43>"5-3+9M>_J<P(,'46L.'\D5<!4 X1$--%LM_BE'7"=1'2V
MRT56LNRB]OS;1](8&6<WF#)EN$^C^4VR^^6'Y_7DTZ?F]F9650R\)B8H;CRO
M1<WLT#L3/#WV8;.YN;/SXN&-YN:+Q[[WM:WWS??;/_:U[[(BY\6&!Z,3*GY?
MV5HI+DAH$$"+M=M*[LCFPX<=L?&39Y,_EO_/&_3Q[]X@:)WR\@3,EXH:+L5N
M*@"U/6ME[YS&S+Y=7CK2/.!4S<HW:OY0<.GU#/0P1"KH3E)AU,QJ[PDX,YF?
M_$#^G'M1YJ+]3VRC^/U'LV$?S,H//<4'I];[35O9:YWPA)S(R)92$Z_CU?]U
M6MD[4E3X[+DWH[:2.F]66UN?H!V?2*"$ 9)WR\T]5',J ERD(A_N"8U4P&+!
MS0Q:KA@T(&BG5_:NO YID&NF8FF'[9BH*06?W;VUG4L3#ZH#%M%;JI"UA<JP
M2 K'J@;2]IGR0P/C"_(?<J2@Q2?'\>@$ [1C: 4?-^MX:'5?&&'75-BKJ&&V
M9A'R9G7K8QOX-<GI,09T*.L9EWT>,R@$&89,T82E\+LF\)JZ7JT&TE[@]Y:<
MG74=NDI+ZS*5:G(H CFEVD\CJER-JX&TI]C(&8^Y80$*<,(J(:=0R$#&N,"%
M5$SN0YF2@3)A#"K[++ E@EJGC<H7$F&T FVG"5#4PF[(!47%\%#TY91;0!CX
M(*YLA\*P*(*&<E['7-=6 VG'--6:>*F:.&0UD78LQ22Q/B]KGNW>0LK7RV[M
M@$VYSS09*FI%9):XZ]JJJNB$464\^)@,F1\*N-6$ SPWMJR#M!-Y&V>U#MI,
MPY3(IBNA"GI-$C!RV3Q#4>DNJ* QLEI7@AMHPZ2P<U]VQAD%K[S?.V>WY M3
MFN&:N3R9)4SM6_^*L.SQRI9SY@8O-9#6BZGV:>*<?2HKJ1=#6QC:1M&-0^H@
MK2?&/'/UZ7L'V/HQG$W@ MB1 U8#:?E<<3;@L*ML,++O(D+6YW[()_197^;:
M2GMHDIWQ,2.>SQGTU6Z=M ;2>F*:0@OI1O0UD/9%1K9Z=?8Q</)N6<!P-86G
MK;ZK1S60UN^<#LJ%&#<NK(&T>'QQ<H!L.#%D=U2CHM27(YYJTHOI!,J)#!?*
M>M4?G)WU%DWAVI6W[CJPZDM[A T+L2X5-,"U O:(U(5A>+P$/"@=322VNI7>
M4-)GQBYX04$4,V3*B >OYHR3CI""Q\3CZH89C@'B, 4IN-8NSYDQBOLWF%95
M>HJAVT%]WNL.<&Y ZXF 4V0>5.=2F9 <,PE=F77$"5)M[)="YY8DT<R-]JLO
M[5Q.87SUEYOQJ(&T@M4#=\4K'%4,X3C_O'G=))Y1LQNFB-?LH*A>^RR:\!27
M#\=@,"@YK16_6(ML'0.QRU1KCJMF#91@DKQ9;6UNM^\9##<H_/[Q0SMZL[JU
ML=.^(2?\/F8F@B_//!5OE@RWN;D&9^YLM)W-5F%)=M.@/&$1OUM,EAPP#871
M;DFM!M**39]K)U),R"G\L_[\!M L1A8FR[P4C(ZGU$QHZ?;-UT%:QJOA)=1G
M:.:7>UI1%J'"=!'.-)>-+IRH9+2\K="C$=-N@WRU%3W"=\9&%$:8<W:#\5B'
M4C&BF[09H2 X%XB989^*=$Q]DZK,90%75_>5:JB#$X,;X2!A^0*")N?,A'FL
M64WVF]<H4"YI0DS15;U:B+L8%%8=MLT9YVR*;5+Z0DEH.B3Z>._OLN07>T^3
M;<ROWOK8;-E<&(G4/$L\8!?3#9^R)ZEBB@OG"30V%I?0D991:IY>\C=I6/)_
M0[5XR!/6&"E&;QIT;)C:I=$MG>D5E]1FJ83?2VI3/B.72,4E4G&)5%PBE5_L
M] CM-X&.-4A]HQ<957H]YP!3?6DOPG/T:B#M 3T'K/K2O&Z/=&DTN\/ "6'\
M&8\I&!@U%9+9ZIZ!=PT7H,/+HX<>@,@M^3JSDCZWR=NVVB;_08+?#DT: #0;
MI! @V@0>\!<S]H,C.E)07BQ^[QB!)EQ)ERFL#M(\KT<.^)1IPTVJ&#9F?:HU
M]<-4,V-PK0&5GKC[5(UH(/4Z.9(*SA"E0P2J[4&%3*00&?_&K>??":.1":T/
M[L+:=JXME5:T\(DO79(<Q=HI6E!,;2Z6]6=B]P)"+!D^$/,;0@VT+A_KF%RE
M"U$HD;FH;%655 #R_TIYOIKOG,.JKJN$9G>90R&HF^ZOO+2GS"[,#,M8HQ2%
M%QD PY*T>ZX')2O7=55;5\FI3-CMB%5;UQ(Q.(BF$<2847V!RC .94BM_XX#
M5EU-!; \YHN+8%-920] <2I<Y*%Z2%IP2[@-6ND&&]765?*RD]>89G=Q!L(H
M<<%-XA&8R$@\L H]2&'%<2KF[E4N@% =I"W0E0X?9 W:R(BMD]D\;A"?MY>/
MN_":2L[4X8?8IQ&=:4[7B1>()MD/<3@/%+)P DPUW%F3?27A3[?9H@;2"G0'
M+#7:#^W F7A,3;G/W Q)E345X ()U8UJ'MDE,XJBC00]]QQ7!*^"UF'_L#,/
M?0ZF'.5B4=F<!5YM727".(GD;#DN);)^#F6^V9)>JF3"J%@._^1J7K5U?8_=
M8C>VPUAQ73^&T7&LNJX?Y.A 5EW7#X%$-;1!;<(_AQ'10A'&7&8%NB,*^*@V
MV-8<4)L2Q9;3Y1T"V "B;C#SZ -8EF8QQE(H0*7"%M0-*"NNJ^!U',G1H]VC
M67!-<J'XU 8:Q#0LL4D[<5)$LOKCW7)SGU<WM)QLLK*/;;O/GIP>8X"&><GN
M6$%_IFV\IYU6V[_1#PDZ@)75]"+ :Z9N:63<MH**:RH EK-;;D19;5T%L-X(
M+J=OB=<\:Q(,P+R$<IS3(KTCKSM/P@E#_8!T?,.GW!3>F @"J>.>B\P,&F>I
MU4'1 AD8UR*;\@>SVT4LJ9&NYQ&Z\4E-=)7X\@ZAF/FZ$E'>;KI.K]J:'O/#
MU-V]A,OEO5JZK<M[Y?)>N;Q7+N^5RWOU2_K7I27!U]#5HB#'=;@P2-S(MB::
M2GZ&VIB*+E]/=145J+Y0*#DY;9ZBX)2I0<GI5()!@JG_\F1JPEP62F!G;$2%
M#2HP&(]U"#+7H3WL-,]0U+.Y.*3@P"H6$^?D4A]-);KTCL4CF:H)U+4WJZW6
M=AO-$&2A#26Z/HT,7=H!A*>CRY0A9O9P%<F!J["B!3B1CJEO4F4]W.>5KC"N
MW?I?Q74]3]%K9LD[K:\2_.PB8=AG=]R72/$!.,/3<M\KEOP3I3"<V+(WTGE+
MU$770VYO,R/<M9"5EE0@.V=!_D:Z2E9Q70MBM^1/1K&YM2S)PHGMVL5OJ(VF
M.;3&0!LF!?<UZ:"8F,2^9?*"^GS,?4S5"W<<_0NFQM).EMMX#=:S, ^V@2HX
MD>W9OC"E&<X%@0N9#44>SI3HI$GNFT3:_S&0S$5BYE?&J\W0 38'KJ*2EL#I
M&VIYW3<=KLI*6N!2)IW0"'J$"R6#U$A-^BS@OH0.[TKPA&DM:02='Y)PWX5@
MG#25' .P^8(<6'6"=&+X1I^Z58*Z2"I9IE 222[=G'.-=#T'SZ,1PV,]+"G#
M3LXQJ[BN@MDE$W*:9W(J#(:,'8K8':\@-.:EC+/$:=[E&09B<SDH4>'JS%Y!
MW&"/I@$G)XQ&)O2A 2E;2 S\<G$=1;$F"?6@E#21@ UAB)Q2'$YTV3:7SCBS
MOM? ,D\49X:JV3HJADLJ<6*TH=/LE)AA_F)GJHL-5V5%)3HXA&RL@MH.R( 1
MS^[?V6FK" ,U[+X-<V0NJ4%%)96<4FV@G8>!<F2C8RYY-;@4(I675D <OEG=
MVMAICT:<='E([R.J\D_ RA-TQLF4D2&W5IXIQIAV%^O.1INK&V8X!LS#%*3@
M]%D9\F\I<%SRR'S[S+(=BD$GXG6[H:)I3%U@]@IK*E%!6_(@WI!;7JVVK@+<
MU2FF.90KD?74IU#(0,98@97!V#A;3OAI A0U[C4P;,)@I">F3!N;CWYN.J 8
MCKP"V\$EC:F')N^/4]*58*Q;=PVZ<(#VI,]90 -X2\DETPE8!YDQ;S_*^D(:
M4 Q,%]I181W">"QFP1VRZ>A!R'%9<</^L<O46G5)P_X7M/NRCN .T*@37,"D
M$AP&(0-E0IG8[07Z525!0(#.M895E30GY%9R:B#-3@YK&QNV&W)!U_.M5C0"
M=-JHU)K593 V1.UB)A8GQW(C_#I&<#BW^1?PRDG(M?WK'DI^^S8<FP[)-;<9
M<TA/XUL2> KSU59)EVIKZ;8NU99+M>52;;E46R[5UJ_I=A%VM5TZBRG.4=.U
MW1"L"_/331W40-JU])FBMI[%J8"2Y"$;.ZDVBMJ<6Q<&5>4KA;T"B%FN>(P[
M_#)A^ &Z]K,&TJY32H5QJ&H@[6MF!)>3XPN7D#R(.P9Z2-U<'I$[5C)-7)6K
M@;1'X!:9DQV]&DC[DR=G=A]F@:^<),8TF,2Y&/4(W>NI;B^N5CPWA?W";/CS
M5WT#TY&/9[]RFK_PLNXN)AA)P!7S332SLY!<+/ZZ!8O//B([)6E"1F1J8"P@
MLD104VFR0-7,SS(I,6U/8M0/BY/I2$Y90]"8!407<[G<AF2ZY2;,3F%W/DNR
M$L U=DHN8!H>"[7[$T8S^(10#4^5ZQNR]N]UN##D\/T_JX"2F'Z3RFXF_A$=
MS1\!]Q.X*[.D]6XD@QG\"$T<[?T/4$L#!!0    ( .-=3%I84CS;BP,   T2
M   4    97@R,VDQ,C,Q,C R-#$P:RYH=&WM6&U/W#@0_GZ_P@<Z6J0-Q,F^
M[Q8)M7"JCCLAJ(3ZJ7)L9S.'UXYL!YK[]3=.EJ6K926@*@74_1!MXGE_9L9C
M3PL_5P?30C)Q\-OT]R@B'PROYE)[PJUD7@I2.= S<B&DNR11M*!Z;\K:PJSP
M)(F3'KDP]A*N6+ONP2MY<"-GNM^^3_<;)=/,B/I@*N"*@'BW!7G.NG30'XQ2
MSKN<CE@W%WTA,D'C9,#R_ O=0E8D;WF<KY5\MS4''14RZ!\/DM)/KD'X8DSC
M^(^M%;J2"8'61TKF"THOO_J(*9CI<6-_^P&T0%/':;_T*" WVJ.A%A6W?]?T
M_Y+[O7)O)'"CC!UOQ\UO$E:BG,U!U>,WAQ:8>M-Q3+O(20MYN^S@/SD>H:KF
M[;K-@BXR*]#R)BLH[6,J''TM( /,T?0M[*XZL9Y2S,XPJS+CO9F/>RA_\<6;
MLGG]QC..SDA[KPC](+&;N'YX6 <8UO=&N] A3$X^(K"E;- E9W(&#DW!GG%:
M90HX.>3<5-J'_G$,=K[FS0,]_;=R'O+Z*5V]D(0OO/6&^$(2T-S8TECFP6B2
MU<3*''W6/"PU%+E1REP'I]N(+$C//;;3T!'=SG9O.'E4,%;J+5339#T\*Q47
MT>'3E5P(&-V[,?Z)5$Y68D+CO5YP^.[(D[?'QL[)>922?\P>2=,T2@:]82_=
M#;E\[FU]*2WN;4M\.X1I\8+12%X$&L,E&K0;C_ITEY32>@8ZU-"B[)(X[I,3
M@Y(_263ZJ$/;@RM)3A73KQ2]]#FCY^Z"KQ>GHWZ(.EFN-466T%%OM '6(3F:
ME\K44J)PPR]Q\["\8.Y50]M]<= .1K2;;(!V>#>TE#ZT8G%G'#UN9_RY8P)Z
M8RJ+HP Z@N$3S<'I6&:V8K8F-.DTQZ0.N09?()4K)5\.%&&^, I:GAPTTQS-
M0;.7:(2@.UY(42FY(7 M394Y$, LR)8IB)=YCLHP[EHZ%[@AC(L:-:!B;XTB
MY@IEW2ING0A WE<5CD2J$FA],P"!(X=:5RCIK)&T2"8:1W_MXFQD&ZMJR2P)
M<Z,@'R27\PQUI+0)TVUIW!_D1^;&<TVI<';9V>X.)JYYDB.KG2<[V^EP0C[C
M1#TC)R>GK\;=;CBU_VE#6IVQ$H3KD+^!%S!C^ID:NU;9&^W\]I*B- Y" 8VM
M5"Q4Y,9KB\5I,;YE81GVB,IO9GG ,7+EV5['[#?70/\#4$L#!!0    ( .-=
M3%KTM<GCU@<  #\C   4    97@S,6DQ,C,Q,C R-#$P:RYH=&WE6EUSV[82
M?>^O0.UI8L](LBA;_I =SRB.,E>3C)VQG;;WZ0Y(@B9JDF !4++ZZ^]9@+(D
M2TZ4IDU<-P^.2.P"B]VS9Q<D3U*;9Z<GJ>#QZ0\G/S:;[(V*JEP4ED5:<"MB
M5AE9W+!?8F%N6;-92YVI<J+E36I9I]WILE^4OI4C[L>MM)DXG<YSLN.O3W;<
M(B>ABB>G)[$<,1F_VI '^_N=, CVNH=A=Z][=, 3$?*.Z(3M.(Z#H_!_P094
M(>YUC)UDXM5&+HMF*FC]WEZG== M[?%8QC;M!>WV3QM.]/0D487%>AKZ_J>?
M9FDR*^YLDV?RINBY+6UXU>EPI#*E>YMM]^^81IH)SV4VZ;WL:\FSEPW#"],T
M0LO$#QOYA^@=P29W-:[MA'(F"S&U.^B0I8.[5(;2LMU@2VXOVOEY"U=L;K52
MA#@(_=?L*V@_V-C!RHV=#2ZOAV^'9_WKX<4YNWC+/EP.S\^&'_KOV>#7P=G'
MZ^'/ ]R&Q.#RB6[AP\?+JX_]\VMV?<&N!F=N([OMSA.U%BZ^_L^ 7?4O7_?/
M!U?-BU_?#_[+^F?7Y/Q.^T_8_6EXY5S?( NM*AW4YR;YK3)6)I._:?>K\VC8
M8._$2!:LWV+O5:@:+!*:K& VY?;%9O?PF*WC@$7;UTZP[['EH,78D*5\))C&
MUL487&U3:5B_*"J>L4M1*FV9*MA;I7,6M)OO6*(T9 2;"*Z9*&*HO!&1R$.A
M7VP&^^WCW:!!C+['5,*NK)[<"@VNUYB)6ZD*./+H^)GYL0,_ON8&KH"K\@F[
M+=0X$_&-:'AW:N_'6 G#"H6ZB!DYD,:+":L*JRL!.U$I7=&$VSC+<45VL81'
MN*69RD'Q5GFY)8$"$3"&ZPF)Y/Q6N!#=SVEP+X8Q6#)S%1=KD$ D-2HLQ JH
MPY(8H1JG,DJ9J>C/3'\LM*@GH0WDTF0HQ535Q]*FV* I1>0,I'E+F*9B;',$
MM9B%DWDW/$< ['X* ((ELH"+*5HSES80?8AC6,^-RP+YE;M$P>\HJRB_$+8Y
M_S40<JFS"2OA=0(, 2G+9HBH@V$>+ W0Q9(F;I!$E4$ ,%"(E5O..'LB;E*6
M9&ILIAC1XD8:JSD6XG33VPTK&W.A-E-CEJQ]CM'>0[2O%USS8O.P$QP<FSJ>
M=>&@]%!)(G&Y9;:=WX:,:^$B!(_+,!..3P5@$6;2I*1!8CG8@1B"KF-IHDR9
M"GK$&UIE/E2E5I&(<=NP+40F%@BU=__@+DIY<2-8'REY6660"'9Y,^AN"6]%
MT(W]E;^45+$+#Q&:GU'>SB''1Y)L67NA9&&A! M-Z\8\GB!!Q<?5UK\:(R6/
MB9^:F4AL;W?_^_<76WR;H50:K _O.8+]?&@;Q/T1K\SZ*D3"H4"8ZI4\K:M*
M8P)DZT@:QP&0$H6;A]J;&7O,,Y 6&7=QKWE]%KM&S4XT*,$DL,6H3,;NN&>J
MT,A8<BUI ])7'\>)!<U4&:H(+E.,*Q^.,901, @'/:=4<@ NJC).1(=M.2-F
ME04:OD[-EU?\"@4)@HN@+^*_A7N>'J[")5RMG=!+\%J?"M9&&9 YDC&!AQM5
M<.(\;@ \:CH(45S'T^@";Y*',I-V0N5GU;*$=0<$%V,/TP71N:;%4>M=O:&R
M0@MJD!Y4+J-(Z=@9X-J7&U&@"F: &D9$21@F$;1F'D[ NBS!;I\&U!<@XY\&
ML0@0&XQX5KG\)O^+)$&/(4?PG%G1*[PTZS"5OUS=.#@L01$L8WQ[$JK*/K[V
M.ES*[Z4%]5[)YYM5%DZ[.I<>POM@>HRA!9X_O\3$+]Z[RU&B(TS=!+B1!R#X
M CZA*J2BJ-(4A3G*7Y@O5\;B#CUDP"PFPA2_5Z@5F'1K23@!A)#=#^1J,]'I
M"G?6HF.8.^UZ6[:])2DW]S61>,%!3L2.,-WN:S*;X$1U*[+ZX/5 OO$5#FD]
MLZ:Y^S5-LWM$$4\QV)AE)9'$/"9F"4JQ_8(ZN-3A(%8<_8U5VMP7'7<#D^4X
MC%LA5M)>J%#0:"26L,FI;P$S8!E#+(;_J;^:@EO\7DF8[.!<%9$[B&W_B_KA
M/@ZNU$%(!)R.!'2XB*1 >.KR<-^7C@6_);[W%=PQONL]W,.1Z2'VBX)>MY#^
M0+8BG7D,12/NLWD%0.I>!<*(-5J*AB\W!K7&5'F.#O@/X;91L^7*@_Z_J)10
MJ]I'Q4@T4JF!  B7^@BA>ZI4Q[KA*5@6(Y6-!/%PP6_JAV.Z9@N1EYF:"(R.
M4^7Y@2\@"9'_RI+T. -_ZT[/NJZYU@F!,Z&;B%3&2R-ZTQ_'X,<RXY.>+)SG
MG=)Q_8P]5-:JO$=ON4;$LRB(]2IN03]<OP [.FH=M _H'9B%Z3:>+ER_'FNY
MUV,[-EX>VV_M'P2/CK9;CX]]:M:];NNP\_CPGYYVK]5I'ZTU[8YSA'<&W&U*
M7KS:V-UX$,5>I[QCP6(,*; //>Z=_:T2S[W-?(/,6JPJ]9;_D;MY*T)=T</N
MH.->-72?Q:Y>;.ZA&7)_V;O!S\-S]R+JXO7%PN[6A&*;-KFQED?6$*TIAU[4
M09:Y)SULZH>G[]F%UWK?WYM/WV%G*9>ZP<Y2*1(VN!-11:=M=N';<M?0?,"!
M6L;NXXR'_MQQE>>;E<W@L%SO:X8'7WN4RKC7(3W_E',DEK[_F,'?%<_V3(6'
MR('*+JM\YI.1^J__@&7'?3CS?U!+ P04    " #C74Q:81'@7M,'   !(P
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M2_XSUY^0H6H2WD"J;(*"S+5]HHH1-FAS"IV!/&\.TW2$;8ZA%HE@NNB&EPB
MSN< 0")6&5S,T9J[M(;H0QS#9F%<9<BOU"4*KL.DY/Q"V!;\5T/(E4FF(H?7
M&3 ,I"29(Z(*AGVP-$ 7*9ZXQA)E @' 0"-6;CGK[ FE'8DXT1,[PXBA&V4+
M([&0Y(?>;EA96PBUG1FS8NU+C/8^HGV]Y)I7VV_:K<-C6\6S*AR<'CJ.%6YW
M[*[SVU!(0RY"\+@*$G)\2H!%D"@[8@T62\$.S!!\'RD;)MJ6T&/>,#KQH<J-
M#BG"8RMV$)F($&KO_L%=.)+9#8D^4O*R3"#1ZLAZJ[M#WHI6-_)W_E9QV<X\
M1'A^P7F[@!P?2;9EXX7BI85B+#2K&XMX@@07'U=;?V^,Y#)B?JHG%!>]SL&W
M;S)VY*Y J;18']YS!/OET-:8^T-9VLU5F(0#0IBJE3RMZ])@ F3K6%G' 9"B
MS,W#[<V</189R% B7=PK7I_'KE:Q$P\J, ELL3I1D3OTV3*P*E+2*-Z \M7'
M<6+&,Y66*X++%.O*AV,,;0D&X;CGE'()P(5E(IGHL"UGQ+RR0,/7J<7RBJN
M6!!<!'V*_A#N>7ZX"E9PM7%"K\!K<RK8&&5 YEA%#!YI=2:9\Z0%\+CI8$1)
M$\VB"[PI&:A$%5,N/^N69:P[(+@8>Y@NB2XT+8Y:[ZH-Y25:4(OTX'(9AMI$
MS@#7OMQ0ABJ8 &H8H9PQS")HS3R<@'65@]T^#Z@G(..O!K$0$!N,95*Z_&;_
M4QRCQU!C>,ZNZ15>VTV8RM^N;QP<EJ (EK&^/0ET63R^]B9<*N^EB7NO^,O-
MJ@AF79U+#_(^F!UC>(&7SR\1\XOW[FJ4^ A3-0%NY $(GL G7(5T&):&H[!
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M 7[6DPQ:LGO(T;ZNX>&F#9(&[,,2@]QP=6 DO@8!AF\'Z9.5Y$&NW 4<2U1
M2%&9<37# ?40 +!NT>E<U=4#_W >6D<< =BX[80>[J<"9$Y^E:%S!TY2L73V
M@$ET1<*M%-A5KRU>AJ(@0<_WT&%[[Y3](IVR'L:2H7"N>CA,@@X(6 XUH55X
M#PW:.;_-HLRJ]V!9.+CY]],;<U<9+B?[1S[9;\/)/@0)+D(;]#&40R 0!X(*
MI-G2Y3TJ,&+87:"P5 ^O7-%!PK+803N.[8<@S\B,A-V".IYCUTO H+36N0-2
M$ ;H559&KF!0#''2.6[*N=UH9+#VVKJ>=%#>&SLY! ('X1& N0:-YP*$*&J5
MR35JFV%DH'\VKA,,L3J9&" BOQCA>P(J:X 7.TF^4^4RU<_I[:EV63LE()!<
M43;PPFI9;#+TI(%"S.@*T"4E,JC]BNV1%P^3' 0R?"H**WT*FX(_GAH$A_QW
MW&+>R87S14].7*ND.)-MQB%_6!L,SWYR7]+T>0"C0_MD=\;DW5S;'8,";D:E
MV:#I$F()JLV$$R$VB=_M*'+]SBD4%X(>EHDCR2"83H)D+C],"7K.8;OD!W.J
M#\DY]PMKHEZ:^D#D_*TI(8MEIG \VAR78#]I7&8JW$(PJTOT  \/>\-?HI#$
M<&#'$$[X7]:1=T(2Y J(!&4V',(4DC5@ X?CF.PB1XM0BH+N3K(#;#WJG,%H
M"$IRC!R=0IDU3FX%[& LXAX]_8L^HE$ARD?HR#2-S7+;YF&>H&])J7I)2M4!
M0H"&(4"P A&YC9@<#(;@94&B%>TH6.P'WO82.4O +8PL8<P:]D[;%:4+%AJ8
M-ST+W/:26LZ: OU4\S%(WP'9.PC*D1@G;OOM>H/V(4CC8$3"1(#9H[A0,D9#
M%"E+P !"+8<"V20N:+?G!1Z-OJ1G.G3RM&P!.[H$V UG+5U$V]4?V.T#IR=E
ME0(ZN?897.KB(9RN.K]P7DHP@!SHWY+0A)VV$,M&08'U54:.?E LT("O.C.V
M@P;SOO,WL_?&X?J21C,00R%B/('+5%3OY0X +.\@<0 0=&5V=C:(4JPN'I1N
MQ=/SC9VO!Z=??;8)R_QR?_JW?Q--RXN39S0-L 9]A*G-UG5?V5RP&+4J4.UV
MA,J.%JNP7Z).!8]1$[+0L_@!QGX<X,HN]F=E>5D1F++T^*H8U30\6\4$PGX>
M6(/KB4Y_^"AKVH-=L>7^K)B<Q;PH(SSY,/8VM6Z[EPH]_=**8M,"%"O#-)>V
MP&,I,9,KU]4:+N&WWNH-''J+WG.PNR+?GUTQM24(U;+U@9T!(N[N&X1C7 @-
MPWV0:IZT?(9H3P(?#AL.$+T#7&*W/TOL+^%86L]"'D<+[--3%+S"B2=D&)KX
M;P)7>E&.<F@&B3D6,WO19)4!#0_2JOX@_-]]O.4^WO+? F)[IX")LPL"0X)4
M>^LN$*R;C7VC>VA4><!'YOO?:/])#1]+^C9Y#0>Y@H.0O&O0M^TQP]]__W)/
MG# WP'(Q=>ABWY?GIXF9+PO"6(CDQA?]HV[>L[LH>2V8'L&-D/C<KA=UJ5K7
M^3_^\T2TKH]8IKM_%TWH!&'._5/W3]T_=?_4_5/W3]T_=2A/W=M07ZP-==/&
M^-2:^H#A\)5;=,FY#WSMCLWLRQ@>G9QB1/M'2D3(>X>\J,\/H-?/AKU^_'"O
M;+MYF];0-E+FW^0*)$>&Z)$^J/![Y7KTX,AQ8Q,3,V@,/K"-85N(#;O@W'**
M.^/OPUM3RSH9]^,:&7,DELUV798L,&&7#=2^<2D14^7"5_4?6=4CLNWT:0HO
M.'V8^KR=B" &1O?+R?E)\BVB#P9F_(^9$*^<M6V]+ )C9(>_<X[^W?:;34F!
MY8 >,5P5X6MHQW<UN<"H?B4Q 8*@]V76&"\?#3XYPA?4T3NB*7JC#09JSG>7
MQ+K)U*"&@!/1:C#8_^KA4%$60U%1,BE"3QK7;;'OP1F)OR[+$#P>4G/Z%_O]
M(>L7@AV4P!,RU&.*TL"5.=O6(7A0!/*X[QZ4=]$A\],<#FATNG#/.=B4F& 0
M-F2.=XX!6P3?BE\_!EC*.PB!4"$*LZ_H,737+$"@9WY+(!\6>]KP\#G<FDSW
MY D4E*;,0U0X0\)]8,\5/<Q<1^.7X;0OX, @)''8,P1:Z>\6G PUX!(X@X^D
MY669%6L?#-#'2H*TC'FY)![ ,\60R:))RCJK#,>&HE/QQ=3\!#V4/PBC5W27
M=>M\3PV'F?:-UDK)H83'[%HS72>(HNCS58TX3VQ9R1<'(V%2#VB:2!'ZI0>$
M9NUELBKA#<S11HPGTE8NP,]NR,7E">A69LFX\9BZ@F7!D*DM&FE6@HR\)K0*
M#9:FES#\5\[NB"7\3\%\10.^- (^PB9L^DVWW$:)?,S)!H<R:QBVZG*#H);<
M?PT?$^.JSY(K-8UG/(6CHP)7RK+K.3</1#8G&RNG)^P:37X/5')$-U?D1<:<
M26;6FBSW^ ^8NF_=,@-YBWL!,]?@/8B&\CN>,Y\EL:FI^XO+B=;Q$SZ5B".C
M"ZO8H(! 6 *T-47.%BC9LM#:%JEE*N8/1>Q#OZ%;R&.'XQNK\X2%X1#2W/J5
MI ^(_U%?(%>@8=C<#GK/.X_H#P*X#'_#ZX%IBR7=NC?UH[4]*0;CU#W$P+3&
MU<U%5H'0#IE>!/:9G(:3Y,T*UXNX?_T[-( XN?YAC#0P_\RUX@!'NRKP$YKP
M=E$-UHZ%C7V7IZ:S$G:J4RJ3IR0Z32JLC1+<]NT=^8GW\(H-BHS/) CL%8KR
M6JFF%(D]?LXD 3H"!TD*1#318]*_B:M8*-9L,OOO?*W O45'&+-Q3A+5G22_
MRN4R_#U3V-6]3VA!S$/C$PR,4)VZ$E.IO2'H"9P$PY-8::Z[(<Z!BT%OE#9;
M.U(Y5(.8I,C*6G,#:Q >GU22.B%U7TFON1<Y<VZAN.A!V5DRY)4P1<C?Q!80
M0FKK-5V<:O*LBH8.GYQ"/278'.LBH^')@#@)2.XG&LB4A:6C0/4^GQP-J28X
M\UW1]3BQ2!!U45H-\";E[QZ(<.]$FW6B?7X)_6N POL3 2<1*9RV$NNGT[&H
MZ_</H*\-J<1K+Z>6-6)\6N73A.'87*H5FN2/GSWYYE0H/?EGG;M !7#=EUVQ
MD0H4^D/Z&9Y31SOMH''I/_L</A*[N<'+56:^#3 YC:U]^DI!& Q<;CPYA_R>
M+U).Q:$K2Y,$&;6QW";(!HQ>!B<ZA4IGS*=D7G:XDGX.IL=T+^6J6Z,:#2]E
M)9DT6VB4TW[A167 :IG=H[=5Q]S^![VH-[L-<-$^#HK1&BS&H^=3A4W@B\</
M_1=B_L*E4&Y)JU!Z[N!3P-70#<#W8LEN F&4%9TI=_CQ@%3/[$/^"G64P]9(
M[^36Y%H*BG>BE8X!4:KFB#G^"\(=@^;&?"KB%)5YEH4/YP-;QE:BA@_!R_=&
MI,2^K_C-YW7ALB8(/>^NH8(.* XEE2CUV2-,G8"4/57R8WWEB T%FE,.*"2N
M0<\Z:"?DS3:_(;?["T^5J&0H!7$!@4"NLK4R! 9A8B2IB'MQ2:V"BT +1.C?
M.6RV(]Z?L(M-_0W\PC/=OBPQ=Z*#RW9-,_.Z;^HE?D;OK3>NHCVNK1XGQ1I)
M#&%F8/28 NV\2PK44W>556-]'8GXIRX4PG>O-[V1DXNL+;SDR98=$E0$LAG*
M81=3'":NJ+G "(\DV.JXH-BI959B_*"3%-'Y)FG%^7JV/K82B8AX$U3#EUR#
M(82<P-&(<%53RAGW'%]LQU18U:J%.S+O2Y?/&33DH-&/"/E>!2$DX&9RI2+I
M' SCKW]^\OP;_F=R].;E#V?'1+= #&$^C-# &U%W"R$*>'>ELDYK2_V0->]=
M9T7?05_1;U;BB9F89W']!%<3LKS3H>#*+D+H&1VDE _D3'OJOJ[;#N1_T']H
MU>DGVG+<JO#)F4V%+67+9=,';S/Y1UHO>?Q6E6(4\]VRG;!O)2<:?K/..O9R
MJ9R;N_M7(.I(OMP\32('Z,P97[;GLJ":$NNB7YNB)E8MUKDD)5./UG $1)VZ
M(F>I:^+?TE"8WE5C)!G%8=.[3'9;A_F6"U[%S<3T[Y[M [C(/:_EJVSOR8?_
MCD$2L5D&OJ\Q)2+,OR7=0X?\:/^>XRF@O7L.RGBV-=2&]IY<B&.L$%>0$K5Z
MQ?XEG*0T^;ZN<@Z.9!6WLBDS3D+VQV%H^<4,R;YT%QA52!L'&XOO>F(YJ S?
M#.46/, +>^.R*CGK.YA>/'AO758^P%E/OFMJF(9SUW4<)P?# WD5VL3G);1;
MT"O6#%!X=_;VN]?O'LEGQVFBG.C]$NS)MI;2;'C'X24-NL$A[.XWF@@.J^5@
MLO9]AY^!6++)S2JP9D2G$:U!>_'/DVRD)"QBX(](VPV[>WR0(B$LLS:HAY9H
M%32*]L'WS$=IBDG5Z&=  (Q(QF)M>4+5A>%9+L.Q6Q;-LE\CF<>25/-M+>5&
M[YVE_WK.TL^4D5T+)W8SW.*@0)0U[-M&3 P"[ B\J<,([IKM/*JPZR\H+Z-_
M /60B,5^J;BR'(;ZB/\DKS>=^&#I71QG*> X]$U#3KRZ\<I(&P1ZO=H39%U$
M^@TS(H&>Z+ZLB> >/<=BG!21,:)W+&8U]17=IS2GF96(5$V#,1\#-$@LM,C/
MDR/8@,CP,>O4+B35?DR&\@I!#34M*A6/8XYI*X]2&[0T7!*L6W1>7(:2,)K
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M/GL'?51^]'5U!@'D$&\AR/>1\8>K[249.8[HTH<)!"F5PL&@D12$ICEKZJI
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M*T<=%FA2VS=D2YA=7A,PLM6^F_IATX7+]W^/7>[7'GN=M4QYDS+]1ON@7CT
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M.PS%+">&13 LL5(/=LOM'^ARGW;=+AQZO#\V4[LB44L]9*&ENYX3=F-V2UH
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MHF61M0T4B -P);'G7\*K73,&60XQEB>8U8NBR[\Q,BY32UL5WR@SO%6^:.6
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MLUREXBDSD%*J^)O5_)LU1?&BK!<^BY P IJT'+#H,"D&J)Y&/:01</?G7T8
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MP$+GFF2W--,Q8-N'*5&#V>8QB*V+]*R8DK#E31B@4'1OD_H4@$442D$[)I-
M$)U+PC69# 90*I92S)D.JV0LT&D2E8P"Q+GLM?HV1M%H)#>(C6)E4RT&KENT
MXWMT#%"-YPO/*3=U@\JD3?N]"@;-;^D !+R/49,P6:4CX1$R,^(7D/3"LRL6
M'8)W%!]-D?$//DZ,,#'RGMQEY^S307AB[H2[[WZ8*=WL 6),9O)B&[E/Q<=+
M-T=4?D:K>>RAC'CZL5-CH<P+#DMJ\I38^8,)L-:_#3@)G>N0O"(<J(B7?(G3
M+D$FC2:-XB=:8IHECNG)/LW\,S/SZC$L*NAQT7&EEXMBU<'-E97D2A'F:8SR
M9F5WF<),</T!9*#EO#ZUS'P):)0$=2BG?)?U3:6.&>UU:,:?  %3*A&V@F;V
M:6:??T+/M$1'LC%XTS+((&8 \_BC7YO;(8UK='/) *3S]5"4QY(H'< !<<T.
M'V=R2RS^.&)XV?6,QE(P7:LG'*=$1"@:2[^E$"HG- CJ6(ID3JBG ^6+S%!5
MQ/E%IG;XC2K>.%Z""IYWYDN1$9Y7R<&R\RCD];FITOSXX0/B1J#2!/NT;[_Z
M6%FL&Y/!:6+(M<GID^>GB59^AC^>1.:<QMS4$N?LMJ%I1UP6B,PQ'F6. @Z
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M3^66?]]RRX&X[F.T@(79LY((#^G6"AH\ MW8;@B\8LZV1.LJE;A.R%IP'2'
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M$;GW5%*R35??,;BWQXG=]FBRR4JPC>3(K2MBT4XZVY^<-66BM<MN-+\VG@Y
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MK#;9=-0<E$MS^SK=C!J/(0ZW?_A/1_;!F,7+^UV:P[(:A]Q;K"8ZH(6#1YE
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MP;DD]*Q%'3F_<6Z%L01EA-,D7C?59?G9[4;:Q7=$(X,WV6$V\J6%1_5RIA1
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M,O.]A'+-[/SE5^<SE7!S_W@9!71:[M)T"T-O^\$=FI((%&.2N5R ZV%:)NK
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MFZY&)&$V>04@8*-C-RI'Q[K';@]KCWV?-DP_DC!/0O.L6CYSSBAT0^$*<(]
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MX%.:;K6"^F7$+D\O2[0TW-+FK#R!7S)5ZD19CE+D@B4Q(.J^(.989EC6+U
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MT=+(^@:ZU1[H&^H4M^ZKLWH(_NYCOW?*7!F*O-B:NY%LJ<=Y,=8>*\VLFJ@
M<@E/:OXVZ9+VMT%H  Z/G*[V3 -G]TB!^5R.P N.?A=Z]>6IRRZBUDXXWBX\
MZI4VZZZ+T@2W'DEMDP-2!%YDZPS3,3,27Y32)5;GS*AL6(>]YQL9+)[/*/;'
M)$O\+<&"&\KI7Q?Y>Q?WNS,VORU K.M]]Q\S8E 31@D>4)B24[*WC:D;$HB#
M-D[C6PY[1ITS\3"-?:=.&"/,O'A'4,Y.U/]#P] J'7V4"JM"L<15@?&1SY0T
MOO_UX"KR44VZN,N5=1@$2G7UGF$U<%;@,Z'M':D:@@BA^3N9^-:FMX))>#?Q
MS=W=5E?N@&NN1W^OYF?'%INF+GI*F3[RE.GC,++8Q4,I"_A<B7*7,X<(5#8I
M:TJRR"=UQ:(QL#=T5!?9/%^13!*5H!LYT\_/W/M]*<4^_4BWOD_K!<&HJ!W5
MU\U9YM[<L)N<.GRCNGP<4&MU9\-H&/ZEEDJ!P.,($ ZD/*>]S>MM-1/<U,O\
M@S0#AN$DH1^ZE]V8&C:^//HFN0&V+,=HPCI?+$)^6MYFYY/<RE%J&YY;.SL_
M1^[%^6279S^=S4X$$$&N^.GX6!%D[LH(Q.;UJ/V1G[D[0_Q@LY[JXR&?<3(B
M@,-;$^WH[C>F XYH4(FABDO,HM"-&:NKTD541;$Y#12.Y\*(JA%($,QYI;\)
M.L!]1Y0@:81R'3B7/5\X.C]GL]]8C_D^FQD2UYX,03\42SBIL3#19&\T20]K
M-B=5:CAM$>A,DF=>E3KT?-+4# X@.H +Z6,O+9/5H ^8&^MZMB+ZRR%GI?ZA
M6>^PMVVU941,&,DOBEJHR Q2F04WQXODK^\4]5W,PR'W1J$-S%%_*T %RGL0
M^CO=-)D.RR0:+=Z&7Z6?L0SMS[WO!G;1O0:5P%*V1;V!C_3 _>/J>P4EL2/H
MT1&FL5O+*M-C%%1R"51RD<=S+" L'P':+Q98EX]KMWU]#-CJO])QTTGL"J+W
M/D/Y\+HMJZGV>6R884IAF \H(K5WO^4DDX!MQ@K>34>=KKDP?JS3S:@Q&F*^
M^\;D=-LI\\%U;$WS?BOYL+S*J8$M%AG$#T*/I_S7@0:"JHYN@S9$VB=@H<BJ
MPC[]&;-ZHNHLF@^WTV&MW[BM_1=0LA[$T1B_XA&$2D(R!,*)<-]H;=C2#IBU
MY,8-M&J:I*'>XJ$'+V&39G,/(JVFC!Z4/%AR\RK](P#M1%8GLU@UX+R4A2+Q
MX7V,')26TY@:B3=>ZB7G=K\7GBS/XK.K2DA"Y-R?./L!Z2P7PN& :F#P$6?G
M2N#S\& @U\(H@HQ0X _V)T>OYGYV]K"*%'M7S7$(WZ4?""E,FGZ'?I[>V7LC
MSL#Z15=W)J(4,'4"4ST(J7>I&H@^;KBOG(M<ZDZUGK$0WTHDIV("%/8\I(8;
M^X2VX+ZE:! *E!/(_\'=LDPXFF;I-;5&XIA0+HM.@G-Q%L)VQ8\A93+T@DM"
MDZG!.HKOQA7+< -P091H!N?D"777U(/5J#!<^@'W&>/<VXUWOQE.1%+.2@'$
M&H\4\:8? OC<CYE9*:CCWD.'N4$-S^?RD9HD3)RS+1)'>IZPK2]X8FJ\"&SH
M_XCH$TKJ+8,R5^L,Y(U_.'>O6>2P;Z>J*:%^IY_99,? T)F@V,]*]'7(AX1V
M1'Z7B0L0HJ"H/3(;[QLRY:C[3)X)1"93Q3, ?'9?4ZSH'K_.2YFDIT3COVNB
M\5-;=5L0(8"#"\P&:72)D7GW,AL)YP+)3S?46&QIF[CQ$)@%LAJ2G83U?O&-
MY:BY#(]@UHCF3)*41W"S;WV/0[_3^TTM4=>*7GFC6I1[]3<L*56,T(@S%R)L
MJ8Q^]%\U[ZC&$.>H>$8LP:G (FKG8*YC=R4!R](TSD_ N)/9HF-BW=I4A-P:
MN$N@OLFD9=IMV3M.4]!3T/5"L5B1W>4J*%W$&:!/=K]VG):#0S(Y)6@7CIO2
M! ?L;^/^7>L&O*#B%M')V*#PJ!.WOW,"*5(\07P!-D4.M]T60R FGD63@:''
M7<VP10F;K<9:+DMK.H[SAES*J*E#[BZCOCS0]=/$+[1I%@_( C) I,K'%%^W
M0^"FQ@6<@N1^G6,=.BKCW<NRX2-8LD0\FFU'<?HDVG-HCR$'LB.'40_>)S]C
M'H_O3%.(,%K3)*4==/FP M6*A%RL<D3PSB#<?.N^[\YK"$5IN!Z#U\2E&4)?
M\E0W1P6>C>G4$>S%FV/[IN!26QSU^XW2!7HMV><G\L_KK,S$]%7W958+,P6%
M%_PKJ0C*Q^@_C<]59!+8S)8YD>&[HYMPIR#<<WTR_52:%"G#YH:;Q846^5<>
M_ZM!N@=9DX3SW@F"7#?(YC9?\W5C]+\Q$#FC>@I3V<)@P?>/8U8P8BQ3VYZI
M"D)X$QE'HJ0<U FRP-^E$TI$8T;^<\JYTJ;BP;OWE1.-;9&5-R[BP"E-A2J?
MHC7/"EZ.F)7PB/!_M^F"I]R-E?8GS2ZZD;3;9_ 8'/A#G[AKFCAYQ52Z85MI
MAEUQ4GK0X].WP:T7^TKMWZ<NS :6NRJR8M-/:L 1N??[.T)B<EYDGN5KG__8
MU5:E?5BE&_?<]^XBCTMO2_77.@/AXJGMKQ[=,NXMG*W]9R;-U7040CKH^)9X
M/GDVU(10BYT8D;G2&I)$4=-0'D-[G@SZ3?Z*S9"T<TN5 ']JA=[WXTQ._6?=
MSY]E'R@G-HMU^N3+PI.EOQN@W6XE+$(N;"B1$R)'YZ[*%U-??A1KM]BR=A(>
MGS]_)L ;>]UX[A\#!"D%M>&;!QLYJ:^_.C^Y/3VY.!W/% KE#Z6B[[*RHZ<M
M4"8Y__KU*\Y64M;,?< B(.F//"!Q0$?AU:6TZ^705R(+*Y$R^A,6ZBYB:>!V
M#G@UC23F6"Z!HUNWW8G"0B0]22-HEM[4&9NKK%2"Z;;2^X1E%=S]3&E,1I,0
M&'-PC0VIF_S2OCX_F=/2GER>ALW G]ZV(@?B++X09Y&&*KZ2Y8$!L()Z>@>>
M77RAL+L4.G_B7^D3(]?.>%^)K]*I*L_&6D"^_Y9Y \0.U^#<IV5-P?9 /FE5
MTB\COY>+6\/!CV6%U4-+K:\)'Y-]T-$/F??!% RGJ?;>JH28?]UKCWKI^)6A
MB8YD[I^RV$]9[$\5,/3C:3CX49 X'N -3P[? R P=/]+I $0W#$?J(V*T5W&
MUW0X<#@ AV1T+_Z"")VU9/8,TY=I7G1A2C1@MF@QB76)5HM0$ALV=P2@R9=2
MI'-^/3D)_M]<M(/6O)0<<0,0TMCBQ)S[.A=93EP+@@N#W1;GGZK%_.QV(S0(
M.X*BP9OLN*#RI06T]5*W%,=WE!B 6N>-YV,8\]5DTL;S7CF#DC;H.0U=>\8A
M)X1@NPF$K,,OP#U)MX1$= 0#43@&8*8?/%J!FOJ0/7G(SCFD@_#2>!\/W_UN
MIG2S!U$NA,G7FRA]*CE>^"@1 [U2YQZ@C?CR8Z?&;VS.E&(>!+$J<7YO FST
M;PM.0KIEN_RT0[$)>"?/HTK3+D4FK28-ZB<J#<H6QXSDD&;^E9EYS1CFI1MQ
M#B:O9':3+PF3E19(I0AC(.$)TH)$;^9"V4H\80ROUAR E^XD2U %&<R'K&\B
M&B78Z^XQ_@1(>X42&"HN_I!F]JM/F)F6ZDBJ$BKVM@BMMH1.H=:5Z*_-[9#$
MVJK,*4ND:QX!=2&] 0&&$K,D^SI3-B=%HT$/[+;/:"V%X+ =**H#1[?@:E!"
MK>9S4OZ%.JJ*F(T$0CWG"PD/#?GXBXSFZ\Y@8E@O(0?/)_.%I]7+1O7G44A'
M%T;']>+Y,[0#@?'VD/;MZX^UQ;HQ68A&4@;-[/SE5^<S5>QT_W@9)0ZTYJ8Y
M'P82]Y,(:-\B#)C)*',5L ?AFBA&>WPV/V8B36(3*IKQH-&?7(\F.SA8Y:PN
M!E&1FB:UQ&@7<-T5TG-2$P"6J):4.S)*WI0BD17-ZG0N9\QAS%>J$1_QD?A5
M,.-//(.[3"=3VC/4#"_7&&XTH,1E<0;$"H>T;[_^R]RK.O@14FV JTPH68;W
M!RABD=Y;&&'21SW<8;?\T2U&(1+XYB'4+]C;\R_[]M986'QJP4S3#S&:DSG2
MSU3!?7[:[W'#4:]6UZ+PYRF/KBN2I *%/QV'-EL] C56(^,MD)*<>V4@KQGM
MZ&!Q>#<+"L=&<0_9?B9HLV#1,](4HUN5NNC7V1PA<&$WETJ-Y50(2^'LQNBZ
MK: T+SDFPL'DWE@_'EH<UD]7#,A'W4;BA9M>?4G?[HOQT,!@Y#&C#SEJ>--E
MPRS)?VZ%K=A<D*4;?] >G0E^P\#GS^J5/J)7/>WWE0^2*)<K-ROS-.&R1U;7
MI#RM2M%NN]#.HMN2:\8Q+73\,.7=^PZ9."X?OZD*9YKR-"AD38Y5HJ1XR"?Y
MJ;@"M)46U/4MD*JHA/R4U7[*:G\:8[ 5K+!G)?XDIUT=PXUZ4"11].9\*(MB
MPPE3(7KFVZV-):'NC=%!L7LO2*6)A.;4L>U!3^P@HR*A#!#IRE&4(R8FGJKI
M&3K%%,G)S[31S6=1*Z\*$C753<R[9J:M6A.9NJ;JZCDG4T[R._XN1G$1V+,W
M6.YQF:/RG-5(O:SK?$4Q=-.M2>.2K\H[)7>+0;XR[0(2 \E$:/@;FZ\&WZ4L
M_MR5=TT-Q2VY+/P<HOL0RUS5/.@[=UZ%WT#2&-3)!9T-<F9HE>Q IE;K+^H]
M_3S8_ZN<E0!^<$?CT#V+X.I:+*S-N>#HRALMW1L=@XK(KT$L0_;;W]=Z#/ZO
M\*U!CO6-4 &0O>&=;CX*6NY#7T!2L=KC-<9X6R7ZC-%VZ3AO8N=)0I"94QO$
M6A^XG6FO&,+(T8[*",#"<2-?'[N=SVJ?/YKR4.\#2]](2,.]UX9X;3B=?Z>_
M\$ G)5H)N=P>X:2'B1O5%O L")*=^!)/W+R3B5YU*S<ID)=/?5*HQYF@H/^(
M.S'Z0U5SI<QK$_,>,(+. \;.O_JF,9K/=HC,ID"IK+2YM6R;Y[Z!=HM:K'_O
M\,2%\&U2<F\+YV9$6F _O0<WJS2\ZV?.9K^S0(OFQ)=5X3:[$@/O<5#09!3S
MD@;RQ]%'C/5/T*A->HCE9+27U(!A7#R<,4?'X+F)W[8DNNY6*FA'F]TG)%OD
MRZT]],CK2LMIT[JWH0Y@R+A1O<$V,;H$Y!R0)'7X"3*5NR<0WH6P&?3.@!B%
M,LJ9824EHQ%U6J"!F_VLB&BSI FHBUR]0E_^8(T[+D%$I$FQBJDE)H#.'$G:
MLTZJ_)1[B9Q#(W+W0W8P-!N73;=:1?[5R"(&E@1&^\'6<%J;)P7JFU)<5^*=
M??8I6>]ZA*%TW[D]ZHR(-'Q%0)%VA!WHUZ[(9N<OLV?G)E"Y"FQ WRL;T"5?
M?^=?7[RT:-=$8Q/[AYQ*"%5DPRZ$&(A^:RL@K<>E)X.:F+:]#SX$^3F+WQ@M
M,$S(@@W8!?;84>X$C-?K0KU'L\#]%XZRG=C.RX+B.#_,/?9S_"W&];B?6.J(
MDGK[ G@A<_%OA9#"K077&6LRJ.+,A+:LQFR9CW\!2G7>Y77;A>M*Y^>H3^#?
MR[TGQA@COYS]D^#6;=D5V_N0UE3P+6^>%=E2\E)V+IY]1N!X[I?RTW_[-]&T
MG)^?O?J*YL$Y7%0ML#5O:27L$>YYO^W3>*0,0"$P,1G8NE=TQ0ED9WM;Y\93
M4O71)E6/X+ ?SFE_?7;QDN9!F.HF>.J"ODO$6FMBN4$$:#,"VZW&X#QS(3O=
MDOLZY*4]G+7]\NSY.:]MD=\QP'B>=HV2FLJ/ S!*F3191<.%F84RY7M7Q*\5
M7P[90%4J%1JGK/9\6@%^S;4WC27WR00(Y[.)Z(^?(_A=_W3!L70SNUH39 >Q
M^C!!-'%6)#L0G3Y%#QI]'KN\\==109RRM7.EF\3WG_3VBB(R!6L>Z(D'N:QT
M5KII GB.;45>#M=7,B%=:?(\H>_* W2=LTM )F,4 C$"@@M\L?\^#>\_@1=R
MU!M00U^)988)S1&?'/E+91;;PV7/EUSWGC%5.K<"T-.5\T23II)1<"]59K47
MV&CQOD@$>5#\/G2^@)1,#A^X;L;1TZ.YZ\",3]^A,5?6\,1QEHBORD6=WI<2
MY>5(&"S9T*(^JLEN8E'/JZXIM"\D /0D/Q2)PO@<4MRJ9WAVK:*.#]=#8CQ*
MB8^DN3V.@Q+H1[V5WRZ]_ W;2,/"\O7S+P#OV7K-C,_F@(D254F_"; %%E6T
M"P)HN&$6B:E-B%1"YND/>^?#XXCM 2GRK*,'=6,%D*2W;;<14L:O,;J7KS>6
MW82S)U4]/"NP(-C=.(2T)@G;AP';)C*H#Z#<C%7G>\G6&^>SE#UJ^V&JOI?4
MCR+$\:0#+\Y@;D--RGBQ/99/&B6K745;J3>:D&;S /PHKVK?TW;(7[% ]W#$
M"M4:"(>B*O,7E6)Z[_KG*C-;'K:E4+/7!!RU%?M=[HFR\GQ8-(&E[Y8#.XTG
MI_$5F+R\JPHA91DI'% G#]#Y.5 N!(3+ 0I%UZ5VH1 &8P$_SUFTQI,*, [_
M;/8[T3F[OTOB7R2,7F?LNC*4VW*0Y4])Y^Z*YH0)V%D]/;5A]:HS:3D2)H]&
M7+S0*F,EKT=V ^T>*4%U$-$@R%'#YBGLZD5VW<:"=&)A '_7T<#?2 4XW]6^
M&ZIQ/O0<_0ETCS-G0XV(YH$AR;]LG^&)_P?S.-\#Y_ =K04OS*$?$C&'WX+W
M\VU@F?D1-!>_<EP)YW.(&!W'$M0LSZY<HH-GNJL0 8:82_D*TJR9YUD3&H#:
M3#N $(RA\X=<U56&3<ZW(HY.7C>MUG)+SR,/'V3./J$PRX_L;]J;7=TS#+Q%
MQ_Z<C+$4AE\-KL<]AL"N-;/EC%2LI<>+W]4K,2 53S>WLR-%1:>+YY_/R%;7
M)-=B"8^-(E-/G*Q,8X$JR-NR175?WNAJH: VNEA]I\)96GQY(&'A=\ <4/"B
M:D:OGK>WZ/&:'/A3BOG?+\7\F=@HO,$:,U5> @K 3-FC]AALV#F4S@R#.J7H
MU(UP^EP-'W4:IV.<4U KR);,T1Y&VEZT0@$7U3D9J9N3]"8T192OME1C$H@M
MA_58,66+ 33-/',,AH-,6=>,/GN_M\(D"@98;='"7[+XMMW)D\!"IPR0_;M'
M(D4VTL.Y,<P,>6._G[TI,_7$":JAK!I<I.G5"E.I.:]7@28CRB62[@+5S=F1
MH@P(I6-8'5M2.6%\]WH; %40))^E#T?D&CC_EPF4:C;/ZWFW:M"UCOQ/S:A!
M=._HSHG!"JH:'58^Z=?[1V\T3F-S(+K[ [Q'XNUFLE>Z^'MLFM.C#EZF((]#
M+ZSGXX3+VCLFV]AI/P\#+1U?$/;PGI+_)]H$RYK@#LE=MDGE['! L\@;KV-A
M6Q"(UH-5'%=9?2-E&>?@5$6^2$5M@C()#*^W:%IUQ^(P2PILR-%X?#VY3YP+
M(I^1>NM:;6X2:6CZ.7T@7^0IIS'2]T082">)3Z4DZ65]X\ZFDU3R'FB%RJ6[
MS W[2ONK+TX6EBO0HI^((C?,!Y.:R*75']4A-2*_T V!7F^M55!O@HI*L^6E
M=RAR%_$N?.^FVPOPX;8Q&7Y.\IK;; !&Y%Z2D&LX,5D9I48);.C<H#.UH8W5
MCSI?O&S3)]QCDH4<V6N);[YN;T>X D]B5DS&!5XLGEU,?+WG^3*&H]C@O(;,
MY9=!6:B%?)M-17=*N0<JL$;'_#\5=MI56\W?'_7-L4-D,,YUV8J589X6 >Z1
M^YDJ4.FI$<A)QRPYF;IB\XR6>!%VPX:/=H_N%@;TY/J4"ENYB^X7)/A=;$Q<
MS=LUC#J9ND!,T8+^PBZI_FSPY=Q);BP\_55#?"SB5YF']O=)-%X#](V'ZPM7
M^[X=)2RY.2X?/S4//P;]J?#%"#,71[WK)UM$^F' +@?*A<RWDZF?O:*5C\E9
M'M,<]U\^GM'4I*6^3=,+)N!K*:OM?+2?JFJQ\>TNA(>@Z(9JS7?.^7-/[*02
M:-EQY8&$I;BIU&V+GB05&OO5WW[[+/[JJ__\CXO7W_SRI[Y4GG'J*<_#,PQ#
M-T?X42([T*D9<J0XC> >V8]''Y&$M^R=:-7BC1-O#=YDE;.[5]1$Z\[FVW)^
M1M=7?)W$GWIC&Z>!0FF;L*:/8@:C3=.C1'#!E:;6XWFAJ9"]ZV& LY,7IR)?
M,_R VXQZ7B!ERUUSVF[M88=$'MH8A,M81CIDGDGS'F$_"]JB%_ IT?N4Z/U$
M!XBB@'SA@Y2Y+^AJH*3TLP7Q5\VK&Z93 +BR8>(:W=]&&\'WLG)_(U!7[C3*
M,="@ZL(YS2>OW($+K2MQYU)LZC7UA@Y][A'@2X).SM1)18(.[@N?OU6B+BR8
MHECV]3&80&_)K/%3<_5C45W[N[7QM\;"DQ8M^W]*?_)(+POK]AM5"G@Z'B4C
ML4;JV\B8QM+[QZ%,;X,')856_GZ3H[4T!7<$(75[E[@WF#D/?I,24<A-<5VE
M-;+/',E4==/[GJ->C'>#:L6N["YGA3)P/-_6='IM*NPO2I^&<4QE.LV6V3?A
MF0PRGF>S2T7, .;+%$TJ;W#M;!D]!R:*&-H\ZYJO_/,$R% '8[1T5_QPQON
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MH^!IW2B&BL\A,Y9)5=E-K'@8NR &<KF.E6W14D<?GBN_)#FA6IPE29FTX1(
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M#(/]6IP**0OUL*A<%O/LI\:ZR4^H%"1RCE0PJ#FND%1[8S4K&!Z+?TEPJV7
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M@)T,C0[PMF.D8[9AP0B:E\XL@6U<*$[.S(,,M27FY97F8 LP2 + Z'RB;*"
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MZP>U!]0*^38U$ IQHW+Q%DT%.<@"Y4(LQ:2"[X-?V!WEGOAF3.%9ZG^APZ"
M@J&G7(A%DT3.4J*G7(BEJ"1QRRGQ0SXOHEQ0+J:CB>#M)8%R0:1B$L$IY7A@
MBP34OQI]H3/FQ^L5010H&[;25/"&LJ#4<;7GJ$ A;BQU7&V_>,B4'W1<;9O-
M? &8WI' N:,+L7CC^#]6ML X=<;>V8,U(=Z8G@*H.;$*I")U>*W8Q)"I9"AU
ME*U9&#ST2QW:VB\>&EGBH=3QI#W@086:GGZIXS_[1EI.13_]4L=K]BOQLC0'
M^\I&3/9I@;UJ$_XOQ/&^,M__//^5VF/'&]]0EV ADC]Q9BN!%.)/SEUV'SV8
MU;:BY;Y0'\Y.%C50BVW++ZA]XD?/+O9?'-I4-HY3"MJ\I,&%=T?] '^H"?0E
M!*IL@$L) GV.""Z99R=T4!RD*QM-4S=FD2G\E0U@*09_)7PS90-,2DC( S0O
MM][$9^(2SZ*#":7!5V9MV(:X_WP:<H[Y2ZQV+$S-2J.N;,"O%'Q15--6,X=@
M#F6CL$HP1Y9FM28X07#*1I#W '8EB%TAW"L;B%9"V&@+]=7,"?+8*J98U+D!
M;:1J_GB</W1^HJAV:G%I3MF4PWX@KP3)*X3^@TP^:&OUS3WXKPX9.FZA+@(V
MZ@>9&=+VJN:0K3E$I^.*:K$6F.I,99-=^X*]$F2O$ 'HA(ZV6M_(GR^D@%0V
M_U0*_M"&:RF81"?JBFJ[%ISPE$V#[1'\2A"_0C2@4SW:@LV0-C.\/-XPE4T)
ME8(VBVH]*D2@.FE5C&M2F2+](),Q"L'_($/]+X"_ MT0&@UE(^1*2,@#-"^S
M]@'?KC _2R'6T(D#;=IJYGB$.736H*@!T8(2G+(1>'U-:N^X5S8(KH2PT19J
MAEF*HHE%G1O01JKFC\?Y0^<GBFJG%I?FE$TYZ&M2;X'^@TP^:&NUM.7XF3+'
M06:&M+VJ.61;#FGJ=%Q1+=8B4YVRR2Y]3>IM"$ G=+356K)"_$SY0]G\DQ+\
MH0GQS0A1)\.*:A\6G/"4337IJTAO1@,%3Z><P<]MF]J+IS>,H]XK31Q"-.=U
M])KEU;FFLJD83:]EH==,Y:O.'16("!08<M-H*IM0N? L-J6# (Z&O]QLF)TR
M/[@:#8A;6DM,!2)I*9M3T$2R3B0YW0-K*9L"T$2R3B2-[8FDD261Z#2!\F'0
M)]G%G_^0T1#Y%*P&/Z<E57LZ9J^)M3#J5\?U-;$6Q@Q0-A=0"&+=2Q)*/>+,
M2^T7/$FAB;/,:K[@&0E-G&56ZP>9?B@JLI2-_&^'K LX#:=^< ,0&-R361$\
MA8):1&UEX_^)T#W[*X1]G;+IC'F8=E[&V8EEA=/01:1=TN"[QREQG7]3>Y%N
MCM/4>TWU-C),];:5#;?OCI,O=.1XU/Y,/?A+<.T2SS^Q_PPE9HJ#$65CV[MC
M)&8'X)9TZ3F])KQ0*%$V@KL[2FXYL(4LG2DB<R@;GBR "E'!\6PK&[)37M\H
M@3YE@UKJ*R<E\*=LW$=93:8$VI2-B+RUVMMZ8S?4<HGOP_%D&.TJ#*Y&J6W(
MZ[JP74XG^%N,$F!D;7G?+UVEI&2H;*SG;96W)L(<B;!3HBC2JTP0385Y4F&)
MXF8O,:0T\>5)?,J&"#6V]X#M$D4?\TR;9'E#KE.B.&1^:9-,,5*BP&*.:9-,
M45*B8.';ITTRQ42)PG[YIDUR*IWHE"@ F&?:)"_TE2APEFO:)"?\=4L4<\HC
M;9(7VDH4I-%ID^*2H;+A&ITV.1PB+%$42:=-"DN%)8J;Z;1)T8A/V1"AQO8>
ML%VBZ&.>:9,L&V%V2Q2'S"]MDBE&2A18S#%MDBE*2A0L?/NT29:8Z"D;]OL<
M^B!\?/_$ DSXSO(]\7\2.&-8TDQ(3]F87CXXV1?I*QNS>A+,IY3OG?";U7J[
M6F]L0_@KC[Z.\)4-X.2!D:5$^1*07T?VRL8G,I N6[_KW/&<@'X%!Q&<#0#F
MV!FZ5 [A_3S_1OYD_!0=S=6&!G?493/0^=2:>,QEX_F-,Y[L>6)RIC)/V?C
MJSFLC*C/E.^5#18HR_>"],"B9U/*3T"Q.7[ G6$8,)X>S5 @[E<V-J$H]ZM
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M[$H:-W3L 'Z(%US"-S%Y=,''O;WYU^]G-^#3WERO4LC5S<EM#D[NMAAZ=_9
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MMHZ].4MOF,UWY/U&G_;1 +?2 18%*6CGN&J4BHGD'/8$P/@$"0**[8D1:X!
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MZ!QI=37/Q>T92,=M/)#BG_7S]\'%Y=E@4-N!6Y<IOKE\KDSGW#]K\HN!MH.
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MVN\IJU6,*W<^G86^<343%@5^:'P-;/AF,'6"2?3H)9U-Z+V$U_KG +BUXYX
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M<3G#.(G;B%",'TQC1S"*LHMP<WP*.8W8\=#U%;%,P3K@S%IJ>HJ/)NF&U'4
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M(EB_DG(?D#/P! N%&7'=%&LLA]*\!NO+EGHKTI]/"J=B*B,DB:1R$(0WR!C
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M VYR%'&5!9.&<8$,ZDN#R"#"4.3>6)QNC50V2AV*60LEJ?M1R2&NV46U84]
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M!8RL&^9.8H8)4RR!O!'Q-[D5[])TP']RR41P2]AT(O2.DB@>)7C9FL/I8ID
M5XF%1C&;TFD-/W&=<.;_04=E)%UQRZ]9R"K#TK'Y?J0"1+D\".4C'F&QLH)P
M9A[RE&*6($4[43%,//2(5DL.X%N2/J"63W.M,O+,-E\8"#'&W]"1J&:BO\R.
M&V+?Y5=0T]/Q!/XO*"22.JYW^KC_*F=_-K1]:;Y52U+1(49>']P#<B@IG/2X
MX5+H!CA%#QT_#$OCJQA3:/$\Z;%EUDQXF:P%A-G/57$VL!UA!H8"%(7.TFE
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M49H)G$*26M]7X3JQ^#3"C$?U:6 %YV#'WTPI'Z>2AF: %ZZ*VQ&/96>I+@&
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M455C9#.#2U):9#GGGI4?CIW,[#4 #E#R7>/Y:@JZ?1F]0ZUP\D+?LNH-1/J
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MWJ6(66<0]T.4T784!1*?.<O33[.,\XP1TW^I('PNXO\0B%5^0QXK\!X$HY7
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MMOFM^6QPGFJ;#>3+J\R]*@9ZI2N6O_4&3HO2;YYSU(MMH^I1MX@Y1C=(= 4
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M(&O:6$0)LV%=<1E^ZVWT[FW[G0(ERO?^ .+GQ6"50ZGRU/):ZNKDCG %*#.
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M3G-W&89I)N<*"PG&@IQ\IMFKS,)-)\-,OA/6"XD@JID[0XB^/XC1"/[O7^3
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M-,76@6*/AN+:FN)V1W$55=?5+X!Y&\2V5S9#22"8[_9#&[#H!,G(8RF25U+
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M3/RS39_#7UJ- C"L>6,A>.F55K<%K[0Z0_Y*JVVM?J4D*#>,XCP]V<8\#!Q
MO.$1U$-V[P9)Y#W)/3GP%_@]4L<,#AX9=P#+$6/^$DXN?">(QL'\:8$$;6-\
M9_M3Q/,&M/<G@S?<(RXG'AL3%.Y8Q,0:""I8VS/NW"@.0A0[QAPX+7 BW'L$
M.V1.(Y4'U7 _R9)4T')Q"5+ L^<1^R#_\M%Q(R"GIP^N3VQ-/_J8?R$.PEB0
MEO1"_O7'!]>)[U"F-9HDUV22L'BS^+H!7_VR_/D0%*AF\5?-AO6STLQ/?BD$
M#QS[W4J%-G=YK$[ 3O7:%<+7=?[KG6MU.BW'&5O#_K#;:?>L47LPMD>.U70F
M+=;J]OY?M_6N &=+4%&^6X#YR O&/Y8@',P%9#N#1KO=7EABF22V=0,L769T
M YP'/L&8!, W%ALW*!)*4/1N+[#<]GW8/I=HP+4D;D"HA,R.X#O,3OG9(+F,
M4@ ^07&%60 _X]-C6"<&X6R,DQ D]_C)Q&=!P#&4*_)#@ST*V1+2[>:SJ1V[
M]PS%UVQNC_.;&#T9S4;WYX9Q\8BBC6XUD(KXF7@<!:L]_CMQ(Q=%?$1[ F@S
M@".*)[BP<F=:VJ5R0'C;$!C/F(3!3/DX\=W8N \\D*;\Q/B,DS 4FG< 2!#,
M<Y!K+.+7L/JX7(2N,W@(< ]86_AQ=.?.N:"VQV$ =Q]*2WD1PJJ'04EME9((
MA$N49#5ZVZ<DZXTH"0V.9TFIB2=^ 2EM0$!?F7.3A%-Z#2E+J3KXI! 7?3T+
M0,?(:3?UIKYB,;SNP/LGE=>=9JV0KA%K==Y,2'<W$-+]W7)6PSA(6EL0X_T"
M6FNAFK!M6FN_G1AO[1^Q+9%<H=H]LQ]/N9[=)C7[XPRHDG_0XA\L*^9%^OX+
M=/I.S77ZW&VX?[=';OOKKHL!*BF+'#PDR;UE!NZ_$0,/<.75_/MZ#JU <:J5
M0W,E[7!O-MX!_&\YR[!=:!D.WY:.>MO4YZUG]/FY#0(/".()7CR)8&7\D6(J
M>L%#1??"6GV]0.W8T)?3+9+M=1/,GPD"W\-@XL9[(X[YIN>T:4+P3U;'['2:
MZ UNF\WN0#B$+;/;'T@IS5W"IN(31IKYP9Z 4F?SP">* !I'LA>, P3&/KQ:
M[]P+YVF__:SS=-.E6L\O]4P#B+7) LN/%41)Q^@&#W<?F%/9R_C'*/SEU^\L
MQ,T5*$$OZHQ1/.^Z?@6QR'%OTG5F;R+FO5;]TZI+ 7O/ N+[W6^F&+TD0$@'
M@FU6D9Y5!_99,5*M:8SF!R<LB\_Z?YDK9.8^5M%>KKYXA3]?C]A]X=>OMI],
M;(SSHX&%^(V2^1Q,'% XR62*XNBPV?BDTWQ_/(Q\Z6.J3! ^P=O8?(X6[APM
MT8GMAL:][27LT)F[+*ZE&>2#0;9:\U]\:A>+[H,46JF+MRM(;]UG7;R];ZT6
MCE<7WQ=9_WI=?&_$>N>(5+8*=/&]4<YZ1V1CO9DJOC=<7(TJOB]\_$:J^-[P
M]DGKF RO&Y%.;WM&,(_=F?MO&X.6Q.<!51]$<S;&4@=@]W#*#IW57X!\;30M
M&DV=HS>:]JSD[[",IGQ1R8K$-+%(MP-OF0<\5>,#55.Y]RP+$2^DBXD <S/[
MB3T"H"7QZI\L!5OW)=+=[30ZW6XED>Y.N]'NK%]JPTAW;<7>)\1::-@SX+*8
M\GI@98_R?]CCF $'S2FEQ@Y9^E 08CX27;,/;L3X58LU<HT-;MF70J28-(F;
MMUH7G;9G$0RZ ?O>A=GAI^QT%#+[QZD] 9[Z8'L/]E.$A*3FG0"CR-*U'NQJ
MD47WA!';5J/5*V:XLHP(2W7;@VJ6PNR5];MZ3L=94S*X2SW':FY$P3>WU__Z
M_>+:.+^Z_GYU?79[>?5M$^5XDT,_D\_S)H![<[FP(5@I4?BWJ^NOAM4\_;V,
MD#B&2M -\OS@2K'QLD%M \0DINJI^:8RA11,>E14?TZ3LRG%%!W^/Z<E%POY
MH*KCEBS$B7T?A"1"U^2BBE_/-O C+9<JNO[$(XO4#I^H;#O"#%J1:8L+3=Q'
MD?9[#S^DO>3?Q!<&H#PPS\/_BOW )0Q[%>8NP,A]UN^QIK)F7]&OX)JCO]48
MR(]:Y=%?$=+%CT/[ 1: VYW<#_2HJW8GB-Q'8P; N:-TU+2/0>X- *O)!';,
M?/C__<V-__/.13V%33$?&_WKE,WK!X!N ,/4!ZUQC"GD3@C62[B0G0M@F*ZB
MD#QYC%C\@/T:"CI#F-A/9,I\%A)[LT?05>/<CA!QV(X!0)+X&6F(I'AL.,$[
ME6#O!49?31+,A^>\"3\# >S. =^ U!"3\>=PI?%]P?8?XCO9%8(GM/,C<2RM
MK5:2>XP!&O3[7 :[^'8/**,X+_T:H&F'XSO3^,3NF1=0QC[!X<*'73)&G'<!
MZ/*C-85$NR7O[!#.PB&8<@@F#O&<B./7F<-449=6;O8R ==>ECR<M, .0_<G
MF'!((R!\8%?N&!N-3!-^&Z62Z )H;<X 3'_X\/$>4-&V$-!>1,! (*"?Z1RM
MHOM>_HB00#=\$&:=9^S$']\QT0WH(71C=@J7#FY MB]R84NP9Y0O=@2W$:^_
MD7<8859IFH/+^.RA-*;E"?8 X\5RXP:T(8"N:7SF,IV@=.: R>Q&<4A>L%1J
M[$]%<7JJJ7(J.W^J5XB1=@>,84[&\-?^&D$RAJVZ?B+IV "C RXW:IR$6^)R
M1H14B,*C-8$82=H>F\+7H!*!3A2MT[65\K-32>RD0-6QJ\)V,-G&#SG2>.\O
M)N0 K_1#*X/WH()G>C\;J82"I26:J)56NZ6*#_+GG8Z(/NP'.W0X,O\O )39
M!IO-O>")82^U.U@>*P#)K BX'J)@*7T=5E(58C8C("<5DG0V3E\(';1@HIA7
M[,E#XQY!'P93AU[)%2E3=.RB?EIY!0LAB*6*8L&<,,8;$4 /\.)9'HRA!191
MSS!T.N!!3.4DP#M J#/:,@% TO$XF,T 6;(?FQ"V:'H!]< 1 C_?V4Q1Y@AF
M(6\UAE)YGL"MA>6+@)ROP<A-(N-R9D^EM7$.* &"O0Z KE';(_#Z>,^#8DS7
MRH@T4?CUB-&/QG<NW(".V-@8/2U4(=?$C<"+$[@=2(]-S4*Z?(C=IWAI8CFG
MZ["0V+>._%9\'YPMF,.7V35Z1M=H#4]2+#D63[*L$% E9 ]K''_JM;N\!K+7
MZN<+(//UCQ%37/O4[2[O0,AW_EM40!2BS5PMZ*\(DBA7*VPJMO@Y"^%;;)5W
M;T?C!*,+7^!>P+><T'?O:8N<V^@77.PTC&LV >+&WH<!%C3WZ+F!;.B8ZY;T
MF^O;/G'B30P?<.&!(FR"#249MN"#?\WVC)@_!X'SX'I<O/ FBI=@AKHAG:^&
MQRBFY$M!+I(2>4M/(9.F\HQN>C+UIC)^ZG1[HL6D5;85_JT[8]A^X@$DY\SV
M-W7H%I_"J# 6OAG<%&9<[GJZ1_UQ)/X%VJ>\D2N\'%L)S.B('CI!4#%I]\I.
M<-QS))/.%[(H\<B))1J,/I'+5^@90OP*M]%"*]>LY2OZA)GG<#4<U*$E 3HP
M#8OSDM6O6HKJCCG5,,G"I9T3E3R1+9.3LBON$!OQ"B'9[2RAW>*J :#^>&[.
MJSEIKL!$ESZHZ:R&&U_1/2;=N$L;YTI>V^P-",OF8"":7;3,0<=:J>HM+9/9
M_P5&)C>>@#JL'C4"4]4[:XB^ FF'Y<TI_D!7M#OB;TZ)CSSW:"%1YY51<$].
M<S( $Q!Q7*DEVX><#D_"Z;_0DV,/'%/EF\(%B]C9/-C5&HI.A!F&6@-JY\HQ
MU%@;0WC-B]6WB!?W,M) FE/C$16]21ZQ+WKB\2-6]B9U6?$FZF";GFFSEC%'
MT3&F\WR[[0H[QM2D^4QOGYK/+%UZK^X_4RZ1Y_GTVSI";8V\W#P/:C^/KLK1
M0ZL3T6V)5D"@5_\YW ?:ENCX:&U8_UFK!TIK!U"7=?0ML/I4GFT<]B%/VL=4
MI\J["QQV\:GH\/4RNMV;4PZ.J">&;F,V/ I1W#JJG@'EDD4/6YIUCT%D5]%2
M=%]$=IF\PP.7:CTNU Y=>!]HH\V*6QH>CF]ET.AJWXKVXVV%UOJ-LEE9FM:T
M'T_[\8[(CW=$K22/P8G7.0:#L']$!J'VX4D+Z< %\7$U_M1.O(4K^,!%=OD)
M$_LKLK4/KPIM9&\.684V4C^Q77%WW</QJ0P;9<L9M4]%^^^TKWB_:*V@RV.-
MJ\^PW"6=I/U,/[*R=3=J.0^6VV!AF])O!HN_?*7WBS+<.S+EAWSZ-]>#TI(V
MZA[RRC8KHBG@Z]H^UK$\<C=X;J=X;KT6S[S%T$8-&$7/HOPW=X!/, 5SS3;'
M]MR-@4A$.ZZTM%J"(1L'G[6!N7/'=[A$&-RG'3#:ZRBF&I)<ZL.4[XZS2?L;
MFS<B]+&*UZ/2^['M,'B&2MD*&N'L+1F_HBX02U/+"2C^.T&Y6B15@4L5?*_'
M90DA]-KFOK*F-&N^B]U!P_OU"%1%7V$[!3WM04][>%-=54][* <OJ[_ IGK:
M@Y[VH*<]Z&D/^SGM06F88FU1 5S1LH?WM^/ZW8GHV?O>Q,8%>Z/$7HF.2?P,
M+#T#ZJ:H@I[\9 W[\.^3GUI6E_<]A(^Z@_?K>C;FU&)<2:S[O$\E-X; 134.
M3$>YO2+%E!O;Z9,++^*[40VNY=VL4;KY;K!W"FBL3#0[M<?CD)NUXIW8TJK;
M3.WNA1[7;#)A8S*=8,>Q1^VJ9$>6/WQJ*DEMK, (8 Y97>*TL?UHV& K\P[^
M3\P.(WB!U8%?AD$RO<-_#!9:9QF6]>J666K7[D4,R'XV-23O8A85S'EK/ZYI
MP5\CGK1:R). OHQLD Y"',Z Q&EU&NV?3<-J8U=WZI'6PNX_TA=0R(S94@IE
MT8JI"R'KM95QID+]XAD@-.REBC\?,9_A1(N -P,.DAA;[QHC.W(CPW'AC2'Y
M:Q:8(1LUP0=,2$98V2&PB.7%CMJT$7ZXW'M"@/Q$M.5" O8\>"+ASC,P#N*G
M=-H&+O 76,X1F.S4!79#@+47.XJI0UO$]EIOS/F$Y/1=(<-&9-C"?)(A2EDN
MP-$@#KIQW%&";X9%?72=X0]P,@B0NA$E(\"B"\)OA1?@32%_)AI9XSO-!=&Y
M@(=H%<'#;B;X3M'*37H@^26Q9KF%EI8H/].I \*3@Q:FVA(>N\*%+.:K #)G
M>^:YN@JGMN]&7.0C."\ 7L','</-D1Z93JR.-SFYNCC_!.H =RZ'# =#\79Y
M &XXCVS]/&.S$?;91P,<R<DT[O!J38BDXSLC?@B(* )D(>SB;K PB.0;Q;B<
MZ,Z=\%%3H3UC#T'X0_1S!VI'.YYHY!&(&I^1(W8\T#.SO?OL,8F,,$$GV\EW
MEWP'5SY[+_*M(IJ"8Z"'<P9DZN%)B47M1[Z&_,WM0_"^ ;\$8(SYT:R6R4FN
M8$2%.'W$N=N>ADPTJ ;YQL1('(:*HP=R#NCQ-WF^__C_!BVK_S$RIEXPHME+
MX3P@R4-;3&:9*()=6EVX"N0 +FQHG8*;&NJ[8IBTD,T%^Z2I0<PE#8#Y]ACY
MF,_\X(C!^1SX0L]^B++-([0SL.15+22/E/$BWKF=:TYVRM[&- &U!&\'W%[!
M "+U&)['=V9$+E _O%+NIV'<!+/T LGM=,3& ,\<OXMVOC3,B1Q!8NW1PF-B
M,!+)7-E^7*PK^N<)Q[G_I)X(3XPS![@D7'@>CN-E/2BY[,PT4/%&X#@W</9A
M3E:QHH7-VB[$G5+364>XQ?3:2U6?7'O%GUKF<-A&'OBIW^CWR)?HN![=F-RG
M2-?]3VW3ZG7IL4&CU2UX3.T^"HNVNP-ZNM>P^BN?WDHK4M?YKW>NU>FT'&<,
MEMVPVVGWK%%[,+9'CM5T)BW6ZO;^7W=0U,-X+0GV=D^"@7_Z^>SLNV+M? 7,
MXMC"EW'5-H^T8OH<X^&<[-* *Q>''X (%GK*)#VL:L,I T! [Z/!-"15^4T)
M-._.*?R:CI6#[]D\SL9[Y!74$X3K>SZF12I O@1WMH.9 +<ZYD0)>2V.E,.!
M'3$.SQLG(9H+3Q]S 3)24,:Y7WT$H8MHP"[\RF ]Y>,R,4SE9V&II&SEAXMQ
M/O6KU:X5Y:E,%\VMNU)959[Q%8'V41RTX*L"@7/R2?SSXOL-Z#5 9B/FX?@5
MQ'W$UN$607Z/^@1\@,M/DCSE@?#"?O#D,\"X?Q#R&Y->?!=X#DHIU^=DB>@G
M*LE3,M?$Q4V+20V1? 9>CM&;U'LA[TYZ/Z@4#>.K[0/U$/K$F:)2-)C:51Q]
M*433\SL,%']WA'VI22Z3 )\A5^(RKH_CS.C4@D$5^P$5DX0KKD]&4?ATK[O1
MUTIRLD<^*X8L,VXUS.PG&MPY8A)+R%Z(I9"0F/@+XRO&J(QF#*Y2I60"FXP7
MFBZ&! FTYSW]&Q^.@9B<-$V'B-VC$0E9IDZ.5I.(AE4]QWSX$K1^V .]Y*YH
M?W B?DM0T"UUI8AYFU)_E1N=!S'J]/ 2P4WI#[(C )/XC.QT?@7@D4:),P4A
M X 8TR@'G]MQ47H_S++#I>D]U)4:Q* 8$>0_?V)0P@/YCU)\;/)!!+. "S4Y
M#14'5@B]W/53ST?*_$ VO$LV]PL0W=C<T2%4LKD=VB,7+%TA*4*:SR627QK&
M]S*BQ@5HV1Y.&$*J0P<+>E \CD[^5"S(S16>H(P*^8XBM'36'V,5"(LNV"J@
M9N8&*]'^'4SMBMV8*P?<>?!2L!9M>S-($OQ>#4Y*-!#*31Y$:X^=PX)Z-<NK
M"]G!YD/,HE@B7D+&$[Y5PH^4;>G@S4S&K00JBKE"28:/IM"6^TKC)E+S$,X^
M>@1Q1[<B\39ZI15MDT_D$V[A_"_Q$]7GAZ3$24%$6 AW\Q C_X^+KY C1=*9
M8.G7$;^!0S[,+B0%UIW);*C50A^U"3OB8"Y2)&YI9K+G!21J\1WLT9Z1VBP.
M$S_-^3_4S:17#;V1$$5*M2U,_-6M]T5$^13#QQ^L0>$5RC^"D\"[/ISB0]N\
M5*U&A3GYZ2MIF0^8WNJ.G]W$QSR4FHTN@N!,&>C(!W[$;,JUKOP8SJT/2VH8
MYY2"EQ]3QS='G(ABS5/&*RJ9O">L,6V8(H</].  ;D9<@^Y@(D#BNG3>'I>(
M/+D.Q,B=.P=Y(4=A&NBL]E,(H;<1:)U"-)A1S&?@Y;,)%2C*3?B96;,,8<Q5
MO@<DL BL'.6^V'QJHYF?[4=A!)F?"$)Q/F?.:3)'(&;KF3*?:RPV*<#FL'1X
M/9>D15#D@UT1+B C^1XPXYC^\GXQ>H5;36:S=&\4T5(H3]6%UBW,-;""2;$;
MA!+J+R1:M142"Z0E)Y@ZRX,C=R FOM/M $2<XP#I*%8H<<VV]YELVG4EFYLU
M\Z&Y+"3Y@\*&#X%\DX.LGP%X7BC<2HE^$G!>0.HI*,<REDO!O*4<<WYN^ R5
M2S>[JD">9:N0Q#5)UH>H(:NW52:7<0^^@V91NEU9&Q-*%1MWG$67X7))I]*C
MX<T>793Z6=Y.>F>8-&[XU'-IKC"R"'=%B?L"'9^G+I([90,O\5,VYIXN-#D+
M7%G27_LC_KTR_"X#W2*I["'#=NK*L%^Q @/8T6'W+A$Y#;FF)(-=<6:JH8#\
M3N8.U_W0 OD[L<D\BYY O9DIA&VC\Q+]V(5$)1_#@>HJ;U+=U0S+/U(=$2.C
MLT6(R!B" AN%.$-&NF@ZL'$Y<KS/=-NM*]U>,Y1(J3((>B9(S)U8+)GJ3IX^
M2JP4@V\E/603W'$0KDE7QEV6IB">"LEK@KJ6^C0&]N\8FL3YI672@OB9&Y'E
M_L,/'L PH%2"*/"$8^J:_96 E(>?F<:7WRYOC?_K-$WC3\JC)N5[C$5+\ZQ@
M,B/OC'D0WGLM@WOUI642+&BW9=90O2EZAP0M58LP@QJ\GE-K#G2%02-=<Z=K
M[G3-79UJ[@:ZYD[7W.F:.UUSMX<U=YLHO=M4<66,DE\L5*Y@WP<\)&H_V*$3
M\9S,K,:B5!)M_77\?EUU_%O[<8<J_:42=D]3&S$]1BK3$6"0O'PBE+[/!1O_
M%(ECZU*#;.J8$QN44P=\@7US3#BH&@('U3XB5Z5P%.%O> I.P8(\U8>[*_%9
MWV71?Z[=PIU]+UVVE$@!V)!I^[X]8U$^>(_%4\MK1'>4+B\V+*.#/(;NPET@
MPC<AK]G!DB5,L!"U6=RS)8K+LIP6-5?4+)4B:I;,##67$D+-=7F@9B[]TUR=
M]6GF,SIY:<NZ%$_NT)\%8(XZ;@B+8DN8+)ED=;85(>C@<A-WR[[/L2UL0RDF
M 6T?Q9I,\K-%PNMR.BGY'/ Q&?#![^D]BPD^F#WC8[!&_)+8/X2GY@'/OUVY
M.YY+)-*#\*_Y$H1<E?%UEH!XI2:]>L$#Y1@#=P7^% B1 7$G(29SK<D1)O\(
MGFXA.3C**IC)%9Z,X KSGDXGKD>)W"@!9-J!&U(('L0^]T.A5.$U24^4;N4_
M&9A:[!7(O]67P^YK]_@#S#FU@2\0C#G6CZCD2V96)U&6U"]3Y 3R-LT6%[<$
ME^DVIC@%("/6+)R*X6<6G@@G&Q*BD'L\2>K%A2L]Z]TSSK%"[.V%K3P<@%5:
M_-6"5;K@"&R3PEK>WBHTV]:W!]UM!=!U3LQ)B?45+\%/\A(\7[@$EXJ%>"^%
M5:5$SZF,F/W>777A;)?,AL/& 'TK)3TRS4:G7XU'IML 'JUD):!\JUW)2F"\
M-%O5;*K7L-JMBE8:M/H5@;QI#2M:J=NOQD->'1ET&U;OL%WM:[O,;W0.'HC9
M_4D^D\WUG6RNPSA1.MSBL[ ;_\.>S3\:9WG+\6+S\19[<.9L6(W:!8(?_$*Q
M?P_KU%>I#<_[!QW(J39H5[;7!RQL]K37)RKLJK#7)[J0'JY_C,)?R(5\#>;\
M89Q-*:JN9";.RLD2.PXB;GIU<"= 9?,T%D]=.+^D'F?_Z>T.7</Y(5;'['2:
M^SZNI8"IRDUL^463]T&2=]_L#?9^&)&F;DW=Q<+;[/3V?JR;IFY-W86G;8/L
M'FKJUM1]D-1]@KW9-9EI,GO;TW:&6H1JVCY,VJ:&KYJZJQLQO!&EUP3Y.$WA
MZ'&_RZ'66IX>FCS%MME'SU(;U(<M;6I"_ZM36*<8UANW6ONP05#O63 \5RVF
M?W\DOW]I#+6(CT%&=>O(6I?/]KI;R5(;:&SU4\J*H=#IO4R<;UD!WA=PTDB9
MUD<-4PW36L-4L[TFT9K#U&II<%8(SG9'@[-"<#8;FCRKA6=SN!N 5N0[J+6M
MPY/1[0V<"2?V4HAS(W(K $J=R>UE%_8:S+\%"^\93$^L9HGXN(;E>EAJ2%:D
M1C8'FLNUY*PU3%MM#<X*P3GH:G#NU-31\'P&GCL":$5AG?K9-R\8-G/(01WM
MCM0PU3 ]3ICV2BN3&IZ:1K<=VBEKDVMXKHWF#LM:/!J>:^FST=3PK!2>NV+X
M@TT,+3TGT3@9'45DIULVC*B=%6L#$7T=TZD*E"T-R8KND[:.Z50*3PW-*J,Y
M^@:JE#BMLLJXAN?Z\(..-E8<SMD1PQ]L..=S$#@/KN<IUHPZV/MD_#)+9L^L
M9NUYU##5,#U.F [[?0U/3:.UAJG5TE&':M/6=$E)I?ZV9J-7NE^;AF6Q3Z/1
M*NLDTA&<]2#]RAQ\/PZZ=,<XE6TJ9KJ!@>,<1:A&^\EVK^)HF*Z]0CI#';.I
M*"ZK0S::V^L-4ZMLB;P&Y]JL- W.:N,,.DQ;,3QW!-"#C=M<,WB[E_82F-EQ
MC+/%3]A1Q&M*DY-V.:Q/ERJA>VM0:N_WEK4;G2*N2;3>,"V=.*7!N;:#F@;G
M;NT9#<]G.JCI(INJ[1F*R6"/:,Q$\]C4]C*K9G(401KM:'P#TZ9=(C"M0:G)
M<\N*3MGFT!J<FD2W"].RV9$:FKIBJ<:6C89GQ9:-CM2L!^FM_9@9,M.C",]H
M#Z.&J8:IAJF&J89I76%ZTAKHF'=%-HUN,5=Q,8U.QZC.GME1=><!1&J*!R&?
M.7\E4<R<L@:BF$K,-_RA#2!U@@2;1<M]'M=,[.JALE/V6S6'WNSVNG4?FUTY
M*EXH@#4':0Y:\KZ;G7;MY\YK!M(,5%<&LLR.U=$,I!E(,]#+P-$U^Y96X30#
M:09Z(3A.K&'Y'#1-R9J2:T?) VNH+P+-/II]7@:.C@F?:P:J/KOJC9FI)N1C
M=1H#33TU0LC/.@2BA?ZS7-MJ:*UI\XCI+[$-+X3_.N[]K_^ /^2F9W8X=7UZ
M=3=/]AB.="=/ JF__F,4XF+BY(O+%/Z.WIE"AY\1(./9\XA]D'_YZ+C1W+.?
M/K@^P9M^]%%L2X ,=[9P/GHA__KC@^O$=Q^&P\:@9_W\+@T/BQ?S;ZT&X.^7
MY<_;S4:G;Q5^U6P4?[YJJ6ZCT^Y5LM*@,;3:E:QD-1O-5C6;ZC6L=JNBE0:M
M?D4@;UK#BE;J]KLU(X-NP^JMW],SV1"U3WIH-5OME9G;&YUCS/R8A;L_R><P
MB"+C>QA,W/@P3G3#//AP:AJ?F<]P2M]_V+/Y1^/,F;F^&\6A';OWS+AXG#,_
M8JN'DN_5F:]9Q.QP?&<:G]@]\X(YCNL0![_PX49BL*P_/;!37\T98A/.=>F/
M@QD[D%/1U!5^(N-$8.R]:7QC!\*@XFBW]N.A$"*@QKBP0Q^V>2 GNIA,V!@%
M):G/6+-T;<<'PF"?7"_!)GD7WV]R!WIIR5D9*ZA^JLPUFP=AF?S-LJ<^"-]$
MZ4/7T?70-IO=VKL,7\!4E09D-'GO*7GW3<NR-'5KZCY(ZK;,]D#+;DW=ATG=
M;7.@J5M3]X%2]TG+ZI:NX-1DILFL9&9V4XM03=N'2=MMTZI_X>B6J+M,8?YA
M9+JUZY_I]N:XKV4BFY:G>RI/!XV6%J>'T9:C&-9GX[\3-W)QJBUU4'?]F$U#
MFG*;3HD:!U$<?=@@J/<L&)H(A,7K2?_^^'Y?4=M.XN-^H]^M(VM=^O?,I]$$
M4<SF<^:<)G,C#HR)[8;&O>TEJ^/D!]1*23>ATS#5,-4PU3#5,-4PU3#5,-4P
MU3"MUJU0:S.(YZG;&_@93FP]K^TEF-<#2'X]:37UO#9-GG6%::OL8%H-3DVB
MVY:@)7*/-"C7@;+3U919[6"#$C,W-"S7P;+9L%IZ4%NU$=19 #OX-YDR1C Q
MYDDXOK,C1C:.[4]=;!)B1Q&+5]=\:GM:^R@T3#5,]QRFO799S4?#4]/H=F%J
MM<LJ0!J>Z^#9;;8U/*NDSX:FSVKAV2X[Z[M>P9WZ63PW<9B,XP1[9@7SV)U)
MXP?C.@%%>Z(Y&\-;##"$PBF+C)/1441VVD/M^*G2\6.U=52G,EAJ2%9TH?1U
M,&?W1HZ&Z=J+J.QH90W.:FU&#<_U48B.AF>E\&SO"* '&]7Y' 3.@^MYBE'C
MSN:V&V+'7#!HQB\S:/;,>-8.2 U3#=/CA&F[I\&I2;36,"WK;M/07)NDVM?@
MK#;52L.S4G@VRWHU="!G/4B_,@??;SCLWATS(V33Q*-0#A@XSE%$;+1?9_<Z
MCH;IVL#-L*,C-Q6IBV4M&@U.S>U;OH_TA50E./LZSE"M"J[)LV(3<4<90P<;
MM[EF\'8O;2DPL^.8A6#.,!VOT7Z'%V9.E:@^U*#4Y+GEW)0=.<4.%)R:1-^@
M'EY#LTJ&U^#4#%]OF#8;S1T1Z<&&:JYY; :[26-&FL>FMI=9-Y.C"-9HA^-;
MA!=:.KR@R;.N,!UJAZ,FT7K#M*6+/JOM(:+!J4MM:@Q/:T=9! <;LKFU'S-+
M9JKC--KIH&&J8:IAJF&ZN1=#AVBK@F2W1*,0#<JU82_=&*W:/(Q&"5>EAN4S
M5HQNBO92D!9/2CYS_DJBF#EES4(QMIAO^$,;0.H$";:,EOL\KJ'9U4-EI^RW
M:E"]V1P.ZSY7NW)4O%  :P[2'+3D)38'74LSD&8@S4 OO(+,UK"M&4@SD&:@
MEX&C8PZ[7<U FH$T [T,'">M5KMTZIFF9$W)M:/D7J^G+P+-/II]7JI)-34#
MO45.U1LS4TW(Q^HTM">H3@CY68= M-!_EFN;C5Y3L^VF$=-?8AM>"/]UW/M?
M_P%_R$TKZV#\T9T\"2S^^H]1B+\61UW\W<P.IZXOS]3)<TRV$KTV!1 _)@#'
ML^<1^R#_\M%QH[EG/WUP?0(Y_>AC_@W=^=(1Z87\ZX\/KA/?(9(:34*4#!&+
M-XNO&_#5+\N?MX:-0;]5^%6S815^OFJI7L-J5;/2H#%L%G]3=B5@E:95_)/=
M':_7&%B]2E;J5G:Z;J/;JVI/G5:_HI6L;GOM2L]D1-0^\:'5;+56YFQO=(XQ
M\V,6[OXDG\,@BHSO83!QX\,XT0WSX,.I:7QF/L-Y??]AS^8?C3-GYOIN%(=V
M[-XSX^)QSOR(K1Y/OE=GOF81L\/QG6E\8O?,"^8XL4,<_,*'*XG!LO[TP$Y]
M-6>(33C7I3\.9NQ 3D6#5_B)C!.!L?>F\8T="(.*H]W:CX="B( :X\(.?=CF
M@9SH8C)A8Q24I%%CM=*U'1\(@WURO03[Y%U\O\D=Z*7%9F4LH?JI,M=L'H1E
M<CC+GOH@_!.E#UU']X-E=ON#NOL?7L!4E09E-'GO*7GWS/:@]B$53=V:NE^8
MN]CI=C1U:^H^2.INF8-.[0.:FKHU=;\LZ\_JEJ_5UF2FR:S<:=NMVN=F:]K6
MM/U"!:'=U:Z+\L7YAY'MUJI_MMN;X[Z6R6Q:GNZI/.TUK/[1L]1AM.8HAO79
M^._$C5P<;$O-TUT_9M.0!MVF@Z+&011''S8(ZCT+AB8"8?%ZTK\_OM]7U+"3
M^+C?Z'?KR%J7_CWS:2I!%+/YG#FGR=R( V-BNZ%Q;WO)ZCCY ;53LLIV*=?=
MJ=;?C;I#HH9I_6&JV5Z3:,UAJEM05CJ-1$-3\WNM8=IL-'=T*57D/:BUM</3
MT>T-W DGMI[(]A+,ZPDCOYY8[1(1<@U+39];MGK:92=.:WAJ&MVRV:.'7E7*
M\J7'^6IXKM?2=S1#[&#AV>KKH6S5QDQG >S@WV35&,'$F"?A^,Z.&)D[MC]U
ML2^('44L7EWE>4!VM?95:)AJF!XG3'NE+Q<-3TVCVS;*=2RRTMEMPZZ&9Y7T
MV= RM%IXMIM['>>IG\5S$X?).$ZP2U8PC]V9-'XPQ!-0X">:LS&\Q0!#*)RR
MR#@9'460IZN=%=7&=[HEYEAJ6*Z%Y:"O05D-*%NE-1X-3QW6V;(E7G9HK0;G
M6I;78;**PQ Z,EYQF&Q'#'^P89W/0> \N)ZG6#7N;&Z[(3;)!8MF_#*+9L^L
M9^V!U##5,#U.F+;Z.W*<'2@\-8V^@<=-0[-*CN]I>%;KP&R4<&!J6*XW<79U
M'1UL'.<K<_#]AL/NW3$S0C9-/(KD@'GC'$7 IFS1I_9":$?NUFN<=."FJE2
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M/0T/8D9$<&IN9=UQ@\D7X[)"Z(YY%*[V@K$HZ F2&,.3A, _?!<C=12?XRD
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MDG:EJ+;<AX]>JDC8)XJ/A9RNJIMJ*9*RS/A+XAL5=8[RM/E@FF^=]8S(-Z(
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MCSE %8V=%<^]IRP#[F0E.A8)!<_]/"T007\/M0O$Z45>%E\4$4^1H+ <5Y3
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MRIB6(P1(1N;:!D(,X-%J-O1)(N08$9*YT[>!$,PQS$GCWSM"3M96=F-2$^-
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M05=!P,+%V6"9*W6YCKZ=EK?E7G7L)\!C1T/0C@J>Q''T%ZY>-L>U&;R23#'
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MU-QWO,'/#.UZ8T&S1K>AZ_K<$+.TK\_N\K\G06@/I_O:-!+'[NZ?;YZ4YWL
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M:K.D7WN:<#@OF"\:!%3#CXL7?8U"KGA;=M^9BIMWUKUO!W%5G&SES]2(\XE
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MT]5+SJ"U_@QZ&/G5R<R #J'<)-IK3T)OUBZUKI:=!/)GI%:A4>&<4(UJY)'
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M&QGMY7_^2VTW/^_L0")*+'PPBY-45A%^FA=**CIK*E)W1$5MI**6I"))1>=
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MY5-)MENS U6/T)Z],%M\I6 J4M*93K&\";:=BR9Y7BQH^[MRY#QJ1^&)'72
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M9>01@+(*+X)#]]G >W&!Z"SE'38&-FD\\0>OL$B%;AX :Z#T&7P#OV2P;9:
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M7#/-%DXD7#E25B=W$UW]ZOS1FA [=LG=>'&)SJ* ,ME]8/%]8U:B?8>AJ7&
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M[STG02?,&X2^IMWK..R5;,X[[DL88K*;CXL=_$Q&41' L9.\;KQK"GFCZK1
M1@E'K(P,[%7>Y049)Z  %GN>TJ#*BR3[=L>DZ2,Q#YLM'L"[>=A$N\X2/L]
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MB:2_8A-C2B6LX.0]4\>J(OW\S??M^?\-87<NI9\?(]A:K ?]/^9T]E&Z]_T
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M6Z9*5$?C?TVB.IJHCM;(%IR%7G)JJHE2UENKJ2H4&G9C:/=T485"5(,1=%A
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MB!H@OUYA3VA!?H+\3I+\:NJ#N92LP^F#6'"BNT\'8T$3@B8.3Q/Y+,7#D<0
MK'2%=R.IH5QW#G.SKFY$2O>Z0"A)NMR&=!:T]; 6*;&5 (PB'\'[I^R>T.G7
MU =R*7@;F%^C. "NW1KV^GOP08&!YCA 25I=PR<O@PC,G[Q@ >_' JHV%VT8
M" J( EWP "Y (.?<,F^# 15[9.;3J=X< R=P)UB, G8Z4F3^V')K?:X9P@?0
M?2G.L]WTQLX/8E_\EP1^$?XU]!,.%%GYR$DFL8!%D4[<#"SRQZ\#^\N[JL7)
MOY\NE-.%FY.#&S" UQ7[.X3$Z3= ]R4%(YH[\SZ<>5,%9,7)[U\TH.12LKF#
M'[2&O;RZRV71D.-U\^8.0XK\*FU =JO6=X[/GT/YNJV=&LZ=8RIZ6;HL[-[=
M^(&\$"\F=2PB0UA$')YV61+@CJ<M=\5I<V@%]:H&#:^=>_Y\Y<*:J\*Z>0<:
M[I4$ONY,PXJ@81YIN*I'OY2&53YH^!PZ,+#BP3^S=/-?I"3=7/0BV$4#O?6]
M)#O>>V;F^C7;SCJ\K3G_O+BL;-!+FU-'-_"V+1C(G[6^GR-6'/ [**"U#GA/
M3[LXX 8/.*>,-G' _<*&(.*$N=8_:YWPH#74.#CA<_!_BLB1/91/MGE/YH\$
MRY^(1\9.5$?U%(Y0'L^]Q!&Z\=QSYZMT&XB$%R?;G'NLI&5LC9.56T-QN<_1
MR98X/FN<K-(:YBN(BY-]MY,MB=NH<;(8B,S+T9YL8 8VF"W(P2M;UW'EW^[;
M8KKVHH^=BLMTZ=UR;?M*83FBW;RV[Y:!+BC@2"G@0 [M76E!+PPXK>TW$70@
MZ( +O_^N=(#MN_:I2"+H0- !3]<CN])!'Q./&G"D"T(0A,#%+=*NA## !.0&
M;H7Y*LC#7W;RQHK%JJA8?.K5N.I1?*X:UYY%N"K?N"E;;MQ$]4A!FR=)FS7%
M<:Y@PJ%*Y?75+HB'O$>>KTIY@B1.D"3J441)K8@&"*$XAT9()$%^)TE^-252
MU8(=#1"BTAIJ!:7KA$@2-,$33<A52WHV0!(JD(2\3_TV4<]8U#-N-B:H^2(^
M._@25)$XQB,V]H@TJ5_<4M4+&Z&+XW^WXR\)WF[X^'NMH;)WK2=Q_(T=?[\D
MPKOAX^_#\:OB_+DY_Y(H\(9/?X"];_+WBN]S^B=P?RARU'C0A&LJP2*%C<N8
MBIP6?.@:MQKFNC70]4@<?Q/'WT2L<;WCEUO#!MRFXO0;./V\$GSPT\<^'W)7
MG#\/Y]]$7&F]T\?$NB;N\8436%0[%M6.#X8B4>UXJ]0\4.U,3?1_X?&T2]+*
M=SYM79PV?RJ1TJ_:_[>L4JK6:PU58>;R0<,EK;UVIN&^H&$>:;AJS$LI#0_X
MH&%1[5B$M=310)NH=JPUYZ\7UY9OIHTV<?)Z<WTXQ,F_@V9:IX:J+K>&')10
M%0=<J*4V<< *J#"BT#4G)UQ5,:UUPONVY. KKH1K)56$F.RAE>Y?!ED7'E(>
MSWW7PIO5SUWX2GD\]Y+B#-4+KNH]44J7JY,M\9?6.-F^.%FN3K8D0[W&R6*Q
M)-&]6A1)%I70N-.T&ZZ%I#?N"A:5 @5]O*-%LF.">Z_;&JJ*( %! L?@:ZQZ
M7; K,<A%FCU?I3(%&9P@&31JR>X*?J4U-/9NZR1(0)# ^YO\NY( S>5HJJ(%
M7R5_^,MXWE@Q6=NQN!*;[ <5MM/VXY%+%KM]7.R@V8)@3>P*AQ7#ZO&+7!&]
MMZJYW-MRO7=<%2X;P-%AR_T)\A?DOX'\2PI%[%\GL*<7Q9P) A<$+@C\+0B\
MI.Y= P1>G/HD*%Q0N*#PMZB#W:]:U:4!6N_CG4ASK1D$V0FR.U*RD]^N'TIO
MT!HJQCZ]*[F@.NJ8^S4RX87P7]MY&=(5X;8Z7FPF6@-;XVT\A2.TAG^'G]%M
M<&1-4VS;DHV^H6MJ3QZI \L<V7+7'BM$T7O_EA6YE8Z+3R6;,36#9\?+K/EC
M\@DN4EVERO_$8>2,Y\U@SBC#G$)#?NZ>KJ6>="']?67A^=H]JZ#Z%(<P5!@"
MF$:.1_?NLQ-:KA_& 7F"!S^YOO5]B2"#P1?VF=B74?(9#DL ;3,8. IBTAI>
M7OU_O]\\WCS=W-T^YHXB!1O=X;6#6[X(!RUXE=(J.96W.H:<\DB/X4\BF=9?
ML1,0>!WLG.1XL(HIO-XAH61ZMO1B!HX?P[_#D$2A%$W,:+%.*?*E,)[-_""2
M_#B08$N=R'2!/\Q<?SXE7D2'F 6^'5M =.2%N/Z,?AY& 7"&9WA+1[HRPXDT
M,X'DQG[ YA,ZM*X/38S%&BT6_B29J2V]FJ'TMUJZPJ"D$.Z]2:<;/OF7["4I
MT AC4#C%Y!M[U=?GQ=,+VX\NDM$+V%@?2P&V>P7J ]V=6@N12V(^ZJTC/U7:
M>"=?N$Q"7* ?GLX86QAV5LF"8XC?)#-_)139+@&!M$1U!FP4?9&/ (9-#QV;
MIB;!@5#,.Y[EQC8Y*N I&X$'QQG/Q@',%0B/S:"8UMKU,5JZY@(F?D4YRC/,
MXRJ[]9=!8,*G='Y7$_SGC?<T(0_XK[OQ71RA%A%N>/BK8XX<UXGF?YAN3/X!
MD"C:(VSGT2U O+48%':*@@!9Y<0!'D89&&X42'R3,4P0%18 50($60!!U ,D
M # !INHABX-)X\]@N0"^#.@N;.""TMAT H DS#+$<2/ZX\7K%^,LCHJAE-0^
MEY* RNKGLMC:HAW5\,HNCSFV"0L>OI0RY,<,,8:K3B4%2I0Q*&$^W0\4+3<>
M2(PX >JU9_NAY<_F;>D;L>EFXPBW) Y\Z0H@@T<Q6A"2].I$$S@G^.UC'#PO
M?QL1:^(![WF>T\_P/4^!&4]-^N?UCR@@4SBF1!+^K^_ :3R ;#,MAH'\*^Z"
M:.+/3)Q4<NJS.+ F9HAK<RQ8OPL*"F,KR&[PE2L\R 1)/(*?PVP\>(2XSA2.
M(IA3>)B)4(2A@,L"?Y3@!ZA@HR!.I"O^L5S6*I<N4#O7N;?MA+"^^0?'HYQT
MA.H4:(X_+EX=.YI\4#NJJO[T$>:4?*"P#]:47] QBW32PL'SCWYD0VL#&%M+
M''\;E"ZE4.E2^5:Z$$P6O!9X5\!.$(]UXLP ,K_YOOWJN #H* J<44S-!CS>
M*"6>%"D!&;O$HBH96:A3EC1BN0R4<!AE ?U2G,$V? <.#Z *B6>1M@1;1((0
M%I_^(D=^%/>F_6)Z%O[&\3S_A<T6P>V$TG,Z7?BWYZ.*AP,X.&<J3<T?2  S
M/T0F>#0JPQWP"G,N*6VJZJ#FL&!;5R2(F:: TI**RE5E ;:])E<N4>F*N?+R
MC<"QO'!, IB=7,2.=6PJFH_BHD<;SQ!:->=;DA"WFW1?$^E;139V&5'RV?ZH
MU(SC" S!0I&)2MS$!#AGQ.T.I]78ZK?*T#[V:,\'80-76&<$$FH0G027H)\"
MR8"$2(0!$UQ3TXO', +L#% I"KX7,[1BUUQ0?"C%*'(HR<+P(/?,*-5R)F3J
M!\'$1.8";,;_OG@;T/S,#*)41-^NC)S*Q@K"MSK7J\)F<O9Z=>_"HS6!@5W
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M$MNX+/GCQ9I)>072*J ]9'0.N/#I%=,2BB8CW140,*ULY9#F5 $)P5"++B@
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M38L+S1./6 %?4!1,UCZACBD"Y2> \EK"KPK*\=I34SE!^;F:F30WK.0G>J&
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M3I98D7G0Z1Y%U&M#!4GXJT*2,:X_5#"Y2A=:8HN=S_.G596QF"\]..'WBW%
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MW7K:S9;ZU^KVHM7'/2FM(RN-U51O<%+J#AIEM4KAAY8PNY8)?P"+"]@+:_2
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M-TLO_8AWA";N]3O=@CK<28GZM#B]RI"705>**5KT#/^1T'KZ8&T.N'8IOV"
MX?S[[MN87W^&RRE*:SC(B^_Z_0?T#;S[@%.G%PJYJ1^@:ORZ(^I]!1-,IFC=
MNPJF>TX$DWH,@@E8W1;!M%HHMFHYU+?4Y'(V"]7DTIU.JC7>QX$U@8V6:+L'
MZ>?KQ_O[7VJL[7W5TG0QH30UY]+,1-W;F;'^/9(?!Q(N1P)<OC@VH<UTYM*4
M$$ _J.DF_(; S)V1XX+L >B## HHCPH9^Y^EFT/[D[#V)##H2I.>9<\%;+<0
MICU]Z(N!O&PRAEE38MK(A;S$[[S.B'I91G1S^R7+9@'76#4-2/!N?.7Z(9@F
M]$!9HXY%:Z+T>.G'M,/'=3B;+3C-A9*!>P]TX/Q][4_IBBSVEF39;$=\UMG(
M-8&71(%)F[78<!+(#C*[1VFP(_T)QQ*&,>Q&[<N!35NQM][!2G3>T&D5!P5M
M:J.;52SZV)]<;?>[&[K[U%YOG^_U@KDD&]VV7M3#ABTI0Q>,%-;UJ[5"V[D&
M&LAU\'V.K&F*;5NRT3=T3>W)(W5@F2-;[MICA2AZ[]^RBO6PRWG56W+9V[NG
M:TGN2A<U6Z%\)J/HLQ,BK<5!OA(W;+W!P (;!7(P2C_$D58K='^^_O0D7=Y^
MEJX>KC_?/$E?+J]NOMX\W5P_;FQZ2'>PN.IX^HZB5RMEY<#?5T8 UYF MB+A
M-Y0]6P&QG2AE1:,Y*/A !7$H :<V/0O>!VB%:48Q-3P PZ NT38:+Z;CTK+E
MH"N- >!4&@"_ ]%^0=D><#K8-6""'B$V")&K1,Q@]S@4'.S-8]-"B>/ =!*9
M(\';84S4XD!W>G6B268R2#*T9P=\_T(\DXJG/U$7"ZB<HT\YM (S?=)TW>4O
MMW5<.AHQ7ZKDX__MWAJJ@+]^A3F 8*7G51HCFN&,:G>?YI(%$P'V/L467*9[
M#\0=U)H+F+N>7^"M7>?8(S\(_%> [6K7-<;!$;<!>?'=%]J?< 7!<RFC$;%9
M@A*&?AA0N9X#<YJT2@1$^J^LO1O,/0X8]N,98GXK?U1!TA1PR*6; -N]%FKS
M0(Z9G0 6I1JY;J](NB'K*H=RBOJ3@%*1,2 U,1UP:H)-$T^3'CH+2EY?,&42
M%M #V%#93436X<VER)FB\E/7%#5*T+&Z&5],BUS2:5:3Z!D[$T6HTE;TO _T
MB-C$C2=] R[,W#%HRLY,)^F@F3F1>D< !+W5&P"J-M.NPKLQGD;AYH(1W^L6
MN)=!B?;07G$SZ,+IUK44U)5">[G0F564W&"M93"C'P#NCQ'Z"):V1*%AH&)F
M?D?M%]D&8&0X0-6Q!V0'"HLM>7X$I&W'A!Z%K*>R!L[FD<PB%IZ8GE B@FN>
M2$EWS\TT47 R8//T"T"/!U'[$)2#'@*8&%JGB$"W'L)RSV4F,HVV]#__9Z#V
MM(\;UT?B@L65W-;4VG2P'@9%Y+#+IJL'W71C)^2O;[JJU&Q@JZHE/L@ZVZUU
M&\2X=LCMUF3$>$_9=[N9E;D3S/4&]UW9P/5WV7?]H/NN(LSWW_<>9?.W8'JL
M</D-<KCL? KIHK>_--9 &NL;SF7L^LQ^"U 73-;.5HR0<C(A]FNKVVDU_096
M \)YT!1U#PZ*,EJUI(X$2^[@?+0>\%"2EF'Q%!1/T I#JHE'> L TQY%J&MG
M,B ^E'F8<OIL8:,VT/\ODF9@M#';1VSRR#Y0V ?Y5FY%[J@=NL!IF[O )8Z7
M0G_,'MWA5H\X+/ _:4??"LXP.IJB;^H$MZDO&#9*:Z8EIBQW>G*]IF1;VIN5
M=+FM.BF]W]'[Q5_57E^WH_7J#77X]=%)J?7;M\G+?(XC;-_V2%DEO8ZAEZ42
MTG=SG9%V_5DS#;VX3\U#R=C\9G.[W,]QG=5RW 4*-;LW.3>.%JS6:7N52F+0
M,,CFA9_6KSB6#M5BIA\+5>P/%8"^,2F[D99Q.]4%:'QR^^:'UYXE?_GE-<L6
M;+(AZUU9U+<B!QM=<CM!^5S.,>N-WZ<4&1?)2<5+K)V<Q$]Z4?V2(26$EW<F
M_9XR?N9)JE[V2#,:*WO$3\E% ?D3@+Q6<C>[!OD\M/5NL8O^."LV[JMI<8OR
M/UA\UCZJZLGOT>+61>X5"_ESJZF5YQ;R@02D+NH"GB)<2L),RH6+TAKJ.B]=
M5H2!VY"!JZF'-7!U=>,UJ3!PMYSC\N9W#_EW0D76\\ MB2G:7?YI)V@@"KB4
M1/R5RS^]-30T85QQSC=KRS_]P/*OUQK*';DQ^7<NY_B_L4=2#Z\NC+^MJ-V%
MF_5;PY[&2V\Z8> U (F26-)R2 P0$GOW(1(&'E\"3CVT@;<YJ4 8>)4\G'O(
MN%/6V,MR=$H96F]#IH@PXHX5$EI)AD$Y)&2 Q/YJCS#B^))QVN"P,JZ'"=>=
MHBP;8<1MC]()K$EJQ?6$%;<5MKNP,[4U- Q>5'9AQ34 B7IA3P60T! 2^<XI
MPHKCBC/6E7!Z]\ 23F\-E8Y<E#,KK+@J5IS:I4*N+\RXK<C=A:-A48O^WAQ-
MF''\0*)>Z%(!)/JMX4#AI66Z,..:$G+*@84<3;;HB;NXG<RX/A5P V'%;47M
M+MS,: UU8<6=$B3V=5WWNSQ!0EAQ30FXLO*8>PJX/JTX550_1UAQE8(M!WO(
MN)/6V.L%6Q8P-(P>-WJ<:.S"B&L $ON&(/55GB AC+BF9%Q9;X-]99S6;+S)
MN9SC0L8EE5.%(;<=N;MP-+TU["GYCE3"D#M:2.P;<-+O 21ZO$!"&')-";D#
M!YST^Y@U5Q2\)@RY"@$GK#2XL.*VHG87;C;@Z=Y%6'$-0&+?>).^ 9 8Y%LZ
M"BN.*\:X7_>'Y@7<H+NQ_X.PXK:<8[X!AC#C:C94*65I QHDOC=+$V8<-Y#H
MU8M!JEXK8*#P5BM'F'@-2<">?& )J&)BN"%,O)KGF$D,5[O"Q-N*VEV$'XT?
MYT6?%R9> Y#86Q_"RB?&WCY,8>)Q)N .G!@^Z&%*06$;+F'B54\IV%'(G;0Z
MOV]XW0"KG_1$]9,3@L2^ 4J# 1C],B]&O[#BFA)R!R[O-3#0BNLVEAE^+N>X
M6MY2E84AMQ6X.S T ZN?]!5.M'9AR#4 B7WCDPP9KV]YL>V%(=>4C.L?5L89
MBHBX;.*N3E6$);<5NKNP-!59&B]5Z84EUP DZ@4I5;^K,YJKZRVL/,XDX(&[
M]!DZ1JLTY\H\EW/,24#1QF [='>1@%@>A9NZ],+.VQ\2_4-%JQA]WCI;"!NP
MJ7C- _LY#58Z15SF[2L!117,[=#=10(:K6&/FZL;80,V( $/U-L0IB)LP".Q
M'>I*P/YA,Q;D+JVM(HN;OIKG>#D+')>EY&%,O3#_MJ"VOO"3N^B<%_&:IP2)
M/:.;Y*[*$R2$B=>4@#ML\3"YJZ& $]=\]7/.YTD^@B:ZE&\'[2[,3$=FMG>5
M*&'<\0.)/>U]N=OC"1+"@&O*A7EH^=87EWC[-O'1=G-?GK*ZKNXMX0:MH3'8
M.X1%6'#<0**_9Z"FW#40$L*"XYPSUK;@#ANH";C!C#M#M*FK>8Z9E')=9-MM
M1^T.W$R6L;&TN)\[(4CL64A.EA6$Q-[)*6]CPME..'/-.4Z4;$;0(7]UG!.4
M:^I_7,J&NVA" F'TK#( N<3FH9OVU?>>GT@PW<@#L ".B%L\'5"4^/4*0%$]
M<$-N+GC_D%;15I;'GSK<+SST)S\R73C*4517$(_\P";!1>3//N"6AK[KV%(Z
MRU+,\['ZOQUNT>]*X,6K;9+K(TTC?8/5.KWT[,>)'T3X[RM_.H(7VY=3V+TU
MJ@=+^<+VHXMDW$+2UT%.J&V]H*EQ>E1OQ@]WTT\K(^2=[!E!UF=-UB5R^U!D
MW0.R5MJ&D;^/$63=G$5%7]SO]'4>C:NO) PE*PX"XD42@"<.G,@AH3"WZ@O>
M*[:+]<FP#V38UKI[%\,2AA@W<*G T'>&RZ U5-I=@Y?KRE.WPEP0O!<H;84]
M)A2WFF(AZVNY]3UK5Y(WJ*(F#_)]7X2B)NPO0<8'%M<-D;'217=[V^CF"SD+
M,EXH$NDDDND:0*.[ZQ:[!DQD%JK"4FP_'KDDM])]PS'>:':G>S7X.]"I#W/X
M+[&I=B8Y81B;GD5@G6&4LV+W-D7X6'5U1EZTKF,WK4J#/1>0H+%<"2"N?\R(
M%Y)"MHS!,;Q$^C5@? N4GP#*2S,T:J-<:0T+.MT(GT&SA_S)#P+_%:8H6>;,
MM)QH+L%1DQ].&.&'8_C(+?2P[AW%QL?Z:QL9)T6U9>X &/UN?!40VXF^,"3,
M'\C4=#S8@05RKA+@U+<O5/0, CUS$M3W!G:YH(HCH(HRZ_K 5*'Q116G:XU]
M,9U >C'=F$C^6 J)Y_@!(",)1)8\/ZHA]H2R>CP$7N%R=)E3@RCY T%2GY)U
MZ@;O#WA18X6Q)O!?\;:W$?RS>!U%YZ6E"!5EOT;FR"7P7]MY&:83NX6E!HXU
M_#M\F$YC:@;/CG?!'D?'9?9-_XG!0!K/FSEBH^R(%7J].R%@CV5%5@2?%(LM
MZ=4,)0)3G&(2H!2':,S]%?OXAY,D"4H!?!>V,U$TDNG9DDF#LT(<?Y0J,Z$T
M,D-X%("5#(+G^$+@V> [B:09[%WR^-PAKAW"U,Q(BGS_.[[.AY];."J=,9PK
M"=PYS@BOJ<-T)<PANL!=V)$>XU$8F5X$.^?.)?@__*D?!ZGO5+)<,PR=L0,3
M>G6BB>-)7\D+<24E'3.S7Q.'!)B7/N\L8+=  -*'X\4FN]O@& -_7YOLHJ*E
M8ER -97F?X(!3QTK>&!^'.$F(N&P?<-3LJCVFC'OV[#SEAO37P7DK]A!*(T)
M'*K#[H_L-CO35WA!\EN*)<G'('W\Q)\2Z>?DQ;^T)8]$\ B&),#O_E:+/VUG
M3^DB$^?1IF01I5]<\Z-=<S(EY=:JS@:KX>I%L\'CJ#>CDFI?56=DP(S4?(0T
MGJG2533,;554.CWXA]+)$XJT2DA(-CBX(VN:8MN6;/0-75-[\D@=6.;(EKOV
M6"&*WONWK()DR#SU[L26NY*EQ'9[]W0MR;)T(?U]14KDX;I^ $@+3^:/STYH
MN7X(;/D)?O[)]:WOR_U7N^Q@83N)?1FE'^)P!$YK!@,")R1 U+=7=]^NI:?+
M___Z,2>ODA/8P!:2\8I>H[PEVUHB)<=L&0JVS%\IGC]PNRQVWI<MWX%, @6%
M,*$8F3^H;*5"N&;&_PKO4]>1=9V^8P$QS/2_8ML#K/MN!C(.7Q,69ONK,BAD
M6B=_=_13N_8\E8-.5,$$CDX^?.@GRH_JSE4]Z%PQ*5'IY&,D?D)]N9"52JC*
M+?&2R,X%;-+'\(N 4,5K'/A3-H@-J@PH5*C<T-_89$Q0/-/'1\0C8Y#KL"?X
M Q3]CDU0>0-ER7;@C0'!V^: N%0O3 9"%<MR9O2C$!:8:D^/,\<S7>EF.G--
M5 E'J$=B /;,#!*ES!^/0U  1_-T1BJ="%O<RGL"("]X/U7W4 5U7?A%#,//
M A]V.)K#[*-70CPZP'] )0UMA^YD6''#U((-4]8V3,D, Q./7(*Z9KK@WP%(
M\# MG1&"^@.**DPP\SHSIFH3O&].3%B+TI4U>!*,E><)_C&@A[QX5P#::  [
MBN,O#BHS',6N[8#*ZXQB?#,,ZE%]&QZ MP"/ 08&6K!C.V: &OJ;[_PEF%SX
M3WQGF[YJXSF$FP /LQGC.^GC"V8NN3XHD]N& _9IPK-A[$:IYG\=XYR!K?L+
MJF0*+:S#!,T%-A,@$+%1X#"GL 2I3.%//E_71Q(6KVL@ V9^2+?A ]U8F.W'
M5\>.)JGUG7DJ45^ZRT?,4>B[<+P;'\D(+RS6 AP,S&&T4I=CT@ :D&&N.0O)
MA_0?'].L>L>C0HD^]'%5C\(TCC6+F+Z/?;V<$[:DQ7DEKM[DS<G7'?CJU_SG
MNM;1=+WPJ^[_8^];FQ-'DG;_BH+SSCG=$9@%7;AT[R'"[<NLW^TQ/K9G)_;3
M&S(4MJ:%Q.ABM_?7G\PJ20A4@(0D+(G:#[-M&Z2Z/)F5E9<G.SWN[[<]2E4Z
MBKK[47LX#2KD;^:G^%WBKCG1!1O0"D\V*83)SRE9PCT:Y,%]T>&&%=W"'90"
M>L=Z,^!"YR[A(,,+;V=KR4O^%>%#DSI7CKE>RFA#<'&F/!].[+\OSFKRS^3L
M"8Z#'V?Z'&3JBVZ^Z>\N BE^YP!!"5ZJ]&%4FR):$T%4>AVYSQ>XK(((C]*4
M83&/4CJC[NY1[6,*8^L=K.!Z#N='!IAZW50(?GB\__<_K^ZEB\G]W>3^_/%F
M<IN&5BO-I/?E8I:Q<*7KA93+2@W?Z\G];U*O>_;/+$IBQSU3X=\SU?5Y)Z0T
M]K<-'?"$]_V$Q-O+0-+584=1E)7K/J5SX6'Z0F:^229S_KWEGL #T*M')_B(
M2\!S/JB;7@:.(P;S=3>*0&MFG@P[(VU0B"KK@8+5^ID>M?T5LI+M2?4;U"B[
MTN\-JV#)#4,%1!_SQ?#@%=,4*BD21HE)HP3B**$\2NL"N:;^4QJT>U3]CM5B
MXOKQEB\J[ SV:B,FO+US34,G+&?!=AVRAO@SY?N(7/C1]VSGG;HN\M 1Y"O=
MJWHU6W%>[W6]>NY=LYUX"#=B[<-\SZT&N(5CK';5;5F1DCE7XHA(*8])7\A:
M<9&; H2M+X3MPZ$BA.W8PG9(Z+$ 81L(8?MPJ/R2SQ[>D;Y?57*N==,836)"
M@W.F/5T+HV*ZF8EQY-!ZGI&9/TU<CT^--[TLVYCNQ[DU^X[;$'V.;$EG&+;&
M/4XV0VU+L@2$BC#YLF%H)##4. SEMV0R84BEG6DJ7027W9M5Z=/[.L@WBJ<[
M!44"09*W]P)#D7O;;Q$-HD_\E/.8=F'8@.A#Y"38B+5/7 ;)>YC\Q9<7UFP^
M(2^?:UAD)O#$.;./#BALN,-)P16 JBF@-@_PHP-*J8B&.H6K.(:?8SG #EGJ
MGL,V+YY;'.8;BWMWRGNW^_XCBX1<!>M['UO_H"4C7T;4UKC+*= 0-Z<: XE_
M^RX;24@^T*E*OSR!I*.<X65C"F-XG221>_H37%S'#W2F.\0EM*LZ^M-G6.1N
M+VGE$JOD/HD&&'FOY-GM7/@EXWD"$6'KSY<+[(B12R[$5:E2P,GO+T^+G"'_
ME!;(J2ER\GO)TR*'QEB2G;#$;;H$&-QPJV:CPEIQ>R[X]OP8K.QD'E_YNV#A
M(Q-U3S/8N+AHW<*ZP8HK4:4T[AX_><&0XT&KUQHK')_-T6]% E$E!KJ/@",9
M?7]5R9HXO2MVF(S&.#Y6Y""G<+7^B)OU0[3"[B5\S(45R':D*U5K\"XN417)
M5BL"7:I 5RW0]9%Q\&TXX^%)PW0*$?T^"B9^M>W9FV&:DK%8ZH9S\"G><$LW
MMYZ]M:T@=?_)#)OYW$1+_MUVW2W9G1J-)"63B\15O,9PRG]NI\-3EE-\(-P^
MC<1:?C_[X;J+QFR2Q,GBGEX6."8E\9B>PLV^X#SVM&ZP8,N^X8Y=1AO&EZ<1
MYH6./MXR%A>L"J2[;0-.AD._7URL1R"K2LC*YYDO EF]JB'K%&[S$RP^.X7[
M^P?6G-$U/I]A[P3JR^+#GT:H\N2<B$M4E?1I_@M[.MA@AP3A[&D6=O)?P--A
M1^6GUM;ZLET]4L,5?>E&$X8"F Q7_9RDF>TC;7 XB9-DA"JS%TU?V]+@IUZ\
M3P4@IC[$4,6IDHI,KRMT1M$ZH]1F6_W^EF9;0FE4"#)5H&X44GF\MG+]P9:V
M<D(J*P09#L?C[O[2!_;ZN+ 72]O"6Q+F%0=X"H*6WUC3OVVM/OK#7:T^8DNZ
MZILIFGOL?91H[G%*S3W"KHS?"!*GQ%I\$)>C'45;CP9/6+3UJ+L'+$4M2&E\
MU5SSMQH+\%_E3;I.[F[?G>UTV9WU^>W>,6'LVK$7/ .?'1LQQM-$IG@_9J^-
M6F--SDT!53J3>C%I#4*R3EJRY*.*UJ#;&@^ZN2LLA6@)T:J^:"G'%2VD'^[F
M3HH^AFC5IXWX=C(2QZ)[I)LI8BW5<[]6T20+*/'6TP$M?W$VL[VSX%U<X,MP
M2VJ/^LG\Y9W0+^=\2.GG;R0BBC<E#H:$0B$QR$B^*2!1_2/P8$BH" EYT#\N
M)!K@K>'[I1YM+WGV?7 4LQHK<ZA%7,2J5#! ][%&Q=5/S]%A^0Q+=]YO/+)P
M;VT+7^K8)HSUF9IR8%-GUR=::ZRTU5'RB!'AX4K=KH6R$<KF6/9J>=JFC]JF
M/Q!YI4+;"&U32VU3_%6H/&V#S8O;_:'0-H??^=:3T$2^5UU2JRHYJ(_)]XJ!
M-@ 9R@M(T\?F@JTR,9%=9)4))@79F-*G(!]S513+$D$S9(95]@2^\!WL\!8O
M$B/AM)^":7_)D"!5[<PGD=O6] F7DMM6:2X%+N6Q2'<3F0.IW:#!&7#-H),H
M0^!:],/66!WE[N4M\FZ$]%1?>O;X]0X1GQ$<5DK&T*$0'R$^%1&?[;1&J3Q5
M6UB-#A"D(>9_)N4H,]%@A=+3:F1LNOA_M'^E:4]%YMK.XX$NV;DU^XXKE0[;
MO=8XJXDE,HX^YO _8'=EL* S,FB)W3UR/MGANZNTQOV,'%<520VK]/F3-5.Z
MN82JAU_S6<)C.AACDN,P8R*TX-RM,$12WF6S8$2#@TPIRA4D,/+Q&$EW*&;"
M"#:'&51%C]0]9D=3I:7IULC=MO6LE9LE8\)0/;PII6<T![*YA5"(*YJ#UGC(
MJ76J6&;.\5V<NSR90I(:($GI3*$LHC1LC0>]Y*U/B)(0I6:+4CJ+,8LH88"L
MGRP^/R%1JKN5>DGF!+9]5EAJ6<K\I(_]V"DXX0K).*J<;B\HKEL=O5Y$Z#9E
MY#:4]2!TFT'1C[JML=I/%CW6L56<@'P3()^X%A2/^1X8-SV!>8'YJF ^;89.
M#LS+K7&/XP$^.N9%,D[M(OJEFBQKL?TL@%8R99Z)U(T//Z@/WFD,@B?CFV*G
M*WL\';S3R,%RO)T^!5^!2-@Y/)@765LLTIX%R-@ JI^[/V=UKADGCY0]P:H<
M4$%NAJ(J4012/AXI>V(Q.9 RY,=D1!+/X4D\LS1!$I'/4Z_0::GWU2P".P)S
M=I#>GA69 0+>A<,[ZRT]/;[E;A<OYAFJ_P2^!;Z/F_ER"*I[K;%6^=:]'YCY
M4G..ZPP)VX(;4G!#ED9[G4X9897JJ/+9X=7D;10LL4(3?+0F2,5)G4X5*&"7
M="MOF A5(%2!4 4'$T:G4P5J:ZS(FE %!]]NUMF<@W6\]1>P"M/][,X%K.]H
MW_K*4?26N+3(U/1GU$\MV=X+<<);S*?@"O.Y+5G$D]YT-_)?VW/IOPJT6G^W
M'#*UGRT8_0Q0&L#3C6![1RS=] SBGENS<-P!E+D8UEKC7FY"\D=C05SIEKQ)
M]_9"M[8L=J^;:K5I\E:!,I1NC[/MT1Y[HNA-PCAV8H\0A$CF2]<+26[I/P)
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M7@WOO<TFJ[_3('D;-FVQ)!Y:<GH0)H=I.39HG!FE7(CE_]$ Q9PXF @XQ7?
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MI7W$<1;[Q#K68)8O=$D#T5KGXT' &'&J-L:O$X#*]^#]0;88#LA>/PL< IB
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M%!Z-.H.>G-4Z[O<Z:E'<O=V.*@^*(A16"V(YKNJ@E-V/2GFA;P2G[(F3Z)[
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M=E 6;H<"MP*W1[HH%HG;D<"MP.V1[HW%X5;K=BEN*U:H&KXGY+=?(DOW@9>
MS EA3?U^ VY36^E\E2QTOH?,M"KTJZEY?NL\R6P$P'6>:6IFX#I/4E &"\I@
MP>.VHVY"Z9;#XZ9U>\A#,AC4KSI0$"@*P3N"X/7*$CP9!6\TJE\IDQ \(7A'
M$#RY+,%3J.!U1T+PA. )P4L*GE*6X%&2_&&O?B0"@C)84 :70W>T[UZ7@V)2
MZVI(*=H5%+)5VN\]UXE<^]W'_>X-<R?\B?TN;K_W6+&Y]IM2@O>T"M4(BOW>
M8SSEVF]*"3[H-JS8KGH6BZ ,+M"".2YAH]8=M<;]0?)N+Q@]JVKR'!D@O6YK
M/!P)@%0(('MLI&,#I < Z0N 5 @@>XRJ"G%*:STD1&C+<E7* QO@5A*4P84;
M9?MH%K4>=A(>U:^=J;C*'BWRO1]#:FL\4.J76"(P=+0@[GX,:7"=$WKHI#&T
MQ_K;P%!6>PV+Y-L]#H/5B4!,, H?D%DM&(4%H[ H1=M6BK9^^SB87%#K#9#
M1*M0_%K M$DP[14$TR'"=)2;8D_ 5,"4!U.Y()B.$*;#Y%U*P%3 M "8*L7
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M%7[<,N:S<_32VXLQ?9'(3W@AWI.CH4@.^<LWG-7 @Y\E^-GP#$)_%WR<2"Y
MQ9B#KH'IN,&TX)G$<O&#+[HGZ?21SSZH2/,=N7%0>\[P(;8C$=V%^>!]?(F.
M.&GNV O)L%AB,V*:_TWOA4C3%X/,)9O5O<'BH_IV\2L+_0=Q.M(?1'K17XGD
M+V<Z/MKVG=@LZ2P,:VKZ,T+_E&LB\/W=PY$^74PN?_O<61?@"HLBK!ZL DP7
MUH[.SXX*#&'98,Y;C]E@\3:/V'T7&E!Q3\29S%=B$DC)>IX[3&>*N>YOMC-S
MB<4[<N'./_;>[,2)"YL72>"3[\*473?<:O>+],GX+/U&9@^^\RR!2$BWQ'=L
MCTQ?+%CGYW?ZNT\&?&CB>"_V4B<S8^H&4D2WR0VA8&!!I:6;P0L1#2ZH^JF'
MTH6/>;'?Z <1$Y+N L(8R AZJ>ADK2GU4^&'=1/.%=@%%Q[GPK>FQ.U(C_!9
M^FV#?>^"HN_J)YGZG@&@G\P!RB@%T0<1AFZ$2E>BLL6>%[X"?M]>#6=C*/B6
M<-7:=&!@#QF>[;CPZ]DS\20P.ES?E6"U?3IWUS=!@>!7GB.)6LD'(YKH2!-8
MA]C&A/M!W^ 0DXIN7&P=,C?)U)-@=IYNX"3 ^')=*KH,GC#8I6. <GDGNB/I
M"S"CX'E4L^"BKVU?.*Y@YW;M?_C1F4_PX],7W7HF* Q[][P^4D_18CLP Q1[
M7(4)[#LH-_CQV89CV07H6CAGA$,@2L0$. >JU 6ICW]=GRT,RX"5"-"U^BO\
MVC-T!"O;:^J;/7O273*CQP$HWN [3,1B+UC],4((; A9+$W[G1#FU06D432T
M$8@>V$[X*?87U%3LG7&(K_XF/3MZB, 9''Q3 /GZ0P-P<IX;?'=CQSDF]B82
M0M>\8=%=>4);\NM"_WGV9LR\ER]*1U&47[["8@:_D-DO-@Q]SUZV4EB',M\Z
M5%K[AY1\X5<V('4((U)7]Z^4)O4]@0],#=.@@YS,)Z&"8,1!8:%[>!8\VA>P
M_DA&B-O.L;J5A'D=GQ)7N@+%$]R\&.\A2)FI+UWR)?S'UXW5H%_ZNBZ_F/"V
MN3[X0O;G8)W@DMKILHMJ$'D)WAS\N0-_^EOR]UJ_(W<5[I^ZG1[W]]L>U0/L
M#+,]:OOO1W+3!Z7M?-2>$-H'1LJ&>Z\UVYIPA-<:>H"GJ1EC,A-(P3I=:!TZ
M<N!%,\4TTU; U7\U%+$:L=60"^G54OF8^0[;MS#RX.8YQ;/-N&;N\J2;7"V)
M+UO!_%6EK?6*RK=*MR%Y>0H.K)L6\G.J\J.5)3^85BNW>_VB,L"%_ CYJ:#\
M],N2'Q7DI]L>%E9!49[\-#9I,^Z8%4F9]4^V2$KOH"SIU5KC4;L[&%0DR^)
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MT$&F>UJ2OUI"OBSW*RAC.&"[<E&=="K@!!)@V=.P\G"PT%;5(S5W)P !ENJ
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M-5,3?J*=/+#!Q[K@/1%800M'?6N_DL53,-:.= X/"]IBA=K\V8*E0%F'+?9
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MQ%5Z>"$$/63G,W;& 6HBNYKG9AAJ/,-:2QK6\;4#76\:^I-APBO(IHFGKYN
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M=^$P=%T,,B)$ )J&EVJ#<FQ%.T "#(TR&2^]6$AP9GA^D* 9FRL=]A/!YRQ
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M H5MCT%UT=M=ZNJLL$S<>%IRZ/P+4WP@1'-V X-00PS/'.I+33XW"6%T8L6
M)^_'\H>B#Y"5%1X.#-C?1G2)>U/9EA9YA*8+;;9B:4]D'?J3?,V%C+Z Q1E?
MJZ^X318ON&X/7%:,"M3KZVO18]5$BF3M[K-F&/W]1><>28T9@QLSW)BAQHQX
M^L;,Q(*I/#X\5>O-(PIT2Z-P1RF+XVTCQ&8\ZW*E2CVUYT"02# I5%$F*O*[
M9X4*=>QS\.;7@/P&JK"N@['=BNG)\)6) 13_<JB$5V8&/=YN=Z%@)T2D+G%$
M<D2R2//31V23$+)1:_U"CS_KU4;S:^T)/=ZA2K71*M?JZ'.U7KVKT4Y ['WJ
M 7HHU\M?:#<A^M=&];[<JMZB9NNQ\NWKX_UMM4$^TFJ1CQ\S:L%LB(>P+'#Y
M,'OK\=4FNF_?&FT/K>4!+0<N(K.LUC!8NGV35D&#6 /_?7H?HH&E;.*8N1[&
M=+)>%L^N:=/R!#ZMF %A6A!0-J Y3L2$I74:R";F_L8^@GPH:@#0+"2P%\A^
M0:] MY+XCYBO4=FA)9&CEXWF=^]J90#IY1/]"!TG!,06T>-H8G'#]]E[M,X=
M_<%QF(5)T[XL)_#H_1=1S-5D+7<V+IF^B<^1"$L=W 5B:$.2ET;48*(2KW,W
M*;W2C*6:K7R&8;D^\BRB6.'8O!"QA1H+X,R &P7))A,_G(HE8S,?!@&'Z@>Y
MEZ%CAQ=DLQ5&%4/)+A;@ 1$VH7-P[&:9*^$5&PQK(0"K*HC<&&% ,U1B#.UP
M-ACZB]&C@$B7H!V&5Y%+AB$[+K$YQU:_%ZN;6EA>7YM6>($HG<' >?4^\-H0
MO#8$KPV1]]H0:AYJ0^PEY9ULV.SI=*&^$-U(/M"-"3ZUL,8 .M3_5B;F[SD!
M/P?1;X91U*F#+YWI)Q=%0<\$G*)1E#,J"R*1-XS5X2B)RX)(14&1=H3SW0>N
M) ,49,-MA^&\W$D]F*A,3B]LOPI)[;$#M[!J*U,!@Q%1M:(DL 7?<P(_JD\9
M_]<H.^R5)FY%^00P$.\T)O(G_0ON7IMD*&0'6I H=ZY3LTC&8N+EXF%4X/3%
MM 9F5/8YK)H!<D<-&V:O+;"\8I/);+!+HE4- FJL,1N'?2*L((B[[*]6_(M$
MSV)_ZUEN5 ."3$HPM*_FO2(KG&EFY_>S2S2X[G4XI9T.QKW>QW [@L!%,3=.
MI]G'M]B=( E""56CY%3F17F*DE,3DC#S>:'KXW 3P^3ZIGR&MRZ=[ZW3IRX7
M-('\7S2VXT*/_F^SI9^5>9)T_8LBNG?LY^L6](^LC?U+\;6?P6B4HJHF&- "
MCPS(T;545)1YO1W*33-3ZE*\6F!5QA^7E.YQ"2BG$BJ*!:TD%V2C%&YP,RLU
MI4S2VQ02W>1-ZNLOG,0<;'K_;YM)2S99^US"HE(LZ8>1AHQHF(N%52H(NEI0
M#2D3G3#O:A_!_E/L8&$"_C(]6-A6]<OYP]Y2Q<GOW66AP.7W[E@-444OZ)IR
M" UMK^9UV$<0HGDV>IHSM[BN[.Q&WT^@5:W-94ML+R37R?;O!I'$@B%I!4-7
M,U2:DZV'S7;^[!Y+<KTA?"PW"\][#A)_HA9+VY@E<E%<<)PP99;L)$IZ;;3,
M2K,.)7+_1KU!D*83DT/26:0%33G0C4))*R&(RV!! *^K_:,>D2U6]@3Y4+*,
M10J$L2&T $D8UKY%.+6N\EA!'BM(8P7ETX\5C*(":< ?U#[X6GMJ3H4 MAKE
M>K/,"B,4Z#M1/BFJU6^K3U7RQY&GBR8("UR<TA(&/,^_%>8<1E4A&SC,[>I;
MHS#:+"ST!4FC[Y"L-2[W=<@PZ1)''T<?19]R^NA[:M3JE=I3^1Z5*Y7'[_56
MN=Y"=]4JPU^SVOA1JU1//=QYG'@MA<AJF+%:84X/E4<CAVA64=E(B*FLQ3JS
M-B9M7<,>S['>SG>6.\P:9\=1PH:'C/*041XRFK^042U]R&@*_:DDCI<^;T+&
MFY#M 1.\"=G1-R$[VJV:5Z>;5*?[D6%QNI)RA%:X2!ZYFDUL>$DO:FLN=2Y6
MN'KZ5GCUWU]KGVNM9@'=U:#N'.0E-UOE%LM%;E:^5F^_WR<PPU>UNQ&C9C>>
MZW]H=OJX&PSP8^]'U(ZO;'?_Q8IVDWD*[5=OTE>C1:[T&2R_6-,;]0)ACUC1
M ' WP(=1T@RCJ);DM$N56%AZ1GJ57I14)=6EEO^[8F23\&(4A5+:WS[',1%B
MZ_SA)1R3MD<WPLX O/C4_]*\"G>;73H ]G8[BQ+E4]S7&G.&?RRCCR5<,HMC
MA?3C$<<6;1H!50589< U)1U8UU_L0VH3K1H95I6-RLJ6EI:5S5ZT,WI$2:,#
M:>B/3O:D/#Y&5OL*)C_5X4<6P9.IP^TVBQO>SKG2ZV4[XZNRW?\T#SL U'?!
MK/BO]::\;EQ\DM0_;\Q/RWQ#NUA>6T:DQIY_>(EK^/P'C2[-?2ZZ*5K&&$E6
M8=5T;=I2#U) P0U'R[C(-+2"O)#6Y/"DAN,N9YFOLNU664DBJTS;]RK+CK+Y
M7650RM'%?6@5]D(S.YPAWGK%\0WOA)=BZ1!+\30WO,_F@"94-?L8NKPZ-BNM
M$ZXWF>]PY[.L#)$L*YWO<-GO<,U8>4 : *=_1%56.X3O<WQ!+EV0"EF0);[/
M[4#E-+T^NH,BG-RTX^O,T,DZ,_*Q\>7:/PF5@VD.WEH/,W=)GO6*(A>Z^"0+
MJY=4=#/1CRMT>]B$LINDA><W*#OQ@2I:U67@B&YE 4!0%#_CS4?D; CCS6=D
MST?EK.O8:L B+YP?:EZPCE+C5F51BQ6H1N\%;<_J6J8+V=-6K.;X?J8S+_&3
M4807JM70-?I1OO_.ZA=##M:_OI?O:W>_H(%WF*+5S&Z69N/G,BFZN/\ENKAH
MPZ:WR:?JT%.5EW49-;A(I#!N/%_&R<S7+8;6C3N?L!->B]G0/$=WODQ0O(YK
MT?3;[(-W<KQ PO,,]N!-G]93_HR?+1L.\EF-ZQY4DK.<;G;S<NQ4J?1-]SDJ
M1>T[=)HJCD?4Q_\VAR-6E+KZ!C6N<891CL<^:]_M3MAQ&J+QRV'BZT\7.@79
MT+2]@.J81G,UB#5-AFLEFCVN%EQ\JO9ZT, )/+6T(35-.KYS7/(9&U4"%U+V
MWR?MJAO$*MI!^&V.)RC$'%V9IH^J=G<%VPZRY>W9:+XEYET%"@G=-1X?4+G9
MK+866W.[1U8VL<S\I_;Z4^>P1LH0($ZC/>#0Z]8)VGXO&$31Q#.^H3R']9_/
MQS+R/65:]3D_)[R_L.DBB)+O+FFXN)LPBC2SFKBF_/Z-X^1EY1?=UUZ+VB:[
MH3 []\YE->YH/U::FQMXW8N99%VEI%Z@+NY80W/@_?/B6HN2=P/O^MDT1Q\F
M:;L1-;VRW6U@,K07[(7Z%Y$?<L/D6UHL:5>#XNS2GS?3HTE;]W;%\7":RK5<
MW+FX4W'7MA'WT$'0<L K0/X]= 8L%'_]XI-F<.GGTG\RTC]QNB\4^-+%)UGC
M L\%_F0$OMR%,J(TD&NAQ$/"(1=X+O!Y$GA]1^J\)$"W##DGXKXK?\"6'0"/
MQ!^0/)TI57N9==_9KF/,L=$E]4T?/7I*NT*/>/%)5)5MT9/V@>QR&^:KB*^B
M):O(V).#0I*R<%#P1<47U:DOJM5^#TF^^*0(?!WQ=<37T5;N%$DA:AY?1WP=
MG<$ZVM6AJZ1F<NBZCU7$0SJV<>'LJ#+&NN^<%Y=2W_2Q<\D0=L4E" ;1](R\
MQ[G8W?DJXJMHR2H2]^7"T8GIN;7*S!<57U2GOJC6N'!*%Y_4K$[R^3HZO&3Q
M=;2C=;3.A9-A1 Q?1X>7++Z.]G_:+0N9G';O8Q5M4, JE9?TF+Z?2;HR'QP?
MW,X&=YBB8?O'. $N:[@]+@[&JIN^]JU.'XU<Y\7R .^6AX9F%T-*/?DT,D>C
M 1DWU# P)WUE7/P<#%@I,=H+"*/O9%>("JEZJ(D[@6OY4%4,2HV-4_$KSG!H
M>?1WH,F0[?CD4G\'%G2OH94$Z;5H,WKR+Y;M^6YHH-"6X2X,*SXBNUN ;[B8
MW DNH+[Y@E$;8S*J(=19Z"[HV)AE94'^L7Q_[!2J.,HGT1&O^M:WVA;O@I?#
MCRWJ#S[5R#9=XV@]WC@Z^E$B-9UK(I.@M7_P@N'0=-_G"Z?LJ42*1*N*1AW3
M:<5]Z2,T/$:BRE8<+?P8;X%\V;F:/EE<TSM];[?1;#5^?:LV4.6Q\?38F%2M
M;'[_W*S=ULJ-6K69SY&'/9=1K7Y;_7<TQ'WP2%I0^FUV9L(^R*!"LA/NH^A_
MKA<%5<JD<:U8-'0YD\:UFE8LR>DZ_"[O@:MK1E97TE=/5++F[C0*8MK&6&Y]
MK(J]6.A1R*S^2RG-%HVDD(C;%"/;NA+9P1K&)YNKIX%)+9]RAQ@O'JU16D -
M[+C/IFW]?Y/]O>RZ8/2 6[B [BWRR6YH,KFH&70ZF!I"R:=YD;3M2#,^1?F^
MM*Z.4*3ISK1DCM(4]T\R1\FZ"TSI<IA!X^-A1A6V'.C[_LC[<'/S^OI:)(,K
M/CLO-V6WT[=>L'>#N\^F>T-6GGDCBX*N*3=DC*)HR**DBH944N62?M,M$<55
M,+KX31*+?9^81D\!N8#I851^=G&XAEF]=9/VB*D[+S3\#-'6,*)10.;0L9\7
M55LOC/_Q<_%'D3I$?M(%@1YP%QXX^N(ZP0C5X=T0OK31(;L"^<GV.R(WBJ&N
M(88&&V-4%T7XJT]+P@^)D+R'_:,\*(<X1*7K;^&@Q\/5V'#19<P5<V<1W:;N
M%!&9F&M1%A7CJKBD.0,'U"X!E1&A=K%G_B07AHM[6U=<-K+1+#A%\T)121($
MK21J-UV1V!^&'*/H&)Z4>I'6](#=9^Q.\_0OTPY,]YWQ29(*P#SXS@JJ_G L
M@D-V,:)0M>F[Q0+]V@^G@UV3^IL#FX@#]2$7@*H[0VQT!V(8BLP1FTO$<BV0
M\VN&7ZH@2*H,6J!A:)J0DE_3Y%+'Y&IC_Q6.HI;UWZG9IFM%*N!^T*2S(1X+
MF68.ZM15 12[7["[O@#'>&I7E<Q=5>O/_>''X;"?@&N"E0A"G]^O[\W7%(T'
MN +"G5!<_<A$_1#82[%$7DJ">H/?9$L4_OY;E@2QQ/2/!O9\NH,O7\6I5 :9
MR-^,SO"/4%L0A>M_T8 @>.]OHB[XY/[>T8@VC AS+IMXY#,WDBQ0/U)IF2IQ
M+1BBIN9&DS@OQ'#&<,9,,T:2X;6H4\98YI NY_;[@&S]U[;S NZ*T.!A;U'=
M8 R?S_2#Z#HQ8U9!YML8,N_SR=Q(/C+G"3=1.(57FB@*-U'6SE6-QOG2]"G4
MQ3T+FO&Q0&#X$-5Y/!90_([ZSH#<HU= EMT9!'!3Y%67?#5PL1?.]4^,3'#<
M (1Z@6M;7C_&HX@JP8C\ =''!'/()/,Y>H=?PF:G'T8>4\?/*'"]P"0OR!58
MK/3 L9^OB78T)(-M^ZE:+$/ ,W[K8$P'+@I_1.'3ON.; V1Z'F;WN^J*G7CW
MYYD.SL@,_+[CDKGO)HD;/9C&%49#+5[M)P6"5!;?RFG9&@R;7IWK<0?7XZ*
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M<V3M76MSVS;6_MY?@?6736=6LB7;<9)ILB/?4L_K1%[+;G<_=2 2E-!2A J
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MG7J/E?^]D?WI\)F]@\LE%N.S_*+_#@*B=5>?Q!?DZX6^Q)VM_OAM@@),Z&/
MY$W0R%4/N@_[@^'I98B&1\.S3V@Q1?0 P"E3-\V^/^ T1 <@@ LDITO5J -Y
M]GWJHYCZ>4I]_&Z)*":N-.']@1OJ=.<#P$2;Y)BK[?R/E(3+]P>ZN%B_+@X
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M4,E>5UT'S&LS?KZ<+U=ORP;#A$4F.$\(Q58;ZCW94"L3Y&!=,8K@^-;>S5<
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M229STX$W2V>.J_K8%3V6O+3^!F[]>>W@]1PZGZTF-)-&(D8HQ?&:9%\@V-H
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M[]:(^-Y7'QG1VPIU!=4-HF6O"%<71F_&&?_\+[P89"%UX"* JRJG7"@0F([
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MO0$YC_9^WT2R#=O2+0&]R'DN1/)?PS"_&;\*9\-9&%V"DX4%EH0G<#5/,V"
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M8&?!]F!RT+:::>&[MH2J43UPAO&HBZC=>1DM?!G!IZP@Y$R#ES:']>[;W"R
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MWWN@7>K_.N!Z,BX>!'88ZZ(9C>NIQPX<]+"// S2,W*^E$V0F*@W+RH$SW0
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M0U!H4M(\XY/QLUL/_AN=:T]&_ALIWXIIN/7AX_SJYVVE< U?%S(KN2;YIQ!
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M)^,/Z^RW7T:SFIM>2Z&:UYX<\,S>JE*.77>C>I7%1E%WCSL&(KF.GA%9Y")
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MK/4@1FH0*2$KY,KIU*)3],"J?^0&<TC-'R+<AAI/DYLQV8]7?[VO)>DA^92
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M]K6I9]VAKXL#?I18>SA@WTXGY$#.O]9Q>O,7X_SKOVY&BZYAKW%^);V,)9L
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MJVWWDF)&"V2M*W4ZP/U!T-8Z[?L2X7'H;Z?X.8QJ*OBBZGXI[/4R<HPY.!_
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ME7:_CT(<79,^\##<J[?F5FR1C-B2=2&CUI$S5GO .5$XU,)^5S#&Z/::>WL
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M1,ZM>_7B>#29_C6>8;J98EYT U(_:<U^N<'?,$YOPO0K9Z0FNSJO3&):J%B
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MC20P2.EO_URYC93VJH]S*1)^V&ZS-I%YAS.<?L'9;4A!:C2>R0#%RIJCAB3
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M>Q!#>%I06PI:6U*L?VZ=;K31(\MLH@C)'SUC5W]<O\0PP__Y/_X_4$L#!!0
M   ( .-=3%HQR!YG)&X  (2T   3    <WEK+3(P,C0Q,C,Q7V<Q+FIP9^R[
M"3B4;=LX?DM14MI44L@:LH>LDV1+]CU)C+&;$3-DG98GBB*R%$5*]J6L(:;(
M3O:=9-_W+,.8^W_?4WIZWO?YWO?]_N^W';_CN1TS<U_GM9[+=6[7!>P$OP+[
M+BJK*0-45%2 *O0'@+/ 7@4KC"4*L *@APH<V).C=,/.&@ T-  ^"+(3H*4Z
M %##== ?0'4,V$%Y!P!+*N:?[_94IWZTV09]B<#? "?T<:$2I;P?@CX1_G;
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M'S]__E#MV;U[S]X]^_;NW7=H[]Z]A^"OO8>^=]G_KPP ?@#V[P3X@1?45.S
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MU>B)7^M=SVT56WASJK+.J2O22 FUW'[L!#):;W>MRXGIWCF7B]Z##1 :KT!
MZR$(]+PH]I_*5"!,,;35Q40&3DARMY@F^S0?:ZYE0O85/,B==G_9P[\BMM01
M; ("(_KXB07"!O8(@3.QOM!FK6CRN<RDN=D$4T/"QA) .(24^AS-RY)^:5,
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M)<?CSH.0!WN@J)[J7W^V_?Y0_WS@0?[0ANK7VG_Q^7Y@6+5MF)IJ_]:!X2>
M%3YUWD;]R[T!VITT.[;OHJ;;1@7LAAKD[@.V45%OIZ*FAJ?<1K,+1[6->OO^
M'0=H3M(>9 =VBAQ2$.5@W*5S_K %I]@1W>NWCEJ&<"G&O9WG/N-"Q_2Q29QG
M0$_B]D+HRPOZKDK*DBK(4P:&1L>R2IL'%ZWN8!__AGJ57=8RQ'O6>@G')R6M
MJG;1V.2RC:V=O9O[#0_/NW[^]^X'A(5'1#YY&A7_.B$Q*3DE)S<O_UU!X:?R
MBLJJZIK6MO:.SJ[NX9'1L?&)R6_+*ZMKQ'48+P@C&NK?SSBATH[MU+3;=E+M
M N@H>.V'\8*/&7=LW[Z=AF:'$X37_NTG#^P0H0'8#RKHT(I:'+J^\_PMCA!&
MW3C+PV*[WG)^;%)TF3\R</L,5ZC>4>2%A9=9W.),^A)*5CQTKG<>*V-AI Q0
M.$/)W^Y2L%KB/186GP.?-X9_/W \I6)D??;GF>/O1YZJQK8W[CU)>E?5.;XF
MI69BYW'_:7)!==<$D4_ZXF5[SX"HE,*:[LEUR@&OV1_/)_N'^@M7KZ[.%G<4
M;V3BYGRG^KS^ OPO <S!QO]Z=B0+D?@RB<^\!\BF7BH#\GH#&#<0B N8[>WU
M65+HU .!5^B7TUIS.[AK*W#BRMV!Y=T;M#Z*]\G,$J,9TDF&3Q.6NG4'.';-
M%K='@\"W0^Y+'2#P?A0$NJS7/$"@=V.NSRL3WZC3WV!.7H):H*('QD# =8Z
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M]:3AOID99_@A[//@@J0W9G<6&9RU#]M&9!'YO!.OX#ZDOW;-B @(%C%7.\5
M<V6? +0%$N4:^OM&%B7=6]UH\:M'K"$>I8C>=S>RFWM>6[*4>BASV/ZR=]!(
MM57*J7'MFP=BN%61!G0!*2\8<+.W_VZ;HQ$T(!!COB1.-@]_8B__F,A;N"ID
M:GEY9X.*NYP&Q@&W0UD:>&$ILN%^O4/"R$JG-@Y7TE5EP1>M\;Z=DQ4WFS]*
MUH>$)@7C;RZ=Q8Q)E%=O0I*/DT+KU-0"RA4+5K?CB@]V,15\TRM3SY;AX#A!
M/7-ZU#"%3"\_$ 1<54U.=I$ZYD_GTU'8[?^WRL?[.6+@"F&%6%(' I].-L9N
M5,"*TD3H'RFJMD+O'>0;(% 72,2...=L\O9O!+KAKHI>QJ6.LPRG5:]H:1HA
M+7!V(N^*"9%5&4;7 FZ^,E/NRB@SD'C$HJ(>!PN-%ND9(19?3ACMR&>V&8J[
M^HAHD?>FDJ>X1 [MW29__DJ)?/@A*TF\SJSRG>.2Y*9$I&=2R9=8_OO<;?JE
MU#O,5"!'L^A7E0RV_[W5\AY##%PV_^SNBLFH_XSG#P[R*DQD;#_ARD5-RNY]
M0C?!%OE6AC$TEE^A13DK)+(ZVW-]%UNL)! 2D2\/ @[2//,)!Z&17AG]MV9J
M_DM-" 4@Q/HH\U-'$TH$EWNC-T8B(_ID4-70I/6KS,J.IKKP0[@<@["Y$TH"
M9@(7'#A=E&O&)YE4V> LB \*! ;.X#_O%B#5D4^-%%:^SZY^3'1=<#M.TS?M
M6*Q7$;Z9W?'4.(77C0?]WDIEK)>1X4$LTSN20JM5\F":Z[[JLFV0H3V!+WTO
M#VG01,*(D6GOFB.F;Q8$[OFD9V_H\/$.+%FQ9N;?/3<Y^Z'B_.FZG/T-A6^E
MHO(.\^YE,)$VR(00J G\%965O2#P6R/I!0A8^Q-EO"^G55GA[Z$_^U>.^8JB
M%T:6Q.F+9:X\Z;NO/*M)X%EGJ7)*?B*\G>G>D<,\D&\X^2N%#@<_)9Q\BS@H
MS^4=2A1[>J;B\2MIO;<;HC$1R;?+(^IFS-)#JV=ZM_4]DM,<;"C34*3KP]5K
MIU[W@G?# .I9/2I?T$'H77;;LM2543SOHWIKE_#@D=1J5%:N2X>5PV2\Q*)^
MNZ'FHHROR7UHVA;S'^Q-)T$TW0\"AW+;O&N)Q5$5"]ME3 ?GS%#'F&\O[PF:
MT>Q/,+EB<I73'Q7>Y'(AZ%BO.202+X3^S:Q=NU2"7Q23/1]7 -T-]E"[L2BE
M@*,6]]5K3V<5Z >=:E*SY@1V-,!SF"+F$[3&,H4:2AHSUIP6O-QJ^ND+,:ZQ
M<\H3I0993:20F>,[U#^Y<^A_^"@JIY>5^LJJI_%V*U&ZW#&;:+2&Z89/\()_
M%6V7N37UAD5VB%^U7E\)3U1J-:+'ULK;O>XGC)>\[\4>>[NYV16-?O]JUKMX
MQQ5?V41=7+ME6&I%36M![S!W2%U8CL&W)3B+4[/%N_.L#4>($]_&%A].3CKE
M_Q9?MI)?IUGSL<UPF?52O0E;^4RO:;'2=K/D'A=MK;V*C&^27(353G =TE5\
MU"ONK*9Q<;Z<$84[ M'KE'EXK #Y@G?/K$]#/PCP>"E>=\NTGGWZ1"OBL_[=
MRJ\+:K(MC3,^<3<3C)V+%&T'-10#+EG+TWFJXK*WM\_.0.Z9\S]-3)H^PK,%
MK^DID]8BGW3A]Y%]T:1^"V_=U A_Q^4YK/5(1@.F(8AOQ.YZ&%--L;B'ST3+
MF?AXZ^>D+H'B2U2O1)M*PW9#([8<I'U6.NLMR.'B]+Y$S-FI[V-@Y>B\U#27
MCZ#1GNC2$3OVS/*1!::+3#8OJX9$]<7B&[5VO]>[,#E>K@K[VMB?1X)8$+@+
M24[/Z 9DHO?YG\?/,<,B:?5/LZV-P:UR15T^M%T;1PJE73U&UU=S/%M<D.[H
MRB]>+JDSHFO'5_@LQ 7TZ6LY&?>IBBOI:$BK:QAI<3[2.OZH:OP+I$H>0_$P
M""R)][#6&WV=+2/N/G2T[HCCS&2R9\LP=U5%MH!@QTQ]@:*"O&'F08TSH:U*
MN9(9_"?5H\MI/-X?:NNW7:S649=BF>HS/?(S+.GX@X+'&LL[> >5>Y]?N[^H
M-TR^RN>9XALP@2Z;CCKMI'?(7S*FQQ1=DN_H5*\PF!/]V(6+:[OOZ\V:D*IU
MRH9^7KR:,#[]<*)HXZ"W=:HDRW)_T2M$L:3O0%455Y5-OO)$K<&8)(U]B?8A
M-9.P6B,-V70+]T>Q$(6X-O\9[?X=@(\??D"T?V4H]C9BY<7L''E7":S#VM^8
MS[\3(L82J @+#*LJY)5H,=C'%OF7(IK)><2 -%YP$<^ C_8OUR@C:5[<$][7
M4\CPP"Q2?73#4S:H:XZN>T_F3>]G=>>5%/)E)#<(42'=-:^8)D^JP>*T/N8=
M,K'G[2)RJ/^&M_N7@$1[]V"]%5I]F]?":7,J0?U%IKQY"54M'(PMI@^83NIH
M3AH,Q7"B4-=VPG16Z]R@QN)4+.8^IW]96_DTIYG[Q>O5-?2T7H30@SYF&2FS
M?->UE=-)Y4F+[R:0DMIH@@*T['B;+>6Y BO/V%/R'5A2RQHRLJI/S%@C<A%Y
M;>B8V6Y&Y6U9+&]F[.,?1C77F]%XV02KTB>K?NHUU8(VNT+_+^1M3T;,O\&'
ML8Z;$DUTL;[\'"L;D2.).,?G=_14#I4<JYSZ7!A>9.,^?!+'KJC!,M2]X<6J
MG?HI!$4GWO0$\KU*C$I^I6E6(HFG:#!RXQ2B1G)P[Z>J(;P_1K"B,W;ZXPH0
MRKH#6Q3Y?M(</S3A\F;",) G;T53;[]?^%$'K8$XTU8XHLAX#&MO:O1'$ A>
M]8(0["_ K[J:PGC[;\V1WD'B! %R;_A"+0@<H*T*WMS<Z(?U"RO,8L6Y-0.A
MI3[RR%!^\.+[M;OOTXN6]'4'Y"W<(KHSLYT<&;T/)Z^MYHN&N=@S^\NIG2*O
M:AR\I71^Z("ZEDY(P&-H_!B57R5D@_#(?_'JE]CZR.& ]CGI2^W=:Z[-75<,
M]0CNFSPQMYWJ=<OY%YX+O,TZ)U@\\IZWQ0!WZ<*#PR=C,L[S<;VXG0F-DC%;
MVNDEE.JFW#R%+N@Y:A;^QHVEMVSFQ-,<MY'M1]_O[>Z1\;U-;WUDU[W*%CX%
MM>!*;3U.'?; '3IP;JL9MFL&!%([XLFJ,9X?[[?IOXA_PQ'_>59:.UHQP7/P
M<D-VZ@Q+?X.N84E;]_6+_@U:]Q(N\BYZ!#PID^,^=CO%N%TMXE0\'.V)0:H
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MC7SZYY]H;?BZ?S3?,/:^ P)?=>9@J?:Y_6L\H;\#THK^/:U,(#!\?<E@ZF3
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M61F5#N4^I9OT#PJ][1=C'W6?PX\'![L+6J0H?%B#'@CPF@=TEB3TQ):NVMS
MY)3/QH84EVFI5AL0)'OU0T^?O7)Z643)7+U#9C\_]\N/.H7EXQY3J(?V4_;J
MD/^#WKIV?&]NZ331@+44 5GAT_)Z::WSHY[^">Y7;5";W:^:]5>N6CZ7R#1$
M3K:?,TAV\0F.*6]1/5UY(:&F\@[$A[(.CI J:U%&HF.NTU5UWK"TE*KA+/'E
M VT=5J*,V<4:*">4_O22?EN;_L5F-8ZW-FZ<H?!MHKBMU.,7+_(!<U*$6Z*K
M <^2/%$F)SE_;W7G1F$V[8*8I<UX:.JN=ZNS31D;/M5]Q,O'GG1'\@1WRMQ^
M_C;:@[GJCIRZJ?YXZ-#$"9C= G^FD,;32?5KKDT(.7EI-]8*1(BI9BP.UW]M
M</BFYGW-:'\;],4;">0Y3-_C\!@ZOX\8N60SH5X= [ZLQQE,H?9VB7Y:D"(5
MZ)<G'UFQ62027?O,#\B8:UP=GG1J7B-9#R>^C@AF*G$S-(2"C+?NHRQ,+,C#
M"'>G2P^Y;/RK.9KJ.<.:):.8 &@9,5N+ZU,A[[^^=#@ST]=LM;_T/=G@L1TI
M<$JA:^/8[9?6-^)F?*-"8CG4 A-/'V!:E3096S00S]K]]""ZA7= @072:;R;
M_TI&!2T% COC(!4;2@H'@7+6/A#8('M2PQI"H^'7O&84?CY/KEA!CU1$%D)7
MG[R?]<0\ZJA<L8HVDN9&DB1"Q5U3G8O>I4=724ZYZ;6-3MG1UMAFB@T5V_)>
M\" 0-K=9+$FT X%!R!>6A/1OP!2L.GU*ME)A^+_];PF]_@:9H3R5$<G%Q\26
M5N.+NT2C'ZYK<74Q(YFU&&**N H\%<7\9M.X>8[>:7>1*MR\&:9]4SDOJ5$S
M LXGK^7\RNDT+:(O7ASSC+66%3<FR?HIHS^YV]BICXNS:"I=DIOOSHUE]%KH
M77HLSF/F^=.@R_;>]:=5*EGT3G#17#Z+H6O;:3*$P<UFZL:2#]\GM5O</AL_
M*72[S87]KGU44,)L6PR2G*$43V15OW04!'*4[Y!@['O[YW,PHV_9#VG&KO%K
M?@I49]!S]SK[M@#06E2^,8V7A%WQI-AO3'-+D',0:SX/V20E5F?\ZGDORB6O
M_QQ<'$$2V$U,+^.KYM$C'4M56+[]*MDKSA*_)O*:>$1#& 2NP:15O@/%E ,8
M5I[K!F&$B:$!!D5,][:%=+M).1#HE%,S?ANZ/5LW8U%S^FX?5>O; NU/=H+Y
MK7(=A81@?\1\NM"(V:(]87^NEQ&"0&;!/'L6HGO:9^*W^.0IM471K&X^S8XN
M@Z<D;GZ6E$^YZ,&$GM8:?3^+B39(@&J+]-R<S%;SYHLJD;-.A/=Y?L.5+2-Y
MLY/=3Y^Y#?9XD PN>_"ZW+@RRIZ0S116V9HH4K\]2WGH$:P#PEA^L#!''I+G
MBHMWTO"1E[C23T?/#3]+RI.-E\$GZ"H7IYW)J4%DPGPG#F_QO6AN36-NLZ3C
MJPJ9<^]'$.@_V0V/M7'B3WV2,140V'T;!)YNS#-#VP4$L/@YNVR8D:]8MR+R
M62@B+\7W+)70@4!WV3 K"&P+]H([3__ABMM+AC4]K<UW8V/NFTG2T+"W,:]A
M(5\8_4-.<%8ZFHPROXP?1'01-CXCX?2L)CZJHUR<F$LJE#?WMKG#4J!1UOE<
MJ""Q\Y"U",_CG)6+'PGK";U'#$! M<CTZ/'$S(K+'=SPC&O^65EB'*D<KQA1
MUPS"P[K"PSI3>0^SP9D77.76GFJ=(N\?6[RS"6D#_@>)2B@7Q/4"><@Y7>PZ
M%*:K/IH2F.$EJM"]H5QB9"VZD[M/)M!%^X/_;X''&'W8^*!Q<F%RI:02O\ I
M"2L0(.J3.F8]98/GZ^ND'<3;B_:F\'KC6C<V"OEXI2/MK*XG[2U(E2";>G!K
MJ=)>TM></L.Q'UI$N>NO6WP94@R_A7GK@@!JC*CA)-]8A_2M]?#.FTZ?ZLM=
MU%=ZQ7&XKJ*UO/TY+C@DC1K)Y]PCZ#ARM,A3+*UCV<X<-YOG\:]9>:.Q5?)*
MGXRKY?1F>:&8R</4=N-G%0R9*\LX;(O%BI^0\ZQCR6*#[M>DW3ZY.^MFO6<,
M4.HI1.X(A?2 > N?7P:":9"W"2T:XWT3"L-9$5[\R3*FUDY51822]6IG_/$B
MO.!L%SV-GEWUXUY3$$A>4-?CUT9.;B#0*B>P!K8A^JH;SHWW6>=TN>';*:N_
MBDTK@7Q8HW?9S(N4*N%OC$SIYHLA$Q7;B[3$E#/T9E?\JGJ*>G+XXYT99KD$
MY[J-6=4.MPZ4I, L7NSX5;*<J!:09,;[I ]D%I+K1'#@)F)AZ6N\&::I#W]S
MJB]=WBNM:#3U.BI9."R0\>I0[_*3X-!.60.WR3XFR5B.L*2$EZ]N>]_5;U;9
M?K%4'#)*D"/^HHT0A2&M(6ZRKO/+*^%7#;ZKHF/Y2QJ0*J*=IX94D4U5)GF2
MXIJ3[QB2[0A+7\D ?CR-R @"?0;?[Z?:]]=+DKU9/S!L,L:R$S92* M>WV-*
M3 "!ACMK5"#P,GO8" 1P1C\NKJ;BS_03Y_$ XINA-^0GSZ; 24UH0$B"1P/[
M"/7^A7D87]+M*7F_J=FRKCY7E;8IHR89I*^3YXGJO+?1=^3>+1Q !_@L=_D\
MUC&/*#=$7ZR*BV%*)E3'&_==46&"!"C5="M7^@S/O7<V96V.U%ZRS>VAG*FV
MGB[IZ933XY@T(]Z5'L6\Q:G6Z&XC_MH+T8K>1D?,9]([EF"L\FC_>51<B1@X
MA%A9- \EK+W:((  ON$<Y4);P:_<;ZDE'\X% 73EV@P4J/9W0%:2H9\3-N1+
MA_YS9O1O_BDMR/AE#"];S-E1/]LOO''AAU5?!RCQ<KHH?WU5,:[*=GNG!,5:
MMN#E^D=BWR$B)!N^U$]=<J-)"7[AI<45,9/YD*DU\9$E7V'+]1'NI&ADF>&1
M#ZYF.I%)CVF-=EEHV[V(3\.JIKZ U'R;Z'_N6E)Z-M$,#_D@4:PUB?A&JT)3
MS[8YEM JU&#:M-9#TRD><[,VKYI0NT,HOOEO=U.XINIG9+?-CUWG952).GO7
MRJ UJ344<E"7(\A7\'4V0YE+LFM=^?(JWAZ?55M=JYX(EDWUUN54%Z]'XEN:
M]=I0><H+<8EN2LFW^ [;2W=FJCU^&2I][V@J(^2[!<.WPW.@0.!N)0A4WB7E
MP_<FB4H@4(B^!U.Q06]+2/KQI1C\S IA&V*!S8V!3-S;"-=W3OWI?X])(]:N
M'"$U]-_L7_/?> 4"7AI/86DXNI5)-7<G<1\D]S^?-R*WL[*!P-HAKQZXW[5?
M ]PF'!&U8)Y =B1Y3YL'@@";LX=<=>N)9(W\"<F((PRQ-3/>X5@9I-M7R;R3
M=MGO+D9=>DWE[^R4HF9<SOYT/YUX&WRTG#1'OB5&OHA?&I11!(&+#'F0I\?Y
M_5^0#B*&$T% GB,'\>W%!@8$LB@!^)\W;Z]\<D7C,#7#_8](CAMOWUU!T?"P
M'JQ:DL4:=QLG37!X6 EP9CPZ_R+[@'%@#&S.1F".!R*6RM=>D:LCE_2(X2V'
MCO8/1)]_E;MHEMAQ9D%QL+*\H[A!2Z-;QH8IP&%'E+]#RVQ"F?V1%@GI"Y8F
M\-XT0&R)C3-^35FKAN&;*:FL"#.D;,2QTLD:+L=LKG<W3G2"S-&U><1$IUAB
M_?2E\X0[Z4LRI>=5TFR/V[6J0!35HIPDS$$&WIJHL-FY-K7 .DC#RO&2D%>D
MB'7W6XI/B+RT,./[ZD-&6W>KR1GZW4/N-"/345%/##^)*]/JO'T WY9ZAO\A
MQ''4R84M.'<MN^5$S>G+B$&9_Z^\[PYK*MWZC04814%&%)$2E:(41;K2,HIT
M$&D"(D:E*55 "-*B(J!(KP("TJ5&:I 6 >F]EQ"0*BV4T ()R=T;Q_/,G#-S
MSLQWSGSWW.?^Q[/)L_>[U[O>M7YKK=]:&ULL26F=-TX(*DBHQ$G/VYL45XXF
M%UH2D.%3^2%G4U6^[N;@-N_.W(D?PG"ZPM)=CYK(?QFL$.@E,686Y[N$LESB
M>%:TXF;$(MB9:';L:.=XYY0D3XHY=ZB*W#R._CL ^A=,K7]00+4[Q0O&\ST<
MOGEE1CGHX_(/-EAN+>(K*HL59VJ5SS3:X/N+1'JB6VC-7PT:TRA*\RDP9YX0
M$3:Z>"H8\'@D R0_*H%T=NL-F7,V(<)(G^A!.S;L$K38;K>P?<#?ZRY"L=<G
MYO4'B60E[E#=FBODJ]<:QOT_:VB]:-#2O4AKQ0AB[N\!Q,O1Y9+L'05)7>2%
MG>S\BZDM&]"&<G*G<6&%XA#60RDP+?BIV'$_V?YS^V,#S$=U *A=Z<+YA^W(
MKR[<<3(?SQCBB.MG*PZ4/VS>/QHK;Z_=PJYX/Z/:]I"SZH']+YZQJCQ\UNMY
M'@F:S279_V2DU,FQM4(N\SQ/A8B,I [M<!&Z'UIL1L&M*;5USFGT;&A$Y,3@
ML7!2,U,Q^DY74FX47['5>X',A\G5=JK$5NF/K^(5',3/A !V1H4*Z>!%-FI2
MW)4>(&>O;(P"B&LW$-_9:T$.IT*^?G;VI81#;:B0#150(P72D&/""4UGWY&\
M,J7[<USA>7G& 5VXB#PWJ[NF\V7M!80U _Q\OW0R2[E$CH>YP.D2WG>-79U?
M'W6H\,C,++?X:?5D,8&O_+=$%O*W>E]OCJXJ4PQ@4$Q,?9T_^B>$C4R)(.6"
M:UQC=T6%=V)JU@B'/(;2F9&Q.A#^WH5%"$T(\4YKO9<:R>^><P2B0J.K&_%X
M9![G'HIY0X40,K=\R;EE=])S*:KK4Z;2^EPA6>GSGG@L\_K@G7?XV^XG)_VR
M+&W34GWXK9NZSH6BZ.\4?O0[(J]V_8Q+:AC.+?/+G^,\&:,)1R@/W%YOW26O
M#!@UBY;P9WA*(N34Z'KAO,YK$3\BZ2B34_EP.Y^%,&7XIX\CR2T $CGF\XY+
M5T)L\EPR?U'7+G<U*"F2;SS0A3OP@7D C\^#.%,_@Y0;*XWL+U5E;%\<N7+*
M"^SGR3F,&;.G0E;&D( JD*4I6LC%V*3=B+CG^Y(0H\NQHR0/U*<@LC('<*PK
MY0MWB\M2O_D2;4'_@J6K#ZCD@1> AGYU!_!1D6\#C$+#N;'KG 3^6*^S#(9H
M9%$+'?/P7EZ=[F-DL[09+4; ZG)K&Q18_$X4L%TM1N5M%V4:T_KY^U@=_2AY
MS6RHZP=AIM1!O:N %T[\3M5/SB.C*S4TEK%?TS^CPI!/SC,(O"]KO[=X>%20
MI\]P>PXES$!?8-_0.*<3.3]<?#URXZ[,<!8]F",:=F!-?._#[_?$)/[ A,J[
M>!;#>S&LNC(.M6>.JW"%G#AV5_G4\&[E*HP*.9B]=8728K?Z?%&V(*!AA])-
MK"EP/ELO6]ZIYGHO%%MX3'KT@^\S@WH.&T;3I>%B*8L=VY*U0]:968 Q*I'[
MCN.!T.Q%.AD(/LSUM\K6%9>:33R!O]UO#F*;)\V_K,J[RL=5=7<MY!:]O%YS
M[0G_A=J1@84B*4:C7%YMVG"'2D ;K'_)X_D79*OO%LJY[8MHF=%YHZ?# [<K
M<6T3ILKYEVXO2A0P1;Z+5$Z.OS1O/_C#PWD^4Q<>_3V=*HIT,R")*N;[@VPT
M@8U6HSS +$20AZ#'24KV'K[UR)C+@L=;").6Y2X!KT9[%M<XC,KDU:</>1PG
MA.9MM*F$W%#CL95*2KK"  L";&OF=PD4 BKN78V_%=,60H&7X<Z8**'+="J*
MLU=?:.?U+'$D]T>[*K_&:A=V6AN^A R\;*5X[>*:O]4R_B3M\ ".IXA_\ZNC
M$V?=.Z7(LB<;SM5#X5KU2.X(M]=.]Q^M-43NGW^2!8%.@.*JT/\/ >O?]QF_
MU8$&+EJ9H6,N/F\1%Y PSSDQCXL8\G JS3C,,#F \RI^1,)8FL^J',HS7;X\
M)[5@ _?[B5-D)3+@D]GIIUS D@PH<&0U(*$H.M?^*32L_OQ7+(P!K:AJ:!%$
M7YPYAJ],3'L?YU_0%GO4HZ][B?]N-UNJ[/'YI$1OAI?OKAUD >S:^04 "EY#
MM:G+VOPTVQX)&"$W.A8V#%;7^3S4>EWN9M*I^BO6YKA!CYHK^Q??SHBW/"OI
M4P)W=#]RYI#0-! WP>3'Z"@!;5\ B.#V#>7]I==[7%%$1:55D_3TR =N+&,*
MCT.21;2U-S:M>*XMT'RV%[>[JM5%9_>.H/IZ!VRD[F4BKU,,1L61D?'$FH6$
M*&/)L &^TM!BFX"*E6AV\X5Y&Q+MI<\";;TC),\T-*-.\+M;+^/3.6[T#-Y2
MGG[U->V5F3^Z=/,:VZ_X^\\I\G!N!Q@_$"#952WVM?4WAN*8/92@NK:E3='E
M@P=;JSK=O"2[]9ZH9X4:YQL2)<0,65DKM#V^A)%VNR"2*2Q0*H23A3 *@JLI
M%LIL*1>HZ[+_=^M1OW^>%##+*4)^L(4AY#FAB$N"MI+$P-59F<-TC3FOTJ E
M\;$\70ZM)0@WK4_OFF6=U3+2AA\?24&6=-V$[//T 2F,OR+TD021?$)Q;B9%
MF%!D/?R-AW<LH7.=KK9EDJ,[,M+4DIB///[H(RYV(+H\/>+I\S)QS7Y1LYU;
M>DDY*C0A_: ,H'*S>./V$5SMT ZN(IT4-S5L'%;IIN:L2_=P/S8,N>B>-M\&
MF#F&F4'!PI0?]X#QEM=WUP57M2,J(&J%%AEKJ)!0F)"HRRBMW:2DS81KOT6O
MKD*FBM1\\HK389W0NC8EO-9TV3X/LP=SQY0):L_]B]9X*OI+<6J_%,P_3P3M
MVGV0B_4"@^2";CA)"[&MEDU=:!>''I5R=!S-*KXSEE@I.@FSQ@]]J,V<R0RK
MCYKS1#=6LYW-T. U$3YIHAE_TCV%'H!Z;8#I#$0*/$-O'F^A/-B11^]W\>CG
M'9F#1>B6E&H(=RRZWC+(XU#!'IL_*&S@2"S5'=KB]Q6NY=#@Y& 6*W*0W TY
MOR\Z\L#7U/B3,0]3TS/2(R_/SIT*&8L_,&;/K2,O:+:+,)J:KFA?V.44#GA1
MCN+([>\H%E"(L_G7D2<-^5#N4C:BW77WUZF1II?5*R<^3^CB+W3%L&4'J QA
MS:.MTMXHL=-=IM6.9TJ* E4Y';2=MP']O%-Q6 ^+:3HJC5GIT= S7D%5;@>5
M\)L^Y^+1OBNJ8^&J?_'I.9&3YZ;Q?I:93_?HJ5[A,C01E.TOW5+Y)2>\,@;:
MZ+8E285P,T[3D(L\A=Q?#T,9).KF\ =W7FM^(#6?B6LGG'Q>>GUN'B&MA#1U
M(+H+/;IQ?]DI%GTZ0)VL6[BVMC:K$/DL\=5IEQX 2SR$K1U"$P#(7<[T"3FS
M"-X9FP6L^\84L&V?D5Q\;QNH$!KA9S']3(C-ILS'7R#GF3F^LJM]FOYT&UP7
M=&<?'=D?MD3S +:6Z&F W-CX9KQ.P";O42$N E>HD%1Z J!L:/2W/--/@-OF
M8B15W6+<.0>/A.Y4?$M,T3)NG4".'.Q SEXE?Z!"\/AO6:R+R(8:RO)-X,BJ
MLDSY4B%V=M\B9B^*(G3S>2%T^P9&$$9R^Y8B.P0E7 1>Y-@[*J3+>PMX/!:[
M&YD5 :\R087P,B0N&'MA9=V646S/1G?@%<ZH^];NDW$3!!-)3C87ZVP\[13V
M\L.+6*^/A!+V4I,"@P9>L:*>(C&G/6(:S"$%IS?OS"W^(?KL'PUA?M][(W^K
M]>V/HX!>82JD^GFEV()0&+R):[J2R\W$?OW8CFRW=/UDX*=6/?FC^C8!*QW$
M0U%WN_3O69IJ]SA%#Q\_@Z$3-A(KO&PX1H4X[W;:*OW2<&WG C>5+8B(MILD
MJ5S1)HA)FTPN(>ZN-(T]KU?24LF7%$BY]O2D:/"P:%%M71K7W _@0LR1U1,-
M% ";K]@[EE5J'8%Q'Y*4'\9NTP=M@+RQK;GOREW63M0@I2#;VK](2V?R+9S?
M?EI&0S,Y>Z$M4&Q_L+@*%XW6.O?3;X=R]:_+ /V^:,4M'KD$M+]HP5=4!:4V
M?T$P")SV:AW/,CFJ9;K":JGR7L1@NR3HQZZ^SAX9![X=Y<^@U,9\5WTG;.%C
M7UN$0D=95@5TS6<69T9Q'@'9V306+3;^%[YD!UG82A])J?FX$=MI>I][[_U,
M[9]VBPP"WT/R8CDBG-R![$"2S\YO19-Y$NP] K<7KB_,DAFUNC7T7$MSD@DB
M/IEAY2L#<X]&=+SK%CR]4(&)BF^2,X?GOFJ%A(,T1\:?45BN?3UW%[<65[-@
M;EX]NV4[=Z@TS;5K-PQQ T\A+&=!:=A1(5..*[=@0'C3W#U^MH[O'%>]A6M-
MJG.*]&(,MT'WSKG%-]PC.SE2F:]G,A<"FL,CG(P+2S[R@E-"E+!_W#>4:DX^
M(R=*']TJ=L](&KSP,2!K)3WK[&?;H%"/='G&@!4V<]=H([9^DG:^BUF29]V"
M?F),+">[<B%SGIXI=Z!I"ND)Z$H/K"OI.8TJKJ?5S8ZD#%VR\>XSMBH69I,T
M65B@D1P:=Z8,5W4I*036=]493@77'_JI40S%O?YC@9I >6";1W^I*CD(6&$?
MDG\;6NQY:9.729+1$"%1UVY]?C1@IRCSMK-MP)<@OE?O(_E\8+!G.4SZ)IF]
MZN%.:QUMD2X](+CG@4M7<CA;?-*,C,.NB!:?,L=QR)?S+Z\]^9P:&@:M</:P
MMC<KEJ#4*' IZS-52$1X<"HR7VC7W*1E/2^H?6[SSDSRW]1_:7(?N2T3$PEM
MQ[^N1)N;)P5-)#SV"+I.#DI\R'UI^W#TV\:KCV3#USZ5 N!(=U'_];FN; ?=
MXE.3#T\7W#P*GM.\N/-ZYYW.BSL=UI U.V8F(Z[K%%Z@I*6FIZ9ULE531T.+
M7D:GN_VHCY*V7OCS R Y18$T55\?4$# CF\V,/K'5B3Y[AG!*6"DZK)."T(?
M/8HP*K#MO[\B'1HO$*!'LA"283UX__(M/U.N6?!Q/IH/G"I79BN;%CB3%]1E
M2&Y()^<-G.R3B@_B/_GY2RP,1C?ARTKLPRSU>&8<!F9->*NW[< 83>A[0!$.
M.,5+HVVMR(@$#_/2A H!0@2<OO+JM+W2AY%0_O(X)8T-=B:%ES4(.2C3==YX
M-/- ;Z"78Y=VG17_2K".[M6"]H#GH<G 2K)I6T>,U/(DXK&CL?2.=Q'QC2.7
MU&TGA]S05E,/"LH<'6S(M=QZ ]E]C*(!,6E>9U\W=+:$ULB(R#AP[4WQ I:2
M*O3'<U]AZ62!*,JHY& "\8744<#%@?Q8*Y[OO[5O)RHP[I1'3:(HYRA+5,CH
M:@=XDK=M_UA6[>>&.(V/ZFU0NNL13[)S)1G5N)LU.:YKET9!KZ\SA*H&<_<Z
MU+"I=U8O,',HZ,8:@)D2P.VER#ZC0F3KVJF0CEAZ*J1WM[]I6WX NCIL387L
M'/B V3':]:G_K_ZP1FO0V%'M4)&X$15BVJU3[:.2_AYG<.Z>GSB+1:2A0"^7
M E1;&?2QMYR0U7'(^* ZXX(5E@*Y?60C?$4"C@-/V!N:8+J1:Y>-II5VMF&(
MG\L+2<T9,1@>P5?KZMMLMZY6S#ZX?NC>NQA+/_Z#I4U^[44A#[JR@.7$1/UR
MB^:E@>"$?WX(%T:.*D7"#/=]JD!A*]8'=%W[U304U :.X:S8MY4/_6CHBF\Z
MNAW:(LL-,BE1L+%'1B+%98ER>S?8'XF:%&/L$#=;,C,ZG?S0GM:M$6_?/6U.
M[^@]XE2K1E/2.\Y;K\D)Q#6SWS,1)Z!^<"Y$_V>AT#@HP2U'0;!L-(DD9.FL
MR.![RNRV^<.-:>V#3?B/41>9M,ALCB;'K3TL_+,3K'1X?6[F@205)[F#2%C0
M5,AJP3V;EFG<%D\_!]_@.G%._N.V $8R<G3^,!52O+FO.@#N4]->)G!Q@+,N
M*3T\T@>S1\N(.?C80^UX.#<3 !>M#4:&YK);I7K'2**H_,+<5V=T)Q#QP[GI
M+I,L 7V6M\/S\B^Q[&>#U@,2>XOLXOQ$A<1/6% A,QK>5,C<MVZ,TPN,6XL2
M2,J+ 3AE=UA&I._I*^$I/AA6(Y60Q/<,=W,2,WQR0^W9 XZ^L>0;438]P"\2
MQSWX#*H%;D$<@GR!GF*Q],F.++_32854I+6 66]_SY^/$JJ,<O0  !3;P(^&
M6C$&(\D'97?!Y(<_T?(?M4063!\/VCY-N8^S)]@Q!I!LT(2)-/L"<ZO(\P>,
MABK8[4G[''-3]DJL.+6:MUDE&$E_E#%(<%HL^LW91;W%R#/M?O"%22I$'.53
M<04>0#E;*!R7$81OJ_5YX%XR*\&BJM/C'(A@C5S[H.XY:X-B8(ZG5PM5V']\
M/R#T#?]_ #O_//N53860N0ML;!;.$F[/6M=!Z5[53B%\+1&+CDZ3[X77"B.P
M8<+R0T9>5IUFHA$WKH5-"<Q*3._U><YG;O$X)<7GU%7%=\!C\]N_6VI1V!@<
MUO1UYXU0 !:YY;,N@2/E#A-1KRA+FPIR(E%WY!'N#@VF:5FL0][>W/&YZ6EH
M1=5;E+W9!NJYUY\D*+"K@F%,W*^HL.GPY;#1Z5>4-ECUEAS71N0XB0H)AM.O
MN!@7^$=QZ4TV+24$]M(1$4:VS"+YS49Z_?E7G6N1 0975#3](BT>9H$-ZL65
MH%Q:]U&.'R#G6Y5*3H[@*/<YS-!QKF%3S#W2^A\9I,+].!()++9C[F)/5*N.
M*)^;E;8SN]>7*9*I_M%?[OK#A$:](W9 ;%CW2P'?820D43SA$LB(\TYR[0.#
MEG*SQ';]L*C3"43<8#3[,ZR8X\T>CSI-@3ZVF#C+ @[#DJRXE"<G0Z6R%=0)
MA;UOAC*>2P'BPR14+Q'UZ A)6T;^GR=(]$4BT"/2$KF7N!JL,2',&CY#&;=^
MNI7^&<')*B)K)W&259FI/2JKJK?)5RM%[2(<4&2E^^0$8O?0I3GW>D.R[TQ;
M[>?>% ?M*0DA&VL.7&!&X(V3?'SSSI0O#3KJH7PTJGG[.<'>G]/_>5>0R@OC
M"FK65H"_1B4WWFB?/-(W,?<N.R6VEJM&R"\M;M)'DSTOO^A5 1]="-A%$O^_
MZ"Z_=1#>>H:L[L7@^XSIJ)#7P'LDD!DP_.!VKN[_-YNW83;&J!)$W0S63>#!
MV#R:80&WM2#7CSUQR)0WF>?ML+37:<U7U6,K:_/F\65G0[/\3@0[=%W:I2E[
M-,CM<S=)(IHMH\:!&#!3*34^.<75Z/Z"1Y6QPCV5J)'P2[=< [82TO?H_H"F
M7<]$Y;+#R<FQ8"W729L*6<X0\MMB#*-"&E?+LXHW1&Y7XHG=)1O(ID,T[$Q1
M443$'0F=/8/'O",,N]@E;]@9UP1[_F!7",'.@4>-^9]VD5?6P):C[4CV[550
MT@T$@@K9/^H$_M] Z"\-H, +MX#0OKJ\$IPD@IHRTL.=^#Y))*^ I&)YRK<U
MV+9\Q&E?%H(B<NQ@RSGMK,?CHL>L!;79>?,?9X%KG%+[+5W((0!V\$<X,^;E
M$NH-1J+ !=N-MRDKJA1=[U,T* ]N#L>)AWM$#"71VB?%ES$%8+%:^W(F+YIQ
M&V7F,0(K[$#_0T+Q<!D=!88#%-+7<XH*P;7: 4\*_5MM& T8+_ ;K?KU0F1E
MZ!G8YN826."T]OC.$P]SP)?3$K#1.XFERP/XVB+TS:,"Q9L71ENTY>$OV[Z(
MAHN.KUZR3CU\M?Q8R4*\5*;RV5<]*2'2?/MW@;P_XVH*Q>@C$(D]6>TODI/-
MN:!HF]+:YB8Y43R5*WH=P:AN.[>]B>UQ[&^>RVVS=MU6S<&$A3P76Q] O_\A
M3Y,)L&B97M]=SS.0<AU/FM^R) _-(B-(HDN$$Q4);T]<[QI<TWFI='=M8]K%
M'N=;8&IH&ABJVE0.V[HC_+7W,*]E8.#[C(M@O=LC5ZJ@H%C(R2GMTR+#AV%=
MMK)<-WD+F]:=/+2B<'.'17':PN>NZ65#59LKIM>RZV_63;$+AH3J]1H< 73Q
MH"?<76MV*98*82.9C(^Z?<$$KJ-L;?P",)%'7(X*/6NHYS8\_+%<HM?XFCB3
MR>;-MF&Q\$$9:SS[*PYC?BL5KKX 8%OJY+="D4(,ZQ1#*-]F?=WUE;I&L9)7
M">+]'-Y*\EIJ122['(&Y3"XL@ RM&H4C]HNO_-31W_G*+(HES"<I\*;%BP(W
MU..K'G_HU*_/42$O\JD0K+_G">10S22*"J%!(, #=?=7OVWLIAQK!G!&[$([
M^2H'@#C*01TI"OU^GY*OY#.^E!$U@CX5PHP$3MG2ULRN-"5E_] Z?NX\^>M,
MF^T*@&/%*>IL885E<#ND*!428J2:S-:-TPK.BAVO'&G7DA$:Q*$45R>F\&\R
M+,-9G>$WFWA.E#Z-L9(\IY(8C#P880;6?_8 *IL64/6TVK:%UL[*UEJ/ 6%K
M>UM1;4_)Q6C5!_/"T6]YS?VLG?6/A:1$WSJ9R>Y-HQ[<RO8<Q19Q!F1+PEGA
M7PW)N8A^0M961D6I:Q9K9-9,W*I1Y"B&%;%SV[%'RS8W)[>!Q<NVU^SMB4P$
MZE;KS3?^P^K:SJ&7K-Q5-."J[8"67_M=?T$Z!)@<,PR^'K8?B;^"&R4?]>@%
M3<9=S%]9,0 O[$7R2$E;N\<05T=@'.@DU*9^N6OL!ZET:8&K!14<M.2A08VB
M"ZK1![2+2@I"CHDMIMZY/*ZH?6(O<&J(VAL25<,[>@/22UF;Q;(K;.TYFY%?
M!Z3+CO'FN+2V%ZPZ8=U@01ZJ ;FO!0(C19UHY]= XZ3X#W8_3Y]\=M]X%(D/
MV40_'K^/)X#"44Y*M]-W?S-Z*^FBIE[8XF#2<.RUOI\^J=$XBV8>M9V85EK/
M#C<]DMY5"2 AQ-]+\W_6'3I ^E6;/Y3,E[QUFPJI\24?;+%;1&,QM7(:9&7?
M1\[U>N=IA&+%RS=N)#ZWQ<[%V)]4T=*7F\ 2W^2[-+ET3K]O'<O@2^XHTCD*
MGD#&7]YU304XMPY4B!A\*;)F!-Y$A: 1+&$.ZT5RCD65%WK-^%$2.JBL^2%,
MP7:IG\K@_@@VR4>F#$B.ZVF&4XF-D]8_)K"#H+<")!YE28(L27XJ)!#6BIBH
ML%#=]-CS:>G0G@9S*7CILLO<K9R5;E)3;ORY6!X_414-LI65.:7OA*/+Y;3
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M5=\3UA5^^2#OC;\>M]B)80]N@5F_2+_ .*X I8-^(%LY[A^\_2?L!^3$S@B
MGQ&+\)WA/L!FSY[^6W+)"1 U#! UC[L#6/DF< $GT7-SEP_Z#P=PTI<*.?B
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M!3T0]0E!J_HZVP+HFPZ"SB8EDO&B37E-OG8V-8%5.GH*N8!6^D^=XE:Y_@G
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M4N=_B='Z=R_\W1SV_P;=_?_X IPZ^'\ 4$L#!!0    ( .-=3%J$];>ZF.0
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M.1^*TWKE\4TOR ]V^9%=[0'DS@8Y@'"KVW+H[,C^GV3JH$J/3$S511(X<)+
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MO2>NXORO:R[&3@$;QWK^&D2?X?TFG:YK=CKNA??&B,O#?W\9%6U?%Q&>;[Y
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M#BO<%U\22 .%H_T/Y*[Z]O$>.89B&J1\S$B2'5@_6+H=^W#4)HHN-ZXFM<U
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M*-\4=*>!0E'#9Y_TLEUG?:O+^ S;AL2;NTO.[,QY1J#&&;Q<R@KTNL]:B3#
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M"7OIN6X^O2#(_<%$- %)Y_QC*^K/2J,<9Y([IA/&=&O)7=[*7B8&8B]IX ]
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MU =<!?L-.$^\CQOEE-P0M#C0=P!V_H=9S2/(S+M8S&NP)(>/\Y-8T],-VX_
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M&\RHXU/.3+[I3X@6ZP([O_G:;/\8[F?=F;T!4?B10<6K)L?."$:HX1=B.)B
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M+6.FBOKM&?"_VTN>UO ](F/5]SU]&S_/1H9_X$QX' )>,GVL:#VS[+JT(M+
ML6/C=88I-8=3I'74?14D>^-&$[#5?KMDL\GI^_SSQ6DKA95+1O<F_%V0$J&A
MH8>W/5,M;0P^PB$HHOWT %.3=5XN]HDK_SJ/4?+-4[<97?R00#C!EK)%?4T>
MN-A/"FJ&B-(N8XR><=1P! V?1;%JB4?7XZJEDWK[_C;UZT\T4%H_*O57HH9W
M:N7M^BNR\C\50#H_^:[)MG!!@@VCIQY@)SW:B9?]?KP-^.A^Z$/95C/ET&]=
M+B@PQ6'SCP#T&#20.%E,-FK'/B2TUF!986.LH$+=KMJK?@V$Z'.9<J_Y\]JF
M5MX8L7:UUO!ZZ0,NJ.\](,]I(7)!YPW(.)H#-MGE#DN_@2:4\F[5[3E9Y3)'
MY M3\UW]6!2TJ=$RU=SL/NP. PMHX5@YL%CTTC07M''2?$=UBB[ N0#=BYXP
MG.."+ R0^WA7&^S ,ZK,F\%&$3<Q3)_-K89.J>T]+!N>F$UAV#)C-$>6-(YS
M 0Q&X_\4<YY&"[S=.0S/QC3D89/K0J;*9NN*XXL?374>T(56?^ U_II*3XYH
M%HG>I$C&V2^1B,!AWT?A&+$ HB3J]+PAF0S;1;R@OR<";N!A%'*E68@Q;9[U
MF_A_ZBOIP%E>CX/N*#>K;V,X1G!7I"K0-HM-\Q :83G.!OQI&EG)GDO)^#O5
MQ[IBC6O_RE,5$C[(',S3!AFH+WI*F *."V;IDC'2P&6F9:-7U"T;Y]W:;2]^
M6RWJ+&$FC6;3DR"22&':X&-3.]WFQLK7^RYT#Y_7N!7Z$O0,^O(>M!Y/M0ME
M&@/GK>MIO76CS9$5'CV[,$47/U@BUA/N%V*:KUA]#/'T6*)Q@J+GVHPU9K2=
M]G6><+'<Z@\\KO3-TDE[0X9OZ-^,(VON7Y9 52.[K!7R:V;]H]CD3S'VJC[U
M>1QPRY.MLW$;=SP$"9-?#N$QH>IXN(2_ZD@;Y\13#N3XB[0SWU T+JC)] +8
M IG#-DKP6SF0YI3GE6PAGE9\(%91$'QQ5P]^SH@ET]_+!<5OTLQ3<?[,BRN;
MDW,I*,4!5$K8;_QO(RJ&;H$ZBIK(EV\>.0E-J#6S))ZK;85M.NZSTH[ZAB'S
M36??)5$+[OUB1U<J4QI8&5)):(;>(G3'3C/2H ,9P04]/T"7XG1-6W%!-N\+
M,O_" (W%4LY Y"60.&'@!PQKP"A"\E14$,,%9?I_X8*J!O"<>+B_O=%GQSGA
M#OBV;4@:;BD%LV,5 B_<W&ZCX3E7IRC8'8H6)V-J2(0-QN9 205$(4>*\#*U
MPC9 ^#46$76YHK@QI=53,0P>86\1HW_%W=4J*L"@^9OJ8?O"C_-G%0[&@DTY
M;>C]V93$Y?6W;M/3,87PG]E,G:N_[O^A@*P.;.JK=FN-8B[25X$CCIT5EV&B
M@.TL.&'R]SCK5O0'Q"WHR7/E94I&3'UU <R.5T 2.R.L@<UCZZ!!5>3A44VF
MX=/*K\&GBD.9#:F[GXNCZ_[T7L<X]5+=I=I$>&1<#@V1DD/:O402=P.[CA<M
M>-QDKOM<N"'P5I%IZSNMK?.1$=F&260013FR +P]J_KHE86(XU^_X8C=\*7U
M?7 ^=-N5P,T81T82</Q68?.517FYE:R@4$Z)F_(+$1[&H%[A_Z.4)D:/<A1H
M(9T5DO)9,#$/=)&-0O_9?7MN7(H6%H#D^>W]Q3.G(E;4'IX<1#Y&G^2"NGG>
M]C&80>&"WC:U0U__2]+<E%_>HH^<8[]M55A Z?[4M/>YHD)]"S4K^BKP_4EB
M]?R#1R(D?)&]\%QBY[_5=_70+IC0(DJ6KO7$5//!N\4C'T/Y>[\YZ91A(7#P
MB8\LG47HQ.JL?A)*F"7\T_0 ^8FNUUCY^Q?5-<_Z%"P#2P1CIPA?L%,/&.6P
MR>S9Z>8<6U=WQ*##:\^10-^KI'=5)WJ_G2$(]W/6*WB#)L:S2_4 X#I;<:T[
MHFH"R%D;T-,/"L+?N;!\LE;J5C((P'-$J5S004<>,C"E>%+T;KQUB=:@JC@,
MXH(PI]$;?'!1=)L[[K<M .>";BU -USPTR@>:6?X6G-!V']?, \ST%DG,CIX
M/9,+8F-P2XL\[;Q8B!U*9FVQJ[B@W_^6@?NN[NPT\$Q,R;P@ZO%_Y4^"_U_G
M4DDAR6B:G9EG-T81>98L(=]](]HJSF#:@^C8.C2C*-9W4&7U#?)]=E32QKI$
MS+J%@%KUIT2[ZH;:!IC>S(Q!\BG.8@E(JO?ZQA7S] 2>NP4#6ODM]&**7!DE
M1!3H'NRX$B!GZU_BXF9QX,1LA-$T1;SE["K<G764IH+EW?<$CA(M+W\\SFID
MMF9=YJ9U[\.3;.?8D.[&'&T%QPS.3W2-5!S4/UV\XP/B'<$:JRMFD/;Q3L0O
ME^K]I*UKW==I=W7PV@56;3O@KR&$'I)*Z8(J'YV108%)=*T1)I=N1CVSA"PF
M9*ZPY9.'6@!7YDW6S9H8]2[(Z2&DT+N!-;<\1=E*=REQ.>MM14$: OM9NR#2
M-)(1PLYJ5F:>0$3\[>BX9QM>0I0-8'O05CY_42_0 JY[/2M,>?X 7_WO7Y7"
M2K\LB,;/U;"*RP23 <B:W"/RC,.WWI1C9\$76RQ R'U:RR9T&".<[LUH8)HB
MR#KN)YBYJ0)N_!=(>86Z:Y]!M(%U\9SY\@WX%+P+0]<;-<"( ):$*W_Z/YZ7
M">TMC7XI]EQYB,%30!G)N>X9'JD]0CA/(^7H6;'>Y*@Z>!+DR/-Q.ZLN F?!
MZYG%O?U=H/VES_.$K^Z*=H#&X3ZAJ0*T9&('03>]6V4_PM8VSW8A8V$U.S'"
M70#L@39FWDCFG_O&!<FU[N(,S9R@AR1YT^:ZV/H7:)4%/[)VKA,>-'6(Z8G*
MJ3S /T,>9#^"&+-V5^$^T:RZ)>0MZUO#GL_*PUYN?7HDLSZ_&SL4K2WV1JI-
M7QPQU0X1>@JC<T%/*EC.9,V\Z4T=OTO6/]\$N1>/8'XTILL"CA?IN(1-%6&W
M3T^O#(>+*,W\';_U,D/A9IS+O[4LRND31F2MKVCI7TN8&GRGU<^*2LFE5&'7
M[U6MD/F^69H)SJ!8I8':4:H_X?V%%O$<NV;X7DY1-'TU4)8QS;M/?7 !'E9L
MT+"=?BA-Y&5Z$+X3KGK!MDNW&]4O0(KWDN@C[.Y&[+_=6O<_-]E&:?$H_@1@
MQ'A%*S>&)>O.F)19^E:/4B]//;UQ*ZYVZUKL2]/]4A>W<SN(_.@ V"1GR*^5
MG]Z=2H&)=T80"$MJN]52PNR]F#@+<NO&NUB,? _-E_$6F+I#@'6F@_U;A6G?
M<;ICV 1U>+W; 06=OU@^:U+<DD/K&72;Z2&Z1R:-8@N$8B> J_UM/T\_P9*C
MWF?Y/.OUUHRNOFTS6!%38\$7.H>+18M!S@#0'OT2Y 7@;3$"U_%WV#HA+\!K
MJ.K5)YE,K2J^!"BATH0\N+S-/ ^LN](O*,&[5;3L:%D5?]OD7AKF+_^<LLY5
M.M&!%?JRA:WP*Y"*Y<AQ.G&UX#:T1'T<B0M*(>AE%IT:N'O3W=AJ>VIU?PY3
M_M\^;9;S+#IQ)SB7$H,"[P.R]FD1PFT1*?YZ[LFSL$N'!6B5/Y)!=!AAWRRQ
MB[C?8WX->1*(\R:]TJ7<BU*9+KSD>]MR^/B(@,&Z)(;)CPP=;M6!(VWJ -P[
M"XK.T(V8"_YK?]HLSAEN,$L+:=BA'&VQ?$<FE&?-8(_"5"R)9,<4*M*_9.#T
M@X!<VU"19-/]'X6Q!HLO>&KS"AJ GI1W -;)6!$ U\8Y6$_#/*W5R)*BBB5-
MLGJ=5$H--]2:,5MCX>CJU>5AS"<NJ!U/6]YY'-U:$Q6E266S+CIHW.<OK8PB
MR%IY+(^MO+ _5AK=G>Y)5CFT>FF4>K!U9/6@GYYNL7G?D6,=.@*CTHX\J6EO
MQ+-X/-L-%4&ZAY)#)M?)@JW[UCG^M68V.;91Q^[O,U-X +TXE R=2EN7"S&*
M"SR[?;FH7KB'Z2KT;]GBES6I=NR$H3]$S15I 8R0^UHU$,,S%L\)AWX=#4I^
M\V$TV/JJC2A"D%]G 9-$@. J 67G$99.:==;Q"/R9&'UJ$]*HVNOU;<_5O8Z
M1>]BP1B<+.X6.!VJ7![6#U-DW?II\#3&,#3T3D5Q;[[;8Q!,!2&[C!'FB'*&
M/*3HE:GA9.+3'-\DI*Z?X2__NTZG0HX(M3_L^2 )/;(3G2P<^J/5! 'KR3]!
MNQ0!EF0YA)#82/?W%27NYM[G16Z(YUK=O\C#WQJX&J*!(0'0*5A5/]43XYQC
M\PWYZD.OX;!FSF#&)4VG8Z?W@U\)P M>V L_Y@QR01*HDX!6ITL>OA/[1$[U
MU/#?>B=J4-!1@ER"^Z2>S>+QK@=U_[G5\[_[?7#_^QVME]E9Z #H7B0*6**#
M.XS37GL6^<THKQ^H3_N5_=S2-DZ5<5O8WECR#+;<[[]T1NP)@$IGGF-C:I4E
M7#U&-H,L9]9(4]TY%EB"BJMBOWB*5/0&(2T 42FS^[:-^6]A>W0>"#G(0W+1
MW;0E<F)GJO+7'=1KLHE*B(./D_R5*B?'Q[Y]VVN[]C"PQ3KK/636\7\! EZ
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MK9U<5L;V%F(K975K]F]TFVG\/['C3EJ&,$_:(RSON?VD>Y(PQTY=Q3X9DJU
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MC$SFY3^HD;^W"&#J'!XF523^GIS?U3G&&J2&8J(6%A4SUTZG&^J(Y>T=H]\
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M$#.7,1:S.]?7, \(DHTG3R(U^I]M@7D7&P3K*BQ*D\V&3J_/_HG/4.+TD?D
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M9U0)DF@YQ"#CIH9#/:_1#EIU]O<(CM*.L5=WUWR]YD$2\^SI!(@*'=Z[#_*
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M-> 4=:^U098*;>87MG&Q'DI#QM^HL)*?>%YM(:W[P/ ;_]J%#'[SOU>=TI%
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MP&I>CDT[\4Q%![W )'(&'38)K7=JJ.1)0YY15WCFE03$,,R [N(1/C$"XA4
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M'!I'/_PVOC/Z,B)U"H/F'ZP<''#3'BX2__SX9 8B2]FB., Y+0U;"9NE!6Q
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MA3 EC:+9=8>\3LW/&[$K]CK."%&JD,(TW- 8!@0'-WS:$=?NNX9D6-$#'E7
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M6LJI4\]O*BZ$/LXX)#LS?2S::W^H6,6B] [Y)^P\*UZ8(1+J!)>&8(LSLE[
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MVJ1&C%6D'1HV!1=8I9]5J:Q\>.!AN(W4,]O2ZB<;&INYP&0I(WH4NV<2.U*
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M,M,I&J7KKG%=1NV^[J3SSBB$>RG-G!$#23 -(;TV9>Q;@@#+B(26:%W*SWP
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M0<9EN!E9[>0"Q/MV?SH_<<QZTY\L) /^82P3&1Z)?TDJB:+C<;K.2U.M/OW
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MCH67UU,Z9US83MP].O[U:XM^>9S10.F9FIJ:&,>PPXY'A'1S]YGIL+T% (0
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MDW[B@<\R'FAH=KA^Z/ZJ0>LY0K^$]'B'R3<N43=@\!00>IF,K&.1H(!+4-.
M5]+X*AV7%JI!Q%YXM>&VZB*A[4--8!EB)D[R8=!^OI&:[U=.,8$)1PJ)C<JX
MCJG1:7VM,$+59$A"Z >/2NP!(H6(WWII4? 'H#B! N0$S9. H,ZSUL[]RK8
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MS*^N.B_T^,.=A!,';ZD"6*\:O8O=/?'"7,<*#ZE16?7> W"Z[ $.+])L(:O
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MF</H8U E$F^;-.NL?2U.,BB)Q]_1 #-0Q>D\AII0LQFN=?^0RE(5PUE:=_D
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MQ<\&9$4KT'4GA\GK\N-:C[ES&IQ.SGGX)B>G1;,&X'K#5;-CJ'K^*;/Q]8-
MUS+_P%ZCV#;'>Z*&[,=MLY\)C;P=D01U@,-OT_A!57<@)Q3%B/Q]X%K6N!'3
M^*4.PPT4MGIG9VP^ *Z\.LOS.H!J#&7[2'\-QY6OT8*/0Y4UV2"\LC&PED=F
M54^K>=V?G.;:6;4^SG=#Y*?>F6LGU1ZP-#*1#%Z6=F*;S$4Q(%V#A^\!N, /
M[, &PZM>T@^W(C,-&MVE!1;FSH1-,W9.*]=#RT3CH]><8SZN=)PM@_5!B":8
MT0:R-:F!=HDR2T)/Z V75HUN"1M]'=%!8QB=%<FO;R_OE)Y.>WC:(2G&D^/!
M-3E60 : O'RA+*KL 5KL^T.:'J[1?N360#6[Y=I#V=4"JWMUD5I'7[0OZ]?+
M/V\*/1UVN/@.P,36KZ.7Z9PZ5AN(!684'/4*]/H 31IG=U+10\=RT*I&VZ[Y
M[(6WLB*5%47ML3W=GR5$\>68!^OC5+(//46J*@B9!.%*U\ULM;AM0X'K5_:O
M;0E?O_-"$2M14U$1:Q/3ZG9=3?3AL8M2VMI7-"[$;A 4R /T=-_>L0PJN;5/
M\^+2;E)+@HKQ)Q2:="KKP,C^$Z&OQ>*;!!09@;KO%3Q%?J*:*N^OO_P(U6'&
MWC/T:-HY4AO&!7R,T2?@7!N+'_;8#"I^6E'OKF9H-',^W#B;[J#\W*ZS47E"
M3_YKV^"!<R&GA?U61X@NIA3^&4GL8;?Z0=X-._](JHE5Z:RSF=6\##?K)]9#
MC8<^K<?_ZKQ"A,A1GAC'0Y@1[ "EH2T#'@F5XYF52S$=0MZW]"@]<^-@UM2H
M"\OAG*RO[RK9F68H0N4HIF7^CBV(8^H6I[*"9J7M/11:/J*.8\;+[I7785*/
MQS:?,+!1BQ&P8FM_=Y']D!/'OD$3>WZB"H/-C'H,U@\^+@WCAO(S\4WQ2D9:
M?MMPQ($,.T*>ZMPQ;\5ZW[9NN9;"L\#7&4/S^V .3W_>9M)"MJM4+IH^91#L
MTGO@US!LQYX;DJGJDCC9LR2UQ4Z]N[#0,[R#/UGKQW5X#LLACXJ91]_QN 0@
M[_Z"C)*)I'0""]$1M]V6Q IE)R6U:FAVM(..B39"6"F^8QDKIB=?]GH_^1%[
M=#!18BQ#9_SUA;K)KP6]L,M_T>:^MP<8J\4KC30CXO< ("F?8*^;M;4(NQC%
MAHD/BI<*%OB5!#/]G<(-=?B<W0NB><Z$-GT#!&4]QE;QMJBMQV,.TK2(F)N#
M^(I/PYL+-;'+/E+)+ZYVLKRX5$#!SHXT@Z)4.R*JP/R4Y?ZO< %C7][(T6*4
M!>1^>08C0.#.[>?-+X<WOMQ/>P'^U%"K&SLI^Q\"LBL:CLW6BF@AXOO7N*4%
MJU,MQI%3<U=#YD7,1(.$S",>?Z->8;H$D @]W0)_*GL/<.P<\<VTV![@F;68
M2UV27NR"X/V&E >2 OP%";P!!WL(.6&7[>%X+*& *D-C'50W>0^UIV#NO>V:
MF1+4'Z3ID"<"R-9-A9.V$Y:G?>-+!GJ5LIK/H9S?.X3/M>3<!9J\0XV0']%_
MY=; X\,M5B@**TE8*0:E%B",C/8I;I1?,1I4K',R))5^2YLSL;W:*/_%7NGH
M_\/>>P8U]45]HT%4I(ETJ5&I2A-I*B4B(B BBDJ'J"A5B"@E2$B0WB,HX!_^
M$!40E1*D2TF 4%1$>@LE!14% B>BX6@*;WSF?KAS9^[,^SSO>^^=._-\V)E\
MR#G9>ZVUU_K]]CEK+8$C%_::H*&\4?A.WA'.169+-S85OF^M"2.-.MY:W\)L
M+O17R7ED,J]GTG'7:B&9;*)[U2/CY[7R!Z=4:OX7NJ+M0JFQSZ.'X+MX?^M9
M7-N&W*)@K62!0+@"<KE?]:BJ!E.%\7G:[3))* GAJA1(#D TS!UX[WYH=K]_
MP-S;?[ +DT,@GB9$@BN#FSU$Z0X/FD[L0FRWO%FTJLS$%W^)2L?(VZR&^FOQ
MCMUJS^8EQ/LEC 5^0!EQU8&E)YEV?5!0"[8F# R>>PN6,.].UEJ= !=C_30?
M4:OT3O?IYCQ[=0+V73&IX-(1<M"WNS0YCYUW$CYM@*=X.\!85M(D3Y7CT=;<
M#IJS]7B#N6" #Z[WF[Y>B0DR=2Y[AGPF14_+MOF8%&QR)<PP-?@G-AT&V.%
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MQ$1B/67M+30E<I9S(8$^.^Z6%M>ZD%UN?V,LPLOOH!K7]\72_JA:#-VR)9T
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M+21NUA;MP2/A]O]M<E8*X]/Q<#"1)Q+ Q/%$G)X&-<R#?KU35JHCJ&A:B=5
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M3<ZY$*HZGQ?[7*)=?J=]NL7H43@#,<V#7+*599_82$;RK8#(ED,=X[:C1?N
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M>!+W-3H%T"8'LDP=7JR0?R6_:V\>K]7[9[*67OSASJCF<M>B+$OV@!P?Z2)
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M0_U,_T&S[J/"M#2C$C_Z_QAY:":Y.=R+)Y.6$ Q^Y-[Y":0!&TMN6-15>@-
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M"W+10<_&=&NGS+_K,VZ%9)X)<KOM^.5=?U#F!^K9-_'H C<-*C&'(DPXA+K
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M_JL\MDI;XZ[$]]N#Y]6F_EJ4^7]QMGOFZK[8K&M_&64X#OT(0QP+:0@$TA#
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M;IUMJ3H\?"P+U>^!O7KZK5*J8$OLBM;Y8QMME1&1RJ6*(0L#M4UG&*9AXL&
M))Y'$A)[+%W618U7>HM6G[31.MXRH/W%5IYCJIJD/'2L /($BNVW'6_Y,$[0
MU(56;\5/ YB9$E!8-0UE/@ZP^E$Q O+U3V"G(Z[.HV:3U&D(@+LD3UW"<R=]
M&@)R) G4=(2I%<WVM!FG2(0I8S!-(W4%ASV8"J&:PH4(I7&:>=@H_<&<A=D,
MB.EUC.$9?EJL)M<YDS@%[#&970V]C'/!'B![M>3(2;'7\F&\X\-K+GA9<G:+
MO[4GI:5/61B+)(*1EV4016D,,R],89RQV \CFD3"+-WS F8F5ED[3RM@'6FY
M"%5)&E#C;U:._HN@U]-F<P%JIM?VV\@LP)8Q,.0,;%E39:DZR"5WYPH$7-9O
MQA*D*9K.F++R<IUG+$$;;3]C.^:EI3NN*-W<;U8JK?M4$2J5//NLDH2'A5)_
M'F0LQ!"E-( X]$*8"(9Q&H0^9D;-^R[D9V)E.*Q ,> /M/>!>QR"EL4N,]RV
MJH?=I.CIR!FA-E.3UBC/5/#C(KB<5_ZPX^:%2H!<!-WI6B"7#6NF.:NR7O8)
M+AN\NB&K_*Y1S6^EOL8KU9*X3_SJ&7Q>]RA!,4?,AY2E/D0BDP?>Q(O4'9C'
M$ _B &GIS(LYF5A;=EV[/\H_?U4WTCL&VR2+_KZZN7SLFWIKVI*7S\*XDIP5
M6S/U.&!K .D"M)RU/=&W":93:$1GV(SI0DEDH ?E;SL=>#G]6;2?,YAZO>=N
M0-O<>/Z <Z8ZLJ^K;:/A)&8!"C,$/>RK]LV8PBQ,$*3(\T/",LI%8I;_?H3*
MQ)JJHPEX2[153T5C;EP2T78<,#WK[&(8S)1*CT!';X(6RZ,".4LV/T9CYH3R
M$3$/D\;''K9;I:\V5;[F525M()*O&_UPW1PC[^38\J<J9]U9<M LIVJKJ;U;
MMX$K-^+4*VH5^/+4E^'0)QQF+(T@2B(*4Y\QB#'!'J(X$$'8=S2\U5_Z,["N
MM8+VNR+>FNN33U+YTB8V7QYAZ)8?]>..(3-=,L>TZFFF[V66K/1<SSP8<+\
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M8!.U4C80V\H+I3/^;$XI V&'/BJ3U^Q<5K]5_$:\J>K\7I5/7A*<HHR3 ))
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M.V@.KD0MA['3/WU2[HVX,/J[[=TK/$X$]05,Y3\0!6$&LS"A,)+JB2"116F
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M.C+$Q(OUUP\?WS69':NBVI0<-!P 493[?N^F[K+^Y>D8).>O31VA8;;F38
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MP=(/_#!) P\&G$3R0"003(5(H9_$*(IB2M-0JZW$"\HPL8[IV8"XZ]Y8]HP
MNN,$R)%5U$(K!2AV8C2^&57>VK0KYDM\'?1,I>]\D@W=R(I3^$JQNM_+:R!/
M4_)K\%PG$VB$VL[Z8K^/YT';SZUP8" =4.(Y#&QYN:EQ%2/S A+,&V[S<E-T
M$+GS@JQ8GJ?;X_JVJ'&*B(\0@5&:Q1 %@L T3@+(:.K'W*,10499 OO#3WT3
M;]';Y)G\FD=;:ZD,#ZX-G4DJ$!\7P=6A<G_P>8^,1P4[.! >?\JJJ$'?\^1]
MCDF^ZHK]/Y2<ML685&65@3=LF?@TQ23R8)CY<HE%00AQF'ERG<4Q)P*QB/C+
M-;]3A]5;[7($9DQH?66S]BM[P(KVUW?(0%M :<""44*V(<3CJW@ZQ"YO6#1@
M!NS!=[7>]Z%/"9]1"OIT,%IGC;N$TS2EVPZ.\2QLPS'G3)RV$_=9KK/E('8&
M3U/8^4A.M'+^]4TGEQR3C(H 0Y10=:TI(D@R594*!SS!8>PS1$V:P.D0-3*.
M;%O"%4V1<+I7^: O%;]JW>'KMI5JC;^965):P%*1\) &'$H(N>JZF<",<P]2
M&B"<"<PRO9XTDP%K6V]_!-()8-0S4UV#8[:O&34\=F?8F@CMR-S5(CFK$6P"
MPG/3V.C="QRSK\X?DU\]/R9O.V5)^WUSWYZ9^Q"#U_ECSOB:J4JI2TY2$C"?
M0R%\3QK9\AR+<>S#"&>$X)!'6)C5TI^:XXF5U#8.@W4TP5/.5\S"@3KIM!FX
M2[^7R9C=.;KK/@@&8@Q";7I)FLK1CCVA<Z#NTN\Y*;_S>SGG@/^H3W,6PO:5
M"&[EJ\N(>M3W$8*)1PE$(4TA9BR!090$J2=\FE)L6GQ #3RQ:MZFWBM:Y@4&
M&M'']>8E AGZ,K1DL:H;,&3\HE(!S4"S5P<8LG^L(,#>WVT+ I7Y8U.[N;\C
M4(/V*3Q)RK#G^3#QPQ BS&.81AZ'+ Q%Z(6AM)4,2RR?)C;U@MF2WM[[6:;I
MC"*F9XNXPL'49V@!@46]GO.R.:O.,T)JYEH\YX4^K+RC\8ZK*E]7ZNZOS/&J
M#UE;9HB'-!1<;G>4RK7M$4A2EL$()2)&.$!>@@QN% Q(SW./L"4+?KR3A*N?
M@/*KF(:YZB"IN^;= ..PC%?_VUZ5CRUL@W#7*:MYG41ALA)>AQ1?N&[720C.
M%^LZ_>JEK0:[YGJ?^(/RHJ_OWJU%4=XWWQ)IN[=_W$5H8APCY@4>]*/8APC1
M$&:9-*B# $=9G'$O,DOTL^1C8B.BK7:I+B5;/^4NWW7 E3J);U/A+FQ1:#8)
MFHZ0Z:$U=&\,6AMV5,&6IR&RBT'3QYEZ'UI!Y+POHAD7+]0ST0JJT_T4[8:S
MTWJ= Z*Z+9HDR9+O$F1V*1[+@")$LI!!D67R-!0'\C2$2 )YP%+$O8RQ0/06
MDYZ6TZ)K82Z9:;6/\O.O6)I&:@'>[U*#*LO4(#TT]925.X2L5%-/7G63[!@
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MU(YA&G*%JLG^,2&D-BTX>VZ@*$JH*@> ^V,8_WE:D#7O>*:#SE3CDGIPW[,
M^S JWA9=-*%#%6PIOJM[(4/J\]X5V4%S<']D.8RK0_P'7G^46TG!<MI]JBSC
M;8Q$@E#*XDP::H'G2U/6RR!A*(498RCT,YRE.+OLA#K.P,2Z2,6,%VN):Z7B
M*R0KH.=%_K"N5(3%Z/G-#<BVYUMWT+DX\>ZAU_]IKRG#)-$JMK!,=D8^0_Z%
M3\UZX)P_1VN.<^G)NKVA69(XPE&413 4.(.(< PSD1+(J(]8($_8/"2VA\:6
MQ.1VY$&Z!/]&OZJL."#W[R;GDJIRP/^'NS=OCAO']D2_"B+>]$Q51*(>%W"[
M\Y<LV]6>J;)T;55W]*L_,K!*[$YEJDFFR[J?_@$D,Y/*A01 D%+=N[AD.8ES
MSH^)@X.S2O ,K<L3L%#F<R]),R@R1-0-.X"8ARGD7LCBD"4IQIZ=^\$<JC%^
MQ#KII_P#/S59/R-1,;U*F\MJ>X5NXM]3W)M?RN#\OMPN_TKWY)?"7;X?'WW.
M<C+,X]-J\\QYV]:HKF%]=USF^GFS_B:_N+PI9BWKX%_WWY6&E+?U?_#J$(YN
ME*A4#NVOU.?\)0WBD(=>#%&L_@C2!.(H2Z%/<1)D4AD2Q$RV\+SLSV"T[0O;
MZ_%:JFO*,Z\Z#>@6:A"%Y$PIU\ZO#2?7S/O2]334VWV59OKO; N"0YVX\BNV
M,NPZ$]2VY.?V57_IO.K;PZON\.YP6L^K0.YJ"-"\S,\[6^A57LS)R*+7X6)T
MI4F3)W"UKODL^(.Z\'YK^R#O[Z9>0B+L"1_&L1^JR1 I))S&,.2^+PU)'B3$
MJ'[9D/[$1\F+\HH7;.QZS#FH0-'"64_Y3XB>H?9V =R8RA03\=T7J6A1?ZUZ
M%1-H>DI7C):Q4T:?>76-RX?;8O,M9YR]>_ZM5!F7GVI5F:_OKZ@TX&OWYY)&
M@I T0I 3)B^U##&IA\)$VL:)M(P]D@918I(/J$]ZXA1!Y3:CDA.P5990OI;_
MU[( \)X',]UC *N>VID&+#.-HW!23( =%ZJ/U0^_-:#]"/:\@*MAU(P5CSD
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M"_ _O)]\#SSA GQ3C)A[LBZ!IN^W<@"$N9=*(O"U0:"FNP =RFY=4@/B.71
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M9])R0]B#J< I1 F*8>81 CUYZ*8^#P."0J/Z$$W"$WLI.FS4R9'UJ=8R\K\
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M<0F)XS3CJ=9X=%/"DQ<M'"C7IP;NT-;/J#*"LG_S30F0V0;=<0$D&_N2I1>
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M5-3VINO6WGJ!VI^\$FVVDC/7M65?'S9%==>9PGGU/2^7R*=!%F0"!C[U50H
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MA0E,_2R&C&$OBC *0Q*;'"M67$Q\7+0\ >6[--/F=ICJ:>G)D3+3OCN0]OR
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MB26$:2:MW"0. TZRP$_U!BQ/ INS(V8!6C#?3P2CY1$S!AP7)\P)+JZ.F!.
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MY^:UO9%BNI'"_*FJ[=R\.-?E>(ZXLFXSKQIIO>-K^4.E? #O:D] [:NYEA;
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M)+]F+KIVA\,OF[*\KC,;[E4FE_KKIW5#:<D"CC/5WEU0%$'$,8=9',00I6'
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M/,\\!GF(5=]!D<",8!]F(2-!ZOD!$EJGG3[)J5,I+PP<KAG9C;2/O'&#F<\
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M$9\YL<,&F--D#ZM5+)LXK%:;/U3;")40KH)!\G+%\V^J3T0;;(P"Y!$U02]
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MU62Y+S'&)//DO4/NVABB,! P92B$091EE*$@C)'1Y>,\F8DWMB+:.$>9)+L
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M#YG[5G:K/'^M^-,39[\]W6WV&6=75=T>LAE>O/14FU>:I9"'@D.4I#[,XDQ
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MRV9'"RAB>IOC5/K^S3%*)D-;5D\<[0URD?4>6U4^T^P-^<-A2YRN-,N6N"C
M;DM<_H!E8OGF\9$7-,>K6_S$BV6">4"C.(1^F'!EAC)(@I3 . K]R M3Q./(
M*&'\Y?I36Z%[:N!)D3/,ZC["0N\,&2&AH>UY$.ZV5SCSM.KS(KA*ESY:?=XT
MZ/.BG:0W7_B8]31'54-_O5DWX]BDJ7TK7^6A27E9M_4]3-_P:1IX))5[+61J
M&'7@0^S)O^)4'D<Q0PD)$I-=9\K Q-NR90=T^0&*H4[7??.ACF80ZVWF*8$S
MV^U:F+6]P*<9B&*+A;MQCF;DYQ[F: 7.F5&.=NN,TDQMLH:BU/YX0U;Y?>T4
MZ+)2OGM6G[G%196KF.FZ6F9!($C$,JB&Q$E5E60PY9C#+(EY$ 1)'(8VJLJ>
MHZFC-(]/J\TSYX!VN;!25B-0-])>\V!II\Y:AFI-MMC_[<#?XH7"*U57Z5KI
M=9ATKN'&X^56Y8W@YS5TX'CX+BA%!PO;:<EWVU+2+TMI%9)\7=/[LL]U^\3D
MS2L7N5++5V7)J[+.'2XXNUJSSCA>^6_;1ZG9F_%VS2<[ [26.$@]IEH>,R]$
M$"$_D3K4S^3%*\88<13)RY:)(IV#Z:F]&[MA3(7E@+M97IR>+GYKK\-,7>^X
M!QWV%^ @ .A* !K&P$Z&VHO;D0*T8BSVTS:;!Q:=088.O:-S(N](\<_"\JQG
MPYPOX?CXF)6V90/J.AST]"057=XPJ)KQEU^OOGS53UO27FQBM=U$!;L,@(8#
M\(/DH;S<V-$2&CT%[!05,^TY!(C#U"=C:5VUIQZD-V^C:EWQ3UI6:S]HGN<A
M+_%/FQ*O?BXVVZ=/ZW;DM+K:;U2WNBUG-T^\:+K945IL7P[[:#7/,D,BQJE@
MT.,,0VDF,IC1)($(^QY#B1=*@U$W,<0)1],;@8JP:GR]IZR?7N$&\WX-\RI(
M&EZW6_9 S=\"[#D$71;!GL<%V,'>97-OL,V-OWX^S.SOP2Z!9J[W891WXQ2[
MGD0=-W1FR^QQ"DLW%<CMPG:&YZ^8/DCCN'B6UJY*S7Y2W^76KDJ#,!(\">5)
MPQE$A!%(LB2"7NI3+Q;8C\P\$CVT)CY#]I3KJ^B>MIDAV@>5G@GJ"  SU7]!
M]@EL3@WQ'%F;?91FM3,U1#ZV,'4><17,455O;9;R<_M-S1#R4I81F,G_@0@)
M#Q*?)S -,YPF),$I,AIII$-T\G RJ4!IF.EO!)IMN&4<%"XB*C4V.Q8FV/,F
M,D\6%3E#\I4#'Y=!&(YM]#SK9+I9:3CWY]+C$_I+CN9VE=-,=1V0:YK!7>7K
MC/T9$G9@=-?IYRV_BGPE__7^9_EM+_!*GH!7[#%?YVKM*O_&/WQ7YBTO;S>K
MG#X?DG7B+(P2->LC8I$\M/Q '5HA@G'FDP@S1A-A-H?/BHVIW:8-4PO0LE7;
M:R\9 SO.#%VH=JAKJH?)L314'@8P+D##%OB]_>\DB5/C$'*EANR8F%=)C0+J
M1(6-6\V5#7Y%JRU>?>'5MEC?U,E<3?!HB?Q,,!P2B#$+U12C2!KA@0\]''#Y
MWY!X3*OFP)STY!Y;1184-=VQUOA%^&QM<A>@N+#,ZS2F7>#[7-M;L2E "V7#
M;=MB>TKC?0B<R4SXBX1?V9 ? F38G!]<P4[1U,.0E3^PX ]2CTF%)K]#FT>N
MOB+ON!H^?>C$37$SZIU7-^(.?U\2&GEAS%)(TE1 A#)I3B5A '$8>G'$I/))
MF8GF&<'+Q*KHYOJ3F0(: ZN>1IH)+#,5U8PL?\$5:-AJE<X"D)HW<,+< JAA
MM1NAV@:Z4TT.4'*DJ\9P,JOR<@#9L39SL:2M'46J0]+[X4Z"N><+C D,O<17
M75"ET123$&9Q$@41S3!+ [.AL!<HF>PUJTFPM6=.6J7@NN!,6@4?,6U3C4Q-
MIO-(Z=I'HZ4W-8:DV >*X/>):E5ZQ7)FQIRG,K/-TBOJJ8'2_W&[[;KOG-R9
MMUGN?_G77-[ "OKPW [#$H+X21J$D%*>0B1$!C/.. P(]T629AAG1O:'$?6)
M+8Y.5^\]X=H%\?GJ;Y;CQ,S U=OWDT%FI@W&H66L%JRD=J0LS&C/JD*L8#E6
M+':+F+<E4ZF[\L!]OA$?BMHV.6BS7^35ZU/%'X>< [K+3/>]WU%7=K.DOUGS
MS;9<M6WQCK)\7IR6BC=0,^>H3YX)#E8=OK0(S-;LRT3<;M\OH^?L3=Y/Z[(J
MZGPR:0[RIGW;,J(L2X(XA#$/J#PN/0:Q8!2RD'A9)C)5-F3F*#Q/:(XPO9#4
M .YO2V>&CKZ=.U9F"T/W0'*A#'SNK".?KEP.+=VS9&8W=?N$/6?K]G[>G;&K
M1MW]MMZ0DA=U0<BG]=.V+A"1DLEKW:[H9%L4^?K^'2[S<E=;\OR55]6J.2Z7
M+)3:GV1REV=A A&/?)CA,(2>P#Z2]]M "&HVPFXZ9K6VSICY=QU:XPUF1R_(
MWKJ>$?21IO@"=-BNIW>"+N.@X1R\9+TNWFN8!S7WBWW)GYI\I/$JG5CS;E&>
MT/1WQ.BKWQ/< JYSJ7!,T;QUW(=U)=>Z8DSNIO)V4U9X]?_E3]<;QI<*U3!*
M8^@A'$'DJ>(<(2TW$B4QDW8<%ES+L]%/9F)#K2$,6LHJ1T+1!I(X4-3UN\SU
M -6O1]V);Z8#;24W:D@W+)A5=[J>96=K53<L6K=OG<:G;<<$RV\]+ZLOTN;X
M^@=^:K-X8QXS'*8$XD -]_'E394D&,G+E+Q=10GV0@^9Q0[.$YH\=+ C"PHU
MG**4A$WG Y_%1\^V&2^SV9[<"ZL( D5Q@C3F?J&<S0 ^2V3FX;]]@IY._>W]
MM+-N*HK.?=&>W"MU4[B6ZJ!<"NRE"/MRQR9I"%&($YCR+)8_!7Z<> %-L]2B
MG[$^!Q9W'(N&QYUAD[7S.S\P XN&&T ?<'%O&ALT@%IO\SM&SF$OD@X;H.4#
MU(Q,VDAD0/CIVH%<(OS:33T& -%HS3&T@F5?6UP^7*V9^H\JNOJ&5W56>W6-
MBT)-S:@O&<L,^W'JD1#&&6%2RR0^Q"F)H,=%'/@,$2%-5R,+08ONY :#(E]K
M%JI^X =&#!OB:H&HITF< V.F1/:(U#]T.%BH8<P[)AI_B,/&NB9"NVJWJT5S
MWB:\)C"<M.8U>MA.6]RVTP$_;HK;8D,Y9Z6:6EJG0ZG!T:6:8WI%J_Q;G;"S
MY"D3:4)]&'FJ7Z^?I#!5196$I8Q1&L1I$EC8*89LS&.L-*F"^8[\ JRY82C'
M%%T]A3(%6%:J9<=(G<#]PXZ7>FCRCZ!!;\\/.##D3LM8(N%(WYA2GU7S6$)S
MK(-LEQF1ZOU9"MCM/=;>V4.I=X(P#6#,/0P12PE,0R^!%*4^2T*?<]^H/W\/
MK8F]CLW.6.]) US3MDC?O@"5GAIQ!("9RFAD/U#==5!T[^C0$,]EWO0%2O/G
M1?>+?#;O>> 1RWL(+ZHF69J7-^(]?]K(>W_[!4T21!#W&<Q0G$)$LA1B3S 8
MX" )(WDM(<(WFK5QF=;$>[E+6:4XL8:VX6VC!RK-.X8;  QO%D>RMV0GV,L:
MXKFZ0_10FO?F,"SRR7U!XQ'S+,3KA_7]I_5'%9R\$3?;JF3RP%^SW];?RHKM
MY[#^7*PK]FE]6Q3_* SG#UL3F'AKJQGI4*7"0?43N'Y0H[/E=0!T4GE54N.+
M,;\_%WBM''+R8[=%+LUB]6P)[A[D71L7'"CY*GD;5Q:QNI3_5MM0G.D/;;5_
M'_VJ9+978:9D9GT+CB<SCX;3*@W5GNILN:FC@>DFK(Y?S++#!WW@;+OB-^(_
MM[BHU%#BC_D:K]4LI4]K>25^K%V[1]-X@H0*B@,$A9=(TX=C"DD88LB8[Q$_
M)C'Q0J,&'S9<3*PYOVX?'W&3\KUG"KS'%39LYF$%L)[!-#EL9EKN -.>"]!A
M8])I1Z.@<-6SPXJ'>5MVC('II&/'J,4L9H!N62Z_!9_Q(U\&88("BCGT \(A
MHAZ!&24!Y#Z*@CB+TU!HM54^6G=BG=)2 HJ4P?3/CMS]BF&$-&9;74L0L[F?
MIVS;3?WLK#/?S,]3YE],_#SSSY;']8.T_-[A\F5OV:NB4 :E\G&^>SY\I'5[
MUN9D8UH>LNO+VF<B;<GUS5-="/YQ4PB>5VIDV=^Y:J+.V94T6/$]K^U0>?#Q
M?7;G,DF"4*2^4(.K*40H\&"*0@YQ%/J8)3$EU,B-^3;$FGCS[^@#W#  [A4'
M@*D\*:'N =^:;.YKJ4'Y:B4_^(,T_=EFM5)F_Q,O0*DP,)W'\":@U35HW@2S
MTZG-FGE8<_^R9K CHIJ9UOU<*V9S*USL[H@=4=L@526%!:VT"]"1=P'VW[Q6
MY.9JJ8Q9WKF!.C3&WM1K=&7=O0VAYC47WX;,E^S/M\6=982AB5DTC5KN\/>V
MSUW;D>JZ:2V?K^_WO>4/_6!Y%!$LX@B*5/6&3G L#V D#>$H%4RPT(M$:A2
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MK/%V'"S D^*AWCI\/P%Q6[,A+]!",W9N J;>_=DQ1&:JZ8#.[1Z=/0,+T+
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M6S9/"CM :%;%O2WPJ0(;O.'HYXIMD_ZJB^0O&<\QSA,,4Z+K"R*AMN XS6%
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M[C@Y^2\.Y&9S<-RAZ'M (T:Q+[SP=KU57]:[8M7VF%F2+$(BR3.((TD@BK"
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MXYNGK>#O5N3!]"CQYD 3;W];^N!K26KEZ+BH]PR:%<'K.O<M1^:'AK<1NGU
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M/0&_T;8&:%=QP=KI'P10Y#F.I-HK)5AF$'&*(1%!I#Y+&D4\E(CCW";7WB>
MKGGU_ *,HBNI2F^55'6"T7B_Y L<ZSU2@TBO&->$168-Y?2W%QJD-O?^QT3T
M"WL>H]=<K2C=MD5KEY)A06,:PBC3%C.6$N8HS6 :9\IP4B8HLLH>Z(T]=7)
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MU:ILQYBO-N4QTT>U*$]^-?.-\J8VQ_NJVO7J7W >QIRR !(1!VHG0!'$61A
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M:2I2EA?"J.I$G[3O\TU#3DWT:3@ E?RKJ4>AC:*NG^$#&U/O@VS!@8D%Z-D
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MM+&;T9YU/[>"Y7@;MUO$SAA]XD_*,5@_J+Y23=^3F,5A'.4"DDP(B#(U8R]
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MI(^;]:^2;E<"\I;7M"J;N-&A*%FS2.GZ2IX-AV0 _GIS<]\W7  #'O3KF30
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M%5HF090$2#!8T#B'**4%Q"D7, Y(&M,H96EHY*E8\N'?5\F]5NKM\=3S5F9
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MZ$9E=9TAEYQ'0EK  D9YFD D"B'=+R2M)%$9>ED1I(E1U: )<<]F\/>U&N0
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MV505I\K<O5_AAZ5(DR!1][XB005$4GT@IFD(.6:QR#*4![%V_X+KY#PK6,]
MWQT.K]ILU^;?&G; @1_P57&D&5G21/.Z/KK%R/!@ZA(>(_75E]I*H366GTW%
M]44=*KW!4ZYR#/L[N?>[[:[B[QZ?5IMG5:B@+N+(KKF_^RC=X/=E3?%*S8%;
M\D+DJJT)+(H8J;)-+G]".<R)LB XP3S6VGH=\N39H+RKM^5C$]02#4> =RP!
M.N0)E&NP5F<XT3 &GB5G4W/ES%^/9G!L7M -+=29K+G%(9&BY1#T+((7/"Z
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MG!,X=8F.(0!'BG-,OSFTT<GQ:\-OBM"EO?YKN=V?=2^'77@LI2E):!0"%2$
ML, 4D+B(013R),MI1F&:N_5$<55I["#MYN%!=>642T;KTM[P!YTRKNU4G&?
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M_X.GUM(^ZE_D3__VM^X3^0_!-?^WO_T?4$L#!!0    ( .-=3%KG6( GAO$
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M2=8$!CQ8 XK1^>DL':>&CBNF9;+%\<98N4M%/R!IK-Y94UD/ 2VST]/9=,W
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M?[T\9*6XY,D6:9FU('@HH!SY95&R"%(%$6-(6J1\J/]R9[6] &-?*&".%.X
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MLO;[-'W \#U(<0.H'M[!SA4KEF?CZBQ!^F>U:$)8\"4F2"QR3$())UO7$CQ
M3K]^PG/F0UKIY 5<N[X.Y($G_/(-:W^"XVX5;GZK]1W" Y2VOS%X/Y[28N,P
MH:AE?*,)8604F+A8*!ZISYY"3K47<)W+%NHM5Q0AM Y<]Z&K2>N#Q77%8@JH
MK9.0HJM)ZD16NK['+[1UBI:LY/A0O\F#6QXLGE;)^0S&I@T2=O8].$S< W"@
M+JC?#,"]EH<O4I*W5V>>"E",+&.07()..OFLE;?8VF/:24B_T#E&LSM!<HR8
M!X"5-V%1FUK5_WOW7RN*JR?U&OC5\DV8S\_'TY/_"),5C@I+RF!0@+*6A];A
M<Z[^MIAH' 47P5T_:&OEZ>Q#V!"P=!0 ;GLVS;4QG"O*+]]F\^57G)]^F'['
MBPAU,9*:Y1(= YO(^5,\2C+2*($%663U 4/L)&^QBYA^,\7MP=1&Z@.P4:^^
MAS']\03?S^9?:$M<W^2\Q;B\_MWER/?$K-"UT$DX9FA_U,'>DGP *Y,4G(*#
MQ)M[1T\CL=]8K3W4NM30("S8JY1J&=OB,R8DLTR<4L1YR8U/**)+=:95220Y
M)"?32A*?MD:A<\:*UHT2'Z*GWQ1J!^!J)?L!F+)JA:?T(^?$PI5PS!KQ,@%?
MOTVT/$$L)@')Q>J((GDE&N-G%QW]YB[;X^9H60\)+Y_#G[]2T#NG2'=!'N*7
MU=G9A SJ.N]5F]/.Z70?21F<C61,F1 9E& !?*BW8IA85MESV?Q-^I,([+LX
M^E@\W >PYLH9$O+^/IO_\6'Z:3Y+N+C%$A,AA1P%:"DH$ F: I%D$$3.R+-5
M(HKVCQ8>):OOCO9=H:R1(H:$K?>UR?$WS'^;S?)MEGR=%&L*9-H8H$A0X+RG
MW>-LEMQS%9NGJ_8@J^^F^%UAJY$BAH2M6ARB%-I2,  Z4[W#.F4T9 U&",X,
MHA;-;XFWU^^[#WY7:'FJ: =PC_MICF=AG#>-SBZC!V(B6"L8>**6I)$XQ'H+
M:0LRYA(&XUH_LMA)2+^=Q]N[WL=+>P"6Y(981B:BRBEGD%J[ZKXA."P2DBLH
MF.?809"_34"_S<4[B.H/ENX@K$GM/[L\K_6Q2_+X:[+^[&9/&2Z=]F1BN;;$
MD+=D9UW48%FB," Y'TWK&Y-'B1I"@KO)S5M;\?=H:NI$Q5_"-+]>C=>O%6KT
M^.'T;#[[?O$<<SVQ:$0GK1$4*T(0J$"YZ.L $ T)4^&I,)O+K;?0.P?A/KI0
MO^%Y8Z7.NI+P $ZF7P/)<HKS\VTQ77#B1$*#D=4AG+76TU4960^867;:%N=2
MZ^ZG]U/3K\'I!E"-=3  --TKITMNA S6&Q)26-\VR]K(Q$"VR5BM.6>B=7;Z
M88KZC<&[155#70S 37J5TNIT-:GE@6^1B$CCM9KHUQ/<5*YO3RBZE_E13B56
M4PP:%44.V3F(JBA K0HKFA/[K8=DMJ*]WQQ MVCM1;]#MI@U,1(4LR:H!,R6
M HHGI/"HQKN(3M$QH'AL78'Z$#W]WNKU9"V?JH<!V,J:>?US/)F,F$D>B]%D
MV2F45L$G"([84$IJ%"73?UI'CI=K#Z$LI4F >) P!V!8;D_H(QQ?-%JJ+]DO
M>2K%V!0]"4;4H5JH&7A-MC.54*P0-@?=^C#<AZXAE)TT 4]S)0P 6&\WRUY-
M_+AB;11"#,%( 29J \H2)U&2Y(0)23@KC$BMSZO[J1E"#4H3$#42^ "@LRXC
MW5 _FZ9-PC9B3-SF#"ZI.@*2U<E^4@,WD2$Y<=PTO_K?2<@0;DZ: .9X,0^C
M4/)BLJPP2F;4FGRY',GY\O7=C5 @I0S):<V";'VQ]H09OAU?DS1\7?(D00[
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M 9B8NU[\%B\E>&$Q)ZAW,Z!L0 B<&))9ZE3J,%7702^0>^D93!C5!#_-)#\
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M9Z=A/!T)[U$FQ8"Q>N:+XH$.9PNHF%;!">>;=U+92<A ,'.\HF\_X#M:Z@.
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MRA2;#&O=(^@& ?UV'GM.)!XN]T' YJIGXYNP^#926#)+%-M)7^K@(,[!6\O
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MKHN20+_F]966 4'_4<8+BZ)U)OI)!#;PDQY?['IW&(?291&!:6Y ::$@(!W
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MY+7EH+_KUZ.1<_^!^^RJ'=!9O,W]]NO_;>XWY4:WWPK5N^*<#3D>BAL*\%V
M*#QI('O-BBA*-:\?/Y[J?MS)9P-PARI\ :"]ETL,AMD"6==';:8@N,P=_:=$
MJS-/O'07Z#R%TGZ<PE[ V4!5 _7PWF)<UKM3HF:\?!_2Y@'2$4\:'OI>FT<-
M>U/<*#-8FVK5?O!UY2NXI=H#A&L+SF0!RKI4IY8GT%KE5%+1QK<^3W;1T;("
M.RZWGXEL=;GWS@3.(+@:4'$*9GP)&KR@_ZHBB[>M4YV/4]5OUN]H1#Q4RMQ
M#0<;F^\XC[,.S<U5?YTC3,S=;[0P*X]0ULB47*VR(W'AO/9<" ',,@>D4?+.
MC50@4=KB@I6ZR,;[[ %RVAF6=Z5@6EX5>-)JG\-RW3]@6HWWKG)['KB)/% \
MPH2MC>P-!)9B;;XDN-580NCNAN'I]/9KC%IAZGZ;U+$&!^6K5[=O-KUX-'+%
M[B;!]QJG6,:W*VQTSC8%9T'J3%Z@U62B$\G8>N=XCC&SV-WY^&1R^[VAZ!ZK
MW>IO4%!]NR& &-S51.!VRD?9Y#TJT)Q3?*0R;49&OW44-]'9:E5B75U!/)'4
M?F\;NH=H=WH;%#Q_G\XO>@3]]YK5S>9;?)Y-)N]G\YJTO'UF6)N=) <Z<^]I
M(U+P'@,SD(KW+K*H<VK=W?)P:ON=P=T]2#O5WD"3(9]Q.;YH:K1N'GM$4\)=
MWVG3D?!1"MO5N5^GOZ;Y>N%=CWCK$2ED  R&3!12?.KKP,[(A4.EE"VY?=NT
MO<D[?D1,&4]Q7:(X'\=57;$*?ZNURNU"!T,^;I*LO@Z.)(Z0*&97'JR6-@M'
M<7II?=(^E<;>J^([P=;=\3(=:FY09VTM_%_4QHUWS<-6!BERI4PN((RO8P:Q
MU-%,"('302%R"1A]AX'*XQ3V7A[_+*CL4&N#PN1F]VT\AS5KVSOONF>),\8H
MIZ$$EDB6AAP'@8&",,]MSD[KW&7OFKV([+U6_IF1V87N!@7.-]_"]*1V"_DT
MG_TGIN45K]=O5NYTVT-M:KM1$"((VHB!$:^ZUB]F*0Q*P7SK_.PQ]/8;H/1@
M3+O5Z##1>SV&L=1-NK/N%H72SI%X"U>F)A $."P.M.,R<A3&W)Z"TP5N]Z!T
M+\1V-N*P1\2VUN*@L/IJ,MGT5'J .Y*;S^310(BUOL<P#9[V()B4#,]1&:YT
M9QC=A\*]L-G9:,3GQV9SK0T*D_4^8.N$V!12WCD>-,;(9(&"GHX'1\Z-=X9#
M#MZ:I (OS1^Q/Y'$O5#9V>C$YT=E>[T--!/Y975Z&N;GL_+OJS"GI2:UGV[X
M?1I6>;S$?'!F<K_OMLA4'L!!H\SEU8)7S?WJRM=-8J1G6@4$$X2G@U36' \A
M,3DKM7*$Q=SZJ'F8HG9F[>XZ'Z;K9H<[+NA33"&'H( ,-0<E/ .7F86HK14N
MV!R:]]L]B-!^,Y4-L72_5>M*;4.U;7A2K7:8YK]A?8I_]FV<JE0/-VH/?[")
M-7L"S8W,V&;)SWA6'YI-3ZZ/4N-E0E,'M!8-JLY(CYD5L%R'$!)C/#7/0]Q#
MR[&FZV8)T<?R\0SG83,(C<[WV@OP/>W)S?*+K[,W%,3/)N-<.PANI>V39J9H
MVG>IT('OBP4GDP>OC:4(/T476T>X;2COU[@U0=AML]:#2@<56MP6ZI8I?WV^
M^<OM-Z*<614\V&#J8-),L916'C G&RBXLDYV%_<^B=1^[V8Z@>IS*&U0V'PW
M78Z7YW\?YZVY(!^GUR?:JSF&Q>T1XM,/TSS^/LZK4 L_<'PR?5.G5<['N*B#
M/^HOMZ93,NFU9$)0G%?]$VT#Q,(D.%%85-R%(+H#=/?\]7L/U/$N&!@\!NJ^
M7O!=YY^7B_GGA_?SO>=+39KZ[D-EJ[$OA)9U_ZX5YLUQ7Q]Q3C/]Q=EL$29_
MF\]69]=M6KU+)5D*DW+,M1%(RN"X0) Q1ADQ2\5:-[I](HD-+\%O?/_#-$U6
MF7;N;GHNJOJNQA:\#I/:L.S+-UQ/07R5\[K]+,6@NZYBT2:+WF6*#"6=2CP4
M\(HQT-$+E)+$++N[GGPV-GL>$],ATA^XC!\DA@9JGK_0";3N>C]=WIW8_1:7
M83PY*,>PSV>;9!J>3'\C*_[ ?'.-*1:?!#A?$%2.A7YE+&A$402WTIK6!OM^
M:HZVS9=;8WTBCE1PB3LE0 <=R'4R&4+ !*F8PC 5<O2;5Q_=H*!?B]9(ZW>,
MU^%"'D#$]&D^(WNZ/*\7G]5JOONOU?AL;4W/O](G7OT8+T:YH-'<.N"AEKN3
MH,"GD$$+%ZV.3*OF$]?V(*OGA-(16I]UJX(AHZHR]'9V&L;3D3,RL)@36(T6
M%-8;4NE(@EH'95CTP;>^<MZ#K'Y1U1P*^T+M0+T, &JO5R31FB"8YLM??C@]
MF\^^7XQ#^Q5/(\Y'+-C@.''AG*I,>0&19P$L"69R<-XUC\/V(FR@<#L4#K.N
M=3, P/T:2*I3G)]O"^R*%;+WM!O!!D]!D*4-ZNE8(*8L8PZ18_/9/@^0TV\>
MNVMPM=)#SY,@/M?"R O#+I*M/3NAK"-27;MYZH2T+6) 7306OM=;JD>F.EPM
MV/,UQ_$.U.'B&X+.-U"-UJ'028+AG-%QSE+M]"_I.!?U4I GCGN]5-I'ZWV>
M.4<HZ[:Z#Y!<SPK_=3P=GZY.+ZU3P6*822 UD:OJI4!49*<P%EZL]>3?[=7R
MY1&5WUBT9Z4?HK)9"_GUK?CP8XOPD(LOV@?0MM[TBW7_/!4A8O"L2*69VFLZ
MRF.*WUZTI[Z:K11_L/P&X"FNN]5>QVU.:+F^0%<U;G.,0T B7NM(_@B/GO/6
MU\4W".CY/K==ON1PL0X $_<TW9S/ZV991T6OSW>W/;YF>YJK3_U;.+UTHYG,
MM2F>!BR^CNQV"9SE 9"5PLC!1A&;=Q/I@(^>T\.'P^IV1KAO'0\ Y^].SR:S
M<\2M7L>7IW?F)14T@$8BQ69"@_?>@? "E<\L2FR=3;Z7F)YSR+WC9-:%T@:
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ME@>"]J0%S_LC:/QMU/M+YF;?+/,1*0!%X%AW*S$?(-9SS9,*8N(NJ]PZNC^
MS/._-DZ-_<,TW,$%\6I&/PN7JU>S-/^"VS_]'A:S*MFJ@$D(PL7,+-BB.2A5
MV\NDX>"XJZ)E@>76=?B_INK\Q^ZW@6AC_76:4;]O^\KR:COXMAOM[L*+(_+J
M1WU<BT?[=OPV>LN_ER!"]7]A_E2!ENA+FS31S\4BWHMDM+. 7@M0*1#0-?U.
M,RP^I)"B;)V"/X+<=C-)KD9Q*HI< E.0>:30)24/,7H.S&7!C50ZQ=:/5G=(
MZ&7/S;#(>7A\R?YZZ.!>OE=L?P_3V>OY<OG;]ROIO<>+3=7>Y^G7]<.?5-8)
M(0HD5DM='0;P22,PE;-T7+&"K1\L#J.T%U > (X=]L$UUE0'>+R'C:M'1J4-
M2<\:8$0T!6]DKB[)#"B]S8P55YH?[P\2TPNJAD/"? BU=("O.HSUY<7\KRN&
MMJ/\=>T\J\6@OHZK2QR!?I,@\61-+C&KYFU6]Q(R+JX:*?F>*;C'2;P#V+S!
MU<T0UA\YD25:]"E#$:H6R9%%A<@I[-%*4<3#A%.E,78>IF;<%Y5A -1(]AV@
MZ-'EGHF3%)CB('D@$453P!?ZHW;:^.(U)MVZ0Z#?%;Q#.TX'2;TK!-VSS3,+
M924GXI'I2$:6/01O'!3+D_0YZ)Q:/Z"=Z2+=O;2^SR+=?530 9P>W^&J),NV
MD*D56U?7<(/@1#0@=.3,R" X;UX[>::+=/?2^UZ+=/=10@>(NKJ?7^"26 K7
MA4(R,\.\BE#HQ 9EB)7@DH&4 M/!<5^:YV[OIV3<]_R6UUH#27>)ERN+<@9]
M0,E I\1J/9""&&I>P:+4M3$EB-:7V4.T=!&5':7G7T+G *%W )XM YB?+:]X
MNKGLK\Y/%#YSZ^MV*D:!)F,:G'4:I"HNJ8 B8NNA1#N0U1ND#M'_3WY16V5T
M@*\W\UF^YNJ*A2@Q&:<U'=2.[N/L H0<!1AT] 6%*OK6Y](]9'01Y[?%S['"
M[@ OOX6+,$OXX3/BZG7][NUA73S+S D.Q($@)XY8<#XB(,^!+OS"4;5^NWZ(
MEG'[_ELZ0$VDW2EJKNPINNRBDA8L#YKPCQF\BW54D[41G37>M-X@\# U(U>A
M-]'V#A Z0/0=@.CMZC,NKK;O;(J%MGMB%9>&PD^2C"4+0[3@36;@4[2*E\*-
M:UT7\! M_0'H$%W/!Q!\+P"B.SC=PXIB1+U* IBJO1D)Z93V,4#$('5,@D*1
MUL?0(^2,/)YS0!@U$'\O2+JRB!_*%3<NG5)1%>4@>1WJTRNO,R48!!]L]JF8
M*%NGRQXE:.1)E,,?2L>IH!<\W9C&S_QP%32CT!)$3!1:6B4A&B& "Q2._HZ)
MYMLD?T73R ,83W)&':>(#H!U$XR\OK4)2/)ZW@(+TH-B(8(ODOQ*-"&:Z*6Q
MLC&6[B%CW*F#PR1?#Y-Q5S!Y,Z\J"!>;;J.)]L(GM Z"B!R4I!,U9&XA)9MD
MLE:;YB,T'J*EE]38@4I^$#1'2+P#Y/P1_CW]<OGE/=:CMU:M;.8:?7];[FRX
MN6%XR2<\*\E4"'1LUJ&'(D5BEZYG*T(R):%!W?H(.HC07BI$VF!N>%UU ,@;
MVJ\[B]Z6.PLX)Y:E%(VS4'0=ZE!'V(02'5"<45A$'U,:;O?MPW3UDKEM?<0U
MTD3_Z+KI720F4N \0O'(R/54BF)9+D"CD<+8$E@PIT78?BVI)W@>/PG*#M-(
M/YW1OV#O334AFR(WBF*0X'/-0V6*=46"I)U-SAO'W'";FA^BJA?W_B0@VU<+
MAQ]D\U6X.&UK:(,)C;O]W,&:/4\RH?&8WCS!LZ/_(211YW0["D-#L0%,9%'E
M6#<[GZ(L^N1=G;NV]OSV?=.2_8$0L9Z)L7WP^>W[?3^LEL!NHGJR>#KS:S=X
M* :4,;4;G$)[7@S3FF&P9KA+>&CN>HF'A\7[\2V")T%/!Z[I T5T+L5H@V20
M/"<N+%U[ 9T"KS0Z;1/=5*V]@R/*4CMJ*#P-;G:K>-U'B5U"\>II/GF,.IL
M@@?B(UARDJ1 *"X7[9/BS@X/QAY*/5KH>=>*UWV$W@%X=BFR9#HPC$Y#L-67
M-[[Z\JJ X:BRB$+$U'X.QKE6O.ZE_P,J7O=11A?X>J1K"CE*GZPDUT34;DOT
MX.M6)CK*-2L.%;.G&/K06X=BUW=F,X5V!<Y[.K#(G)A/9%[.J01*&@8QHX-D
MC7)&D^&EUAU&9]K\N)?6]VE^W$<%'<#I\;Z[H#US.CE@(EE0D2>*PT*IO>M,
M!":B"\VWPI]I\^->>M^K^7$?)72 J.U8O/=TP'_X*WR]XB)E(XP.%,A+6:<*
M&P6.(8,2O2B:1XZZ=9W _93T<F,VQE #L3=<#'0X?'XGLG/&?.M!?3H+LS0-
M%[=\C"ONBA"<2ZV@Y#I !8E/EXT$*92(5MN28NOGNWWHZR5;VQAJ@ZFH@]/K
MP+%25INL4J*XR=<9+"A(G+IHX)FKF'A6H?E%.> HN!- \NSBA<8@Z #J#P\J
M8LY))QG?[)!3DDZ(Z+@"KKUB+!5AV4!MYT]DRMQ>2-AYRMP^:ND 7X^,K+*9
M.^VP@(X*03&Z'F*6$7@2TLNLLPRMAZH<.2YLA'ES>ZE[]W%A^\B^ Q0]:H$W
MM1OH6=0Z!XA12E"!8UUB;8'<&,%BR+$F\$]X ;_>JXK]!+54YWOA'J;DKJ![
MIX(;6<FL7@JY)/*)#?,0@HE@H@W).K+LYI,V>Z^9;Z?W7<OH]U%"%Y'QK8X4
M7'S9K'G95$N05*SUMKYE,E#9>W#%"<B1)TLF66(>[NS[D99>'E=. *<CE-#!
MV?1N,4^(>?F2A%AO =RX"S\4YDR$%=RB82 H>">>@@%GE8#DF(JVT.]-ZPWV
MN]#5<0S;!F3-E=,!X#XNPFRY<3.>Y?^]W'BF+^>+GSQ58C8M,"SQ!6[^2=_Q
MMGP,_YX4M#8Q0=+TLH#B18'SO(#W%&69X#.:UD_(QU/=L?_7!JPG5FP'4+X]
MS!NWPOPX_PW?8[H(R^6T3#'_]W3U>3K[^!=>?,,_Z)+XO)Q$SKVLVSU9MAI4
M(5%[PQ*$.B5#**=D\WOZ0%)[J<T?#+2G4&$'2+W5IO?G$O.KV<]&N67^-N,?
MYU<[K9;7)HI*AU+;GSES9*+.I4U7N^,L6DN,*S-<R'(D\3NAV9PQFL=1<\.@
MZ 1=*G_,OVVV9<XO5_/R]OFKQMTJ#_[\P;I6=N.H@^X5]-&E(@C01@50PECZ
M'88Z&C'HR(3)OO6TFRZZ5Z[6*7/KL 0+0<@Z#T0ZB(QGB$$P"@L9EMQ^]NH3
MV4FV#W)^M9-L'SUT<'4_5/_MI;=U?Q%)0('2,8-/R@)*%%Y*:8QKW0G6=[/&
M <K=L:-B#TEWB9=M&HF3:XJBAE3,@Y+(P0NEP1ABCWLG++:.FL^KHV(?/>_:
M4;&/T#L SRY%_#G8Y(JHFW(Y.:A&*@I]C $=&$M"D:\ZP"OSN794[*7_ SHJ
M]E%&!_BZ;ZRUULQH'TJ=&A-J*%VC:))3\KXPSXO"TKJ1XGQFB!^#GV.%W0%>
M'BW=)^Y#=%X#\U9N)K%Y@0HTJN(*U]KSUEF)<^C .=X1:B;UKA!T7_%K2::@
ML,!MG<O/67UKR0@V:YEL(H[\<.,4SJI-9B^M[]4FLX<*.H#3XQT:*$PQ.3K(
MKFA0F,CH? I0<O:&,YE2:#U>_&S;9/;1^UYM,OLHH0-$/5!EM;8Z;DUA&@7P
MG#(HE31$)P,X$T,V1C+E6@^?>X2<7M+MQU]PK63>+WRNK,PS\AZ539"8J)OX
M%()G.H"TT9N4F<RE?;/5(P2->R U4_MN<#I !QT ZOE\N7I;/H2+ZT'6=&S&
M4$@J+$515Z63:%)=:^0$<]PQ4T)K$/U$1)? .43!=_//1TE[1+@LO_]S,P)]
M(QO\]U><+7';Z\64B:H&K,80#Z($DDB,8)F+3!;A8[GC!_V46WOLYX\;:;4'
M0S-9=G!\W#=/D4?,3#$.J78QK&M[ G,"=&'!<R4'K4M]W5L!?LOX_# 9=P"3
M.V.DU[5CY,*3,JZ;$K#0]]1:!":<34(5H'^0&8@@@-ACU0*TM!Z]=P,-']B%
MO%YBK .A<']HU5PO'4"N77%,-I(G1 0C1 "5+0,?Z' NT7.K.#F2<KA,_BEJ
MH$XZI_X8N(ZCTV9@;EON]"RERR^7%_6U?[/R:/Z%?O)G\B6JO$D$&_?BV=OG
MKSZDSY@O+W!>-DTP53KS3[/I_V&>SG[^ES?_8OT1AQ=+G9*Z%J56HTGSR$*M
MZDS>8#W=J<=>OJTU8H_R=L/7=?E-,D7Y*"U(58NS!8\0-8O ?'(&N5,BVQW\
M^<9D'7LA[/!QZVK@M;\F8_(.60(TILX$5^2JH550'+=!LV!S\U;X?>@;QPL9
M&VMWKX/!--J!^W(=</[^K\OIZGME;3Y;E]"MGZ]2Y)AE@B)9J:M7-(00)&3N
M78Q".V9:K\EYE*!QO>+A<# ?2BD=(.P.#]M$#=<J!Y6 )5_?HU@ Y] !.?F1
M.$J%-<^1WDO(N(AJJ.B[0Y2.EGH'T+EE<.11_SE;8+BH[L^-+[YUP[>38)UB
MTAH#&!0CIY\.>)>8!L^-0:FC*[9U"+4OC>,"K@$L'KX<V^NH+PR^P$+A9?X-
M9_2;U;N+,%O>N"7;=W9M)(N*' MI2JV<2\1=*I"20VX=3]:WSFKL1^&XD?J@
M^&NMG[[0MS4CLK(?V@O?K06_73LL48HZ^]ISN\X3K$>WDTRUDD4KKIAH/=]^
M3Q+'3?</BK_F&NH+@/=V8F_-BAL?;$TGZ9I>C"2\D J=\0E+#,Z0(].ZI&0W
MRL9-SPP*MU;ZZ !E=Z-]"O'?[A3B5S=9JEBD51Y"=M6AT Q\EAZ,%9D7*U34
MK0MVCZ%WW OX9#'LR51ZQO#=[L=@F4*ZZ&LO- =5A(00,[G%EIF,G-EH6H\K
M/([B<6.8TR&K$:0/4/,9@WK;$A(2-]HR$,83MXQ+B(H\'HLZ:89%\>;]-\=1
M?)Z@/@1;C6!]@*([@/6.%^!-(ME:+F+T"91U 53=V!MY9==ZZ[/@S+'6;^#[
MTCAN3'4REV)0U?4 S9JP6JT6TWBYJL+Z.-]$CMMJ@O?SBXN7\\5?89$GDJ*&
MC+;6QEB28W!YLX(!D2E!K&7!6@^]V(.\L\C3'(B3NZ <2&D]X'$W.5X7NW M
M952< XKHZ!(B1ND.XB1&NH]\#,RG 1^?=B%Q9%P.!97#SLF#]'8P++_B8CK/
M'U9AL6H"SL<XVQ03WO5K;A@VDOPB1:;N#8MD],;42TB#"#PKHP/'NX7D1P/U
M"')'?C X$6A/I<\.SM4#6*U<1FV((2W E5K1&+V&NJ\:= Q1>"=UM*W?N0ZC
M=&1WM%_ [JO%#K"ZZ21ZC]]P=HD3'AWWEKQWJ[VLVY8,2<YP8)('7XPGU[XU
M!'\@8-S7_%,AZW"9=P"8-_/9G.[ZL%K/E:D&\?NF\6A25'(DB  VA[JUAC,@
MO$O06C'-922)M*YU?)"8<2?0G@I(;731 :@VQ)-DKNB_2O%/BHE2Y&(@R_KL
MQ8B#J&."G+7Q/,0L=>MZGP=(&7<([*D U4(/'<!IIZ@H:<.YP3H<4KHZFP3)
MJ8R:?J>U%IH%45JW%S8+8>VY ZVYACI W;YA>=*Q&$6<21$2,14*N. $&,VD
M4Q:=DLV?^ 9X3G'GCL4A]7;D<\KOLSQ@W]>_+J?+Z2;2#HO%NA_NF$:M1WY<
MF\ZJ7>EM-+/ZM\OE=(;+)>$A3C?C]9;7_2:1,2\2I\.H)IL58J13JE@PT64N
MN<E"MUX=_!@]1[>)7/6BO2W;3[DM[M^^W_K3)L^C%4^>QTQA;EW7YM% J'_T
MW&@A+ ^%N\;\[TOCN(_!S=#S4_/(D*KJX!J]AZO-H-T8<C")?-#U#$J2%QV[
M)@)Z) ^TE,)3ZSSM Z2,W%,RJ/[G[971*:;J;Q>X+;"0JNXD-YDL4M O 05$
MY1 2LQ)E]%F[UC5:OR2JCP/L*-7O *?#]3#R'*-_!'+1+J_;7LC1=)PDXF/Q
M-4?AP#%9(#J5!282&>._<*%^^J'] > (9<U;2&YDE3_'Q379*C$9@ZK56)*1
M'=#OHDH9,J(V&",7=T^,>Q5^ZT>.FP@<3MV'2JW/B^/U=5F)+D:P).ML;5.'
MD5H%OO ,QFM!?AU';5LOM7J,GG'A,[9;<IA:.H#8N_!]/?;@X_S*W+;,X>;)
MH;8:77TE4^ @DR+!0)V<#"J*!%$H!4$GD4-17N;6;T;[T-?=A74@*NXN5!U*
M11W [YXXM4Y&GLX^$<?TN^4TKS-,586+.C=Y+8GGZQ'*KV8?/^/[^KNWY>WE
MJKZ4+1_XEU]/0YQ>3%??_Q$N+O&_II\^DR.9D_+:UNF$](LKM2R)"Y 4_MI0
M2!_8^@EA-&:[N]K;&,9Y@.>LK.R:UTGT@ORMLEXI7SM)HX487 &1HN/9)RMM
MZQ$:!Y Y;C%0!\@^3&'=8O*&L77_Z88R/M$1_3H-)TJI@^Y$I*@?/;@4F2O>
M)2=:9TOWH6_<PJ$3H["!BKJ%WZ_NCCL7QLV%D*V1*:<(UG/BWH8(/M1YV#*[
MR%7TR%MWJ+?E8-R2I0X.TN9J[G;@YDU<_.SBXFH0^-M"[M"[!5Y,OY"8%M_?
M72[2Y["DOYHF_#BG+VXC# HYGE'HL5K6+KZ;']4F=3L 0:V3OT/+[!3I8Z%0
M\:(5E#H@1-ELP2.K+^G<J\!-D;EU]VQ7Z>-"' J)D:)B;VI!#P,GK >41I2,
MEO[;NE;T":6/]T'/T>GC?535D5MQ-VV5C!$\V R\9JS6$U-B';;'BO8157#2
M#/7:<-[IX[WTOV/Z>!]E=(JI'U,C*B=K3?*0>$R@'/WB8D2@_Q>-VK#8?#[2
MF::/]U+]WNGC??305?K8"0PBUB0H2@_*APR.(P<*Y9@*F0EA]"_<N+-+'^^E
MK ?3Q_M(KJ/T,1-62V829)7I6(V& AEM#!A'=$N#Q?.\@\+/*'U\J+H/E5H'
M%\?+Z6RZPM?3;W5>ZHIBVBG=J)M Y+?O?X3_G2^>UP["]<%HK2N&/#A(,3M0
MRC&(W#G(1B0IDG"%-]\"NCMY9Y9</L9I&4II?>/QAK$WX7KLD)(^E<P]V2@9
MF4*.-<O"P9&UYOI_U]RMV9/$<>^XP:"R.R2/UMO8=^+E<C7_@HMGL_QBNMQT
M>\P7[W$S^'+Y>?IU>_;;X*(7Q$52PM8-O?7*%QJT\%($;PK)=Y<;<]</[!9:
MQZM\/K3\.SCK7N WO)A_Q?P1T^?9_&+^Z?O[Z:?/JRT[0;N@DDH0ZD 4922'
M6I8/E@R2%Q4C3ZT[.'Y!TKAW["D -X1N.H#:QT7(6$6SI=^3,VJ9]Z!-BG36
M^PS!9P8RY2BS*L:+UL^;=VD8-R]_2C =)?T.T+,]@>\[<X4L4A61H21%9ZZ6
M$D*NX_1809L8"UZW=L >(6?<+/LI,=5*)QW :VT>7\+BG]?T!Q.<R72:IL+J
M LX(T6H-U@0K(A<YZ]9ERW=I&#?7??+#Z5#I=X">=V%5\_';6; R),U1D OH
M1%UW3V$U$QR*=R*4NFI<M[[7?B!@W"D<I\3-X7+O #1OYK5K_BNN\-FG!6XJ
M.K9[R97&XKP#7B]HXH9!L)*!P:(S4^3WL=83IAZF9MQ9&Z>$4R.-=("M1PN5
MLHZ)H42PG*)3)1T''U'6+9 2M76&GR+)>TW/N#[XV)G>P]32$<1NU5[<K.9]
ME4GTTS(-U\:ZK3%Z-LO;6N I+NEKEU\P;U:B7Q4?T4_!Z;?Z;RXIQ V8>%;
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MC-M /H3;<9R<.P+*JR]?PW11;>CU?+F<B$3.=R@>3"&DD\<=($B9("G#L=C
M1&@]B>5^2OHH>SM0O0^ Y0A9=X28CXLP6Q(%RXD2R0L;,C#N:IZ<3LE@Z6S4
M2=I MP?ZV'IDU$]$C'O]#(.3PR3<$41N-WLX\I="]<Z9Y1KJ75K'3F;(428C
M>=&BM&XEO(>,<5^3AX')H5+N""B3Q%Q.PL:Z>)'N8+2&/#85P9G,4" )([0N
MCMU^=A\WS,%*?  4>TFTF\;DZS+S]*_+*1'QXG(QG7UZM_Z4.GZ,F6BJ<8@
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M@U/]^*>,7(#6"[8:JZ.#(^YWBDSGWW'#RA4+$GD6 >O:B%#7TJQK/+."PG7
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M5<B3K.J^%ULW9]294#9I"J!E 1(UX\5QQGWKO8?[4]GY),\18#ZLHO>'LM]
M>8:?PB8H[<0](F$7G-9^ZANC]CY)I5T"QH3==']&A0$2U\KR0D8=>W.0[F%C
MW-%./=K$R%!Y.D;SL[.(T3%K& -9ZN.JB@@QL0(1?4 AT64K.C.9PV**P8IS
MGZ#!' >3(V.*WV>Y"UNYNF#K-.,K(6@NE;>A/L.F6L*L'/B,!I#[Z'-Q"<5I
M&NJ/8**S&H4QGYF.4W /0<&1 OC'IJULEJ]3#O/Z5S];?RI"8 @.2DH4+,7:
M=4*'$QBAN68ZQ>Q[\ZMVY:VS"H4Q[6$0.#P!,[DE@#N%?C_.!:#+NUQ=WJDH
MYT2MUG:9=*FR@<BD N%+8-IP=*IY['UR+CLK8^@D8S$$1/YSC&@2N8NH)(.4
M#)TM(3H(C'Y)B$EGPT5_\[]V9.W)9#X&0?@X!KD7W,XG5_+@ J)=JM=_%)#-
M 1U#64]51[^@JS,*$V2+FAGDS/)^5B_NS=Z3R;)T89,CP>X<;L=?B>:GX8:/
M2@>YD$XX"X4%3L&J\>!-9F!DBMY8Y#J=O%2\*8=/)BUT%G8Y'/B>@FG>DSUX
M5#Z"N6PS(BAN>$W'%8@N<C#D:7@7D^#LY'V C7E\,AFJLS#/(0%X#@;:R-7G
MP@K%N 0FH@:5%".Q! <V)G39BQBQM_[<EI'E.>2_NC#'$>#V]#)FCXI&)Q;8
M>C]BL;D.L:I[D%D!DWFV.I24Q2!M+,.SUEE/2R?9M69@> *WU:^3+(]**WG$
M6 >^A8*J5@4D<%8F\,'$)+WQ.?96KG$<Q^-L=>K2HDX(G2=@:,]R7H\]#1<O
MILMT,5]6__E:CRSQQ)BWP(62H'P6$(VMBZI5L-$'D67S_5!#,C3."JDNS:2=
MXGNQ@D,Z2W_IK5[OUGH^GZU%<QDN:LNIF&B;>1+60(I%;R9S!,DDE#H(+&C&
M!]B==GHVSSL=UQ#DK7J93X2X)V"4#[O&#XF(3PPRZ16S8*0-H**OL[M] ,WH
M/%7)Z*P'&<MX6C;/.Q_7KU$.C;@G8)1[>]</2RY'+G0J$JQ.I%\M(P1?.-AL
MD86L#/.#]*1WP?UYI^[Z->&1\-F+9;=YL;VS+5 +*RPC!9I<9^ACCE"7;@)R
M8U)Q*HCFRXH&8^:\<W(#V]WHZ.G%C-KX$#\*@D\XMXX'DT 47O5C&$1!XN#<
M>:6]TXQU[)S>X>:\LVG]7F"-\-.+)0WZD/OLTZ?%NG?TSI$3D'SQ.A2>]$A'
M3F(:8F$,1 I1J5A0ZMXR9P<S.\[+_YG88??H.Z=9=.\__$F,O_OPYT"3Z![\
M^8/-H=N-HZ&FT%%48033!G@J#%36'D*,!0H*^H=5BAG["SD.-H4N?<9\>8%O
M-Z/Z?OO^_"(LEQ_KI30)KF2=! ?O?.T%((P'05R@+#5#7;_6_'!]F)S.YL'M
MH].?3JQ&0N_@ZE\?I!_IFY_]>[J<&!MUK:<#8;0#Y;2&D'(&(81,J$5.O'4V
M_@<"1LYAM%+KO)6,.P#(X=6>-VS3R7T19F_"%WPQKV\X$V]+*8F1^++EH)B+
M-6M/@K Y1LZT+:>?:W, '^/"]0A8-:OH;:3C#G#^GES&Q;2ZCVOC_W,V72W)
MZ_@#-^-"5,Q*HP99''FU13+B0T;(5C+%ZX('V?I!X%&".D_V#HZ7^5#*&W]3
M8YDOOH19PFM.WBTOEU><!.V1>6'(OBLG,BGP-M9:E&),B#[%N\W$#ZUB?.13
M.L]9G@I;C=71P1&W=F>NG)O7UWOY0DE*>+()IC5Y-KPF3PQ*0"TYBB1,R*T;
M8N\E9&38#>3['2_S#H!S\ O-+]=%7^^"OSTI+&F>?"H9+',%E(B20K.40.CD
M$*U3P723Q3J(PW%O[P:0/-DZ\:/Q\9]A/5=SC)1(&4.B@XHG5J\Y!I%'^J-.
MJ3@9N77=;-S:E[G./=X1$7YZ8SP ;N<S:^1@\=P9R,VYUN0J%%*:)P\QU,X$
M&0*PJ'7A/$@;NAG\LR=OG4<(_PFV> 38GO25N$D&7LNEE&QL9AD<DO^NG)+@
MM!)@:BFH-\EHT<WR]SUY.].ZQ*=DA$> [0F,X/ZE>*[F/-R24'0I!N4=1!5K
MTBV0QR!MA/7XYR)=*:R;)<G[LW>F%8M/R2*/@]Q_@E'>=>*YT;GHD"$[&4 I
M[DB/$H'+K*SCCCGYM&/&_BH?GY)!'@.W<Y\BLKMP[G0ZK)W[%W2B7*]3O:UH
M+HH/*18PCNF:Z8T0@DZ (02N& KI^?E9[#XB&#?^/,OWT\$0]J2CR=W%-RE)
M&V5< BEDW;^F.'BF%.@H?"WX=EQW,\BD(=]/_EEV.,/I\!#8"\7_<4^ZOQ9?
M%%$7(QW%_74D3>)UE&B2P&...A;)C#J?S.6>S#_Y1^$G<!(,B><G[0C\^-+W
M:\'Q;'.R)#//R"6D8"P"B8P.4SI-T48;I.QF76]KYI_\P_03. B&Q/.3/@AN
MS2[^M=1THKB/8P0A5 %5(@,?F(!L=;:B!,_.*/NT#^=/_B7\"1P!@R'Y2=O_
M'K$4$\XH1N)*)E,L95@ %WT-J"QBXG71P/DDNQJ_")SSH_L3L/V!4-STP;YM
MG_0+C+49_#E1-%V]#&EZ,5U-<?DFD#17TV]X>(?TKC^Y16_T05P<V16]1>/K
M^>Q3';=4:;CNHLW<:BVE .T8@M*Y@"^$<7()F2U6::.P\1EW'QW'WA?U&?]M
M^4&LWS>U_S:DS+U%2"J9.LF#@S,\0'!UX#UJ%TKK9]T'B1GWK?5H_=\]WMH(
MO0MO8[Y8;45SW9 9!&<2HX3DN -E9:T+4A*L]2D55$8,L(C^'D)&1DT;)?]T
M,QXK\1YA<]6L)HQ+!E4$5A0GFRH)HA66+F!M7+3*96S?''TO*6,G=XY6\J]@
M<X#$.P .>8-?ZNBI</$ND.=TU8Q(1"H=@P068ZJ>IH&@I0&CG$S:$U.F]3J@
M>PGI##2'J/AN#]_1\NX -%4>-Q'!VI1X$N34HX.<B'C%Z ;WGF4P12I6"H:2
M6B/F9RK&31L-<ST=*>ONT'*KDSK*9%66"@I7'I1T&B)S";1./NED@\;6HX ?
MHF7<@^98'3\*F0,%/O+P@I<7<Q+_[-/[L,(/.)O.%V_F*UR^N,0W\V_K0Y.;
MJMWM6(8<;"Q90A%U41+)CL25(J!!,C2G+.(NPPSV^]2>0'.HEN<G$?G(8-IP
M\^=LB>F2/GG-EOJ;TXQX(X[<%4>)HD]5M .;8P"%Q8$CHP/)BJ=+74N1\@X@
MVNW3QKVKFH-G !%W"!HIK?Z1H9)5XMD4D*8F,S.Y;U$:1;^D@,9($>_>83MC
MYJ</&S<9?A+('"?@#A&C_B:V-N"O./+""?0: 5F@J[WN\W/1!^#9&\TM3SH>
M"IF?/VW<[.F)CIFC1-PA:-@-1]O;ECLNHA<<BG6UF-+6J4/)@0QH*1XM%O.O
MD@N[?]JX:;>3@.9($7<(&OFWS=GY1_C.]2VV4N1.%>?),2..E T"8G(,LE8\
MFE HD#@4.0]\Y+C#J4]S3S40=L<8(H[T%4=6J*R=96"P*%"^3@-(6H.01<BH
ML^7&'PF?FT\;9U/C*,@Y4,0=@D89L6%(F:T5D$L?+-*EJTP"Q3VY:ZX(.DXS
MDXES3>P>ZN'<_;"=(./.&C+'";A#Q,B_;3F26XZ"370XE@ I&@[*Y #!& $8
ML]4RFASO=COL<<S<_;2=,.//&C-'BKB#9^/[GM-?7[=(ENQXI&@1'.;ZD!!=
M7:); (-3N3C.+6O=:OXH0>/&YL.D'MIIH ,XW4F\3>J\?E--C+.Z9<11L!BS
MD>"5UFA<3$*T[JJX0T)_Q10'*O?Q%.=>DNX *+<%,PDA:CH619V$3G(@>B%&
M\NR-2ZP8D3D+0Y9L]9?0; .1@V7< 3Y^O+YK><!$1A>")"DP5*F^45H(@;PS
ME:265N:B6>NSY&<J^KN!VF#E2'EW@)CW^'534+U\6RHW$SKW; Z);F%1GR>1
M&[J4A0 ID-F8 LMW=P UV #P(PWCO@L/AY:C9-T!5GY$.\D&GWV97\[HE,R(
MIN2KB?.*2P;.!@^1:Q.=U"'+UIAYB)9QGX=/==(<*/ON,/1J1C\9EZMU6G]5
M1XN](^^L:NP33B3+"G6)X(2F\].Q#%X[BD +A816:.Y2:_]F=^K&?4<^%<Z:
MZ:<#Y&UYJ=L39TM<'\"%69Z,+%"DLZ ,'<4N\ Q,.,4B2Z4TO^SN(6/<E^7A
ML'2LQ#M=1?E <](?876Y6/_N;;G=0W)KC6CSYJL]/G/ MJQ#.1^R82L&@PD9
M@C6:W'!C.7A,Y%HQ)QDOMI30NKE@B(:M6^M:?BCX7K^?>>-D+,Q#TG4WCY?D
M/DI&IDH\<NU-*LW=KL?HZ;!M:Q\4/++\\CC1=W#WW5/$:TK,ONX%#29F.M@9
M<5"$!Z-B**9H*TKK=4@'%L6?8@_FD1K^=5W\/N+N#C"W\D#&,LY4),+K6Y@*
M=4"*$ $8(T<@<%]D\\VI9U,7OY>.=ZV+WT?@7:93[R]&$2**3*8$27)5G\E$
M]2O)N;16T&$M!+^[L_DDE3^GKXC?2[\'5O[L(^R1,?2/L)C.KQ</,L^\RR07
MINC\53P7.G]+HA S*,,8W>=ZE]:)'WYHI\7MA^+@<(%U>%K<4_F(R6>A#0/.
M# 6@,4=P2B X;X/T2KNLS8$'Q8'%I:>O8F]Y1APIX@Y!P__&MQQMJ]:\+VA-
MK6U<-T\7SR'4&FM3'&,I*B'QT-OEYT_KM(R])6B.%/'_9^]-N]O*C77A7X2^
MF(>/'G/\+L?VM=VY*Y^X,,I,*-(A*:=U?OU;X*"!(J7-36P"[.2LDVYY:.P:
M'@ UH:I!T.PI=62!F3SI%'F-&7!$81O@X!&E07,G.?R?.-$D.1(TYR]C'\(:
MZ2GB)D$C\&8;W%4[>NLCU1[) 'N!YQ8QAGJ!M'=)2J$9VRW". (TNU]KM'B]
M+&A.$G&#H*&_D56UX_:A*G"F-IP)AWD(P$HP(7<;S&D[JQ1RC$GO5#0A]GW^
M</BKC=:QEP11(9$W"";VF]Q]MNH2; 0O+-CX/N9Z:YHK]#D2 JODI;.$D]XG
MT.[7&JUH+WL"G23B!D&SYZUSHEBH( 'W6H'U%KE 5AN&I.-"6DP88UT<ZX+/
MR<]?TEX2-">*N$'0/'WM;"GF1EJ'DA(ZRPMV02[7YK !N//<)>7Z'C2]GI,3
M?-&8.4W"#4(&_Z8$#H\>.P<1#,%>(:KS5$)F(K*8!60"#@);HACIZX@__5HW
MT%QVB/=$&3>(FCU/Y#/\<T0*:15I[L4+1AIS# 61&,Z][[!EO6^G7ET(R.4$
MA >0<8.H(;^9#4<,;TU[8KST%".I>;;22'ZJZCF2-/%$99*Z=^^*IU_KAIK+
M#A6?*.,&44/O7QYN.:+,22*210Q'DAU"CS1U&@5EK!8<!&;ZO@=^^K5NJ+GL
M6/&),FX0->0WC-=W+B-;CQ!8<DY21+CW(##,D Y$(F44Q])'I6E?I_OIU[JA
MYK*#Q2?*N$'4W(>_&=W>N7'E$UH4# ;[/@2-K"4:)0K;0!M+N?8]4?/T:]U0
M<^G1XI-DW"!J^.;T_!9_+M=]#0DPM\W4)JE2L-(B8?-S1"<CT@2\1&DY]I&3
MZ%G?3@3/?K@;EBX[:%Q.\@W":D_+!495$#I?RC87!6%M<T<'D)W5U"MO A.V
M?]RX3U<+<O&!XU-DW"!J^&]DDXSC;)OV#\D$ A:_D01,.6L\L@R,.NH#URYZ
M''>'LA]Q NU^K1MJ+CUR?)*,FT0-7,HK4XYO3T^N.*?2  O8R'PI&V3 WD-&
M,"EEPMB0OD5<3[_6K<#OLF/')\JX1=0\:20E _.,Z82(RO**^?$&B0K< : 8
M/ .E6%]KN5^G+GK9H>/3)-P@9.AO9N,SBFVD(3%J8LP/-F1.NGE.D,V#G!,%
M(::8N_7VS6L^_5HWT%QVY/A$&3?PE&7U;CE+Z./=H]:(A03O4"&V:E$7240N
M)HE,@C\ O]$F7OKMTU,J*L^1'^KMTXGB;@ P1SR!I]A*; U#FC.67_Q89!2!
MK2!(8E%RDO"PC^A.;E$PW..Z$W'0OR_!,4II &YWY^WZ?;Q)8*\1A9(**C<-
M\DCGIJM4^,@I]5+M6LHG(^H1 95/I;*@Z2_:!G"QFF7[\%7S2$1*H@\466%S
MOQ<?D.7<H)A'[P8XF(TK_:;]"1%U7\@4QL=I(FX (YGF3#^L>/UJ&E97>?[Y
MS>S:@83"ID=02-+IX )2/!G$=0Y#">W@EQ('*Q*G/@UP3;U,6=VG,P-<4865
MT1]BLZ6=%(/8FYMYEN>(!!5X"A;1: /8A=PB3;E"PIG B7>"%#^ 'GR^\L#U
M\F#I(]8&#IV'!^:GV=1ON(B.)JQ20F!^@=F%P?]T*F(4O"2<$ V^*"X,COV4
MU'TE4Q@G!83=&S*_XMS-BEFY]AK.P_'_KHVQ#XO%C9WZN&D--9+*4VL$6.HF
MJ<P/B$AB@0*)@249B-2EQRT^3U'=5S+%[>!BPF\"3!_WM"S[&G/L:SR]>CV;
MSV?_AA_>V)_P9\O;D?8!$Y;Y"\ 5=PFO)Q)X&Z(AP*#1H?3)=!2%=5_5E#ZQ
MAE-.$^#;[<0YGO_-3FXB',DB/Z0W2,*-C3@#1HQ,$;$@0B3$8:6'G3)\1TK=
M]S:#!G[ZB;L@;LJV$OPPA1_C=_M'7'RR\SDL]ROV;Q+XW&HEVO]UIK908[^[
M[]TW$KSK[!:)$C$/'8Y.:K"9'<X=*D7.20@LC.+&EK8VGR'G]-ZDFZ7?S*9Y
MS&V<^LV,#(V]X)YC9(U+L'4H15K0@)B13GJ!HU:E#:.#Q-0-*)="P],NI25D
MWX!?=L?(JYOEC]D<+M=55S+L*<-.,W 5\M@W02URF2FG5.0\..U,' I!CRAI
M!#ZGJ?D0>/K+O$GD;#+)S#K*L1'(!D<0#SJ!CR %8BEF'A1<Y:4G&1VBI1'T
MG*#G%Z'30^@-@ >HCHOEV+_)T<WY[?:A$-CMUFJ,9)Z/S+W7R%B!45*.4.54
M"-26MH;W$=(:;/KH>-<B/EG@#:!FY26\FH:/\#<G_]_-?+P(8Y_5LFUDYTD2
M#FYTPJU"8./FAV;@%D:?).7*DLA+VW<OD%0W,SH(DDHJH0%,O9_-X_AJ^GA?
M$!-M(#@33<#W=-S#Z>P=PN V*J<Y(;:T^;./CKIYTT'0<[*X&X#,/JOP/FX1
ML,2!"86T7+]V5<@P!K<]391BR[#8[9(RB//UL8V2L8$MZ),UT "<WJ44?0Z+
MW'&5*Y36G-T <Y]_QOE*7XN1ML1ZKQ@R@03$*1/(I>17':.Q%"::6#HGWYVZ
M1JRFTR$Q.XM^&D#>[]-Y]+.K:<[Q %NOXS2F\7)QQ^>7.+63/*(#KON=N2PC
MS'WD!JQ&A7/^1U!@F@:,O%.<Z.2]3Z6/N1/(;>\0+(/-<VFP<B'_FI^E_2.N
M:7=K/K_D_.1L.DN?XG*S"Z=7'V>+Q1L[G]^FV?S?=AZ^W@EH9*41N9,?LL[#
ME0-LPI7#+8I1*>N%Y7@WV[*WT+\,-8T8=\4@64E/#1RC=[)\]X>]'D]7.MRW
M\5YY/[\!]C#VC$AID*78P"T!OI(V!.QGY3'SWE#*2J>6CR2Q;HG=<,?ED)IJ
M (@']]9B%*7WS@:/O,J=MZ.1R'F"$3?".YP\89$5QMQA:NH6Y0T'KT+R;P!)
M;S>?S=[_8A&7B\.L?;MQ_P#[^/L,[(KQVA >:1*#3!38XYR":>%,C@$Y8#E0
M0P48Q[)\S><I%-<M_QL.D6?48V43L0-CN09DK=/)9/;O7,PV"LI;$3)O+C?I
M9; MK7 6L9"PL)*#+]>EGT6OC]>M%AS& !Q>"PT<CEEHJTJUAPQN"O6%5;FO
MD .+(5<M<0_G/)$4"6:93]K%Q$WAD^\9<NK6" YWK)720*M@VK-'O)$"F!%P
M &/8*+F(S9D8D=!&,A\U$[)T2J(C:74K!\\,LA,UTP#@[J.8X'!/<ZGMBI^O
M\:==SM<_?TZ;-,T[.\\%N*O IK<D<&1<?CI I #?7'@DJ991.9!Q*CW!L0^=
ME3N G\%Q'4II#0#S]VD8+X ;=[.,8<O$'5=@/RS&86SGX*F/\J0QEZQ#,:<A
M.0YYCA06B!@2E%+$!E$:CMVIJ]Q1?,A@\R *:@)Z!\+HZW#0Y^F#*N9M^-SY
MW&D+3GR!)4C28(^L)_GLYY1JBV7PI<O<>I!9N5%YA<Q'(94U@,H#AS[\QK>X
M7$Y6[R46(Z-8<%3IW.>6(.XUA9\21N"GDYS)P4&4'NC>B;#*S<[/?A>?H)8F
MLFNKJ/AJGVSVTB.&OL9)M(OX.6U"X]M]-G+:TL 415[&D'N<,N2B!IE2:YWE
MU-%.0X%.H:%R@_0A4VEG4,KQX#-K\$WC56ZB\WT'@X,]=MIVGYJEQQMOEG[_
MEHL2;P#AMX]J-):S-[/KGW9ZN]A?PY%UN:^.H\AKJO.36_BY5F5YG^$]&,$L
M:FDHBH9RV!S"(&VC1$%:RZ10B?G22;$!WX/ME_ECW;U:OH]P'-K)?@6.B/?*
M2YJ050XDXG-17@H166NU)DK!>56ZJJ< V8U4GIV(L&YU9\/ILP&+MPO+C^K/
M'QQ7(R(L$2IW;Q/,(!Y2@CM7<T2UP#8EYGPL'10XA=Y&2M(J@+:(!B\$K9O@
MR*._\78,_V%6TMA.1CYJ8(^Y7"T*/*=<8A*<080[$QP'B\V4#B.4H+N1ZK4*
MZ"VJT<J>WQ'\;N-]#T/.F_Z9(V54,-1J1(V%S2M-0H;"52-CQ$H(0XQ7'7S
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M*PW207*D5& 2XT0P*7WF-7G(#>6/E)#[)66"[XO8QP].[%6EY^+-[/KG?+R
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M>1:D22XAH1T#QS\0:0<_Z.[)J9Q?/O]!UE,3+8+JZ9F<Y0G_WFZA;2/Y;S]
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M\7)!Q6#GL>6&0T+[SLZ@5V\^1T**B6)KD4RYFLY0\ VM=<@Y&H11"F[?TH.
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M_5)":7]%\5_CM8OS48S2!$L%DM&R?/RKW,X5+%G8B90*Z4@L'10H1'I=>!8
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MC=$2RFOR(-V)P[X#RW%VFYL6!:.I]\")\@EQ!G:SU9X!EH0PX% RIH<OY#A
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MY6=\?AG#B!)IDC1PK>/@\]-4CV#7422D3)88[D&0 Z&K$X%-U8^515MY!36
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M8[Y3+=E=2,-=A-B@VO\VGDU68OZ<_F=V'=_DM]+SVX_VWT/H_MF/U4N<ET1
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M<'1I;VYA=V%R9&PN:'1M4$L! A0#%     @ XUU,6BC10X^=EP  2[T# !X
M             ( !;Z$  &5X,3!I:3(P,C5R<W5A=V%R9&QE='1E<F%N+FAT
M;5!+ 0(4 Q0    ( .-=3%H, M# AZ(  -I !  >              "  4@Y
M 0!E>#$P:6EI,C R-7!S=6%W87)D;&5T=&5R82YH=&U02P$"% ,4    " #C
M74Q:*"T1\?N3  "[L0, '@              @ $+W $ 97@Q,&EV,C R-6YO
M<F5R<W5A=V%R9&QE='0N:'1M4$L! A0#%     @ XUU,6@=Q[$37"0  Q2<
M !X              ( !0G " &5X,3!X>'AI=')A;G-I=&EO;F%G<F5E;65N
M+FAT;5!+ 0(4 Q0    ( .-=3%HPP3UX!0@  #T2   <              "
M 55Z @!E>#$Y:6-O<G!O<F%T97!O;&EC>39?87,N:'1M4$L! A0#%     @
MXUU,6L/5"Y"U%@  ?T4  !P              ( !E((" &5X,3EI:6EN<VED
M97)T<F%D:6YG9W5I9"YH=&U02P$"% ,4    " #C74Q:>1*3+2T/  "@6 $
M%               @ &#F0( 97@R,6DQ,C,Q,C R-#$P:RYH=&U02P$"% ,4
M    " #C74Q:6%(\VXL#   -$@  %               @ 'BJ ( 97@R,VDQ
M,C,Q,C R-#$P:RYH=&U02P$"% ,4    " #C74Q:]+7)X]8'   _(P  %
M            @ &?K ( 97@S,6DQ,C,Q,C R-#$P:RYH=&U02P$"% ,4
M" #C74Q:81'@7M,'   !(P  %0              @ &GM ( 97@S,6EI,3(S
M,3(P,C0Q,&LN:'1M4$L! A0#%     @ XUU,6AXQ= "0!   V!,  !0
M         ( !K;P" &5X,S)I,3(S,3(P,C0Q,&LN:'1M4$L! A0#%     @
MXUU,6N37HL^*!   [1,  !4              ( !;\$" &5X,S)I:3$R,S$R
M,#(T,3!K+FAT;5!+ 0(4 Q0    ( .-=3%H<D2%4,/4  ..-!0 5
M      "  2S& @!E>#1X>'8Q,C,Q,C R-#$P:RYH=&U02P$"% ,4    " #C
M74Q:[).JS ;' @!M_"H $               @ &/NP, <WEK+3(P,C0Q,C,Q
M+FAT;5!+ 0(4 Q0    ( .-=3%K@GUT1SA<  +H/ 0 0              "
M <."!@!S>6LM,C R-#$R,S$N>'-D4$L! A0#%     @ XUU,6F.Z_E,2+0
M$M$! !0              ( !OYH& '-Y:RTR,#(T,3(S,5]C86PN>&UL4$L!
M A0#%     @ XUU,6KAS5#HFA   @<X% !0              ( ! \@& '-Y
M:RTR,#(T,3(S,5]D968N>&UL4$L! A0#%     @ XUU,6C'('F<D;@  A+0
M !,              ( !6TP' '-Y:RTR,#(T,3(S,5]G,2YJ<&=02P$"% ,4
M    " #C74Q:A/6WNICD   N!P$ $P              @ &PN@< <WEK+3(P
M,C0Q,C,Q7V<R+FIP9U!+ 0(4 Q0    ( .-=3%H1#8DH4,T  *_X   3
M          "  7F?" !S>6LM,C R-#$R,S%?9S,N:G!G4$L! A0#%     @
MXUU,6GI$JP!KGP$ #240 !0              ( !^FP) '-Y:RTR,#(T,3(S
M,5]L86(N>&UL4$L! A0#%     @ XUU,6N=8@">&\0  7D<+ !0
M     ( !EPP+ '-Y:RTR,#(T,3(S,5]P<F4N>&UL4$L%!@     7 !< * 8
' $_^"P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>syk-20241231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2024"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:syk="http://www.stryker.com/20241231"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="syk-20241231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes2.125Due2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes3375Due2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes2.625Due2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes3.375Due2032Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes3.625Due2036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialInterventionalSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialInterventionalSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialInterventionalSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopedicsEnablingTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopedicsEnablingTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopedicsEnablingTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:CerusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:CerusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-02</startDate>
            <endDate>2023-05-02</endDate>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:CerusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-02</instant>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:CerusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-02</instant>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">syk:CustomerAndDistributorRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:CerusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">syk:CustomerAndDistributorRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-02</instant>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:CerusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-02</instant>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:CerusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-02</instant>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:CerusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-02</startDate>
            <endDate>2023-05-02</endDate>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VariousMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">syk:RecallMattersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">syk:RecallMattersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">syk:SpineReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">syk:SpinalImplantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">syk:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375DueMay152024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="c-331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375DueMay152024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="c-332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.250Due2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4625Due2046Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.625Due2036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:FloatingRateSeniorNotesDueNovember162024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="c-337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.250Due2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="c-338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.250Due2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="c-339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375DueMay152024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375DueMay152024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:VariousMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:VariousMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.250Due2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.250Due2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.150Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.150Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.500Due2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.500Due2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.125DueNovember2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.125DueNovember2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.650Due2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.650Due2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.850Due2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.850Due2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3375Due2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3375Due2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.250Due2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.950Due2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.950Due2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.625Due2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.625Due2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375Due2032Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375Due2032Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.625DueSeptember112034Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.625DueSeptember112034Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.625Due2036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.100Due2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.100Due2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.375due2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.375due2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4625Due2046Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.900due2050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.900due2050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">syk:AccruedCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">syk:AccruedCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-434">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-435">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-436">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-438">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-441">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-442">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-444">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-446">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-447">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-449">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-450">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-451">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-455">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-460">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-461">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-462">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-463">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-464">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-465">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-466">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-467">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-468">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-469">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-470">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-471">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-472">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-473">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-474">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">syk:LongLivedAssetsAndIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-475">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">syk:LongLivedAssetsAndIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-476">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">syk:LongLivedAssetsAndIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-477">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">syk:SpinalImplantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">syk:SpinalImplantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-479">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:InariMedicalInc.MergerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-480">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:InariMedicalInc.MergerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c-481">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.550DueFebruary102027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-12</instant>
        </period>
    </context>
    <context id="c-482">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.700DueFebruary102028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-12</instant>
        </period>
    </context>
    <context id="c-483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.850DueFebruary102030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-12</instant>
        </period>
    </context>
    <context id="c-484">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes5.200DueFebruary282035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-12</instant>
        </period>
    </context>
    <context id="c-485">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-486">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-487">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-488">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-490">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-491">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="segment">
        <measure>syk:segment</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-54">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-55">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-56">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-57">0000310764</dei:EntityCentralIndexKey>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="-6" id="f-131" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-13" decimals="-6" id="f-132" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-45" id="f-409">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-47" id="f-411">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-49" id="f-414">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-52" decimals="4" id="f-425" unitRef="number">0.3333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-14" id="f-816">http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-15" id="f-817">http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-14" id="f-820">http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-15" id="f-821">http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-15" id="f-824">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-14" id="f-825">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration contextRef="c-14" id="f-856">http://fasb.org/us-gaap/2024#AccountsPayableTradeCurrent</us-gaap:SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration contextRef="c-15" id="f-857">http://fasb.org/us-gaap/2024#AccountsPayableTradeCurrent</us-gaap:SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration contextRef="c-14" id="f-858">http://fasb.org/us-gaap/2024#AccountsPayableTradeCurrent</us-gaap:SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-4">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-13149</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">STRYKER CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">MI</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">38-1239739</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">1941 Stryker Way,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">Portage,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">MI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">49002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">(269)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">385-2600</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-2" id="f-16">Common Stock, $.10 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-2" id="f-17">SYK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-2" id="f-18">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-3" id="f-19">2.125% Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-3" id="f-20">SYK27</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-3" id="f-21">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-4" id="f-22">3.375% Notes due 2028</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-4" id="f-23">SYK28</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-4" id="f-24">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-5" id="f-25">0.750% Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-5" id="f-26">SYK29</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-5" id="f-27">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-6" id="f-28">2.625% Notes due 2030</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-6" id="f-29">SYK30</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-6" id="f-30">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-7" id="f-31">1.000% Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-7" id="f-32">SYK31</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-7" id="f-33">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-8" id="f-34">3.375% Notes due 2032</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-8" id="f-35">SYK32</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-8" id="f-36">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-9" id="f-37">3.625% Notes due 2036</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-9" id="f-38">SYK36</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-9" id="f-39">NYSE</dei:SecurityExchangeName>
    <dei:Security12gTitle contextRef="c-1" id="f-40">None</dei:Security12gTitle>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-41">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-42">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-43">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-44">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-45">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-46">false</dei:EntityEmergingGrowthCompany>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-47">false</dei:EntitySmallBusiness>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-48">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-49">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-50">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-10" decimals="0" id="f-51" unitRef="usd">123147898554</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-11" decimals="INF" id="f-52" unitRef="shares">381579123</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-53">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;Portions of the proxy statement to be filed with the U.S. Securities and Exchange Commission relating to the 2025 Annual Meeting of Shareholders (the 2025 proxy statement) are incorporated by reference into Part III.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId contextRef="c-1" id="f-58">42</dei:AuditorFirmId>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c-1" id="f-59">We review cybersecurity risk as part of our overall enterprise risk management program. This ensures that cybersecurity risk management remains a top priority in our business strategy and operations.</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c-1" id="f-60">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="c-1" id="f-61">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Primary management responsibility for assessing, monitoring and managing our cybersecurity risks rests with our chief information security officer ("CISO"). Our current CISO has over 30 years of experience in information technology including over 20 years in cybersecurity and oversees a team of cybersecurity professionals with over 140 security, risk, and compliance certifications. The CISO is regularly informed about recent developments in cybersecurity, including potential threats and innovative risk management techniques. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The CISO implements and oversees processes for the regular monitoring of our information systems. We use various tools and methodologies to manage cybersecurity risk that are tested regularly. We also monitor and evaluate our cybersecurity posture and performance on an ongoing basis through regular vulnerability scans, penetration tests and threat intelligence feeds. In addition, we engage third-party consultants to conduct annual cybersecurity assessments and to conduct audits for compliance with regulatory, Sarbanes-Oxley Act, Service Organization Control Type 2 and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;International Organization for Standardization standards. We also engage third parties to assess our cybersecurity maturity and risk management programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We use a cross-departmental approach to addressing cybersecurity risk, with our cybersecurity, product security and legal teams presenting quarterly on key topics to a committee of leaders in finance, regulatory, and corporate affairs functions. This leadership committee meets quarterly to ensure that we have input and oversight from critical stakeholders into our cybersecurity program and evolving issues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The CISO oversees a training and awareness program for employees to take part in protecting the Company against cybersecurity risks. We have implemented annual mandatory security education to help employees understand cybersecurity risks and comply with our cybersecurity policies. Additionally, we provide frequent communications around pertinent cybersecurity topics and policies to all employees. We also provide additional &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;cybersecurity and data protection training to employees in certain roles. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As part of our cybersecurity risk management program, we also conduct cybersecurity and privacy assessments on all third parties who integrate with Stryker&#x2019;s data, network, systems and products. We use a combination of internal and external tools to confirm that these third parties meet our security requirements. We leverage standard industry threat model and privacy impact assessment concepts to confirm that data minimization and adequate data protections are in place. We perform supplemental reviews as necessary, commensurate with the risk associated with each vendor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In the event of a cybersecurity incident, we have an incident response plan that includes immediate actions to mitigate the impact and long-term strategies for remediation and prevention of future incidents. The cybersecurity and product security teams routinely practice this plan with functions across the organization. We conduct tabletop exercises with senior management, during which we practice the procedures in place to ensure that potentially material cybersecurity risks and incidents are escalated to management and the Board of Directors where applicable.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c-1" id="f-63">Primary management responsibility for assessing, monitoring and managing our cybersecurity risks rests with our chief information security officer ("CISO"). Our current CISO has over 30 years of experience in information technology including over 20 years in cybersecurity and oversees a team of cybersecurity professionals with over 140 security, risk, and compliance certifications. The CISO is regularly informed about recent developments in cybersecurity, including potential threats and innovative risk management techniques.</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-62">Primary management responsibility for assessing, monitoring and managing our cybersecurity risks rests with our chief information security officer ("CISO")</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="c-1" id="f-64">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock contextRef="c-1" id="f-65">Our current CISO has over 30 years of experience in information technology including over 20 years in cybersecurity and oversees a team of cybersecurity professionals with over 140 security, risk, and compliance certifications. The CISO is regularly informed about recent developments in cybersecurity, including potential threats and innovative risk management techniques.</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c-1" id="f-66">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-67">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The CISO oversees a training and awareness program for employees to take part in protecting the Company against cybersecurity risks. We have implemented annual mandatory security education to help employees understand cybersecurity risks and comply with our cybersecurity policies. Additionally, we provide frequent communications around pertinent cybersecurity topics and policies to all employees. We also provide additional &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;cybersecurity and data protection training to employees in certain roles. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As part of our cybersecurity risk management program, we also conduct cybersecurity and privacy assessments on all third parties who integrate with Stryker&#x2019;s data, network, systems and products. We use a combination of internal and external tools to confirm that these third parties meet our security requirements. We leverage standard industry threat model and privacy impact assessment concepts to confirm that data minimization and adequate data protections are in place. We perform supplemental reviews as necessary, commensurate with the risk associated with each vendor.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c-1" id="f-68">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-70">Cybersecurity risks are overseen by the full Board of Directors and the Audit Committee. The Audit Committee is central to the Board of Directors&#x2019; oversight of cybersecurity risks and bears the primary responsibility for overseeing cybersecurity risk. The Audit Committee actively participates in strategic decisions related to cybersecurity, offering guidance and approval for major cybersecurity initiatives. This involvement ensures that cybersecurity considerations are integrated into our broader strategic objectives.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c-1" id="f-69">Cybersecurity risks are overseen by the full Board of Directors and the Audit Committee. The Audit Committee is central to the Board of Directors&#x2019; oversight of cybersecurity risks and bears the primary responsibility for overseeing cybersecurity risk. The Audit Committee actively participates in strategic decisions related to cybersecurity, offering guidance and approval for major cybersecurity initiatives. This involvement ensures that cybersecurity considerations are integrated into our broader strategic objectives.</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-71">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our CISO provides comprehensive updates to the Audit Committee quarterly and the full Board of Directors periodically. These briefings include a range of topics, including:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt"&gt;Current cybersecurity landscape and emerging threats&#x37e;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt"&gt;Status of ongoing cybersecurity initiatives and strategies&#x37e;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt"&gt;Incident reports and learnings from any cybersecurity events&#x37e; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt"&gt;Metrics demonstrating company and industry-standard prevention of common threats; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt"&gt;Regulatory changes impacting cybersecurity requirements and strategy.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c-1" id="f-72">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c-1" id="f-73">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <dei:AuditorName contextRef="c-1" id="f-74">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-75">Grand Rapids, Michigan</dei:AuditorLocation>
    <us-gaap:Revenues contextRef="c-1" decimals="-6" id="f-76" unitRef="usd">22595000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-12" decimals="-6" id="f-77" unitRef="usd">20498000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-13" decimals="-6" id="f-78" unitRef="usd">18449000000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue contextRef="c-1" decimals="-6" id="f-79" unitRef="usd">8155000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-12" decimals="-6" id="f-80" unitRef="usd">7440000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-13" decimals="-6" id="f-81" unitRef="usd">6871000000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-6" id="f-82" unitRef="usd">14440000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-12" decimals="-6" id="f-83" unitRef="usd">13058000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-13" decimals="-6" id="f-84" unitRef="usd">11578000000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-6" id="f-85" unitRef="usd">1466000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-12" decimals="-6" id="f-86" unitRef="usd">1388000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-13" decimals="-6" id="f-87" unitRef="usd">1454000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-6" id="f-88" unitRef="usd">7685000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-12" decimals="-6" id="f-89" unitRef="usd">7111000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-13" decimals="-6" id="f-90" unitRef="usd">6386000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-6" id="f-91" unitRef="usd">623000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-12" decimals="-6" id="f-92" unitRef="usd">635000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-13" decimals="-6" id="f-93" unitRef="usd">627000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AssetImpairmentCharges contextRef="c-1" decimals="-6" id="f-94" unitRef="usd">977000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-12" decimals="-6" id="f-95" unitRef="usd">36000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-13" decimals="-6" id="f-96" unitRef="usd">270000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-6" id="f-97" unitRef="usd">10751000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-12" decimals="-6" id="f-98" unitRef="usd">9170000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-13" decimals="-6" id="f-99" unitRef="usd">8737000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-6" id="f-100" unitRef="usd">3689000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-12" decimals="-6" id="f-101" unitRef="usd">3888000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-13" decimals="-6" id="f-102" unitRef="usd">2841000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-6" id="f-103" unitRef="usd">-197000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-12" decimals="-6" id="f-104" unitRef="usd">-215000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-13" decimals="-6" id="f-105" unitRef="usd">-158000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-106" unitRef="usd">3492000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-12" decimals="-6" id="f-107" unitRef="usd">3673000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-13" decimals="-6" id="f-108" unitRef="usd">2683000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-109" unitRef="usd">499000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-110" unitRef="usd">508000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-111" unitRef="usd">325000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-6" id="f-112" unitRef="usd">2993000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-12" decimals="-6" id="f-113" unitRef="usd">3165000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-6" id="f-114" unitRef="usd">2358000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-115"
      unitRef="usdPerShare">7.86</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-12"
      decimals="2"
      id="f-116"
      unitRef="usdPerShare">8.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-13"
      decimals="2"
      id="f-117"
      unitRef="usdPerShare">6.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-118"
      unitRef="usdPerShare">7.76</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-12"
      decimals="2"
      id="f-119"
      unitRef="usdPerShare">8.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-13"
      decimals="2"
      id="f-120"
      unitRef="usdPerShare">6.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-121" unitRef="shares">381000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-12" decimals="-5" id="f-122" unitRef="shares">379600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-13" decimals="-5" id="f-123" unitRef="shares">378200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c-1" decimals="-5" id="f-124" unitRef="shares">4600000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c-12" decimals="-5" id="f-125" unitRef="shares">4100000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c-13" decimals="-5" id="f-126" unitRef="shares">4000000.0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-127" unitRef="shares">385600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-12" decimals="-5" id="f-128" unitRef="shares">383700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-13" decimals="-5" id="f-129" unitRef="shares">382200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-12" decimals="-5" id="f-130" unitRef="shares">4300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-6" id="f-133" unitRef="usd">2993000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-12" decimals="-6" id="f-134" unitRef="usd">3165000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-6" id="f-135" unitRef="usd">2358000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-6" id="f-136" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-12" decimals="-6" id="f-137" unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-13" decimals="-6" id="f-138" unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-1" decimals="-6" id="f-139" unitRef="usd">-32000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-12" decimals="-6" id="f-140" unitRef="usd">59000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-13" decimals="-6" id="f-141" unitRef="usd">-186000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-1" decimals="-6" id="f-142" unitRef="usd">-8000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-12" decimals="-6" id="f-143" unitRef="usd">-13000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-13" decimals="-6" id="f-144" unitRef="usd">12000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-6" id="f-145" unitRef="usd">99000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-12" decimals="-6" id="f-146" unitRef="usd">-124000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-13" decimals="-6" id="f-147" unitRef="usd">113000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="-6" id="f-148" unitRef="usd">123000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-12" decimals="-6" id="f-149" unitRef="usd">-195000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-13" decimals="-6" id="f-150" unitRef="usd">310000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-6" id="f-151" unitRef="usd">3116000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-12" decimals="-6" id="f-152" unitRef="usd">2970000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-13" decimals="-6" id="f-153" unitRef="usd">2668000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-14" decimals="-6" id="f-154" unitRef="usd">3652000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-15" decimals="-6" id="f-155" unitRef="usd">2971000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:OtherShortTermInvestments contextRef="c-14" decimals="-6" id="f-156" unitRef="usd">750000000</us-gaap:OtherShortTermInvestments>
    <us-gaap:OtherShortTermInvestments contextRef="c-15" decimals="-6" id="f-157" unitRef="usd">0</us-gaap:OtherShortTermInvestments>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-14" decimals="-6" id="f-158" unitRef="usd">91000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-15" decimals="-6" id="f-159" unitRef="usd">82000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-14" decimals="-6" id="f-160" unitRef="usd">213000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-15" decimals="-6" id="f-161" unitRef="usd">182000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-14" decimals="-6" id="f-162" unitRef="usd">3987000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-15" decimals="-6" id="f-163" unitRef="usd">3765000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves contextRef="c-14" decimals="-6" id="f-164" unitRef="usd">1147000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves contextRef="c-15" decimals="-6" id="f-165" unitRef="usd">1242000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-14" decimals="-6" id="f-166" unitRef="usd">336000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-15" decimals="-6" id="f-167" unitRef="usd">330000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-14" decimals="-6" id="f-168" unitRef="usd">3291000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-15" decimals="-6" id="f-169" unitRef="usd">3271000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet contextRef="c-14" decimals="-6" id="f-170" unitRef="usd">4774000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-15" decimals="-6" id="f-171" unitRef="usd">4843000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-14" decimals="-6" id="f-172" unitRef="usd">1593000000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-15" decimals="-6" id="f-173" unitRef="usd">857000000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent contextRef="c-14" decimals="-6" id="f-174" unitRef="usd">14847000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-15" decimals="-6" id="f-175" unitRef="usd">12518000000</us-gaap:AssetsCurrent>
    <syk:LandBuildingsAndImprovementsGross contextRef="c-14" decimals="-6" id="f-176" unitRef="usd">1627000000</syk:LandBuildingsAndImprovementsGross>
    <syk:LandBuildingsAndImprovementsGross contextRef="c-15" decimals="-6" id="f-177" unitRef="usd">1692000000</syk:LandBuildingsAndImprovementsGross>
    <us-gaap:MachineryAndEquipmentGross contextRef="c-14" decimals="-6" id="f-178" unitRef="usd">5056000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross contextRef="c-15" decimals="-6" id="f-179" unitRef="usd">4652000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-14" decimals="-6" id="f-180" unitRef="usd">6683000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-15" decimals="-6" id="f-181" unitRef="usd">6344000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-14" decimals="-6" id="f-182" unitRef="usd">3235000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-15" decimals="-6" id="f-183" unitRef="usd">3129000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-14" decimals="-6" id="f-184" unitRef="usd">3448000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-15" decimals="-6" id="f-185" unitRef="usd">3215000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill contextRef="c-14" decimals="-6" id="f-186" unitRef="usd">15855000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-15" decimals="-6" id="f-187" unitRef="usd">15243000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-14" decimals="-6" id="f-188" unitRef="usd">4395000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-15" decimals="-6" id="f-189" unitRef="usd">4593000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-14" decimals="-6" id="f-190" unitRef="usd">1742000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-15" decimals="-6" id="f-191" unitRef="usd">1670000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-14" decimals="-6" id="f-192" unitRef="usd">2684000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-15" decimals="-6" id="f-193" unitRef="usd">2673000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-14" decimals="-6" id="f-194" unitRef="usd">42971000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-15" decimals="-6" id="f-195" unitRef="usd">39912000000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c-14" decimals="-6" id="f-196" unitRef="usd">1679000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c-15" decimals="-6" id="f-197" unitRef="usd">1517000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-14" decimals="-6" id="f-198" unitRef="usd">1403000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-15" decimals="-6" id="f-199" unitRef="usd">1478000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-14" decimals="-6" id="f-200" unitRef="usd">539000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-15" decimals="-6" id="f-201" unitRef="usd">391000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="c-14" decimals="-6" id="f-202" unitRef="usd">320000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="c-15" decimals="-6" id="f-203" unitRef="usd">304000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-14" decimals="-6" id="f-204" unitRef="usd">2266000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-15" decimals="-6" id="f-205" unitRef="usd">2137000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DebtCurrent contextRef="c-14" decimals="-6" id="f-206" unitRef="usd">1409000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent contextRef="c-15" decimals="-6" id="f-207" unitRef="usd">2094000000</us-gaap:DebtCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-14" decimals="-6" id="f-208" unitRef="usd">7616000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-15" decimals="-6" id="f-209" unitRef="usd">7921000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-14" decimals="-6" id="f-210" unitRef="usd">12188000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-15" decimals="-6" id="f-211" unitRef="usd">10901000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent contextRef="c-14" decimals="-6" id="f-212" unitRef="usd">349000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent contextRef="c-15" decimals="-6" id="f-213" unitRef="usd">567000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-14" decimals="-6" id="f-214" unitRef="usd">2184000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-15" decimals="-6" id="f-215" unitRef="usd">1930000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-14" decimals="-6" id="f-216" unitRef="usd">22337000000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-15" decimals="-6" id="f-217" unitRef="usd">21319000000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-15"
      decimals="INF"
      id="f-218"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-14"
      decimals="INF"
      id="f-219"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockValueOutstanding contextRef="c-14" decimals="-6" id="f-220" unitRef="usd">38000000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding contextRef="c-15" decimals="-6" id="f-221" unitRef="usd">38000000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-14" decimals="-6" id="f-222" unitRef="usd">2361000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-15" decimals="-6" id="f-223" unitRef="usd">2200000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-14" decimals="-6" id="f-224" unitRef="usd">18528000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-15" decimals="-6" id="f-225" unitRef="usd">16771000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-14" decimals="-6" id="f-226" unitRef="usd">-293000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-15" decimals="-6" id="f-227" unitRef="usd">-416000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-14" decimals="-6" id="f-228" unitRef="usd">20634000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-15" decimals="-6" id="f-229" unitRef="usd">18593000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-14" decimals="-6" id="f-230" unitRef="usd">42971000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-15" decimals="-6" id="f-231" unitRef="usd">39912000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-16" decimals="-5" id="f-232" unitRef="shares">380100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-16" decimals="-6" id="f-233" unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-17" decimals="-5" id="f-234" unitRef="shares">378700000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-17" decimals="-6" id="f-235" unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-18" decimals="-5" id="f-236" unitRef="shares">377500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-18" decimals="-6" id="f-237" unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-19" decimals="-5" id="f-238" unitRef="shares">1300000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-19" decimals="-6" id="f-239" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-20" decimals="-5" id="f-240" unitRef="shares">1400000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-20" decimals="-6" id="f-241" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-21" decimals="-5" id="f-242" unitRef="shares">1200000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-21" decimals="-6" id="f-243" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-22" decimals="-5" id="f-244" unitRef="shares">381400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-22" decimals="-6" id="f-245" unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-16" decimals="-5" id="f-246" unitRef="shares">380100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-16" decimals="-6" id="f-247" unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-17" decimals="-5" id="f-248" unitRef="shares">378700000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-17" decimals="-6" id="f-249" unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-23" decimals="-6" id="f-250" unitRef="usd">2200000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-24" decimals="-6" id="f-251" unitRef="usd">2034000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-25" decimals="-6" id="f-252" unitRef="usd">1890000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-26" decimals="-6" id="f-253" unitRef="usd">-68000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-27" decimals="-6" id="f-254" unitRef="usd">-39000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-28" decimals="-6" id="f-255" unitRef="usd">-24000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-26" decimals="-6" id="f-256" unitRef="usd">229000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-27" decimals="-6" id="f-257" unitRef="usd">205000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-28" decimals="-6" id="f-258" unitRef="usd">168000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-29" decimals="-6" id="f-259" unitRef="usd">2361000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-23" decimals="-6" id="f-260" unitRef="usd">2200000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-24" decimals="-6" id="f-261" unitRef="usd">2034000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-30" decimals="-6" id="f-262" unitRef="usd">16771000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-31" decimals="-6" id="f-263" unitRef="usd">14765000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-32" decimals="-6" id="f-264" unitRef="usd">13480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-33" decimals="-6" id="f-265" unitRef="usd">2993000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-34" decimals="-6" id="f-266" unitRef="usd">3165000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-35" decimals="-6" id="f-267" unitRef="usd">2358000000</us-gaap:NetIncomeLoss>
    <us-gaap:DividendsCash contextRef="c-33" decimals="-6" id="f-268" unitRef="usd">1236000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash contextRef="c-34" decimals="-6" id="f-269" unitRef="usd">1159000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash contextRef="c-35" decimals="-6" id="f-270" unitRef="usd">1073000000</us-gaap:DividendsCash>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-36" decimals="-6" id="f-271" unitRef="usd">18528000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-30" decimals="-6" id="f-272" unitRef="usd">16771000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-31" decimals="-6" id="f-273" unitRef="usd">14765000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-37" decimals="-6" id="f-274" unitRef="usd">-416000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-38" decimals="-6" id="f-275" unitRef="usd">-221000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-39" decimals="-6" id="f-276" unitRef="usd">-531000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="-6" id="f-277" unitRef="usd">123000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-40" decimals="-6" id="f-278" unitRef="usd">-195000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-41" decimals="-6" id="f-279" unitRef="usd">310000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-42" decimals="-6" id="f-280" unitRef="usd">-293000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-37" decimals="-6" id="f-281" unitRef="usd">-416000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-38" decimals="-6" id="f-282" unitRef="usd">-221000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-14" decimals="-6" id="f-283" unitRef="usd">20634000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-15" decimals="-6" id="f-284" unitRef="usd">18593000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-43" decimals="-6" id="f-285" unitRef="usd">16616000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-6" id="f-286" unitRef="usd">2993000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-12" decimals="-6" id="f-287" unitRef="usd">3165000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-6" id="f-288" unitRef="usd">2358000000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation contextRef="c-1" decimals="-6" id="f-289" unitRef="usd">427000000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-12" decimals="-6" id="f-290" unitRef="usd">393000000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-13" decimals="-6" id="f-291" unitRef="usd">371000000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization contextRef="c-1" decimals="-6" id="f-292" unitRef="usd">623000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c-12" decimals="-6" id="f-293" unitRef="usd">635000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c-13" decimals="-6" id="f-294" unitRef="usd">627000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AssetImpairmentCharges contextRef="c-1" decimals="-6" id="f-295" unitRef="usd">977000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-12" decimals="-6" id="f-296" unitRef="usd">36000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-13" decimals="-6" id="f-297" unitRef="usd">270000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-6" id="f-298" unitRef="usd">229000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-12" decimals="-6" id="f-299" unitRef="usd">205000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-13" decimals="-6" id="f-300" unitRef="usd">168000000</us-gaap:ShareBasedCompensation>
    <syk:InventorySteppedUpToFairValueAtAcquisition contextRef="c-1" decimals="-6" id="f-301" unitRef="usd">46000000</syk:InventorySteppedUpToFairValueAtAcquisition>
    <syk:InventorySteppedUpToFairValueAtAcquisition contextRef="c-12" decimals="-6" id="f-302" unitRef="usd">0</syk:InventorySteppedUpToFairValueAtAcquisition>
    <syk:InventorySteppedUpToFairValueAtAcquisition contextRef="c-13" decimals="-6" id="f-303" unitRef="usd">12000000</syk:InventorySteppedUpToFairValueAtAcquisition>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-304" unitRef="usd">-370000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-305" unitRef="usd">-206000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-306" unitRef="usd">58000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-6" id="f-307" unitRef="usd">321000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-12" decimals="-6" id="f-308" unitRef="usd">175000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-13" decimals="-6" id="f-309" unitRef="usd">579000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-6" id="f-310" unitRef="usd">206000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-12" decimals="-6" id="f-311" unitRef="usd">797000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-13" decimals="-6" id="f-312" unitRef="usd">762000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c-1" decimals="-6" id="f-313" unitRef="usd">192000000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c-12" decimals="-6" id="f-314" unitRef="usd">77000000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c-13" decimals="-6" id="f-315" unitRef="usd">290000000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-1" decimals="-6" id="f-316" unitRef="usd">74000000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-12" decimals="-6" id="f-317" unitRef="usd">516000000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-13" decimals="-6" id="f-318" unitRef="usd">156000000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-1" decimals="-6" id="f-319" unitRef="usd">-116000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-12" decimals="-6" id="f-320" unitRef="usd">-4000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-13" decimals="-6" id="f-321" unitRef="usd">-238000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="c-1" decimals="-6" id="f-322" unitRef="usd">306000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="c-12" decimals="-6" id="f-323" unitRef="usd">134000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="c-13" decimals="-6" id="f-324" unitRef="usd">107000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-6" id="f-325" unitRef="usd">4242000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-12" decimals="-6" id="f-326" unitRef="usd">3711000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-13" decimals="-6" id="f-327" unitRef="usd">2624000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-1" decimals="-6" id="f-328" unitRef="usd">1628000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-12" decimals="-6" id="f-329" unitRef="usd">390000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-13" decimals="-6" id="f-330" unitRef="usd">2563000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c-1" decimals="-6" id="f-331" unitRef="usd">750000000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c-12" decimals="-6" id="f-332" unitRef="usd">0</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c-13" decimals="-6" id="f-333" unitRef="usd">0</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-1" decimals="-6" id="f-334" unitRef="usd">58000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-12" decimals="-6" id="f-335" unitRef="usd">52000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-13" decimals="-6" id="f-336" unitRef="usd">52000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-1" decimals="-6" id="f-337" unitRef="usd">49000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-12" decimals="-6" id="f-338" unitRef="usd">54000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-13" decimals="-6" id="f-339" unitRef="usd">43000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-6" id="f-340" unitRef="usd">755000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-12" decimals="-6" id="f-341" unitRef="usd">575000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-13" decimals="-6" id="f-342" unitRef="usd">588000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromHedgeInvestingActivities contextRef="c-1" decimals="-6" id="f-343" unitRef="usd">99000000</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:ProceedsFromHedgeInvestingActivities contextRef="c-12" decimals="-6" id="f-344" unitRef="usd">0</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:ProceedsFromHedgeInvestingActivities contextRef="c-13" decimals="-6" id="f-345" unitRef="usd">197000000</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-1" decimals="-6" id="f-346" unitRef="usd">-43000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-12" decimals="-6" id="f-347" unitRef="usd">-1000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-13" decimals="-6" id="f-348" unitRef="usd">-39000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-6" id="f-349" unitRef="usd">-3000000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-12" decimals="-6" id="f-350" unitRef="usd">-962000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-13" decimals="-6" id="f-351" unitRef="usd">-2924000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="c-1" decimals="-6" id="f-352" unitRef="usd">-32000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="c-12" decimals="-6" id="f-353" unitRef="usd">540000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="c-13" decimals="-6" id="f-354" unitRef="usd">-375000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-1" decimals="-6" id="f-355" unitRef="usd">3011000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-12" decimals="-6" id="f-356" unitRef="usd">1241000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-13" decimals="-6" id="f-357" unitRef="usd">1500000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-1" decimals="-6" id="f-358" unitRef="usd">2039000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-12" decimals="-6" id="f-359" unitRef="usd">2058000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-13" decimals="-6" id="f-360" unitRef="usd">653000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDividends contextRef="c-1" decimals="-6" id="f-361" unitRef="usd">1219000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends contextRef="c-12" decimals="-6" id="f-362" unitRef="usd">1139000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends contextRef="c-13" decimals="-6" id="f-363" unitRef="usd">1051000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-6" id="f-364" unitRef="usd">195000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-12" decimals="-6" id="f-365" unitRef="usd">155000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-13" decimals="-6" id="f-366" unitRef="usd">122000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-1" decimals="-6" id="f-367" unitRef="usd">-51000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-12" decimals="-6" id="f-368" unitRef="usd">-23000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-13" decimals="-6" id="f-369" unitRef="usd">-48000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-6" id="f-370" unitRef="usd">-525000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-12" decimals="-6" id="f-371" unitRef="usd">-1594000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-13" decimals="-6" id="f-372" unitRef="usd">-749000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-6" id="f-373" unitRef="usd">-36000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-12" decimals="-6" id="f-374" unitRef="usd">-28000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-13" decimals="-6" id="f-375" unitRef="usd">-51000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-6" id="f-376" unitRef="usd">681000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-12" decimals="-6" id="f-377" unitRef="usd">1127000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-13" decimals="-6" id="f-378" unitRef="usd">-1100000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-15" decimals="-6" id="f-379" unitRef="usd">2971000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-43" decimals="-6" id="f-380" unitRef="usd">1844000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-44" decimals="-6" id="f-381" unitRef="usd">2944000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-14" decimals="-6" id="f-382" unitRef="usd">3652000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-15" decimals="-6" id="f-383" unitRef="usd">2971000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-43" decimals="-6" id="f-384" unitRef="usd">1844000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-1" decimals="-6" id="f-385" unitRef="usd">989000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-12" decimals="-6" id="f-386" unitRef="usd">693000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-13" decimals="-6" id="f-387" unitRef="usd">505000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-6" id="f-388" unitRef="usd">396000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-12" decimals="-6" id="f-389" unitRef="usd">356000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-13" decimals="-6" id="f-390" unitRef="usd">324000000</us-gaap:InterestPaidNet>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-391">SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Nature of Operations: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Stryker (the "Company," "we," "us," or "our") is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Our products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and artificial intelligence-assisted virtual care platform technology; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the fourth quarter 2024 we changed the name of our &#x201c;Orthopaedics and Spine&#x201d; operating segment to &#x201c;Orthopaedics.&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Basis of Presentation and Consolidation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Consolidated Financial Statements include the Company and its subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. We have no material interests in variable interest entities. Certain prior year amounts have been reclassified to conform with current year presentation in our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our reportable segments and related disclosures reflect certain reclassifications of prior year amounts from our Orthopaedics segment to our MedSurg and Neurotechnology segment due to changes in our internal reporting structure.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Use of Estimates: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of net sales and expenses in the reporting period. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Revenue Recognition: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales are recognized as the performance obligations to deliver products or services (including services under extended warranty service contracts) are satisfied and are recorded based on the amount of consideration we expect to receive in exchange for satisfying the performance obligations. Our sales are recognized primarily when we transfer control to the customer, which can be on the date of shipment, the date of receipt by the customer or, for most Orthopaedics products, when we have received a purchase order and appropriate notification the product has been used or implanted. Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales represent the amount of consideration we expect to receive from customers in exchange for transferring products and services. Net sales exclude sales, value added and other taxes we collect from customers. Other costs to obtain and fulfill contracts are generally expensed as incurred due to the short-term nature of most of our sales. We extend terms of payment to our customers based on commercially reasonable terms for the markets of our customers, while also considering their credit quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A provision for estimated sales returns, discounts and rebates is recognized as a reduction of sales in the same period that the sales are recognized. Our estimate of the provision for sales &lt;/span&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.334%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;returns has been established based on contract terms with our customers and historical business practices and current trends. Shipping and handling costs charged to customers are included in net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Cost of Sales: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cost of sales include direct materials and supplies consumed in the manufacture of product, as well as manufacturing labor, depreciation expense and direct overhead expense necessary to acquire and convert the purchased materials and supplies into finished product. Cost of sales also includes the cost to distribute products to customers, inbound freight costs, warehousing costs and other shipping and handling activity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Research, Development and Engineering Expenses: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research, development and engineering costs are charged to expense as incurred and include research, development and engineering activities relating to the development of new products, improvement of existing products, technical support of products and compliance with governmental regulations for the protection of customers and patients. Costs primarily include salaries, wages, consulting and depreciation and maintenance of research facilities and equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Selling, General and Administrative Expenses: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Costs include selling expenses, marketing expenses, administrative and other indirect overhead costs, amortization of loaner instrumentation, depreciation and amortization expense of non-manufacturing assets and other miscellaneous operating items. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Currency Translation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Financial statements of subsidiaries outside the United States generally are measured using the local currency as the functional currency. Adjustments to translate those statements into United States Dollars are recorded in other comprehensive income (OCI). Transactional exchange gains and losses are included in other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Cash Equivalents: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Highly liquid investments with remaining stated maturities of three months or less when purchased or other money market instruments that are redeemable upon demand are considered cash equivalents and recorded at cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Short-term Investments: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Short-term investments that have a maturity greater than three months and less than a year from the date of purchase primarily include time deposits, certificates of deposit, commercial paper, bonds and notes, substantially all of which are denominated in United States Dollars and are stated at cost plus accrued interest, which approximates fair value. We expect to hold all of our short-term investments to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Marketable Securities: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities include marketable debt securities and mutual funds. Mutual funds are acquired to offset changes in certain liabilities related to deferred compensation arrangements and are expected to be used to settle these liabilities and are recognized in other noncurrent assets. Pursuant to our investment policy, all individual marketable security investments must have a minimum credit quality of single A (Standard&#160;&amp;amp; Poor&#x2019;s and Fitch) and A2 (Moody&#x2019;s Corporation) at the time of acquisition, while the overall portfolio of marketable securities must maintain a minimum average credit quality of double A (Standard&#160;&amp;amp; Poor&#x2019;s and Fitch) or Aa (Moody&#x2019;s Corporation). In the event of a rating downgrade below the minimum credit quality subsequent to purchase, the marketable security investment is evaluated to determine the appropriate action to take to minimize the overall risk to our marketable security investment portfolio. Our marketable securities are classified as available-for-sale and trading securities. Investments in trading securities represent participant-directed investments of deferred employee compensation.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="width:100.000%"&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.333%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Accounts Receivable: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable include trade and other miscellaneous receivables. An allowance is maintained for doubtful accounts for estimated losses in the collection of accounts receivable. Estimates are made regarding the ability of customers to make required payments based on historical credit experience, current market conditions and expected credit losses. Accounts receivable are written off when all reasonable collection efforts are exhausted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Inventories: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or net realizable value, with cost generally determined using the first-in, first-out (FIFO) cost method. For excess and obsolete inventory resulting from the potential inability to sell specific products at prices in excess of current carrying costs, reserves are maintained to reduce current carrying cost to net realizable value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Financial Instruments:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Our financial instruments include cash, cash equivalents, marketable securities, accounts receivable, other investments, accounts payable, debt and foreign currency exchange contracts. The carrying value of our financial instruments, with the exception of our senior unsecured notes, approximates fair value on December&#160;31, 2024 and 2023. Refer to Notes 3 and 10 for further details. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;All marketable securities are recognized at fair value. Adjustments to the fair value of marketable securities that are classified as available-for-sale are recognized as increases or decreases, net of income taxes, within accumulated other comprehensive income (AOCI) in shareholders&#x2019; equity and adjustments to the fair value of marketable securities that are classified as trading are recognized in earnings. The amortized cost of marketable debt securities is adjusted for amortization of premiums and discounts to maturity computed under the effective interest method. Such amortization and interest and realized gains and losses are included in other income (expense), net. The cost of securities sold is determined by the specific identification method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We review declines in the fair value of our investments classified as available-for-sale to determine whether the decline in fair value is a result of credit loss or other factors. Impairments of available-for-sale marketable debt securities related to credit loss are included in earnings and impairments related to other factors are recognized within AOCI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Derivatives:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; All derivatives are recognized at fair value and reported on a gross basis. We enter into forward currency exchange contracts to mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, thereby limiting our risk that would otherwise result from changes in exchange rates. The periods of the forward currency exchange contracts correspond to the periods of the exposed transactions, with realized gains and losses included in the measurement and recording of transactions denominated in the nonfunctional currencies. All forward currency exchange contracts are recorded at their fair value each period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forward currency exchange contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. These nonfunctional currency exposures principally relate to forecasted intercompany sales and purchases of manufactured products and generally have maturities up to eighteen months. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#x2019; equity is reclassified into &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.334%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;earnings and is included in cost of goods sold. Cash flows associated with these hedges are included in cash provided by operating activities in the same category as the cash flows from the items being hedged.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forward currency exchange contracts are used to offset our exposure to the change in value of specific foreign currency denominated assets and liabilities, primarily intercompany payables and receivables. These derivatives are not designated as hedges and, therefore, changes in the value of these forward contracts are recognized in earnings, thereby offsetting the current earnings effect of the related changes in value of foreign currency denominated assets and liabilities. The estimated fair value of our forward currency exchange contracts represents the measurement of the contracts at month-end spot rates as adjusted by current forward points. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;From time to time, we designate derivative and non-derivative financial instruments as net investment hedges of our investments in certain international subsidiaries. For derivative instruments that are designated and qualify as a net investment hedge, the effective portion of the derivative's gain or loss is recognized in OCI and reported as a component of AOCI. We have elected to use the spot method to assess effectiveness for our derivatives designated as net investment hedges. Accordingly, the change in fair value attributable to changes in the spot rate is recorded in AOCI. We exclude the spot-forward difference from the assessment of hedge effectiveness and amortize this amount separately on a straight-line basis over the term of the forward contracts. This amortization is recognized in other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;From time to time, we designate forward starting interest rate derivative instruments as cash flow hedges to manage the exposure to interest rate volatility with regard to future issuance and refinancing of debt. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#x2019; equity is reclassified into earnings and is included in interest expense within other income (expense), net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest rate derivative instruments designated as fair value hedges have been used in the past to manage the exposure to interest rate movements and to reduce borrowing costs by converting fixed-rate debt into floating-rate debt. Under these agreements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Property, plant and equipment is stated at cost. Depreciation is generally computed by the straight-line method over the estimated useful lives of &lt;span style="-sec-ix-hidden:f-409"&gt;three&lt;/span&gt; to 30 years for buildings and improvements and &lt;span style="-sec-ix-hidden:f-411"&gt;three&lt;/span&gt; to 15 years for machinery and equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Goodwill and Other Intangible Assets:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Goodwill represents the excess of purchase price over fair value of tangible net assets of acquired businesses at the acquisition date, after amounts allocated to other identifiable intangible assets. Factors that contribute to the recognition of goodwill include synergies that are specific to our business and not available to other market participants and are expected to increase net sales and profits; acquisition of a talented workforce; cost savings opportunities; the strategic benefit of expanding our presence in core and adjacent markets; and diversifying our product portfolio.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values of other identifiable intangible assets acquired in a business combination are primarily determined using the income &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="width:100.000%"&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.333%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;approach. Other intangible assets include, but are not limited to, developed technology, customer and distributor relationships (which reflect expected continued customer or distributor patronage) and trademarks and patents. Intangible assets with determinable useful lives are amortized on a straight-line basis over their estimated useful lives of &lt;span style="-sec-ix-hidden:f-414"&gt;four&lt;/span&gt; to 40 years. Certain acquired trade names are considered to have indefinite lives and are not amortized, but are assessed annually for potential impairment as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations IPRD is considered to be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions IPRD is expensed immediately unless there is an alternative future use.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Goodwill, Intangibles and Long-Lived Asset Impairment Tests:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; We perform our annual impairment test for goodwill as of October 31 each year. We consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill and periodically corroborate that assessment with quantitative information. In certain circumstances, we may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. Indefinite-lived intangible assets are also tested at least annually for impairment by comparing the individual carrying values to the fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We review long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows. Undiscounted cash flows expected to be generated by the related assets are estimated over the asset's useful life based on updated projections. If the evaluation indicates that the carrying amount of the asset may not be recoverable, any potential impairment is measured based upon the fair value of the related asset or asset group as determined by an appropriate market appraisal or other valuation technique.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Assets and Liabilities Held for Sale: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;classify assets and liabilities or disposal groups to be sold as held for sale in the period in which all of the following criteria are met: management, having the authority to approve the action, commits to a plan to sell the disposal group; the disposal group is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such disposal groups; an active program to locate a buyer and other actions required to complete the plan to sell the disposal group have been initiated; the sale of the disposal group is probable, and transfer of the disposal group is expected to qualify for recognition as a completed sale within one year, except if events or circumstances beyond our control extend the period of time required to sell the disposal group beyond one year; the disposal group is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.334%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We initially measure a disposal group that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held for sale criteria are met. Conversely, gains are not recognized on the sale of a disposal group until the sale is completed. We assess the fair value of a disposal group, less any costs to sell, each reporting period it remains classified as held for sale and report any subsequent changes as an adjustment to the carrying value of the disposal group, as long as the new carrying value does not exceed the carrying value of the disposal group at the time it was initially classified as held for sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Upon determining that a disposal group meets the criteria to be classified as held for sale, we cease depreciation and amortization of the assets and disclose the major classes of assets and liabilities of the disposal group in the Notes to the Consolidated Financial Statements. Refer to Note 16 for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Share-based compensation is in the form of stock options, restricted stock units (RSUs) and performance stock units (PSUs). Stock options are granted under long-term incentive plans to certain key employees and non-employee directors at an exercise price not less than the fair market value of the underlying common stock, which is the quoted closing price of our common stock on the day prior to the date of grant. The options are granted for periods of up to 10 years and become exercisable in varying installments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We grant RSUs to key employees and non-employee directors and PSUs to certain key employees under our long-term incentive plans. The fair value of RSUs is determined based on the number of shares granted and the quoted closing price of our common stock on the date of grant, adjusted for the fact that RSUs do not include anticipated dividends. RSUs generally vest in one-third increments over a three-year period and are settled in stock. PSUs are earned over a three-year performance cycle and vest in March of the year following the end of that performance cycle. The number of PSUs that will ultimately be earned is based on our performance relative to pre-established goals in that three-year performance cycle. The fair value of PSUs is determined based on the quoted closing price of our common stock on the day of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Compensation expense is recognized in the Consolidated Statements of Earnings based on the estimated fair value of the awards on the grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized associated with such grants will be reversed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Income Taxes:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Deferred income tax assets and liabilities are determined based on differences between financial reporting and income tax bases of assets and liabilities and are measured using the enacted income tax rates in effect for the years in which the differences are expected to reverse. Deferred income tax benefits generally represent the change in net deferred income tax assets and liabilities in the year. Other amounts result from &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;adjustments related to acquisitions and foreign currency as appropriate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We operate in multiple income tax jurisdictions both within the United States and internationally. Accordingly, management must determine the appropriate allocation of income to each of these jurisdictions based on current interpretations of complex income tax regulations. Income tax authorities in these jurisdictions regularly perform audits of our income tax filings. Income tax audits associated with the allocation of this income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period of time to resolve and may result in significant income tax adjustments if changes to the income allocation are required between jurisdictions with different income tax rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Tax Cuts and Jobs Act (the Act) was enacted in 2017 in the United States. The Act also subjects a United States shareholder to tax on Global Intangible Low-Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to account for GILTI tax in the year the tax is incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In November 2024 the Financial Accounting Standards Board (FASB) issued ASU 2024-03 (Subtopic 220-40): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; which requires disaggregation of certain expense captions into specified categories in disclosures within the Notes to the Consolidated Financial Statements. The new disclosure requirements are effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. We are currently evaluating these new expanded disclosure requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In December 2023 the FASB issued ASU 2023-09 (Topic 740): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes: Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; which expands the existing rules on income tax disclosures. This update requires entities to disclose specific categories in the tax rate reconciliation, provide additional information for reconciling items that meet a quantitative threshold and disclose additional information about income taxes paid on an annual basis. The new disclosure requirements are effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating these new expanded disclosure requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Recently Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On January 1, 2024 we adopted ASU 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. Refer to Note 14 for further information.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On January 1, 2023 we adopted ASU 2022-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liabilities - Supplier Finance Programs: Disclosure of Supplier Finance Program Obligations&lt;/span&gt;. Refer to Note 7 for required disclosures.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:NatureOfOperations contextRef="c-1" id="f-392">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Stryker (the "Company," "we," "us," or "our") is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Our products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and artificial intelligence-assisted virtual care platform technology; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties.&lt;/span&gt;During the fourth quarter 2024 we changed the name of our &#x201c;Orthopaedics and Spine&#x201d; operating segment to &#x201c;Orthopaedics.&#x201d;</us-gaap:NatureOfOperations>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-393">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Consolidated Financial Statements include the Company and its subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. We have no material interests in variable interest entities. Certain prior year amounts have been reclassified to conform with current year presentation in our Consolidated Financial Statements.&lt;/span&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our reportable segments and related disclosures reflect certain reclassifications of prior year amounts from our Orthopaedics segment to our MedSurg and Neurotechnology segment due to changes in our internal reporting structure.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-394">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of net sales and expenses in the reporting period. Actual results could differ from those estimates.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c-1" id="f-395">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales are recognized as the performance obligations to deliver products or services (including services under extended warranty service contracts) are satisfied and are recorded based on the amount of consideration we expect to receive in exchange for satisfying the performance obligations. Our sales are recognized primarily when we transfer control to the customer, which can be on the date of shipment, the date of receipt by the customer or, for most Orthopaedics products, when we have received a purchase order and appropriate notification the product has been used or implanted. Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time.&lt;/span&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales represent the amount of consideration we expect to receive from customers in exchange for transferring products and services. Net sales exclude sales, value added and other taxes we collect from customers. Other costs to obtain and fulfill contracts are generally expensed as incurred due to the short-term nature of most of our sales. We extend terms of payment to our customers based on commercially reasonable terms for the markets of our customers, while also considering their credit quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A provision for estimated sales returns, discounts and rebates is recognized as a reduction of sales in the same period that the sales are recognized. Our estimate of the provision for sales &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;returns has been established based on contract terms with our customers and historical business practices and current trends. Shipping and handling costs charged to customers are included in net sales.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="c-1" id="f-396">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cost of sales include direct materials and supplies consumed in the manufacture of product, as well as manufacturing labor, depreciation expense and direct overhead expense necessary to acquire and convert the purchased materials and supplies into finished product. Cost of sales also includes the cost to distribute products to customers, inbound freight costs, warehousing costs and other shipping and handling activity.&lt;/span&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c-1" id="f-397">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research, development and engineering costs are charged to expense as incurred and include research, development and engineering activities relating to the development of new products, improvement of existing products, technical support of products and compliance with governmental regulations for the protection of customers and patients. Costs primarily include salaries, wages, consulting and depreciation and maintenance of research facilities and equipment.&lt;/span&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock contextRef="c-1" id="f-398">include selling expenses, marketing expenses, administrative and other indirect overhead costs, amortization of loaner instrumentation, depreciation and amortization expense of non-manufacturing assets and other miscellaneous operating items.</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-399">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Financial statements of subsidiaries outside the United States generally are measured using the local currency as the functional currency. Adjustments to translate those statements into United States Dollars are recorded in other comprehensive income (OCI). Transactional exchange gains and losses are included in other income (expense), net.&lt;/span&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-400">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Highly liquid investments with remaining stated maturities of three months or less when purchased or other money market instruments that are redeemable upon demand are considered cash equivalents and recorded at cost.&lt;/span&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <syk:ShortTermInvestmentsPolicyPolicyTextBlock contextRef="c-1" id="f-401">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Short-term investments that have a maturity greater than three months and less than a year from the date of purchase primarily include time deposits, certificates of deposit, commercial paper, bonds and notes, substantially all of which are denominated in United States Dollars and are stated at cost plus accrued interest, which approximates fair value. We expect to hold all of our short-term investments to maturity.&lt;/span&gt;</syk:ShortTermInvestmentsPolicyPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy contextRef="c-1" id="f-402">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities include marketable debt securities and mutual funds. Mutual funds are acquired to offset changes in certain liabilities related to deferred compensation arrangements and are expected to be used to settle these liabilities and are recognized in other noncurrent assets. Pursuant to our investment policy, all individual marketable security investments must have a minimum credit quality of single A (Standard&#160;&amp;amp; Poor&#x2019;s and Fitch) and A2 (Moody&#x2019;s Corporation) at the time of acquisition, while the overall portfolio of marketable securities must maintain a minimum average credit quality of double A (Standard&#160;&amp;amp; Poor&#x2019;s and Fitch) or Aa (Moody&#x2019;s Corporation). In the event of a rating downgrade below the minimum credit quality subsequent to purchase, the marketable security investment is evaluated to determine the appropriate action to take to minimize the overall risk to our marketable security investment portfolio. Our marketable securities are classified as available-for-sale and trading securities. Investments in trading securities represent participant-directed investments of deferred employee compensation.&lt;/span&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="c-1" id="f-403">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable include trade and other miscellaneous receivables. An allowance is maintained for doubtful accounts for estimated losses in the collection of accounts receivable. Estimates are made regarding the ability of customers to make required payments based on historical credit experience, current market conditions and expected credit losses. Accounts receivable are written off when all reasonable collection efforts are exhausted.&lt;/span&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock contextRef="c-1" id="f-404">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or net realizable value, with cost generally determined using the first-in, first-out (FIFO) cost method. For excess and obsolete inventory resulting from the potential inability to sell specific products at prices in excess of current carrying costs, reserves are maintained to reduce current carrying cost to net realizable value.&lt;/span&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:FairValueOptionTextBlock contextRef="c-1" id="f-405">Our financial instruments include cash, cash equivalents, marketable securities, accounts receivable, other investments, accounts payable, debt and foreign currency exchange contracts. The carrying value of our financial instruments, with the exception of our senior unsecured notes, approximates fair value on December&#160;31, 2024 and 2023. Refer to Notes 3 and 10 for further details. &lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;All marketable securities are recognized at fair value. Adjustments to the fair value of marketable securities that are classified as available-for-sale are recognized as increases or decreases, net of income taxes, within accumulated other comprehensive income (AOCI) in shareholders&#x2019; equity and adjustments to the fair value of marketable securities that are classified as trading are recognized in earnings. The amortized cost of marketable debt securities is adjusted for amortization of premiums and discounts to maturity computed under the effective interest method. Such amortization and interest and realized gains and losses are included in other income (expense), net. The cost of securities sold is determined by the specific identification method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We review declines in the fair value of our investments classified as available-for-sale to determine whether the decline in fair value is a result of credit loss or other factors. Impairments of available-for-sale marketable debt securities related to credit loss are included in earnings and impairments related to other factors are recognized within AOCI.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOptionTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c-1" id="f-406">All derivatives are recognized at fair value and reported on a gross basis. We enter into forward currency exchange contracts to mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, thereby limiting our risk that would otherwise result from changes in exchange rates. The periods of the forward currency exchange contracts correspond to the periods of the exposed transactions, with realized gains and losses included in the measurement and recording of transactions denominated in the nonfunctional currencies. All forward currency exchange contracts are recorded at their fair value each period.&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forward currency exchange contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. These nonfunctional currency exposures principally relate to forecasted intercompany sales and purchases of manufactured products and generally have maturities up to eighteen months. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#x2019; equity is reclassified into &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;earnings and is included in cost of goods sold. Cash flows associated with these hedges are included in cash provided by operating activities in the same category as the cash flows from the items being hedged.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forward currency exchange contracts are used to offset our exposure to the change in value of specific foreign currency denominated assets and liabilities, primarily intercompany payables and receivables. These derivatives are not designated as hedges and, therefore, changes in the value of these forward contracts are recognized in earnings, thereby offsetting the current earnings effect of the related changes in value of foreign currency denominated assets and liabilities. The estimated fair value of our forward currency exchange contracts represents the measurement of the contracts at month-end spot rates as adjusted by current forward points. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;From time to time, we designate derivative and non-derivative financial instruments as net investment hedges of our investments in certain international subsidiaries. For derivative instruments that are designated and qualify as a net investment hedge, the effective portion of the derivative's gain or loss is recognized in OCI and reported as a component of AOCI. We have elected to use the spot method to assess effectiveness for our derivatives designated as net investment hedges. Accordingly, the change in fair value attributable to changes in the spot rate is recorded in AOCI. We exclude the spot-forward difference from the assessment of hedge effectiveness and amortize this amount separately on a straight-line basis over the term of the forward contracts. This amortization is recognized in other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;From time to time, we designate forward starting interest rate derivative instruments as cash flow hedges to manage the exposure to interest rate volatility with regard to future issuance and refinancing of debt. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#x2019; equity is reclassified into earnings and is included in interest expense within other income (expense), net. &lt;/span&gt;&lt;/div&gt;Interest rate derivative instruments designated as fair value hedges have been used in the past to manage the exposure to interest rate movements and to reduce borrowing costs by converting fixed-rate debt into floating-rate debt. Under these agreements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DerivativeTermOfContract contextRef="c-1" id="f-407">P18M</us-gaap:DerivativeTermOfContract>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-408">Property, plant and equipment is stated at cost. Depreciation is generally computed by the straight-line method over the estimated useful lives of &lt;span style="-sec-ix-hidden:f-409"&gt;three&lt;/span&gt; to 30 years for buildings and improvements and &lt;span style="-sec-ix-hidden:f-411"&gt;three&lt;/span&gt; to 15 years for machinery and equipment.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-46" id="f-410">P30Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-48" id="f-412">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="c-1" id="f-413">Goodwill represents the excess of purchase price over fair value of tangible net assets of acquired businesses at the acquisition date, after amounts allocated to other identifiable intangible assets. Factors that contribute to the recognition of goodwill include synergies that are specific to our business and not available to other market participants and are expected to increase net sales and profits; acquisition of a talented workforce; cost savings opportunities; the strategic benefit of expanding our presence in core and adjacent markets; and diversifying our product portfolio.&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values of other identifiable intangible assets acquired in a business combination are primarily determined using the income &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;approach. Other intangible assets include, but are not limited to, developed technology, customer and distributor relationships (which reflect expected continued customer or distributor patronage) and trademarks and patents. Intangible assets with determinable useful lives are amortized on a straight-line basis over their estimated useful lives of &lt;span style="-sec-ix-hidden:f-414"&gt;four&lt;/span&gt; to 40 years. Certain acquired trade names are considered to have indefinite lives and are not amortized, but are assessed annually for potential impairment as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations IPRD is considered to be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions IPRD is expensed immediately unless there is an alternative future use.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-50" id="f-415">P40Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <syk:GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock contextRef="c-1" id="f-416">We perform our annual impairment test for goodwill as of October 31 each year. We consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill and periodically corroborate that assessment with quantitative information. In certain circumstances, we may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. Indefinite-lived intangible assets are also tested at least annually for impairment by comparing the individual carrying values to the fair value.&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We review long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows. Undiscounted cash flows expected to be generated by the related assets are estimated over the asset's useful life based on updated projections. If the evaluation indicates that the carrying amount of the asset may not be recoverable, any potential impairment is measured based upon the fair value of the related asset or asset group as determined by an appropriate market appraisal or other valuation technique.&lt;/span&gt;&lt;/div&gt;</syk:GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock>
    <syk:AssetsAndLiabilitiesHeldForSalePolicyTextBlock contextRef="c-1" id="f-417">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;classify assets and liabilities or disposal groups to be sold as held for sale in the period in which all of the following criteria are met: management, having the authority to approve the action, commits to a plan to sell the disposal group; the disposal group is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such disposal groups; an active program to locate a buyer and other actions required to complete the plan to sell the disposal group have been initiated; the sale of the disposal group is probable, and transfer of the disposal group is expected to qualify for recognition as a completed sale within one year, except if events or circumstances beyond our control extend the period of time required to sell the disposal group beyond one year; the disposal group is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.&lt;/span&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We initially measure a disposal group that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held for sale criteria are met. Conversely, gains are not recognized on the sale of a disposal group until the sale is completed. We assess the fair value of a disposal group, less any costs to sell, each reporting period it remains classified as held for sale and report any subsequent changes as an adjustment to the carrying value of the disposal group, as long as the new carrying value does not exceed the carrying value of the disposal group at the time it was initially classified as held for sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Upon determining that a disposal group meets the criteria to be classified as held for sale, we cease depreciation and amortization of the assets and disclose the major classes of assets and liabilities of the disposal group in the Notes to the Consolidated Financial Statements. Refer to Note 16 for further information.&lt;/span&gt;&lt;/div&gt;</syk:AssetsAndLiabilitiesHeldForSalePolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-418">hare-based compensation is in the form of stock options, restricted stock units (RSUs) and performance stock units (PSUs). Stock options are granted under long-term incentive plans to certain key employees and non-employee directors at an exercise price not less than the fair market value of the underlying common stock, which is the quoted closing price of our common stock on the day prior to the date of grant. The options are granted for periods of up to 10 years and become exercisable in varying installments.&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We grant RSUs to key employees and non-employee directors and PSUs to certain key employees under our long-term incentive plans. The fair value of RSUs is determined based on the number of shares granted and the quoted closing price of our common stock on the date of grant, adjusted for the fact that RSUs do not include anticipated dividends. RSUs generally vest in one-third increments over a three-year period and are settled in stock. PSUs are earned over a three-year performance cycle and vest in March of the year following the end of that performance cycle. The number of PSUs that will ultimately be earned is based on our performance relative to pre-established goals in that three-year performance cycle. The fair value of PSUs is determined based on the quoted closing price of our common stock on the day of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Compensation expense is recognized in the Consolidated Statements of Earnings based on the estimated fair value of the awards on the grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized associated with such grants will be reversed.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-51" id="f-419">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-52" id="f-420">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <syk:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod contextRef="c-53" id="f-421">P3Y</syk:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod>
    <syk:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod contextRef="c-53" id="f-422">P3Y</syk:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-423">Deferred income tax assets and liabilities are determined based on differences between financial reporting and income tax bases of assets and liabilities and are measured using the enacted income tax rates in effect for the years in which the differences are expected to reverse. Deferred income tax benefits generally represent the change in net deferred income tax assets and liabilities in the year. Other amounts result from &lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;adjustments related to acquisitions and foreign currency as appropriate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We operate in multiple income tax jurisdictions both within the United States and internationally. Accordingly, management must determine the appropriate allocation of income to each of these jurisdictions based on current interpretations of complex income tax regulations. Income tax authorities in these jurisdictions regularly perform audits of our income tax filings. Income tax audits associated with the allocation of this income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period of time to resolve and may result in significant income tax adjustments if changes to the income allocation are required between jurisdictions with different income tax rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Tax Cuts and Jobs Act (the Act) was enacted in 2017 in the United States. The Act also subjects a United States shareholder to tax on Global Intangible Low-Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to account for GILTI tax in the year the tax is incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-424">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In November 2024 the Financial Accounting Standards Board (FASB) issued ASU 2024-03 (Subtopic 220-40): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; which requires disaggregation of certain expense captions into specified categories in disclosures within the Notes to the Consolidated Financial Statements. The new disclosure requirements are effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. We are currently evaluating these new expanded disclosure requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In December 2023 the FASB issued ASU 2023-09 (Topic 740): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes: Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; which expands the existing rules on income tax disclosures. This update requires entities to disclose specific categories in the tax rate reconciliation, provide additional information for reconciling items that meet a quantitative threshold and disclose additional information about income taxes paid on an annual basis. The new disclosure requirements are effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating these new expanded disclosure requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Recently Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On January 1, 2024 we adopted ASU 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. Refer to Note 14 for further information.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On January 1, 2023 we adopted ASU 2022-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liabilities - Supplier Finance Programs: Disclosure of Supplier Finance Program Obligations&lt;/span&gt;. Refer to Note 7 for required disclosures.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-426">REVENUE RECOGNITION&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We disaggregate our net sales by business and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time. In 2024 less than 10% of our sales were recognized as services transferred over time. Refer to Note 1 for further discussion on our revenue recognition policies. &lt;/span&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.334%"&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In the fourth quarter 2024 we reorganized our Spine business to align with certain updates to our internal reporting structure. The spine enabling technologies portfolio (Enabling Technologies) was reclassified to Other Orthopaedics and Spine, the interventional spine portfolio was reclassified to Neuro Cranial and the remaining Spine business was renamed to Spinal Implants. In addition, we changed the name of our &#x201c;Orthopaedics and Spine&#x201d; operating segment to &#x201c;Orthopaedics.&#x201d; Neuro Cranial includes sales related to interventional spine of $413, $327 and $282 for 2024, 2023 and 2022. Other Orthopaedics includes sales related to Enabling Technologies of $152, $149 and $131 for 2024, 2023 and 2022. In the first quarter of 2024 a product line previously included in Instruments has been reclassified to Endoscopy to align with a change in our internal reporting structure. We have reflected these changes in all historical periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.259%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,518&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,163&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,893&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spinal Implants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,335&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,556&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,595&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,498&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,449&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.259%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;United States Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,517&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,328&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,248&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spinal Implants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,426&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,929&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,390&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;16,943&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15,257&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,638&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.259%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;International Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,001&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,835&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,645&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spinal Implants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,651&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,406&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,166&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,652&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,241&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,811&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.333%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;MedSurg and Neurotechnology products include surgical equipment, patient and caregiver safety technologies (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical), minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke (Neurovascular), cranial, maxillofacial and chest wall devices as well as dural substitutes and sealants; a comprehensive line of products for traditional brain and open skull based surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products (Neuro Cranial). Substantially all MedSurg and Neurotechnology sales are recognized when a purchase order has been received and control has transferred. For certain Endoscopy, Instruments and Medical services, we may recognize sales over time as we satisfy performance obligations that may include an obligation to complete installation, provide training and perform ongoing services, generally performed within one year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Orthopaedics&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries, and cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. Substantially all Orthopaedics sales are recognized when we have received a purchase order and appropriate notification the product has been used or implanted. Substantially all Spinal Implants sales are recognized when a purchase order has been received and control has transferred. For certain Orthopaedic products in the "other" category, we recognize sales at a point in time, as well as over time for performance obligations that may include an obligation to complete installation and provide training and ongoing services. Performance obligations are generally satisfied within one year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Costs to Obtain or Fulfill a Contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We typically do not incur costs to fulfill a contract before a product or service is provided to a customer due to the nature of our products and services. Our costs to obtain contracts are typically in the form of sales commissions paid to employees or third-party agents. Certain sales commissions paid to employees prior to recognition of sales are recorded as deferred contract costs. We expense sales commissions associated with obtaining a contract at the time of the sale or as incurred as the amortization period is generally less than one year. These costs have been presented within selling, general and administrative expenses. On December&#160;31, 2024 and 2023 deferred contracts costs recorded in our Consolidated Balance Sheets were not significant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Assets and Liabilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our contract assets primarily relate to conditional rights to consideration for work completed but not billed at the reporting date. On December&#160;31, 2024 and 2023 contract assets recorded in our Consolidated Balance Sheets were not significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our contract liabilities arise as a result of consideration received from customers at inception of contracts for certain businesses or where the timing of billing for services precedes satisfaction of our performance obligations. This occurs primarily when payment is received upfront for certain multi-period extended warranty service contracts. Our contract liabilities of $978 and $860 on &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2024 and 2023 are classified within accrued expenses and other liabilities and other noncurrent liabilities within our Consolidated Balance Sheets based on the timing of when we expect to complete our performance obligations. Changes in contract liabilities during the year were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:81.658%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;860&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Revenue recognized from beginning of year contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net advance consideration received during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;978&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <syk:PercentageofServiceRevenueRecognizeoverTime contextRef="c-1" decimals="2" id="f-427" unitRef="number">0.10</syk:PercentageofServiceRevenueRecognizeoverTime>
    <us-gaap:Revenues contextRef="c-54" decimals="-6" id="f-428" unitRef="usd">413000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-55" decimals="-6" id="f-429" unitRef="usd">327000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-56" decimals="-6" id="f-430" unitRef="usd">282000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-57" decimals="-6" id="f-431" unitRef="usd">152000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-58" decimals="-6" id="f-432" unitRef="usd">149000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-59" decimals="-6" id="f-433" unitRef="usd">131000000</us-gaap:Revenues>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-434">&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.259%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,518&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,163&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,893&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spinal Implants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,335&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,556&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,595&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,498&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,449&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.259%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;United States Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,517&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,328&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,248&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spinal Implants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,426&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,929&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,390&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;16,943&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15,257&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,638&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.259%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;International Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,001&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,835&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,645&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spinal Implants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,651&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,406&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,166&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,652&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,241&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,811&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues contextRef="c-60" decimals="-6" id="f-435" unitRef="usd">2834000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-61" decimals="-6" id="f-436" unitRef="usd">2534000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-62" decimals="-6" id="f-437" unitRef="usd">2245000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-63" decimals="-6" id="f-438" unitRef="usd">3389000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-64" decimals="-6" id="f-439" unitRef="usd">3068000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-65" decimals="-6" id="f-440" unitRef="usd">2759000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-66" decimals="-6" id="f-441" unitRef="usd">3852000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-67" decimals="-6" id="f-442" unitRef="usd">3459000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-68" decimals="-6" id="f-443" unitRef="usd">3031000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-69" decimals="-6" id="f-444" unitRef="usd">1307000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-70" decimals="-6" id="f-445" unitRef="usd">1226000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-71" decimals="-6" id="f-446" unitRef="usd">1200000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-72" decimals="-6" id="f-447" unitRef="usd">2136000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-73" decimals="-6" id="f-448" unitRef="usd">1876000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-74" decimals="-6" id="f-449" unitRef="usd">1658000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-75" decimals="-6" id="f-450" unitRef="usd">13518000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-76" decimals="-6" id="f-451" unitRef="usd">12163000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-77" decimals="-6" id="f-452" unitRef="usd">10893000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-78" decimals="-6" id="f-453" unitRef="usd">2447000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-79" decimals="-6" id="f-454" unitRef="usd">2273000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-80" decimals="-6" id="f-455" unitRef="usd">1997000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-81" decimals="-6" id="f-456" unitRef="usd">1704000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-82" decimals="-6" id="f-457" unitRef="usd">1544000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-83" decimals="-6" id="f-458" unitRef="usd">1413000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-84" decimals="-6" id="f-459" unitRef="usd">3507000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-85" decimals="-6" id="f-460" unitRef="usd">3147000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-86" decimals="-6" id="f-461" unitRef="usd">2807000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-87" decimals="-6" id="f-462" unitRef="usd">707000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-88" decimals="-6" id="f-463" unitRef="usd">713000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-89" decimals="-6" id="f-464" unitRef="usd">733000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-90" decimals="-6" id="f-465" unitRef="usd">712000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-91" decimals="-6" id="f-466" unitRef="usd">658000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-92" decimals="-6" id="f-467" unitRef="usd">606000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-93" decimals="-6" id="f-468" unitRef="usd">9077000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-94" decimals="-6" id="f-469" unitRef="usd">8335000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-95" decimals="-6" id="f-470" unitRef="usd">7556000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-1" decimals="-6" id="f-471" unitRef="usd">22595000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-12" decimals="-6" id="f-472" unitRef="usd">20498000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-13" decimals="-6" id="f-473" unitRef="usd">18449000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-96" decimals="-6" id="f-474" unitRef="usd">2267000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-97" decimals="-6" id="f-475" unitRef="usd">2016000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-98" decimals="-6" id="f-476" unitRef="usd">1776000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-99" decimals="-6" id="f-477" unitRef="usd">2792000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-100" decimals="-6" id="f-478" unitRef="usd">2513000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-101" decimals="-6" id="f-479" unitRef="usd">2245000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-102" decimals="-6" id="f-480" unitRef="usd">3191000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-103" decimals="-6" id="f-481" unitRef="usd">2785000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-104" decimals="-6" id="f-482" unitRef="usd">2422000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-105" decimals="-6" id="f-483" unitRef="usd">506000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-106" decimals="-6" id="f-484" unitRef="usd">483000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-107" decimals="-6" id="f-485" unitRef="usd">446000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-108" decimals="-6" id="f-486" unitRef="usd">1761000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-109" decimals="-6" id="f-487" unitRef="usd">1531000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-110" decimals="-6" id="f-488" unitRef="usd">1359000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-111" decimals="-6" id="f-489" unitRef="usd">10517000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-112" decimals="-6" id="f-490" unitRef="usd">9328000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-113" decimals="-6" id="f-491" unitRef="usd">8248000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-114" decimals="-6" id="f-492" unitRef="usd">1788000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-115" decimals="-6" id="f-493" unitRef="usd">1676000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-116" decimals="-6" id="f-494" unitRef="usd">1493000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-117" decimals="-6" id="f-495" unitRef="usd">1059000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-118" decimals="-6" id="f-496" unitRef="usd">988000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-119" decimals="-6" id="f-497" unitRef="usd">896000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-120" decimals="-6" id="f-498" unitRef="usd">2586000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-121" decimals="-6" id="f-499" unitRef="usd">2297000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-122" decimals="-6" id="f-500" unitRef="usd">2035000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-123" decimals="-6" id="f-501" unitRef="usd">489000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-124" decimals="-6" id="f-502" unitRef="usd">500000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-125" decimals="-6" id="f-503" unitRef="usd">511000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-126" decimals="-6" id="f-504" unitRef="usd">504000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-127" decimals="-6" id="f-505" unitRef="usd">468000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-128" decimals="-6" id="f-506" unitRef="usd">455000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-129" decimals="-6" id="f-507" unitRef="usd">6426000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-130" decimals="-6" id="f-508" unitRef="usd">5929000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-131" decimals="-6" id="f-509" unitRef="usd">5390000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-132" decimals="-6" id="f-510" unitRef="usd">16943000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-133" decimals="-6" id="f-511" unitRef="usd">15257000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-134" decimals="-6" id="f-512" unitRef="usd">13638000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-135" decimals="-6" id="f-513" unitRef="usd">567000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-136" decimals="-6" id="f-514" unitRef="usd">518000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-137" decimals="-6" id="f-515" unitRef="usd">469000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-138" decimals="-6" id="f-516" unitRef="usd">597000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-139" decimals="-6" id="f-517" unitRef="usd">555000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-140" decimals="-6" id="f-518" unitRef="usd">514000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-141" decimals="-6" id="f-519" unitRef="usd">661000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-142" decimals="-6" id="f-520" unitRef="usd">674000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-143" decimals="-6" id="f-521" unitRef="usd">609000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-144" decimals="-6" id="f-522" unitRef="usd">801000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-145" decimals="-6" id="f-523" unitRef="usd">743000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-146" decimals="-6" id="f-524" unitRef="usd">754000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-147" decimals="-6" id="f-525" unitRef="usd">375000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-148" decimals="-6" id="f-526" unitRef="usd">345000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-149" decimals="-6" id="f-527" unitRef="usd">299000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-150" decimals="-6" id="f-528" unitRef="usd">3001000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-151" decimals="-6" id="f-529" unitRef="usd">2835000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-152" decimals="-6" id="f-530" unitRef="usd">2645000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-153" decimals="-6" id="f-531" unitRef="usd">659000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-154" decimals="-6" id="f-532" unitRef="usd">597000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-155" decimals="-6" id="f-533" unitRef="usd">504000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-156" decimals="-6" id="f-534" unitRef="usd">645000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-157" decimals="-6" id="f-535" unitRef="usd">556000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-158" decimals="-6" id="f-536" unitRef="usd">517000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-159" decimals="-6" id="f-537" unitRef="usd">921000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-160" decimals="-6" id="f-538" unitRef="usd">850000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-161" decimals="-6" id="f-539" unitRef="usd">772000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-162" decimals="-6" id="f-540" unitRef="usd">218000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-163" decimals="-6" id="f-541" unitRef="usd">213000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-164" decimals="-6" id="f-542" unitRef="usd">222000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-165" decimals="-6" id="f-543" unitRef="usd">208000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-166" decimals="-6" id="f-544" unitRef="usd">190000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-167" decimals="-6" id="f-545" unitRef="usd">151000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-168" decimals="-6" id="f-546" unitRef="usd">2651000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-169" decimals="-6" id="f-547" unitRef="usd">2406000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-170" decimals="-6" id="f-548" unitRef="usd">2166000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-171" decimals="-6" id="f-549" unitRef="usd">5652000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-172" decimals="-6" id="f-550" unitRef="usd">5241000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-173" decimals="-6" id="f-551" unitRef="usd">4811000000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerLiability contextRef="c-14" decimals="-6" id="f-552" unitRef="usd">978000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-15" decimals="-6" id="f-553" unitRef="usd">860000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="c-1" id="f-554">Changes in contract liabilities during the year were as follows:&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:81.658%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;860&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Revenue recognized from beginning of year contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net advance consideration received during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;978&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability contextRef="c-15" decimals="-6" id="f-555" unitRef="usd">860000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-1" decimals="-6" id="f-556" unitRef="usd">553000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <syk:ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod contextRef="c-1" decimals="-6" id="f-557" unitRef="usd">671000000</syk:ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod>
    <us-gaap:ContractWithCustomerLiability contextRef="c-14" decimals="-6" id="f-558" unitRef="usd">978000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-559">FAIR VALUE MEASUREMENTS &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets and liabilities carried at fair value are classified in their entirety based on the lowest level of input and disclosed in one of the following three categories:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.693%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.107%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unobservable inputs reflecting our assumptions or external inputs from active markets.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Use of observable market data, when available, is required in making fair value measurements. When inputs used fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement. We determine fair value for Level 1 instruments using exchange-traded prices for identical instruments. We determine fair value of Level 2 instruments using exchange-traded prices of similar instruments, where available, or utilizing other observable inputs that take into account our credit risk and that of our counterparties. Foreign currency exchange contracts and interest rate hedges, when outstanding, are included in Level 2 and are primarily valued using standard calculations and models that use readily observable market data as their basis. Our Level 3 liabilities are comprised of contingent consideration arising from recently completed acquisitions. We determine fair value of these Level 3 liabilities using a discounted cash flow technique. Significant unobservable inputs were used in our assessment of fair value, including assumptions regarding future business results, discount rates, discount periods and probability assessments based on the likelihood of reaching various targets. We remeasure the fair value of our assets and liabilities each reporting period. We record the changes in fair value within selling, general and administrative expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In 2024 we recorded $208 of contingent consideration related to various acquisitions described in Note 6.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In 2023 we recorded $192 of contingent consideration related to the acquisition of Cerus described in Note 6.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There were no significant transfers into or out of any level of the fair value hierarchy in 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.179%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.253%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Assets Measured at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trading marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1 - Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,661&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,180&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Available-for-sale marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and asset-backed debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States agency debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States treasury debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total available-for-sale marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2 - Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;316&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;198&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,977&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.179%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.253%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Liabilities Measured at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred compensation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;259&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;209&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;77&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contingent consideration:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Beginning&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Change in estimate and foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Ending&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;452&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;289&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;788&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;595&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.179%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.253%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Fair Value of Available for Sale Securities by Maturity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Due after one year through three years&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On December&#160;31, 2024 the aggregate difference between the cost and fair value of available-for-sale marketable securities was nominal. Interest income on cash and cash equivalents, short-term investments and marketable securities income was $139, $75 and $25 in 2024, 2023 and 2022, which was recorded in other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our investments in available-for-sale marketable securities had a minimum credit quality rating of A2 (Moody's), A (Standard &amp;amp; Poor's) and A (Fitch). We do not plan to sell the investments, and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost basis, which may be maturity.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1 contextRef="c-12" decimals="-6" id="f-560" unitRef="usd">-208000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-174" decimals="-6" id="f-561" unitRef="usd">192000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-562">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.179%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.253%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Assets Measured at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trading marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1 - Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,661&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,180&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Available-for-sale marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and asset-backed debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States agency debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States treasury debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total available-for-sale marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2 - Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;316&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;198&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,977&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.179%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.253%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Liabilities Measured at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred compensation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;259&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;209&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;77&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contingent consideration:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Beginning&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Change in estimate and foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Ending&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;452&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;289&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;788&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;595&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-175" decimals="-6" id="f-563" unitRef="usd">3652000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-176" decimals="-6" id="f-564" unitRef="usd">2971000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:ShortTermInvestments contextRef="c-175" decimals="-6" id="f-565" unitRef="usd">750000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-176" decimals="-6" id="f-566" unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:TradingSecuritiesDebt contextRef="c-175" decimals="-6" id="f-567" unitRef="usd">259000000</us-gaap:TradingSecuritiesDebt>
    <us-gaap:TradingSecuritiesDebt contextRef="c-176" decimals="-6" id="f-568" unitRef="usd">209000000</us-gaap:TradingSecuritiesDebt>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-175" decimals="-6" id="f-569" unitRef="usd">4661000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-176" decimals="-6" id="f-570" unitRef="usd">3180000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-177" decimals="-6" id="f-571" unitRef="usd">53000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-178" decimals="-6" id="f-572" unitRef="usd">43000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-179" decimals="-6" id="f-573" unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-180" decimals="-6" id="f-574" unitRef="usd">4000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-181" decimals="-6" id="f-575" unitRef="usd">34000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-182" decimals="-6" id="f-576" unitRef="usd">31000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-183" decimals="-6" id="f-577" unitRef="usd">3000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-184" decimals="-6" id="f-578" unitRef="usd">4000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-185" decimals="-6" id="f-579" unitRef="usd">91000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-186" decimals="-6" id="f-580" unitRef="usd">82000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DerivativeAssets contextRef="c-187" decimals="-6" id="f-581" unitRef="usd">225000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-188" decimals="-6" id="f-582" unitRef="usd">116000000</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-185" decimals="-6" id="f-583" unitRef="usd">316000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-186" decimals="-6" id="f-584" unitRef="usd">198000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-14" decimals="-6" id="f-585" unitRef="usd">4977000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-15" decimals="-6" id="f-586" unitRef="usd">3378000000</us-gaap:AssetsFairValueDisclosure>
    <syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities contextRef="c-175" decimals="-6" id="f-587" unitRef="usd">259000000</syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities>
    <syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities contextRef="c-176" decimals="-6" id="f-588" unitRef="usd">209000000</syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-175" decimals="-6" id="f-589" unitRef="usd">259000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-176" decimals="-6" id="f-590" unitRef="usd">209000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="c-187" decimals="-6" id="f-591" unitRef="usd">77000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="c-188" decimals="-6" id="f-592" unitRef="usd">97000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-185" decimals="-6" id="f-593" unitRef="usd">77000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-186" decimals="-6" id="f-594" unitRef="usd">97000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-189" decimals="-6" id="f-595" unitRef="usd">289000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-190" decimals="-6" id="f-596" unitRef="usd">121000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues contextRef="c-191" decimals="-6" id="f-597" unitRef="usd">208000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues contextRef="c-192" decimals="-6" id="f-598" unitRef="usd">192000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease contextRef="c-191" decimals="-6" id="f-599" unitRef="usd">-8000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease contextRef="c-192" decimals="-6" id="f-600" unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="c-191" decimals="-6" id="f-601" unitRef="usd">53000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="c-192" decimals="-6" id="f-602" unitRef="usd">22000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-193" decimals="-6" id="f-603" unitRef="usd">452000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-189" decimals="-6" id="f-604" unitRef="usd">289000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-193" decimals="-6" id="f-605" unitRef="usd">452000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-189" decimals="-6" id="f-606" unitRef="usd">289000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-14" decimals="-6" id="f-607" unitRef="usd">788000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-15" decimals="-6" id="f-608" unitRef="usd">595000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock contextRef="c-1" id="f-609">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.179%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.253%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Fair Value of Available for Sale Securities by Maturity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Due after one year through three years&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue contextRef="c-14" decimals="-6" id="f-610" unitRef="usd">47000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue contextRef="c-15" decimals="-6" id="f-611" unitRef="usd">46000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue contextRef="c-14" decimals="-6" id="f-612" unitRef="usd">44000000</syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue>
    <syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue contextRef="c-15" decimals="-6" id="f-613" unitRef="usd">36000000</syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue>
    <us-gaap:InterestIncomeInterestEarningAsset contextRef="c-1" decimals="-6" id="f-614" unitRef="usd">139000000</us-gaap:InterestIncomeInterestEarningAsset>
    <us-gaap:InterestIncomeInterestEarningAsset contextRef="c-12" decimals="-6" id="f-615" unitRef="usd">75000000</us-gaap:InterestIncomeInterestEarningAsset>
    <us-gaap:InterestIncomeInterestEarningAsset contextRef="c-13" decimals="-6" id="f-616" unitRef="usd">25000000</us-gaap:InterestIncomeInterestEarningAsset>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="c-1" id="f-617">DERIVATIVE INSTRUMENTS&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We use operational and economic hedges, foreign currency exchange forward contracts, net investment hedges (both derivative and non-derivative financial instruments) and interest rate derivative instruments to manage the impact of currency exchange and interest rate fluctuations on earnings, cash flow and equity. We do not enter into derivative instruments for speculative purposes. We are exposed to potential credit loss in the event of nonperformance by counterparties on our outstanding derivative instruments but do not anticipate nonperformance by any of our counterparties. Should a counterparty default, our maximum loss exposure is the asset balance of the instrument. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Foreign Currency Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.805%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.805%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.805%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.661%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-Designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross notional amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,588&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,338&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,164&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,090&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Maximum term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;78&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-Designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross notional amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,650&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,662&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,315&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,627&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Maximum term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We had &#x20ac;2.3&#160;billion and &#x20ac;1.5&#160;billion at December 31, 2024 and 2023 in certain forward currency contracts designated as net investment hedges, for which the maximum term is 9.7 years, to hedge a portion of our investments in certain of our entities with functional currencies denominated in Euros. In addition to these derivative financial instruments designated as net investment hedges, we had &#x20ac;5.0&#160;billion and &#x20ac;4.9&#160;billion at December 31, 2024 and 2023 of senior unsecured notes designated as net investment hedges to selectively hedge portions of our investment in certain international subsidiaries. The currency effects of our Euro-denominated senior unsecured notes are reflected in AOCI within shareholders' equity where they offset gains and losses recorded on our net investment in international subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In 2024 we settled certain foreign currency forward contracts designated as net investment hedges resulting in cash proceeds of $99. The amounts in AOCI related to settled net investment hedges will remain in AOCI until the hedged investment is either sold or substantially liquidated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The total after-tax gain (loss) recognized in OCI related to designated net investment hedges was $325 in 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.917%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.437%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.956%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.437%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.956%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.440%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Currency Exchange Rate Gains (Losses) Recognized in Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Recognized in:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-Designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;106&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;98&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;92&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Pretax gains (losses) on derivatives designated as cash flow hedges of $14 and net investment hedges of $43 recorded in AOCI are expected to be reclassified to cost of sales and other income (expense), net in earnings within 12 months of December&#160;31, 2024. This cash flow hedge reclassification is primarily due to the sale of inventory that includes previously hedged purchases. A component of the AOCI amounts related to net investment hedges is reclassified over the life of the hedge instruments as we elected to exclude the initial value of the component related to the spot-forward difference from the effectiveness assessment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Interest Rate Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Pretax gains of $4 recorded in AOCI related to interest rate hedges closed in conjunction with debt issuances are expected to be reclassified to other income (expense), net in earnings within 12 months of December&#160;31, 2024. The cash flow effect of interest rate hedges is recorded in cash flow from operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="c-1" id="f-618">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.805%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.805%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.805%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.661%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-Designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross notional amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,588&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,338&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,164&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,090&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Maximum term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;78&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-Designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross notional amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,650&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,662&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,315&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,627&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Maximum term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeNotionalAmount contextRef="c-194" decimals="-6" id="f-619" unitRef="usd">1588000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-195" decimals="-6" id="f-620" unitRef="usd">2338000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-196" decimals="-6" id="f-621" unitRef="usd">5164000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-197" decimals="-6" id="f-622" unitRef="usd">9090000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1 contextRef="c-198" id="f-623">P9Y8M12D</us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-199" decimals="-6" id="f-624" unitRef="usd">43000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-200" decimals="-6" id="f-625" unitRef="usd">24000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-201" decimals="-6" id="f-626" unitRef="usd">119000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-202" decimals="-6" id="f-627" unitRef="usd">186000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-203" decimals="-6" id="f-628" unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-204" decimals="-6" id="f-629" unitRef="usd">35000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-205" decimals="-6" id="f-630" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-206" decimals="-6" id="f-631" unitRef="usd">39000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-207" decimals="-6" id="f-632" unitRef="usd">29000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-208" decimals="-6" id="f-633" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-209" decimals="-6" id="f-634" unitRef="usd">41000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-210" decimals="-6" id="f-635" unitRef="usd">70000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-211" decimals="-6" id="f-636" unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-212" decimals="-6" id="f-637" unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-213" decimals="-6" id="f-638" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-214" decimals="-6" id="f-639" unitRef="usd">7000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="c-194" decimals="-6" id="f-640" unitRef="usd">15000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="c-195" decimals="-6" id="f-641" unitRef="usd">55000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="c-196" decimals="-6" id="f-642" unitRef="usd">78000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="c-197" decimals="-6" id="f-643" unitRef="usd">148000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount contextRef="c-215" decimals="-6" id="f-644" unitRef="usd">1650000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-216" decimals="-6" id="f-645" unitRef="usd">1662000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-217" decimals="-6" id="f-646" unitRef="usd">4315000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-218" decimals="-6" id="f-647" unitRef="usd">7627000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1 contextRef="c-219" id="f-648">P2Y10M24D</us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-220" decimals="-6" id="f-649" unitRef="usd">24000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-221" decimals="-6" id="f-650" unitRef="usd">74000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-222" decimals="-6" id="f-651" unitRef="usd">16000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-223" decimals="-6" id="f-652" unitRef="usd">114000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-224" decimals="-6" id="f-653" unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-225" decimals="-6" id="f-654" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-226" decimals="-6" id="f-655" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-227" decimals="-6" id="f-656" unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-228" decimals="-6" id="f-657" unitRef="usd">16000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-229" decimals="-6" id="f-658" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-230" decimals="-6" id="f-659" unitRef="usd">36000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-231" decimals="-6" id="f-660" unitRef="usd">52000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-232" decimals="-6" id="f-661" unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-233" decimals="-6" id="f-662" unitRef="usd">43000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-234" decimals="-6" id="f-663" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-235" decimals="-6" id="f-664" unitRef="usd">45000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="c-215" decimals="-6" id="f-665" unitRef="usd">8000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="c-216" decimals="-6" id="f-666" unitRef="usd">31000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="c-217" decimals="-6" id="f-667" unitRef="usd">-20000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="c-218" decimals="-6" id="f-668" unitRef="usd">19000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount contextRef="c-195" decimals="-8" id="f-669" unitRef="eur">2300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-216" decimals="-8" id="f-670" unitRef="eur">1500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeTermOfContract contextRef="c-198" id="f-671">P9Y8M12D</us-gaap:DerivativeTermOfContract>
    <us-gaap:DerivativeNotionalAmount contextRef="c-236" decimals="-8" id="f-672" unitRef="eur">5000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-237" decimals="-8" id="f-673" unitRef="eur">4900000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ProceedsFromHedgeInvestingActivities contextRef="c-1" decimals="-6" id="f-674" unitRef="usd">99000000</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax contextRef="c-238" decimals="-6" id="f-675" unitRef="usd">325000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock contextRef="c-1" id="f-676">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.917%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.437%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.956%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.437%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.956%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.440%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Currency Exchange Rate Gains (Losses) Recognized in Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Recognized in:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-Designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;106&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;98&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;92&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-239" decimals="-6" id="f-677" unitRef="usd">31000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-240" decimals="-6" id="f-678" unitRef="usd">39000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-241" decimals="-6" id="f-679" unitRef="usd">23000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-242" decimals="-6" id="f-680" unitRef="usd">35000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-243" decimals="-6" id="f-681" unitRef="usd">34000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-244" decimals="-6" id="f-682" unitRef="usd">39000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-245" decimals="-6" id="f-683" unitRef="usd">40000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-246" decimals="-6" id="f-684" unitRef="usd">25000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-247" decimals="-6" id="f-685" unitRef="usd">30000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-198" decimals="-6" id="f-686" unitRef="usd">106000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-219" decimals="-6" id="f-687" unitRef="usd">98000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-248" decimals="-6" id="f-688" unitRef="usd">92000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths contextRef="c-238" decimals="-6" id="f-689" unitRef="usd">14000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax contextRef="c-238" decimals="-6" id="f-690" unitRef="usd">43000000</us-gaap:DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths contextRef="c-249" decimals="-6" id="f-691" unitRef="usd">4000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="c-1" id="f-692">ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME (AOCI)&lt;div style="margin-bottom:1pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.565%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.868%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.868%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.902%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.871%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial Statement Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reclassifications to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reclassifications to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-693">&lt;div style="margin-bottom:1pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.565%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.868%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.868%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.902%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.871%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial Statement Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reclassifications to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reclassifications to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-250" decimals="-6" id="f-694" unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-251" decimals="-6" id="f-695" unitRef="usd">31000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-252" decimals="-6" id="f-696" unitRef="usd">52000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-253" decimals="-6" id="f-697" unitRef="usd">-303000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-43" decimals="-6" id="f-698" unitRef="usd">-221000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-254" decimals="-6" id="f-699" unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-255" decimals="-6" id="f-700" unitRef="usd">-67000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-256" decimals="-6" id="f-701" unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-257" decimals="-6" id="f-702" unitRef="usd">-157000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-12" decimals="-6" id="f-703" unitRef="usd">-196000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-254" decimals="-6" id="f-704" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-255" decimals="-6" id="f-705" unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-256" decimals="-6" id="f-706" unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-257" decimals="-6" id="f-707" unitRef="usd">59000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-12" decimals="-6" id="f-708" unitRef="usd">66000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:CostOfRevenue contextRef="c-258" decimals="-6" id="f-709" unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-259" decimals="-6" id="f-710" unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-260" decimals="-6" id="f-711" unitRef="usd">-39000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-261" decimals="-6" id="f-712" unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-262" decimals="-6" id="f-713" unitRef="usd">-39000000</us-gaap:CostOfRevenue>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-258" decimals="-6" id="f-714" unitRef="usd">0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-259" decimals="-6" id="f-715" unitRef="usd">-5000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-260" decimals="-6" id="f-716" unitRef="usd">-5000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-261" decimals="-6" id="f-717" unitRef="usd">-34000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-262" decimals="-6" id="f-718" unitRef="usd">-44000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-258" decimals="-6" id="f-719" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-259" decimals="-6" id="f-720" unitRef="usd">1000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-260" decimals="-6" id="f-721" unitRef="usd">9000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-261" decimals="-6" id="f-722" unitRef="usd">8000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-262" decimals="-6" id="f-723" unitRef="usd">18000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-258" decimals="-6" id="f-724" unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-259" decimals="-6" id="f-725" unitRef="usd">-59000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-260" decimals="-6" id="f-726" unitRef="usd">-13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-261" decimals="-6" id="f-727" unitRef="usd">-124000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-262" decimals="-6" id="f-728" unitRef="usd">-195000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-263" decimals="-6" id="f-729" unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-264" decimals="-6" id="f-730" unitRef="usd">-28000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-265" decimals="-6" id="f-731" unitRef="usd">39000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-266" decimals="-6" id="f-732" unitRef="usd">-427000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-15" decimals="-6" id="f-733" unitRef="usd">-416000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-267" decimals="-6" id="f-734" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-268" decimals="-6" id="f-735" unitRef="usd">43000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-269" decimals="-6" id="f-736" unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-270" decimals="-6" id="f-737" unitRef="usd">236000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-1" decimals="-6" id="f-738" unitRef="usd">305000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-267" decimals="-6" id="f-739" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-268" decimals="-6" id="f-740" unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-269" decimals="-6" id="f-741" unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-270" decimals="-6" id="f-742" unitRef="usd">-110000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-1" decimals="-6" id="f-743" unitRef="usd">-128000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:CostOfRevenue contextRef="c-271" decimals="-6" id="f-744" unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-272" decimals="-6" id="f-745" unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-273" decimals="-6" id="f-746" unitRef="usd">-31000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-274" decimals="-6" id="f-747" unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-275" decimals="-6" id="f-748" unitRef="usd">-31000000</us-gaap:CostOfRevenue>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-271" decimals="-6" id="f-749" unitRef="usd">0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-272" decimals="-6" id="f-750" unitRef="usd">0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-273" decimals="-6" id="f-751" unitRef="usd">-4000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-274" decimals="-6" id="f-752" unitRef="usd">-35000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-275" decimals="-6" id="f-753" unitRef="usd">-39000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-271" decimals="-6" id="f-754" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-272" decimals="-6" id="f-755" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-273" decimals="-6" id="f-756" unitRef="usd">8000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-274" decimals="-6" id="f-757" unitRef="usd">8000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-275" decimals="-6" id="f-758" unitRef="usd">16000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-271" decimals="-6" id="f-759" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-272" decimals="-6" id="f-760" unitRef="usd">32000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-273" decimals="-6" id="f-761" unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-274" decimals="-6" id="f-762" unitRef="usd">99000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-275" decimals="-6" id="f-763" unitRef="usd">123000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-276" decimals="-6" id="f-764" unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-277" decimals="-6" id="f-765" unitRef="usd">4000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-278" decimals="-6" id="f-766" unitRef="usd">31000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-279" decimals="-6" id="f-767" unitRef="usd">-328000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-14" decimals="-6" id="f-768" unitRef="usd">-293000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c-1" id="f-769">ACQUISITIONS&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We acquire stock in companies and various assets that continue to support our capital deployment and product development strategies. Cash paid for acquisitions, net of cash acquired was $1,628 and $390  in 2024 and 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In 2024 we completed various acquisitions for total consideration that includes $1,628 in upfront payments, net of cash acquired, and $400 contingent upon the achievement of certain commercial or clinical milestones. The combined acquisition-date fair values of the contingent milestone payments totaled $208. The acquired companies expand the product portfolios of our Instruments, Endoscopy, Medical and Neuro Cranial businesses within MedSurg and Neurotechnology and our Trauma and Extremities and Joint Replacement businesses within Orthopaedics. The purchase price allocation for our acquisitions are based on preliminary valuations, primarily related to developed technology &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and customer relationships. Goodwill attributable to the acquisitions reflects the strategic benefits of expanding our market presence, diversifying our product portfolio and advancing innovations. This goodwill is not deductible for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On May 2, 2023 we acquired Cerus for net cash consideration of $289 and up to $225 in future milestone payments that had a fair value of $192 at the acquisition date. Cerus designs, develops and manufactures neurovascular products used for the treatment of hemorrhagic stroke. Cerus is part of our Neurovascular business within MedSurg and Neurotechnology. Goodwill attributable to the acquisition is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The purchase price allocations for the acquisitions completed in 2024 and Cerus are:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.956%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.463%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.465%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Purchase Price Allocation of Acquired Net Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cerus&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tangible assets acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchase price, net of cash acquired of $57 and $7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,836&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;481&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average amortization period at acquisition (years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The purchase price allocation for Cerus was finalized in the second quarter 2024 with no material adjustments.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-280" decimals="-6" id="f-770" unitRef="usd">1628000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-12" decimals="-6" id="f-771" unitRef="usd">390000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-280" decimals="-6" id="f-772" unitRef="usd">1628000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh contextRef="c-280" decimals="-6" id="f-773" unitRef="usd">400000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-281" decimals="-6" id="f-774" unitRef="usd">208000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-282" decimals="-6" id="f-775" unitRef="usd">289000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="c-283" decimals="-6" id="f-776" unitRef="usd">225000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-283" decimals="-6" id="f-777" unitRef="usd">192000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="c-1" id="f-778">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The purchase price allocations for the acquisitions completed in 2024 and Cerus are:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.956%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.463%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.208%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.465%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Purchase Price Allocation of Acquired Net Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cerus&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tangible assets acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchase price, net of cash acquired of $57 and $7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,836&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;481&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average amortization period at acquisition (years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables contextRef="c-281" decimals="-6" id="f-779" unitRef="usd">46000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables contextRef="c-283" decimals="-6" id="f-780" unitRef="usd">1000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory contextRef="c-281" decimals="-6" id="f-781" unitRef="usd">112000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory contextRef="c-283" decimals="-6" id="f-782" unitRef="usd">2000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets contextRef="c-281" decimals="-6" id="f-783" unitRef="usd">28000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets contextRef="c-283" decimals="-6" id="f-784" unitRef="usd">4000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets contextRef="c-281" decimals="-6" id="f-785" unitRef="usd">27000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets contextRef="c-283" decimals="-6" id="f-786" unitRef="usd">1000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <syk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt contextRef="c-281" decimals="-6" id="f-787" unitRef="usd">42000000</syk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt>
    <syk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt contextRef="c-283" decimals="-6" id="f-788" unitRef="usd">0</syk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities contextRef="c-281" decimals="-6" id="f-789" unitRef="usd">205000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities contextRef="c-283" decimals="-6" id="f-790" unitRef="usd">60000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther contextRef="c-281" decimals="-6" id="f-791" unitRef="usd">102000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther contextRef="c-283" decimals="-6" id="f-792" unitRef="usd">22000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-284" decimals="-6" id="f-793" unitRef="usd">596000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-285" decimals="-6" id="f-794" unitRef="usd">240000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-286" decimals="-6" id="f-795" unitRef="usd">214000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-287" decimals="-6" id="f-796" unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-288" decimals="-6" id="f-797" unitRef="usd">6000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-289" decimals="-6" id="f-798" unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-290" decimals="-6" id="f-799" unitRef="usd">2000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-291" decimals="-6" id="f-800" unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill contextRef="c-281" decimals="-6" id="f-801" unitRef="usd">1154000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-283" decimals="-6" id="f-802" unitRef="usd">315000000</us-gaap:Goodwill>
    <us-gaap:CashAcquiredFromAcquisition contextRef="c-280" decimals="-6" id="f-803" unitRef="usd">57000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition contextRef="c-282" decimals="-6" id="f-804" unitRef="usd">7000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-281" decimals="-6" id="f-805" unitRef="usd">1836000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-283" decimals="-6" id="f-806" unitRef="usd">481000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-292" id="f-807">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-293" id="f-808">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-294" id="f-809">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-295" id="f-810">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-296" id="f-811">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-812">CONTINGENCIES AND COMMITMENTS&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We are involved in various ongoing proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor, intellectual property and other matters, the most significant of which are more fully described below. The outcomes of these matters will generally not be known for prolonged periods of time. In certain of the legal proceedings the claimants seek damages as well as other compensatory and equitable relief that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief. For legal matters for which management had sufficient information to reasonably estimate our future obligations, a liability representing management's best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, is recorded. The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those estimated by management, additional expense may be incurred, which could unfavorably affect future operating results. We are self-insured for certain claims and expenses. The ultimate cost to us with respect to product liability claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.333%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We are currently investigating whether certain business activities in certain foreign countries violated provisions of the FCPA and have engaged outside counsel to conduct these investigations. We have been contacted by the United States Securities and Exchange Commission, United States Department of Justice and certain other regulatory authorities and are cooperating with these agencies. At this time we are unable to predict the outcome of the investigations or the potential impact, if any, on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We have conducted voluntary recalls of certain products, including our Rejuvenate and ABG II Modular-Neck hip stems and certain lot-specific sizes and offsets of LFIT Anatomic CoCr V40 Femoral Heads. Additionally, we are responsible for certain product liability claims, primarily related to certain hip products sold by Wright prior to its 2014 divestiture of the OrthoRecon business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We have incurred, and expect to incur in the future, costs associated with the defense and settlement of claims and lawsuits. Based on the information that has been received related to the matters discussed above, we recorded charges of $17 in 2024 and our accrual for these matters was $202 at December&#160;31, 2024, representing our best estimate of probable loss. The final outcomes of these matters are dependent on many factors that are difficult to predict. Accordingly the ultimate cost related to these matters may be materially different than the amount of our current estimate and accruals and could have a material adverse effect on our results of operations and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment under operating leases. We evaluate our contracts to identify leases, which is generally if there is an identified asset and we have the right to direct the use of and obtain substantially all of the economic benefit from the use of the identified asset. Certain of our lease agreements contain rent escalation clauses (including index-based escalations), rent holidays, capital improvement funding or other lease incentives. We recognize our minimum rental expense on a straight-line basis over the term of the lease beginning with the date of initial control of the asset. Right-of-use assets are recorded in Other noncurrent assets on our Consolidated Balance Sheets. Current and noncurrent lease liabilities are recorded in Accrued expenses and other liabilities and Other noncurrent liabilities, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We have made certain significant assumptions and judgments when recording leases. For all asset classes, we do not recognize a right-of-use asset and lease liability for short-term leases. We also do not separate non-lease components from lease components to which they relate and account for the combined lease and non-lease components as a single lease component. The determination of the discount rate used in a lease is our incremental borrowing rate which is based on what we would normally pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.493%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.253%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-816"&gt;&lt;span style="-sec-ix-hidden:f-817"&gt;Right-of-use assets&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-820"&gt;&lt;span style="-sec-ix-hidden:f-821"&gt;Lease liabilities, current&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-824"&gt;&lt;span style="-sec-ix-hidden:f-825"&gt;Lease liabilities, noncurrent&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;text-indent:-0.01pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease expense totaled $190, $172, and $149 in 2024, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Future Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We have purchase commitments for materials, supplies, services and property, plant and equipment as part of the normal course of business. In addition, we lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment under operating leases. Refer to Note 10 for more information on the debt obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.945%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.570%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt repayments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Purchase obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Other Contractual Obligations and Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We participate in a supplier financing program that enables our suppliers, at their sole discretion, to sell their Stryker receivables to a financial institution on a non-recourse basis in order to be paid earlier than our payment terms provide. Under this program, we agree to pay participating banks the stated amount of confirmed invoices from its designated suppliers on the original maturity dates of the invoices, generally within 90 days of the invoice date. We or the banks may agree to terminate the agreements with advance notice. Separately, the banks may have arrangements with the suppliers that provide them the option to request early payment from the bank for invoices confirmed by us. Our outstanding balances of confirmed invoices in the programs were $71 and $51 in 2024 and 2023 and are included within &lt;span style="-sec-ix-hidden:f-856"&gt;&lt;span style="-sec-ix-hidden:f-857"&gt;&lt;span style="-sec-ix-hidden:f-858"&gt;Accounts payable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; of the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.922%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.878%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning confirmed obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(372)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending confirmed obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;71&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyLossInPeriod contextRef="c-297" decimals="-6" id="f-813" unitRef="usd">17000000</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:LossContingencyEstimateOfPossibleLoss contextRef="c-298" decimals="-6" id="f-814" unitRef="usd">202000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-815">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.493%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.253%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-816"&gt;&lt;span style="-sec-ix-hidden:f-817"&gt;Right-of-use assets&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-820"&gt;&lt;span style="-sec-ix-hidden:f-821"&gt;Lease liabilities, current&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-824"&gt;&lt;span style="-sec-ix-hidden:f-825"&gt;Lease liabilities, noncurrent&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;text-indent:-0.01pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-14" decimals="-6" id="f-818" unitRef="usd">516000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-15" decimals="-6" id="f-819" unitRef="usd">494000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-14" decimals="-6" id="f-822" unitRef="usd">144000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-15" decimals="-6" id="f-823" unitRef="usd">143000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-14" decimals="-6" id="f-826" unitRef="usd">379000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-15" decimals="-6" id="f-827" unitRef="usd">356000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-14" id="f-828">P5Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-15" id="f-829">P5Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-14" decimals="4" id="f-830" unitRef="number">0.0387</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-15" decimals="4" id="f-831" unitRef="number">0.0387</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseExpense contextRef="c-1" decimals="-6" id="f-832" unitRef="usd">190000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-12" decimals="-6" id="f-833" unitRef="usd">172000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-13" decimals="-6" id="f-834" unitRef="usd">149000000</us-gaap:OperatingLeaseExpense>
    <srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock contextRef="c-1" id="f-835">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.945%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.570%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt repayments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Purchase obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c-14" decimals="-6" id="f-836" unitRef="usd">1410000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c-14" decimals="-6" id="f-837" unitRef="usd">1000000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="c-14" decimals="-6" id="f-838" unitRef="usd">779000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="c-14" decimals="-6" id="f-839" unitRef="usd">1823000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive contextRef="c-14" decimals="-6" id="f-840" unitRef="usd">1581000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive contextRef="c-14" decimals="-6" id="f-841" unitRef="usd">7109000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear contextRef="c-14" decimals="-6" id="f-842" unitRef="usd">2610000000</us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueInSecondYear contextRef="c-14" decimals="-6" id="f-843" unitRef="usd">157000000</us-gaap:RecordedUnconditionalPurchaseObligationDueInSecondYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueInThirdYear contextRef="c-14" decimals="-6" id="f-844" unitRef="usd">43000000</us-gaap:RecordedUnconditionalPurchaseObligationDueInThirdYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueInFourthYear contextRef="c-14" decimals="-6" id="f-845" unitRef="usd">16000000</us-gaap:RecordedUnconditionalPurchaseObligationDueInFourthYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueInFifthYear contextRef="c-14" decimals="-6" id="f-846" unitRef="usd">14000000</us-gaap:RecordedUnconditionalPurchaseObligationDueInFifthYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueAfterFifthYear contextRef="c-14" decimals="-6" id="f-847" unitRef="usd">15000000</us-gaap:RecordedUnconditionalPurchaseObligationDueAfterFifthYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-14" decimals="-6" id="f-848" unitRef="usd">156000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-14" decimals="-6" id="f-849" unitRef="usd">126000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-14" decimals="-6" id="f-850" unitRef="usd">91000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-14" decimals="-6" id="f-851" unitRef="usd">61000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-14" decimals="-6" id="f-852" unitRef="usd">43000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-14" decimals="-6" id="f-853" unitRef="usd">73000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:SupplierFinanceProgramObligationCurrent contextRef="c-14" decimals="-6" id="f-854" unitRef="usd">71000000</us-gaap:SupplierFinanceProgramObligationCurrent>
    <us-gaap:SupplierFinanceProgramObligationCurrent contextRef="c-15" decimals="-6" id="f-855" unitRef="usd">51000000</us-gaap:SupplierFinanceProgramObligationCurrent>
    <us-gaap:SupplierFinanceProgramTableTextBlock contextRef="c-1" id="f-859">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.922%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.878%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning confirmed obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(372)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending confirmed obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;71&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplierFinanceProgramTableTextBlock>
    <us-gaap:SupplierFinanceProgramObligation contextRef="c-15" decimals="-6" id="f-860" unitRef="usd">51000000</us-gaap:SupplierFinanceProgramObligation>
    <us-gaap:SupplierFinanceProgramObligationIncrease contextRef="c-1" decimals="-6" id="f-861" unitRef="usd">392000000</us-gaap:SupplierFinanceProgramObligationIncrease>
    <us-gaap:SupplierFinanceProgramObligationDecreaseSettlement contextRef="c-1" decimals="-6" id="f-862" unitRef="usd">372000000</us-gaap:SupplierFinanceProgramObligationDecreaseSettlement>
    <us-gaap:SupplierFinanceProgramObligation contextRef="c-14" decimals="-6" id="f-863" unitRef="usd">71000000</us-gaap:SupplierFinanceProgramObligation>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-864">GOODWILL AND OTHER INTANGIBLE ASSETS&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In our annual impairment tests of goodwill as of October 31, 2024 and 2023 we performed a quantitative assessment of the Spine reporting unit using a discounted cash flow analysis to estimate the fair value. Significant inputs to the analysis included assumptions for future revenue growth and operating margin. The analysis also included a rate to discount the estimated future cash flow projections to their present value based on the reporting unit&#x2019;s estimated weighted average cost of capital. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In 2024 the carrying value of the Spine reporting unit exceeded its fair value and a charge of $273 was recognized in goodwill and other impairments in the Consolidated Statements of Earnings. The impairment charge for the Spine reporting unit was driven by a decrease in future product demand due to the competitive environment and an increase in the Spine reporting unit&#x2019;s weighted average cost of capital. Subsequent to the annual goodwill impairment test management committed to a plan to sell certain assets associated with&#x202f;the Spinal Implants business (disposal group).&#x202f;Goodwill was allocated to the disposal group based on the relative fair values of the disposal group and the portion of the Spine reporting unit that will be retained. Goodwill allocated to the disposal group was tested for impairment which resulted in an impairment charge of $183 recognized in goodwill and other impairments. Refer to Note 16 for additional information on the assets classified as held for sale. For our annual impairment test in 2023 we also elected to perform a quantitative assessment. As a result of that assessment we concluded that the goodwill of the Spine reporting unit was not impaired in 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;For our other reporting units, we considered qualitative indicators of impairment as it was considered more likely than not that the fair values of those reporting units exceeded their respective carrying values. No impairment was identified for those reporting units in 2024 or 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill, including discount and tax rates and future cash flow projections, could result in significantly different estimates of the fair values. A significant reduction in the estimated fair values could result in impairment charges that could materially affect our results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Goodwill of $117 previously reported within Orthopaedics was reclassified to MedSurg and Neurotechnology to reflect the reclassification of the interventional spine reporting unit from Orthopaedics to MedSurg and Neurotechnology to align with certain updates in our internal reporting structure. Goodwill recorded in the first three quarters of 2024 related to interventional spine is presented in the additions and adjustments line within MedSurg and Neurotechnology. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.037%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.037%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.132%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Changes in the Net Carrying Value of Goodwill by Segment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,935&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,945&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,880&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,973&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15,243&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,208&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,647&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.037%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.037%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.132%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Summary of Other Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&lt;br/&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,416&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,395&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,549&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,956&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,593&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.787%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Estimated Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-299" decimals="-6" id="f-865" unitRef="usd">273000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-300" decimals="-6" id="f-866" unitRef="usd">183000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillTransfers contextRef="c-301" decimals="-6" id="f-867" unitRef="usd">117000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers contextRef="c-302" decimals="-6" id="f-868" unitRef="usd">-117000000</us-gaap:GoodwillTransfers>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="c-1" id="f-869">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.037%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.037%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.132%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Changes in the Net Carrying Value of Goodwill by Segment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,935&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,945&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,880&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,973&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15,243&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,208&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,647&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill contextRef="c-303" decimals="-6" id="f-870" unitRef="usd">7935000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-304" decimals="-6" id="f-871" unitRef="usd">6945000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-43" decimals="-6" id="f-872" unitRef="usd">14880000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-76" decimals="-6" id="f-873" unitRef="usd">301000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-94" decimals="-6" id="f-874" unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-12" decimals="-6" id="f-875" unitRef="usd">301000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="c-76" decimals="-6" id="f-876" unitRef="usd">34000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="c-94" decimals="-6" id="f-877" unitRef="usd">28000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="c-12" decimals="-6" id="f-878" unitRef="usd">62000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill contextRef="c-305" decimals="-6" id="f-879" unitRef="usd">8270000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-306" decimals="-6" id="f-880" unitRef="usd">6973000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-15" decimals="-6" id="f-881" unitRef="usd">15243000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-75" decimals="-6" id="f-882" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-93" decimals="-6" id="f-883" unitRef="usd">456000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="-6" id="f-884" unitRef="usd">456000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-75" decimals="-6" id="f-885" unitRef="usd">852000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-93" decimals="-6" id="f-886" unitRef="usd">300000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-1" decimals="-6" id="f-887" unitRef="usd">1152000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="c-75" decimals="-6" id="f-888" unitRef="usd">86000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="c-93" decimals="-6" id="f-889" unitRef="usd">-170000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="c-1" decimals="-6" id="f-890" unitRef="usd">-84000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill contextRef="c-307" decimals="-6" id="f-891" unitRef="usd">9208000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-308" decimals="-6" id="f-892" unitRef="usd">6647000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-14" decimals="-6" id="f-893" unitRef="usd">15855000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-894">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.037%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.037%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.132%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Summary of Other Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&lt;br/&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,416&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,395&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,549&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,956&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,593&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-309" decimals="-6" id="f-895" unitRef="usd">5698000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-309" decimals="-6" id="f-896" unitRef="usd">2931000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-309" decimals="-6" id="f-897" unitRef="usd">2767000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-310" decimals="-6" id="f-898" unitRef="usd">5769000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-310" decimals="-6" id="f-899" unitRef="usd">2815000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-310" decimals="-6" id="f-900" unitRef="usd">2954000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-311" decimals="-6" id="f-901" unitRef="usd">3055000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-311" decimals="-6" id="f-902" unitRef="usd">1636000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-311" decimals="-6" id="f-903" unitRef="usd">1419000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-312" decimals="-6" id="f-904" unitRef="usd">2907000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-312" decimals="-6" id="f-905" unitRef="usd">1504000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-312" decimals="-6" id="f-906" unitRef="usd">1403000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-313" decimals="-6" id="f-907" unitRef="usd">153000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-313" decimals="-6" id="f-908" unitRef="usd">136000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-313" decimals="-6" id="f-909" unitRef="usd">17000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-314" decimals="-6" id="f-910" unitRef="usd">329000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-314" decimals="-6" id="f-911" unitRef="usd">302000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-314" decimals="-6" id="f-912" unitRef="usd">27000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-315" decimals="-6" id="f-913" unitRef="usd">413000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-315" decimals="-6" id="f-914" unitRef="usd">256000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-315" decimals="-6" id="f-915" unitRef="usd">157000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-316" decimals="-6" id="f-916" unitRef="usd">427000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-316" decimals="-6" id="f-917" unitRef="usd">246000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-316" decimals="-6" id="f-918" unitRef="usd">181000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-317" decimals="-6" id="f-919" unitRef="usd">34000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-317" decimals="-6" id="f-920" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-317" decimals="-6" id="f-921" unitRef="usd">34000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-318" decimals="-6" id="f-922" unitRef="usd">21000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-318" decimals="-6" id="f-923" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-318" decimals="-6" id="f-924" unitRef="usd">21000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-319" decimals="-6" id="f-925" unitRef="usd">63000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-319" decimals="-6" id="f-926" unitRef="usd">62000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-319" decimals="-6" id="f-927" unitRef="usd">1000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-320" decimals="-6" id="f-928" unitRef="usd">96000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-320" decimals="-6" id="f-929" unitRef="usd">89000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-320" decimals="-6" id="f-930" unitRef="usd">7000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-14" decimals="-6" id="f-931" unitRef="usd">9416000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-14" decimals="-6" id="f-932" unitRef="usd">5021000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-14" decimals="-6" id="f-933" unitRef="usd">4395000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-15" decimals="-6" id="f-934" unitRef="usd">9549000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-15" decimals="-6" id="f-935" unitRef="usd">4956000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-15" decimals="-6" id="f-936" unitRef="usd">4593000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c-1" id="f-937">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.787%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Estimated Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-14" decimals="-6" id="f-938" unitRef="usd">605000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-14" decimals="-6" id="f-939" unitRef="usd">550000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-14" decimals="-6" id="f-940" unitRef="usd">528000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-14" decimals="-6" id="f-941" unitRef="usd">480000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-14" decimals="-6" id="f-942" unitRef="usd">465000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-943">CAPITAL STOCK&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The aggregate number of shares of all classes of stock which we are authorized to issue is up to 1,000,500,000, divided into two classes consisting of 500,000 shares of $1 par value preferred stock and 1,000,000,000 shares of common stock with a par &lt;/span&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.334%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;value of $0.10. No shares of preferred stock were outstanding on December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We made no repurchases of shares in 2024. The manner, timing and amount of repurchases are determined by management based on an evaluation of market conditions, stock price and other factors and are subject to regulatory considerations. Purchases are made from time-to-time in the open market, in privately negotiated transactions or otherwise. On December&#160;31, 2024 the total dollar value of shares that could be purchased under our authorized repurchase program was $1,033.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Shares reserved for future compensation grants of our common stock were 18&#160;million and 20&#160;million&#160;on December&#160;31, 2024 and 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We measure the cost of employee stock options based on the grant-date fair value and recognize that cost using the straight-line method over the period in which a recipient is required to provide services in exchange for the options, typically the vesting period. The weighted-average fair value per share of options is estimated on the date of grant using the Black-Scholes option pricing model. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.060%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.555%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.555%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Option Value and Assumptions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;118.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;83.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected option life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The risk-free interest rate for periods within the expected life of options granted is based on the United States Treasury yield curve in effect at the time of grant. Expected stock price volatility is based on the historical volatility of our stock. The expected option life, representing the period of time that options granted are expected to be outstanding, is based on historical option exercise and employee termination data. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.819%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.479%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.173%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.513%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.196%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;2024 Stock Option Activity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares &lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Outstanding January&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;189.70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;339.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;134.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canceled or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;274.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Outstanding December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;214.87&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,572.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Exercisable December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;175.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,223.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options expected to vest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;275.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;331.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value of options, which represents the cumulative difference between the fair market value of the underlying common stock and the option exercise prices, exercised was $362, $318 and $218 in 2024, 2023 and 2022. Exercise prices for options outstanding ranged from $92.24 to $339.77 on December&#160;31, 2024. On December&#160;31, 2024 there was $159 of unrecognized compensation cost related to nonvested stock options granted under the long-term incentive plans. That cost is expected to be recognized as expense over the weighted-average period of approximately 1.5 years.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.118%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.405%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.405%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.129%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.135%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) Activity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant&#160;Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nonvested on January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;246.98&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;250.17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;332.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;305.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;244.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;233.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canceled or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;276.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;233.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nonvested on December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;290.58&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;287.51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On December&#160;31, 2024 there was $90 of unrecognized compensation cost related to nonvested RSUs. That cost is expected to be recognized as expense over the weighted-average period of approximately one year. The weighted-average grant date fair value per share of RSUs granted was $332.64 and $257.09 in 2024 and 2023. The fair value of RSUs and PSUs vested in 2024 was $81 and $23. On December&#160;31, 2024 there was $23 of unrecognized compensation cost related to nonvested PSUs. That cost is expected to be recognized as expense over the weighted-average period of approximately one year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plans (ESPP)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Employees may participate in our ESPP provided they meet certain eligibility requirements. The purchase price for our common stock under the terms of the ESPP is defined as 95% of the closing stock price on the last trading day of a purchase period. We issued 173,708 and 190,524 shares under the ESPP in 2024 and 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <syk:CommonAndPreferredStockSharesAuthorized contextRef="c-1" decimals="INF" id="f-944" unitRef="shares">1000500000</syk:CommonAndPreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-14"
      decimals="INF"
      id="f-945"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-14"
      decimals="INF"
      id="f-946"
      unitRef="usdPerShare">1</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-14"
      decimals="INF"
      id="f-947"
      unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-14"
      decimals="INF"
      id="f-948"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-14"
      decimals="INF"
      id="f-949"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-14" decimals="-6" id="f-950" unitRef="usd">1033000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-14" decimals="-6" id="f-951" unitRef="shares">18000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-15" decimals="-6" id="f-952" unitRef="shares">20000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-953">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.060%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.555%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.555%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Option Value and Assumptions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;118.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;83.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected option life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-1"
      decimals="2"
      id="f-954"
      unitRef="usdPerShare">118.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-12"
      decimals="2"
      id="f-955"
      unitRef="usdPerShare">83.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-13"
      decimals="2"
      id="f-956"
      unitRef="usdPerShare">68.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-1" decimals="3" id="f-957" unitRef="number">0.043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-12" decimals="3" id="f-958" unitRef="number">0.040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-13" decimals="3" id="f-959" unitRef="number">0.018</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-1" decimals="3" id="f-960" unitRef="number">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-12" decimals="3" id="f-961" unitRef="number">0.012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-13" decimals="3" id="f-962" unitRef="number">0.010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-1" decimals="3" id="f-963" unitRef="number">0.299</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-12" decimals="3" id="f-964" unitRef="number">0.290</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-13" decimals="3" id="f-965" unitRef="number">0.270</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-1" id="f-966">P6Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-12" id="f-967">P6Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-13" id="f-968">P5Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-969">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.819%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.479%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.173%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.513%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.196%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;2024 Stock Option Activity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares &lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Outstanding January&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;189.70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;339.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;134.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canceled or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;274.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Outstanding December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;214.87&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,572.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Exercisable December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;175.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,223.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options expected to vest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;275.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;331.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-15" decimals="-5" id="f-970" unitRef="shares">11500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-15"
      decimals="2"
      id="f-971"
      unitRef="usdPerShare">189.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="c-1" decimals="-5" id="f-972" unitRef="shares">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-973"
      unitRef="usdPerShare">339.72</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-1" decimals="-5" id="f-974" unitRef="shares">1700000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-975"
      unitRef="usdPerShare">134.86</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-1" decimals="-5" id="f-976" unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-977"
      unitRef="usdPerShare">274.74</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-14" decimals="-5" id="f-978" unitRef="shares">10800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-14"
      decimals="2"
      id="f-979"
      unitRef="usdPerShare">214.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-980">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-14" decimals="-5" id="f-981" unitRef="usd">1572600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c-14" decimals="-5" id="f-982" unitRef="shares">6600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-14"
      decimals="2"
      id="f-983"
      unitRef="usdPerShare">175.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-984">P3Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-14" decimals="-5" id="f-985" unitRef="usd">1223300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="c-14" decimals="-5" id="f-986" unitRef="shares">3900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c-14"
      decimals="2"
      id="f-987"
      unitRef="usdPerShare">275.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-988">P7Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="c-14" decimals="-5" id="f-989" unitRef="usd">331800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-1" decimals="-6" id="f-990" unitRef="usd">362000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-12" decimals="-6" id="f-991" unitRef="usd">318000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-13" decimals="-6" id="f-992" unitRef="usd">218000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-1"
      decimals="2"
      id="f-993"
      unitRef="usdPerShare">92.24</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-1"
      decimals="2"
      id="f-994"
      unitRef="usdPerShare">339.77</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-14" decimals="-6" id="f-995" unitRef="usd">159000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-1" id="f-996">P1Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="c-1" id="f-997">&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.118%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.405%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.405%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.129%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.135%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) Activity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant&#160;Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nonvested on January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;246.98&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;250.17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;332.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;305.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;244.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;233.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canceled or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;276.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;233.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nonvested on December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;290.58&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;287.51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-321"
      decimals="-5"
      id="f-998"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-322"
      decimals="-5"
      id="f-999"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-321"
      decimals="2"
      id="f-1000"
      unitRef="usdPerShare">246.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-322"
      decimals="2"
      id="f-1001"
      unitRef="usdPerShare">250.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-52"
      decimals="-5"
      id="f-1002"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-53"
      decimals="-5"
      id="f-1003"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-52"
      decimals="2"
      id="f-1004"
      unitRef="usdPerShare">332.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-53"
      decimals="2"
      id="f-1005"
      unitRef="usdPerShare">305.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-52"
      decimals="-5"
      id="f-1006"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-53"
      decimals="-5"
      id="f-1007"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-52"
      decimals="2"
      id="f-1008"
      unitRef="usdPerShare">244.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-53"
      decimals="2"
      id="f-1009"
      unitRef="usdPerShare">233.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-52"
      decimals="-5"
      id="f-1010"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-53"
      decimals="-5"
      id="f-1011"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-52"
      decimals="2"
      id="f-1012"
      unitRef="usdPerShare">276.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-53"
      decimals="2"
      id="f-1013"
      unitRef="usdPerShare">233.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-323"
      decimals="-5"
      id="f-1014"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-324"
      decimals="-5"
      id="f-1015"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-323"
      decimals="2"
      id="f-1016"
      unitRef="usdPerShare">290.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-324"
      decimals="2"
      id="f-1017"
      unitRef="usdPerShare">287.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-323" decimals="-6" id="f-1018" unitRef="usd">90000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-52" id="f-1019">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-52"
      decimals="2"
      id="f-1020"
      unitRef="usdPerShare">332.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-325"
      decimals="2"
      id="f-1021"
      unitRef="usdPerShare">257.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue contextRef="c-52" decimals="-6" id="f-1022" unitRef="usd">81000000</syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue>
    <syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue contextRef="c-53" decimals="-6" id="f-1023" unitRef="usd">23000000</syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-324" decimals="-6" id="f-1024" unitRef="usd">23000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-53" id="f-1025">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <syk:PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp
      contextRef="c-326"
      decimals="INF"
      id="f-1026"
      unitRef="number">0.95</syk:PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c-326"
      decimals="INF"
      id="f-1027"
      unitRef="shares">173708</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c-327"
      decimals="INF"
      id="f-1028"
      unitRef="shares">190524</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-1029">DEBT AND CREDIT FACILITIES&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We have lines of credit issued by various financial institutions that are available to fund our day-to-day operating needs. Certain of our credit facilities require us to comply with financial and other covenants. We were in compliance with all covenants on December&#160;31, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On December&#160;31, 2024 there were no borrowings outstanding under our revolving credit facility or our commercial paper program which allows for maturities up to 397 days from the date of issuance. The maximum amount of our commercial paper that can be outstanding at any time is $2,250. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In May 2024 we repaid the outstanding $600 principal amount of the 3.375% senior unsecured notes due May 15, 2024. In September 2024 we issued $750 of 4.250% senior unsecured notes due September 11, 2029, &#x20ac;800 of 3.375% senior unsecured notes due September 11, 2032, $750 of 4.625% senior unsecured notes due September 11, 2034 and &#x20ac;600 of 3.625% senior unsecured notes due September 11, 2036. In November 2024 we repaid the outstanding &#x20ac;500 of floating rate senior notes and in December 2024 we repaid &#x20ac;850 of 0.250% senior unsecured notes. The following table summarizes our total debt at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.616%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.245%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.570%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.460%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.245%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.463%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Summary of Total Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Due&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Senior unsecured notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;May 15, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 16, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.250%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 3, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.150%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.500%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 15, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.125%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 30, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.650%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 7, 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.850%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 8, 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 11, 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.750%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 1, 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.250%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 11, 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.950%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 30, 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.000%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 3, 2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 11, 2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 11, 2034&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 11, 2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 1, 2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;May 15, 2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 15, 2046&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.900%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,597&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,995&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,188&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,901&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Borrowing capacity on existing facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of senior unsecured notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair value of the senior unsecured notes was estimated using quoted interest rates, maturities and amounts of borrowings based on quoted active market prices and yields that took into account the underlying terms of the debt instruments. Substantially all of our debt is classified within Level 2 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;Interest expense on outstanding debt and credit facilities, including required fees incurred, that were included in other income (expense), net, totaled $396, $356, and $337 in 2024, 2023 and 2022.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCredit contextRef="c-14" decimals="INF" id="f-1030" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:CommercialPaper contextRef="c-14" decimals="INF" id="f-1031" unitRef="usd">0</us-gaap:CommercialPaper>
    <us-gaap:DebtInstrumentTerm contextRef="c-328" id="f-1032">P397D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-329" decimals="INF" id="f-1033" unitRef="usd">2250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RepaymentsOfDebt contextRef="c-330" decimals="-6" id="f-1034" unitRef="usd">600000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-331"
      decimals="5"
      id="f-1035"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-332" decimals="-6" id="f-1036" unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-332"
      decimals="5"
      id="f-1037"
      unitRef="number">0.04250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-333" decimals="-6" id="f-1038" unitRef="eur">800000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-333"
      decimals="5"
      id="f-1039"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-334" decimals="-6" id="f-1040" unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-334"
      decimals="5"
      id="f-1041"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-335" decimals="-6" id="f-1042" unitRef="eur">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-335"
      decimals="5"
      id="f-1043"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt contextRef="c-336" decimals="-6" id="f-1044" unitRef="usd">500000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="c-337" decimals="-6" id="f-1045" unitRef="usd">850000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-338"
      decimals="5"
      id="f-1046"
      unitRef="number">0.00250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="c-1" id="f-1047">&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.616%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.245%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.570%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.460%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.245%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.463%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Summary of Total Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Due&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Senior unsecured notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;May 15, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 16, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.250%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 3, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.150%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.500%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 15, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.125%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 30, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.650%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 7, 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.850%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 8, 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 11, 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.750%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 1, 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.250%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 11, 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.950%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 30, 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.000%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 3, 2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 11, 2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 11, 2034&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 11, 2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 1, 2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;May 15, 2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 15, 2046&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.900%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,597&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,995&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,188&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,901&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Borrowing capacity on existing facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of senior unsecured notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-339"
      decimals="INF"
      id="f-1048"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-339" decimals="-6" id="f-1049" unitRef="usd">0</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-340" decimals="-6" id="f-1050" unitRef="usd">600000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-341" decimals="-6" id="f-1051" unitRef="usd">0</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-342" decimals="-6" id="f-1052" unitRef="usd">554000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-343"
      decimals="INF"
      id="f-1053"
      unitRef="number">0.00250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-344" decimals="-6" id="f-1054" unitRef="usd">0</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-343" decimals="-6" id="f-1055" unitRef="usd">940000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-345"
      decimals="INF"
      id="f-1056"
      unitRef="number">0.01150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-345" decimals="-6" id="f-1057" unitRef="usd">649000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-346" decimals="-6" id="f-1058" unitRef="usd">648000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-333"
      decimals="INF"
      id="f-1059"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-333" decimals="-6" id="f-1060" unitRef="usd">750000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-347" decimals="-6" id="f-1061" unitRef="usd">749000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-348"
      decimals="INF"
      id="f-1062"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-348" decimals="-6" id="f-1063" unitRef="usd">998000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-349" decimals="-6" id="f-1064" unitRef="usd">997000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-350"
      decimals="INF"
      id="f-1065"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-350" decimals="-6" id="f-1066" unitRef="usd">777000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-351" decimals="-6" id="f-1067" unitRef="usd">828000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-352"
      decimals="INF"
      id="f-1068"
      unitRef="number">0.03650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-352" decimals="-6" id="f-1069" unitRef="usd">598000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-353" decimals="-6" id="f-1070" unitRef="usd">598000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-354"
      decimals="INF"
      id="f-1071"
      unitRef="number">0.04850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-354" decimals="-6" id="f-1072" unitRef="usd">596000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-355" decimals="-6" id="f-1073" unitRef="usd">596000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-356"
      decimals="INF"
      id="f-1074"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-356" decimals="-6" id="f-1075" unitRef="usd">621000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-357" decimals="-6" id="f-1076" unitRef="usd">661000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-358"
      decimals="INF"
      id="f-1077"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-358" decimals="-6" id="f-1078" unitRef="usd">828000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-359" decimals="-6" id="f-1079" unitRef="usd">883000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-332"
      decimals="INF"
      id="f-1080"
      unitRef="number">0.04250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-332" decimals="-6" id="f-1081" unitRef="usd">743000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-360" decimals="-6" id="f-1082" unitRef="usd">0</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-361"
      decimals="INF"
      id="f-1083"
      unitRef="number">0.01950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-361" decimals="-6" id="f-1084" unitRef="usd">993000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-362" decimals="-6" id="f-1085" unitRef="usd">991000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-363"
      decimals="INF"
      id="f-1086"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-363" decimals="-6" id="f-1087" unitRef="usd">669000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-364" decimals="-6" id="f-1088" unitRef="usd">713000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-365"
      decimals="INF"
      id="f-1089"
      unitRef="number">0.01000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-365" decimals="-6" id="f-1090" unitRef="usd">772000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-366" decimals="-6" id="f-1091" unitRef="usd">823000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-367"
      decimals="INF"
      id="f-1092"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-367" decimals="-6" id="f-1093" unitRef="usd">824000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-368" decimals="-6" id="f-1094" unitRef="usd">0</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-369"
      decimals="INF"
      id="f-1095"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-369" decimals="-6" id="f-1096" unitRef="usd">740000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-370" decimals="-6" id="f-1097" unitRef="usd">0</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-335"
      decimals="INF"
      id="f-1098"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-335" decimals="-6" id="f-1099" unitRef="usd">613000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-371" decimals="-6" id="f-1100" unitRef="usd">0</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-372"
      decimals="INF"
      id="f-1101"
      unitRef="number">0.04100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-372" decimals="-6" id="f-1102" unitRef="usd">393000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-373" decimals="-6" id="f-1103" unitRef="usd">393000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-374"
      decimals="INF"
      id="f-1104"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-374" decimals="-6" id="f-1105" unitRef="usd">396000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-375" decimals="-6" id="f-1106" unitRef="usd">396000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-334"
      decimals="INF"
      id="f-1107"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-334" decimals="-6" id="f-1108" unitRef="usd">984000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-376" decimals="-6" id="f-1109" unitRef="usd">983000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-377"
      decimals="INF"
      id="f-1110"
      unitRef="number">0.02900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt contextRef="c-377" decimals="-6" id="f-1111" unitRef="usd">643000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt contextRef="c-378" decimals="-6" id="f-1112" unitRef="usd">642000000</us-gaap:UnsecuredDebt>
    <us-gaap:OtherLongTermDebt contextRef="c-14" decimals="-6" id="f-1113" unitRef="usd">10000000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLongTermDebt contextRef="c-15" decimals="-6" id="f-1114" unitRef="usd">0</us-gaap:OtherLongTermDebt>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount contextRef="c-14" decimals="-6" id="f-1115" unitRef="usd">13597000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount contextRef="c-15" decimals="-6" id="f-1116" unitRef="usd">12995000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtCurrent contextRef="c-14" decimals="-6" id="f-1117" unitRef="usd">1409000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent contextRef="c-15" decimals="-6" id="f-1118" unitRef="usd">2094000000</us-gaap:DebtCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-14" decimals="-6" id="f-1119" unitRef="usd">12188000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-15" decimals="-6" id="f-1120" unitRef="usd">10901000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-14" decimals="-6" id="f-1121" unitRef="usd">63000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-15" decimals="-6" id="f-1122" unitRef="usd">50000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-14" decimals="-6" id="f-1123" unitRef="usd">2160000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-15" decimals="-6" id="f-1124" unitRef="usd">2160000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentFairValue contextRef="c-14" decimals="-6" id="f-1125" unitRef="usd">12780000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="c-15" decimals="-6" id="f-1126" unitRef="usd">12252000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:InterestExpenseDebt contextRef="c-1" decimals="-6" id="f-1127" unitRef="usd">396000000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-12" decimals="-6" id="f-1128" unitRef="usd">356000000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-13" decimals="-6" id="f-1129" unitRef="usd">337000000</us-gaap:InterestExpenseDebt>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-1130">INCOME TAXES&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our effective tax rate was 14.3%, 13.8% and 12.1% for 2024, 2023 and 2022. The effective income tax rate for 2024 increased from 2023 due to the 2024 deferred tax benefit on the outside basis difference related to the anticipated sale of the Spinal Implants business partially offset by the 2023 tax effect related to transfers of intellectual property between tax jurisdictions. The effective income tax rate for 2023 increased from 2022 due to the 2022 effective settlement of the United States federal income tax audit for years 2014 through 2018 and the 2022 reversal of deferred income tax on undistributed earnings of foreign subsidiaries partially offset by the 2023 tax effect related to transfers of intellectual property between tax jurisdictions. Additionally, the effective income tax rates for 2024, 2023 and 2022 reflect the continued lower effective income tax rates as a result of our European operations and certain discrete tax items.  &lt;/span&gt;&lt;/div&gt;&lt;div style="width:100.000%"&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.333%"&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.259%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Effective Income Tax Rate Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;United States federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local income taxes, less federal deduction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign income tax at rates other than 21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tax related to repatriation of foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Intellectual property transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States federal audit settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Outside basis difference related to the anticipated sale of the Spinal Implants business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14.3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.259%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Earnings Before Income Taxes&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,492&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,673&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,683&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.259%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Components of Income Tax Expense (Benefit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current income tax expense (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total current income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;714&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax expense (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;58&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;499&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;508&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;325&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest included in other income (expense), net was expense of $13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$1 in 2024 and 2023 and income of $71 in 2022. The United States federal deferred income tax expense (benefit) includes the utilization of net operating loss carryforwards of $9, $189 and $56 in 2024, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.463%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Deferred Income Tax Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;State income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development capitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International interest expense carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net operating loss and credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Outside basis difference related to the anticipated sale of the Spinal Implants business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,090&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Less valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,862&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,666&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,012)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Undistributed earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,660&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,660&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accrued interest was $71 and $67 on December&#160;31, 2024 and 2023 which was reported in accrued expenses and other liabilities and other noncurrent liabilities.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.334%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;United States federal loss carryforwards of $335, with $70 of associated deferred tax asset and with $2 being subject to a valuation allowance, begin to expire in 2025. United States state loss carryforwards of $3,480, with $85 associated deferred tax asset and with $49 being subject to a valuation allowance, begin to expire in 2025. International loss carryforwards of $269, with $69 of associated deferred tax asset and with $63 being subject to a valuation allowance, begin to expire in 2026; however, some have no expiration. We also have tax credit carryforwards of $204 with $83 being subject to a full valuation allowance. The credits with a full valuation allowance begin to expire in 2025. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We recorded deferred income tax on undistributed earnings of foreign subsidiaries not determined to be indefinitely reinvested. In 2022 it was determined that, based on our revised capital plan, certain cash outside the United States would no longer need to be repatriated during the period previously contemplated. As a result deferred taxes of $71 that were recorded on the associated earnings were reversed. The amount of undistributed earnings of foreign subsidiaries determined to be indefinitely reinvested at December 31, 2024 was approximately $10&#160;billion. Determination of the total amount of unrecognized deferred income tax on undistributed earnings of foreign subsidiaries is not practicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.750%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.258%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Uncertain Income Tax Positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;286&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases related to current year income tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases related to prior year income tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year income tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Settlements of income tax audits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Statute of limitations expirations and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;349&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our income tax expense would have been reduced by $224 and $248 in 2024 and 2023 had these uncertain income tax positions been favorably resolved. It is reasonably possible that the amount of unrecognized tax benefits will significantly change due to one or more of the following events in the next 12 months: expiring statutes, audit activity, tax payments, competent authority proceedings related to transfer pricing or final decisions in matters that are the subject of controversy in various taxing jurisdictions in which we operate, including inventory transfer pricing, cost sharing, product royalty and foreign branch arrangements. We are not able to reasonably estimate the amount or the future periods in which changes in unrecognized tax benefits may be resolved. Interest incurred associated with uncertain tax positions is included in other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In the normal course of business, income tax authorities in various income tax jurisdictions both within the United States and internationally conduct routine audits of our income tax returns filed in prior years. These audits are generally designed to determine if individual income tax authorities are in agreement with our interpretations of complex income tax regulations regarding the allocation of income to the various income tax jurisdictions. Any income tax audit assessment or draft income tax audit assessment received at the conclusion of an audit is reviewed and evaluated for proper financial statement treatment. We have not received any audit assessments or draft assessments that have not been reviewed and evaluated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Income tax expense in 2022 decreased $162 due to the effective settlement of the United States federal income tax audit for years 2014 through 2018. In addition 2022 other income (expense), net includes a benefit of $50 related to the release of accrued interest &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;associated with this settlement. Income tax years are open from 2019 through the current year for the United States federal jurisdiction. Income tax years open for our other major jurisdictions range from 2010 through the current year.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-1131" unitRef="number">0.143</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-12" decimals="3" id="f-1132" unitRef="number">0.138</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-13" decimals="3" id="f-1133" unitRef="number">0.121</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-1134">&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.259%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Effective Income Tax Rate Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;United States federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local income taxes, less federal deduction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign income tax at rates other than 21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tax related to repatriation of foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Intellectual property transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States federal audit settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Outside basis difference related to the anticipated sale of the Spinal Implants business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14.3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="3" id="f-1135" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-12" decimals="3" id="f-1136" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-13" decimals="3" id="f-1137" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="3" id="f-1138" unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-12" decimals="3" id="f-1139" unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-13" decimals="3" id="f-1140" unitRef="number">0.020</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-1" decimals="3" id="f-1141" unitRef="number">-0.041</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-12" decimals="3" id="f-1142" unitRef="number">-0.068</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-13" decimals="3" id="f-1143" unitRef="number">-0.041</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent contextRef="c-1" decimals="3" id="f-1144" unitRef="number">0.003</syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent>
    <syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent contextRef="c-12" decimals="3" id="f-1145" unitRef="number">0.012</syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent>
    <syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent contextRef="c-13" decimals="3" id="f-1146" unitRef="number">-0.024</syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-1" decimals="3" id="f-1147" unitRef="number">0.014</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-12" decimals="3" id="f-1148" unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-13" decimals="3" id="f-1149" unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent contextRef="c-1" decimals="3" id="f-1150" unitRef="number">0</syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent>
    <syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent contextRef="c-12" decimals="3" id="f-1151" unitRef="number">-0.033</syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent>
    <syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent contextRef="c-13" decimals="3" id="f-1152" unitRef="number">0.001</syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic contextRef="c-1" decimals="3" id="f-1153" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic contextRef="c-12" decimals="3" id="f-1154" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic contextRef="c-13" decimals="3" id="f-1155" unitRef="number">-0.061</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses contextRef="c-1" decimals="3" id="f-1156" unitRef="number">0.028</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses contextRef="c-12" decimals="3" id="f-1157" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses contextRef="c-13" decimals="3" id="f-1158" unitRef="number">0.017</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <syk:EffectiveIncomeTaxRateReconciliationOutsideBasisDifference contextRef="c-1" decimals="3" id="f-1159" unitRef="number">-0.049</syk:EffectiveIncomeTaxRateReconciliationOutsideBasisDifference>
    <syk:EffectiveIncomeTaxRateReconciliationOutsideBasisDifference contextRef="c-12" decimals="3" id="f-1160" unitRef="number">0</syk:EffectiveIncomeTaxRateReconciliationOutsideBasisDifference>
    <syk:EffectiveIncomeTaxRateReconciliationOutsideBasisDifference contextRef="c-13" decimals="3" id="f-1161" unitRef="number">0</syk:EffectiveIncomeTaxRateReconciliationOutsideBasisDifference>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-1" decimals="3" id="f-1162" unitRef="number">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-12" decimals="3" id="f-1163" unitRef="number">0.018</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-13" decimals="3" id="f-1164" unitRef="number">0.014</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-1165" unitRef="number">0.143</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-12" decimals="3" id="f-1166" unitRef="number">0.138</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-13" decimals="3" id="f-1167" unitRef="number">0.121</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-1168">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.259%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Earnings Before Income Taxes&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,492&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,673&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,683&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.259%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Components of Income Tax Expense (Benefit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current income tax expense (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total current income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;714&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax expense (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;58&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;499&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;508&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;325&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-1" decimals="-6" id="f-1169" unitRef="usd">523000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-12" decimals="-6" id="f-1170" unitRef="usd">701000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-13" decimals="-6" id="f-1171" unitRef="usd">407000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-1" decimals="-6" id="f-1172" unitRef="usd">2969000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-12" decimals="-6" id="f-1173" unitRef="usd">2972000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-13" decimals="-6" id="f-1174" unitRef="usd">2276000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-1175" unitRef="usd">3492000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-12" decimals="-6" id="f-1176" unitRef="usd">3673000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-13" decimals="-6" id="f-1177" unitRef="usd">2683000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1178" unitRef="usd">490000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1179" unitRef="usd">236000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1180" unitRef="usd">-76000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1181" unitRef="usd">90000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1182" unitRef="usd">48000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1183" unitRef="usd">64000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1184" unitRef="usd">289000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1185" unitRef="usd">430000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1186" unitRef="usd">279000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1187" unitRef="usd">869000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1188" unitRef="usd">714000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1189" unitRef="usd">267000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1190" unitRef="usd">-462000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1191" unitRef="usd">-212000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1192" unitRef="usd">-179000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1193" unitRef="usd">-76000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1194" unitRef="usd">-20000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1195" unitRef="usd">-30000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1196" unitRef="usd">168000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1197" unitRef="usd">26000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1198" unitRef="usd">267000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1199" unitRef="usd">-370000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1200" unitRef="usd">-206000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1201" unitRef="usd">58000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1202" unitRef="usd">499000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1203" unitRef="usd">508000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1204" unitRef="usd">325000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-1" decimals="-6" id="f-1205" unitRef="usd">13000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-12" decimals="-6" id="f-1206" unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-13" decimals="-6" id="f-1207" unitRef="usd">71000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized contextRef="c-1" decimals="-6" id="f-1208" unitRef="usd">9000000</syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized>
    <syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized contextRef="c-12" decimals="-6" id="f-1209" unitRef="usd">189000000</syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized>
    <syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized contextRef="c-13" decimals="-6" id="f-1210" unitRef="usd">56000000</syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-1211">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.463%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Deferred Income Tax Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;State income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development capitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International interest expense carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net operating loss and credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Outside basis difference related to the anticipated sale of the Spinal Implants business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,090&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Less valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,862&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,666&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,012)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Undistributed earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,660&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,660&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsInventory contextRef="c-14" decimals="-6" id="f-1212" unitRef="usd">551000000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory contextRef="c-15" decimals="-6" id="f-1213" unitRef="usd">521000000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther contextRef="c-14" decimals="-6" id="f-1214" unitRef="usd">207000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther contextRef="c-15" decimals="-6" id="f-1215" unitRef="usd">253000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <syk:DeferredTaxAssetsDepreciationAndAmortization contextRef="c-14" decimals="-6" id="f-1216" unitRef="usd">715000000</syk:DeferredTaxAssetsDepreciationAndAmortization>
    <syk:DeferredTaxAssetsDepreciationAndAmortization contextRef="c-15" decimals="-6" id="f-1217" unitRef="usd">918000000</syk:DeferredTaxAssetsDepreciationAndAmortization>
    <us-gaap:DeferredTaxAssetsStateTaxes contextRef="c-14" decimals="-6" id="f-1218" unitRef="usd">167000000</us-gaap:DeferredTaxAssetsStateTaxes>
    <us-gaap:DeferredTaxAssetsStateTaxes contextRef="c-15" decimals="-6" id="f-1219" unitRef="usd">150000000</us-gaap:DeferredTaxAssetsStateTaxes>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-14" decimals="-6" id="f-1220" unitRef="usd">100000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-15" decimals="-6" id="f-1221" unitRef="usd">86000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <syk:DeferredTaxAssetsResearchAndDevelopmentCapitalization contextRef="c-14" decimals="-6" id="f-1222" unitRef="usd">408000000</syk:DeferredTaxAssetsResearchAndDevelopmentCapitalization>
    <syk:DeferredTaxAssetsResearchAndDevelopmentCapitalization contextRef="c-15" decimals="-6" id="f-1223" unitRef="usd">295000000</syk:DeferredTaxAssetsResearchAndDevelopmentCapitalization>
    <us-gaap:DeferredTaxAssetInterestCarryforward contextRef="c-14" decimals="-6" id="f-1224" unitRef="usd">52000000</us-gaap:DeferredTaxAssetInterestCarryforward>
    <us-gaap:DeferredTaxAssetInterestCarryforward contextRef="c-15" decimals="-6" id="f-1225" unitRef="usd">46000000</us-gaap:DeferredTaxAssetInterestCarryforward>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-14" decimals="-6" id="f-1226" unitRef="usd">410000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-15" decimals="-6" id="f-1227" unitRef="usd">385000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <syk:DeferredTaxAssetsOutsideBasisDifference contextRef="c-14" decimals="-6" id="f-1228" unitRef="usd">170000000</syk:DeferredTaxAssetsOutsideBasisDifference>
    <syk:DeferredTaxAssetsOutsideBasisDifference contextRef="c-15" decimals="-6" id="f-1229" unitRef="usd">0</syk:DeferredTaxAssetsOutsideBasisDifference>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-14" decimals="-6" id="f-1230" unitRef="usd">310000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-15" decimals="-6" id="f-1231" unitRef="usd">235000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-14" decimals="-6" id="f-1232" unitRef="usd">3090000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-15" decimals="-6" id="f-1233" unitRef="usd">2889000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-14" decimals="-6" id="f-1234" unitRef="usd">228000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-15" decimals="-6" id="f-1235" unitRef="usd">223000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-14" decimals="-6" id="f-1236" unitRef="usd">2862000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-15" decimals="-6" id="f-1237" unitRef="usd">2666000000</us-gaap:DeferredTaxAssetsNet>
    <syk:DeferredTaxLiabilitiesDepreciationAndAmortization contextRef="c-14" decimals="-6" id="f-1238" unitRef="usd">1141000000</syk:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <syk:DeferredTaxLiabilitiesDepreciationAndAmortization contextRef="c-15" decimals="-6" id="f-1239" unitRef="usd">1012000000</syk:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="c-14" decimals="-6" id="f-1240" unitRef="usd">61000000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="c-15" decimals="-6" id="f-1241" unitRef="usd">47000000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-14" decimals="-6" id="f-1242" unitRef="usd">1202000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-15" decimals="-6" id="f-1243" unitRef="usd">1059000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-14" decimals="-6" id="f-1244" unitRef="usd">1660000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-15" decimals="-6" id="f-1245" unitRef="usd">1607000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-14" decimals="-6" id="f-1246" unitRef="usd">1742000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-15" decimals="-6" id="f-1247" unitRef="usd">1670000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-14" decimals="-6" id="f-1248" unitRef="usd">82000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-15" decimals="-6" id="f-1249" unitRef="usd">63000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-14" decimals="-6" id="f-1250" unitRef="usd">1660000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-15" decimals="-6" id="f-1251" unitRef="usd">1607000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="c-14" decimals="-6" id="f-1252" unitRef="usd">71000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="c-15" decimals="-6" id="f-1253" unitRef="usd">67000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:OperatingLossCarryforwards contextRef="c-379" decimals="-6" id="f-1254" unitRef="usd">335000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-379" decimals="-6" id="f-1255" unitRef="usd">70000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <syk:OperatingLossCarryforwardsSubjectToValuationAllowance contextRef="c-379" decimals="-6" id="f-1256" unitRef="usd">2000000</syk:OperatingLossCarryforwardsSubjectToValuationAllowance>
    <us-gaap:OperatingLossCarryforwards contextRef="c-380" decimals="-6" id="f-1257" unitRef="usd">3480000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-380" decimals="-6" id="f-1258" unitRef="usd">85000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <syk:OperatingLossCarryforwardsSubjectToValuationAllowance contextRef="c-380" decimals="-6" id="f-1259" unitRef="usd">49000000</syk:OperatingLossCarryforwardsSubjectToValuationAllowance>
    <us-gaap:OperatingLossCarryforwards contextRef="c-381" decimals="-6" id="f-1260" unitRef="usd">269000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-381" decimals="-6" id="f-1261" unitRef="usd">69000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <syk:OperatingLossCarryforwardsSubjectToValuationAllowance contextRef="c-381" decimals="-6" id="f-1262" unitRef="usd">63000000</syk:OperatingLossCarryforwardsSubjectToValuationAllowance>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-14" decimals="-6" id="f-1263" unitRef="usd">204000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardValuationAllowance contextRef="c-15" decimals="-6" id="f-1264" unitRef="usd">83000000</us-gaap:TaxCreditCarryforwardValuationAllowance>
    <us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings contextRef="c-13" decimals="-6" id="f-1265" unitRef="usd">71000000</us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries contextRef="c-14" decimals="-8" id="f-1266" unitRef="usd">10000000000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="c-1" id="f-1267">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.750%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.258%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Uncertain Income Tax Positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;286&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases related to current year income tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases related to prior year income tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year income tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Settlements of income tax audits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Statute of limitations expirations and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;349&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-15" decimals="-6" id="f-1268" unitRef="usd">371000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-43" decimals="-6" id="f-1269" unitRef="usd">286000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-1" decimals="-6" id="f-1270" unitRef="usd">18000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-12" decimals="-6" id="f-1271" unitRef="usd">102000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-6" id="f-1272" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-12" decimals="-6" id="f-1273" unitRef="usd">10000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-6" id="f-1274" unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-12" decimals="-6" id="f-1275" unitRef="usd">33000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities contextRef="c-1" decimals="-6" id="f-1276" unitRef="usd">21000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities contextRef="c-12" decimals="-6" id="f-1277" unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-1" decimals="-6" id="f-1278" unitRef="usd">3000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-12" decimals="-6" id="f-1279" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation contextRef="c-1" decimals="-6" id="f-1280" unitRef="usd">12000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation contextRef="c-12" decimals="-6" id="f-1281" unitRef="usd">7000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-14" decimals="-6" id="f-1282" unitRef="usd">349000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-15" decimals="-6" id="f-1283" unitRef="usd">371000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-14" decimals="-6" id="f-1284" unitRef="usd">349000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-15" decimals="-6" id="f-1285" unitRef="usd">371000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense contextRef="c-1" decimals="-6" id="f-1286" unitRef="usd">224000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense contextRef="c-12" decimals="-6" id="f-1287" unitRef="usd">248000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:IncomeTaxReconciliationTaxSettlements contextRef="c-1" decimals="-6" id="f-1288" unitRef="usd">162000000</us-gaap:IncomeTaxReconciliationTaxSettlements>
    <syk:IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest contextRef="c-1" decimals="-6" id="f-1289" unitRef="usd">50000000</syk:IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="c-1" id="f-1290">RETIREMENT PLANS&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Defined Contribution Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We provide certain employees with defined contribution plans and other types of retirement plans. A portion of our retirement plan expense under the defined contribution plans is funded with Stryker common stock. The use of Stryker common stock represents a non-cash operating activity that is not reflected in our Consolidated Statements of Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.436%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Plan expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expense funded with Stryker common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Stryker common stock held by plan:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dollar amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shares (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Value as a percentage of total plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Defined Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain of our subsidiaries have both funded and unfunded defined benefit pension plans covering some or all of their employees. The majority of our defined benefit pension plans have projected benefit obligations in excess of plan assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Discount Rate&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The discount rates were selected using a hypothetical portfolio of high quality bonds on December 31 that would provide the necessary cash flows to match our projected benefit payments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Expected Return on Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The expected return on plan assets is determined by applying the target allocation in each asset category of plan investments to the anticipated return for each asset category based on historical and projected returns. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.436%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Components of Net Periodic Pension Cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recognized actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Changes in assets and benefit obligations recognized in OCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recognized net actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Prior service credit and transition amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total recognized in other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;43&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;252&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total recognized in net periodic benefit cost and OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;193&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted-average rates used to determine net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate used to determine projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The actuarial gain (loss) for all pension plans was primarily related to a change in the discount rate used to measure the benefit obligations of those plans.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Investment Strategy&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The investment strategy for our defined benefit pension plans is to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk &lt;/span&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.334%"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;tolerances.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.474%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.396%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(826)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&#x2014;other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current liabilities&#x2014;accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pre-tax amounts recognized in AOCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unrecognized net actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.474%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.396%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Change in Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;826&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;673&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial (gains) losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;782&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;826&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending accumulated benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;748&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;790&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.474%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.396%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Change in Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;420&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actual return&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;492&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.770%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.649%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.649%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.652%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Allocation of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025 Target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024 Actual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023 Actual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.329%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.220%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.220%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.220%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.511%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Valuation of Plan Assets &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;404&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;57&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;492&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our Level 3 pension plan assets primarily include guaranteed investment contracts with insurance companies. The insurance contracts guarantee us principal repayment and a fixed rate of return. The $8 decrease in Level 3 pension plan assets is primarily driven by the change in the corresponding pension liability. We expect to contribute $21 to our defined benefit pension plans in 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Estimated Future Benefit Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2030-2034&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanDisclosuresTableTextBlock contextRef="c-1" id="f-1291">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.436%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Plan expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expense funded with Stryker common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Stryker common stock held by plan:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dollar amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shares (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Value as a percentage of total plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DefinedContributionPlanDisclosuresTableTextBlock>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-1" decimals="-6" id="f-1292" unitRef="usd">376000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-12" decimals="-6" id="f-1293" unitRef="usd">327000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-13" decimals="-6" id="f-1294" unitRef="usd">305000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-1" decimals="-6" id="f-1295" unitRef="usd">62000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-12" decimals="-6" id="f-1296" unitRef="usd">57000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-13" decimals="-6" id="f-1297" unitRef="usd">41000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany contextRef="c-1" decimals="-6" id="f-1298" unitRef="usd">781000000</syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany>
    <syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany contextRef="c-12" decimals="-6" id="f-1299" unitRef="usd">649000000</syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany>
    <syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany contextRef="c-13" decimals="-6" id="f-1300" unitRef="usd">522000000</syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany>
    <syk:DefinedContributionRetirementPlansCommonStockHeldByCompany contextRef="c-1" decimals="-5" id="f-1301" unitRef="shares">2200000</syk:DefinedContributionRetirementPlansCommonStockHeldByCompany>
    <syk:DefinedContributionRetirementPlansCommonStockHeldByCompany
      contextRef="c-12"
      decimals="-5"
      id="f-1302"
      unitRef="shares">2200000</syk:DefinedContributionRetirementPlansCommonStockHeldByCompany>
    <syk:DefinedContributionRetirementPlansCommonStockHeldByCompany
      contextRef="c-13"
      decimals="-5"
      id="f-1303"
      unitRef="shares">2100000</syk:DefinedContributionRetirementPlansCommonStockHeldByCompany>
    <syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany contextRef="c-1" decimals="2" id="f-1304" unitRef="number">0.10</syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany>
    <syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany contextRef="c-12" decimals="2" id="f-1305" unitRef="number">0.10</syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany>
    <syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany contextRef="c-13" decimals="2" id="f-1306" unitRef="number">0.10</syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany>
    <us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock contextRef="c-1" id="f-1307">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.436%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Components of Net Periodic Pension Cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recognized actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Changes in assets and benefit obligations recognized in OCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recognized net actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Prior service credit and transition amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total recognized in other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;43&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;252&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total recognized in net periodic benefit cost and OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;193&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted-average rates used to determine net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate used to determine projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-1" decimals="-6" id="f-1308" unitRef="usd">39000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-12" decimals="-6" id="f-1309" unitRef="usd">32000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-13" decimals="-6" id="f-1310" unitRef="usd">56000000</us-gaap:DefinedBenefitPlanServiceCost>
    <syk:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag contextRef="c-12" id="f-1311">Interest cost</syk:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <syk:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag contextRef="c-1" id="f-1312">Interest cost</syk:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <syk:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag contextRef="c-13" id="f-1313">Interest cost</syk:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-1" decimals="-6" id="f-1314" unitRef="usd">21000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-12" decimals="-6" id="f-1315" unitRef="usd">23000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-13" decimals="-6" id="f-1316" unitRef="usd">10000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-1" decimals="-6" id="f-1317" unitRef="usd">19000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-12" decimals="-6" id="f-1318" unitRef="usd">18000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-13" decimals="-6" id="f-1319" unitRef="usd">15000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="c-1" decimals="-6" id="f-1320" unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="c-12" decimals="-6" id="f-1321" unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="c-13" decimals="-6" id="f-1322" unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c-1" decimals="-6" id="f-1323" unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c-12" decimals="-6" id="f-1324" unitRef="usd">4000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c-13" decimals="-6" id="f-1325" unitRef="usd">-9000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-1" decimals="-6" id="f-1326" unitRef="usd">41000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-12" decimals="-6" id="f-1327" unitRef="usd">32000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-13" decimals="-6" id="f-1328" unitRef="usd">59000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-6" id="f-1329" unitRef="usd">43000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-12" decimals="-6" id="f-1330" unitRef="usd">-67000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-13" decimals="-6" id="f-1331" unitRef="usd">244000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax contextRef="c-1" decimals="-6" id="f-1332" unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax contextRef="c-12" decimals="-6" id="f-1333" unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax contextRef="c-13" decimals="-6" id="f-1334" unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-6" id="f-1335" unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax contextRef="c-12" decimals="-6" id="f-1336" unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax contextRef="c-13" decimals="-6" id="f-1337" unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-6" id="f-1338" unitRef="usd">-43000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-12" decimals="-6" id="f-1339" unitRef="usd">72000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-13" decimals="-6" id="f-1340" unitRef="usd">-252000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax contextRef="c-1" decimals="-6" id="f-1341" unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax contextRef="c-12" decimals="-6" id="f-1342" unitRef="usd">-104000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax contextRef="c-13" decimals="-6" id="f-1343" unitRef="usd">193000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate contextRef="c-1" decimals="3" id="f-1344" unitRef="number">0.028</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate contextRef="c-12" decimals="3" id="f-1345" unitRef="number">0.033</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate contextRef="c-13" decimals="3" id="f-1346" unitRef="number">0.011</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets contextRef="c-1" decimals="3" id="f-1347" unitRef="number">0.043</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets contextRef="c-12" decimals="3" id="f-1348" unitRef="number">0.042</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets contextRef="c-13" decimals="3" id="f-1349" unitRef="number">0.031</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease contextRef="c-1" decimals="3" id="f-1350" unitRef="number">0.030</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease contextRef="c-12" decimals="3" id="f-1351" unitRef="number">0.030</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease contextRef="c-13" decimals="3" id="f-1352" unitRef="number">0.026</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations contextRef="c-1" decimals="3" id="f-1353" unitRef="number">0.029</syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations>
    <syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations contextRef="c-12" decimals="3" id="f-1354" unitRef="number">0.028</syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations>
    <syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations contextRef="c-13" decimals="3" id="f-1355" unitRef="number">0.033</syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations>
    <us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock contextRef="c-1" id="f-1356">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.474%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.396%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(826)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&#x2014;other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current liabilities&#x2014;accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pre-tax amounts recognized in AOCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unrecognized net actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-14" decimals="-6" id="f-1357" unitRef="usd">492000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-15" decimals="-6" id="f-1358" unitRef="usd">485000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-14" decimals="-6" id="f-1359" unitRef="usd">782000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-15" decimals="-6" id="f-1360" unitRef="usd">826000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-14" decimals="-6" id="f-1361" unitRef="usd">-290000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-15" decimals="-6" id="f-1362" unitRef="usd">-341000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-382" decimals="-6" id="f-1363" unitRef="usd">48000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-383" decimals="-6" id="f-1364" unitRef="usd">21000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-384" decimals="-6" id="f-1365" unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-385" decimals="-6" id="f-1366" unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-386" decimals="-6" id="f-1367" unitRef="usd">-335000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-387" decimals="-6" id="f-1368" unitRef="usd">-359000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax contextRef="c-388" decimals="-6" id="f-1369" unitRef="usd">-6000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax contextRef="c-389" decimals="-6" id="f-1370" unitRef="usd">39000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax contextRef="c-388" decimals="-6" id="f-1371" unitRef="usd">8000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax contextRef="c-389" decimals="-6" id="f-1372" unitRef="usd">11000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax contextRef="c-14" decimals="-6" id="f-1373" unitRef="usd">14000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax contextRef="c-15" decimals="-6" id="f-1374" unitRef="usd">-28000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock contextRef="c-1" id="f-1375">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.474%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.396%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Change in Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;826&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;673&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial (gains) losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;782&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;826&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending accumulated benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;748&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;790&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-15" decimals="-6" id="f-1376" unitRef="usd">826000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-43" decimals="-6" id="f-1377" unitRef="usd">673000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-1" decimals="-6" id="f-1378" unitRef="usd">39000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-12" decimals="-6" id="f-1379" unitRef="usd">32000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-1" decimals="-6" id="f-1380" unitRef="usd">21000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-12" decimals="-6" id="f-1381" unitRef="usd">23000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="c-1" decimals="-6" id="f-1382" unitRef="usd">-52000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="c-12" decimals="-6" id="f-1383" unitRef="usd">32000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant contextRef="c-1" decimals="-6" id="f-1384" unitRef="usd">7000000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant contextRef="c-12" decimals="-6" id="f-1385" unitRef="usd">7000000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-1" decimals="-6" id="f-1386" unitRef="usd">40000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-12" decimals="-6" id="f-1387" unitRef="usd">-79000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid contextRef="c-1" decimals="-6" id="f-1388" unitRef="usd">19000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid contextRef="c-12" decimals="-6" id="f-1389" unitRef="usd">20000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-14" decimals="-6" id="f-1390" unitRef="usd">782000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-15" decimals="-6" id="f-1391" unitRef="usd">826000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation contextRef="c-14" decimals="-6" id="f-1392" unitRef="usd">748000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation contextRef="c-15" decimals="-6" id="f-1393" unitRef="usd">790000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock contextRef="c-1" id="f-1394">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.474%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.396%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Change in Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;420&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actual return&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;492&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.329%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.220%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.220%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.220%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.511%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Valuation of Plan Assets &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;404&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;57&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;492&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent contextRef="c-15" decimals="-6" id="f-1395" unitRef="usd">485000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent contextRef="c-43" decimals="-6" id="f-1396" unitRef="usd">420000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-1" decimals="-6" id="f-1397" unitRef="usd">22000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-12" decimals="-6" id="f-1398" unitRef="usd">29000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-1" decimals="-6" id="f-1399" unitRef="usd">23000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-12" decimals="-6" id="f-1400" unitRef="usd">23000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant contextRef="c-1" decimals="-6" id="f-1401" unitRef="usd">7000000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant contextRef="c-12" decimals="-6" id="f-1402" unitRef="usd">7000000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss contextRef="c-1" decimals="-6" id="f-1403" unitRef="usd">-31000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss contextRef="c-12" decimals="-6" id="f-1404" unitRef="usd">22000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid contextRef="c-1" decimals="-6" id="f-1405" unitRef="usd">14000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid contextRef="c-12" decimals="-6" id="f-1406" unitRef="usd">16000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent contextRef="c-14" decimals="-6" id="f-1407" unitRef="usd">492000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent contextRef="c-15" decimals="-6" id="f-1408" unitRef="usd">485000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock contextRef="c-1" id="f-1409">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.770%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.649%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.649%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.240%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.652%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Allocation of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025 Target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024 Actual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023 Actual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="c-390"
      decimals="2"
      id="f-1410"
      unitRef="number">0.24</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-390"
      decimals="2"
      id="f-1411"
      unitRef="number">0.28</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-391"
      decimals="2"
      id="f-1412"
      unitRef="number">0.28</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="c-392"
      decimals="2"
      id="f-1413"
      unitRef="number">0.44</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-392"
      decimals="2"
      id="f-1414"
      unitRef="number">0.40</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-393"
      decimals="2"
      id="f-1415"
      unitRef="number">0.37</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="c-394"
      decimals="2"
      id="f-1416"
      unitRef="number">0.32</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-394"
      decimals="2"
      id="f-1417"
      unitRef="number">0.32</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-395"
      decimals="2"
      id="f-1418"
      unitRef="number">0.35</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="c-14"
      decimals="INF"
      id="f-1419"
      unitRef="number">1</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-14"
      decimals="INF"
      id="f-1420"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-15"
      decimals="INF"
      id="f-1421"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-396" decimals="-6" id="f-1422" unitRef="usd">17000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-397" decimals="-6" id="f-1423" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-398" decimals="-6" id="f-1424" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-399" decimals="-6" id="f-1425" unitRef="usd">17000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-400" decimals="-6" id="f-1426" unitRef="usd">8000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-401" decimals="-6" id="f-1427" unitRef="usd">125000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-402" decimals="-6" id="f-1428" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-390" decimals="-6" id="f-1429" unitRef="usd">133000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-403" decimals="-6" id="f-1430" unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-404" decimals="-6" id="f-1431" unitRef="usd">203000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-405" decimals="-6" id="f-1432" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-406" decimals="-6" id="f-1433" unitRef="usd">205000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-407" decimals="-6" id="f-1434" unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-408" decimals="-6" id="f-1435" unitRef="usd">76000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-409" decimals="-6" id="f-1436" unitRef="usd">57000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-410" decimals="-6" id="f-1437" unitRef="usd">137000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-175" decimals="-6" id="f-1438" unitRef="usd">31000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-185" decimals="-6" id="f-1439" unitRef="usd">404000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-193" decimals="-6" id="f-1440" unitRef="usd">57000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-14" decimals="-6" id="f-1441" unitRef="usd">492000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-411" decimals="-6" id="f-1442" unitRef="usd">15000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-412" decimals="-6" id="f-1443" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-413" decimals="-6" id="f-1444" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-414" decimals="-6" id="f-1445" unitRef="usd">15000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-415" decimals="-6" id="f-1446" unitRef="usd">20000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-416" decimals="-6" id="f-1447" unitRef="usd">130000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-417" decimals="-6" id="f-1448" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-391" decimals="-6" id="f-1449" unitRef="usd">150000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-418" decimals="-6" id="f-1450" unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-419" decimals="-6" id="f-1451" unitRef="usd">185000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-420" decimals="-6" id="f-1452" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-421" decimals="-6" id="f-1453" unitRef="usd">187000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-422" decimals="-6" id="f-1454" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-423" decimals="-6" id="f-1455" unitRef="usd">63000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-424" decimals="-6" id="f-1456" unitRef="usd">65000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-425" decimals="-6" id="f-1457" unitRef="usd">133000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-176" decimals="-6" id="f-1458" unitRef="usd">42000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-186" decimals="-6" id="f-1459" unitRef="usd">378000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-189" decimals="-6" id="f-1460" unitRef="usd">65000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-15" decimals="-6" id="f-1461" unitRef="usd">485000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-191" decimals="-6" id="f-1462" unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear contextRef="c-193" decimals="-6" id="f-1463" unitRef="usd">21000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock contextRef="c-1" id="f-1464">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Estimated Future Benefit Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2030-2034&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths contextRef="c-14" decimals="-6" id="f-1465" unitRef="usd">24000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo contextRef="c-14" decimals="-6" id="f-1466" unitRef="usd">23000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree contextRef="c-14" decimals="-6" id="f-1467" unitRef="usd">25000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour contextRef="c-14" decimals="-6" id="f-1468" unitRef="usd">26000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive contextRef="c-14" decimals="-6" id="f-1469" unitRef="usd">27000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter contextRef="c-14" decimals="-6" id="f-1470" unitRef="usd">171000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="c-1" id="f-1471">SUMMARY OF QUARTERLY DATA (UNAUDITED)&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.031%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.368%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024 Quarters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Mar 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Jun&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Sep 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Dec 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,243&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,422&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,494&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,436&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;788&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;825&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;834&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;546&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings per share of common stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dividends declared per share of common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023 Quarters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Mar 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Jun&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Sep 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Dec 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,996&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,909&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;592&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;738&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,143&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings per share of common stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dividends declared per share of common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="c-1" id="f-1472">&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.031%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.368%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024 Quarters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Mar 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Jun&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Sep 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Dec 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,243&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,422&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,494&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,436&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;788&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;825&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;834&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;546&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings per share of common stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dividends declared per share of common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023 Quarters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Mar 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Jun&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Sep 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Dec 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,996&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,909&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;592&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;738&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,143&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings per share of common stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dividends declared per share of common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:Revenues contextRef="c-426" decimals="-6" id="f-1473" unitRef="usd">5243000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-427" decimals="-6" id="f-1474" unitRef="usd">5422000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-428" decimals="-6" id="f-1475" unitRef="usd">5494000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-429" decimals="-6" id="f-1476" unitRef="usd">6436000000</us-gaap:Revenues>
    <us-gaap:GrossProfit contextRef="c-426" decimals="-6" id="f-1477" unitRef="usd">3333000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-427" decimals="-6" id="f-1478" unitRef="usd">3416000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-428" decimals="-6" id="f-1479" unitRef="usd">3517000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-429" decimals="-6" id="f-1480" unitRef="usd">4174000000</us-gaap:GrossProfit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-426" decimals="-6" id="f-1481" unitRef="usd">923000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-427" decimals="-6" id="f-1482" unitRef="usd">998000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-428" decimals="-6" id="f-1483" unitRef="usd">1043000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-429" decimals="-6" id="f-1484" unitRef="usd">528000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-426" decimals="-6" id="f-1485" unitRef="usd">788000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-427" decimals="-6" id="f-1486" unitRef="usd">825000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-428" decimals="-6" id="f-1487" unitRef="usd">834000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-429" decimals="-6" id="f-1488" unitRef="usd">546000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-426"
      decimals="2"
      id="f-1489"
      unitRef="usdPerShare">2.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-427"
      decimals="2"
      id="f-1490"
      unitRef="usdPerShare">2.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-428"
      decimals="2"
      id="f-1491"
      unitRef="usdPerShare">2.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-429"
      decimals="2"
      id="f-1492"
      unitRef="usdPerShare">1.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-426"
      decimals="2"
      id="f-1493"
      unitRef="usdPerShare">2.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-427"
      decimals="2"
      id="f-1494"
      unitRef="usdPerShare">2.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-428"
      decimals="2"
      id="f-1495"
      unitRef="usdPerShare">2.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-429"
      decimals="2"
      id="f-1496"
      unitRef="usdPerShare">1.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-426"
      decimals="INF"
      id="f-1497"
      unitRef="usdPerShare">0.80</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-427"
      decimals="INF"
      id="f-1498"
      unitRef="usdPerShare">0.80</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-428"
      decimals="INF"
      id="f-1499"
      unitRef="usdPerShare">0.80</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-429"
      decimals="INF"
      id="f-1500"
      unitRef="usdPerShare">0.84</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Revenues contextRef="c-430" decimals="-6" id="f-1501" unitRef="usd">4778000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-431" decimals="-6" id="f-1502" unitRef="usd">4996000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-432" decimals="-6" id="f-1503" unitRef="usd">4909000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-433" decimals="-6" id="f-1504" unitRef="usd">5815000000</us-gaap:Revenues>
    <us-gaap:GrossProfit contextRef="c-430" decimals="-6" id="f-1505" unitRef="usd">3016000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-431" decimals="-6" id="f-1506" unitRef="usd">3181000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-432" decimals="-6" id="f-1507" unitRef="usd">3158000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-433" decimals="-6" id="f-1508" unitRef="usd">3703000000</us-gaap:GrossProfit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-430" decimals="-6" id="f-1509" unitRef="usd">679000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-431" decimals="-6" id="f-1510" unitRef="usd">899000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-432" decimals="-6" id="f-1511" unitRef="usd">869000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-433" decimals="-6" id="f-1512" unitRef="usd">1226000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-430" decimals="-6" id="f-1513" unitRef="usd">592000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-431" decimals="-6" id="f-1514" unitRef="usd">738000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-432" decimals="-6" id="f-1515" unitRef="usd">692000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-433" decimals="-6" id="f-1516" unitRef="usd">1143000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-430"
      decimals="2"
      id="f-1517"
      unitRef="usdPerShare">1.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-431"
      decimals="2"
      id="f-1518"
      unitRef="usdPerShare">1.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-432"
      decimals="2"
      id="f-1519"
      unitRef="usdPerShare">1.82</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-433"
      decimals="2"
      id="f-1520"
      unitRef="usdPerShare">3.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-430"
      decimals="2"
      id="f-1521"
      unitRef="usdPerShare">1.54</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-431"
      decimals="2"
      id="f-1522"
      unitRef="usdPerShare">1.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-432"
      decimals="2"
      id="f-1523"
      unitRef="usdPerShare">1.80</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-433"
      decimals="2"
      id="f-1524"
      unitRef="usdPerShare">2.98</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-430"
      decimals="INF"
      id="f-1525"
      unitRef="usdPerShare">0.75</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-431"
      decimals="INF"
      id="f-1526"
      unitRef="usdPerShare">0.75</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-432"
      decimals="INF"
      id="f-1527"
      unitRef="usdPerShare">0.75</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-433"
      decimals="INF"
      id="f-1528"
      unitRef="usdPerShare">0.80</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-1529">SEGMENT AND GEOGRAPHIC DATA&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On January 1, 2024 we adopted ASU 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; which expands disclosure requirements to require entities to disclose significant segment expenses that are regularly provided to or easily computed from information regularly provided to the chief operating decision maker. We have updated our disclosures to include our significant segment expenses that are regularly provided to our chief operating decision maker (CODM).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We segregate our operations into two reportable business segments: (i) MedSurg and Neurotechnology and (ii) Orthopaedics which aligns to our internal reporting structure and how our CODM assesses the performance of and allocates resources. The CODM is the Chief Executive Officer. The CODM makes decisions on resource allocation, assesses performance of the business, and monitors budget versus actual results using segment operating income. Our reportable segments and related disclosures reflect certain reclassifications of prior year amounts from our Orthopaedics segment to our MedSurg and Neurotechnology segment due to changes in our internal reporting structure.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Corporate and Other category shown in the table below includes corporate and administration, corporate initiatives and share-based compensation, which includes compensation related to employee stock options, restricted stock units and performance stock unit grants and director stock options and restricted stock unit grants.&lt;/span&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.334%"&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.203%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Results&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,595&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,498&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,449&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cost of sales &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,720&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,130&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,557&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Segment research, development and engineering expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,324&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,210&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Segment selling, general and administrative expenses &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,314&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,856&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,172&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Segment depreciation and amortization &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;641&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;567&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;528&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,426&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,341&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,278&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,595&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,033&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Items not allocated to segments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Inventory stepped up to fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisition and integration-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Structural optimization and other special charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(295)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill and other impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(977)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical device regulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recall-related matters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Regulatory and legal matters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,689&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,888&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,841&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.221%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.693%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.949%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.693%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.949%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Assets and Capital Spending&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;41,622&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;38,827&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;42,971&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;39,912&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchases of property, plant and equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total segment purchases of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;506&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;362&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;348&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total purchases of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;755&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;575&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;588&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We measure the financial results of our reportable segments using an internal performance measure that excludes acquisition and integration-related charges, structural optimization and other special charges, goodwill and other impairments, reserves for certain product recall matters and reserves for certain legal and regulatory matters. Identifiable assets are those assets used exclusively in the operations of each business segment or allocated when used jointly. Corporate assets are principally property, plant and equipment and noncurrent assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The countries in which we have local revenue generating operations have been combined into the following geographic areas: the United States; Europe, Middle East, Africa; Asia Pacific; and other foreign countries, which include Canada and countries in the Latin American region. Net sales are reported based on the geographic area of the Stryker location where the sales to the customer originated. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.762%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.693%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.949%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.693%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.949%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.693%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.693%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.696%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Geographic Information&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Property, Plant and Equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Europe, Middle East, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,595&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,498&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,449&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,448&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,215&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-1530"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock contextRef="c-1" id="f-1531">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.203%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Results&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,595&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,498&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,449&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cost of sales &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,720&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,130&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,557&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Segment research, development and engineering expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,324&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,210&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Segment selling, general and administrative expenses &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,314&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,856&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,172&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Segment depreciation and amortization &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;641&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;567&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;528&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,426&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,341&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,278&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,595&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,033&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Items not allocated to segments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Inventory stepped up to fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisition and integration-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Structural optimization and other special charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(295)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill and other impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(977)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical device regulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recall-related matters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Regulatory and legal matters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,689&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,888&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,841&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:Revenues contextRef="c-434" decimals="-6" id="f-1532" unitRef="usd">13518000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-435" decimals="-6" id="f-1533" unitRef="usd">12163000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-436" decimals="-6" id="f-1534" unitRef="usd">10893000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-437" decimals="-6" id="f-1535" unitRef="usd">9077000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-438" decimals="-6" id="f-1536" unitRef="usd">8335000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-439" decimals="-6" id="f-1537" unitRef="usd">7556000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-440" decimals="-6" id="f-1538" unitRef="usd">22595000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-441" decimals="-3" id="f-1539" unitRef="usd">20498000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-442" decimals="-3" id="f-1540" unitRef="usd">18449000000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue contextRef="c-434" decimals="-6" id="f-1541" unitRef="usd">5320000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-435" decimals="-6" id="f-1542" unitRef="usd">4876000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-436" decimals="-6" id="f-1543" unitRef="usd">4637000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-437" decimals="-6" id="f-1544" unitRef="usd">2400000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-438" decimals="-6" id="f-1545" unitRef="usd">2254000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-439" decimals="-6" id="f-1546" unitRef="usd">1920000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-440" decimals="-6" id="f-1547" unitRef="usd">7720000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-441" decimals="-6" id="f-1548" unitRef="usd">7130000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-442" decimals="-6" id="f-1549" unitRef="usd">6557000000</us-gaap:CostOfRevenue>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-434" decimals="-6" id="f-1550" unitRef="usd">784000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-435" decimals="-6" id="f-1551" unitRef="usd">702000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-436" decimals="-6" id="f-1552" unitRef="usd">682000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-437" decimals="-6" id="f-1553" unitRef="usd">540000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-438" decimals="-6" id="f-1554" unitRef="usd">508000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-439" decimals="-6" id="f-1555" unitRef="usd">477000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-440" decimals="-6" id="f-1556" unitRef="usd">1324000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-441" decimals="-6" id="f-1557" unitRef="usd">1210000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-442" decimals="-6" id="f-1558" unitRef="usd">1159000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-434" decimals="-6" id="f-1559" unitRef="usd">3203000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-435" decimals="-6" id="f-1560" unitRef="usd">2934000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-436" decimals="-6" id="f-1561" unitRef="usd">2564000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-437" decimals="-6" id="f-1562" unitRef="usd">3111000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-438" decimals="-6" id="f-1563" unitRef="usd">2922000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-439" decimals="-6" id="f-1564" unitRef="usd">2608000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-440" decimals="-6" id="f-1565" unitRef="usd">6314000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-441" decimals="-6" id="f-1566" unitRef="usd">5856000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-442" decimals="-6" id="f-1567" unitRef="usd">5172000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-434" decimals="-6" id="f-1568" unitRef="usd">208000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-435" decimals="-6" id="f-1569" unitRef="usd">181000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-436" decimals="-6" id="f-1570" unitRef="usd">178000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-437" decimals="-6" id="f-1571" unitRef="usd">433000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-438" decimals="-6" id="f-1572" unitRef="usd">386000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-439" decimals="-6" id="f-1573" unitRef="usd">350000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-440" decimals="-6" id="f-1574" unitRef="usd">641000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-441" decimals="-6" id="f-1575" unitRef="usd">567000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-442" decimals="-6" id="f-1576" unitRef="usd">528000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-443" decimals="-6" id="f-1577" unitRef="usd">162000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-444" decimals="-6" id="f-1578" unitRef="usd">139000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-445" decimals="-6" id="f-1579" unitRef="usd">123000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-440" decimals="-6" id="f-1580" unitRef="usd">623000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-441" decimals="-6" id="f-1581" unitRef="usd">635000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-442" decimals="-6" id="f-1582" unitRef="usd">627000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-6" id="f-1583" unitRef="usd">1426000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-12" decimals="-6" id="f-1584" unitRef="usd">1341000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-13" decimals="-6" id="f-1585" unitRef="usd">1278000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OperatingIncomeLoss contextRef="c-434" decimals="-6" id="f-1586" unitRef="usd">4004000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-435" decimals="-6" id="f-1587" unitRef="usd">3470000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-436" decimals="-6" id="f-1588" unitRef="usd">2831000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-437" decimals="-6" id="f-1589" unitRef="usd">2591000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-438" decimals="-6" id="f-1590" unitRef="usd">2265000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-439" decimals="-6" id="f-1591" unitRef="usd">2202000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-440" decimals="-6" id="f-1592" unitRef="usd">6595000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-441" decimals="-6" id="f-1593" unitRef="usd">5735000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-442" decimals="-6" id="f-1594" unitRef="usd">5033000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="c-443" decimals="-6" id="f-1595" unitRef="usd">-880000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="c-444" decimals="-6" id="f-1596" unitRef="usd">-780000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="c-445" decimals="-6" id="f-1597" unitRef="usd">-649000000</us-gaap:IncomeLossFromContinuingOperations>
    <syk:InventorySteppedUpToFairValueAtAcquisition contextRef="c-446" decimals="-6" id="f-1598" unitRef="usd">46000000</syk:InventorySteppedUpToFairValueAtAcquisition>
    <syk:InventorySteppedUpToFairValueAtAcquisition contextRef="c-447" decimals="-6" id="f-1599" unitRef="usd">0</syk:InventorySteppedUpToFairValueAtAcquisition>
    <syk:InventorySteppedUpToFairValueAtAcquisition contextRef="c-448" decimals="-6" id="f-1600" unitRef="usd">0</syk:InventorySteppedUpToFairValueAtAcquisition>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-446" decimals="-6" id="f-1601" unitRef="usd">108000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-447" decimals="-6" id="f-1602" unitRef="usd">20000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-448" decimals="-6" id="f-1603" unitRef="usd">138000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-6" id="f-1604" unitRef="usd">623000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-12" decimals="-6" id="f-1605" unitRef="usd">635000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-13" decimals="-6" id="f-1606" unitRef="usd">627000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RestructuringCosts contextRef="c-446" decimals="-6" id="f-1607" unitRef="usd">138000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-447" decimals="-6" id="f-1608" unitRef="usd">170000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-448" decimals="-6" id="f-1609" unitRef="usd">295000000</us-gaap:RestructuringCosts>
    <us-gaap:AssetImpairmentCharges contextRef="c-1" decimals="-6" id="f-1610" unitRef="usd">977000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-12" decimals="-6" id="f-1611" unitRef="usd">36000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-13" decimals="-6" id="f-1612" unitRef="usd">270000000</us-gaap:AssetImpairmentCharges>
    <syk:MedicalDeviceRegulationsExpense contextRef="c-446" decimals="-6" id="f-1613" unitRef="usd">58000000</syk:MedicalDeviceRegulationsExpense>
    <syk:MedicalDeviceRegulationsExpense contextRef="c-447" decimals="-6" id="f-1614" unitRef="usd">96000000</syk:MedicalDeviceRegulationsExpense>
    <syk:MedicalDeviceRegulationsExpense contextRef="c-448" decimals="-6" id="f-1615" unitRef="usd">140000000</syk:MedicalDeviceRegulationsExpense>
    <syk:RejuvenateABGIIHipRecallCharges contextRef="c-446" decimals="-6" id="f-1616" unitRef="usd">40000000</syk:RejuvenateABGIIHipRecallCharges>
    <syk:RejuvenateABGIIHipRecallCharges contextRef="c-447" decimals="-6" id="f-1617" unitRef="usd">18000000</syk:RejuvenateABGIIHipRecallCharges>
    <syk:RejuvenateABGIIHipRecallCharges contextRef="c-448" decimals="-6" id="f-1618" unitRef="usd">-15000000</syk:RejuvenateABGIIHipRecallCharges>
    <us-gaap:LegalFees contextRef="c-446" decimals="-6" id="f-1619" unitRef="usd">36000000</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="c-447" decimals="-6" id="f-1620" unitRef="usd">92000000</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="c-448" decimals="-6" id="f-1621" unitRef="usd">76000000</us-gaap:LegalFees>
    <us-gaap:NetIncomeLoss contextRef="c-446" decimals="-6" id="f-1622" unitRef="usd">3689000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-447" decimals="-6" id="f-1623" unitRef="usd">3888000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-448" decimals="-6" id="f-1624" unitRef="usd">2841000000</us-gaap:NetIncomeLoss>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-1625">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.221%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.693%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.949%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.693%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.949%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Assets and Capital Spending&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;41,622&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;38,827&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;42,971&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;39,912&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchases of property, plant and equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total segment purchases of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;506&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;362&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;348&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total purchases of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;755&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;575&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;588&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Assets contextRef="c-449" decimals="-6" id="f-1626" unitRef="usd">23115000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-450" decimals="-6" id="f-1627" unitRef="usd">20804000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-451" decimals="-6" id="f-1628" unitRef="usd">18507000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-452" decimals="-6" id="f-1629" unitRef="usd">18023000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-453" decimals="-6" id="f-1630" unitRef="usd">41622000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-454" decimals="-6" id="f-1631" unitRef="usd">38827000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-455" decimals="-6" id="f-1632" unitRef="usd">1349000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-456" decimals="-6" id="f-1633" unitRef="usd">1085000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-14" decimals="-6" id="f-1634" unitRef="usd">42971000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-15" decimals="-6" id="f-1635" unitRef="usd">39912000000</us-gaap:Assets>
    <syk:CapitalExpendituresDuringPeriod contextRef="c-437" decimals="-6" id="f-1636" unitRef="usd">230000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod contextRef="c-438" decimals="-6" id="f-1637" unitRef="usd">179000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod contextRef="c-439" decimals="-6" id="f-1638" unitRef="usd">173000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod contextRef="c-434" decimals="-6" id="f-1639" unitRef="usd">276000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod contextRef="c-435" decimals="-6" id="f-1640" unitRef="usd">183000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod contextRef="c-436" decimals="-6" id="f-1641" unitRef="usd">175000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod contextRef="c-440" decimals="-6" id="f-1642" unitRef="usd">506000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod contextRef="c-441" decimals="-6" id="f-1643" unitRef="usd">362000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod contextRef="c-442" decimals="-6" id="f-1644" unitRef="usd">348000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod contextRef="c-443" decimals="-6" id="f-1645" unitRef="usd">249000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod contextRef="c-444" decimals="-6" id="f-1646" unitRef="usd">213000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod contextRef="c-445" decimals="-6" id="f-1647" unitRef="usd">240000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod contextRef="c-1" decimals="-6" id="f-1648" unitRef="usd">755000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod contextRef="c-12" decimals="-6" id="f-1649" unitRef="usd">575000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod contextRef="c-13" decimals="-6" id="f-1650" unitRef="usd">588000000</syk:CapitalExpendituresDuringPeriod>
    <us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock contextRef="c-1" id="f-1651">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.762%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.693%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.949%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.693%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.949%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.693%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.693%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.696%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Geographic Information&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Property, Plant and Equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Europe, Middle East, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,595&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,498&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,449&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,448&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,215&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock>
    <us-gaap:Revenues contextRef="c-132" decimals="-6" id="f-1652" unitRef="usd">16943000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-133" decimals="-6" id="f-1653" unitRef="usd">15257000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-134" decimals="-6" id="f-1654" unitRef="usd">13638000000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-457" decimals="-6" id="f-1655" unitRef="usd">1997000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-458" decimals="-6" id="f-1656" unitRef="usd">1874000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues contextRef="c-459" decimals="-6" id="f-1657" unitRef="usd">2897000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-460" decimals="-6" id="f-1658" unitRef="usd">2618000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-461" decimals="-6" id="f-1659" unitRef="usd">2348000000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-462" decimals="-6" id="f-1660" unitRef="usd">1260000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-463" decimals="-6" id="f-1661" unitRef="usd">1151000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues contextRef="c-464" decimals="-6" id="f-1662" unitRef="usd">2020000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-465" decimals="-6" id="f-1663" unitRef="usd">1946000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-466" decimals="-6" id="f-1664" unitRef="usd">1885000000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-467" decimals="-6" id="f-1665" unitRef="usd">75000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-468" decimals="-6" id="f-1666" unitRef="usd">77000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues contextRef="c-469" decimals="-6" id="f-1667" unitRef="usd">735000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-470" decimals="-6" id="f-1668" unitRef="usd">677000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-471" decimals="-6" id="f-1669" unitRef="usd">578000000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-472" decimals="-6" id="f-1670" unitRef="usd">116000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-473" decimals="-6" id="f-1671" unitRef="usd">113000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues contextRef="c-1" decimals="-6" id="f-1672" unitRef="usd">22595000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-12" decimals="-6" id="f-1673" unitRef="usd">20498000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-13" decimals="-6" id="f-1674" unitRef="usd">18449000000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-14" decimals="-6" id="f-1675" unitRef="usd">3448000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-15" decimals="-6" id="f-1676" unitRef="usd">3215000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AssetImpairmentChargesTextBlock contextRef="c-1" id="f-1677">ASSET IMPAIRMENTSDuring 2024, 2023 and 2022 we recorded impairment charges of $159, $36 and $54 to write off long-lived and intangible assets excluding long-lived assets held for sale which included charges related to certain product line exits</us-gaap:AssetImpairmentChargesTextBlock>
    <us-gaap:AssetImpairmentCharges contextRef="c-474" decimals="-6" id="f-1678" unitRef="usd">159000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-475" decimals="-6" id="f-1679" unitRef="usd">36000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-476" decimals="-6" id="f-1680" unitRef="usd">54000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock contextRef="c-1" id="f-1681">ASSETS HELD FOR SALE&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the fourth quarter 2024 management committed to a plan to sell certain assets associated with the Spinal Implants business and such assets were classified as held for sale beginning November 2024. As a result we recognized an estimated loss of $362 to record the disposal group at its fair value less cost to sell within goodwill and other impairments in our Consolidated Statements of Earnings. The fair value of the disposal group was measured using a discounted cash flow analysis based upon unobservable inputs, such as estimated selling price derived from Company-specific information, market conditions and the rate used to discount the estimated future cash flows to their present value based on factors including the disposal group&#x2019;s cost of equity and market yield rates, which are Level 3 inputs. Future changes in the judgments, assumptions and estimates that are used in our fair value estimate, including discount rates and cash flow projections, could result in a significantly different estimate of fair value. In January 2025 we entered into a definitive agreement to sell the Spinal Implants disposal group as further discussed in Note 17. The terms of the definitive agreement were materially the same as those considered as inputs to the valuation of the disposal group at December 31, 2024. A change in the amount or timing of consideration received could increase the fair value by up to $84 or decrease the fair value by up to $218.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A valuation allowance was recorded to reflect the estimated loss on the disposal group. The assets associated with the Spinal Implants disposal group are reported in our Orthopaedics segment. The assets and liabilities held for sale are classified within prepaid expenses and other current assets and accrued expenses and other liabilities in our Consolidated Balance Sheets and included the following as of December 31, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total inventories &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;183&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;51&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other intangibles, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;326&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;171&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Valuation allowance &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total assets held for sale &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accounts payable &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accrued compensation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;104&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax contextRef="c-477" decimals="-6" id="f-1682" unitRef="usd">-362000000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <syk:DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue contextRef="c-478" decimals="-6" id="f-1683" unitRef="usd">84000000</syk:DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialIncreaseInFairValue>
    <syk:DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue contextRef="c-478" decimals="-6" id="f-1684" unitRef="usd">-218000000</syk:DisposalGroupIncludingDiscontinuedOperationTimingOfDisposalPotentialDecreaseInFairValue>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock contextRef="c-1" id="f-1685">The assets and liabilities held for sale are classified within prepaid expenses and other current assets and accrued expenses and other liabilities in our Consolidated Balance Sheets and included the following as of December 31, 2024:&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total inventories &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;183&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;51&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other intangibles, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;326&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;171&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Valuation allowance &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total assets held for sale &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accounts payable &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accrued compensation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;104&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet contextRef="c-478" decimals="-6" id="f-1686" unitRef="usd">62000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent contextRef="c-478" decimals="-6" id="f-1687" unitRef="usd">183000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent contextRef="c-478" decimals="-6" id="f-1688" unitRef="usd">10000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent contextRef="c-478" decimals="-6" id="f-1689" unitRef="usd">51000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent contextRef="c-478" decimals="-6" id="f-1690" unitRef="usd">326000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets contextRef="c-478" decimals="-6" id="f-1691" unitRef="usd">9000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets contextRef="c-478" decimals="-6" id="f-1692" unitRef="usd">171000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets>
    <syk:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent contextRef="c-478" decimals="-6" id="f-1693" unitRef="usd">362000000</syk:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-478" decimals="-6" id="f-1694" unitRef="usd">450000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent contextRef="c-478" decimals="-6" id="f-1695" unitRef="usd">28000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent>
    <syk:DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent contextRef="c-478" decimals="-6" id="f-1696" unitRef="usd">26000000</syk:DisposalGroupIncludingDiscontinuedOperationAccruedCompensationCurrent>
    <syk:DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent contextRef="c-478" decimals="-6" id="f-1697" unitRef="usd">29000000</syk:DisposalGroupIncludingDiscontinuedOperationAccruedExpensesAndOtherLiabilitiesCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities contextRef="c-478" decimals="-6" id="f-1698" unitRef="usd">21000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-478" decimals="-6" id="f-1699" unitRef="usd">104000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-1700">SUBSEQUENT EVENTS&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In January 2025 we announced a definitive merger agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. (Inari). Pursuant to the agreement we commenced a tender offer to purchase all of the outstanding shares of common stock of Inari for $80 per share in cash, or an aggregate purchase price of approximately $4.9&#160;billion. The boards of directors of both Stryker and Inari have unanimously approved the transaction. We expect the acquisition to close in the first quarter of 2025, subject to completion of the tender offer and other customary closing conditions. Inari&#x2019;s product portfolio includes mechanical thrombectomy solutions for peripheral vascular diseases such as deep vein thrombosis and pulmonary embolism. Following closing, we plan to integrate Inari into our MedSurg and Neurotechnology segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In January 2025 we announced a definitive agreement to sell our United States Spinal Implants business to Viscogliosi Brothers, LLC. The definitive agreement includes a binding offer to sell our Spinal Implants business in France, subject to required consultations with employees and employee representatives. We expect the sale of the United States business to close in the first half of 2025, subject to customary closing conditions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In February 2025 we issued $500 of 4.550% senior unsecured notes due February 10, 2027, $700 of 4.700% senior unsecured notes due February 10, 2028, $800 of 4.850% senior unsecured notes due February 10, 2030 and $1,000 of 5.200% senior unsecured notes due February 10, 2035. We intend to use the net proceeds from the notes due in 2030 and 2035, together with cash on hand or other immediately available funds, to consummate the Inari Tender Offer and to pay related fees and expenses. We intend to use the net proceeds from the notes due in 2027 and 2028 for general corporate purposes, which may include working capital, other acquisitions  and repayment of indebtedness.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="c-479"
      decimals="0"
      id="f-1701"
      unitRef="usdPerShare">80</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationPriceOfAcquisitionExpected contextRef="c-480" decimals="-8" id="f-1702" unitRef="usd">4900000000</us-gaap:BusinessCombinationPriceOfAcquisitionExpected>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-481" decimals="-6" id="f-1703" unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-481"
      decimals="5"
      id="f-1704"
      unitRef="number">0.04550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-482" decimals="-6" id="f-1705" unitRef="usd">700000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-482"
      decimals="5"
      id="f-1706"
      unitRef="number">0.04700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-483" decimals="-6" id="f-1707" unitRef="usd">800000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-483"
      decimals="5"
      id="f-1708"
      unitRef="number">0.04850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-484" decimals="-6" id="f-1709" unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-484"
      decimals="5"
      id="f-1710"
      unitRef="number">0.05200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-429" id="f-1711">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-429" id="f-1712">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-429" id="f-1713">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-429" id="f-1714">false</ecd:NonRule10b51ArrAdoptedFlag>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock contextRef="c-1" id="f-1715">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.478%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.254%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.754%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&#160;1.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The following Consolidated Financial Statements are set forth in Part II, Item 8 of this report.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Report of Independent Registered Public Accounting Firm&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&lt;a href="#i1442ddc197954361b38cabd10df2e256_79" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;25&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated Statements of Earnings for 2024, 2023 and 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&lt;a href="#i1442ddc197954361b38cabd10df2e256_82" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;26&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated Statements of Comprehensive Income for 2024, 2023 and 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&lt;a href="#i1442ddc197954361b38cabd10df2e256_88" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;26&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated Balance Sheets on 2024 and 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&lt;a href="#i1442ddc197954361b38cabd10df2e256_91" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;27&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated Statements of Shareholders&#x2019; Equity for 2024, 2023 and 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&lt;a href="#i1442ddc197954361b38cabd10df2e256_94" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;28&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated Statements of Cash Flows for 2024, 2023 and 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&lt;a href="#i1442ddc197954361b38cabd10df2e256_97" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;29&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Notes to Consolidated Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&lt;a href="#i1442ddc197954361b38cabd10df2e256_100" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;30&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) 2.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financial Statement Schedules&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The Consolidated Financial Statement schedule of Stryker Corporation and its subsidiaries is:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Charged&#160;to&lt;br/&gt;Costs &amp;amp;&lt;br/&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Uncollectible Amounts Written Off, Net of Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect of Changes in Foreign Currency Exchange Rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&lt;br/&gt;at End&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;DEDUCTED FROM ASSET ACCOUNTS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Allowance for Doubtful Accounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ended December&#160;31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ended December&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ended December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other schedules for which provision is made in the applicable accounting regulation of the United States Securities and Exchange Commission are not required under the related instructions or are inapplicable and, therefore, have been omitted.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) 3.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exhibits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-485" decimals="-6" id="f-1716" unitRef="usd">182000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-486" decimals="-6" id="f-1717" unitRef="usd">69000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-486" decimals="-6" id="f-1718" unitRef="usd">36000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesAdjustments contextRef="c-486" decimals="-6" id="f-1719" unitRef="usd">2000000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-487" decimals="-6" id="f-1720" unitRef="usd">213000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-488" decimals="-6" id="f-1721" unitRef="usd">154000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-489" decimals="-6" id="f-1722" unitRef="usd">69000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-489" decimals="-6" id="f-1723" unitRef="usd">40000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesAdjustments contextRef="c-489" decimals="-6" id="f-1724" unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-485" decimals="-6" id="f-1725" unitRef="usd">182000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-490" decimals="-6" id="f-1726" unitRef="usd">167000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-491" decimals="-6" id="f-1727" unitRef="usd">41000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-491" decimals="-6" id="f-1728" unitRef="usd">52000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesAdjustments contextRef="c-491" decimals="-6" id="f-1729" unitRef="usd">2000000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-488" decimals="-6" id="f-1730" unitRef="usd">154000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-1731">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
